PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bai, XD; Mamidala, P; Rajarapu, SP; Jones, SC; Mittapalli, O				Bai, Xiaodong; Mamidala, Praveen; Rajarapu, Swapna P.; Jones, Susan C.; Mittapalli, Omprakash			Transcriptomics of the Bed Bug (Cimex lectularius)	PLOS ONE			English	Article							ARTHROPOD CUTICULAR PROTEINS; EXPRESSED SEQUENCE TAGS; PUBLIC-HEALTH PROBLEM; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; HEMIPTERA-CIMICIDAE; WOLBACHIA; GENES; EVOLUTION; DATABASE	Background: Bed bugs (Cimex lectularius) are blood-feeding insects poised to become one of the major pests in households throughout the United States. Resistance of C. lectularius to insecticides/pesticides is one factor thought to be involved in its sudden resurgence. Despite its high-impact status, scant knowledge exists at the genomic level for C. lectularius. Hence, we subjected the C. lectularius transcriptome to 454 pyrosequencing in order to identify potential genes involved in pesticide resistance. Methodology and Principal Findings: Using 454 pyrosequencing, we obtained a total of 216,419 reads with 79,596,412 bp, which were assembled into 35,646 expressed sequence tags (3902 contigs and 31744 singletons). Nearly 85.9% of the C. lectularius sequences showed similarity to insect sequences, but 44.8% of the deduced proteins of C. lectularius did not show similarity with sequences in the GenBank non-redundant database. KEGG analysis revealed putative members of several detoxification pathways involved in pesticide resistance. Lamprin domains, Protein Kinase domains, Protein Tyrosine Kinase domains and cytochrome P450 domains were among the top Pfam domains predicted for the C. lectularius sequences. An initial assessment of putative defense genes, including a cytochrome P450 and a glutathione-S-transferase (GST), revealed high transcript levels for the cytochrome P450 (CYP9) in pesticide-exposed versus pesticide-susceptible C. lectularius populations. A significant number of single nucleotide polymorphisms (296) and microsatellite loci (370) were predicted in the C. lectularius sequences. Furthermore, 59 putative sequences of Wolbachia were retrieved from the database. Conclusions: To our knowledge this is the first study to elucidate the genetic makeup of C. lectularius. This pyrosequencing effort provides clues to the identification of potential detoxification genes involved in pesticide resistance of C. lectularius and lays the foundation for future functional genomics studies.	[Bai, Xiaodong; Mamidala, Praveen; Rajarapu, Swapna P.; Mittapalli, Omprakash] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA; [Jones, Susan C.] Ohio State Univ, Dept Entomol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bai, XD (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	mittapalli.1@osu.edu	Rajarapu, Swapna Priya/H-3514-2019	Mamidala, Praveen/0000-0001-8587-0635	State and Federal funds	State and Federal funds	This research was supported by State and Federal funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Naser M, 2006, PARASITOL RES, V98, P550, DOI 10.1007/s00436-005-0076-9; Ahier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005651; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson AL, 2008, J ENVIRON HEALTH, V70, P24; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Barbehenn RV, 2002, J CHEM ECOL, V28, P1329, DOI 10.1023/A:1016288201110; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Benoit JB, 2009, MED VET ENTOMOL, V23, P418, DOI 10.1111/j.1365-2915.2009.00832.x; Boase C., 2001, Pesticide Outlook, V12, P159, DOI 10.1039/b106301b; Bochicchio B, 2001, MATRIX BIOL, V20, P243, DOI 10.1016/S0945-053X(01)00139-1; COGILL P, 2008, CURR PROTOC BIOINFOR, V2; COHEN MB, 1992, P NATL ACAD SCI USA, V89, P10920, DOI 10.1073/pnas.89.22.10920; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x; Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Gangloff-Kaufmann J., 2006, American Entomologist, V52, P105; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Goddard J., 2010, INFECT DIS ARTHROPOD, P177; Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; HAMODRAKAS SJ, 1988, PROTEIN ENG, V2, P201, DOI 10.1093/protein/2.3.201; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Hwang SW, 2005, EMERG INFECT DIS, V11, P533, DOI 10.3201/eid1104.041126; Jaworski DC, 2010, INSECT MOL BIOL, V19, P617, DOI 10.1111/j.1365-2583.2010.01037.x; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karunaratne SHPP, 2007, PESTIC BIOCHEM PHYS, V88, P102, DOI 10.1016/j.pestbp.2006.09.006; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Lee IY, 2008, KOREAN J PARASITOL, V46, P269, DOI 10.3347/kjp.2008.46.4.269; Leverkus M, 2006, J INVEST DERMATOL, V126, P91, DOI 10.1038/sj.jid.5700012; LEWIS RV, 1992, ACCOUNTS CHEM RES, V25, P392, DOI 10.1021/ar00021a002; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Magkrioti CK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-138; Maier D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-74; McNeil GP, 2001, GENETICS, V159, P229; Mittapalli O, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.2001; Mittapalli O, 2007, P NATL ACAD SCI USA, V104, P1889, DOI 10.1073/pnas.0604722104; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Moore DJ, 2006, J ECON ENTOMOL, V99, P2080, DOI 10.1603/0022-0493-99.6.2080; Myamba J, 2002, MED VET ENTOMOL, V16, P448, DOI 10.1046/j.1365-2915.2002.00389.x; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Ogura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008030; Olafson PU, 2010, ARCH INSECT BIOCHEM, V74, P179, DOI 10.1002/arch.20372; Panagiotakopulu E, 1999, ANTIQUITY, V73, P908, DOI 10.1017/S0003598X00065674; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Potter M. F., 2005, Pest Control Technology, V33, P82; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P1138, DOI 10.1016/j.ibmb.2007.07.001; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Reinhardt K, 2009, MED VET ENTOMOL, V23, P163, DOI 10.1111/j.1365-2915.2008.00793.x; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Rendahl KG, 1996, J NEUROSCI, V16, P1511; Rhodes JD, 1997, PHYSIOL ENTOMOL, V22, P373, DOI 10.1111/j.1365-3032.1997.tb01182.x; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robson P, 2000, MOL BIOL EVOL, V17, P1739, DOI 10.1093/oxfordjournals.molbev.a026272; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Rose RL, 1997, INSECT BIOCHEM MOLEC, V27, P605, DOI 10.1016/S0965-1748(97)00036-2; Rossi L, 2010, J ENVIRON HEALTH, V72, P34; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Scarupa MD, 2006, J ALLERGY CLIN IMMUN, V117, P1508, DOI 10.1016/j.jaci.2006.03.034; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Stanewsky R, 1996, GENETICS, V143, P259; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; Stibich AS, 2001, DERMATOLOGY, V202, P193, DOI 10.1159/000051635; Stucki A, 2008, NEW ENGL J MED, V359, P1047, DOI 10.1056/NEJMicm060268; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Ter Poorten MC, 2005, PEDIATR DERMATOL, V22, P183, DOI 10.1111/j.1525-1470.2005.22301.x; THURSTON MI, 2005, MSATFINDER DETECTION; TOMITA T, 1995, INSECT BIOCHEM MOLEC, V25, P275, DOI 10.1016/0965-1748(94)00066-Q; Usinger R., 1966, MONOGRAPH CIMICIDAE, V7; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang CL, 2010, J ECON ENTOMOL, V103, P172, DOI 10.1603/EC09230; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Werren JH, 1997, P NATL ACAD SCI USA, V94, P11154, DOI 10.1073/pnas.94.21.11154; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; WERREN JH, 1995, P ROY SOC LOND B BIO, V265, P1447; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009	94	123	139	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16336	10.1371/journal.pone.0016336	http://dx.doi.org/10.1371/journal.pone.0016336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283830	gold, Green Published, Green Submitted			2022-12-25	WOS:000286520600041
J	Munoz, P; Humeres, A; Elgueta, C; Kirkwood, A; Hidalgo, C; Nunez, MT				Munoz, Pablo; Humeres, Alexis; Elgueta, Claudio; Kirkwood, Alfredo; Hidalgo, Cecilia; Nunez, Marco T.			Iron Mediates N-Methyl-D-aspartate Receptor-dependent Stimulation of Calcium-induced Pathways and Hippocampal Synaptic Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; NMDA RECEPTOR; LASTING POTENTIATION; CREB PHOSPHORYLATION; MEMORY FUNCTION; NADPH OXIDASE; NITRIC-OXIDE; CA2+; ACTIVATION; DEFICIENCY	Iron deficiency hinders hippocampus-dependent learning processes and impairs cognitive performance, but current knowledge on the molecular mechanisms underlying the unique role of iron in neuronal function is sparse. Here, we investigated the participation of iron on calcium signal generation and ERK1/2 stimulation induced by the glutamate agonist N-methyl-D-aspartate (NMDA), and the effects of iron addition/chelation on hippocampal basal synaptic transmission and long-term potentiation (LTP). Addition of NMDA to primary hippocampal cultures elicited persistent calcium signals that required functional NMDA receptors and were independent of calcium influx through L-type calcium channels or alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors; NMDA also promoted ERK1/2 phosphorylation and nuclear translocation. Iron chelation with desferrioxamine or inhibition of ryanodine receptor (RyR)-mediated calcium release with ryanodine-reduced calcium signal duration and prevented NMDA-induced ERK1/2 activation. Iron addition to hippocampal neurons readily increased the intracellular labile iron pool and stimulated reactive oxygen species production; the antioxidant N-acetyl-cysteine or the hydroxyl radical trapper MCI-186 prevented these responses. Iron addition to primary hippocampal cultures kept in calcium-free medium elicited calcium signals and stimulated ERK1/2 phosphorylation; RyR inhibition abolished these effects. Iron chelation decreased basal synaptic transmission in hippocampal slices, inhibited iron-induced synaptic stimulation, and impaired sustained LIP in hippocampal CA1 neurons induced by strong stimulation. In contrast, iron addition facilitated sustained LTP induction after suboptimal tetanic stimulation. Together, these results suggest that hippocampal neurons require iron to generate RyR-mediated calcium signals after NMDA receptor stimulation, which in turn promotes ERK1/2 activation, an essential step of sustained LTP.	[Munoz, Pablo; Elgueta, Claudio] Univ Valparaiso, Ctr Neurociencia, Valparaiso 2360102, Chile; [Munoz, Pablo] Ctr Reg Estudios Alimentos Saludables, Valparaiso 2362696, Chile; [Humeres, Alexis; Hidalgo, Cecilia] Univ Chile, Fac Med, Ctr Estudios Mol Celula, Santiago 8380453, Chile; [Kirkwood, Alfredo] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA; [Hidalgo, Cecilia] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Fisiol & Biofis, Santiago 8389100, Chile; [Nunez, Marco T.] Univ Chile, Fac Ciencias, Dept Biol, Santiago 7800024, Chile; [Nunez, Marco T.] Univ Chile, Inst Cell Dynam & Biotechnol, Santiago 7800024, Chile	Universidad de Valparaiso; Universidad de Chile; Johns Hopkins University; Universidad de Chile; Universidad de Chile; Universidad de Chile	Munoz, P (corresponding author), Univ Valparaiso, Ctr Neurociencia, Valparaiso 2360102, Chile.	pmunoz@cnv.cl	HIDALGO, Cecilia/H-7107-2013; Nunez, Marco/H-6348-2014	Nunez, Marco/0000-0002-1967-8570	Millennium Scientific Initiative [ICM-P05-001-F]; Fondecyt-FONDAP [15010006]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 3080046]; NATIONAL INSTITUTE ON AGING [R01AG034606] Funding Source: NIH RePORTER	Millennium Scientific Initiative; Fondecyt-FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Millennium Scientific Initiative Grant ICM-P05-001-F (to M. T. N.), Fondecyt-FONDAP Grant 15010006 (to C. H.), and Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant FONDECYT 3080046 (to P. M.).	Aguirre P, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-3; ALFORD S, 1993, J PHYSIOL-LONDON, V469, P693, DOI 10.1113/jphysiol.1993.sp019838; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; BICKEL H, 1960, EXPERIENTIA, V16, P129, DOI 10.1007/BF02157712; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Bull R, 2008, J NEUROSCI, V28, P9463, DOI 10.1523/JNEUROSCI.2286-08.2008; Bull R, 2007, AM J PHYSIOL-CELL PH, V293, pC162, DOI 10.1152/ajpcell.00518.2006; Carlson ES, 2007, HIPPOCAMPUS, V17, P679, DOI 10.1002/hipo.20307; Carlson ES, 2009, J NUTR, V139, P672, DOI 10.3945/jn.108.096354; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Donoso P, 2000, BIOPHYS J, V79, P279, DOI 10.1016/S0006-3495(00)76290-4; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Garrick MD, 2006, BIOL RES, V39, P79, DOI 10.4067/S0716-97602006000100009; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haeger P, 2010, NEUROTOX RES, V17, P238, DOI 10.1007/s12640-009-9096-z; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Halliwell B, 2009, FREE RADICAL BIO MED, V46, P531, DOI 10.1016/j.freeradbiomed.2008.11.008; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Hidalgo C, 2005, IUBMB LIFE, V57, P315, DOI 10.1080/15216540500092328; Hidalgo C, 2007, IUBMB LIFE, V59, P280, DOI 10.1080/15216540701222906; Hidalgo C, 2007, ANTIOXID REDOX SIGN, V9, P245, DOI 10.1089/ars.2007.9.245; Jorgenson LA, 2005, HIPPOCAMPUS, V15, P1094, DOI 10.1002/hipo.20128; Kahlert S, 2005, J NEUROSCI RES, V79, P262, DOI 10.1002/jnr.20322; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Kemmerling U, 2007, CELL CALCIUM, V41, P491, DOI 10.1016/j.ceca.2006.10.001; Kishida KT, 2007, ANTIOXID REDOX SIGN, V9, P233, DOI 10.1089/ars.2007.9.233; Kishida KT, 2005, J NEUROCHEM, V94, P299, DOI 10.1111/j.1471-4159.2005.03189.x; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Kruszewski M, 2004, ACTA BIOCHIM POL, V51, P471; Lauri SE, 2003, NEURON, V39, P327, DOI 10.1016/S0896-6273(03)00369-6; Lozoff B, 1996, J PEDIATR-US, V129, P382, DOI 10.1016/S0022-3476(96)70070-7; Lu YF, 2002, J NEUROPHYSIOL, V88, P1270, DOI 10.1152/jn.2002.88.3.1270; Maaroufi K, 2009, PHYSIOL BEHAV, V96, P343, DOI 10.1016/j.physbeh.2008.10.019; Marengo JJ, 1998, BIOPHYS J, V74, P1263, DOI 10.1016/S0006-3495(98)77840-3; Martell A.E., 1982, CRITICAL STABILITY C, V5, P604; McEchron MD, 2005, NUTR NEUROSCI, V8, P277, DOI 10.1080/10284150500499644; Munoz P, 2006, BIOL RES, V39, P189, DOI 10.4067/S0716-97602006000100021; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Nunez MT, 2004, FREE RADICAL BIO MED, V37, P953, DOI 10.1016/j.freeradbiomed.2004.06.005; Nunez MT, 2003, BIOMETALS, V16, P83, DOI 10.1023/A:1020743405347; Nunez-Millacura C, 2002, J NEUROCHEM, V82, P240, DOI 10.1046/j.1471-4159.2002.00971.x; OBENAUS A, 1989, NEUROSCI LETT, V98, P172, DOI 10.1016/0304-3940(89)90505-3; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Pelizzoni I, 2008, BIOCHEM SOC T, V36, P1309, DOI 10.1042/BST0361309; Ranade SC, 2008, NEUROSCIENCE, V152, P859, DOI 10.1016/j.neuroscience.2008.01.002; Satoh K, 2002, REDOX REP, V7, P219, DOI 10.1179/135100002125000587; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Symons M., 1998, FREE RADICALS IRON C; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Yamamoto T, 1997, BRAIN RES, V762, P240, DOI 10.1016/S0006-8993(97)00490-3; Youdim MBH, 2008, NEUROTOX RES, V14, P45, DOI 10.1007/BF03033574	62	85	86	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13382	13392		10.1074/jbc.M110.213785	http://dx.doi.org/10.1074/jbc.M110.213785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21296883	Green Published, hybrid			2022-12-25	WOS:000289282200058
J	Cha, J; Yuan, HY; Liu, Y				Cha, Joonseok; Yuan, Haiyan; Liu, Yi			Regulation of the Activity and Cellular Localization of the Circadian Clock Protein FRQ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIOD PROTEIN; NEUROSPORA CLOCK; FREQUENCY DETERMINES; NUCLEAR-LOCALIZATION; LIGHT RESPONSES; FEEDBACK LOOP; DOUBLE-TIME; PHOSPHORYLATION; DROSOPHILA; TRANSCRIPTION	Eukaryotic circadian clocks employ autoregulatory negative feedback loops to control daily rhythms. In the filamentous fungus Neurospora, FRQ, FRH, WC-1, and WC-2 are the core components of the circadian negative feedback loop. To close the transcription-based negative feedback loop, the FRQ-FRH complex inhibits the activity of the WC complex in the nucleus by promoting the casein kinases-mediated WC phosphorylation. Despite its essential role in the nucleus, most FRQ is found in the cytoplasm. In this study, we mapped the FRQ regions that are important for its cellular localization. We show that the C-terminal part of FRQ, particularly the FRQ-FRH interaction domain, plays a major role in controlling FRQ localization. Both the mutation of the FRQ-FRH interaction domain and the down-regulation of FRH result in the nuclear enrichment of FRQ, suggesting that FRH regulates FRQ localization via a physical interaction. To study the role of FRQ phosphorylation, we examined the FRQ localization in wild-type as well as an array of FRQ kinase, FRQ phosphatase, and FRQ phosphorylation site mutants. Collectively, our results suggest that FRQ phosphorylation does not play a significant role in regulating its cellular localization. Instead, we find that phosphorylation of FRQ inhibits its transcriptional repressor activity in the circadian negative feedback loop. Such an effect is achieved by inhibiting the ability of FRQ to interact with WCC and casein kinase 1a. Our results indicate that the rhythmic FRQ phosphorylation profile observed is an important part of the negative feedback mechanism that drives robust circadian gene expression.	[Cha, Joonseok; Yuan, Haiyan; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, ND13-214A,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Yi.Liu@UTsouthwestern.edu	Cha, Joonseok/AAE-9918-2020	Cha, Joonseok/0000-0001-9362-5285	National Institutes of Health [GM068496, GM062591]; Welch Foundation [I-1560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068496, R01GM062591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health Grants GM068496 and GM062591. This work was also supported by the Welch Foundation (I-1560) (to Y. L.).	Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Cha J, 2007, COLD SPRING HARB SYM, V72, P185, DOI 10.1101/sqb.2007.72.010; Cha J, 2008, EMBO J, V27, P3246, DOI 10.1038/emboj.2008.245; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2002, MOL CELL BIOL, V22, P517, DOI 10.1128/MCB.22.2.517-524.2002; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Diernfellner ACR, 2009, GENE DEV, V23, P2192, DOI 10.1101/gad.538209; Dunlap JC, 2006, J BIOL CHEM, V281, P28489, DOI 10.1074/jbc.R600018200; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Guo JH, 2010, J BIOL CHEM, V285, P11508, DOI 10.1074/jbc.M109.071688; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hong CI, 2008, GENE DEV, V22, P3196, DOI 10.1101/gad.1706908; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Liu Y, 2006, EUKARYOT CELL, V5, P1184, DOI 10.1128/EC.00133-06; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Mehra A, 2009, CELL, V137, P749, DOI 10.1016/j.cell.2009.03.019; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schafmeier T, 2008, GENE DEV, V22, P3397, DOI 10.1101/gad.507408; Shafer OT, 2002, J NEUROSCI, V22, P5946; Shi M, 2010, GENETICS, V184, P351, DOI 10.1534/genetics.109.111393; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Vitalini MW, 2004, GENETICS, V167, P119, DOI 10.1534/genetics.167.1.119; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; Yang YH, 2004, GENE DEV, V18, P255, DOI 10.1101/gad.1152604; Yang YH, 2003, MOL CELL BIOL, V23, P6221, DOI 10.1128/MCB.23.17.6221-6228.2003; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174	51	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11469	11478		10.1074/jbc.M111.219782	http://dx.doi.org/10.1074/jbc.M111.219782			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21300798	Green Published, hybrid			2022-12-25	WOS:000288797100058
J	Wang, HX; Song, PP; Du, L; Tian, WL; Yue, W; Liu, M; Li, DW; Wang, B; Zhu, YS; Cao, C; Zhou, J; Chen, QA				Wang, Hongxia; Song, Pingping; Du, Lei; Tian, Weili; Yue, Wen; Liu, Min; Li, Dengwen; Wang, Bin; Zhu, Yushan; Cao, Cheng; Zhou, Jun; Chen, Quan			Parkin Ubiquitinates Drp1 for Proteasome-dependent Degradation IMPLICATION OF DYSREGULATED MITOCHONDRIAL DYNAMICS IN PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR PATHWAYS; JUVENILE PARKINSONISM; PINK1/PARKIN PATHWAY; PROTEIN-DEGRADATION; OXIDATIVE STRESS; FISSION; PINK1; NEURODEGENERATION; MORPHOLOGY; DROSOPHILA	Mutations in Parkin, an E3 ubiquitin ligase that regulates protein turnover, represent one of the major causes of familial Parkinson disease, a neurodegenerative disorder characterized by the loss of dopaminergic neurons and impaired mitochondrial functions. The underlying mechanism by which pathogenic Parkin mutations induce mitochondrial abnormality is not fully understood. Here, we demonstrate that Parkin interacts with and subsequently ubiquitinates dynamin-related protein 1 (Drp1), for promoting its proteasome-dependent degradation. Pathogenic mutation or knockdown of Parkin inhibits the ubiquitination and degradation of Drp1, leading to an increased level of Drp1 for mitochondrial fragmentation. These results identify Drp1 as a novel substrate of Parkin and suggest a potential mechanism linking abnormal Parkin expression to mitochondrial dysfunction in the pathogenesis of Parkinson disease.	[Zhou, Jun; Chen, Quan] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; [Zhou, Jun; Chen, Quan] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Du, Lei; Yue, Wen; Wang, Bin; Chen, Quan] Chinese Acad Sci, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing 100101, Peoples R China; [Cao, Cheng] Beijing Inst Biotechnol, Beijing 100850, Peoples R China	Nankai University; Nankai University; Chinese Academy of Sciences; Institute of Zoology, CAS	Zhou, J (corresponding author), Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China.	junzhou@nankai.edu.cn; chenquan@nankai.edu.cn	Zhou, Jun/D-4654-2017; Wang, Hongxia/D-8812-2014	Zhou, Jun/0000-0001-7858-8260; Chen, Quan/0000-0001-7539-8728	National Natural Science Foundation of China [2006CB910102, 2010CB912200, 30825022, 30630038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Key Project Grant 30630038 and 973 Program Grants 2006CB910102 and 2010CB912200 from the National Natural Science Foundation of China (to Q. C.) and Grant 30825022 from the National Natural Science Foundation of China (to J. Z.).	Biskup S, 2008, J NEUROL, V255, P8, DOI 10.1007/s00415-008-5005-2; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dawson TM, 2007, PARKINSONISM RELAT D, V13, pS248, DOI 10.1016/S1353-8020(08)70010-5; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P1, DOI 10.1016/S0028-3908(02)00337-4; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Ferrer I, 2009, PROG NEUROBIOL, V88, P89, DOI 10.1016/j.pneurobio.2009.02.004; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Giasson BI, 2001, NEURON, V31, P885, DOI 10.1016/S0896-6273(01)00439-1; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; Kahle PJ, 2004, EMBO REP, V5, P681, DOI 10.1038/sj.embor.7400188; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Ko HS, 2006, J BIOL CHEM, V281, P16193, DOI 10.1074/jbc.C600041200; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Li H, 2009, J CLIN INVEST, V119, P442, DOI 10.1172/JCI38619; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Marin I., 2004, PHYSIOL GENOMICS, V17, P253; Mata IF, 2004, HUM MOL GENET, V13, pR127, DOI 10.1093/hmg/ddh089; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Van Laar VS, 2009, EXP NEUROL, V218, P247, DOI 10.1016/j.expneurol.2009.03.019; Wells RC, 2007, J BIOL CHEM, V282, P33769, DOI 10.1074/jbc.M700807200; Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Yaffe MP, 1999, NAT CELL BIOL, V1, pE149, DOI 10.1038/14101; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	56	257	266	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11649	11658		10.1074/jbc.M110.144238	http://dx.doi.org/10.1074/jbc.M110.144238			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21292769	Green Published, hybrid			2022-12-25	WOS:000288797100073
J	Desplats, P; Spencer, B; Coffee, E; Patel, P; Michael, S; Patrick, C; Adame, A; Rockenstein, E; Masliah, E				Desplats, Paula; Spencer, Brian; Coffee, Elizabeth; Patel, Pruthul; Michael, Sarah; Patrick, Christina; Adame, Anthony; Rockenstein, Edward; Masliah, Eliezer			alpha-Synuclein Sequesters Dnmt1 from the Nucleus A NOVEL MECHANISM FOR EPIGENETIC ALTERATIONS IN LEWY BODY DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; DNA METHYLATION; EXPRESSION; MEMORY	DNA methylation is a major epigenetic modification that regulates gene expression. Dnmt1, the maintenance DNA methylation enzyme, is abundantly expressed in the adult brain and is mainly located in the nuclear compartment, where it has access to chromatin. Hypomethylation of CpG islands at intron 1 of the SNCA gene has recently been reported to result in overexpression of alpha-synuclein in Parkinson disease (PD) and related disorders. We therefore investigated the mechanisms underlying altered DNA methylation in PD and dementia with Lewy bodies (DLB). We present evidence of reduction of nuclear Dnmt1 levels in human postmortem brain samples from PD and DLB patients as well as in the brains of alpha-synuclein transgenic mice models. Furthermore, sequestration of Dnmt1 in the cytoplasm results in global DNA hypomethylation in human and mouse brains, involving CpG islands upstream of SNCA, SEPW1, and PRKAR2A genes. We report that association of Dnmt1 and alpha-synuclein might mediate aberrant subcellular localization of Dnmt1. Nuclear Dnmt1 levels were partially rescued by overexpression of Dnmt1 in neuronal cell cultures and in alpha-synuclein transgenic mice brains. Our results underscore a novel mechanism for epigenetic dysregulation in Lewy body diseases, which might underlie the decrease in DNA methylation reported for PD and DLB.	[Desplats, Paula; Spencer, Brian; Coffee, Elizabeth; Patel, Pruthul; Michael, Sarah; Patrick, Christina; Adame, Anthony; Rockenstein, Edward; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Desplats, P (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, 9500 Gilman Dr,MTF 344, La Jolla, CA 92093 USA.	pdesplat@ucsd.edu	Desplats, Paula/AFW-5030-2022	Desplats, Paula/0000-0002-4758-4280	National Institutes of Health [AG5131, AG18440, AG22074, AG3197, AG10435, NS05709]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS105709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, R01AG018440, P01AG022074, R37AG018440, P01AG010435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG5131, AG18440, AG22074, AG3197, AG10435, and NS05709 (to E. M.).	Burn DJ, 2006, CURR OPIN NEUROL, V19, P572, DOI 10.1097/01.wco.0000247607.34697.a2; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; George JM, 2002, GENOME BIOL, V3; HERNANDEZ DG, 2011, HUM MOL GEN IN PRESS; Jowaed A, 2010, J NEUROSCI, V30, P6355, DOI 10.1523/JNEUROSCI.6119-09.2010; Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3; Liu L, 2009, NEUROBIOL AGING, V30, P549, DOI 10.1016/j.neurobiolaging.2007.07.020; Matsumoto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015522; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stamper C, 2008, MOVEMENT DISORD, V23, P1588, DOI 10.1002/mds.22184; Takeda A, 1998, AM J PATHOL, V152, P367; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Yacoubian TA, 2008, NEUROBIOL DIS, V29, P515, DOI 10.1016/j.nbd.2007.11.008	20	195	203	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9031	9037		10.1074/jbc.C110.212589	http://dx.doi.org/10.1074/jbc.C110.212589			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21296890	Green Published, hybrid			2022-12-25	WOS:000288247700034
J	Van den Eede, P; Soto-Calle, VE; Delgado, C; Gamboa, D; Grande, T; Rodriguez, H; Llanos-Cuentas, A; Anne, J; D'Alessandro, U; Erhart, A				Van den Eede, Peter; Soto-Calle, Veronica E.; Delgado, Christopher; Gamboa, Dionicia; Grande, Tanilu; Rodriguez, Hugo; Llanos-Cuentas, Alejandro; Anne, Jozef; D'Alessandro, Umberto; Erhart, Annette			Plasmodium vivax Sub-Patent Infections after Radical Treatment Are Common in Peruvian Patients: Results of a 1-Year Prospective Cohort Study	PLOS ONE			English	Article							CIRCUMSPOROZOITE PROTEIN; MALARIA CONTROL; AMAZON REGION; PRIMAQUINE; CHLOROQUINE; PREVALENCE; FALCIPARUM; EPIDEMIOLOGY; RESISTANCE; DIVERSITY	Background: There is an increasing body of literature reporting treatment failure of the currently recommended radical treatment of Plasmodium vivax infections. As P. vivax is the main malaria species outside the African continent, emerging tolerance to its radical treatment regime could have major consequences in countries like Peru, where 80% of malaria cases are due to P. vivax. Here we describe the results of a 1-year longitudinal follow up of 51 confirmed P. vivax patients living around Iquitos, Peruvian Amazon, and treated according to the Peruvian national guidelines. Methodology: Each month a blood sample for microscopy and later genotyping was systematically collected. Recent exposure to infection was estimated by detecting antibodies against the P. vivax circumsporozoite protein (CSP) and all PCR confirmed P. vivax infections were genotyped with 16 polymorphic microsatellites. Results: During a 1-year period, 84 recurrent infections, 22 positive also by microscopy, were identified, with a median survival time to first recurrent infection of 203 days. Most of them (71%) were asymptomatic; in 13 patients the infection persisted undetected by microscopy for several consecutive months. The genotype of mostly recurrent infections differed from that at day 0 while fewer differences were seen between the recurrent infections. The average expected heterozygosity was 0.56. There was strong linkage disequilibrium (I-A(s) = 0.29, p<1.10(-4)) that remained also when analyzing only the unique haplotypes, suggesting common inbreeding. Conclusion: In Peru, the P. vivax recurrent infections were common and displayed a high turnover of parasite genotypes compared to day 0. Plasmodium vivax patients, even when treated according to the national guidelines, may still represent an important parasite reservoir that can maintain transmission. Any elimination effort should consider such a hidden reservoir.	[Van den Eede, Peter; D'Alessandro, Umberto; Erhart, Annette] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Soto-Calle, Veronica E.; Delgado, Christopher; Gamboa, Dionicia; Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Von Humboldt, Lima, Peru; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Bioquim Biol Mol & Farmacol, Lima, Peru; [Grande, Tanilu; Rodriguez, Hugo] Organismo Andinode Salud Convenio Hipolito Unanue, Multicountry Malaria Project Malaria Control Cros, Lima, Peru; [Anne, Jozef] Catholic Univ Louvain, Dept Microbiol & Immunol, B-3000 Louvain, Belgium	Institute of Tropical Medicine (ITM); Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Universite Catholique Louvain	Van den Eede, P (corresponding author), Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium.	pvandeneede@itg.be	ANNE, Jozef/H-7983-2019; Delgado Ratto, Christopher/D-3838-2013; Gamboa, Dionicia/CAF-2097-2022; D'Alessandro, Umberto/D-3457-2015	ANNE, Jozef/0000-0002-0493-2644; Gamboa, Dionicia/0000-0002-1420-7729; D'Alessandro, Umberto/0000-0001-6341-5009; Delgado-Ratto, Christopher/0000-0003-2300-5181; Llanos-Cuentas, Alejandro/0000-0002-7567-5534; Soto-Calle, Veronica Elena/0000-0003-0257-7869	"Fonds voor Wetenschappelijk Onderzoek" (FWO); "Institute for the Promotion of Innovation by Science, and Technology in Flanders" (IWT); Directorate General for Development Cooperation (DGCD) of the Belgian Government [95501, 95502]	"Fonds voor Wetenschappelijk Onderzoek" (FWO)(FWO); "Institute for the Promotion of Innovation by Science, and Technology in Flanders" (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Directorate General for Development Cooperation (DGCD) of the Belgian Government	This study was funded by the Flemish government funds: "Fonds voor Wetenschappelijk Onderzoek" (FWO), and the "Institute for the Promotion of Innovation by Science, and Technology in Flanders" (IWT, PhD grant). The sample collection was funded by the Directorate General for Development Cooperation (DGCD) of the Belgian Government (framework agreement 2 and 3; project 95501 and 95502 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez G, 2006, AM J TROP MED HYG, V75, P605, DOI 10.4269/ajtmh.2006.75.605; Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; Arevalo-Herrera M, 1998, ANN TROP MED PARASIT, V92, P539, DOI 10.1080/00034989859230; Arnaud-Haond S, 2005, J HERED, V96, P434, DOI 10.1093/jhered/esi043; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Arruda ME, 2007, MEM I OSWALDO CRUZ, V102, P367, DOI 10.1590/S0074-02762007005000041; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; Baragatti M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-13; Bautista CT, 2006, AM J TROP MED HYG, V75, P1216, DOI 10.4269/ajtmh.2006.75.1216; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; BROWN AE, 1991, AM J TROP MED HYG, V44, P21, DOI 10.4269/ajtmh.1991.44.21; CONTACOS PG, 1972, AM J TROP MED HYG, V21, P707, DOI 10.4269/ajtmh.1972.21.707; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; da Silva NS, 2010, T ROY SOC TROP MED H, V104, P343, DOI 10.1016/j.trstmh.2009.12.010; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; EEDE PV, 2010, AM J TROP MED HYG, V82, P223; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; FRANKE ED, 1992, AM J TROP MED HYG, V46, P708, DOI 10.4269/ajtmh.1992.46.708; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grietens KP, 2010, AM J TROP MED HYG, V82, P1017, DOI 10.4269/ajtmh.2010.09-0521; Hanf M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-278; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Havryliuk T, 2008, EXP PARASITOL, V120, P330, DOI 10.1016/j.exppara.2008.08.012; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; JELINEK T, 1995, AM J TROP MED HYG, V52, P322, DOI 10.4269/ajtmh.1995.52.322; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Leslie T, 2004, T ROY SOC TROP MED H, V98, P168, DOI 10.1016/S0035-9203(03)00041-5; Lim CS, 2005, MICROBIOL IMMUNOL, V49, P521, DOI 10.1111/j.1348-0421.2005.tb03757.x; *MIN HLTH PER, NAT GUID MAL TREATM; *MIN SAL PER DIR G, SIT MAL PER 2009; Orjuela-Sanchez P, 2009, AM J TROP MED HYG, V81, P961, DOI 10.4269/ajtmh.2009.09-0337; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Razakandrainibe R, 2009, ACTA TROP, V111, P160, DOI 10.1016/j.actatropica.2009.04.007; Roper MH, 2000, AM J TROP MED HYG, V62, P247, DOI 10.4269/ajtmh.2000.62.247; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199; Ruebush TK, 2003, AM J TROP MED HYG, V69, P548, DOI 10.4269/ajtmh.2003.69.548; Suphavilai C, 2004, AM J TROP MED HYG, V71, P29, DOI 10.4269/ajtmh.2004.71.29; Sutton PL, 2009, AM J TROP MED HYG, V81, P950, DOI 10.4269/ajtmh.2009.09-0132; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Villalobos-Salcedo JM, 2000, ANN TROP MED PARASIT, V94, P749, DOI 10.1080/00034980020027960	43	51	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16257	10.1371/journal.pone.0016257	http://dx.doi.org/10.1371/journal.pone.0016257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297986	Green Published, gold, Green Submitted			2022-12-25	WOS:000286664100016
J	Lofmark, S; de Klerk, N; Aro, H				Lofmark, Sonja; de Klerk, Nele; Aro, Helena			Neisseria gonorrhoeae Infection Induces Altered Amphiregulin Processing and Release	PLOS ONE			English	Article							GROWTH-FACTOR; EPITHELIAL-CELLS; IV PILI; PATHOGENIC NEISSERIAE; UP-REGULATION; EXPRESSION; CANCER; RECEPTOR; GENE; APOPTOSIS	Adhesion of the human pathogen Neisseria gonorrhoeae has established effects on the host cell and evokes a variety of cellular events including growth factor activation. In the present study we report that infection with N. gonorrhoeae causes altered amphiregulin processing and release in human epithelial cells. Amphiregulin is a well-studied growth factor with functions in various cell processes and is upregulated in different forms cancer and proliferative diseases. The protein is prototypically cleaved on the cell surface in response to external stimuli. We demonstrate that upon infection, a massive upregulation of amphiregulin mRNA is seen. The protein changes its subcellular distribution and is also alternatively cleaved at the plasma membrane, which results in augmented release of an infection-specific 36 kDa amphiregulin product from the surface of human cervical epithelial cells. Further, using antibodies directed against different domains of the protein we could determine the impact of infection on pro-peptide processing. In summary, we present data showing that the infection of N. gonorrhoeae causes an alternative amphiregulin processing, subcellular distribution and release in human epithelial cervical cells that likely contribute to the predisposition cellular abnormalities and anti-apoptotic features of N. gonorrhoeae infections.	[Lofmark, Sonja; de Klerk, Nele; Aro, Helena] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	Stockholm University	Lofmark, S (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden.	Helena.Aro@gmt.su.se						Berasain C, 2007, CANCER LETT, V254, P30, DOI 10.1016/j.canlet.2007.01.015; Binnicker MJ, 2003, CELL MICROBIOL, V5, P549, DOI 10.1046/j.1462-5822.2003.00300.x; Bostwick DG, 2004, PROSTATE, V58, P164, DOI 10.1002/pros.10322; Brown CL, 1998, J BIOL CHEM, V273, P17258, DOI 10.1074/jbc.273.27.17258; Busiello I, 2004, CELL MICROBIOL, V6, P255, DOI 10.1046/j.1462-5822.2004.00366.x; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; EBERT M, 1994, CANCER RES, V54, P3959; Fichorova RN, 2002, J IMMUNOL, V168, P2424, DOI 10.4049/jimmunol.168.5.2424; Follows SA, 2009, INFECT IMMUN, V77, P3602, DOI 10.1128/IAI.01366-08; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hsu D, 2010, LAB INVEST, V90, P1295, DOI 10.1038/labinvest.2010.100; Hurbin A, 2002, J BIOL CHEM, V277, P49127, DOI 10.1074/jbc.M207584200; Isokane M, 2008, J CELL SCI, V121, P3608, DOI 10.1242/jcs.031443; Jones A, 2007, FASEB J, V21, P345, DOI 10.1096/fj.06-6675com; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; Kallstrom H, 2000, CELL MICROBIOL, V2, P341, DOI 10.1046/j.1462-5822.2000.00063.x; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; Kim Y, 2009, INT J FOOD MICROBIOL, V131, P224, DOI 10.1016/j.ijfoodmicro.2009.03.002; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; Merz AJ, 1996, MOL MED, V2, P745, DOI 10.1007/BF03401658; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Michaud DS, 2007, UROL ONCOL-SEMIN ORI, V25, P260, DOI 10.1016/j.urolonc.2006.10.002; Narita K, 2007, J BIOL CHEM, V282, P14413, DOI 10.1074/jbc.M611395200; Pedron T, 2003, J BIOL CHEM, V278, P33878, DOI 10.1074/jbc.M303749200; PIEPKORN M, 1995, J INVEST DERMATOL, V105, P802, DOI 10.1111/1523-1747.ep12326567; Plant L, 2004, CELL MICROBIOL, V6, P663, DOI 10.1111/j.1462-5822.2004.00393.x; PLOWMAN GD, 1990, MOL CELL BIOL, V10, P1969, DOI 10.1128/MCB.10.5.1969; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Shin HS, 2003, CIRC RES, V93, P302, DOI 10.1161/01.RES.0000086803.64109.9E; SHOYAB M, 1988, P NATL ACAD SCI USA, V85, P6528, DOI 10.1073/pnas.85.17.6528; Sutcliffe S, 2006, J UROLOGY, V175, P1937, DOI 10.1016/S0022-5347(05)00892-X; Sutcliffe S, 2006, CANCER EPIDEM BIOMAR, V15, P2160, DOI 10.1158/1055-9965.EPI-05-0913; SWANSON J, 1986, CELL, V47, P267, DOI 10.1016/0092-8674(86)90449-6; SWANSON J, 1973, J EXP MED, V137, P571, DOI 10.1084/jem.137.3.571; THORNE BA, 1994, MOL CELL BIOL, V14, P1635, DOI 10.1128/MCB.14.3.1635	38	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16369	10.1371/journal.pone.0016369	http://dx.doi.org/10.1371/journal.pone.0016369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298020	Green Submitted, Green Published, gold			2022-12-25	WOS:000286663900042
J	Sato, F; Hatano, E; Kitamura, K; Myomoto, A; Fujiwara, T; Takizawa, S; Tsuchiya, S; Tsujimoto, G; Uemoto, S; Shimizu, K				Sato, Fumiaki; Hatano, Etsuro; Kitamura, Koji; Myomoto, Akira; Fujiwara, Takeshi; Takizawa, Satoko; Tsuchiya, Soken; Tsujimoto, Gozoh; Uemoto, Shinji; Shimizu, Kazuharu			MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; LIVER-TRANSPLANTATION; SUPPRESSOR GENE; CANCER; CIRRHOSIS; OUTCOMES; CLASSIFICATION; IDENTIFICATION; GENOMICS; TUMORS	Objective: Hepatocellular carcinoma (HCC) is difficult to manage due to the high frequency of post-surgical recurrence. Early detection of the HCC recurrence after liver resection is important in making further therapeutic options, such as salvage liver transplantation. In this study, we utilized microRNA expression profiling to assess the risk of HCC recurrence after liver resection. Methods: We examined microRNA expression profiling in paired tumor and non-tumor liver tissues from 73 HCC patients who satisfied the Milan Criteria. We constructed prediction models of recurrence-free survival using the Cox proportional hazard model and principal component analysis. The prediction efficiency was assessed by the leave-one-out cross-validation method, and the time-averaged area under the ROC curve (ta-AUROC). Results: The univariate Cox analysis identified 13 and 56 recurrence-related microRNAs in the tumor and non-tumor tissues, such as miR-96. The number of recurrence-related microRNAs was significantly larger in the non-tumor-derived microRNAs (N-miRs) than in the tumor-derived microRNAs (T-miRs, P < 0.0001). The best ta-AUROC using the whole dataset, T-miRs, N-miRs, and clinicopathological dataset were 0.8281, 0.7530, 0.7152, and 0.6835, respectively. The recurrence-free survival curve of the low-risk group stratified by the best model was significantly better than that of the high-risk group (Log-rank: P = 0.00029). The T-miRs tend to predict early recurrence better than late recurrence, whereas N-miRs tend to predict late recurrence better (P, 0.0001). This finding supports the concept of early recurrence by the dissemination of primary tumor cells and multicentric late recurrence by the 'field effect'. Conclusion: microRNA profiling can predict HCC recurrence in Milan criteria cases.	[Sato, Fumiaki; Fujiwara, Takeshi; Tsuchiya, Soken; Shimizu, Kazuharu] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan; [Hatano, Etsuro; Kitamura, Koji; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Myomoto, Akira; Takizawa, Satoko] Toray Industries Ltd, New Frontiers Res Labs, Kanagawa, Japan; [Myomoto, Akira; Tsujimoto, Gozoh] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacogenom, Kyoto, Japan	Kyoto University; Kyoto University; Toray Industries, Inc.; Kyoto University	Hatano, E (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan.	fsato@pharm.kyoto-u.ac.jp	Hatano, Etsuro/AAX-2407-2020	Hatano, Etsuro/0000-0003-3407-1918	Japanese federal organization; New Energy and Industrial Technology Development Organization (NEDO), Japan	Japanese federal organization; New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by a Japanese federal fund promoting academia-industry collaboration, "Grant for Practical Application of University R&D Results under the Matching Fund Method, from a Japanese federal organization, the New Energy and Industrial Technology Development Organization ( NEDO), Japan''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Toray Industries, Inc. is a funder due to employment of Arira Myomoto and Satoko Takizawa, who provided technical support to conduct this project, but did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akriviadis EA, 1998, BRIT J SURG, V85, P1319; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Centeno BA, 2005, CANCER CYTOPATHOL, V105, P101, DOI 10.1002/cncr.20737; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; F Simon, 2010, LANGENBECKS ARCH SUR; Figueras J, 2000, J AM COLL SURGEONS, V190, P580, DOI 10.1016/S1072-7515(00)00251-9; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Iizuka N, 2004, LANCET, V364, P1837, DOI 10.1016/S0140-6736(04)17455-2; Ito T, 2007, LIVER TRANSPLANT, V13, P1637, DOI 10.1002/lt.21281; Ito T, 2007, ONCOLOGY-BASEL, V73, P366, DOI 10.1159/000136156; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Liver Cancer Study Group of Japan, 2000, GEN RUL CLIN PATH ST; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michel J, 1997, J HEPATOL, V26, P1274, DOI 10.1016/S0168-8278(97)80462-X; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Stewart B.W., 2003, WORLD CANC REPORT; Taura K, 2007, SURGERY, V142, P685, DOI 10.1016/j.surg.2007.05.009; TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0; Tsuchiya S, 2006, J PHARMACOL SCI, V101, P267, DOI 10.1254/jphs.CPJ06013X; Utsunomiya T, 2010, J GASTROENTEROL, V45, P146, DOI 10.1007/s00535-009-0164-1; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	34	98	107	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16435	10.1371/journal.pone.0016435	http://dx.doi.org/10.1371/journal.pone.0016435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298008	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900048
J	Young, SRL; Hum, JM; Rodenberg, E; Turner, CH; Pavalko, FM				Young, Suzanne R. L.; Hum, Julia M.; Rodenberg, Eric; Turner, Charles H.; Pavalko, Fredrick M.			Non-Overlapping Functions for Pyk2 and FAK in Osteoblasts during Fluid Shear Stress-Induced Mechanotransduction	PLOS ONE			English	Article							FOCAL ADHESION KINASE; BONE-CELLS; MC3T3-E1 OSTEOBLASTS; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; PROSTAGLANDIN RELEASE; SIGNAL-TRANSDUCTION; MECHANICAL STRAIN; NITRIC-OXIDE; FLOW	Mechanotransduction, the process by which cells convert external mechanical stimuli such as fluid shear stress (FSS) into biochemical changes, plays a critical role in maintenance of the skeleton. We have proposed that mechanical stimulation by FSS across the surfaces of bone cells results in formation of unique signaling complexes called mechanosomes that are launched from sites of adhesion with the extracellular matrix and with other bone cells [1]. Deformation of adhesion complexes at the cell membrane ultimately results in alteration of target gene expression. Recently, we reported that focal adhesion kinase (FAK) functions as a part of a mechanosome complex that is required for FSS-induced mechanotransduction in bone cells. This study extends this work to examine the role of a second member of the FAK family of non-receptor protein tyrosine kinases, proline-rich tyrosine kinase 2 (Pyk2), and determine its role during osteoblast mechanotransduction. We use osteoblasts harvested from mice as our model system in this study and compared the contributions of Pyk2 and FAK during FSS induced mechanotransduction in osteoblasts. We exposed Pyk2(+/+) and Pyk2(-/-) primary calvarial osteoblasts to short period of oscillatory fluid flow and analyzed downstream activation of ERK1/2, and expression of c-fos, cyclooxygenase-2 and osteopontin. Unlike FAK, Pyk2 was not required for fluid flow-induced mechanotransduction as there was no significant difference in the response of Pyk2(+/+) and Pyk2(-/-) osteoblasts to short periods of fluid flow (FF). In contrast, and as predicted, FAK(-/-) osteoblasts were unable to respond to FF. These data indicate that FAK and Pyk2 have distinct, non-redundant functions in launching mechanical signals during osteoblast mechanotransduction. Additionally, we compared two methods of generating FF in both cell types, oscillatory pump method and another orbital platform method. We determined that both methods of generating FF induced similar responses in both primary calvarial osteoblasts and immortalized calvarial osteoblasts.	[Young, Suzanne R. L.; Hum, Julia M.; Rodenberg, Eric; Pavalko, Fredrick M.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA; [Turner, Charles H.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Young, SRL (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA.	fpavalko@iupui.edu			NIH [AR049728, AR052682]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049728, R01AR052682] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was funded by the grants NIH AR049728, AR052682. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1; Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009; Bidwell JP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3153pe51; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Charoonpatrapong-Panyayong K, 2007, J CELL BIOCHEM, V102, P1202, DOI 10.1002/jcb.21349; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Damsky C, 2002, CURR OPIN CELL BIOL, V14; Duong LT, 1998, J CLIN INVEST, V102, P881, DOI 10.1172/JCI3212; Duong LT, 2001, J BIOL CHEM, V276, P7484, DOI 10.1074/jbc.M008368200; Ferraro JT, 2004, AM J PHYSIOL-CELL PH, V286, pC831, DOI 10.1152/ajpcell.00224.2003; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Guignandon A, 2006, BIOCHEM BIOPH RES CO, V343, P407, DOI 10.1016/j.bbrc.2006.02.162; Harder AT, 2003, J CLIN PHARMACOL, V43, P807, DOI 10.1177/0091270003256061; JACKSON ME, 1994, J CELL BIOCHEM, V55, P366, DOI 10.1002/jcb.240550314; Jackson RA, 2006, J CELL PHYSIOL, V209, P894, DOI 10.1002/jcp.20779; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Jiang GL, 2002, AM J PHYSIOL-ENDOC M, V283, pE383, DOI 10.1152/ajpendo.00547.2001; Kalogeropoulos M, 2010, FASEB J, V24, P2893, DOI 10.1096/fj.09-148908; Kapur S, 2004, BONE, V35, P525, DOI 10.1016/j.bone.2004.04.007; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Kido S, 2009, BONE, V45, P1125, DOI 10.1016/j.bone.2009.07.087; Kim JB, 2007, BONE, V41, P39, DOI 10.1016/j.bone.2007.01.024; KleinNulend J, 1997, J BONE MINER RES, V12, P45, DOI 10.1359/jbmr.1997.12.1.45; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Miller SB, 2006, SEMIN ARTHRITIS RHEU, V36, P37, DOI 10.1016/j.semarthrit.2006.03.005; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; Norvell SM, 2004, J APPL PHYSIOL, V96, P957, DOI 10.1152/japplphysiol.00869.2003; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Peake MA, 2003, FEBS LETT, V537, P117, DOI 10.1016/S0014-5793(03)00108-X; Pfaff M, 2001, J CELL SCI, V114, P2775; PIEKARSKI K, 1977, NATURE, V269, P80, DOI 10.1038/269080a0; Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089; Radi ZA, 2005, INFLAMM RES, V54, P358, DOI 10.1007/s00011-005-1367-4; Raisz Lawrence G., 2001, American Journal of Medicine, V110, p43S; Reich KM, 1997, ENDOCRINOLOGY, V138, P1014, DOI 10.1210/en.138.3.1014; REICH KM, 1991, AM J PHYSIOL, V261, pC428, DOI 10.1152/ajpcell.1991.261.3.C428; Schaller MD, 1997, J BIOL CHEM, V272, P25319, DOI 10.1074/jbc.272.40.25319; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SHEFFIELD JB, 1987, ANAL BIOCHEM, V166, P49, DOI 10.1016/0003-2697(87)90544-6; Smalt R, 1997, ADV EXP MED BIOL, V433, P311; Tanaka SM, 2005, CALCIFIED TISSUE INT, V76, P261, DOI 10.1007/s00223-004-0238-2; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; Wadhwa S, 2002, J BONE MINER RES, V17, P266, DOI 10.1359/jbmr.2002.17.2.266; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Xiong WC, 1998, J CELL SCI, V111, P1981; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Young SRL, 2010, BONE, V47, P74, DOI 10.1016/j.bone.2010.03.014; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI 10.1359/JBMR.081102; Zhou XZ, 2010, J BIOMECH, V43, P1598, DOI 10.1016/j.jbiomech.2009.12.028	58	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16026	10.1371/journal.pone.0016026	http://dx.doi.org/10.1371/journal.pone.0016026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283581	Green Submitted, gold, Green Published			2022-12-25	WOS:000286661400022
J	Hessel, A; Schwendinger, M; Holzer, GW; Orlinger, KK; Coulibaly, S; Savidis-Dacho, H; Zips, ML; Crowe, BA; Kreil, TR; Ehrlich, HJ; Barrett, PN; Falkner, FG				Hessel, Annett; Schwendinger, Michael; Holzer, Georg W.; Orlinger, Klaus K.; Coulibaly, Sogue; Savidis-Dacho, Helga; Zips, Marie-Luise; Crowe, Brian A.; Kreil, Thomas R.; Ehrlich, Hartmut J.; Barrett, P. Noel; Falkner, Falko G.			Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity	PLOS ONE			English	Article							T-CELL EPITOPES; VIRUS; INFECTION; SEQUENCE; STRAIN; MICE	Background: New highly pathogenic H5N1 influenza viruses are continuing to evolve with a potential threat for an influenza pandemic. So far, the H5N1 influenza viruses have not widely circulated in humans and therefore constitute a high risk for the non immune population. The aim of this study was to evaluate the cross-protective potential of the hemagglutinins of five H5N1 strains of divergent clades using a live attenuated modified vaccinia Ankara (MVA) vector vaccine. Methodology/Principal Findings: The replication-deficient MVA virus was used to express influenza hemagglutinin (HA) proteins. Specifically, recombinant MVA viruses expressing the HA genes of the clade 1 virus A/Vietnam/1203/2004 (VN/ 1203), the clade 2.1.3 virus A/Indonesia/5/2005 (IN5/05), the clade 2.2 viruses A/turkey/Turkey/1/2005 (TT01/05) and A/chicken/Egypt/3/2006 (CE/06), and the clade 2.3.4 virus A/Anhui/1/2005 (AH1/05) were constructed. These experimental live vaccines were assessed in a lethal mouse model. Mice vaccinated with the VN/1203 hemagglutinin-expressing MVA induced excellent protection against all the above mentioned clades. Also mice vaccinated with the IN5/05 HA expressing MVA induced substantial protection against homologous and heterologous AH1/05 challenge. After vaccination with the CE/06 HA expressing MVA, mice were fully protected against clade 2.2 challenge and partially protected against challenge of other clades. Mice vaccinated with AH1/05 HA expressing MVA vectors were only partially protected against homologous and heterologous challenge. The live vaccines induced substantial amounts of neutralizing antibodies, mainly directed against the homologous challenge virus, and high levels of HA-specific IFN-gamma secreting CD4 and CD8 T-cells against epitopes conserved among the H5 clades and subclades. Conclusions/Significance: The highest level of cross-protection was induced by the HA derived from the VN/1203 strain, suggesting that pandemic H5 vaccines utilizing MVA vector technology, should be based on the VN/1203 hemagglutinin. Furthermore, the recombinant MVA-HA-VN, as characterized in the present study, would be a promising candidate for such a vaccine.	[Hessel, Annett; Holzer, Georg W.; Orlinger, Klaus K.; Coulibaly, Sogue; Kreil, Thomas R.; Falkner, Falko G.] Baxter Biosci, Dept Virol, Biomed Res Ctr, Orth, Austria; [Schwendinger, Michael; Crowe, Brian A.] Baxter Biosci, Dept Immunol, Biomed Res Ctr, Orth, Austria; [Savidis-Dacho, Helga] Baxter Biosci, Dept Anim Models, Biomed Res Ctr, Orth, Austria; [Zips, Marie-Luise] Baxter Biosci, Dept Bacteriol, Biomed Res Ctr, Orth, Austria; [Ehrlich, Hartmut J.; Barrett, P. Noel] Baxter Biosci, Global R&D Vaccines, Biomed Res Ctr, Orth, Austria		Hessel, A (corresponding author), Baxter Biosci, Dept Virol, Biomed Res Ctr, Orth, Austria.	falknef@baxter.com			Baxter BioScience	Baxter BioScience	This study was funded by Baxter BioScience. The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Boltz DA, 2010, J GEN VIROL, V91, P949, DOI 10.1099/vir.0.017459-0; Boon ACM, 2009, CURR TOP MICROBIOL, V333, P25, DOI 10.1007/978-3-540-92165-3_2; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Carroll MW, 1997, CURR OPIN BIOTECH, V8, P573, DOI 10.1016/S0958-1669(97)80031-6; Crevar CJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-131; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epstein SL, 1998, J IMMUNOL, V160, P322; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hessel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012217; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Holzer GW, 1998, VIROLOGY, V249, P160, DOI 10.1006/viro.1998.9307; Holzer GW, 1999, J VIROL, V73, P4536, DOI 10.1128/JVI.73.6.4536-4542.1999; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kreijtz JHCM, 2009, VACCINE, V27, P6296, DOI 10.1016/j.vaccine.2009.03.020; Kreijtz JHCM, 2009, J INFECT DIS, V199, P405, DOI 10.1086/595984; Kreijtz JHCM, 2007, J INFECT DIS, V195, P1598, DOI 10.1086/517614; Kreijtz JHCM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007790; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-80; Mayr A, 1978, Dev Biol Stand, V41, P225; MAYR A, 1975, INFECTION, V3, P9; Mayrhofer J, 2009, J VIROL, V83, P5192, DOI 10.1128/JVI.02081-08; Murakami S, 2008, VACCINE, V26, P6398, DOI 10.1016/j.vaccine.2008.08.053; REED L. J., 1938, AMER JOUR HYG, V27, P493; Scheiflinger F, 1998, ARCH VIROL, V143, P467, DOI 10.1007/s007050050303; Su Y, 2008, ARCH VIROL, V153, P2253, DOI 10.1007/s00705-008-0255-y; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; WRIGHT PF, 2007, FIELDS VIROLOGY, P1728; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200	38	44	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16247	10.1371/journal.pone.0016247	http://dx.doi.org/10.1371/journal.pone.0016247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283631	gold, Green Published, Green Submitted			2022-12-25	WOS:000286523400028
J	Gopalan, S; Ausubel, FM				Gopalan, Suresh; Ausubel, Frederick M.			A High Throughput Amenable Arabidopsis-P. aeruginosa System Reveals a Rewired Regulatory Module and the Utility to Identify Potent Anti-Infectives	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; VIRULENCE FACTORS; PSEUDOMONAS; GACA; PATHOGENICITY; INFLAMMATION; EXPRESSION; MUTUALISM; INTESTINE; DISEASE	We previously demonstrated that in a metasystem consisting of Arabidopsis seedlings growing in liquid medium (in 96 well plates) even microbes considered to be innocuous such as laboratory strains of E. coli and B. subtilis can cause potent damage to the host. We further posited that such environment-induced adaptations are brought about by 'system status changes' (rewiring of pre-existing cellular signaling networks and components) of the host and the microbe, and that prolongation of such a situation could lead to the emergence of pathogenic states in real-life. Here, using this infection model, we show that the master regulator GacA of the human opportunistic pathogen P. aeruginosa (strain PA14) is dispensable for pathogenesis, as evidenced by three independent read-outs. The gene expression profile of the host after infection with wild type PA14 or the gacA mutant are also identical. GacA normally acts upstream of the quorum sensing regulatory circuit (that includes the regulator LasR) that controls a subset of virulence factors. Double mutants in gacA and lasR behave similar to the lasR mutant, as seen by abrogation of a characteristic cell type specific host cell damage caused by PA14 or the gacA mutant. This indicates that a previously unrecognized regulatory mechanism is operative under these conditions upstream of LasR. In addition, the detrimental effect of PA14 on Arabidopsis seedlings is resistant to high concentrations of the aminoglycoside antibiotic gentamicin. These data suggest that the Arabidopsis seedling infection system could be used to identify anti-infectives with potentially novel modes of action.	[Gopalan, Suresh; Ausubel, Frederick M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Gopalan, Suresh; Ausubel, Frederick M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gopalan, S (corresponding author), ReSurfX LLC, Lexington, MA USA.	gopalans@resurfx.com			NIH [R37 GM48707]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by grant R37 GM48707 from NIH to F.M.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Chatterjee A, 2003, MOL PLANT MICROBE IN, V16, P1106, DOI 10.1094/MPMI.2003.16.12.1106; De Kievit TR, 2001, ANTIMICROB AGENTS CH, V45, P1761, DOI 10.1128/AAC.45.6.1761-1770.2001; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gauthier JD, 2010, MICROBIOL-SGM, V156, P3722, DOI 10.1099/mic.0.043422-0; Gopalan S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003891; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Medzhitov R, 2010, NAT IMMUNOL, V11, P551, DOI 10.1038/ni0710-551; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Wolfgang MC, 2004, P NATL ACAD SCI USA, V101, P6664, DOI 10.1073/pnas.0307553101	18	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16381	10.1371/journal.pone.0016381	http://dx.doi.org/10.1371/journal.pone.0016381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283656	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522300042
J	Yuan, A; Lin, CY; Chou, CH; Shih, CM; Chen, CY; Cheng, HW; Chen, YF; Chen, JJW; Chen, JH; Yang, PC; Chang, C				Yuan, Ang; Lin, Chien-Yuan; Chou, Cheng-Hung; Shih, Chia-Ming; Chen, Chih-Yuan; Cheng, Hao-Wei; Chen, Yi-Fang; Chen, Jeremy J. W.; Chen, Jyh-Horng; Yang, Pan-Chyr; Chang, Chen			Functional and Structural Characteristics of Tumor Angiogenesis in Lung Cancers Overexpressing Different VEGF Isoforms Assessed by DCE- and SSCE-MRI	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CONTRAST-ENHANCED MRI; CELL-ASSOCIATED ISOFORM; MESSENGER-RNA; VASCULAR-PERMEABILITY; EXTRACELLULAR-MATRIX; EXPRESSION PATTERN; HUMAN-MELANOMA; COLON-CANCER; METASTASIS	The expressions of different vascular endothelial growth factor (VEGF) isoforms are associated with the degree of tumor invasiveness and the patient's prognosis in human cancers. We hypothesized that different VEGF isoforms can exert different effects on the functional and structural characteristics of tumor angiogenesis. We used dynamic contrast-enhanced MRI (DCE-MRI) and steady-state contrast-enhanced MRI (SSCE-MRI) to evaluate in vivo vascular functions (e.g., perfusion and permeability) and structural characteristics (e.g., vascular size and vessel density) of the tumor angiogenesis induced by different VEGF isoforms (VEGF121, VEGF165, and VEGF189) in a murine xenograft model of human lung cancer. Tumors overexpressing VEGF189 were larger than those overexpressing the other two VEGF isoforms. The K(trans) map obtained from DCE-MRI revealed that the perfusion and permeability functions of tumor microvessels was highest in both the rim and core regions of VEGF189-overexpressing tumors (p < 0.001 for both tumor rim and core). The relative vessel density and relative vessel size indexes derived from SSCE-MRI revealed that VEGF189-overexpressing tumors had the smallest (p < 0.05) and the most-dense (p < 0.01) microvessels, which penetrated deeply from the tumor rim into the core, followed by the VEGF165-overepxressing tumor, whose microvessels were located mainly in the tumor rim. The lowest-density microvessels were found in the VEGF121-overexpressing tumor; these microvessels had a relatively large lumen and were found mainly in the tumor rim. We conclude that among the three VEGF isoforms evaluated, VEGF189 induces the most densely sprouting and smallest tumor microvessels with the highest in vivo perfusion and permeability functions. These characteristics of tumor microvessels may contribute to the reported adverse effects of VEGF189 overexpression on tumor progression, metastasis, and patient survival in several human cancers, including non-small cell lung cancer, and suggest that applying aggressive therapy may be necessary in human cancers in which VEGF189 is overexpressed.	[Yuan, Ang; Cheng, Hao-Wei; Chen, Yi-Fang; Yang, Pan-Chyr] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lin, Chien-Yuan; Chou, Cheng-Hung; Shih, Chia-Ming; Chen, Chih-Yuan; Chang, Chen] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Biomed Sci & Mol Biol, Taichung 40227, Taiwan; [Chen, Jyh-Horng] Natl Taiwan Univ, Inst Biomed Elect & Bioinformat, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Chung Hsing University; National Taiwan University	Yuan, A (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	pcyang@ntu.edu.tw; bmcchen@ibms.sinica.edu.tw	Tu, Yiling/C-5610-2011; Chang, Chen/B-5079-2009	Chen, Jeremy J.W./0000-0003-1049-3825; YANG, PAN-CHYR/0000-0001-6330-6048; YUAN, ANG/0000-0002-5664-1339	National Science Council [NSC 98-3112-B-001-019]; Center for Genomic Medicine, National Taiwan University College of Medicine; Department of Medical Research, National Taiwan University Hospital, Taiwan, ROC	National Science Council(Ministry of Science and Technology, Taiwan); Center for Genomic Medicine, National Taiwan University College of Medicine; Department of Medical Research, National Taiwan University Hospital, Taiwan, ROC	The study is funded by National Science Council (http://web1.nsc.gov.tw), grant number NSC 98-3112-B-001-019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the technical assistance from the Functional and Micro-Magnetic Resonance Imaging Center supported by the National Research Program for Genomic Medicine, National Science Council; Center for Genomic Medicine, National Taiwan University College of Medicine; and Department of Medical Research, National Taiwan University Hospital, Taiwan, ROC. The authors also thank Miss Sui-Shan Lin for cell culture and operation on image scanning.	Ancelin M, 2002, P NATL ACAD SCI USA, V99, P6023, DOI 10.1073/pnas.082110999; Barrett T, 2007, J MAGN RESON IMAGING, V26, P235, DOI 10.1002/jmri.20991; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Checkley D, 2003, BRIT J CANCER, V89, P1889, DOI 10.1038/sj.bjc.6601386; Chen JJW, 2001, CANCER RES, V61, P5223; Cheng SY, 1997, P NATL ACAD SCI USA, V94, P12081, DOI 10.1073/pnas.94.22.12081; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Cressey R, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-128; Cuenod CA, 2006, ABDOM IMAGING, V31, P188, DOI 10.1007/s00261-005-0386-5; Dennie J, 1998, MAGN RESON MED, V40, P793, DOI 10.1002/mrm.1910400602; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 2006, TUMOR ANGIOGENESIS; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Goh V, 2006, ABDOM IMAGING, V31, P194, DOI 10.1007/s00261-005-0387-4; Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; Jacobsen J, 2006, BJU INT, V97, P1102, DOI 10.1111/j.1464-410X.2006.06138.x; Jensen JH, 2000, MAGNET RESON MED, V44, P224, DOI 10.1002/1522-2594(200008)44:2<224::AID-MRM9>3.0.CO;2-M; Kusters B, 2003, CANCER RES, V63, P5408; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lin CY, 2008, J CEREBR BLOOD F MET, V28, P1491, DOI 10.1038/jcbfm.2008.42; Mattei MG, 1996, GENOMICS, V32, P168, DOI 10.1006/geno.1996.0098; Miller JC, 2005, JNCI-J NATL CANCER I, V97, P172, DOI 10.1093/jnci/dji023; Neeman M, 2003, ANNU REV BIOMED ENG, V5, P29, DOI 10.1146/annurev.bioeng.5.040202.121606; Oshika Y, 1998, INT J ONCOL, V12, P541; Padhani AR, 2001, CLIN RADIOL, V56, P607, DOI 10.1053/crad.2001.0762; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Parker G J, 1999, Top Magn Reson Imaging, V10, P130, DOI 10.1097/00002142-199904000-00006; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Schaefer JF, 2006, LUNG CANCER-J IASLC, V53, P39, DOI 10.1016/j.lungcan.2006.03.010; SHIH C, 2009, P INT SOC MAG RESON, V17, P2286; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; TAKAHASHI Y, 1995, CANCER RES, V55, P3964; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Tokunaga T, 1998, ONCOL REP, V5, P1115; Tokunaga T, 1998, BRIT J CANCER, V77, P998, DOI 10.1038/bjc.1998.164; Tozer GM, 2008, CANCER RES, V68, P2301, DOI 10.1158/0008-5472.CAN-07-2011; WEIDNER N, 1995, AM J PATHOL, V147, P9; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Wu EX, 2004, NMR BIOMED, V17, P478, DOI 10.1002/nbm.923; Wu EX, 2004, NMR BIOMED, V17, P507, DOI 10.1002/nbm.921; Yuan A, 2001, J CLIN ONCOL, V19, P432, DOI 10.1200/JCO.2001.19.2.432; Yuan A, 2002, J CLIN ONCOL, V20, P900, DOI 10.1200/JCO.20.4.900	49	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16062	10.1371/journal.pone.0016062	http://dx.doi.org/10.1371/journal.pone.0016062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283766	gold, Green Submitted, Green Published			2022-12-25	WOS:000286522200026
J	Lin, RY; Lu, GD; Wang, JH; Zhang, CS; Xie, WJ; Lu, XM; Mantion, G; Martin, H; Richert, L; Vuitton, DA; Wen, H				Lin, Renyong; Lue, Guodong; Wang, Junhua; Zhang, Chuanshan; Xie, Wenjuan; Lu, Xiaomei; Mantion, Georges; Martin, Helene; Richert, Lysiane; Vuitton, Dominique A.; Wen, Hao			Time Course of Gene Expression Profiling in the Liver of Experimental Mice Infected with Echinococcus multilocularis	PLOS ONE			English	Article							SERUM AMYLOID-A; EXPERIMENTAL ALVEOLAR ECHINOCOCCOSIS; DOWN-REGULATION; MESSENGER-RNA; CELL-SURVIVAL; HEPATITIS-B; APOPTOSIS; PROTEIN; CYTOCHROME-P450; IDENTIFICATION	Background: Alveolar echinococcosis (AE) is a severe chronic parasitic disease which behaves like a slow-growing liver cancer. Clinical observations suggest that the parasite, Echinococcus multilocularis (E. multilocularis) influences liver homeostasis and hepatic cell metabolism. However, this has never been analyzed during the time course of infection in the common model of secondary echinococcosis in experimental mice. Methodology/Principal Findings: Gene expression profiles were assessed using DNA microarray analysis, 1, 2, 3 and 6 months after injection of E. multilocularis metacestode in the liver of susceptible mice. Data were collected at different time points to monitor the dynamic behavior of gene expression. 557 differentially expressed genes were identified at one or more time points, including 351 up-regulated and 228 down-regulated genes. Time-course analysis indicated, at the initial stage of E. multilocularis infection (month 1-2), that most of up-regulated pathways were related to immune processes and cell trafficking such as chemokine-, mitogen-activated protein kinase (MAPK) signaling, and down-regulated pathways were related to xenobiotic metabolism; at the middle stage (month 3), MAPK signaling pathway was maintained and peroxisome proliferator-activated receptor (PPAR) signaling pathway emerged; at the late stage (month 6), most of up-regulated pathways were related to PPAR signaling pathway, complement and coagulation cascades, while down-regulated pathways were related to metabolism of xenobiotics by cytochrome P450. Quantitative RT-PCR analysis of a random selection of 19 genes confirmed the reliability of the microarray data. Immunohistochemistry analysis showed that proliferating cell nuclear antigen (PCNA) was increased in the liver of E. multilocularis infected mice from 2 months to 6 months. Conclusions: E. multilocularis metacestode definitely exerts a deep influence on liver homeostasis, by modifying a number of gene expression and metabolic pathways. It especially promotes hepatic cell proliferation, as evidenced by the increased PCNA constantly found in all the experimental time-points we studied and by an increased gene expression of key metabolic pathways.	[Lin, Renyong; Lue, Guodong; Wang, Junhua; Zhang, Chuanshan; Xie, Wenjuan; Lu, Xiaomei; Wen, Hao] Xinjiang Med Univ, Affiliated Hosp 1, Xinjiang Key Lab Echinococcosis, Urumqi, Peoples R China; [Lin, Renyong; Lue, Guodong; Wang, Junhua; Zhang, Chuanshan; Xie, Wenjuan; Lu, Xiaomei; Wen, Hao] Xinjiang Med Univ, Affiliated Hosp 1, Med Res Ctr, Urumqi, Peoples R China; [Lin, Renyong; Mantion, Georges; Martin, Helene; Richert, Lysiane] Univ Franche Comte, Lab Toxicol Cellulaire, Fac Med & Pharm, EA 4267, F-25030 Besancon, France; [Mantion, Georges; Vuitton, Dominique A.] Univ Franche Comte, Jean Minjoz Hosp, Dept Digest Surg, World Hlth Org Collaborating Ctr Prevent & Treatm, F-25030 Besancon, France; [Mantion, Georges; Vuitton, Dominique A.] Univ Hosp, Besancon, France	Xinjiang Medical University; Xinjiang Medical University; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; World Health Organization; Universite de Franche-Comte; CHU Besancon	Lin, RY (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Xinjiang Key Lab Echinococcosis, Urumqi, Peoples R China.	dominique.vuitton@univ-fcomte.fr; Dr.wenhao@163.com	Wang, Junhua/ABB-6324-2021	MARTIN, helene/0000-0001-8318-3858; Wang, Junhua/0000-0002-6110-3711	National Science Foundation of China [30860253]; Technology Foundation for Xinjiang Uygur Autonomous Region of China [200891126]; French Ministry of Foreign Affairs for LRY (French Embassy in Beijing)	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Foundation for Xinjiang Uygur Autonomous Region of China; French Ministry of Foreign Affairs for LRY (French Embassy in Beijing)	This work was supported by grants from the National Science Foundation of China (30860253), the Technology Foundation for Xinjiang Uygur Autonomous Region of China (200891126), and a PhD grant (theses en alternance) from the French Ministry of Foreign Affairs for LRY (French Embassy in Beijing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIKHAN Z, 1988, EXP PARASITOL, V67, P334, DOI 10.1016/0014-4894(88)90080-X; ARMSTRONG SG, 1994, INT J IMMUNOPHARMACO, V16, P747, DOI 10.1016/0192-0561(94)90094-9; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Bell AW, 1996, SCAND J IMMUNOL, V43, P173, DOI 10.1046/j.1365-3083.1996.d01-26.x; BONDY SC, 1994, BIOCHEM PHARMACOL, V48, P155, DOI 10.1016/0006-2952(94)90235-6; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; BRESSONHADNI S, 1994, EUR CYTOKINE NETW, V5, P461; BRESSONHADNI S, 1990, CLIN EXP IMMUNOL, V82, P378, DOI 10.1111/j.1365-2249.1990.tb05457.x; BRESSONHADNI S, 2007, TXB HEPATOLOGY BASIC, V1, P1047; CELIS JE, 1987, FEBS LETT, V220, P1, DOI 10.1016/0014-5793(87)80865-7; Chawla M, 2003, J LIPID RES, V44, P594, DOI 10.1194/jlr.M200296-JLR200; Chen L, 2002, J BIOL CHEM, V277, P34329, DOI 10.1074/jbc.M201344200; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; Craig P, 2003, CURR OPIN INFECT DIS, V16, P437, DOI 10.1097/00001432-200310000-00010; De-Oliveira ACAX, 2006, EXP PARASITOL, V113, P256, DOI 10.1016/j.exppara.2006.01.013; Deplazes P, 2005, VET PARASITOL, V130, P213, DOI 10.1016/j.vetpar.2005.03.034; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; DU T, 1990, J EXP PATHOL, V71, P313; El-Kowrany Samy I., 2001, Journal of the Egyptian Society of Parasitology, V31, P245; FORNACE AJ, 1992, ANN NY ACAD SCI, V663, P139, DOI 10.1111/j.1749-6632.1992.tb38657.x; GABRION C, 1995, INT J PARASITOL, V25, P127, DOI 10.1016/0020-7519(94)00086-4; Gavrilescu LC, 2001, J IMMUNOL, V167, P902, DOI 10.4049/jimmunol.167.2.902; Gottstein B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009779; Gressner OA, 2008, J GASTROEN HEPATOL, V23, P1024, DOI 10.1111/j.1440-1746.2008.05345.x; Guerret S, 1998, PARASITOL RES, V84, P657, DOI 10.1007/s004360050466; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hatanaka E, 2003, FEMS IMMUNOL MED MIC, V38, P81, DOI 10.1016/S0928-8244(03)00112-3; Hauet-Broere F, 2006, ANN RHEUM DIS, V65, P65, DOI 10.1136/ard.2006.058495; Hill EW, 2005, VET IMMUNOL IMMUNOP, V105, P247, DOI 10.1016/j.vetimm.2005.02.004; Honda M, 2001, GASTROENTEROLOGY, V120, P955, DOI 10.1053/gast.2001.22468; Horton J, 2003, FUND CLIN PHARMACOL, V17, P205; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jirillo E, 2002, J ENDOTOXIN RES, V8, P319, DOI 10.1179/096805102125000641; Kepron C, 2002, J HELMINTHOL, V76, P31, DOI 10.1079/JOH200188; Leu JI, 2003, J CLIN INVEST, V111, P129, DOI 10.1172/JCI200316712; LIANCE M, 1984, EXPERIENTIA, V40, P1436, DOI 10.1007/BF01951932; Lin RY, 2009, WORLD J GASTROENTERO, V15, P2116, DOI 10.3748/wjg.15.2116; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Missiaglia E, 2004, INT J CANCER, V112, P100, DOI 10.1002/ijc.20376; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ortona E, 2003, PARASITE IMMUNOL, V25, P119, DOI 10.1046/j.1365-3024.2003.00617.x; Pahlavan PS, 2006, J SURG RES, V134, P238, DOI 10.1016/j.jss.2005.12.011; Prosser CC, 2006, WORLD J GASTROENTERO, V12, P509, DOI 10.3748/wjg.v12.i4.509; Ribeiro FP, 2003, MEDIAT INFLAMM, V12, P173, DOI 10.1080/0962935031000134897; Richardson TA, 2006, DRUG METAB DISPOS, V34, P354, DOI 10.1124/dmd.105.007393; Rodriguez EVA, 2003, J LEUKOCYTE BIOL, V73, P127, DOI 10.1189/jlb.0702353; Roudkenar MH, 2008, J RADIAT RES, V49, P29, DOI 10.1269/jrr.07078; Roudkenar MH, 2007, J RADIAT RES, V48, P39, DOI 10.1269/jrr.06057; Samanta TB, 2003, BIOCHEM BIOPH RES CO, V312, P75, DOI 10.1016/j.bbrc.2003.09.227; Sharma MR, 2008, EXP MOL PATHOL, V84, P46, DOI 10.1016/j.yexmp.2007.10.001; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Stiles JK, 2001, ANN TROP MED PARASIT, V95, P797, DOI 10.1080/00034980120111145; Tangkijvanich P, 2002, EUR J SURG, V168, P100; Tannapfel A, 2002, VIRCHOWS ARCH, V440, P345, DOI 10.1007/s00428-002-0617-x; Volkmann X, 2008, HEPATOLOGY, V47, P1624, DOI 10.1002/hep.22237; VUITTON D, 1999, HEPATOLOGY; Vuitton DA, 2003, ACTA TROP, V85, P119, DOI 10.1016/S0001-706X(02)00230-9; VUITTON DA, 1986, Z PARASITENKD, V72, P97, DOI 10.1007/BF00927740; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Wiese L, 2006, EXP NEUROL, V200, P216, DOI 10.1016/j.expneurol.2006.02.011; Wu Jian, 1999, Frontiers in Bioscience, V4, pd520; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Zhang S, 2008, J INFECT DIS, V197, P1341, DOI 10.1086/586709; Zhang WY, 2009, ACTA PHARMACOL SIN, V30, P424, DOI 10.1038/aps.2009.22; Zuniga E, 2000, CLIN EXP IMMUNOL, V119, P507, DOI 10.1046/j.1365-2249.2000.01150.x	69	88	96	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e14557	10.1371/journal.pone.0014557	http://dx.doi.org/10.1371/journal.pone.0014557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283804	Green Published, Green Submitted, gold			2022-12-25	WOS:000286520600004
J	Franck, N; Montembault, E; Rome, P; Pascal, A; Cremet, JY; Giet, R				Franck, Nathalie; Montembault, Emilie; Rome, Pierre; Pascal, Aude; Cremet, Jean-Yves; Giet, Regis			CDK11(p58) Is Required for Centriole Duplication and Plk4 Recruitment to Mitotic Centrosomes	PLOS ONE			English	Article							HUMAN-CELLS; PROTEIN SPD-2; POLO KINASE; C-ELEGANS; CYTOKINESIS; ABERRATIONS; BIOGENESIS; MATURATION; NUMBER; CYCLE	Background: CDK11(p58) is a mitotic protein kinase, which has been shown to be required for different mitotic events such as centrosome maturation, chromatid cohesion and cytokinesis. Methodology/Principal Findings: In addition to these previously described roles, our study shows that CDK11(p58) inhibition induces a failure in the centriole duplication process in different human cell lines. We propose that this effect is mediated by the defective centrosomal recruitment of proteins at the onset of mitosis. Indeed, Plk4 protein kinase and the centrosomal protein Cep192, which are key components of the centriole duplication machinery, showed reduced levels at centrosomes of mitotic CDK11-depleted cells. CDK11(p58), which accumulates only in the vicinity of mitotic centrosomes, directly interacts with the centriole-associated protein kinase Plk4 that regulates centriole number in cells. In addition, we show that centriole from CDK11 defective cells are not able to be over duplicated following Plk4 overexpression. Conclusion/Significance: We thus propose that CDK11 is required for centriole duplication by two non-mutually-exclusive mechanisms. On one hand, the observed duplication defect could be caused indirectly by a failure of the centrosome to fully maturate during mitosis. On the other hand, CDK11(p58) could also directly regulate key centriole components such as Plk4 during mitosis to trigger essential mitotic centriole modifications, required for centriole duplication during subsequent interphase.	[Franck, Nathalie; Montembault, Emilie; Rome, Pierre; Pascal, Aude; Cremet, Jean-Yves; Giet, Regis] Univ Rennes 1, CNRS, UMR6061, Inst Genet & Dev Rennes, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Franck, N (corresponding author), Univ Rennes 1, CNRS, UMR6061, Inst Genet & Dev Rennes, Rennes, France.	regis.giet@univ-rennes1.fr		Rome, Pierre/0000-0001-5611-5323; MONTEMBAULT-SEVIN, Emilie/0000-0002-4191-9094	Agence Nationale de la Recherche (programme Jeune Chercheur); Ligue Nationale Contre le Cancer (Equipe Labellise)	Agence Nationale de la Recherche (programme Jeune Chercheur)(French National Research Agency (ANR)); Ligue Nationale Contre le Cancer (Equipe Labellise)	RG and NF are funded by the Agence Nationale de la Recherche (programme Jeune Chercheur) and the Ligue Nationale Contre le Cancer (Equipe Labellise). EM and PR are doctoral fellows of the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bonni S, 2008, CELL CYCLE, V7, P545, DOI 10.4161/cc.7.4.5387; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Cunha-Ferreira I, 2009, TRAFFIC, V10, P482, DOI 10.1111/j.1600-0854.2009.00905.x; Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; DZHINDZHEV NS, NATURE; Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Hu DL, 2007, J CELL SCI, V120, P2424, DOI 10.1242/jcs.007963; KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Kitagawa D, 2009, DEV CELL, V17, P900, DOI 10.1016/j.devcel.2009.11.002; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Montembault E, 2007, J CELL BIOL, V179, P601, DOI 10.1083/jcb.200703133; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Palazzo RE, 1999, J CELL SCI, V112, P1291; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Petrinac S, 2009, CELL CYCLE, V8, P327, DOI 10.4161/cc.8.2.7355; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Tanenbaum ME, 2007, NAT CELL BIOL, V9, P1127, DOI 10.1038/ncb1007-1127; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055	35	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14600	10.1371/journal.pone.0014600	http://dx.doi.org/10.1371/journal.pone.0014600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297952	Green Published, gold			2022-12-25	WOS:000286834300003
J	Sautya, S; Ingole, B; Ray, D; Stohr, S; Samudrala, K; Raju, KAK; Mudholkar, A				Sautya, Sabyasachi; Ingole, Baban; Ray, Durbar; Stohr, Sabine; Samudrala, Kiranmai; Raju, K. A. Kamesh; Mudholkar, Abhay			Megafaunal Community Structure of Andaman Seamounts Including the Back-Arc Basin - A Quantitative Exploration from the Indian Ocean	PLOS ONE			English	Article							HEXACTINELLID SPONGE; PHERONEMA-CARPENTERI; SPECIES RICHNESS; ENDEMISM	Species rich benthic communities have been reported from some seamounts, predominantly from the Atlantic and Pacific Oceans, but the fauna and habitats on Indian Ocean seamounts are still poorly known. This study focuses on two seamounts, a submarine volcano (cratered seamount - CSM) and a non-volcano (SM2) in the Andaman Back-arc Basin (ABB), and the basin itself. The main purpose was to explore and generate regional biodiversity data from summit and flank (upper slope) of the Andaman seamounts for comparison with other seamounts worldwide. We also investigated how substratum types affect the megafaunal community structure along the ABB. Underwater video recordings from TeleVision guided Gripper (TVG) lowerings were used to describe the benthic community structure along the ABB and both seamounts. We found 13 varieties of substratum in the study area. The CSM has hard substratum, such as boulders and cobbles, whereas the SM2 was dominated by cobbles and fine sediment. The highest abundance of megabenthic communities was recorded on the flank of the CSM. Species richness and diversity were higher at the flank of the CSM than other are of ABB. Non-metric multi-dimensional scaling (nMDS) analysis of substratum types showed 50% similarity between the flanks of both seamounts, because both sites have a component of cobbles mixed with fine sediments in their substratum. Further, nMDS of faunal abundance revealed two groups, each restricted to one of the seamounts, suggesting faunal distinctness between them. The sessile fauna corals and poriferans showed a significant positive relation with cobbles and fine sediments substratum, while the mobile categories echinoderms and arthropods showed a significant positive relation with fine sediments only.	[Sautya, Sabyasachi; Ingole, Baban; Ray, Durbar; Samudrala, Kiranmai; Raju, K. A. Kamesh; Mudholkar, Abhay] Natl Inst Oceanog CSIR, Panaji, Goa, India; [Stohr, Sabine] Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Swedish Museum of Natural History	Sautya, S (corresponding author), Natl Inst Oceanog CSIR, Panaji, Goa, India.	sabya_aqua@rediffmail.com	Stöhr, Sabine/B-8629-2011; Ingole, Baban Shravan/GLR-9722-2022	Stöhr, Sabine/0000-0002-2586-7239; Sautya, Sabyasachi/0000-0003-2229-5834; Ingole, Baban/0000-0001-6096-6980	CenSeam (Global Census of Marine Life on Seamount)	CenSeam (Global Census of Marine Life on Seamount)	The CenSeam (Global Census of Marine Life on Seamount) provided the financial support to identify the benthic invertebrates and publish the data. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Barthel D, 1996, MAR ECOL-P S Z N I, V17, P603, DOI 10.1111/j.1439-0485.1996.tb00420.x; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clarke K.R., 2006, PRIMER; Clarke KR, 1994, CHANGE MARINE COMMUN; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; GRANGE K, 1994, P 2 INT TEMP REEF S, P169; Grigg R.W., 1974, Proceedings int Coral Reef Symp, V2, P235; GRIGG RICHARD W., 1965, PACIFIC SCI, V19, P244; GRIGG RW, 1984, PSZNI MAR ECOL, V5, P57, DOI 10.1111/j.1439-0485.1984.tb00307.x; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Hoff Gerald R., 2005, Alaska Fishery Research Bulletin, V11, P27; Holme N. A., 1984, METHODS STUDY MARINE; HUBBS CARL L., 1959, PACIFIC SCI, V13, P311; INGOLE B, 2009, JMBA 2 BIODIVERSITY, P1; KAMESHRAJU KA, 2007, GEOPHYS RES LETT, V34, DOI DOI 10.1029/2006GL028730; KATTOJU KR, 2010, EOS T AGU S, V89; Margalef R., 1968, PERSPECTIVES ECOLOGI; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; McClain CR, 2007, J BIOGEOGR, V34, P2001, DOI 10.1111/j.1365-2699.2007.01783.x; McClain CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004141; O'Hara TD, 2007, GLOBAL ECOL BIOGEOGR, V16, P720, DOI 10.1111/j.1466-8238.2007.00329.x; O'Hara TD, 2010, MAR ECOL-EVOL PERSP, V31, P26, DOI 10.1111/j.1439-0485.2010.00373.x; PIELOU EC, 1966, J THEOR BIOL, V10, P370, DOI 10.1016/0022-5193(66)90133-0; Pitcher TJ, 2010, OCEANOGRAPHY, V23, P134, DOI 10.5670/oceanog.2010.66; Raju KAK, 2004, EARTH PLANET SC LETT, V221, P145, DOI 10.1016/S0012-821X(04)00075-5; RAYMORE PA, 1982, PAC SCI, V36, P15; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; RICE AL, 1990, PROG OCEANOGR, V24, P179, DOI 10.1016/0079-6611(90)90029-2; Sautya S, 2010, ZOOTAXA, P64; Shannon C.E., 1963, MATH THEORY COMMUNIC; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; STOCKS K, SEAMOUNTS ONLINE ONL; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; WRIGHT IC, 1994, MAR GEOL, V118, P217, DOI 10.1016/0025-3227(94)90085-X	35	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16162	10.1371/journal.pone.0016162	http://dx.doi.org/10.1371/journal.pone.0016162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297959	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300037
J	Biber, U; Ilg, UJ				Biber, Ulrich; Ilg, Uwe J.			Visual Stability and the Motion Aftereffect: A Psychophysical Study Revealing Spatial Updating	PLOS ONE			English	Article							FRONTAL EYE FIELD; MONKEY SUPERIOR COLLICULUS; BRAIN-STEM TELLS; CORTICAL AREA MT; COROLLARY DISCHARGE; RESPONSE PROPERTIES; RECEPTIVE-FIELDS; TRANSSACCADIC INTEGRATION; FUNCTIONAL-PROPERTIES; TEMPORAL INTEGRATION	Eye movements create an ever-changing image of the world on the retina. In particular, frequent saccades call for a compensatory mechanism to transform the changing visual information into a stable percept. To this end, the brain presumably uses internal copies of motor commands. Electrophysiological recordings of visual neurons in the primate lateral intraparietal cortex, the frontal eye fields, and the superior colliculus suggest that the receptive fields (RFs) of special neurons shift towards their post-saccadic positions before the onset of a saccade. However, the perceptual consequences of these shifts remain controversial. We wanted to test in humans whether a remapping of motion adaptation occurs in visual perception. The motion aftereffect (MAE) occurs after viewing of a moving stimulus as an apparent movement to the opposite direction. We designed a saccade paradigm suitable for revealing pre-saccadic remapping of the MAE. Indeed, a transfer of motion adaptation from pre-saccadic to post-saccadic position could be observed when subjects prepared saccades. In the remapping condition, the strength of the MAE was comparable to the effect measured in a control condition (33 +/- 7% vs. 27 +/- 4%). Contrary, after a saccade or without saccade planning, the MAE was weak or absent when adaptation and test stimulus were located at different retinal locations, i.e. the effect was clearly retinotopic. Regarding visual cognition, our study reveals for the first time predictive remapping of the MAE but no spatiotopic transfer across saccades. Since the cortical sites involved in motion adaptation in primates are most likely the primary visual cortex and the middle temporal area (MT/V5) corresponding to human MT, our results suggest that pre-saccadic remapping extends to these areas, which have been associated with strict retinotopy and therefore with classical RF organization. The pre-saccadic transfer of visual features demonstrated here may be a crucial determinant for a stable percept despite saccades.	[Biber, Ulrich; Ilg, Uwe J.] Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Biber, U (corresponding author), Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany.	ulrich.biber@student.uni-tuebingen.de		Ilg, Uwe/0000-0003-2623-1627; Biber, Ulrich/0000-0001-9788-1761	Deutsche Forschungsgemeinschaft (DFG IL) [34/6-1]	Deutsche Forschungsgemeinschaft (DFG IL)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG IL) 34/6-1 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Andersen R A, 1992, Curr Opin Neurobiol, V2, P840, DOI 10.1016/0959-4388(92)90143-9; ANGEL RW, 1980, ANN NEUROL, V7, P73, DOI 10.1002/ana.410070113; Bair W, 2004, J NEUROSCI, V24, P7305, DOI 10.1523/JNEUROSCI.0554-04.2004; BAIZER JS, 1982, INVEST OPHTH VIS SCI, V23, P87; Baizer JS, 1999, J NEUROPHYSIOL, V81, P1960, DOI 10.1152/jn.1999.81.4.1960; BAKER JF, 1981, J NEUROPHYSIOL, V45, P397, DOI 10.1152/jn.1981.45.3.397; Bakola S, 2007, J NEUROSCI, V27, P2224, DOI 10.1523/JNEUROSCI.4224-06.2007; BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; Bisley James W, 2003, Adv Neurol, V93, P141; BLATT GJ, 1990, J COMP NEUROL, V300, P1; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; CHAPMAN J, 1966, BRIT J PSYCHIAT, V112, P225, DOI 10.1192/bjp.112.484.225; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; DUHAMEL JR, 1992, BRAIN, V115, P1387, DOI 10.1093/brain/115.5.1387; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Ezzati A, 2008, J VISION, V8, DOI 10.1167/8.14.23; Feinberg I, 1999, BRIT J PSYCHIAT, V174, P196, DOI 10.1192/bjp.174.3.196; FELLEMAN DJ, 1984, J NEUROPHYSIOL, V52, P488, DOI 10.1152/jn.1984.52.3.488; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Filehne W., 1922, Z SINNESPHYSIOL, V53, P134; Ford JM, 2001, AM J PSYCHIAT, V158, P2069, DOI 10.1176/appi.ajp.158.12.2069; GAYMARD B, 1994, EXP BRAIN RES, V102, P1; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Gysen V, 2002, VISION RES, V42, P1785, DOI 10.1016/S0042-6989(02)00105-0; Gysen V, 2002, VISION RES, V42, P379, DOI 10.1016/S0042-6989(01)00296-6; Haarmeier T, 1997, NATURE, V389, P849, DOI 10.1038/39872; HALLETT PE, 1976, VISION RES, V16, P107, DOI 10.1016/0042-6989(76)90084-5; HARTING JK, 1980, J COMP NEUROL, V192, P853, DOI 10.1002/cne.901920414; HEIDE W, 1995, ANN NEUROL, V38, P739, DOI 10.1002/ana.410380508; Heiser LM, 2006, J NEUROPHYSIOL, V95, P2751, DOI 10.1152/jn.00054.2005; Helmholtz Hermann von, 1962, PHYSL OPTICS; HIRIS E, 1992, P NATL ACAD SCI USA, V89, P9025, DOI 10.1073/pnas.89.19.9025; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Khayat PS, 2004, P NATL ACAD SCI USA, V101, P12712, DOI 10.1073/pnas.0301935101; Knapen T, 2009, J VISION, V9, DOI [10.1167/9.13.16, 10.1167/9.5.16]; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; KORNMULLER AE, 1931, PSYCHOLOGIE, V41, P354; LEICHNETZ GR, 1989, VISUAL NEUROSCI, V3, P171, DOI 10.1017/S0952523800004478; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; MAIOLI MG, 1983, BRAIN RES, V265, P294, DOI 10.1016/0006-8993(83)90345-1; MASLAND RH, 1969, SCIENCE, V165, P819, DOI 10.1126/science.165.3895.819; Mather G., 1998, MOTION AFTEREFFECT M; Mather G, 2008, TRENDS COGN SCI, V12, P481, DOI 10.1016/j.tics.2008.09.002; MATIN L, 1982, SCIENCE, V216, P198, DOI 10.1126/science.7063881; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; Melcher D, 2007, NAT NEUROSCI, V10, P903, DOI 10.1038/nn1917; Melcher D, 2008, TRENDS COGN SCI, V12, P466, DOI 10.1016/j.tics.2008.09.003; Meng X, 2006, VISION RES, V46, P3681, DOI 10.1016/j.visres.2006.05.012; Merriam EP, 2007, J NEUROPHYSIOL, V97, P1738, DOI 10.1152/jn.00189.2006; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NEWSOME WT, 1990, COLD SPRING HARB SYM, V55, P697; Ong WS, 2009, J NEUROPHYSIOL, V102, P2435, DOI 10.1152/jn.00684.2009; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Parks NA, 2008, PSYCHOPHYSIOLOGY, V45, P776, DOI 10.1111/j.1469-8986.2008.00669.x; PETERSEN SE, 1985, BRAIN RES, V346, P146, DOI 10.1016/0006-8993(85)91105-9; Pollatsek A, 2002, PERCEPT PSYCHOPHYS, V64, P1120, DOI 10.3758/BF03194761; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P354, DOI 10.1152/jn.00852.2001; RAFAL RD, 1994, CURR OPIN NEUROBIOL, V4, P231, DOI 10.1016/0959-4388(94)90078-7; RODMAN HR, 1990, J NEUROSCI, V10, P1154; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1362, DOI 10.1152/jn.1976.39.6.1362; SCHILLER PH, 1998, COGNITIVE NEUROSCIEN, V464, P463; Shepherd AJ, 2006, BRAIN, V129, P1833, DOI 10.1093/brain/awl124; Smith AT, 2008, J VISION, V8, DOI 10.1167/8.10.1; Snowden RJ, 1997, CURR BIOL, V7, P717, DOI 10.1016/S0960-9822(06)00329-0; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; Sommer MA, 2008, PERCEPTION, V37, P408, DOI 10.1068/p5873; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; SPERRY RW, 1950, J COMP PHYSL, V43, P483; STANDAGE GP, 1983, BRAIN RES, V262, P288, DOI 10.1016/0006-8993(83)91020-X; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; STEVENS JK, 1976, VISION RES, V16, P93, DOI 10.1016/0042-6989(76)90082-1; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; THOMPSON P, 1994, PERCEPTION, V23, P1233, DOI 10.1068/p231233; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; Van Wezel RJA, 2002, J NEUROPHYSIOL, V88, P3469, DOI 10.1152/jn.00276.2002; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051; VERFAILLIE K, 1994, J EXP PSYCHOL LEARN, V20, P649, DOI 10.1037/0278-7393.20.3.649; Versino M, 2000, J NEUROL NEUROSUR PS, V68, P234, DOI 10.1136/jnnp.68.2.234; Verstraten FAJ, 1998, PERCEPTION, V27, P1055, DOI 10.1068/p271055; VONDERHEYDT R, 1978, ARCH ITAL BIOL, V116, P248; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; WEISSTEIN N, 1977, SCIENCE, V198, P955, DOI 10.1126/science.929181; Wenderoth P, 2008, VISION RES, V48, P1949, DOI 10.1016/j.visres.2008.06.013; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wohlgemuth A., 1911, AFTER EFFECT SEEN MO, V1; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; ZEKI SM, 1978, J PHYSIOL-LONDON, V277, P273, DOI 10.1113/jphysiol.1978.sp012272	104	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16265	10.1371/journal.pone.0016265	http://dx.doi.org/10.1371/journal.pone.0016265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JL	21298104	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800021
J	de Groot, GA; During, HJ; Maas, JW; Schneider, H; Vogel, JC; Erkens, RHJ				de Groot, G. Arjen; During, Heinjo J.; Maas, Jan W.; Schneider, Harald; Vogel, Johannes C.; Erkens, Roy H. J.			Use of rbcL and trnL-F as a Two-Locus DNA Barcode for Identification of NW-European Ferns: An Ecological Perspective	PLOS ONE			English	Article							NONCODING REGIONS; LAND PLANTS; CHLOROPLAST; PHYLOGENY; SEQUENCES; PCR; AMPLIFICATION; POLYPODIIDAE; CONSERVATION; POPULATIONS	Although consensus has now been reached on a general two-locus DNA barcode for land plants, the selected combination of markers (rbcL + matK) is not applicable for ferns at the moment. Yet especially for ferns, DNA barcoding is potentially of great value since fern gametophytes-while playing an essential role in fern colonization and reproduction-generally lack the morphological complexity for morphology-based identification and have therefore been underappreciated in ecological studies. We evaluated the potential of a combination of rbcL with a noncoding plastid marker, trnL-F, to obtain DNA-identifications for fern species. A regional approach was adopted, by creating a reference database of trusted rbcL and trnL-F sequences for the wild-occurring homosporous ferns of NW-Europe. A combination of parsimony analyses and distance-based analyses was performed to evaluate the discriminatory power of the two-region barcode. DNA was successfully extracted from 86 tiny fern gametophytes and was used as a test case for the performance of DNA-based identification. Primer universality proved high for both markers. Based on the combined rbcL + trnL-F dataset, all genera as well as all species with non-equal chloroplast genomes formed their own well supported monophyletic clade, indicating a high discriminatory power. Interspecific distances were larger than intraspecific distances for all tested taxa. Identification tests on gametophytes showed a comparable result. All test samples could be identified to genus level, species identification was well possible unless they belonged to a pair of Dryopteris species with completely identical chloroplast genomes. Our results suggest a high potential of the combined use of rbcL and trnL-F as a two-locus cpDNA barcode for identification of fern species. A regional approach may be preferred for ecological tests. We here offer such a ready-to-use barcoding approach for ferns, which opens the way for answering a whole range of questions previously unaddressed in fern gametophyte ecology.	[de Groot, G. Arjen; During, Heinjo J.; Maas, Jan W.; Erkens, Roy H. J.] Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Utrecht, Netherlands; [Schneider, Harald; Vogel, Johannes C.] Nat Hist Museum, Dept Bot, London SW7 5BD, England	Utrecht University; Natural History Museum London	de Groot, GA (corresponding author), Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Utrecht, Netherlands.	G.A.deGroot@uu.nl	Erkens, Roy H.J./B-9961-2008; Schneider, Harald/B-6681-2008	Erkens, Roy H.J./0000-0002-1093-0370; Schneider, Harald/0000-0002-4548-7268	Schure-Beijerink-Popping Fund (KNAW) [SBP/JK/2009-21]; Miquel Fund	Schure-Beijerink-Popping Fund (KNAW); Miquel Fund	This work was supported by grants from the Schure-Beijerink-Popping Fund (KNAW, SBP/JK/2009-21) and Miquel Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; BARRINGTON DS, 1989, AM FERN J, V79, P55, DOI 10.2307/1547160; Bremer P, 2010, GORTERIA, V34, P146; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; *CONS BARC LIF, 2007, NONCOI BARC REG GUID; COUSENS MI, 1981, BOT GAZ, V142, P251, DOI 10.1086/337220; de Groot GA, 2008, GORTERIA, V33, P59; DEOLIVIERA SM, 2010, THESIS UTRECHT U UTR; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Devey DS, 2009, TAXON, V58, P7, DOI 10.1002/tax.581003; Duffy AM, 2009, GENE, V438, P17, DOI 10.1016/j.gene.2009.02.006; DYER AF, 1994, BIODIVERS CONSERV, V3, P160, DOI 10.1007/BF02291886; Ekrt L, 2009, PRESLIA, V81, P261; Erkens RHJ, 2009, J BIOGEOGR, V36, P2338, DOI 10.1111/j.1365-2699.2009.02162.x; Farrar DR, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P222, DOI 10.1017/CBO9780511541827.010; Fazekas AJ, 2010, TAXON, V59, P694, DOI 10.1002/tax.593002; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fraser-Jenkins C. R., 2007, Fern Gazette, V18, P1; GASTONY GJ, 1992, AM J BOT, V79, P716, DOI 10.2307/2444887; Geiger JMO, 2005, MOL PHYLOGENET EVOL, V34, P392, DOI 10.1016/j.ympev.2004.11.001; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Ishikawa H, 2002, J PLANT RES, V115, P65, DOI 10.1007/s102650200010; Janssen T, 2005, PLANT SYST EVOL, V252, P175, DOI 10.1007/s00606-004-0264-6; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lambinon J., 1998, FLORA BELGIE GROOTHE; Landergott U, 2001, HEREDITY, V87, P344, DOI 10.1046/j.1365-2540.2001.00912.x; Le Clerc-Blain J, 2010, MOL ECOL RESOUR, V10, P69, DOI 10.1111/j.1755-0998.2009.02725.x; Li FW, 2010, MOL ECOL RESOUR, V10, P92, DOI 10.1111/j.1755-0998.2009.02745.x; Li FW, 2009, PLANT SYST EVOL, V281, P77, DOI 10.1007/s00606-009-0188-2; Little DP, 2003, AM J BOT, V90, P508, DOI 10.3732/ajb.90.3.508; Liu Y, 2010, J SYST EVOL, V48, P36, DOI 10.1111/j.1759-6831.2009.00063.x; Lovis JD, 1977, ADV BOT RES, V4, P229, DOI DOI 10.1016/S0065-2296(08)60371-7; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Ovcharenko Ivan, 2003, Current Genomics, V4, P557, DOI 10.2174/1389202033490169; Pryer KM, 2010, MOL ECOL RESOUR, V10, P979, DOI 10.1111/j.1755-0998.2010.02858.x; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Ptacek Travis, 2005, Briefings in Functional Genomics & Proteomics, V4, P178, DOI 10.1093/bfgp/4.2.178; Quintanilla LG, 2006, ANN BOT-LONDON, V98, P609, DOI 10.1093/aob/mcl137; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Schneider H, 2005, P ROY SOC B-BIOL SCI, V272, P455, DOI 10.1098/rspb.2004.2965; Schneider H, 2004, SYST BOT, V29, P260, DOI 10.1600/036364404774195476; Schneider H, 2006, MOL ECOL NOTES, V6, P989, DOI 10.1111/j.1471-8286.2006.01424.x; SCHNELLER J J, 1975, Bulletin de la Societe Botanique Suisse, V85, P110; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Schuettpelz E, 2007, MOL PHYLOGENET EVOL, V44, P1172, DOI 10.1016/j.ympev.2007.04.011; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; SLEEP A, 1971, British Fern Gazette, V10, P208; SLEEP A, 1983, ACTA BOT MALACITANA, V8, P11; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Stace C., 1997, NEW FLORA BRIT ISLES; Stein DB, 2010, AM J BOT, V97, P998, DOI 10.3732/ajb.0900355; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Trewick SA, 2002, MOL ECOL, V11, P2003, DOI 10.1046/j.1365-294X.2002.01583.x; Van De Wiel CCM, 2009, MOL ECOL RESOUR, V9, P1086, DOI 10.1111/j.1755-0998.2009.02547.x; Van der Meijden R., 2005, HEUKELS FLORA NEDERL; Vogel JC, 1999, SYST ASSOC SPEC VOL, V57, P101; Watkins JE, 2007, AM J BOT, V94, P701, DOI 10.3732/ajb.94.4.701; WERTH C R, 1989, American Journal of Botany, V76, P208; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; WOLF PG, 1994, MOL PHYLOGENET EVOL, V3, P383, DOI 10.1006/mpev.1994.1044	72	68	74	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16371	10.1371/journal.pone.0016371	http://dx.doi.org/10.1371/journal.pone.0016371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298108	Green Published, Green Submitted, gold			2022-12-25	WOS:000286662800032
J	Mizuguchi, Y; Mishima, T; Yokomuro, S; Arima, Y; Kawahigashi, Y; Shigehara, K; Kanda, T; Yoshida, H; Uchida, E; Tajiri, T; Takizawa, T				Mizuguchi, Yoshiaki; Mishima, Takuya; Yokomuro, Shigeki; Arima, Yasuo; Kawahigashi, Yutaka; Shigehara, Kengo; Kanda, Tomohiro; Yoshida, Hiroshi; Uchida, Eiji; Tajiri, Takashi; Takizawa, Toshihiro			Sequencing and Bioinformatics-Based Analyses of the microRNA Transcriptome in Hepatitis B-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							EXPRESSION; GENES; MOUSE; IDENTIFICATION; MODULATION; CANCER; MIRNAS	MicroRNAs (miRNAs) participate in crucial biological processes, and it is now evident that miRNA alterations are involved in the progression of human cancers. Recent studies on miRNA profiling performed with cloning suggest that sequencing is useful for the detection of novel miRNAs, modifications, and precise compositions and that miRNA expression levels calculated by clone count are reproducible. Here we focus on sequencing of miRNA to obtain a comprehensive profile and characterization of these transcriptomes as they relate to human liver. Sequencing using 454 sequencing and conventional cloning from 22 pair of HCC and adjacent normal liver (ANL) and 3 HCC cell lines identified reliable reads of more than 314000 miRNAs from HCC and more than 268000 from ANL for registered human miRNAs. Computational bioinformatics identified 7 novel miRNAs with high conservation, 15 novel opposite miRNAs, and 3 novel antisense miRNAs. Moreover sequencing can detect miRNA modifications including adenosine-to-inosine editing in miR-376 families. Expression profiling using clone count analysis was used to identify miRNAs that are expressed aberrantly in liver cancer including miR-122, miR-21, and miR-34a. Furthermore, sequencing-based miRNA clustering, but not individual miRNA, detects high risk patients who have high potentials for early tumor recurrence after liver surgery (P = 0.006), and which is the only significant variable among pathological and clinical and variables (P = 0,022). We believe that the combination of sequencing and bioinformatics will accelerate the discovery of novel miRNAs and biomarkers involved in human liver cancer.	[Mizuguchi, Yoshiaki; Yokomuro, Shigeki; Arima, Yasuo; Kawahigashi, Yutaka; Shigehara, Kengo; Kanda, Tomohiro; Yoshida, Hiroshi; Uchida, Eiji; Tajiri, Takashi] Nippon Med Sch, Dept Surg Organ Funct & Biol Regulat, Tokyo 113, Japan; [Mizuguchi, Yoshiaki; Mishima, Takuya; Kawahigashi, Yutaka; Shigehara, Kengo; Kanda, Tomohiro; Takizawa, Toshihiro] Nippon Med Sch, Dept Mol Anat & Med, Tokyo 113, Japan	Nippon Medical School; Nippon Medical School	Mizuguchi, Y (corresponding author), Nippon Med Sch, Dept Surg Organ Funct & Biol Regulat, 1-1-5 Sendagi, Tokyo 113, Japan.	yoshi1224@gmail.com; t-takizawa@nms.ac.jp	Mishima, Takuya/G-1671-2011		Ministry of Education, Science, Sports, and Culture of Japan [19-879, S0801034]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by the Ministry of Education, Science, Sports, and Culture of Japan, through two separate grants: 1) Grants-in-Aid for Scientific Research, Research Fellowships for young scientists (#19-879; http://www.jsps.go.jp/english/e-grants/grants.html) and 2) Core Research Project for Private University: matching fund subsidy (#S0801034; http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; LCSGo, 2000, GEN RUL CLIN PATH ST; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meyers BC, 2006, CURR OPIN BIOTECH, V17, P139, DOI 10.1016/j.copbio.2006.01.008; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Sobin, 2009, UICC TNM CLASSIFICAT; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	30	59	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15304	10.1371/journal.pone.0015304	http://dx.doi.org/10.1371/journal.pone.0015304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283620	gold, Green Published, Green Submitted			2022-12-25	WOS:000286661400007
J	Tuzmen, C; Erman, B				Tuzmen, Ceren; Erman, Burak			Identification of Ligand Binding Sites of Proteins Using the Gaussian Network Model	PLOS ONE			English	Article							GLUTATHIONE TRANSFERASE A1-1; ACETYL-COA CARBOXYLASE; HUMAN HEME OXYGENASE; RECEPTOR TYROSINE KINASES; COENZYME-A CARBOXYLASE; CARBONIC-ANHYDRASE-II; ACTIVE-SITE; CATALYTIC MECHANISM; CRYSTAL-STRUCTURES; S-TRANSFERASE	The nonlocal nature of the protein-ligand binding problem is investigated via the Gaussian Network Model with which the residues lying along interaction pathways in a protein and the residues at the binding site are predicted. The predictions of the binding site residues are verified by using several benchmark systems where the topology of the unbound protein and the bound protein-ligand complex are known. Predictions are made on the unbound protein. Agreement of results with the bound complexes indicates that the information for binding resides in the unbound protein. Cliques that consist of three or more residues that are far apart along the primary structure but are in contact in the folded structure are shown to be important determinants of the binding problem. Comparison with known structures shows that the predictive capability of the method is significant.	[Tuzmen, Ceren; Erman, Burak] Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey	Koc University	Tuzmen, C (corresponding author), Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey.	berman@ku.edu.tr	erman, burak/F-5900-2015	erman, burak/0000-0002-2496-6059				Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Allardyce CS, 1999, BIOCHEM J, V343, P525, DOI 10.1042/0264-6021:3430525; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; ATKINS WM, 1993, J BIOL CHEM, V268, P19188; Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001; BJORNESTEDT R, 1995, J MOL BIOL, V247, P765; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; CALABRETTA B, 1986, P NATL ACAD SCI USA, V83, P1495, DOI 10.1073/pnas.83.5.1495; CALABRETTA B, 1985, P NATL ACAD SCI USA, V82, P4463, DOI 10.1073/pnas.82.13.4463; CAMERON AD, 1995, STRUCTURE, V3, P717, DOI 10.1016/S0969-2126(01)00206-4; Castle JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004369; Cvetkovic D.C., 1997, EIGENSPACES GRAPHS; DOMSIC JF, 2010, STRUCTURAL KINETIC S; ENGELKAMP D, 1993, P NATL ACAD SCI USA, V90, P6547, DOI 10.1073/pnas.90.14.6547; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Haliloglu T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000845; Haliloglu T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.088103; Haliloglu T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228102; Hansen SK, 2005, BIOCHEMISTRY-US, V44, P7704, DOI 10.1021/bi047417s; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; JEREMY M, 2007, BIOCHEMISTRY-US, P254; JORGENSEN WL, 1991, SCIENCE, V254, P954, DOI 10.1126/science.1719636; Komatsu K, 2000, CLIN CANCER RES, V6, P172; Kuhnert DC, 2005, J MOL BIOL, V349, P825, DOI 10.1016/j.jmb.2005.04.025; La Mar GN, 2001, J BIOL CHEM, V276, P15676, DOI 10.1074/jbc.M009974200; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Le Trong I, 2002, PROTEINS, V48, P618, DOI 10.1002/prot.10162; Li YM, 2004, J BIOL CHEM, V279, P10195, DOI 10.1074/jbc.M308379200; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MANI RS, 1992, BIOCHEMISTRY-US, V31, P11896, DOI 10.1021/bi00162a031; Maupin CM, 2009, J AM CHEM SOC, V131, P7598, DOI 10.1021/ja8091938; Mizoue LS, 2002, CURR OPIN STRUC BIOL, V12, P459, DOI 10.1016/S0959-440X(02)00348-2; Munday MR, 2002, BIOCHEM SOC T, V30, P1059, DOI 10.1042/bst0301059; MURPHY LC, 1988, J BIOL CHEM, V263, P2397; Nathaniel C, 2003, BIOCHEM J, V372, P241, DOI 10.1042/BJ20021765; Nelson MR, 2002, PROTEIN SCI, V11, P198, DOI 10.1110/ps.33302; Otterbein LR, 2002, STRUCTURE, V10, P557, DOI 10.1016/S0969-2126(02)00740-2; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; PERRY RDL, 1949, PSYCHOMETRIKA, V14, P95; Peters GH, 1998, BIOCHEMISTRY-US, V37, P5383, DOI 10.1021/bi971187i; PORTER GBC, 2010, CATALYTIC SITE ATLAS; Scapin G, 2003, BIOCHEMISTRY-US, V42, P11451, DOI 10.1021/bi035098j; Scapin G, 2001, PROTEIN SCI, V10, P1596, DOI 10.1110/ps.11001; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; Sudo T, 1999, FEBS LETT, V444, P11, DOI 10.1016/S0014-5793(99)00014-9; Sugishima M, 2002, BIOCHEMISTRY-US, V41, P7293, DOI 10.1021/bi025662a; Thorson JS, 1998, J AM CHEM SOC, V120, P451, DOI 10.1021/ja9731682; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; WAKIL SJ, 1986, ANN NY ACAD SCI, V478, P203, DOI 10.1111/j.1749-6632.1986.tb15532.x; Weatherly SC, 2004, BIOCHEM J, V380, P105, DOI 10.1042/BJ20031960; Yogurtcu ON, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3078517; EMBL EBI PDBSUM	72	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16474	10.1371/journal.pone.0016474	http://dx.doi.org/10.1371/journal.pone.0016474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283550	Green Published, Green Submitted, gold			2022-12-25	WOS:000286661400054
J	Bonney, KM; Taylor, JM; Daniels, MD; Epting, CL; Engman, DM				Bonney, Kevin M.; Taylor, Joann M.; Daniels, Melvin D.; Epting, Conrad L.; Engman, David M.			Heat-Killed Trypanosoma cruzi Induces Acute Cardiac Damage and Polyantigenic Autoimmunity	PLOS ONE			English	Article							EXPERIMENTAL CHAGAS-DISEASE; T-CELL RESPONSES; TH17 CELLS; TROPONIN-I; MYOSIN AUTOIMMUNITY; INTERFERON-GAMMA; HELPER TYPE-1; ANTIBODIES; MICE; AUTOANTIBODIES	Chagas heart disease, caused by the protozoan parasite Trypanosoma cruzi, is a potentially fatal cardiomyopathy often associated with cardiac autoimmunity. T. cruzi infection induces the development of autoimmunity to a number of antigens via molecular mimicry and other mechanisms, but the genesis and pathogenic potential of this autoimmune response has not been fully elucidated. To determine whether exposure to T. cruzi antigens alone in the absence of active infection is sufficient to induce autoimmunity, we immunized A/J mice with heat-killed T. cruzi (HKTC) emulsified in complete Freund's adjuvant, and compared the resulting immune response to that induced by infection with live T. cruzi. We found that HKTC immunization is capable of inducing acute cardiac damage, as evidenced by elevated serum cardiac troponin I, and that this damage is associated with the generation of polyantigenic humoral and cell-mediated autoimmunity with similar antigen specificity to that induced by infection with T. cruzi. However, while significant and preferential production of Th1 and Th17-associated cytokines, accompanied by myocarditis, develops in T. cruzi-infected mice, HKTC-immunized mice produce lower levels of these cytokines, do not develop Th1-skewed immunity, and lack tissue inflammation. These results demonstrate that exposure to parasite antigen alone is sufficient to induce autoimmunity and cardiac damage, yet additional immune factors, including a dominant Th1/Th17 immune response, are likely required to induce cardiac inflammation.	[Bonney, Kevin M.; Daniels, Melvin D.; Epting, Conrad L.; Engman, David M.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Bonney, Kevin M.; Taylor, Joann M.; Daniels, Melvin D.; Engman, David M.] Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Epting, Conrad L.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University	Bonney, KM (corresponding author), Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA.	k-bonney@northwestern.edu	Engman, David/T-6747-2018	Engman, David/0000-0001-5869-9844	National Institutes of Health (NIH) [HL075822, AI007476]; American Heart Association; Northwestern University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007476] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Northwestern University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant HL075822 (to D.M.E.), NIH training grant AI007476 (to M.D.D.), and a predoctoral fellowship from the American Heart Association (to K.M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Karin G. Klein for production of the pKK25-pLysE plasmid and Manuel Fresno, Universidad Autonoma de Madrid, Spain for providing the Cha expression plasmid. This work was supported by the Northwestern University Interdepartmental ImmunoBiology Flow Cytometry Core Facility.	Barr SC, 2005, ANTIMICROB AGENTS CH, V49, P5160, DOI 10.1128/AAC.49.12.5160-5161.2005; Bergami PL, 1997, FEMS IMMUNOL MED MIC, V18, P75, DOI 10.1016/S0928-8244(97)00026-6; BONFA E, 1993, J IMMUNOL, V150, P3917; Bonney KM, 2008, CURR MOL MED, V8, P510, DOI 10.2174/156652408785748004; Cardillo F, 2007, IMMUNOLOGY, V122, P584, DOI 10.1111/j.1365-2567.2007.02677.x; Chan LS, 1998, J INVEST DERMATOL, V110, P103, DOI 10.1046/j.1523-1747.1998.00107.x; Chen L, 2001, EUR J IMMUNOL, V31, P265, DOI 10.1002/1521-4141(200101)31:1<265::AID-IMMU265>3.3.CO;2-C; Collinson PO, 2007, MED PRIN PRACT, V16, P247, DOI 10.1159/000102146; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Cooke Anne, 2006, Review of Diabetic Studies, V3, P72, DOI 10.1900/RDS.2006.3.72; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; Cunha-Neto E, 1995, Sao Paulo Med J, V113, P757; CunhaNeto E, 1996, J CLIN INVEST, V98, P1709, DOI 10.1172/JCI118969; Daniels MD, 2008, AUTOIMMUNITY, V41, P490, DOI 10.1080/08916930802167902; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; DAVILA DF, 1989, PARASITOL TODAY, V5, P327, DOI 10.1016/0169-4758(89)90127-0; DECARVALHO LCP, 2002, J AUTOIMMUN, V18, P131; DOSSANTOS RR, 1992, J EXP MED, V175, P29, DOI 10.1084/jem.175.1.29; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Ellis NMJ, 2005, J IMMUNOL, V175, P5448, DOI 10.4049/jimmunol.175.8.5448; GAZZINELLI R, 1988, T ROY SOC TROP MED H, V82, P574, DOI 10.1016/0035-9203(88)90513-5; Giordanengo L, 2000, MUSCLE NERVE, V23, P1407, DOI 10.1002/1097-4598(200009)23:9<1407::AID-MUS12>3.3.CO;2-V; Giordanengo L, 2000, EUR J IMMUNOL, V30, P3181, DOI 10.1002/1521-4141(200011)30:11&lt;3181::AID-IMMU3181&gt;3.0.CO;2-A; Girones N, 2001, J CLIN INVEST, V107, P985, DOI 10.1172/JCI10734; Girones N, 2001, CLIN DIAGN LAB IMMUN, V8, P1039, DOI 10.1128/CDLI.8.6.1039-1043.2001; Girones N, 2007, ANN NY ACAD SCI, V1107, P434, DOI 10.1196/annals.1381.046; Godsel LM, 2003, J IMMUNOL, V171, P346, DOI 10.4049/jimmunol.171.1.346; Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; GUEDES PMD, PLOS NEGL TROP DIS, V4, pE604; Guo SQ, 2009, J IMMUNOL, V182, P6179, DOI 10.4049/jimmunol.0803821; Hamm CW, 2002, CIRCULATION, V106, P2871, DOI 10.1161/01.CIR.0000044342.50593.63; Hessel MHM, 2008, PFLUG ARCH EUR J PHY, V455, P979, DOI 10.1007/s00424-007-0354-8; Hoft DF, 2002, INFECT IMMUN, V70, P6715, DOI 10.1128/IAI.70.12.6715-6725.2002; Hyland KV, 2007, INFECT IMMUN, V75, P3641, DOI 10.1128/IAI.00423-07; Kaplan D, 1997, P NATL ACAD SCI USA, V94, P10301, DOI 10.1073/pnas.94.19.10301; KAYA Z, 2009, CLIN IMMUNOL; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kidd BA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2523; KIPNIS TL, 1981, AM J TROP MED HYG, V30, P47, DOI 10.4269/ajtmh.1981.30.47; Konstadoulakis M M, 1993, J Clin Lab Immunol, V40, P61; Krebs P, 2007, J AUTOIMMUN, V28, P224, DOI 10.1016/j.jaut.2007.01.003; LANE JR, 1992, J EXP MED, V175, P1123, DOI 10.1084/jem.175.4.1123; Leon JS, 2004, INFECT IMMUN, V72, P3410, DOI 10.1128/IAI.72.6.3410-3417.2004; Leon JS, 2003, J IMMUNOL, V171, P4271, DOI 10.4049/jimmunol.171.8.4271; Leon JS, 2001, INFECT IMMUN, V69, P5643, DOI 10.1128/IAI.69.9.5643-5649.2001; Li Y, 2006, J IMMUNOL, V177, P8234, DOI 10.4049/jimmunol.177.11.8234; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x; Martin DL, 2005, J IMMUNOL, V174, P1594, DOI 10.4049/jimmunol.174.3.1594; MOLINA HA, 1988, IMMUNOLOGY, V64, P725; MOLINA HA, 1989, IMMUNOLOGY, V66, P289; Motran CC, 2000, CLIN IMMUNOL, V97, P89, DOI 10.1006/clim.2000.4919; Moudgil KD, 1997, J EXP MED, V185, P1307, DOI 10.1084/jem.185.7.1307; NEU N, 1987, J IMMUNOL, V138, P2488; Nussinovitch U, 2010, HEART, V96, P1518, DOI 10.1136/hrt.2010.195255; O'Brien PJ, 2006, LAB ANIM-UK, V40, P153, DOI 10.1258/002367706776319042; RIZZO LV, 1989, INFECT IMMUN, V57, P2640, DOI 10.1128/IAI.57.9.2640-2644.1989; ROSSI MA, 1990, AM HEART J, V120, P233, DOI 10.1016/0002-8703(90)90191-Y; SANTOSBU.CA, 1974, J EXP MED, V140, P38, DOI 10.1084/jem.140.1.38; Schijman AG, 2004, AM J TROP MED HYG, V70, P210, DOI 10.4269/ajtmh.2004.70.210; SCHMITT E, 1994, EUR J IMMUNOL, V24, P343, DOI 10.1002/eji.1830240211; Shah K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2964; Smith SC, 1997, CIRCULATION, V95, P163, DOI 10.1161/01.CIR.95.1.163; TANOWITZ HB, 1992, CLIN MICROBIOL REV, V5, P400, DOI 10.1128/CMR.5.4.400-419.1992; Tanowitz HB, 2009, PROG CARDIOVASC DIS, V51, P524, DOI 10.1016/j.pcad.2009.02.001; Teixeira ARL, 2006, MEM I OSWALDO CRUZ, V101, P463, DOI 10.1590/S0074-02762006000500001; TERNYNCK T, 1990, J IMMUNOL, V144, P1504; TIBBETTS RS, 1994, J IMMUNOL, V152, P1493; Tzelepis F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000393; Valaperti A, 2008, J IMMUNOL, V180, P2686, DOI 10.4049/jimmunol.180.4.2686; von Herrath MG, 2003, NAT REV MICROBIOL, V1, P151, DOI 10.1038/nrmicro754; Watthanakulpanich D, 2008, ACTA TROP, V106, P90, DOI 10.1016/j.actatropica.2008.01.008; Zhang L, 1999, J INFECT DIS, V180, P480, DOI 10.1086/314889	73	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14571	10.1371/journal.pone.0014571	http://dx.doi.org/10.1371/journal.pone.0014571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283741	Green Published, gold			2022-12-25	WOS:000286522300009
J	Alverson, AJ; Zhuo, S; Rice, DW; Sloan, DB; Palmer, JD				Alverson, Andrew J.; Zhuo, Shi; Rice, Danny W.; Sloan, Daniel B.; Palmer, Jeffrey D.			The Mitochondrial Genome of the Legume Vigna radiata and the Analysis of Recombination across Short Mitochondrial Repeats	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; INTRACELLULAR GENE-TRANSFER; BETA-VULGARIS L.; HOMOLOGOUS RECOMBINATION; EXTENSIVE LOSS; DNA; NUCLEUS; EVOLUTION; SUBUNIT-2; ORGANIZATION	The mitochondrial genomes of seed plants are exceptionally fluid in size, structure, and sequence content, with the accumulation and activity of repetitive sequences underlying much of this variation. We report the first fully sequenced mitochondrial genome of a legume, Vigna radiata (mung bean), and show that despite its unexceptional size (401,262 nt), the genome is unusually depauperate in repetitive DNA and "promiscuous" sequences from the chloroplast and nuclear genomes. Although Vigna lacks the large, recombinationally active repeats typical of most other seed plants, a PCR survey of its modest repertoire of short (38-297 nt) repeats nevertheless revealed evidence for recombination across all of them. A set of novel control assays showed, however, that these results could instead reflect, in part or entirely, artifacts of PCR-mediated recombination. Consequently, we recommend that other methods, especially high-depth genome sequencing, be used instead of PCR to infer patterns of plant mitochondrial recombination. The average-sized but repeat-and feature-poor mitochondrial genome of Vigna makes it ever more difficult to generalize about the factors shaping the size and sequence content of plant mitochondrial genomes.	[Alverson, Andrew J.; Zhuo, Shi; Rice, Danny W.; Palmer, Jeffrey D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Sloan, Daniel B.] Univ Virginia, Dept Biol, Charlottesville, VA USA	Indiana University System; Indiana University Bloomington; University of Virginia	Alverson, AJ (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	andy.alverson@gmail.com	Palmer, Jeffrey/P-6747-2014; Sloan, Daniel/D-4152-2011	Palmer, Jeffrey/0000-0002-4626-2220; Alverson, Andrew/0000-0003-1241-2654; Rice, Danny/0000-0002-1123-4617; Sloan, Daniel/0000-0002-3618-0897	National Institutes of Health [1F32GM080079-01A1, RO1-GM-70612]; METACyt Initiative of Indiana University; Lilly Endowment, Inc.; U.S. Department of Energy's Office of Science, Biological and Environmental Research; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080079, R01GM070612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); METACyt Initiative of Indiana University; Lilly Endowment, Inc.; U.S. Department of Energy's Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health Ruth L. Kirschstein NRSA Postdoctoral Fellowship (1F32GM080079-01A1) to AJA, NIH research grant RO1-GM-70612 to JDP, and the METACyt Initiative of Indiana University, funded in part through a major grant from the Lilly Endowment, Inc. to JDP. This work was performed under the auspices of the U.S. Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Adams KL, 2001, GENETICS, V158, P1289; Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; ANDRE C, 1992, TRENDS GENET, V8, P128, DOI 10.1016/0168-9525(92)90370-J; Arrieta-Montiel MP, 2009, GENETICS, V183, P1261, DOI 10.1534/genetics.109.108514; COVELLO PS, 1992, EMBO J, V11, P3815, DOI 10.1002/j.1460-2075.1992.tb05473.x; Daley DO, 2002, P NATL ACAD SCI USA, V99, P10510, DOI 10.1073/pnas.122354399; Daley DO, 2002, PLANT J, V30, P11, DOI 10.1046/j.1365-313X.2002.01263.x; FALCONET D, 1984, EMBO J, V3, P297, DOI 10.1002/j.1460-2075.1984.tb01799.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Handa H, 2002, MOL GENET GENOMICS, V267, P797, DOI 10.1007/s00438-002-0711-4; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Knoop V, 1996, GENETICS, V142, P579; KOLODNER R, 1972, P NATL ACAD SCI USA, V69, P1830, DOI 10.1073/pnas.69.7.1830; Kubo N, 2010, DNA RES, V17, P1, DOI 10.1093/dnares/dsp024; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lilly JW, 2001, CURR GENET, V40, P144, DOI 10.1007/s002940100238; LONSDALE DM, 1988, PHILOS T ROY SOC B, V319, P149, DOI 10.1098/rstb.1988.0039; LONSDALE DM, 1984, NUCLEIC ACIDS RES, V12, P9249, DOI 10.1093/nar/12.24.9249; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; McDermott P, 2008, THEOR APPL GENET, V117, P459, DOI 10.1007/s00122-008-0790-7; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Mower JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-265; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; NUGENT JM, 1991, CELL, V66, P473, DOI 10.1016/0092-8674(81)90011-8; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; Ong HC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-55; PALMER JD, 1984, NATURE, V307, P437, DOI 10.1038/307437a0; PALMER JD, 1987, CURR GENET, V11, P565, DOI 10.1007/BF00384620; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; PALMER JD, 1982, NUCLEIC ACIDS RES, V10, P1593, DOI 10.1093/nar/10.5.1593; PALMER JD, 1980, CARNEGIE I WASH YB, V79, P120; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Qualmann SR, 2003, PLANT BIOLOGY, V5, P481, DOI 10.1055/s-2003-44781; Satoh M, 2004, MOL GENET GENOMICS, V272, P247, DOI 10.1007/s00438-004-1058-9; Satoh M, 2006, THEOR APPL GENET, V113, P477, DOI 10.1007/s00122-006-0312-4; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; Sloan DB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-274; Sloan DB, 2010, GENETICS, V185, P1369, DOI 10.1534/genetics.110.118000; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Woloszynska M, 2001, MOL GENET GENOMICS, V265, P865, DOI 10.1007/s004380100481; Woloszynska M, 2009, PLANT MOL BIOL, V70, P511, DOI 10.1007/s11103-009-9488-8; Yamato KT, 1999, J HERED, V90, P369, DOI 10.1093/jhered/90.3.369	49	117	120	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16404	10.1371/journal.pone.0016404	http://dx.doi.org/10.1371/journal.pone.0016404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283772	gold, Green Submitted, Green Published			2022-12-25	WOS:000286522200062
J	Tsagaratou, A; Kontoyiannis, DL; Mosialos, G				Tsagaratou, Ageliki; Kontoyiannis, Dimitris L.; Mosialos, George			Truncation of the Deubiquitinating Domain of CYLD in Myelomonocytic Cells Attenuates Inflammatory Responses	PLOS ONE			English	Article							NF-KAPPA-B; ENZYME CYLD; NEGATIVE REGULATOR; MICE; MACROPHAGES; ACTIVATION; MODULATOR; RECEPTOR	The cylindromatosis tumor suppressor (CYLD) is a deubiquitinating enzyme that has been implicated in various aspects of adaptive and innate immune responses. Nevertheless, the role of CYLD in the function of specific types of immune cells remains elusive. In this report we have used conditional gene targeting in mice to address the role of the deubiquitinating activity of CYLD in the myelomonocytic lineage. Truncation of the deubiquitinating domain of CYLD specifically in myelomonocytic cells impaired the development of lethal LPS-induced endotoxic shock and the accumulation of thioglycollate-elicited peritoneal macrophages. Our data establish CYLD as a regulator of monocyte-macrophage activation in response to inflammatory stimuli and identify it as a potential target for therapeutic intervention in relevant inflammatory disorders in humans.	[Tsagaratou, Ageliki; Mosialos, George] Aristotle Univ Thessaloniki, Sch Biol, GR-54006 Thessaloniki, Macedonia, Greece; [Tsagaratou, Ageliki; Kontoyiannis, Dimitris L.] Biomed Sci Res Ctr Al Fleming, Inst Immunol, Vari, Greece	Aristotle University of Thessaloniki; Alexander Fleming Biomedical Sciences Research Center	Tsagaratou, A (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, GR-54006 Thessaloniki, Macedonia, Greece.	gmosialo@bio.auth.gr		Tsagaratou, Ageliki/0000-0002-7121-3789; Tsangaratou, Angeliki/0000-0001-9895-0394; Kontoyiannis, Dimitris/0000-0003-4682-9490	General Secretariat for Research and Technology of the Hellenic Ministry of Education	General Secretariat for Research and Technology of the Hellenic Ministry of Education	This work was supported by the General Secretariat for Research and Technology of the Hellenic Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Jin W, 2007, J BIOL CHEM, V282, P15884, DOI 10.1074/jbc.M609952200; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kolls JK, 2007, IMMUNITY, V27, P187, DOI 10.1016/j.immuni.2007.08.004; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lim JH, 2008, CELL MICROBIOL, V10, P2247, DOI 10.1111/j.1462-5822.2008.01204.x; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; MELLINGHOFF I, 1991, VIROLOGY, V185, P922, DOI 10.1016/0042-6822(91)90574-U; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Timmer AM, 2008, J EXP MED, V205, P1255, DOI 10.1084/jem.20081056; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Trompouki E, 2009, NEOPLASIA, V11, P469, DOI 10.1593/neo.81424; Tsagaratou A, 2010, J IMMUNOL, V185, P2032, DOI 10.4049/jimmunol.0903919; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746	23	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16397	10.1371/journal.pone.0016397	http://dx.doi.org/10.1371/journal.pone.0016397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283724	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522200059
J	Bergeron, SE; Wedemeyer, EW; Lee, R; Wen, KK; McKane, M; Pierick, AR; Berger, AP; Rubenstein, PA; Bartlett, HL				Bergeron, Sarah E.; Wedemeyer, Elesa W.; Lee, Rose; Wen, Kuo-Kuang; McKane, Melissa; Pierick, Alyson R.; Berger, Anthony P.; Rubenstein, Peter A.; Bartlett, Heather L.			Allele-specific Effects of Thoracic Aortic Aneurysm and Dissection alpha-Smooth Muscle Actin Mutations on Actin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ACTIN; BUDDING YEAST; F-ACTIN; SACCHAROMYCES-CEREVISIAE; SKELETAL-MUSCLE; IN-VITRO; MITOCHONDRIAL INHERITANCE; MASS-SPECTROMETRY; GENE ACTA1; CELL-CYCLE	Twenty-two missense mutations in ACTA2, which encodes alpha-smooth muscle actin, have been identified to cause thoracic aortic aneurysm and dissection. Limited access to diseased tissue, the presence of multiple unresolvable actin isoforms in the cell, and lack of an animal model have prevented analysis of the biochemical mechanisms underlying this pathology. We have utilized actin from the yeast Saccharomyces cerevisiae, 86% identical to human alpha-smooth muscle actin, as a model. Two of the known human mutations, N115T and R116Q, were engineered into yeast actin, and their effect on actin function in vivo and in vitro was investigated. Both mutants exhibited reduced ability to grow under a variety of stress conditions, which hampered N115T cells more than R116Q cells. Both strains exhibited abnormal mitochondrial morphology indicative of a faulty actin cytoskeleton. In vitro, the mutant actins exhibited altered thermostability and nucleotide exchange rates, indicating effects of the mutations on monomer conformation, with R116Q the most severely affected. N115T demonstrated a biphasic elongation phase during polymerization, whereas R116Q demonstrated a markedly extended nucleation phase. Allele-specific effects were also seen on critical concentration, rate of depolymerization, and filament treadmilling. R116Q filaments were hypersensitive to severing by the actin-binding protein cofilin. In contrast, N115T filaments were hyposensitive to cofilin despite nearly normal binding affinities of actin for cofilin. The mutant-specific effects on actin behavior suggest that individual mechanisms may contribute to thoracic aortic aneurysm and dissection.	[Bergeron, Sarah E.; Lee, Rose; Wen, Kuo-Kuang; McKane, Melissa; Pierick, Alyson R.; Berger, Anthony P.; Rubenstein, Peter A.; Bartlett, Heather L.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Wedemeyer, Elesa W.; Lee, Rose; Pierick, Alyson R.; Bartlett, Heather L.] Univ Iowa, Dept Pediat, Roy A & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Bergeron, Sarah E.] Univ Iowa, Interdisciplinary Program Mol & Cellular Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Bartlett, HL (corresponding author), Univ Iowa, Dept Biochem, 200 Hawkins Dr,2801 JPP, Iowa City, IA 52242 USA.	heather-bartlett@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414; Bartlett, Heather/0000-0002-4224-6151; Berger, Anthony/0000-0002-1320-5887	National Institutes of Health (NIH) [DC008803]; NIH, NCRR [UL1RR024979]; American Heart Association [0830053N]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008803, R55DC008803] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant DC008803 (to P.A.R.), and NIH, NCRR, Grant UL1RR024979 (to H.L.B. and P.A.R.). This work was also supported by American Heart Association Grant 0830053N (to H.L.B.).	Albornoz G, 2006, ANN THORAC SURG, V82, P1400, DOI 10.1016/j.athoracsur.2006.04.098; Amberg DC, 1998, MOL BIOL CELL, V9, P3259, DOI 10.1091/mbc.9.12.3259; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Blondin L, 2001, EUR J BIOCHEM, V268, P6426, DOI 10.1046/j.0014-2956.2001.02592.x; Boldogh IR, 2005, GENE, V354, P28, DOI 10.1016/j.gene.2005.03.049; Boldogh IR, 2001, TRAFFIC, V2, P368, DOI 10.1034/j.1600-0854.2001.002006368.x; BRETSCHER A, 1994, J CELL BIOL, V126, P821, DOI 10.1083/jcb.126.4.821; Bryan KE, 2006, J BIOL CHEM, V281, P20129, DOI 10.1074/jbc.M601514200; Bryan KE, 2009, J BIOL CHEM, V284, P18260, DOI 10.1074/jbc.M109.015818; Chen WZ, 2006, BIOPHYS J, V90, P1308, DOI 10.1529/biophysj.105.064634; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; COOK RK, 1992, J BIOL CHEM, V267, P9430; COOK RK, 1991, J BIOL CHEM, V266, P16825; Disabella E, 2011, HEART, V97, P321, DOI 10.1136/hrt.2010.204388; DRUBIN DG, 1990, CELL MOTIL CYTOSKEL, V15, P7, DOI 10.1002/cm.970150103; EGELMAN EH, 1995, J STRUCT BIOL, V115, P159, DOI 10.1006/jsbi.1995.1040; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; FATIGATI V, 1984, J BIOL CHEM, V259, P4383; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; GANCEDO C, 1968, EUR J BIOCHEM, V5, P165, DOI 10.1111/j.1432-1033.1968.tb00353.x; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Hoyert D L, 2001, Natl Vital Stat Rep, V49, P1; Kamal JKA, 2007, P NATL ACAD SCI USA, V104, P7910, DOI 10.1073/pnas.0611283104; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; KLINGENBERG M, 1970, EUR J BIOCHEM, V13, P247, DOI 10.1111/j.1432-1033.1970.tb00924.x; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; MILLER MJ, 1979, P NATL ACAD SCI USA, V76, P5222, DOI 10.1073/pnas.76.10.5222; Mohri K, 2006, MOL BIOL CELL, V17, P2190, DOI 10.1091/mbc.E05-11-1016; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Morisaki H, 2009, HUM MUTAT, V30, P1406, DOI 10.1002/humu.21081; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; Oda T, 2010, STRUCTURE, V18, P761, DOI 10.1016/j.str.2010.05.009; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400; Pearson GD, 2008, CIRCULATION, V118, P785, DOI 10.1161/CIRCULATIONAHA.108.783753; SHARTAVA A, 1995, J CELL BIOL, V128, P805, DOI 10.1083/jcb.128.5.805; Simon VR, 1997, CELL MOTIL CYTOSKEL, V37, P199, DOI 10.1002/(SICI)1097-0169(1997)37:3<199::AID-CM2>3.0.CO;2-2; Slaninova I, 2000, ARCH MICROBIOL, V173, P245, DOI 10.1007/s002030000136; Sparrow JC, 2003, NEUROMUSCULAR DISORD, V13, P519, DOI 10.1016/S0960-8966(03)00101-9; Stokasimov E, 2009, J BIOL CHEM, V284, P25421, DOI 10.1074/jbc.M109.013078; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Yoo EH, 2010, ANN CLIN LAB SCI, V40, P278; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	56	19	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11356	11369		10.1074/jbc.M110.203174	http://dx.doi.org/10.1074/jbc.M110.203174			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21288906	Green Published, hybrid			2022-12-25	WOS:000288797100048
J	Wong, WF; Kurokawa, M; Satake, M; Kohu, K				Wong, Won Fen; Kurokawa, Mineo; Satake, Masanobu; Kohu, Kazuyoshi			Down-regulation of Runx1 Expression by TCR Signal Involves an Autoregulatory Mechanism and Contributes to IL-2 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-HELPER TYPE-1; TRANSCRIPTION FACTORS; CELLS; DIFFERENTIATION; THYMOCYTES; LINEAGE; CD4; DISTINCT; ROLES; GENE	Runx1 transcription factor plays multiple roles in T cell development, differentiation, and function. However, the regulatory mechanisms and functional significance of high Runx1 protein expression in resting peripheral CD4+ T cells is not well understood. Here, we demonstrate that T-cell receptor (TCR) activation down-regulates distal Runx1 transcription, resulting in a significant reduction of Runx1 protein. Interestingly, this downregulation of distal Runx1 transcription appears to be mediated through a negative auto-regulatory mechanism, whereby Runx1 protein binds to a Runx consensus site in the distal promoter. Through the use of Runx1-overexpressing cells from transgenic mice, we demonstrate that interference with TCR-mediated Runx1 down-regulation inhibits IL-2 production and proliferation in activated CD4+ T cells. In contrast, using Runx1-deficient cells prepared from targeted mice, we show that the absence of Runx1 in unstimulated CD4+ T cells results in IL-2 derepression. In summary, we propose that high levels of Runx1 in resting CD4+ T cells functions negatively in the regulation of IL-2 transcription, and that TCR activation-mediated downregulation of Runx1 involves negative auto-regulation of the distal Runx1 promoter and contributes to IL-2 production.	[Satake, Masanobu] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kurokawa, Mineo] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo 1138655, Japan; [Satake, Masanobu] Tohoku Univ, Global COE Program Network Med, Sendai, Miyagi 9808575, Japan	Tohoku University; University of Tokyo; Tohoku University	Satake, M (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	satake@idac.tohoku.ac.jp; kohu@idac.tohoku.ac.jp	Wong, Won Fen/D-3087-2012	Wong, Won Fen/0000-0003-1082-1956	Ministry of Education, Science, Sports, Culture and Technology, Japan	Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a research grants from the Ministry of Education, Science, Sports, Culture and Technology, Japan.	Abe N, 2005, J IMMUNOL, V175, P4475, DOI 10.4049/jimmunol.175.7.4475; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hayashi K, 2000, J IMMUNOL, V165, P6816, DOI 10.4049/jimmunol.165.12.6816; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Ito K, 2009, ONCOGENE, V28, P1379, DOI 10.1038/onc.2008.496; KAGOSHIMA H, 1993, TRENDS GENET, V9, P338, DOI 10.1016/0168-9525(93)90026-E; Kanto S, 2000, LEUKEMIA, V14, P1253, DOI 10.1038/sj.leu.2401821; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Klunker S, 2009, J EXP MED, V206, P2701, DOI 10.1084/jem.20090596; Kohu K, 2005, J IMMUNOL, V174, P2627, DOI 10.4049/jimmunol.174.5.2627; Kohu K, 2009, J IMMUNOL, V183, P7817, DOI 10.4049/jimmunol.0802527; Kohu Kazuyoshi, 2008, Current Immunology Reviews, V4, P101, DOI 10.2174/157339508784325073; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Levanon D, 1996, DNA CELL BIOL, V15, P175, DOI 10.1089/dna.1996.15.175; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pozner A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-84; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; SATAKE M, 1995, MOL CELL BIOL, V15, P1662; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Telfer JC, 2001, DEV BIOL, V229, P363, DOI 10.1006/dbio.2000.9991; Wong WF, 2010, IMMUNOLOGY, V130, P243, DOI 10.1111/j.1365-2567.2009.03230.x; Wong WF, 2011, IMMUNOLOGY, V132, P157, DOI 10.1111/j.1365-2567.2010.03381.x	33	30	31	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11110	11118		10.1074/jbc.M110.166694	http://dx.doi.org/10.1074/jbc.M110.166694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21292764	hybrid, Green Published			2022-12-25	WOS:000288797100022
J	Jones, PB; Adams, KW; Rozkalne, A; Spires-Jones, TL; Hshieh, TT; Hashimoto, T; von Armin, CAF; Mielke, M; Bacskai, BJ; Hyman, BT				Jones, Phillip B.; Adams, Kenneth W.; Rozkalne, Anete; Spires-Jones, Tara L.; Hshieh, Tammy T.; Hashimoto, Tadafumi; von Armin, Christine A. F.; Mielke, Mathew; Bacskai, Brian J.; Hyman, Bradley T.			Apolipoprotein E: Isoform Specific Differences in Tertiary Structure and Interaction with Amyloid-beta in Human Alzheimer Brain	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; DOMAIN INTERACTION; A-BETA; TRANSGENIC MICE; TYPE-4 ALLELE; E GENOTYPE; DISEASE; APOE; BINDING; PROTEIN	We applied a novel application of FLIM-FRET to in situ measurement and quantification of protein interactions to explore isoform specific differences in A beta-ApoE interaction and ApoE tertiary conformation in senile plaques in human Alzheimer brain. ApoE3 interacts more closely with A beta than ApoE4, but a greater proportion of A beta molecules within plaques are decorated with ApoE4 than ApoE3, lending strong support to the hypothesis that isoform specific differences in ApoE are linked with A beta deposition. We found an increased number of ApoE N-terminal fragments in ApoE4 plaques, consistent with the observation that ApoE4 is more easily cleaved than ApoE3. In addition, we measured a small but significant isoform specific difference in ApoE domain interaction. Based on our in situ data, supported by traditional biochemical data, we propose a pathway by which isoform specific conformational differences increase the level of cleavage at the hinge region of ApoE4, leading to a loss of ApoE function to mediate clearance of A beta and thereby increase the risk of AD for carriers of the APOE epsilon 4 allele.	[Jones, Phillip B.; Adams, Kenneth W.; Rozkalne, Anete; Spires-Jones, Tara L.; Hshieh, Tammy T.; Hashimoto, Tadafumi; Mielke, Mathew; Bacskai, Brian J.; Hyman, Bradley T.] Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Charlestown, MA USA; [von Armin, Christine A. F.] Univ Ulm Klinikum, Neurol Klin, Ulm, Germany	Harvard University; Massachusetts General Hospital; Ulm University	Jones, PB (corresponding author), Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Charlestown, MA USA.	bhyman@partners.org	Spires-Jones, Tara/AAR-7697-2020; Bacskai, Brian/AAE-9583-2021; Hashimoto, Tadafumi/A-7723-2013	Spires-Jones, Tara/0000-0003-2530-0598; Jones, Phill/0000-0003-0525-6323; Hashimoto, Tadafumi/0000-0001-5442-4800	National Institutes of Health (NIH) [AG026240, AG005134, K99 AG033670-01A1, DK048549]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG033670, P50AG005134, R01AG026240] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants AG026240, AG005134, K99 AG033670-01A1, and DK048549 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacskai BJ, 2003, J BIOMED OPT, V8, P368, DOI 10.1117/1.1584442; Bales K R, 2002, Mol Interv, V2, P363, DOI 10.1124/mi.2.6.363; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Cho HS, 2001, J NEUROPATH EXP NEUR, V60, P342, DOI 10.1093/jnen/60.4.342; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; ELLIOTT DA, 2009, NEUROBIOLOGY AGING; Fan JJ, 2009, BIOFACTORS, V35, P239, DOI 10.1002/biof.37; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hatters DM, 2005, J BIOL CHEM, V280, P34288, DOI 10.1074/jbc.M506044200; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; HYMAN BT, 1994, J NEUROPATH EXP NEUR, V53, P427, DOI 10.1097/00005072-199409000-00001; Jones PB, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363367; Jones PB, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2837169; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Luo JH, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000663; Mahley RW, 2006, ACTA NEUROL SCAND, V114, P8, DOI 10.1111/j.1600-0404.2006.00679.x; Mahley RW, 2009, ANN NEUROL, V65, P623, DOI 10.1002/ana.21736; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; Masi A, 2010, ADV EXP MED BIOL, V674, P33; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Phu MJ, 2005, J NEUROSCI RES, V80, P877, DOI 10.1002/jnr.20503; Rebeck GW, 1998, EXP NEUROL, V149, P175, DOI 10.1006/exnr.1997.6710; REBECK GW, 1993, NEURON, V11, P575; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Sever S, 2006, EMBO J, V25, P4163, DOI 10.1038/sj.emboj.7601298; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tamamizu-Kato S, 2008, BIOCHEMISTRY-US, V47, P5225, DOI 10.1021/bi702097s; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Weisgraber K H, 1986, Methods Enzymol, V129, P145; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; Weisgraber KH, 1996, FASEB J, V10, P1485, DOI 10.1096/fasebj.10.13.8940294; WISNIEWSKI T, 1995, LANCET, V345, P956, DOI 10.1016/S0140-6736(95)90701-7; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200; Zhao LZ, 2009, J NEUROSCI, V29, P3603, DOI 10.1523/JNEUROSCI.5302-08.2009	43	55	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14586	10.1371/journal.pone.0014586	http://dx.doi.org/10.1371/journal.pone.0014586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297948	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300002
J	Mangin, L; Leseche, G; Duprey, A; Clerici, C				Mangin, Laurence; Leseche, Guy; Duprey, Alain; Clerici, Christine			Ventilatory Chaos Is Impaired in Carotid Atherosclerosis	PLOS ONE			English	Article							LIPID-RICH; VARIABILITY; FREQUENCY; DYNAMICS; NUCLEUS; NEURONS; PLAQUES	Ventilatory chaos is strongly linked to the activity of central pattern generators, alone or influenced by respiratory or cardiovascular afferents. We hypothesized that carotid atherosclerosis should alter ventilatory chaos through baroreflex and autonomic nervous system dysfunctions. Chaotic dynamics of inspiratory flow was prospectively evaluated in 75 subjects undergoing carotid ultrasonography: 27 with severe carotid stenosis (>70%), 23 with moderate stenosis (<70%), and 25 controls. Chaos was characterized by the noise titration method, the correlation dimension and the largest Lyapunov exponent. Baroreflex sensitivity was estimated in the frequency domain. In the control group, 92% of the time series exhibit nonlinear deterministic chaos with positive noise limit, whereas only 68% had a positive noise limit value in the stenoses groups. Ventilatory chaos was impaired in the groups with carotid stenoses, with significant parallel decrease in the noise limit value, correlation dimension and largest Lyapunov exponent, as compared to controls. In multiple regression models, the percentage of carotid stenosis was the best in predicting the correlation dimension (p<0.001, adjusted R-2 : 0.35) and largest Lyapunov exponent (p<0.001, adjusted R-2 : 0.6). Baroreflex sensitivity also predicted the correlation dimension values (p = 0.05), and the LLE (p = 0.08). Plaque removal after carotid surgery reversed the loss of ventilatory complexity. To conclude, ventilatory chaos is impaired in carotid atherosclerosis. These findings depend on the severity of the stenosis, its localization, plaque surface and morphology features, and is independently associated with baroreflex sensitivity reduction. These findings should help to understand the determinants of ventilatory complexity and breathing control in pathological conditions.	[Mangin, Laurence; Clerici, Christine] Hop Bichat Claude Bernard, AP HP, Serv Physiol, F-75877 Paris 18, France; [Mangin, Laurence; Leseche, Guy; Clerici, Christine] Univ Paris 07, Paris, France; [Mangin, Laurence] CNRS, UMR 7057, Lab Matieres & Syst Complexes MSC, Paris, France; [Leseche, Guy; Duprey, Alain] Hop Bichat Claude Bernard, AP HP, Serv Chirurg Thorac Vasc & Transplantat Pulm, F-75877 Paris 18, France; [Clerici, Christine] INSERM, U773, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mangin, L (corresponding author), Hop Bichat Claude Bernard, AP HP, Serv Physiol, F-75877 Paris 18, France.	laurence.mangin@bch.aphp.fr		Breakspear, Michael/0000-0003-4943-3969	ANTADIR/SPLF	ANTADIR/SPLF	This work was supported by a grant from the ANTADIR/SPLF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELLJAMES JE, 1989, CARDIOVASC RES, V23, P541, DOI 10.1093/cvr/23.6.541; ANGELLJAMES JE, 1974, CIRC RES, V34, P27, DOI 10.1161/01.RES.34.1.27; Barahona M, 1996, NATURE, V381, P215, DOI 10.1038/381215a0; BENCHETRIT G, 1975, RESP PHYSIOL, V23, P147, DOI 10.1016/0034-5687(75)90056-0; Brack T, 2002, AM J RESP CRIT CARE, V165, P1260, DOI 10.1164/rccm.2201018; BRUNNER MJ, 1982, CIRC RES, V51, P624, DOI 10.1161/01.RES.51.5.624; Del Negro CA, 2002, BIOPHYS J, V82, P206, DOI 10.1016/S0006-3495(02)75387-3; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Gianaros PJ, 2002, AM J HYPERTENS, V15, P486, DOI 10.1016/S0895-7061(02)02923-0; Good DC, 1996, STROKE, V27, P252, DOI 10.1161/01.STR.27.2.252; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; Gronholdt MLM, 1999, ARTERIOSCL THROM VAS, V19, P2, DOI 10.1161/01.ATV.19.1.2; Gronholdt MLM, 2002, J VASC SURG, V35, P137, DOI 10.1067/mva.2002.119042; GRUNSTEIN MM, 1975, J APPL PHYSIOL, V39, P395, DOI 10.1152/jappl.1975.39.3.395; HEATH D, 1973, J PATHOL, V110, P49, DOI 10.1002/path.1711100106; Kantz H., 2004, NONLINEAR TIME SERIE; Li Z, 1996, CIRC RES, V79, P802, DOI 10.1161/01.RES.79.4.802; LIEBERT W, 1991, EUROPHYS LETT, V14, P521, DOI 10.1209/0295-5075/14/6/004; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mangin L, 2008, RESP PHYSIOL NEUROBI, V161, P189, DOI 10.1016/j.resp.2008.02.006; Mangin L, 2009, AM J PHYSIOL-REG I, V296, pR1088, DOI 10.1152/ajpregu.90862.2008; Mathiesen EB, 2001, CEREBROVASC DIS, V12, P44, DOI 10.1159/000047680; McMullan S, 2009, RESP PHYSIOL NEUROBI, V166, P80, DOI 10.1016/j.resp.2009.02.006; Nasr N, 2005, STROKE, V36, P1891, DOI 10.1161/01.STR.0000177890.30065.cb; PANNETON WM, 1980, BRAIN RES, V191, P239, DOI 10.1016/0006-8993(80)90326-1; PEREZ W, 1985, J APPL PHYSIOL, V59, P1515, DOI 10.1152/jappl.1985.59.5.1515; Poon CS, 2001, P NATL ACAD SCI USA, V98, P7107, DOI 10.1073/pnas.131173198; REILLY LM, 1983, AM J SURG, V146, P188, DOI 10.1016/0002-9610(83)90370-7; RICHTER DW, 1975, BRAIN RES, V86, P168, DOI 10.1016/0006-8993(75)90651-4; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; SAMMON M, 1993, J APPL PHYSIOL, V75, P887, DOI 10.1152/jappl.1993.75.2.887; SAMMON MP, 1991, J APPL PHYSIOL, V70, P1748, DOI 10.1152/jappl.1991.70.4.1748; SEAGARD JL, 1995, NEUROSCI LETT, V191, P13, DOI 10.1016/0304-3940(95)11545-1; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; TOBIN MJ, 1988, J APPL PHYSIOL, V65, P309, DOI 10.1152/jappl.1988.65.1.309; Zureik M, 2001, AM J RESP CRIT CARE, V164, P2181, DOI 10.1164/ajrccm.164.12.2107137; Zureik M, 2001, ARCH INTERN MED, V161, P1669, DOI 10.1001/archinte.161.13.1669	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16297	10.1371/journal.pone.0016297	http://dx.doi.org/10.1371/journal.pone.0016297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297985	gold, Green Submitted, Green Published			2022-12-25	WOS:000286664100020
J	Kuespert, K; Roth, A; Hauck, CR				Kuespert, Katharina; Roth, Alexandra; Hauck, Christof R.			Neisseria meningitidis Has Two Independent Modes of Recognizing Its Human Receptor CEACAM1	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CARCINOEMBRYONIC ANTIGEN FAMILY; NONTYPABLE HAEMOPHILUS-INFLUENZAE; IMMUNOGENIC AUTOTRANSPORTER PROTEIN; GONOCOCCAL OPACITY PROTEINS; EPITHELIAL-CELLS; ESCHERICHIA-COLI; OPA PROTEINS; PATHOGENIC NEISSERIAE; N-DOMAIN	Background: Several human-restricted Gram-negative bacteria exploit carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) for host colonization. For example, Neisseria meningitidis engages these human receptors via outer membrane proteins of the colony opacity-associated (Opa) protein family triggering internalization into non-phagocytic cells. Principal Findings: We report that a non-opaque strain of N. meningitidis selectively interacts with CEACAM1, but not other CEACAM family members. Using functional assays of bacterial adhesion and internalisation, microscopic analysis, and a panel of CEACAM1 deletion mutants we demonstrate that the engagement of CEACAM1 by non-opaque meningococci occurs in a manner distinct from Opa protein-mediated association. In particular, the amino-terminal domain of CEACAM1 is necessary, but not sufficient for Opa protein-independent binding, which requires multiple extracellular domains of the human receptor in a cellular context. Knock-down of CEACAM1 interferes with binding to lung epithelial cells, whereas chemical or pharmacological disruption of host protein glycosylation does not abrogate CEACAM1 recognition by nonopaque meningococci. The previously characterized meningococcal invasins NadA or Opc do not operate in a CEACAM1dependent manner. Conclusions: The results demonstrate a mechanistically distinct, Opa protein-independent interaction between N. meningitidis and human CEACAM1. Our functional investigations suggest the presence of a second CEACAM1-binding invasin on the meningococcal surface that associates with the protein backbone and not the carbohydrate structures of CEACAM1. The redundancy in meningococcal CEACAM1-binding factors further highlights the important role of CEACAM recognition in the biology of this human-adapted pathogen.	[Kuespert, Katharina; Roth, Alexandra; Hauck, Christof R.] Univ Konstanz, Lehrstuhl Zellbiol, Constance, Germany	University of Konstanz	Kuespert, K (corresponding author), Hain Lifesci GmbH, Nehren, Germany.	christof.hauck@uni-konstanz.de			Deutsche Forschungsgemeinschaft (DFG) [Ha2568/3-3]; GRK [1331]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); GRK(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) Ha2568/3-3 to CRH. AR was supported by a fellowship of the GRK 1331. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella MA, 2010, MANDELL DOUGLAS BENN, V7, P2737; Berger CN, 2004, MOL MICROBIOL, V52, P963, DOI 10.1111/j.1365-2958.2004.04033.x; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; Bos MP, 1999, J EXP MED, V190, P331, DOI 10.1084/jem.190.3.331; Bos MP, 2002, INFECT IMMUN, V70, P1715, DOI 10.1128/IAI.70.4.1715-1723.2002; Bos MP, 1997, INFECT IMMUN, V65, P2353, DOI 10.1128/IAI.65.6.2353-2361.1997; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Brooks MJ, 2008, INFECT IMMUN, V76, P5322, DOI 10.1128/IAI.00572-08; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Conners R, 2008, EMBO J, V27, P1779, DOI 10.1038/emboj.2008.101; de Vries FP, 1998, MOL MICROBIOL, V27, P1203, DOI 10.1046/j.1365-2958.1998.00763.x; Duim B, 1997, INFECT IMMUN, V65, P1351, DOI 10.1128/IAI.65.4.1351-1356.1997; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; Hadi HA, 2001, MOL MICROBIOL, V41, P611, DOI 10.1046/j.1365-2958.2001.02516.x; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hauck CR, 2001, J BIOL CHEM, V276, P17653, DOI 10.1074/jbc.M009329200; Heise T, 2006, P NATL ACAD SCI USA, V103, P3375, DOI 10.1073/pnas.0507749103; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Klaile E, 2009, J CELL BIOL, V187, P553, DOI 10.1083/jcb.200904149; Korotkova N, 2006, J BIOL CHEM, V281, P29120, DOI 10.1074/jbc.M605681200; Kuespert K, 2007, J MICROBIOL METH, V68, P478, DOI 10.1016/j.mimet.2006.10.003; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; LEUSCH HG, 1991, INFECT IMMUN, V59, P2051, DOI 10.1128/IAI.59.6.2051-2057.1991; Malorny B, 1998, J BACTERIOL, V180, P1323, DOI 10.1128/JB.180.5.1323-1330.1998; Marrazzo J, 2010, PRINCIPLES PRACTICE, P2753; McCaw SE, 2003, MOL MICROBIOL, V49, P623, DOI 10.1046/j.1365-2958.2003.03591.x; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; MEYER TF, 1990, ANNU REV MICROBIOL, V44, P451; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Muenzner P, 2001, J BIOL CHEM, V276, P24331, DOI 10.1074/jbc.M006883200; Muenzner P, 2008, CELL MICROBIOL, V10, P1074, DOI 10.1111/j.1462-5822.2007.01106.x; Muenzner P, 2010, SCIENCE, V329, P1197, DOI 10.1126/science.1190892; OLYHOEK AJM, 1991, MICROB PATHOGENESIS, V11, P249, DOI 10.1016/0882-4010(91)90029-A; Peak IRA, 2000, FEMS IMMUNOL MED MIC, V28, P329, DOI 10.1111/j.1574-695X.2000.tb01494.x; Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; SARKARI J, 1994, MOL MICROBIOL, V13, P207, DOI 10.1111/j.1365-2958.1994.tb00416.x; SAUTER SL, 1993, J BIOL CHEM, V268, P15510; Schmitt C, 2007, J BACTERIOL, V189, P7968, DOI 10.1128/JB.00851-07; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Schmitter T, 2007, INFECT IMMUN, V75, P4116, DOI 10.1128/IAI.01835-06; Schmitter T, 2007, J IMMUNOL, V178, P3797, DOI 10.4049/jimmunol.178.6.3797; Serruto D, 2003, MOL MICROBIOL, V48, P323, DOI 10.1046/j.1365-2958.2003.03420.x; Singer BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008747; Slanina H, 2010, INFECT IMMUN, V78, P1905, DOI 10.1128/IAI.01267-09; Snyder LAS, 2001, MICROBIOL-SGM, V147, P2321, DOI 10.1099/00221287-147-8-2321; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Turner DPJ, 2006, INFECT IMMUN, V74, P2957, DOI 10.1128/IAI.74.5.2957-2964.2006; Unkmeir A, 2002, MOL MICROBIOL, V46, P933, DOI 10.1046/j.1365-2958.2002.03222.x; VANPUTTEN JPM, 1995, EMBO J, V14, P2144, DOI 10.1002/j.1460-2075.1995.tb07208.x; Virji M, 2000, MOL MICROBIOL, V36, P784, DOI 10.1046/j.1365-2958.2000.01885.x; VIRJI M, 1994, MOL MICROBIOL, V14, P173, DOI 10.1111/j.1365-2958.1994.tb01277.x; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Vogel U, 1999, MOL MICROBIOL, V32, P1133, DOI 10.1046/j.1365-2958.1999.01469.x; Webb DC, 1998, J MED MICROBIOL, V47, P1059, DOI 10.1099/00222615-47-12-1059; Zhu PX, 1999, MOL MICROBIOL, V33, P635, DOI 10.1046/j.1365-2958.1999.01514.x	70	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14609	10.1371/journal.pone.0014609	http://dx.doi.org/10.1371/journal.pone.0014609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298042	Green Submitted, Green Published, gold			2022-12-25	WOS:000286663900012
J	Ma, N; Liu, Y; Fu, XM; Li, N; Wang, CX; Zhang, H; Qian, RB; Xu, HS; Hu, XP; Zhang, DR				Ma, Ning; Liu, Ying; Fu, Xian-Ming; Li, Nan; Wang, Chang-Xin; Zhang, Hao; Qian, Ruo-Bing; Xu, Hu-Sheng; Hu, Xiaoping; Zhang, Da-Ren			Abnormal Brain Default-Mode Network Functional Connectivity in Drug Addicts	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; DETOXIFIED ALCOHOLIC PATIENTS; STRUCTURAL CONNECTIVITY; RECEPTOR AVAILABILITY; COCAINE ADDICTION; FLUCTUATIONS; DYSFUNCTION; ATTENTION; MEMORY; DISORDERS	Background: The default mode network (DMN) is a set of brain regions that exhibit synchronized low frequency oscillations at resting-state, and is believed to be relevant to attention and self-monitoring. As the anterior cingulate cortex and hippocampus are impaired in drug addiction and meanwhile are parts of the DMN, the present study examined addiction-related alteration of functional connectivity of the DMN. Methodology: Resting-state functional magnetic resonance imaging data of chronic heroin users (14 males, age: 30.1+/-5.3 years, range from 22 to 39 years) and non-addicted controls (13 males, age: 29.8+/-7.2 years, range from 20 to 39 years) were investigated with independent component analysis to address their functional connectivity of the DMN. Principal Findings: Compared with controls, heroin users showed increased functional connectivity in right hippocampus and decreased functional connectivity in right dorsal anterior cingulate cortex and left caudate in the DMN. Conclusions: These findings suggest drug addicts' abnormal functional organization of the DMN, and are discussed as addiction-related abnormally increased memory processing but diminished cognitive control related to attention and self-monitoring, which may underlie the hypersensitivity toward drug related cues but weakened strength of cognitive control in the state of addiction.	[Ma, Ning; Li, Nan; Xu, Hu-Sheng; Zhang, Da-Ren] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230026, Peoples R China; [Ma, Ning; Li, Nan; Xu, Hu-Sheng; Zhang, Da-Ren] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Liu, Ying; Wang, Chang-Xin] Anhui Med Univ, Dept MRI, Prov Hosp, Hefei, Peoples R China; [Fu, Xian-Ming; Qian, Ruo-Bing] Anhui Med Univ, Dept Neurosurg, Prov Hosp, Hefei, Peoples R China; [Fu, Xian-Ming; Qian, Ruo-Bing] Anhui Prov Inst Stereotact Neurosurg, Hefei, Peoples R China; [Zhang, Hao] Anhui Detoxificat & Rehabil Ctr, Hefei, Peoples R China; [Hu, Xiaoping] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Hu, Xiaoping] Emory Univ, Atlanta, GA 30322 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Anhui Medical University; University System of Georgia; Georgia Institute of Technology; Emory University	Ma, N (corresponding author), Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230026, Peoples R China.	man@ustc.edu.cn		Hu, Xiaoping/0000-0001-7014-5983; Qian, Ruobing/0000-0002-9559-1952	National Nature Science Foundation of China [31000458, 30770713, 30870764, 30973084]; Ministry of Science and Technology of China [2006CB500705]; Academic Exchange Fund of International Medical MR [N7014]; US National Institutes of Health [RO1EB002009, RO1DA17795]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017795] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Academic Exchange Fund of International Medical MR; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research is supported by the National Nature Science Foundation of China (31000458, 30770713, 30870764, and 30973084), Ministry of Science and Technology of China (2006CB500705), Academic Exchange Fund of International Medical MR, (N7014), and the US National Institutes of Health (RO1EB002009 and RO1DA17795). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calhoun VD, 2001, NEUROIMAGE, V14, P1080, DOI 10.1006/nimg.2001.0921; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Garavan H, 2007, NEUROPSYCHOL REV, V17, P337, DOI 10.1007/s11065-007-9034-x; Goldstein RZ, 2007, NEUROSCIENCE, V144, P1153, DOI 10.1016/j.neuroscience.2006.11.024; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Heinz A, 2005, AM J PSYCHIAT, V162, P1515, DOI 10.1176/appi.ajp.162.8.1515; Heinz A, 2005, ARCH GEN PSYCHIAT, V62, P57, DOI 10.1001/archpsyc.62.1.57; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; Heinz A, 2003, PHARMACOPSYCHIATRY, V36, pS149; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hong LE, 2009, ARCH GEN PSYCHIAT, V66, P431, DOI 10.1001/archgenpsychiatry.2009.2; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Lundqvist T, 2005, PHARMACOL BIOCHEM BE, V81, P319, DOI 10.1016/j.pbb.2005.02.017; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Talairach J, 1992, Adv Neurol, V57, P651; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Zhao XH, 2007, EUR J RADIOL, V63, P373, DOI 10.1016/j.ejrad.2007.02.006; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	44	107	113	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16560	10.1371/journal.pone.0016560	http://dx.doi.org/10.1371/journal.pone.0016560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298074	Green Published, Green Submitted, gold			2022-12-25	WOS:000286662800055
J	Gilmore, SJ				Gilmore, Stephen J.			Control Strategies for Endemic Childhood Scabies	PLOS ONE			English	Article							DISEASE; IVERMECTIN; CHILDREN; MODEL	Human scabies is a major global public health issue, with an estimated 300 million cases per year worldwide. Prevalence rates are particularly high in many third-world regions and within various indigenous communities in developed countries. Infestation with Sarcoptes Scabiei is associated with group-A streptococcal pyoderma which in turn predisposes to rheumatic fever, acute glomerulonephritis and their respective long-term sequelae: rheumatic heart disease and chronic renal insufficiency. The documented difficulties inherent in achieving scabies control within affected communities have motivated us to develop a network-dependent Monte-Carlo model of the scabies contagion, with the dual aims of gaining insight into its dynamics, and in determining the effects of various treatment strategies. Here we show that scabies burden is adversely affected by increases in average network degree, prominent network clustering, and by a person-to-person transmissibility of greater magnitude. We demonstrate that creating a community-specific model allows for the determination of an effective treatment protocol that can satisfy any pre-defined target prevalence. We find frequent low-density treatment protocols are inherently advantageous in comparison with infrequent mass screening and treatment regimes: prevalence rates are lower when compared with protocols that administer the same number of treatments over a given time interval less frequently, and frequent low-density treatment protocols have economic, practical and public acceptance advantages that may facilitate their long-term implementation. This work demonstrates the importance of stochasticity, community structure and the heterogeneity of individuals in influencing the dynamics of the human scabies contagion, and provides a practical method for investigating the outcomes of various intervention strategies.	Univ Queensland, Dermatol Res Ctr, Sch Med, Princess Alexandra Hosp, Brisbane, Qld, Australia	University of Queensland	Gilmore, SJ (corresponding author), Univ Queensland, Dermatol Res Ctr, Sch Med, Princess Alexandra Hosp, Brisbane, Qld, Australia.	s.gilmore1@uq.edu.au			University of Queensland, Brisbane, Australia	University of Queensland, Brisbane, Australia(University of Queensland)	This work was supported by The University of Queensland, Brisbane, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Andrews RM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000554; Australian Bureau of Statistics Australian Institute of Health Welfare, 2008, HLTH WELF AUSTR AB T; Carapetis JR, 1996, MED J AUSTRALIA, V164, P146, DOI 10.5694/j.1326-5377.1996.tb122012.x; Carapetis JR, 1997, PEDIATR INFECT DIS J, V16, P494, DOI 10.1097/00006454-199705000-00008; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Clucas DB, 2008, B WORLD HEALTH ORGAN, V86, P275, DOI 10.2471/BLT.07.043034; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Heukelbach J, 2006, LANCET, V367, P1767, DOI 10.1016/S0140-6736(06)68772-2; Johnston G, 2005, BMJ-BRIT MED J, V331, P619, DOI 10.1136/bmj.331.7517.619; Karthikeyan K, 2005, POSTGRAD MED J, V81, P7, DOI 10.1136/pgmj.2003.018390; La Vincente S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000444; Lawrence G, 2005, B WORLD HEALTH ORGAN, V83, P34; LIN XD, 1993, MATH BIOSCI, V118, P181, DOI 10.1016/0025-5564(93)90051-B; Medina DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001181; REID HFM, 1990, EPIDEMIOL INFECT, V105, P595, DOI 10.1017/S0950268800048238; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Savin JA, 2005, J ROY SOC MED, V98, P124, DOI 10.1258/jrsm.98.3.124; Speare R, 2004, B WORLD HEALTH ORGAN, V82, P562; Steer AC, 2009, B WHO, V87; Steer AC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000467; Strong M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000320.pub2; TAPLIN D, 1983, J AM ACAD DERMATOL, V9, P546, DOI 10.1016/S0190-9622(83)70167-2; TAPLIN D, 1991, LANCET, V337, P1016, DOI 10.1016/0140-6736(91)92669-S; Usha V, 2000, J AM ACAD DERMATOL, V42, P236, DOI 10.1016/S0190-9622(00)90131-2; White AV, 2001, MED J AUSTRALIA, V174, P492, DOI 10.5694/j.1326-5377.2001.tb143394.x	26	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15990	10.1371/journal.pone.0015990	http://dx.doi.org/10.1371/journal.pone.0015990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283575	Green Published, gold, Green Submitted			2022-12-25	WOS:000286661400020
J	Meyer-Hoffert, U; Zimmermann, A; Czapp, M; Bartels, J; Koblyakova, Y; Glaser, R; Schroder, JM; Gerstel, U				Meyer-Hoffert, Ulf; Zimmermann, Alexandra; Czapp, Manfred; Bartels, Joachim; Koblyakova, Yulia; Glaeser, Regine; Schroeder, Jens-Michael; Gerstel, Ulrich			Flagellin Delivery by Pseudomonas aeruginosa Rhamnolipids Induces the Antimicrobial Protein Psoriasin in Human Skin	PLOS ONE			English	Article							BACTERIAL FLAGELLIN; SURFACE-PROPERTIES; PEPTIDE; BIOSURFACTANT; MICROBIOTA; MECHANISM	The opportunistic pathogen Pseudomonas aeruginosa can cause severe infections in patients suffering from disruption or disorder of the skin barrier as in burns, chronic wounds, and after surgery. On healthy skin P. aeruginosa causes rarely infections. To gain insight into the interaction of the ubiquitous bacterium P. aeruginosa and healthy human skin, the induction of the antimicrobial protein psoriasin by P. aeruginosa grown on an ex vivo skin model was analyzed. We show that presence of the P. aeruginosa derived biosurfactant rhamnolipid was indispensable for flagellin-induced psoriasin expression in human skin, contrary to in vitro conditions. The importance of the bacterial virulence factor flagellin as the major inducing factor of psoriasin expression in skin was demonstrated by use of a flagellin-deficient mutant. Rhamnolipid mediated shuttle across the outer skin barrier was not restricted to flagellin since rhamnolipids enable psoriasin expression by the cytokines IL-17 and IL-22 after topical application on human skin. Rhamnolipid production was detected for several clinical strains and the formation of vesicles was observed under skin physiological conditions. In conclusion we demonstrate herein that rhamnolipids enable the induction of the antimicrobial protein psoriasin by flagellin in human skin without direct contact of bacteria and responding cells. Hereby, human skin might control the microflora to prevent colonization of unwanted microbes in the earliest steps before potential pathogens can develop strategies to subvert the immune response.	[Meyer-Hoffert, Ulf; Zimmermann, Alexandra; Czapp, Manfred; Bartels, Joachim; Koblyakova, Yulia; Glaeser, Regine; Schroeder, Jens-Michael; Gerstel, Ulrich] Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Meyer-Hoffert, U (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany.	Ugerstel@dermatology.uni-kiel.de	Meyer-Hoffert, Ulf/F-4623-2012; Gläser, Regine/B-3168-2010	Meyer-Hoffert, Ulf/0000-0003-2305-1428; Bartels, Joachim/0000-0003-4395-4552	medical faculty Kiel	medical faculty Kiel	This study was supported by grants of the medical faculty Kiel (U. Meyer-Hoffert, U. Gerstel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtin A, 2008, FASEB J, V22, P2168, DOI 10.1096/fj.07-104117; Abtin A, 2010, J INVEST DERMATOL, V130, P2423, DOI 10.1038/jid.2010.158; Al-Tahhan RA, 2000, APPL ENVIRON MICROB, V66, P3262, DOI 10.1128/AEM.66.8.3262-3268.2000; Benincasa M, 2004, ANTON LEEUW INT J G, V85, P1, DOI 10.1023/B:ANTO.0000020148.45523.41; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Bosgelmez-Tinaz G, 2008, MICROB PATHOGENESIS, V44, P13, DOI 10.1016/j.micpath.2007.06.005; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Cao B, 2004, J HOSP INFECT, V57, P112, DOI 10.1016/j.jhin.2004.03.021; Choi MJ, 2005, SKIN PHARMACOL PHYS, V18, P209, DOI 10.1159/000086666; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Dahrazma B, 2008, J COLLOID INTERF SCI, V319, P590, DOI 10.1016/j.jcis.2007.11.045; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Dekio I, 2005, J MED MICROBIOL, V54, P1231, DOI 10.1099/jmm.0.46075-0; Deziel E, 1999, BBA-MOL CELL BIOL L, V1440, P244, DOI 10.1016/S1388-1981(99)00129-8; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Gerstel U, 2009, CELL MICROBIOL, V11, P842, DOI 10.1111/j.1462-5822.2009.01299.x; Glaser R, 2009, J INVEST DERMATOL, V129, P641, DOI 10.1038/jid.2008.268; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Haba E, 2003, BIOTECHNOL BIOENG, V81, P316, DOI 10.1002/bit.10474; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Harder J, 2005, J LEUKOCYTE BIOL, V77, P476, DOI 10.1189/jlb.0704409; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; KOCH AK, 1991, J BACTERIOL, V173, P4212, DOI 10.1128/jb.173.13.4212-4219.1991; Lequette Y, 2005, J BACTERIOL, V187, P37, DOI 10.1128/JB.187.1.37-44.2005; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; NOBLE W. C., 1981, MICROBIOLOGY HUMAN S; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Pinzon NM, 2009, APPL MICROBIOL BIOT, V82, P975, DOI 10.1007/s00253-009-1896-9; Ramphal R, 1996, AM J RESP CRIT CARE, V154, pS170, DOI 10.1164/ajrccm/154.4_Pt_2.S170; Sahl HG, 2005, J LEUKOCYTE BIOL, V77, P466, DOI 10.1189/jlb.0804452; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Soberon-Chavez G, 2005, APPL MICROBIOL BIOT, V68, P718, DOI 10.1007/s00253-005-0150-3; Stipcevic T, 2005, J DERMATOL SCI, V40, P141, DOI 10.1016/j.jdermsci.2005.08.005; SYLDATK C, 1985, Z NATURFORSCH C, V40, P61; Wiedow O, 1998, BIOCHEM BIOPH RES CO, V248, P904, DOI 10.1006/bbrc.1998.9069; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; ZHANG YM, 1994, APPL ENVIRON MICROB, V60, P2101, DOI 10.1128/AEM.60.6.2101-2106.1994	42	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16433	10.1371/journal.pone.0016433	http://dx.doi.org/10.1371/journal.pone.0016433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283546	Green Published, gold, Green Submitted			2022-12-25	WOS:000286661400052
J	Levesque, S; Michaud, S; Arbeit, RD; Frost, EH				Levesque, Simon; Michaud, Sophie; Arbeit, Robert D.; Frost, Eric H.			High-Resolution Melting System to Perform Multilocus Sequence Typing of Campylobacter jejuni	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; CLONAL COMPLEXES; GENE; ELECTROPHORESIS; IDENTIFICATION; DIVERSITY; STRAINS; QUEBEC; CANADA; COLI	Multi-locus sequence typing (MLST) has emerged as the state-of-the-art method for resolving bacterial population genetics but it is expensive and time consuming. We evaluated the potential of high resolution melting (HRM) to identify known MLST alleles of Campylobacter jejuni at reduced cost and time. Each MLST locus was amplified in two or three sub fragments, which were analyzed by HRM. The approach was investigated using 47 C. jejuni isolates, previously characterized by classical MLST, representing isolates from diverse environmental, animal and clinical sources and including the six most prevalent sequence types (ST) and the most frequent alleles. HRM was then applied to a validation set of 84 additional C. jejuni isolates from chickens; 92% of the alleles were resolved in 35 hours of laboratory time and the cost of reagents per isolate was $20 compared with $100 for sequence-based typing. HRM has the potential to complement sequence-based methods for resolving SNPs and to facilitate a wide range of genotyping studies.	[Levesque, Simon; Michaud, Sophie; Frost, Eric H.] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada; [Arbeit, Robert D.] Tufts Univ, Sch Med, Infect Dis Sect, Boston, MA 02111 USA	University of Sherbrooke; Tufts University	Levesque, S (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada.	Eric.Frost@USherbrooke.ca		Frost, Eric/0000-0001-8958-4388; Levesque, Simon/0000-0002-4356-9702	Canadian Institutes of Health Research [313026-2005]; Natural Sciences and Engineering Research Council of Canada; Centre de Recherche Clinique Etienne Le-Bel of the Centre Hospitalier Universitaire de Sherbrooke	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Centre de Recherche Clinique Etienne Le-Bel of the Centre Hospitalier Universitaire de Sherbrooke	Financial support (grant number 313026-2005) was received jointly from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). Funding was also obtained from the Centre de Recherche Clinique Etienne Le-Bel of the Centre Hospitalier Universitaire de Sherbrooke (http://www.crc.chus.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, decision to publish or preparation of the manuscript.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; Best EL, 2005, J MED MICROBIOL, V54, P919, DOI 10.1099/jmm.0.45971-0; Best EL, 2004, J CLIN MICROBIOL, V42, P2836, DOI 10.1128/JCM.42.6.2836-2839.2004; Clark CG, 2005, J CLIN MICROBIOL, V43, P2080, DOI 10.1128/JCM.43.5.2080-2091.2005; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Djordjevic SP, 2007, J CLIN MICROBIOL, V45, P102, DOI 10.1128/JCM.01012-06; Duim B, 2003, J CLIN MICROBIOL, V41, P5593, DOI 10.1128/JCM.41.12.5593-5597.2003; Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Manning G, 2003, APPL ENVIRON MICROB, V69, P6370, DOI 10.1128/AEM.69.11.6370-6379.2003; Merchant-Patel S, 2010, APPL ENVIRON MICROB, V76, P493, DOI 10.1128/AEM.01164-09; Michaud S, 2004, EMERG INFECT DIS, V10, P1844, DOI 10.3201/eid1010.040228; Millat G, 2009, CLIN BIOCHEM, V42, P892, DOI 10.1016/j.clinbiochem.2009.01.016; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; *ROCH DIAGN GMBH, 2008, 1 ROCH DIAGN GMBH; Sails AD, 2003, J CLIN MICROBIOL, V41, P4733, DOI 10.1128/JCM.41.10.4733-4739.2003; Sails AD, 2003, J CLIN MICROBIOL, V41, P4058, DOI 10.1128/JCM.41.9.4058-4067.2003; Schouls LM, 2003, J CLIN MICROBIOL, V41, P15, DOI 10.1128/JCM.41.1.15-26.2003; Taylor CF, 2009, BIOCHEM SOC T, V37, P433, DOI 10.1042/BST0370433	24	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16167	10.1371/journal.pone.0016167	http://dx.doi.org/10.1371/journal.pone.0016167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21297862	Green Published, gold, Green Submitted			2022-12-25	WOS:000286523400025
J	Ryan, J; Curran, CE; Hennessy, E; Newell, J; Morris, JC; Kerin, MJ; Dwyer, RM				Ryan, James; Curran, Catherine E.; Hennessy, Emer; Newell, John; Morris, John C.; Kerin, Michael J.; Dwyer, Roisin M.			The Sodium Iodide Symporter (NIS) and Potential Regulators in Normal, Benign and Malignant Human Breast Tissue	PLOS ONE			English	Article							THYROID-HORMONE RECEPTORS; RETINOIC ACID RECEPTORS; SODIUM/IODIDE SYMPORTER; GENE-EXPRESSION; CANCER CELLS; TRANSCRIPTION; THYROGLOBULIN; METASTASES	Introduction: The presence, relevance and regulation of the Sodium Iodide Symporter (NIS) in human mammary tissue remains poorly understood. This study aimed to quantify relative expression of NIS and putative regulators in human breast tissue, with relationships observed further investigated in vitro. Methods: Human breast tissue specimens (malignant n = 75, normal n = 15, fibroadenoma n = 10) were analysed by RQ-PCR targeting NIS, receptors for retinoic acid (RAR alpha, RAR beta), oestrogen (ER alpha), thyroid hormones (THR alpha, THR beta), and also phosphoinositide-3-kinase (PI3K). Breast cancer cells were treated with Retinoic acid (ATRA), Estradiol and Thyroxine individually and in combination followed by analysis of changes in NIS expression. Results: The lowest levels of NIS were detected in normal tissue (Mean(SEM) 0.70(0.12) Log(10) Relative Quantity (RQ)) with significantly higher levels observed in fibroadenoma (1.69(0.21) Log(10)RQ, p < 0.005) and malignant breast tissue (1.18(0.07) Log(10)RQ, p < 0.05). Significant positive correlations were observed between human NIS and ER alpha (r = 0.22, p < 0.05) and RAR alpha (r = 0.29, p < 0.005), with the strongest relationship observed between NIS and RAR beta (r = 0.38, p < 0.0001). An inverse relationship between NIS and PI3K expression was also observed (r = -0.21, p < 0.05). In vitro, ATRA, Estradiol and Thyroxine individually stimulated significant increases in NIS expression (range 6-16 fold), while ATRA and Thyroxine combined caused the greatest increase (range 16-26 fold). Conclusion: Although NIS expression is significantly higher in malignant compared to normal breast tissue, the highest level was detected in fibroadenoma. The data presented supports a role for retinoic acid and estradiol in mammary NIS regulation in vivo, and also highlights potential thyroidal regulation of mammary NIS mediated by thyroid hormones.	[Ryan, James; Curran, Catherine E.; Hennessy, Emer; Kerin, Michael J.; Dwyer, Roisin M.] Natl Univ Ireland Galway, Sch Med, Div Surg, Galway, Ireland; [Newell, John] Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway, Ireland; [Newell, John] Natl Univ Ireland Galway, Clin Res Facil, Galway, Ireland; [Morris, John C.] Mayo Clin, Div Endocrinol, Rochester, MN USA	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Mayo Clinic	Ryan, J (corresponding author), Natl Univ Ireland Galway, Sch Med, Div Surg, Galway, Ireland.	roisin.dwyer@nuigalway.ie	Kerin, Michael J/D-6748-2013; Dwyer, Roisin M/C-6654-2013	Dwyer, Roisin M/0000-0002-5854-0339; Newell, John/0000-0001-7685-6655; Kerin, Michael/0000-0003-4164-5561	Cancer Research Ireland; Health Research Board of Ireland; National Breast Cancer Research Institute (NBCRI)	Cancer Research Ireland; Health Research Board of Ireland; National Breast Cancer Research Institute (NBCRI)	This study was supported by funding from Cancer Research Ireland (www.cancer.ie/research) (J. Ryan), Health Research Board of Ireland (www.hrb.ie) (R. M. Dwyer, J. Newell), and the National Breast Cancer Research Institute (NBCRI) (www.nbcri.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alotaibi H, 2006, BIOCHEM BIOPH RES CO, V345, P1487, DOI 10.1016/j.bbrc.2006.05.049; Alotaibi H, 2010, NUCLEIC ACIDS RES, V38, P3172, DOI 10.1093/nar/gkq023; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; Berger F, 2006, BIOCHEM BIOPH RES CO, V349, P1258, DOI 10.1016/j.bbrc.2006.08.170; Castro MR, 1999, J CLIN ENDOCR METAB, V84, P2957, DOI 10.1210/jc.84.8.2957; Choe JG, 2005, NUCL MED COMMUN, V26, P1155, DOI 10.1097/00006231-200512000-00017; Conde I, 2006, ANN ONCOL, V17, P60, DOI 10.1093/annonc/mdj040; Dohan O, 2003, MOL CELL ENDOCRINOL, V213, P59, DOI 10.1016/j.mce.2003.10.059; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Kilbane MT, 2000, J CLIN ENDOCR METAB, V85, P1245, DOI 10.1210/jc.85.3.1245; Knostman KAB, 2004, J CLIN ENDOCR METAB, V89, P5196, DOI 10.1210/jc.2004-0907; Knostman KAB, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-137; Kogai T, 2005, ENDOCRINOLOGY, V146, P3059, DOI 10.1210/en.2004-1334; Lee S, 2005, MOL ENDOCRINOL, V19, P863, DOI 10.1210/me.2004-0210; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; McNeill RE, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-107; Moon DH, 2001, NUCL MED BIOL, V28, P829; NAGAYA T, 1993, J BIOL CHEM, V268, P15766; Ohashi E, 2009, CANCER RES, V69, P3443, DOI 10.1158/0008-5472.CAN-08-3234; Renier C, 2010, J NEURO-ONCOL, V96, P331, DOI 10.1007/s11060-009-9971-8; Renier C, 2009, ANN SURG ONCOL, V16, P962, DOI 10.1245/s10434-008-0280-9; Riesco-Eizaguirre G, 2006, EUR J ENDOCRINOL, V155, P495, DOI 10.1530/eje.1.02257; Rudnicka L, 2003, FOLIA HISTOCHEM CYTO, V41, P37; Silva EG, 2002, INT J SURG PATHOL, V10, P33, DOI 10.1177/106689690201000106; Silva JM, 2002, ONCOGENE, V21, P4307, DOI 10.1038/sj.onc.1205534; Suzuki K, 1999, ENDOCRINOLOGY, V140, P5422, DOI 10.1210/en.140.11.5422; Suzuki K, 1998, P NATL ACAD SCI USA, V95, P8251, DOI 10.1073/pnas.95.14.8251; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; Upadhyay G, 2003, BREAST CANCER RES TR, V77, P157, DOI 10.1023/A:1021321409159; Wallden B, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-140; Wapnir IL, 2004, CLIN CANCER RES, V10, P4294, DOI 10.1158/1078-0432.CCR-04-0074; Wapnir IL, 2003, J CLIN ENDOCR METAB, V88, P1880, DOI 10.1210/jc.2002-021544; Willhauck MJ, 2008, BREAST CANCER RES TR, V109, P263, DOI 10.1007/s10549-007-9646-0; Willhauck MJ, 2011, BREAST CANCER RES TR, V125, P377, DOI 10.1007/s10549-010-0835-x	35	23	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16023	10.1371/journal.pone.0016023	http://dx.doi.org/10.1371/journal.pone.0016023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283523	Green Published, Green Submitted, gold			2022-12-25	WOS:000286520600019
J	Sumida, T; Fujimoto, K; Ito, M				Sumida, Tomomi; Fujimoto, Ken; Ito, Makoto			Molecular Cloning and Catalytic Mechanism of a Novel Glycosphingolipid-degrading beta-N-Acetylgalactosaminidase from Paenibacillus sp. TS12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; GLYCOSYL HYDROLASES; HEXOSAMINIDASE; SEQUENCE; ACETYLHEXOSAMINIDASE; CLASSIFICATION; PURIFICATION; INHIBITORS; KINETICS; BRAIN	We report here the molecular cloning, characterization, and catalytic mechanism of a novel glycosphingolipid-degrading beta-N-acetylgalactosaminidase (beta-NGA) from Paenibacillus sp. TS12 (NgaP). Consisting of 1034 putative amino acid residues, NgaP shares no sequence similarity with known proteins. Recombinant NgaP, expressed in Escherichia coli, cleaved the nonreducing terminal beta-GalNAc residues of gangliotriaosylceramide and globotetraosylceramide. The enzyme hydrolyzed para-nitrophenyl-beta-N-acetylgalactosaminide similar to 100 times faster than para-nitrophenyl-beta-N-acetylglucosaminide. GalNAc thiazoline, an analog of the oxazolinium intermediate and potent inhibitor for enzymes adopting substrate-assisted catalysis, competitively inhibited the enzyme. The K-i of the enzyme for GalNAc thiazoline was 1.3 nM, whereas that for GlcNAc thiazoline was 46.8 mu M. Comparison of the secondary structure with those of known enzymes exhibiting substrate-assisted catalysis and point mutation analysis indicated that NgaP adopts substrate-assisted catalysis in which Glu-608 and Asp-607 could function as a proton donor and a stabilizer of the 2-acetamide group of the beta-GalNAc at the active site, respectively. These results clearly indicate that NgaP is a beta-NGA showing substrate-assisted catalysis. This is the first report describing the molecular cloning of a beta-NGA adopting substrate-assisted catalysis.	[Sumida, Tomomi; Fujimoto, Ken; Ito, Makoto] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan	Kyushu University	Ito, M (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	makotoi@agr.kyushu-u.ac.jp	Ito, Makoto/Q-6164-2019	ito, Makoto/0000-0003-3159-7818	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21380066]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Basic Research 21380066 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; FROHWEIN YZ, 1967, BIOCHEMISTRY-US, V6, P2775, DOI 10.1021/bi00861a018; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Gutternigg M, 2009, BIOCHEM J, V419, P83, DOI 10.1042/BJ20081630; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; IZUMI T, 1983, J BIOL CHEM, V258, P6991; KANFER JN, 1969, METHOD ENZYMOL, V14, P660; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEATHERBARROW RJ, 1990, TRENDS BIOCHEM SCI, V15, P455, DOI 10.1016/0968-0004(90)90295-M; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Sumida T, 2002, APPL ENVIRON MICROB, V68, P5241, DOI 10.1128/AEM.68.11.5241-5248.2002; Sumida T, 2002, J BIOCHEM, V132, P237, DOI 10.1093/oxfordjournals.jbchem.a003216; Sumida T, 2009, J MOL BIOL, V392, P87, DOI 10.1016/j.jmb.2009.06.025; SVENNERHOLM L, 1956, J NEUROCHEM, V1, P42, DOI 10.1111/j.1471-4159.1956.tb12053.x; Tanaka A, 1997, J BIOCHEM-TOKYO, V122, P330; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	31	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14065	14072		10.1074/jbc.M110.182592	http://dx.doi.org/10.1074/jbc.M110.182592			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21297160	Green Published, hybrid			2022-12-25	WOS:000289556200029
J	Xu, YZ; Thuraisingam, T; Marino, R; Radzioch, D				Xu, Yong Zhong; Thuraisingam, Thusanth; Marino, Rafael; Radzioch, Danuta			Recruitment of SWI/SNF Complex Is Required for Transcriptional Activation of the SLC11A1 Gene during Macrophage Differentiation of HL-60 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; ACTIN-RELATED PROTEINS; Z-DNA; NRAMP1 GENE; MUSCLE DIFFERENTIATION; NUCLEAR RECEPTORS; INDUCED APOPTOSIS; FORMERLY NRAMP1; MESSENGER-RNA; CYCLE CONTROL	The solute carrier family 11 member 1 (SLC11A1) gene is strictly regulated and exclusively expressed in myeloid lineage cells. However, little is known about the transcriptional regulation of the SLC11A1 gene during myeloid development. In this study, we used HL-60 cells as a model to investigate the regulatory elements/factors involved in the transactivation of the SLC11A1 gene during phorbol 12-myristate 13-acetate (PMA)-induced macrophage differentiation of HL-60 cells. Promoter deletion analysis showed that a 7-base AP-1-like element (TGACTCT) was critical for the responsiveness of the SLC11A1 promoter to PMA. Stimulation by PMA induced the binding of ATF-3 and the recruitment of two components of the SWI/SNF complex, BRG1 and beta-actin, to this element in an ATF-3-dependent manner. RNAi-mediated depletion of ATF-3 or BRG1 markedly decreased SLC11A1 gene expression and its promoter activity induced by PMA. Luciferase reporter experiments demonstrated that ATF-3 cooperated with BRG1 and beta-actin to activate the SLC11A1 promoter. Furthermore, we showed that PMA can induce the proximal (GT/AC)(n) repeat sequence to convert to the Z-DNA structure in the SLC11A1 gene promoter, and depletion of BRG1 resulted in a significant decrease of Z-DNA formation. Our results demonstrated that recruitment of the SWI/SNF complex initiated Z-DNA formation and subsequently helped to transactivate the SLC11A1 gene.	[Xu, Yong Zhong; Marino, Rafael; Radzioch, Danuta] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3G 1A4, Canada; [Thuraisingam, Thusanth; Radzioch, Danuta] McGill Univ, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; [Xu, Yong Zhong; Marino, Rafael; Radzioch, Danuta] McGill Univ, McGill Univ Hlth Ctr, Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; McGill University	Radzioch, D (corresponding author), McGill Univ, Dept Med, Div Expt Med, 1650 Cedar Ave,L11-218, Montreal, PQ H3G 1A4, Canada.	danuta.radzioch@mcgill.ca		Radzioch, Danuta/0000-0002-1601-2757	Canadian Institute of Health Research; Natural Sciences and Engineering Research Council of Canada; Fonds de la Recherche en Sante du Quebec [17734]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institute of Health Research and Natural Sciences and Engineering Research Council of Canada grants (to D. R.) and Fonds de la Recherche en Sante du Quebec Grant 17734 (to Y. Z. X.).	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Albini S, 2010, EXP CELL RES, V316, P3073, DOI 10.1016/j.yexcr.2010.05.023; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Bakshi R, 2010, J CELL PHYSIOL, V225, P569, DOI 10.1002/jcp.22240; Bayele HK, 2007, BLOOD, V110, P3039, DOI 10.1182/blood-2006-12-063289; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; BLACKWELL JM, 1994, IMMUNOL LETT, V43, P99, DOI 10.1016/0165-2478(94)00161-8; Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x; BRADLEY DJ, 1977, CLIN EXP IMMUNOL, V30, P130; Bultman SJ, 2005, GENE DEV, V19, P2849, DOI 10.1101/gad.1364105; Cellier M, 1997, J LEUKOCYTE BIOL, V61, P96, DOI 10.1002/jlb.61.1.96; Cellier MF, 2007, MICROBES INFECT, V9, P1662, DOI 10.1016/j.micinf.2007.09.006; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Cohet N, 2010, J CELL PHYSIOL, V223, P667, DOI 10.1002/jcp.22072; Corey LL, 2003, GENE DEV, V17, P1392, DOI 10.1101/gad.1071803; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200; Donninger H, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013318; Fry CJ, 2002, SCIENCE, V295, P1847, DOI 10.1126/science.1070260; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Govoni G, 1998, INFLAMM RES, V47, P277, DOI 10.1007/s000110050330; Gresh L, 2005, EMBO J, V24, P3313, DOI 10.1038/sj.emboj.7600802; Hah N, 2010, CANCER RES, V70, P4402, DOI 10.1158/0008-5472.CAN-09-2767; Henderson A, 2004, MOL CELL BIOL, V24, P389, DOI 10.1128/MCB.24.1.389-397.2004; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Juliandi B, 2010, CURR OPIN NEUROBIOL, V20, P408, DOI 10.1016/j.conb.2010.04.001; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Ko M, 2008, MUTAT RES-FUND MOL M, V647, P59, DOI 10.1016/j.mrfmmm.2008.08.004; Lal A, 2005, MOL CELL PROBE, V19, P385, DOI 10.1016/j.mcp.2005.06.007; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu H, 2006, MOL CELL BIOL, V26, P2550, DOI 10.1128/MCB.26.7.2550-2559.2006; Liu H, 2004, METHOD ENZYMOL, V377, P412; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; Ma ZD, 2004, MOL CELL BIOL, V24, P5496, DOI 10.1128/MCB.24.12.5496-5509.2004; Moshkin YM, 2007, MOL CELL BIOL, V27, P651, DOI 10.1128/MCB.01257-06; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; PLANT J, 1976, J INFECT DIS, V133, P72, DOI 10.1093/infdis/133.1.72; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043; Richer E, 2008, FEBS J, V275, P5074, DOI 10.1111/j.1742-4658.2008.06640.x; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Roig EA, 2002, J LEUKOCYTE BIOL, V71, P890; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; SKAMENE E, 1982, NATURE, V297, P506, DOI 10.1038/297506a0; Song ZX, 2007, J CELL BIOCHEM, V102, P403, DOI 10.1002/jcb.21300; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Stober CB, 2007, INFECT IMMUN, V75, P5059, DOI 10.1128/IAI.00153-07; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Vradii D, 2006, J CELL PHYSIOL, V206, P112, DOI 10.1002/jcp.20432; Wang GL, 2007, FRONT BIOSCI-LANDMRK, V12, P4424, DOI 10.2741/2399; Wang J, 2003, J BIOL CHEM, V278, P32899, DOI 10.1074/jbc.M305456200; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Xu YZ, 2010, MOL BIOL CELL, V21, P811, DOI 10.1091/mbc.E09-06-0534; Xu YZ, 2005, MOL CELL BIOL, V25, P8139, DOI 10.1128/MCB.25.18.8139-8149.2005; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Zaahl MG, 2005, CANCER GENET CYTOGEN, V159, P48, DOI 10.1016/j.cancergencyto.2004.09.017; Zhang B, 2007, ONCOGENE, V26, P7153, DOI 10.1038/sj.onc.1210509; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	75	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12839	12849		10.1074/jbc.M110.185637	http://dx.doi.org/10.1074/jbc.M110.185637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21300803	Green Published, hybrid			2022-12-25	WOS:000289282200004
J	Sariyer, IK; Khalili, K				Sariyer, Ilker Kudret; Khalili, Kamel			Regulation of Human Neurotropic JC Virus Replication by Alternative Splicing Factor SF2/ASF in Glial Cells	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SR PROTEINS; MESSENGER-RNA; NATALIZUMAB; IDENTIFICATION; AGNOPROTEIN; INHIBITION; GENERATION; INFECTION; ELEMENTS	Background: The human neurotropic virus, JC virus (JCV), is the etiologic agent of the fatal demyelinating disease of the central nervous system, Progressive Multifocal Leukoencephlopathy (PML) that is seen primarily in immunodeficient individuals. Productive infection of JCV occurs only in glial cells, and this restriction is, to a great extent, due to the activation of the viral promoter that has cell type-specific characteristics. Earlier studies led to the hypothesis that glial-specific activation of the JCV promoter is mediated through positive and negative transcription factors that control reactivation of the JCV genome under normal physiological conditions and suppress its activation in non-glial cells. Methodololgy/Principal Findings: Using a variety of virological and molecular biological approaches, we demonstrate that the alternative splicing factor SF2/ASF has the capacity to exert a negative effect on transcription of the JCV promoter in glial cells through direct association with a specific DNA sequence within the viral enhancer/promoter region. Our results show that down-regulation of SF2/ASF in fetal and adult glial cells increases the level of JCV gene expression and its replication indicating that negative regulation of the JCV promoter by SF2/ASF may control reactivation of JCV replication in brain. Conclusions/Significance: Our results establish a new regulatory role for SF2/ASF in controlling gene expression at the transcriptional level.	[Sariyer, Ilker Kudret] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sariyer, IK (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	kamel.khalili@temple.edu	Sariyer, Ilker/AAE-7677-2020		National Institutes of Health (NIH) [R01 NS350000, R01 MH086358]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086358] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (NIH) grant R01 NS350000 (Proteins mediating interaction of HIV-1 and JCV in glial cells) and NIH grant R01 MH086358 (BAG3 mediates interplay of HIV-1 and JCV in brain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akan I, 2006, VIROLOGY, V349, P66, DOI 10.1016/j.virol.2006.01.025; BERGER JR, 1995, J NEUROVIROL, V1, P5, DOI 10.3109/13550289509111006; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Carson KR, 2009, LANCET ONCOL, V10, P816, DOI 10.1016/S1470-2045(09)70161-5; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Eng PM, 2006, NEUROLOGY, V67, P884, DOI 10.1212/01.wnl.0000233918.21986.9c; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Imperiale M.J., 2007, FIELDS VIROLOGY, V2, P2263; Kinoshita Y, 2004, J BIOL CHEM, V279, P35879, DOI 10.1074/jbc.M401640200; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Krynska B, 2000, VIROLOGY, V274, P65, DOI 10.1006/viro.2000.0450; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MILLER JR, 1982, NEW ENGL J MED, V307, P1436, DOI 10.1056/NEJM198212023072307; Radhakrishnan S, 2003, J VIROL, V77, P10638, DOI 10.1128/JVI.77.19.10638-10644.2003; Romagnoli L, 2008, VIROLOGY, V375, P331, DOI 10.1016/j.virol.2008.02.021; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Safak M., 2005, The neurology of AIDS, P461; Sandborn WJ, 2005, NEW ENGL J MED, V353, P375; SANFORD SR, 2005, PNAS, V102, P15042; Sariyer IK, 2006, J VIROL, V80, P3893, DOI 10.1128/JVI.80.8.3893-3903.2006; Sariyer IK, 2008, VIROLOGY, V375, P464, DOI 10.1016/j.virol.2008.02.020; Sariyer IK, 2009, J VIROL METHODS, V159, P122, DOI 10.1016/j.jviromet.2009.02.023; Song Y, 2007, BIOCHEM J, V406, P427, DOI 10.1042/BJ20070631; TROWBRIDGE PW, 1995, J NEUROVIROL, V1, P195, DOI 10.3109/13550289509113966; WANG J, 1995, RNA, V1, P335; Weber T, 2008, NEUROL CLIN, V26, P833, DOI 10.1016/j.ncl.2008.03.007; White MK, 2006, ONCOGENE, V25, P5286, DOI 10.1038/sj.onc.1209618; White MK, 2009, J VIROL, V83, P10846, DOI 10.1128/JVI.00542-09; ZUO P, 1993, EMBO J, V12, P4727, DOI 10.1002/j.1460-2075.1993.tb06161.x	34	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14630	10.1371/journal.pone.0014630	http://dx.doi.org/10.1371/journal.pone.0014630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297941	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300012
J	Simo, L; Koci, J; Zitnan, D; Park, Y				Simo, Ladislav; Koci, Juraj; Zitnan, Dusan; Park, Yoonseong			Evidence for D1 Dopamine Receptor Activation by a Paracrine Signal of Dopamine in Tick Salivary Glands	PLOS ONE			English	Article							IXODID TICKS; FLUID SECRETION; MECHANISM; QUANTIFICATION; PHYSIOLOGY; CALCIUM	Ticks that feed on vertebrate hosts use their salivary secretion, which contains various bioactive components, to manipulate the host's responses. The mechanisms controlling the tick salivary gland in this dynamic process are not well understood. We identified the tick D1 receptor activated by dopamine, a potent inducer of the salivary secretion of ticks. Temporal and spatial expression patterns examined by immunohistochemistry and reverse transcription polymerase chain reaction suggest that the dopamine produced in the basal cells of salivary gland acini is secreted into the lumen and activates the D1 receptors on the luminal surface of the cells lining the acini. Therefore, we propose a paracrine function of dopamine that is mediated by the D1 receptor in the salivary gland at an early phase of feeding. The molecular and pharmacological characterization of the D1 receptor in this study provides the foundation for understanding the functions of dopamine in the blood-feeding of ticks.	[Simo, Ladislav; Koci, Juraj; Park, Yoonseong] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Zitnan, Dusan] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia	Kansas State University; Slovak Academy of Sciences	Simo, L (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	ypark@ksu.edu	Koči, Juraj/C-3754-2014; Park, Yoonseong/J-5861-2013	Koči, Juraj/0000-0002-5560-806X; Simo, Ladislav/0000-0002-4472-1016; Park, Yoonseong/0000-0003-1191-7335	National Institutes of Health (NIH) [R01AI090062-01, 1R21AI081136-01]; National Center for Research Resources [NIH P20 RR017686]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081136, R01AI090062] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This paper is contribution no. 11-168-J from the Kansas Agricultural Experiment Station. The project described was supported by National Institutes of Health (NIH) Grant Numbers R01AI090062-01 and 1R21AI081136-01. The confocal facility in the K-state is supported by NIH P20 RR017686 from the IDEA Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINNINGTON KC, 1978, INT J PARASITOL, V8, P97, DOI 10.1016/0020-7519(78)90004-8; Bowman AS, 2004, PARASITOLOGY, V129, pS67, DOI 10.1017/S0031182004006468; COONS LB, 1973, J PARASITOL, V59, P900, DOI 10.2307/3278433; Gaede K, 1997, J EXP BIOL, V200, P1491; GOTZES F, 1994, RECEPTOR CHANNEL, V2, P131; Grigorieva LA, 2008, J EVOL BIOCHEM PHYS+, V44, P735, DOI 10.1134/S0022093008060100; KAUFMAN W, 1976, J EXP BIOL, V64, P727; Kaufman WR, 1999, EXP APPL ACAROL, V23, P251, DOI 10.1023/A:1006071031547; KAUFMAN WR, 1983, EUR J PHARMACOL, V87, P43, DOI 10.1016/0014-2999(83)90048-1; KAUFMAN WR, 1980, AM J PHYSIOL, V238, pR102, DOI 10.1152/ajpregu.1980.238.1.R102; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; NEEDHAM GR, 1979, J PARASITOL, V65, P531, DOI 10.2307/3280316; Nuttall PA, 2006, PARASITE IMMUNOL, V28, P155, DOI 10.1111/j.1365-3024.2006.00806.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335; RUDOLPH D, 1974, NATURE, V249, P84, DOI 10.1038/249084a0; Sauer JR, 2000, J INSECT PHYSIOL, V46, P1069, DOI 10.1016/S0022-1910(99)00210-3; SAUER JR, 1995, ANNU REV ENTOMOL, V40, P245, DOI 10.1146/annurev.en.40.010195.001333; Scheckelhoff MR, 2007, P NATL ACAD SCI USA, V104, P7247, DOI 10.1073/pnas.0607263104; SCHMIDT SP, 1981, J CYCLIC NUCL PROT, V7, P375; Simo L, 2009, CELL TISSUE RES, V335, P639, DOI 10.1007/s00441-008-0731-4; Simo L, 2009, J COMP NEUROL, V517, P551, DOI 10.1002/cne.22182; Vernon WI, 2002, BIOTECHNIQUES, V33, P730, DOI 10.2144/02334bm02	24	33	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16158	10.1371/journal.pone.0016158	http://dx.doi.org/10.1371/journal.pone.0016158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297964	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300036
J	Wang, X; Shi, Q; Xu, K; Gao, C; Chen, C; Li, XL; Wang, GR; Tian, C; Han, J; Dong, XP				Wang, Xin; Shi, Qi; Xu, Kun; Gao, Chen; Chen, Cao; Li, Xiao-Li; Wang, Gui-Rong; Tian, Chan; Han, Jun; Dong, Xiao-Ping			Familial CJD Associated PrP Mutants within Transmembrane Region Induced Ctm-PrP Retention in ER and Triggered Apoptosis by ER Stress in SH-SY5Y Cells	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; ENDOPLASMIC-RETICULUM; PRION PROTEIN; MEMBRANE-PROTEIN; GENE; TRANSMISSION; DETERMINANT; ORIENTATION; BIOGENESIS; INDUCTION	Background: Genetic prion diseases are linked to point and inserted mutations in the prion protein (PrP) gene that are presumed to favor conversion of the cellular isoform of PrP (PrPC) to the pathogenic one (PrPSc). The pathogenic mechanisms and the subcellular sites of the conversion are not completely understood. Here we introduce several PRNP gene mutations (such as, PrP-KDEL, PrP-3AV, PrP-A117V, PrP-G114V, PrP-P102L and PrP-E200K) into the cultured cells in order to explore the pathogenic mechanism of familial prion disease. Methodology/Principal Findings: To address the roles of aberrant retention of PrP in endoplasmic reticulum (ER), the recombinant plasmids expressing full-length human PrP tailed with an ER signal peptide at the COOH-terminal (PrP-KDEL) and PrP with three amino acids exchange in transmembrane region (PrP-3AV) were constructed. In the preparations of transient transfections, 18-kD COOH-terminal proteolytic resistant fragments (Ctm-PrP) were detected in the cells expressing PrP-KDEL and PrP-3AV. Analyses of the cell viabilities in the presences of tunicamycin and brefeldin A revealed that expressions of PrP-KDEL and PrP-3AV sensitized the transfected cells to ER stress stimuli. Western blots and RT-PCR identified the clear alternations of ER stress associated events in the cells expressing PrP-KDEL and PrP-3AV that induced ER mediated apoptosis by CHOP and capase-12 apoptosis pathway. Moreover, several familial CJD related PrP mutants were transiently introduced into the cultured cells. Only the mutants within the transmembrane region (G114V and A117V) induced the formation of Ctm-PrP and caused the ER stress, while the mutants outside the transmembrane region (P102L and E200K) failed. Conclusions/Significance: The data indicate that the retention of PrP in ER through formation of Ctm-PrP results in ER stress and cell apoptosis. The cytopathic activities caused by different familial CJD associated PrP mutants may vary, among them the mutants within the transmembrane region undergo an ER-stress mediated cell apoptosis.	[Wang, Xin; Shi, Qi; Xu, Kun; Gao, Chen; Chen, Cao; Li, Xiao-Li; Wang, Gui-Rong; Tian, Chan; Han, Jun; Dong, Xiao-Ping] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Xu, Kun] Xi An Jiao Tong Univ, Sch Med, Xian 710049, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Xi'an Jiaotong University	Wang, X (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	dongxp238@sina.com	Chen, Cao/CAF-1246-2022	Chen, Cao/0000-0002-5193-9283	Chinese National Natural Science Foundation [30771914, 30800975]; National Science and Technology Task Force Project [2006BAD06A13-2]; Institution Technique RD Grant [2008EG150300]; National Basic Research Program of China [2007CB310505]; China Mega-Project for Infectious Disease [2009ZX10004-101]; SKLID development Grant [2008SKLID102, 2008SKLID202]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Task Force Project; Institution Technique RD Grant; National Basic Research Program of China(National Basic Research Program of China); China Mega-Project for Infectious Disease; SKLID development Grant	This work was supported by Chinese National Natural Science Foundation Grants 30771914 and 30800975, National Science and Technology Task Force Project (2006BAD06A13-2), Institution Technique R&D Grant (2008EG150300), National Basic Research Program of China (973 Program) (2007CB310505), China Mega-Project for Infectious Disease (2009ZX10004-101) and the SKLID development Grant (2008SKLID102 and 2008SKLID202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; An R, 2008, SCI CHINA SER C, V51, P630, DOI 10.1007/s11427-008-0062-4; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; Chen L, 2007, J BIOCHEM MOL BIOL, V40, P662; COLLINGE J, 1995, LANCET, V346, P569, DOI 10.1016/S0140-6736(95)91405-6; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Dimcheff DE, 2003, J VIROL, V77, P12617, DOI 10.1128/JVI.77.23.12617-12629.2003; Gafvelin G, 1997, J BIOL CHEM, V272, P6119, DOI 10.1074/jbc.272.10.6119; Harris DA, 2003, BRIT MED BULL, V66, P71, DOI 10.1093/bmb/66.1.71; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hegde RS, 1999, TRENDS CELL BIOL, V9, P132, DOI 10.1016/S0962-8924(99)01504-4; HITT AL, 1994, J CELL BIOL, V126, P1421, DOI 10.1083/jcb.126.6.1421; HOWELL S, 1994, J BIOL CHEM, V269, P16993; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; LOPEZ CD, 1990, SCIENCE, V248, P226, DOI 10.1126/science.1970195; Ozols J, 1998, BIOCHEMISTRY-US, V37, P10336, DOI 10.1021/bi9807916; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rodriguez MM, 2005, NEUROLOGY, V64, P1455, DOI 10.1212/01.WNL.0000158618.39527.93; Shi Q, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-360; TATEISHI J, 1995, NATURE, V376, P434, DOI 10.1038/376434a0; Tranchant C, 1999, NEUROLOGY, V52, P1244, DOI 10.1212/WNL.52.6.1244; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Winklhofer KF, 2006, HANDB EXP PHARM, V172, P221; Ye Jing, 2008, J Med Case Rep, V2, P331, DOI 10.1186/1752-1947-2-331; YOST CS, 1990, NATURE, V343, P669, DOI 10.1038/343669a0	32	39	42	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14602	10.1371/journal.pone.0014602	http://dx.doi.org/10.1371/journal.pone.0014602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298055	Green Submitted, gold, Green Published			2022-12-25	WOS:000286663900006
J	Dechanet, C; Fort, A; Barbero-Camps, E; Dechaud, H; Richard, S; Virsolvy, A				Dechanet, Clotilde; Fort, Aurelie; Barbero-Camps, Elisabet; Dechaud, Herve; Richard, Sylvain; Virsolvy, Anne			Endothelin-Dependent Vasoconstriction in Human Uterine Artery: Application to Preeclampsia	PLOS ONE			English	Article							NORMOTENSIVE PREGNANT-WOMEN; RESISTANCE ARTERIES; PLACENTAL ISCHEMIA; ET(A) RECEPTOR; BLOOD-VESSELS; HYPERTENSION; CALCIUM; EXPRESSION; PATHOPHYSIOLOGY; MYOMETRIAL	Background: Reduced uteroplacental perfusion, the initiating event in preeclampsia, is associated with enhanced endothelin-1 (ET-1) production which feeds the vasoconstriction of uterine artery. Whether the treatments of preeclampsia were effective on ET-1 induced contraction and could reverse placental ischemia is the question addressed in this study. We investigated the effect of antihypertensive drugs used in preeclampsia and of ET receptor antagonists on the contractile response to ET-1 on human uterine arteries. Methodology/Principal Findings: Experiments were performed, ex vivo, on human uterine artery samples obtained after hysterectomy. We studied variations in isometric tension of arterial rings in response to the vasoconstrictor ET-1 and evaluated the effects of various vasodilators and ET-receptor antagonists on this response. Among antihypertensive drugs, only dihydropyridines were effective in blocking and reversing the ET-1 contractile response. Their efficiency, independent of the concentration of ET-1, was only partial. Hydralazine, alpha-methyldopa and labetalol had no effect on ET-1 induced contraction which is mediated by both ETA and ETB receptors in uterine artery. ET receptors antagonists, BQ-123 and BQ-788, slightly reduced the amplitude of the response to ET-1. Combination of both antagonists was more efficient, but it was not possible to reverse the maximal ET-1-induced contraction with antagonists used alone or in combination. Conclusion: Pharmacological drugs currently used in the context of preeclampsia, do not reverse ET-1 induced contraction. Only dihydropyridines, which partially relax uterine artery previously contracted with ET-1, might offer interesting perspectives to improve placental perfusion.	[Dechanet, Clotilde; Fort, Aurelie; Barbero-Camps, Elisabet; Dechaud, Herve; Richard, Sylvain; Virsolvy, Anne] Univ Montpellier 1 & 2, INSERM, U637, Montpellier, France; [Dechanet, Clotilde; Dechaud, Herve] CHU Villeneuve, Serv Gynecol Obstet, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Dechanet, C (corresponding author), Univ Montpellier 1 & 2, INSERM, U637, Montpellier, France.	anne.virsolvy@inserm.fr	VIRSOLVY, Anne/E-4964-2016; Richard, Sylvain/C-9695-2016; Petit, Aurelie/O-1731-2018	VIRSOLVY, Anne/0000-0002-5819-3306; Petit, Aurelie/0000-0002-9069-9868; Richard, Sylvain/0000-0001-9460-6705	INSERM (Institut National de la Sante et de la Recherche Medical); University of Montpellier 1	INSERM (Institut National de la Sante et de la Recherche Medical)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier 1	This research was funded by INSERM (Institut National de la Sante et de la Recherche Medical; http://inserm.fr) and University of Montpellier 1 (http://univ-montp1.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajne G, 2005, AM J OBSTET GYNECOL, V193, P234, DOI 10.1016/j.ajog.2004.11.023; BENIGNI A, 1992, BRIT J OBSTET GYNAEC, V99, P798, DOI 10.1111/j.1471-0528.1992.tb14409.x; BODELSSON G, 1992, AM J OBSTET GYNECOL, V167, P745, DOI 10.1016/S0002-9378(11)91582-8; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; CHUN MY, 1995, J BIOL CHEM, V270, P10855, DOI 10.1074/jbc.270.18.10855; CLARK BA, 1992, AM J OBSTET GYNECOL, V166, P962, DOI 10.1016/0002-9378(92)91372-H; Cnossen JS, 2008, CAN MED ASSOC J, V178, P701, DOI 10.1503/cmaj.070430; Duley L, 2006, BMJ-BRIT MED J, V332, P463, DOI 10.1136/bmj.332.7539.463; Faxen M, 2000, ARCH GYNECOL OBSTET, V264, P143, DOI 10.1007/s004040000111; FENAKEL K, 1991, OBSTET GYNECOL, V77, P331; Fort A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007360; FRIED G, 1994, ACTA PHYSIOL SCAND, V151, P477, DOI 10.1111/j.1748-1716.1994.tb09770.x; FRIED G, 1991, AM J OBSTET GYNECOL, V164, P1330, DOI 10.1016/0002-9378(91)90709-Z; Goldman-Wohl D, 2002, MOL CELL ENDOCRINOL, V187, P233, DOI 10.1016/S0303-7207(01)00687-6; Gomez O, 2006, ULTRASOUND OBST GYN, V28, P802, DOI 10.1002/uog.2814; Granger JP, 2001, HYPERTENSION, V38, P718, DOI 10.1161/01.HYP.38.3.718; Hawfield Amret, 2009, Ther Adv Cardiovasc Dis, V3, P65, DOI 10.1177/1753944708097114; Higgins JR, 2001, LANCET, V357, P131, DOI 10.1016/S0140-6736(00)03552-2; KUBLICKIENE KR, 1994, AM J HYPERTENS, V7, pS50, DOI 10.1093/ajh/7.7.50S; LaMarca BD, 2008, GENDER MED, V5, pS133, DOI 10.1016/j.genm.2008.03.013; LUNNELL NO, 1982, BRIT J OBSTET GYNAEC, V89, P640, DOI 10.1111/j.1471-0528.1982.tb04719.x; Lyall F, 2002, PLACENTA, V23, pS142, DOI 10.1053/plac.2002.0803; Mccoy S, 2009, AM J HEALTH-SYST PH, V66, P337, DOI 10.2146/ajhp080104; MCMAHON LP, 1993, CLIN SCI, V85, P417, DOI 10.1042/cs0850417; Miwa Soichi, 2005, Journal of Smooth Muscle Research, V41, P61, DOI 10.1540/jsmr.41.61; MONTAN S, 1993, AM J OBSTET GYNECOL, V168, P152, DOI 10.1016/S0002-9378(12)90905-9; Murphy SR, 2010, HYPERTENSION, V55, P394, DOI 10.1161/HYPERTENSIONAHA.109.141473; Mutter WP, 2008, MICROVASC RES, V75, P1, DOI 10.1016/j.mvr.2007.04.009; NISELL H, 1991, J HYPERTENS, V9, pS168; NOVA A, 1991, AM J OBSTET GYNECOL, V165, P724, DOI 10.1016/0002-9378(91)90317-K; NYLUND L, 1984, ACTA OBSTET GYN SCAN, P71; POLLOCK DM, 1995, FASEB J, V9, P1196, DOI 10.1096/fasebj.9.12.7672512; Richard S, 2005, DRUGS, V65, P1; Sand AE, 1998, ACTA PHYSIOL SCAND, V163, P227, DOI 10.1046/j.1365-201x.1998.00368.x; SEO B, 1994, CIRCULATION, V89, P1203, DOI 10.1161/01.CIR.89.3.1203; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Singh HJ, 2001, ACTA OBSTET GYN SCAN, V80, P99, DOI 10.1034/j.1600-0412.2001.080002099.x; Spence S, 1999, REPROD TOXICOL, V13, P15, DOI 10.1016/S0890-6238(98)00064-1; Steiner MK, 2008, VASC HEALTH RISK MAN, V4, P943; TAYLOR RN, 1990, J CLIN ENDOCR METAB, V71, P1675, DOI 10.1210/jcem-71-6-1675; Thaete LG, 2007, BIOL REPROD, V77, P526, DOI 10.1095/biolreprod.107.061820; Wimalasundera RC, 2005, AM J OBSTET GYNECOL, V192, P625, DOI 10.1016/j.ajog.2004.07.040; Wimalasundera RC, 2010, J HYPERTENS, V28, P568, DOI 10.1097/HJH.0b013e328334f20b; Wolff K, 1996, REGUL PEPTIDES, V67, P211, DOI 10.1016/S0167-0115(96)00122-X; Wolff K, 1996, ACTA OBSTET GYN SCAN, V75, P432, DOI 10.3109/00016349609033349	45	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16540	10.1371/journal.pone.0016540	http://dx.doi.org/10.1371/journal.pone.0016540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298073	Green Published, Green Submitted, gold			2022-12-25	WOS:000286662800054
J	Sanchez-Villegas, A; Verberne, L; De Irala, J; Ruiz-Canela, M; Toledo, E; Serra-Majem, L; Martinez-Gonzalez, MA				Sanchez-Villegas, Almudena; Verberne, Lisa; De Irala, Jokin; Ruiz-Canela, Miguel; Toledo, Estefania; Serra-Majem, Lluis; Angel Martinez-Gonzalez, Miguel			Dietary Fat Intake and the Risk of Depression: The SUN Project	PLOS ONE			English	Article							OLIVE OIL CONSUMPTION; MEDITERRANEAN DIET; FOLLOW-UP; MYOCARDIAL-INFARCTION; INFLAMMATORY MARKERS; ENDOTHELIAL-CELLS; MAJOR DEPRESSION; NERVOUS-SYSTEM; ACIDS; MOOD	Emerging evidence relates some nutritional factors to depression risk. However, there is a scarcity of longitudinal assessments on this relationship. Objective: To evaluate the association between fatty acid intake or the use of culinary fats and depression incidence in a Mediterranean population. Material and Methods: Prospective cohort study (1999-2010) of 12,059 Spanish university graduates (mean age: 37.5 years) initially free of depression with permanently open enrolment. At baseline, a 136-item validated food frequency questionnaire was used to estimate the intake of fatty acids (saturated fatty acids (SFA), polyunsaturated fatty acids (PUFA), trans unsaturated fatty acids (TFA) and monounsaturated fatty acids (MUFA) and culinary fats (olive oil, seed oils, butter and margarine) During follow-up participants were classified as incident cases of depression if they reported a new clinical diagnosis of depression by a physician and/or initiated the use of antidepressant drugs. Cox regression models were used to calculate Hazard Ratios (HR) of incident depression and their 95% confidence intervals (CI) for successive quintiles of fats. Results: During follow-up (median: 6.1 years), 657 new cases of depression were identified. Multivariable-adjusted HR (95% CI) for depression incidence across successive quintiles of TFA intake were: 1 (ref), 1.08 (0.82-1.43), 1.17 (0.88-1.53), 1.28 (0.97-1.68), 1.42 (1.09-1.84) with a significant dose-response relationship (p for trend = 0.003). Results did not substantially change after adjusting for potential lifestyle or dietary confounders, including adherence to a Mediterranean Dietary Pattern. On the other hand, an inverse and significant dose-response relationship was obtained for MUFA (p for trend = 0.05) and PUFA (p for trend = 0.03) intake. Conclusions: A detrimental relationship was found between TFA intake and depression risk, whereas weak inverse associations were found for MUFA, PUFA and olive oil. These findings suggest that cardiovascular disease and depression may share some common nutritional determinants related to subtypes of fat intake.	[Sanchez-Villegas, Almudena; Verberne, Lisa; Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Sanchez-Villegas, Almudena; De Irala, Jokin; Ruiz-Canela, Miguel; Toledo, Estefania; Angel Martinez-Gonzalez, Miguel] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Verberne, Lisa] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Universidad de Las Palmas de Gran Canaria; University of Navarra; Wageningen University & Research	Sanchez-Villegas, A (corresponding author), Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain.	asanchez@dcc.ulpgc.es	Sanchez-Villegas, Almudena/T-6733-2019; Ruiz-Canela, Miguel/I-7738-2016; Serra-Majem, Lluis/I-6708-2019; Martinez-Gonzalez, Miguel A./AAE-7669-2019; de Irala, Jokin/H-2936-2017; Toledo, Estefania/H-6211-2014	Sanchez-Villegas, Almudena/0000-0001-7733-9238; Ruiz-Canela, Miguel/0000-0002-7684-2787; Serra-Majem, Lluis/0000-0002-9658-9061; de Irala, Jokin/0000-0002-7249-6581; Toledo, Estefania/0000-0002-6263-4434; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	Spanish Government Instituto de Salud Carlos III; Fondo de Investigaciones Sanitarias [PI042241, PI040233, PI050976, PI070240, PI0801943, RD 06/0045]; Navarra Regional Government [PI41/2005]	Spanish Government Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Navarra Regional Government	The Spanish Government Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias, projects PI042241, PI040233, PI050976, PI070240, PI0801943, and RD 06/0045 and the Navarra Regional Government project PI41/2005 have supported the SUN Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Anisman H, 2009, J PSYCHIATR NEUROSCI, V34, P4; Appleton KM, 2008, PROSTAG LEUKOTR ESS, V78, P337, DOI 10.1016/j.plefa.2008.04.009; Appleton KM, 2010, AM J CLIN NUTR, V91, P757, DOI 10.3945/ajcn.2009.28313; Assies J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010635; Barzi F, 2003, EUR J CLIN NUTR, V57, P604, DOI 10.1038/sj.ejcn.1601575; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bilici M, 2001, J AFFECT DISORDERS, V64, P43, DOI 10.1016/S0165-0327(00)00199-3; Bourre JM, 2006, J NUTR HEALTH AGING, V10, P386; Bourre JM, 2006, J NUTR HEALTH AGING, V10, P377; Bremmer MA, 2008, J AFFECT DISORDERS, V106, P249, DOI 10.1016/j.jad.2007.07.002; Chishti P, 2003, EUR J PUBLIC HEALTH, V13, P108, DOI 10.1093/eurpub/13.2.108; de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065; Di Benedetto R, 2007, NUTR METAB CARDIOVAS, V17, P535, DOI 10.1016/j.numecd.2006.03.005; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Fernandez-Jarne E, 2002, INT J EPIDEMIOL, V31, P474, DOI 10.1093/ije/31.2.474; Freeman MP, 2010, AM J PSYCHIAT, V167, P244, DOI 10.1176/appi.ajp.2009.09121746; Gilbody S, 2007, J EPIDEMIOL COMMUN H, V61, P631, DOI 10.1136/jech.2006.050385; Gimeno D, 2009, PSYCHOL MED, V39, P413, DOI 10.1017/S0033291708003723; Glassman Alexander H, 2007, Dialogues Clin Neurosci, V9, P9; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Greenland S, 2008, MODERN EPIDEMIOLOGY, V3rd; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Hayley S, 2005, NEUROSCIENCE, V135, P659, DOI 10.1016/j.neuroscience.2005.03.051; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Kiecolt-Glaser JK, 2007, PSYCHOSOM MED, V69, P217, DOI 10.1097/PSY.0b013e3180313a45; Kontogianni MD, 2007, CLIN CARDIOL, V30, P125, DOI 10.1002/clc.20043; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Kovess-Masfety V, 2007, PSYCHIAT SERV, V58, P213, DOI 10.1176/appi.ps.58.2.213; Kyrozis A, 2009, J PSYCHIATR RES, V43, P763, DOI 10.1016/j.jpsychires.2008.09.003; Logan AC, 2005, PROSTAG LEUKOTR ESS, V72, P441, DOI 10.1016/j.plefa.2005.02.006; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; Martinez-Gonzalez MA, 2002, NUTR NEUROSCI, V5, P65, DOI 10.1080/10284150290007047; Mena MP, 2009, AM J CLIN NUTR, V89, P248, DOI 10.3945/ajcn.2008.26094; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS5, DOI 10.1038/sj.ejcn.1602973; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Naska A, 2006, EUR J CLIN NUTR, V60, P181, DOI 10.1038/sj.ejcn.1602284; Oh K, 2005, AM J EPIDEMIOL, V161, P161, DOI 10.1093/aje/kwi026; Pauwels EKJ, 2008, DRUG NEWS PERSPECT, V21, P446, DOI 10.1358/dnp.2008.21.8.1272136; Payne Martha E, 2010, Aging health, V6, P133, DOI 10.2217/ahe.09.90; Puri BK, 2000, ARCH GEN PSYCHIAT, V57, P715, DOI 10.1001/archpsyc.57.7.715; Rogers PJ, 2008, BRIT J NUTR, V99, P421, DOI 10.1017/S0007114507801097; Salas-Salvado J, 2008, EUR J CLIN NUTR, V62, P651, DOI 10.1038/sj.ejcn.1602762; Sanchez-Villegas A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-43; Sanchez-Villegas A, 2009, ARCH GEN PSYCHIAT, V66, P1090, DOI 10.1001/archgenpsychiatry.2009.129; Sarris J, 2009, NUTR REV, V67, P125, DOI 10.1111/j.1753-4887.2009.00180.x; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Silvers KM, 2005, PROSTAG LEUKOTR ESS, V72, P211, DOI 10.1016/j.plefa.2004.11.004; Skarupski KA, 2010, AM J CLIN NUTR, V92, P330, DOI 10.3945/ajcn.2010.29413; Soh NL, 2009, ACTA NEUROPSYCHIATR, V21, P214, DOI 10.1111/j.1601-5215.2009.00413.x; Stender S, 2006, NEW ENGL J MED, V354, P1650, DOI 10.1056/NEJMc052959; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Uauy R, 2009, EUR J CLIN NUTR, V63, pS68, DOI 10.1038/ejcn.2009.15; Vaccarino V, 2007, J AM COLL CARDIOL, V50, P2044, DOI 10.1016/j.jacc.2007.07.069; Wagner JA, 2006, PSYCHOSOM MED, V68, P80, DOI 10.1097/01.psy.0000195868.68122.9e; Waterman E, 2007, ALTERN MED REV, V12, P331; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wolfe AR, 2009, PROG NEURO-PSYCHOPH, V33, P972, DOI 10.1016/j.pnpbp.2009.05.002; World Health Organization, 2008, GLOB BURD DIS 2004 U	65	144	149	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16268	10.1371/journal.pone.0016268	http://dx.doi.org/10.1371/journal.pone.0016268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298116	Green Published, gold			2022-12-25	WOS:000286662800023
J	Thelin, J; Jorntell, H; Psouni, E; Garwicz, M; Schouenborg, J; Danielsen, N; Linsmeier, CE				Thelin, Jonas; Jorntell, Henrik; Psouni, Elia; Garwicz, Martin; Schouenborg, Jens; Danielsen, Nils; Linsmeier, Cecilia Eriksson			Implant Size and Fixation Mode Strongly Influence Tissue Reactions in the CNS	PLOS ONE			English	Article							INTRACORTICAL ELECTRODE ARRAY; SILICON MICROELECTRODE ARRAYS; RODENT SOMATOSENSORY CORTEX; DEEP BRAIN-STIMULATION; RAT; BIOCOMPATIBILITY; CAPABILITY; INTERFACES; MULTISITE; TITANIUM	The function of chronic brain machine interfaces depends on stable electrical contact between neurons and electrodes. A key step in the development of interfaces is therefore to identify implant configurations that minimize adverse long-term tissue reactions. To this end, we here characterized the separate and combined effects of implant size and fixation mode at 6 and 12 weeks post implantation in rat (n = 24) cerebral cortex. Neurons and activated microglia and astrocytes were visualized using NeuN, ED1 and GFAP immunofluorescence microscopy, respectively. The contributions of individual experimental variables to the tissue response were quantified. Implants tethered to the skull caused larger tissue reactions than un-tethered implants. Small diameter (50 mu m) implants elicited smaller tissue reactions and resulted in the survival of larger numbers of neurons than did large diameter (200 mu m) implants. In addition, tethering resulted in an oval-shaped cavity, with a cross-section area larger than that of the implant itself, and in marked changes in morphology and organization of neurons in the region closest to the tissue interface. Most importantly, for implants that were both large diameter and tethered, glia activation was still ongoing 12 weeks after implantation, as indicated by an increase in GFAP staining between week 6 and 12, while this pattern was not observed for un-tethered, small diameter implants. Our findings therefore clearly indicate that the combined small diameter, un-tethered implants cause the smallest tissue reactions.	[Thelin, Jonas; Jorntell, Henrik; Garwicz, Martin; Schouenborg, Jens; Danielsen, Nils; Linsmeier, Cecilia Eriksson] Lund Univ, Neuronano Res Ctr, Lund, Sweden; [Psouni, Elia] Kristianstad Univ, Ctr Psychol, Kristianstad, Sweden; [Psouni, Elia] Lund Univ, Dept Psychol, Lund, Sweden	Lund University; Kristianstad University; Lund University	Thelin, J (corresponding author), Lund Univ, Neuronano Res Ctr, Lund, Sweden.	Jonas.Thelin@med.lu.se	LInsmeier, Cecilia Eriksson/N-2212-2015	Danielsen, Nils/0000-0002-4917-8294; Schouenborg, Jens/0000-0002-2815-6918; Thelin, Jonas/0000-0002-6452-1476; Garwicz-Psouni, Elia/0000-0003-2758-5785	Knut and Alice Wallenberg foundation [KAW 2004-0119]; Swedish Research Council [60012701, 600012701]; Medical Faculty at Lund University; Royal Physiographic Society in Lund; Magnus Bergvall Foundation	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty at Lund University; Royal Physiographic Society in Lund; Magnus Bergvall Foundation	This work was funded by the Knut and Alice Wallenberg foundation and by Linne grants (project number 60012701) from the Swedish Research Council and the Medical Faculty at Lund University. The project was sponsored by The Royal Physiographic Society in Lund, The Magnus Bergvall Foundation, The Knut and Alice Wallenberg Foundation (project number: KAW 2004-0119), and a Linne grant (project number: 600012701) from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benabid AL, 2007, EXPERT REV MED DEVIC, V4, P895, DOI 10.1586/17434440.4.6.895; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Biran R, 2007, J BIOMED MATER RES A, V82A, P169, DOI 10.1002/jbm.a.31138; CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; DRAKE KL, 1988, IEEE T BIO-MED ENG, V35, P719, DOI 10.1109/10.7273; EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Gilletti A, 2006, J NEURAL ENG, V3, P189, DOI 10.1088/1741-2560/3/3/001; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kim YT, 2004, BIOMATERIALS, V25, P2229, DOI 10.1016/j.biomaterials.2003.09.010; Kipke DR, 2008, J NEUROSCI, V28, P11830, DOI 10.1523/JNEUROSCI.3879-08.2008; Kipke DR, 2004, P ANN INT IEEE EMBS, V26, P5344; Lind G, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046005; Linsmeier CE, 2008, BIOMATERIALS, V29, P4598, DOI 10.1016/j.biomaterials.2008.08.028; Linsmeier CE, 2009, NANO LETT, V9, P4184, DOI 10.1021/nl902413x; Lundgren D, 1992, Clin Oral Implants Res, V3, P136, DOI 10.1034/j.1600-0501.1992.030306.x; Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0; McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055005; McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/056003; Mushahwar VK, 2007, J NEURAL ENG, V4, pS181, DOI 10.1088/1741-2560/4/3/S05; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Otto KJ, 2005, J NEURAL ENG, V2, P42, DOI 10.1088/1741-2560/2/2/005; Otto KJ, 2005, HEARING RES, V210, P112, DOI 10.1016/j.heares.2005.08.004; Purcell EK, 2009, J NEUROSCI METH, V183, P149, DOI 10.1016/j.jneumeth.2009.06.026; ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800; Song YK, 2007, P ANN INT IEEE EMBS, P445, DOI 10.1109/IEMBS.2007.4352319; Stice P, 2007, J NEURAL ENG, V4, P42, DOI 10.1088/1741-2560/4/2/005; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983; Westby GWM, 1997, J NEUROSCI METH, V76, P123, DOI 10.1016/S0165-0270(97)00088-5; Winslow BD, 2010, BIOMATERIALS, V31, P1558, DOI 10.1016/j.biomaterials.2009.11.049; WISE KD, 1991, SCIENCE, V254, P1335, DOI 10.1126/science.1962192	37	121	127	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16267	10.1371/journal.pone.0016267	http://dx.doi.org/10.1371/journal.pone.0016267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298109	Green Published, Green Submitted, gold			2022-12-25	WOS:000286662800022
J	Wood, LM; Sankar, S; Reed, RE; Haas, AL; Liu, LF; McKinnon, P; Desai, SD				Wood, Laurence M.; Sankar, Surendran; Reed, Ryan E.; Haas, Arthur L.; Liu, Leroy F.; McKinnon, Peter; Desai, Shyamal D.			A Novel Role for ATM in Regulating Proteasome-Mediated Protein Degradation through Suppression of the ISG15 Conjugation Pathway	PLOS ONE			English	Article							INNATE ANTIVIRAL RESPONSE; UBIQUITIN-LIKE PROTEIN; ATAXIA-TELANGIECTASIA; PARKINSONS-DISEASE; TUMOR-CELLS; DNA-REPAIR; HELA-CELLS; E2 ENZYME; SYSTEM; LIGASE	Ataxia Telangiectasia (A-T) is an inherited immunodeficiency disorder wherein mutation of the ATM kinase is responsible for the A-T pathogenesis. Although the precise role of ATM in A-T pathogenesis is still unclear, its function in responding to DNA damage has been well established. Here we demonstrate that in addition to its role in DNA repair, ATM also regulates proteasome-mediated protein turnover through suppression of the ISG15 pathway. This conclusion is based on three major pieces of evidence: First, we demonstrate that proteasome-mediated protein degradation is impaired in A-T cells. Second, we show that the reduced protein turnover is causally linked to the elevated expression of the ubiquitin-like protein ISG15 in A-T cells. Third, we show that expression of the ISG15 is elevated in A-T cells derived from various A-T patients, as well as in brain tissues derived from the ATM knockout mice and A-T patients, suggesting that ATM negatively regulates the ISG15 pathway. Our current findings suggest for the first time that proteasome-mediated protein degradation is impaired in A-T cells due to elevated expression of the ISG15 conjugation pathway, which could contribute to progressive neurodegeneration in A-T patients.	[Wood, Laurence M.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Sankar, Surendran; Reed, Ryan E.; Haas, Arthur L.; Desai, Shyamal D.] Louisiana State Univ, Sch Med, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA USA; [Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [McKinnon, Peter] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	University of Pennsylvania; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Rutgers State University New Brunswick; Rutgers State University Medical Center; St Jude Children's Research Hospital	Wood, LM (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.	sdesai@lsuhsc.edu		Liu, Leroy/0000-0001-9396-763X; surendran, Sankar/0000-0003-1430-5393	LSU-Health Science Center School of Medicine; NIH/NINDS [1R21NS060960]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS060960, R01NS037956] Funding Source: NIH RePORTER	LSU-Health Science Center School of Medicine; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by funds from the LSU-Health Science Center School of Medicine and NIH/NINDS grant 1R21NS060960 to S.D. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAMANOLIS DP, 1979, J NEUROPATH EXP NEUR, V38, P475, DOI 10.1097/00005072-197909000-00003; Ardley HC, 2005, FEBS LETT, V579, P571, DOI 10.1016/j.febslet.2004.12.058; Ashburner BP, 1999, CANCER RES, V59, P5456; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; BODER E, 1985, ATAXIA TELANGIECTASI, V19, P1; Brignone C, 2004, ONCOGENE, V23, P4121, DOI 10.1038/sj.onc.1207540; Chen SJ, 2004, BIOCHEM BIOPH RES CO, V317, P1037, DOI 10.1016/j.bbrc.2004.03.149; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; DCunha J, 1996, J IMMUNOL, V157, P4100; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Desai SD, 2001, CANCER RES, V61, P5926; Desai SD, 2008, MOL CANCER THER, V7, P1430, DOI 10.1158/1535-7163.MCT-07-2345; Eilam R, 2003, NEUROSCIENCE, V121, P83, DOI 10.1016/S0306-4522(03)00322-1; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Haas AL, 2006, PROTEIN DEGRADATION, V5, P103; Hamerman JA, 2002, J IMMUNOL, V168, P2415, DOI 10.4049/jimmunol.168.5.2415; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Lavin MF, 2004, DNA REPAIR, V3, P1197, DOI 10.1016/j.dnarep.2004.03.011; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Lim KL, 2007, EXPERT REV PROTEOMIC, V4, P769, DOI 10.1586/14789450.4.6.769; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Lu G, 2006, CELL MOL BIOL, V52, P29, DOI 10.1170/T695; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Mitra S, 2008, THESCIENTIFICWORLDJO, V8, P421, DOI 10.1100/tsw.2008.60; Narasimhan J, 1996, J BIOL CHEM, V271, P324, DOI 10.1074/jbc.271.1.324; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Owhashi M, 2003, BIOCHEM BIOPH RES CO, V309, P533, DOI 10.1016/j.bbrc.2003.08.038; Padovan E, 2002, CANCER RES, V62, P3453; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Paul S, 2008, BIOESSAYS, V30, P1172, DOI 10.1002/bies.20852; Pitha-Rowe I, 2004, J BIOL CHEM, V279, P18178, DOI 10.1074/jbc.M309259200; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sakaguchi A, 2004, J CELL SCI, V117, P1047, DOI 10.1242/jcs.00977; SiddooAtwal C, 1996, CANCER RES, V56, P443; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Takeuchi T, 2005, BIOCHEM BIOPH RES CO, V336, P9, DOI 10.1016/j.bbrc.2005.08.034; TSCHERNE JS, 1975, ANTIMICROB AGENTS CH, V8, P479, DOI 10.1128/AAC.8.4.479; Ulane CM, 2005, J VIROL, V79, P10180, DOI 10.1128/JVI.79.16.10180-10189.2005; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200; Zou WG, 2005, BIOCHEM BIOPH RES CO, V336, P61, DOI 10.1016/j.bbrc.2005.08.038	60	38	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16422	10.1371/journal.pone.0016422	http://dx.doi.org/10.1371/journal.pone.0016422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298066	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800039
J	Ferri, F; Campione, GC; Volta, RD; Gianelli, C; Gentilucci, M				Ferri, Francesca; Campione, Giovanna Cristina; Volta, Riccardo Dalla; Gianelli, Claudia; Gentilucci, Maurizio			Social Requests and Social Affordances: How They Affect the Kinematics of Motor Sequences during Interactions between Conspecifics	PLOS ONE			English	Article							PREHENSION MOVEMENTS; INTENTION; TRANSPORT	The present study aimed at determining whether and what factors affect the control of motor sequences related to interactions between conspecifics. Experiment 1 demonstrated that during interactions between conspecifics guided by the social intention of feeding, a social affordance was activated, which modified the kinematics of sequences constituted by reaching-grasping and placing. This was relative to the same sequence directed to an inanimate target. Experiments 2 and 4 suggested that the related-to-feeding social request emitted by the receiver (i.e. the request gesture of mouth opening) is prerequisite in order to activate a social affordance. Specifically, the two experiments showed that the social request to be fed activated a social affordance even when the sequences directed towards a conspecific were not finalized to feed. Experiment 3 showed that moving inside the peripersonal space of a conspecific, who did not produce any social request, marginally affected the sequence. Finally, experiments 5 and 6 indicated that the gaze of a conspecific is necessary to make a social request effective at activating a social affordance. Summing up, the results of the present study suggest that the control of motor sequences can be changed by the interaction between giver and receiver: the interaction is characterized by a social affordance that the giver activates on the basis of social requests produced by the receiver. The gaze of the receiver is a prerequisite to make a social request effective.	[Ferri, Francesca; Campione, Giovanna Cristina; Volta, Riccardo Dalla; Gianelli, Claudia; Gentilucci, Maurizio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gentilucci, Maurizio] Italian Inst Technol, Brain Ctr Social & Motor Cognit, Parma, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT	Ferri, F (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	gentiluc@unipr.it	Gianelli, Claudia/AAC-1518-2019; Ferri, Francesca/AAC-2527-2022	Ferri, Francesca/0000-0003-1821-5870; DALLA VOLTA, Riccardo/0000-0002-2621-4459; Campione, Giovanna Cristina/0000-0003-0410-5400; Gianelli, Claudia/0000-0002-3970-9055	MUR (Ministero dell'Universita e della Ricerca)	MUR (Ministero dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR))	This work was supported by MUR (Ministero dell'Universita e della Ricerca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri F, 2007, EXP BRAIN RES, V180, P421, DOI 10.1007/s00221-007-0869-4; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; CHIEFFI S, 1993, EXP BRAIN RES, V94, P471; Ferri F, 2010, EXP BRAIN RES, V203, P637, DOI 10.1007/s00221-010-2271-x; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Gentilucci M, 1997, EXP BRAIN RES, V115, P116, DOI 10.1007/PL00005671; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; GENTILUCCI M, 1983, EXP BRAIN RES, V50, P464; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Johnson-Frey SH, 2004, VIS COGN, V11, P371, DOI 10.1080/13506280344000329; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; LOVELAND K A, 1991, Ecological Psychology, V3, P99, DOI 10.1207/s15326969eco0302_3; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Mon-Williams M, 2000, EXP BRAIN RES, V134, P268, DOI 10.1007/s002210000479; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ORAM M, 1993, J NEUROPHYSIOL, V76, P109; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; ROSENBAUM DA, 1992, HUM MOVEMENT SCI, V11, P61, DOI 10.1016/0167-9457(92)90050-L; Sartori L, 2009, CONSCIOUS COGN, V18, P766, DOI 10.1016/j.concog.2009.06.004; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.	25	69	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e15855	10.1371/journal.pone.0015855	http://dx.doi.org/10.1371/journal.pone.0015855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710PJ	21283642	Green Published, gold, Green Submitted			2022-12-25	WOS:000286523400006
J	Murakami, Y; Toyoda, H; Tanaka, M; Kuroda, M; Harada, Y; Matsuda, F; Tajima, A; Kosaka, N; Ochiya, T; Shimotohno, K				Murakami, Yoshiki; Toyoda, Hidenori; Tanaka, Masami; Kuroda, Masahiko; Harada, Yoshinori; Matsuda, Fumihiko; Tajima, Atsushi; Kosaka, Nobuyoshi; Ochiya, Takahiro; Shimotohno, Kunitada			The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 Families	PLOS ONE			English	Article							MICRORNA EXPRESSION; HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; MIR-200 FAMILY; STELLATE CELLS; EPIDEMIOLOGY; MECHANISMS; INFECTION; CIRRHOSIS; RNA	Background: Chronic hepatitis C (CH) can develop into liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Liver fibrosis and HCC development are strongly correlated, but there is no effective treatment against fibrosis because the critical mechanism of progression of liver fibrosis is not fully understood. microRNAs (miRNAs) are now essential to the molecular mechanisms of several biological processes. In order to clarify how the aberrant expression of miRNAs participates in development of the liver fibrosis, we analyzed the liver fibrosis in mouse liver fibrosis model and human clinical samples. Methodology: In a CCL(4)-induced mouse liver fibrosis model, we compared the miRNA expression profile from CCL(4) and olive oil administrated liver specimens on 4, 6, and 8 weeks. We also measured expression profiles of human miRNAs in the liver biopsy specimens from 105 CH type C patients without a history of anti-viral therapy. Principle Findings: Eleven mouse miRNAs were significantly elevated in progressed liver fibrosis relative to control. By using a large amount of human material in CH analysis, we determined the miRNA expression pattern according to the grade of liver fibrosis. We detected several human miRNAs whose expression levels were correlated with the degree of progression of liver fibrosis. In both the mouse and human studies, the expression levels of miR-199a, 199a*, 200a, and 200b were positively and significantly correlated to the progressed liver fibrosis. The expression level of fibrosis related genes in hepatic stellate cells (HSC), were significantly increased by overexpression of these miRNAs. Conclusion: Four miRNAs are tightly related to the grade of liver fibrosis in both human and mouse was shown. This information may uncover the critical mechanism of progression of liver fibrosis. miRNA expression profiling has potential for diagnostic and therapeutic applications.	[Murakami, Yoshiki; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Toyoda, Hidenori] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan; [Tanaka, Masami; Kuroda, Masahiko] Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan; [Harada, Yoshinori] Kyoto Prefectural Univ Med, Dept Pathol & Cell Regulat, Kyoto, Japan; [Tajima, Atsushi] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Kosaka, Nobuyoshi; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo 104, Japan; [Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Narashino, Chiba 275, Japan	Kyoto University; Ogaki Municipal Hospital; Tokyo Medical University; Kyoto Prefectural University of Medicine; Tokai University; National Cancer Center - Japan; Chiba Institute of Technology	Murakami, Y (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan.	ymurakami@genome.med.kyoto-u.ac.jp	Tajima, Atsushi/C-1053-2008; Matsuda, Fumihiko/B-9893-2009; Ochiya, Takahiro/AAH-7585-2019	Tajima, Atsushi/0000-0001-6808-5491; Harada, Yoshinori/0000-0001-5942-130X	Japanese Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japanese Ministry of Health, Labour and Welfare (Y.M, and K.S). This work was also supported by the 'Strategic Research-Based Support' Project for private universities; with matching funds from the Ministry of Education, Culture, Sports, Science and Technology (M.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; FRIEDMAN SL, 2008, TOXICOLOGY; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; JIN X, 2008, DIG LIVER DIS; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; MARQUEZ RT, 2010, LAB INVEST; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Murakami Y, 2009, J HEPATOL, V50, P453, DOI 10.1016/j.jhep.2008.06.010; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Oberti F, 1997, GASTROENTEROLOGY, V113, P1609, DOI 10.1053/gast.1997.v113.pm9352863; OGAWA T, 2009, BIOCH BIOPHYS RES CO; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; RODERBURG C, 2010, HEPATOLOGY; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yamamoto Y, 2009, BIOMARKERS, V14, P529, DOI 10.3109/13547500903150771; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	27	209	228	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16081	10.1371/journal.pone.0016081	http://dx.doi.org/10.1371/journal.pone.0016081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283674	Green Published, Green Submitted, gold			2022-12-25	WOS:000286523400016
J	Steinmetz, R; Garshelis, DL; Chutipong, W; Seuaturien, N				Steinmetz, Robert; Garshelis, David L.; Chutipong, Wanlop; Seuaturien, Naret			The Shared Preference Niche of Sympatric Asiatic Black Bears and Sun Bears in a Tropical Forest Mosaic	PLOS ONE			English	Article							HABITAT SELECTION; HELARCTOS-MALAYANUS; COMMUNITY STRUCTURE; FEEDING ECOLOGY; COMPETITION; POPULATION; FRUGIVORY; PHENOLOGY; OVERLAP; TAIWAN	Background: Ecologically similar species often coexist by partitioning use of habitats or resources. Such partitioning can occur through divergent or shared niches. We investigated overlap in habitat use and spatial co-occurrence by sympatric Asiatic black bears and sun bears in three habitats in Thailand, and thereby assessed which niche model best accounts for their coexistence. Methods/Principal Findings: We used density of species-specific signs to assess habitat use. Signs of both bear species occurred in all three habitats, and on >60% of sampling transects. Both species fed mostly on fruit; insect feeding signs were uncommon, and were mostly from sun bears. Significant differences in habitat use occurred only in montane forest, the habitat in which fruit was most abundant; incidence of black bear sign there was six times higher than that of sun bears. Habitat use was similar between the two species in the other habitats, which comprised 85% of the area. Of 10 habitat attributes examined, fruiting tree density was the best predictor of occurrence for both species. Models that included interspecific competition (fresh foraging activity of the other species) were less supported than the top models without competition. Conclusions/Significance: Bear species co-occurrence at both coarse and fine spatial scales and use of the same resources (fruit trees) indicated common niche preferences. However, their habitat use differed in ways expected from their physical differences: larger black bears dominated in the most fruit-rich habitat, and smaller sun bears used less-preferred insects. These results indicate broadly overlapping fundamental niches combined with asymmetric competition-features consistent with the concept of shared preference niches. This model of the niche has received little attention in ecology, but appears to be relatively common in nature.	[Steinmetz, Robert; Seuaturien, Naret] World Wide Fund Nat Thailand, Conservat Biol Unit, Bangkok, Thailand; [Garshelis, David L.] Minnesota Dept Nat Resources, Grand Rapids, MI USA; [Chutipong, Wanlop] King Mongkuts Univ Technol Thonburi, Conservat Ecol Program, Bangkok, Thailand	King Mongkuts University of Technology Thonburi	Steinmetz, R (corresponding author), World Wide Fund Nat Thailand, Conservat Biol Unit, Bangkok, Thailand.	robtyn@hotmail.com			World Wildlife Fund United Kingdom; World Wildlife Fund Netherlands; University of Minnesota	World Wildlife Fund United Kingdom; World Wildlife Fund Netherlands; University of Minnesota(University of Minnesota System)	This study was funded through grants from World Wildlife Fund United Kingdom (http://www.panda.org/united_kingdom/) and World Wildlife Fund Netherlands (http://www.panda.org/netherlands/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Department of National Parks, Wildlife, and Plant Conservation, and the National Research Council of Thailand, for granting permission for this research. We are grateful to Kietiphum Kaewplang for assistance in the field; to Chris Bingham, Sandy Weisberg, and Nicholas Gotelli for statistical advice; and to Surasak Srirattanaporn for GIS help. RS was supported by a Doctoral Dissertation Fellowship from the Graduate School, and by the Conservation Biology Program, University of Minnesota. We thank Dave Smith, Todd Arnold, Peter Jordan, Edward Cushing, and two anonymous reviewers for insights that helped us improve the paper. We thank Paiboon Sawetmelanon and Erb Chirng-saard, previous Superintendents of Thung Yai, for their assistance.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Apps CD, 2006, ECOGRAPHY, V29, P561, DOI 10.1111/j.0906-7590.2006.04564.x; Belant JL, 2006, ECOL APPL, V16, P2333, DOI 10.1890/1051-0761(2006)016[2333:IRPISU]2.0.CO;2; Buskirk SW, 2006, J WILDLIFE MANAGE, V70, P358, DOI 10.2193/0022-541X(2006)70[358:MFSORS]2.0.CO;2; Christiansen P, 2007, J ZOOL, V272, P423, DOI 10.1111/j.1469-7998.2006.00286.x; Christiansen P, 2008, J MORPHOL, V269, P896, DOI 10.1002/jmor.10643; CLARK JD, 1994, INT C BEAR RES MANAG, V9, P309; COLLINS NM, 1980, OECOLOGIA, V44, P263, DOI 10.1007/BF00572689; COSTELLO CM, 1994, INT C BEAR RES MAN, V9, P375; Creel S, 2001, CONSERV BIOL SER, V5, P35; CROME FHJ, 1988, ECOLOGY, V69, P1960, DOI 10.2307/1941173; Davis H, 2006, URSUS, V17, P41, DOI 10.2192/1537-6176(2006)17[41:IOPOSS]2.0.CO;2; DICKMAN CR, 1988, ECOLOGY, V69, P569, DOI 10.2307/1941006; Erdbrink DP., 1953, REV FOSSIL RECENT BE; Field A., 2009, DISCOVERING STAT USI; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fredriksson GM, 2006, BIOL J LINN SOC, V89, P489, DOI 10.1111/j.1095-8312.2006.00688.x; Garneau DE, 2008, MAMM BIOL, V73, P48, DOI 10.1016/j.mambio.2006.11.004; Garshelis David L., 2004, P53; Garshelis DL, 2008, FRONTIERS WILDLIFE S, P139; Glen AS, 2008, J APPL ECOL, V45, P700, DOI 10.1111/j.1365-2664.2007.01449.x; Gotelli N., 2001, ECOSIM NULL MODELS S, V78, DOI 10.5281/zenodo.16504; Hara Masatoshi, 2002, Natural History Research (Chiba), V7, P1; HERRERO S, 1978, CARNIVORE, V1, P7; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; Holm Greg W., 1999, Ursus, V11, P99; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; HTUN S, 2006, JAPAN BEAR NETWORK C, P45; Huygens OC, 2001, URSUS-SERIES, V12, P47; Huygens Oscar C., 2003, Ursus, V14, P236; Hwang MH, 2010, URSUS, V21, P81, DOI 10.2192/09GR024.1; Hwang MH, 2002, URSUS, V13, P111; IUCN, 2014, IUCN RED LIST THREAT; Jacoby ME, 1999, J WILDLIFE MANAGE, V63, P921, DOI 10.2307/3802806; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KOTLER BP, 1988, ANNU REV ECOL SYST, V19, P281, DOI 10.1146/annurev.es.19.110188.001433; KOTLER BP, 1984, ECOLOGY, V65, P689, DOI 10.2307/1938041; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Lekagul B., 1988, MAMMALS THAILAND; Linkie M, 2007, BIOL CONSERV, V137, P20, DOI 10.1016/j.biocon.2007.01.016; MANJREKAR N, 1989, THESIS SAURASHTRA U; Mattson DJ, 2005, URSUS, V16, P11, DOI 10.2192/1537-6176(2005)016[0011:ABBAFI]2.0.CO;2; MATTSON DJ, 1991, CAN J ZOOL, V69, P2430, DOI 10.1139/z91-341; Maxwell J. F., 1995, Natural History Bulletin of the Siam Society, V43, P131; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McLoughlin PD, 2002, OECOLOGIA, V132, P102, DOI 10.1007/s00442-002-0941-5; Nakhasathien S., 1990, NOMINATION THUNG YAI; Neale JCC, 2001, OIKOS, V94, P236, DOI 10.1034/j.1600-0706.2001.940204.x; PHOONJAMPA R, 2002, THESIS KASETSART U B; PIMM SL, 1985, ECOLOGY, V66, P798, DOI 10.2307/1940541; REID D, 1991, MAMMALIA, V55, P221, DOI 10.1515/mamm.1991.55.2.221; Ritchie M, 2002, ECOL STU AN, V161, P109; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Schaller G.B., 1989, P212; SCHOEN JW, 1990, INT C BEAR, V8, P143; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; STEINMETZ R, DRY FORESTS IN PRESS; STEINMETZ R, ESTIMATING IN PRESS; STEINMETZ R, 2009, THESIS U MINNESOTA; Steinmetz R, 2008, J WILDLIFE MANAGE, V72, P814, DOI 10.2193/2007-098; Steinmetz R, 2006, CONSERV BIOL, V20, P1391, DOI 10.1111/j.1523-1739.2006.00505.x; Stewart KM, 2002, J MAMMAL, V83, P229, DOI 10.1644/1545-1542(2002)083&lt;0229:TDOEMD&gt;2.0.CO;2; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; THEBERGE JB, 1989, CAN J ZOOL, V67, P1285, DOI 10.1139/z89-183; Tougard C, 2001, PALAEOGEOGR PALAEOCL, V168, P337, DOI 10.1016/S0031-0182(00)00243-1; TUMBELAKA L, 2006, JAPAN BEAR NETWORK C, P73; VINITPORNSAWAN S, 2006, JAPAN BEAR NETWORK C, P50; WEBB EL, 2007, BOTANICAL EXPLORATIO; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; Wisheu IC, 1998, OIKOS, V83, P246, DOI 10.2307/3546836; Wong ST, 2005, J TROP ECOL, V21, P627, DOI 10.1017/S0266467405002622; Wong ST, 2004, BIOL CONSERV, V119, P169, DOI 10.1016/j.biocon.2003.10.029; Wong ST, 2002, URSUS, V13, P127; Young KA, 2004, ECOLOGY, V85, P134, DOI 10.1890/02-0402; [No title captured]	75	27	30	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14509	10.1371/journal.pone.0014509	http://dx.doi.org/10.1371/journal.pone.0014509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283792	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522200001
J	Raybuck, JD; Lattal, KM				Raybuck, Jonathan D.; Lattal, K. Matthew			Double Dissociation of Amygdala and Hippocampal Contributions to Trace and Delay Fear Conditioning	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; REVERSIBLE INACTIVATION; DORSAL HIPPOCAMPUS; ENTORHINAL CORTEX; PERIRHINAL CORTEX; C57BL/6 MICE; EXPRESSION; MEMORY; RAT	A key finding in studies of the neurobiology of learning memory is that the amygdala is critically involved in Pavlovian fear conditioning. This is well established in delay-cued and contextual fear conditioning; however, surprisingly little is known of the role of the amygdala in trace conditioning. Trace fear conditioning, in which the CS and US are separated in time by a trace interval, requires the hippocampus and prefrontal cortex. It is possible that recruitment of cortical structures by trace conditioning alters the role of the amygdala compared to delay fear conditioning, where the CS and US overlap. To investigate this, we inactivated the amygdala of male C57BL/6 mice with GABA (A) agonist muscimol prior to 2-pairing trace or delay fear conditioning. Amygdala inactivation produced deficits in contextual and delay conditioning, but had no effect on trace conditioning. As controls, we demonstrate that dorsal hippocampal inactivation produced deficits in trace and contextual, but not delay fear conditioning. Further, pre- and post-training amygdala inactivation disrupted the contextual but the not cued component of trace conditioning, as did muscimol infusion prior to 1- or 4-pairing trace conditioning. These findings demonstrate that insertion of a temporal gap between the CS and US can generate amygdala-independent fear conditioning. We discuss the implications of this surprising finding for current models of the neural circuitry involved in fear conditioning.	[Raybuck, Jonathan D.; Lattal, K. Matthew] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA	Oregon Health & Science University	Raybuck, JD (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	raybuck@ohsu.edu	Lattal, K/W-8386-2019		National Institutes of Health-NIMH/NIDA [RO1MH077111, RO1DA025922];  [T32DA007262]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262, R01DA025922] Funding Source: NIH RePORTER	National Institutes of Health-NIMH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute on Drug Abuse (NIDA)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank grant support from National Institutes of Health-NIMH/NIDA (RO1MH077111 & RO1DA025922, KML) and JD Raybuck was supported by (T32DA007262, KA Neve). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier T, 2007, COMPUTATION STAT, V22, P91, DOI 10.1007/s00180-007-0023-6; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Blair HT, 2003, ANN NY ACAD SCI, V985, P485; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; Blum S, 2006, NEUROREPORT, V17, P341, DOI 10.1097/01.wnr.0000201509.53750.bc; Cahill L, 1999, NEURON, V23, P227, DOI 10.1016/S0896-6273(00)80774-6; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Esclassan F, 2009, J NEUROSCI, V29, P8087, DOI 10.1523/JNEUROSCI.0543-09.2009; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FANSELOW MS, 1994, BEHAV NEUROSCI, V108, P210, DOI 10.1037/0735-7044.108.1.210; Gilmartin MR, 2010, LEARN MEMORY, V17, P289, DOI 10.1101/lm.1597410; Gilmartin MR, 2005, BEHAV NEUROSCI, V119, P1496, DOI 10.1037/0735-7044.119.6.1496; Gould TJ, 1999, BEHAV BRAIN RES, V102, P31, DOI 10.1016/S0166-4328(98)00157-0; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P1005, DOI 10.1037/0735-7044.108.5.1005; Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002; Hobin JA, 2006, HIPPOCAMPUS, V16, P174, DOI 10.1002/hipo.20144; Hui IR, 2006, NEUROBIOL LEARN MEM, V86, P160, DOI 10.1016/j.nlm.2006.02.002; Ishikawa A, 2006, J NEUROPHYSIOL, V96, P2134, DOI 10.1152/jn.00069.2006; Kholodar-Smith DB, 2008, NEUROBIOL LEARN MEM, V90, P537, DOI 10.1016/j.nlm.2008.06.006; Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004; Lewis MC, 2007, HIPPOCAMPUS, V17, P462, DOI 10.1002/hipo.20284; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 1999, BEHAV NEUROSCI, V113, P283, DOI 10.1037/0735-7044.113.2.283; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Misane I, 2005, HIPPOCAMPUS, V15, P418, DOI 10.1002/hipo.20067; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pare D, 2003, PROG NEUROBIOL, V70, P409, DOI 10.1016/S0301-0082(03)00104-7; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Ponnusamy R, 2007, NEUROSCIENCE, V147, P919, DOI 10.1016/j.neuroscience.2007.04.026; Quinn JJ, 2008, LEARN MEMORY, V15, P368, DOI 10.1101/lm.813608; Radulovic J, 2010, REV NEUROSCIENCE, V21, P1; Raybuck JD, 2010, NEUROBIOL LEARN MEM, V94, P353, DOI 10.1016/j.nlm.2010.08.001; Raybuck JD, 2009, EUR J NEUROSCI, V29, P377, DOI 10.1111/j.1460-9568.2008.06580.x; Runyan JD, 2004, J NEUROSCI, V24, P1288, DOI 10.1523/JNEUROSCI.4880-03.2004; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Stafford JM, 2009, LEARN MEMORY, V16, P494, DOI 10.1101/lm.1452209; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Wood MA, 2006, LEARN MEMORY, V13, P609, DOI 10.1101/lm.213906	42	75	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15982	10.1371/journal.pone.0015982	http://dx.doi.org/10.1371/journal.pone.0015982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710OH	21283812	Green Submitted, Green Published, gold			2022-12-25	WOS:000286520600017
J	Kiris, E; Ventimiglia, D; Sargin, ME; Gaylord, MR; Altinok, A; Rose, K; Manjunath, BS; Jordan, MA; Wilson, L; Feinstein, SC				Kiris, Erkan; Ventimiglia, Donovan; Sargin, Mehmet E.; Gaylord, Michelle R.; Altinok, Alphan; Rose, Kenneth; Manjunath, B. S.; Jordan, Mary Ann; Wilson, Leslie; Feinstein, Stuart C.			Combinatorial Tau Pseudophosphorylation MARKEDLY DIFFERENT REGULATORY EFFECTS ON MICROTUBULE ASSEMBLY AND DYNAMIC INSTABILITY THAN THE SUM OF THE INDIVIDUAL PARTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE-DIRECTED PHOSPHORYLATION; PAIRED HELICAL FILAMENTS; AXONAL-TRANSPORT DEFECTS; ALZHEIMERS-DISEASE; PROTEIN-TAU; NEUROFIBRILLARY TANGLES; NEURODEGENERATIVE DISEASES; INDIVIDUAL MICROTUBULES; STABILIZED MICROTUBULES; SYNTHASE KINASE-3-BETA	Tau is a multiply phosphorylated protein that is essential for the development and maintenance of the nervous system. Errors in Tau action are associated with Alzheimer disease and related dementias. A huge literature has led to the widely held notion that aberrant Tau hyperphosphorylation is central to these disorders. Unfortunately, our mechanistic understanding of the functional effects of combinatorial Tau phosphorylation remains minimal. Here, we generated four singly pseudophosphorylated Tau proteins (at Thr(231), Ser(262), Ser(396), and Ser(404)) and four doubly pseudophosphorylated Tau proteins using the same sites. Each Tau preparation was assayed for its abilities to promote microtubule assembly and to regulate microtubule dynamic instability in vitro. All four singly pseudophosphorylated Tau proteins exhibited loss-of-function effects. In marked contrast to the expectation that doubly pseudophosphorylated Tau would be less functional than either of its corresponding singly pseudophosphorylated forms, all of the doubly pseudophosphorylated Tau proteins possessed enhanced microtubule assembly activity and were more potent at regulating dynamic instability than their compromised singly pseudophosphorylated counterparts. Thus, the effects of multiple pseudophosphorylations were not simply the sum of the effects of the constituent single pseudophosphorylations; rather, they were generally opposite to the effects of singly pseudophosphorylated Tau. Further, despite being pseudophosphorylated at different sites, the four singly pseduophosphorylated Tau proteins often functioned similarly, as did the four doubly pseudophosphorylated proteins. These data lead us to reassess the conventional view of combinatorial phosphorylation in normal and pathological Tau action. They may also be relevant to the issue of combinatorial phosphorylation as a general regulatory mechanism.	[Kiris, Erkan; Ventimiglia, Donovan; Gaylord, Michelle R.; Jordan, Mary Ann; Wilson, Leslie; Feinstein, Stuart C.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Kiris, Erkan; Ventimiglia, Donovan; Gaylord, Michelle R.; Jordan, Mary Ann; Wilson, Leslie; Feinstein, Stuart C.] Univ Calif Santa Barbara, Dept Mol & Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Kiris, Erkan; Sargin, Mehmet E.; Altinok, Alphan; Rose, Kenneth; Manjunath, B. S.; Wilson, Leslie; Feinstein, Stuart C.] Univ Calif Santa Barbara, Ctr Bioimage Informat, Santa Barbara, CA 93106 USA; [Sargin, Mehmet E.; Altinok, Alphan; Rose, Kenneth; Manjunath, B. S.] Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA; [Kiris, Erkan] TRUE Res Fdn, San Antonio, TX 78217 USA; [Kiris, Erkan] NCI, NIH, Ft Detrick, MD 21702 USA; [Ventimiglia, Donovan] Rockefeller Univ, New York, NY 10065 USA; [Altinok, Alphan] CALTECH, Pasadena, CA 91125 USA; [Gaylord, Michelle R.] Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; California Institute of Technology; University of California System; University of California San Diego	Feinstein, SC (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Bldg 571,Rm 6129, Santa Barbara, CA 93106 USA.	feinstei@lifesci.ucsb.edu	Kiris, Erkan/AAZ-6719-2020; Manjunath, B S/AAM-8190-2020	Kiris, Erkan/0000-0003-2095-0460; Manjunath, B S/0000-0003-2804-3611	National Institutes of Health [NS-35010, NS-13560, CA-57291]; National Science Foundation [ITR-0331697]; NATIONAL CANCER INSTITUTE [R01CA057291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035010, R01NS013560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-35010 (to S. C. F.), NS-13560 (to L. W.), and CA-57291 (to M. A. J.). This work was also supported by National Science Foundation Grant ITR-0331697 (to B. S. M., K. R., S. C. F., and L. W.).	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Bunker JM, 2006, J BIOL CHEM, V281, P11856, DOI 10.1074/jbc.M509420200; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CACERES A, 1991, J NEUROSCI, V11, P1515; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Choi MC, 2009, BIOPHYS J, V97, P519, DOI 10.1016/j.bpj.2009.04.047; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Delobel P, 2002, J BIOL CHEM, V277, P9199, DOI 10.1074/jbc.M107716200; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Devred F, 2002, FEBS LETT, V523, P247, DOI 10.1016/S0014-5793(02)02999-X; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Drewes G, 2004, TRENDS BIOCHEM SCI, V29, P548, DOI 10.1016/j.tibs.2004.08.001; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Duncan JE, 2006, PLOS GENET, V2, P1275, DOI 10.1371/journal.pgen.0020124; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Eidenmuller J, 2001, BIOCHEM J, V357, P759, DOI 10.1042/0264-6021:3570759; ENNULAT DJ, 1989, J BIOL CHEM, V264, P5327; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Fath T, 2002, J NEUROSCI, V22, P9733; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; Flaherty DB, 2000, J NEUROSCI RES, V62, P463, DOI 10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7; Gamblin TC, 2003, BIOCHEMISTRY-US, V42, P15009, DOI 10.1021/bi035722s; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Gong CX, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/31825; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hanger DP, 1998, J NEUROCHEM, V71, P2465; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Johnson GVW, 2006, J ALZHEIMERS DIS, V9, P243; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kelleher I, 2007, J NEUROCHEM, V103, P2256, DOI 10.1111/j.1471-4159.2007.04930.x; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Leboeuf AC, 2008, J BIOL CHEM, V283, P36406, DOI 10.1074/jbc.M803519200; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lim JN, 2005, BBA-MOL BASIS DIS, V1739, P311, DOI 10.1016/j.bbadis.2004.10.003; Lu PJ, 1999, NATURE, V399, P784; Miller HP, 2010, METHOD CELL BIOL, V95, P3, DOI 10.1016/S0091-679X(10)95001-2; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Necula M, 2004, J BIOL CHEM, V279, P49694, DOI 10.1074/jbc.M405527200; Panda D, 1996, J BIOL CHEM, V271, P29807, DOI 10.1074/jbc.271.47.29807; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Peck A, 2011, CYTOSKELETON, V68, P44, DOI 10.1002/cm.20494; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Rankin CA, 2005, MOL BRAIN RES, V138, P84, DOI 10.1016/j.molbrainres.2005.04.012; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Seifert F, 2007, BIOCHEMISTRY-US, V46, P6277, DOI 10.1021/bi700083z; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Singh TJ, 1996, FEBS LETT, V387, P145, DOI 10.1016/0014-5793(96)00485-1; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TOSO RJ, 1993, BIOCHEMISTRY-US, V32, P1285, DOI 10.1021/bi00056a013; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; VULLIET R, 1992, J BIOL CHEM, V267, P22570; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; WATANABE A, 1993, J BIOL CHEM, V268, P25712; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; ZHAI Y, 1994, J CELL SCI, V107, P881; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	95	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14257	14270		10.1074/jbc.M111.219311	http://dx.doi.org/10.1074/jbc.M111.219311			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21288907	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-25	WOS:000289556200049
J	Bammens, L; Chavez-Gutierrez, L; Tolia, A; Zwijsen, A; De Strooper, B				Bammens, Leen; Chavez-Gutierrez, Lucia; Tolia, Alexandra; Zwijsen, An; De Strooper, Bart			Functional and Topological Analysis of Pen-2, the Fourth Subunit of the gamma-Secretase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; CATALYTIC PORE; PRESENILIN ENDOPROTEOLYSIS; TRANSMEMBRANE DOMAIN-4; INTRACELLULAR DOMAIN; TERMINAL FRAGMENT; NICASTRIN; NOTCH; CLEAVAGE; APH-1	The gamma-secretase complex is a member of the family of intramembrane cleaving proteases, involved in the generation of the A beta peptides in Alzheimer disease. One of the four subunits of the complex, presenilin, harbors the catalytic site, although the role of the other three subunits is less well understood. Here, we studied the role of the smallest subunit, Pen-2, in vivo and in vitro. We found a profound Notch-deficiency phenotype in Pen-2(-/-) embryos confirming the essential role of Pen-2 in the gamma-secretase complex. We used Pen-2(-/-) fibroblasts to investigate the structure-function relation of Pen-2 by the scanning cysteine accessibility method. We showed that glycine 22 and proline 27 in hydrophobic domain 1 of Pen-2 are essential for complex formation and stability of gamma-secretase. We also demonstrated that hydrophobic domain 1 and the loop domain of Pen-2 are located in a water-containing cavity and are in short proximity to the presenilin C-terminal fragment. We finally demonstrated the essential role of Pen-2 for the proteolytic activity of the complex. Our study supports the hypothesis that Pen-2 is more than a structural component of the gamma-secretase complex and may contribute to the catalytic mechanism of the enzyme.	[Bammens, Leen; Chavez-Gutierrez, Lucia; Tolia, Alexandra; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, Lab Res Neurodegenerat Dis, B-3000 Louvain, Belgium; [Bammens, Leen; Chavez-Gutierrez, Lucia; Tolia, Alexandra; Zwijsen, An; De Strooper, Bart] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Zwijsen, An] Katholieke Univ Leuven VIB, Ctr Human Genet, Lab Dev Signaling, B-3000 Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven	De Strooper, B (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Lab Res Neurodegenerat Dis, B-3000 Louvain, Belgium.	Bart.DeStrooper@cme.vib-kuleuven.be	Zwijsen, An/AAK-2897-2020; De Strooper, Bart/F-6507-2012; Chávez-Gutiérrez, Lucía/E-2657-2017; de+Strooper, Bart/Z-1638-2019	De Strooper, Bart/0000-0001-5455-5819; Zwijsen, An/0000-0002-8583-1721	Vlaams Instituut voor Biotechnologie; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen; Stichting Alzheimer Onderzoek-Fondation pour la Recherche de la Maladie d'Alzheimer; Federal Office for Scientific Affairs, Belgium [IUAP P6/43/]; KULeuven; Flemish Government; European Union [FZ-2007-200611]	Vlaams Instituut voor Biotechnologie; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Stichting Alzheimer Onderzoek-Fondation pour la Recherche de la Maladie d'Alzheimer; Federal Office for Scientific Affairs, Belgium; KULeuven(KU Leuven); Flemish Government(European Commission); European Union(European Commission)	This work was supported in part by Vlaams Instituut voor Biotechnologie, Fonds voor Wetenschappelijk Onderzoek-Vlaanderen, and Stichting Alzheimer Onderzoek-Fondation pour la Recherche de la Maladie d'Alzheimer, the Federal Office for Scientific Affairs, Belgium, Grant IUAP P6/43/, Methusalem grant from KULeuven, and Flemish Government and Memosad Grant FZ-2007-200611 from the European Union.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ALTONA C, 1972, J AM CHEM SOC, V94, P8205, DOI 10.1021/ja00778a043; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Bergman A, 2004, J BIOL CHEM, V279, P16744, DOI 10.1074/jbc.M313999200; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Crystal AS, 2003, J BIOL CHEM, V278, P20117, DOI 10.1074/jbc.M213107200; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Goutte C, 2000, DEVELOPMENT, V127, P2481; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Laudon H, 2004, J BIOL CHEM, V279, P23925, DOI 10.1074/jbc.M401277200; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Li JH, 2003, J BIOL CHEM, V278, P33445, DOI 10.1074/jbc.M301288200; Li T, 2003, J NEUROSCI, V23, P3272; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Parker MH, 1997, PROTEIN ENG, V10, P487, DOI 10.1093/protein/10.5.487; PerezTur J, 1995, NEUROREPORT, V7, P297; Prihar G, 1999, NAT MED, V5, P1090, DOI 10.1038/13383; Prokop S, 2005, J NEUROCHEM, V94, P57, DOI 10.1111/j.1471-4159.2005.03165.x; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; RAMACHAN.GN, 1970, BIOCHIM BIOPHYS ACTA, V221, P165, DOI 10.1016/0005-2795(70)90257-6; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shiraishi H, 2004, J NEUROCHEM, V90, P1402, DOI 10.1111/j.1471-4159.2004.02597.x; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Zhao B, 2008, J BIOL CHEM, V283, P2927, DOI 10.1074/jbc.M708870200; Zhao GJ, 2010, J NEUROSCI, V30, P1648, DOI 10.1523/JNEUROSCI.3826-09.2010	60	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.216978	http://dx.doi.org/10.1074/jbc.M110.216978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21296884	hybrid, Green Published			2022-12-25	WOS:000289077500041
J	Sun, H; Wu, YM; Qi, JP; Pan, YD; Ge, GX; Chen, JF				Sun, Hao; Wu, YuMei; Qi, JunPeng; Pan, YouDong; Ge, Gaoxiang; Chen, JianFeng			The CC ' and DE Loops in Ig Domains 1 and 2 of MAdCAM-1 Play Different Roles in MAdCAM-1 Binding to Low- and High-affinity Integrin alpha(4)beta(7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE-1; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FIRM ADHESION; RECOGNITION; IMMUNOGLOBULIN; SUBUNIT; SITES; LYMPHOCYTES; SPECIFICITY	Lymphocyte homing is regulated by the dynamic interaction between integrins and their ligands. Integrin alpha(4)beta(7) mediates both rolling and firm adhesion of lymphocytes by modulating its affinity to the ligand, mucosal addressin cell adhesion molecule-1 (MAdCAM-1). Although previous studies have revealed some mechanisms of alpha(4)beta(7)-MAdCAM-1 binding, little is known about the different molecular bases of the low- and high-affinity alpha(4)beta(7)-MAdCAM-1 interactions, which mediate rolling and firm adhesion of lymphocytes, respectively. Here, we found that two loops in immunoglobulin domains 1 and 2 (D1 and D2) of MAdCAM-1 played different roles in MAdCAM-1 binding to low-affinity (inactive) and high-affinity (activated) alpha(4)beta(7). The Asp-42 in the CC` loop of D1 was indispensable for MAdCAM-1 binding to both low-affinity and high-affinity alpha(4)beta(7). The other CC` loop residues except for Arg-39 and Ser-44 were essential for MAdCAM-1 binding to both inactive alpha(4)beta(7) and alpha(4)beta(7) activated by SDF-1 alpha or talin, but not required for MAdCAM-1 binding to Mn2+-activated alpha(4)beta(7). Single amino acid substitution of the DE loop residues mildly decreased MAdCAM-1 binding to both inactive and activated alpha(4)beta(7). Notably, removal of the DE loop greatly impaired MAdCAM-1 binding to inactive and SDF-1 alpha- or talin-activated alpha(4)beta(7), but only decreased 60% of MAdCAM-1 binding to Mn2+-activated alpha(4)beta(7). Moreover, DE loop residues were important for stabilizing the low-affinity alpha(4)beta(7)-MAdCAM-1 interaction. Thus, our findings demonstrate the distinct roles of the CC` and DE loops in the recognition of MAdCAM-1 by low-and high-affinity alpha(4)beta(7) and suggest that the inactive alpha(4)beta(7) and alpha(4)beta(7) activated by different stimuli have distinct conformations with different structural requirements for MAdCAM-1 binding.	[Sun, Hao; Wu, YuMei; Qi, JunPeng; Pan, YouDong; Chen, JianFeng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Ge, Gaoxiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, JF (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, 320 YueYang Rd, Shanghai 200031, Peoples R China.	jfchen@sibs.ac.cn	Sun, Hao/L-7372-2018; Qi, Junpeng/G-6949-2019; Qi, Junpeng/AAH-5525-2020	Sun, Hao/0000-0002-4790-8847; 	National Basic Research Program of China [2010CB529703]; National Natural Science Foundation of China [30700119, 30970604]; Chinese Academy of Sciences [KSCX2-YW-R-67]; Shanghai Pujiang Program [08PJ14106]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by grants from the National Basic Research Program of China (Grant 2010CB529703), National Natural Science Foundation of China (Grants 30700119 and 30970604), the Chinese Academy of Sciences (Grant KSCX2-YW-R-67), and the Shanghai Pujiang Program (Grant 08PJ14106).	Adams DH, 2006, NAT REV IMMUNOL, V6, P244, DOI 10.1038/nri1784; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Briskin MJ, 1996, J IMMUNOL, V156, P719; BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; Dando J, 2002, ACTA CRYSTALLOGR D, V58, P233, DOI 10.1107/S0907444901020522; de Chateau M, 2001, BIOCHEMISTRY-US, V40, P13972, DOI 10.1021/bi011582f; Eksteen B, 2008, INFLAMM BOWEL DIS, V14, P1298, DOI 10.1002/ibd.20453; ERLE DJ, 1994, J IMMUNOL, V153, P517; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Green N, 1999, CELL ADHES COMMUN, V7, P167, DOI 10.3109/15419069909010800; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Leitinger B, 2000, BBA-MOL CELL RES, V1498, P91, DOI 10.1016/S0167-4889(00)00086-0; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Newham P, 1997, J BIOL CHEM, V272, P19429, DOI 10.1074/jbc.272.31.19429; Pan YP, 2010, P NATL ACAD SCI USA, V107, P21388, DOI 10.1073/pnas.1015487107; Shyjan AM, 1996, J IMMUNOL, V156, P2851; Springer TA, 2004, ADV PROTEIN CHEM, V68, P29; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Tan K, 1998, STRUCTURE, V6, P793, DOI 10.1016/S0969-2126(98)00080-X; Tidswell M, 1997, J IMMUNOL, V159, P1497; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Viney JL, 1996, J IMMUNOL, V157, P2488; Wright N, 2002, J IMMUNOL, V168, P5268, DOI 10.4049/jimmunol.168.10.5268; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	38	11	11	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.208900	http://dx.doi.org/10.1074/jbc.M110.208900			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21296888	Green Published, hybrid			2022-12-25	WOS:000289077500023
J	Domercq, M; Alberdi, E; Sanchez-Gomez, MV; Ariz, U; Perez-Samartin, A; Matute, C				Domercq, Maria; Alberdi, Elena; Victoria Sanchez-Gomez, Maria; Ariz, Usue; Perez-Samartin, Alberto; Matute, Carlos			Dual-specific Phosphatase-6 (Dusp6) and ERK Mediate AMPA Receptor-induced Oligodendrocyte Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; MULTIPLE-SCLEROSIS; OXIDATIVE TOXICITY; NMDA RECEPTORS; CELL-DEATH; KINASE; EXPRESSION; APOPTOSIS; PHOSPHORYLATION; ACTIVATION	Oligodendrocytes, the myelinating cells of the CNS, are highly vulnerable to glutamate excitotoxicity, a mechanism involved in tissue damage in multiple sclerosis. Thus, understanding oligodendrocyte death at the molecular level is important to develop new therapeutic approaches to treat the disease. Here, using microarray analysis and quantitative PCR, we observed that dual-specific phosphatase-6 (Dusp6), an extracellular regulated kinase-specific phosphatase, is up-regulated in oligodendrocyte cultures as well as in optic nerves after AMPA receptor activation. In turn, Dusp6 is overexpressed in optic nerves from multiple sclerosis patients before the appearance of evident damage in this structure. We further analyzed the role of Dusp6 and ERK signaling in excitotoxic oligodendrocyte death and observed that AMPA receptor activation induces a rapid increase in ERK1/2 phosphorylation. Blocking Dusp6 expression, which enhances ERK1/2 phosphorylation, significantly diminished AMPA receptor-induced oligodendrocyte death. In contrast, MAPK/ERK pathway inhibition with UO126 significantly potentiates excitotoxic oligodendrocyte death and increases cytochrome c release, mitochondrial depolarization, and mitochondrial calcium overload produced by AMPA receptor stimulation. Upstream analysis demonstrated that MAPK/ERK signaling alters AMPA receptor properties. Indeed, Dusp6 overexpression as well as incubation with UO126 produced an increase in AMPA receptor-induced inward currents and cytosolic calcium overload. Together, these data suggest that levels of phosphorylated ERK, controlled by Dusp6 phosphatase, regulate glutamate receptor permeability and oligodendroglial excitotoxicity. Therefore, targeting Dusp6 may be a useful strategy to prevent oligodendrocyte death in multiple sclerosis and other diseases involving CNS white matter.	[Domercq, Maria; Alberdi, Elena; Victoria Sanchez-Gomez, Maria; Ariz, Usue; Perez-Samartin, Alberto; Matute, Carlos] Univ Basque Country, Dept Neurociencias, E-48940 Leioa, Spain; [Domercq, Maria; Alberdi, Elena; Victoria Sanchez-Gomez, Maria; Matute, Carlos] Univ Basque Country, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-48940 Leioa, Spain	University of Basque Country; CIBERNED; University of Basque Country	Matute, C (corresponding author), Univ Basque Country, Dept Neurociencias, E-48940 Leioa, Spain.	carlos.matute@ehu.es	Matute, Carlos/N-5559-2014; Sánchez-Gómez, M Victoria/AAU-9720-2021; Alberdi, Elena/D-6383-2017; Domercq, Maria/Z-2274-2019; Samartín, Alberto Pérez/AAB-6428-2019; Samartín, Alberto Pérez/AAB-1336-2019; Alberdi, Elena/AAH-1757-2019	Matute, Carlos/0000-0001-8672-711X; Sánchez-Gómez, M Victoria/0000-0001-5730-8194; Alberdi, Elena/0000-0002-8000-142X; Domercq, Maria/0000-0002-4918-9276; Samartín, Alberto Pérez/0000-0003-0834-0424; Alberdi, Elena/0000-0002-8000-142X	Fundacion de Investigacion Medica Mutua Madrilena, Centro de Investigaciones Biomedicas en Red Enfermedades Neurodegenerativas; Spanish Ministry of Education and Science; Basque Government; European Leukodystrophy Association	Fundacion de Investigacion Medica Mutua Madrilena, Centro de Investigaciones Biomedicas en Red Enfermedades Neurodegenerativas; Spanish Ministry of Education and Science(Spanish Government); Basque Government(Basque Government); European Leukodystrophy Association	This work was supported by the Fundacion de Investigacion Medica Mutua Madrilena, Centro de Investigaciones Biomedicas en Red Enfermedades Neurodegenerativas, the Spanish Ministry of Education and Science, the Basque Government, and the European Leukodystrophy Association.	Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Boschert U, 1998, NEUROREPORT, V9, P4081, DOI 10.1097/00001756-199812210-00014; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cheung Eric C C, 2004, Sci STKE, V2004, pPE45; de Bernardo S, 2004, J NEUROCHEM, V91, P667, DOI 10.1111/j.1471-4159.2004.02744.x; Deng WB, 2006, J BIOL CHEM, V281, P36004, DOI 10.1074/jbc.M606459200; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; Jin KL, 2002, J NEUROCHEM, V80, P119, DOI 10.1046/j.0022-3042.2001.00678.x; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Kawahara N, 2004, J CEREBR BLOOD F MET, V24, P212, DOI 10.1097/01.WCB.0000106012.33322.A2; Lawrence MS, 1996, J NEUROSCI, V16, P486; Levinthal DJ, 2005, J BIOL CHEM, V280, P5875, DOI 10.1074/jbc.M410771200; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Liu Y, 2010, NAT NEUROSCI, V13, P223, DOI 10.1038/nn.2474; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Luo Y, 2006, J BIOL CHEM, V281, P16436, DOI 10.1074/jbc.M512430200; Matute C, 1998, P NATL ACAD SCI USA, V95, P10229, DOI 10.1073/pnas.95.17.10229; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Ness JK, 2004, GLIA, V46, P183, DOI 10.1002/glia.10360; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Prineas J. W., 2002, GREENFIELDS NEUROPAT, V2, P471; Rossig L, 2000, J BIOL CHEM, V275, P25502, DOI 10.1074/jbc.M002283200; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sanchez-Gomez MV, 1999, NEUROBIOL DIS, V6, P475, DOI 10.1006/nbdi.1999.0264; Sanchez-Gomez MV, 2003, J NEUROSCI, V23, P9519; Sarchielli P, 2003, ARCH NEUROL-CHICAGO, V60, P1082, DOI 10.1001/archneur.60.8.1082; Schenk U, 2004, BIOL CELL, V96, P257, DOI 10.1016/j.biolcel.2004.01.008; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Soriano MA, 2000, J CEREBR BLOOD F MET, V20, P1045, DOI 10.1097/00004647-200007000-00004; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Tashker JS, 2002, MOL BIOL CELL, V13, P393, DOI 10.1091/mbc.01-06-0291; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vallejo-Illarramendi A, 2006, NEUROBIOL DIS, V21, P154, DOI 10.1016/j.nbd.2005.06.017; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang CX, 2006, CELL DEATH DIFFER, V13, P1203, DOI 10.1038/sj.cdd.4401804; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang XD, 2003, ONCOGENE, V22, P2869, DOI 10.1038/sj.onc.1206427	52	28	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11825	11836		10.1074/jbc.M110.153049	http://dx.doi.org/10.1074/jbc.M110.153049			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21300799	hybrid, Green Published			2022-12-25	WOS:000288797100089
J	Teufel, R; Gantert, C; Voss, M; Eisenreich, W; Haehnel, W; Fuchs, G				Teufel, Robin; Gantert, Carla; Voss, Michaela; Eisenreich, Wolfgang; Haehnel, Wolfgang; Fuchs, Georg			Studies on the Mechanism of Ring Hydrolysis in Phenylacetate Degradation A METABOLIC BRANCHING POINT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HARVEYI ALDEHYDE DEHYDROGENASE; SITE-DIRECTED MUTAGENESIS; TROPODITHIETIC ACID BIOSYNTHESIS; ACYL-COENZYME-A; VIBRIO-HARVEYI; CATABOLIC PATHWAY; CATALYTIC MECHANISM; BIOCHEMICAL-CHARACTERIZATION; NUCLEOTIDE SPECIFICITY; PSEUDOMONAS-PUTIDA	The widespread, long sought-after bacterial aerobic phenylalanine/phenylacetate catabolic pathway has recently been elucidated. It proceeds via coenzyme A (CoA) thioesters and involves the epoxidation of the aromatic ring of phenylacetyl-CoA, subsequent isomerization to an uncommon seven-membered C-O-heterocycle (oxepin-CoA), and non-oxygenolytic ring cleavage. Here we characterize the hydrolytic oxepin-CoA ring cleavage catalyzed by the bifunctional fusion protein PaaZ. The enzyme consists of a C-terminal (R)-specific enoyl-CoA hydratase domain (formerly MaoC) that cleaves the ring and produces a highly reactive aldehyde and an N-terminal NADP(+)-dependent aldehyde dehydrogenase domain that oxidizes the aldehyde to 3-oxo-5,6-dehydrosuberyl-CoA. In many phenylacetate-utilizing bacteria, the genes for the pathway exist in a cluster that contains an NAD(+)-dependent aldehyde dehydrogenase in place of PaaZ, whereas the aldehyde-producing hydratase is encoded outside of the cluster. If not oxidized immediately, the reactive aldehyde condenses intramolecularly to a stable cyclic derivative that is largely prevented by PaaZ fusion in vivo. Interestingly, the derivative likely serves as the starting material for the synthesis of antibiotics (e. g. tropodithietic acid) and other tropone/tropolone related compounds as well as for omega-cycloheptyl fatty acids. Apparently, bacteria made a virtue out of the necessity of disposing the dead-end product with ring hydrolysis as a metabolic branching point.	[Haehnel, Wolfgang] Univ Freiburg, Fak Biol, Lehrstuhl Biochem, D-79104 Freiburg, Germany; [Eisenreich, Wolfgang] Tech Univ Munich, Ctr Isotopologue Profiling, Lehrstuhl Biochem, D-85748 Munich, Germany; Univ Freiburg, Fak Biol, Lehrstuhl Mikrobiol, D-79104 Freiburg, Germany	University of Freiburg; Technical University of Munich; University of Freiburg		georg.fuchs@biologie.uni-freiburg.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279; Teufel, Robin/0000-0001-5863-7248	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (to G. F., W. E., and W. H.).	Ahvazi B, 2000, BIOCHEM J, V349, P853, DOI 10.1042/bj3490853; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bains J, 2008, J MOL BIOL, V379, P597, DOI 10.1016/j.jmb.2008.04.031; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bentley R, 2008, NAT PROD REP, V25, P118, DOI 10.1039/b711474e; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Binstock J F, 1981, Methods Enzymol, V71 Pt C, P403; Boch J, 1997, ARCH MICROBIOL, V168, P282, DOI 10.1007/s002030050500; Boll M, 1995, EUR J BIOCHEM, V234, P921, DOI 10.1111/j.1432-1033.1995.921_a.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkhoff T, 2004, APPL ENVIRON MICROB, V70, P2560, DOI 10.1128/AEM.70.4.2560-2565.2003; Butler CS, 1997, ADV MICROB PHYSIOL, V38, P47; CANE DE, 1992, J AM CHEM SOC, V114, P8479, DOI 10.1021/ja00048a019; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; D'Alvise PW, 2010, APPL ENVIRON MICROB, V76, P2366, DOI 10.1128/AEM.02717-09; DECKER K, 1959, AKTIVIERTE ESSIGSAUR, P84; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Erb TJ, 2008, CURR MICROBIOL, V57, P27, DOI 10.1007/s00284-008-9147-3; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Geng HF, 2008, APPL ENVIRON MICROB, V74, P1535, DOI 10.1128/AEM.02339-07; Geng HF, 2010, J BACTERIOL, V192, P4377, DOI 10.1128/JB.00410-10; Gescher J, 2006, J BACTERIOL, V188, P2919, DOI 10.1128/JB.188.8.2919-2927.2006; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; HEMPEL J, 1993, PROTEIN SCI, V2, P1890, DOI 10.1002/pro.5560021111; Hisano T, 2003, J BIOL CHEM, V278, P617, DOI 10.1074/jbc.M205484200; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; Ismail W, 2003, EUR J BIOCHEM, V270, P3047, DOI 10.1046/j.1432-1033.2003.03683.x; KORTH H, 1982, ZBL BAKT-INT J MED M, V252, P83, DOI 10.1016/S0174-3031(82)80090-5; Koski MK, 2004, J BIOL CHEM, V279, P24666, DOI 10.1074/jbc.M400293200; Koski MK, 2003, ACTA CRYSTALLOGR D, V59, P1302, DOI 10.1107/S090744490300982X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Law RJ, 2008, J BACTERIOL, V190, P7209, DOI 10.1128/JB.00481-08; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Luengo JM, 2001, MOL MICROBIOL, V39, P1434, DOI 10.1046/j.1365-2958.2001.02344.x; MARTINEZBLANCO H, 1990, J BIOL CHEM, V265, P7084; Moore BS, 1997, J ORG CHEM, V62, P2173, DOI 10.1021/jo962402o; Olivera ER, 1998, P NATL ACAD SCI USA, V95, P6419, DOI 10.1073/pnas.95.11.6419; Park SJ, 2003, J BACTERIOL, V185, P5391, DOI 10.1128/JB.185.18.5391-5397.2003; Perozich J, 2000, EUR J BIOCHEM, V267, P6197, DOI 10.1046/j.1432-1327.2000.01697.x; Perozich J, 1999, ADV EXP MED BIOL, V463, P1; Perozich J, 2001, CHEM-BIOL INTERACT, V130, P115, DOI 10.1016/S0009-2797(00)00227-1; Qin YM, 2000, J BIOL CHEM, V275, P4965, DOI 10.1074/jbc.275.7.4965; Rather LJ, 2010, J BIOL CHEM, V285, P20615, DOI 10.1074/jbc.M110.124156; Rost R, 2002, MOL GENET GENOMICS, V267, P656, DOI 10.1007/s00438-002-0699-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHACHTER D, 1953, J BIOL CHEM, V203, P925; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; SUGINO H, 1992, J BACTERIOL, V174, P2485, DOI 10.1128/jb.174.8.2485-2492.1992; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Thiel V, 2010, ORG BIOMOL CHEM, V8, P234, DOI 10.1039/b909133e; Vedadi M, 1997, BIOCHEM BIOPH RES CO, V238, P448, DOI 10.1006/bbrc.1997.7300; Vedadi M, 1995, BIOCHEMISTRY-US, V34, P16725, DOI 10.1021/bi00051a022; VITOVSKI S, 1993, FEMS MICROBIOL LETT, V108, P1; WEINER H, 1995, ADV EXP MED BIOL, V372, P1; Zhang L, 1999, BIOCHEMISTRY-US, V38, P11440, DOI 10.1021/bi991101g; Zhang L, 2001, CHEM-BIOL INTERACT, V130, P29, DOI 10.1016/S0009-2797(00)00219-2; Zhang L, 2000, BIOCHEMISTRY-US, V39, P14409, DOI 10.1021/bi0014913	63	47	49	1	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11021	11034		10.1074/jbc.M110.196667	http://dx.doi.org/10.1074/jbc.M110.196667			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296885	hybrid, Green Published			2022-12-25	WOS:000288797100014
J	Shields, MA; Dangi-Garimella, S; Krantz, SB; Bentrem, DJ; Munshi, HG				Shields, Mario A.; Dangi-Garimella, Surabhi; Krantz, Seth B.; Bentrem, David J.; Munshi, Hidayatullah G.			Pancreatic Cancer Cells Respond to Type I Collagen by Inducing Snail Expression to Promote Membrane Type 1 Matrix Metalloproteinase-dependent Collagen Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITIONS; 3-DIMENSIONAL EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR SNAIL; INTEGRIN-LINKED KINASE; N-CADHERIN EXPRESSION; TGF-BETA; CARCINOMA-CELLS; HEPATOCYTE GROWTH; TISSUE INHIBITOR	Pancreatic ductal adenocarcinoma (PDAC) is characterized by pronounced fibrotic reaction composed primarily of type I collagen. Although type I collagen functions as a barrier to invasion, pancreatic cancer cells have been shown to respond to type I collagen by becoming more motile and invasive. Because epithelial-mesenchymal transition is also associated with cancer invasion, we examined the extent to which collagen modulated the expression of Snail, a well known regulator of epithelial-mesenchymal transition. Relative to cells grown on tissue culture plastic, PDAC cells grown in three-dimensional collagen gels induced Snail. Inhibiting the activity or expression of the TGF-beta type I receptor abrogated collagen-induced Snail. Downstream of the receptor, we showed that Smad3 and Smad4 were critical for the induction of Snail by collagen. In contrast, Smad2 or ERK1/2 was not involved in collagen-mediated Snail expression. Overexpression of Snail in PDAC cells resulted in a robust membrane type 1-matrix metalloproteinase (MT1-MMP, MMP-14)-dependent invasion through collagen-coated transwell chambers. Snail-expressing PDAC cells also demonstrated MT1-MMP-dependent scattering in three-dimensional collagen gels. Mechanistically, Snail increased the expression of MT1-MMP through activation of ERK-MAPK signaling, and inhibiting ERK signaling in Snail-expressing cells blocked two-dimensional collagen invasion and attenuated scattering in three-dimensional collagen. To provide in vivo support for our findings that Snail can regulate MT1-MMP, we examined the expression of Snail and MT1-MMP in human PDAC tumors and found a statistically significant positive correlation between MT1-MMP and Snail in these tumors. Overall, our data demonstrate that pancreatic cancer cells increase Snail on encountering collagen-rich milieu and suggest that the desmoplastic reaction actively contributes to PDAC progression.	[Shields, Mario A.; Dangi-Garimella, Surabhi; Munshi, Hidayatullah G.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Krantz, Seth B.; Bentrem, David J.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Div Gastrointestinal & Oncol Surg, Chicago, IL 60611 USA; [Bentrem, David J.; Munshi, Hidayatullah G.] Northwestern Univ, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Bentrem, David J.; Munshi, Hidayatullah G.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Munshi, HG (corresponding author), Northwestern Univ, Sch Med, Dept Med, 303 E Super Ave,Lurie 3-117, Chicago, IL 60611 USA.	h-munshi@northwestern.edu	Krantz, Seth/T-3900-2019		National Institutes of Health [R01CA126888]; Rosenberg Family Foundation; Baseball Charities Foundation; NATIONAL CANCER INSTITUTE [R01CA126888] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosenberg Family Foundation; Baseball Charities Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA126888 (NCI; to H. G. M.). This work was also supported by the Rosenberg Family Foundation (to H. G. M.) and the Baseball Charities Foundation (to M. A. S.).	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Diamond ME, 2008, J CELL SCI, V121, P2197, DOI 10.1242/jcs.021782; Garamszegi N, 2010, ONCOGENE, V29, P2368, DOI 10.1038/onc.2009.514; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Heyer J, 1999, P NATL ACAD SCI USA, V96, P12595, DOI 10.1073/pnas.96.22.12595; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Joseph MJ, 2009, J CELL BIOCHEM, V108, P726, DOI 10.1002/jcb.22309; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Medici D, 2010, MATRIX BIOL, V29, P161, DOI 10.1016/j.matbio.2009.12.003; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Munshi HG, 2004, J BIOL CHEM, V279, P39042, DOI 10.1074/jbc.M404958200; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Munshi HG, 2002, METHOD CELL BIOL, V69, P195, DOI 10.1016/S0091-679X(02)69013-2; Nishimura SL, 2009, AM J PATHOL, V175, P1362, DOI 10.2353/ajpath.2009.090393; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Sun LM, 2008, MOL CANCER RES, V6, P10, DOI 10.1158/1541-7786.MCR-07-0208; Tan C, 2001, ONCOGENE, V20, P133, DOI 10.1038/sj.onc.1204052; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100	56	93	93	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10495	10504		10.1074/jbc.M110.195628	http://dx.doi.org/10.1074/jbc.M110.195628			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21288898	Green Published, hybrid			2022-12-25	WOS:000288547000066
J	Cui, JA; Liu, JH; Li, YH; Shi, TL				Cui, Jian; Liu, Jinghua; Li, Yuhua; Shi, Tieliu			Integrative Identification of Arabidopsis Mitochondrial Proteome and Its Function Exploitation through Protein Interaction Network	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; LOCALIZING PROTEINS; ELECTRON-TRANSPORT; EXPRESSION DATA; CELL; PREDICTION; SEQUENCE; STRESS; BIOSYNTHESIS; DATABASE	Mitochondria are major players on the production of energy, and host several key reactions involved in basic metabolism and biosynthesis of essential molecules. Currently, the majority of nucleus-encoded mitochondrial proteins are unknown even for model plant Arabidopsis. We reported a computational framework for predicting Arabidopsis mitochondrial proteins based on a probabilistic model, called Naive Bayesian Network, which integrates disparate genomic data generated from eight bioinformatics tools, multiple orthologous mappings, protein domain properties and co-expression patterns using 1,027 microarray profiles. Through this approach, we predicted 2,311 candidate mitochondrial proteins with 84.67% accuracy and 2.53% FPR performances. Together with those experimental confirmed proteins, 2,585 mitochondria proteins (named CoreMitoP) were identified, we explored those proteins with unknown functions based on protein-protein interaction network (PIN) and annotated novel functions for 26.65% CoreMitoP proteins. Moreover, we found newly predicted mitochondrial proteins embedded in particular subnetworks of the PIN, mainly functioning in response to diverse environmental stresses, like salt, draught, cold, and wound etc. Candidate mitochondrial proteins involved in those physiological acitivites provide useful targets for further investigation. Assigned functions also provide comprehensive information for Arabidopsis mitochondrial proteome.	[Cui, Jian; Li, Yuhua; Shi, Tieliu] E China Normal Univ, Coll Life Sci, Ctr Bioinformat, Shanghai 200062, Peoples R China; [Cui, Jian; Li, Yuhua] E China Normal Univ, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Cui, Jian; Shi, Tieliu] NE Forestry Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China; [Liu, Jinghua] So Med Univ, Guangzhou, Guangdong, Peoples R China; [Shi, Tieliu] Chinese Acad Sci, Shanghai Informat Ctr Life Sci, Shanghai, Peoples R China; [Cui, Jian; Liu, Jinghua; Li, Yuhua; Shi, Tieliu] NE Forestry Univ, Daqing Inst Biotechnol, Daqing, Heilongjiang, Peoples R China	East China Normal University; East China Normal University; Northeast Forestry University - China; Southern Medical University - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences; Northeast Forestry University - China	Cui, JA (corresponding author), E China Normal Univ, Coll Life Sci, Ctr Bioinformat, Shanghai 200062, Peoples R China.	lyhshen@126.com; tlshi@sibs.ac.cn			National 973 Key Basic Research Program [2008CB713807, 2007CB108800]; National High Technology Research and Development Program of China (863 project) [2006AA02Z320]; National Natural Science Foundation of China [90408010, 30870575]	National 973 Key Basic Research Program(National Basic Research Program of China); National High Technology Research and Development Program of China (863 project)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National 973 Key Basic Research Program (Grant Nos. 2008CB713807 and 2007CB108800), the National High Technology Research and Development Program of China (863 project) (Grant No. 2006AA02Z320), the National Natural Science Foundation of China (Grant No. 90408010 and 30870575). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Balk J, 1999, FEBS LETT, V463, P151, DOI 10.1016/S0014-5793(99)01611-7; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bardel J, 2002, PROTEOMICS, V2, P880, DOI 10.1002/1615-9861(200207)2:7<880::AID-PROT880>3.0.CO;2-0; Bartoli CG, 2000, PLANT PHYSIOL, V123, P335, DOI 10.1104/pp.123.1.335; Bota DA, 2001, MITOCHONDRION, V1, P33, DOI 10.1016/S1567-7249(01)00005-8; Cai YD, 2003, BIOCHEM BIOPH RES CO, V305, P407, DOI 10.1016/S0006-291X(03)00775-7; Cai Yu-Dong, 2000, Molecular Cell Biology Research Communications, V4, P230, DOI 10.1006/mcbr.2001.0285; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cui J, 2008, NUCLEIC ACIDS RES, V36, pD999, DOI 10.1093/nar/gkm844; DAVID M, 2006, BASIC PRACTICE STAT; Delannoy E, 2007, BIOCHEM SOC T, V35, P1643, DOI 10.1042/BST0351643; Drawid A, 2000, TRENDS GENET, V16, P426, DOI 10.1016/S0168-9525(00)02108-9; Drawid A, 2000, J MOL BIOL, V301, P1059, DOI 10.1006/jmbi.2000.3968; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; GAVEL Y, 1990, FEBS LETT, V261, P455, DOI 10.1016/0014-5793(90)80614-O; Gong XQ, 2010, SCI CHINA LIFE SCI, V53, P1152, DOI 10.1007/s11427-010-4050-0; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Gueguen V, 2000, J BIOL CHEM, V275, P5016, DOI 10.1074/jbc.275.7.5016; Haas BJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-7; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Heazlewood JL, 2005, PLANT PHYSIOL, V139, P598, DOI 10.1104/pp.105.065532; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Huang J, 2005, ACTA BIOTHEOR, V53, P39, DOI 10.1007/s10441-005-7002-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Jambrina E, 2003, J BIOL CHEM, V278, P14134, DOI 10.1074/jbc.M211388200; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Karlberg EOL, 2003, NAT REV GENET, V4, P391, DOI 10.1038/nrg1063; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Koroleva OA, 2005, PLANT J, V41, P162, DOI 10.1111/j.1365-313X.2004.02281.x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kruft V, 2001, PLANT PHYSIOL, V127, P1694, DOI 10.1104/pp.010474; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Lee CM, 1999, J BIOL CHEM, V274, P20937, DOI 10.1074/jbc.274.30.20937; Li LF, 2010, SCI CHINA LIFE SCI, V53, P131, DOI 10.1007/s11427-010-0012-9; Li SJ, 2006, PLANT PHYSIOL, V141, P527, DOI 10.1104/pp.106.078881; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Marcotte EM, 2000, P NATL ACAD SCI USA, V97, P12115, DOI 10.1073/pnas.220399497; Mazzucotelli E, 2008, PLANT SCI, V174, P420, DOI 10.1016/j.plantsci.2008.02.005; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Millar AH, 2005, TRENDS PLANT SCI, V10, P36, DOI 10.1016/j.tplants.2004.12.002; Millar AH, 2001, PLANT PHYSIOL, V127, P1711, DOI 10.1104/pp.010387; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Nair R, 2005, J MOL BIOL, V348, P85, DOI 10.1016/j.jmb.2005.02.025; Nair R, 2002, PROTEIN SCI, V11, P2836, DOI 10.1110/ps.0207402; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pavlidis P, 2002, J COMPUT BIOL, V9, P401, DOI 10.1089/10665270252935539; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Rebeille F, 1997, EMBO J, V16, P947, DOI 10.1093/emboj/16.5.947; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tian GW, 2004, PLANT PHYSIOL, V135, P25, DOI 10.1104/pp.104.040139; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Van Aken O, 2009, MOL PLANT, V2, P1310, DOI 10.1093/mp/ssp053; Vashisht AA, 2006, J PHOTOCH PHOTOBIO B, V84, P150, DOI 10.1016/j.jphotobiol.2006.02.010; Vianello A, 2007, PHYSIOL PLANTARUM, V129, P242, DOI 10.1111/j.1399-3054.2006.00767.x; Werhahn W, 2002, ELECTROPHORESIS, V23, P640, DOI 10.1002/1522-2683(200202)23:4&lt;640::AID-ELPS640&gt;3.0.CO;2-F; Yuan Z, 1999, FEBS LETT, V451, P23, DOI 10.1016/S0014-5793(99)00506-2; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8	84	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16022	10.1371/journal.pone.0016022	http://dx.doi.org/10.1371/journal.pone.0016022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297957	Green Submitted, gold, Green Published			2022-12-25	WOS:000286834300032
J	Uzochukwu, BSC; Onwujekwe, E; Ezuma, NN; Ezeoke, OP; Ajuba, MO; Sibeudu, FT				Uzochukwu, Benjamin S. C.; Onwujekwe, Emmanuel; Ezuma, Nkoli N.; Ezeoke, Ogochukwu P.; Ajuba, Miriam O.; Sibeudu, Florence T.			Improving Rational Treatment of Malaria: Perceptions and Influence of RDTs on Prescribing Behaviour of Health Workers in Southeast Nigeria	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; UNCOMPLICATED MALARIA; RANDOMIZED-TRIAL; FACILITIES; CHILDREN; PREDICTORS; ERROR; MANAGEMENT; DISTRICT; TANZANIA	Introduction: Developments in rapid diagnostic tests (RDTs) have opened new possibilities for improved remote malaria diagnosis that is independent of microscopic diagnosis. Studies in some settings have tried to assess the influence of RDTs on the prescribing behaviour of health workers, but such information is generally lacking in Nigeria and many parts of sub-Saharan Africa. This study analysed health workers' perceptions of RDTs and their potential influence on their prescribing and treatment practices after their introduction. Methods: The study was conducted in four health centers in the Enugu East local government of Enugu State, Nigeria. All 32 health workers in the health centers where RDTs were deployed were interviewed by field workers. Information was sought on their perception of symptoms-based, RDT-based, and microscopy-based malaria diagnoses. In addition, prescription analysis was carried out on 400 prescriptions before and 12 months after RDT deployment. Results: The majority of the health workers perceived RDTs to be more effective for malaria diagnosis than microscopy and clinical diagnosis. They also felt that the benefits of RDTs included increased use of RDTs in the facilities and the tendency to prescribe more Artemisinin-based combination therapies (ACTs) and less chloroquine and SP. Some of the health workers experienced some difficulties in the process of using RDT kits. ACTs were prescribed in 74% of RDT-negative results. Conclusions/Significance: RDT-supported malaria diagnosis may have led to the overprescription of ACTs, with the drug being prescribed to people with RDT-negative results. However, the prescription of other antimalarial drugs that are not first-line drugs has been reduced. Efforts should be made to encourage health workers to trust RDT results and prescribe ACTs only to those with positive RDT results. In-depth studies are needed to determine why health workers continue to prescribe ACTs in RDT-negative results.	[Uzochukwu, Benjamin S. C.] Univ Nigeria, Coll Med, Dept Community Med, Enugu, Nigeria; [Uzochukwu, Benjamin S. C.; Onwujekwe, Emmanuel; Ezuma, Nkoli N.; Ezeoke, Ogochukwu P.; Ajuba, Miriam O.] Univ Nigeria, Coll Med, Hlth Policy Res Grp, Enugu, Nigeria; [Uzochukwu, Benjamin S. C.; Onwujekwe, Emmanuel; Ezeoke, Ogochukwu P.] Univ Nigeria, Coll Med, Dept Hlth Adm & Management, Enugu, Nigeria; [Ezuma, Nkoli N.] Univ Nigeria, Dept Sociol, Nsukka, Nigeria; [Ajuba, Miriam O.] Enugu State Univ Technol, Dept Community Med, Enugu, Nigeria; [Sibeudu, Florence T.] Nnamdi Azikiwe Univ, Dept Nursing Sci, Awka, Nigeria	University of Nigeria; University of Nigeria; University of Nigeria; University of Nigeria	Uzochukwu, BSC (corresponding author), Univ Nigeria, Coll Med, Dept Community Med, Enugu Campus, Enugu, Nigeria.	bscuzochukwu@yahoo.com	Sibeudu, Florence/ABF-9104-2021; Onwujekwe, Obinna/O-6232-2014	Onwujekwe, Obinna/0000-0002-1214-4285; Sibeudu, Florence Tochukwu/0000-0001-6213-4539	UNICEF [A50076]; World Bank/World Health Organization (WHO)	UNICEF; World Bank/World Health Organization (WHO)(World Health Organization)	This study received financial support under the Multilateral Initiative on Malaria A50076 through the The United Nations Children's Fund (UNICEF)/United Nations Development Programme (UNDP)/World Bank/World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante F. A., 2003, EC BURDEN MALA UNPUB; Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]; Bisoffi Z, 2008, BRIT MED J, V336, P168, DOI 10.1136/bmj.39401.486655.80; Bisoffi Z, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000063; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; Bojang KA, 2000, TROP MED INT HEALTH, V5, P231, DOI 10.1046/j.1365-3156.2000.00538.x; Chanda Pascalina, 2009, Cost Eff Resour Alloc, V7, P5, DOI 10.1186/1478-7547-7-5; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Craig MH, 2002, T ROY SOC TROP MED H, V96, P258, DOI 10.1016/S0035-9203(02)90092-1; DACREMONT V, 2008, ASTMH 57 ANN M 7 11; *EN STAT MIN HLTH, 2008, MAL SIT EN STAT NIG; Federal Government of Nigeria, 2007, OFFICIAL GAZETTE LAG, V24, P94; Federal Ministry of Health, 2005, NAT ANT TREATM GUID; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Lubell Y, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-21; Luchavez J, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-149; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Njama-Meya D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-7; Okeke TA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-97; Onwujekwe O, 2000, HEALTH POLICY, V54, P143, DOI 10.1016/S0168-8510(00)00105-6; Osterholt DM, 2006, TROP MED INT HEALTH, V11, P1147, DOI 10.1111/j.1365-3156.2006.01666.x; *PRES MAL IN, 2009, MAL OP PLAN MOP; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Rolland E, 2006, TROP MED INT HEALTH, V11, P398, DOI 10.1111/j.1365-3156.2006.01580.x; Rowe AK, 2000, AM J EPIDEMIOL, V151, P1029, DOI 10.1093/oxfordjournals.aje.a010131; Rowe AK, 2003, INT J EPIDEMIOL, V32, P296, DOI 10.1093/ije/dyg063; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Uzochukwu B, 2005, HEALTH POLICY, V75, P1, DOI 10.1016/j.healthpol.2005.01.019; Uzochukwu BSC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-265; Uzochukwu BS, 2002, HEALTH POLICY PLANN, V17, P378, DOI 10.1093/heapol/17.4.378; UZOCHUKWU BSC, 2008, COST EFFECTIVE UNPUB; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2006, WHO GUID TREATM MAL; *WHO, 2003, MAL RAP DIAGN MAK WO; *WHO UNICEF, 2003, WHOCDSMAL20031093; World Health Organization, 1993, INVESTIGATE DRUG USE; Zurovac D, 2005, BRIT MED J, V331, P734, DOI 10.1136/bmj.331.7519.734; Zurovac D, 2004, INT J EPIDEMIOL, V33, P1080, DOI 10.1093/ije/dyh253	42	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14627	10.1371/journal.pone.0014627	http://dx.doi.org/10.1371/journal.pone.0014627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	714UK	21297938	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300009
J	Gamell, C; Susperregui, AG; Bernard, O; Rosa, JL; Ventura, F				Gamell, Cristina; Susperregui, Antonio G.; Bernard, Ora; Luis Rosa, Jose; Ventura, Francesc			The p38/MK2/Hsp25 Pathway Is Required for BMP-2-Induced Cell Migration	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BONE MORPHOGENETIC PROTEIN-2; TGF-BETA; SIGNAL-TRANSDUCTION; NEUTROPHIL CHEMOTAXIS; ACTIN DYNAMICS; NUCLEAR EXPORT; AXON GUIDANCE; BMP RECEPTOR; MAP KINASE	Background: Bone morphogenetic proteins (BMPs) have been shown to participate in the patterning and specification of several tissues and organs during development and to regulate cell growth, differentiation and migration in different cell types. BMP-mediated cell migration requires activation of the small GTPase Cdc42 and LIMK1 activities. In our earlier report we showed that activation of LIMK1 also requires the activation of PAKs through Cdc42 and PI3K. However, the requirement of additional signaling is not clearly known. Methodology/Principal Findings: Activation of p38 MAPK has been shown to be relevant for a number of BMP-29s physiological effects. We report here that BMP-2 regulation of cell migration and actin cytoskeleton remodelling are dependent on p38 activity. BMP-2 treatment of mesenchymal cells results in activation of the p38/MK2/Hsp25 signaling pathway downstream from the BMP receptors. Moreover, chemical inhibition of p38 signaling or genetic ablation of either p38 alpha or MK2 blocks the ability to activate the downstream effectors of the pathway and abolishes BMP-2-induction of cell migration. These signaling effects on p38/MK2/Hsp25 do not require the activity of either Cdc42 or PAK, whereas p38/MK2 activities do not significantly modify the BMP-2-dependent activation of LIMK1, measured by either kinase activity or with an antibody raised against phospho-threonine 508 at its activation loop. Finally, phosphorylated Hsp25 colocalizes with the BMP receptor complexes in lamellipodia and overexpression of a phosphorylation mutant form of Hsp25 is able to abolish the migration of cells in response to BMP-2. Conclusions: These results indicate that Cdc42/PAK/LIMK1 and p38/MK2/Hsp25 pathways, acting in parallel and modulating specific actin regulatory proteins, play a critical role in integrating responses during BMP-induced actin reorganization and cell migration.	[Gamell, Cristina; Susperregui, Antonio G.; Luis Rosa, Jose; Ventura, Francesc] Univ Barcelona, Dept Ciencies Fisiol 2, IDIBELL, Lhospitalet De Llobregat, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Gamell, C (corresponding author), Univ Barcelona, Dept Ciencies Fisiol 2, IDIBELL, Lhospitalet De Llobregat, Spain.	fventura@ub.edu	Ventura, Francesc/K-9700-2014; Ventura, Francesc/ABG-2285-2020; Rosa, Jose Luis/K-6685-2014	Ventura, Francesc/0000-0001-9673-9405; Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688; Gamell, Cristina/0000-0003-0720-2652	MICINN (Ministerio De Ciencia E Innovacion) [BFU2008-02010]; ISCIII (Instituto ce Salud Carlos III) [RETIC RD06/0020]; M.E.C.	MICINN (Ministerio De Ciencia E Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII (Instituto ce Salud Carlos III)(Instituto de Salud Carlos III); M.E.C.(European Commission)	This research was supported by public grants from the MICINN (Ministerio De Ciencia E Innovacion) (BFU2008-02010) and ISCIII (Instituto ce Salud Carlos III) (RETIC RD06/0020). http://www.micinn.es; http://www.isciii.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Wyeth for providing BMP-2. We also thank Drs. G. Bokoch, X. Bustelo, M. Gaestel, K. Kim and A. Nebreda for reagents and E. Adanero, E. Castano and especially B. Torrejon for technical assistance. C. Gamell is recipient of a fellowship from the M.E.C.	Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; BERNSTEIN BW, TRENDS CELL BIOL, V20, P187; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; CHEN HF, 1927, MOL CELL BIOCHEM, V333, P49; Damarla M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004600; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Edlund S, 2004, J CELL SCI, V117, P1835, DOI 10.1242/jcs.01036; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Eyers CE, 2005, BIOCHEM J, V389, P127, DOI 10.1042/BJ20050387; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286; Goldstein AM, 2005, MECH DEVELOP, V122, P821, DOI 10.1016/j.mod.2005.03.003; Hannigan MO, 2001, J IMMUNOL, V167, P3953, DOI 10.4049/jimmunol.167.7.3953; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Hu JH, 2007, CELL SIGNAL, V19, P393, DOI 10.1016/j.cellsig.2006.07.010; Huang CK, 1997, J BIOL CHEM, V272, P17, DOI 10.1074/jbc.272.1.17; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Jog NR, 2007, J IMMUNOL, V178, P2421, DOI 10.4049/jimmunol.178.4.2421; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee SJ, 2001, INVEST OPHTH VIS SCI, V42, pS455; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nomura N, 2007, MOL VIS, V13, P2320; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Philip A, 2000, J BIOL CHEM, V275, P5911, DOI 10.1074/jbc.275.8.5911; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ronkina N, 2008, FRONT BIOSCI-LANDMRK, V13, P5511, DOI 10.2741/3095; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Singh S, 2003, J BIOL CHEM, V278, P36410, DOI 10.1074/jbc.M306428200; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sotobori T, 2006, EXP CELL RES, V312, P3927, DOI 10.1016/j.yexcr.2006.08.024; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wu R, 2007, J BIOL CHEM, V282, P21598, DOI 10.1074/jbc.M611316200; Wu Y, 2004, BIOCHEM BIOPH RES CO, V316, P666, DOI 10.1016/j.bbrc.2004.02.107; Xu X, 2008, DEV CELL, V15, P322, DOI 10.1016/j.devcel.2008.06.004; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yamauchi K, 2008, DEVELOPMENT, V135, P1119, DOI 10.1242/dev.012989; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	65	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16477	10.1371/journal.pone.0016477	http://dx.doi.org/10.1371/journal.pone.0016477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297993	gold, Green Published, Green Submitted			2022-12-25	WOS:000286664100037
J	Mao, LM; Yang, PZ; Hou, SP; Li, FZ; Kijlstra, A				Mao, Liming; Yang, Peizeng; Hou, Shengping; Li, Fuzhen; Kijlstra, Aize			Label-Free Proteomics Reveals Decreased Expression of CD18 and AKNA in Peripheral CD4(+) T Cells from Patients with Vogt-Koyanagi-Harada Syndrome	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; MEMBRANE-PROTEINS; HUMAN NEUTROPHILS; DISEASE; APOPTOSIS; MOUSE; INFLAMMATION; LYMPHOCYTES; TECHNOLOGY; UVEITIS	Vogt-Koyanagi-Harada (VKH) syndrome is a systemic autoimmune disease. CD4(+) T cells have been shown to be involved in autoimmune diseases including VKH syndrome. To screen aberrantly expressed membrane proteins in CD4(+) T cell from patients with active VKH syndrome, blood samples were taken from five patients with active VKH syndrome and five healthy individuals. A label-free quantitative proteomic strategy was used to identify the differently expressed proteins between the two groups. The results revealed that the expression of 102 peptides was significantly altered (p<0.05) between two groups and matched amino acid sequences of proteins deposited in the international protein index (ipi.HUMAN.v3.36.fasta). The identified peptides corresponded to 64 proteins, in which 30 showed more than a 1.5-fold difference between the two groups. The decreased expression of CD18 and AKNA transcription factor (AKNA), both being three-fold lower than controls in expression identified by the label-free method, was further confirmed in an additional group of five active VKH patients and six normal individuals using the Western blot technique. A significantly decreased expression of CD18 and AKNA suggests a role for both proteins in the pathogenesis of this syndrome.	[Mao, Liming; Yang, Peizeng; Hou, Shengping; Li, Fuzhen] Chongqing Med Univ, Chongqing Eye Inst, Lab Ophthalmol, Affiliated Hosp 1, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Maastricht, Dept Ophthalmol, Maastricht, Netherlands	Chongqing Medical University; Maastricht University	Mao, LM (corresponding author), Chongqing Med Univ, Chongqing Eye Inst, Lab Ophthalmol, Affiliated Hosp 1, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013; Hou, Shengping/E-5250-2013	Mao, Liming/0000-0002-9740-820X	National Natural Science Foundation [30973242]; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Health Bureau of Chongqing [2008115]; Project of Medical Science and Technology of Chongqing [2008-1-15]; Natural Science Foundation of Chongqing (CSTC) [2009BA5037]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; PAR-EU	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Health Bureau of Chongqing; Project of Medical Science and Technology of Chongqing; Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); PAR-EU	This work was supported by National Natural Science Foundation Project (30973242), Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality, Key Project of Health Bureau of Chongqing (2008115), Project of Medical Science and Technology of Chongqing (2008-1-15), Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037), Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), and PAR-EU SCHOLARS PROGRAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHER O, 1992, FEBS LETT, V299, P15, DOI 10.1016/0014-5793(92)80089-Y; Chambers G, 2000, J PATHOL, V192, P280, DOI 10.1002/1096-9896(200011)192:3<280::AID-PATH748>3.0.CO;2-L; Corden L D, 1996, Exp Dermatol, V5, P297, DOI 10.1111/j.1600-0625.1996.tb00133.x; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Friedman David B, 2007, Methods Mol Biol, V367, P219; Ghosh S, 2006, J IMMUNOL, V177, P2486, DOI 10.4049/jimmunol.177.4.2486; Gillardon F, 2007, J NEUROCHEM, V101, P1483, DOI 10.1111/j.1471-4159.2006.04438.x; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Hu XF, 2009, OMICS, V13, P291, DOI 10.1089/omi.2009.0016; Irvine AD, 1999, BRIT J DERMATOL, V140, P815, DOI 10.1046/j.1365-2133.1999.02810.x; Johansson C, 2006, PROTEOMICS, V6, P4475, DOI 10.1002/pmic.200500921; Jungblut PR, 1999, ELECTROPHORESIS, V20, P2100; Kavallaris M, 2005, MED J AUSTRALIA, V182, P575, DOI 10.5694/j.1326-5377.2005.tb06817.x; Klein E, 2004, CONTRIB NEPHROL, V141, P25; Kraemer KH, 2004, NAT GENET, V36, P677, DOI 10.1038/ng0704-677; Ku NO, 2001, NEW ENGL J MED, V344, P1580, DOI 10.1056/NEJM200105243442103; Larsson J, 2000, INFLAMM RES, V49, P452, DOI 10.1007/s000110050616; Le Bihan T, 2006, J PROTEOME RES, V5, P2701, DOI 10.1021/pr060190y; Li B, 2005, BRIT J OPHTHALMOL, V89, P1410, DOI 10.1136/bjo.2005.074062; Liu XL, 2009, CLIN IMMUNOL, V131, P333, DOI 10.1016/j.clim.2008.12.007; McGregor E, 2003, HUM MOL GENET, V12, pR135, DOI 10.1093/hmg/ddg278; Ohta K, 2002, OCUL IMMUNOL INFLAMM, V10, P93, DOI 10.1076/ocii.10.2.93.13984; Quintana LF, 2009, MOL CELL PROTEOMICS, V8, P1658, DOI 10.1074/mcp.M900059-MCP200; Rabilloud T, 2002, PROTEOMICS, V2, P3, DOI 10.1002/1615-9861(200201)2:1<3::AID-PROT3>3.3.CO;2-I; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Shin Tae-kyun, 2003, J Vet Sci, V4, P9; Siddiqa A, 2001, NATURE, V410, P383, DOI 10.1038/35066602; Sigle KJ, 2006, JAVMA-J AM VET MED A, V228, P543, DOI 10.2460/javma.228.4.543; Smith FJD, 2003, AM J CLIN DERMATOL, V4, P347, DOI 10.2165/00128071-200304050-00005; Walzog B, 1997, FASEB J, V11, P1177, DOI 10.1096/fasebj.11.13.9367353; Wang HL, 2009, J INVEST DERMATOL, V129, P1100, DOI 10.1038/jid.2009.43; Watanabe M, 2004, CLIN EXP IMMUNOL, V136, P555, DOI 10.1111/j.1365-2249.2004.02482.x; WILSON RW, 1993, J IMMUNOL, V151, P1571; Wright GL, 2003, J BIOMED BIOTECHNOL, P215, DOI 10.1155/S1110724303002997; Wu MX, 1996, J IMMUNOL, V157, P707; Xu H, 2008, J PROTEOME RES, V7, P1098, DOI 10.1021/pr7006768; Xue H, 2010, J PROTEOME RES, V9, P545, DOI 10.1021/pr9008817; Xun ZY, 2009, J PROTEOME RES, V8, P4500, DOI 10.1021/pr9006238; Yamaki K, 2000, EXP EYE RES, V71, P361, DOI 10.1006/exer.2000.0893; Yamaki Kunihiko, 2002, International Ophthalmology Clinics, V42, P13; Yang PZ, 2002, OCUL IMMUNOL INFLAMM, V10, P47, DOI 10.1076/ocii.10.1.47.10331; Yang PZ, 2001, OCUL IMMUNOL INFLAMM, V9, P185, DOI 10.1076/ocii.9.3.185.3961; Zhang LJ, 2005, PROTEOMICS, V5, P4510, DOI 10.1002/pmic.200401318	44	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14616	10.1371/journal.pone.0014616	http://dx.doi.org/10.1371/journal.pone.0014616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297967	gold, Green Published, Green Submitted			2022-12-25	WOS:000286664100003
J	Chen, XA; Cho, K; Singer, BH; Zhang, HP				Chen, Xiang; Cho, Kelly; Singer, Burton H.; Zhang, Heping			The Nuclear Transcription Factor PKNOX2 Is a Candidate Gene for Substance Dependence in European-Origin Women	PLOS ONE			English	Article							NICOTINE DEPENDENCE; ALCOHOL DEPENDENCE; ASSOCIATION; RISK; RECEPTOR; PREVALENCE; MARIJUANA; GENOTYPES; SUBUNIT; COCAINE	Substance dependence or addiction is a complex environmental and genetic disorder that results in serious health and socio-economic consequences. Multiple substance dependence categories together, rather than any one individual addiction outcome, may explain the genetic variability of such disorder. In our study, we defined a composite substance dependence phenotype derived from six individual diagnoses: addiction to nicotine, alcohol, marijuana, cocaine, opiates or other drugs as a whole. Using data from several genomewide case-control studies, we identified a strong (Odds ratio = 1.77) and significant (p-value = 7E-8) association signal with a novel gene, PBX/knotted 1 homeobox 2 (PKNOX2), on chromosome 11 with the composite phenotype in European-origin women. The association signal is not as significant when individual outcomes for addiction are considered, or in males or African-origin population. Our findings underscore the importance of considering multiple addiction types and the importance of considering population and gender stratification when analyzing data with heterogeneous population.	[Chen, Xiang; Cho, Kelly; Zhang, Heping] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Singer, Burton H.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Yale University; State University System of Florida; University of Florida	Chen, XA (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.	heping.zhang@yale.edu	Chen, Xiang/N-2524-2018; Zhang, He/GXN-0028-2022	Chen, Xiang/0000-0002-2499-8261; 	National Institutes of Health [K02DA017713, R01DA016750, T32 MH014235, U01 HG004446, U10 AA008401, P01 CA089392, R01 DA013423, HHSN268200782096C]; National Institutes of Health Genes, Environment, and Health Initiative [U01 HG004422, U01HG004438]; National Institute on Alcohol Abuse and Alcoholism; National Institute on Drug Abuse; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004446, U01HG004422, U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA017713, R01DA013423, R01DA016750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Genes, Environment, and Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grants K02DA017713, R01DA016750, and T32 MH014235. Study of Addiction: Genetics and Environment (SAGE) was supported by National Institutes of Health Genes, Environment, and Health Initiative Grant U01 HG004422. Study of Addiction: Genetics and Environment is one of the genome-wide association studies funded as part of the Gene Environment Association Studies under Genes, Environment, and Health Initiative. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the Gene Environment Association Studies Coordinating Center, which is supported by National Institutes of Health Grant U01 HG004446. Assistance with data cleaning was provided by the National Center for Biotechnology Information. Support for collection of datasets and samples was provided by the Collaborative Study on the Genetics of Alcoholism, which is supported by National Institutes of Health Grant U10 AA008401; the Collaborative Genetic Study of Nicotine Dependence, which is supported by National Institutes of Health Grant P01 CA089392; and the Family Study of Cocaine Dependence which is supported by National Institutes of Health Grant R01 DA013423. Genotyping was performed at the Johns Hopkins University Center for Inherited Disease Research and was supported by National Institutes of Health Genes, Environment, and Health Initiative Grant U01HG004438, the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, and National Institutes of Health contract HHSN268200782096C, "High throughput genotyping for studying the genetic contributions to human disease." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Adhikari B., 2009, Morbidity and Mortality Weekly Report, V58, P29; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Begleiter H, 1995, ALCOHOL HEALTH RES W, V19, P228; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, DRUG ALCOHOL DEPEN, V95, P14, DOI 10.1016/j.drugalcdep.2007.11.023; Bierut LJ, 2007, PHARMACOGENOMICS, V8, P881, DOI 10.2217/14622416.8.8.881; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Breslau N, 2001, ARCH GEN PSYCHIAT, V58, P810, DOI 10.1001/archpsyc.58.9.810; Curtin K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-448; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Edenberg HJ, 2006, ADDICT BIOL, V11, P386, DOI 10.1111/j.1369-1600.2006.00035.x; Hartel DM, 2006, CLIN INFECT DIS, V43, P525, DOI 10.1086/505978; HIGUCHI S, 1994, LANCET, V343, P741, DOI 10.1016/S0140-6736(94)91629-2; Imoto I, 2001, BIOCHEM BIOPH RES CO, V287, P270, DOI 10.1006/bbrc.2001.5578; Kandel D, 1997, DRUG ALCOHOL DEPEN, V44, P11, DOI 10.1016/S0376-8716(96)01315-4; Karch DL, 2006, INJURY PREV, V12, P22, DOI 10.1136/ip.2006.013557; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Li MD, 2008, HUM GENET, V123, P119, DOI 10.1007/s00439-008-0473-0; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; Luo ZH, 2008, NICOTINE TOB RES, V10, P1223, DOI 10.1080/14622200802163266; MAEZAWA Y, 1995, ALCOHOL CLIN EXP RES, V19, P951, DOI 10.1111/j.1530-0277.1995.tb00972.x; Makhija Nita J, 2007, Int J Adolesc Med Health, V19, P53; Merikangas KR, 1998, ARCH GEN PSYCHIAT, V55, P973, DOI 10.1001/archpsyc.55.11.973; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Nakamura K, 1996, ALCOHOL CLIN EXP RES, V20, P52, DOI 10.1111/j.1530-0277.1996.tb01043.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redden DT, 2006, PLOS GENET, V2, P1254, DOI 10.1371/journal.pgen.0020137; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Reich T, 1996, ALCOHOL CLIN EXP RES, V20, pA133, DOI 10.1111/j.1530-0277.1996.tb01763.x; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; Song JZ, 2003, AM J MED GENET B, V117B, P39, DOI 10.1002/ajmg.b.10022; True WR, 1999, AM J MED GENET, V88, P391, DOI 10.1002/(SICI)1096-8628(19990820)88:4<391::AID-AJMG17>3.0.CO;2-L; Uhl George R., 1995, P1793	35	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16002	10.1371/journal.pone.0016002	http://dx.doi.org/10.1371/journal.pone.0016002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298047	gold, Green Submitted, Green Published			2022-12-25	WOS:000286663900021
J	Houdelier, C; Lumineau, S; Bertin, A; Guibert, F; De Margerie, E; Augery, M; Richard-Yris, MA				Houdelier, Cecilia; Lumineau, Sophie; Bertin, Aline; Guibert, Floriane; De Margerie, Emmanuel; Augery, Matthieu; Richard-Yris, Marie-Annick			Development of Fearfulness in Birds: Genetic Factors Modulate Non-Genetic Maternal Influences	PLOS ONE			English	Article							COTURNIX-COTURNIX-JAPONICA; JAPANESE-QUAIL; EMOTIONAL REACTIVITY; TONIC IMMOBILITY; BEHAVIOR; MICE; FEAR; STRESS; CHICKS; CARE	The development of fearfulness and the capacity of animals to cope with stressful events are particularly sensitive to early experience with mothers in a wide range of species. However, intrinsic characteristics of young animals can modulate maternal influence. This study evaluated the effect of intrinsic fearfulness on non-genetic maternal influence. Quail chicks, divergently selected for either higher (LTI) or lower fearfulness (STI) and from a control line (C), were cross-fostered by LTI or STI mothers. Behavioural tests estimated the chicks' emotional profiles after separation from the mother. Whatever their genotype, the fearfulness of chicks adopted by LTI mothers was higher than that of chicks adopted by STI mothers. However, genetic background affected the strength of maternal effects: the least emotional chicks (STI) were the least affected by early experience with mothers. We demonstrated that young animal's intrinsic fearfulness affects strongly their sensitivity to non-genetic maternal influences. A young animal's behavioural characteristics play a fundamental role in its own behavioural development processes.	[Houdelier, Cecilia; Lumineau, Sophie; Guibert, Floriane; De Margerie, Emmanuel; Augery, Matthieu; Richard-Yris, Marie-Annick] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France; [Bertin, Aline] Univ Tours Haras Nationaux, CNRS, INRA, UMR Physiol Reprod & Comportements 85, Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); INRAE	Houdelier, C (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	cecilia.houdelier@univ-rennes1.fr		Lumineau, Sophie/0000-0002-2076-9947; de Margerie, Emmanuel/0000-0002-5380-3355	CNRS (National Committee of Scientific Research); University of Rennes 1	CNRS (National Committee of Scientific Research)(Centre National de la Recherche Scientifique (CNRS)); University of Rennes 1	The experiment was financed by the authors' regular funding from research organizations (CNRS (National Committee of Scientific Research) and University of Rennes 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; Archer J., 1976, P231; Bertin A, 2005, J EXP ZOOL PART A, V303A, P792, DOI 10.1002/jez.a.202; Bertin A, 2004, APPL ANIM BEHAV SCI, V89, P215, DOI 10.1016/j.applanim.2004.06.004; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Brinks V, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08.008.2007, 10.3389/neuro.08/008.2007]; Calatayud F, 2004, PHYSIOL BEHAV, V80, P465, DOI 10.1016/j.physbeh.2003.10.001; Calatayud F, 2001, PHYSIOL BEHAV, V74, P355, DOI 10.1016/S0031-9384(01)00566-2; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Crews D, 2008, FRONT NEUROENDOCRIN, V29, P344, DOI 10.1016/j.yfrne.2008.01.003; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Formanek L, 2008, ETHOLOGY, V114, P817, DOI 10.1111/j.1439-0310.2008.01536.x; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; GALLUP GG, 1977, PSYCHOL REC, V27, P41, DOI 10.1007/BF03394432; GEBHARDT MD, 1993, J EVOLUTION BIOL, V6, P17, DOI 10.1046/j.1420-9101.1993.6010017.x; Hager R, 2009, P ROY SOC B-BIOL SCI, V276, P2949, DOI 10.1098/rspb.2009.0515; Hazard D, 2008, GEN COMP ENDOCR, V155, P288, DOI 10.1016/j.ygcen.2007.05.009; Jablonca E, 2005, EVOLUTION 4 DIMENSIO; JONES RB, 1978, BRIT POULTRY SCI, V19, P725, DOI 10.1080/00071667808416535; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; JONES RB, 1986, WORLD POULTRY SCI J, V42, P82, DOI 10.1079/WPS19860008; JONES RB, 1987, COGNITIVE ASPECTS SO, P40; Jones RB, 1996, WORLDS POULT SCI J, P133; Kendrick KM, 2001, HORM BEHAV, V40, P322, DOI 10.1006/hbeh.2001.1672; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; LARSSON K, 1992, EVOLUTION, V46, P235, DOI 10.1111/j.1558-5646.1992.tb01998.x; Launay F., 1993, CONSEQUENCES COMPORT; LEBOUCHER G, 1991, ETHOL ECOL EVOL, V3, P101, DOI 10.1080/08927014.1991.9525377; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Mameli M, 2004, BRIT J PHILOS SCI, V55, P35, DOI 10.1093/bjps/55.1.35; Marx BP, 2008, CLIN PSYCHOL-SCI PR, V15, P74, DOI 10.1111/j.1468-2850.2008.00112.x; Mills A. D., 1994, COMPORTEMENT BIEN ET, P127; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; MILLS AD, 1986, BIOL BEHAV, V11, P235; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; ORCUTT FS, 1976, AUK, V93, P135; Perre Y, 2002, APPL ANIM BEHAV SCI, V75, P133, DOI 10.1016/S0168-1591(01)00189-7; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Price E. O., 1998, GENETICS BEHAV DOMES; Richard-Yris M. A., 1994, COMPORTEMENT ADAPTAT, P61; Richard-Yris MA, 2005, DEV PSYCHOBIOL, V46, P1, DOI 10.1002/dev.20040; RINGO J, 1986, BEHAVIOUR, V97, P226, DOI 10.1163/156853986X00612; Sandi C, 2008, FRONT NEUROSCI-SWITZ, V2, P134, DOI 10.3389/neuro.01.042.2008; Shettleworth, 2010, COGNITION EVOLUTION; TURROVINCENT I, 1995, BEHAV PROCESS, V34, P23, DOI 10.1016/0376-6357(94)00045-I; Wauters AM, 2002, DEV PSYCHOBIOL, V41, P25, DOI 10.1002/dev.10042; WECHSLER B, 1995, APPL ANIM BEHAV SCI, V43, P123, DOI 10.1016/0168-1591(95)00557-9	48	23	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14604	10.1371/journal.pone.0014604	http://dx.doi.org/10.1371/journal.pone.0014604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298038	Green Published, gold, Green Submitted			2022-12-25	WOS:000286663900008
J	Marquet, F; Bonneau, M; Pascale, F; Urien, C; Kang, C; Schwartz-Cornil, I; Bertho, N				Marquet, Florian; Bonneau, Michel; Pascale, Florentina; Urien, Celine; Kang, Chantal; Schwartz-Cornil, Isabelle; Bertho, Nicolas			Characterization of Dendritic Cells Subpopulations in Skin and Afferent Lymph in the Swine Model	PLOS ONE			English	Article							EPIDERMAL LANGERHANS CELLS; TRANSCUTANEOUS IMMUNIZATION; DISTINCT POPULATIONS; PORCINE SKIN; IN-VIVO; ANTIGEN; SUBSET; MACROPHAGES; RESPONSES; IMMUNITY	Transcutaneous delivery of vaccines to specific skin dendritic cells (DC) subsets is foreseen as a promising strategy to induce strong and specific types of immune responses such as tolerance, cytotoxicity or humoral immunity. Because of striking histological similarities between human and pig skin, pig is recognized as the most suitable model to study the cutaneous delivery of medicine. Therefore improving the knowledge on swine skin DC subsets would be highly valuable to the skin vaccine field. In this study, we showed that pig skin DC comprise the classical epidermal langerhans cells (LC) and dermal DC (DDC) that could be divided in 3 subsets according to their phenotypes: (1) the CD163(neg)/CD172a(neg), (2) the CD163(high)CD172a(pos) and (3) the CD163(low)CD172a(pos) DDC. These subtypes have the capacity to migrate from skin to lymph node since we detected them in pseudo-afferent lymph. Extensive phenotyping with a set of markers suggested that the CD163(high) DDC resemble the antibody response-inducing human skin DC/macrophages whereas the CD163(neg)CD172(low) DDC share properties with the CD8(+) T cell response-inducing murine skin CD103(pos) DC. This work, by showing similarities between human, mouse and swine skin DC, establishes pig as a model of choice for the development of transcutaneous immunisation strategies targeting DC.	[Marquet, Florian; Pascale, Florentina; Urien, Celine; Schwartz-Cornil, Isabelle; Bertho, Nicolas] INRA, Virol & Immunol Mol UR892, Jouy En Josas, France; [Bonneau, Michel; Pascale, Florentina; Kang, Chantal] INRA, Ctr Rech Imagerie Intervent, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Marquet, F (corresponding author), INRA, Virol & Immunol Mol UR892, Jouy En Josas, France.	isabelle.schwartz@jouy.inra.fr; nicolas.bertho@jouy.inra.fr	BERTHO, Nicolas/B-8167-2019; schwartz-cornil, isabelle/D-8547-2011	BERTHO, Nicolas/0000-0002-6732-3483; 	Institut National de la Recherche Agronomique (INRA)	Institut National de la Recherche Agronomique (INRA)	This work was funded by the Institut National de la Recherche Agronomique (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista EM, 2002, VET IMMUNOL IMMUNOP, V88, P131, DOI 10.1016/S0165-2427(02)00152-6; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belyakov IM, 2004, J CLIN INVEST, V113, P998, DOI 10.1172/JCI200420261; Bullido R, 1996, J IMMUNOL METHODS, V195, P125, DOI 10.1016/0022-1759(96)00095-6; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Caminschi I, 2009, EUR J IMMUNOL, V39, P931, DOI 10.1002/eji.200839035; Carter RW, 2006, J IMMUNOL, V177, P2276, DOI 10.4049/jimmunol.177.4.2276; Contreras V, 2010, J IMMUNOL, V185, P3313, DOI 10.4049/jimmunol.1000824; Corbett AJ, 2005, EUR J IMMUNOL, V35, P2815, DOI 10.1002/eji.200526100; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Epardaud M, 2004, J LEUKOCYTE BIOL, V76, P553, DOI 10.1189/jlb.0404223; Etchart N, 2007, VACCINE, V25, P6891, DOI 10.1016/j.vaccine.2007.07.014; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Grabbe S, 1994, Exp Dermatol, V3, P276, DOI 10.1111/j.1600-0625.1994.tb00289.x; Guilliams M, 2010, EUR J IMMUNOL, V40, P2089, DOI 10.1002/eji.201040498; Hammond SA, 2000, ADV DRUG DELIVER REV, V43, P45, DOI 10.1016/S0169-409X(00)00076-4; Henri S, 2009, J EXP MED, p[189, S181]; Huang YW, 2009, DEV COMP IMMUNOL, V33, P464, DOI 10.1016/j.dci.2008.09.010; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Nfon CK, 2008, VET IMMUNOL IMMUNOP, V126, P236, DOI 10.1016/j.vetimm.2008.07.012; Ochoa MT, 2008, J INVEST DERMATOL, V128, pS180; Pascale F, 2008, J IMMUNOL, V180, P5963, DOI 10.4049/jimmunol.180.9.5963; Takeuchi A, 2009, J IMMUNOL, V183, P4220, DOI 10.4049/jimmunol.0901248; Turnbull E, 2001, IMMUNOL REV, V184, P58, DOI 10.1034/j.1600-065x.2001.1840106.x; Vardaxis NJ, 1997, J ANAT, V190, P601, DOI 10.1046/j.1469-7580.1997.19040601.x; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282	32	66	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16320	10.1371/journal.pone.0016320	http://dx.doi.org/10.1371/journal.pone.0016320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298011	Green Published, gold, Green Submitted			2022-12-25	WOS:000286663900034
J	Galli, C; Bernasconi, R; Solda, T; Calanca, V; Molinari, M				Galli, Carmela; Bernasconi, Riccardo; Solda, Tatiana; Calanca, Verena; Molinari, Maurizio			Malectin Participates in a Backup Glycoprotein Quality Control Pathway in the Mammalian ER	PLOS ONE			English	Article							EARLY SECRETORY PATHWAY; ALPHA-D-MANNOSIDASE; N-LINKED GLYCANS; ENDOPLASMIC-RETICULUM; INFLUENZA HEMAGGLUTININ; BINDING PROTEIN; CALNEXIN CYCLE; DEGRADATION; CALRETICULIN; CONSEQUENCES	Malectin is a conserved, endoplasmic reticulum (ER)-resident lectin that recognizes high mannose oligosaccharides displaying terminal glucose residues. Here we show that Malectin is an ER stress-induced protein that selectively associates with glycopolypeptides without affecting their entry and their retention in the Calnexin chaperone system. Analysis of the obligate Calnexin client influenza virus hemagglutinin (HA) revealed that Calnexin and Malectin associated with different timing to different HA conformers and that Malectin associated with misfolded HA. Analysis of the facultative Calnexin clients NHK and alpha 1-antitrypsin (alpha 1AT) revealed that induction of Malectin expression to simulate conditions of ER stress resulted in persistent association between the ER lectin and the model cargo glycoproteins, interfered with processing of cargo-linked oligosaccharides and reduced cargo secretion. We propose that Malectin intervention is activated upon ER stress to inhibit secretion of defective gene products that might be generated under conditions of aberrant functioning of the ER quality control machinery.	[Galli, Carmela; Bernasconi, Riccardo; Solda, Tatiana; Calanca, Verena; Molinari, Maurizio] Inst Biomed Res, Bellinzona, Switzerland; [Molinari, Maurizio] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland	Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Galli, C (corresponding author), Inst Biomed Res, Bellinzona, Switzerland.	maurizio.molinari@irb.unisi.ch	Molinari, Maurizio/N-2587-2019	Molinari, Maurizio/0000-0002-7636-5829	Foundation for Research on Neurodegenerative Diseases; Fondazione San Salvatore; Swiss National Center of Competence in Research on Neural Plasticity and Repair; Swiss National Science Foundation; ONELIFE Advisors SA	Foundation for Research on Neurodegenerative Diseases; Fondazione San Salvatore; Swiss National Center of Competence in Research on Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ONELIFE Advisors SA	M.M. is supported by grants from the Foundation for Research on Neurodegenerative Diseases, the Fondazione San Salvatore, the Swiss National Center of Competence in Research on Neural Plasticity and Repair, the Swiss National Science Foundation, and ONELIFE Advisors SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HIRAIZUMI S, 1993, J BIOL CHEM, V268, P9927; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; LUBAS WA, 1987, J BIOL CHEM, V262, P3775; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; Muller LN, 2010, ORG BIOMOL CHEM, V8, P3294, DOI 10.1039/c004502k; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; ROTHMAN JE, 1984, J CELL BIOL, V99, P248, DOI 10.1083/jcb.99.1.248; Schallus T, 2008, MOL BIOL CELL, V19, P3404, DOI 10.1091/mbc.E08-04-0354; Schallus T, 2010, GLYCOBIOLOGY, V20, P1010, DOI 10.1093/glycob/cwq059; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; Solda T, 2007, MOL CELL, V27, P238, DOI 10.1016/j.molcel.2007.05.032; Vanoni O, 2008, MOL BIOL CELL, V19, P4086, DOI 10.1091/mbc.E08-05-0459; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang JX, 1997, MOL BIOL CELL, V8, P1943, DOI 10.1091/mbc.8.10.1943	42	61	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16304	10.1371/journal.pone.0016304	http://dx.doi.org/10.1371/journal.pone.0016304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298103	Green Published, gold			2022-12-25	WOS:000286662800024
J	Simonsen, KT; Nielsen, G; Bjerrum, JV; Kruse, T; Kallipolitis, BH; Moller-Jensen, J				Simonsen, Karina T.; Nielsen, Gorm; Bjerrum, Janni Vester; Kruse, Thomas; Kallipolitis, Birgitte H.; Moller-Jensen, Jakob			A Role for the RNA Chaperone Hfq in Controlling Adherent-Invasive Escherichia coli Colonization and Virulence	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; CROHNS-DISEASE; CAENORHABDITIS-ELEGANS; STRAIN LF82; ILEAL MUCOSA; SALMONELLA-TYPHIMURIUM; BACTERIAL-FLORA; HIGH PREVALENCE; MODEL HOST	Adherent-invasive Escherichia coli (AIEC) has been linked with the onset and perpetuation of inflammatory bowel diseases. The AIEC strain LF82 was originally isolated from an ileal biopsy from a patient with Crohn's disease. The pathogenesis of LF82 results from its abnormal adherence to and subsequent invasion of the intestinal epithelium coupled with its ability to survive phagocytosis by macrophages once it has crossed the intestinal barrier. To gain further insight into AIEC pathogenesis we employed the nematode Caenorhabditis elegans as an in vivo infection model. We demonstrate that AIEC strain LF82 forms a persistent infection in C. elegans, thereby reducing the host lifespan significantly. This host killing phenotype was associated with massive bacterial colonization of the nematode intestine and damage to the intestinal epithelial surface. C. elegans killing was independent of known LF82 virulence determinants but was abolished by deletion of the LF82 hfq gene, which encodes an RNA chaperone involved in mediating posttranscriptional gene regulation by small non-coding RNAs. This finding reveals that important aspects of LF82 pathogenesis are controlled at the posttranscriptional level by riboregulation. The role of Hfq in LF82 virulence was independent of its function in regulating RpoS and RpoE activity. Further, LF82 Delta hfq mutants were non-motile, impaired in cell invasion and highly sensitive to various chemical stress conditions, reinforcing the multifaceted function of Hfq in mediating bacterial adaptation. This study highlights the usefulness of simple non-mammalian infection systems for the identification and analysis of bacterial virulence factors.	[Simonsen, Karina T.; Nielsen, Gorm; Bjerrum, Janni Vester; Kallipolitis, Birgitte H.; Moller-Jensen, Jakob] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Kruse, Thomas] Novozymes, Bagsvaerd, Denmark	University of Southern Denmark; Novozymes	Simonsen, KT (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark.	jakobm@bmb.sdu.dk	Møller-Jensen, Jakob/AAO-8480-2020	Møller-Jensen, Jakob/0000-0002-6008-3771; Kallipolitis, Birgitte H./0000-0003-1233-9776; Kruse, Thomas/0000-0002-2619-7388	The Danish Colitis-Crohn Association; The Danish Natural Science Research Council; The Danish Council for Strategic Research	The Danish Colitis-Crohn Association; The Danish Natural Science Research Council(Det Frie Forskningsrad (DFF)); The Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by The Danish Colitis-Crohn Association, The Danish Natural Science Research Council and The Danish Council for Strategic Research. TK is affiliated with Novozymes A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Barnich N, 2007, CURR OPIN GASTROEN, V23, P16, DOI 10.1097/MOG.0b013e3280105a38; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Bringer MA, 2005, INFECT IMMUN, V73, P712, DOI 10.1128/IAI.73.2.712-721.2005; Bringer MA, 2007, J BACTERIOL, V189, P4860, DOI 10.1128/JB.00233-07; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Carvalho FA, 2008, INFLAMM BOWEL DIS, V14, P1051, DOI 10.1002/ibd.20423; Carvalho FA, 2009, J EXP MED, V206, P2179, DOI 10.1084/jem.20090741; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Darfeuille-Michaud A, 2002, INT J MED MICROBIOL, V292, P185, DOI 10.1078/1438-4221-00201; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dienst D, 2008, MICROBIOL-SGM, V154, P3134, DOI 10.1099/mic.0.2008/020222-0; Dogan B, 2008, EXPERT REV CLIN IMMU, V4, P133, DOI 10.1586/1744666X.4.2.133; Eaves-Pyles T, 2008, INT J MED MICROBIOL, V298, P397, DOI 10.1016/j.ijmm.2007.05.011; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; ISBERG RR, 1985, NATURE, V317, P262, DOI 10.1038/317262a0; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Mellies JL, 2006, INFECT IMMUN, V74, P64, DOI 10.1128/IAI.74.1.64-72.2006; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Mylonaki M, 2005, INFLAMM BOWEL DIS, V11, P481, DOI 10.1097/01.MIB.0000159663.62651.4f; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Neut C, 2002, AM J GASTROENTEROL, V97, P939, DOI 10.1111/j.1572-0241.2002.05613.x; Rolhion N, 2005, J BACTERIOL, V187, P2286, DOI 10.1128/JB.187.7.2286-2296.2005; Rolhion N, 2007, MOL MICROBIOL, V63, P1684, DOI 10.1111/j.1365-2958.2007.05638.x; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; van Asten FJAM, 2004, INT J MED MICROBIOL, V294, P395, DOI 10.1016/j.ijmm.2004.07.012; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	51	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16387	10.1371/journal.pone.0016387	http://dx.doi.org/10.1371/journal.pone.0016387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298102	gold, Green Published, Green Submitted			2022-12-25	WOS:000286662800036
J	Bartels, MD; Hansen, LH; Boye, K; Sorensen, SJ; Westh, H				Bartels, Mette Damkjaer; Hansen, Lars Hestbjerg; Boye, Kit; Sorensen, Soren J.; Westh, Henrik			An Unexpected Location of the Arginine Catabolic Mobile Element (ACME) in a USA300-Related MRSA Strain	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CASSETTE CHROMOSOME MEC; USA300; MULTIPLEX; VIRULENCE; CLONE; GENE; PCR	In methicillin resistant Staphylococcus aureus (MRSA), the arginine catabolic mobile element (ACME) was initially described in USA300 (t008-ST8) where it is located downstream of the staphylococcal cassette chromosome mec (SCCmec). A common health-care associated MRSA in Copenhagen, Denmark (t024-ST8) is clonally related to USA300 and is frequently PCR positive for the ACME specific arcA-gene. This study is the first to describe an ACME element upstream of the SCCmec in MRSA. By traditional SCCmec typing schemes, the SCCmec of t024-ST8 strain M1 carries SCCmec IVa, but full sequencing of the cassette revealed that the entire J3 region had no homology to published SCCmec IVa. Within the J3 region of M1 was a 1705 bp sequence only similar to a sequence in S. haemolyticus strain JCSC1435 and 2941 bps with no homology found in GenBank. In addition to the usual direct repeats (DR) at each extremity of SCCmec, M1 had two new DR between the orfX gene and the J3 region of the SCCmec. The region between the orfX DR (DR1) and DR2 contained the ccrAB4 genes. An ACME II-like element was located between DR2 and DR3. The entire 26,468 bp sequence between DR1 and DR3 was highly similar to parts of the ACME composite island of S. epidermidis strain ATCC12228. Sequencing of an ACME negative t024-ST8 strain (M299) showed that DR1 and the sequence between DR1 and DR3 was missing. The finding of a mobile ACME II-like element inserted downstream of orfX and upstream of SCCmec indicates a novel recombination between staphylococcal species.	[Bartels, Mette Damkjaer; Boye, Kit; Westh, Henrik] Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, DK-2650 Hvidovre, Denmark; [Hansen, Lars Hestbjerg; Sorensen, Soren J.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Westh, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Bartels, MD (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, DK-2650 Hvidovre, Denmark.	mette.damkjaer@dadlnet.dk	Sørensen, Søren Johannes/N-2120-2019; Bartels, Mette Damkjær/AAY-5809-2020; Sørensen, Søren J/J-5015-2014	Sørensen, Søren Johannes/0000-0001-6227-9906; Bartels, Mette Damkjær/0000-0002-8187-3684; Sørensen, Søren J/0000-0001-6227-9906; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Westh, Henrik/0000-0001-5681-647X				Bartels MD, 2007, EMERG INFECT DIS, V13, P1533, DOI 10.3201/eid1310.070503; Bordoni R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-464; Boye K, 2007, CLIN MICROBIOL INFEC, V13, P725, DOI 10.1111/j.1469-0691.2007.01720.x; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Heusser R, 2007, ANTIMICROB AGENTS CH, V51, P390, DOI 10.1128/AAC.00921-06; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Larsen AR, 2009, J CLIN MICROBIOL, V47, P3765, DOI 10.1128/JCM.00934-09; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miragaia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007722; Mongkolrattanothai K, 2004, ANTIMICROB AGENTS CH, V48, P1823, DOI 10.1128/AAC.48.5.1823-1836.2004; Montgomery CP, 2009, INFECT IMMUN, V77, P2650, DOI 10.1128/IAI.00256-09; Oliveira DC, 2000, ANTIMICROB AGENTS CH, V44, P1906, DOI 10.1128/AAC.44.7.1906-1910.2000; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Zhang KY, 2009, ANTIMICROB AGENTS CH, V53, P531, DOI 10.1128/AAC.01118-08	17	33	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16193	10.1371/journal.pone.0016193	http://dx.doi.org/10.1371/journal.pone.0016193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283578	gold, Green Published			2022-12-25	WOS:000286661400033
J	Grangeiro, A; Escuder, MM; Menezes, PR; Alencar, R; de Castilho, EA				Grangeiro, Alexandre; Escuder, Maria Mercedes; Menezes, Paulo Rossi; Alencar, Rosa; de Castilho, Euclides Ayres			Late Entry into HIV Care: Estimated Impact on AIDS Mortality Rates in Brazil, 2003-2006	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; UNITED-STATES; HIV-1-INFECTED PATIENTS; GENDER-DIFFERENCES; INFECTED PATIENTS; MEDICAL-CARE; SAO-PAULO; DIAGNOSIS; SURVIVAL; DELAY	Background: Worldwide, a high proportion of HIV-infected individuals enter into HIV care late. Here, our objective was to estimate the impact that late entry into HIV care has had on AIDS mortality rates in Brazil. Methodology/Principal Findings: We analyzed data from information systems regarding HIV-infected adults who sought treatment at public health care facilities in Brazil from 2003 to 2006. We initially estimated the prevalence of late entry into HIV care, as well as the probability of death in the first 12 months, the percentage of the risk of death attributable to late entry, and the number of avoidable deaths. We subsequently adjusted the annual AIDS mortality rate by excluding such deaths. Of the 115,369 patients evaluated, 50,358 (43.6%) had entered HIV care late, and 18,002 died in the first 12 months, representing a 16.5% probability of death in the first 12 months (95% CI: 16.3-16.7). By comparing patients who entered HIV care late with those who gained timely access, we found that the risk ratio for death was 49.5 (95% CI: 45.1-54.2). The percentage of the risk of death attributable to late entry was 95.5%, translating to 17,189 potentially avoidable deaths. Averting those deaths would have lowered the 2003-2006 AIDS mortality rate by 39.5%. Including asymptomatic patients with CD4(+) T cell counts >200 and <= 350 cells/mm(3) in the group who entered HIV care late increased this proportion by 1.8%. Conclusions/Significance: In Brazil, antiretroviral drugs reduced AIDS mortality by 43%. Timely entry would reduce that rate by a similar proportion, as well as resulting in a 45.2% increase in the effectiveness of the program for HIV care. The World Health Organization recommendation that asymptomatic patients with CD4(+) T cell counts <= 350 cells/mm(3) be treated would not have a significant impact on this scenario.	[Grangeiro, Alexandre; Menezes, Paulo Rossi; de Castilho, Euclides Ayres] Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil; [Escuder, Maria Mercedes] Secretaria Estado Saude Sao Paulo, Inst Saude, Sao Paulo, Brazil; [Alencar, Rosa] Secretaria Estado Saude Sao Paulo, Ctr Referencia & Treinamento DST Aids, Sao Paulo, Brazil	Universidade de Sao Paulo	Grangeiro, A (corresponding author), Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil.	ale.grangeiro@gmail.com	Menezes, Paulo R/C-9985-2010; Menezes, Paulo/AAM-3529-2021; DE CASTILHO, EUCLIDES AYRES/K-7906-2016	Menezes, Paulo R/0000-0001-6330-3314; Menezes, Paulo/0000-0001-6330-3314; Castilho, Euclides/0000-0002-7352-8784	Brazilian National Ministry of Health; Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ, German Agency for Technical Cooperation) in Brazil; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)	Brazilian National Ministry of Health; Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ, German Agency for Technical Cooperation) in Brazil; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funded by the Brazilian National Ministry of Health Sexually Transmitted Diseases and AIDS Program and by the Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ, German Agency for Technical Cooperation) in Brazil. PRM is the recipient of a scholarship from the Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development). The funders had no role in study design, data collection, data analysis, decision to publish, or manuscript preparation.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Braga P, 2007, AIDS PATIENT CARE ST, V21, P321, DOI 10.1089/apc.2006.0111; Braga PE, 2007, CAD SAUDE PUBLICA, V23, P2653, DOI 10.1590/S0102-311X2007001100013; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; *BRAZ MIN HLTH HLT, 2008, UN GEN ASS SPEC SESS; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Burns FM, 2008, AIDS, V22, P115, DOI 10.1097/QAD.0b013e3282f1d4b6; Campos DP, 2005, AIDS, V19, pS22, DOI 10.1097/01.aids.0000191486.92285.1c; CARNICERPONT D, 2006, CURRENT HIV RES, V7, P237; Chasombat S, 2009, JAIDS-J ACQ IMM DEF, V50, P506, DOI 10.1097/QAI.0b013e3181967602; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Delpierre C, 2007, INT J STD AIDS, V18, P312, DOI 10.1258/095646207780749709; DONNELL D, 2010, LANCET, DOI DOI 10.1016/SO140-6736(10)60705-2; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fonseca MGP, 2007, CAD SAUDE PUBLICA, V23, pS333, DOI 10.1590/S0102-311X2007001500002; FRANCA I, 2008, REV SAUDE PUBL S1, V42, pNI201; FUENTE L, 2009, J EPIDEMIOL COMMUNIT, V63, P552; Gonçalves Valéria Freire, 2008, Rev. bras. epidemiol., V11, P356, DOI 10.1590/S1415-790X2008000300003; Grangeiro A, 2009, CAD SAUDE PUBLICA, V25, P2053, DOI 10.1590/S0102-311X2009000900019; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Jorge Maria Helena Prado de Mello, 2007, Ciênc. saúde coletiva, V12, P643, DOI 10.1590/S1413-81232007000300014; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kelsey JL., 1996, METHODS OBSERVATIONA; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Lucena FF, 2006, CADERNOS SAUDE COLET, V14, P305; Fernandes JRM, 2009, CAD SAUDE PUBLICA, V25, P1369, DOI 10.1590/S0102-311X2009000600019; *MIN SAUD BRAS, 2000, REC TER ANT AD AD IN; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Okie S, 2006, NEW ENGL J MED, V354, P1977, DOI 10.1056/NEJMp068069; Ostermann J, 2007, ARCH INTERN MED, V167, P2128, DOI 10.1001/archinte.167.19.2128; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Fonseca MGP, 2010, CAD SAUDE PUBLICA, V26, P1431, DOI 10.1590/S0102-311X2010000700022; Reed JB, 2009, AIDS PATIENT CARE ST, V23, P765, DOI 10.1089/apc.2008.0213; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Shouse R. L., 2009, Morbidity and Mortality Weekly Report, V58, P661; Siegfried N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008272.pub2; SIGHEN V, 2005, J ACQ IMMUN DEF SYND, V40, P212; Signorelli C, 2006, EUR J PUBLIC HEALTH, V16, P498, DOI 10.1093/eurpub/ckl024; Souza PRB, 2007, CLINICS, V62, P579, DOI 10.1590/S1807-59322007000500008; Thanawuth N, 2008, AIDS CARE, V20, P43, DOI 10.1080/09540120701439303; The Strategies for Management of Antiretroviral Therapy (SMART) Study Group, 2008, JID, V197, P1133; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; Valente de Lemos K R, 2001, Cad Saude Publica, V17, P617, DOI 10.1590/S0102-311X2001000300016; *WHO JOINT UN PROG, 2009, UN ACC SCAL PRIOR HI; World Health Organization, 2009, RAP ADV ANT THER HIV; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	47	51	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e14585	10.1371/journal.pone.0014585	http://dx.doi.org/10.1371/journal.pone.0014585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712IZ	21283618	gold, Green Submitted, Green Published			2022-12-25	WOS:000286661400003
J	Kessler, H; Taubner, S; Buchheim, A; Munte, TF; Stasch, M; Kachele, H; Roth, G; Heinecke, A; Erhard, P; Cierpka, M; Wiswede, D				Kessler, Henrik; Taubner, Svenja; Buchheim, Anna; Muente, Thomas F.; Stasch, Michael; Kaechele, Horst; Roth, Gerhard; Heinecke, Armin; Erhard, Peter; Cierpka, Manfred; Wiswede, Daniel			Individualized and Clinically Derived Stimuli Activate Limbic Structures in Depression: An fMRI Study	PLOS ONE			English	Article							BRAIN ACTIVATION; MAJOR DEPRESSION; NEGATIVE AFFECT; MOOD DISORDERS; AMYGDALA; RESPONSES; FEATURES; SYSTEM; MODEL; PANAS	Objectives: In the search for neurobiological correlates of depression, a major finding is hyperactivity in limbic-paralimbic regions. However, results so far have been inconsistent, and the stimuli used are often unspecific to depression. This study explored hemodynamic responses of the brain in patients with depression while processing individualized and clinically derived stimuli. Methods: Eighteen unmedicated patients with recurrent major depressive disorder and 17 never-depressed control subjects took part in standardized clinical interviews from which individualized formulations of core interpersonal dysfunction were derived. In the patient group such formulations reflected core themes relating to the onset and maintenance of depression. In controls, formulations reflected a major source of distress. This material was thereafter presented to subjects during functional magnetic resonance imaging (fMRI) assessment. Results: Increased hemodynamic responses in the anterior cingulate cortex, medial frontal gyrus, fusiform gyrus and occipital lobe were observed in both patients and controls when viewing individualized stimuli. Relative to control subjects, patients with depression showed increased hemodynamic responses in limbic-paralimbic and subcortical regions (e.g. amygdala and basal ganglia) but no signal decrease in prefrontal regions. Conclusions: This study provides the first evidence that individualized stimuli derived from standardized clinical interviewing can lead to hemodynamic responses in regions associated with self-referential and emotional processing in both groups and limbic-paralimbic and subcortical structures in individuals with depression. Although the regions with increased responses in patients have been previously reported, this study enhances the ecological value of fMRI findings by applying stimuli that are of personal relevance to each individual's depression.	[Kessler, Henrik; Taubner, Svenja; Roth, Gerhard; Wiswede, Daniel] Hanse Inst Adv Study, Delmenhorst, Germany; [Kessler, Henrik; Kaechele, Horst; Wiswede, Daniel] Univ Ulm, Dept Psychosomat Med & Psychotherapy, Ulm, Germany; [Taubner, Svenja] Univ Kassel, Inst Social Therapy Supervis & Coaching, Kassel, Germany; [Buchheim, Anna] Univ Innsbruck, Inst Psychol, A-6020 Innsbruck, Austria; [Muente, Thomas F.] Univ Magdeburg, Dept Neuropsychol, D-39106 Magdeburg, Germany; [Stasch, Michael; Cierpka, Manfred] Heidelberg Univ, Inst Psychosomat Cooperat Res & Family Therapy, Heidelberg, Germany; [Roth, Gerhard; Erhard, Peter] Univ Bremen, Brain Res Inst, Bremen, Germany; [Heinecke, Armin] Brain Innovat, Maastricht, Netherlands; [Kessler, Henrik] Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; [Wiswede, Daniel] Univ Jena, Dept Gen Psychol 2, Jena, Germany	Ulm University; Universitat Kassel; University of Innsbruck; Otto von Guericke University; Ruprecht Karls University Heidelberg; University of Bremen; Maastricht University; University of Bonn; Friedrich Schiller University of Jena	Kessler, H (corresponding author), Hanse Inst Adv Study, Delmenhorst, Germany.	henrik.kessler@ukb.uni-bonn.de	Münte, Thomas/C-2077-2014; Taubner, Svenja/AAY-5144-2020	Taubner, Svenja/0000-0001-8058-762X; Wiswede, Daniel/0000-0002-2702-8316; Buchheim, Anna/0000-0002-1339-5246	Hanse Institute for Advanced Study, Delmenhorst; DFG; International Psychoanalytic Association	Hanse Institute for Advanced Study, Delmenhorst; DFG(German Research Foundation (DFG)); International Psychoanalytic Association	Subjects were paid by research funds from the Hanse Institute for Advanced Study, Delmenhorst. Armin Heinecke is employed by BrainInnovation, Maastricht, Netherlands, as a member of the software support team. The funder had a role in the preparation of data for publication. DW, ST and HK were fellows of the Hanse Institute for Advanced Study, Delmenhorst, during data acquisition. AB and HK were fellows of the Hanse Institute for Advanced Study during the preparation phase of the study. TM is supported by grants from the DFG. This study was supported by a research grant of the International Psychoanalytic Association. Those institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedny M, 2006, BRAIN LANG, V98, P127, DOI 10.1016/j.bandl.2006.04.008; Britton JC, 2005, BIOL PSYCHIAT, V57, P832, DOI 10.1016/j.biopsych.2004.12.025; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Camara E, 2009, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.019.2008; Canli T, 2004, NEUROREPORT, V15, P2585, DOI 10.1097/00001756-200412030-00005; Cierpka M, 2007, PSYCHOPATHOLOGY, V40, P209, DOI 10.1159/000101363; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Fitzgerald PB, 2006, PSYCHIAT RES-NEUROIM, V148, P33, DOI 10.1016/j.pscychresns.2006.04.006; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Franke G.H., 2002, SCL 90 R SYMPTOM CHE, V2nd; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Gross S, 2007, PSYCHOTHER RES, V17, P522, DOI 10.1080/10503300701320629; Hamilton JP, 2008, BIOL PSYCHIAT, V63, P1155, DOI 10.1016/j.biopsych.2007.12.015; Harvey PO, 2005, NEUROIMAGE, V26, P860, DOI 10.1016/j.neuroimage.2005.02.048; Hautzinger M, 1994, BECK DEPRESSIONS INV; Klerman GL, 1984, INTERPERSONAL PSYCHO; Kopell BH, 2008, NEUROSCI BIOBEHAV R, V32, P408, DOI 10.1016/j.neubiorev.2007.07.004; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Kumari V, 2006, ACTA NEUROPSYCHIATR, V18, P61, DOI 10.1111/j.1601-5215.2006.00127.x; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; LEMOGNE C, 2009, SOC COGN AFFECT NEUR; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; McCullough JP, 2003, J CLIN PSYCHOL, V59, P833, DOI 10.1002/jclp.10176; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; OPD Task Force, 2008, OP PSYCH DIAGN OPD 2; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Surguladze SA, 2003, NEUROIMAGE, V19, P1317, DOI 10.1016/S1053-8119(03)00085-5; Talairach J., 1988, COPLANAR STEREOTAXIC; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whalen Paul J, 2002, Semin Clin Neuropsychiatry, V7, P234, DOI 10.1053/scnp.2002.35219; WITTCHEN HU, M SKID 1 STRUKTURIER	41	45	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15712	10.1371/journal.pone.0015712	http://dx.doi.org/10.1371/journal.pone.0015712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283580	Green Published, Green Submitted, gold			2022-12-25	WOS:000286661400012
J	Chowdhury, S; Erickson, SW; MacLeod, SL; Cleves, MA; Hu, P; Karim, MA; Hobbs, CA				Chowdhury, Shimul; Erickson, Stephen W.; MacLeod, Stewart L.; Cleves, Mario A.; Hu, Ping; Karim, Mohammad A.; Hobbs, Charlotte A.			Maternal Genome-Wide DNA Methylation Patterns and Congenital Heart Defects	PLOS ONE			English	Article							GENE-ENVIRONMENT INTERACTIONS; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; CURRENT KNOWLEDGE; BIRTH-DEFECTS; RISK; EXPRESSION; HYPOMETHYLATION; FOLATE; ASSOCIATION	The majority of congenital heart defects (CHDs) are thought to result from the interaction between multiple genetic, epigenetic, environmental, and lifestyle factors. Epigenetic mechanisms are attractive targets in the study of complex diseases because they may be altered by environmental factors and dietary interventions. We conducted a population based, case-control study of genome-wide maternal DNA methylation to determine if alterations in gene-specific methylation were associated with CHDs. Using the Illumina Infinium Human Methylation27 BeadChip, we assessed maternal gene-specific methylation in over 27,000 CpG sites from DNA isolated from peripheral blood lymphocytes. Our study sample included 180 mothers with non-syndromic CHD-affected pregnancies (cases) and 187 mothers with unaffected pregnancies (controls). Using a multi-factorial statistical model, we observed differential methylation between cases and controls at multiple CpG sites, although no CpG site reached the most stringent level of genome-wide statistical significance. The majority of differentially methylated CpG sites were hypermethylated in cases and located within CpG islands. Gene Set Enrichment Analysis (GSEA) revealed that the genes of interest were enriched in multiple biological processes involved in fetal development. Associations with canonical pathways previously shown to be involved in fetal organogenesis were also observed. We present preliminary evidence that alterations in maternal DNA methylation may be associated with CHDs. Our results suggest that further studies involving maternal epigenetic patterns and CHDs are warranted. Multiple candidate processes and pathways for future study have been identified.	[Chowdhury, Shimul; Erickson, Stephen W.; MacLeod, Stewart L.; Cleves, Mario A.; Hu, Ping; Karim, Mohammad A.; Hobbs, Charlotte A.] Univ Arkansas Med Sci, Dept Pediat, Coll Med, Arkansas Childrens Hosp,Res Inst, Little Rock, AR 72205 USA	Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences	Chowdhury, S (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Coll Med, Arkansas Childrens Hosp,Res Inst, Little Rock, AR 72205 USA.	schowdhury@uams.edu	Pillay, Nischalan/F-9536-2012		National Institute for Child Health and Development [5-R01-HD039054-08]; Centers for Disease Control and Prevention [3-U50DD613236-10W1]; Arkansas Biosciences Institute; University of Arkansas for Medical Sciences College of Medicine Children's University Medical Group; CENTERS FOR DISEASE CONTROL AND PREVENTION [U50DD613236] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039054] Funding Source: NIH RePORTER	National Institute for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Arkansas Biosciences Institute; University of Arkansas for Medical Sciences College of Medicine Children's University Medical Group; CENTERS FOR DISEASE CONTROL AND PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research is supported by grants from the National Institute for Child Health and Development (5-R01-HD039054-08), the Centers for Disease Control and Prevention (3-U50DD613236-10W1), the Arkansas Biosciences Institute (the major research component of the Tobacco Settlement Proceeds Act of 2000), and the University of Arkansas for Medical Sciences College of Medicine Children's University Medical Group Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2009, AM J RESP CRIT CARE, V179; Baker JE, 2004, ANTIOXID REDOX SIGN, V6, P423, DOI 10.1089/152308604322899495; Bell CG, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-33; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Bottini E, 1998, DIS MARKERS, V14, P143, DOI 10.1155/1998/861096; Botto LD, 2007, BIRTH DEFECTS RES A, V79, P714, DOI 10.1002/bdra.20403; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Candiloro ILM, 2009, CANCER PREV RES, V2, P862, DOI 10.1158/1940-6207.CAPR-09-0056; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Chen XL, 2010, BIRTH DEFECTS RES A, V88, P575, DOI 10.1002/bdra.20670; Cooney CA, 2002, J NUTR, V132, p2393S; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Doolin MT, 2002, AM J HUM GENET, V71, P1222, DOI 10.1086/344209; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ehrlich M, 2003, J CELL BIOCHEM, V88, P899, DOI 10.1002/jcb.10464; Enquobahrie DA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-56; Feinberg AP, 2010, VIRCHOWS ARCH, V456, P13, DOI 10.1007/s00428-009-0847-2; Filkowski JN, 2010, CARCINOGENESIS, V31, P1110, DOI 10.1093/carcin/bgp300; Furness DLF, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.020; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Hobbs CA, 2005, AM J CLIN NUTR, V81, P147; Hobbs CA, 2010, OBSTET GYNECOL, V116, P316, DOI 10.1097/AOG.0b013e3181e80979; Hoyert DL, 2003, BIRTH DEFECTS RES A, V67, P651, DOI 10.1002/bdra.10117; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Joziasse IC, 2008, BASIC RES CARDIOL, V103, P216, DOI 10.1007/s00395-008-0713-4; Jugessur A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011493; Kajimoto H, 2007, CIRCULATION, V115, P1777, DOI 10.1161/CIRCULATIONAHA.106.649566; Kaynak B, 2003, CIRCULATION, V107, P2467, DOI 10.1161/01.CIR.0000066694.21510.E2; Kile ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013730; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Li DQ, 2006, J NUTR, V136, P1774, DOI 10.1093/jn/136.7.1774; Li DQ, 2005, AM J CLIN NUTR, V82, P188, DOI 10.1093/ajcn/82.1.188; Liu L, 2008, CURR ISSUES MOL BIOL, V10, P25, DOI 10.21775/cimb.010.025; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Mirabello L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-77; Mitchell LE, 2005, AM J EPIDEMIOL, V162, P676, DOI 10.1093/aje/kwi249; Morgan DK, 2008, MAMM GENOME, V19, P394, DOI 10.1007/s00335-008-9124-y; Nyirenda MJ, 2006, DIABETOLOGIA, V49, P1412, DOI 10.1007/s00125-006-0188-5; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oommen AA, 2005, J NUTR BIOCHEM, V16, P74, DOI 10.1016/j.jnutbio.2004.08.004; Ozanne SE, 2007, NAT CLIN PRACT ENDOC, V3, P539, DOI 10.1038/ncpendmet0531; Phillips HM, 2007, CIRC RES, V101, P137, DOI 10.1161/CIRCRESAHA.106.142406; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; POPLIKER M, 1987, DEV BIOL, V119, P38, DOI 10.1016/0012-1606(87)90204-1; Qing M, 2003, J AM COLL CARDIOL, V41, P2266, DOI 10.1016/S0735-1097(03)00477-7; R Core Team, 2022, R LANG ENV STAT COMP; Roy J, 2001, DIFFERENTIATION, V67, P50, DOI 10.1046/j.1432-0436.2001.067001050.x; Schleiffarth JR, 2007, PEDIATR RES, V61, P386, DOI 10.1203/pdr.0b013e3180323810; Shames DS, 2007, CURR MOL MED, V7, P85, DOI 10.2174/156652407779940413; SHAW GM, 1995, AM J MED GENET, V59, P536, DOI 10.1002/ajmg.1320590428; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun CJ, 2009, J PERINAT MED, V37, P609, DOI 10.1515/JPM.2009.103; Teschendorff AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008274; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; van Driel LMJW, 2008, OBSTET GYNECOL, V112, P277, DOI 10.1097/AOG.0b013e31817dd058; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; WOLF M, 2010, CURR OPIN CARDIOL; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Yoon PW, 2001, PUBLIC HEALTH REP, V116, P32, DOI 10.1093/phr/116.S1.32; Zhu HP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-128; 2007, J CLIN INVEST, V117, P2369	70	53	59	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16506	10.1371/journal.pone.0016506	http://dx.doi.org/10.1371/journal.pone.0016506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21297937	gold, Green Published, Green Submitted			2022-12-25	WOS:000286523400040
J	Deo, RC; Wilson, JG; Xing, C; Lawson, K; Kao, WHL; Reich, D; Tandon, A; Akylbekova, E; Patterson, N; Mosley, TH; Boerwinkle, E; Taylor, HA				Deo, Rahul C.; Wilson, James G.; Xing, Chao; Lawson, Kim; Kao, W. H. Linda; Reich, David; Tandon, Arti; Akylbekova, Ermeg; Patterson, Nick; Mosley, Thomas H., Jr.; Boerwinkle, Eric; Taylor, Herman A., Jr.			Single-Nucleotide Polymorphisms in LPA Explain Most of the Ancestry-Specific Variation in Lp(a) Levels in African Americans	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; TRANSCRIPTION-FACTOR-BINDING; ATHEROSCLEROSIS RISK; PLASMA LIPOPROTEIN(A); JACKSON HEART; APOLIPOPROTEIN(A) SIZE; CARDIOVASCULAR HEALTH; APO(A) GENE; ASSOCIATION; ISOFORMS	Lipoprotein(a) (Lp(a)) is an important causal cardiovascular risk factor, with serum Lp(a) levels predicting atherosclerotic heart disease and genetic determinants of Lp(a) levels showing association with myocardial infarction. Lp(a) levels vary widely between populations, with African-derived populations having nearly 2-fold higher Lp(a) levels than European Americans. We investigated the genetic basis of this difference in 4464 African Americans from the Jackson Heart Study (JHS) using a panel of up to 1447 ancestry informative markers, allowing us to accurately estimate the African ancestry proportion of each individual at each position in the genome. In an unbiased genome-wide admixture scan for frequency-differentiated genetic determinants of Lp(a) level, we found a convincing peak (LOD = 13.6) at 6q25.3, which spans the LPA locus. Dense fine-mapping of the LPA locus identified a number of strongly associated, common biallelic SNPs, a subset of which can account for up to 7% of the variation in Lp(a) level, as well as >70% of the African-European population differences in Lp(a) level. We replicated the association of the most strongly associated SNP, rs9457951 (p = 6x10(-22), 27% change in Lp(a) per allele, similar to 5% of Lp(a) variance explained in JHS), in 1,726 African Americans from the Dallas Heart Study and found an even stronger association after adjustment for the kringle(IV) repeat copy number. Despite the strong association with Lp(a) levels, we find no association of any LPA SNP with incident coronary heart disease in 3,225 African Americans from the Atherosclerosis Risk in Communities Study.	[Deo, Rahul C.; Reich, David; Tandon, Arti; Patterson, Nick] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02163 USA; [Deo, Rahul C.] Harvard Univ, Sch Med, Div Cardiol, Massachusetts Gen Hosp, Boston, MA USA; [Deo, Rahul C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Wilson, James G.; Akylbekova, Ermeg; Mosley, Thomas H., Jr.; Taylor, Herman A., Jr.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Xing, Chao] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; [Lawson, Kim; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX USA; [Lawson, Kim; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Kao, W. H. Linda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Reich, David; Patterson, Nick] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Akylbekova, Ermeg; Taylor, Herman A., Jr.] Jackson State Univ, Jackson, MS USA; [Taylor, Herman A., Jr.] Tougaloo Coll, Tougaloo, MS USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Jackson State University; Tougaloo College	Deo, RC (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02163 USA.	rdeo@partners.org		Xing, Chao/0000-0002-1838-0502	National Heart, Lung, and Blood Institute and the National Center on Minority Health and Health Disparities [R01 HL084107]; NIH [N01-HC-95170, N01-HC-95171, N01-HC-95172]; National Institutes of Health [T32 HL007208, K08 HL098361]; Donald W. Reynolds Foundation; NHLBI [HL082896, HL092550]; National Center for Research Resources [UL1RR024982]; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; WHLK [R21DK073482, K01DK067207]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055021, N01HC055016, N01HC055015, N01HC095171, N01HC055019, N01HC055022, N01HC095170, N01HC095172, N01HC055018] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL055018, R41HL055018, R01HL084107, R01HL082896, T32HL007208, R41HL095172, R41HL055019, RL1HL092550, K08HL098361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK067207, R21DK073482] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute and the National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)NIH National Institute on Minority Health & Health Disparities (NIMHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Foundation; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WHLK; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by the National Heart, Lung, and Blood Institute and the National Center on Minority Health and Health Disparities through R01 HL084107 to JGW and NIH contracts N01-HC-95170, N01-HC-95171, and N01-HC-95172. RCD was supported by National Institutes of Health grant T32 HL007208 and K08 HL098361. The Dallas Heart Study was supported by the Donald W. Reynolds Foundation and grants HL082896 and HL092550 from NHLBI. CX was supported by a Pilot Award from UL1RR024982 from the National Center for Research Resources. The ARIC Study was carried out as a collaborative study supported by the National Heart, Lung, and Blood Institute (NHLBI) contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021 and N01-HC-55022 with support for this analysis by R21DK073482 and K01DK067207 (WHLK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Bennet A, 2008, ARCH INTERN MED, V168, P598, DOI 10.1001/archinte.168.6.598; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Carpenter MA, 2004, AM J MED SCI, V328, P131, DOI 10.1097/00000441-200409000-00001; Chretien JP, 2006, J MED GENET, V43, P917, DOI 10.1136/jmg.2006.042119; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Danik JS, 2006, JAMA-J AM MED ASSOC, V296, P1363, DOI 10.1001/jama.296.11.1363; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Draper NR, 1998, APPL REGRESSION ANAL, P407; GAVISH D, 1989, J CLIN INVEST, V84, P2021, DOI 10.1172/JCI114395; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Guerra R, 2005, CIRCULATION, V111, P1471, DOI 10.1161/01.CIR.0000159263.50305.BD; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; Lanktree MB, 2010, CIRC-CARDIOVASC GENE, V3, P39, DOI 10.1161/CIRCGENETICS.109.907642; Marcovina SM, 1996, CLIN CHEM, V42, P436; Marcovina SM, 1996, J LIPID RES, V37, P2569; MARCOVINA SM, 1995, CLIN CHEM, V41, P246; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mooser V, 1997, AM J HUM GENET, V61, P402, DOI 10.1086/514851; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; SANDHOLZER C, 1991, HUM GENET, V86, P607; Schreiner PJ, 1996, ARTERIOSCL THROM VAS, V16, P471, DOI 10.1161/01.ATV.16.3.471; SCHREINER PJ, 1993, ARTERIOSCLER THROMB, V13, P826, DOI 10.1161/01.ATV.13.6.826; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; VANDERHOEK YY, 1993, HUM MOL GENET, V2, P361, DOI 10.1093/hmg/2.4.361; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WHITE AL, 1994, J BIOL CHEM, V269, P9060; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zhou M, 2001, AM STAT, V55, P153, DOI 10.1198/000313001750358491	40	50	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e14581	10.1371/journal.pone.0014581	http://dx.doi.org/10.1371/journal.pone.0014581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283670	gold, Green Submitted, Green Published			2022-12-25	WOS:000286523400003
J	Dou, XY; Wang, Q; Qi, ZQ; Song, WW; Wang, W; Guo, M; Zhang, HF; Zhang, ZG; Wang, P; Zheng, XB				Dou, Xianying; Wang, Qi; Qi, Zhongqiang; Song, Wenwen; Wang, Wei; Guo, Min; Zhang, Haifeng; Zhang, Zhengguang; Wang, Ping; Zheng, Xiaobo			MoVam7, a Conserved SNARE Involved in Vacuole Assembly, Is Required for Growth, Endocytosis, ROS Accumulation, and Pathogenesis of Magnaporthe oryzae	PLOS ONE			English	Article							RICE BLAST FUNGUS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; ASPERGILLUS-NIDULANS; SEQUENCE ALIGNMENT; USTILAGO-MAYDIS; FULL VIRULENCE; PX DOMAIN; T-SNARE; GRISEA	Soluble NSF attachment protein receptor (SNARE) proteins play a central role in membrane fusion and vesicle transport of eukaryotic organisms including fungi. We previously identified MoSce22 as a homolog of Saccharomyces cerevisiae SNARE protein Sec22 to be involved in growth, stress resistance, and pathogenicity of Magnaporthe oryzae. Here, we provide evidences that MoVam7, an ortholog of S. cerevisiae SNARE protein Vam7, exerts conserved functions in vacuolar morphogenesis and functions in pathogenicity of M. oryzae. Staining with neutral red and FM4-64 revealed the presence of abnormal fragmented vacuoles and an absence of the Spitzenkorper body in the Delta Movam7 mutant. The Delta Movam7 mutant also exhibited reduced vegetative growth, poor conidiation, and failure to produce the infection structure appressorium. Additionally, treatments with cell wall perturbing agents indicated weakened cell walls and altered distributions of the cell wall component chitin. Furthermore, the Delta Movam7 mutant showed a reduced accumulation of reactive oxygen species (ROS) in the hyphal apex and failed to cause diseases on the rice plant. In summary, our studies indicate that MoVam7, like MoSec22, is a component of the SNARE complex whose functions in vacuole assembly also underlies the growth, conidiation, appressorium formation, and pathogenicity of M. oryzae. Further studies of MoVam7, MoSec22, and additional members of the SNARE complex are likely to reveal critical mechanisms in vacuole formation and membrane trafficking that is linked to fungal pathogenicity.	[Dou, Xianying; Wang, Qi; Qi, Zhongqiang; Song, Wenwen; Wang, Wei; Guo, Min; Zhang, Haifeng; Zhang, Zhengguang; Zheng, Xiaobo] Nanjing Agr Univ, Key Lab Monitoring & Management Crop Dis & Pest I, Minist Agr, Nanjing, Peoples R China; [Dou, Xianying; Wang, Qi; Qi, Zhongqiang; Song, Wenwen; Wang, Wei; Guo, Min; Zhang, Haifeng; Zhang, Zhengguang; Zheng, Xiaobo] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Wang, Ping] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, New Orleans, LA USA; [Wang, Ping] Louisiana State Univ, Res Inst Children, Hlth Sci Ctr, New Orleans, LA USA	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Nanjing Agricultural University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Zhang, ZG (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	zhgzhang@njau.edu.cn	Zhang, Zhengguang/F-3917-2014		Special Fund for Agro-Scientific Research in the Public Interest [200803008]; Natural Science Foundations of China [30771394, 30971890]; Ministry of Education of China [NCET-07-0442]; US grant [NIH/NIAID AI054958]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054958] Funding Source: NIH RePORTER	Special Fund for Agro-Scientific Research in the Public Interest; Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); US grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Special Fund for Agro-Scientific Research in the Public Interest (200803008 to ZG Zhang), the Natural Science Foundations of China (30771394 and 30971890 to XB Zheng), and the New Century Excellent Scholar Project of the Ministry of Education of China (NCET-07-0442 to ZG Zhang). Research in Ping Wang's lab was partially supported by a US grant (NIH/NIAID AI054958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2001, BIOCHEM BIOPH RES CO, V287, P733, DOI 10.1006/bbrc.2001.5629; Atkinson HA, 2002, FUNGAL GENET BIOL, V37, P233, DOI 10.1016/S1087-1845(02)00535-2; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Caracuel-Rios Z, 2007, CURR OPIN MICROBIOL, V10, P339, DOI 10.1016/j.mib.2007.05.019; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Ellson CD, 2002, J CELL SCI, V115, P1099; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Fuchs U, 2006, PLANT CELL, V18, P2066, DOI 10.1105/tpc.105.039388; Fujikawa T, 2009, MOL MICROBIOL, V73, P553, DOI 10.1111/j.1365-2958.2009.06786.x; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Guo M, 2010, MOL PLANT MICROBE IN, V23, P1053, DOI 10.1094/MPMI-23-8-1053; HARRIS SD, 1994, GENETICS, V136, P517; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Harris SD, 2006, INT REV CYTOL, V251, P41, DOI 10.1016/S0074-7696(06)51002-2; Hoffmann J, 1998, FUNGAL GENET BIOL, V24, P77, DOI 10.1006/fgbi.1998.1059; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kuratsu M, 2007, FUNGAL GENET BIOL, V44, P1310, DOI 10.1016/j.fgb.2007.04.012; Lesage G, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-8; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mehrabi R, 2008, EUKARYOT CELL, V7, P791, DOI 10.1128/EC.00009-08; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; Penalva MA, 2005, FUNGAL GENET BIOL, V42, P963, DOI 10.1016/j.fgb.2005.09.004; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Pratelli J, 2004, TRENDS PLANT SCI, V9, P187, DOI 10.1016/j.tplants.2004.02.007; Sietsma JH, 1996, MICROBIOL-UK, V142, P1591, DOI 10.1099/13500872-142-7-1591; Song WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013193; Song X, 2001, BIOCHEMISTRY-US, V40, P8940, DOI 10.1021/bi0155100; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsui MMK, 2001, MOL BIOL CELL, V12, P521, DOI 10.1091/mbc.12.3.521; VALENT B, 1991, GENETICS, V127, P87; Virag A, 2006, MYCOL RES, V110, P4, DOI 10.1016/j.mycres.2005.09.005; WADA Y, 1992, J BIOL CHEM, V267, P18671; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Wedlich-Soldner R, 2000, EMBO J, V19, P1974, DOI 10.1093/emboj/19.9.1974; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zhang HF, 2010, CURR GENET, V56, P517, DOI 10.1007/s00294-010-0319-x; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x; Zheng W, 2007, EUKARYOT CELL, V6, P2240, DOI 10.1128/EC.00104-07; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402	44	70	79	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16439	10.1371/journal.pone.0016439	http://dx.doi.org/10.1371/journal.pone.0016439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283626	Green Published, gold, Green Submitted			2022-12-25	WOS:000286523400035
J	Hayward, A; Gillooly, JF				Hayward, April; Gillooly, James F.			The Cost of Sex: Quantifying Energetic Investment in Gamete Production by Males and Females	PLOS ONE			English	Article							SPERM COMPETITION; TESTIS SIZE; MAMMALS; METABOLISM; EVOLUTION; NUMBER; BIRDS	The relative energetic investment in reproduction between the sexes forms the basis of sexual selection and life history theories in evolutionary biology. It is often assumed that males invest considerably less in gametes than females, but quantifying the energetic cost of gamete production in both sexes has remained a difficult challenge. For a broad diversity of species (invertebrates, reptiles, amphibians, fishes, birds, and mammals), we compared the cost of gamete production between the sexes in terms of the investment in gonad tissue and the rate of gamete biomass production. Investment in gonad biomass was nearly proportional to body mass in both sexes, but gamete biomass production rate was approximately two to four orders of magnitude higher in females. In both males and females, gamete biomass production rate increased with organism mass as a power law, much like individual metabolic rate. This suggests that whole-organism energetics may act as a primary constraint on gamete production among species. Residual variation in sperm production rate was positively correlated with relative testes size. Together, these results suggest that understanding the heterogeneity in rates of gamete production among species requires joint consideration of the effects of gonad mass and metabolism.	[Hayward, April; Gillooly, James F.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Hayward, A (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	april.hayward@ufl.edu			University of Florida	University of Florida(University of Florida)	This work was funded by the University of Florida. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2007, OIKOS, V116, P1073, DOI 10.1111/j.2007.0030-1299.16079.x; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bokma F, 2004, FUNCT ECOL, V18, P184, DOI 10.1111/j.0269-8463.2004.00817.x; Calder WA., 1984, SIZE FUNCTION LIFE H; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GINSBERG JR, 1989, TRENDS ECOL EVOL, V4, P74, DOI 10.1016/0169-5347(89)90152-3; HAMILTON MJ, 2010, P ROYAL SOC B; Hemmingsen AM., 1960, REPORTS STENO MEM HO, V9, P1; Hosken DJ, 2001, ECOL LETT, V4, P10, DOI 10.1046/j.1461-0248.2001.00198.x; King J.R., 1973, P78; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Kokko H, 2003, TRENDS ECOL EVOL, V18, P103, DOI 10.1016/S0169-5347(03)00009-0; MCNAB BK, 1988, Q REV BIOL, V63, P25, DOI 10.1086/415715; MOLLER AP, 1991, AM NAT, V137, P882, DOI 10.1086/285199; MOLLER AP, 1989, FUNCT ECOL, V3, P91, DOI 10.2307/2389679; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P245, DOI 10.1098/rspb.1993.0110; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Salvante KG, 2010, J EXP BIOL, V213, P1991, DOI 10.1242/jeb.036319; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stockley P, 1997, AM NAT, V149, P933, DOI 10.1086/286031; Thomsen R, 2006, PRIMATES, V47, P272, DOI 10.1007/s10329-005-0171-7; Trivers R., 1972, SEXUAL SELECTION DES, P139; Vezina F, 2005, J EXP BIOL, V208, P2533, DOI 10.1242/jeb.01675	28	160	160	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16557	10.1371/journal.pone.0016557	http://dx.doi.org/10.1371/journal.pone.0016557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283632	Green Published, gold, Green Submitted			2022-12-25	WOS:000286523400042
J	Radpour, R; Barekati, Z; Kohler, C; Lv, Q; Burki, N; Diesch, C; Bitzer, J; Zheng, H; Schmid, S; Zhong, XY				Radpour, Ramin; Barekati, Zeinab; Kohler, Corina; Lv, Qing; Buerki, Nicole; Diesch, Claude; Bitzer, Johannes; Zheng, Hong; Schmid, Seraina; Zhong, Xiao Yan			Hypermethylation of Tumor Suppressor Genes Involved in Critical Regulatory Pathways for Developing a Blood-Based Test in Breast Cancer	PLOS ONE			English	Article							DNA METHYLATION; CLINICOPATHOLOGICAL FEATURES; PROMOTER HYPERMETHYLATION; PROGNOSTIC MARKER; MATERNAL PLASMA; MASS ARRAY; FETAL DNA; RAR-BETA; SERUM; PROFILE	Background: Aberrant DNA methylation patterns might be used as a biomarker for diagnosis and management of cancer patients. Methods and Findings: To achieve a gene panel for developing a breast cancer blood-based test we quantitatively assessed the DNA methylation proportion of 248 CpG sites per sample (total of 31,248 sites in all analyzed samples) on 10 candidate genes (APC, BIN1, BMP6, BRCA1, CST6, ESR-b, GSTP1, P16, P21 and TIMP3). The number of 126 samples consisting of two different cohorts was used (first cohort: plasma samples from breast cancer patients and normal controls; second cohort: triple matched samples including cancerous tissue, matched normal tissue and serum samples). In the first cohort, circulating cell free methylated DNA of the 8 tumor suppressor genes (TSGs) was significantly higher in patients with breast cancer compared to normal controls (P<0.01). In the second cohort containing triple matched samples, seven genes showed concordant hypermethylated profile in tumor tissue and serum samples compared to normal tissue (P<0.05). Using eight genes as a panel to develop a blood-based test for breast cancer, a sensitivity and specificity of more than 90% could be achieved in distinguishing between tumor and normal samples. Conclusions: Our study suggests that the selected TSG panel combined with the high-throughput technology might be a useful tool to develop epigenetic based predictive and prognostic biomarker for breast cancer relying on pathologic methylation changes in tumor tissue, as well as in circulation.	[Radpour, Ramin; Barekati, Zeinab; Kohler, Corina; Zhong, Xiao Yan] Univ Basel, Womens Hosp, Dept Biomed, Lab Gynecol Oncol, Basel, Switzerland; [Lv, Qing] Sichuan Univ, W China Sch Med, W China Hosp, Dept Breast Surg, Chengdu 610064, Peoples R China; [Bitzer, Johannes; Schmid, Seraina] Univ Basel, Dept Obstet & Gynecol, Womens Hosp, Basel, Switzerland; [Buerki, Nicole; Diesch, Claude] Kantonsspital Liestal, Dept Obstet & Gynecol, CH-4410 Liestal, Switzerland; [Zheng, Hong] Sichuan Univ, W China Sch Med, W China Hosp, Lab Mol Diag Canc,Dept Oncol,State Key Lab Biothe, Chengdu 610064, Peoples R China	University of Basel; Sichuan University; University of Basel; Kantonsspital Baselland; Sichuan University	Radpour, R (corresponding author), Univ Basel, Womens Hosp, Dept Biomed, Lab Gynecol Oncol, Basel, Switzerland.	sschmid@uhbs.ch; zhongx@uhbs.ch	; Radpour, Ramin/J-4949-2014	Buerki, Nicole/0000-0002-2625-7619; Radpour, Ramin/0000-0002-5632-7833	Swiss National Science Foundation [320000-119722/1, 320030_124958/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation (320000-119722/1 and 320030_124958/1) (http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SEER CANC STAT REV 1; Barekati Z, 2010, HUM MOL GENET, V19, P2936, DOI 10.1093/hmg/ddq199; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Dulaimi E, 2004, CLIN CANCER RES, V10, P6189, DOI 10.1158/1078-0432.CCR-04-0597; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrich M, 2008, P NATL ACAD SCI USA, V105, P4844, DOI 10.1073/pnas.0712251105; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Fackler MJ, 2004, CANCER RES, V64, P4442, DOI 10.1158/0008-5472.CAN-03-3341; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Gautschi O, 2004, J CLIN ONCOL, V22, P4157, DOI 10.1200/JCO.2004.11.123; Giacona MB, 1998, PANCREAS, V17, P89, DOI 10.1097/00006676-199807000-00012; Jahr S, 2001, CANCER RES, V61, P1659; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; LEON SA, 1977, CANCER RES, V37, P646; Li SY, 2006, CANCER LETT, V237, P272, DOI 10.1016/j.canlet.2005.06.011; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Muller HM, 2003, CANCER RES, V63, P7641; Parrella P, 2004, CLIN CANCER RES, V10, P5349, DOI 10.1158/1078-0432.CCR-04-0555; Radpour R, 2009, ONCOGENE, V28, P2969, DOI 10.1038/onc.2009.149; Radpour R, 2008, MOL CANCER RES, V6, P1702, DOI 10.1158/1541-7786.MCR-08-0262; Radpour R, 2010, MODERN PATHOL, V23, P763, DOI 10.1038/modpathol.2009.195; Radpour R, 2009, J PROTEOME RES, V8, P5264, DOI 10.1021/pr900591w; Radpour R, 2009, GENET TEST MOL BIOMA, V13, P565, DOI 10.1089/gtmb.2009.0060; Shinozaki M, 2005, CLIN CANCER RES, V11, P2156, DOI 10.1158/1078-0432.CCR-04-1810; Shukla S, 2006, EPIGENETICS-US, V1, P88, DOI 10.4161/epi.1.2.2679; SUNAMI EVA, 2009, ANAL METHYLATED CIRC, P349; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tao MH, 2009, BREAST CANCER RES TR, V114, P559, DOI 10.1007/s10549-008-0028-z; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Wong TS, 2004, CLIN CANCER RES, V10, P2401, DOI 10.1158/1078-0432.CCR-03-0139; Zhong Xiao Yan, 2007, Archives of Gynecology and Obstetrics, V276, P327, DOI 10.1007/s00404-007-0345-1	35	101	112	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16080	10.1371/journal.pone.0016080	http://dx.doi.org/10.1371/journal.pone.0016080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283676	Green Submitted, gold, Green Published			2022-12-25	WOS:000286523400015
J	Gibert, Y; Lattanzi, VJ; Zhen, AW; Vedder, L; Brunet, F; Faasse, SA; Babitt, JL; Lin, HY; Hammerschmidt, M; Fraenkel, PG				Gibert, Yann; Lattanzi, Victoria J.; Zhen, Aileen W.; Vedder, Lea; Brunet, Frederic; Faasse, Sarah A.; Babitt, Jodie L.; Lin, Herbert Y.; Hammerschmidt, Matthias; Fraenkel, Paula G.			BMP Signaling Modulates Hepcidin Expression in Zebrafish Embryos Independent of Hemojuvelin	PLOS ONE			English	Article							IRON OVERLOAD; SOLUBLE HEMOJUVELIN; SEQUENCE ALIGNMENT; MEMBRANE; MODEL; GENE; FERROPORTIN1; CLEAVAGE; MUTANTS; DEFECTS	Hemojuvelin (Hjv), a member of the repulsive-guidance molecule (RGM) family, upregulates transcription of the iron regulatory hormone hepcidin by activating the bone morphogenetic protein (BMP) signaling pathway in mammalian cells. Mammalian models have identified furin, neogenin, and matriptase-2 as modifiers of Hjv's function. Using the zebrafish model, we evaluated the effects of hjv and its interacting proteins on hepcidin expression during embryonic development. We found that hjv is strongly expressed in the notochord and somites of the zebrafish embryo and that morpholino knockdown of hjv impaired the development of these structures. Knockdown of hjv or other hjv-related genes, including zebrafish orthologs of furin or neogenin, however, failed to decrease hepcidin expression relative to liver size. In contrast, overexpression of bmp2b or knockdown of matriptase-2 enhanced the intensity and extent of hepcidin expression in zebrafish embryos, but this occurred in an hjv-independent manner. Furthermore, we demonstrated that zebrafish hjv can activate the human hepcidin promoter and enhance BMP responsive gene expression in vitro, but is expressed at low levels in the zebrafish embryonic liver. Taken together, these data support an alternative mechanism for hepcidin regulation during zebrafish embryonic development, which is independent of hjv.	[Gibert, Yann; Lattanzi, Victoria J.; Zhen, Aileen W.; Vedder, Lea; Fraenkel, Paula G.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Gibert, Yann; Lattanzi, Victoria J.; Zhen, Aileen W.; Vedder, Lea; Fraenkel, Paula G.] Harvard Univ, Sch Med, Boston, MA USA; [Brunet, Frederic] Ecole Normale Super, Inst Genom Fonct Lyon, Lyon, France; [Faasse, Sarah A.; Babitt, Jodie L.; Lin, Herbert Y.] Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Boston, MA 02114 USA; [Hammerschmidt, Matthias] Univ Cologne, Inst Dev Biol, Cologne, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Harvard University; Massachusetts General Hospital; University of Cologne	Gibert, Y (corresponding author), Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA.	pfraenke@bidmc.harvard.edu		Fraenkel, Paula/0000-0001-8894-0117; Brunet, Frederic/0000-0001-5145-8925	NIH [K08 DK061685, 3P30 DK034854-24S1, K08 DK075846, R01 DK087727, R01 DK071837, R01 DK069533]; Cooley's Anemia Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087727, R01DK071837, P30DK034854, K08DK061685, K08DK075846, R01DK069533] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cooley's Anemia Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH K08 DK061685 (P.G.F.), 3P30 DK034854-24S1 (P.G.F.), K08 DK075846 (J.L.B.), R01 DK087727 (J.L.B), R01 DK071837 (H.Y.L.), R01 DK069533 (H.Y.L) and the Cooley's Anemia Foundation (P.G.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; ARNDT S, 2009, GASTROENTEROLOGY; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Camberlein E, 2007, HAEMATOLOGICA, V93, P111, DOI 10.3324/haematol.11656; Chocron S, 2007, DEV BIOL, V305, P577, DOI 10.1016/j.ydbio.2007.03.001; De Domenico I, 2007, BLOOD, V110, P3780, DOI 10.1182/blood-2007-07-100248; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fraenkel PG, 2009, BLOOD, V113, P2843, DOI 10.1182/blood-2008-06-165340; Fraenkel PG, 2005, J CLIN INVEST, V115, P1532, DOI 10.1172/JCI23780; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Kattamis A, 2006, HAEMATOLOGICA, V91, P809; KAUTZ L, 2010, HAEMATOLOGICA; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Krijt J, 2004, BLOOD, V104, P4308, DOI 10.1182/blood-2004-06-2422; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Lumsden AL, 2007, HUM MOL GENET, V16, P1905, DOI 10.1093/hmg/ddm138; Mawdsley DJ, 2004, DEV BIOL, V269, P302, DOI 10.1016/j.ydbio.2004.02.001; Mayer AN, 2003, DEVELOPMENT, V130, P3917, DOI 10.1242/dev.00600; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; NUSSLEINVOLHARD C, 2005, ZEBRAFISH PRACTICAL, P68; NUSSLEINVOLHARD C, 2005, ZEBRAFISH PRACTICAL, P45; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Parkin CA, 2009, INT J DEV BIOL, V53, P45, DOI 10.1387/ijdb.082669cp; Ransom DG, 1996, DEVELOPMENT, V123, P311; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Schmidtmer J, 2004, GENE EXPR PATTERNS, V4, P105, DOI 10.1016/S1567-133X(03)00144-3; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thisse B., 2001, R01RR15402 NIH ZFIN; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Truksa J, 2009, BRIT J HAEMATOL, V147, P571, DOI 10.1111/j.1365-2141.2009.07873.x; Walker MB, 2006, DEV BIOL, V295, P194, DOI 10.1016/j.ydbio.2006.03.028; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Wingert RA, 2004, DEVELOPMENT, V131, P6225, DOI 10.1242/dev.01540; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200	60	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14553	10.1371/journal.pone.0014553	http://dx.doi.org/10.1371/journal.pone.0014553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283739	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522300003
J	Hsu, RJ; Hsiao, KM; Lin, MJ; Li, CY; Wang, LC; Chen, LK; Pan, HC				Hsu, Ren-Jun; Hsiao, Kuang-Ming; Lin, Min-Jon; Li, Chui-Yen; Wang, Li-Chun; Chen, Luen-Kui; Pan, Huichin			Long Tract of Untranslated CAG Repeats Is Deleterious in Transgenic Mice	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; FRAGILE-X PREMUTATION; EXPANDED CTG REPEATS; MYOTONIC-DYSTROPHY; TRINUCLEOTIDE REPEAT; SKELETAL-MUSCLE; CUG REPEATS; MEDIATED NEURODEGENERATION; DROSOPHILA MODEL; BINDING PROTEIN	The most frequent trinucleotide repeat found in human disorders is the CAG sequence. Expansion of CAG repeats is mostly found in coding regions and is thought to cause diseases through a protein mechanism. Recently, expanded CAG repeats were shown to induce toxicity at the RNA level in Drosophila and C. elegans. These findings raise the possibility that CAG repeats may trigger RNA-mediated pathogenesis in mammals. Here, we demonstrate that transgenic mice expressing EGFP transcripts with long CAG repeats in the 39 untranslated region develop pathogenic features. Expression of the transgene was directed to the muscle in order to compare the resulting phenotype to that caused by the CUG expansion, as occurs in myotonic dystrophy. Transgenic mice expressing 200, but not those expressing 0 or 23 CAG repeats, showed alterations in muscle morphology, histochemistry and electrophysiology, as well as abnormal behavioral phenotypes. Expression of the expanded CAG repeats in testes resulted in reduced fertility due to defective sperm motility. The production of EGFP protein was significantly reduced by the 200 CAG repeats, and no polyglutamine-containing product was detected, which argues against a protein mechanism. Moreover, nuclear RNA foci were detected for the long CAG repeats. These data support the notion that expanded CAG repeat RNA can cause deleterious effects in mammals. They also suggest the possible involvement of an RNA mechanism in human diseases with long CAG repeats.	[Hsu, Ren-Jun; Li, Chui-Yen] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hsiao, Kuang-Ming] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Lin, Min-Jon; Wang, Li-Chun; Chen, Luen-Kui; Pan, Huichin] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Pan, Huichin] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; National Chung Cheng University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Hsu, RJ (corresponding author), Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan.	hp29@csmu.edu.tw			National Science Council of Taiwan [NSC91-2320-B040-034, NSC92-2320-B040-046, NSC93-2320-B040-054, NSC94-2320-B040-045, NSC95-2320-B040-040-MY2]; National Science Council; Ministry of Education	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education	This work was supported by grants NSC91-2320-B040-034, NSC92-2320-B040-046, NSC93-2320-B040-054, NSC94-2320-B040-045 and NSC95-2320-B040-040-MY2 from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. S. Noguchi for kindly providing the plasmid 5'gsg-EGFP, and Dr. M. Hsieh for mutant ataxin-3 expressing cells and the anti-polyglutamine monoclonal antibody. We also thank Dr. H. Li and IMB Transgenic Core Facility (Academia Sinica) for assistance in microinjection of the transgenes. Confocal microscopy and flow cytometry were performed in the Instrument Center of Chung Shan Medical University, which is supported by National Science Council and Ministry of Education.	Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Arenas J, 1998, ANN NEUROL, V43, P397, DOI 10.1002/ana.410430321; AUGER J, 1993, J HISTOCHEM CYTOCHEM, V41, P1247, DOI 10.1177/41.8.8331289; Bando Y, 2005, NEUROCHEM INT, V46, P11, DOI 10.1016/j.neuint.2004.07.005; BULBRING E, 1946, BRIT J PHARM CHEMOTH, V1, P38; CASH K, 1994, LAB HISTOPATHOLOGY C, P7; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Chen KY, 2007, BIOCHEM BIOPH RES CO, V352, P774, DOI 10.1016/j.bbrc.2006.11.102; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Hsiao KM, 1999, J CLIN LAB ANAL, V13, P188, DOI 10.1002/(SICI)1098-2825(1999)13:4<188::AID-JCLA8>3.0.CO;2-G; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Jasinska A, 2003, NUCLEIC ACIDS RES, V31, P5463, DOI 10.1093/nar/gkg767; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; McLaughlin BA, 1996, AM J HUM GENET, V59, P561; McLeod CJ, 2005, HUM MOL GENET, V14, P1041, DOI 10.1093/hmg/ddi096; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Michlewski G, 2004, J MOL BIOL, V340, P665, DOI 10.1016/j.jmb.2004.05.021; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Noguchi S, 2001, FEBS LETT, V495, P77, DOI 10.1016/S0014-5793(01)02368-7; ONO S, 1986, J NEUROL SCI, V74, P247, DOI 10.1016/0022-510X(86)90110-3; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Osborne RJ, 2006, HUM MOL GENET, V15, pR162, DOI 10.1093/hmg/ddl181; Peel AL, 2001, HUM MOL GENET, V10, P1531, DOI 10.1093/hmg/10.15.1531; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Ranum LPW, 2004, TRENDS GENET, V20, P506, DOI 10.1016/j.tig.2004.08.004; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Siciliano G, 2001, BRAIN RES BULL, V56, P405, DOI 10.1016/S0361-9230(01)00653-0; Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tian B, 2000, RNA, V6, P79, DOI 10.1017/S1355838200991544; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Troiano L, 1998, EXP CELL RES, V241, P384, DOI 10.1006/excr.1998.4064; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Turner C, 2007, MOVEMENT DISORD, V22, P1715, DOI 10.1002/mds.21540; WANG LC, 2010, CELL MOL LI IN PRESS; Wheeler TM, 2007, CURR OPIN NEUROL, V20, P572, DOI 10.1097/WCO.0b013e3282ef6064; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	65	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16417	10.1371/journal.pone.0016417	http://dx.doi.org/10.1371/journal.pone.0016417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283659	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522300044
J	Huege, J; Goetze, J; Schwarz, D; Bauwe, H; Hagemann, M; Kopka, J				Huege, Jan; Goetze, Jan; Schwarz, Doreen; Bauwe, Hermann; Hagemann, Martin; Kopka, Joachim			Modulation of the Major Paths of Carbon in Photorespiratory Mutants of Synechocystis	PLOS ONE			English	Article							METABOLIC FLUX ANALYSIS; SP STRAIN PCC-6803; MASS-SPECTROMETRY; GAS-CHROMATOGRAPHY; WILD-TYPE; CYCLE; CYANOBACTERIA; MICROORGANISMS; PURIFICATION; ARABIDOPSIS	Background: Recent studies using transcript and metabolite profiles of wild-type and gene deletion mutants revealed that photorespiratory pathways are essential for the growth of Synechocystis sp. PCC 6803 under atmospheric conditions. Pool size changes of primary metabolites, such as glycine and glycolate, indicated a link to photorespiration. Methodology/Principal Findings: The (13)C labelling kinetics of primary metabolites were analysed in photoautotrophically grown cultures of Synechocystis sp. PCC 6803 by gas chromatography-mass spectrometry (GC-MS) to demonstrate the link with photorespiration. Cells pre-acclimated to high CO(2) (5%, HC) or limited CO(2) (0.035%, LC) conditions were pulse-labelled under very high (2% w/w) (13)C-NaHCO(3) (VHC) conditions followed by treatment with ambient (12)C at HC and LC conditions, respectively. The (13)C enrichment, relative changes in pool size, and (13)C flux of selected metabolites were evaluated. We demonstrate two major paths of CO(2) assimilation via Rubisco in Synechocystis, i.e., from 3PGA via PEP to aspartate, malate and citrate or, to a lesser extent, from 3PGA via glucose-6-phosphate to sucrose. The results reveal evidence of carbon channelling from 3PGA to the PEP pool. Furthermore, (13)C labelling of glycolate was observed under conditions thought to suppress photorespiration. Using the glycolate-accumulating Delta glcD1 mutant, we demonstrate enhanced (13)C partitioning into the glycolate pool under conditions favouring photorespiration and enhanced (13)C partitioning into the glycine pool of the glycine-accumulating Delta gcvT mutant. Under LC conditions, the photorespiratory mutants Delta glcD1 and Delta gcvT showed enhanced activity of the additional carbon-fixing PEP carboxylase pathway. Conclusions/Significance: With our approach of non-steady-state (13)C labelling and analysis of metabolite pool sizes with respective (13)C enrichments, we identify the use and modulation of major pathways of carbon assimilation in Synechocystis in the presence of high and low inorganic carbon supplies.	[Huege, Jan] Leibniz Inst Plant Genet & Crop Plant Res, Dept Physiol & Cell Biol, Gatersleben, Germany; [Goetze, Jan] Univ Potsdam, Dept Chem, Potsdam, Germany; [Schwarz, Doreen; Bauwe, Hermann; Hagemann, Martin] Univ Rostock, Dept Plant Physiol, Rostock, Germany; [Kopka, Joachim] Max Planck Inst Mol Plant Physiol, Dept Mol Physiol, Potsdam, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Potsdam; University of Rostock; Max Planck Society	Huege, J (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res, Dept Physiol & Cell Biol, Gatersleben, Germany.	Kopka@mpimp-golm.mpg.de	Götze, Jan/N-4922-2016; Götze, Jan Philipp/AAS-2821-2020	Götze, Jan/0000-0003-2211-2057; Götze, Jan Philipp/0000-0003-2211-2057; Schwarz, Doreen/0000-0002-1071-5865; Kopka, Joachim/0000-0001-9675-4883	DFG (Deutsche Forschungsgemeinschaft); Max Planck Society; Bundesministerium fur Bildung und Forschung (BMBF) [FOOD-CT-2006-036220]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported by a grant from the DFG (Deutsche Forschungsgemeinschaft) to M.H. and J.K. and by the Max Planck Society. The development of the CORRECTOR software tool was supported in part by the European META-PHOR project, FOOD-CT-2006-036220, and the GoFORSYS project (http://www.goforsys.de/) funded by the Bundesministerium fur Bildung und Forschung (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, MOL PLANT, V2, P32, DOI 10.1093/mp/ssn075; Allwood JW, 2009, METABOLOMICS, V5, P479, DOI 10.1007/s11306-009-0169-z; Bauwe H, 2010, BIOCHEM SOC T, V38, P677, DOI 10.1042/BST0380677; CALVIN M, 1956, J CHEM SOC, P1895, DOI 10.1039/jr9560001895; CALVIN M, 1961, NOBEL LECT CHEM 1942, P618; Cegelski L, 2006, J MAGN RESON, V178, P1, DOI 10.1016/j.jmr.2005.10.010; COLMAN B, 1989, AQUAT BOT, V34, P211, DOI 10.1016/0304-3770(89)90057-0; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; DOHLER G, 1974, PLANTA, V118, P259, DOI 10.1007/BF00384781; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; Eisenhut M, 2006, PLANT PHYSIOL, V142, P333, DOI 10.1104/pp.106.082982; Eisenhut M, 2008, PLANT PHYSIOL, V148, P2109, DOI 10.1104/pp.108.129403; Erban Alexander, 2007, V358, P19, DOI 10.1007/978-1-59745-244-1_2; Hagemann M, 2005, PLANT BIOLOGY, V7, P15, DOI 10.1055/s-2004-830445; Huege J, 2007, PHYTOCHEMISTRY, V68, P2258, DOI 10.1016/j.phytochem.2007.03.026; Hummel J, 2010, METABOLOMICS, V6, P322, DOI 10.1007/s11306-010-0198-7; HUSIC DW, 1987, CRIT REV PLANT SCI, V5, P45, DOI 10.1080/07352688709382234; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; KELLY GJ, 1977, PLANT PHYSIOL, V60, P295, DOI 10.1104/pp.60.2.295; Knoll Andrew H., 2008, P1; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Krall L, 2009, J CHROMATOGR B, V877, P2952, DOI 10.1016/j.jchromb.2009.07.006; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Maheswaran M, 2006, J BACTERIOL, V188, P2730, DOI 10.1128/JB.188.7.2730-2734.2006; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; NORMAN EG, 1991, PLANT PHYSIOL, V95, P693, DOI 10.1104/pp.95.3.693; Ratcliffe RG, 2006, PLANT J, V45, P490, DOI 10.1111/j.1365-313X.2005.02649.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roessner-Tunali U, 2004, PLANT J, V39, P668, DOI 10.1111/j.1365-313X.2004.02157.x; Schauer N, 2005, J EXP BOT, V56, P297, DOI 10.1093/jxb/eri057; Shastri AA, 2007, PHYTOCHEMISTRY, V68, P2302, DOI 10.1016/j.phytochem.2007.03.042; Somerville CR, 2001, PLANT PHYSIOL, V125, P20, DOI 10.1104/pp.125.1.20; Tabita FR, 2009, P NATL ACAD SCI USA, V106, P21015, DOI 10.1073/pnas.0912486107; TABITA FR, 1988, MICROBIOL REV, V52, P155, DOI 10.1128/MMBR.52.2.155-189.1988; Tolbert NE, 1997, ANNU REV PLANT PHYS, V48, P1, DOI 10.1146/annurev.arplant.48.1.1; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Wittmann C, 1999, BIOTECHNOL BIOENG, V62, P739, DOI 10.1002/(SICI)1097-0290(19990320)62:6<739::AID-BIT13>3.0.CO;2-E; WOLFE RR, 2004, ISOTOPE TRACERS META, P21; Yang C, 2002, METAB ENG, V4, P202, DOI 10.1006/mben.2002.0226	40	65	66	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16278	10.1371/journal.pone.0016278	http://dx.doi.org/10.1371/journal.pone.0016278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283704	Green Published, gold			2022-12-25	WOS:000286522300029
J	Gu, WD; Muller, G; Schlein, Y; Novak, RJ; Beier, JC				Gu, Weidong; Mueller, Guenter; Schlein, Yosef; Novak, Robert J.; Beier, John C.			Natural Plant Sugar Sources of Anopheles Mosquitoes Strongly Impact Malaria Transmission Potential	PLOS ONE			English	Article							INOCULATION RATES; SAND FLIES; POPULATIONS; PARAMETERS; SERGENTII; VECTORS; ECOLOGY; AFRICA	An improved knowledge of mosquito life history could strengthen malaria vector control efforts that primarily focus on killing mosquitoes indoors using insecticide treated nets and indoor residual spraying. Natural sugar sources, usually floral nectars of plants, are a primary energy resource for adult mosquitoes but their role in regulating the dynamics of mosquito populations is unclear. To determine how the sugar availability impacts Anopheles sergentii populations, mark-release-recapture studies were conducted in two oases in Israel with either absence or presence of the local primary sugar source, flowering Acacia raddiana trees. Compared with population estimates from the sugar-rich oasis, An. sergentii in the sugar-poor oasis showed smaller population size (37,494 vs. 85,595), lower survival rates (0.72 vs. 0.93), and prolonged gonotrophic cycles (3.33 vs. 2.36 days). The estimated number of females older than the extrinsic incubation period of malaria (10 days) in the sugar rich site was 4 times greater than in the sugar poor site. Sugar feeding detected in mosquito guts in the sugar-rich site was significantly higher (73%) than in the sugar-poor site (48%). In contrast, plant tissue feeding (poor quality sugar source) in the sugar-rich habitat was much less (0.3%) than in the sugar-poor site (30%). More important, the estimated vectorial capacity, a standard measure of malaria transmission potential, was more than 250-fold higher in the sugar-rich oasis than that in the sugar-poor site. Our results convincingly show that the availability of sugar sources in the local environment is a major determinant regulating the dynamics of mosquito populations and their vector potential, suggesting that control interventions targeting sugar-feeding mosquitoes pose a promising tactic for combating transmission of malaria parasites and other pathogens.	[Gu, Weidong; Novak, Robert J.] Univ Alabama Birmingham, Sch Med, Div Infect Dis, Birmingham, AL 35294 USA; [Mueller, Guenter; Schlein, Yosef] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Fac Med, IMRIC,Kuvin Ctr Study Infect & Trop Dis, Jerusalem, Israel; [Beier, John C.] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Ctr Global Hlth Sci, Miami, FL 33136 USA	University of Alabama System; University of Alabama Birmingham; Hebrew University of Jerusalem; University of Miami	Gu, WD (corresponding author), Univ Alabama Birmingham, Sch Med, Div Infect Dis, Birmingham, AL 35294 USA.	wgu@uab.edu			Bill and Melinda Gates Foundation [47302]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This project was supported by the Bill and Melinda Gates Foundation (grant 47302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, INS TREAT MOSQ NETS; AUCLAIR JL, 1963, ANNU REV ENTOMOL, V8, P439, DOI 10.1146/annurev.en.08.010163.002255; BEIER MS, 1987, J AM MOSQUITO CONTR, V3, P266; Buonaccorsi JP, 2003, J MED ENTOMOL, V40, P6, DOI 10.1603/0022-2585-40.1.6; Chambers RG, 2008, LANCET, V371, P1399, DOI 10.1016/S0140-6736(08)60609-1; Corbet S. A., 1979, Plant Cell and Environment, V2, P293, DOI 10.1111/j.1365-3040.1979.tb00084.x; DYE C, 1986, Parasitology Today, V2, P203; FARID M. A., 1956, BULL WORLD HEALTH ORGAN, V15, P821; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; GARRETTJ.C, 1964, B WORLD HEALTH ORGAN, V31, P71; Gu WD, 2005, AM J TROP MED HYG, V73, P546, DOI 10.4269/ajtmh.2005.73.546; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Gu WD, 2009, T ROY SOC TROP MED H, V103, P1105, DOI 10.1016/j.trstmh.2009.01.006; KASTEN FH, 1980, METHODS FLUORESCENCE; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2001, T ROY SOC TROP MED H, V95, P469, DOI 10.1016/S0035-9203(01)90005-7; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Muller G, 2006, INT J PARASITOL, V36, P1077, DOI 10.1016/j.ijpara.2006.06.008; Muller GC, 2008, J AM MOSQUITO CONTR, V24, P147, DOI 10.2987/8756-971X(2008)24[147:DOASAA]2.0.CO;2; Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-210; Muller G, 2005, MED VET ENTOMOL, V19, P413, DOI 10.1111/j.1365-2915.2005.00590.x; Parida AK, 2004, AQUAT BOT, V80, P77, DOI 10.1016/j.aquabot.2004.07.005; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; SCHLEIN Y, 1995, J MED ENTOMOL, V32, P882, DOI 10.1093/jmedent/32.6.882; SCHLEIN Y, 1994, AM J TROP MED HYG, V50, P20, DOI 10.4269/ajtmh.1994.50.1.TM0500010020; Schlein Y, 2008, J MED ENTOMOL, V45, P384, DOI 10.1603/0022-2585(2008)45[384:AATMCU]2.0.CO;2; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Team RDC, 2019, R LANG ENV STAT COMP; Tracy CR, 2006, INTEGR COMP BIOL, V46, P1191, DOI 10.1093/icb/icl054; VANHANDE.E, 1972, MOSQ NEWS, V32, P458; VANHANDEL E, 1968, ANAL BIOCHEM, V22, P280, DOI 10.1016/0003-2697(68)90317-5; *WHO, 2004, WHOCDSCPEPVC20041011; World Health Organisation, 2008, WKLY EPIDEMIOL REC, V83, P177; Yuval B., 1992, Bulletin of the Society for Vector Ecology, V17, P150; ZAHAR AR, 1974, B WORLD HEALTH ORGAN, V50, P427; ZOHARY M., 1949, PALESTINE JOUR BOT JERUSALEM SER, V4, P177	36	85	87	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15996	10.1371/journal.pone.0015996	http://dx.doi.org/10.1371/journal.pone.0015996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283732	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522200022
J	Johnson, JR; Roos, A; Berg, T; Nord, M; Fuxe, J				Johnson, Jill R.; Roos, Abraham; Berg, Tove; Nord, Magnus; Fuxe, Jonas			Chronic Respiratory Aeroallergen Exposure in Mice Induces Epithelial-Mesenchymal Transition in the Large Airways	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; MAMMARY CARCINOMAS; IMMUNE-RESPONSES; INFLAMMATION; CELLS; ALLIANCE; PATHWAYS; EMT	Chronic allergic asthma is characterized by Th2-polarized inflammation and leads to airway remodeling and fibrosis but the mechanisms involved are not clear. To determine whether epithelial-mesenchymal transition contributes to airway remodeling in asthma, we induced allergic airway inflammation in mice by intranasal administration of house dust mite (HDM) extract for up to 15 consecutive weeks. We report that respiratory exposure to HDM led to significant airway inflammation and thickening of the smooth muscle layer in the wall of the large airways. Transforming growth factor beta-1 (TGF-beta 1) levels increased in mouse airways while epithelial cells lost expression of E-cadherin and occludin and gained expression of the mesenchymal proteins vimentin, alpha-smooth muscle actin (alpha-SMA) and pro-collagen I. We also observed increased expression and nuclear translocation of Snail1, a transcriptional repressor of E-cadherin and a potent inducer of EMT, in the airway epithelial cells of HDM-exposed mice. Furthermore, fate-mapping studies revealed migration of airway epithelial cells into the sub-epithelial regions of the airway wall. These results show the contribution of EMT to airway remodeling in chronic asthma-like inflammation and suggest that Th2-polarized airway inflammation can trigger invasion of epithelial cells into the subepithelial regions of the airway wall where they contribute to fibrosis, demonstrating a previously unknown plasticity of the airway epithelium in allergic airway disease.	[Johnson, Jill R.; Berg, Tove; Fuxe, Jonas] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden; [Roos, Abraham; Nord, Magnus] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Med, Div Resp Med,Lung Res Lab, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Johnson, JR (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden.	jonas.fuxe@ki.se	Fuxe, Jonas/T-4433-2017; berg, tove/H-9916-2012	Fuxe, Jonas/0000-0003-4576-9377; Johnson, Jill/0000-0002-5149-0084	Swedish Research Council [2008-2598]; Swedish Childhood Cancer Foundation [PROJ08/108]; Swedish Cancer Society [CAN 2009/1211]; Swedish Wenner-Gren Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Wenner-Gren Foundations	J.F. was supported by grants from The Swedish Research Council (2008-2598), the Swedish Childhood Cancer Foundation (PROJ08/108), the Swedish Cancer Society (CAN 2009/1211). J.R.J. was supported by the Swedish Wenner-Gren Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron Celine, 2009, Proc Am Thorac Soc, V6, P301, DOI 10.1513/pats.200808-089RM; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Fattouh R, 2008, AM J RESP CRIT CARE, V177, P593, DOI 10.1164/rccm.200706-958OC; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Grande M, 2002, J CELL SCI, V115, P4227, DOI 10.1242/jcs.00091; Hackett TL, 2007, CURR OPIN ALLERGY CL, V7, P63, DOI 10.1097/ACI.0b013e328013d61b; Heijink IH, 2010, AM J RESP CELL MOL, V42, P69, DOI 10.1165/rcmb.2008-0449OC; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Johansson M, 2008, IMMUNOL REV, V222, P145, DOI 10.1111/j.1600-065X.2008.00600.x; Johnson JR, 2007, AM J PHYSIOL-LUNG C, V293, pL730, DOI 10.1152/ajplung.00056.2007; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kariyawasam HH, 2009, J ALLERGY CLIN IMMUN, V124, P454, DOI 10.1016/j.jaci.2009.06.022; Llop-Guevara A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002426; Lloyd CM, 2010, NAT MED, V16, P273, DOI 10.1038/nm0310-273; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Saunders R, 2009, J ALLERGY CLIN IMMUN, V123, P376, DOI 10.1016/j.jaci.2008.10.048; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V377, P622, DOI 10.1016/j.bbrc.2008.10.018; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wan H, 2000, CLIN EXP ALLERGY, V30, P685, DOI 10.1046/j.1365-2222.2000.00820.x; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004	35	90	99	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16175	10.1371/journal.pone.0016175	http://dx.doi.org/10.1371/journal.pone.0016175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283768	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000286522200032
J	Kring, SII; Barefoot, J; Brummett, BH; Boyle, SH; Siegler, IC; Toubro, S; Hansen, T; Astrup, A; Pedersen, O; Williams, RB; Sorensen, TIA				Kring, Sofia I. Iqbal; Barefoot, John; Brummett, Beverly H.; Boyle, Stephen H.; Siegler, Ilene C.; Toubro, Soren; Hansen, Torben; Astrup, Arne; Pedersen, Oluf; Williams, Redford B.; Sorensen, Thorkild I. A.			Associations between APOE Variants and Metabolic Traits and the Impact of Psychological Stress	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; SLEEP QUALITY; BODY-WEIGHT; OBESITY; RISK; RESISTANCE; GENOTYPE; MEN	Objective: In a previous study, we observed that associations between APOE rs439401 and metabolic traits were moderated by chronic stress. Thus, in a population of stressed and non-stressed Danish men, we examined whether associations between APOE rs439401 and a panel of metabolic quantitative traits, all metabolic traits which may lead to T2D and CVD were moderated by psychological stress. Methods: Obese young men (n = 475, BMI >= 31.0 kg/m(2)) and a randomly selected control group (n = 709) identified from a population of 141,800 men were re-examined in two surveys (S-46: mean age 46, S-49: mean age 49 years) where anthropometric and biochemical measures were available. Psychological stress factors were assessed by a self-administered 7-item questionnaire. Each item had the possible response categories "yes" and "no" and assessed familial problems and conflicts. Summing positive responses constituted a stress item score, which was then dichotomized into stressed and non-stressed. Logistic regression analysis, applying a recessive genetic model, was used to assess odds ratios (OR) of the associations between APOE rs439401 genotypes and adverse levels of metabolic traits. Results: The APOE rs439401 TT-genotype associated positively with BMI (OR = 1.09 [1.01; 1.17]), waist circumference (OR = 1.09 [1.02; 1.17]) in stressed men at S-46. Positive associations were observed for fasting plasma glucose (OR = 1.42 [1.07; 1.87]), serum triglycerides (OR = 1.41 [1.05; 1.91]) and with fasting plasma insulin (OR = 1.48 [1.05; 2.08]) in stressed men at S-49. Rs439401 TT-genotype also associated positively with surrogate measures of insulin resistance (HOMA-IR; OR = 1.21 [1.03; 1.41]) and inversely with insulin sensitivity (Stumvoll index; OR = 0.90 [0.82; 0.99], BIGTT-S(I); OR = 0.60 [0.43; 0.85]) in stressed men. No significant associations were observed in non-stressed men, albeit the estimates showed similar but weaker trends as in stressed men. Conclusion: The present results suggest that the APOE rs439401 TT-genotype is associated with an adverse metabolic profile in a population of psychologically stressed Danish men.	[Kring, Sofia I. Iqbal; Sorensen, Thorkild I. A.] Inst Prevent Med, Copenhagen, Denmark; [Kring, Sofia I. Iqbal] Univ Copenhagen, Ctr Pharmacogen, Copenhagen, Denmark; [Barefoot, John; Brummett, Beverly H.; Boyle, Stephen H.; Siegler, Ilene C.; Williams, Redford B.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Toubro, Soren] Hvidovre Univ Hosp, Res Clin Nutr, DK-2650 Hvidovre, Denmark; [Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Astrup, Arne] Univ Copenhagen, Dept Human Nutr, Ctr Adv Food Res, Fac Life Sci, Copenhagen, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Inst Biomed, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark	University of Copenhagen; Duke University; University of Copenhagen; Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; University of Southern Denmark; University of Copenhagen; University of Copenhagen; Aarhus University	Kring, SII (corresponding author), Inst Prevent Med, Copenhagen, Denmark.	si@ipm.regionh.dk	Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Astrup, Arne/B-1407-2015	Pedersen, Oluf/0000-0002-3321-3972; Astrup, Arne/0000-0001-8968-8996	Center for Pharmacogenomics at the University of Copenhagen, Denmark; NHLBI [P01HL36587]; Behavioral Medicine Research Center, Duke University Medical Center, Durham, NC, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036587] Funding Source: NIH RePORTER	Center for Pharmacogenomics at the University of Copenhagen, Denmark; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Behavioral Medicine Research Center, Duke University Medical Center, Durham, NC, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was financially supported by Center for Pharmacogenomics at the University of Copenhagen, Denmark, and by NHLBI grant P01HL36587 and the Behavioral Medicine Research Center, Duke University Medical Center, Durham, NC, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Benyamin B, 2007, DIABETOLOGIA, V50, P1880, DOI 10.1007/s00125-007-0758-1; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; Breslow JL, 2000, ANNU REV GENET, V34, P233, DOI 10.1146/annurev.genet.34.1.233; Brummett BH, 2007, PSYCHOSOM MED, V69, P621, DOI 10.1097/PSY.0b013e31814b8de6; Brummett BH, 2007, PSYCHOSOM MED, V69, P396, DOI 10.1097/PSY.0b013e31806d040b; Brummett BH, 2006, HEALTH PSYCHOL, V25, P220, DOI 10.1037/0278-6133.25.2.220; Buemann B, 2005, INT J OBESITY, V29, P624, DOI 10.1038/sj.ijo.0802929; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Despres JP, 2001, ANN MED, V33, P534, DOI 10.3109/07853890108995963; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Elosua R, 2003, OBES RES, V11, P1502, DOI 10.1038/oby.2003.201; FUMERON F, 1988, CLIN GENET, V34, P258; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Jemaa R, 2006, CLIN BIOCHEM, V39, P816, DOI 10.1016/j.clinbiochem.2006.04.018; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kring SII, 2010, PSYCHOSOM MED, V72, P427, DOI 10.1097/PSY.0b013e3181de30ad; Kring SII, 2008, OBESITY FACTS, V1, P138, DOI 10.1159/000137665; Martyn JAJ, 2008, ANESTHESIOLOGY, V109, P137, DOI 10.1097/ALN.0b013e3181799d45; Prescott E, 2003, INT J EPIDEMIOL, V32, P990, DOI 10.1093/ije/dyg235; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; SONNEHOLM S, 1989, BRIT MED J, V299, P767, DOI 10.1136/bmj.299.6702.767; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; *WHO, 2003, PHYS STAT US INT ANT	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15745	10.1371/journal.pone.0015745	http://dx.doi.org/10.1371/journal.pone.0015745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283811	Green Published, gold			2022-12-25	WOS:000286520600009
J	St Hill, CA; Baharo-Hassan, D; Farooqui, M				St Hill, Catherine A.; Baharo-Hassan, Dahabo; Farooqui, Mariya			C2-O-sLe(X) Glycoproteins Are E-Selectin Ligands that Regulate Invasion of Human Colon and Hepatic Carcinoma Cells	PLOS ONE			English	Article							SIALYL-LEWIS-X; CORE 2 BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; INFLAMMATION-INDUCED EXPRESSION; P-SELECTIN; COLORECTAL-CANCER; MONOCLONAL-ANTIBODY; LEUKOCYTE ADHESION; O-GLYCANS; EPITHELIAL EXPRESSION; DEPENDENT ADHESION	Similar to mechanisms of recruitment of activated leukocytes to inflamed tissues, selectins mediate adhesion and extravasation of circulating cancer cells. Our objective was to determine whether sialyl Lewis X modified core 2 O-glycans (C2-O-sLe(X)) present on colon and hepatic carcinoma cells promote their adhesion and invasion. We examined membrane expression of C2-O-sLe(X), selectin binding, invasion of human colon and hepatic carcinoma cell lines, and mRNA levels of alpha-2,3 fucosyltransferase (FucT-III) and core 2 beta-1,6 N-acetylglucosaminyltransferase (C2GnT1) genes, necessary for C2-O-sLe(X) synthesis, by quantitative reverse-transcriptase (RT) PCR. Synthesis of core 2 branched O-glycans decorated by sLe(X) is dependent on C2GnT1 function and thus we determined enzyme activity of C2GnT1. The cell lines that expressed C2GnT1 and FucT-III mRNA by quantitative RT-PCR were highly positive for C2-O-sLe(X) by flow cytometry, and colon carcinoma cells possessed highly active C2GnT1 enzyme. Cells bound avidly to E-selection but not to P-and L-selectin. Gene knock-down of C2GnT1 in colon and hepatic carcinoma cells using short hairpin RNAs (shRNA) resulted in a 40-90% decrease in C2-O-sLe(X) and a 30-50% decrease in E-selectin binding compared to control cells. Invasion of hepatic and colon carcinoma cells containing C2GnT1 shRNA was significantly reduced compared to control cells in Matrigel assays and C2GnT1 activity was down-regulated in the latter cells. The sLe(X) epitope was predominantly distributed on core 2 O-glycans on colon and hepatic carcinoma cells. Our findings indicate that C2GnT1 gene expression and the resulting C2-O-sLe(X) carbohydrates produced mediate the adhesive and invasive behaviors of human carcinomas which may influence their metastatic potential.	[St Hill, Catherine A.; Baharo-Hassan, Dahabo; Farooqui, Mariya] Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	St Hill, CA (corresponding author), Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA.	sthil001@umn.edu		Farooqui, Mariya/0000-0002-2136-8694	National Institutes of Health, National Cancer Institute [5KO8CA111829-04]; NATIONAL CANCER INSTITUTE [K08CA111829] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by funds from the National Institutes of Health, National Cancer Institute grant 5KO8CA111829-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; BERG EL, 1992, BIOCHEM BIOPH RES CO, V184, P1048, DOI 10.1016/0006-291X(92)90697-J; Beum PV, 1999, J BIOL CHEM, V274, P24641, DOI 10.1074/jbc.274.35.24641; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Brinkman-van der Linden ECM, 1998, GLYCOCONJUGATE J, V15, P177, DOI 10.1023/A:1006972307166; BROCKHAUSEN I, 1991, CANCER RES, V51, P1257; Dalziel M, 2001, J BIOL CHEM, V276, P11007, DOI 10.1074/jbc.M006523200; DEGRAAF TW, 1993, J EXP MED, V177, P657, DOI 10.1084/jem.177.3.657; Descheny L, 2006, J INVEST DERMATOL, V126, P2065, DOI 10.1038/sj.jid.5700364; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Epperson TR, 2000, J BIOL CHEM, V275, P7839, DOI 10.1074/jbc.275.11.7839; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; Hagisawa S, 2005, GLYCOBIOLOGY, V15, P1016, DOI 10.1093/glycob/cwi086; Haier J, 2000, ANN SURG, V231, P11, DOI 10.1097/00000658-200001000-00003; Hakomori S, 1996, CANCER RES, V56, P5309; Harada T, 1998, J HEPATOL, V28, P231, DOI 10.1016/0168-8278(88)80010-2; Hill CAS, 2005, CANCER LETT, V217, P105, DOI 10.1016/j.canlet.2004.06.038; Hiraga Y, 1998, ONCOLOGY-BASEL, V55, P307, DOI 10.1159/000011868; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; IRIMURA T, 1993, SEMIN CANCER BIOL, V4, P319; Ito K, 2001, J GASTROENTEROL, V36, P823, DOI 10.1007/s005350170004; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Katnik I, 1996, GLYCOCONJUGATE J, V13, P1043, DOI 10.1007/BF01053200; Lafrenie R M, 1993, Cell Biophys, V23, P3; LARSEN E, 1990, CELL, V63, P467, DOI 10.1016/0092-8674(90)90443-I; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Lee MJ, 2003, MODERN PATHOL, V16, P403, DOI 10.1097/01.MP.0000067683.84284.66; Leeman MF, 2003, J PATHOL, V201, P528, DOI 10.1002/path.1466; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; Machida E, 2001, CANCER RES, V61, P2226; MANNORI G, 1995, CANCER RES, V55, P4425; MITSAKOS A, 1988, BIOL CHEM H-S, V369, P661, DOI 10.1515/bchm3.1988.369.2.661; NAKAMORI S, 1994, GASTROENTEROLOGY, V106, P353, DOI 10.1016/0016-5085(94)90592-4; NAKAMORI S, 1993, CANCER RES, V53, P3632; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Ni ZY, 2006, J IMMUNOL, V177, P4742, DOI 10.4049/jimmunol.177.7.4742; PAULI BU, 1990, CANCER METAST REV, V9, P175, DOI 10.1007/BF00046359; Prorok-Hamon Maelle, 2006, V347, P171; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Ratnikov BI, 2002, J BIOL CHEM, V277, P7377, DOI 10.1074/jbc.M109580200; Renkonen J, 1997, INT J CANCER, V74, P296; Renkonen J, 2000, APMIS, V108, P705, DOI 10.1034/j.1600-0463.2000.d01-18.x; Renkonen J, 2001, APMIS, V109, P500, DOI 10.1111/j.1600-0463.2001.apm090703.x; SAITOH O, 1991, BLOOD, V77, P1491; SAWADA R, 1994, J BIOL CHEM, V269, P1425; Shimodaira K, 1997, CANCER RES, V57, P5201; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Smith MJ, 2004, J BIOL CHEM, V279, P21984, DOI 10.1074/jbc.M402731200; Sperandio M, 2001, BLOOD, V97, P3812, DOI 10.1182/blood.V97.12.3812; St Hill CA, 2003, J LEUKOCYTE BIOL, V73, P464, DOI 10.1189/jlb.1002491; St Hill CA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-79; Thathiah A, 2004, BIOCHEM J, V382, P363, DOI 10.1042/BJ20040513; URDAL DL, 1983, BLOOD, V62, P1022; Walcheck B, 2002, BLOOD, V99, P4063, DOI 10.1182/blood-2001-12-0265; WEISS L, 1989, CLIN EXP METASTAS, V7, P127, DOI 10.1007/BF01787020; WILLIAMS D, 1980, J BIOL CHEM, V255, P1247; Yago T, 2003, J BIOL CHEM, V278, P37987, DOI 10.1074/jbc.M305778200; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772; Zhang Bao-Hua, 2002, Hepatobiliary Pancreat Dis Int, V1, P80; Zhang K, 1996, J CELL BIOCHEM, V60, P538, DOI 10.1002/(SICI)1097-4644(19960315)60:4<538::AID-JCB10>3.3.CO;2-A	64	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16281	10.1371/journal.pone.0016281	http://dx.doi.org/10.1371/journal.pone.0016281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283832	Green Submitted, Green Published, gold			2022-12-25	WOS:000286520600037
J	Straub, C; Quillardet, P; Vergalli, J; de Marsac, NT; Humbert, JF				Straub, Cecile; Quillardet, Philippe; Vergalli, Julia; de Marsac, Nicole Tandeau; Humbert, Jean-Francois			A Day in the Life of Microcystis aeruginosa Strain PCC 7806 as Revealed by a Transcriptomic Analysis	PLOS ONE			English	Article							CYANOBACTERIA; EXPRESSION; METABOLISM; BUOYANCY; PCC-6803; CLOCK; LIGHT	The cyanobacterium, Microcystis aeruginosa, is able to proliferate in a wide range of freshwater ecosystems and to produce many secondary metabolites that are a threat to human and animal health. The dynamic of this production and more globally the metabolism of this species is still poorly known. A DNA microarray based on the genome of M. aeruginosa PCC 7806 was constructed and used to study the dynamics of gene expression in this cyanobacterium during the light/dark cycle, because light is a critical factor for this species, like for other photosynthetic microorganisms. This first application of transcriptomics to a Microcystis species has revealed that more than 25% of the genes displayed significant changes in their transcript abundance during the light/dark cycle and in particular during the dark/light transition. The metabolism of M. aeruginosa is compartmentalized between the light period, during which carbon uptake, photosynthesis and the reductive pentose phosphate pathway lead to the synthesis of glycogen, and the dark period, during which glycogen degradation, the oxidative pentose phosphate pathway, the TCA branched pathway and ammonium uptake promote amino acid biosynthesis. We also show that the biosynthesis of secondary metabolites, such as microcystins, aeruginosin and cyanopeptolin, occur essentially during the light period, suggesting that these metabolites may interact with the diurnal part of the central metabolism.	[Straub, Cecile; Quillardet, Philippe] Inst Pasteur, Unite Dynam Genome, Paris, France; [Vergalli, Julia] Univ Paul Cezanne, Inst Mediterraneen Ecol & Paleoecol, UMR CNRS 6116, Fac St Jerome, Marseille, France; [de Marsac, Nicole Tandeau] Univ Aix Marseille, CNRS UPR9043, Chim Bacterienne Lab, Marseille, France; [Humbert, Jean-Francois] INRA, UMR BIOEMCO, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Straub, C (corresponding author), Inst Pasteur, Unite Dynam Genome, Paris, France.	humbert@biologie.ens.fr	Vergalli, Julia/AAQ-2604-2021	Humbert, Jean-Francois/0000-0002-1519-5651; Vergalli, Julia/0000-0003-3253-6275	ANR (French governemental agency for the research)	ANR (French governemental agency for the research)(French National Research Agency (ANR))	This work has been funded by the ANR (French governemental agency for the research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUSSIBA S, 1989, PLANT CELL PHYSIOL, V30, P303, DOI 10.1093/oxfordjournals.pcp.a077743; Briand JF, 2003, VET RES, V34, P361, DOI 10.1051/vetres:2003019; Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406; Cooley JW, 2000, J BACTERIOL, V182, P714, DOI 10.1128/JB.182.3.714-722.2000; de Marsac NT, 2001, J APPL PHYCOL, V13, P287; Elvitigala T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-226; Finzi-Hart JA, 2009, P NATL ACAD SCI USA, V106, P6345, DOI 10.1073/pnas.0810547106; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Gill RT, 2002, J BACTERIOL, V184, P3671, DOI 10.1128/JB.184.13.3671-3681.2002; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; IBELINGS BW, 1991, ARCH HYDROBIOL, V120, P385; Imamura S, 2009, GENE REGUL SYST BIO, V3, P65; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; KUIPERGOODMAN T, 1999, TOXIC CYANOBACTERIA, P41; Muro-Pastor MI, 2005, PHOTOSYNTH RES, V83, P135, DOI 10.1007/s11120-004-2082-7; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rabouille S, 2003, CR BIOL, V326, P349, DOI 10.1016/S1631-0691(03)00123-9; REYNOLDS CS, 1976, HYDROBIOLOGIA, V48, P17, DOI 10.1007/BF00033486; REYNOLDS CS, 1975, BIOL REV, V50, P437, DOI 10.1111/j.1469-185X.1975.tb01060.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; TAN X, 2007, J ENVIRON SCI, V21, P892; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Toepel J, 2009, J PHYCOL, V45, P610, DOI 10.1111/j.1529-8817.2009.00674.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vermaas W. F. J., 2001, ENCY LIFE SCI, DOI [10.1038/npg.els.0001670, DOI 10.1038/NPG.ELS.0001670]; Wu ZX, 2008, PHYCOLOGIA, V47, P98, DOI 10.2216/07-49.1; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	33	71	74	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16208	10.1371/journal.pone.0016208	http://dx.doi.org/10.1371/journal.pone.0016208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283831	Green Published, Green Submitted, gold			2022-12-25	WOS:000286520600032
J	Lau, MT; Klausen, C; Leung, PCK				Lau, M-T; Klausen, C.; Leung, P. C. K.			E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via beta-catenin-Egr1-mediated PTEN expression	ONCOGENE			English	Article						E-cadherin; PTEN; PI3K/Akt; beta-catenin; ovarian cancer	GLYCOGEN-SYNTHASE KINASE-3; ACTIVATED PROTEIN-KINASE; BETA-CATENIN; OVARIAN-CANCER; PHOSPHATASE-ACTIVITY; CARCINOMA-CELLS; FACTOR RECEPTOR; CYCLE ARREST; TRANSCRIPTIONAL ACTIVATION; INCREASES SENSITIVITY	E-cadherin is a cell-cell adhesion protein and tumor suppressor that is silenced in many malignancies. E-cadherin is thought to suppress tumor cell growth by antagonizing beta-catenin signaling. However, the role of E-cadherin in ovarian cancer progression is still controversial. In this study, we showed that loss of E-cadherin induced ovarian cancer cell growth and constitutive activation of phosphoinositide 3-kinase (PI3K)/Akt signaling by the inhibition of phosphatase and tensin homolog (PTEN) transcription through the downregulation of early growth response gene 1 (Egr1). In addition, immunofluorescence microscopy and T-cell factor promoter/luciferase reporter assays showed that E-cadherin loss was associated with enhanced nuclear beta-catenin signaling. Constitutive activation of PI3K/Akt signaling reinforced nuclear beta-catenin signaling by inactivating glycogen synthase kinase-3 beta indicating cross-talk between the PI3K/Akt and beta-catenin signaling pathways. Finally, we found that E-cadherin negatively regulates tumor cell growth, in part, by positively regulating PTEN expression via beta-catenin-mediated Egr1 regulation, thus influencing PI3K/Akt signaling. In summary, endogenous E-cadherin inhibits PI3K/Akt signaling by antagonizing beta-catenin-Egr1-mediated repression of PTEN expression. Thus, the loss of E-cadherin itself may contribute to dysregulated PI3K/Akt signaling through its effects on PTEN, or it may exacerbate the frequent activation of PI3K/Akt signaling that occurs as a result of overexpression, mutation and/or amplification. Oncogene (2011) 30, 2753-2766; doi: 10.1038/onc.2011.6; published online 7 February 2011	[Lau, M-T; Klausen, C.; Leung, P. C. K.] Univ British Columbia, Dept Obstet Gynecol, Child & Family Res Inst, Vancouver, BC V6H 3N1, Canada	Child & Family Research Institute; University of British Columbia	Leung, PCK (corresponding author), Univ British Columbia, Dept Obstet Gynecol, Child & Family Res Inst, 2H30,4490 Oak St, Vancouver, BC V6H 3N1, Canada.	peleung@interchange.ubc.ca		Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research; Interdisciplinary Women's Reproductive Health Research Training Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Interdisciplinary Women's Reproductive Health Research Training Program	We thank Dr H Clevers (University Hospital, the Netherlands), Dr E Fearon (University of Michigan School of Medicine, Detroit, MI, USA), Dr A Passaniti (University of Maryland Greenebaum Cancer Center, Baltimore, MD, USA), Dr AH Ross (University of Massachusetts Medical School, Worcester, MA, USA), Dr V Stambolic (Ontario Cancer Institute, Toronto, Ontario, Canada), Dr RA Weinberg (Massachusetts Institute of Technology, Cambridge, MA, USA) and Dr J Woodgett (Ontario Cancer Institute) for kindly and generously giving us the constructs. This work was supported by the Canadian Institutes of Health Research (PCKL). PCKL is recipient of a Distinguished Scientist Award from the Child and Family Research Institute and MTL is the recipient of a Graduate Studentship Award from the Interdisciplinary Women's Reproductive Health Research Training Program.	Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Black PC, 2008, CLIN CANCER RES, V14, P1478, DOI 10.1158/1078-0432.CCR-07-1593; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Santis G, 2009, ONCOGENE, V28, P1206, DOI 10.1038/onc.2008.470; EldarFinkelman H, 1996, P NATL ACAD SCI USA, V93, P10228, DOI 10.1073/pnas.93.19.10228; Fournier MV, 2009, CANCER RES, V69, P4545, DOI 10.1158/0008-5472.CAN-08-1694; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Furnari FB, 1998, CANCER RES, V58, P5002; Geiger B, 1995, ACTA ANAT, V154, P46; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Hu YL, 2007, ARCH BIOCHEM BIOPHYS, V467, P1, DOI 10.1016/j.abb.2007.07.027; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li ZX, 2007, BIOCHEM BIOPH RES CO, V363, P165, DOI 10.1016/j.bbrc.2007.08.154; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nollet F, 1999, Mol Cell Biol Res Commun, V2, P77, DOI 10.1006/mcbr.1999.0155; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Reddy P, 2005, MOL ENDOCRINOL, V19, P2564, DOI 10.1210/me.2004-0342; Sasaki CY, 2000, INT J CANCER, V86, P660, DOI 10.1002/(SICI)1097-0215(20000601)86:5<660::AID-IJC9>3.0.CO;2-X; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Subauste MC, 2005, J BIOL CHEM, V280, P5676, DOI 10.1074/jbc.M405561200; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; VEATCH AL, 1994, INT J CANCER, V58, P393, DOI 10.1002/ijc.2910580315; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Weng LP, 1999, CANCER RES, V59, P5808; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Weng ZG, 2002, J BIOL CHEM, V277, P18677, DOI 10.1074/jbc.M105331200; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Woenckhaus J, 2007, VIRCHOWS ARCH, V450, P387, DOI 10.1007/s00428-006-0358-3; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Wu C, 2008, DIFFERENTIATION, V76, P193, DOI 10.1111/j.1432-0436.2007.00193.x; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; Yagi T, 2000, GENE DEV, V14, P1169; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yu YC, 2006, CLIN EXP METASTAS, V23, P65, DOI 10.1007/s10585-006-9020-3	58	90	100	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	24					2753	2766		10.1038/onc.2011.6	http://dx.doi.org/10.1038/onc.2011.6			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778DB	21297666				2022-12-25	WOS:000291678500006
J	Trinh, BQ; Barengo, N; Naora, H				Trinh, B. Q.; Barengo, N.; Naora, H.			Homeodomain protein DLX4 counteracts key transcriptional control mechanisms of the TGF-beta cytostatic program and blocks the antiproliferative effect of TGF-beta	ONCOGENE			English	Article						cell growth; homeobox genes; Smad; Sp1; TGF-beta	GROWTH-FACTOR-BETA; HOMEOBOX GENE-EXPRESSION; MICROSATELLITE INSTABILITY; BREAST-CANCER; C-MYC; EPITHELIAL-CELLS; LUNG CANCERS; COLON-CANCER; II RECEPTOR; DNA-BINDING	The antiproliferative activity of transforming growth factor-beta (TGF-beta) is essential for maintaining normal tissue homeostasis and is lost in many types of tumors. Gene responses that are central to the TGF-beta cytostatic program include activation of the cyclin-dependent kinase inhibitors, p15(Ink4B) and p21(WAF1/Cip1), and repression of c-myc. These gene responses are tightly regulated by a repertoire of transcription factors that include Smad proteins and Sp1. The DLX4 homeobox patterning gene encodes a transcription factor that is absent from most normal adult tissues, but is expressed in a wide variety of malignancies, including lung, breast, prostate and ovarian cancers. In this study, we demonstrate that DLX4 blocks the antiproliferative effect of TGF-b. DLX4 inhibited TGF-beta-mediated induction of p15(Ink4B) and p21(WAF1/Cip1) expression. DLX4 bound and prevented Smad4 from forming complexes with Smad2 and Smad3, but not with Sp1. However, DLX4 also bound and inhibited DNA-binding activity of Sp1. In addition, DLX4 induced expression of c-myc independently of TGF-beta/Smad signaling. The ability of DLX4 to counteract key transcriptional control mechanisms of the TGF-beta cytostatic program could explain, in part, the resistance of tumors to the antiproliferative effect of TGF-beta Oncogene (2011) 30, 2718-2729; doi: 10.1038/onc.2011.4; published online 7 February 2011	[Trinh, B. Q.; Barengo, N.; Naora, H.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77054 USA; [Trinh, B. Q.; Naora, H.] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Naora, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, 7435 Fannin St,Unit 950, Houston, TX 77054 USA.	hnaora@mdanderson.org	Trinh, Bon/K-7132-2014	Trinh, Bon/0000-0002-0956-8941	Schissler Foundation; Vietnam Education Foundation; US Department of Defense [W81XWH-06-1-0259]; National Institutes of Health [R01 CA141078]; NATIONAL CANCER INSTITUTE [R01CA141078] Funding Source: NIH RePORTER	Schissler Foundation; Vietnam Education Foundation; US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Schissler Foundation Fellowship (B Trinh), the Vietnam Education Foundation (B Trinh), the US Department of Defense grant W81XWH-06-1-0259 (H Naora) and the National Institutes of Health grant R01 CA141078 (H Naora). We thank Sabine Thonard for technical assistance, and Song Yi Ko, Gary Gallick, Michelle Barton, Janet Price, Peng Huang and Miles Wilkinson	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Bello-DeOcampo D, 2003, CURR DRUG TARGETS, V4, P197, DOI 10.2174/1389450033491118; Berghorn KA, 2006, J BIOL CHEM, V281, P20357, DOI 10.1074/jbc.M603049200; Boogerd KJ, 2008, CARDIOVASC RES, V78, P485, DOI 10.1093/cvr/cvn049; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chiba S, 2003, P NATL ACAD SCI USA, V100, P15577, DOI 10.1073/pnas.2536757100; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Francis-Thickpenny KM, 2001, BRIT J CANCER, V85, P687, DOI 10.1054/bjoc.2001.1950; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gemma A, 1996, INT J CANCER, V68, P605, DOI 10.1002/(SICI)1097-0215(19961127)68:5<605::AID-IJC9>3.0.CO;2-2; Haga SB, 2000, LEUKEMIA, V14, P1867, DOI 10.1038/sj.leu.2401912; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hara F, 2007, AM J PATHOL, V170, P1594, DOI 10.2353/ajpath.2007.061025; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hyman E, 2002, CANCER RES, V62, P6240; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; Man YG, 2005, BREAST CANCER RES TR, V90, P241, DOI 10.1007/s10549-004-4492-9; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nagatake M, 1996, CANCER RES, V56, P2718; Naora H, 2001, P NATL ACAD SCI USA, V98, P4060, DOI 10.1073/pnas.071594398; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Park GT, 2002, NUCLEIC ACIDS RES, V30, P515, DOI 10.1093/nar/30.2.515; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Samuel S, 2005, EUR J CANCER, V41, P2428, DOI 10.1016/j.ejca.2005.08.014; Schutte M, 1996, CANCER RES, V56, P2527; Schwartz AM, 2009, MODERN PATHOL, V22, P1, DOI 10.1038/modpathol.2008.168; Shen WF, 1999, MOL CELL BIOL, V19, P3051; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Takenoshita S, 1998, ONCOL REP, V5, P367; Takenoshita S, 1997, CARCINOGENESIS, V18, P1427, DOI 10.1093/carcin/18.7.1427; Tokunaga H, 1999, CLIN CANCER RES, V5, P2520; Tomida S, 2007, ONCOGENE, V26, P4600, DOI 10.1038/sj.onc.1210242; Tournay O, 1996, MOL CELL BIOL, V16, P2418; Wang D, 2000, CANCER RES, V60, P4507; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Williams TM, 2005, NUCLEIC ACIDS RES, V33, P4475, DOI 10.1093/nar/gki761; Woodford-Richens KL, 2001, P NATL ACAD SCI USA, V98, P9719, DOI 10.1073/pnas.171321498; Yamada SD, 1999, GYNECOL ONCOL, V75, P72, DOI 10.1006/gyno.1999.5535; Yang XL, 2000, J BIOL CHEM, V275, P1065, DOI 10.1074/jbc.275.2.1065; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	53	29	32	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	24					2718	2729		10.1038/onc.2011.4	http://dx.doi.org/10.1038/onc.2011.4			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778DB	21297662	Green Accepted			2022-12-25	WOS:000291678500003
J	Shen, BY; Wu, N; Yang, JM; Gould, SJ				Shen, Beiyi; Wu, Ning; Yang, Jr-Ming; Gould, Stephen J.			Protein Targeting to Exosomes/Microvesicles by Plasma Membrane Anchors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; TUMOR-GROWTH; HIV GAG; EXOSOMES; CELLS; MACROPHAGES; VESICLES; RELEASE; INFECTIVITY; SECRETION	Animal cells secrete small vesicles, otherwise known as exosomes and microvesicles (EMVs). A short, N-terminal acylation tag can target a highly oligomeric cytoplasmic protein, TyA, into secreted vesicles (Fang, Y., Wu, N., Gan, X., Yan, W., Morell, J. C., and Gould, S. J. (2007) PLoS Biol. 5, 1267-1283). However, it is not clear whether this is true for other membrane anchors or other highly oligomeric, cytoplasmic proteins. We show here that a variety of plasma membrane anchors can target TyA-GFP to sites of vesicle budding and into EMVs, including: (i) a myristoylation tag; (ii) a phosphatidylinositol-(4,5)-bisphosphate (PIP2)-binding domain; (iii), a phosphatidylinositol-(3,4,5)-trisphosphate- binding domain; (iv) a prenylation/palmitoylation tag, and (v) a type-1 plasma membrane protein, CD43. However, the relative budding efficiency induced by these plasma membrane anchors varied over a 10-fold range, from 100% of control (AcylTyA-GFP) for the myristoylation tag and PIP2-binding domain, to one-third or less for the others, respectively. Targeting TyA-GFP to endosome membranes by fusion to a phosphatidylinositol 3-phosphate-binding domain induced only a slight budding of TyA-GFP, similar to 2% of control, and no budding was observed when TyA-GFP was targeted to Golgi membranes via a phosphatidylinositol 4-phosphate-binding domain. We also found that a plasma membrane anchor can target two other highly oligomeric, cytoplasmic proteins to EMVs. These observations support the hypothesis that plasma membrane anchors can target highly oligomeric, cytoplasmic proteins to EMVs. Our data also provide additional parallels between EMV biogenesis and retrovirus budding, as the anchors that induced the greatest budding of TyA-GFP are the same as those that mediate retrovirus budding.	[Shen, Beiyi; Wu, Ning; Yang, Jr-Ming; Gould, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Gould, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	sgould@jhmi.edu		Yang, Jr-Ming/0000-0002-6296-8987	National Institutes of Health [DK45787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported, in whole or in part, by National Institutes of Health Grant DK45787.	ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Chen K, 2008, BIOCHEMISTRY-US, V47, P1928, DOI 10.1021/bi701984h; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Coffin JM, 1997, RETROVIRUSES; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Dukers DF, 2000, J IMMUNOL, V165, P663, DOI 10.4049/jimmunol.165.2.663; Fang Y, 2007, PLOS BIOL, V5, P1267, DOI 10.1371/journal.pbio.0050158; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Freed EO, 2006, P NATL ACAD SCI USA, V103, P11101, DOI 10.1073/pnas.0604715103; Gillooly DJ, 2003, HISTOCHEM CELL BIOL, V120, P445, DOI 10.1007/s00418-003-0591-7; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Hamard-Peron E, 2010, J VIROL, V84, P503, DOI 10.1128/JVI.01134-09; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Kolotuev I, 2009, TRAFFIC, V10, P803, DOI [10.1111/j.1600-0854.2009.00871.x, 10.1111/j.1600-0854.2008.00871.x]; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Mager DL, 2000, J VIROL, V74, P7221, DOI 10.1128/JVI.74.16.7221-7229.2000; Marsh M, 2009, BIOCHEM SOC T, V37, P185, DOI 10.1042/BST0370185; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Roth JF, 2000, YEAST, V16, P785, DOI 10.1002/1097-0061(20000630)16:9<785::AID-YEA550>3.0.CO;2-L; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	54	186	193	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14383	14395		10.1074/jbc.M110.208660	http://dx.doi.org/10.1074/jbc.M110.208660			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21300796	Green Published, hybrid			2022-12-25	WOS:000289556200060
J	Frasch, SC; Fernandez-Boyanapalli, RF; Berry, KZ; Leslie, CC; Bonventre, JV; Murphy, RC; Henson, PM; Bratton, DL				Frasch, S. Courtney; Fernandez-Boyanapalli, Ruby F.; Berry, Karin Zemski; Leslie, Christina C.; Bonventre, Joseph V.; Murphy, Robert C.; Henson, Peter M.; Bratton, Donna L.			Signaling via Macrophage G2A Enhances Efferocytosis of Dying Neutrophils by Augmentation of Rac Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; COUPLED-RECEPTOR G2A; CYTOSOLIC PHOSPHOLIPASE A(2); OXIDATION-SPECIFIC EPITOPES; PROSTAGLANDIN-E RECEPTORS; PROGRAMMED CELL-DEATH; FREE FATTY-ACIDS; APOPTOTIC CELLS; PHOSPHATIDYLSERINE RECEPTOR; 9-HYDROXYOCTADECADIENOIC ACID	Phosphatidylserine (PS) and oxidized PS species have been identified as key ligands on apoptotic cells important for their recognition and removal (efferocytosis) by phagocytes, a requisite step for resolution of inflammation. We have recently demonstrated that lysophosphatidylserine (lyso-PS) generated and retained on neutrophils following short term activation of the NADPH oxidase in vitro and in vivo enhanced their clearance via signaling through the macrophage G-protein-coupled receptor G2A. Here, we investigated the signaling pathway downstream of G2A. Lyso-PS, either made endogenously in apoptosing neutrophils or supplied exogenously in liposomes along with lyso-PSneg apoptotic cells, signaled to macrophages in a G2A-dependent manner for their enhanced production of prostaglandin E-2 (PGE(2)) via a calcium-dependent cytosolic phospholipase A(2)/cyclooxygenase-mediated mechanism. Subsequent signaling by PGE(2) via EP2 receptors activated macrophage adenylyl cyclase and protein kinase A. These events, in turn, culminated in enhanced activity of Rac1, resulting in an increase in both the numbers of macrophages efferocytosing apoptotic cells and the numbers of cells ingested per macrophage. These data were surprising in light of previous reports demonstrating that signaling by PGE(2) and adenylyl cyclase activation are associated with macrophage deactivation and inhibition of apoptotic cell uptake. Further investigation revealed that the impact of this pathway, either the enhancement or inhibition of efferocytosis, was exquisitely sensitive to concentration effects of these intermediaries. Together, these data support the hypothesis that lyso-PS presented on the surface of activated and dying neutrophils provides a tightly controlled, proresolution signal for high capacity clearance of neutrophils in acute inflammation.	[Frasch, S. Courtney; Fernandez-Boyanapalli, Ruby F.; Leslie, Christina C.; Henson, Peter M.; Bratton, Donna L.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Leslie, Christina C.; Henson, Peter M.; Bratton, Donna L.] Natl Jewish Hlth, Cell Biol Program, Denver, CO 80206 USA; [Berry, Karin Zemski; Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Bonventre, Joseph V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA	National Jewish Health; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Brigham & Women's Hospital	Frasch, SC (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	fraschc@njhealth.org	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	National Institutes of Health [AI058228, HL34303, GM61031, HL81151]; Chronic Granulomatous Disorder Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081151, P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI058228, R01AI058228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chronic Granulomatous Disorder Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058228 (to D. L. B.), HL34303 (to D. L. B., C. C. L., and R. C. M.), and GM61031 and HL81151 (to P. M. H.). This work was also supported by the Chronic Granulomatous Disorder Research Trust (to D.L.B.).	Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Aronoff DM, 2007, J IMMUNOL, V178, P1628, DOI 10.4049/jimmunol.178.3.1628; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Arroyo A, 2002, J BIOL CHEM, V277, P49965, DOI 10.1074/jbc.M204513200; Bolick DT, 2007, CIRC RES, V100, P572, DOI 10.1161/01.RES.0000258877.57836.d2; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; FADOK VA, 1992, J IMMUNOL, V149, P4029; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Fernandez-Boyanapalli R, 2010, BLOOD, V116, P4512, DOI 10.1182/blood-2010-02-272005; Fernandez-Boyanapalli RF, 2009, BLOOD, V113, P2047, DOI 10.1182/blood-2008-05-160564; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frasch SC, 2007, J IMMUNOL, V178, P6540, DOI 10.4049/jimmunol.178.10.6540; Frasch SC, 2008, J BIOL CHEM, V283, P33736, DOI 10.1074/jbc.M807047200; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; HASLETT C, 1985, AM J PATHOL, V119, P101; Hattori T, 2008, J INVEST DERMATOL, V128, P1123, DOI 10.1038/sj.jid.5701172; Henson PM, 2009, PHAGOCYTE-PATHOGEN INTERACTIONS: MACROPHAGES AND THE HOST RESPONSE TO INFECTION, P341; Ikegami R, 2001, J IMMUNOL, V166, P4689, DOI 10.4049/jimmunol.166.7.4689; Kabarowski JH, 2009, PROSTAG OTH LIPID M, V89, P73, DOI 10.1016/j.prostaglandins.2009.04.007; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kasahara Y, 1997, BLOOD, V89, P1748, DOI 10.1182/blood.V89.5.1748.1748_1748_1753; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morimoto K, 2006, J IMMUNOL, V176, P7657, DOI 10.4049/jimmunol.176.12.7657; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; Nakaya M, 2008, P NATL ACAD SCI USA, V105, P9198, DOI 10.1073/pnas.0803677105; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Obinata H, 2009, PROSTAG OTH LIPID M, V89, P66, DOI 10.1016/j.prostaglandins.2008.11.002; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Rajakariar R, 2009, J IMMUNOL, V182, P3262, DOI 10.4049/jimmunol.0801739; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Rossi AG, 1998, J IMMUNOL, V160, P3562; Sanford AN, 2006, RHEUMATOLOGY, V45, P178, DOI 10.1093/rheumatology/kei135; SAVILL J, 1991, CHEST, V99, pS6, DOI 10.1378/chest.99.3_Supplement.6S-a; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Tosello-Trampont AC, 2003, J BIOL CHEM, V278, P49911, DOI 10.1074/jbc.M306079200; Tosello-Trampont AC, 2001, J BIOL CHEM, V276, P13797, DOI 10.1074/jbc.M011238200; Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Yan JJ, 2004, NAT MED, V10, P161, DOI 10.1038/nm989; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200	67	64	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.181800	http://dx.doi.org/10.1074/jbc.M110.181800			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21297111	Green Published, hybrid			2022-12-25	WOS:000289077500026
J	Ratti, J; Rostkova, E; Gautel, M; Pfuhl, M				Ratti, Joyce; Rostkova, Elena; Gautel, Mathias; Pfuhl, Mark			Structure and Interactions of Myosin-binding Protein C Domain C0 CARDIAC-SPECIFIC REGULATION OF MYOSIN AT ITS NECK?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MODEL-FREE APPROACH; DIFFERENTIAL SCANNING CALORIMETRY; MAGNETIC-RESONANCE RELAXATION; LIGHT-CHAIN PHOSPHORYLATION; SMOOTH-MUSCLE TROPOMYOSIN; F-ACTIN; NOESY SPECTRA; MYBP-C; M-BAND	Myosin-binding protein C (MyBP-C) is a multidomain protein present in the thick filaments of striated muscles and is involved in both sarcomere formation and contraction regulation. The latter function is believed to be located at the N terminus, which is close to the motor domain of myosin. The cardiac isoform of MyBP-C is linked to hypertrophic cardiomyopathy. Here, we use NMR spectroscopy and biophysical and biochemical assays to study the three-dimensional structure and interactions of the cardiac-specific Ig-like domain C0, a part of cardiac MyBP-C of which little is known. The structure confirmed that C0 is a member of the IgI class of proteins, showing many of the characteristic features of this fold. Moreover, we identify a novel interaction between C0 and the regulatory light chain of myosin, thus placing the N terminus of the protein in proximity to the motor domain of myosin. This novel interaction is disrupted by several cardiomyopathy-linked mutations in the MYBPC3 gene. These results provide new insights into how cardiac MyBP-C incorporates in the sarcomere and how it can contribute to the regulation of muscle contraction.	[Rostkova, Elena; Gautel, Mathias; Pfuhl, Mark] Kings Coll London, Randall Div Cell & Mol Biophys, BHF Ctr Res Excellence, London SE1 1UL, England; [Rostkova, Elena; Gautel, Mathias; Pfuhl, Mark] Kings Coll London, Div Cardiovasc, BHF Ctr Res Excellence, London SE1 1UL, England; Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of London; King's College London; University of London; King's College London; University of Leicester	Pfuhl, M (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, BHF Ctr Res Excellence, London SE1 1UL, England.	Mark.Pfuhl@kcl.ac.uk	Gautel, Mathias/AAB-9860-2019	Pfuhl, Mark/0000-0001-9592-6639; Gautel, Mathias/0000-0003-4027-9803	BHF; Medical Research Council of Great Britain; MRC [G0600251] Funding Source: UKRI; Medical Research Council [G0600251, G0200496] Funding Source: researchfish	BHF(British Heart Foundation); Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a BHF studentship (to M.P.) and the Medical Research Council of Great Britain (to M.G.).	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; Auerbach D, 1999, MOL BIOL CELL, V10, P1297, DOI 10.1091/mbc.10.5.1297; BAGSHAW C R, 1977, Biochemistry, V16, P59, DOI 10.1021/bi00620a010; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BAX A, 1990, J MAGN RESON, V87, P620, DOI 10.1016/0022-2364(90)90320-9; Bennett PM, 1999, REV PHYSIOL BIOCH P, V138, P203, DOI 10.1007/BF02346664; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; CLORE GM, 1991, ANNU REV BIOPHYS BIO, V20, P29, DOI 10.1146/annurev.biophys.20.1.29; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DANGOOR M, 1990, J MUSCLE RES CELL M, V11, P216, DOI 10.1007/BF01843575; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; GRONENBORN AM, 1989, FEBS LETT, V243, P93, DOI 10.1016/0014-5793(89)81224-4; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Harris SP, 2004, CIRC RES, V95, P930, DOI 10.1161/01.RES.0000147312.02673.56; HEMMINGSEN JM, 1994, PROTEIN SCI, V3, P1927, DOI 10.1002/pro.5560031104; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Herron TJ, 2006, CIRC RES, V98, P1290, DOI 10.1161/01.RES.0000222059.54917.ef; HOLTZER ME, 1990, BIOPOLYMERS, V30, P985, DOI 10.1002/bip.360300913; Idowu SM, 2003, J MOL BIOL, V329, P745, DOI 10.1016/S0022-2836(03)00425-X; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; Lange S, 2005, J MOL BIOL, V345, P289, DOI 10.1016/j.jmb.2004.10.040; Levine R, 2001, BIOPHYS J, V81, P1070, DOI 10.1016/S0006-3495(01)75764-5; Levitsky DI, 2000, EUR J BIOCHEM, V267, P1869, DOI 10.1046/j.1432-1327.2000.01192.x; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MAJUMDAR A, 1993, J MAGN RESON SER B, V102, P242, DOI 10.1006/jmrb.1993.1093; MARGOSSIAN SS, 1985, J BIOL CHEM, V260, P3747; MARGOSSIAN SS, 1987, J MUSCLE RES CELL M, V8, P437, DOI 10.1007/BF01578433; Mayans O, 2001, STRUCTURE, V9, P331, DOI 10.1016/S0969-2126(01)00591-3; McClellan G, 2001, BIOPHYS J, V81, P1083, DOI 10.1016/S0006-3495(01)75765-7; MERABET EK, 1993, BIOCHIM BIOPHYS ACTA, V1161, P272, DOI 10.1016/0167-4838(93)90224-F; Meurs KM, 2005, HUM MOL GENET, V14, P3587, DOI 10.1093/hmg/ddi386; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Oakley CE, 2004, CELL RES, V14, P95, DOI 10.1038/sj.cr.7290208; Offer G, 1996, J MOL BIOL, V256, P407, DOI 10.1006/jmbi.1996.0096; Orlov VN, 1998, FEBS LETT, V433, P241, DOI 10.1016/S0014-5793(98)00923-5; RATTI J, 2009, THESIS U LEICESTER; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Takashima S, 2009, CIRC J, V73, P208, DOI 10.1253/circj.CJ-08-1041; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; WANG AC, 1994, J MAGN RESON SER B, V105, P196, DOI 10.1006/jmrb.1994.1123; Weisberg A, 1996, P NATL ACAD SCI USA, V93, P8999, DOI 10.1073/pnas.93.17.8999; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; Winegrad S, 2003, ADV EXP MED BIOL, V538, P31; Winegrad S, 2000, CIRC RES, V86, P6, DOI 10.1161/01.RES.86.1.6; XIE X, 1994, NATURE, V368, P306, DOI 10.1038/368306a0	58	86	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.156646	http://dx.doi.org/10.1074/jbc.M110.156646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21297165	Green Published, hybrid			2022-12-25	WOS:000289077500076
J	Sela, DA; Li, YH; Lerno, L; Wu, SA; Marcobal, AM; German, JB; Chen, X; Lebrilla, CB; Mills, DA				Sela, David A.; Li, Yanhong; Lerno, Larry; Wu, Shuai; Marcobal, Angela M.; German, J. Bruce; Chen, Xi; Lebrilla, Carlito B.; Mills, David A.			An Infant-associated Bacterial Commensal Utilizes Breast Milk Sialyloligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIC-ACID TRANSPORTER; MASS-SPECTROMETRY; BIFIDOBACTERIAL CONSUMPTION; SUBSTRATE-SPECIFICITY; BACTEROIDES-FRAGILIS; EPITHELIAL-CELLS; OLIGOSACCHARIDES; IDENTIFICATION; PROTECTION; STRATEGY	Lactating mothers secrete milk sialyloligosaccharides (MSOs) that function as anti-adhesives once provided to the neonate. Particular infant-associated commensals, such as Bifidobacterium longum subsp. infantis, consume neutral milk oligosaccharides, although their ability to utilize acidic oligosaccharides has not been assessed. Temporal glycoprofiling of acidic HMO consumed during fermentation demonstrated a single composition, with several isomers, corresponding to sialylated lacto-N-tetraose. To utilize MSO, B. longum subsp. infantis deploys a sialidase that cleaves alpha 2-6 and alpha 2-3 linkages. NanH2, encoded within the HMO catabolic cluster is up-regulated during HMO fermentation and is active on sialylated lacto-N-tetraose. These results demonstrate that commensal microorganisms do utilize MSO, a substrate that may be enriched in the distal gastrointestinal tract.	[Mills, David A.] Univ Calif Davis, Robert Mondavi Inst, Dept Viticulture & Enol, RMI N Lab, Davis, CA 95616 USA; [Sela, David A.] Univ Calif Davis, Robert Mondavi Inst, Microbiol Grad Grp, Davis, CA 95616 USA; [Li, Yanhong; Lerno, Larry; Wu, Shuai; Chen, Xi; Lebrilla, Carlito B.] Univ Calif Davis, Robert Mondavi Inst, Dept Chem, Davis, CA 95616 USA; [German, J. Bruce] Univ Calif Davis, Robert Mondavi Inst, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Mills, DA (corresponding author), Univ Calif Davis, Robert Mondavi Inst, Dept Viticulture & Enol, RMI N Lab, 595 Hilgard Lane, Davis, CA 95616 USA.	damills@ucdavis.edu	Wu, Shuai/I-8696-2012; Chen, Xi/H-1811-2018; Mills, David/GXF-1821-2022; Lebrilla, Carlito Bangeles/ABE-6369-2020; Mills, David Andrew/G-2282-2011; Wu, Shuai/N-8552-2014	Chen, Xi/0000-0002-3160-614X; Mills, David Andrew/0000-0003-1913-9865; 	National Institutes of Health NICHD [5R01HD059127, 1R01HD061923]; National Institutes of Health-NIGMS [3R01GM076360, T32-GM08799]; University of California; Dairy Management Inc.; California Dairy Research Foundation; USDA NRI-CSREES [2008-35200-18776]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059127, R01HD061923, R01HD065122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076360] Funding Source: NIH RePORTER	National Institutes of Health NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of California(University of California System); Dairy Management Inc.; California Dairy Research Foundation; USDA NRI-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NICHD Awards 5R01HD059127 and 1R01HD061923 and by National Institutes of Health-NIGMS 3R01GM076360. This work was also supported by grant support from the University of California Discovery Grant Program, Dairy Management Inc., the California Dairy Research Foundation, and the USDA NRI-CSREES Award 2008-35200-18776.; Supported by a predoctoral training grant (National Institutes of Health-NIGMS T32-GM08799).	Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Bao YW, 2007, ANAL BIOCHEM, V370, P206, DOI 10.1016/j.ab.2007.07.004; Barthelson R, 1998, INFECT IMMUN, V66, P1439, DOI 10.1128/IAI.66.4.1439-1444.1998; Bode L, 2006, J NUTR, V136, P2127, DOI 10.1093/jn/136.8.2127; Brigham C, 2009, J BACTERIOL, V191, P3629, DOI 10.1128/JB.00811-08; Brigham CJ, 2005, J BACTERIOL, V187, P890, DOI 10.1128/JB.187.3.890-901.2005; Cao HZ, 2009, ORG BIOMOL CHEM, V7, P5137, DOI 10.1039/b916305k; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chokhawala HA, 2007, CHEMBIOCHEM, V8, P194, DOI 10.1002/cbic.200600410; Clowers BH, 2008, ANAL BIOCHEM, V381, P205, DOI 10.1016/j.ab.2008.06.041; Dodds ED, 2007, ANAL CHEM, V79, P9547, DOI 10.1021/ac701763t; Dodds ED, 2009, ANAL CHEM, V81, P5533, DOI 10.1021/ac9008918; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Falony G, 2006, APPL ENVIRON MICROB, V72, P7835, DOI 10.1128/AEM.01296-06; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; GYORGY P, 1974, EUR J BIOCHEM, V43, P29, DOI 10.1111/j.1432-1033.1974.tb03380.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Le Blay G, 1999, J NUTR, V129, P2231, DOI 10.1093/jn/129.12.2231; Lewis AL, 2009, P NATL ACAD SCI USA, V106, P13552, DOI 10.1073/pnas.0902431106; Lievin V, 2000, GUT, V47, P646, DOI 10.1136/gut.47.5.646; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; LoCascio RG, 2009, MICROB BIOTECHNOL, V2, P333, DOI 10.1111/j.1751-7915.2008.00072.x; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Markowitz Victor M., 2007, V395, P35; MARTINEZ J, 1995, J BACTERIOL, V177, P6005, DOI 10.1128/jb.177.20.6005-6010.1995; Mavromatis K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007979; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Ninonuevo M, 2005, ELECTROPHORESIS, V26, P3641, DOI 10.1002/elps.200500246; Parche S, 2006, J BACTERIOL, V188, P1260, DOI 10.1128/JB.188.4.1260-1265.2006; Post DMB, 2005, INFECT IMMUN, V73, P6727, DOI 10.1128/IAI.73.10.6727-6735.2005; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; RUIZPALACIOS GM, 1990, J PEDIATR-US, V116, P707, DOI 10.1016/S0022-3476(05)82652-6; Schauer R, 2000, GLYCOCONJUGATE J, V17, P485, DOI 10.1023/A:1011062223612; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Simon PM, 1997, INFECT IMMUN, V65, P750, DOI 10.1128/IAI.65.2.750-757.1997; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao N, 2008, J DAIRY SCI, V91, P3768, DOI 10.3168/jds.2008-1305; TAYLOR G, 1992, J MOL BIOL, V225, P1135, DOI 10.1016/0022-2836(92)90112-W; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Ward RE, 2007, MOL NUTR FOOD RES, V51, P1398, DOI 10.1002/mnfr.200700150; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05; Wilson D, 2007, NUCLEIC ACIDS RES, V35, pD308, DOI 10.1093/nar/gkl910; Xie YM, 2004, ANAL CHEM, V76, P5186, DOI 10.1021/ac0496953; YOLKEN RH, 1992, J CLIN INVEST, V90, P1984, DOI 10.1172/JCI116078; Zhang JH, 2004, ANAL CHEM, V76, P5990, DOI 10.1021/ac049666s	52	138	142	1	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.193359	http://dx.doi.org/10.1074/jbc.M110.193359			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288901	Green Published, hybrid			2022-12-25	WOS:000289077500004
J	Clausen, JD; McIntosh, DB; Woolley, DG; Andersen, JP				Clausen, Johannes D.; McIntosh, David B.; Woolley, David G.; Andersen, Jens Peter			Modulatory ATP Binding Affinity in Intermediate States of E2P Dephosphorylation of Sarcoplasmic Reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-INSENSITIVE PHOSPHOENZYME; NUCLEOTIDE-BINDING; CALCIUM-PUMP; CATALYTIC SITE; ADENOSINE-TRIPHOSPHATASE; FUNCTIONAL CONSEQUENCES; INORGANIC-PHOSPHATE; ACTUATOR DOMAIN; TRANSPORT SITES; CA2+ BINDING	The mechanism of ATP modulation of E2P dephosphorylation of sarcoplasmic reticulum Ca2+-ATPase wild type and mutant forms was examined in nucleotide binding studies of states analogous to the various intermediates of the dephosphorylation reaction, obtained by binding of metal fluorides, vanadate, or thapsigargin. Wild type Ca2+-ATPase displays an ATP affinity of 4 mu M for the E2P ground state analog, 1 mu M for the E2P transition state and product state analogs, and 11 mu M for the E2 dephosphoenzyme. Hence, ATP binding stabilizes the transition and product states relative to the ground state, thereby explaining the accelerating effect of ATP on dephosphorylation. Replacement of Phe(487) (N-domain) with serine, Arg(560) (N-domain) with leucine, or Arg(174) (A-domain) with alanine or glutamate reduces ATP affinity in all E2/E2P intermediate states. Alanine substitution of Ile(188) (A-domain) increases the ATP affinity, although ATP acceleration of dephosphorylation is disrupted, thus indicating that the critical role of Ile(188) in ATP modulation is mechanistically based rather than being associated with the binding of nucleotide. Mutants with alanine replacement of Lys(205) (A-domain) or Glu(439) (N-domain) exhibit an anomalous inhibition by ATP of E2P dephosphorylation, due to ATP binding increasing the stability of the E2P ground state relative to the transition state. The ATP affinity of Ca(2)E2P, stabilized by inserting four glycines in the A-M1 linker, is similar to that of the E2P ground state, but the Ca2+-free E1 state of this mutant exhibits 3 orders of magnitude reduction of ATP affinity.	[Clausen, Johannes D.; Andersen, Jens Peter] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark; [McIntosh, David B.; Woolley, David G.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Div Chem Pathol, ZA-7925 Cape Town, South Africa	Aarhus University; University of Cape Town	Andersen, JP (corresponding author), Ole Worms Alle 6,Bldg 1180, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300	Danish Medical Research Council; Novo Nordisk Foundation; Danish National Research Foundation (PUMPKIN Centre); Centre for Membrane Pumps in Cells and Disease, PUMPKIN, Danish National Research Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation (PUMPKIN Centre)(Danmarks Grundforskningsfond); Centre for Membrane Pumps in Cells and Disease, PUMPKIN, Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported in part by grants from the Danish Medical Research Council (to J. P. A.), the Novo Nordisk Foundation (to J. P. A.), and the Danish National Research Foundation (PUMPKIN Centre).; Supported by the Centre for Membrane Pumps in Cells and Disease, PUMPKIN, Danish National Research Foundation.	Abu-Abed M, 2002, BIOCHEMISTRY-US, V41, P1156, DOI 10.1021/bi015703n; ANDERSEN JP, 1985, BIOCHIM BIOPHYS ACTA, V815, P9, DOI 10.1016/0005-2736(85)90467-5; ARIKI M, 1980, BIOCHEMISTRY-US, V19, P2001, DOI 10.1021/bi00550a042; BISHOP JE, 1987, J BIOL CHEM, V262, P4658; BODLEY AL, 1987, J BIOL CHEM, V262, P13997; CABLE MB, 1985, BIOCHEMISTRY-US, V24, P5612, DOI 10.1021/bi00341a049; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CHAMPEIL P, 1985, BIOCHEMISTRY-US, V24, P69, DOI 10.1021/bi00322a012; CHAMPEIL P, 1986, BIOCHEMISTRY-US, V25, P7623, DOI 10.1021/bi00371a053; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; CHAMPEIL P, 1978, J BIOL CHEM, V253, P1179; Champeil P, 1998, J BIOL CHEM, V273, P6619, DOI 10.1074/jbc.273.12.6619; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOWDHRY V, 1979, ANNU REV BIOCHEM, V48, P293, DOI 10.1146/annurev.bi.48.070179.001453; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Clausen JD, 2003, J BIOL CHEM, V278, P20245, DOI 10.1074/jbc.M301122200; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Clausen JD, 2010, J BIOL CHEM, V285, P20780, DOI 10.1074/jbc.M110.116459; Clausen JD, 2008, J BIOL CHEM, V283, P35703, DOI 10.1074/jbc.M806795200; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2010, J BIOL CHEM, V285, P24538, DOI 10.1074/jbc.M110.144535; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; FORGE V, 1993, J BIOL CHEM, V268, P10953; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Laursen M, 2009, J BIOL CHEM, V284, P13513, DOI 10.1074/jbc.C900031200; Liu XY, 2009, J BIOL CHEM, V284, P25190, DOI 10.1074/jbc.M109.034140; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PICK U, 1982, J BIOL CHEM, V257, P6111; REYNOLDS JA, 1985, P NATL ACAD SCI USA, V82, P3658, DOI 10.1073/pnas.82.11.3658; SAGARA Y, 1992, J BIOL CHEM, V267, P1286; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; SEEBREGTS CJ, 1989, J BIOL CHEM, V264, P2043; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; VILSEN B, 1991, J BIOL CHEM, V266, P16157; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WAKABAYASHI S, 1990, BIOCHEMISTRY-US, V29, P7309, DOI 10.1021/bi00483a022; WAKABAYASHI S, 1986, J BIOL CHEM, V261, P9762	52	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11792	11802		10.1074/jbc.M110.206094	http://dx.doi.org/10.1074/jbc.M110.206094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21288896	hybrid, Green Published			2022-12-25	WOS:000288797100086
J	Lim, YS; Hwang, SB				Lim, Yun-Sook; Hwang, Soon B.			Hepatitis C Virus NS5A Protein Interacts with Phosphatidylinositol 4-Kinase Type III alpha and Regulates Viral Propagation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL 5A PROTEIN; RNA REPLICATION COMPLEX; EXIT SITES; KINASE; IDENTIFICATION; EXPRESSION; INFECTION; SCREEN	Hepatitis C Virus (HCV) nonstructural 5A (NS5A) is a pleiotropic protein involved in viralRNAreplication and modulation of the cellular physiology in HCV-infected cells. Toelucidate the mechanisms of the HCV life cycle, we identified cellular factors interacting with the NS5A protein in HCV-infected cells. Huh7.5 cells were electroporated with HCV Jc1 RNA. Cellular factors associated with HCV NS5A were identified by immunoprecipitation with Dynabead-conjugated NS5A antibody and LC-MS/MS. Phosphatidylinositol 4-kinase type III alpha (PI4KIII alpha) was identified as a binding partner for the NS5A protein. NS5A derived from both genotypes 1b and 2a interacted with PI4KIII alpha. NS5A interacted with PI4KIII alpha through amino acids 401-600 of PI4KIII alpha and domain I of NS5A. Interference of the protein interaction between NS5A and PI4KIII alpha decreased HCV propagation. Knockdown of PI4KIII alpha significantly reduced HCV replication in Huh7 cells harboring the subgenomic replicon and in Huh7.5 cells infected with cell culture grown virus (HCVcc). Silencing of PI4KIII alpha further inhibited HCV release into the tissue culture medium. NS5A may recruit PI4KIII alpha to the HCV RNA replication complex. These data suggest that PI4KIII alpha is an essential host factor that supports HCV proliferation and therefore PI4KIII alpha may be a legitimate target for anti-HCV therapy.	[Lim, Yun-Sook; Hwang, Soon B.] Hallym Univ, Natl Res Lab Hepatitis Virus C, Ilsong Inst Life Sci, Anyang 431060, South Korea	Hallym University	Hwang, SB (corresponding author), 1605-4 Gwanyang Dong, Anyang 431060, South Korea.	sbhwang@hallym.ac.kr			Ministry of Education, Science and Technology, Korea [ROA-2007-000-20051-0]; Ministry for Health and Welfare, Korea [1020290]	Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by National Research Laboratory Grant ROA-2007-000-20051-0 from the Ministry of Education, Science and Technology, Korea, and the National R&D Program for Cancer Control, Ministry for Health and Welfare, Korea (1020290).	Ahn J, 2004, J BIOCHEM MOL BIOL, V37, P741; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Blumental-Perry A, 2006, DEV CELL, V11, P671, DOI 10.1016/j.devcel.2006.09.001; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; El-Serag HB, 2002, J CLIN GASTROENTEROL, V35, pS72, DOI 10.1097/00004836-200211002-00002; Farhan H, 2008, EMBO J, V27, P2043, DOI 10.1038/emboj.2008.136; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gehrmann T, 1999, BBA-MOL CELL BIOL L, V1437, P341, DOI 10.1016/S1388-1981(99)00029-3; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002; Hughes M, 2009, J VIROL, V83, P10788, DOI 10.1128/JVI.02406-08; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Park CY, 2009, J HEPATOL, V51, P853, DOI 10.1016/j.jhep.2009.06.026; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; Park KJ, 2003, J BIOL CHEM, V278, P30711, DOI 10.1074/jbc.M209623200; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Shelton H, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-24; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; Wang AG, 2009, J PATHOL, V219, P253, DOI 10.1002/path.2592	30	82	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11290	11298		10.1074/jbc.M110.194472	http://dx.doi.org/10.1074/jbc.M110.194472			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21297162	Green Published, hybrid			2022-12-25	WOS:000288797100041
J	Paterniti, I; Mazzon, E; Gil, C; Impellizzeri, D; Palomo, V; Redondo, M; Perez, DI; Esposito, E; Martinez, A; Cuzzocrea, S				Paterniti, Irene; Mazzon, Emanuela; Gil, Carmen; Impellizzeri, Daniela; Palomo, Valle; Redondo, Myriam; Perez, Daniel I.; Esposito, Emanuela; Martinez, Ana; Cuzzocrea, Salvatore			PDE 7 Inhibitors: New Potential Drugs for the Therapy of Spinal Cord Injury	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; KAPPA-B ACTIVATION; CELL-DEATH; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; MESSENGER-RNA; EXPRESSION; APOPTOSIS; PHOSPHODIESTERASES; NEURONS	Background: Primary traumatic mechanical injury to the spinal cord (SCI) causes the death of a number of neurons that to date can neither be recovered nor regenerated. During the last years our group has been involved in the design, synthesis and evaluation of PDE7 inhibitors as new innovative drugs for several neurological disorders. Our working hypothesis is based on two different facts. Firstly, neuroinflammation is modulated by cAMP levels, thus the key role for phosphodiesterases (PDEs), which hydrolyze cAMP, is undoubtedly demonstrated. On the other hand, PDE7 is expressed simultaneously on leukocytes and on the brain, highlighting the potential crucial role of PDE7 as drug target for neuroinflammation. Methodology/Principal Findings: Here we present two chemically diverse families of PDE7 inhibitors, designed using computational techniques such as virtual screening and neuronal networks. We report their biological profile and their efficacy in an experimental SCI model induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. We have selected two candidates, namely S14 and VP1.15, as PDE7 inhibitors. These compounds increase cAMP production both in macrophage and neuronal cell lines. Regarding drug-like properties, compounds were able to cross the blood brain barrier using parallel artificial membranes (PAMPA) methodology. SCI in mice resulted in severe trauma characterized by edema, neutrophil infiltration, and production of a range of inflammatory mediators, tissue damage, and apoptosis. Treatment of the mice with S14 and VP1.15, two PDE7 inhibitors, significantly reduced the degree of spinal cord inflammation, tissue injury (histological score), and TNF-alpha, IL-6, COX-2 and iNOS expression. Conclusions/Significance: All these data together led us to propose PDE7 inhibitors, and specifically S14 and VP1.15, as potential drug candidates to be further studied for the treatment of SCI.	[Paterniti, Irene; Impellizzeri, Daniela; Esposito, Emanuela; Cuzzocrea, Salvatore] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy; [Mazzon, Emanuela; Esposito, Emanuela; Cuzzocrea, Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Gil, Carmen; Palomo, Valle; Redondo, Myriam; Perez, Daniel I.; Martinez, Ana] CSIC, Inst Quim Med, E-28006 Madrid, Spain	University of Messina; IRCCS Bonino Pulejo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); CSIC - Instituto de Quimica Organica General (IQOG)	Paterniti, I (corresponding author), Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy.	salvator@unime.it	Mazzon, Emanuela/AAL-4334-2020; del Valle Palomo Ruiz, María/N-2932-2016; Martinez, Ana/L-6414-2014; Perez Fernandez, Daniel Ignacio/L-6245-2014; Gil, Carmen/J-8932-2014	del Valle Palomo Ruiz, María/0000-0002-1473-4086; Martinez, Ana/0000-0002-2707-8110; Perez Fernandez, Daniel Ignacio/0000-0003-1774-4471; Gil, Carmen/0000-0002-3882-6081; mazzon, emanuela/0000-0002-5073-717X; Esposito, Emanuela/0000-0002-2663-6387; Impellizzeri, Daniela/0000-0001-9492-3161	MICINN; ISCiii [SAF2009-13015-CO2-01, RD0060/0015]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); ISCiii(Instituto de Salud Carlos III)	The financial support of MICINN and ISCiii (projects no. SAF2009-13015-CO2-01 and RD0060/0015, programs SAF and RETICS respectively) are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa T, 2003, CIRC RES, V93, P406, DOI 10.1161/01.RES.0000091074.33584.F0; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; Bao F, 2003, J NEUROSCI RES, V71, P220, DOI 10.1002/jnr.10481; Bar-Peled O, 1999, J NEUROSCI RES, V55, P542, DOI 10.1002/(SICI)1097-4547(19990301)55:5<542::AID-JNR2>3.0.CO;2-7; BARTHOLDI D, 1995, BRAIN RES, V672, P177, DOI 10.1016/0006-8993(94)01410-J; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bhat NR, 1998, J NEUROSCI, V18, P1633; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Castano T, 2009, CHEMMEDCHEM, V4, P866, DOI 10.1002/cmdc.200900043; Castro A, 2005, MED RES REV, V25, P229, DOI 10.1002/med.20020; Castro A, 2008, EUR J MED CHEM, V43, P1349, DOI 10.1016/j.ejmech.2007.10.027; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Choi SH, 2003, NEUROBIOL DIS, V14, P181, DOI 10.1016/S0969-9961(03)00085-8; Choi SH, 2003, J NEUROSCI, V23, P5877; Combs CK, 2001, J NEUROSCI, V21, P1179; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Crivori P, 2000, J MED CHEM, V43, P2204, DOI 10.1021/jm990968+; Cuzzocrea S, 2006, J PHARMACOL EXP THER, V319, P127, DOI 10.1124/jpet.106.108076; de Castro R, 2004, EXP NEUROL, V190, P414, DOI 10.1016/j.expneurol.2004.05.046; Di L, 2003, EUR J MED CHEM, V38, P223, DOI 10.1016/S0223-5234(03)00012-6; Dyke HJ, 2002, EXPERT OPIN INV DRUG, V11, P1; Essayan DM, 1999, BIOCHEM PHARMACOL, V57, P965, DOI 10.1016/S0006-2952(98)00331-1; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; Genovese T, 2006, J NEUROSURG-SPINE, V4, P145, DOI 10.3171/spi.2006.4.2.145; Giembycz MA, 1996, BRIT J PHARMACOL, V118, P1945, DOI 10.1111/j.1476-5381.1996.tb15629.x; Giembycz MA, 2005, CURR OPIN PHARMACOL, V5, P238, DOI 10.1016/j.coph.2005.04.001; Gil C, 2009, J NEUROCHEM, V110, P119; Gil C, 2008, EXPERT OPIN THER PAT, V18, P1127, DOI 10.1517/13543776.18.10.1127; Glaser J, 2006, J NEUROSCI RES, V84, P724, DOI 10.1002/jnr.20982; Haddad JJ, 2002, CELL SIGNAL, V14, P879, DOI 10.1016/S0898-6568(02)00053-0; Hong GY, 2010, J SURG RES, V159, P565, DOI 10.1016/j.jss.2008.12.018; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; La Rosa G, 2004, J NEUROSURG-SPINE, V1, P311, DOI 10.3171/spi.2004.1.3.0311; Lee R, 2002, CELL SIGNAL, V14, P277, DOI 10.1016/S0898-6568(01)00250-9; Levy M L, 1999, Neurosurg Focus, V6, pe11; Li LS, 1999, SCIENCE, V283, P848, DOI 10.1126/science.283.5403.848; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Maegele M, 2005, CRIT CARE MED, V33, P1136, DOI 10.1097/01.CCM.0000163269.42524.50; Manning CD, 1999, BRIT J PHARMACOL, V128, P1393, DOI 10.1038/sj.bjp.0702911; MARTINEZ AC, 2009, 5 IMINO SUBSTITUTED; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Mullane K, 1989, Prog Clin Biol Res, V301, P39; Nakata A, 2002, CLIN EXP IMMUNOL, V128, P460, DOI 10.1046/j.1365-2249.2002.01856.x; Nesic-Taylor O, 2005, J NEUROSCI RES, V79, P628, DOI 10.1002/jnr.20400; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rahman A, 2004, AM J PHYSIOL-LUNG C, V287, pL1017, DOI 10.1152/ajplung.00072.2004; Redondo M, 2009, DRUG FUTURE, V34, P142; Reyes-Irisarri E, 2005, NEUROSCIENCE, V132, P1173, DOI 10.1016/j.neuroscience.2005.01.050; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Sirin BH, 2002, ACTA CARDIOL, V57, P279, DOI 10.2143/AC.57.4.2005427; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Spina D, 2003, DRUGS, V63, P2575, DOI 10.2165/00003495-200363230-00002; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; vanAsperen J, 1997, J PHARM SCI, V86, P881, DOI 10.1021/js9701364; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Yang GC, 2003, J IMMUNOL, V171, P6414, DOI 10.4049/jimmunol.171.12.6414	65	56	60	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15937	10.1371/journal.pone.0015937	http://dx.doi.org/10.1371/journal.pone.0015937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297958	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300030
J	Mukherjee, A; Badal, Y; Nguyen, XT; Miller, J; Chenna, A; Tahir, H; Newton, A; Parry, G; Williams, S				Mukherjee, Ali; Badal, Youssouf; Nguyen, Xuan-Thao; Miller, Johanna; Chenna, Ahmed; Tahir, Hasan; Newton, Alicia; Parry, Gordon; Williams, Stephen			Profiling the HER3/PI3K Pathway in Breast Tumors Using Proximity-Directed Assays Identifies Correlations between Protein Complexes and Phosphoproteins	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR-RECEPTOR; PHOSPHATIDYLINOSITOL-3-OH KINASE; MONOCLONAL-ANTIBODY; SIGNAL-TRANSDUCTION; GENE AMPLIFICATION; POOR-PROGNOSIS; ERBB RECEPTORS; CELL-LINES; CANCER	Background: The identification of patients for targeted antineoplastic therapies requires accurate measurement of therapeutic targets and associated signaling complexes. HER3 signaling through heterodimerization is an important growth-promoting mechanism in several tumor types and may be a principal resistance mechanism by which EGFR and HER2 expressing tumors elude targeted therapies. Current methods that can study these interactions are inadequate for formalin-fixed, paraffin-embedded (FFPE) tumor samples. Methodology and Principal Findings: Herein, we describe a panel of proximity-directed assays capable of measuring protein-interactions and phosphorylation in FFPE samples in the HER3/PI3K/Akt pathway and examine the capability of these assays to inform on the functional state of the pathway. We used FFPE breast cancer cell line and tumor models for this study. In breast cancer cell lines we observe both ligand-dependent and independent activation of the pathway and strong correlations between measured activation of key analytes. When selected cell lines are treated with HER2 inhibitors, we not only observe the expected molecular effects based on mechanism of action knowledge, but also novel effects of HER2 inhibition on key targets in the HER receptor pathway. Significantly, in a xenograft model of delayed tumor fixation, HER3 phosphorylation is unstable, while alternate measures of pathway activation, such as formation of the HER3PI3K complex is preserved. Measurements in breast tumor samples showed correlations between HER3 phosphorylation and receptor interactions, obviating the need to use phosphorylation as a surrogate for HER3 activation. Significance: This assay system is capable of quantitatively measuring therapeutically relevant responses and enables molecular profiling of receptor networks in both preclinical and tumor models.	[Mukherjee, Ali; Badal, Youssouf; Nguyen, Xuan-Thao; Miller, Johanna; Chenna, Ahmed; Tahir, Hasan; Newton, Alicia; Parry, Gordon; Williams, Stephen] Monogram Biosci, Dept Oncol, San Francisco, CA USA		Mukherjee, A (corresponding author), Monogram Biosci, Dept Oncol, San Francisco, CA USA.	amukherjee@monogrambio.com			Monogram Biosciences	Monogram Biosciences	Study design, data collection and analysis, decision to publish, and preparation of the manuscript were done by employees of Monogram Biosciences. The research described in this manuscript was performed at Monogram Biosciences. All authors are employees of Monogram Biosciences. All authors received funding, including salaries, equipment, supplies, reimbursement for attending symposia, etc, from Monogram Biosciences.	AKIYAMA T, 1991, MOL CELL BIOL, V11, P833, DOI 10.1128/MCB.11.2.833; Albanell J, 2001, JNCI-J NATL CANCER I, V93, P1830, DOI 10.1093/jnci/93.24.1830; Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bhargava R, 2001, HUM PATHOL, V32, P1344, DOI 10.1053/hupa.2001.29668; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Chua YL, 2009, ONCOGENE, V28, P4041, DOI 10.1038/onc.2009.259; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; DUA R, 2009, BREAST CANC IN PRESS; Erjala K, 2006, CLIN CANCER RES, V12, P4103, DOI 10.1158/1078-0432.CCR-05-2404; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Hynes NE, 2000, BREAST CANCER RES, V2, P154, DOI 10.1186/bcr48; Johnston S, 2008, J CLIN ONCOL, V26, P1066, DOI 10.1200/JCO.2007.13.9949; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kong A, 2006, CANCER RES, V66, P2834, DOI 10.1158/0008-5472.CAN-05-2994; Koos B, 2009, AM J PATHOL, V175, P1631, DOI 10.2353/ajpath.2009.081022; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Mandell JW, 2008, HISTOCHEM CELL BIOL, V130, P465, DOI 10.1007/s00418-008-0474-z; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Menard S, 2000, J CELL PHYSIOL, V182, P150, DOI 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E; Menendez JA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1773; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Petricoin EF, 2005, J CLIN ONCOL, V23, P3614, DOI 10.1200/JCO.2005.02.509; Reschke M, 2008, CLIN CANCER RES, V14, P5188, DOI 10.1158/1078-0432.CCR-08-0186; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shi YN, 2009, DIAGN MOL PATHOL, V18, P11, DOI 10.1097/PDM.0b013e31818cbdb2; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith BL, 2004, BRIT J CANCER, V91, P1190, DOI 10.1038/sj.bjc.6602090; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Winters ZE, 2003, BREAST CANCER RES, V5, pR242, DOI 10.1186/bcr654; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Zieba A, 2010, CLIN CHEM, V56, P99, DOI 10.1373/clinchem.2009.134452	42	17	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16443	10.1371/journal.pone.0016443	http://dx.doi.org/10.1371/journal.pone.0016443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297994	Green Published, gold, Green Submitted			2022-12-25	WOS:000286664100032
J	Tomaselli, S; Megiorni, F; Lin, L; Mazzilli, MC; Gerrelli, D; Majore, S; Grammatico, P; Achermann, JC				Tomaselli, Sara; Megiorni, Francesca; Lin, Lin; Mazzilli, Maria Cristina; Gerrelli, Dianne; Majore, Silvia; Grammatico, Paola; Achermann, John C.			Human RSPO1/R-spondin1 Is Expressed during Early Ovary Development and Augments beta-Catenin Signaling	PLOS ONE			English	Article							SEX DETERMINATION REVEALS; GENE-EXPRESSION; R-SPONDIN; GONADAL DEVELOPMENT; ADULT OVARIES; R-SPONDIN1; DIFFERENTIATION; REVERSAL; RSPO1; ACTIVATION	Human testis development starts from around 42 days post conception with a transient wave of SRY expression followed by up-regulation of testis specific genes and a distinct set of morphological, paracrine and endocrine events. Although anatomical changes in the ovary are less marked, a distinct sub-set of ovary specific genes are also expressed during this time. The furin-domain containing peptide R-spondin1 (RSPO1) has recently emerged as an important regulator of ovary development through up-regulation of the WNT/beta-catenin pathway to oppose testis formation. Here, we show that RSPO1 is upregulated in the ovary but not in the testis during critical early stages of gonad development in humans (between 6-9 weeks post conception), whereas the expression of the related genes WNT4 and CTNNB1 (encoding beta catenin) is not significantly different between these tissues. Furthermore, reduced R-spondin1 function in the ovotestis of an individual (46,XX) with a RSPO1 mutation leads to reduced beta-catenin protein and WNT4 mRNA levels, consistent with down regulation of ovarian pathways. Transfection of wildtype RSPO1 cDNA resulted in weak dose-dependent activation of a beta-catenin responsive TOPFLASH reporter (1.8 fold maximum), whereas co-transfection of CTNNB1 (encoding beta-catenin) with RSPO1 resulted in dose-dependent synergistic augmentation of this reporter (approximately 10 fold). Furthermore, R-spondin1 showed strong nuclear localization in several different cell lines. Taken together, these data show that R-spondin1 is upregulated during critical stages of early human ovary development and may function as a tissue-specific amplifier of beta-catenin signaling to oppose testis determination.	[Tomaselli, Sara; Majore, Silvia; Grammatico, Paola] Univ Roma La Sapienza, S Camillo Forlanini Hosp, Dept Mol Med, Rome, Italy; [Tomaselli, Sara; Lin, Lin; Achermann, John C.] UCL Inst Child Hlth, Dev Endocrinol Res Grp, London, England; [Megiorni, Francesca; Mazzilli, Maria Cristina] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Gerrelli, Dianne] UCL Inst Child Hlth, Neural Dev Unit, London, England	Azienda Ospedaliera San Camillo-Forlanini; Sapienza University Rome; University of London; University College London; Sapienza University Rome; University of London; University College London	Tomaselli, S (corresponding author), Univ Roma La Sapienza, S Camillo Forlanini Hosp, Dept Mol Med, Rome, Italy.	j.achermann@ich.ucl.ac.uk	Megiorni, Francesca/AAC-1597-2019; Majore, Silvia/AAH-1210-2019; Achermann, John/N-2906-2019; Achermann, John/C-5476-2008	Megiorni, Francesca/0000-0003-3705-3248; Achermann, John/0000-0001-8787-6272; Achermann, John/0000-0001-8787-6272; Majore, Silvia/0000-0001-7153-9351	Medical Research Council [G0700089]; Wellcome Trust [082557]; MIUR [COFIN 2008 CAP7245/1]; Auriga ONLUS; Medical Research Council [G9900837] Funding Source: researchfish; MRC [G9900837, G0700089] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MIUR(Ministry of Education, Universities and Research (MIUR)); Auriga ONLUS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JCA is a Wellcome Trust Senior Fellow in Clinical Science [079666]. The Human Developmental Biology Resource receives funding from the Medical Research Council [G0700089] and The Wellcome Trust [082557]. This work was partially supported by a grant from MIUR (COFIN 2008 CAP7245/1) and by the Auriga ONLUS project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Buscara L, 2009, TRANSGENIC RES, V18, P649, DOI 10.1007/s11248-009-9247-2; Chadi S, 2009, BIOCHEM BIOPH RES CO, V390, P1040, DOI 10.1016/j.bbrc.2009.10.104; Chassot AA, 2008, SEX DEV, V2, P219, DOI 10.1159/000152038; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dignam DJ, 1983, NUCLEIC ACIDS RES, V11, P1475; Jaaskelainen M, 2010, MOL CELL ENDOCRINOL, V317, P106, DOI 10.1016/j.mce.2009.11.013; Jordan BK, 2001, AM J HUM GENET, V68, P1102, DOI 10.1086/320125; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kocer A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-36; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WY, 2008, FEBS LETT, V582, P643, DOI 10.1016/j.febslet.2008.01.035; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Mendonca BB, 2009, CLIN ENDOCRINOL, V70, P173, DOI 10.1111/j.1365-2265.2008.03392.x; Mizusaki H, 2003, MOL ENDOCRINOL, V17, P507, DOI 10.1210/me.2002-0362; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-72; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tomaselli S, 2008, HUM MUTAT, V29, P220, DOI 10.1002/humu.20665; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106	43	61	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16366	10.1371/journal.pone.0016366	http://dx.doi.org/10.1371/journal.pone.0016366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297984	Green Published, Green Submitted, gold			2022-12-25	WOS:000286664100024
J	Gascoin-Lachambre, G; Brauner, R; Duche, L; Chalumeau, M				Gascoin-Lachambre, Geraldine; Brauner, Raja; Duche, Laetitia; Chalumeau, Martin			Pituitary Stalk Interruption Syndrome: Diagnostic Delay and Sensitivity of the Auxological Criteria of the Growth Hormone Research Society	PLOS ONE			English	Article							GH DEFICIENCY; SHORT STATURE; LONG-TERM; HEALTH-CARE; WORK-UP; CHILDREN; CHILDHOOD; PREVALENCE; GUIDELINES; HEIGHT	Objectives: To study the diagnostic delay for pituitary stalk interruption syndrome (PSIS) with growth hormone deficiency (GHD) and the sensitivity of the auxological criteria of the Growth Hormone Research Society (GHRS) consensus guidelines. Methods: A single-center retrospective case-cohort study covering records from January 2000 through December 2007 evaluated the performance of each GHRS auxological criterion for patients with GHD and PSIS. Diagnostic delay was calculated as the difference between the age at which the earliest GHRS criterion could have been observed and the age at diagnosis of PSIS with GHD. A diagnostic delay exceeding one year was defined as late diagnosis. Results: The study included 21 patients, 16 (76%) of whom had isolated GHD and 5 (24%) multiple pituitary hormone deficiencies. The median age at diagnosis was 3.6 years (interquartile range, IQR, 2.6-5.5). The median diagnostic delay was 2.3 years (range 0-12.6; IQR 1.5-3.6), with late diagnosis for 17 patients (81%). Height more than 1.5 SDS below target height was the most effective criterion: 90% of the patients met the criterion before diagnosis at a median age of 1 year, and it was the first criterion to be fulfilled for 84%. Conclusion: In our cohort, the delay for diagnosis of PSIS with GHD was long and could have been reduced by using the GHRS criteria, in particular, height more than 1.5 SDS below the target height. The specificity of such a strategy needs to be tested in healthy populations.	[Gascoin-Lachambre, Geraldine; Brauner, Raja; Duche, Laetitia] Univ Paris 05, Hop Bicetre, AP HP, Unite Endocrinol Pediat, Le Kremlin Bicetre, France; [Gascoin-Lachambre, Geraldine] Univ Paris 05, Grp Hosp Cochin St Vincent de Paul, Serv Med Neonatale Port Royal, AP HP, Paris, France; [Duche, Laetitia; Chalumeau, Martin] Univ Paris 05, Hop Necker Enfants Malad, Serv Pediat Gen, AP HP, Le Kremlin Bicetre, France; [Duche, Laetitia; Chalumeau, Martin] Hop St Vincent de Paul, INSERM, U953,drens Hlth, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Gascoin-Lachambre, G (corresponding author), Univ Paris 05, Hop Bicetre, AP HP, Unite Endocrinol Pediat, Le Kremlin Bicetre, France.	martin.chalumeau@nck.aphp.fr	Chalumeau, Martin/F-4293-2017	Chalumeau, Martin/0000-0001-8175-3706				Albertsson-Wikland K, 1990, Acta Paediatr Scand Suppl, V370, P115; Albertsson-Wikland K, 1990, ACTA PAEDIATR SC   S, V370, P121; ARGYROPOULOU M, 1992, J PEDIATR-US, V120, P886, DOI 10.1016/S0022-3476(05)81955-9; Arrigo T, 1998, EUR J ENDOCRINOL, V139, P84, DOI 10.1530/eje.0.1390084; Badaru A, 2004, TRENDS ENDOCRIN MET, V15, P252, DOI 10.1016/j.tem.2004.06.004; BAO XL, 1992, CHINESE MED J-PEKING, V105, P401; Carayol M, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, pS37; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Duche L, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-29; Fayter D, 2008, ARCH DIS CHILD, V93, P278, DOI 10.1136/adc.2006.109843; Ghigo E, 2008, GROWTH HORM IGF RES, V18, P1, DOI 10.1016/j.ghir.2007.07.004; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Grote FK, 2008, ARCH DIS CHILD, V93, P212, DOI 10.1136/adc.2007.120188; Grote FK, 2005, J PEDIATR ENDOCR MET, V18, P1031; Grote FK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-77; Grote FK, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-21; Grumbach MM, 1998, HORM RES, V49, P41, DOI 10.1159/000053087; Hall DMB, 2000, ARCH DIS CHILD, V82, P10, DOI 10.1136/adc.82.1.10; Hanew K, 2006, ENDOCR J, V53, P259, DOI 10.1507/endocrj.53.259; Hindmarsh PC, 2004, ARCH DIS CHILD, V89, P296, DOI 10.1136/adc.2003.039560; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Juul A, 2002, HORM RES, V58, P233, DOI 10.1159/000066265; Le Ray C, 2006, OBSTET GYNECOL, V107, P1269; Lemaire P, 2009, MED SCI MONITOR, V15, pMT5; LINDSAY R, 1994, J PEDIATR-US, V125, P29, DOI 10.1016/S0022-3476(94)70117-2; Louvel M, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-29; Maghnie M, 1999, J CLIN ENDOCR METAB, V84, P1324, DOI 10.1210/jc.84.4.1324; Marcu Mariana, 2008, BMC Endocr Disord, V8, P7, DOI 10.1186/1472-6823-8-7; Mills JL, 2004, J PEDIATR-US, V144, P430, DOI 10.1016/j.jpeds.2003.12.036; Oostdijk W, 2009, HORM RES, V72, P206, DOI 10.1159/000236082; PENEAU S, 2007, OBES REV, V8, P22; Pinto G, 1997, J CLIN ENDOCR METAB, V82, P3450, DOI 10.1210/jc.82.10.3450; Pinto G, 1999, ANN ENDOCRINOL-PARIS, V60, P224; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Rottembourg D, 2008, CLIN ENDOCRINOL, V69, P105, DOI 10.1111/j.1365-2265.2007.03155.x; Sempe M, 1979, AUXOLOGIE METHODE SE, P1; Sizonenko PC, 2001, GROWTH HORM IGF RES, V11, P137, DOI 10.1054/ghir.2001.0203; Taback SP, 1996, J CLIN ENDOCR METAB, V81, P1693, DOI 10.1210/jc.81.5.1693; TANNER JM, 1970, ARCH DIS CHILD, V45, P755, DOI 10.1136/adc.45.244.755; Tauber M, 2005, HORM RES, V64, P266, DOI 10.1159/000089425; Trivin C, 2006, J PEDIATR ENDOCR MET, V19, P481; van Buuren S, 2004, ARCH DIS CHILD, V89, P336, DOI 10.1136/adc.2003.027839; van Buuren S, 2004, ARCH DIS CHILD, V89, P351, DOI 10.1136/adc.2003.038208; VIMPANI GV, 1977, BMJ-BRIT MED J, V2, P427, DOI 10.1136/bmj.2.6084.427	44	25	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16367	10.1371/journal.pone.0016367	http://dx.doi.org/10.1371/journal.pone.0016367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298012	gold, Green Published, Green Submitted			2022-12-25	WOS:000286663900041
J	Zhang, HH; Gogada, R; Yadav, N; Lella, RK; Badeaux, M; Ayres, M; Gandhi, V; Tang, DG; Chandra, D				Zhang, Honghao; Gogada, Raghu; Yadav, Neelu; Lella, Ravi K.; Badeaux, Mark; Ayres, Mary; Gandhi, Varsha; Tang, Dean G.; Chandra, Dhyan			Defective Molecular Timer in the Absence of Nucleotides Leads to Inefficient Caspase Activation	PLOS ONE			English	Article							CYTOCHROME-C; APOPTOSOME FORMATION; APAF-1 APOPTOSOME; STRUCTURAL BASIS; CELL-DEATH; XIAP; PROCASPASE-9; BINDING; INHIBITION; MECHANISM	In the intrinsic death pathway, cytochrome C (CC) released from mitochondria to the cytosol triggers Apaf-1 apoptosome formation and subsequent caspase activation. This process can be recapitulated using recombinant Apaf-1 and CC in the presence of nucleotides ATP or dATP [(d)ATP] or using fresh cytosol and CC without the need of exogenous nucleotides. Surprisingly, we found that stored cytosols failed to support CC-initiated caspase activation. Storage of cytosols at different temperatures led to the loss of all (deoxy)nucleotides including (d)ATP. Addition of (d)ATP to such stored cytosols partially restored CC-initiated caspase activation. Nevertheless, CC could not induce complete caspase-9/3 activation in stored cytosols, even with the addition of (d)ATP, despite robust Apaf-1 oligomerization. The Apaf-1 apoptosome, which functions as a proteolytic-based molecular timer appeared to be defective as auto-processing of recruited procaspase-9 was inhibited. Far Western analysis revealed that procaspase-9 directly interacted with Apaf-1 and this interaction was reduced in the presence of physiological levels of ATP. Co-incubation of recombinant Apaf-1 and procaspase-9 prior to CC and ATP addition inhibited CC-induced caspase activity. These findings suggest that in the absence of nucleotide such as ATP, direct association of procaspase-9 with Apaf-1 leads to defective molecular timer, and thus, inhibits apoptosome-mediated caspase activation. Altogether, our results provide novel insight on nucleotide regulation of apoptosome.	[Zhang, Honghao; Gogada, Raghu; Yadav, Neelu; Lella, Ravi K.; Chandra, Dhyan] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Badeaux, Mark; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Ayres, Mary; Gandhi, Varsha] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Roswell Park Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Zhang, HH (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	dhyan.chandra@roswellpark.org	Gogada, Raghu/AAG-6624-2019; Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174; Gogada, Raghu/0000-0003-0933-7999; Chandra, Dhyan/0000-0001-7272-9384; Zhang, Honghao/0000-0002-2338-6992	National Institutes of Health [CA123142, ES015888, ES015893-01A1, CA57629, CA85915]; National Cancer Institute Center [CA16056]; Roswell Park Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA085915, R01CA057629, P30CA016056, K01CA123142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015893, R01ES015888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Roswell Park Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by a National Institutes of Health K01 award CA123142 to DC, National Cancer Institute Center grant CA16056 to Roswell Park Cancer Institute, and institutional start-up support to DC. The authors also acknowledge support by grants from the National Institutes of Health (ES015888 and ES015893-01A1 to DGT, and CA57629 and CA85915 to VG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.291pe62; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Benedict MA, 2000, J BIOL CHEM, V275, P8461, DOI 10.1074/jbc.275.12.8461; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chandra D, 2003, J BIOL CHEM, V278, P17408, DOI 10.1074/jbc.M300750200; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chandra D, 2005, J BIOL CHEM, V280, P19051, DOI 10.1074/jbc.M501391200; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; CRAIG DB, 1991, BIOCHEM J, V279, P781, DOI 10.1042/bj2790781; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Gandhi V, 2001, CANCER RES, V61, P5474; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kim HE, 2008, MOL CELL, V30, P239, DOI 10.1016/j.molcel.2008.03.014; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Martin AG, 2004, BIOCHEM BIOPH RES CO, V319, P944, DOI 10.1016/j.bbrc.2004.05.084; Martin SJ, 1996, EMBO J, V15, P2407, DOI 10.1002/j.1460-2075.1996.tb00598.x; Mesner PW, 1999, J BIOL CHEM, V274, P22635, DOI 10.1074/jbc.274.32.22635; MILLER DS, 1986, J BIOL CHEM, V261, P13911; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Samali A, 2007, APOPTOSIS, V12, P465, DOI 10.1007/s10495-006-0017-9; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; XIE CX, 1995, CANCER RES, V55, P2847; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16379	10.1371/journal.pone.0016379	http://dx.doi.org/10.1371/journal.pone.0016379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21297999	Green Published, gold, Green Submitted			2022-12-25	WOS:000286663900044
J	Traversa, G; Spila-Alegiani, S; Bianchi, C; degli Atti, MC; Frova, L; Massari, M; Raschetti, R; Salmaso, S; Tomba, GS				Traversa, Giuseppe; Spila-Alegiani, Stefania; Bianchi, Clara; degli Atti, Marta Ciofi; Frova, Luisa; Massari, Marco; Raschetti, Roberto; Salmaso, Stefania; Tomba, Gianpaolo Scalia		Hera Study Grp	Sudden Unexpected Deaths and Vaccinations during the First Two Years of Life in Italy: A Case Series Study	PLOS ONE			English	Article							TETANUS-PERTUSSIS IMMUNIZATION; INFANT-DEATH; ADVERSE REACTIONS; DIPHTHERIA; POLIOMYELITIS; VACCINES; RISK	Background: The signal of an association between vaccination in the second year of life with a hexavalent vaccine and sudden unexpected deaths (SUD) in the two days following vaccination was reported in Germany in 2003. A study to establish whether the immunisation with hexavalent vaccines increased the short term risk of SUD in infants was conducted in Italy. Methodology/Principal Findings: The reference population comprises around 3 million infants vaccinated in Italy in the study period 1999-2004 (1.5 million received hexavalent vaccines). Events of SUD in infants aged 1-23 months were identified through the death certificates. Vaccination history was retrieved from immunisation registries. Association between immunisation and death was assessed adopting a case series design focusing on the risk periods 0-1, 0-7, and 0-14 days after immunisation. Among the 604 infants who died of SUD, 244 (40%) had received at least one vaccination. Four deaths occurred within two days from vaccination with the hexavalent vaccines (RR = 1.5; 95% CI 0.6 to 4.2). The RRs for the risk periods 0-7 and 0-14 were 2.0 (95% CI 1.2 to 3.5) and 1.5 (95% CI 0.9 to 2.4). The increased risk was limited to the first dose (RR = 2.2; 95% CI 1.1 to 4.4), whereas no increase was observed for the second and third doses combined. Conclusions: The RRs of SUD for any vaccines and any risk periods, even when greater than 1, were almost an order of magnitude lower than the estimates in Germany. The limited increase in RRs found in Italy appears confined to the first dose and may be partly explained by a residual uncontrolled confounding effect of age.	[Traversa, Giuseppe; Spila-Alegiani, Stefania; Bianchi, Clara; Massari, Marco; Raschetti, Roberto; Salmaso, Stefania] Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy; [degli Atti, Marta Ciofi] Bambino Gesu Pediat Hosp, Med Direct, Rome, Italy; [Frova, Luisa] Italian Natl Inst Stat ISTAT, Rome, Italy; [Tomba, Gianpaolo Scalia] Univ Roma Tor Vergata, Dept Math, Rome, Italy	Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; University of Rome Tor Vergata	Traversa, G (corresponding author), Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy.	stefania.spila@iss.it	Spinelli, Angela/K-2004-2018; degli Atti, Marta Ciofi/K-4650-2018; Michelozzi, Paola/J-8608-2016; Ancarani, Cristina/AAB-6152-2022; Frova, Luisa/GOH-1169-2022	Spinelli, Angela/0000-0002-4068-3569; degli Atti, Marta Ciofi/0000-0001-6492-4497; Michelozzi, Paola/0000-0002-1646-2555; Ancarani, Cristina/0000-0003-1251-4589; Di Spiezio Sardo, Attilio/0000-0001-6485-5735; Frova, Luisa/0000-0002-4594-1125	Italian Medicines Agency	Italian Medicines Agency	Only public resources (National Institutes of Health, ISTAT and NHS) were used in conducting the study. An ad hoc funding was provided by the Italian Medicines Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atti MLC, 2004, VACCINE, V22, P4351, DOI 10.1016/j.vaccine.2004.04.026; BARAFF LJ, 1983, PEDIATR INFECT DIS J, V2, P7, DOI 10.1097/00006454-198301000-00003; BERNIER RH, 1982, J PEDIATR-US, V101, P419, DOI 10.1016/S0022-3476(82)80076-0; BOUVIERCOLLE MH, 1989, INT J EPIDEMIOL, V18, P121, DOI 10.1093/ije/18.1.121; Carpenter RG, 2004, LANCET, V363, P185, DOI 10.1016/S0140-6736(03)15323-8; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; Fleming PJ, 2001, BMJ-BRIT MED J, V322, P822, DOI 10.1136/bmj.322.7290.822; GRIFFIN MR, 1988, NEW ENGL J MED, V319, P618, DOI 10.1056/NEJM198809083191006; *HER STUD GROUP, 2007, 0734 ISTISAN; *HER STUD GROUP, 2005, 052 ISTISAN; HOFFMAN HJ, 1987, PEDIATRICS, V79, P598; Hutcheson R, 1979, MMWR-MORBID MORTAL W, V28, P131; Jonville-Bera AP, 2001, BRIT J CLIN PHARMACO, V51, P271, DOI 10.1046/j.1365-2125.2001.00341.x; JONVILLEBERA AP, 1995, FUNDAM CLIN PHARM, V9, P263, DOI 10.1111/j.1472-8206.1995.tb00294.x; Jorch G, 2007, VACCINE, V25, P5707, DOI 10.1016/j.vaccine.2007.02.068; Mitchell EA, 1995, ARCH DIS CHILD, V73, P498, DOI 10.1136/adc.73.6.498; *OP U STAT GROUP, US STATA SELF CONTR; StataCorp L, 2007, STAT DAT AN STAT SOF; TAYLOR EM, 1982, LANCET, V2, P721; von Kries R, 2005, EUR J PEDIATR, V164, P61, DOI 10.1007/s00431-004-1594-7; WALKER AM, 1987, AM J PUBLIC HEALTH, V77, P945, DOI 10.2105/AJPH.77.8.945; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342; *WHO EUR CDCP OFF, 2010, OUTBR POL TAJ 2010 R	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16363	10.1371/journal.pone.0016363	http://dx.doi.org/10.1371/journal.pone.0016363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298113	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800030
J	Real, S; Meo-Evoli, N; Espada, L; Tauler, A				Real, Sebastian; Meo-Evoli, Nathalie; Espada, Lilia; Tauler, Albert			E2F1 Regulates Cellular Growth by mTORC1 Signaling	PLOS ONE			English	Article							TUBEROUS SCLEROSIS; ACTIVATION; EXPRESSION; RHEB; TSC2; PHOSPHORYLATION; PROLIFERATION; TARGET; GENES; LIFE	During cell proliferation, growth must occur to maintain homeostatic cell size. Here we show that E2F1 is capable of inducing growth by regulating mTORC1 activity. The activation of cell growth and mTORC1 by E2F1 is dependent on both E2F1's ability to bind DNA and to regulate gene transcription, demonstrating that a gene induction expression program is required in this process. Unlike E2F1, E2F3 is unable to activate mTORC1, suggesting that growth activity could be restricted to individual E2F members. The effect of E2F1 on the activation of mTORC1 does not depend on Akt. Furthermore, overexpression of TSC2 does not interfere with the effect of E2F1, indicating that the E2F1-induced signal pathway can compensate for the inhibitory effect of TSC2 on Rheb. Immunolocalization studies demonstrate that E2F1 induces the translocation of mTORC1 to the late endosome vesicles, in a mechanism dependent of leucine. E2F1 and leucine, or insulin, together affect the activation of S6K stronger than alone suggesting that they are complementary in activating the signal pathway. From these studies, E2F1 emerges as a key protein that integrates cell division and growth, both of which are essential for cell proliferation.	[Real, Sebastian; Meo-Evoli, Nathalie; Espada, Lilia; Tauler, Albert] Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain	University of Barcelona	Real, S (corresponding author), Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain.	tauler@ub.edu	Tauler, Albert/D-5183-2014	Tauler, Albert/0000-0003-0193-0667; Espada, Lilia/0000-0002-6218-7785	Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion, Spain [BFU2009-099339]; MAE; University Barcelona	Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MAE(Ministry of Foreign Affairs and International Cooperation (Italy)); University Barcelona	This work was supported by Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion, Spain (BFU2009-099339), and the publication cost was provided by Vicerectorat de Politica Docent i Cientifica de la Universitat de Barcelona. Sebastian Real and Lilia Espada were the recipients of a fellowship from MAE and University Barcelona, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balke Maurice, 2010, BMC Res Notes, V3, P58, DOI 10.1186/1756-0500-3-58; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Cohen A, 2009, CELL, V136, P399, DOI 10.1016/j.cell.2009.01.021; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Feng ZH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001057; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Hlaing M, 2002, J BIOL CHEM, V277, P23794, DOI 10.1074/jbc.M201980200; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Ivanova IA, 2009, ONCOGENE, V28, P52, DOI 10.1038/onc.2008.354; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Korotayev K, 2008, CELL SIGNAL, V20, P1221, DOI 10.1016/j.cellsig.2008.02.012; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Ladu S, 2008, GASTROENTEROLOGY, V135, P1322, DOI 10.1053/j.gastro.2008.07.012; LI L, 2009, GEF MOL CELL, V35, P563; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yan LJ, 2010, MOL CELL, V37, P633, DOI 10.1016/j.molcel.2010.01.031; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200	35	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16163	10.1371/journal.pone.0016163	http://dx.doi.org/10.1371/journal.pone.0016163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283628	gold, Green Published, Green Submitted			2022-12-25	WOS:000286523400024
J	Matsumaru, D; Haraguchi, R; Miyagawa, S; Motoyama, J; Nakagata, N; Meijlink, F; Yamada, G				Matsumaru, Daisuke; Haraguchi, Ryuma; Miyagawa, Shinichi; Motoyama, Jun; Nakagata, Naomi; Meijlink, Frits; Yamada, Gen			Genetic Analysis of Hedgehog Signaling in Ventral Body Wall Development and the Onset of Omphalocele Formation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AP-2; TAMOXIFEN-INDUCIBLE FORM; SONIC-HEDGEHOG; LIMB DEVELOPMENT; VERTEBRATE LIMB; ABDOMINAL-WALL; EXTERNAL GENITALIA; CRANIOFACIAL DEVELOPMENT; RECOMBINASE ACTIVITY; POLARIZING ACTIVITY	Background: An omphalocele is one of the major ventral body wall malformations and is characterized by abnormally herniated viscera from the body trunk. It has been frequently found to be associated with other structural malformations, such as genitourinary malformations and digit abnormalities. In spite of its clinical importance, the etiology of omphalocele formation is still controversial. Hedgehog (Hh) signaling is one of the essential growth factor signaling pathways involved in the formation of the limbs and urogenital system. However, the relationship between Hh signaling and ventral body wall formation remains unclear. Methodology/Principal Findings: To gain insight into the roles of Hh signaling in ventral body wall formation and its malformation, we analyzed phenotypes of mouse mutants of Sonic hedgehog (Shh), GLI-Kruppel family member 3 (Gli3) and Aristaless-like homeobox 4 (Alx4). Introduction of additional Alx4(Lst) mutations into the Gli3(Xt/Xt) background resulted in various degrees of severe omphalocele and pubic diastasis. In addition, loss of a single Shh allele restored the omphalocele and pubic symphysis of Gli3(Xt/+); Alx4(Lst/Lst) embryos. We also observed ectopic Hh activity in the ventral body wall region of Gli3(Xt/Xt) embryos. Moreover, tamoxifen-inducible gain-of-function experiments to induce ectopic Hh signaling revealed Hh signal dose-dependent formation of omphaloceles. Conclusions/Significance: We suggest that one of the possible causes of omphalocele and pubic diastasis is ectopically-induced Hh signaling. To our knowledge, this would be the first demonstration of the involvement of Hh signaling in ventral body wall malformation and the genetic rescue of omphalocele phenotypes.	[Matsumaru, Daisuke; Haraguchi, Ryuma; Miyagawa, Shinichi; Yamada, Gen] Kumamoto Univ, IMEG, Dept Organ Format, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto, Japan; [Motoyama, Jun] Doshisha Univ, Dept Med Life Syst, Kyoto 602, Japan; [Nakagata, Naomi] Kumamoto Univ, CARD, Kumamoto, Japan; [Meijlink, Frits] Univ Med Ctr, Utrecht, Netherlands; [Meijlink, Frits] KNAW, Hubrecht Inst, Utrecht, Netherlands	Kumamoto University; Doshisha University; Kumamoto University; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Matsumaru, D (corresponding author), Kumamoto Univ, IMEG, Dept Organ Format, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto, Japan.	gensan@gpo.kumamoto-u.ac.jp		Matsumaru, Daisuke/0000-0002-1832-624X; Yamada, Gen/0000-0001-6160-2660; Nakagata, Naomi/0000-0002-5737-9993	Ministry of Education, Culture, Sports, Science, and Technology, Japan [22132006]; Ministry of Health, Labor, and Welfare, Japan [20-3]; National Institutes of Health [R01ES016597]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016597] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by Grant-in-Aid for Scientific Research B, for Scientific Research on Innovative Areas; Molecular mechanisms for establishment of sex differences (22132006), and the Global COE program Cell Fate Regulation Research and Education Unit from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and a grant for Child Health and Development (20-3) and Health Sciences Research Grant from the Ministry of Health, Labor, and Welfare, Japan. This work was also supported by National Institutes of Health Grant R01ES016597. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHIRON R, 1995, ULTRASOUND OBST GYN, V6, P256, DOI 10.1046/j.1469-0705.1995.06040256.x; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Aspelund G, 2006, CURR PAEDIAT, V16, P192; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bassett EA, 2010, HUM MOL GENET, V19, P1791, DOI 10.1093/hmg/ddq060; Bohring A, 2002, AM J MED GENET, V107, P72, DOI 10.1002/ajmg.10084; Brewer S, 2004, BIOESSAYS, V26, P1307, DOI 10.1002/bies.20137; Brewer S, 2004, DEV BIOL, V267, P399, DOI 10.1016/j.ydbio.2003.11.021; Brugmann SA, 2010, HUM MOL GENET, V19, P1577, DOI 10.1093/hmg/ddq030; Butterfield NC, 2009, DEVELOPMENT, V136, P3515, DOI 10.1242/dev.037507; Carey JC, 2001, AM J MED GENET, V99, P270, DOI 10.1002/ajmg.1211; Chan KK, 2005, DEV DYNAM, V233, P473, DOI 10.1002/dvdy.20347; Chan KK, 2003, J CELL BIOCHEM, V90, P573, DOI 10.1002/jcb.10656; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CHRIST B, 1983, ANAT EMBRYOL, V166, P87, DOI 10.1007/BF00317946; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dunker N, 2002, ANAT EMBRYOL, V206, P73, DOI 10.1007/s00429-002-0273-6; Ebert AK, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-23; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Feldkamp ML, 2007, AM J MED GENET A, V143A, P639, DOI 10.1002/ajmg.a.31578; Gage PJ, 1999, DEVELOPMENT, V126, P4643; GLASSER JG, 2009, OMPHALOCELE GASTROSC; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; Habib Hasina, 2007, Congenital Anomalies, V47, P53, DOI 10.1111/j.1741-4520.2007.00143.x; Haraguchi R, 2001, DEVELOPMENT, V128, P4241; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hill P, 2009, DEV BIOL, V328, P506, DOI 10.1016/j.ydbio.2009.02.017; Hilton T, 2010, J BIOL CHEM, V285, P11129, DOI 10.1074/jbc.M109.087429; Hirano M, 2006, DEV DYNAM, V235, P2229, DOI 10.1002/dvdy.20823; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Katz LA, 2004, AM J MED GENET A, V130A, P277, DOI 10.1002/ajmg.a.30329; KAUFMAN MH, 1992, ATLAS MOUSE DEV, pR16; KAWAMURA DM, 1997, ABDOMEN SUPERFICIAL, pR15; Kim PCW, 2001, J PEDIATR SURG, V36, P381, DOI 10.1053/jpsu.2001.20722; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kolterud A, 2009, GASTROENTEROLOGY, V137, P618, DOI 10.1053/j.gastro.2009.05.002; Kuijper S, 2005, DEVELOPMENT, V132, P1601, DOI 10.1242/dev.01735; Kuijper S, 2005, DEV BIOL, V285, P533, DOI 10.1016/j.ydbio.2005.06.017; Lallemand Y, 2005, DEVELOPMENT, V132, P3003, DOI 10.1242/dev.01877; Langer JC, 2003, WORLD J SURG, V27, P117, DOI 10.1007/s00268-002-6746-1; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Ludwig M, 2009, BIRTH DEFECTS RES A, V85, P509, DOI 10.1002/bdra.20557; Malashichev Y, 2008, CELL TISSUE RES, V331, P595, DOI 10.1007/s00441-007-0556-6; Mann S, 2008, PRENATAL DIAG, V28, P626, DOI 10.1002/pd.2008; Mao JH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni146; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Masuya H, 1997, DEV BIOL, V182, P42, DOI 10.1006/dbio.1996.8457; McGlinn E, 2006, CURR OPIN GENET DEV, V16, P426, DOI 10.1016/j.gde.2006.06.013; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Milenkovic L, 1999, DEVELOPMENT, V126, P4431; Mingin GC, 2002, PEDIATRICS, V110, P1193, DOI 10.1542/peds.110.6.1193; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Miyagawa S, 2009, MOL ENDOCRINOL, V23, P871, DOI 10.1210/me.2008-0478; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; NOVICK C, 2009, POLYDACTYLY FOOT; Ogi H, 2005, ANAT REC PART A, V284A, P424, DOI 10.1002/ar.a.20180; Ovchinnikov DA, 2006, DEV BIOL, V295, P103, DOI 10.1016/j.ydbio.2006.03.013; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Panman L, 2005, INT J DEV BIOL, V49, P443, DOI 10.1387/ijdb.051984lp; Perovic S. V., 1999, ATLAS CONGENITAL ANO; Pomikal C, 2010, J MORPHOL, V271, P116, DOI 10.1002/jmor.10785; Qu SM, 1997, DEVELOPMENT, V124, P3999; Qu SM, 1998, DEVELOPMENT, V125, P2711; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sadler TW, 2010, SEMIN PEDIATR SURG, V19, P209, DOI 10.1053/j.sempedsurg.2010.03.006; SADLER TW, 2006, LANGMANS MED EMBRYOL, pR13; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Shih HP, 2007, GENE EXPR PATTERNS, V7, P441, DOI 10.1016/j.modgep.2006.11.004; SNELL RS, 1992, CLIN ANATOMY MED STU, pR10; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPONSELLER PD, 1995, J BONE JOINT SURG AM, V77A, P177, DOI 10.2106/00004623-199502000-00003; Stepan H, 1999, ULTRASOUND OBST GYN, V13, P207, DOI 10.1046/j.1469-0705.1999.13030207.x; Sun J, 2007, BIOCHEM BIOPH RES CO, V360, P238, DOI 10.1016/j.bbrc.2007.06.049; Suzuki K, 2009, CURR OPIN GENET DEV, V19, P491, DOI 10.1016/j.gde.2009.08.004; Suzuki K, 2009, DEVELOPMENT, V136, P367, DOI 10.1242/dev.021295; TAEUSCH HW, 2005, AVERYS DIS NEWBORN, pR21; Takahashi M, 1998, DEVELOPMENT, V125, P4417; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Weber TR, 2002, CURR OPIN PEDIATR, V14, P491, DOI 10.1097/00008480-200208000-00023; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Williams T, 2008, AM J MED GENET C, V148C, P186, DOI 10.1002/ajmg.c.30179; YAZBECK S, 1986, J PEDIATR SURG, V21, P761, DOI 10.1016/S0022-3468(86)80360-8; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	98	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16260	10.1371/journal.pone.0016260	http://dx.doi.org/10.1371/journal.pone.0016260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283718	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200045
J	Tiso, M; Tejero, J; Basu, S; Azarov, I; Wang, XD; Simplaceanu, V; Frizzell, S; Jayaraman, T; Geary, L; Shapiro, C; Ho, C; Shiva, S; Kim-Shapiro, DB; Gladwin, MT				Tiso, Mauro; Tejero, Jesus; Basu, Swati; Azarov, Ivan; Wang, Xunde; Simplaceanu, Virgil; Frizzell, Sheila; Jayaraman, Thottala; Geary, Lisa; Shapiro, Calli; Ho, Chien; Shiva, Sruti; Kim-Shapiro, Daniel B.; Gladwin, Mark T.			Human Neuroglobin Functions as a Redox-regulated Nitrite Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; MYOCARDIAL-ISCHEMIA; OXYGEN-AFFINITY; GLOBIN FAMILY; CYTOCHROME-C; BLOOD-CELLS; HEME; OXIDE; HEMOGLOBIN; CYTOGLOBIN	Neuroglobin is a highly conserved hemoprotein of uncertain physiological function that evolved from a common ancestor to hemoglobin and myoglobin. It possesses a six-coordinate heme geometry with proximal and distal histidines directly bound to the heme iron, although coordination of the sixth ligand is reversible. We show that deoxygenated human neuroglobin reacts with nitrite to form nitric oxide (NO). This reaction is regulated by redox-sensitive surface thiols, cysteine 55 and 46, which regulate the fraction of the five-coordinated heme, nitrite binding, and NO formation. Replacement of the distal histidine by leucine or glutamine leads to a stable five-coordinated geometry; these neuroglobin mutants reduce nitrite to NO similar to 2000 times faster than the wild type, whereas mutation of either Cys-55 or Cys-46 to alanine stabilizes the six-coordinate structure and slows the reaction. Using lentivirus expression systems, we show that the nitrite reductase activity of neuroglobin inhibits cellular respiration via NO binding to cytochrome c oxidase and confirm that the six-to-five-coordinate status of neuroglobin regulates intracellular hypoxic NO-signaling pathways. These studies suggest that neuroglobin may function as a physiological oxidative stress sensor and a post-translationally redox-regulated nitrite reductase that generates NO under six-to-five-coordinate heme pocket control. We hypothesize that the six-coordinate heme globin superfamily may subserve a function as primordial hypoxic and redox-regulated NO-signaling proteins.	[Tiso, Mauro; Tejero, Jesus; Frizzell, Sheila; Jayaraman, Thottala; Geary, Lisa; Shapiro, Calli; Shiva, Sruti; Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15213 USA; [Basu, Swati; Azarov, Ivan; Kim-Shapiro, Daniel B.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Simplaceanu, Virgil; Ho, Chien] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Wang, Xunde] NHLBI, NIH, Bethesda, MD 20892 USA; [Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Carnegie Mellon University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gladwin, MT (corresponding author), Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15213 USA.	gladwinmt@upmc.edu	Tejero, Jesus/G-3953-2017; Ho, Chien/O-6112-2016; Kim-Shapiro, Daniel/HGA-2682-2022	Tejero, Jesus/0000-0003-3245-9978; Ho, Chien/0000-0002-4094-9232; Azarov, Ivan/0000-0002-9886-3298	National Institutes of Health [HL058091, GM084614, HL098032]; Institute for Transfusion Medicine, Hemophilia Center of Western Pennsylvania; American Heart Association [109SDG2150066]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058091, R29HL058091, R01HL058091, R01HL098032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine, Hemophilia Center of Western Pennsylvania; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL058091 (to D. B. K.-S.), GM084614 (to C. H.), and HL098032 (to M. T. G.). This work was also supported by Institute for Transfusion Medicine, Hemophilia Center of Western Pennsylvania (to M. T. G. and S. S.), and American Heart Association Grant 109SDG2150066 (to S. S.). M. Tiso, M. T. Gladwin, and D. B. Kim-Shapiro are listed as co-inventors on a patent application entitled "Neuroglobin as a Six-to-Five-coordinate Regulated Nitrite Reductase."	Azarov I, 2005, J BIOL CHEM, V280, P39024, DOI 10.1074/jbc.M509045200; Basu S, 2008, J BIOL CHEM, V283, P32590, DOI 10.1074/jbc.M806934200; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; BIRAM D, 1993, BIOCHIM BIOPHYS ACTA, V1163, P67, DOI 10.1016/0167-4838(93)90280-5; BRANCACCIO A, 1994, J BIOL CHEM, V269, P13843; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Brunori M, 2004, BBA-BIOENERGETICS, V1655, P365, DOI 10.1016/j.bbabio.2003.06.008; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2004, IUBMB LIFE, V56, P703, DOI 10.1080/15216540500037257; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Capece L, 2009, PROTEINS, V75, P885, DOI 10.1002/prot.22297; Copeland DM, 2006, J INORG BIOCHEM, V100, P1413, DOI 10.1016/j.jinorgbio.2006.04.011; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Du WH, 2003, J AM CHEM SOC, V125, P8080, DOI 10.1021/ja034584r; Garrocho-Villegas V, 2007, GENE, V398, P78, DOI 10.1016/j.gene.2007.01.035; Giuffre A, 2008, BIOCHEM BIOPH RES CO, V367, P893, DOI 10.1016/j.bbrc.2008.01.021; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hamdane D, 2004, MICRON, V35, P59, DOI 10.1016/j.micron.2003.10.019; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hendgen-Cotta UB, 2008, P NATL ACAD SCI USA, V105, P10256, DOI 10.1073/pnas.0801336105; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; IKEDASAITO M, 1992, J BIOL CHEM, V267, P22843; Jung KH, 2010, BIOCHEM BIOPH RES CO, V403, P66, DOI 10.1016/j.bbrc.2010.10.116; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Kiger L, 2004, IUBMB LIFE, V56, P709, DOI 10.1080/15216540500037711; Kriegl JM, 2002, P NATL ACAD SCI USA, V99, P7992, DOI 10.1073/pnas.082244399; Liu JX, 2009, J NEUROSCI RES, V87, P164, DOI 10.1002/jnr.21826; Mason MG, 2006, P NATL ACAD SCI USA, V103, P708, DOI 10.1073/pnas.0506562103; Nadra AD, 2008, PROTEINS, V71, P695, DOI 10.1002/prot.21814; Nicolis S, 2007, BIOCHEM J, V407, P89, DOI 10.1042/BJ20070372; Nienhaus K, 2004, J BIOL CHEM, V279, P22944, DOI 10.1074/jbc.M401561200; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Presley TD, 2011, NITRIC OXIDE-BIOL CH, V24, P34, DOI 10.1016/j.niox.2010.10.002; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Van Doorslaer S, 2003, J BIOL CHEM, V278, P4919, DOI 10.1074/jbc.M210617200; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; Weiland TR, 2004, J AM CHEM SOC, V126, P11930, DOI 10.1021/ja046990w; Xu J, 2009, J INORG BIOCHEM, V103, P1693, DOI 10.1016/j.jinorgbio.2009.09.016; Yi J, 2008, BIOCHEMISTRY-US, V47, P8247, DOI 10.1021/bi801015c; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651	56	209	217	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18277	18289		10.1074/jbc.M110.159541	http://dx.doi.org/10.1074/jbc.M110.159541			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21296891	hybrid, Green Published			2022-12-25	WOS:000290585200088
J	Guillet, V; Gueguen, N; Cartoni, R; Chevrollier, A; Desquiret, V; Angebault, C; Amati-Bonneau, P; Procaccio, V; Bonneau, D; Martinou, JC; Reynier, P				Guillet, Virginie; Gueguen, Naig; Cartoni, Romain; Chevrollier, Arnaud; Desquiret, Valerie; Angebault, Claire; Amati-Bonneau, Patrizia; Procaccio, Vincent; Bonneau, Dominique; Martinou, Jean-Claude; Reynier, Pascal			Bioenergetic defect associated with mK(ATP) channel opening in a mouse model carrying a mitofusin 2 mutation	FASEB JOURNAL			English	Article						Charcot-Marie-Tooth type 2A; succinate dehydrogenase; F0F1-ATP synthase; mitochondria; potassium channel	SENSITIVE POTASSIUM CHANNELS; MARIE-TOOTH-DISEASE; NEUROPATHY TYPE 2A; MITOCHONDRIAL FUSION; SUCCINATE OXIDATION; ATP SYNTHASE; RAT-HEART; DIAZOXIDE; MFN2; INHIBITOR	Charcot-Marie-Tooth disease type 2A (CMT2A) is an autosomal dominant axonal form of peripheral neuropathy caused by mutations in the mitofusin 2 gene (MFN2), which encodes a mitochondrial outer membrane protein that promotes mitochondrial fusion. Emerging evidence also points to a role of MFN2 in the regulation of mitochondrial metabolism. To examine whether mitochondrial dysfunction is a feature of CMT2A, we used a transgenic mouse model expressing in neurons a mutated R94Q form of human MFN2 shown to induce a CMT2A phenotype. Oxygraphic and enzymatic measurements both revealed a combined defect of mitochondrial complexes II and V (40 and 30% decrease, respectively) in the brain of Tg-R94 mice, leading to a drastic decrease of ATP synthesis. These deficiencies were reversed by the mitochondrial ATP-sensitive potassium channel (mK(ATP)) inhibitor 5-hydroxydecanoate. Conversely, in controls and wild-type human MFN2 mice, the mK(ATP) activator diazoxide mimicked the deficiency observed with the R94Q mutation. The physical links between complexes II and V, previously proposed as part of mK(ATP), were reinforced in Tg-R94Q mice. Our results show that the R94Q MFN2 mutation induces a combined defect of complexes II and V linked to the opening of mK(ATP), which could participate in the pathophysiology of the disease.-Guillet, V., Gueguen, N., Cartoni, R., Chevrollier, A., Desquiret, V., Angebault, C., Amati-Bonneau, P., Procaccio, V., Bonneau, D., Martinou, J.-C., Reynier, P. Bioenergetic defect associated with mKATP channel opening in a mouse model carrying a mitofusin 2 mutation. FASEB J. 25, 1618-1627 (2011). www.fasebj.org	[Guillet, Virginie; Gueguen, Naig; Chevrollier, Arnaud; Angebault, Claire; Amati-Bonneau, Patrizia; Procaccio, Vincent; Bonneau, Dominique; Reynier, Pascal] CNRS, UMR 6214, INSERM, U771, Angers, France; [Guillet, Virginie; Angebault, Claire; Procaccio, Vincent; Bonneau, Dominique; Reynier, Pascal] Univ Angers, Sch Med, Angers, France; [Guillet, Virginie; Gueguen, Naig; Chevrollier, Arnaud; Desquiret, Valerie; Amati-Bonneau, Patrizia; Procaccio, Vincent; Bonneau, Dominique; Reynier, Pascal] Univ Hosp Angers, Dept Biochem & Genet, Angers, France; [Cartoni, Romain; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, Geneva, Switzerland; [Cartoni, Romain] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Cartoni, Romain] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Universite de Franche-Comte; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; University of Geneva; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Gueguen, N (corresponding author), CHU Angers, Lab Biochim & Biol Mol, F-49000 Angers, France.	naiggueguen@yahoo.fr	amati-bonneau, patrizia/K-6198-2015; CHEVROLLIER, Arnaud/K-2853-2015; CHEVROLLIER, Arnaud/P-6630-2019; CHEVROLLIER, Arnaud/GSD-3887-2022; Desquiret-Dumas, Valérie/K-2695-2015; Bonneau, Dominique/K-6110-2015; Reynier, Pascal/K-3677-2015; LENAERS, Guy/K-2421-2015	CHEVROLLIER, Arnaud/0000-0002-5135-6643; CHEVROLLIER, Arnaud/0000-0002-5135-6643; CHEVROLLIER, Arnaud/0000-0002-5135-6643; LENAERS, Guy/0000-0003-2736-3349; Desquiret-Dumas, Valerie/0000-0001-9551-9400; Reynier, Pascal/0000-0003-0802-4608; Bonneau, Dominique/0000-0002-6886-0969; procaccio, Vincent/0000-0002-1537-4684; martinou, Jean-claude/0000-0002-9847-2051	Institut National de la Sante et de la Recherche Medicale (INSERM); University Hospital of Angers [PHRC 04-12]; University of Angers; Association Contre les Maladies Mitochondriales (AMMi); Retina France, Ouvrir les Yeux (OLY); Union Nationale des Aveugles et Deficients Visuel (UNADEV)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Hospital of Angers; University of Angers; Association Contre les Maladies Mitochondriales (AMMi); Retina France, Ouvrir les Yeux (OLY); Union Nationale des Aveugles et Deficients Visuel (UNADEV)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the University Hospital of Angers (PHRC 04-12), the University of Angers, and grants from the following associations of patients: Association Contre les Maladies Mitochondriales (AMMi), Retina France, Ouvrir les Yeux (OLY), and Union Nationale des Aveugles et Deficients Visuel (UNADEV). The authors are grateful to C. Wetterwald, to the technicians of the laboratory for technical assistance, and to Kanaya Malkani for critical reading and comments on the manuscript.	Ala-Rami A, 2003, BASIC RES CARDIOL, V98, P250, DOI 10.1007/s00395-003-0413-z; Amiott EA, 2008, EXP NEUROL, V211, P115, DOI 10.1016/j.expneurol.2008.01.010; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bajgar R, 2001, J BIOL CHEM, V276, P33369, DOI 10.1074/jbc.M103320200; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Briere JJ, 2005, CELL MOL LIFE SCI, V62, P2317, DOI 10.1007/s00018-005-5237-6; Cairns CB, 1998, AM J PHYSIOL-REG I, V274, pR1376, DOI 10.1152/ajpregu.1998.274.5.R1376; Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082; Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Comelli M, 2007, AM J PHYSIOL-HEART C, V292, pH820, DOI 10.1152/ajpheart.00366.2006; Contessi S, 2004, BIOCHEM PHARMACOL, V67, P1843, DOI 10.1016/j.bcp.2004.02.001; Costa ADT, 2006, AM J PHYSIOL-HEART C, V290, pH406, DOI 10.1152/ajpheart.00794.2005; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Fritz S, 2001, J CELL BIOL, V152, P683, DOI 10.1083/jcb.152.4.683; Guillery O, 2008, BIOL CELL, V100, P315, DOI 10.1042/BC20070110; Hanley PJ, 2002, J PHYSIOL-LONDON, V542, P735, DOI 10.1113/jphysiol.2002.023960; HEDERSTEDT L, 1989, BIOCHEM J, V260, P491, DOI 10.1042/bj2600491; Horiguchi T, 2003, STROKE, V34, P1015, DOI 10.1161/01.STR.0000063404.27912.5B; Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2; Kis B, 2003, J NEUROCHEM, V87, P969, DOI 10.1046/j.1471-4159.2003.02072.x; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; Kopustinskiene DM, 2003, J BIOENERG BIOMEMBR, V35, P141, DOI 10.1023/A:1023746103401; Lim KHH, 2002, J PHYSIOL-LONDON, V545, P961, DOI 10.1113/jphysiol.2002.031484; Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086; Neusch C, 2007, EUR J NEUROL, V14, P575, DOI 10.1111/j.1468-1331.2006.01688.x; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Pasdois P, 2006, J BIOENERG BIOMEMBR, V38, P101, DOI 10.1007/s10863-006-9016-3; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; SCHAFER G, 1969, BIOCHEM PHARMACOL, V18, P2678; SKRE H, 1974, CLIN GENET, V6, P98; Vallat JM, 2008, J NEUROPATH EXP NEUR, V67, P1097, DOI 10.1097/NEN.0b013e31818b6cbc; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wojtovich AP, 2008, BBA-BIOENERGETICS, V1777, P882, DOI 10.1016/j.bbabio.2008.03.025; Wojtovich AP, 2009, BASIC RES CARDIOL, V104, P121, DOI 10.1007/s00395-009-0001-y; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; 2004, P NATL ACAD SCI US, V101, P11880	42	36	38	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2011	25	5					1618	1627		10.1096/fj.10-173609	http://dx.doi.org/10.1096/fj.10-173609			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21285398	Green Published			2022-12-25	WOS:000290023800019
J	Lim, S; Strahl, T; Thorner, J; Ames, JB				Lim, Sunghyuk; Strahl, Thomas; Thorner, Jeremy; Ames, James B.			Structure of a Ca2+-Myristoyl Switch Protein That Controls Activation of a Phosphatidylinositol 4-Kinase in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CALCIUM SENSOR-1; PHOTORECEPTOR GUANYLYL CYCLASE; DOMINANT CONE DYSTROPHY; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; 3-DIMENSIONAL STRUCTURE; MOLECULAR-STRUCTURE; BOVINE NEUROCALCIN; BINDING PROPERTIES; RHODOPSIN KINASE	Neuronal calcium sensor (NCS) proteins transduce Ca2+ signals and are highly conserved from yeast to humans. We determined NMR structures of the NCS-1 homolog from fission yeast (Ncs1), which activates a phosphatidylinositol 4-kinase. Ncs1 contains an alpha-NH2-linked myristoyl group on a long N-terminal arm and four EF-hand motifs, three of which bind Ca2+, assembled into a compact structure. In Ca2+-free Ncs1, the N-terminal arm positions the fatty acyl chain inside a cavity near the C terminus. The C14 end of the myristate is surrounded by residues in the protein core, whereas its amide-linked (C1) end is flanked by residues at the protein surface. In Ca2+-bound Ncs1, the myristoyl group is extruded (Ca2+-myristoyl switch), exposing a prominent patch of hydrophobic residues that specifically contact phosphatidylinositol 4-kinase. The location of the buried myristate and structure of Ca2+-free Ncs1 are quite different from those in other NCS proteins. Thus, a unique remodeling of each NCS protein by its myristoyl group, and Ca2+-dependent unmasking of different residues, may explain how each family member recognizes distinct target proteins.	[Lim, Sunghyuk; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Strahl, Thomas; Thorner, Jeremy] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94025 USA	University of California System; University of California Davis; University of California System; University of California Berkeley	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	ames@chem.ucdavis.edu	Strahl, Thomas/E-4315-2010; THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X	National Institutes of Health [EY012347]; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant EY012347 (to J. B. A.).	Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Ames JB, 2000, METHOD ENZYMOL, V316, P121; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Ames JB, 2002, BIOCHEMISTRY-US, V41, P5776, DOI 10.1021/bi012153k; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1996, CURR OPIN STRUC BIOL, V6, P432, DOI 10.1016/S0959-440X(96)80106-0; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Badger J, 1999, PROTEINS, V35, P25, DOI 10.1002/(SICI)1097-0134(19990401)35:1<25::AID-PROT3>3.3.CO;2-M; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Clore GM, 1997, NAT STRUCT BIOL, V4, P849; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; Erickson MA, 1998, P NATL ACAD SCI USA, V95, P6474, DOI 10.1073/pnas.95.11.6474; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; FLANAGAN CA, 1992, J BIOL CHEM, V267, P24117; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gromada J, 2005, P NATL ACAD SCI USA, V102, P10303, DOI 10.1073/pnas.0504487102; Hamasaki-Katagiri N, 2004, J BIOL CHEM, V279, P12744, DOI 10.1074/jbc.M311895200; Hamasaki-Katagiri N, 2010, J BIOL CHEM, V285, P4405, DOI 10.1074/jbc.M109.058594; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; HENDRICKS KB, 1999, THESIS U CALIFORNIA; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; HIDAKA H, 1993, NEUROSCI RES, V16, P73, DOI 10.1016/0168-0102(93)90074-Z; Huttner IG, 2003, J BIOL CHEM, V278, P4862, DOI 10.1074/jbc.M207920200; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KOBAYASHI M, 1993, J BIOL CHEM, V268, P18898; LADANT D, 1995, J BIOL CHEM, V270, P3179; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Lim S, 2009, BIOMOL NMR ASSIGN, V3, P269, DOI 10.1007/s12104-009-9191-3; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Nahorski SR, 2003, TRENDS NEUROSCI, V26, P444, DOI 10.1016/S0166-2236(03)00178-4; O'Callaghan DW, 2004, J BIOL CHEM, V279, P14347, DOI 10.1074/jbc.M310152200; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Park JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006179; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Strahl T, 2003, J BIOL CHEM, V278, P49589, DOI 10.1074/jbc.M309017200; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Tzingounis AV, 2007, NEURON, V53, P487, DOI 10.1016/j.neuron.2007.01.011; Valentine KG, 2010, STRUCTURE, V18, P9, DOI 10.1016/j.str.2009.11.010; Valentine KG, 2003, BIOCHEMISTRY-US, V42, P6333, DOI 10.1021/bi0206816; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhao CJ, 2009, CELL MOL NEUROBIOL, V29, P273, DOI 10.1007/s10571-008-9320-z; Zhao XH, 2001, J BIOL CHEM, V276, P40183, DOI 10.1074/jbc.M104048200; Zheng Q, 2005, J NEUROCHEM, V92, P442, DOI 10.1111/j.1471-4159.2004.02897.x; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	68	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.208868	http://dx.doi.org/10.1074/jbc.M110.208868			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288895	Green Published, hybrid			2022-12-25	WOS:000289077500069
J	Matsumura, S; Shinoda, K; Yamada, M; Yokojima, S; Inoue, M; Ohnishi, T; Shimada, T; Kikuchi, K; Masui, D; Hashimoto, S; Sato, M; Ito, A; Akioka, M; Takagi, S; Nakamura, Y; Nemoto, K; Hasegawa, Y; Takamoto, H; Inoue, H; Nakamura, S; Nabeshima, Y; Teplow, DB; Kinjo, M; Hoshia, M				Matsumura, Satoko; Shinoda, Keiko; Yamada, Mayumi; Yokojima, Satoshi; Inoue, Masafumi; Ohnishi, Takayuki; Shimada, Tetsuya; Kikuchi, Kazuya; Masui, Dai; Hashimoto, Shigeki; Sato, Michio; Ito, Akane; Akioka, Manami; Takagi, Shinsuke; Nakamura, Yoshihiro; Nemoto, Kiyokazu; Hasegawa, Yutaka; Takamoto, Hisayoshi; Inoue, Haruo; Nakamura, Shinichiro; Nabeshima, Yo-ichi; Teplow, David B.; Kinjo, Masataka; Hoshia, Minako			Two Distinct Amyloid beta-Protein (A beta) Assembly Pathways Leading to Oligomers and Fibrils Identified by Combined Fluorescence Correlation Spectroscopy, Morphology, and Toxicity Analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; INTEGRAL-EQUATIONS; AGGREGATION; POLYMERIZATION; NEUROTOXICITY; MEMORY; NEURODEGENERATION; FIBRILLOGENESIS; INTERMEDIATE; PATHOGENESIS	Nonfibrillar assemblies of amyloid beta-protein (A beta) are considered to play primary roles in Alzheimer disease (AD). Elucidating the assembly pathways of these specific aggregates is essential for understanding disease pathogenesis and developing knowledge-based therapies. However, these assemblies cannot be monitored in vivo, and there has been no reliable in vitro monitoring method at low protein concentration. We have developed a highly sensitive in vitro monitoring method using fluorescence correlation spectroscopy (FCS) combined with transmission electron microscopy (TEM) and toxicity assays. Using A beta labeled at the N terminus or Lys(16), we uncovered two distinct assembly pathways. One leads to highly toxic 10-15-nm spherical A beta assemblies, termed amylospheroids (ASPDs). The other leads to fibrils. The first step in ASPD formation is trimerization. ASPDs of similar to 330 kDa in mass form from these trimers after 5 h of slow rotation. Up to at least 24 h, ASPDs remain the dominant structures in assembly reactions. Neurotoxicity studies reveal that the most toxic ASPDs are similar to 128 kDa (similar to 32-mers). In contrast, fibrillogenesis begins with dimer formation and then proceeds to formation of 15-40-nm spherical intermediates, from which fibrils originate after 15 h. Unlike ASPD formation, the Lys(16)-labeled peptide disturbed fibril formation because the A beta(16-20) region is critical for this final step. These differences in the assembly pathways clearly indicated that ASPDs are not fibril precursors. The method we have developed should facilitate identifying A beta assembly steps at which inhibition may be beneficial.	[Matsumura, Satoko; Yamada, Mayumi; Sato, Michio; Ito, Akane; Akioka, Manami; Hoshia, Minako] Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; [Shinoda, Keiko; Yokojima, Satoshi; Nakamura, Shinichiro] Mitsubishi Chem Grp Sci & Technol Res Ctr Inc, Yokohama, Kanagawa 2278502, Japan; [Inoue, Masafumi; Ohnishi, Takayuki; Nabeshima, Yo-ichi; Hoshia, Minako] Kyoto Univ, Kyoto 6068501, Japan; [Shimada, Tetsuya; Masui, Dai; Takagi, Shinsuke; Inoue, Haruo] Tokyo Metropolitan Univ, Tokyo 1920397, Japan; [Kikuchi, Kazuya] Osaka Univ, Suita, Osaka 5650871, Japan; [Hashimoto, Shigeki] Tokyo Univ Sci, Tokyo, Hokkaido 0493514, Japan; [Nakamura, Yoshihiro] Nagoya Inst Technol, Nagoya, Aichi 4668555, Japan; [Hasegawa, Yutaka; Takamoto, Hisayoshi] Hamamatsu Photon KK, Shizuoka 4380193, Japan; [Teplow, David B.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Kinjo, Masataka] Hokkaido Univ, Sapporo, Hokkaido 0010021, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); Kyoto University; Tokyo Metropolitan University; Osaka University; Tokyo University of Science; Nagoya Institute of Technology; Hamamatsu Photonics; University of California System; University of California Los Angeles; Hokkaido University	Hoshia, M (corresponding author), Sakyo Ku, Kyoto 6068501, Japan.	minhoshi@lmls.med.kyoto-u.ac.jp	Kikuchi, Kazuya/D-2370-2009; Takagi, Shinsuke/M-7035-2013; Kinjo, Masataka/F-5267-2011	Takagi, Shinsuke/0000-0001-7013-4942; Kinjo, Masataka/0000-0001-8889-8369; Yokojima, Satoshi/0000-0002-6555-0877	Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science, and Technology; New Energy and Industrial Technology Development Organization; Alzheimer's Drug Discovery and Biomarkers; Grants-in-Aid for Scientific Research [19058001] Funding Source: KAKEN	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Alzheimer's Drug Discovery and Biomarkers; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Health, Labor and Welfare (Research on Nanotechnical Medical) (to M. H.), Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology (to K. K. and M. H.), the New Energy and Industrial Technology Development Organization (Translational Research Promotion Project) (to M. H.), and the Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarkers (to D. B. T.).	Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bark N, 1999, BIOCHEM BIOPH RES CO, V260, P35, DOI 10.1006/bbrc.1999.0850; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bjorling S, 1998, BIOCHEMISTRY-US, V37, P12971, DOI 10.1021/bi980694c; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gosch M, 2005, ADV DRUG DELIVER REV, V57, P169, DOI 10.1016/j.addr.2004.07.016; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1995, NEUROBIOL AGING, V16, P755, DOI 10.1016/0197-4580(95)00052-G; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; PALMER AG, 1987, BIOPHYS J, V52, P257, DOI 10.1016/S0006-3495(87)83213-7; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sengupta P, 2003, BIOCHEMISTRY-US, V42, P10506, DOI 10.1021/bi0341410; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1999, CHEM BIOL, V6, P53, DOI 10.1016/S1074-5521(99)80020-9; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x	48	83	85	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11555	11562		10.1074/jbc.M110.181313	http://dx.doi.org/10.1074/jbc.M110.181313			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21292768	Green Published, hybrid			2022-12-25	WOS:000288797100065
J	Bacolla, A; Wang, GL; Jain, A; Chuzhanova, NA; Cer, RZ; Collins, JR; Cooper, DN; Bohr, VA; Vasquez, KM				Bacolla, Albino; Wang, Guliang; Jain, Aklank; Chuzhanova, Nadia A.; Cer, Regina Z.; Collins, Jack R.; Cooper, David N.; Bohr, Vilhelm A.; Vasquez, Karen M.			Non-B DNA-forming Sequences and WRN Deficiency Independently Increase the Frequency of Base Substitution in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNER-SYNDROME PROTEIN; SYNDROME RECQ HELICASE; HUMAN DHX9 HELICASE; GENETIC INSTABILITY; IN-VIVO; ELECTRON-TRANSFER; OXIDATIVE DAMAGE; REPLICATION FORK; AQUEOUS-SOLUTION; MAMMALIAN-CELLS	Although alternative DNA secondary structures (non-B DNA) can induce genomic rearrangements, their associated mutational spectra remain largely unknown. The helicase activity of WRN, which is absent in the human progeroid Werner syndrome, is thought to counteract this genomic instability. We determined non-B DNA-induced mutation frequencies and spectra in human U2OS osteosarcoma cells and assessed the role of WRN in isogenic knockdown (WRN-KD) cells using a supF gene mutation reporter system flanked by triplex-or Z-DNA-forming sequences. Although both non-B DNA and WRN-KD served to increase the mutation frequency, the increase afforded by WRN-KD was independent of DNA structure despite the fact that purified WRN helicase was found to resolve these structures in vitro. In U2OS cells, similar to 70% of mutations comprised single-base substitutions, mostly at G.C base-pairs, with the remaining similar to 30% being microdeletions. The number of mutations at G.C base-pairs in the context of NGNN/NNCN sequences correlated well with predicted free energies of base stacking and ionization potentials, suggesting a possible origin via oxidation reactions involving electron loss and subsequent electron transfer (hole migration) between neighboring bases. A set of similar to 40,000 somatic mutations at G.C base pairs identified in a lung cancer genome exhibited similar correlations, implying that hole migration may also be involved. We conclude that alternative DNA conformations, WRN deficiency and lung tumorigenesis may all serve to increase the mutation rate by promoting, through diverse pathways, oxidation reactions that perturb the electron orbitals of neighboring bases. It follows that such "hole migration" is likely to play a much more widespread role in mutagenesis than previously anticipated.	[Bacolla, Albino; Wang, Guliang; Jain, Aklank; Vasquez, Karen M.] Univ Texas MD Anderson Canc Ctr, Div Sci Pk Res, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Chuzhanova, Nadia A.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England; [Cer, Regina Z.; Collins, Jack R.] NCI, Adv Biomed Comp Ctr, SAIC Frederick Inc, Frederick, MD 21702 USA; [Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; [Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	University of Texas System; UTMD Anderson Cancer Center; Nottingham Trent University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Cardiff University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Vasquez, KM (corresponding author), 1400 Barbara Jordan Blvd,R1800, Austin, TX 78723 USA.	karen.vasquez@austin.utexas.edu	Jain, Aklank/AAM-5067-2021; Cooper, David N/H-4384-2011; Bacolla, Albino/N-3877-2013; Bohr, Vilhelm/AAP-5931-2020; Bacolla, Albino/AAP-1727-2020	Jain, Aklank/0000-0001-5539-3225; Cooper, David N/0000-0002-8943-8484; Bacolla, Albino/0000-0003-0206-8423; Bacolla, Albino/0000-0003-0206-8423; Chuzhanova, Nadia/0000-0002-4655-3618	National Institutes of Health [CA093729, HHSN261200800001E]; National Institute of Environmental Health Sciences Center [P30ES007784]; National Institute on Aging, National Institutes of Heath; National Institutes of Health through M.D. Anderson Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [R01CA093729, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Aging, National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health through M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA093729 (to K. M. V.) and HHSN261200800001E (to A. B.). This work was also supported by National Institute of Environmental Health Sciences Center Grant P30ES007784, by the Intramural Program of the National Institute on Aging, National Institutes of Heath, and by the National Institutes of Health through M.D. Anderson Cancer Center Support Grant CA016672.	Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bacolla A, 2001, J BIOL CHEM, V276, P18597, DOI 10.1074/jbc.M100845200; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; Bergeron F, 2010, P NATL ACAD SCI USA, V107, P5528, DOI 10.1073/pnas.1000193107; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Brosh RM, 2001, J BIOL CHEM, V276, P3024, DOI 10.1074/jbc.M006784200; Brosh RM, 2006, METHOD ENZYMOL, V409, P52, DOI 10.1016/S0076-6879(05)09004-X; Bukowy Z, 2008, NUCLEIC ACIDS RES, V36, P4975, DOI 10.1093/nar/gkn468; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; CANDEIAS LP, 1993, J AM CHEM SOC, V115, P2437, DOI 10.1021/ja00059a044; Chakraborty P, 2010, NUCLEIC ACIDS RES, V38, P4722, DOI 10.1093/nar/gkq240; Christensen LA, 2006, CANCER RES, V66, P4089, DOI 10.1158/0008-5472.CAN-05-4288; Chuzhanova N, 2009, HUM MUTAT, V30, P1189, DOI 10.1002/humu.21020; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cooper David N, 2010, Hum Genomics, V4, P406; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; Deschenes F, 2005, HUM MOL GENET, V14, P3293, DOI 10.1093/hmg/ddi362; Dhillon KK, 2007, AGING CELL, V6, P53, DOI 10.1111/j.1474-9726.2006.00260.x; Ditlevson JV, 2008, NUCLEIC ACIDS RES, V36, P3163, DOI 10.1093/nar/gkn136; FRIEDMAN RA, 1995, BIOPHYS J, V69, P1528, DOI 10.1016/S0006-3495(95)80023-8; Friedrich K, 2010, HUM GENET, V128, P103, DOI 10.1007/s00439-010-0832-5; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Gajecka M, 2008, GENOME RES, V18, P1733, DOI 10.1101/gr.077453.108; Gotter AL, 2004, HUM MOL GENET, V13, P103, DOI 10.1093/hmg/ddh004; Gotter AL, 2007, GENOME RES, V17, P470, DOI 10.1101/gr.6130907; Harrigan JA, 2006, NUCLEIC ACIDS RES, V34, P745, DOI 10.1093/nar/gkj475; Huang SR, 2006, HUM MUTAT, V27, P558, DOI 10.1002/humu.20337; Inagaki H, 2009, GENOME RES, V19, P191, DOI 10.1101/gr.079244.108; Jain A, 2010, BIOCHEMISTRY-US, V49, P6992, DOI 10.1021/bi100795m; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Kato T, 2006, SCIENCE, V311, P971, DOI 10.1126/science.1121452; Kino K, 2005, MUTAT RES-FUND MOL M, V571, P33, DOI 10.1016/j.mrfmmm.2004.10.010; Kolb J, 2009, CHROMOSOME RES, V17, P469, DOI 10.1007/s10577-009-9039-9; KRAEMER KH, 1989, MUTAT RES, V220, P61, DOI 10.1016/0165-1110(89)90011-0; Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100; Kyoizumi S, 1998, HUM GENET, V103, P405, DOI 10.1007/s004390050841; Lau SS, 1996, ADV EXP MED BIOL, V387, P267; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lewis FD, 2008, ANGEW CHEM INT EDIT, V47, P3798, DOI 10.1002/anie.200705903; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Massip L, 2010, FASEB J, V24, P158, DOI 10.1096/fj.09-137133; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Moser MJ, 2000, CANCER RES, V60, P2492; Muftuoglu M, 2008, HUM GENET, V124, P369, DOI 10.1007/s00439-008-0562-0; Nyunoya T, 2009, AM J RESP CRIT CARE, V179, P279, DOI 10.1164/rccm.200802-320OC; Ozgenc A, 2005, MUTAT RES-FUND MOL M, V577, P237, DOI 10.1016/j.mrfmmm.2005.03.020; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Prince PR, 2001, GENE DEV, V15, P933, DOI 10.1101/gad.877001; Quemener S, 2010, HUM MUTAT, V31, P421, DOI 10.1002/humu.21196; Sambrook J, 2001, MOL CLONING LAB MANU; Senthilkumar K, 2005, J AM CHEM SOC, V127, P14894, DOI 10.1021/ja054257e; Shao FW, 2005, J AM CHEM SOC, V127, P17445, DOI 10.1021/ja0563399; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stoltzfus A, 2008, MUTAT RES-FUND MOL M, V644, P71, DOI 10.1016/j.mrfmmm.2008.05.003; Sugiyama H, 1996, J AM CHEM SOC, V118, P7063, DOI 10.1021/ja9609821; Szekely AM, 2005, MOL CELL BIOL, V25, P10492, DOI 10.1128/MCB.25.23.10492-10506.2005; Turaga RVN, 2009, CELL CYCLE, V8, P2080, DOI 10.4161/cc.8.13.8925; Ungvari Z, 2008, AGE, V30, P121, DOI 10.1007/s11357-008-9059-y; Wang GL, 2006, P NATL ACAD SCI USA, V103, P2677, DOI 10.1073/pnas.0511084103; Wang GL, 2004, P NATL ACAD SCI USA, V101, P13448, DOI 10.1073/pnas.0405116101; Wang GL, 2009, MOL CARCINOGEN, V48, P286, DOI 10.1002/mc.20508; Wang GL, 2008, JNCI-J NATL CANCER I, V100, P1815, DOI 10.1093/jnci/djn385; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wojciechowska M, 2006, J BIOL CHEM, V281, P24531, DOI 10.1074/jbc.M603888200; Yokote K, 2008, J AM GERIATR SOC, V56, P1770, DOI 10.1111/j.1532-5415.2008.01817.x	70	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10017	10026		10.1074/jbc.M110.176636	http://dx.doi.org/10.1074/jbc.M110.176636			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21285356	Green Published, hybrid			2022-12-25	WOS:000288547000016
J	Nestor, MW; Cai, X; Stone, MR; Bloch, RJ; Thompson, SM				Nestor, Michael W.; Cai, Xiang; Stone, Michele R.; Bloch, Robert J.; Thompson, Scott M.			The Actin Binding Domain of beta I-Spectrin Regulates the Morphological and Functional Dynamics of Dendritic Spines	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; F-ACTIN; NMDA RECEPTORS; POSTSYNAPTIC DENSITY; HIPPOCAMPAL-NEURONS; AMPA RECEPTORS; MOLECULAR-MECHANISMS; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY	Actin microfilaments regulate the size, shape and mobility of dendritic spines and are in turn regulated by actin binding proteins and small GTPases. The beta I isoform of spectrin, a protein that links the actin cytoskeleton to membrane proteins, is present in spines. To understand its function, we expressed its actin-binding domain (ABD) in CA1 pyramidal neurons in hippocampal slice cultures. The ABD of beta I-spectrin bundled actin in principal dendrites and was concentrated in dendritic spines, where it significantly increased the size of the spine head. These effects were not observed after expression of homologous ABDs of utrophin, dystrophin, and alpha-actinin. Treatment of slice cultures with latrunculin-B significantly decreased spine head size and decreased actin-GFP fluorescence in cells expressing the ABD of alpha-actinin, but not the ABD of beta I-spectrin, suggesting that its presence inhibits actin depolymerization. We also observed an increase in the area of GFP-tagged PSD-95 in the spine head and an increase in the amplitude of mEPSCs at spines expressing the ABD of beta I-spectrin. The effects of the beta I-spectrin ABD on spine size and mEPSC amplitude were mimicked by expressing wild-type Rac3, a small GTPase that co-immunoprecipitates specifically with beta I-spectrin in extracts of cultured cortical neurons. Spine size was normal in cells co-expressing a dominant negative Rac3 construct with the beta I-spectrin ABD. We suggest that beta I-spectrin is a synaptic protein that can modulate both the morphological and functional dynamics of dendritic spines, perhaps via interaction with actin and Rac3.	[Nestor, Michael W.; Cai, Xiang; Stone, Michele R.; Bloch, Robert J.; Thompson, Scott M.] Univ Maryland, Dept Physiol, Sch Med, Baltimore, MD 21201 USA; [Nestor, Michael W.; Bloch, Robert J.; Thompson, Scott M.] Univ Maryland, Program Neurosci, Sch Med, Baltimore, MD 21201 USA; [Nestor, Michael W.; Bloch, Robert J.; Thompson, Scott M.] Univ Maryland, Training Program Integrat Membrane Biol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Nestor, MW (corresponding author), Natl Inst Child Hlth & Dev, NIH, Bethesda, MD USA.	sthom003@umaryland.edu	Cai, Xiang/AAD-8012-2021; Thompson, Scott M/K-8921-2015		Muscular Dystrophy Association [T32 GM08181, T32 NS07375]; National Institutes of Health [R01 HL75106, R01 MH65488]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by stipends to MWN from T32 GM08181, to MRS from T32 NS07375, and from grants from the Muscular Dystrophy Association (RJB) and the National Institutes of Health (R01 HL75106 to RJB and R01 MH65488 to SMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DW, 1998, J NEUROSCI, V18, P2423; Amann KJ, 1998, J BIOL CHEM, V273, P28419, DOI 10.1074/jbc.273.43.28419; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; CALVERT R, 1980, EUR J BIOCHEM, V107, P355; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COLEMAN TR, 1987, J CELL BIOL, V104, P519, DOI 10.1083/jcb.104.3.519; Corbetta S, 2005, MOL CELL BIOL, V25, P5763, DOI 10.1128/MCB.25.13.5763-5776.2005; Corbetta S, 2008, BEHAV BRAIN RES, V186, P246, DOI 10.1016/j.bbr.2007.08.019; Corbetta S, 2009, FASEB J, V23, P1347, DOI 10.1096/fj.08-121574; DAVIS LH, 1994, J BIOL CHEM, V269, P4409; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gahwiler BH, 1998, CULTURING NERVE CELL, P461; Galkin VE, 2002, J CELL BIOL, V157, P243, DOI 10.1083/jcb.200111097; Hajdo-Milasinovic A, 2007, J CELL SCI, V120, P555, DOI 10.1242/jcs.03364; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hering H, 2003, J NEUROSCI, V23, P11759; HUGHES CA, 1995, J BIOL CHEM, V270, P18990, DOI 10.1074/jbc.270.32.18990; Kim CH, 1999, J NEUROSCI, V19, P4314; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Li XL, 1996, J BIOL CHEM, V271, P15695, DOI 10.1074/jbc.271.26.15695; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Malosio ML, 1997, J NEUROSCI, V17, P6717; MARKHAM JA, 1986, DEV BRAIN RES, V27, P263, DOI 10.1016/0165-3806(86)90253-1; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; MCALLISTER AK, 2000, BIOL TRANSFECTION NE, P11; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Oliver CJ, 2002, MOL CELL BIOL, V22, P4690, DOI 10.1128/MCB.22.13.4690-4701.2002; Oray S, 2006, CEREB CORTEX, V16, P730, DOI 10.1093/cercor/bhj019; Orioli D, 2006, MOL BIOL CELL, V17, P2391, DOI 10.1091/mbc.E05-08-0753; Ouyang Y, 2005, EUR J NEUROSCI, V22, P2995, DOI 10.1111/j.1460-9568.2005.04521.x; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Shen L, 2000, J NEUROSCI, V20, P7932; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stone MR, 2005, MOL BIOL CELL, V16, P4280, DOI 10.1091/mbc.E05-02-0112; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Ursitti JA, 2001, DEV BRAIN RES, V129, P81, DOI 10.1016/S0165-3806(01)00160-2; Viel A, 1996, CURR OPIN CELL BIOL, V8, P49, DOI 10.1016/S0955-0674(96)80048-2; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Zhang WD, 2000, HIPPOCAMPUS, V10, P512, DOI 10.1002/1098-1063(2000)10:5<512::AID-HIPO2>3.0.CO;2-M; Zhou DX, 1998, MOL BIOL CELL, V9, P47, DOI 10.1091/mbc.9.1.47; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	78	27	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16197	10.1371/journal.pone.0016197	http://dx.doi.org/10.1371/journal.pone.0016197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297961	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300040
J	Tretyakov, K; Laur, S; Vilo, J				Tretyakov, Konstantin; Laur, Sven; Vilo, Jaak			G = MAT: Linking Transcription Factor Expression and DNA Binding Data	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; GENOMIC SCALE; NETWORKS; PROFILES; IDENTIFICATION; REGRESSION; PROGRAMS; GROWTH; SITES	Transcription factors are proteins that bind to motifs on the DNA and thus affect gene expression regulation. The qualitative description of the corresponding processes is therefore important for a better understanding of essential biological mechanisms. However, wet lab experiments targeted at the discovery of the regulatory interplay between transcription factors and binding sites are expensive. We propose a new, purely computational method for finding putative associations between transcription factors and motifs. This method is based on a linear model that combines sequence information with expression data. We present various methods for model parameter estimation and show, via experiments on simulated data, that these methods are reliable. Finally, we examine the performance of this model on biological data and conclude that it can indeed be used to discover meaningful associations. The developed software is available as a web tool and Scilab source code at http://biit.cs.ut.ee/gmat/.	[Tretyakov, Konstantin; Laur, Sven] Univ Tartu, Inst Comp Sci, EE-50090 Tartu, Estonia; [Vilo, Jaak] Quretec, Tartu, Estonia	University of Tartu	Tretyakov, K (corresponding author), Univ Tartu, Inst Comp Sci, Ulikooli 18, EE-50090 Tartu, Estonia.	vilo@ut.ee	Laur, Sven/ABA-9120-2021; Vilo, Jaak/AAK-2228-2020; Vilo, Jaak/A-7183-2008	Vilo, Jaak/0000-0001-5604-4107; Vilo, Jaak/0000-0001-5604-4107	Estonian Center of Excellence in Computer Science (EXCS); Estonian Science Foundation [ETF7437]; European Union [LSHG-CT-2005-518254]	Estonian Center of Excellence in Computer Science (EXCS); Estonian Science Foundation; European Union(European Commission)	This work was supported by the European Regional Development Fund through the Estonian Center of Excellence in Computer Science (EXCS), the Estonian Science Foundation grant ETF7437, and the European Union FP6 NoE ENFIN (LSHG-CT-2005-518254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attfield PV, 1997, NAT BIOTECHNOL, V15, P1351, DOI 10.1038/nbt1297-1351; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Brazma A, 1998, GENOME RES, V8, P1202, DOI 10.1101/gr.8.11.1202; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Daubechies I, 2004, COMMUN PUR APPL MATH, V57, P1413, DOI 10.1002/cpa.20042; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; HAEUSSLER M, 2005, 5714 INR RES; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Kao KC, 2004, P NATL ACAD SCI USA, V101, P641, DOI 10.1073/pnas.0305287101; Keles S, 2002, BIOINFORMATICS, V18, P1167, DOI 10.1093/bioinformatics/18.9.1167; Kundaje A, 2007, ANN NY ACAD SCI, V1115, P178, DOI 10.1196/annals.1407.020; Latchman D. S., 2005, GENE REGULATION EUKA; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Lu L, 2005, CURR GENET, V48, P235, DOI 10.1007/s00294-005-0023-4; Ma J., 2006, GENE EXPRESSION REGU; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Middendorf M, 2004, BIOINFORMATICS, V20, P232, DOI 10.1093/bioinformatics/bth923; Nguyen DH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100054; POTTHOFF RF, 1964, BIOMETRIKA, V51, P313, DOI [10.2307/2334137, 10.1093/biomet/51.3-4.313]; PRAEKELT UM, 1990, MOL GEN GENET, V223, P97, DOI 10.1007/BF00315801; Rao C. R, 2007, LINEAR MODELS GEN LE; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rep M, 1999, MOL CELL BIOL, V19, P5474; RHODE PR, 1989, GENE DEV, V3, P1926, DOI 10.1101/gad.3.12a.1926; Rhodes DR, 2002, CANCER RES, V62, P4427; Ruan JH, 2006, BIOINFORMATICS, V22, P332, DOI 10.1093/bioinformatics/bti792; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Soinov LA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r6; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Vilo J, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P384; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; [No title captured]	40	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14559	10.1371/journal.pone.0014559	http://dx.doi.org/10.1371/journal.pone.0014559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297945	Green Submitted, Green Published, gold			2022-12-25	WOS:000286834300001
J	Fragel-Madeira, L; Meletti, T; Mariante, RM; Monteiro, RQ; Einicker-Lamas, M; Bernardo, RR; Lopes, AH; Linden, R				Fragel-Madeira, Lucianne; Meletti, Tamara; Mariante, Rafael M.; Monteiro, Robson Q.; Einicker-Lamas, Marcelo; Bernardo, Robson R.; Lopes, Angela H.; Linden, Rafael			Platelet Activating Factor Blocks Interkinetic Nuclear Migration in Retinal Progenitors through an Arrest of the Cell Cycle at the S/G2 Transition	PLOS ONE			English	Article							INFLAMMATORY LIPID MEDIATORS; DNA-DAMAGE CHECKPOINT; NEURONAL MIGRATION; ISCHEMIC RETINOPATHY; CYTOPLASMIC DYNEIN; KINASE ACTIVATION; PROTEIN-KINASES; IN-VITRO; S-PHASE; LIS1	Nuclear migration is regulated by the LIS1 protein, which is the regulatory subunit of platelet activating factor (PAF) acetylhydrolase, an enzyme complex that inactivates the lipid mediator PAF. Among other functions, PAF modulates cell proliferation, but its effects upon mechanisms of the cell cycle are unknown. Here we show that PAF inhibited interkinetic nuclear migration (IKNM) in retinal proliferating progenitors. The lipid did not, however, affect the velocity of nuclear migration in cells that escaped IKNM blockade. The effect depended on the PAF receptor, Erk and p38 pathways and Chk1. PAF induced no cell death, nor a reduction in nucleotide incorporation, which rules out an intra-S checkpoint. Notwithstanding, the expected increase in cyclin B1 content during G2-phase was prevented in the proliferating cells. We conclude that PAF blocks interkinetic nuclear migration in retinal progenitor cells through an unusual arrest of the cell cycle at the transition from S to G2 phases. These data suggest the operation, in the developing retina, of a checkpoint that monitors the transition from S to G2 phases of the cell cycle.	[Fragel-Madeira, Lucianne; Meletti, Tamara; Mariante, Rafael M.; Einicker-Lamas, Marcelo; Linden, Rafael] Univ Fed Rio de Janeiro, Inst Biophys, Rio De Janeiro, Brazil; [Monteiro, Robson Q.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil; [Bernardo, Robson R.] Univ Fed Rio de Janeiro, Inst Chem, Rio De Janeiro, Brazil; [Lopes, Angela H.] Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Fragel-Madeira, L (corresponding author), Univ Fed Fluminense, Inst Biol, Dept Neurobiol, Niteroi, RJ, Brazil.	rlinden@biof.ufrj.br	de Queiroz Monteiro, Robson/M-7097-2019; Linden, Rafael/F-2275-2011; Lopes, Angela/AAX-2501-2021; Fisiologia, Ciencias Biologicas/C-2407-2012; Mariante, Rafael/AAM-6010-2021; Fragel-Madeira, Lucianne/I-2208-2016; Fragel-Madeira, Lucianne/V-1665-2019; Mariante, Rafael/A-2971-2015; bernardo, robson roney/C-6163-2018; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Monteiro, Robson/GRX-0672-2022	Linden, Rafael/0000-0003-3287-336X; Mariante, Rafael/0000-0001-8024-9612; Fragel-Madeira, Lucianne/0000-0001-6747-2828; Mariante, Rafael/0000-0001-8024-9612; bernardo, robson roney/0000-0002-0035-5149; Monteiro, Robson/0000-0002-5260-2332; Hampshire Lopes, Angela/0000-0003-0660-4596	CNPq; FINEP; CEPG-UFRJ; FAPERJ; PRONEX-MCT; FUJB-UFRJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); CEPG-UFRJ; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PRONEX-MCT; FUJB-UFRJ	This investigation was supported by grants from CNPq, FINEP, CEPG-UFRJ, FAPERJ, PRONEX-MCT, and FUJB-UFRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 1996, DEV BIOL, V180, P579, DOI 10.1006/dbio.1996.0330; Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; Arai H, 2002, J BIOCHEM, V131, P635, DOI 10.1093/oxfordjournals.jbchem.a003145; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Bazan NG, 2007, CURR OPIN CLIN NUTR, V10, P136, DOI 10.1097/MCO.0b013e32802b7030; Beauchamp MH, 2002, INVEST OPHTH VIS SCI, V43, P3327; Bix GJ, 1998, J NEUROSCI, V18, P307; Boije H, 2009, DEV BIOL, V330, P105, DOI 10.1016/j.ydbio.2009.03.013; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Boye Erik, 2009, V521, P55, DOI [10.1007/978-1-60327-815-7_4, 10.1007/978-1-60327-817-5_4]; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; BUSSOLINO F, 1986, J BIOL CHEM, V261, P6502; Callegari AJ, 2006, P NATL ACAD SCI USA, V103, P15877, DOI 10.1073/pnas.0607343103; Campos CBL, 2002, NEUROSCIENCE, V112, P583, DOI 10.1016/S0306-4522(02)00096-9; CASTROFARIANETO HC, 1990, J PHARM PHARMACOL, V42, P203, DOI 10.1111/j.2042-7158.1990.tb05388.x; Cerella C, 2009, APOPTOSIS, V14, P641, DOI 10.1007/s10495-009-0328-8; Chew LJ, 2005, GLIA, V52, P127, DOI 10.1002/glia.20232; Chin CF, 2010, MOL CELL BIOL, V30, P22, DOI 10.1128/MCB.00687-09; Chou YH, 2007, FOOD CHEM TOXICOL, V45, P1356, DOI 10.1016/j.fct.2007.01.012; Chow JPH, 2003, J BIOL CHEM, V278, P40815, DOI 10.1074/jbc.M306683200; Ciliberto A, 2009, EMBO J, V28, P2162, DOI 10.1038/emboj.2009.186; Cook JG, 2009, FRONT BIOSCI-LANDMRK, V14, P5013, DOI 10.2741/3584; DEARAUJO EG, 1993, EUR J NEUROSCI, V5, P1181; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; DOVER R, 1994, HISTOCHEMISTRY, V102, P383, DOI 10.1007/BF00268909; Carneiro ACD, 2008, DEV NEUROBIOL, V68, P620, DOI 10.1002/dneu.20613; Faretta M, 1998, CYTOMETRY, V31, P53; Frade JM, 2002, PROG BRAIN RES, V136, P67; Francis Dennis, 2008, SEB Exp Biol Ser, V59, P81; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Grallert B, 2008, CELL CYCLE, V7, P2315, DOI 10.4161/cc.6389; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; Hardy P, 2005, PHARMACOL REP, V57, P169; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Hayes NL, 2000, DEV NEUROSCI-BASEL, V22, P44, DOI 10.1159/000017426; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; JANERO DR, 1988, THROMB RES, V50, P789, DOI 10.1016/0049-3848(88)90339-8; Latasa MJ, 2009, INT J DEV BIOL, V53, P895, DOI 10.1387/ijdb.082721ml; Kanno T, 1999, DIABETES, V48, P1741, DOI 10.2337/diabetes.48.9.1741; Kubrusly RCC, 2008, NEUROCHEM INT, V53, P63, DOI 10.1016/j.neuint.2008.05.002; LINDEN R, 1986, HISTOCHEMISTRY, V85, P335, DOI 10.1007/BF00493486; Liu XX, 2010, J NEUROSCI, V30, P4197, DOI 10.1523/JNEUROSCI.4187-09.2010; Marques M, 2002, J INVEST DERMATOL, V119, P913, DOI 10.1046/j.1523-1747.2002.01859.x; Marrache AM, 2002, J IMMUNOL, V169, P6474, DOI 10.4049/jimmunol.169.11.6474; MARTINS MA, 1987, EUR J PHARMACOL, V136, P353, DOI 10.1016/0014-2999(87)90308-6; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MAZZOTTI G, 1990, J HISTOCHEM CYTOCHEM, V38, P13, DOI 10.1177/38.1.2403578; McCormick C, 2010, EUR J PHARMACOL, V641, P160, DOI 10.1016/j.ejphar.2010.04.035; MESSIER PE, 1978, EXPERIENTIA, V34, P289, DOI 10.1007/BF01922992; Miyata T, 2008, DEV GROWTH DIFFER, V50, pS105, DOI 10.1111/j.1440-169x.2007.00980.x; Mogila V, 2006, DEV CELL, V11, P575, DOI 10.1016/j.devcel.2006.08.010; Monteiro RQ, 1997, TOXICON, V35, P649, DOI 10.1016/S0041-0101(96)00176-6; Moriguchi S, 2009, HIPPOCAMPUS, V19, P844, DOI 10.1002/hipo.20572; Morris NR, 1998, TRENDS CELL BIOL, V8, P467, DOI 10.1016/S0962-8924(98)01389-0; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Nakayama R, 1997, BIOSCI BIOTECH BIOCH, V61, P631, DOI 10.1271/bbb.61.631; Nelson RJ, 1998, NEUROSCI BIOBEHAV R, V22, P453, DOI 10.1016/S0149-7634(97)00053-5; Nojima H, 2006, GENOME DYN, V1, P131, DOI 10.1159/000092505; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Oshima K, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-112; Panaro MA, 2007, IMMUNOPHARM IMMUNOT, V29, P201, DOI 10.1080/08923970701511942; Pearson RA, 2005, J NEUROSCI, V25, P10803, DOI 10.1523/JNEUROSCI.2312-05.2005; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Qiu I, 2001, BIOCHEM BIOPH RES CO, V287, P1017, DOI 10.1006/bbrc.2001.5691; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rotstein NP, 2010, J LIPID RES, V51, P1247, DOI 10.1194/jlr.R003442; SAMBASIVARAO K, 1963, J LIPID RES, V4, P106; Sarkaria JN, 1999, CANCER RES, V59, P4375; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Shiromizu T, 2006, GENES CELLS, V11, P477, DOI 10.1111/j.1365-2443.2006.00955.x; Shukla SD, 1996, ADV EXP MED BIOL, V416, P153; Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Tokuoka SM, 2003, EUR J NEUROSCI, V18, P563, DOI 10.1046/j.1460-9568.2003.02778.x; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; VASQUEZBRAVO YLAR, 1993, J LIPID MEDIATOR, V8, P135; Wang HM, 2003, ONCOGENE, V22, P2186, DOI 10.1038/sj.onc.1206348; Weltzin MM, 2010, J PHARMACOL EXP THER, V334, P917, DOI 10.1124/jpet.110.167684; Wu YM, 2009, J NEUROCHEM, V109, P1157, DOI 10.1111/j.1471-4159.2009.06043.x; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; YAVIN E, 1977, ANAL BIOCHEM, V80, P430, DOI 10.1016/0003-2697(77)90665-0; YOUSUFZAI SYK, 1985, BIOCHEM J, V228, P697, DOI 10.1042/bj2280697; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhuang SH, 2007, CLIN CANCER RES, V13, P7480, DOI 10.1158/1078-0432.CCR-06-2883	95	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16058	10.1371/journal.pone.0016058	http://dx.doi.org/10.1371/journal.pone.0016058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298035	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900022
J	Li, SY; Yang, D; Yeung, CM; Yu, WY; Chang, RCC; So, KF; Wong, D; Lo, ACY				Li, Suk-Yee; Yang, Di; Yeung, Chung-Man; Yu, Wing-Yan; Chang, Raymond Chuen-Chung; So, Kwok-Fai; Wong, David; Lo, Amy C. Y.			Lycium Barbarum Polysaccharides Reduce Neuronal Damage, Blood-Retinal Barrier Disruption and Oxidative Stress in Retinal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							AMYLOID PEPTIDE NEUROTOXICITY; CEREBRAL-ARTERY OCCLUSION; ISCHEMIA-REPERFUSION; MULLER CELLS; RAT RETINA; IN-VIVO; SYNCHROTRON-RADIATION; DIABETIC-NEUROPATHY; PROTEIN COMPLEX; MOUSE RETINA	Neuronal cell death, glial cell activation, retinal swelling and oxidative injury are complications in retinal ischemia/reperfusion (I/R) injuries. Lycium barbarum polysaccharides (LBP), extracts from the wolfberries, are good for "eye health'' according to Chinese medicine. The aim of our present study is to explore the use of LBP in retinal I/R injury. Retinal I/R injury was induced by surgical occlusion of the internal carotid artery. Prior to induction of ischemia, mice were treated orally with either vehicle (PBS) or LBP (1 mg/kg) once a day for 1 week. Paraffin-embedded retinal sections were prepared. Viable cells were counted; apoptosis was assessed using TUNEL assay. Expression levels of glial fibrillary acidic protein (GFAP), aquaporin-4 (AQP4), poly(ADP-ribose) (PAR) and nitrotyrosine (NT) were investigated by immunohistochemistry. The integrity of blood-retinal barrier (BRB) was examined by IgG extravasations. Apoptosis and decreased viable cell count were found in the ganglion cell layer (GCL) and the inner nuclear layer (INL) of the vehicle-treated I/R retina. Additionally, increased retinal thickness, GFAP activation, AQP4 up-regulation, IgG extravasations and PAR expression levels were observed in the vehicle-treated I/R retina. Many of these changes were diminished or abolished in the LBP-treated I/R retina. Pre-treatment with LBP for 1 week effectively protected the retina from neuronal death, apoptosis, glial cell activation, aquaporin water channel up-regulation, disruption of BRB and oxidative stress. The present study suggests that LBP may have a neuroprotective role to play in ocular diseases for which I/R is a feature.	[Li, Suk-Yee; Yang, Di; Yeung, Chung-Man; Yu, Wing-Yan; Wong, David; Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Hong Kong, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai; Wong, David; Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Wong, David] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England	University of Hong Kong; University of Hong Kong; University of Hong Kong; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Li, SY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Hong Kong, Hong Kong, Peoples R China.	amylo@hkucc.hku.hk	Wong, Sai Hung David/D-8482-2015; Chang, Raymond Chuen-Chung/C-1107-2009; Lo, Amy C. Y./C-1195-2009	Chang, Raymond Chuen-Chung/0000-0001-8538-7993; Lo, Amy C. Y./0000-0003-4239-6851; YU, Wing Yan/0000-0003-4980-3712; So, Kwok-Fai/0000-0003-4039-4246	Small Project Funding; The University of Hong Kong	Small Project Funding; The University of Hong Kong(University of Hong Kong)	This project was supported by the Small Project Funding (C.M. Yeung) and the University Development Fund from The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J HUAZHONG U SCI TEC; Aslan M, 2006, FREE RADICAL RES, V40, P147, DOI 10.1080/10715760500456219; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031; Chang RCC, 2008, CELL MOL NEUROBIOL, V28, P643, DOI 10.1007/s10571-007-9181-x; Chatterjee PK, 2000, FASEB J, V14, P641, DOI 10.1096/fasebj.14.5.641; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; Cheung AKH, 2007, EXP EYE RES, V85, P608, DOI 10.1016/j.exer.2007.07.013; Chiu Kin, 2009, J Ocul Biol Dis Infor, V2, P47; Da T, 2004, INVEST OPHTH VIS SCI, V45, pU96; Dijk F, 2004, BRAIN RES, V1026, P205, DOI 10.1016/j.brainres.2004.08.014; DREIXLER JC, 2010, EXP EYE RES; Du Guang, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P518; El-Remessy AB, 2003, AM J PATHOL, V163, P1997, DOI 10.1016/S0002-9440(10)63558-4; Erdelyi K, 2005, CELL MOL LIFE SCI, V62, P751, DOI 10.1007/s00018-004-4506-0; Fernandez DC, 2009, J NEUROCHEM, V111, P488, DOI 10.1111/j.1471-4159.2009.06334.x; Fernandez DC, 2009, INVEST OPHTH VIS SCI, V50, P3922, DOI 10.1167/iovs.08-3344; Gan L, 2004, INT IMMUNOPHARMACOL, V4, P563, DOI 10.1016/j.intimp.2004.01.023; Gan L, 2003, EUR J PHARMACOL, V471, P217, DOI 10.1016/S0014-2999(03)01827-2; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Gong HY, 2005, CANCER BIOTHER RADIO, V20, P155, DOI 10.1089/cbr.2005.20.155; Gresle MM, 2006, BRAIN RES, V1110, P13, DOI 10.1016/j.brainres.2006.06.111; Ha KT, 2005, J ETHNOPHARMACOL, V96, P529, DOI 10.1016/j.jep.2004.09.054; Hai-Yang Gong, 2004, J Exp Ther Oncol, V4, P181; Haurigot V, 2009, J BIOL CHEM, V284, P22961, DOI 10.1074/jbc.M109.014787; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Huang Xiaolan, 2003, Wei Sheng Yan Jiu, V32, P599; Iandiev I, 2006, NEUROSCI LETT, V408, P108, DOI 10.1016/j.neulet.2006.08.084; Jarlestedt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010397; Ji D, 2008, NEUROCHEM INT, V52, P786, DOI 10.1016/j.neuint.2007.09.012; Kaja S, 2003, INVEST OPHTH VIS SCI, V44, P3155, DOI 10.1167/iovs.02-1204; Kalesnykas G, 2008, NEUROSCIENCE, V155, P937, DOI 10.1016/j.neuroscience.2008.06.038; Kaur C, 2007, J PATHOL, V212, P429, DOI 10.1002/path.2195; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; Kidoguchi K, 2006, STROKE, V37, P1856, DOI 10.1161/01.STR.0000226904.96059.a6; KLONER RA, 1989, CIRCULATION, V80, P1115, DOI 10.1161/01.CIR.80.5.1115; Kuroki M, 1996, J CLIN INVEST, V98, P1667, DOI 10.1172/JCI118962; LEAL EC, 2010, DIABETES; Lelong DC, 2007, STROKE, V38, P3237, DOI 10.1161/STROKEAHA.107.499319; Li SY, 2010, INT J MOL SCI, V11, P2109, DOI 10.3390/ijms11052109; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; Li XM, 2007, J ETHNOPHARMACOL, V111, P504, DOI 10.1016/j.jep.2006.12.024; Luo Q, 2004, LIFE SCI, V76, P137, DOI 10.1016/j.lfs.2004.04.056; Melena J, 2003, BRAIN RES, V989, P128, DOI 10.1016/S0006-8993(03)03375-4; Miranda M, 2010, FREE RADICAL BIO MED, V48, P216, DOI 10.1016/j.freeradbiomed.2009.10.042; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Nakajima Y, 2009, CURR EYE RES, V34, P311, DOI 10.1080/02713680902745408; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; Obrosova IG, 2005, DIABETES, V54, P3435, DOI 10.2337/diabetes.54.12.3435; Obrosova IG, 2004, DIABETES, V53, P711, DOI 10.2337/diabetes.53.3.711; Palamalai V, 2006, MOL VIS, V12, P1543; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Sarthy V P, 2000, Arch Soc Esp Oftalmol, V75, P367; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; Schwartz M, 2005, J NEUROL SCI, V233, P163, DOI 10.1016/j.jns.2005.03.014; Steele EC, 2008, STROKE, V39, P2099, DOI 10.1161/STROKEAHA.107.504357; Tamaki Masahiro, 2006, Kobe Journal of Medical Sciences, V52, P111; Verkman AS, 2008, PROG RETIN EYE RES, V27, P420, DOI 10.1016/j.preteyeres.2008.04.001; Wu H, 2006, YAKUGAKU ZASSHI, V126, P365, DOI 10.1248/yakushi.126.365; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yu MS, 2007, INT J MOL MED, V20, P261; Yu MS, 2005, EXP GERONTOL, V40, P716, DOI 10.1016/j.exger.2005.06.010	66	125	141	6	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16380	10.1371/journal.pone.0016380	http://dx.doi.org/10.1371/journal.pone.0016380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298100	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800034
J	Xie, LS; Qiao, XH; Wu, YF; Tang, J				Xie, Lishi; Qiao, Xiaohang; Wu, Yanfang; Tang, Jie			beta-Arrestin1 Mediates the Endocytosis and Functions of Macrophage Migration Inhibitory Factor	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR MIF; BETA-ARRESTIN; CYCLIN D1; MAP KINASE; ERK ACTIVATION; RECEPTOR; EXPRESSION; ANGIOGENESIS; CLATHRIN	Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine, regulating inflammatory and immune responses. MIF binds to cell surface receptor CD74, resulting in both rapid and sustained ERK activation. It was reported that MIF-induced rapid ERK activation requires its co-receptor CD44. But the exact mechanism underlying sustained ERK activation is not well understood. In the current study, we described a detailed mechanism of MIF mediated sustained ERK activation. We found that beta-arrestin1, a scaffold protein involved in the activation of the MAPK cascade, interacts with CD74 upon MIF stimulation, resulting in CD74-mediated MIF endocytosis in a chlorpromazine (CPZ)-sensitive manner. beta-arrestin1 is also involved in endocytotic MIF signaling, leading to sustained ERK activation. Therefore beta-arrestin1 plays a central role in coupling MIF endocytosis to sustained ERK activation.	[Xie, Lishi; Qiao, Xiaohang; Wu, Yanfang; Tang, Jie] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100080, Peoples R China; [Xie, Lishi; Qiao, Xiaohang] Chinese Acad Sci, Grad Univ, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xie, LS (corresponding author), Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100080, Peoples R China.	jtang@ibp.ac.cn	Xie, Lishi/C-2334-2019	Xie, Lishi/0000-0003-2376-6685	Ministry of Science and Technololgy of China [2006CB504304]; Ministry of Health of China [008ZX10002-008]	Ministry of Science and Technololgy of China; Ministry of Health of China	This work was supported by grants from Ministry of Science and Technololgy of China (2006CB504304) and Ministry of Health of China (008ZX10002-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MA, 2003, CIRC RES, V93, P321, DOI 10.1161/01.RES.0000087641.56024.DA; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; COOPERSTOCK MS, 1974, ANTIMICROB AGENTS CH, V6, P422, DOI 10.1128/AAC.6.4.422; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; GEORGE M, 1962, P SOC EXP BIOL MED, V111, P514; Hira E, 2005, CANCER, V103, P588, DOI 10.1002/cncr.20818; Kleemann R, 2002, J INTERF CYTOK RES, V22, P351, DOI 10.1089/107999002753675785; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Legendre H, 2003, MODERN PATHOL, V16, P491, DOI 10.1097/01.MP.0000068235.45178.C1; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Liang Wei, 2004, Current Drug Delivery, V1, P1, DOI 10.2174/1567201043480063; Liao H, 2003, J BIOL CHEM, V278, P76, DOI 10.1074/jbc.M208820200; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McCormick PJ, 2005, P NATL ACAD SCI USA, V102, P7910, DOI 10.1073/pnas.0502206102; MELOCHE S, 1992, FASEB J, V6, pA1852; Meyer-Siegler KL, 2002, CANCER-AM CANCER SOC, V94, P1449, DOI 10.1002/cncr.10354; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Santos LL, 2008, CLIN EXP IMMUNOL, V152, P372, DOI 10.1111/j.1365-2249.2008.03639.x; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Swant JD, 2005, J BIOL CHEM, V280, P23066, DOI 10.1074/jbc.M500636200; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Vrecl M, 1998, MOL ENDOCRINOL, V12, P1818, DOI 10.1210/me.12.12.1818; Wadgaonkar R, 2005, J CELL BIOCHEM, V95, P849, DOI 10.1002/jcb.20472; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044	39	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16428	10.1371/journal.pone.0016428	http://dx.doi.org/10.1371/journal.pone.0016428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283538	Green Submitted, gold, Green Published			2022-12-25	WOS:000286661400051
J	Ghatak, P; Karmakar, K; Kasetty, S; Chatterji, D				Ghatak, Payel; Karmakar, Kajari; Kasetty, Sanjay; Chatterji, Dipankar			Unveiling the Role of Dps in the Organization of Mycobacterial Nucleoid	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL CHROMATIN; DNA CONDENSATION; SMEGMATIS DPS; PROTECTS DNA; SURVIVAL; STRESS; MICROSCOPY; MOLECULES; PROTEINS	In order to preserve genetic information in stress conditions, bacterial DNA is organized into higher order nucleoid structure. In this paper, with the help of Atomic Force Microscopy, we show the different structural changes in mycobacterial nucleoid at different points of growth in the presence of different concentrations of glucose in the medium. We also observe that in Mycobacterium smegmatis, two different Dps proteins (Dps1 and Dps2) promote two types of nucleoid organizations. At the late stationary phase, under low glucose availability, Dps1 binds to DNA to form a very stable toroid structure. On the other hand, under the same condition, Dps2-DNA complex forms an incompletely condensed toroid and finally forms a further stable coral reef structure in the presence of RNA. This coral reef structure is stable in high concentration of bivalent ion like Mg2+.	[Ghatak, Payel; Karmakar, Kajari; Kasetty, Sanjay; Chatterji, Dipankar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Karmakar, Kajari] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Indian Institute of Science (IISC) - Bangalore; Friedrich Miescher Institute for Biomedical Research	Ghatak, P (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	dipankar@mbu.iisc.ernet.in		Chatterji, Dipankar/0000-0002-9985-0632	Department of Science and Technology (DST), Government of India	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	The work was funded by the Department of Science and Technology (DST), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 1997, NUCLEIC ACIDS RES, V25, P2221, DOI 10.1093/nar/25.11.2221; ALLISON SA, 1981, BIOPOLYMERS, V20, P469, DOI 10.1002/bip.1981.360200305; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Basu D, 2009, NUCLEIC ACIDS RES, V37, P4944, DOI 10.1093/nar/gkp502; Ceci P, 2004, NUCLEIC ACIDS RES, V32, P5935, DOI 10.1093/nar/gkh915; Chowdhury RP, 2010, IUBMB LIFE, V62, P67, DOI 10.1002/iub.285; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; Cunha S, 2001, BIOCHIMIE, V83, P149, DOI 10.1016/S0300-9084(01)01245-7; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; ENRIGHT HU, 1992, NUCLEIC ACIDS RES, V20, P3341, DOI 10.1093/nar/20.13.3341; Facey PD, 2009, MOL MICROBIOL, V73, P1186, DOI 10.1111/j.1365-2958.2009.06848.x; Fang Y, 1999, NUCLEIC ACIDS RES, V27, P1943, DOI 10.1093/nar/27.8.1943; Frenkiel-Krispin D, 2004, MOL MICROBIOL, V51, P395, DOI 10.1046/j.1365-2958.2003.03855.x; Frenkiel-Krispin D, 2001, EMBO J, V20, P1184, DOI 10.1093/emboj/20.5.1184; Frenkiel-Krispin D, 2002, ASM NEWS, V68, P277; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Gupta S, 2005, IUBMB LIFE, V57, P149, DOI 10.1080/15216540500090611; Gupta S, 2003, J BIOL CHEM, V278, P5235, DOI 10.1074/jbc.M208825200; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; HECHT RM, 1976, NUCLEIC ACIDS RES, V3, P767, DOI 10.1093/nar/3.3.767; Hud NV, 2005, ANNU REV BIOPH BIOM, V34, P295, DOI 10.1146/annurev.biophys.34.040204.144500; Ishihama A, 1999, GENES CELLS, V4, P135, DOI 10.1046/j.1365-2443.1999.00247.x; Kim J, 2004, NUCLEIC ACIDS RES, V32, P1982, DOI 10.1093/nar/gkh512; KLEPPE K, 1979, J GEN MICROBIOL, V112, P1; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kumar M, 2008, MICROBIOL-SGM, V154, P2942, DOI 10.1099/mic.0.2008/017806-0; LANGE R, 1991, J BACTERIOL, V173, P4474, DOI 10.1128/JB.173.14.4474-4481.1991; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; Minsky A, 2002, NAT REV MOL CELL BIO, V3, P50, DOI 10.1038/nrm700; Morikawa K, 2006, GENES CELLS, V11, P409, DOI 10.1111/j.1365-2443.2006.00949.x; Mukherjee A, 2009, FEMS MICROBIOL LETT, V291, P232, DOI 10.1111/j.1574-6968.2008.01458.x; Ohniwa RL, 2007, GENES CELLS, V12, P1141, DOI 10.1111/j.1365-2443.2007.01125.x; Ojha AK, 2002, MICROBIOL-SGM, V148, P3039, DOI 10.1099/00221287-148-10-3039; Ojha AK, 2000, INFECT IMMUN, V68, P4084, DOI 10.1128/IAI.68.7.4084-4091.2000; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Roy S, 2004, J MOL BIOL, V339, P1103, DOI 10.1016/j.jmb.2004.04.042; Roy S, 2008, J MOL BIOL, V375, P948, DOI 10.1016/j.jmb.2007.10.023; Sambrook J., 2002, MOL CLONING LAB MANU; Saraswathi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008017; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004; Yoshikawa Y, 1999, LANGMUIR, V15, P4085, DOI 10.1021/la981159g; Yoshimura SH, 2003, J ELECTRON MICROSC, V52, P415, DOI 10.1093/jmicro/52.4.415; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	48	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16019	10.1371/journal.pone.0016019	http://dx.doi.org/10.1371/journal.pone.0016019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283627	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000286523400011
J	Orwig, SD; Lieberman, RL				Orwig, Susan D.; Lieberman, Raquel L.			Biophysical Characterization of the Olfactomedin Domain of Myocilin, an Extracellular Matrix Protein Implicated in Inherited Forms of Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; HUMAN TRABECULAR MESHWORK; CIRCULAR-DICHROISM; CHONDROITIN SULFATE; SECONDARY STRUCTURE; DISEASE PHENOTYPE; BINDING; IDENTIFICATION; STABILITY; LOCALIZATION	Myocilin is an eye protein found in the trabecular extracellular matrix (TEM), within the anatomic region that controls fluid flow. Variants of myocilin, localized to its olfactomedin (OLF) domain, have been linked to inherited forms of glaucoma, a disease associated with elevated intraocular pressure. OLF domains have also been implicated in psychiatric diseases and cancers by their involvement in signaling, neuronal growth, and development. However, molecular characterization of OLFs has been hampered by challenges in recombinant expression, a hurdle we have recently overcome for the myocilin OLF domain (myoc-OLF). Here, we report the first detailed solution biophysical characterization of myoc-OLF to gain insight into its structure and function. Myoc-OLF is stable in the presence of glycosaminoglycans, as well as in a wide pH range in buffers with functional groups reminiscent of such glycosaminoglycans. Circular dichroism (CD) reveals significant beta-sheet and beta-turn secondary structure. Unexpectedly, the CD signature is reminiscent of alpha-chymotrypsin as well as another ocular protein family, the beta gamma-crystallins. At neutral pH, intrinsic tryptophan fluorescence and CD melts indicate a highly cooperative transition with a melting temperature of similar to 55 degrees C. Limited proteolysis combined with mass spectrometry reveals that the compact core structural domain of OLF consists of approximately residues 238-461, which retains the single disulfide bond and is as stable as the full myoc-OLF construct. The data presented here inform new testable hypotheses for interactions with specific TEM components, and will assist in design of therapeutic agents for myocilin glaucoma.	[Orwig, Susan D.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Orwig, SD (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	raquel.lieberman@chemistry.gatech.edu			Glaucoma Research Foundation; American Health Assistance Foundation; United States Department of Education [P200A060188]; NATIONAL EYE INSTITUTE [R01EY021205] Funding Source: NIH RePORTER	Glaucoma Research Foundation; American Health Assistance Foundation(BrightFocus Foundation); United States Department of Education(US Department of Education); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants to R.L.L. from the Glaucoma Research Foundation and American Health Assistance Foundation. S.D.O. was supported in part by a United States Department of Education Graduate Assistance in Areas of National Need program P200A060188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; Burns JN, 2010, ACS CHEM BIOL, V5, P477, DOI 10.1021/cb900282e; Evans P, 2007, EXP EYE RES, V84, P1001, DOI 10.1016/j.exer.2007.01.016; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Filla MS, 2002, INVEST OPHTH VIS SCI, V43, P151; Fuchs PFJ, 2005, PROTEINS, V59, P828, DOI 10.1002/prot.20461; Furutani Y, 2005, BIOCHEM J, V389, P675, DOI 10.1042/BJ20050120; Ganesh C, 1997, BIOCHEMISTRY-US, V36, P5020, DOI 10.1021/bi961967b; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Goldwich A, 2009, HISTOCHEM CELL BIOL, V131, P167, DOI 10.1007/s00418-008-0518-4; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Greenfield NJ, 2004, METHOD ENZYMOL, V383, P282; Hillier BJ, 2007, BIOCHEM CELL BIOL, V85, P552, DOI 10.1139/O07-055; Jia LY, 2009, INVEST OPHTH VIS SCI, V50, P3743, DOI 10.1167/iovs.08-3151; JOHNSON PM, 1974, IMMUNOLOGY, V27, P27; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Knepper PA, 1996, INVEST OPHTH VIS SCI, V37, P1360; Knepper PA, 2005, INVEST OPHTH VIS SCI, V46, P2829, DOI 10.1167/iovs.04-1472; Knepper PA, 2005, J GLAUCOMA, V14, P230, DOI 10.1097/01.ijg.0000159130.00710.78; Kuleshova ON, 2007, B EXP BIOL MED+, V143, P381, DOI 10.1007/s10517-007-0117-8; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lam DSC, 2000, INVEST OPHTH VIS SCI, V41, pS30; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Liton PB, 2009, EXP EYE RES, V88, P724, DOI 10.1016/j.exer.2008.11.002; MANDAL K, 1987, J BIOL CHEM, V262, P8096; Mertts M, 1999, LAB INVEST, V79, P1237; MORRISETT JD, 1971, J AM CHEM SOC, V93, P7297, DOI 10.1021/ja00755a030; Nagy I, 2003, BIOCHEM BIOPH RES CO, V302, P554, DOI 10.1016/S0006-291X(03)00198-0; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pace CN, 2010, PROTEIN SCI, V19, P929, DOI 10.1002/pro.370; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Peters DM, 2005, EXP CELL RES, V303, P218, DOI 10.1016/j.yexcr.2004.09.026; Rajini B, 2003, BIOCHEMISTRY-US, V42, P4552, DOI 10.1021/bi027384l; Resch ZT, 2009, EXP EYE RES, V88, P704, DOI 10.1016/j.exer.2008.08.011; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Tawara A, 2000, CURR EYE RES, V21, P934, DOI 10.1076/ceyr.21.6.934.6988; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Ueda J, 2002, INVEST OPHTH VIS SCI, V43, P1068; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; Wentz-Hunter K, 2004, J CELL PHYSIOL, V200, P45, DOI 10.1002/jcp.10478; WU J, 1992, ANAL BIOCHEM, V200, P359, DOI 10.1016/0003-2697(92)90479-Q; Xu D, 1998, FOLD DES, V3, P11, DOI 10.1016/S1359-0278(98)00004-2; Yam GHF, 2005, FASEB J, V19, P12, DOI 10.1096/fj.04-2375com	53	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16347	10.1371/journal.pone.0016347	http://dx.doi.org/10.1371/journal.pone.0016347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283635	Green Published, gold, Green Submitted			2022-12-25	WOS:000286523400031
J	Moccand, C; Kaufmann, M; Fitzpatrick, TB				Moccand, Cyril; Kaufmann, Markus; Fitzpatrick, Teresa B.			It Takes Two to Tango: Defining an Essential Second Active Site in Pyridoxal 5 '-Phosphate Synthase	PLOS ONE			English	Article							VITAMIN-B-6 BIOSYNTHESIS; ESCHERICHIA-COLI; CHROMOPHORIC INTERMEDIATE; PHOSPHATE SYNTHASE; BACILLUS-SUBTILIS; ARGININE FINGER; PLP SYNTHASE; GENE; PATHWAY; BINDING	The prevalent de novo biosynthetic pathway of vitamin B6 involves only two enzymes (Pdx1 and Pdx2) that form an ornate multisubunit complex functioning as a glutamine amidotransferase. The synthase subunit, Pdx1, utilizes ribose 5-phosphate and glyceraldehyde 3-phosphate, as well as ammonia derived from the glutaminase activity of Pdx2 to directly form the cofactor vitamer, pyridoxal 5'-phosphate. Given the fact that a single enzyme performs the majority of the chemistry behind this reaction, a complicated mechanism is anticipated. Recently, the individual steps along the reaction co-ordinate are beginning to be unraveled. In particular, the binding of the pentose substrate and the first steps of the reaction have been elucidated but it is not known if the latter part of the chemistry, involving the triose sugar, takes place in the same or a disparate site. Here, we demonstrate through the use of enzyme assays, enzyme kinetics, and mutagenesis studies that indeed a second site is involved in binding the triose sugar and moreover, is the location of the final vitamin product, pyridoxal 5'-phosphate. Furthermore, we show that product release is triggered by the presence of a PLP-dependent enzyme. Finally, we provide evidence that a single arginine residue of the C terminus of Pdx1 is responsible for coordinating co-operativity in this elaborate protein machinery.	[Moccand, Cyril; Fitzpatrick, Teresa B.] Univ Geneva, Dept Bot & Plant Biol, Geneva, Switzerland	University of Geneva	Moccand, C (corresponding author), Univ Geneva, Dept Bot & Plant Biol, Geneva, Switzerland.	theresa.fitzpatrick@unige.ch			Swiss National Science Foundation [PPOOA_119186]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Financial support is gratefully acknowledged from the Swiss National Science Foundation (Grant PPOOA_119186) to T.B.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER DA, 1989, EUR J CLIN NUTR, V43, P289; Biesebeke RT, 2001, BIOCHEMISTRY-US, V40, P7474, DOI 10.1021/bi010027a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Cane DE, 1999, J AM CHEM SOC, V121, P7722, DOI 10.1021/ja9914947; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Dick T, 2010, MOL MICROBIOL, V78, P980, DOI 10.1111/j.1365-2958.2010.07381.x; Ehrenshaft M, 1998, MOL CELL, V1, P603, DOI 10.1016/S1097-2765(00)80060-X; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; Ehrenshaft M, 2001, J BACTERIOL, V183, P3383, DOI 10.1128/JB.183.11.3383-3390.2001; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Fitzpatrick TB, 2010, CHEMBIOCHEM, V11, P1185, DOI 10.1002/cbic.201000084; Hanes JW, 2008, NAT CHEM BIOL, V4, P425, DOI 10.1038/nchembio.93; Hanes JW, 2008, J AM CHEM SOC, V130, P3043, DOI 10.1021/ja076604l; HANES JW, 2008, ANGEW CHEM, V120, P2132; Hill RE, 1996, J BIOL CHEM, V271, P30426, DOI 10.1074/jbc.271.48.30426; JOHN RA, 1995, BBA-PROTEIN STRUCT M, V1248, P81, DOI 10.1016/0167-4838(95)00025-P; KAYA SJ, 1994, J BIOL CHEM, V269, P7419; Komatsu S, 2003, BBA-PROTEINS PROTEOM, V1647, P127, DOI 10.1016/S1570-9639(03)00076-1; Laber B, 1999, FEBS LETT, V449, P45, DOI 10.1016/S0014-5793(99)00393-2; Li H, 2005, ACTA CRYSTALLOGR E, V61, pM761, DOI 10.1107/S1600536805009098; Mahon MM, 1999, BBA-PROTEIN STRUCT M, V1434, P191, DOI 10.1016/S0167-4838(99)00181-8; Matxain JM, 2009, J PHYS CHEM B, V113, P9629, DOI 10.1021/jp903023c; MIDDLETON SA, 1988, BIOCHEMISTRY-US, V27, P8653, DOI 10.1021/bi00423a022; Mozzarelli A, 2006, CHEM REC, V6, P275, DOI 10.1002/tcr.20094; Muller IB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001815; Neuwirth M, 2009, FEBS LETT, V583, P2179, DOI 10.1016/j.febslet.2009.06.009; Osmani AH, 1999, J BIOL CHEM, V274, P23565, DOI 10.1074/jbc.274.33.23565; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; Raschle T, 2007, J BIOL CHEM, V282, P6098, DOI 10.1074/jbc.M610614200; Raschle T, 2009, J BIOL CHEM, V284, P7706, DOI 10.1074/jbc.M804728200; Rodriguez-Navarro S, 2002, YEAST, V19, P1261, DOI 10.1002/yea.916; Sakai A, 2002, J BIOSCI BIOENG, V93, P309, DOI 10.1263/jbb.93.309; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Tambasco-Studart M, 2005, P NATL ACAD SCI USA, V102, P13687, DOI 10.1073/pnas.0506228102; TAZUYA K, 1995, BBA-GEN SUBJECTS, V1244, P113, DOI 10.1016/0304-4165(94)00205-C; Titiz O, 2006, PLANT J, V48, P933, DOI 10.1111/j.1365-313X.2006.02928.x; Vacca Rosa A., 2008, BMC Biochemistry, V9, P17, DOI 10.1186/1471-2091-9-17; Yang ES, 2000, ARCH BIOCHEM BIOPHYS, V377, P109, DOI 10.1006/abbi.2000.1737; Zein F, 2006, BIOCHEMISTRY-US, V45, P14609, DOI 10.1021/bi061464y; Zhang BL, 1999, J BIOL CHEM, V274, P2609, DOI 10.1074/jbc.274.5.2609; Zhang XA, 2010, BIOCHEM J, V432, P445, DOI 10.1042/BJ20101241; Zhu JH, 2005, J BIOL CHEM, V280, P27914, DOI 10.1074/jbc.M503642200	44	19	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16042	10.1371/journal.pone.0016042	http://dx.doi.org/10.1371/journal.pone.0016042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283685	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522300015
J	Srivastava, K; Srivastava, A; Kumar, A; Mittal, B				Srivastava, Kshitij; Srivastava, Anvesha; Kumar, Ashok; Mittal, Balraj			Gallbladder Cancer Predisposition: A Multigenic Approach to DNA-Repair, Apoptotic and Inflammatory Pathway Genes	PLOS ONE			English	Article							HOGG1 SER326CYS POLYMORPHISM; SQUAMOUS-CELL-CARCINOMA; BILIARY-TRACT CANCER; BREAST-CANCER; RAS GENE; RISK; CYCLOOXYGENASE-2; ASSOCIATION; POPULATION; EXPRESSION	Gallbladder cancer (GBC) is a multifactorial disease with complex interplay between multiple genetic variants. We performed Classification and Regression Tree Analysis (CART) and Grade of Membership (GoM) analysis to identify combinations of alleles among the DNA repair, inflammatory and apoptotic pathway genetic variants in modifying the risk for GBC. We analyzed 16 polymorphisms in 8 genes involved in DNA repair, apoptotic and inflammatory pathways to find out combinations of genetic variants contributing to GBC risk. The genes included in the study were XRCC1, OGG1, ERCC2, MSH2, CASP8, TLR2, TLR4 and PTGS2. Single locus analysis by logistic regression showed association of MSH2 IVS1+9G>C (rs2303426), ERCC2 Asp312Asn (rs1799793), OGG1 Ser326Cys (rs1052133), OGG1 IVS4-15C>G (rs2072668), CASP8 -652 6N ins/del (rs3834129), PTGS2 -1195G>A (rs689466), PTGS2 -765G>C (rs20417), TLR4 Ex4+936C>T (rs4986791) and TLR2 -196 to -174del polymorphisms with GBC risk. The CART analysis revealed OGG1 Ser326Cys, and OGG1 IVS4-15C>G polymorphisms as the best polymorphic signature for discriminating between cases and controls. In the GoM analysis, the data was categorized into six sets representing risk for GBC with respect to the investigated polymorphisms. Sets I, II and III described low intrinsic risk (controls) characterized by multiple protective alleles while sets IV, V and VI represented high intrinsic risk groups (GBC cases) characterized by the presence of multiple risk alleles. The CART and GoM analyses also showed the importance of PTGS2 -1195G>A polymorphism in susceptibility to GBC risk. In conclusion, the present multigenic approach can be used to define individual risk profiles for gallbladder cancer in North Indian population.	[Srivastava, Kshitij; Srivastava, Anvesha; Mittal, Balraj] Sanjay Gandhi Post Grad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India; [Kumar, Ashok] Sanjay Gandhi Post Grad Inst Med Sci, Dept Surg Gastroenterol, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Srivastava, K (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India.	balraj@sgpgi.ac.in	Srivastava, Kshitij/AAB-4468-2021	Srivastava, Kshitij/0000-0002-3658-0815	Counsel of Scientific and Industrial Research (CSIR), Govt. of India [09/590(0135)/2007-EMR-I]	Counsel of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	The study was supported by grants from Counsel of Scientific and Industrial Research (CSIR), Govt. of India (09/590(0135)/2007-EMR-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiki T, 1996, GUT, V38, P426, DOI 10.1136/gut.38.3.426; Arizono K, 2008, JPN J CLIN ONCOL, V38, P186, DOI 10.1093/jjco/hym176; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bernard-Gallon D, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-36; BREIMAN L., 1984, CRC PRESS; Cai QY, 2006, CANCER EPIDEM BIOMAR, V15, P403, DOI 10.1158/1055-9965.EPI-05-0868; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Corder EH, 2008, REJUV RES, V11, P667, DOI 10.1089/rej.2008.0742; Davis JN, 2005, CANCER RES, V65, P3633, DOI 10.1158/0008-5472.CAN-04-3129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Fan CY, 2001, MODERN PATHOL, V14, p149A; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Fujita H, 2002, PROSTATE, V53, P232, DOI 10.1002/pros.10152; Gasparini G, 2003, LANCET ONCOL, V4, P605, DOI 10.1016/S1470-2045(03)01220-8; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hanada K, 1997, EUR J CANCER, V33, P1136, DOI 10.1016/S0959-8049(97)00080-4; Hsing AW, 2007, BRIT J CANCER, V97, P1577, DOI 10.1038/sj.bjc.6604047; Jiao XY, 2007, INT J CANCER, V121, P501, DOI 10.1002/ijc.22748; KAMIYA H, 1995, CARCINOGENESIS, V16, P883, DOI 10.1093/carcin/16.4.883; Kim JI, 2003, WORLD J GASTROENTERO, V9, P956; KOVESDI I, 1987, P NATL ACAD SCI USA, V84, P2180, DOI 10.1073/pnas.84.8.2180; Lazcano-Ponce EC, 2001, CA-CANCER J CLIN, V51, P349, DOI 10.3322/canjclin.51.6.349; Liu F, 2006, GASTROENTEROLOGY, V130, P1975, DOI 10.1053/j.gastro.2006.03.021; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Manton K.G., 1994, STAT APPL USING FUZZ; Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5; Park J, 2004, PHARMACOGENETICS, V14, P103, DOI 10.1097/00008571-200402000-00004; Ramsay RG, 2003, EXPERT OPIN THER TAR, V7, P235; Randi G, 2006, INT J CANCER, V118, P1591, DOI 10.1002/ijc.21683; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sakoda LC, 2006, CARCINOGENESIS, V27, P1251, DOI 10.1093/carcin/bgi314; Sanguansin S, 2006, J EXP CLIN CANC RES, V25, P251; Sobin LH, 2002, TNM CLASSIFICATION M, P184; Srivastava A, 2009, ANN SURG ONCOL, V16, P1695, DOI 10.1245/s10434-009-0354-3; SRIVASTAVA K, 2010, CANCER IN PRESS; Srivastava K, 2010, LIVER INT, V30, P1067, DOI 10.1111/j.1478-3231.2010.02268.x; Srivastava K, 2010, CANCER-AM CANCER SOC, V116, P3160, DOI 10.1002/cncr.25063; Srivastava K, 2009, J GASTROENTEROL, V44, P774, DOI 10.1007/s00535-009-0071-5; Steinberg D., 1995, CART TREE STRUCTURED; Szczeklik W, 2004, J ALLERGY CLIN IMMUN, V114, P248, DOI 10.1016/j.jaci.2004.05.030; TAZAWA R, 1994, BIOCHEM BIOPH RES CO, V203, P190, DOI 10.1006/bbrc.1994.2167; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; WOODBURY MA, 1982, METHOD INFORM MED, V21, P210; Xing D, 2000, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V17, P377; YOSHIDA S, 1995, CANCER RES, V55, P2756; Zha S, 2004, CANCER LETT, V215, P1, DOI 10.1016/j.canlet.2004.06.014; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003	49	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16449	10.1371/journal.pone.0016449	http://dx.doi.org/10.1371/journal.pone.0016449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283657	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522300048
J	Tredwell, GD; Edwards-Jones, B; Leak, DJ; Bundy, JG				Tredwell, Gregory D.; Edwards-Jones, Bryn; Leak, David J.; Bundy, Jacob G.			The Development of Metabolomic Sampling Procedures for Pichia pastoris, and Baseline Metabolome Data	PLOS ONE			English	Article							ESCHERICHIA-COLI; YEAST; EXTRACTION; QUANTIFICATION; SPECTROSCOPY; SPECTROMETRY; MIXTURES; PROFILES; BACTERIA; H-1-NMR	Metabolic profiling is increasingly being used to investigate a diverse range of biological questions. Due to the rapid turnover of intracellular metabolites it is important to have reliable, reproducible techniques for sampling and sample treatment. Through the use of non-targeted analytical techniques such as NMR and GC-MS we have performed a comprehensive quantitative investigation of sampling techniques for Pichia pastoris. It was clear that quenching metabolism using solutions based on the standard cold methanol protocol caused some metabolite losses from P. pastoris cells. However, these were at a low level, with the NMR results indicating metabolite increases in the quenching solution below 5% of their intracellular level for 75% of metabolites identified; while the GC-MS results suggest a slightly higher level with increases below 15% of their intracellular values. There were subtle differences between the four quenching solutions investigated but broadly, they all gave similar results. Total culture extraction of cells + broth using high cell density cultures typical of P. pastoris fermentations, was an efficient sampling technique for NMR analysis and provided a gold standard of intracellular metabolite levels; however, salts in the media affected the GC-MS analysis. Furthermore, there was no benefit in including an additional washing step in the quenching process, as the results were essentially identical to those obtained just by a single centrifugation step. We have identified the major high-concentration metabolites found in both the extra- and intracellular locations of P. pastoris cultures by NMR spectroscopy and GC-MS. This has provided us with a baseline metabolome for P. pastoris for future studies. The P. pastoris metabolome is significantly different from that of Saccharomyces cerevisiae, with the most notable difference being the production of high concentrations of arabitol by P. pastoris.	[Tredwell, Gregory D.; Bundy, Jacob G.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Edwards-Jones, Bryn; Leak, David J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England	Imperial College London; Imperial College London	Tredwell, GD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England.	j.bundy@imperial.ac.uk	Bundy, Jacob G/C-2131-2008; Tredwell, Greg/L-2294-2015	Bundy, Jacob G/0000-0002-1164-8465; Tredwell, Greg/0000-0002-0020-5626	Bioprocessing Research Industry Club (BRIC); BBSRC; EPSRC;  [BBF0049071]; BBSRC [BB/F004907/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F004907/1] Funding Source: researchfish; Medical Research Council [G0801056B] Funding Source: researchfish	Bioprocessing Research Industry Club (BRIC); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was wholly funded by the Bioprocessing Research Industry Club (BRIC), a partnership between BBSRC, EPSRC and a consortium of leading companies (http://www.bbsrc.ac.uk/business/collaborative-research/industry-clubs/bric/background.aspx, grant reference BBF0049071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bolten CJ, 2008, BIOTECHNOL LETT, V30, P1993, DOI 10.1007/s10529-008-9789-z; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canelas AB, 2008, METABOLOMICS, V4, P226, DOI 10.1007/s11306-008-0116-4; Castrillo JI, 2003, PHYTOCHEMISTRY, V62, P929, DOI 10.1016/S0031-9422(02)00713-6; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; Curvers S, 2001, BIOTECHNOL PROGR, V17, P495, DOI 10.1021/bp000164j; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; DIETMAIR S, 2010, ANAL BIOCH; FAN TWM, 1986, BIOCHIM BIOPHYS ACTA, V882, P154, DOI 10.1016/0304-4165(86)90150-9; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Fredlund E, 2004, APPL MICROBIOL BIOT, V64, P403, DOI 10.1007/s00253-003-1464-7; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; Hounsa CG, 1998, MICROBIOL-UK, V144, P671, DOI 10.1099/00221287-144-3-671; Jensen NBS, 1999, BIOTECHNOL BIOENG, V63, P356, DOI 10.1002/(SICI)1097-0290(19990505)63:3&lt;356::AID-BIT12&gt;3.0.CO;2-1; Kayingo G, 2001, ARCH MICROBIOL, V177, P29, DOI 10.1007/s00203-001-0358-2; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Letisse F, 2000, BIOTECHNOL LETT, V22, P1673, DOI 10.1023/A:1005663526753; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; Mergler M, 2001, ACTA BIOL HUNG, V52, P265; NICHOLSON JK, 1989, PROG NUCL MAG RES SP, V21, P449, DOI 10.1016/0079-6565(89)80008-1; Parsons HM, 2009, ANALYST, V134, P478, DOI 10.1039/b808986h; Sellick CA, 2009, ANAL CHEM, V81, P174, DOI 10.1021/ac8016899; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Taymaz-Nikerel H, 2009, ANAL BIOCHEM, V386, P9, DOI 10.1016/j.ab.2008.11.018; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; Villas-Boas SG, 2007, ANAL BIOCHEM, V370, P87, DOI 10.1016/j.ab.2007.06.028; Wittmann C, 2004, ANAL BIOCHEM, V327, P135, DOI 10.1016/j.ab.2004.01.002; Zhang SC, 2010, ANALYST, V135, P1490, DOI 10.1039/c000091d	33	44	46	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16286	10.1371/journal.pone.0016286	http://dx.doi.org/10.1371/journal.pone.0016286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283710	gold, Green Published, Green Submitted			2022-12-25	WOS:000286522300031
J	Yao, JG; Gao, X; Yan, HM; Li, CY				Yao, Jian-Gao; Gao, Xin; Yan, Hong-Mei; Li, Chao-Yi			Field of Attention for Instantaneous Object Recognition	PLOS ONE			English	Article							VISUAL-SEARCH; SELECTIVE ATTENTION; VISION; CORTEX; CATEGORIZATION; PERCEPTION; PICTURES; CONJUNCTIONS; ORIENTATION; ASYMMETRIES	Background: Instantaneous object discrimination and categorization are fundamental cognitive capacities performed with the guidance of visual attention. Visual attention enables selection of a salient object within a limited area of the visual field; we referred to as "field of attention'' (FA). Though there is some evidence concerning the spatial extent of object recognition, the following questions still remain unknown: (a) how large is the FA for rapid object categorization, (b) how accuracy of attention is distributed over the FA, and (c) how fast complex objects can be categorized when presented against backgrounds formed by natural scenes. Methodology/Principal Findings: To answer these questions, we used a visual perceptual task in which subjects were asked to focus their attention on a point while being required to categorize briefly flashed (20 ms) photographs of natural scenes by indicating whether or not these contained an animal. By measuring the accuracy of categorization at different eccentricities from the fixation point, we were able to determine the spatial extent and the distribution of accuracy over the FA, as well as the speed of categorizing objects using stimulus onset asynchrony (SOA). Our results revealed that subjects are able to rapidly categorize complex natural images within about 0.1 s without eye movement, and showed that the FA for instantaneous image categorization covers a visual field extending 20 degrees x24 degrees, and accuracy was highest (>90%) at the center of FA and declined with increasing eccentricity. Conclusions/Significance: In conclusion, human beings are able to categorize complex natural images at a glance over a large extent of the visual field without eye movement.	[Yao, Jian-Gao; Gao, Xin; Yan, Hong-Mei; Li, Chao-Yi] Univ Elect Sci & Technol China, Minist Educ China, Key Lab Neuroinformat, Chengdu 610054, Peoples R China; [Li, Chao-Yi] Chinese Acad Sci, Shanghai Inst Biol Sci, Ctr Life Sci, Shanghai, Peoples R China	Ministry of Education, China; University of Electronic Science & Technology of China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yao, JG (corresponding author), Univ Elect Sci & Technol China, Minist Educ China, Key Lab Neuroinformat, Chengdu 610054, Peoples R China.	cyli@sibs.ac.cn			Major State Basic Research Program [2007CB311001]; Natural Science Foundations of China [90820301, 60835005]; Shanghai Municipal Committee of Science and Technology [088014158, 098014026]	Major State Basic Research Program(National Basic Research Program of China); Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by the Major State Basic Research Program (2007CB311001 to CYL), the Natural Science Foundations of China (90820301, 60835005 to CYL), and the Shanghai Municipal Committee of Science and Technology (088014158, 098014026 to CYL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J., 1983, HUMAN MACHINE VISION, P1; CHRISTOPHER GH, 2005, PERCEPTION VISUALIZA; Delorme A, 2000, VISION RES, V40, P2187, DOI 10.1016/S0042-6989(00)00083-3; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DOWNING CJ, 1985, ATTENTION PERFORMANC, V40; DRIVER J, 1992, J EXP PSYCHOL HUMAN, V18, P22, DOI 10.1037/0096-1523.18.1.22; ERIKSEN CW, 1985, J EXP PSYCHOL HUMAN, V11, P583, DOI 10.1037/0096-1523.11.5.583; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Healey CG., 1996, ACM T COMPUT-HUM INT, V3, P107, DOI [10.1145/230562.230563, DOI 10.1145/230562.230563]; HOFFMAN JE, 1981, PERCEPT PSYCHOPHYS, V30, P283, DOI 10.3758/BF03214284; JULESZ B, 1983, BELL SYST TECH J, V62, P1619, DOI 10.1002/j.1538-7305.1983.tb03502.x; Kanwisher N, 1997, J NEUROSCI, V17, P4302; LABERGE D, 1983, J EXP PSYCHOL HUMAN, V9, P371, DOI 10.1037/0096-1523.9.3.371; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; LOFTUS GR, 1978, J EXP PSYCHOL HUMAN, V4, P565, DOI 10.1037/0096-1523.4.4.565; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MANGUN GR, 1993, ATTENTION PERFORM, V14, P219; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; NAGY AL, 1990, J OPT SOC AM A, V7, P1209, DOI 10.1364/JOSAA.7.001209; NAKAYAMA K, 1986, NATURE, V320, P264, DOI 10.1038/320264a0; NELSON WW, 1980, J EXP PSYCHOL-HUM L, V6, P391, DOI 10.1037/0278-7393.6.4.391; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POTTER MC, 1975, NATURE, V253, P437, DOI 10.1038/253437a0; POTTER MC, 1969, J EXP PSYCHOL, V81, P10, DOI 10.1037/h0027470; Subramaniam S, 2000, VIS COGN, V7, P511, DOI 10.1080/135062800394630; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Thorpe SJ, 2001, EUR J NEUROSCI, V14, P869, DOI 10.1046/j.0953-816x.2001.01717.x; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V22, P54, DOI 10.3758/BF03206080; WOLFE JM, 1992, J EXP PSYCHOL HUMAN, V18, P34, DOI 10.1037/0096-1523.18.1.34	36	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16343	10.1371/journal.pone.0016343	http://dx.doi.org/10.1371/journal.pone.0016343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710OY	21283690	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522300036
J	Izzotti, A; Longobardi, M; Cartiglia, C; Sacca, SC				Izzotti, Alberto; Longobardi, Mariagrazia; Cartiglia, Cristina; Sacca, Sergio Claudio			Mitochondrial Damage in the Trabecular Meshwork Occurs Only in Primary Open-Angle Glaucoma and in Pseudoexfoliative Glaucoma	PLOS ONE			English	Article							OXIDATIVE STRESS; CONGENITAL GLAUCOMA; JUVENILE GLAUCOMA; OUTFLOW PATHWAY; AQUEOUS OUTFLOW; DNA-DAMAGE; CELLS; PIGMENTARY; TISSUES; EXFOLIATION	Background: Open-angle glaucoma appears to be induced by the malfunction of the trabecular meshwork cells due to injury induced by oxidative damage and mitochondrial impairment. Here, we report that, in fact, we have detected mitochondrial damage only in primary open-angle glaucoma and pseudo-exfoliation glaucoma, among several glaucoma types compared. Methodology/Principal Findings: Mitochondrial damage was evaluated by analyzing the common mitochondrial DNA deletion by real-time PCR in trabecular meshwork specimens collected at surgery from glaucomatous patients and controls. Glaucomatous patients included 38 patients affected by various glaucoma types: primary open-angle, pigmented, juvenile, congenital, pseudoexfoliative, acute, neovascular, and chronic closed-angle glaucoma. As control samples, we used 16 specimens collected from glaucoma-free corneal donors. Only primary open-angle glaucoma (3.0-fold) and pseudoexfoliative glaucoma (6.3-fold) showed significant increases in the amount of mitochondrial DNA deletion. In all other cases, deletion was similar to controls. Conclusions/Significance: Despite the fact that the trabecular meshwork is the most important tissue in the physiopathology of aqueous humor outflow in all glaucoma types, the present study provides new information regarding basic physiopathology of this tissue: only in primary open-angle and pseudoexfoliative glaucomas oxidative damage arising from mitochondrial failure play a role in the functional decay of trabecular meshwork.	[Izzotti, Alberto; Longobardi, Mariagrazia; Cartiglia, Cristina] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Sacca, Sergio Claudio] St Martino Hosp, Ophthalmol Unit, Dept Head Neck Pathol, Genoa, Italy	University of Genoa	Izzotti, A (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	sergio.sacca@hsanmartino.it	Sacca, Sergio/D-5118-2018; Saccà, Sergio/AAG-3335-2019	Sacca, Sergio/0000-0001-6973-5978; Saccà, Sergio/0000-0001-6973-5978; izzotti, alberto/0000-0002-8588-0347	United States Glaucoma Foundation (New York, NY)	United States Glaucoma Foundation (New York, NY)	This study was supported by the United States Glaucoma Foundation (New York, NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Alvarado JA, 2005, BRIT J OPHTHALMOL, V89, P1500, DOI 10.1136/bjo.2005.081307; ALVARADO JA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1769, DOI 10.1001/archopht.1992.01080240109042; Alvarado Jorge A, 2005, Trans Am Ophthalmol Soc, V103, P148; Anderson D R, 1981, Trans Am Ophthalmol Soc, V79, P458; Bakunowicz-Lazarczyk A., 2001, Journal of Submicroscopic Cytology and Pathology, V33, P17; Brenner C, 2000, SCIENCE, V289, P1150, DOI 10.1126/science.289.5482.1150; Brusini P, 2003, J GLAUCOMA, V12, P417, DOI 10.1097/00061198-200310000-00004; Caprioli J, 1994, Trans Am Ophthalmol Soc, V92, P589; DiMauro S, 1998, NEUROSCIENTIST, V4, P53, DOI 10.1177/107385849800400113; Ehlers JP, 2008, RETINA-J RET VIT DIS, V28, P696, DOI 10.1097/IAE.0b013e3181679c0b; Furuyoshi N, 1997, OPHTHALMOLOGICA, V211, P140, DOI 10.1159/000310781; Gottanka JY, 2006, J GLAUCOMA, V15, P142, DOI 10.1097/00061198-200604000-00011; Gupta N, 2007, EXP EYE RES, V84, P176, DOI 10.1016/j.exer.2006.09.013; HAMBLET NS, 1995, BIOCHEM BIOPH RES CO, V207, P839, DOI 10.1006/bbrc.1995.1262; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Izzotti A, 2010, ARCH OPHTHALMOL-CHIC, V128, P724, DOI 10.1001/archophthalmol.2010.87; Izzotti A, 2009, INVEST OPHTH VIS SCI, V50, P5251, DOI 10.1167/iovs.09-3871; Konstas AGP, 1997, ARCH OPHTHALMOL-CHIC, V115, P182, DOI 10.1001/archopht.1997.01100150184006; Krieger C, 2002, EUR J PHARMACOL, V447, P177, DOI 10.1016/S0014-2999(02)01842-3; LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6; Li GR, 2007, MOL VIS, V13, P2282; LINNANE AW, 1990, BIOCHEM INT, V22, P1067; Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268; MAUL E, 1980, AM J OPHTHALMOL, V89, P667, DOI 10.1016/0002-9394(80)90286-X; MURPHY CG, 1992, ARCH OPHTHALMOL-CHIC, V110, P1779, DOI 10.1001/archopht.1992.01080240119043; PANG CY, 1994, ARCH BIOCHEM BIOPHYS, V312, P534, DOI 10.1006/abbi.1994.1342; Ramamurthy B, 2007, CORNEA, V26, P647, DOI 10.1097/ICO.0b013e31804e4579; Ritch R, 2003, PROG RETIN EYE RES, V22, P253, DOI 10.1016/S1350-9462(02)00014-9; RITCH R, 1995, NEW DEV GLAUCOMA OPH, P281; Sacca S C, 1996, Eur J Ophthalmol, V6, P421; Sacca SC, 2008, PROG BRAIN RES, V173, P385, DOI 10.1016/S0079-6123(08)01127-8; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; Sas K, 2007, J NEUROL SCI, V257, P221, DOI 10.1016/j.jns.2007.01.033; SCHLOTZERSCHREHARDT U, 1995, INVEST OPHTH VIS SCI, V36, P1750; Shieds M. B., 1996, GLAUCOMAS, P717; Shields M B, 1983, Trans Am Ophthalmol Soc, V81, P736; Shifera AS, 2010, EXP EYE RES, V91, P42, DOI 10.1016/j.exer.2010.04.001; Takahashi A, 2004, BRAIN RES BULL, V62, P497, DOI 10.1016/j.brainresbull.2003.07.009; Tane N, 2007, EXP EYE RES, V84, P832, DOI 10.1016/j.exer.2007.01.002; TAWARA A, 1994, AM J OPHTHALMOL, V117, P741, DOI 10.1016/S0002-9394(14)70317-4; TAWARA A, 1984, AM J OPHTHALMOL, V98, P82, DOI 10.1016/0002-9394(84)90193-4; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Waring G O 3rd, 1975, Surv Ophthalmol, V20, P3, DOI 10.1016/0039-6257(75)90034-X; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0	51	60	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14567	10.1371/journal.pone.0014567	http://dx.doi.org/10.1371/journal.pone.0014567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283745	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200008
J	Jacobs, L; Emmerechts, J; Hoylaerts, MF; Mathieu, C; Hoet, PH; Nemery, B; Nawrot, TS				Jacobs, Lotte; Emmerechts, Jan; Hoylaerts, Marc F.; Mathieu, Chantal; Hoet, Peter H.; Nemery, Benoit; Nawrot, Tim S.			Traffic Air Pollution and Oxidized LDL	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; LONG-TERM EXPOSURE; ATHEROSCLEROSIS; INFLAMMATION; DISEASE; PLASMA; MACROPHAGES; ENVIRONMENT; MORTALITY; MARKER	Background: Epidemiologic studies indirectly suggest that air pollution accelerates atherosclerosis. We hypothesized that individual exposure to particulate matter (PM) derived from fossil fuel would correlate with plasma concentrations of oxidized low-density lipoprotein (LDL), taken as a marker of atherosclerosis. We tested this hypothesis in patients with diabetes, who are at high risk for atherosclerosis. Methodology/Principal Findings: In a cross-sectional study of non-smoking adult outpatients with diabetes we assessed individual chronic exposure to PM by measuring the area occupied by carbon in airway macrophages, collected by sputum induction and by determining the distance from the patient's residence to a major road, through geocoding. These exposure indices were regressed against plasma concentrations of oxidized LDL, von Willebrand factor and plasminogen activator inhibitor 1 (PAI-1). We could assess the carbon load of airway macrophages in 79 subjects (58 percent). Each doubling in the distance of residence from major roads was associated with a 0.027 mu m(2) decrease (95% confidence interval (CI): -0.048 to -0.0051) in the carbon load of airway macrophages. Independently from other covariates, we found that each increase of 0.25 mu m(2) [interquartile range (IQR)] in carbon load was associated with an increase of 7.3 U/L (95% CI: 1.3 to 13.3) in plasma oxidized LDL. Each doubling in distance of residence from major roads was associated with a decrease of -2.9 U/L (95% CI: -5.2 to -0.72) in oxidized LDL. Neither the carbon load of macrophages nor the distance from residence to major roads, were associated with plasma von Willebrand factor or PAI-1. Conclusions: The observed positive association, in a susceptible group of the general population, between plasma oxidized LDL levels and either the carbon load of airway macrophages or the proximity of the subject's residence to busy roads suggests a proatherogenic effect of traffic air pollution.	[Jacobs, Lotte; Hoet, Peter H.; Nemery, Benoit; Nawrot, Tim S.] Katholieke Univ Leuven, Unit Lung Toxicol, Leuven, Belgium; [Emmerechts, Jan; Hoylaerts, Marc F.] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Leuven, Belgium; [Mathieu, Chantal] Katholieke Univ Leuven, Dept Endocrinol, Leuven, Belgium; [Nawrot, Tim S.] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium	KU Leuven; KU Leuven; KU Leuven; Hasselt University	Jacobs, L (corresponding author), Katholieke Univ Leuven, Unit Lung Toxicol, Leuven, Belgium.	ben.nemery@med.kuleuven.be	Nawrot, Tim/AAA-4531-2019; mathieu, chantal/ABD-5505-2021; Hoet, Peter/H-9987-2013	mathieu, chantal/0000-0002-4055-5233; Nemery, Benoit/0000-0003-0571-4689; Hoylaerts, Marc/0000-0002-6474-3933; Nawrot, Tim/0000-0002-3583-3593; Hoet, Peter/0000-0002-0292-6603	Ministry of the Flemish Community (Department of Economics, Science and Innovation); Ministry of the Flemish Community (Flemish Agency for Care and Health); Ministry of the Flemish Community (Department of Environment, Nature and Energy); Flemish Fund for Scientific Research (FWO-Vlaanderen, krediet aan navorsers); Excellentie financiering KULeuven [EF/05/13]	Ministry of the Flemish Community (Department of Economics, Science and Innovation); Ministry of the Flemish Community (Flemish Agency for Care and Health); Ministry of the Flemish Community (Department of Environment, Nature and Energy); Flemish Fund for Scientific Research (FWO-Vlaanderen, krediet aan navorsers)(FWO); Excellentie financiering KULeuven(KU Leuven)	The studies of the Flemish Center of Expertise on Environment and Health were commissioned, financed and steered by the Ministry of the Flemish Community (Department of Economics, Science and Innovation; Flemish Agency for Care and Health; Department of Environment, Nature and Energy). T Nawrot received a grant of the Flemish Fund for Scientific Research (FWO-Vlaanderen, krediet aan navorsers). The center for Molecular and Vascular Biology is supported by the "Excellentie financiering KULeuven" (EF/05/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro-Moreno E, 2007, CURR OPIN PULM MED, V13, P98, DOI 10.1097/MCP.0b013e328013f47e; Araujo JA, 2008, CIRC RES, V102, P589, DOI 10.1161/CIRCRESAHA.107.164970; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Brodsky SV, 2002, CIRCULATION, V106, P2372, DOI 10.1161/01.CIR.0000033972.90653.AF; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Soares SRC, 2009, ATHEROSCLEROSIS, V207, P368, DOI 10.1016/j.atherosclerosis.2009.04.041; Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127; Fredrikson GN, 2003, J INTERN MED, V253, P425, DOI 10.1046/j.1365-2796.2003.01128.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622; Holvoet P, 2001, ARTERIOSCL THROM VAS, V21, P844, DOI 10.1161/01.ATV.21.5.844; Holvoet P, 2007, ATHEROSCLEROSIS, V194, P245, DOI 10.1016/j.atherosclerosis.2006.08.002; Horvath Beata, 2004, Exp Clin Cardiol, V9, P31; Jacobs L, 2010, ENVIRON HEALTH PERSP, V118, P191, DOI 10.1289/ehp.0900942; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Kulkarni N, 2006, NEW ENGL J MED, V355, P21, DOI 10.1056/NEJMoa052972; Kulkarni NS, 2005, SCI TOTAL ENVIRON, V345, P23, DOI 10.1016/j.scitotenv.2004.10.016; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Nawrot TS, 2006, EUR HEART J, V27, P2269, DOI 10.1093/eurheartj/ehl221; O'Neill MS, 2007, OCCUP ENVIRON MED, V64, P373, DOI 10.1136/oem.2006.030023; O'Neill MS, 2005, CIRCULATION, V111, P2913, DOI 10.1161/CIRCULATIONAHA.104.517110; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Pizzichini E, 1996, EUR RESPIR J, V9, P1174, DOI 10.1183/09031936.96.09061174; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Ren CZ, 2010, EPIDEMIOLOGY, V21, P198, DOI 10.1097/EDE.0b013e3181cc8bfc; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schwartz J, 2005, AM J RESP CRIT CARE, V172, P1529, DOI 10.1164/rccm.200412-1698OC; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; Tani S, 2004, ATHEROSCLEROSIS, V175, P7, DOI 10.1016/j.atherosclerosis.2004.01.035; Wallenfeldt K, 2004, J INTERN MED, V256, P413, DOI 10.1111/j.1365-2796.2004.01402.x	35	52	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16200	10.1371/journal.pone.0016200	http://dx.doi.org/10.1371/journal.pone.0016200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283820	Green Published, gold, Green Submitted			2022-12-25	WOS:000286520600029
J	Wamain, Y; Tallet, J; Zanone, PG; Longcamp, M				Wamain, Yannick; Tallet, Jessica; Zanone, Pier-Giorgio; Longcamp, Marieke			"Biological Geometry Perception": Visual Discrimination of Eccentricity Is Related to Individual Motor Preferences	PLOS ONE			English	Article							MOTION PERCEPTION; COORDINATION DYNAMICS; APPARENT MOTION; PREMOTOR CORTEX; FRONTAL-CORTEX; HUMAN-BODY; MOVEMENTS; HAND; REPRESENTATION; INFORMATION	Background: In the continuum between a stroke and a circle including all possible ellipses, some eccentricities seem more "biologically preferred" than others by the motor system, probably because they imply less demanding coordination patterns. Based on the idea that biological motion perception relies on knowledge of the laws that govern the motor system, we investigated whether motorically preferential and non-preferential eccentricities are visually discriminated differently. In contrast with previous studies that were interested in the effect of kinematic/time features of movements on their visual perception, we focused on geometric/spatial features, and therefore used a static visual display. Methodology/Principal Findings: In a dual-task paradigm, participants visually discriminated 13 static ellipses of various eccentricities while performing a finger-thumb opposition sequence with either the dominant or the non-dominant hand. Our assumption was that because the movements used to trace ellipses are strongly lateralized, a motor task performed with the dominant hand should affect the simultaneous visual discrimination more strongly. We found that visual discrimination was not affected when the motor task was performed by the non-dominant hand. Conversely, it was impaired when the motor task was performed with the dominant hand, but only for the ellipses that we defined as preferred by the motor system, based on an assessment of individual preferences during an independent graphomotor task. Conclusions/Significance: Visual discrimination of ellipses depends on the state of the motor neural networks controlling the dominant hand, but only when their eccentricity is "biologically preferred". Importantly, this effect emerges on the basis of a static display, suggesting that what we call "biologica geometry", i.e., geometric features resulting from preferential movements is relevant information for the visual processing of bidimensional shapes.	[Wamain, Yannick; Tallet, Jessica; Zanone, Pier-Giorgio; Longcamp, Marieke] Univ Toulouse, Lab Adaptat Percept Motrice & Apprentissage, Toulouse, France; [Longcamp, Marieke] Univ Aix Marseille 2, CNRS, Inst Neurosci Cognit Mediterranee, Marseille, France	Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Wamain, Y (corresponding author), Univ Toulouse, Lab Adaptat Percept Motrice & Apprentissage, Toulouse, France.	longcamp@cict.fr	Zanone, Pier-Giorgio/B-7165-2011	Zanone, Pier-Giorgio/0000-0002-6744-9772; TALLET, Jessica/0000-0002-2832-6112; Longcamp, Marieke/0000-0003-0454-2934	French Ministry of Research and Education; Paul Sabatier University	French Ministry of Research and Education; Paul Sabatier University	The French Ministry of Research and Education supported YW. The Paul Sabatier University provided funding for experimental materials, and attendance to meetings where previous versions of the work were presented. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, P886; Ahlstrom V, 1997, PERCEPTION, V26, P1539, DOI 10.1068/p261539; Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Athenes S, 2004, HUM MOVEMENT SCI, V23, P621, DOI 10.1016/j.humov.2004.10.004; BABCOCK MK, 1988, AM J PSYCHOL, V101, P111, DOI 10.2307/1422797; Beilock SL, 2007, PSYCHOL SCI, V18, P51, DOI 10.1111/j.1467-9280.2007.01848.x; BERTENTHAL BI, 1994, PSYCHOL SCI, V5, P221, DOI 10.1111/j.1467-9280.1994.tb00504.x; Bidet-Ildei C, 2006, PERCEPTION, V35, P1137, DOI 10.1068/p5482; Buchanan JJ, 1996, BIOL CYBERN, V74, P41, DOI 10.1007/BF00199136; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Casile A, 2010, CEREB CORTEX, V20, P1647, DOI 10.1093/cercor/bhp229; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Dayan E, 2007, P NATL ACAD SCI USA, V104, P20582, DOI 10.1073/pnas.0710033104; Deiber MP, 2001, CLIN NEUROPHYSIOL, V112, P1419, DOI 10.1016/S1388-2457(01)00536-3; Dipietro L, 2007, J NEUROPHYSIOL, V98, P757, DOI 10.1152/jn.01295.2006; Dipietro L, 2009, CORTEX, V45, P318, DOI 10.1016/j.cortex.2008.02.008; Dounskaia N, 2000, EXP BRAIN RES, V135, P127, DOI 10.1007/s002210000495; FREYD JJ, 1983, PERCEPT PSYCHOPHYS, V33, P575, DOI 10.3758/BF03202940; FREYD JJ, 1983, MEM COGNITION, V11, P342, DOI 10.3758/BF03202447; FREYD JJ, 1987, PSYCHOL REV, V94, P427, DOI 10.1037/0033-295X.94.4.427; Grosjean M, 2007, PSYCHOL SCI, V18, P95, DOI 10.1111/j.1467-9280.2007.01854.x; Grossman ED, 1999, VISION RES, V39, P3721, DOI 10.1016/S0042-6989(99)00084-X; HOLLERBACH JM, 1981, BIOL CYBERN, V39, P139, DOI 10.1007/BF00336740; Jacobs A, 2005, J EXP PSYCHOL HUMAN, V31, P157, DOI 10.1037/0096-1523.31.1.157; James KH, 2006, NEUROPSYCHOLOGIA, V44, P2937, DOI 10.1016/j.neuropsychologia.2006.06.026; James KH, 2009, J EXP PSYCHOL GEN, V138, P416, DOI 10.1037/a0015836; James KH, 2009, COGN NEUROPSYCHOL, V26, P91, DOI 10.1080/02643290802425914; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Kandel S, 2000, PERCEPTION, V29, P953, DOI 10.1068/p2864; Kandel S, 2000, PERCEPT PSYCHOPHYS, V62, P706, DOI 10.3758/BF03206917; Kinsbourne M., 1978, ATTENTION PERFORM, VVII, P345; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Levit-Binnun N, 2006, EXP BRAIN RES, V172, P533, DOI 10.1007/s00221-006-0355-4; Liu BX, 2002, PERCEPT PSYCHOPHYS, V64, P1227, DOI 10.3758/BF03194768; Longcamp M, 2006, NEUROIMAGE, V33, P681, DOI 10.1016/j.neuroimage.2006.06.042; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; LURCAT L, 1974, ETUDES ACTE GRAPHIQU; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; MCFARLAND K, 1978, PERCEPT PSYCHOPHYS, V23, P344, DOI 10.3758/BF03199720; MCFARLAND K, 1978, CORTEX, V14, P102, DOI 10.1016/S0010-9452(78)80012-4; MCFARLAND K, 1978, NEUROPSYCHOLOGIA, V16, P735, DOI 10.1016/0028-3932(78)90008-8; Meary D, 2005, PERCEPTION, V34, P1061, DOI 10.1068/p3388; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Musseler J, 1997, J EXP PSYCHOL HUMAN, V23, P861, DOI 10.1037/0096-1523.23.3.861; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orliaguet JP, 1997, PERCEPTION, V26, P905, DOI 10.1068/p260905; PITTENGER JB, 1985, PERCEPTION, V14, P247, DOI 10.1068/p140247; Polyakov F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000427; Polyakov F, 2009, BIOL CYBERN, V100, P159, DOI 10.1007/s00422-008-0287-0; Proffitt DR, 2003, PSYCHOL SCI, V14, P106, DOI 10.1111/1467-9280.t01-1-01427; Proverbio AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005389; Reina GA, 2003, HUM MOVEMENT SCI, V22, P137, DOI 10.1016/S0167-9457(02)00156-2; ROLAND PE, 1980, J NEUROPHYSIOL, V43, P137, DOI 10.1152/jn.1980.43.1.137; RUNESON S, 1981, J EXP PSYCHOL HUMAN, V7, P733, DOI 10.1037/0096-1523.7.4.733; Sallagoity I, 2004, MOTOR CONTROL, V8, P405, DOI 10.1123/mcj.8.4.405; Saumier D, 2005, BRAIN COGNITION, V59, P299, DOI 10.1016/j.bandc.2004.02.060; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Schubo A, 2001, PSYCHOL RES-PSYCH FO, V65, P145, DOI 10.1007/s004260100061; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Schwartz AB, 2004, SCIENCE, V303, P380, DOI 10.1126/science.1087788; Senior C, 2000, CURR BIOL, V10, P16, DOI 10.1016/S0960-9822(99)00259-6; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; SHIFFRAR M, 1993, PSYCHOL SCI, V4, P379, DOI 10.1111/j.1467-9280.1993.tb00585.x; SHIFFRAR M, 1990, PSYCHOL SCI, V1, P257, DOI 10.1111/j.1467-9280.1990.tb00210.x; Sosnik R, 2004, EXP BRAIN RES, V156, P422, DOI 10.1007/s00221-003-1799-4; Sosnik R, 2007, COGN NEURODYNAMICS, V1, P341, DOI 10.1007/s11571-007-9025-x; STAPPERS PJ, 1993, B PSYCHONOMIC SOC, V31, P125; Tai YF, 2004, CURR BIOL, V14, P117, DOI 10.1016/j.cub.2004.01.005; Torres E, 2006, J NEUROPHYSIOL, V96, P2613, DOI 10.1152/jn.00188.2006; VIVIANI P, 1989, PERCEPT PSYCHOPHYS, V46, P266, DOI 10.3758/BF03208089; VIVIANI P, 1992, J EXP PSYCHOL HUMAN, V18, P603, DOI 10.1037/0096-1523.18.3.603; Viviani P, 2002, ATTENTION PERFORM, V19, P406; VIVIANI P, 1991, J EXP PSYCHOL HUMAN, V17, P198, DOI 10.1037/0096-1523.17.1.198; Wexler M, 1998, COGNITION, V68, P77, DOI 10.1016/S0010-0277(98)00032-8; Whitaker D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001930; Yang SJ, 2009, J EXP PSYCHOL LEARN, V35, P1359, DOI 10.1037/a0016547; Zanker JM, 1999, NATURWISSENSCHAFTEN, V86, P492, DOI 10.1007/s001140050661; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403	83	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15995	10.1371/journal.pone.0015995	http://dx.doi.org/10.1371/journal.pone.0015995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710OH	21283813	gold, Green Published, Green Submitted			2022-12-25	WOS:000286520600018
J	Lee, CH; Pan, YJ; Huang, YT; Liu, TH; Hsu, SH; Lee, CH; Chen, YW; Lin, SM; Huang, LK; Pan, RL				Lee, Chien-Hsien; Pan, Yih-Jiuan; Huang, Yun-Tzu; Liu, Tseng-Huang; Hsu, Shen-Hsing; Lee, Ching-Hung; Chen, Yen-Wei; Lin, Shih-Ming; Huang, Lin-Kun; Pan, Rong-Long			Identification of Essential Lysines Involved in Substrate Binding of Vacuolar H+-Pyrophosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC PYROPHOSPHATASE; RHODOSPIRILLUM-RUBRUM; ESCHERICHIA-COLI; INHIBITION; RESIDUES; PPASE; YEAST; SITE; INACTIVATION; ARABIDOPSIS	H+-translocating pyrophosphatase (H+-PPase; EC 3.6.1.1) drives proton transport against an electrochemical potential gradient by hydrolyzing pyrophosphate (PPi) and is found in various endomembranes of higher plants, bacteria, and some protists. H+-PPase contains seven highly conserved lysines. We examined the functional roles of these lysines, which are, for the most part, found in the cytosolic regions of mung bean H+-PPase by site-directed mutagenesis. Construction of mutants that each had a cytosolic and highly conserved lysine substituted with an alanine resulted in dramatic drops in the PPi hydrolytic activity. The effects caused by ions on the activities of WT and mutant H+-PPases suggest that Lys-730 may be in close proximity to the Mg2+-binding site, and the great resistance of the K694A and K695A mutants to fluoride inhibition suggests that these lysines are present in the active site. The modifier fluorescein 5`-isothiocyanate (FITC) labeled a lysine at the H+-PPase active site but did not inhibit the hydrolytic activities of K250A, K250N, K250T, and K250S, which suggested that Lys-250 is essential for substrate binding and may be involved in proton translocation. Analysis of tryptic digests indicated that Lys-711 and Lys-717 help maintain the conformation of the active site. Proteolytic evidence also demonstrated that Lys-250 is the primary target of trypsin and confirmed its crucial role in H+-PPase hydrolysis.	Natl Tsing Hua Univ, Coll Life Sci, Dept Life Sci, Hsinchu 30043, Taiwan; Natl Tsing Hua Univ, Coll Life Sci, Inst Bioinformat & Struct Biol, Hsinchu 30043, Taiwan	National Tsing Hua University; National Tsing Hua University	Pan, RL (corresponding author), Natl Tsing Hua Univ, Coll Life Sci, Dept Life Sci, Hsinchu 30013, Taiwan.	rlpan@life.nthu.edu.tw			National Science Council, Taiwan [NSC 98-2627-M-007-002, NSC 98-2627-M-007-001, NSC 97-2311-B-007-003-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Taiwan, Grants NSC 98-2627-M-007-002, NSC 98-2627-M-007-001, and NSC 97-2311-B-007-003-MY3 (to R.-L. P.).	Baltscheffsky M, 1999, FEBS LETT, V457, P525, DOI 10.1016/S0014-5793(99)00914-X; BARIK S, 1995, MOL BIOTECHNOL, V3, P1, DOI 10.1007/BF02821329; BAYKOV AA, 1993, FEBS LETT, V327, P199, DOI 10.1016/0014-5793(93)80169-U; Belogurov GA, 2002, J BIOL CHEM, V277, P22209, DOI 10.1074/jbc.M202951200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; Fraichard A, 1996, BIOCHIMIE, V78, P259, DOI 10.1016/0300-9084(96)82189-4; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Guo SL, 2006, PLANT MOL BIOL, V60, P41, DOI 10.1007/s11103-005-2417-6; Hsiao YY, 2007, BBA-BIOENERGETICS, V1767, P965, DOI 10.1016/j.bbabio.2007.04.007; Hsiao YY, 2004, BBA-BIOENERGETICS, V1608, P190, DOI 10.1016/j.bbabio.2004.01.001; Hsiao YY, 2002, J PROTEIN CHEM, V21, P51, DOI 10.1023/A:1014183100021; Hsu SH, 2009, BOT STUD, V50, P291; Huang YT, 2010, J BIOL CHEM, V285, P23655, DOI 10.1074/jbc.M110.134916; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; MAESHIMA M, 1991, EUR J BIOCHEM, V196, P11, DOI 10.1111/j.1432-1033.1991.tb15779.x; Malinen AM, 2004, J BIOL CHEM, V279, P26811, DOI 10.1074/jbc.M404154200; Mimura H, 2004, J BIOL CHEM, V279, P35106, DOI 10.1074/jbc.M406264200; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; REA PA, 1992, PLANT PHYSIOL, V100, P1706, DOI 10.1104/pp.100.4.1706; Samygina VR, 2007, J MOL BIOL, V366, P1305, DOI 10.1016/j.jmb.2006.11.082; SATO MH, 1991, FEBS LETT, V290, P177, DOI 10.1016/0014-5793(91)81254-6; Serrano A, 2004, J BIOENERG BIOMEMBR, V36, P127, DOI 10.1023/B:JOBB.0000019604.49875.b3; TAKESHIGE K, 1988, PLANT CELL PHYSIOL, V29, P649; WU JJ, 1991, FEBS LETT, V283, P57, DOI 10.1016/0014-5793(91)80552-E; Yang SJ, 2000, BBA-BIOENERGETICS, V1460, P375, DOI 10.1016/S0005-2728(00)00203-6; Yang SJ, 1999, BIOCHEM J, V342, P641, DOI 10.1042/0264-6021:3420641; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340	35	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.190215	http://dx.doi.org/10.1074/jbc.M110.190215			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21292767	Green Published, hybrid			2022-12-25	WOS:000289077500010
J	Takahashi, M; Koi, M; Balaguer, F; Boland, CR; Goel, A				Takahashi, Masanobu; Koi, Minoru; Balaguer, Francesc; Boland, C. Richard; Goel, Ajay			MSH3 Mediates Sensitization of Colorectal Cancer Cells to Cisplatin, Oxaliplatin, and a Poly(ADP-ribose) Polymerase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTRAND CROSS-LINKS; MISMATCH-REPAIR SYSTEM; MICROSATELLITE-INSTABILITY; COLON-CANCER; ADJUVANT THERAPY; MUTANT-CELLS; DNA ADDUCTS; FLUOROURACIL; RECOGNITION; CARCINOMA	The MSH3 gene is one of the DNA mismatch repair (MMR) genes that has undergone somatic mutation frequently in MMR-deficient cancers. MSH3, together with MSH2, forms the MutS beta heteroduplex, which interacts with interstrand cross-links (ICLs) induced by drugs such as cisplatin and psoralen. However, the precise role of MSH3 in mediating the cytotoxic effects of ICL-inducing agents remains poorly understood. In this study, we first examined the effects of MSH3 deficiency on cytotoxicity caused by cisplatin and oxaliplatin, another ICL-inducing platinum drug. Using isogenic HCT116-derived clones in which MSH3 expression is controlled by shRNA expression in a Tet-off system, we discovered that MSH3 deficiency sensitized cells to both cisplatin and oxaliplatin at clinically relevant doses. Interestingly, siRNA-induced down-regulation of the MLH1 protein did not affect MSH3-dependent toxicity of these drugs, indicating that this process does not require participation of the canonical MMR pathway. Furthermore, MSH3-deficient cells maintained higher levels of phosphorylated histone H2AX and 53BP1 after oxaliplatin treatment in comparison with MSH3-proficient cells, suggesting that MSH3 plays an important role in repairing DNA double strand breaks (DSBs). This role of MSH3 was further supported by our findings that MSH3-deficient cells were sensitive to olaparib, a poly(ADP-ribose) polymerase inhibitor. Moreover, the combination of oxaliplatin and olaparib exhibited a synergistic effect compared with either treatment individually. Collectively, our results provide novel evidence that MSH3 deficiency contributes to the cytotoxicity of platinum drugs through deficient DSB repair. These data lay the foundation for the development of effective prediction and treatments for cancers with MSH3 deficiency.	[Koi, Minoru] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr,Dept Internal Med, Gastrointestinal Canc Res Lab,Div Gastroenterol, Dallas, TX 75246 USA; Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX 75246 USA	Baylor University; Baylor University Medical Center; Baylor Scott & White Health; Baylor University; Baylor University Medical Center	Koi, M (corresponding author), Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr,Dept Internal Med, Gastrointestinal Canc Res Lab,Div Gastroenterol, Dallas, TX 75246 USA.	minoruk@baylorhealth.edu; rickbo@baylorhealth.edu; ajay.goel@baylorhealth.edu	Koi, Minoru/C-3489-2012; Balaguer, Francesc/GPX-7801-2022; BALAGUER, FRANCESC/G-2389-2016; Koi, Minoru/G-9197-2014	Balaguer, Francesc/0000-0002-0206-0539; Goel, Ajay/0000-0003-1396-6341	NCI, National Institutes of Health [R01 CA72851, CA129286]; Baylor Research Institute; Cell Science Research Foundation; Charles Sammons Cancer Center; NATIONAL CANCER INSTITUTE [R01CA072851, R01CA129286] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Charles Sammons Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants R01 CA72851 and CA129286. This work was also supported by funds from the Baylor Research Institute (to C. R. B. and A.G.).; Supported by a grant from the Cell Science Research Foundation.; Supported by funds from an institutional grant from Charles Sammons Cancer Center.	Abuin A, 2000, MOL CELL BIOL, V20, P149, DOI 10.1128/MCB.20.1.149-157.2000; Bertagnolli MM, 2009, J CLIN ONCOL, V27, P1814, DOI 10.1200/JCO.2008.18.2071; Black D, 2006, J CLIN ONCOL, V24, P1745, DOI 10.1200/JCO.2005.04.1574; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; HAWN MT, 1995, CANCER RES, V55, P3721; Hendriks YMC, 2006, CA-CANCER J CLIN, V56, P213, DOI 10.3322/canjclin.56.4.213; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Hinz JM, 2010, ENVIRON MOL MUTAGEN, V51, P582, DOI 10.1002/em.20577; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kohonen-Corish MRJ, 2005, J CLIN ONCOL, V23, P2318, DOI 10.1200/JCO.2005.00.109; KOI M, 1994, CANCER RES, V54, P4308; Kucherlapati MH, 2010, GASTROENTEROLOGY, V138, P993, DOI 10.1053/j.gastro.2009.11.009; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Nehme A, 1999, BRIT J CANCER, V79, P1104, DOI 10.1038/sj.bjc.6690176; Pal T, 2008, CLIN CANCER RES, V14, P6847, DOI 10.1158/1078-0432.CCR-08-1387; Plaschke J, 2004, CANCER RES, V64, P864, DOI 10.1158/0008-5472.CAN-03-2807; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Reynolds MF, 2009, CANCER RES, V69, P1071, DOI 10.1158/0008-5472.CAN-08-2306; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Rodriguez R, 2008, CLIN CANCER RES, V14, P5476, DOI 10.1158/1078-0432.CCR-08-0274; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Tejpar S, 2009, J CLIN ONCOL, V27; Vaisman A, 1998, CANCER RES, V58, P3579; Vasquez KM, 2010, ENVIRON MOL MUTAGEN, V51, P527, DOI 10.1002/em.20557; Vilar E, 2008, BRIT J CANCER, V99, P1607, DOI 10.1038/sj.bjc.6604691; Wright CM, 2005, GUT, V54, P103, DOI 10.1136/gut.2003.034579; Wu Q, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000189; Zhang NX, 2007, DNA REPAIR, V6, P1670, DOI 10.1016/j.dnarep.2007.06.002; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002; Zhao JH, 2009, NUCLEIC ACIDS RES, V37, P4420, DOI 10.1093/nar/gkp399; Zhu GY, 2009, BIOCHEMISTRY-US, V48, P4916, DOI 10.1021/bi900389b	42	62	63	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.198804	http://dx.doi.org/10.1074/jbc.M110.198804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285347	hybrid, Green Published			2022-12-25	WOS:000289077500031
J	Cheng, E; Haque, A; Rimmer, MA; Hussein, ITM; Sheema, S; Little, A; Mir, MA				Cheng, Erdong; Haque, Absarul; Rimmer, Mary Ashley; Hussein, Islam T. M.; Sheema, Sheema; Little, Alex; Mir, Mohammad A.			Characterization of the Interaction between Hantavirus Nucleocapsid Protein (N) and Ribosomal Protein S19 (RPS19)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-INDUCED ACTIVATION; SIN NOMBRE HANTAVIRUS; VIRAL-RNA PANHANDLE; HARE BUNYAVIRUS S; MESSENGER-RNA; 5 ENDS; P-PROTEINS; VIRUS; BINDING; GENOME	Hantaviruses, members of the Bunyaviridae family, are negative-stranded emerging RNA viruses and category A pathogens that cause serious illness when transmitted to humans through aerosolized excreta of infected rodent hosts. Hantaviruses have evolved a novel translation initiation mechanism, operated by nucleocapsid protein (N), which preferentially facilitates the translation of viral mRNAs. N binds to the ribosomal protein S19 (RPS19), a structural component of the 40 S ribosomal subunit. In addition, N also binds to both the viral mRNA 5' cap and a highly conserved triplet repeat sequence of the viral mRNA 5' UTR. The simultaneous binding of N at both the terminal cap and the 5' UTR favors ribosome loading on viral transcripts during translation initiation. We characterized the binding between N and RPS19 and demonstrate the role of the N-RPS19 interaction in N-mediated translation initiation mechanism. We show that N specifically binds to RPS19 with high affinity and a binding stoichiometry of 1:1. The N-RPS19 interaction is an enthalpy-driven process. RPS19 undergoes a conformational change after binding to N. Using T7 RNA polymerase, we synthesized the hantavirus S segment mRNA, which matches the transcript generated by the viral RNA-dependent RNA polymerase in cells. We show that the N-RPS19 interaction plays a critical role in the translation of this mRNA both in cells and rabbit reticulocyte lysates. Our results demonstrate that the N-mediated translation initiation mechanism, which lures the host translation machinery for the preferential translation of viral transcripts, primarily depends on the N-RPS19 interaction. We suggest that the N-RPS19 interaction is a novel target to shut down the N-mediated translation strategy and hence virus replication in cells.	[Cheng, Erdong; Haque, Absarul; Rimmer, Mary Ashley; Hussein, Islam T. M.; Sheema, Sheema; Little, Alex; Mir, Mohammad A.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Mir, MA (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, 4022 Orr Major,3901 Rainbow Blvd, Kansas City, KS 66103 USA.	mmir@kumc.edu	HAQUE, ABSARUL/H-9610-2012	Mir, Sheema/0000-0001-7279-8734	National Institutes of Health [RAI083672Z, P20 RR016443]; Centers of Biomedical Research Excellence grant; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers of Biomedical Research Excellence grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RAI083672Z and P20 RR016443, a Centers of Biomedical Research Excellence grant (to the Department of Microbiology, Molecular Genetics, and Immunology, Kansas University Medical Center).	Alfadhli A, 2002, J BIOL CHEM, V277, P27103, DOI 10.1074/jbc.M203395200; Alfadhli A, 2001, J VIROL, V75, P2019, DOI 10.1128/JVI.75.4.2019-2023.2001; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Battisti AJ, 2011, J VIROL, V85, P835, DOI 10.1128/JVI.01847-10; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; BISHOP DHL, 1983, NUCLEIC ACIDS RES, V11, P6409, DOI 10.1093/nar/11.18.6409; Blakqori G, 2003, J GEN VIROL, V84, P1207, DOI 10.1099/vir.0.18876-0; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; BOULOY M, 1990, VIROLOGY, V175, P50, DOI 10.1016/0042-6822(90)90185-T; BRAAM J, 1983, CELL, V34, P609; Bridgen A, 1996, P NATL ACAD SCI USA, V93, P15400, DOI 10.1073/pnas.93.26.15400; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; CATON AJ, 1980, NUCLEIC ACIDS RES, V8, P2591, DOI 10.1093/nar/8.12.2591; Das S, 2005, J INORG BIOCHEM, V99, P707, DOI 10.1016/j.jinorgbio.2004.11.027; DHAR R, 1980, CELL, V21, P495, DOI 10.1016/0092-8674(80)90486-9; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; ESHITA Y, 1985, J VIROL, V55, P681, DOI 10.1128/JVI.55.3.681-689.1985; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; GARCIN D, 1995, J VIROL, V69, P5754, DOI 10.1128/JVI.69.9.5754-5762.1995; GOTT P, 1993, VIROLOGY, V194, P332, DOI 10.1006/viro.1993.1263; Haque A, 2010, J VIROL, V84, P12450, DOI 10.1128/JVI.01388-10; HELLEN CUT, 1994, J VIROL, V68, P6312, DOI 10.1128/JVI.68.10.6312-6322.1994; Hemmings-Mieszczak M, 1998, RNA, V4, P101; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; JIN H, 1993, J GEN VIROL, V74, P2293, DOI 10.1099/0022-1317-74-10-2293; Jonsson CB, 2001, CURR TOP MICROBIOL, V256, P15; Jonsson CB, 2001, PROTEIN EXPRES PURIF, V23, P134, DOI 10.1006/prep.2001.1489; Kohl A, 2004, J VIROL, V78, P5679, DOI 10.1128/JVI.78.11.5679-5685.2004; Lakowitcz J.R, 1999, PRINCIPLES FLUORESCE, P237, DOI DOI 10.1007/978-1-4757-3061-6_8; Mir MA, 2006, J VIROL, V80, P11283, DOI 10.1128/JVI.00820-06; Mir MA, 2008, P NATL ACAD SCI USA, V105, P19294, DOI 10.1073/pnas.0807211105; Mir MA, 2006, RNA, V12, P272, DOI 10.1261/rna.2101906; Mir MA, 2005, J VIROL, V79, P1824, DOI 10.1128/JVI.79.3.1824-1835.2005; Mir MA, 2004, J VIROL, V78, P8281, DOI 10.1128/jvi.78.15.8281-8288.2004; Mir MA, 2001, BIOCHEMISTRY-US, V40, P11578, DOI 10.1021/bi010731r; Mir MA, 2010, J VIROL, V84, P8937, DOI 10.1128/JVI.02720-09; Mir MA, 2010, J BIOL CHEM, V285, P11357, DOI 10.1074/jbc.M110.102459; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; OBIJESKI JF, 1976, J VIROL, V19, P985, DOI 10.1128/JVI.19.3.985-997.1976; Osborne JC, 2000, J VIROL, V74, P9946, DOI 10.1128/JVI.74.21.9946-9952.2000; Padmanabhan U, 2001, J BIOL CHEM, V276, P43635, DOI 10.1074/jbc.M107531200; PATTERSON JL, 1984, J VIROL, V52, P215, DOI 10.1128/JVI.52.1.215-222.1984; PATTERSON JL, 1984, J VIROL, V49, P680, DOI 10.1128/JVI.49.3.680-685.1984; PETTERSSON RF, 1975, J VIROL, V15, P386, DOI 10.1128/JVI.15.2.386-392.1975; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; RAJU R, 1987, J VIROL, V61, P667, DOI 10.1128/JVI.61.3.667-672.1987; RAJU R, 1986, VIRUS RES, V5, P1, DOI 10.1016/0168-1702(86)90061-4; RAJU R, 1989, J VIROL, V63, P122, DOI 10.1128/JVI.63.1.122-128.1989; RAJU R, 1990, VIROLOGY, V174, P53, DOI 10.1016/0042-6822(90)90053-T; Schmaljohn C, 2001, FIELDS VIROLOGY, P1581; Schmaljohn C. M., 1996, MOL BIOL HANTAVIRUSE, P1; Severson W, 2005, J VIROL, V79, P10032, DOI 10.1128/JVI.79.15.10032-10039.2005; Severson W, 1999, J BIOL CHEM, V274, P33732, DOI 10.1074/jbc.274.47.33732; Severson WE, 2001, J VIROL, V75, P2646, DOI 10.1128/JVI.75.6.2646-2652.2001; SIMONS JF, 1991, J VIROL, V65, P4741, DOI 10.1128/JVI.65.9.4741-4748.1991; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Taylor SL, 2009, ANN NY ACAD SCI, V1171, pE86, DOI 10.1111/j.1749-6632.2009.05049.x; Taylor SL, 2009, J VIROL, V83, P1271, DOI 10.1128/JVI.00986-08; ULMANEN I, 1981, P NATL ACAD SCI-BIOL, V78, P7355, DOI 10.1073/pnas.78.12.7355; WANG JL, 1971, J BIOL CHEM, V246, P1185; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033	62	32	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11814	11824		10.1074/jbc.M110.210179	http://dx.doi.org/10.1074/jbc.M110.210179			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296889	Green Published, hybrid			2022-12-25	WOS:000288797100088
J	Ozawa, D; Kaji, Y; Yagi, H; Sakurai, K; Kawakami, T; Naiki, H; Goto, Y				Ozawa, Daisaku; Kaji, Yuichi; Yagi, Hisashi; Sakurai, Kazumasa; Kawakami, Toru; Naiki, Hironobu; Goto, Yuji			Destruction of Amyloid Fibrils of Keratoepithelin Peptides by Laser Irradiation Coupled with Amyloid-specific Thioflavin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; IN-VITRO; INHIBITORS; GROWTH; PROPAGATION; MUTATIONS; THERAPY	Mutations in keratoepithelin are associated with blinding ocular diseases, including lattice corneal dystrophy type 1 and granular corneal dystrophy type 2. These diseases are characterized by deposits of amyloid fibrils and/or granular non-amyloid aggregates in the cornea. Removing the deposits in the cornea is important for treatment. Previously, we reported the destruction of amyloid fibrils of beta(2)-microglobulin K3 fragments and amyloid beta by laser irradiation coupled with the binding of an amyloid-specific thioflavin T. Here, we studied the effects of this combination on the amyloid fibrils of two 22-residue fragments of keratoepithelin. The direct observation of individual amyloid fibrils was performed in real time using total internal reflection fluorescence microscopy. Both types of amyloid fibrils were broken up by the laser irradiation, dependent on the laser power. The results suggest the laser-induced destruction of amyloid fibrils to be a useful strategy for the treatment of these corneal dystrophies.	[Ozawa, Daisaku; Yagi, Hisashi; Sakurai, Kazumasa; Kawakami, Toru; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Kaji, Yuichi] Univ Tsukuba, Inst Clin Med, Dept Ophthalmol, Ibaraki 3058575, Japan; [Naiki, Hironobu] Univ Fukui, Dept Pathol Sci, Fac Med Sci, Matsuoka, Fukui 9101193, Japan	Osaka University; University of Tsukuba; University of Fukui	Goto, Y (corresponding author), Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Naiki, Hironobu/G-5599-2014		Japanese Ministry of Education, Culture, Sports, and Science and Technology; Japan Society for the Promotion of Science	Japanese Ministry of Education, Culture, Sports, and Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid from the Japanese Ministry of Education, Culture, Sports, and Science and Technology and by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (to H. Y.).	Agon VV, 2006, FREE RADICAL BIO MED, V40, P698, DOI 10.1016/j.freeradbiomed.2005.09.039; Augustin AJ, 2006, OPHTHALMOLOGY, V113, P14, DOI 10.1016/j.ophtha.2005.09.002; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Ban T, 2006, J BIOL CHEM, V281, P33677, DOI 10.1074/jbc.M606072200; Ban T, 2006, ACCOUNTS CHEM RES, V39, P663, DOI 10.1021/ar050074l; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Esteras-Chopo A, 2008, J MOL BIOL, V383, P266, DOI 10.1016/j.jmb.2008.07.076; Giuliano EA, 2007, VET OPHTHALMOL, V10, P337, DOI 10.1111/j.1463-5224.2007.00578.x; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; Korvatska E, 1998, AM J HUM GENET, V62, P320, DOI 10.1086/301720; Levine H, 2007, AMYLOID, V14, P185, DOI 10.1080/13506120701461020; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ohhashi Y, 2004, J BIOL CHEM, V279, P10814, DOI 10.1074/jbc.M310334200; Ozawa D, 2009, J BIOL CHEM, V284, P1009, DOI 10.1074/jbc.M805118200; Schmitt-Bernard CF, 2002, EUR J BIOCHEM, V269, P5149, DOI 10.1046/j.1432-1033.2002.03205.x; Schmitt-Bernard CF, 2000, BIOCHEM BIOPH RES CO, V273, P649, DOI 10.1006/bbrc.2000.2955; Sekijima Y, 2008, CURR PHARM DESIGN, V14, P3219, DOI 10.2174/138161208786404155; Stoppini M, 2004, PHARMACOL RES, V50, P419, DOI 10.1016/j.phrs.2003.12.025; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n; Yagi H, 2010, J BIOL CHEM, V285, P19660, DOI 10.1074/jbc.M109.076505; Yuan C, 2007, FEBS LETT, V581, P241, DOI 10.1016/j.febslet.2006.12.019	30	15	17	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10856	10863		10.1074/jbc.M111.222901	http://dx.doi.org/10.1074/jbc.M111.222901			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21300800	Green Published, hybrid			2022-12-25	WOS:000288547000099
J	Gerstner, JR; Vanderheyden, WM; Shaw, PJ; Landry, CF; Yin, JCP				Gerstner, Jason R.; Vanderheyden, William M.; Shaw, Paul J.; Landry, Charles F.; Yin, Jerry C. P.			Fatty-Acid Binding Proteins Modulate Sleep and Enhance Long-Term Memory Consolidation in Drosophila	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; BRAIN GENE-EXPRESSION; EYE-MOVEMENT SLEEP; NUCLEAR RECEPTORS; MOUSE-BRAIN; PROSTAGLANDIN D-2; WAKING EXPERIENCE; DEPENDENT MEMORY; CIRCADIAN CLOCK; PPAR-ALPHA	Sleep is thought to be important for memory consolidation, since sleep deprivation has been shown to interfere with memory processing. However, the effects of augmenting sleep on memory formation are not well known, and testing the role of sleep in memory enhancement has been limited to pharmacological and behavioral approaches. Here we test the effect of overexpressing the brain-type fatty acid binding protein (Fabp7) on sleep and long-term memory (LTM) formation in Drosophila melanogaster. Transgenic flies carrying the murine Fabp7 or the Drosophila homologue dFabp had reduced baseline sleep but normal LTM, while Fabp induction produced increases in both net sleep and LTM. We also define a post-training consolidation "window" that is sufficient for the observed Fabp-mediated memory enhancement. Since Fabp overexpression increases consolidated daytime sleep bouts, these data support a role for longer naps in improving memory and provide a novel role for lipid-binding proteins in regulating memory consolidation concurrently with changes in behavioral state.	[Gerstner, Jason R.; Yin, Jerry C. P.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Vanderheyden, William M.; Shaw, Paul J.] Washington Univ, Sch Med, St Louis, MO USA; [Landry, Charles F.] Scarab Genom LLC, Madison, WI USA; [Yin, Jerry C. P.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Yin, Jerry C. P.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gerstner, JR (corresponding author), Univ Penn, Sch Med, Ctr Sleep & Circadian Neurobiol, Translat Res Labs, Philadelphia, PA 19104 USA.	gerstner@upenn.edu; jcyin@wisc.edu	Gerstner, Jason/J-3778-2013	Gerstner, Jason/0000-0003-3113-6974	National Institutes of Health [MH60774, GM07507]; Waisman Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waisman Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by the National Institutes of Health (MH60774 to JC), its Training Grant Program (GM07507), and start up funds from the Waisman Center (to JCY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Arai Y, 2005, J NEUROSCI, V25, P9752, DOI 10.1523/JNEUROSCI.2512-05.2005; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Brawn TP, 2008, LEARN MEMORY, V15, P815, DOI 10.1101/lm.1180908; Brawn TP, 2010, J NEUROSCI, V30, P609, DOI 10.1523/JNEUROSCI.4237-09.2010; Cai DJ, 2009, BEHAV NEUROSCI, V123, P713, DOI 10.1037/a0016415; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P8027, DOI 10.1073/pnas.0903038106; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Cirelli C, 2006, J NEUROCHEM, V98, P1632, DOI 10.1111/j.1471-4159.2006.04058.x; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Datta S, 2008, EUR J NEUROSCI, V27, P1876, DOI 10.1111/j.1460-9568.2008.06166.x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Gerstner JR, 2006, NEUROSCIENCE, V139, P1435, DOI 10.1016/j.neuroscience.2006.01.020; Gerstner JR, 2010, NAT REV NEUROSCI, V11, P577, DOI 10.1038/nrn2881; Gerstner JR, 2010, AGING-US, V2, P251, DOI 10.18632/aging.100144; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; Gerstner JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001631; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Glaser ST, 2009, NEUROSCIENCE, V163, P594, DOI 10.1016/j.neuroscience.2009.06.043; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Helledie T, 2000, J LIPID RES, V41, P1740; Huang ZL, 2007, CURR OPIN PHARMACOL, V7, P33, DOI 10.1016/j.coph.2006.09.004; INOUE S, 1984, P NATL ACAD SCI-BIOL, V81, P6240, DOI 10.1073/pnas.81.19.6240; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005; Kondratova AA, 2010, AGING-US, V2, P285; Li XJ, 2009, SLEEP, V32, P1417, DOI 10.1093/sleep/32.11.1417; Lyons LC, 2006, J BIOL RHYTHM, V21, P245, DOI 10.1177/0748730406289890; Lyons LC, 2009, LEARN MEMORY, V16, P19, DOI 10.1101/lm.1146009; MATSUMURA H, 1991, P NATL ACAD SCI USA, V88, P9046, DOI 10.1073/pnas.88.20.9046; Mazzola C, 2009, LEARN MEMORY, V16, P332, DOI 10.1101/lm.1145209; McDermott CM, 2003, J NEUROSCI, V23, P9687; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Mednick SC, 2002, NAT NEUROSCI, V5, P677, DOI 10.1038/nn864; Mizoguchi A, 2001, P NATL ACAD SCI USA, V98, P11674, DOI 10.1073/pnas.201398898; Murillo-Rodniguez E, 2006, LIFE SCI, V79, P30, DOI 10.1016/j.lfs.2005.12.028; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Owada Y, 1996, MOL BRAIN RES, V42, P156, DOI 10.1016/S0169-328X(96)00182-9; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Pandey HP, 1995, BIOCHEM MOL BIOL INT, V37, P431; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Ram A, 1997, BRAIN RES, V751, P81, DOI 10.1016/S0006-8993(96)01401-1; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; Ribeiro S, 2002, J NEUROSCI, V22, P10914, DOI 10.1523/jneurosci.22-24-10914.2002; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Schulze G, 2004, MED HYPOTHESES, V63, P203, DOI 10.1016/j.mehy.2004.02.040; Shioda N, 2010, J NEUROSCI, V30, P3146, DOI 10.1523/JNEUROSCI.4140-09.2010; SMITH C, 1988, PHYSIOL BEHAV, V43, P213, DOI 10.1016/0031-9384(88)90240-5; Smith Carlyle, 1996, Physiology and Behavior, V59, P93, DOI 10.1016/0031-9384(95)02054-3; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Tafti M, 2002, J APPL PHYSIOL, V92, P1339, DOI 10.1152/japplphysiol.00834.2001; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Terao A, 2003, NEUROSCIENCE, V120, P1115, DOI 10.1016/S0306-4522(03)00395-6; Terao A, 2005, NEUROSCIENCE; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; Tononi G, 2001, NEUROPSYCHOPHARMACOL, V25, pS28, DOI 10.1016/S0893-133X(01)00322-0; Tucker MA, 2008, SLEEP, V31, P197, DOI 10.1093/sleep/31.2.197; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; Vertes RP, 2005, SLEEP, V28, P1228, DOI 10.1093/sleep/28.10.1228; Wamsley EJ, 2010, LEARN MEMORY, V17, P332, DOI 10.1101/lm.1828310; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Wetzel W, 2003, EUR J NEUROSCI, V18, P2611, DOI 10.1046/j.1460-9568.2003.02890.x; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17; Zimmerman JE, 2006, PHYSIOL GENOMICS, V27, P337, DOI 10.1152/physiolgenomics.00030.2006	82	50	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15890	10.1371/journal.pone.0015890	http://dx.doi.org/10.1371/journal.pone.0015890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298037	Green Published, gold			2022-12-25	WOS:000286663900018
J	Moitra, K; Scally, M; Mcgee, K; Lancaster, G; Gold, B; Dean, M				Moitra, Karobi; Scally, Mark; McGee, Kate; Lancaster, Germaine; Gold, Bert; Dean, Michael			Molecular Evolutionary Analysis of ABCB5: The Ancestral Gene Is a Full Transporter with Potentially Deleterious Single Nucleotide Polymorphisms	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; HUMAN-MALIGNANT MELANOMA; CANCER STEM-CELLS; PROTEIN SEQUENCES; CODON ALIGNMENTS; LEUKEMIA-CELLS; COILED-COILS; PREDICTION; MODEL; CHEMORESISTANCE	Background: ABCB5 is a member of the ABC protein superfamily, which includes the transporters ABCB1, ABCC1 and ABCG2 responsible for causing drug resistance in cancer patients and also several other transporters that have been linked to human disease. The ABCB5 full transporter (ABCB5.ts) is expressed in human testis and its functional significance is presently unknown. Another variant of this transporter, ABCB5 beta posses a "half-transporter-like'' structure and is expressed in melanoma stem cells, normal melanocytes, and other types of pigment cells. ABCB5 beta has important clinical implications, as it may be involved with multidrug resistance in melanoma stem cells, allowing these stem cells to survive chemotherapeutic regimes. Methodology/Principal Findings: We constructed and examined in detail topological structures of the human ABCB5 protein and determined in-silico the cSNPs (coding single nucleotide polymorphisms) that may affect its function. Evolutionary analysis of ABCB5 indicated that ABCB5, ABCB1, ABCB4, and ABCB11 share a common ancestor, which began duplicating early in the evolutionary history of chordates. This suggests that ABCB5 has evolved as a full transporter throughout its evolutionary history. Conclusions/Significance: From our in-silco analysis of cSNPs we found that a large number of non-synonymous cSNPs map to important functional regions of the protein suggesting that these SNPs if present in human populations may play a role in diseases associated with ABCB5. From phylogenetic analyses, we have shown that ABCB5 evolved as a full transporter throughout its evolutionary history with an absence of any major shifts in selection between the various lineages suggesting that the function of ABCB5 has been maintained during mammalian evolution. This finding would suggest that ABCB5 beta may have evolved to play a specific role in human pigment cells and/or melanoma cells where it is predominantly expressed.	[Moitra, Karobi; Scally, Mark; McGee, Kate; Lancaster, Germaine; Gold, Bert; Dean, Michael] NCI, Expt Immunol Lab, Human Genet Sect, Canc & Inflammat Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Moitra, K (corresponding author), NCI, Expt Immunol Lab, Human Genet Sect, Canc & Inflammat Program, Frederick, MD 21701 USA.	deanm@mail.nih.gov	Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019	Dean, Michael C/0000-0003-2234-0631; 	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011301] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000098; BENTON MJ, 1990, J MOL EVOL, V30, P409, DOI 10.1007/BF02101113; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Calcagno Anna Maria, 2007, Current Drug Delivery, V4, P324, DOI 10.2174/156720107782151241; Chen KG, 2005, PIGM CELL RES, V18, P102, DOI 10.1111/j.1600-0749.2005.00214.x; Cheung ST, 2010, GASTROENTER IN PRESS; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Frank NY, 2009, LEUKEMIA RES, V33, P1303, DOI 10.1016/j.leukres.2009.04.035; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Huang Y, 2004, CANCER RES, V64, P4294, DOI 10.1158/0008-5472.CAN-03-3884; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jamison DC, 2003, BIOINFORMATICS, V19, P679, DOI 10.1093/bioinformatics/btg214; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kalow W, 2001, PHARMACOGENOMICS; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lehne G, 2009, LEUKEMIA RES, V33, P1379, DOI 10.1016/j.leukres.2009.03.028; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Pagni M, 2007, NUCLEIC ACIDS RES, V35, pW433, DOI 10.1093/nar/gkm352; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Stein L, 2002, NATURE, V417, P119, DOI 10.1038/417119a; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1; Wu HJ, 2008, MOL BIOTECHNOL, V39, P21, DOI 10.1007/s12033-007-9024-5; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	41	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16318	10.1371/journal.pone.0016318	http://dx.doi.org/10.1371/journal.pone.0016318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298007	gold, Green Published, Green Submitted			2022-12-25	WOS:000286663900032
J	Patel, R; Martin, RM; Kramer, MS; Oken, E; Bogdanovich, N; Matush, L; Smith, GD; Lawlor, DA				Patel, Rita; Martin, Richard M.; Kramer, Michael S.; Oken, Emily; Bogdanovich, Natalia; Matush, Lidia; Smith, George Davey; Lawlor, Debbie A.			Familial Associations of Adiposity: Findings from a Cross-Sectional Study of 12,181 Parental-Offspring Trios from Belarus	PLOS ONE			English	Article							BODY-MASS INDEX; FETAL OVERNUTRITION HYPOTHESIS; CARDIOVASCULAR RISK; CHILD OVERWEIGHT; MOTHER-DAUGHTER; OBESITY; WEIGHT; PREGNANCY; PREVALENCE	Background: It is suggested that maternal adiposity has a stronger association with offspring adiposity than does paternal adiposity. Furthermore, a recent small study reported gender assortment in parental-offspring adiposity associations. We aimed to examine these associations in one of the largest studies to date using data from a low-middle income country that has recently undergone a major political and economic transition. Methods and Principal Findings: In a cross-sectional study of 12,181 parental-offspring trios from Belarus (mean age (SD) of mothers 31.7 (4.9), fathers 34.1 (5.1) and children 6.6 (0.3) at time of assessment), we found positive graded associations of mother's and father's BMI with offspring adiposity. There was no evidence that these associations differed between mothers and fathers. For example, the odds ratio of offspring overweight or obesity (based on BMI) comparing obese and overweight mothers to normal weight mothers was 2.03 (95% CI 1.77, 2.31) in fully adjusted models; the equivalent result for father's overweight/obesity was 1.81 (1.58, 2.07). Equivalent results for offspring being in the top 10% waist circumference were 1.91 (1.67, 2.18) comparing obese/overweight to normal weight mothers and 1.72 (1.53, 1.95) comparing obese/overweight to normal weight fathers. Similarly, results for offspring being in the top 10% of percent fat mass were 1.58 (1.36, 1.84) and 1.76 (1.49, 2.07), for mother's and father's obese/overweight exposures respectively. There was no strong or consistent evidence of gender assortment - i.e. associations of maternal adiposity exposures with offspring outcomes were similar in magnitude for their daughters compared to equivalent associations in their sons and paternal associations were also similar in sons and daughters. Conclusions/Significance: These findings suggest that genetic and/or shared familial environment explain family clustering of adiposity. Interventions aimed at changing overall family lifestyle are likely to be important for population level obesity prevention.	[Patel, Rita; Martin, Richard M.; Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Martin, Richard M.; Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Kramer, Michael S.] McGill Univ, Dept Pediat, Fac Med, Montreal, PQ H3A 2T5, Canada; [Kramer, Michael S.] McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ H3A 2T5, Canada; [Oken, Emily] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Oken, Emily] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Bogdanovich, Natalia; Matush, Lidia] Natl Res & Appl Med Mother & Child Ctr, Minsk, BELARUS	University of Bristol; University of Bristol; McGill University; McGill University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Patel, R (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	d.a.lawlor@bristol.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	Canadian Institutes of Health Research; US National Institutes of Health (NIH): National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK077659]; European Union [FOOD-DT-2005-007036]; UK Medical Research Council [G0600705]; University of Bristol; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD050758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077659, P30DK040561] Funding Source: NIH RePORTER; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health (NIH): National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The PROBIT study is supported by a grant from the Canadian Institutes of Health Research. The US National Institutes of Health (NIH): National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK077659) provides funding for DAL's work on this study. The European Union's project on Early Nutrition Programming: Long-term Efficacy and Safety Trials (FOOD-DT-2005-007036) provided funding for RP and for RMM and GDS's work on this study. The UK Medical Research Council provides funding for the MRC Centre for Causal Analyses in Translational Epidemiology (G0600705). RP is recipient of a University of Bristol Departmental PhD bursary. The views expressed in this study are those of the authors and not necessarily the funding bodies. Authors had access to the data and DAL, MK & RP acted as guarantors for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brion MJA, 2010, AM J CLIN NUTR, V91, P748, DOI 10.3945/ajcn.2009.28623; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Danielzik S, 2002, EUR J NUTR, V41, P132, DOI 10.1007/s00394-002-0367-1; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Hui LL, 2003, INT J OBESITY, V27, P1411, DOI 10.1038/sj.ijo.0802423; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1848; Kivimaki M, 2007, AM J CLIN NUTR, V86, P1509, DOI 10.1093/ajcn/86.5.1509; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Kuh D., 2004, LIFE COURSE APPROACH, P189, DOI DOI 10.1093/ACPROF:OSO/9780198578154.003.0008; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Lawlor DA, 2010, CIRCULATION IN PRESS; Lawlor DA., 2009, FAMILY MATTERS DESIG, DOI [DOI 10.1093/ACPROF:OSO/9780199231034.001.0001, 10.1093/acprof:oso/9780199231034.001.0001]; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Lawlor DA, 2008, PLOS MED, V5, P484, DOI 10.1371/journal.pmed.0050033; Leary S, 2010, INT J OBESITY, V34, P1191, DOI 10.1038/ijo.2010.60; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Lobstein T, 2007, INT J PEDIATR OBES, V2, P62, DOI 10.1080/17477160601103948; Martin RM, 2009, ADV EXP MED BIOL, V646, P41, DOI 10.1007/978-1-4020-9173-5_4; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Perez-Pastor EM, 2009, INT J OBESITY, V33, P727, DOI 10.1038/ijo.2009.76; PETTITT D J, 1988, Journal of Obesity and Weight Regulation, V7, P61; Sekine Michikazu, 2002, J Epidemiol, V12, P33; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Smith GD, 2007, ARCH DIS CHILD, V92, P876, DOI 10.1136/adc.2006.104869; SORENSEN TIA, 1992, INT J OBESITY, V16, P227; Steer CD, 2009, HUM BIOL, V2000, P447; Subramanian SV, 2010, PEDIATRICS, V126, pE663, DOI 10.1542/peds.2010-0222; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Whitlock G, 2001, EUR J EPIDEMIOL, V17, P907, DOI 10.1023/A:1016228410194	35	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14607	10.1371/journal.pone.0014607	http://dx.doi.org/10.1371/journal.pone.0014607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298034	Green Submitted, gold, Green Published			2022-12-25	WOS:000286663900011
J	Gomez, JM; Perfectti, F; Jordano, P				Gomez, Jose M.; Perfectti, Francisco; Jordano, Pedro			The Functional Consequences of Mutualistic Network Architecture	PLOS ONE			English	Article							COEVOLUTIONARY NETWORKS; METABOLIC NETWORK; NESTEDNESS; SPECIALIZATION; COMPETITION	The architecture and properties of many complex networks play a significant role in the functioning of the systems they describe. Recently, complex network theory has been applied to ecological entities, like food webs or mutualistic plant-animal interactions. Unfortunately, we still lack an accurate view of the relationship between the architecture and functioning of ecological networks. In this study we explore this link by building individual-based pollination networks from eight Erysimum mediohispanicum (Brassicaceae) populations. In these individual-based networks, each individual plant in a population was considered a node, and was connected by means of undirected links to conspecifics sharing pollinators. The architecture of these unipartite networks was described by means of nestedness, connectivity and transitivity. Network functioning was estimated by quantifying the performance of the population described by each network as the number of per-capita juvenile plants produced per population. We found a consistent relationship between the topology of the networks and their functioning, since variation across populations in the average per-capita production of juvenile plants was positively and significantly related with network nestedness, connectivity and clustering. Subtle changes in the composition of diverse pollinator assemblages can drive major consequences for plant population performance and local persistence through modifications in the structure of the inter-plant pollination networks.	[Gomez, Jose M.] Univ Granada, Dept Ecol, Granada, Spain; [Perfectti, Francisco] Univ Granada, Dept Genet, Granada, Spain; [Jordano, Pedro] CSIC, Estn Biol Donana, Integrat Ecol Grp, E-41080 Seville, Spain	University of Granada; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Gomez, JM (corresponding author), Univ Granada, Dept Ecol, Granada, Spain.	jmgreyes@ugr.es	Gómez, José M/K-8061-2017; Perfectti, Francisco/C-5087-2008; Jordano, Pedro/A-5162-2008	Gómez, José M/0000-0002-2487-4664; Perfectti, Francisco/0000-0002-5551-213X; Jordano, Pedro/0000-0003-2142-9116	MARM [078/2007]; CYTED [409AC0369]; Consolider-Ingenio Montes [CSD2008-00040]; Spanish Ministry of Education and Science [CGL2009-07015, CGL2006-00373]; Junta de Andalucia [RNM220, CV165, P07-RNM2824]; Unidad Asociada CSIC-UGR "Grupo de Ecologia, Genetica y Coevolucion"	MARM; CYTED; Consolider-Ingenio Montes; Spanish Ministry of Education and Science(Spanish Government); Junta de Andalucia(Junta de Andalucia); Unidad Asociada CSIC-UGR "Grupo de Ecologia, Genetica y Coevolucion"	This work was supported by MARM grant (078/2007), CYTED (409AC0369), and Consolider-Ingenio Montes (CSD2008-00040) to JMG, the Spanish Ministry of Education and Science (CGL2009-07015 to FP and CGL2006-00373 to PJ), and by the Junta de Andalucia (RNM220 to JMG, CV165 to FP, P07-RNM2824 to PJ). Our collaborative work is supported by the Unidad Asociada CSIC-UGR "Grupo de Ecologia, Genetica y Coevolucion." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Araujo MS, 2008, ECOLOGY, V89, P1981, DOI 10.1890/07-0630.1; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; CEDER A, 1986, TRANSPORT RES B-METH, V20, P331, DOI 10.1016/0191-2615(86)90047-0; Colwell RK, ESTIMATES STAT ESTIM; Dalsgaard B, 2008, OIKOS, V117, P789, DOI 10.1111/j.0030-1299.2008.16537.x; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Fortuna MA, 2008, ECOL LETT, V11, P490, DOI 10.1111/j.1461-0248.2008.01167.x; FU BY, 2006, ORYZAE P NATL ACAD S, V103, P7994; Gomez JM, 2009, ECOL MONOGR, V79, P245, DOI 10.1890/08-0511.1; Gomez JM, 2007, OECOLOGIA, V153, P597, DOI 10.1007/s00442-007-0758-3; Greenberg AJ, 2008, MOL BIOL EVOL, V25, P2537, DOI 10.1093/molbev/msn205; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; HAINING R, 2002, SPATIAL DATA ANAL; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; McDonald DB, 2007, P NATL ACAD SCI USA, V104, P10910, DOI 10.1073/pnas.0701159104; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nooy De W., 2005, EXPLORATORY NETWORK; Olesen JM, 2006, J THEOR BIOL, V240, P270, DOI 10.1016/j.jtbi.2005.09.014; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pardalos P.M., 1997, NETWORK OPTIMIZATION; Parker D, 2006, PHILOS T R SOC B, V361, P81, DOI 10.1098/rstb.2005.1779; R Core Team, 2022, R LANG ENV STAT COMP; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Wasserman S., 1994, SOCIAL NETWORK ANAL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	39	51	54	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16143	10.1371/journal.pone.0016143	http://dx.doi.org/10.1371/journal.pone.0016143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283583	Green Submitted, Green Published, gold			2022-12-25	WOS:000286661400028
J	Rowe, M; Pruett-Jones, S				Rowe, Melissah; Pruett-Jones, Stephen			Sperm Competition Selects for Sperm Quantity and Quality in the Australian Maluridae	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; RELATIVE TESTIS SIZE; EJACULATE QUALITY; FAIRY-WRENS; ARTIFICIAL-INSEMINATION; INTERSPECIFIC VARIATION; SEMEN CHARACTERISTICS; OXIDATIVE STRESS; JAPANESE QUAIL; SEMINAL FLUID	When ejaculates from rival males compete for fertilization, there is strong selection for sperm traits that enhance fertilization success. Sperm quantity is one such trait, and numerous studies have demonstrated a positive association between sperm competition and both testes size and the number of sperm available for copulations. Sperm competition is also thought to favor increases in sperm quality and changes in testicular morphology that lead to increased sperm production. However, in contrast to sperm quantity, these hypotheses have received considerably less empirical support and remain somewhat controversial. In a comparative study using the Australian Maluridae (fairy-wrens, emu-wrens, grasswrens), we tested whether increasing levels of sperm competition were associated with increases in both sperm quantity and quality, as well as an increase in the relative amount of seminiferous tubule tissue contained within the testes. After controlling for phylogeny, we found positive associations between sperm competition and sperm numbers, both in sperm reserves and in ejaculate samples. Additionally, as sperm competition level increased, the proportion of testicular spermatogenic tissue also increased, suggesting that sperm competition selects for greater sperm production per unit of testicular tissue. Finally, we also found that sperm competition level was positively associated with multiple sperm quality traits, including the proportion of motile sperm in ejaculates and the proportion of both viable and morphologically normal sperm in sperm reserves. These results suggest multiple ejaculate traits, as well as aspects of testicular morphology, have evolved in response to sperm competition in the Australian Maluridae. Furthermore, our findings emphasize the importance of postcopulatory sexual selection as an evolutionary force shaping macroevolutionary differences in sperm phenotype.	[Rowe, Melissah; Pruett-Jones, Stephen] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Rowe, Melissah] Univ Oslo, Natl Ctr Biosystemat, Nat Hist Museum, Oslo, Norway	University of Chicago; University of Oslo	Rowe, M (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	melissah.rowe@nhm.uio.no	Rowe, Melissah/G-3905-2015	Rowe, Melissah/0000-0001-9747-041X	National Science Foundation [IOB-051697]; University of Chicago	National Science Foundation(National Science Foundation (NSF)); University of Chicago(University of Chicago)	This work was supported by a grant to SP-J from the National Science Foundation (IOB-051697, 2005-2008) and by a grant to MR from the Hinds Fund from the University of Chicago (2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2008, OXID MED CELL LONGEV, V1, P15, DOI 10.4161/oxim.1.1.6843; ALLEN TE, 1958, AUST J AGR RES, V8, P788; AMANN RP, 1981, J ANDROL, V2, P37; Anderson MJ, 2007, AM J PHYS ANTHROPOL, V134, P274, DOI 10.1002/ajpa.20674; Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; BAKST MR, 1997, TECHNIQUES SEMEN EVA, V3, P29; Balshine S, 2001, BEHAV ECOL, V12, P726, DOI 10.1093/beheco/12.6.726; BIRKHEAD TR, 1995, P ROY SOC B-BIOL SCI, V261, P153, DOI 10.1098/rspb.1995.0130; BIRKHEAD TR, 1993, BEHAV ECOL SOCIOBIOL, V32, P85, DOI 10.1007/BF00164040; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; BIRKHEAD TR, 1995, NATURE, V377, P422, DOI 10.1038/377422a0; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; BLUMENSTIEL JP, 2010, J THEO BIOL, V249, P624; BRISKIE JV, 1992, P ROY SOC B-BIOL SCI, V247, P89, DOI 10.1098/rspb.1992.0013; BRISKIE JV, 1993, AUK, V110, P875, DOI 10.2307/4088641; BROOKER MG, 1990, BEHAV ECOL SOCIOBIOL, V26, P191; Byrne PG, 2002, J EVOLUTION BIOL, V15, P347, DOI 10.1046/j.1420-9101.2002.00409.x; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Christidis L, 1997, AUST J ZOOL, V45, P113, DOI 10.1071/ZO96068; Christidis L, 1999, AUST J ZOOL, V47, P113, DOI 10.1071/ZO98054; Ciereszko A, 2010, ANIM REPROD SCI, V122, P222, DOI 10.1016/j.anireprosci.2010.08.014; CLULOW J, 1982, J REPROD FERTIL, V64, P259, DOI 10.1530/jrf.0.0640259; COHEN J, 1967, NATURE, V215, P862, DOI 10.1038/215862a0; COHEN J, 1973, HEREDITY, V31, P408, DOI 10.1038/hdy.1973.96; COOPER DM, 1958, POULTRY SCI, V37, P699, DOI 10.3382/ps.0370699; Costantini D, 2010, FUNCT ECOL, V24, P950, DOI 10.1111/j.1365-2435.2010.01746.x; Denk AG, 2005, BEHAV ECOL, V16, P825, DOI 10.1093/beheco/ari065; Double M, 2000, P ROY SOC B-BIOL SCI, V267, P465, DOI 10.1098/rspb.2000.1023; DRISKELL AC, 2011, MOL PHYLO E IN PRESS; Dunn PO, 2001, EVOLUTION, V55, P161; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Firman RC, 2010, EVOLUTION, V64, P1245, DOI 10.1111/j.1558-5646.2009.00894.x; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Froman DP, 2006, BIOL REPROD, V74, P487, DOI 10.1095/biolreprod.105.046755; Froman DP, 2002, P ROY SOC B-BIOL SCI, V269, P607, DOI 10.1098/rspb.2001.1925; FUJIHARA N, 1978, POULTRY SCI, V57, P1766, DOI 10.3382/ps.0571766; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Gage MJG, 2003, P ROY SOC B-BIOL SCI, V270, P625, DOI 10.1098/rspb.2002.2258; GAGE MJG, 1991, ANIM BEHAV, V42, P1036, DOI 10.1016/S0003-3472(05)80162-9; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Gasparini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012146; Gee GF, 2004, AVIAN POULT BIOL REV, V15, P47, DOI 10.3184/147020604783637435; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; HARCOURT AH, 1995, FUNCT ECOL, V9, P468, DOI 10.2307/2390011; HARRISON CJO, 1969, AMYTORNIS EMU, V69, P1; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; Hosken DJ, 2001, ECOL LETT, V4, P10, DOI 10.1046/j.1461-0248.2001.00198.x; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; Immler S, 2007, P ROY SOC B-BIOL SCI, V274, P561, DOI 10.1098/rspb.2006.3752; Karubian J, 2002, EVOLUTION, V56, P1673; Kingma Sjouke A., 2009, BMC Ecology, V9, P15, DOI 10.1186/1472-6785-9-15; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Lake P.E., 1975, Symposia Zool Soc Lond, VNo. 35, P225; Laskemoen T, 2010, BEHAV ECOL SOCIOBIOL, V64, P1473, DOI 10.1007/s00265-010-0962-8; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LIN M, 1990, J REPROD FERTIL, V88, P481, DOI 10.1530/jrf.0.0880481; Lupold S, 2009, BEHAV ECOL SOCIOBIOL, V63, P899, DOI 10.1007/s00265-009-0733-6; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Lupold S, 2009, EVOLUTION, V63, P391, DOI 10.1111/j.1558-5646.2008.00571.x; Maguire GS, 2008, AUST J ZOOL, V56, P79, DOI 10.1071/ZO08047; Maguire GS, 2004, AUST J ZOOL, V52, P583, DOI 10.1071/ZO04043; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; MARTIN PA, 1974, J REPROD FERTIL, V39, P251, DOI 10.1530/jrf.0.0390251; MOLLER AP, 1991, AM NAT, V137, P882, DOI 10.1086/285199; MOLLER AP, 1988, BIOL J LINN SOC, V33, P273, DOI 10.1111/j.1095-8312.1988.tb00812.x; MOLLER AP, 1995, BEHAV ECOL SOCIOBIOL, V36, P357, DOI 10.1007/BF00167797; MOLLER AP, 1989, FUNCT ECOL, V3, P91, DOI 10.2307/2389679; MOLLER AP, 1988, J HUM EVOL, V17, P479, DOI 10.1016/0047-2484(88)90037-1; MULDER RA, 1993, AUK, V110, P588, DOI 10.2307/4088422; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; Noirault K, 2006, THERIOGENOLOGY, V65, P845, DOI 10.1016/j.theriogenology.2005.01.012; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parapanov R, 2008, REPROD FERT DEVELOP, V20, P431, DOI 10.1071/RD07207; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Peirce EJ, 2001, REPRODUCTION, V121, P239, DOI 10.1530/rep.0.1210239; Penfold LM, 2000, REPROD FERT DEVELOP, V12, P229, DOI 10.1071/RD00093; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Pizzari T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-332; Ramm SA, 2010, BIOL LETTERS, V6, P219, DOI 10.1098/rsbl.2009.0635; Reviers M. de, 1984, Reproductive biology. Proceedings of the 17th Poultry Science Symposium, 1982., P183; Rowe M, 2006, AVIAN POULT BIOL REV, V17, P21, DOI 10.3184/147020606783437949; Rowe M, 2010, ANIM BEHAV, V79, P1239, DOI 10.1016/j.anbehav.2010.02.020; Rowe M, 2008, CONDOR, V110, P694, DOI 10.1525/cond.2008.8604; Rowley I., 1997, FAIRY WRENS GRASSWRE; Schultz AH, 1938, ANAT REC, V72, P387, DOI 10.1002/ar.1090720310; Simmons LW, 2008, EVOLUTION, V62, P2580, DOI 10.1111/j.1558-5646.2008.00479.x; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Sontakke SD, 2004, THERIOGENOLOGY, V62, P139, DOI 10.1016/j.theriogenology.2003.08.018; Stockley P, 1997, AM NAT, V149, P933, DOI 10.1086/286031; Taborsky M, 1998, TRENDS ECOL EVOL, V13, P222, DOI 10.1016/S0169-5347(97)01318-9; Tuttle EM, 1996, P ROY SOC B-BIOL SCI, V263, P1359, DOI 10.1098/rspb.1996.0199; Tuttle EM, 2004, ANIM BEHAV, V68, P541, DOI 10.1016/j.anbehav.2003.09.014; Webster MS, 2008, BEHAV ECOL, V19, P517, DOI 10.1093/beheco/arn015; Webster MS, 2004, BEHAV ECOL, V15, P907, DOI 10.1093/beheco/arh093; Westneat DF, 1998, BEHAV ECOL SOCIOBIOL, V43, P161, DOI 10.1007/s002650050477; WISHART GJ, 1984, J REPROD FERTIL, V71, P113, DOI 10.1530/jrf.0.0710113; Wishart GJ, 2002, REPROD FERT DEVELOP, V14, P401, DOI 10.1071/RD02014; WISHART GJ, 1997, TECHNIQUES SEMEN EVA; Wolfson A., 1952, Bird-Banding, V23, P159; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	105	67	68	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15720	10.1371/journal.pone.0015720	http://dx.doi.org/10.1371/journal.pone.0015720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283577	gold, Green Published			2022-12-25	WOS:000286661400013
J	Alimirah, F; Peng, XJ; Murillo, G; Mehta, RG				Alimirah, Fatouma; Peng, Xinjian; Murillo, Genoveva; Mehta, Rajendra G.			Functional Significance of Vitamin D Receptor FokI Polymorphism in Human Breast Cancer Cells	PLOS ONE			English	Article							SIGNALING PATHWAYS; UP-REGULATION; KAPPA-B; PROTEIN; RISK; GENE; D-3; DEGRADATION; METASTASIS; THERAPY	Background: The FokI vitamin D receptor (VDR) polymorphism results in different translation initiation sites on VDR. In the VDRff variant, initiation of translation occurs at the first ATG site, giving rise to a full length VDR protein of 427 amino acids. Conversely, in the VDRFF variant, translation begins at the second ATG site, resulting in a truncated protein with three less amino acids. Epidemiological studies have paradoxically implicated this polymorphism with increased breast cancer risk. 1 alpha,25 (OH)(2)D-3, the active metabolite of vitamin D, is known to inhibit cell proliferation, induce apoptosis and potentiate differentiation in human breast cancer cells. It is well documented that 1 alpha,25 (OH)(2)D-3 downregulates estrogen receptor alpha expression and inhibits estrogen mediated signaling in these cells. The functional significance of the VDR FokI polymorphism in vitamin D action is undefined. Methods/Findings: To elucidate the functional role of FokI polymorphism in breast cancer, MCF-7-Vector, MCF-7-VDRff and MCF-7-VDRFF stable cell lines were established from parental MCF-7 cells as single-cell clones. In response to 1 alpha,25 (OH)(2)D-3 treatments, cell growth was inhibited by 60% in VDRFF cells compared to 28% in VDRff cells. The induction of the vitamin D target gene CYP24A1 mRNA was 1.8 fold higher in VDRFF cells than in VDRff cells. Estrogen receptor-a protein expression was downregulated by 62% in VDRFF cells compared to 25% in VDRff cells. VDR protein stability was greater in MCF-7-VDRFF cells in the presence of cycloheximide. PCR array analyses of VDRff and VDRFF cells revealed increased basal expression levels of pro-inflammatory genes Cyclooxygenase-2, Interleukin-8 and Chemokine (C-C Motif) Ligand 2 in MCF-7-VDRff cells by 14, 52.7 and 5 fold, respectively. Conclusions/Significance: These results suggest that a VDRff genotype may play a role in amplifying aggressive breast cancer, paving the way for understanding why some breast cancer cells respond inefficiently to vitamin D treatment.	[Alimirah, Fatouma; Peng, Xinjian; Murillo, Genoveva; Mehta, Rajendra G.] IIT, IIT Res Inst, Div Canc Biol, Chicago, IL 60616 USA; [Alimirah, Fatouma; Murillo, Genoveva; Mehta, Rajendra G.] IIT, Dept Biol Chem & Phys Sci, Chicago, IL 60616 USA	Illinois Institute of Technology; Illinois Institute of Technology	Alimirah, F (corresponding author), IIT, IIT Res Inst, Div Canc Biol, Chicago, IL 60616 USA.	rmehta@iitri.org			NCI [1F31CA132619]; Illinois State DFI [NCI RO3 CA12136-02]; NATIONAL CANCER INSTITUTE [F31CA132619] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Illinois State DFI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded by NCI Predoctoral Fellowship 1F31CA132619 (FA), Illinois State DFI Predoctoral Fellowship (FA) NCI RO3 CA12136-02 (XP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2006, FEBS LETT, V580, P1659, DOI 10.1016/j.febslet.2006.02.015; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chen WY, 2005, CANCER EPIDEM BIOMAR, V14, P2335, DOI 10.1158/1055-9965.EPI-05-0283; Crew KD, 2009, J CLIN ONCOL, V27, P2151, DOI 10.1200/JCO.2008.19.6162; Dalloul A, 2009, AUTOIMMUN REV, V8, P349, DOI 10.1016/j.autrev.2008.11.007; De Larco JE, 2001, AM J PATHOL, V158, P639, DOI 10.1016/S0002-9440(10)64005-9; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Ellison TI, 2007, J BIOL CHEM, V282, P10953, DOI 10.1074/jbc.M609717200; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; Guy M, 2004, CLIN CANCER RES, V10, P5472, DOI 10.1158/1078-0432.CCR-04-0206; Hussain EA, 2003, RECENT RESULTS CANC, V164, P393; Jensen SS, 2002, J STEROID BIOCHEM, V81, P123, DOI 10.1016/S0960-0760(02)00057-2; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; Kang JX, 2005, CARCINOGENESIS, V26, P1934, DOI 10.1093/carcin/bgi154; Kemmis CM, 2006, J NUTR, V136, P887, DOI 10.1093/jn/136.4.887; Li XY, 1999, MOL ENDOCRINOL, V13, P1686, DOI 10.1210/me.13.10.1686; Lima RT, 2004, CANCER GENE THER, V11, P309, DOI 10.1038/sj.cgt.7700706; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; McCullough ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1642; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Pan MR, 2008, J BIOL CHEM, V283, P11155, DOI 10.1074/jbc.M710038200; Peng XJ, 2007, CARCINOGENESIS, V28, P1000, DOI 10.1093/carcin/bgl230; Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103; Reichrath J, 2007, CANCER BIOL THER, V6, P48, DOI 10.4161/cbt.6.1.3493; Singh B, 2006, J SURG RES, V134, P44, DOI 10.1016/j.jss.2006.03.018; Sinotte M, 2008, ENDOCR-RELAT CANCER, V15, P975, DOI 10.1677/ERC-08-0056; Swami S, 2000, CLIN CANCER RES, V6, P3371; Tang CB, 2009, BREAST CANCER RES TR, V117, P391, DOI 10.1007/s10549-008-0262-4; Trabert B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1833; Turunen MM, 2007, NUCLEIC ACIDS RES, V35, P2734, DOI 10.1093/nar/gkm179; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Warren MA, 2009, MOL CANCER THER, V8, P2655, DOI 10.1158/1535-7163.MCT-09-0358; Whitfield GK, 2001, MOL CELL ENDOCRINOL, V177, P145; Whyte L, 2007, CANCER RES, V67, P12007, DOI 10.1158/0008-5472.CAN-07-2464; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Zhang X, 2003, J BIOL CHEM, V278, P7580, DOI 10.1074/jbc.M212050200; Zinser GM, 2003, MOL CELL ENDOCRINOL, V200, P67, DOI 10.1016/S0303-7207(02)00416-1	39	52	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16024	10.1371/journal.pone.0016024	http://dx.doi.org/10.1371/journal.pone.0016024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283672	Green Published, gold, Green Submitted			2022-12-25	WOS:000286523400012
J	Lamers, RP; Stinnett, JW; Muthukrishnan, G; Parkinson, CL; Cole, AM				Lamers, Ryan P.; Stinnett, Jason W.; Muthukrishnan, Gowrishankar; Parkinson, Christopher L.; Cole, Alexander M.			Evolutionary Analyses of Staphylococcus aureus Identify Genetic Relationships between Nasal Carriage and Clinical Isolates	PLOS ONE			English	Article							METHICILLIN-RESISTANT; CLUMPING FACTOR; HUMAN INFECTIONS; REPEAT REGION; CLONAL GROUPS; SPA; DIVERSITY; EMERGENCE; COAGULASE; INFERENCE	Nasal carriage of Staphylococcus aureus has long been hypothesized to be a major vector for the transmission of virulent strains throughout the community. To address this hypothesis, we have analyzed the relatedness between a cohort of nasal carriage strains and clinical isolates to understand better the genetic conformity therein. To assess the relatedness between nasal carriage and clinical isolates of S. aureus, a genetic association study was conducted using multilocus sequence typing (MLST) and typing of the hypervariable regions of clumping factor and fibronectin binding protein genes. At all loci analyzed, genetic associations between both nasal carriage and clinical isolates were observed. Computational analyses of MLST data indicate that nasal carriage and clinical isolates belong to the same genetic clusters (clades), despite differences in sequence type assignments. Genetic analyses of the hypervariable regions from the clumping factor and fibronectin binding protein genes revealed that not only do clinically relevant strains belong to identical genetic lineages as the nasal carriage isolates within our cohort, but they also exhibit 100% sequence similarity within these regions. The findings of this report indicate that strains of S. aureus being carried asymptomatically throughout the community via nasal colonization are genetically related to those responsible for high levels of morbidity and mortality.	[Lamers, Ryan P.; Muthukrishnan, Gowrishankar; Cole, Alexander M.] Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Stinnett, Jason W.] Univ Cent Florida, Sch Elect Engn & Comp Sci, Orlando, FL 32816 USA; [Parkinson, Christopher L.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Lamers, RP (corresponding author), Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA.	acole@mail.ucf.edu	Parkinson, Christopher L./AAV-9370-2021; Muthukrishnan, Gowrishankar/H-3031-2019	Muthukrishnan, Gowrishankar/0000-0001-7521-6154	National Institutes of Health [AI060753]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were funded in part by grant #AI060753 from the National Institutes of Health (to A.M.C.) and from a doctoral postgraduate scholarship (PGS-D) from the Natural Sciences and Engineering Research Council of Canada (to R.P.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos DH, 2005, DEV COMP IMMUNOL, V29, P211, DOI 10.1016/j.dci.2004.07.007; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crisostomo MI, 2001, P NATL ACAD SCI USA, V98, P9865, DOI 10.1073/pnas.161272898; De Lencastre H, 2000, MICROB DRUG RESIST, V6, P1, DOI 10.1089/mdr.2000.6.1; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gomes AR, 2005, ANTIMICROB AGENTS CH, V49, P366, DOI 10.1128/AAC.49.1.366-379.2005; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hartford O, 1997, MOL MICROBIOL, V25, P1065, DOI 10.1046/j.1365-2958.1997.5291896.x; Hidron AI, 2009, LANCET INFECT DIS, V9, P384, DOI 10.1016/S1473-3099(09)70133-1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Koreen L, 2005, J CLIN MICROBIOL, V43, P3985, DOI 10.1128/JCM.43.8.3985-3994.2005; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Kuhn G, 2007, J CLIN MICROBIOL, V45, P54, DOI 10.1128/JCM.01457-06; Kuhn G, 2006, J BACTERIOL, V188, P169, DOI 10.1128/JB.188.1.169-178.2006; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Miller M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006708; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; NEI M, 1986, MOL BIOL EVOL, V3, P418; O'Neill E, 2009, J MED MICROBIOL, V58, P399, DOI 10.1099/jmm.0.005504-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 5; Said KB, 2010, J CLIN MICROBIOL, V48, P375, DOI 10.1128/JCM.01768-09; Said KB, 2010, FOODBORNE PATHOG DIS, V7, P111, DOI 10.1089/fpd.2009.0334; Said KB, 2009, DIAGN MICR INFEC DIS, V63, P24, DOI 10.1016/j.diagmicrobio.2008.09.004; Sakwinska O, 2009, APPL ENVIRON MICROB, V75, P175, DOI 10.1128/AEM.01860-08; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shopsin B, 2000, J CLIN MICROBIOL, V38, P3453, DOI 10.1128/JCM.38.9.3453-3456.2000; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; VanBelkum A, 1997, J MED MICROBIOL, V46, P222, DOI 10.1099/00222615-46-3-222; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155	46	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16426	10.1371/journal.pone.0016426	http://dx.doi.org/10.1371/journal.pone.0016426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283661	gold, Green Published			2022-12-25	WOS:000286522300047
J	Twine, NA; Janitz, K; Wilkins, MR; Janitz, M				Twine, Natalie A.; Janitz, Karolina; Wilkins, Marc R.; Janitz, Michal			Whole Transcriptome Sequencing Reveals Gene Expression and Splicing Differences in Brain Regions Affected by Alzheimer's Disease	PLOS ONE			English	Article							RNA-SEQ; APOLIPOPROTEIN-E; MESSENGER-RNA; ADULT BRAIN; PROTEIN; CELLS; MICROARRAY; DISORDERS; RECEPTOR; NEURONS	Recent studies strongly indicate that aberrations in the control of gene expression might contribute to the initiation and progression of Alzheimer's disease (AD). In particular, alternative splicing has been suggested to play a role in spontaneous cases of AD. Previous transcriptome profiling of AD models and patient samples using microarrays delivered conflicting results. This study provides, for the first time, transcriptomic analysis for distinct regions of the AD brain using RNA-Seq next-generation sequencing technology. Illumina RNA-Seq analysis was used to survey transcriptome profiles from total brain, frontal and temporal lobe of healthy and AD post-mortem tissue. We quantified gene expression levels, splicing isoforms and alternative transcript start sites. Gene Ontology term enrichment analysis revealed an overrepresentation of genes associated with a neuron's cytological structure and synapse function in AD brain samples. Analysis of the temporal lobe with the Cufflinks tool revealed that transcriptional isoforms of the apolipoprotein E gene, APOE-001, -002 and -005, are under the control of different promoters in normal and AD brain tissue. We also observed differing expression levels of APOE-001 and -002 splice variants in the AD temporal lobe. Our results indicate that alternative splicing and promoter usage of the APOE gene in AD brain tissue might reflect the progression of neurodegeneration.	[Twine, Natalie A.; Wilkins, Marc R.; Janitz, Michal] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Twine, Natalie A.; Wilkins, Marc R.] Univ New S Wales, New S Wales Syst Biol Initiat, Sydney, NSW, Australia; [Janitz, Karolina; Wilkins, Marc R.] Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Twine, NA (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	m.janitz@unsw.edu.au	Twine, Natalie A/AAH-7966-2021; Twine, Natalie/R-6441-2018; Janitz, Michael/E-9823-2015; Twine, Natalie/AAM-5043-2021	Janitz, Michael/0000-0002-4878-0259; Twine, Natalie/0000-0002-2051-8275	UNSW Science Faculty [2010]; New South Wales Office for Science and Medical Research; Australian Government's Super Science Initiative	UNSW Science Faculty; New South Wales Office for Science and Medical Research; Australian Government's Super Science Initiative(Australian GovernmentDepartment of Industry, Innovation and Science)	MJ acknowledges support from a UNSW Science Faculty Research Grant 2010. MW and the NSW Systems Biology Initiative acknowledge support from the New South Wales Office for Science and Medical Research and the Australian Government's Super Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Atz M, 2007, J NEUROSCI METH, V163, P295, DOI 10.1016/j.jneumeth.2007.03.022; Bales KR, 2010, NEUROPHARMACOLOGY, V59, P295, DOI 10.1016/j.neuropharm.2010.01.005; Beffert U, 2006, CURR BIOL, V16, P2446, DOI 10.1016/j.cub.2006.10.029; Bettens K, 2010, HUM MOL GENET, V19, pR4, DOI 10.1093/hmg/ddq142; Bossers K, 2010, BRAIN, V133, P3699, DOI 10.1093/brain/awq258; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Courtney E, 2010, J NEUROSCI METH, V193, P189, DOI 10.1016/j.jneumeth.2010.08.018; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GEULA C, 1995, ALZ DIS ASSOC DIS, V9, P23, DOI 10.1097/00002093-199501002-00005; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Guo H, 2002, MOL CELL NEUROSCI, V21, P546, DOI 10.1006/mcne.2002.1198; Hata R, 2001, BIOCHEM BIOPH RES CO, V284, P310, DOI 10.1006/bbrc.2001.4968; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Ishunina TA, 2009, NEUROENDOCRINOLOGY, V89, P187, DOI 10.1159/000158573; Janitz M., 2008, NEXT GENERATION GENO, V1st; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kaneko N, 2010, NEURON, V67, P213, DOI 10.1016/j.neuron.2010.06.018; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Maruszak A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-115; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Matigian N, 2010, DIS MODEL MECH, V3, P785, DOI 10.1242/dmm.005447; Monoranu CM, 2009, NEUROPATH APPL NEURO, V35, P329, DOI 10.1111/j.1365-2990.2008.01003a.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Raschetti R, 2007, PLOS MED, V4, P1818, DOI 10.1371/journal.pmed.0040338; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; SUTHERLAND GT, 2010, J NEUROCHEM; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xu PT, 1999, AM J PATHOL, V154, P601, DOI 10.1016/S0002-9440(10)65305-9; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zweig AS, 2008, GENOMICS, V92, P75, DOI 10.1016/j.ygeno.2008.02.003	50	213	216	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16266	10.1371/journal.pone.0016266	http://dx.doi.org/10.1371/journal.pone.0016266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283692	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522300025
J	Yang, C; Zhang, MJ; Niu, WP; Yang, RJ; Zhang, YH; Qiu, ZY; Sun, BX; Zhao, ZH				Yang, Chun; Zhang, Mingjun; Niu, Weiping; Yang, Runjun; Zhang, Yonghong; Qiu, Zhengyan; Sun, Boxing; Zhao, Zhihui			Analysis of DNA Methylation in Various Swine Tissues	PLOS ONE			English	Article							CYTOSINE METHYLATION; GENE-EXPRESSION; AFLP; RICE; AMPLIFICATION; PATTERNS; METHYLTRANSFERASES; HYBRIDIZATION; SEQUENCE; CHICKEN	DNA methylation is known to play an important role in regulating gene expression during biological development and tissue differentiation in eukaryotes. In this study, we used the fluorescence-labeled methylation-sensitive amplified polymorphism (F-MSAP) method to assess the extent and pattern of cytosine methylation in muscle, heart, liver, spleen, lung, kidney and stomach from the swine strain Laiwu, and we also examined specific methylation patterns in the seven tissues. In total, 96,371 fragments, each representing a recognition site cleaved by either or both EcoRI + HpaII and EcoRI + MspI, the HpaII and MspI are isoschizomeric enzymes, were amplified using 16 pairs of selective primers. A total of 50,094 sites were found to be methylated at cytosines in seven tissues. The incidence of DNA methylation was approximately 53.99% in muscle, 51.24% in the heart, 50.18% in the liver, 53.31% in the spleen, 51.97% in the lung, 51.15% in the kidney and 53.39% in the stomach, as revealed by the incidence of differential digestion. Additionally, differences in DNA methylation levels imply that such variations may be related to specific gene expression during tissue differentiation, growth and development. Three types of bands were generated in the F-MSAP profile, the total numbers of these three types of bands in the seven tissues were 46,277, 24,801 and 25,293, respectively. In addition, different methylation patterns were observed in seven tissues from pig, and almost all of the methylation patterns detected by F-MSAP could be confirmed by Southern analysis using the isolated amplified fragments as probes. The results clearly demonstrated that the F-MSAP technique can be adapted for use in large-scale DNA methylation detection in the pig genome.	[Yang, Chun; Zhang, Mingjun; Niu, Weiping; Yang, Runjun; Zhang, Yonghong; Qiu, Zhengyan; Sun, Boxing; Zhao, Zhihui] Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Peoples R China	Jilin University	Yang, C (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Peoples R China.	sbx@jlu.edu.cn; zhzhao@jlu.edu.cn	Yang, Runjun/ABA-5056-2021	Yang, Runjun/0000-0003-1401-4318; siva, Vinu/0000-0003-4252-5211	National Natural Science Foundation [30771543]; National High-Tech Research and Development Program [2008AA10Z136]; Jilin Scientific and Technological Development Program [20070567]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program(National High Technology Research and Development Program of China); Jilin Scientific and Technological Development Program	This work was supported by the National Natural Science Foundation (30771543), National High-Tech Research and Development Program (2008AA10Z136) and Jilin Scientific and Technological Development Program (20070567). We thank Professor Yunliang Jiang of Shandong Agricultural University for providing experimental samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aina R, 2004, PHYSIOL PLANTARUM, V121, P472, DOI 10.1111/j.1399-3054.2004.00343.x; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; CHEN B, 1976, CHEM-BIOL INTERACT, V14, P101, DOI 10.1016/0009-2797(76)90028-4; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; De Montera B, 2004, CLONING STEM CELLS, V6, P133, DOI 10.1089/1536230041372382; Dong ZY, 2006, THEOR APPL GENET, V113, P196, DOI 10.1007/s00122-006-0286-2; Eggermann T, 2009, HORM RES, V71, P30, DOI 10.1159/000192433; Finnegan E J, 1993, EXS, V64, P218; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; Grunau C, 2000, HUM MOL GENET, V9, P2651, DOI 10.1093/hmg/9.18.2651; Gurrieri F, 2009, ENDOCRIN DEV, V14, P20, DOI 10.1159/000207473; Huang J, 1999, BIOTECHNOL TECH, V13, P277, DOI 10.1023/A:1008970618252; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; JOST J, 1993, DNA METHYLATION MOLE; Labra M, 2004, CHEMOSPHERE, V54, P1049, DOI 10.1016/j.chemosphere.2003.10.024; LI X, 2002, PLANT PHYSL, V159; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; MANDEL JL, 1979, NUCLEIC ACIDS RES, V7, P2081, DOI 10.1093/nar/7.8.2081; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Portis E, 2004, PLANT SCI, V166, P169, DOI 10.1016/j.plantsci.2003.09.004; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sasaki H., 1993, Experientia Supplementum (Basel), V64, P469; Sha AH, 2005, MOL GENET GENOMICS, V273, P484, DOI 10.1007/s00438-005-1148-3; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Sharma R, 2009, FEBS J, V276, P6301, DOI 10.1111/j.1742-4658.2009.07338.x; Terefework Z, 2001, J BIOTECHNOL, V91, P169, DOI 10.1016/S0168-1656(01)00338-8; Vanyushin BF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P488, DOI 10.1007/s10541-005-0143-y; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WAALWIJK C, 1978, NUCLEIC ACIDS RES, V5, P4631, DOI 10.1093/nar/5.12.4631; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wang X, 2008, CANCER LETT, V270, P132, DOI 10.1016/j.canlet.2008.04.053; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu ML, 2004, THEOR APPL GENET, V109, P899, DOI 10.1007/s00122-004-1717-6; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Xu Q, 2005, CHINESE SCI BULL, V50, P2039, DOI 10.1360/982005-834; Xu Q, 2007, ANIM BIOTECHNOL, V18, P231, DOI 10.1080/10495390701574838; Yeivin A, 1993, EXS, V64, P523; Zhao SH, 2000, MICROBES INFECT, V2, P107, DOI 10.1016/S1286-4579(00)00278-1	46	113	124	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16229	10.1371/journal.pone.0016229	http://dx.doi.org/10.1371/journal.pone.0016229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283691	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522300021
J	Zhang, F; Zhai, HQ; Paterson, AH; Xu, JL; Gao, YM; Zheng, TQ; Wu, RL; Fu, BY; Ali, J; Li, ZK				Zhang, Fan; Zhai, Hu-Qu; Paterson, Andrew H.; Xu, Jian-Long; Gao, Yong-Ming; Zheng, Tian-Qing; Wu, Rong-Ling; Fu, Bin-Ying; Ali, Jauhar; Li, Zhi-Kang			Dissecting Genetic Networks Underlying Complex Phenotypes: The Theoretical Framework	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; OVERDOMINANT EPISTATIC LOCI; INBRED RICE POPULATION; DROSOPHILA-MELANOGASTER; INBREEDING DEPRESSION; ARTIFICIAL SELECTION; GREEN-REVOLUTION; YIELD COMPONENTS; GIBBERELLIN; EVOLUTION	Great progress has been made in genetic dissection of quantitative trait variation during the past two decades, but many studies still reveal only a small fraction of quantitative trait loci (QTLs), and epistasis remains elusive. We integrate contemporary knowledge of signal transduction pathways with principles of quantitative and population genetics to characterize genetic networks underlying complex traits, using a model founded upon one-way functional dependency of downstream genes on upstream regulators (the principle of hierarchy) and mutual functional dependency among related genes (functional genetic units, FGU). Both simulated and real data suggest that complementary epistasis contributes greatly to quantitative trait variation, and obscures the phenotypic effects of many 'downstream' loci in pathways. The mathematical relationships between the main effects and epistatic effects of genes acting at different levels of signaling pathways were established using the quantitative and population genetic parameters. Both loss of function and "co-adapted'' gene complexes formed by multiple alleles with differentiated functions (effects) are predicted to be frequent types of allelic diversity at loci that contribute to the genetic variation of complex traits in populations. Downstream FGUs appear to be more vulnerable to loss of function than their upstream regulators, but this vulnerability is apparently compensated by different FGUs of similar functions. Other predictions from the model may account for puzzling results regarding responses to selection, genotype by environment interaction, and the genetic basis of heterosis.	[Zhang, Fan; Zhai, Hu-Qu; Xu, Jian-Long; Gao, Yong-Ming; Zheng, Tian-Qing; Fu, Bin-Ying; Li, Zhi-Kang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Paterson, Andrew H.; Ali, Jauhar] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Wu, Rong-Ling] Penn State Univ, Ctr Stat Genet, Hershey, PA USA; [Li, Zhi-Kang] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Manila 1099, Philippines	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; University System of Georgia; University of Georgia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; CGIAR; International Rice Research Institute (IRRI)	Zhang, F (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	lizhk@caas.net.cn	Xu, Jianlong/AAI-8310-2020; Ali, Jauhar Ali or A. Jauhar/E-4432-2012	Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607	China National Natural Science Foundation [U0631002]; Ministry of Agriculture of China [2006-G51]; Ministry of Science and Technology of China [2010AA101806, 2003CB114308]; CGIAR [12]; Rockefeller Foundation [2005 FS029]; Bill & Melinda Gates Foundation [OPP51587]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Ministry of Science and Technology of China(Ministry of Science and Technology, China); CGIAR(CGIAR); Rockefeller Foundation; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was funded by grants from the China National Natural Science Foundation (#U0631002), the "948'' Program of the Ministry of Agriculture of China (#2006-G51), the "863'' program (#2010AA101806) and "973'' Program (#2003CB114308) from the Ministry of Science and Technology of China, the Generation Challenge Program (#12) of CGIAR, the Rockefeller Foundation (#2005 FS029) and the Bill & Melinda Gates Foundation (OPP51587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylor DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000029; BENNETT JH, 1954, ANN EUGENIC, V18, P311; Calvo AP, 2004, J PLANT GROWTH REGUL, V23, P44, DOI 10.1007/s00344-004-0074-7; Carlborg O, 2003, GENOME RES, V13, P413, DOI 10.1101/gr.528003; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cooper M, 2005, AUST J AGR RES, V56, P895, DOI 10.1071/AR05154; Cooper Mark, 2002, Complexity, V7, P31, DOI 10.1002/cplx.10044; Davidson EH, 2003, P NATL ACAD SCI USA, V100, P1475, DOI 10.1073/pnas.0437746100; DEFRIES JC, 1978, BEHAV GENET, V8, P3, DOI 10.1007/BF01067700; DOEBLEY J, 1995, GENETICS, V141, P333; Falconer D. S., 1981, INTRO QUANTITATIVE G; FALCONER DS, 1955, COLD SPRING HARB SYM, V20, P178, DOI 10.1101/SQB.1955.020.01.018; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; Gjuvsland AB, 2007, GENETICS, V175, P411, DOI 10.1534/genetics.106.058859; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; HILL WG, 1992, ANNU REV ECOL SYST, V23, P287, DOI 10.1146/annurev.es.23.110192.001443; HILL WG, 1986, GENET RES, V48, P41, DOI 10.1017/S0016672300024642; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Hua JP, 2002, GENETICS, V162, P1885; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Johannsen W., 1909, ELEMENTE EXAKTEN ERB; Kao CH, 2002, GENETICS, V160, P1243; Kusterer B, 2007, GENETICS, V177, P1839, DOI 10.1534/genetics.107.077628; LARK KG, 1995, P NATL ACAD SCI USA, V92, P4656, DOI 10.1073/pnas.92.10.4656; Li ZK, 2006, P NATL ACAD SCI USA, V103, P7994, DOI 10.1073/pnas.0507492103; Li ZK, 1997, GENETICS, V145, P453; Li ZK, 1997, GENETICS, V145, P1139; Li ZK, 2005, PLANT MOL BIOL, V59, P33, DOI 10.1007/s11103-005-8519-3; Li ZK, 2003, THEOR APPL GENET, V108, P141, DOI 10.1007/s00122-003-1401-2; Li ZK, 2001, GENETICS, V158, P1737; Luo LJ, 2001, GENETICS, V158, P1755; Mackay TFC, 2005, GENETICS, V170, P1723, DOI 10.1534/genetics.104.032581; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Malmberg RL, 2005, GENET RES, V86, P89, DOI 10.1017/S0016672305007780; Malmberg RL, 2005, GENETICS, V171, P2013, DOI 10.1534/genetics.105.046078; Mariani L, 2004, PROG BIOPHYS MOL BIO, V86, P45, DOI 10.1016/j.pbiomolbio.2004.02.007; Mather K, 1982, BIOMETRICAL GENETICS; Mei HW, 2005, THEOR APPL GENET, V110, P649, DOI 10.1007/s00122-004-1890-7; Mei HW, 2003, THEOR APPL GENET, V107, P89, DOI 10.1007/s00122-003-1192-5; Melchinger AE, 1998, GENETICS, V149, P383; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Peccoud J, 2004, GENETICS, V166, P1715, DOI 10.1534/genetics.166.4.1715; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Podlich DW, 1998, BIOINFORMATICS, V14, P632, DOI 10.1093/bioinformatics/14.7.632; Sanjuan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002663; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schon CC, 2004, GENETICS, V167, P485, DOI 10.1534/genetics.167.1.485; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Stanton ML, 2000, EVOLUTION, V54, P93, DOI 10.1111/j.0014-3820.2000.tb00011.x; Steffens B, 2005, PLANT PHYSIOL, V139, P713, DOI 10.1104/pp.105.064469; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Tong JP, 2007, GENET RES, V89, P221, DOI 10.1017/S0016672307009020; Veitia RA, 2003, BIOL REV, V78, P149, DOI 10.1017/S1464793102006036; Vellend M, 2005, AM NAT, V166, P199, DOI 10.1086/431318; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Weir BS., 1996, METHODS DISCRETE POP; WELBERGEN P, 1992, BEHAV GENET, V22, P113, DOI 10.1007/BF01066796; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xiong LM, 2001, PHYSIOL PLANTARUM, V112, P152, DOI 10.1034/j.1399-3054.2001.1120202.x; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Zhuang JY, 1997, THEOR APPL GENET, V95, P799, DOI 10.1007/s001220050628	66	21	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14541	10.1371/journal.pone.0014541	http://dx.doi.org/10.1371/journal.pone.0014541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283795	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200003
J	Adhikary, T; Kaddatz, K; Finkernagel, F; Schonbauer, A; Meissner, W; Scharfe, M; Jarek, M; Blocker, H; Muller-Brusselbach, S; Muller, R				Adhikary, Till; Kaddatz, Kerstin; Finkernagel, Florian; Schoenbauer, Anne; Meissner, Wolfgang; Scharfe, Maren; Jarek, Michael; Bloecker, Helmut; Mueller-Bruesselbach, Sabine; Mueller, Rolf			Genomewide Analyses Define Different Modes of Transcriptional Regulation by Peroxisome Proliferator-Activated Receptor-beta/delta (PPAR beta/delta)	PLOS ONE			English	Article							CANCER-CELL-LINES; SIGNALING PATHWAY; RESPONSE ELEMENT; GAMMA-RXR; COREPRESSOR; LIGANDS; BINDING; BETA; BIOINFORMATICS; DETERMINANTS	Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors with essential functions in lipid, glucose and energy homeostasis, cell differentiation, inflammation and metabolic disorders, and represent important drug targets. PPARs heterodimerize with retinoid X receptors (RXRs) and can form transcriptional activator or repressor complexes at specific DNA elements (PPREs). It is believed that the decision between repression and activation is generally governed by a ligand-mediated switch. We have performed genomewide analyses of agonist-treated and PPAR beta/delta-depleted human myofibroblasts to test this hypothesis and to identify global principles of PPAR beta/delta-mediated gene regulation. Chromatin immunoprecipitation sequencing (ChIP-Seq) of PPAR beta/delta, H3K4me3 and RNA polymerase II enrichment sites combined with transcriptional profiling enabled the definition of 112 bona fide PPAR beta/delta target genes showing either of three distinct types of transcriptional response: (I) ligand-independent repression by PPAR beta/delta; (II) ligand-induced activation and/or derepression by PPAR beta/delta; and (III) ligand-independent activation by PPAR beta/delta. These data identify PPRE-mediated repression as a major mechanism of transcriptional regulation by PPAR beta/delta, but, unexpectedly, also show that only a subset of repressed genes are activated by a ligand-mediated switch. Our results also suggest that the type of transcriptional response by a given target gene is connected to the structure of its associated PPRE(s) and the biological function of its encoded protein. These observations have important implications for understanding the regulatory PPAR network and PPAR beta/delta ligand-based drugs.	[Adhikary, Till; Kaddatz, Kerstin; Finkernagel, Florian; Schoenbauer, Anne; Meissner, Wolfgang; Mueller-Bruesselbach, Sabine; Mueller, Rolf] Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany; [Scharfe, Maren; Jarek, Michael; Bloecker, Helmut] Helmholtz Ctr Infect Res HZI, Braunschweig, Germany	Philipps University Marburg; Helmholtz Association; Helmholtz-Center for Infection Research	Adhikary, T (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany.	rmueller@imt.uni-marburg.de	Müller, Rolf/L-4997-2016; Adhikary, Till/O-5678-2018	Müller, Rolf/0000-0003-3339-4248; Adhikary, Till/0000-0003-1951-5605	Deutsche Forschungsgemeinschaft [Mu601/12-1, SFB-TR17/A3]; Genomics and Bioinformatics Core Units [SFB-TR17]; LOEWE-Schwerpunkt "Tumor and Inflammation"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Genomics and Bioinformatics Core Units; LOEWE-Schwerpunkt "Tumor and Inflammation"	This work was supported by the Deutsche Forschungsgemeinschaft (Mu601/12-1 and SFB-TR17/A3) and by the Genomics and Bioinformatics Core Units of the SFB-TR17 and the LOEWE-Schwerpunkt "Tumor and Inflammation." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali F, 2010, CARDIOVASC RES, V85, P701, DOI 10.1093/cvr/cvp365; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Berghagen H, 2002, J BIOL CHEM, V277, P49517, DOI 10.1074/jbc.M209546200; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Girroir EE, 2008, TOXICOLOGY, V243, P236, DOI 10.1016/j.tox.2007.10.023; Grimaldi PA, 2010, CURR OPIN LIPIDOL, V21, P186, DOI 10.1097/MOL.0b013e32833884a4; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; He PF, 2008, TOXICOLOGY, V254, P112, DOI 10.1016/j.tox.2008.09.023; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kaddatz K, 2010, J BIOL CHEM, V285, P29469, DOI 10.1074/jbc.M110.142018; Kilgore KS, 2008, CURR OPIN INVEST DR, V9, P463; Lakatos HF, 2007, PPAR RES, V2007, DOI 10.1155/2007/71323; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Molnar F, 2005, J BIOL CHEM, V280, P26543, DOI 10.1074/jbc.M502463200; Muller R, 2008, PPAR RES, V2008, DOI 10.1155/2008/534294; Muller-Brusselbach S, 2007, EMBO J, V26, P3686, DOI 10.1038/sj.emboj.7601803; Naruhn S, 2010, MOL PHARMACOL, V77, P171, DOI 10.1124/mol.109.060541; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; OISHI Y, 2008, NAT MED; Peraza MA, 2006, TOXICOL SCI, V90, P269, DOI 10.1093/toxsci/kfj062; Peters JM, 2009, BBA-REV CANCER, V1796, P230, DOI 10.1016/j.bbcan.2009.06.002; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Semple RK, 2005, ENDOCRINOLOGY, V146, P1871, DOI 10.1210/en.2004-1405; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Stockert J, 2011, NUCLEIC ACIDS RES, V39, P119, DOI 10.1093/nar/gkq773; van der Meer D.L., 2010, NUCL ACIDS RES; Webber MM, 1999, CARCINOGENESIS, V20, P1185, DOI 10.1093/carcin/20.7.1185; Yu ST, 2007, BBA-MOL CELL BIOL L, V1771, P936, DOI 10.1016/j.bbalip.2007.01.008; Zandi PP, 2008, ARCH GEN PSYCHIAT, V65, P785, DOI 10.1001/archpsyc.65.7.785; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	64	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16344	10.1371/journal.pone.0016344	http://dx.doi.org/10.1371/journal.pone.0016344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283829	Green Published, Green Submitted, gold			2022-12-25	WOS:000286520600042
J	Rosbottom, A; Gibney, H; Kaiser, P; Hartley, C; Smith, RF; Robinson, R; Kipar, A; Williams, DJL				Rosbottom, Anne; Gibney, Helen; Kaiser, Peter; Hartley, Catherine; Smith, Robert F.; Robinson, Rebecca; Kipar, Anja; Williams, Diana J. L.			Up Regulation of the Maternal Immune Response in the Placenta of Cattle Naturally Infected with Neospora caninum	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INTERFERON-GAMMA; PREGNANT CATTLE; LISTERIA-MONOCYTOGENES; IFN-GAMMA; TROPHOBLAST; ABORTION; PATHOGENESIS; INOCULATION; LYMPHOCYTES	Neospora caninum is an intracellular protozoan parasite which is a major cause of abortion in cattle worldwide. It forms persistent infections which recrudesce during pregnancy leading to foetal infection and in a proportion of cases, abortion. The mechanisms underlying abortion are not understood. In this study, recrudescence of a persistent infection in eight naturally infected cows occurred between 20 and 33 weeks of gestation. Animals were killed at the time of recrudescence and parasites were detected in the placentae and foetuses. An active maternal immune response consisting of an infiltration of CD4+ and CD8+ T cells and a 46-49 fold increase in interferon-gamma and interleukin-4 mRNA was detected. Other cytokines, notably interleukin-12 p40, interleukin-10 and tumour necrosis factor-alpha were also significantly increased and Major Histocompatibility Class II antigen was expressed on maternal and foetal epithelial and stromal fibroblastoid cells. Significantly, despite the presence of an active maternal immune response in the placenta, all the foetuses were alive at the time of maternal euthanasia. There was evidence of parasites within foetal tissues; their distribution was restricted to the central nervous system and skeletal muscle and their presence was associated with tissue necrosis and a non-suppurative inflammatory response involving lymphocytes and macrophages, irrespective of the gestational age of the foetus. Whilst an active maternal immune response to a pathogen in the placenta is generally considered to be damaging to the foetal trophoblast, our findings suggest that the presence of a parasite-induced maternal immune response in the placenta is not detrimental to foetal survival but may contribute to the control of placental parasitosis.	[Rosbottom, Anne; Gibney, Helen; Hartley, Catherine; Robinson, Rebecca; Kipar, Anja; Williams, Diana J. L.] Univ Liverpool, Dept Vet Pathol, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England; [Kaiser, Peter] Inst Anim Hlth, Compton, Berks, England; [Smith, Robert F.] Vet Teaching Hosp, Dept Vet Clin Sci, Neston, England	University of Liverpool; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Liverpool	Rosbottom, A (corresponding author), Univ Liverpool, Dept Vet Pathol, Sch Vet Sci, POB 147, Liverpool L69 3BX, Merseyside, England.	williadj@liv.ac.uk	Kipar, Anja/L-7214-2014	Kipar, Anja/0000-0001-7289-3459; Smith, Robert/0000-0003-0944-310X	Wellcome Trust [GR066695MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grant number GR066695MA from the Wellcome Trust. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. www.wellcome.ac.uk	Abram M, 2002, VIRCHOWS ARCH, V441, P368, DOI 10.1007/s00428-002-0649-2; Andrianarivo AG, 2001, PARASITOL RES, V87, P817, DOI 10.1007/s004360100442; ATHANASSAKIS I, 1995, AM J REPROD IMMUNOL, V34, P281, DOI 10.1111/j.1600-0897.1995.tb00954.x; Athanassakis I, 2000, J INTERF CYTOK RES, V20, P823, DOI 10.1089/10799900050151094; Barber EM, 2005, INFECT IMMUN, V73, P6322, DOI 10.1128/IAI.73.10.6322-6331.2005; Bartley PM, 2004, J COMP PATHOL, V130, P81, DOI 10.1016/j.jcpa.2003.08.003; Collantes-Fernandez E, 2006, THERIOGENOLOGY, V65, P629, DOI 10.1016/j.theriogenology.2005.06.003; Davies CJ, 2007, J ANIM SCI, V85, pE32, DOI 10.2527/jas.2006-492; Dubey JP, 2006, J COMP PATHOL, V134, P267, DOI 10.1016/j.jcpa.2005.11.004; Dubey JP, 1996, VET PARASITOL, V67, P1, DOI 10.1016/S0304-4017(96)01035-7; Entrican G, 2009, VET MICROBIOL, V135, P98, DOI 10.1016/j.vetmic.2008.09.028; Gibney EH, 2008, INT J PARASITOL, V38, P579, DOI 10.1016/j.ijpara.2007.09.015; Guy CS, 2001, VET REC, V149, P443, DOI 10.1136/vr.149.15.443; HEIN WR, 1988, IMMUNOLOGY, V64, P621; INNES EA, 1995, J COMP PATHOL, V113, P95, DOI 10.1016/S0021-9975(05)80075-1; Innes EA, 2002, TRENDS PARASITOL, V18, P497, DOI 10.1016/S1471-4922(02)02372-3; Kim S, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-22; Koga K, 2009, J OBSTET GYNAECOL RE, V35, P191, DOI 10.1111/j.1447-0756.2008.00963.x; Krishnan L, 1996, J IMMUNOL, V156, P653; Krishnan L, 2010, AM J REPROD IMMUNOL, V63, P54, DOI 10.1111/j.1600-0897.2009.00766.x; Lopez-Gatius F, 2007, THERIOGENOLOGY, V68, P1067, DOI 10.1016/j.theriogenology.2007.08.006; Maley SW, 2003, J COMP PATHOL, V129, P186, DOI 10.1016/S0021-9975(03)00032-X; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Mor G, 2008, ANN NY ACAD SCI, V1127, P121, DOI 10.1196/annals.1434.006; Murphy SP, 2009, BIOL REPROD, V80, P848, DOI 10.1095/biolreprod.108.073353; Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4; Rosbottom A, 2007, PARASITE IMMUNOL, V29, P219, DOI 10.1111/j.1365-3024.2007.00936.x; Rosbottom A, 2008, INFECT IMMUN, V76, P2352, DOI 10.1128/IAI.01780-06; Staska LM, 2005, INFECT IMMUN, V73, P1321, DOI 10.1128/IAI.73.3.1321-1329.2005; Staska LM, 2003, INFECT IMMUN, V71, P3272, DOI 10.1128/IAI.71.6.3272-3279.2003; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Tierney TJ, 1997, VET IMMUNOL IMMUNOP, V59, P369, DOI 10.1016/S0165-2427(97)00076-7; Tierney TJ, 1997, VET IMMUNOL IMMUNOP, V57, P229, DOI 10.1016/S0165-2427(97)00011-1; Trees AJ, 2005, TRENDS PARASITOL, V21, P558, DOI 10.1016/j.pt.2005.09.005; Uggla A, 1998, INT J PARASITOL, V28, P1467, DOI 10.1016/S0020-7519(98)00110-6; von Rango U, 2008, IMMUNOL LETT, V115, P21, DOI 10.1016/j.imlet.2007.09.014; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Williams DJL, 2009, PARASITOLOGY, V136, P1895, DOI 10.1017/S0031182009990588; Williams DJL, 1999, VET REC, V145, P571, DOI 10.1136/vr.145.20.571; Williams DJL, 2000, PARASITOLOGY, V121, P347, DOI 10.1017/S0031182099006587	40	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15799	10.1371/journal.pone.0015799	http://dx.doi.org/10.1371/journal.pone.0015799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283810	Green Published, gold, Green Submitted			2022-12-25	WOS:000286520600012
J	Sun, WY; Chang, SS; Fu, YM; Liu, Y; Califano, JA				Sun, Wenyue; Chang, Steven S.; Fu, Yumei; Liu, Yan; Califano, Joseph A.			Chronic CSE Treatment Induces the Growth of Normal Oral Keratinocytes via PDK2 Upregulation, Increased Glycolysis and HIF1 alpha Stabilization	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MITOCHONDRIAL-DNA MUTATIONS; CANCER-CELLS; PYRUVATE-DEHYDROGENASE; CIGARETTE-SMOKING; PROSTATE-CANCER; LUNG-CANCER; NECK-CANCER; HEAD; EXPRESSION	Background: Exposure to cigarette smoke is a major risk factor for head and neck squamous cell carcinoma (HNSCC). We have previously established a chronic cigarette smoke extract (CSE)-treated human oral normal keratinocyte model, demonstrating an elevated frequency of mitochondrial mutations in CSE treated cells. Using this model we further characterized the mechanism by which chronic CSE treatment induces increased cellular proliferation. Methodology/Principal Findings: We demonstrate that chronic CSE treatment upregulates PDK2 expression, decreases PDH activity and thereby increases the glycolytic metabolites pyruvate and lactate. We also found that the chronic CSE treatment enhanced HIF1 alpha accumulation through increased pyruvate and lactate production in a manner selectively reversible by ascorbate. Use of a HIF1 alpha small molecule inhibitor blocked the growth induced by chronic CSE treatment in OKF6 cells. Furthermore, chronic CSE treatment was found to increase ROS (reactive oxygen species) production, and application of the ROS scavengers N-acetylcysteine abrogated the expression of PDK2 and HIF1 alpha. Notably, treatment with dichloroacetate, a PDK2 inhibitor, also decreased the HIF1 alpha expression as well as cell proliferation in chronic CSE treated OKF6 cells. Conclusions/Significance: Our findings suggest that chronic CSE treatment contribute to cell growth via increased ROS production through mitochondrial mutations, upregulation of PDK2, attenuating PDH activity thereby increasing glycolytic metabolites, resulting in HIF1 alpha stabilization. This study suggests a role for chronic tobacco exposure in the development of aerobic glycolysis and normoxic HIF alpha activation as a part of HNSCC initiation. These data may provide insights into development of chemopreventive strategies for smoking related cancers.	[Sun, Wenyue; Chang, Steven S.; Fu, Yumei; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Liu, Yan] Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21205 USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Sun, WY (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu		Sun, Wenyue/0000-0003-1673-0895	Flight Attendant Medical Research Institute; National Cancer Institute [5P50CA096784-05, U01CA084986]; NATIONAL CANCER INSTITUTE [P50CA096784, U01CA084986] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by a Clinical Innovator Award from the Flight Attendant Medical Research Institute, and the National Cancer Institute SPORE (5P50CA096784-05) and EDRN U01CA084986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs G, 2003, AM J PATHOL, V162, P1789, DOI 10.1016/S0002-9440(10)64314-3; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; CARP H, 1978, AM REV RESPIR DIS, V118, P617; CHANG SS, 2009, INT J CANC; Chau NM, 2005, CANCER RES, V65, P4918, DOI 10.1158/0008-5472.CAN-04-4453; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Hockenbery DM, 2002, CANCER CELL, V2, P1, DOI 10.1016/S1535-6108(02)00087-9; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Koukourakis MI, 2005, NEOPLASIA, V7, P1, DOI 10.1593/neo.04373; Lin PY, 2008, J ORAL PATHOL MED, V37, P18, DOI 10.1111/j.1600-0714.2007.0057.x; Liu Y, 2007, LUNG CANCER, V56, P307, DOI 10.1016/j.lungcan.2007.01.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Masayesva BG, 2006, CANCER EPIDEM BIOMAR, V15, P19, DOI 10.1158/1055-9965.EPI-05-0210; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Michaud SE, 2003, FASEB J, V17, P1150, DOI 10.1096/fj.02-0172fje; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Samudio I, 2008, CANCER RES, V68, P5198, DOI 10.1158/0008-5472.CAN-08-0555; Sharifi N, 2008, CLIN CANCER RES, V14, P6073, DOI 10.1158/1078-0432.CCR-08-0591; Sun WY, 2009, CLIN CANCER RES, V15, P476, DOI 10.1158/1078-0432.CCR-08-0930; Tan DJ, 2008, CARCINOGENESIS, V29, P1170, DOI 10.1093/carcin/bgn034; WARBURG O, 1956, SCIENCE, V124, P269; Zhang QZ, 2007, CLIN CANCER RES, V13, P4686, DOI 10.1158/1078-0432.CCR-06-2898; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104	29	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16207	10.1371/journal.pone.0016207	http://dx.doi.org/10.1371/journal.pone.0016207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283817	Green Submitted, Green Published, gold			2022-12-25	WOS:000286520600031
J	Gildea, DE; Luetkemeier, ES; Bao, XZ; Loftus, SK; Mackem, S; Yang, YZ; Pavan, WJ; Biesecker, LG				Gildea, Derek E.; Luetkemeier, Erin S.; Bao, Xiaozhong; Loftus, Stacie K.; Mackem, Susan; Yang, Yingzi; Pavan, William J.; Biesecker, Leslie G.			The pleiotropic mouse phenotype extra-toes spotting is caused by translation initiation factor Eif3c mutations and is associated with disrupted sonic hedgehog signaling	FASEB JOURNAL			English	Article						development; polydactyly; positional cloning; GLI3 processing	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; DEVELOPING NEURAL-TUBE; LIMB DEVELOPMENT; POLARIZING ACTIVITY; FEEDBACK LOOP; IN-VIVO; GLI3; GENE; EXPRESSION; DELETION	Polydactyly is a common malformation and can be an isolated anomaly or part of a pleiotropic syndrome. The elucidation of the mutated genes that cause polydactyly provides insight into limb development pathways. The extra-toes spotting (Xs) mouse phenotype manifests anterior polydactyly, predominantly in the forelimbs, with ventral hypopigmenation. The mapping of Xs(J) to chromosome 7 was confirmed, and the interval was narrowed to 322 kb using intersubspecific crosses. Two mutations were identified in eukaryotic translation initiation factor 3 subunit C (Eif3c). An Eif3c c.907C > T mutation (p.Arg303X) was identified in Xs(J), and a c.1702_1758del mutation (p.Leu568_Leu586del) was identified in extra-toes spotting-like (Xsl), an allele of Xs(J). The effect of the Xs(J) mutation on the SHH/GLI3 pathway was analyzed by in situ hybridization analysis, and we show that Xs mouse embryos have ectopic Shh and Ptch1 expression in the anterior limb. In addition, anterior limb buds show aberrant Gli3 processing, consistent with perturbed SHH/GLI3 signaling. Based on the occurrence of Eif3c mutations in 2 Xs lines and haploinsufficiency of the Xs(J) allele, we conclude that the Xs phenotype is caused by a mutation in Eif3c, a component of the translation initiation complex, and that the phenotype is associated with aberrant SHH/GLI3 signaling.-Gildea, D. E., Luetkemeier, E. S., Bao, X., Loftus, S. K., Mackem, S., Yang, Y., Pavan, W. J., Biesecker, L. G. The pleiotropic mouse phenotype extra-toes spotting is caused by translation initiation factor Eif3c mutations and is associated with disrupted sonic hedgehog signaling. FASEB J. 25, 1596-1605 (2011). www.fasebj.org	[Gildea, Derek E.; Luetkemeier, Erin S.; Loftus, Stacie K.; Yang, Yingzi; Pavan, William J.; Biesecker, Leslie G.] NHGRI, NIH, Bethesda, MD 20892 USA; [Gildea, Derek E.] George Washington Univ, Inst Biomed Sci, Washington, DC USA; [Bao, Xiaozhong; Mackem, Susan] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Biesecker, LG (corresponding author), NHGRI, NIH, Bldg 49,Rm 4A56, Bethesda, MD 20892 USA.	leslieb@helix.nih.gov		Loftus, Stacie/0000-0002-1958-4689; Pavan, William/0000-0001-8281-5120	National Human Genome Research Institute; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011118] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200328, ZIAHG000070] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank Arturo Incao, Marjorie Lindhurst, and Julie Nadel for assistance with animal husbandry. The authors also thank Julia Fekecs for help with generating figures. This research was supported by the Intramural Research Programs of the National Human Genome Research Institute and the National Cancer Institute. Information on Xsl can be found online (http://mousemutant.jax.org/articles/mmrmutantxsl.html).	Aoto K, 2002, DEV BIOL, V251, P320, DOI 10.1006/dbio.2002.0811; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Chen YT, 2004, DEVELOPMENT, V131, P2339, DOI 10.1242/dev.01115; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; JOHNSON DR, 1967, J EMBRYOL EXP MORPH, V17, P543; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; KO V, 1998, GENOMICS APPROACH ST; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus SK, 2002, P NATL ACAD SCI USA, V99, P4471, DOI 10.1073/pnas.072087599; LYON MF, 1989, MOUSE NEWS LETT, V83, P158; Mackem S, 1999, CELL TISSUE RES, V296, P27, DOI 10.1007/s004410051263; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; MASUYA H, 1995, GENE DEV, V9, P1645, DOI 10.1101/gad.9.13.1645; Maynard TM, 2002, MAMM GENOME, V13, P58, DOI 10.1007/s00335-001-2115-X; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; O'Rourke MP, 2002, DEV BIOL, V248, P143, DOI 10.1006/dbio.2002.0730; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; SAMPLES RM, 2006, MGI DIRECT DATA SUBM, P6090; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Southard J., 1977, MOUSE NEWS LETT, V56, P40; Valasek L, 2003, GENE DEV, V17, P786, DOI 10.1101/gad.1065403; Valasek L, 2002, EMBO J, V21, P5886, DOI 10.1093/emboj/cdf563; VORTKAMP A, 1992, MAMM GENOME, V3, P461, DOI 10.1007/BF00356157; WINTER RM, 1988, AM J MED GENET, V31, P793, DOI 10.1002/ajmg.1320310411; Yang Y, 1998, DEVELOPMENT, V125, P3123; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049	37	9	9	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2011	25	5					1596	1605		10.1096/fj.10-169771	http://dx.doi.org/10.1096/fj.10-169771			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21292980	Green Published			2022-12-25	WOS:000290023800017
J	Xu, M; Wang, WF; Frontera, JR; Neely, MC; Lu, JH; Aires, D; Hsu, FF; Turk, J; Swerdlow, RH; Carlson, SE; Zhu, H				Xu, Ming; Wang, WenFang; Frontera, Jennifer R.; Neely, Melanie C.; Lu, Jianghua; Aires, Daniel; Hsu, Fong-Fu; Turk, John; Swerdlow, Russell H.; Carlson, Susan E.; Zhu, Hao			Ncb5or Deficiency Increases Fatty Acid Catabolism and Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE; INDUCED GENE-EXPRESSION; LIPOTOXIC CELL-DEATH; ENDOPLASMIC-RETICULUM; CONGENITAL METHEMOGLOBINEMIA; CYTOCHROME-B5 REDUCTASE; GENERALIZED DEFICIENCY; TRIGLYCERIDE SYNTHESIS; 3T3-L1 PREADIPOCYTES; MENTAL-RETARDATION	The endoplasmic reticulum-associated NADH cytochrome b(5) oxidoreductase (Ncb5or) is widely distributed in animal tissues. Ncb5or(-/-) mice develop diabetes at age 7 weeks and have increased susceptibility to the diabetogenic oxidant streptozotocin. Ncb5or deficiency also results in lipoatrophy and increased hepatocyte sensitivity to cytotoxic effects of saturated fatty acids. Here we investigate the mechanisms of these phenomena in prediabetic Ncb5or(-/-) mice and find that, despite increased rates of fatty acid uptake and synthesis and higher stearoyl-CoA desaturase (SCD) expression, Ncb5or(-/-) liver accumulates less triacylglycerol (TAG) than wild type (WT). Increased fatty acid catabolism and oxidative stress are evident in Ncb5or(-/-) hepatocytes and reflect increased mitochondrial content, peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha) expression, fatty acid oxidation rates, oxidative stress response gene expression, and oxidized glutathione content. Ncb5or(-/-) hepatocytes readily incorporate exogenous fatty acids into TAG but accumulate more free fatty acids (FFA) and have greater palmitate-induced oxidative stress responses and cell death than WT, all of which are alleviated by co-incubation with oleate via TAG channeling. A high fat diet rich in palmitate and oleate stimulates both lipogenesis and fatty acid catabolism in Ncb5or(-/-) liver, resulting in TAG levels similar to WT but increased intracellular FFA accumulation. Hepatic SCD-specific activity is lower in Ncb5or(-/-) than in WT mice, although Ncb5or(-/-) liver has a greater increase in Scd1 mRNA and protein levels. Together, these findings suggest that increased FFA accumulation and catabolism and oxidative stress are major consequences of Ncb5or deficiency in liver.	[Zhu, Hao] Univ Kansas, Med Ctr, Dept Clin Lab Sci, Kansas City, KS 66160 USA; [Xu, Ming; Wang, WenFang; Zhu, Hao] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66160 USA; [Neely, Melanie C.; Carlson, Susan E.] Univ Kansas, Med Ctr, Dept Nutr & Dietet, Kansas City, KS 66160 USA; [Wang, WenFang; Frontera, Jennifer R.; Aires, Daniel] Univ Kansas, Med Ctr, Dept Internal Med, Div Dermatol, Kansas City, KS 66160 USA; [Lu, Jianghua; Swerdlow, Russell H.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USA; [Swerdlow, Russell H.; Zhu, Hao] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Wang, WenFang] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66160 USA; [Hsu, Fong-Fu; Turk, John] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Washington University (WUSTL)	Zhu, H (corresponding author), 3901 Rainbow Blvd,MSN 4048G Eaton, Kansas City, KS 66160 USA.	hzhu@kumc.edu	Xu, Ming/AAR-1681-2021; Xu, Ming/L-4044-2019	Xu, Ming/0000-0002-4477-939X; xu, ming/0000-0002-3920-8947; Hsu, Fong-Fu/0000-0001-5368-0183	National Institutes of Health [RO1-DK067355, R01-HD047315, RO1-AG022407, R37-DK34388, P41-RR00954, P60-DK20579, P30-DK56341]; NICHD, National Institutes of Health [HD02528]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528, R01HD047315] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067355, P30DK056341, P60DK020579, R37DK034388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022407, P30AG035982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK067355 (to H. Franklin Bunn and H. Z.) and in part by R01-HD047315 (to S. E. C.), RO1-AG022407 (to R. H. S.), R37-DK34388, P41-RR00954, P60-DK20579, and P30-DK56341 (to J. T.). Core facilities at the University of Kansas Medical Center were supported by NICHD, National Institutes of Health Grant HD02528.	Andersen G, 2004, DIABETES, V53, P2992, DOI 10.2337/diabetes.53.11.2992; Askari B, 2007, DIABETES, V56, P1143, DOI 10.2337/db06-0267; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Bu SY, 2010, J LIPID RES, V51, P3270, DOI 10.1194/jlr.M009407; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Coggan M, 2002, BIOCHEM J, V366, P323, DOI 10.1042/bj20011878; Deng B, 2010, J BIOL CHEM, V285, P30181, DOI 10.1074/jbc.M110.120329; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Durgan DJ, 2006, AM J PHYSIOL-HEART C, V290, pH2480, DOI 10.1152/ajpheart.01344.2005; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Finn RD, 2008, J BIOL CHEM, V283, P31385, DOI 10.1074/jbc.M803496200; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; Gardner AM, 2010, J BIOL CHEM, V285, P23850, DOI 10.1074/jbc.M110.132340; Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; HIRONO H, 1984, LIPIDS, V19, P60, DOI 10.1007/BF02534610; HIRONO H, 1983, TOHOKU J EXP MED, V140, P391, DOI 10.1620/tjem.140.391; HUANG IY, 1981, J BIOCHEM-TOKYO, V89, P1839, DOI 10.1093/oxfordjournals.jbchem.a133385; JAESCHKE H, 1990, METHOD ENZYMOL, V186, P752; KAESTNER KH, 1989, J BIOL CHEM, V264, P14755; KAGEYAMA H, 1988, CANCER RES, V48, P4795; Kim ND, 2006, TOXICOL SCI, V90, P586, DOI 10.1093/toxsci/kfj111; KIRCHGESSNER TG, 1987, J BIOL CHEM, V262, P8463; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Larade K, 2007, BIOCHEM J, V404, P467, DOI 10.1042/BJ20061859; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Miyazaki M, 2001, J BIOL CHEM, V276, P39455, DOI 10.1074/jbc.M106442200; Miyazaki M, 2001, J LIPID RES, V42, P1018; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; MORRISON WR, 1964, J LIPID RES, V5, P600; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; PAULAUSKIS JD, 1988, J BIOL CHEM, V263, P7049; Pigeon C, 2001, BBA-MOL BASIS DIS, V1535, P275, DOI 10.1016/S0925-4439(01)00024-2; RAO GA, 1980, LIPIDS, V15, P55, DOI 10.1007/BF02534119; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; STRITTMATTER P, 1988, J BIOL CHEM, V263, P2532; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xie JX, 2004, P NATL ACAD SCI USA, V101, P10750, DOI 10.1073/pnas.0404044101; Zhang L, 2010, J PROTEOME RES, V9, P458, DOI 10.1021/pr900818g; Zhang YZ, 2010, J LIPID RES, V51, P53, DOI 10.1194/jlr.M900146-JLR200; Zhu H, 2004, J BIOL CHEM, V279, P30316, DOI 10.1074/jbc.M402664200; Zhu H, 1999, P NATL ACAD SCI USA, V96, P14742, DOI 10.1073/pnas.96.26.14742	65	26	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11141	11154		10.1074/jbc.M110.196543	http://dx.doi.org/10.1074/jbc.M110.196543			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21300801	Green Published, hybrid			2022-12-25	WOS:000288797100025
J	Pekar, S; Martisova, M; Bilde, T				Pekar, Stano; Martisova, Martina; Bilde, Trine			Intersexual Trophic Niche Partitioning in an Ant-Eating Spider (Araneae: Zodariidae)	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; NATURAL-POPULATIONS; ECOLOGICAL CAUSES; MORTALITY COSTS; SELECTION; FECUNDITY; EVOLUTION; DIET; CONSEQUENCES; MORPHOLOGY	Background: Divergence in trophic niche between the sexes may function to reduce competition between the sexes ("intersexual niche partitioning hypothesis"), or may be result from differential selection among the sexes on maximizing reproductive output ("sexual selection hypothesis"). The latter may lead to higher energy demands in females driven by fecundity selection, while males invest in mate searching. We tested predictions of the two hypotheses underlying intersexual trophic niche partitioning in a natural population of spiders. Zodarion jozefienae spiders specialize on Messor barbarus ants that are polymorphic in body size and hence comprise potential trophic niches for the spider, making this system well-suited to study intersexual trophic niche partitioning. \ Methodology/Principal Findings: Comparative analysis of trophic morphology (the chelicerae) and body size of males, females and juveniles demonstrated highly female biased SSD (Sexual Size Dimorphism) in body size, body weight, and in the size of chelicerae, the latter arising from sex-specific growth patterns in trophic morphology. In the field, female spiders actively selected ant sub-castes that were larger than the average prey size, and larger than ants captured by juveniles and males. Female fecundity was highly positively correlated with female body mass, which reflects foraging success during the adult stage. Females in laboratory experiments preferred the large ant sub-castes and displayed higher capture efficiency. In contrast, males occupied a different trophic niche and showed reduced foraging effort and reduced prey capture and feeding efficiency compared with females and juveniles. Conclusions/Significance: Our data indicate that female-biased dimorphism in trophic morphology and body size correlate with sex-specific reproductive strategies. We propose that intersexual trophic niche partitioning is shaped primarily by fecundity selection in females, and results from sex-differences in the route to successful reproduction where females are selected to maximize energy intake and fecundity, while males switch from foraging to invest in mating effort.	[Pekar, Stano; Martisova, Martina] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Bilde, Trine] Aarhus Univ, Dept Biol Sci, Aarhus, Denmark	Masaryk University Brno; Aarhus University	Pekar, S (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic.	pekar@sci.muni.cz	Pekar, Stano/F-4148-2010; Bilde, Trine/J-2872-2013; Bilde, Trine/AAS-2098-2020	Pekar, Stano/0000-0002-0197-5040; Bilde, Trine/0000-0002-0341-161X; Bilde, Trine/0000-0002-0341-161X	Ministry of Education, Youth and Sports of the Czech Republic [0021622416]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Grant no. 0021622416 (Ministry of Education, Youth and Sports of the Czech Republic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; BOSMANS R, 1994, EOS, V69, P115; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; CASTILLA AM, 1991, J HERPETOL, V25, P30, DOI 10.2307/1564791; Clutton-Brock TH, 2007, P ROY SOC B-BIOL SCI, V274, P3097, DOI 10.1098/rspb.2007.1138; Cox RM, 2003, EVOLUTION, V57, P1653, DOI 10.1554/02-227; Crawley M. J, 2002, STAT COMPUTING INTRO; Delph LF, 2005, AM NAT, V166, pS1, DOI 10.1086/462434; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Haeger JF, 1999, INSECT SOC, V46, P1; HEAD G, 1995, EVOLUTION, V49, P776, DOI 10.1111/j.1558-5646.1995.tb02313.x; Holldobler B., 1990, pi; Houston AI, 2007, BEHAV ECOL, V18, P241, DOI 10.1093/beheco/arl080; HOUSTON D, 1993, J ANIM ECOL, V62, P737, DOI 10.2307/5393; Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560; Lindeman PV, 2003, CAN J ZOOL, V81, P1185, DOI 10.1139/Z03-101; Lindsay WR, 2009, ANIM BEHAV, V77, P1525, DOI 10.1016/j.anbehav.2009.02.027; Luiselli L, 1996, OECOLOGIA, V106, P100, DOI 10.1007/BF00334412; Martisova M, 2009, ANIM BEHAV, V78, P1115, DOI 10.1016/j.anbehav.2009.07.025; Pekar S, 2005, J ARACHNOL, V33, P50, DOI 10.1636/S03-2; Pekar S, 2004, J INSECT BEHAV, V17, P555, DOI 10.1023/B:JOIR.0000042541.23748.d7; Pinheiro J, 2001, MIXED EFFECTS MODELS; POLLARD SD, 1995, ANIM BEHAV, V49, P1443, DOI 10.1016/0003-3472(95)90065-9; POLLARD SD, 1994, J ZOOL, V234, P203, DOI 10.1111/j.1469-7998.1994.tb06068.x; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V250, P143, DOI 10.1098/rspb.1992.0142; R Development Core Team, 2007, R LANG ENV STAT COMP; Santos X, 2000, ECOGRAPHY, V23, P185, DOI 10.1034/j.1600-0587.2000.230204.x; Schneider JM, 1998, OIKOS, V83, P496, DOI 10.2307/3546677; Selander R.K., 1972, SEXUAL SELECTION DES, P180, DOI DOI 10.4324/9781315129266-8; Serrano-Meneses MA, 2006, OIKOS, V113, P385, DOI 10.1111/j.0030-1299.2006.14246.x; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Shine Richard, 1993, P49; SIMPSON MR, 1995, ECOLOGY, V76, P795, DOI 10.2307/1939345; SLATKIN M, 1984, EVOLUTION, V38, P622, DOI 10.1111/j.1558-5646.1984.tb00327.x; SUTER RB, 1990, J ARACHNOL, V18, P263; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Verwaijen D, 2002, FUNCT ECOL, V16, P842, DOI 10.1046/j.1365-2435.2002.00696.x; Walker SE, 2002, CAN J ZOOL, V80, P679, DOI 10.1139/Z02-037; Walker SE, 2001, AM MIDL NAT, V146, P161, DOI 10.1674/0003-0031(2001)146[0161:SDIFRA]2.0.CO;2	41	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14603	10.1371/journal.pone.0014603	http://dx.doi.org/10.1371/journal.pone.0014603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298048	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900007
J	Rubinoff, D; Holland, BS; Jose, MS; Powell, JA				Rubinoff, Daniel; Holland, Brenden S.; Jose, Michael San; Powell, Jerry A.			Geographic Proximity Not a Prerequisite for Invasion: Hawaii Not the Source of California Invasion by Light Brown Apple Moth (Epiphyas postvittana)	PLOS ONE			English	Article							DNA POLYMORPHISM; POPULATION; EVOLUTION; SEQUENCES; SOFTWARE; PATTERNS; PRIMERS; BIOLOGY	Background: The light brown apple moth (LBAM), Epiphyas postvittana (Walker), is native to Australia but invaded England, New Zealand, and Hawaii more than 100 years ago. In temperate climates, LBAM can be a major agricultural pest. In 2006 LBAM was discovered in California, instigating eradication efforts and quarantine against Hawaiian agriculture, the assumption being that Hawaii was the source of the California infestation. Genetic relationships among populations in Hawaii, California, and New Zealand are crucial to understanding LBAM invasion dynamics across the Pacific. Methodology/Principal Findings: We sequenced mitochondrial DNA (mtDNA) from 1293 LBAM individuals from California (695), Hawaii (448), New Zealand (147), and Australia (3) to examine haplotype diversity and structure among introduced populations, and evaluate the null hypothesis that invasive populations are from a single panmictic source. However, invasive populations in California and New Zealand harbor deep genetic diversity, whereas Hawaii shows low level, shallow diversity. Conclusions/Significance: LBAM recently has established itself in California, but was in Hawaii and New Zealand for hundreds of generations, yet California and New Zealand show similar levels of genetic diversity relative to Hawaii. Thus, there is no clear relationship between duration of invasion and genetic structure. Demographic statistics suggest rapid expansion occurring in California and past expansions in New Zealand; multiple introductions of diverse, genetically fragmented lineages could contribute to these patterns. Hawaii and California share no haplotypes, therefore, Hawaii is not the source of the California introduction. Paradoxically, Hawaii and California share multiple haplotypes with New Zealand. New Zealand may be the source for the California and Hawaii infestations, but the introductions were independent, and Hawaii was invaded only once. This has significant implications for quarantine, and suggests that probability of invasion is not directly related to geographic distance. Surprisingly, Hawaiian LBAM populations have much lower genetic diversity than California, despite being older.	[Rubinoff, Daniel; Holland, Brenden S.] Univ Hawaii, Pacific Biosci Res Ctr, Ctr Conservat Res & Training, Honolulu, HI 96822 USA; [Powell, Jerry A.] Univ Calif Berkeley, Essig Museum Entomol, Berkeley, CA 94720 USA	University of Hawaii System; University of California System; University of California Berkeley	Rubinoff, D (corresponding author), Univ Hawaii, Pacific Biosci Res Ctr, Ctr Conservat Res & Training, Honolulu, HI 96822 USA.	rubinoff@hawaii.edu	San Jose, Michael/N-8376-2019; Holland, Brenden/H-9872-2013; holland, brenden/J-5630-2019	San Jose, Michael/0000-0001-9877-2794; holland, brenden/0000-0002-7832-8589	United States Department of Agriculture-National Institute of Food and Agriculture [58-5320-9-430]; USDA Cooperative State Research, Education, and Extension Service [HAW00942-H, HAW00956-H]; United States Army Oahu Natural Resources Program	United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United States Army Oahu Natural Resources Program	Research funding was provided by United States Department of Agriculture-National Institute of Food and Agriculture Agreement No. 58-5320-9-430 and USDA Cooperative State Research, Education, and Extension Service project HAW00942-H and HAW00956-H, both administered by the College of Tropical Agriculture and Human Resources, University of Hawaii at Manoa. BSH was supported by a grant from the United States Army Oahu Natural Resources Program during preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley JD, 1956, B ENTOMOL RES, V47, P104; BRIGHT C, 1998, LIFE OUT BOUNDS; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Brown John W., 2010, American Entomologist, V56, P34; Carey JR, 1996, ECOLOGY, V77, P1690, DOI 10.2307/2265775; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DUMBLETON L. J., 1932, NEW ZEALAND JOUR SCI AND TECHNOL, V14, P83; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FU YX, 1993, GENETICS, V133, P693; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Howarth, 1982, CAMBR P 3 C EUR LEP, P74; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Nei M, 1982, Prog Clin Biol Res, V103 Pt A, P167; Nei M, 1987, MOL EVOLUTIONARY GEN, P254, DOI [10.7312/nei-92038, DOI 10.7312/NEI-92038]; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rubinoff D, 2010, PAC SCI, V64, P23, DOI 10.2984/64.1.023; Simberloff D, 2004, BIOL INVASIONS, V6, P161, DOI 10.1023/B:BINV.0000022133.49752.46; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SLATKIN M, 1991, GENETICS, V129, P555; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; TAJIMA F, 1989, GENETICS, V123, P585; Zimmerman EC., 1978, INSECTS HAWAII 1, V9	26	8	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16361	10.1371/journal.pone.0016361	http://dx.doi.org/10.1371/journal.pone.0016361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298019	Green Published, gold, Green Submitted			2022-12-25	WOS:000286663900040
J	Coler, RN; Bertholet, S; Moutaftsi, M; Guderian, JA; Windish, HP; Baldwin, SL; Laughlin, EM; Duthie, MS; Fox, CB; Carter, D; Friede, M; Vedvick, TS; Reed, SG				Coler, Rhea N.; Bertholet, Sylvie; Moutaftsi, Magdalini; Guderian, Jeff A.; Windish, Hillarie Plessner; Baldwin, Susan L.; Laughlin, Elsa M.; Duthie, Malcolm S.; Fox, Christopher B.; Carter, Darrick; Friede, Martin; Vedvick, Thomas S.; Reed, Steven G.			Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant	PLOS ONE			English	Article							INNATE IMMUNITY; LIPOPOLYSACCHARIDE RECOGNITION; BACTERIAL LIPOPOLYSACCHARIDES; MYCOBACTERIUM-TUBERCULOSIS; CUTANEOUS LEISHMANIASIS; TLR4-MD-2 COMPLEX; DENDRITIC CELLS; HUMAN MD-2; IMMUNOGENICITY; TLR4	Innate immune responses to vaccine adjuvants based on lipopolysaccharide (LPS), a component of Gram-negative bacterial cell walls, are driven by Toll-like receptor (TLR) 4 and adaptor proteins including MyD88 and TRIF, leading to the production of inflammatory cytokines, type I interferons, and chemokines. We report here on the characterization of a synthetic hexaacylated lipid A derivative, denoted as glucopyranosyl lipid adjuvant (GLA). We assessed the effects of GLA on murine and human dendritic cells (DC) by combining microarray, mRNA and protein multiplex assays and flow cytometry analyses. We demonstrate that GLA has multifunctional immunomodulatory activity similar to naturally-derived monophosphory lipid A (MPL) on murine DC, including the production of inflammatory cytokines, chemokines, DC maturation and antigen-presenting functions. In contrast, hexaacylated GLA was overall more potent on a molar basis than heterogeneous MPL when tested on human DC and peripheral blood mononuclear cells (PBMC). When administered in vivo, GLA enhanced the immunogenicity of co-administered recombinant antigens, producing strong cell-mediated immunity and a qualitative T(H)1 response. We conclude that the GLA adjuvant stimulates and directs innate and adaptive immune responses by inducing DC maturation and the concomitant release of pro-inflammatory cytokines and chemokines associated with immune cell trafficking, activities which have important implications for the development of future vaccine adjuvants.	[Coler, Rhea N.; Bertholet, Sylvie; Moutaftsi, Magdalini; Guderian, Jeff A.; Windish, Hillarie Plessner; Baldwin, Susan L.; Laughlin, Elsa M.; Duthie, Malcolm S.; Fox, Christopher B.; Carter, Darrick; Vedvick, Thomas S.; Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA; [Friede, Martin] World Hlth Org, Initiat Vaccine Res, Geneva, Switzerland; [Reed, Steven G.] Immune Design Corp, Seattle, WA USA	World Health Organization	Coler, RN (corresponding author), Infect Dis Res Inst, Seattle, WA USA.	sreed@idri.org	Rivet, Catherine A/M-7978-2014; Carter, Darrick/N-3304-2016	Carter, Darrick/0000-0001-5901-3402; Duthie, Malcolm/0000-0002-8515-5516; Fox, Christopher/0000-0002-4644-2619	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [AI-044373, AI-067251, AI-25479, HHSN272200800045C, U01-AI078054]; Bill and Melinda Gates Foundation [42387]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078054, R01AI044373, UC1AI067251] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) grants AI-044373 and AI-067251 to S.G.R., and contracts AI-25479 and #HHSN272200800045C, and grant U01-AI078054 to R.N.C. and by grant 42387 from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by funds and personnel from Immune Design Corporation. Immune Design Corporation had a role in the study design and collection, and review of the manuscript.	Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Baldridge JR, 1999, METHODS, V19, P103, DOI 10.1006/meth.1999.0834; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Baldwin SL, 2009, VACCINE, V27, P3063, DOI 10.1016/j.vaccine.2009.03.018; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Bertholet S, 2009, VACCINE, V27, P7036, DOI 10.1016/j.vaccine.2009.09.066; Brandenburg K, 2004, CURR TOP MED CHEM, V4, P1127, DOI 10.2174/1568026043388213; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Darveau RP, 1998, CURR OPIN MICROBIOL, V1, P36, DOI 10.1016/S1369-5274(98)80140-9; Edelman R, 2002, MOL BIOTECHNOL, V21, P129, DOI 10.1385/MB:21:2:129; Evans Jay T, 2003, Expert Rev Vaccines, V2, P219, DOI 10.1586/14760584.2.2.219; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Fox CB, 2008, COLLOID SURFACE B, V65, P98, DOI 10.1016/j.colsurfb.2008.03.003; Fox CB, 2010, SUBCELL BIOCHEM, V53, P303, DOI 10.1007/978-90-481-9078-2_14; GUPTA RK, 1993, VACCINE, V11, P293, DOI 10.1016/0264-410X(93)90190-9; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Nascimento E, 2010, VACCINE, V28, P6581, DOI 10.1016/j.vaccine.2010.07.063; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Qureshi N, 1997, J BIOL CHEM, V272, P10594; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Raman VS, 2009, INFECT IMMUN, V77, P5623, DOI 10.1128/IAI.00508-09; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Steinman RM, 2002, J CLIN INVEST, V109, P1519, DOI 10.1172/JCI200215962; Von Eschen K, 2009, HUM VACCINES, V5, P475, DOI 10.4161/hv.8570; Wack A, 2005, CURR OPIN IMMUNOL, V17, P411, DOI 10.1016/j.coi.2005.05.005; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245	43	231	281	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16333	10.1371/journal.pone.0016333	http://dx.doi.org/10.1371/journal.pone.0016333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298114	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800027
J	Purwar, R; Campbell, J; Murphy, G; Richards, WG; Clark, RA; Kupper, TS				Purwar, Rahul; Campbell, James; Murphy, George; Richards, William G.; Clark, Rachael A.; Kupper, Thomas S.			Resident Memory T Cells (T-RM) Are Abundant in Human Lung: Diversity, Function, and Antigen Specificity	PLOS ONE			English	Article							HUMAN SKIN; CHEMOKINE RECEPTORS; PERIPHERAL-TISSUES; IMMUNE; EXPRESSION; MIGRATION; RESPONSES; RECALL	Recent studies have shown that tissue resident memory T cells (T-RM) are critical to antiviral host defense in peripheral tissues. This new appreciation of T-RM that reside in epithelial tissues and mediate host defense has been studied most extensively in skin: adult human skin contains large numbers of functional T-RM that express skin specific markers. Indeed, more than twice as many T cells reside in skin as in peripheral blood. This T cell population has a diverse T cell receptor repertoire, and can produce a broad array of cytokines. More recently, we have begun to examine other epithelial tissues for the presence of resident T cells. In the present study, we asked whether analogous populations of resident T cells could be found in human lung. We were able to demonstrate abundant resident T cells in human lung-more than 10 billion T cells were present. Lung T cells were largely of the effector memory T cell (T-EM) phenotype, though small numbers of central memory T cells (T-CM) and T regulatory cells (T-reg) could be identified. Lung T cells had a diverse T cell receptor repertoire and subsets produced IL-17, IL-4, IFN gamma, as well as TNF alpha. A significant number of lung T-RM CD4+ Th cells produced more than one cytokine, identifying them as "multifunctional'' Th1 type cells. Finally, lung T-RM, but not T-RM resident to skin or T cells from blood, proliferated in response to influenza virus. This work suggests that normal human lung contains large numbers of T-RM cells, and these cells are poised to respond to recall antigens previously encountered through lung mucosa. This population of T cells may contribute to the pathogenesis of asthma and other T cell mediated lung diseases.	[Purwar, Rahul; Campbell, James; Clark, Rachael A.; Kupper, Thomas S.] Brigham & Womens Hosp, Dept Dermatol, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Murphy, George] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Richards, William G.] Brigham & Womens Hosp, Tissue Bank, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Purwar, R (corresponding author), Brigham & Womens Hosp, Dept Dermatol, Harvard Skin Dis Res Ctr, 75 Francis St, Boston, MA 02115 USA.	tkupper@partners.org	Kupper, Thomas/O-4962-2019		National Institutes of Health (NIH) [RO1 AI-41707-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056720, R01AR065807] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	National Institutes of Health (NIH, www.nih.gov) and the grant number is RO1 AI-41707-10 to Thomas S. Kupper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Campbell JJ, 2001, J IMMUNOL, V166, P2842, DOI 10.4049/jimmunol.166.4.2842; Clark JG, 2004, AM J RESP CELL MOL, V30, P220, DOI 10.1165/rcmb.2003-0208OC; Clark RA, 2005, J CLIN INVEST, V115, P3239, DOI 10.1172/JCI24731; Clark RA, 2007, BLOOD, V109, P194, DOI 10.1182/blood-2006-02-002873; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; HOLT PG, 1988, IMMUNOLOGY, V64, P649; HOLT PG, 1986, CLIN EXP IMMUNOL, V66, P188; Kunkel EJ, 2002, AM J PATHOL, V160, P347, DOI 10.1016/S0002-9440(10)64378-7; Liu L., NAT MED, V16, P224; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; PICKER LJ, 1994, EUR J IMMUNOL, V24, P1269, DOI 10.1002/eji.1830240605; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Sauer KA, 2006, NAT PROTOC, V1, P2870, DOI 10.1038/nprot.2006.435; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496	24	226	230	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16245	10.1371/journal.pone.0016245	http://dx.doi.org/10.1371/journal.pone.0016245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298112	Green Submitted, Green Published, gold			2022-12-25	WOS:000286662800019
J	Schmucker, S; Martelli, A; Colin, F; Page, A; Wattenhofer-Donze, M; Reutenauer, L; Puccio, H				Schmucker, Stephane; Martelli, Alain; Colin, Florent; Page, Adeline; Wattenhofer-Donze, Marie; Reutenauer, Laurence; Puccio, Helene			Mammalian Frataxin: An Essential Function for Cellular Viability through an Interaction with a Preformed ISCU/NFS1/ISD11 Iron-Sulfur Assembly Complex	PLOS ONE			English	Article							YEAST FRATAXIN; FRIEDREICHS-ATAXIA; CLUSTER BIOSYNTHESIS; 2FE-2S CLUSTERS; BINDING; BIOGENESIS; SCAFFOLD; PROTEIN; ISD11; CYAY	Background: Frataxin, the mitochondrial protein deficient in Friedreich ataxia, a rare autosomal recessive neurodegenerative disorder, is thought to be involved in multiple iron-dependent mitochondrial pathways. In particular, frataxin plays an important role in the formation of iron-sulfur (Fe-S) clusters biogenesis. Methodology/Principal Findings: We present data providing new insights into the interactions of mammalian frataxin with the Fe-S assembly complex by combining in vitro and in vivo approaches. Through immunoprecipitation experiments, we show that the main endogenous interactors of a recombinant mature human frataxin are ISCU, NFS1 and ISD11, the components of the core Fe-S assembly complex. Furthemore, using a heterologous expression system, we demonstrate that mammalian frataxin interacts with the preformed core complex, rather than with the individual components. The quaternary complex can be isolated in a stable form and has a molecular mass of approximate to 190 kDa. Finally, we demonstrate that the mature human FXN81-210 form of frataxin is the essential functional form in vivo. Conclusions/Significance: Our results suggest that the interaction of frataxin with the core ISCU/NFS1/ISD11 complex most likely defines the essential function of frataxin. Our results provide new elements important for further understanding the early steps of de novo Fe-S cluster biosynthesis.	[Schmucker, Stephane; Martelli, Alain; Colin, Florent; Page, Adeline; Wattenhofer-Donze, Marie; Reutenauer, Laurence; Puccio, Helene] IGBMC, Dept Translat Med & Neurogenet, Illkirch Graffenstaden, France; [Schmucker, Stephane; Martelli, Alain; Colin, Florent; Page, Adeline; Wattenhofer-Donze, Marie; Reutenauer, Laurence; Puccio, Helene] INSERM, U596, Illkirch Graffenstaden, France; [Schmucker, Stephane; Martelli, Alain; Colin, Florent; Page, Adeline; Wattenhofer-Donze, Marie; Reutenauer, Laurence; Puccio, Helene] CNRS, UMR7104, Illkirch Graffenstaden, France; [Schmucker, Stephane; Martelli, Alain; Colin, Florent; Page, Adeline; Wattenhofer-Donze, Marie; Reutenauer, Laurence; Puccio, Helene] Univ Strasbourg, Strasbourg, France; [Schmucker, Stephane; Martelli, Alain; Colin, Florent; Wattenhofer-Donze, Marie; Reutenauer, Laurence; Puccio, Helene] Coll France, Chaire Genet Humaine, Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France	Schmucker, S (corresponding author), IGBMC, Dept Translat Med & Neurogenet, Illkirch Graffenstaden, France.	hpuccio@igbmc.fr	Puccio, Hélène/G-1717-2013	Puccio, Hélène/0000-0003-4711-2248; Martelli, Alain/0000-0001-5246-565X; COLIN, Florent/0000-0002-0527-2879	French National Agency for Research [ANR-05-MRAR-013-01]; EC under the European Research Council (ERC) [206634/ISCATAXIA, 242193/EFACTS]; French Ministry for Research; American Friedreich Ataxia Research Alliance; Association Francaise pour l'Ataxie de Friedreich	French National Agency for Research(French National Research Agency (ANR)); EC under the European Research Council (ERC)(European Research Council (ERC)); French Ministry for Research(Ministry of Research, France); American Friedreich Ataxia Research Alliance; Association Francaise pour l'Ataxie de Friedreich	This work was supported by the French National Agency for Research (ANR-05-MRAR-013-01) and the EC under the European Research Council (ERC) grant 206634/ISCATAXIA and under the FP7 grant 242193/EFACTS to H.P. S.S. was supported by the French Ministry for Research (MRT award), A. M. by the American Friedreich Ataxia Research Alliance, and M.W.D. by the Association Francaise pour l'Ataxie de Friedreich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Calmels N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006379; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Correia AR, 2006, BIOCHEM J, V398, P605, DOI 10.1042/BJ20060345; Duby G, 2002, HUM MOL GENET, V11, P2635, DOI 10.1093/hmg/11.21.2635; Gellera C, 2007, NEUROGENETICS, V8, P289, DOI 10.1007/s10048-007-0101-5; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Leidgens S, 2010, HUM MOL GENET, V19, P276, DOI 10.1093/hmg/ddp495; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; Pandolfo M, 2009, J NEUROL, V256, P1, DOI 10.1007/s00415-009-1001-4; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Prischi F, 2009, FEBS J, V276, P6669, DOI 10.1111/j.1742-4658.2009.07381.x; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Puccio H, 2009, J NEUROL, V256, P18, DOI 10.1007/s00415-009-1004-1; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	39	182	187	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16199	10.1371/journal.pone.0016199	http://dx.doi.org/10.1371/journal.pone.0016199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298097	Green Submitted, gold, Green Published			2022-12-25	WOS:000286662800018
J	Dama, MS; Singh, NMP; Rajender, S				Dama, Madhukar Shivajirao; Singh, Negi Mahendra Pal; Rajender, Singh			High Fat Diet Prevents Over-Crowding Induced Decrease of Sex Ratio in Mice	PLOS ONE			English	Article							HAMSTER MESOCRICETUS-AURATUS; GOLDEN-HAMSTER; MATERNAL DIET; POPULATION-DENSITY; LITTER DEFICITS; RED DEER; STRESS; CORTICOSTERONE; PROGESTERONE; ENVIRONMENT	Adaptive theory predicts that mothers would be advantaged by adjusting the sex ratio of their offspring in relation to their offspring's future reproductive success. In the present study, we tested the effect of housing mice under crowded condition on the sex ratio and whether the fat content of the diet has any influence on the outcome of pregnancies. Three-week-old mice were placed on the control diet (NFD) for 3 weeks. Thereafter the mice were allotted randomly to two groups of 7 cages each with 4, 6, 8, 10, 12, 14, and 16 mice in every cage to create increasing crowding gradient and fed either NFD or high fat diet (HFD). After 4 weeks, dams were bred and outcomes of pregnancy were analyzed. The average dam body weight (DBW) at conception, litter size (LS) and SR were significantly higher in HFD fed dams. Further, male biased litters declined with increasing crowding in NFD group but not in HFD. The LS and SR in NFD declined significantly with increasing crowding, whereas only LS was reduced in HFD group. We conclude that female mice housed under overcrowding conditions shift offspring SR in favor of daughters in consistent with the TW hypothesis and high fat diet reduces this influence of overcrowding.	[Dama, Madhukar Shivajirao; Rajender, Singh] CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Singh, Negi Mahendra Pal] CSIR, Cent Drug Res Inst, Biometry & Stat Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Dama, MS (corresponding author), CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India.	rajender_singh@cdri.res.in	Singh, Rajender/ABE-3512-2020; Dama, Madhukar/H-9945-2012	Rajender, Singh/0000-0002-4592-6566; Dama, Madhukar/0000-0002-8361-1530	Council of Scientific and Industrial Research, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	MSD is grateful to Dr. Pramod Kulkarni for fruitful discussions on the sex ratio adjustments over the years. MSD would like to thank Council of Scientific and Industrial Research, India for research fellowship. We are thankful to Dr. Naibedya Chattopadhay and Dr. Nagarajan Perumal for helpful suggestions on designing and conducting the experiments. We are grateful to Dr. Srinidhi KP and his team at Tetragon Chemie PVT, LTD. Bangalore, for generously formulating experimental diet for the present study. We thank an anonymous reviewer, Dr. Fumihito Shibata, Dr. Takeo Kawamachi and the academic editor Dr. Amit Singh for their constructive comments. The CDRI communication number of this article is 7766.	Aioi A, 2001, J DERMATOL SCI, V25, P189, DOI 10.1016/S0923-1811(00)00133-X; Alexenko AP, 2007, BIOL REPROD, V77, P599, DOI 10.1095/biolreprod.107.062174; Ashworth CJ, 2009, PHILOS T R SOC B, V364, P3351, DOI 10.1098/rstb.2009.0184; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; Correa SM, 2005, BIOL LETTERS, V1, P215, DOI 10.1098/rsbl.2004.0283; Denda M, 1998, BRIT J DERMATOL, V138, P780; Flint APF, 1997, GEN COMP ENDOCR, V106, P374, DOI 10.1006/gcen.1997.6879; Fountain ED, 2008, BIOL REPROD, V78, P211, DOI 10.1095/biolreprod.107.065003; GEIRINGER E, 1961, P SOC EXP BIOL MED, V106, P752, DOI 10.3181/00379727-106-26464; GOERLICH VC, PHYSL BIOCH ZOOL, V83, P490; GRANT VJ, 1994, BRIT J MED PSYCHOL, V67, P343, DOI 10.1111/j.2044-8341.1994.tb01802.x; Hotchkiss AK, 2005, CONTEMP TOP LAB ANIM, V44, P46; Ideta A, 2009, J REPROD DEVELOP, V55, P529, DOI 10.1262/jrd.20209; Kimura K, 2005, MOL REPROD DEV, V72, P201, DOI 10.1002/mrd.20342; Komdeur J, 2002, P ROY SOC B-BIOL SCI, V269, P1067, DOI 10.1098/rspb.2002.1965; Krackow S, 1997, J REPROD FERTIL, V110, P87, DOI 10.1530/jrf.0.1100087; Kruuk LEB, 1999, P ROY SOC B-BIOL SCI, V266, P1655, DOI 10.1098/rspb.1999.0828; LANE EA, 1973, J ABNORM PSYCHOL, V82, P78, DOI 10.1037/h0034851; Larson MA, 2001, P NATL ACAD SCI USA, V98, P9677, DOI 10.1073/pnas.171305398; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; MORIYA K, 1978, INT J BIOMETEOROL, V22, P312, DOI 10.1007/BF01552813; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; PENG X, 1989, LAB ANIM, V23, P302, DOI 10.1258/002367789780746042; Pike TW, 2005, BIOL LETTERS, V1, P204, DOI 10.1098/rsbl.2005.0295; Pike TW, 2006, P ROY SOC B-BIOL SCI, V273, P1093, DOI 10.1098/rspb.2005.3422; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; PRATT NC, 1991, J REPROD FERTIL, V92, P139, DOI 10.1530/jrf.0.0920139; PRATT NC, 1990, BEHAV NEURAL BIOL, V54, P1, DOI 10.1016/0163-1047(90)91201-L; PRATT NC, 1989, J REPROD FERTIL, V87, P763, DOI 10.1530/jrf.0.0870763; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Veiga JP, 2004, HORM BEHAV, V46, P47, DOI 10.1016/j.yhbeh.2004.01.007; von Engelhardt N, 2004, HORM BEHAV, V45, P306, DOI 10.1016/j.yhbeh.2003.12.009; Wang HB, 2005, P NATL ACAD SCI USA, V102, P9960, DOI 10.1073/pnas.0501632102; Whyte JJ, 2007, J ENDOCRINOL, V192, P75, DOI 10.1677/JOE-06-0095; Widdig A, 2004, P ROY SOC B-BIOL SCI, V271, P819, DOI 10.1098/rspb.2003.2666	39	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16296	10.1371/journal.pone.0016296	http://dx.doi.org/10.1371/journal.pone.0016296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283594	Green Published, Green Submitted, gold			2022-12-25	WOS:000286661400041
J	Fan, XJ; Ren, PG; Dhal, S; Bejerano, G; Goodman, SB; Druzin, ML; Gambhir, SS; Nayak, NR				Fan, Xiujun; Ren, Peigen; Dhal, Sabita; Bejerano, Gill; Goodman, Stuart B.; Druzin, Maurice L.; Gambhir, Sanjiv S.; Nayak, Nihar R.			Noninvasive Monitoring of Placenta-Specific Transgene Expression by Bioluminescence Imaging	PLOS ONE			English	Article							REPORTER GENE-EXPRESSION; IN-VIVO; MANIPULATION; LENTIVIRUS	Background: Placental dysfunction underlies numerous complications of pregnancy. A major obstacle to understanding the roles of potential mediators of placental pathology has been the absence of suitable methods for tissue-specific gene manipulation and sensitive assays for studying gene functions in the placentas of intact animals. We describe a sensitive and noninvasive method of repetitively tracking placenta-specific gene expression throughout pregnancy using lentivirus-mediated transduction of optical reporter genes in mouse blastocysts. Methodology/Principal Findings: Zona-free blastocysts were incubated with lentivirus expressing firefly luciferase (Fluc) and Tomato fluorescent fusion protein for trophectoderm-specific infection and transplanted into day 3 pseudopregnant recipients (GD3). Animals were examined for Fluc expression by live bioluminescence imaging (BLI) at different points during pregnancy, and the placentas were examined for tomato expression in different cell types on GD18. In another set of experiments, blastocysts with maximum photon fluxes in the range of 2.0E+4 to 6.0E+4 p/s/cm(2)/sr were transferred. Fluc expression was detectable in all surrogate dams by day 5 of pregnancy by live imaging, and the signal increased dramatically thereafter each day until GD12, reaching a peak at GD16 and maintaining that level through GD18. All of the placentas, but none of the fetuses, analyzed on GD18 by BLI showed different degrees of Fluc expression. However, only placentas of dams transferred with selected blastocysts showed uniform photon distribution with no significant variability of photon intensity among placentas of the same litter. Tomato expression in the placentas was limited to only trophoblast cell lineages. Conclusions/Significance: These results, for the first time, demonstrate the feasibility of selecting lentivirally-transduced blastocysts for uniform gene expression in all placentas of the same litter and early detection and quantitative analysis of gene expression throughout pregnancy by live BLI. This method may be useful for a wide range of applications involving trophoblast-specific gene manipulations in utero.	[Fan, Xiujun; Dhal, Sabita; Druzin, Maurice L.; Nayak, Nihar R.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Ren, Peigen; Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA USA; [Bejerano, Gill] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Sch Med, Mol Imaging Program Stanford, Dept Radiol,Bio X Program, Stanford, CA USA; [Gambhir, Sanjiv S.] Stanford Univ, Sch Med, Mol Imaging Program Stanford, Dept Bioengn,Bio X Program, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Fan, XJ (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	nayakn@stanford.edu	Ren, Pei-Gen/A-4099-2009; Goodman, Stuart/AAZ-7499-2020	Druzin, Maurice/0000-0001-7185-6664; Goodman, Stuart/0000-0002-1919-3717; Fan, Xiujun/0000-0003-3322-1857	Children's Health Initiative at Stanford	Children's Health Initiative at Stanford	This work was supported by the Children's Health Initiative at Stanford (to NRN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan CT, 2009, MOL IMAGING BIOL, V11, P144, DOI 10.1007/s11307-008-0187-7; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; De A, 2003, MOL THER, V7, P681, DOI 10.1016/S1525-0016(03)00070-4; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Deroose CM, 2006, MOL THER, V14, P423, DOI 10.1016/j.ymthe.2006.05.007; Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401; Georgiades P, 2007, BIOTECHNIQUES, V42, P317, DOI 10.2144/000112341; Germeyer A, 2005, J CLIN ENDOCR METAB, V90, P1783, DOI 10.1210/jc.2004-1769; Johnson M, 2006, HUM GENE THER, V17, P1262, DOI 10.1089/hum.2006.17.1262; Lee DS, 2009, GENESIS, V47, P433, DOI 10.1002/dvg.20518; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Malashicheva A, 2007, GENESIS, V45, P456, DOI 10.1002/dvg.20313; Man Y, 2000, AM J RESP CELL MOL, V23, P610, DOI 10.1165/ajrcmb.23.5.4046; Marino Michael P, 2003, Methods Mol Biol, V229, P43; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Morioka Y, 2009, GENESIS, V47, P793, DOI 10.1002/dvg.20563; Nagy A, 2003, MANIPULATING MOUSE E, P268; Nayak NR, 2002, J CLIN ENDOCR METAB, V87, P1845, DOI 10.1210/jc.87.4.1845; Niu G, 2007, MOL IMAGING BIOL, V9, P126, DOI 10.1007/s11307-007-0079-2; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Reid Susan W., 2009, V530, P269, DOI 10.1007/978-1-59745-471-1_14; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Wu JC, 2001, MOL THER, V4, P297, DOI 10.1006/mthe.2001.0460; Yoshimitsu M, 2004, P NATL ACAD SCI USA, V101, P16909, DOI 10.1073/pnas.0407572101; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149	27	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16348	10.1371/journal.pone.0016348	http://dx.doi.org/10.1371/journal.pone.0016348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283713	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522300037
J	Miller, PM; Saltz, JB; Cochrane, VA; Marcinkowski, CM; Mobin, R; Turner, TL				Miller, Paige M.; Saltz, Julia B.; Cochrane, Veronica A.; Marcinkowski, Caitlin M.; Mobin, Raisa; Turner, Thomas L.			Natural Variation in Decision-Making Behavior in Drosophila melanogaster	PLOS ONE			English	Article							OVIPOSITION SITE PREFERENCE; QUANTITATIVE GENETIC-VARIATION; LIFE-HISTORY; ACETIC-ACID; SELECTION; POPULATION; EVOLUTION; SEQUENCE	There has been considerable recent interest in using Drosophila melanogaster to investigate the molecular basis of decision-making behavior. Deciding where to place eggs is likely one of the most important decisions for a female fly, as eggs are vulnerable and larvae have limited motility. Here, we show that many natural genotypes of D. melanogaster prefer to lay eggs near nutritious substrate, rather than in nutritious substrate. These preferences are highly polymorphic in both degree and direction, with considerable heritability (0.488) and evolvability. Relative preferences are modulated by the distance between options and the overall concentration of ethanol, suggesting Drosophila integrate many environmental factors when making oviposition decisions. As oviposition-related decisions can be efficiently assessed by simply counting eggs, oviposition behavior is an excellent model for understanding information processing in insects. Associating natural genetic polymorphisms with decision-making variation will shed light on the molecular basis of host choice behavior, the evolutionary maintenance of genetic variation, and the mechanistic nature of preference variation in general.	[Miller, Paige M.; Cochrane, Veronica A.; Marcinkowski, Caitlin M.; Mobin, Raisa; Turner, Thomas L.] Univ Calif Santa Barbara, Ecol Evolut & Marine Biol Dept, Santa Barbara, CA 93106 USA; [Saltz, Julia B.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Saltz, Julia B.] Univ So Calif, Mol & Computat Biol Dept, Los Angeles, CA USA	University of California System; University of California Santa Barbara; University of California System; University of California Davis; University of Southern California	Miller, PM (corresponding author), Univ Calif Santa Barbara, Ecol Evolut & Marine Biol Dept, Santa Barbara, CA 93106 USA.	tturner@lifesci.ucsb.edu	Saltz, Julia/AAJ-4869-2020	Miller, Paige/0000-0002-5419-8601	University of California, Santa Barbara	University of California, Santa Barbara(University of California System)	This work was supported by the University of California, Santa Barbara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBORNOZ J, 1987, BEHAV GENET, V17, P257, DOI 10.1007/BF01065505; [Anonymous], 2006, SAS MIXED MODELS; Barker JSF, 1999, HEREDITAS, V130, P145, DOI 10.1111/j.1601-5223.1999.00145.x; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Courtney SP, 1988, FUNCT ECOL, V2, P521, DOI 10.2307/2389395; COYNE JA, 1982, AM NAT, V119, P589, DOI 10.1086/283936; DELSOLAR E, 1968, GENETICS, V58, P275; Eisses KT, 1997, BEHAV GENET, V27, P171, DOI 10.1023/A:1025697627556; Evans AT, 1916, J ECON ENTOMOL, V9, P354, DOI 10.1093/jee/9.3.354; FOGLEMAN JC, 1979, BEHAV GENET, V9, P407, DOI 10.1007/BF01066978; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; GARCIADORADO A, 1991, HEREDITY, V66, P313, DOI 10.1038/hdy.1991.40; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; GONZALEZ D, 1989, BEHAV GENET, V19, P301, DOI 10.1007/BF01065912; GONZALEZ D, 1990, BEHAV GENET, V20, P675, DOI 10.1007/BF01065878; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; HOFFMANN AA, 1991, EVOLUTION, V45, P1000, DOI 10.1111/j.1558-5646.1991.tb04366.x; HOFFMANN AA, 1985, AM NAT, V126, P41, DOI 10.1086/284394; JAENIKE J, 1983, OECOLOGIA, V58, P320, DOI 10.1007/BF00385230; JAENIKE J, 1982, AM NAT, V119, P784, DOI 10.1086/283955; Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106; LUTZ F. E., 1914, J NEW YORK ENTOMOL S, V22, P134; MACKAY TF, 2008, PROPOSAL SEQUENCE DR; Mery F, 2002, P NATL ACAD SCI USA, V99, P14274, DOI 10.1073/pnas.222371199; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Possidente B, 1999, BEHAV GENET, V29, P193, DOI 10.1023/A:1021696019426; RUIZDUBREUIL G, 1994, HEREDITY, V73, P103, DOI 10.1038/hdy.1994.105; SCHAALJE GB, 2001, 26262 SUGI SAS I; SCHABENBERGER O, 2007, 19630 SUGI SAS I; Tatum EL, 1939, P NATL ACAD SCI USA, V25, P490, DOI 10.1073/pnas.25.9.490; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; VANDELDEN W, 1990, BEHAV GENET, V20, P661, DOI 10.1007/BF01065877; Wertheim B, 2002, ENTOMOL EXP APPL, V103, P61, DOI 10.1023/A:1019832101537; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842	34	38	38	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16436	10.1371/journal.pone.0016436	http://dx.doi.org/10.1371/journal.pone.0016436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283727	Green Published, gold			2022-12-25	WOS:000286522200063
J	Shorning, BY; Griffiths, D; Clarke, AR				Shorning, Boris Y.; Griffiths, David; Clarke, Alan R.			Lkb1 and Pten Synergise to Suppress mTOR-Mediated Tumorigenesis and Epithelial-Mesenchymal Transition in the Mouse Bladder	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; TUMOR-SUPPRESSOR; GLUCOSE-TRANSPORTER; GENE-EXPRESSION; CELL CARCINOMA; TGF-BETA; CANCER; HYPOXIA; INVASIVENESS; PATHWAY	The AKT/PI3K/mTOR pathway is frequently altered in a range of human tumours, including bladder cancer. Here we report the phenotype of mice characterised by deletion of two key players in mTOR regulation, Pten and Lkb1, in a range of tissues including the mouse urothelium. Despite widespread recombination within the range of epithelial tissues, the primary phenotype we observe is the rapid onset of bladder tumorigenesis, with median onset of approximately 100 days. Single deletion of either Pten or Lkb1 had no effect on bladder cell proliferation or tumour formation. However, simultaneous deletion of Lkb1 and Pten led to an upregulation of the mTOR pathway and the hypoxia marker GLUT1, increased bladder epithelial cell proliferation and ultimately tumorigenesis. Bladder tissue also exhibited characteristic features of epithelial-mesenchymal transition, with loss of the epithelial markers E-cadherin and the tight junction protein ZO-1, and increases in the mesenchymal marker vimentin as well as nuclear localization of epithelial-mesenchymal transition (EMT) regulator Snail. We show that these effects were all dependent upon mTOR activity, as rapamycin treatment blocked both EMT and tumorigenesis. Our data therefore establish clear synergy between Lkb1 and Pten in controlling the mTOR pathway within bladder epithelium, and show that loss of this control leads to the disturbance of epithelial structure, EMT and ultimately tumorigenesis.	[Shorning, Boris Y.; Clarke, Alan R.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Griffiths, David] Cardiff Univ, Dept Pathol, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Shorning, BY (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales.	shorningb@cf.ac.uk	clarke, alan r/P-2820-2014; Clarke, Alan R/A-6256-2008	Clarke, Alan/0000-0002-4281-426X	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2008, EMBO REP, V9, P322, DOI 10.1038/embor.2008.30; Alessi DR, 2001, BIOCHEM SOC T, V29, P1, DOI 10.1042/bst029a059; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Askham JM, 2010, ONCOGENE, V29, P150, DOI 10.1038/onc.2009.315; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; BEHRENS J, 1994, INVAS METAST, V14, P61; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brugarolas J, 2004, CANCER CELL, V6, P7, DOI 10.1016/j.ccr.2004.06.020; Bruyere F, 2010, UROL ONCOL-SEMIN ORI, V28, P591, DOI 10.1016/j.urolonc.2008.11.005; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cappellen D, 1997, ONCOGENE, V14, P3059, DOI 10.1038/sj.onc.1201154; Chang SG, 2000, UROLOGY, V55, P448, DOI 10.1016/S0090-4295(99)00474-4; Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258; CLAVEL J, 1989, INT J CANCER, V44, P605, DOI 10.1002/ijc.2910440408; Eble JN, 2004, PATHOLOGY GENETICS T; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Grille SJ, 2003, CANCER RES, V63, P2172; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; HABUCHI T, 1995, ONCOGENE, V11, P1671; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoskin PJ, 2003, BRIT J CANCER, V89, P1290, DOI 10.1038/sj.bjc.6601260; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; JENSEN OM, 1990, EUR J CANCER, V26, P1167; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; MELAMED MR, 1964, CANCER, V17, P1533, DOI 10.1002/1097-0142(196412)17:12<1533::AID-CNCR2820171205>3.0.CO;2-7; Miyoshi H, 2002, CANCER RES, V62, P2261; Peinado H, 2008, NAT CELL BIOL, V10, P253, DOI 10.1038/ncb0308-253; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Shorning BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004264; SILVERBERG E, 1989, CA-CANCER J CLIN, V39, P3; SILVERMAN DT, 1989, J NATL CANCER I, V81, P1480, DOI 10.1093/jnci/81.19.1480; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Syrigos KN, 1995, INT J CANCER, V64, P367, DOI 10.1002/ijc.2910640603; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tsuruta H, 2006, CANCER RES, V66, P8389, DOI 10.1158/0008-5472.CAN-05-4627; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; WALKER BE, 1960, AM J ANAT, V107, P95, DOI 10.1002/aja.1001070202; Yan W, 2009, BIOCHEM BIOPH RES CO, V382, P631, DOI 10.1016/j.bbrc.2009.03.088; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yoo LI, 2006, CANCER RES, V66, P1929, DOI 10.1158/0008-5472.CAN-05-1986; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zundel W, 2000, GENE DEV, V14, P391	63	55	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16209	10.1371/journal.pone.0016209	http://dx.doi.org/10.1371/journal.pone.0016209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283818	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000286520600033
J	Takano, K; Okamoto, T; Okada, J; Tanaka, S; Angkawidjaja, C; Koga, Y; Kanaya, S				Takano, Kazufumi; Okamoto, Tomohiro; Okada, Jun; Tanaka, Shun-ichi; Angkawidjaja, Clement; Koga, Yuichi; Kanaya, Shigenori			Stabilization by Fusion to the C-terminus of Hyperthermophile Sulfolobus tokodaii RNase HI: A Possibility of Protein Stabilization Tag	PLOS ONE			English	Article							COLI RIBONUCLEASE HI; STABILITY; SUPPRESSOR; EVOLUTION	RNase HI from the hyperthermophile Sulfolobus tokodaii (Sto-RNase HI) is stabilized by its C-terminal residues. In this work, the stabilization effect of the Sto-RNase HI C-terminal residues was investigated in detail by thermodynamic measurements of the stability of variants lacking the disulfide bond (C58/145A), or the six C-terminal residues (Delta C6) and by structural analysis of Delta C6. The results showed that the C-terminal does not affect overall structure and stabilization is caused by local interactions of the C-terminal, suggesting that the C-terminal residues could be used as a "stabilization tag." The Sto-RNase HI C-terminal residues (-IGCIILT) were introduced as a tag on three proteins. Each chimeric protein was more stable than its wild-type protein. These results suggested the possibility of a simple stabilization technique using a stabilization tag such as Sto-RNase HI C-terminal residues.	[Takano, Kazufumi; Okamoto, Tomohiro; Okada, Jun; Tanaka, Shun-ichi; Angkawidjaja, Clement; Koga, Yuichi; Kanaya, Shigenori] Osaka Univ, Dept Mat & Life Sci, Osaka, Japan; [Takano, Kazufumi] Japan Sci & Technol Agcy, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST)	Takano, K (corresponding author), Osaka Univ, Dept Mat & Life Sci, Osaka, Japan.	ktakano@mls.eng.osaka-u.ac.jp		Angkawidjaja, Clement/0000-0002-5019-2536; Takano, Kazufumi/0000-0002-7548-7314	Ministry of Education, Culture, Sports, Science, and Technology of Japan; New Energy and Industrial Technology Development Organization (NEDO) of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by an Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUNGER AT, 1998, ACTA CRYSTALLOGR A, V47, P110; Dong HJ, 2008, J MOL BIOL, V378, P264, DOI 10.1016/j.jmb.2008.02.039; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu Y, 2010, BIOCHEMISTRY-US, V49, P6420, DOI 10.1021/bi100489x; Gribenko AV, 2009, P NATL ACAD SCI USA, V106, P2601, DOI 10.1073/pnas.0808220106; Hailey DW, 2002, METHOD ENZYMOL, V351, P34; HARUKI M, 1994, J BIOL CHEM, V269, P26904; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; KANAYA S, 1991, J BIOL CHEM, V266, P6038; Kato A, 2007, BIOPOLYMERS, V85, P12, DOI 10.1002/bip.20596; KIMURA S, 1992, J BIOL CHEM, V267, P21535; Kondo N, 2009, ANAL BIOCHEM, V385, P278, DOI 10.1016/j.ab.2008.10.050; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Matsuura T, 1999, NAT BIOTECHNOL, V17, P58, DOI 10.1038/5232; Miyazaki K, 2000, J MOL BIOL, V297, P1015, DOI 10.1006/jmbi.2000.3612; Mukaiyama A, 2004, BIOCHEMISTRY-US, V43, P13859, DOI 10.1021/bi0487645; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-207; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Schulenburg C, 2010, CHEMBIOCHEM, V11, P978, DOI 10.1002/cbic.200900773; Soling A, 2002, FEBS LETT, V527, P153, DOI 10.1016/S0014-5793(02)03201-5; Tadokoro T, 2008, BIOCHEMISTRY-US, V47, P8040, DOI 10.1021/bi800246e; Tadokoro T, 2007, BIOCHEMISTRY-US, V46, P7460, DOI 10.1021/bi7001423; Takano K, 2006, FEBS J, V273, P150, DOI 10.1111/j.1742-4658.2005.05051.x; Takano K, 2007, PROTEINS, V68, P617, DOI 10.1002/prot.21451; Trevino SR, 2007, J MOL BIOL, V373, P211, DOI 10.1016/j.jmb.2007.07.061; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang M, 2010, BIOCHEMISTRY-US, V49, P4318, DOI 10.1021/bi100118k; Watanabe K, 2006, J MOL BIOL, V355, P664, DOI 10.1016/j.jmb.2005.10.011; You DJ, 2007, BIOCHEMISTRY-US, V46, P11494, DOI 10.1021/bi700830f; You DJ, 2006, ACTA CRYSTALLOGR F, V62, P781, DOI 10.1107/S1744309106024420	33	12	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16226	10.1371/journal.pone.0016226	http://dx.doi.org/10.1371/journal.pone.0016226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283826	gold, Green Published, Green Submitted			2022-12-25	WOS:000286520600034
J	Abdel-Samad, R; Zalzali, H; Rammah, C; Giraud, J; Naudin, C; Dupasquier, S; Poulat, F; Boizet-Bonhoure, B; Lumbroso, S; Mouzat, K; Bonnans, C; Pignodel, C; Raynaud, P; Fort, P; Quittau-Prevostel, C; Blache, P				Abdel-Samad, R.; Zalzali, H.; Rammah, C.; Giraud, J.; Naudin, C.; Dupasquier, S.; Poulat, F.; Boizet-Bonhoure, B.; Lumbroso, S.; Mouzat, K.; Bonnans, C.; Pignodel, C.; Raynaud, P.; Fort, P.; Quittau-Prevostel, C.; Blache, P.			MiniSOX9, a dominant-negative variant in colon cancer cells	ONCOGENE			English	Article						PKC alpha; SOX9; Wnt/beta-catenin signaling pathway	MESSENGER-RNA POLYADENYLATION; BETA-CATENIN; TRANSCRIPTION FACTOR; CAMPOMELIC DYSPLASIA; GENE-EXPRESSION; FACTOR SOX9; MOUSE; IDENTIFICATION; INHIBITION; EPITHELIUM	Inherited and acquired changes in pre-mRNA processing have significant roles in human diseases, especially cancer. Characterization of aberrantly spliced mRNAs may thus contribute to understand malignant transformation. We recently reported an anti-oncogenic potential for the SOX9 transcription factor in the colon. For instance, the Sox9 gene knock out in the mouse intestine results in an excess of proliferation with appearance of hyperplasia. SOX9 is expressed in colon cancer cells but its endogenous activity is weak. We looked for SOX9 variants that may impair SOX9 activity in colon cancer cells and we discovered MiniSOX9, a truncated version of SOX9 devoid of transactivation domain as a result of retention of the second intron. A significant overexpression of MiniSOX9 mRNA in human tumor samples compared with their matched normal tissues was observed by real-time reverse transcriptase-PCR. Immunohistochemistry revealed that MiniSOX9 is expressed at high levels in human colon cancer samples whereas it is undetectable in the surrounding healthy tissues. Finally, we discovered that MiniSOX9 behaves as a SOX9 inhibitor, inhibits protein kinase C alpha promoter activity and stimulates the canonical Wnt pathway. This potential oncogenic activity of the SOX9 locus gives new insights on its role in colon cancer. Oncogene (2011) 30, 2493-2503; doi:10.1038/onc.2010.621; published online 7 February 2011	[Abdel-Samad, R.; Zalzali, H.; Rammah, C.; Giraud, J.; Naudin, C.; Dupasquier, S.; Bonnans, C.; Raynaud, P.; Quittau-Prevostel, C.; Blache, P.] Univ Montpellier 1, INSERM, CNRS, Inst Genom Fonct,UMR 5203,U661, F-34094 Montpellier 5, France; [Abdel-Samad, R.; Zalzali, H.; Rammah, C.; Giraud, J.; Naudin, C.; Dupasquier, S.; Bonnans, C.; Raynaud, P.; Quittau-Prevostel, C.; Blache, P.] Univ Montpellier 2, F-34094 Montpellier 5, France; [Poulat, F.; Boizet-Bonhoure, B.] UPR, CNRS, Inst Genet Humaine, Montpellier, France; [Lumbroso, S.; Mouzat, K.] CHU Nimes, Biochim Lab, Nimes, France; [Pignodel, C.] CHU Nimes, Serv Anat & Cytol Pathol, Nimes, France; [Fort, P.] CNRS, UMR 5237, Ctr Rech Biochim Macromol, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Blache, P (corresponding author), Univ Montpellier 1, INSERM, CNRS, Inst Genom Fonct,UMR 5203,U661, 141 Rue Cardonille, F-34094 Montpellier 5, France.	philippe.blache@igf.cnrs.fr	POULAT, FRANCIS/AAV-2170-2020; Fort, Philippe/M-9498-2015; Prevostel, Corinne/AAO-1433-2020; Raynaud, Peggy/AAC-5749-2020; Lumbroso, Serge/AFS-0438-2022	POULAT, FRANCIS/0000-0003-2070-1296; Fort, Philippe/0000-0001-5997-8722; Raynaud, Peggy/0000-0003-1224-8495; Giraud, Julie/0000-0001-6173-4276; Abdel-Samad, Rana/0000-0002-7753-8779; PREVOSTEL, Corinne/0000-0002-7553-087X	Ligue Nationale contre le Cancer (Equipe Labellisee); Ligue Regionale contre le Cancer (Comite Languedoc-Roussillon); Association pour la Recherche sur le Cancer [4994]; Region Languedoc-Roussillon (Chercheur d'Avenir); CNRS du LIBAN; Ligue Nationale contre le Cancer; Association pour la Recherche sur le Cancer	Ligue Nationale contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer); Ligue Regionale contre le Cancer (Comite Languedoc-Roussillon); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Region Languedoc-Roussillon (Chercheur d'Avenir)(Region Occitanie); CNRS du LIBAN; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by the 'Ligue Nationale contre le Cancer (Equipe Labellisee)', the 'Ligue Regionale contre le Cancer (Comite Languedoc-Roussillon)', the 'Association pour la Recherche sur le Cancer (grant number 4994)' and the 'Region Languedoc-Roussillon (Chercheur d'Avenir)'. Rana Abdel-Samad and Hassan Zalzali fellowships were from 'CNRS du LIBAN'. Sebastien Dupasquier fellowships were from 'Ligue Nationale contre le Cancer' and 'Association pour la Recherche sur le Cancer'. Peggy Raynaud post-doctoral fellowship was from 'Association pour la Recherche sur le Cancer'. Cyrine Rammah doctoral fellowship was from the 'Ligue Nationale contre le Cancer'. We thank Dr Christine Perret for providing the APC Delta 14 mice, Dr Pascal Roger 'CHU Nimes tumorotheque' for human colon biopsy samples, Geraldine Leguelinel for preparation of RNA from biopsy samples and Dr Sabine Laurent-Chabalier for statistical analysis.	Afonja O, 2002, ONCOGENE, V21, P7850, DOI 10.1038/sj.onc.1205985; Agrawal R, 2009, FEBS J, V276, P4184, DOI 10.1111/j.1742-4658.2009.07127.x; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Aleman A, 2008, BRIT J CANCER, V98, P466, DOI 10.1038/sj.bjc.6604143; Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; Darido C, 2008, CANCER RES, V68, P4258, DOI 10.1158/0008-5472.CAN-07-5805; Dupasquier S, 2009, J CELL SCI, V122, P2191, DOI 10.1242/jcs.036483; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GEISINGER KR, 1989, CANCER-AM CANCER SOC, V63, P280, DOI 10.1002/1097-0142(19890115)63:2<280::AID-CNCR2820630213>3.0.CO;2-N; Gilmartin GM, 2005, GENE DEV, V19, P2517, DOI 10.1101/gad.1378105; Giordano J, 2001, AM J MED GENET, V98, P176, DOI 10.1002/1096-8628(20010115)98:2<176::AID-AJMG1027>3.0.CO;2-Q; HOUSTON CS, 1983, AM J MED GENET, V15, P3, DOI 10.1002/ajmg.1320150103; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Jay P, 2005, CANCER RES, V65, P2193, DOI 10.1158/0008-5472.CAN-04-1484; Jin L, 2008, EXP BIOL MED, V233, P849, DOI 10.3181/0712-RM-352; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; Leung N, 2008, ONCOGENE, V27, P4943, DOI 10.1038/onc.2008.136; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muller P, 2010, BREAST CANCER RES TR, V120, P317, DOI 10.1007/s10549-009-0381-6; Notarnicola C, 2006, GENE EXPR PATTERNS, V6, P695, DOI 10.1016/j.modgep.2006.01.001; Passeron T, 2009, J CLIN INVEST, V119, P954, DOI 10.1172/JCI34015; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; Retelska D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-176; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Tago K, 2000, GENE DEV, V14, P1741; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; Zalzali H, 2008, ONCOGENE, V27, P7131, DOI 10.1038/onc.2008.331; Zhang H, 2000, MOL HUM REPROD, V6, P146, DOI 10.1093/molehr/6.2.146	40	26	28	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	22					2493	2503		10.1038/onc.2010.621	http://dx.doi.org/10.1038/onc.2010.621			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	771ZE	21297661				2022-12-25	WOS:000291198400001
J	Nielsen, MM; Suits, MDL; Yang, M; Barry, CS; Martinez-Fleites, C; Tailford, LE; Flint, JE; Dumon, C; Davis, BG; Gilbert, HJ; Davies, GJ				Nielsen, Morten M.; Suits, Michael D. L.; Yang, Min; Barry, Conor S.; Martinez-Fleites, Carlos; Tailford, Louise E.; Flint, James E.; Dumon, Claire; Davis, Benjamin G.; Gilbert, Harry J.; Davies, Gideon J.			Substrate and Metal Ion Promiscuity in Mannosylglycerate Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BLOOD-GROUP; GLYCOSYLTRANSFERASE; INSIGHT; COMPLEX; DONOR	The enzymatic transfer of the sugar mannose from activated sugar donors is central to the synthesis of a wide range of biologically significant polysaccharides and glycoconjugates. In addition to their importance in cellular biology, mannosyltransferases also provide model systems with which to study catalytic mechanisms of glycosyl transfer. Mannosylglycerate synthase (MGS) catalyzes the synthesis of alpha-mannosyl-D-glycerate using GDP-mannose as the preferred donor species, a reaction that occurs with a net retention of anomeric configuration. Past work has shown that the Rhodothermus marinus MGS, classified as a GT78 glycosyltransferase, displays a GT-A fold and performs catalysis in a metal ion-dependent manner. MGS shows very unusual metal ion dependences with Mg2+ and Ca2+ and, to a lesser extent, Mn2+, Ni2+, and Co2+, thus facilitating catalysis. Here, we probe these dependences through kinetic and calorimetric analyses of wild-type and site-directed variants of the enzyme. Mutation of residues that interact with the guanine base of GDP are correlated with a higher k(cat) value, whereas substitution of His-217, a key component of the metal coordination site, results in a change in metal specificity to Mn2+. Structural analyses of MGS complexes not only provide insight into metal coordination but also how lactate can function as an alternative acceptor to glycerate. These studies highlight the role of flexible loops in the active center and the subsequent coordination of the divalent metal ion as key factors in MGS catalysis and metal ion dependence. Furthermore, Tyr-220, located on a flexible loop whose conformation is likely influenced by metal binding, also plays a critical role in substrate binding.	[Nielsen, Morten M.; Tailford, Louise E.; Flint, James E.; Dumon, Claire; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Suits, Michael D. L.; Martinez-Fleites, Carlos; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Yang, Min; Barry, Conor S.; Davis, Benjamin G.] Univ Oxford, Chem Res Lab, Dept Chem, Oxford OX1 3TA, England; [Gilbert, Harry J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Newcastle University - UK; University of York - UK; University of Oxford; University System of Georgia; University of Georgia	Gilbert, HJ (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	h.j.gilbert@ncl.ac.uk; davies@ysbl.york.ac.uk	Davis, Benjamin G/C-5281-2011; Davies, Gideon J/A-9042-2011; Claire, Dumon/AAI-2553-2021	Davis, Benjamin G/0000-0002-5056-407X; Davies, Gideon J/0000-0002-7343-776X; Claire, Dumon/0000-0003-4925-7336; Flint, James/0000-0003-2923-7813	Biotechnology and Biological Sciences Research Council of the United Kingdom; European Molecular Biology Laboratory; Royal Society; Biotechnology and Biological Sciences Research Council [BB/E000568/1, BB/E001696/1, EGA17763, BB/C510824/1, BB/E004350/1, BBS/E/F/00044452] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/T26542/01, EP/D023343/1, EP/G026688/1, EP/I500200/1, EP/D023335/1, EP/E000614/1] Funding Source: researchfish; BBSRC [BB/E004350/1, BB/E000568/1, BBS/E/F/00044452, BB/E001696/1] Funding Source: UKRI; EPSRC [EP/I500200/1, EP/G026688/1, EP/E000614/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Laboratory; Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported in part by Biotechnology and Biological Sciences Research Council of the United Kingdom.; Recipient of a European Molecular Biology Laboratory long term fellowship.; Recipient of a Royal Society Wolfson research merit award.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Davis BG, 2000, J CHEM SOC PERK T 1, P2137, DOI 10.1039/a809774g; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flint J, 2005, NAT STRUCT MOL BIOL, V12, P608, DOI 10.1038/nsmb950; Fulton Z, 2008, J BIOL CHEM, V283, P27881, DOI 10.1074/jbc.M801853200; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Goncalves S, 2010, J BIOL CHEM, V285, P17857, DOI 10.1074/jbc.M109.095976; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LEWIS ES, 1952, J AM CHEM SOC, V74, P308, DOI 10.1021/ja01122a005; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Martins LO, 1999, J BIOL CHEM, V274, P35407, DOI 10.1074/jbc.274.50.35407; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pais TM, 2009, J MOL BIOL, V394, P237, DOI 10.1016/j.jmb.2009.09.012; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Ramakrishnan B, 2004, BIOCHEMISTRY-US, V43, P12513, DOI 10.1021/bi049007+; Seto NOL, 1997, J BIOL CHEM, V272, P14133, DOI 10.1074/jbc.272.22.14133; Yang M, 2005, CHEMBIOCHEM, V6, P346, DOI 10.1002/cbic.200400100	33	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15155	15164		10.1074/jbc.M110.199844	http://dx.doi.org/10.1074/jbc.M110.199844			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21288903	Green Published, hybrid			2022-12-25	WOS:000289788300047
J	Kim, MJ; Woo, SJ; Yoon, CH; Lee, JS; An, S; Choi, YH; Hwang, SG; Yoon, G; Lee, SJ				Kim, Min-Jung; Woo, Soo-Jung; Yoon, Chang-Hwan; Lee, Jae-Seong; An, Sungkwan; Choi, Yung-Hyun; Hwang, Sang-Gu; Yoon, Gyesoon; Lee, Su-Jae			Involvement of Autophagy in Oncogenic K-Ras-induced Malignant Cell Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISM; UP-REGULATION; DEATH; CANCER; SURVIVAL; APOPTOSIS; GENES; ACTIVATION; HEALTH; TUMORIGENESIS	Autophagy has recently been implicated in both the prevention and progression of cancer. However, the molecular basis for the relationship between autophagy induction and the initial acquisition of malignancy is currently unknown. Here, we provide the first evidence that autophagy is essential for oncogenic K-Ras (K-Ras(V12))-induced malignant cell transformation. Retroviral expression of K-Ras(V12) induced autophagic vacuole formation and malignant transformation in human breast epithelial cells. Interestingly, pharmacological inhibition of autophagy completely blocked K-Ras(V12)-induced, anchorage-independent cell growth on soft agar. Both mRNA and protein levels of ATG5 and ATG7 (autophagy-specific genes 5 and 7, respectively) were increased in cells overexpressing K-Ras(V12), Targeted suppression of ATG5 or ATG7 expression by short hairpin (sh) RNA inhibited cell growth on soft agar and tumor formation in nude mice. Moreover, inhibition of reactive oxygen species (ROS) with antioxidants clearly attenuated K-Ras(V12)-induced ATG5 and ATG7 induction, autophagy, and malignant cell transformation. MAPK pathway components were activated in cells overexpressing K-Ras(V12), and inhibition of JNK blunted induction of ATG5 and ATG7 and subsequent autophagy. In addition, pretreatment with antioxidants completely inhibited K-Ras(V12)-induced JNK activation. Our results provide novel evidence that autophagy is critically involved in malignant transformation by oncogenic K-Ras and show that reactive oxygen species-mediated INK activation plays a causal role in autophagy induction through up-regulation of ATG5 and ATG7.	[Kim, Min-Jung; Woo, Soo-Jung; Yoon, Chang-Hwan; Lee, Jae-Seong; Lee, Su-Jae] Hanyang Univ, Dept Chem, Seoul 133791, South Korea; [Kim, Min-Jung; Woo, Soo-Jung; Yoon, Chang-Hwan; Lee, Jae-Seong; Lee, Su-Jae] Hanyang Univ, Res Inst Nat Sci, Seoul 133791, South Korea; [An, Sungkwan] Konkuk Univ, Dept Microbiol Engn, Seoul 143701, South Korea; [Choi, Yung-Hyun] Dong Eui Univ, Dept Biochem, Coll Oriental Med, Pusan 614052, South Korea; [Hwang, Sang-Gu] Korea Inst Radiol & Med Sci, Div Radiat Canc Biol, Seoul 139706, South Korea; [Yoon, Gyesoon] Ajou Univ, Dept Biochem & Mol Biol, Sch Med, Suwon 443721, South Korea	Hanyang University; Hanyang University; Konkuk University; Dong-Eui University; Korea Institute of Radiological & Medical Sciences; Ajou University	Lee, SJ (corresponding author), Hanyang Univ, Dept Chem, 17 Haengdang Dong, Seoul 133791, South Korea.	sj0420@hanyang.ac.kr	Yoon, Changhwan/AAK-7842-2021; Lee, Jae-Seong/H-6013-2015	Yoon, Changhwan/0000-0002-8420-9818; Lee, Jae-Seong/0000-0003-0944-5172	Korea Science and Engineering Foundation (KOSEF); Ministry of Education, Science and Technology (MEST), Korean government [2009-0081812]; Basic Atomic Energy Research Institute (BAERI)	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology (MEST), Korean government(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Basic Atomic Energy Research Institute (BAERI)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) and Ministry of Education, Science and Technology (MEST), Korean government, through its National Nuclear Technology Program (2009-0081812) and the Program of Basic Atomic Energy Research Institute (BAERI).	Alexandrova AY, 2006, EXP CELL RES, V312, P2066, DOI 10.1016/j.yexcr.2006.03.004; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Botti J, 2006, AUTOPHAGY, V2, P67, DOI 10.4161/auto.2.2.2458; Castagnola P, 2005, BBA-REV CANCER, V1756, P115, DOI 10.1016/j.bbcan.2005.06.003; Chen N, 2009, BBA-MOL CELL RES, V1793, P1516, DOI 10.1016/j.bbamcr.2008.12.013; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Furuta S, 2004, ONCOGENE, V23, P3898, DOI 10.1038/sj.onc.1207539; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; KARNOUB AE, 2008, NAT REV, V9, P531; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Kopnin PB, 2007, CANCER RES, V67, P4671, DOI 10.1158/0008-5472.CAN-06-2466; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mathew R, 2007, AUTOPHAGY, V3, P502, DOI 10.4161/auto.4605; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ng G, 2005, MOL CARCINOGEN, V43, P183, DOI 10.1002/mc.20097; Noguchi T, 2008, J BIOL CHEM, V283, P7657, DOI 10.1074/jbc.M708402200; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Rockwell P, 2004, CELL SIGNAL, V16, P343, DOI 10.1016/j.cellsig.2003.08.006; Sahu RP, 2009, CARCINOGENESIS, V30, P1744, DOI 10.1093/carcin/bgp157; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Yang CS, 2008, CELL MICROBIOL, V10, P741, DOI 10.1111/j.1462-5822.2007.01081.x; Yang YP, 2005, ACTA PHARMACOL SIN, V26, P1421, DOI 10.1111/j.1745-7254.2005.00235.x; Yoo BH, 2010, J BIOL CHEM, V285, P5438, DOI 10.1074/jbc.M109.046789; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103	50	165	175	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12924	12932		10.1074/jbc.M110.138958	http://dx.doi.org/10.1074/jbc.M110.138958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21300795	hybrid, Green Published			2022-12-25	WOS:000289282200012
J	Page, AN; George, NP; Marceau, AH; Cox, MM; Keck, JL				Page, Asher N.; George, Nicholas P.; Marceau, Aimee H.; Cox, Michael M.; Keck, James L.			Structure and Biochemical Activities of Escherichia coli MgsA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; SINGLE-STRANDED-DNA; POLYMERASE-III HOLOENZYME; ENHANCER-BINDING PROTEIN; CLAMP-LOADER COMPLEX; AAA PLUS ATPASES; RECA PROTEIN; ATP HYDROLYSIS; CHROMOSOME SEGREGATION; PHYSICAL INTERACTION	Bacterial "maintenance of genome stability protein A" (MgsA) and related eukaryotic enzymes play important roles in cellular responses to stalled DNA replication processes. Sequence information identifies MgsA enzymes as members of the clamp loader clade of AAA(+) proteins, but structural information defining the family has been limited. Here, the x-ray crystal structure of Escherichia coli MgsA is described, revealing a homotetrameric arrangement for the protein that distinguishes it from other clamp loader clade AAA(+) proteins. Each MgsA protomer is composed of three elements as follows: ATP-binding and helical lid domains (conserved among AAA(+) proteins) and a tetramerization domain. Although the tetramerization domains bury the greatest amount of surface area in the MgsA oligomer, each of the domains participates in oligomerization to form a highly intertwined quaternary structure. Phosphate is bound at each AAA(+) ATP-binding site, but the active sites do not appear to be in a catalytically competent conformation due to displacement of Arg finger residues. E. coli MgsA is also shown to form a complex with the single-stranded DNA-binding protein through co-purification and biochemical studies. MgsA DNA-dependent ATPase activity is inhibited by single-stranded DNA-binding protein. Together, these structural and biochemical observations provide insights into the mechanisms of MgsA family AAA(+) proteins.	[George, Nicholas P.; Marceau, Aimee H.; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA; [Page, Asher N.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Keck, JL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA.	jlkeck@wisc.edu		Keck, James/0000-0002-5961-0220	National Institutes of Health from NIGMS [GM32335, GM068061]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068061, U01GM032335, R01GM032335] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32335 from NIGMS (to M. M. C.) and Grant GM068061 (to J. L. K.).	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Barre FX, 2001, P NATL ACAD SCI USA, V98, P8189, DOI 10.1073/pnas.111008998; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Bowman GD, 2005, FEBS LETT, V579, P863, DOI 10.1016/j.febslet.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Brunger AT, 2003, FEBS LETT, V555, P126, DOI 10.1016/S0014-5793(03)01107-4; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; Crosetto N, 2008, J BIOL CHEM, V283, P35173, DOI 10.1074/jbc.M803219200; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Hishida T, 2001, P NATL ACAD SCI USA, V98, P8283, DOI 10.1073/pnas.121009098; Hishida T, 2006, MOL CELL BIOL, V26, P5509, DOI 10.1128/MCB.00307-06; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Kazmirski SL, 2004, P NATL ACAD SCI USA, V101, P16750, DOI 10.1073/pnas.0407904101; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Laue T, 1992, ULTRACENTRIFUGATION, P90; LAUE TM, 1995, METHOD ENZYMOL, V259, P61; Lestini R, 2007, EMBO J, V26, P3804, DOI 10.1038/sj.emboj.7601804; Lew CM, 2002, J BIOL CHEM, V277, P41517, DOI 10.1074/jbc.M206912200; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MERTENS N, 1995, BIO-TECHNOL, V13, P175, DOI 10.1038/nbt0295-175; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; Neuwald AF, 1999, GENOME RES, V9, P27; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; O'Donnell M, 2006, CURR OPIN STRUC BIOL, V16, P35, DOI 10.1016/j.sbi.2005.12.004; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rombel I, 1999, J BACTERIOL, V181, P4628, DOI 10.1128/JB.181.15.4628-4638.1999; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Sherratt DJ, 2004, PHILOS T R SOC B, V359, P61, DOI 10.1098/rstb.2003.1365; Shibata T, 2005, GENES CELLS, V10, P181, DOI 10.1111/j.1365-2443.2005.00831.x; Steel GJ, 2000, MOL BIOL CELL, V11, P1345, DOI 10.1091/mbc.11.4.1345; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Tsurimoto T, 2005, GENES CELLS, V10, P13, DOI 10.1111/j.1365-2443.2004.00812.x; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Vandewiele D, 2002, MUTAT RES-FUND MOL M, V499, P85, DOI 10.1016/S0027-5107(01)00268-8; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Watts FZ, 2006, DNA REPAIR, V5, P399, DOI 10.1016/j.dnarep.2005.11.002; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; Yoshimura A, 2009, GENES GENET SYST, V84, P171, DOI 10.1266/ggs.84.171	81	22	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.210187	http://dx.doi.org/10.1074/jbc.M110.210187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21297161	hybrid, Green Published			2022-12-25	WOS:000289077500022
J	Wafar, M; Venkataraman, K; Ingole, B; Khan, SA; LokaBharathi, P				Wafar, Mohideen; Venkataraman, Krishnamurthy; Ingole, Baban; Khan, Syed Ajmal; LokaBharathi, Ponnapakkam			State of Knowledge of Coastal and Marine Biodiversity of Indian Ocean Countries	PLOS ONE			English	Review							ECOSYSTEMS	The Indian Ocean (IO) extends over 30% of the global ocean area and is rimmed by 36 littoral and 11 hinterland nations sustaining about 30% of the world's population. The landlocked character of the ocean along its northern boundary and the resultant seasonally reversing wind and sea surface circulation patterns are features unique to the IO. The IO also accounts for 30% of the global coral reef cover, 40,000 km(2) of mangroves, some of the world's largest estuaries, and 9 large marine ecosystems. Numerous expeditions and institutional efforts in the last two centuries have contributed greatly to our knowledge of coastal and marine biodiversity within the IO. The current inventory, as seen from the Ocean Biogeographic Information System, stands at 34,989 species, but the status of knowledge is not uniform among countries. Lack of human, institutional, and technical capabilities in some IO countries is the main cause for the heterogeneous level of growth in our understanding of the biodiversity of the IO. The gaps in knowledge extend to several smaller taxa and to large parts of the shelf and deep-sea ecosystems, including seamounts. Habitat loss, uncontrolled developmental activities in the coastal zone, overextraction of resources, and coastal pollution are serious constraints on maintenance of highly diverse biota, especially in countries like those of the IO, where environmental regulations are weak.	[Wafar, Mohideen; Ingole, Baban; LokaBharathi, Ponnapakkam] Natl Inst Oceanog, Div Biol Oceanog, Panaji, Goa, India; [Venkataraman, Krishnamurthy] Zool Survey India, Marine Biol Reg Ctr, Madras, Tamil Nadu, India; [Khan, Syed Ajmal] Ctr Adv Study Marine Biol, Fac Marine Sci, Parangipettai, Tamil Nadu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Zoological survey of India	Wafar, M (corresponding author), Natl Inst Oceanog, Div Biol Oceanog, Panaji, Goa, India.	mwafar@gmail.com	Ingole, Baban Shravan/GLR-9722-2022	Ingole, Baban/0000-0001-6096-6980	Census of Marine Life Secretariat	Census of Marine Life Secretariat	The source of funding for this work is the Census of Marine Life Secretariat. The funders had no role in study design, data collection and analysis and preparation of the manuscript except to the extent of having the manuscript subjected to internal review to conform with the pattern agreed upon for the publication in the collection "Marine biodiversity and biogeography - regional comparisons of global issues".	[Anonymous], 1997, WORLD MANGROVE ATLAS; BELYANINA TN, 1992, J ICHTHYOL+, V32, P41; BERGHE EV, 2005, INDIAN J MAR SCI, V34, P128; Bhattathiri PMA, 2001, INDIAN OCEAN - A PERSPECTIVE, VOLS 1 AND 2, P271; Bourmaud CAF, 2005, INDIAN J MAR SCI, V34, P98; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Chun C., 1900, TIEFEN WELTMEERES SC; COLLETTE BB, 1991, B MAR SCI, V48, P1; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; DANIEL R, 1977, P S WARM WATER ZOOPL, P124; DAS A, 2009, 4 INT S CHEM BAS EC; DEBILIUS H, 2000, RED SEA REEF GUIDE; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; GEYNRIKH AK, 1992, OCEANOLOGY, V32, P84; GONSALVES MJ, 2009, INT CENS MAR MICR 45; Griffiths CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012008; Griffiths CL, 2005, INDIAN J MAR SCI, V34, P35; Gupta RS, 2001, INDIAN OCEAN - A PERSPECTIVE, VOLS 1 AND 2, P327; HAPLERN BS, 2008, SCIENCE, V319, P948; Helmcke J. G., 1940, Wiss Ergebn Deuts Tiefsee Exped 1898-9 Jena, V24, P215; Hutomo M, 2005, INDIAN J MAR SCI, V34, P88; Ingole B, 2005, INDIAN J MAR SCI, V34, P27; *IOGOOS, 2002, STRAWM 1 IOGOOS M MA; Kathiresan K, 2005, INDIAN J MAR SCI, V34, P104; Keesing J, 2005, INDIAN J MAR SCI, V34, P11; Krishnan KP, 2006, GEOMICROBIOL J, V23, P31, DOI 10.1080/01490450500398286; Longhurst AR, 1987, ECOLOGY TROPICAL OCE; Mazlan AG, 2005, INDIAN J MAR SCI, V34, P76; Menzies R.J., 1973, ABYSSAL ENV ECOLOGY; MOISEYEV YV, 1986, OCEANOLOGY, V26, P86; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Nair V. R., 1977, P S WARM WAT ZOOPL N, P168; Nesis K. N., 1986, OCEANOLOGY, V26, P91; Oza RM, 2001, REVISED CHECKLIST IN; Parin N.V., 1985, OCEANOLOGY, V25, P781; Pasternak FA, 1964, T I OKEANOLOGII AKAD, V69, P183; Pasternak FA, 1976, T I OKEANOL AKAD NAU, V99, P45; PETTERSSON H, 1957, REP SWED DEEP SEA EX, V1, P1; QASIM S Z, 1978, Indian Journal of Marine Sciences, V7, P84; QASIM S Z, 1977, Indian Journal of Marine Sciences, V6, P122; Qasim S.Z., 1999, INDIAN OCEAN IMAGES; Qasim S. Z., 1998, GLIMPSES INDIAN OCEA; Qasim S. Z., 1990, RESOURCE MANAG OPTIM, V7, P141; Richmond M. D., 2001, MARINE SCI DEV TANZA, P241; RICHMOND MD, 2002, FIELD GUIDE SEASHORE; Romanov E.V., 2003, 991 FAO; ROYAN J P, 1978, Indian Journal of Marine Sciences, V7, P116; Sherman K., 2009, 182 UNEP; Tomczak M., 1994, REGIONAL OCEANOGRAPH; Venkataraman K, 2005, INDIAN J MAR SCI, V34, P57; Veron J.E.N., 2000, CORALS WORLD, V1-3; WAFAR M, 2005, ENCY COASTAL SCI, P557; Wafar S, 2001, INDIAN OCEAN - A PERSPECTIVE, VOLS 1 AND 2, P539; WIN K, 1977, P S WARM WATER ZOOPL, P93; ZEITZCHEL B, 1973, BIOL INDIAN OCEAN	55	65	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14613	10.1371/journal.pone.0014613	http://dx.doi.org/10.1371/journal.pone.0014613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297949	gold, Green Submitted, Green Published			2022-12-25	WOS:000286834300005
J	Wang, ZR; Ren, XM; Wang, D; Guan, YM; Xia, L				Wang, Zhuoran; Ren, Xiaomei; Wang, Dong; Guan, Yongmei; Xia, Lei			Effects of Thioglycolic Acid on Parthenogenetic Activation of Xenopus Oocytes	PLOS ONE			English	Article							PROTEIN-KINASE; MOUSE EGGS; MATURATION; TRANSITION; HAIRDRESSERS; CYCLIN	Background: Existing in Permanent-wave solutions (PWS), thioglycolic acid (TGA) is widely used in hairdressing industry for its contribution to hair styling. However, the toxicity of TGA, especially its reproductive toxicity, gradually calls the attention of more and more researchers. Method: In this work, xenopus oocytes were pretreated with different concentration of TGA, and then activated by calcium ionophore A23187. During culture, the oocytes activation rates were taken note at different time after adding calcium ionophore A23187. At the end of the culture period, the nuclear status was detected under confocal microscope. In addition, some other samples were collected for Western-Blotting analysis. Result: TGA significantly inhibited the oocytes activation rate and pronuclear formation. It may be resulted from the inhibition of the degradation of p-ERK1, Mos and CyclinB2. Conclusion: TGA inhibits in vitro parthenogenetic activation of xenopus oocytes with inhibited the degradation of proteins involved in mitogenic-activated protein kinase (MAPK) and maturation-promoting factor (MPF) pathways.	[Wang, Zhuoran; Guan, Yongmei; Xia, Lei] Harbin Med Coll, Affiliated Hosp 1, Dept Reprod Med, Harbin, Peoples R China; [Ren, Xiaomei; Wang, Dong] Harbin Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China; [Wang, Dong] Mudanjiang Med Coll, Sch Publ Hlth, Mudanjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Mudanjiang Medical University	Wang, ZR (corresponding author), Harbin Med Coll, Affiliated Hosp 1, Dept Reprod Med, Harbin, Peoples R China.	xialeiivf@126.com			National Nature Science Foundation of China [30400356]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China (number 30400356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieu A, 1996, J CELL SCI, V109, P239; Becker Bret E., 2006, V322, P69; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Castro A, 2003, J BIOL CHEM, V278, P2236, DOI 10.1074/jbc.M207894200; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; Dumont J, 2005, J CELL BIOL, V169, P227, DOI 10.1083/jcb.200501027; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Gan HF, 2003, J OCCUP HEALTH, V45, P400, DOI 10.1539/joh.45.400; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GLOTZER AWM, 1991, NATURE, V349, P132; Hill WG, 2005, AM J PHYSIOL-RENAL, V289, pF217, DOI 10.1152/ajprenal.00022.2005; Hou SY, 2008, TOXICOL IND HEALTH, V24, P227, DOI 10.1177/0748233708095862; Iwao Y, 1996, DEV BIOL, V177, P558, DOI 10.1006/dbio.1996.0185; Kersemaekers WM, 1997, EPIDEMIOLOGY, V8, P396, DOI 10.1097/00001648-199707000-00008; Peters C, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-24; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; Rylander L, 2002, OCCUP ENVIRON MED, V59, P517, DOI 10.1136/oem.59.8.517; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SONG CH, 1994, J HARBIN MED U, V28, P387; Song Chunhua, 1990, IND HLTH OCCUP DIS, V16, P142; SONG CHZ, 2002, CHINESE J IND MED, V15, P78; SUN HLQ, 1997, J REPROD DEVELOP, V43, P189; Sun QY, 1998, ZYGOTE, V6, P277, DOI 10.1017/S0967199498000227; Sun QY, 1999, Z NATURFORSCH C, V54, P285; Tatemoto H, 2001, ZYGOTE, V9, P15, DOI 10.1017/S0967199401001034; [夏蕾 XIA Lei], 2009, [癌变·畸变·突变, Carcinogenesis, Teratogenesis and Mutagenesis], V21, P302; ZHANG GQ, 1990, HLTH TOXICOL, V4, P89; Zhang L, 2009, J TOXICOL ENV HEAL A, V72, P1123, DOI 10.1080/15287390902953519	28	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16220	10.1371/journal.pone.0016220	http://dx.doi.org/10.1371/journal.pone.0016220			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297954	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300041
J	Thirant, C; Bessette, B; Varlet, P; Puget, S; Cadusseau, J; Tavares, SD; Studler, JM; Silvestre, DC; Susini, A; Villa, C; Miquel, C; Bogeas, A; Surena, AL; Dias-Morais, A; Leonard, N; Pflumio, F; Bieche, I; Boussin, FD; Sainte-Rose, C; Grill, J; Daumas-Duport, C; Chneiweiss, H; Junier, MP				Thirant, Cecile; Bessette, Barbara; Varlet, Pascale; Puget, Stephanie; Cadusseau, Josette; Tavares, Silvina Dos Reis; Studler, Jeanne-Marie; Silvestre, David Carlos; Susini, Aurelie; Villa, Chiara; Miquel, Catherine; Bogeas, Alexandra; Surena, Anne-Laure; Dias-Morais, Amelia; Leonard, Nadine; Pflumio, Francoise; Bieche, Ivan; Boussin, Francois D.; Sainte-Rose, Christian; Grill, Jacques; Daumas-Duport, Catherine; Chneiweiss, Herve; Junier, Marie-Pierre			Clinical Relevance of Tumor Cells with Stem-Like Properties in Pediatric Brain Tumors	PLOS ONE			English	Article							NEURAL STEM; IN-VITRO; GLIOBLASTOMA-MULTIFORME; NEUROSPHERE FORMATION; PRECURSOR CELLS; NERVOUS-SYSTEM; GROWTH-FACTOR; RADIAL GLIA; CANCER; EXPRESSION	Background: Primitive brain tumors are the leading cause of cancer-related death in children. Tumor cells with stem-like properties (TSCs), thought to account for tumorigenesis and therapeutic resistance, have been isolated from high-grade gliomas in adults. Whether TSCs are a common component of pediatric brain tumors and are of clinical relevance remains to be determined. Methodology/Principal Findings: Tumor cells with self-renewal properties were isolated with cell biology techniques from a majority of 55 pediatric brain tumors samples, regardless of their histopathologies and grades of malignancy (57% of embryonal tumors, 57% of low-grade gliomas and neuro-glial tumors, 70% of ependymomas, 91% of high-grade gliomas). Most high-grade glioma-derived oncospheres (10/12) sustained long-term self-renewal akin to neural stem cells (>7 self-renewals), whereas cells with limited renewing abilities akin to neural progenitors dominated in all other tumors. Regardless of tumor entities, the young age group was associated with self-renewal properties akin to neural stem cells (P = 0.05, chi-square test). Survival analysis of the cohort showed an association between isolation of cells with long-term self-renewal abilities and a higher patient mortality rate (P = 0.013, log-rank test). Sampling of low-and high-grade glioma cultures showed that self-renewing cells forming oncospheres shared a molecular profile comprising embryonic and neural stem cell markers. Further characterization performed on subsets of high-grade gliomas and one low-grade glioma culture showed combination of this profile with mesenchymal markers, the radio-chemoresistance of the cells and the formation of aggressive tumors after intracerebral grafting. Conclusions/Significance: In brain tumors affecting adult patients, TSCs have been isolated only from high-grade gliomas. In contrast, our data show that tumor cells with stem cell-like or progenitor-like properties can be isolated from a wide range of histological sub-types and grades of pediatric brain tumors. They suggest that cellular mechanisms fueling tumor development differ between adult and pediatric brain tumors.	[Thirant, Cecile; Bessette, Barbara; Varlet, Pascale; Tavares, Silvina Dos Reis; Studler, Jeanne-Marie; Villa, Chiara; Miquel, Catherine; Bogeas, Alexandra; Surena, Anne-Laure; Dias-Morais, Amelia; Leonard, Nadine; Daumas-Duport, Catherine; Chneiweiss, Herve; Junier, Marie-Pierre] Univ Paris 05, Team Glial Plast, INSERM, UMR894, Paris, France; [Varlet, Pascale; Villa, Chiara; Miquel, Catherine; Leonard, Nadine; Daumas-Duport, Catherine; Junier, Marie-Pierre] Hosp St Anne, Dept Neuropathol, Paris, France; [Puget, Stephanie; Sainte-Rose, Christian] Univ Paris 05, Necker Hosp, Pediat Neurosurg Dept, Paris, France; [Puget, Stephanie; Grill, Jacques] Gustave Roussy Canc Inst, CNRS UMR 8203, Villejuif, France; [Cadusseau, Josette] Univ Paris 12, Inserm U955, Team 10, Creteil, France; [Studler, Jeanne-Marie] Coll France, F-75231 Paris, France; [Silvestre, David Carlos; Boussin, Francois D.] Univ Paris 07, CEA, INSERM, Lab Radiopathol UMR 967, Fontenay Aux Roses, France; [Susini, Aurelie; Bieche, Ivan] Hop Rene Huguenin, Inst Curie, INSERM U735, Lab Oncogenet, St Cloud, France; [Pflumio, Francoise] Univ Paris 07, CEA, INSERM, Lab Cellules Souches Hematopoiet & Leucem,UMR U96, Fontenay Aux Roses, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; PSL Research University Paris; College de France; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Thirant, C (corresponding author), Univ Paris 05, Team Glial Plast, INSERM, UMR894, Paris, France.	marie-pierre.junier@inserm.fr	Bessette, Barbara/G-2317-2015; Bièche, Ivan/O-7399-2017; miquel, catherine/B-5536-2013; Grill, Jacques/R-8093-2019; Pflumio, Francoise/E-2074-2017; Thirant, Cecile/CAG-6257-2022; herve, chneiweiss/Q-6818-2019	Bessette, Barbara/0000-0001-6673-3694; Bièche, Ivan/0000-0002-2430-5429; herve, chneiweiss/0000-0001-7675-5061; Boussin, francois/0000-0003-3778-4403; Pflumio, Francoise/0000-0001-8995-596X; Thirant, Cecile/0000-0003-3873-5240; VARLET, pascale/0000-0002-8164-1517	Institut National du Cancer (INCa); Association pour la Recherche sur le Cancer (ARC); Ile de France Cancer stem cell network (INCa/ARC and INCa-CSC network Ile-de-France); Region Ile-de-France; Fondation pour la Recherche Medicale	Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ile de France Cancer stem cell network (INCa/ARC and INCa-CSC network Ile-de-France)(Region Ile-de-FranceInstitut National du Cancer (INCA) France); Region Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This research was supported by Institut National du Cancer (INCa), Association pour la Recherche sur le Cancer (ARC), and the Ile de France Cancer stem cell network (grants INCa/ARC and INCa-CSC network Ile-de-France), the Region Ile-de-France (study fellowships to CT and AB), and the Fondation pour la Recherche Medicale (study fellowships to ALS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Bax DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005209; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bieche I, 2001, ONCOGENE, V20, P8109, DOI 10.1038/sj.onc.1204917; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Bredel M, 1999, CLIN CANCER RES, V5, P1786; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Dai C, 2003, CANCER J, V9, P72, DOI 10.1097/00130404-200303000-00002; Dufour C, 2009, STEM CELLS, V27, P2373, DOI 10.1002/stem.155; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Grimmer MR, 2006, CURR OPIN PEDIATR, V18, P634, DOI 10.1097/MOP.0b013e32801080fe; Gritti A, 2001, PROTOCOLS NEURAL CEL, P173, DOI DOI 10.1385/1-59259-207-4:173; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Kageyama R, 1997, INT J BIOCHEM CELL B, V29, P1389, DOI 10.1016/S1357-2725(97)89968-2; Kalifa C, 2005, J NEURO-ONCOL, V75, P279, DOI 10.1007/s11060-005-6752-x; Katsetos CD, 2009, J CELL PHYSIOL, V221, P514, DOI 10.1002/jcp.21884; Kelley TW, 2005, DIAGN MOL PATHOL, V14, P1, DOI 10.1097/01.pdm.0000138207.96718.85; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Liu QH, 2009, J NEURO-ONCOL, V94, P1, DOI 10.1007/s11060-009-9919-z; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632; Nakai E, 2009, CANCER INVEST, V27, P901, DOI 10.3109/07357900801946679; Nakamura M, 2007, NEURO-ONCOLOGY, V9, P113, DOI 10.1215/15228517-2006-036; Nicolis SK, 2007, NEUROBIOL DIS, V25, P217, DOI 10.1016/j.nbd.2006.08.022; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Panosyan EH, 2010, PEDIATR BLOOD CANCER, V55, P644, DOI 10.1002/pbc.22627; Park DM, 2009, MOL CELLS, V28, P7, DOI 10.1007/s10059-009-0111-2; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Real C, 2006, DEV BIOL, V300, P656, DOI 10.1016/j.ydbio.2006.09.032; Sharif A, 2007, ONCOGENE, V26, P2695, DOI 10.1038/sj.onc.1210071; Sharif A, 2004, NEUROSCIENCE, V126, P263, DOI 10.1016/j.neuroscience.2004.02.039; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sung T, 2000, BRAIN PATHOL, V10, P249, DOI 10.1111/j.1750-3639.2000.tb00258.x; Sutter R, 2007, BBA-REV CANCER, V1776, P125, DOI 10.1016/j.bbcan.2007.07.006; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Varlet P, 2004, NEUROSURGERY, V55, P1377, DOI 10.1227/01.NEU.0000143033.36582.40; Varlet P, 2005, NEUROCHIRURGIE, V51, P239; Vescovi AL, 1999, J NEUROTRAUM, V16, P689, DOI 10.1089/neu.1999.16.689; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	59	48	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16375	10.1371/journal.pone.0016375	http://dx.doi.org/10.1371/journal.pone.0016375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297991	Green Published, gold, Green Submitted			2022-12-25	WOS:000286664100026
J	Holdo, RM; Fryxell, JM; Sinclair, ARE; Dobson, A; Holt, RD				Holdo, Ricardo M.; Fryxell, John M.; Sinclair, Anthony R. E.; Dobson, Andrew; Holt, Robert D.			Predicted Impact of Barriers to Migration on the Serengeti Wildebeest Population	PLOS ONE			English	Article							HETEROGENEITY; FRAGMENTATION; VIABILITY; RAINFALL; FORAGE; SCALE	The Serengeti wildebeest migration is a rare and spectacular example of a once-common biological phenomenon. A proposed road project threatens to bisect the Serengeti ecosystem and its integrity. The precautionary principle dictates that we consider the possible consequences of a road completely disrupting the migration. We used an existing spatially-explicit simulation model of wildebeest movement and population dynamics to explore how placing a barrier to migration across the proposed route (thus creating two disjoint but mobile subpopulations) might affect the long-term size of the wildebeest population. Our simulation results suggest that a barrier to migration-even without causing habitat loss-could cause the wildebeest population to decline by about a third. The driver of this decline is the effect of habitat fragmentation (even without habitat loss) on the ability of wildebeest to effectively track temporal shifts in high-quality forage resources across the landscape. Given the important role of the wildebeest migration for a number of key ecological processes, these findings have potentially important ramifications for ecosystem biodiversity, structure, and function in the Serengeti.	[Holdo, Ricardo M.] Univ Missouri, Div Biol, Columbia, MO 65211 USA; [Fryxell, John M.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Sinclair, Anthony R. E.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Dobson, Andrew] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Holt, Robert D.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA	University of Missouri System; University of Missouri Columbia; University of Guelph; University of British Columbia; Princeton University; State University System of Florida; University of Florida	Holdo, RM (corresponding author), Univ Missouri, Div Biol, Columbia, MO 65211 USA.	holdor@missouri.edu			National Science Foundation [DEB 0308486]	National Science Foundation(National Science Foundation (NSF))	The authors would like to acknowledge financial support from the National Science Foundation Biocomplexity Program (DEB 0308486) for supporting development of the Savanna Dynamics model. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Boone RB, 2006, HUM ECOL, V34, P809, DOI 10.1007/s10745-006-9031-3; Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; CAMPBELL BM, 1995, SERENGETI, V2, P534; Coughenour M., 1993, SAVANNA LANDSCAPE RE; Dobson A, 2010, NATURE, V467, P272, DOI 10.1038/467272a; Fryxell JM, 2004, ECOLOGY, V85, P2429, DOI 10.1890/04-0147; Fryxell JM, 2005, ECOL LETT, V8, P328, DOI 10.1111/j.1461-0248.2005.00727.x; FRYXELL JM, 1988, AFR J ECOL, V26, P17, DOI 10.1111/j.1365-2028.1988.tb01125.x; FYNN RWS, 2010, AFRICAN J ECOLOGY, P1; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hilborn Ray, 1997, V28; Hobbs NT, 2008, GLOBAL ENVIRON CHANG, V18, P776, DOI 10.1016/j.gloenvcha.2008.07.011; Holdo RM, 2010, ECOL APPL, V20, P381, DOI 10.1890/08-0780.1; Holdo RM, 2009, AM NAT, V173, P431, DOI 10.1086/597229; Holdo RM, 2009, ECOL APPL, V19, P95, DOI 10.1890/07-1954.1; Illius AW, 1999, ECOL APPL, V9, P798, DOI 10.1890/1051-0761(1999)009[0798:OTRONC]2.0.CO;2; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; McNaughton SJ., 1979, SERENGETI DYNAMICS E, P46; Mduma SAR, 1999, J ANIM ECOL, V68, P1101, DOI 10.1046/j.1365-2656.1999.00352.x; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; Owen-Smith N, 2004, LANDSCAPE ECOL, V19, P761, DOI 10.1007/s10980-005-0247-2; Pascual MA, 1997, CONSERV BIOL, V11, P966, DOI 10.1046/j.1523-1739.1997.95437.x; Searle KR, 2010, OECOLOGIA, V163, P815, DOI 10.1007/s00442-010-1610-8; Talbot L.M., 1963, WILDLIFE MONOGR, V12, P1; WILCOVE DS, 2008, NO WAY BACK DECLINE; Wilmshurst JE, 1999, ECOLOGY, V80, P2338, DOI 10.1890/0012-9658(1999)080[2338:WCDIIT]2.0.CO;2; Wilmshurst JF, 2000, P ROY SOC B-BIOL SCI, V267, P345, DOI 10.1098/rspb.2000.1007; Wilmshurst JF, 1999, CAN J ZOOL, V77, P1223, DOI 10.1139/cjz-77-8-1223	30	71	71	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16370	10.1371/journal.pone.0016370	http://dx.doi.org/10.1371/journal.pone.0016370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283536	Green Published, Green Submitted, gold			2022-12-25	WOS:000286661400046
J	Mamo, G; Bayleyegn, G; Tessema, TS; Legesse, M; Medhin, G; Bjune, G; Abebe, F; Ameni, G				Mamo, Gezahegne; Bayleyegn, Gizachew; Tessema, Tesfaye Sisay; Legesse, Mengistu; Medhin, Girmay; Bjune, Gunnar; Abebe, Fekadu; Ameni, Gobena			Pathology of Camel Tuberculosis and Molecular Characterization of Its Causative Agents in Pastoral Regions of Ethiopia	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTION; RISK-FACTORS; CATTLE HUSBANDRY; TUBERCLE-BACILLI; IDENTIFICATION; EPIDEMIOLOGY; TRANSMISSION; POPULATIONS; PREVALENCE; DIAGNOSIS	A cross sectional study was conducted on 906 apparently healthy camels slaughtered at Akaki and Metehara abattoirs to investigate the pathology of camel tuberculosis (TB) and characterize its causative agents using postmortem examination, mycobacteriological culturing, and multiplex polymerase chain reaction (PCR), region of difference-4 (RD4)-based PCR and spoligotyping. The prevalence of camel TB was 10.04% (91/906) on the basis of pathology and it was significantly higher in females (chi(2) = 4.789; P = 0.029). The tropism of TB lesions was significantly different among the lymph nodes (chi(2) = 22.697; P = 0.002) and lung lobes (chi(2) = 17.901; P = 0.006). Mycobacterial growth was observed in 34% (31/91) of camels with grossly suspicious TB lesions. Upon further molecular characterization using multiplex PCR, 68% (21/31) of the colonies showed a positive signal for the genus Mycobacterium, of which two were confirmed Mycobacterium bovis (M. bovis) by RD4 deletion typing. Further characterization of the two M. bovis at strains level revealed that one of the strains was SB0133 while the other strain was new and had not been reported to the M. bovis database prior to this study. Hence, it has now been reported to the database, and designated as SB1953. In conclusion, the results of the present study have shown that the majority of camel TB lesions are caused by mycobacteria other than Mycobacterium tuberculosis complex. And hence further identification and characterization of these species would be useful towards the efforts made to control TB in camels.	[Mamo, Gezahegne; Bayleyegn, Gizachew; Tessema, Tesfaye Sisay] Univ Addis Ababa, Fac Vet Med, Debre Zeit, Ethiopia; [Legesse, Mengistu; Medhin, Girmay; Ameni, Gobena] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Mamo, Gezahegne; Legesse, Mengistu; Bjune, Gunnar; Abebe, Fekadu] Univ Oslo, Inst Hlth & Soc, Fac Med, Dept Gen Practice & Community Med, Oslo, Norway	Addis Ababa University; Addis Ababa University; University of Oslo	Mamo, G (corresponding author), Univ Addis Ababa, Fac Vet Med, Debre Zeit, Ethiopia.	gezahegnemamo@yahoo.com	Tessema, Tesfaye Sisay/AAD-6230-2020; Ameni, Gobena/AAR-4201-2020; Kassa, Gezahegne Mamo/AAN-2144-2020	Ameni, Gobena/0000-0003-3987-0671; Kassa, Gezahegne Mamo/0000-0002-4200-884X; Medhin, Girmay/0000-0003-2146-4261	Norwegian Programme for Development, Research and Education (NUFU) [PRO-2007/10198]	Norwegian Programme for Development, Research and Education (NUFU)	This study was financially supported by the Norwegian Programme for Development, Research and Education (NUFU), PRO-2007/10198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameni G, 2007, VET REC, V161, P782; Ameni G, 2010, VET REC, V167, P138, DOI 10.1136/vr.b4881; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Biffa D, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-28; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; CORNER LA, 1994, VET MICROBIOL, V40, P53, DOI 10.1016/0378-1135(94)90046-9; *CSA, 2008, STAT B, V2, P16; ELMOSSALAMI E, 1971, Zentralblatt fuer Veterinaermedizin Reihe B, V18, P253; GETAHUN T, 2002, NOMADIC PEOPLES, V6, P155; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; HUSSEN N, 2009, THESIS ADDIS ABABA U; Inangolet FO, 2008, TROP ANIM HEALTH PRO, V40, P501, DOI 10.1007/s11250-007-9126-x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kazwala RR, 2001, VET RES COMMUN, V25, P609, DOI 10.1023/A:1012757011524; KINNE J, 2006, TROP ANIM HLTH PROD, V38, P38; MAMO G, 2009, B ANIM HLTH PROD AFR, V57, P1; Manefield GW, 1997, CAMELS COMPENDIUM C; Markakis John., 2004, PASTORALISM MARGIN; Menzies FD, 2000, VET J, V160, P92, DOI 10.1053/tvjl.2000.0482; Munyeme M, 2009, TROP ANIM HEALTH PRO, V41, P345, DOI 10.1007/s11250-008-9195-5; Munyeme M, 2008, PREV VET MED, V85, P317, DOI 10.1016/j.prevetmed.2008.03.006; NORI M, 2005, SUSTAINABLE CAMEL MI; *OIE, 2004, OIE MAN STAND DIAGN, P451; Oloya J, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-95; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Ozygit MO, 2007, VET REC, V160, P307, DOI 10.1136/vr.160.9.307; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; Refai M, 1992, P 1 INT CAM C; Sheik-Mohamed A, 1999, TROP MED INT HEALTH, V4, P695, DOI 10.1046/j.1365-3156.1999.00473.x; UNDP (United Nations Development Programme), 2007, ROCK HARD PLAC ARM V; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Wernery U, 2002, INFECT DIS CAMELIDS, p[23, 33]; Wilton S, 1992, PCR Methods Appl, V1, P269; Zubair R., 2004, J CAMEL SCI, V1, P103	37	35	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e15862	10.1371/journal.pone.0015862	http://dx.doi.org/10.1371/journal.pone.0015862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283668	Green Submitted, Green Published, gold			2022-12-25	WOS:000286523400007
J	Pedroso, DCS; Tellechea, A; Moura, L; Fidalgo-Carvalho, I; Duarte, J; Carvalho, E; Ferreira, L				Pedroso, Dora C. S.; Tellechea, Ana; Moura, Liane; Fidalgo-Carvalho, Isabel; Duarte, Joao; Carvalho, Eugenia; Ferreira, Lino			Improved Survival, Vascular Differentiation and Wound Healing Potential of Stem Cells Co-Cultured with Endothelial Cells	PLOS ONE			English	Article							CORD BLOOD-CELLS; PROGENITOR CELLS; HEMATOPOIETIC PROGENITOR; CYTOKINE; ANGIOGENESIS; PROMOTE; FIBRIN; EXPRESSION; IL-10	In this study, we developed a methodology to improve the survival, vascular differentiation and regenerative potential of umbilical cord blood (UCB)-derived hematopoietic stem cells (CD34(+) cells), by co-culturing the stem cells in a 3D fibrin gel with CD34(+)-derived endothelial cells (ECs). ECs differentiated from CD34(+) cells appear to have superior angiogenic properties to fully differentiated ECs, such as human umbilical vein endothelial cells (HUVECs). Our results indicate that the pro-survival effect of CD34(+)-derived ECs on CD34(+) cells is mediated, at least in part, by bioactive factors released from ECs. This effect likely involves the secretion of novel cytokines, including interleukin-17 (IL-17) and interleukin-10 (IL-10), and the activation of the ERK 1/2 pathway in CD34(+) cells. We also show that the endothelial differentiation of CD34(+) cells in co-culture with CD34(+)-derived ECs is mediated by a combination of soluble and insoluble factors. The regenerative potential of this co-culture system was demonstrated in a chronic wound diabetic animal model. The co-transplantation of CD34(+) cells with CD34(+)-derived ECs improved the wound healing relatively to controls, by decreasing the inflammatory reaction and increasing the neovascularization of the wound.	[Pedroso, Dora C. S.; Tellechea, Ana; Moura, Liane; Carvalho, Eugenia; Ferreira, Lino] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Pedroso, Dora C. S.; Ferreira, Lino] Ctr Inovacao Biotecnol, Cantanhede, Portugal; [Fidalgo-Carvalho, Isabel] Inst Biol Mol & Celular, Oporto, Portugal; [Duarte, Joao] Crioestaminal, Cantanhede, Portugal	Universidade de Coimbra; Universidade do Porto	Pedroso, DCS (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	lino@biocant.pt	Tellechea, Ana/C-4900-2013; Moura, Liane IF/F-6534-2015; iMed.ULisboa, InTraCellADD/B-4826-2014; Tellechea, Ana/O-8325-2019; Fidalgo-Carvalho, Isabel/E-1335-2011; Carvalho, Eugenia/AAV-6868-2021; Fidalgo-Carvalho, Isabel SS/P-5192-2015	Moura, Liane IF/0000-0003-4264-6865; Tellechea, Ana/0000-0001-9387-7706; Carvalho, Eugenia/0000-0001-6264-3632; Fidalgo-Carvalho, Isabel SS/0000-0002-7882-3555; Pedroso, Dora/0000-0002-5735-5094; ferreira, lino/0000-0001-8985-9302	Crioestaminal S.A.; Crioestaminal; Associacao Viver a Ciencia; MIT- Portugal Program; Marie Curie Reintegration Grant; EFSD/JDRF/Novo Nordisk European Programme; Fundacao para a Ciencia e Tecnologia [PTDC/CTM/099659/2008, PTDC/SAU-MII/098567/2008, SFRH/BD/48624/2008, SFRH/BD/60837/2009, BPD 000081/CMIT]	Crioestaminal S.A.; Crioestaminal; Associacao Viver a Ciencia; MIT- Portugal Program; Marie Curie Reintegration Grant(European Commission); EFSD/JDRF/Novo Nordisk European Programme(Juvenile Diabetes Research Foundation); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by Crioestaminal S.A. (project reference: INJECTCORD), Crioestaminal (LF), Associacao Viver a Ciencia (LF), MIT- Portugal Program (LF) and a Marie Curie Reintegration Grant (LF), EFSD/JDRF/Novo Nordisk European Programme in Type 1 Diabetes Research (EC), and Fundacao para a Ciencia e Tecnologia (PTDC/CTM/099659/2008 (LF), PTDC/SAU-MII/098567/2008 (EC), SFRH/BD/48624/2008 (AT), SFRH/BD/60837/2009 (LM), and BPD 000081/CMIT (DP)). Joao Duarte is an employee of Crioestaminal, a Portuguese cryobanking stem cell company. He contributed for the characterization of stem cells and their progenies. Crioestaminal had no other role in the study. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Behringer D, 1997, BRIT J HAEMATOL, V97, P9, DOI 10.1046/j.1365-2141.1997.d01-2143.x; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Broxmeyer HE, 2003, P NATL ACAD SCI USA, V100, P645, DOI 10.1073/pnas.0237086100; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Cha JS, 2007, CLIN DERMATOL, V25, P73, DOI 10.1016/j.clindermatol.2006.10.002; Chen CC, 1996, CYTOKINE, V8, P58, DOI 10.1006/cyto.1995.0008; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; de Boer HC, 2006, ARTERIOSCL THROM VAS, V26, P1653, DOI 10.1161/01.ATV.0000222982.55731.f1; Deng XM, 2000, P NATL ACAD SCI USA, V97, P1578, DOI 10.1073/pnas.97.4.1578; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Finkenzeller G, 2009, CELL PROLIFERAT, V42, P498, DOI 10.1111/j.1365-2184.2009.00610.x; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Geest CR, 2009, BLOOD, V114, P3402, DOI 10.1182/blood-2008-08-175141; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Henning RJ, 2006, CELL TRANSPLANT, V15, P647, DOI 10.3727/000000006783981611; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Leor J, 2005, CYTOTHERAPY, V7, P251, DOI 10.1080/14653240510027163; Lozito TP, 2009, J CELL BIOCHEM, V107, P714, DOI 10.1002/jcb.22167; Nakamuta JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006005; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Parada Y, 2001, J BIOL CHEM, V276, P23572, DOI 10.1074/jbc.M101885200; Pradhan L, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000945; Ratajczak J, 1998, LEUKEMIA, V12, P371, DOI 10.1038/sj.leu.2400927; Romagnani P, 2005, CIRC RES, V97, P314, DOI 10.1161/01.RES.0000177670.72216.9b; SCHEUBEL RJ, 2008, INT J CARDIOL; Sivan-Loukianova E, 2003, J VASC RES, V40, P368, DOI 10.1159/000072701; Smadja DM, 2008, J CELL MOL MED, V12, P975, DOI 10.1111/j.1582-4934.2008.00161.x; Starnes T, 2001, J IMMUNOL, V167, P4137, DOI 10.4049/jimmunol.167.8.4137; Tang H, 2006, BLOOD, V108, P1189, DOI 10.1182/blood-2006-01-007187; Valbonesi M, 2004, TRANSFUS APHER SCI, V30, P153, DOI 10.1016/j.transci.2003.11.006; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; WeberNordt RM, 1996, BLOOD, V88, P2549, DOI 10.1182/blood.V88.7.2549.bloodjournal8872549; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226	38	78	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16114	10.1371/journal.pone.0016114	http://dx.doi.org/10.1371/journal.pone.0016114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283630	Green Published, gold			2022-12-25	WOS:000286523400018
J	Petrella, S; Gelus-Ziental, N; Maudry, A; Laurans, C; Boudjelloul, R; Sougakoff, W				Petrella, Stephanie; Gelus-Ziental, Nathalie; Maudry, Arnaud; Laurans, Caroline; Boudjelloul, Rachid; Sougakoff, Wladimir			Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide	PLOS ONE			English	Article							DRUG PYRAZINAMIDE; TUBERCLE-BACILLI; PNCA MUTATIONS; GENE; IDENTIFICATION; NICOTINAMIDASE; MECHANISM; DYNAMICS; STRAINS; BINDING	Pyrazinamidase (PncA) activates the first-line antituberculous drug pyrazinamide into pyrazinoic acid. The crystal structure of the Mycobacterium tuberculosis PncA protein has been determined, showing significant differences in the substrate binding cavity when compared to the pyrazinamidases from Pyrococcus horikoshii and Acinetobacter baumanii. In M. tuberculosis, this region was found to hold a Fe2+ ion coordinated by one aspartate and three histidines, one of them corresponding to His57 which is replaced by Asp in Mycobacterium bovis, a species naturally resistant to pyrazinamide. The binding cavity also contains a Cys138-Asp8-Lys96 motif evocating a cysteine-based catalytic mechanism. Mutants have been constructed and investigated by kinetic and thermal shift assays, highlighting the importance of protein folding and thermal stability in the pyrazinamidase activity.	[Petrella, Stephanie; Gelus-Ziental, Nathalie; Maudry, Arnaud; Laurans, Caroline; Boudjelloul, Rachid; Sougakoff, Wladimir] Univ Paris 06, UPMC, Fac Med Pitie Salpetriere, ER Bacteriol Hyg EA1541 5, Paris, France; [Gelus-Ziental, Nathalie] Univ Lille 1, INSERM, U908, F-59655 Villeneuve Dascq, France; [Gelus-Ziental, Nathalie] Univ Lille 1, CNRS, FRE3249, F-59655 Villeneuve Dascq, France; [Laurans, Caroline] Ctr Hosp Victor Provo, Equipe Operat Hyg & Infectiol, Roubaix, France; [Sougakoff, Wladimir] INSERM, LRMA, UMRS Pitie Salpetriere 872 12, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Petrella, S (corresponding author), Univ Paris 06, UPMC, Fac Med Pitie Salpetriere, ER Bacteriol Hyg EA1541 5, Paris, France.	wladimir.sougakoff@upmc.fr	SOUGAKOFF, Wladimir/O-9754-2017	SOUGAKOFF, Wladimir/0000-0002-2447-517X; Petrella, Stephanie/0000-0001-6641-5901	Ministere de la Recherche [UPRES EA1541]	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by a grant from the Ministere de la Recherche (program grant UPRES EA1541). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doustdar F, 2009, MICROB DRUG RESIST, V15, P251, DOI 10.1089/mdr.2009.0066; Du XL, 2001, BIOCHEMISTRY-US, V40, P14166, DOI 10.1021/bi0115479; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fyfe PK, 2009, ANGEW CHEM INT EDIT, V48, P9176, DOI 10.1002/anie.200903407; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jureen P, 2008, ANTIMICROB AGENTS CH, V52, P1852, DOI 10.1128/AAC.00110-08; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KONNO K, 1967, AM REV RESPIR DIS, V95, P461; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lemaitre N, 1999, ANTIMICROB AGENTS CH, V43, P1761, DOI 10.1128/AAC.43.7.1761; Lemaitre N, 2001, BIOCHEM J, V353, P453, DOI 10.1042/0264-6021:3530453; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MCCOY AJ, 2007, J APPL CRYSTALLOGR, V40, P1297; McDonnell PA, 2009, ANAL BIOCHEM, V392, P59, DOI 10.1016/j.ab.2009.05.044; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Pandey S, 2009, PATHOLOGY, V41, P582, DOI 10.1080/00313020903071587; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Scorpio A, 1997, J CLIN MICROBIOL, V35, P106, DOI 10.1128/JCM.35.1.106-110.1997; Seiner DR, 2010, BIOCHEMISTRY-US, V49, P9613, DOI 10.1021/bi1011157; Sekiguchi JI, 2007, J CLIN MICROBIOL, V45, P2802, DOI 10.1128/JCM.00352-07; Sheen P, 2009, TUBERCULOSIS, V89, P109, DOI 10.1016/j.tube.2009.01.004; Unissa AN, 2009, BIOINFORMATION, V4, P24, DOI 10.6026/97320630004024; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Zhang H, 2009, J INT MED RES, V37, P1430, DOI 10.1177/147323000903700517; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zimic M, 2010, INFECT GENET EVOL, V10, P346, DOI 10.1016/j.meegid.2009.11.016	31	99	103	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e15785	10.1371/journal.pone.0015785	http://dx.doi.org/10.1371/journal.pone.0015785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283666	Green Published, Green Submitted, gold			2022-12-25	WOS:000286523400005
J	Getz, WM; Owen-Smith, N				Getz, Wayne M.; Owen-Smith, Norman			Consumer-Resource Dynamics: Quantity, Quality, and Allocation	PLOS ONE			English	Article								Background: The dominant paradigm for modeling the complexities of interacting populations and food webs is a system of coupled ordinary differential equations in which the state of each species, population, or functional trophic group is represented by an aggregated numbers-density or biomass-density variable. Here, using the metaphysiological approach to model consumer-resource interactions, we formulate a two-state paradigm that represents each population or group in a food web in terms of both its quantity and quality. Methodology and Principal Findings: The formulation includes an allocation function controlling the relative proportion of extracted resources to increasing quantity versus elevating quality. Since lower quality individuals senesce more rapidly than higher quality individuals, an optimal allocation proportion exists and we derive an expression for how this proportion depends on population parameters that determine the senescence rate, the per-capita mortality rate, and the effects of these rates on the dynamics of the quality variable. We demonstrate that oscillations do not arise in our model from quantity-quality interactions alone, but require consumer-resource interactions across trophic levels that can be stabilized through judicious resource allocation strategies. Analysis and simulations provide compelling arguments for the necessity of populations to evolve quality-related dynamics in the form of maternal effects, storage or other appropriate structures. They also indicate that resource allocation switching between investments in abundance versus quality provide a powerful mechanism for promoting the stability of consumer-resource interactions in seasonally forcing environments. Conclusions/Significance: Our simulations show that physiological inefficiencies associated with this switching can be favored by selection due to the diminished exposure of inefficient consumers to strong oscillations associated with the well-known paradox of enrichment. Also our results demonstrate how allocation switching can explain observed growth patterns in experimental microbial cultures and discuss how our formulation can address questions that cannot be answered using the quantity-only paradigms that currently predominate.	[Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ Stellenbosch, Stellenbosch Inst Adv Study STIAS, Wallenberg Res Ctr, ZA-7600 Stellenbosch, South Africa; [Owen-Smith, Norman] Univ Witwatersrand, Sch Anim Plant & Environm Sci, ZA-2050 Johannesburg, South Africa	University of California System; University of California Berkeley; Stellenbosch University; University of Witwatersrand	Getz, WM (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	wgetz@berkeley.edu	Owen-Smith, Norman/ABI-5113-2020; Getz, Wayne/I-4521-2013	Owen-Smith, Norman/0000-0001-8429-1201; Getz, Wayne/0000-0001-8784-9354	NIH [GM083863]; James S. McDonnell Foundation; South African NRF; Stellenbosch Institute for Advanced Study, Stellenbosch, South Africa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; South African NRF(National Research Foundation - South Africa); Stellenbosch Institute for Advanced Study, Stellenbosch, South Africa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported with funding from NIH Grant GM083863 (WMG), the James S. McDonnell Foundation (WMG), the South African NRF (NOS), and the Stellenbosch Institute for Advanced Study, Stellenbosch, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AANES R, 2002, ECOL LETT, P445; Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Abrams PA, 2005, J EVOLUTION BIOL, V18, P1162, DOI 10.1111/j.1420-9101.2004.00843.x; ABRAMS PA, 1988, ECOLOGY, V69, P1418, DOI 10.2307/1941639; ABRAMS PA, 1994, ECOLOGY, V75, P1118, DOI 10.2307/1939435; ABRAMS PA, 1994, EVOLUTIONARY ECOLOGY, P150; ABRAMS PA, 2009, AM NAT, P321; ABRAMS PA, 2004, EVOLUTIONARY ECOLOGY, V8, P150; AKCAKAYA HR, 1988, B MATH BIOL, V50, P503, DOI 10.1007/BF02458849; ALLEN AP, 2009, ECOL LETT, P369; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; ANDERSEN T, 2004, ECOL LETT, P884; ARDITI R, 1992, ECOLOGY, V73, P1544, DOI 10.2307/1940007; BALTENSWEILER W, 1977, ANNU REV ENTOMOL, V22, P79, DOI 10.1146/annurev.en.22.010177.000455; BARBOSA PA, 1997, PLANT RESOURCE ALLOC; Batzli GO, 1999, TRENDS ECOL EVOL, V14, P129, DOI 10.1016/S0169-5347(98)01581-X; BAXTER PWJ, 2005, ECOLOGICAL APPL, P1331; BEDDINGTON JR, 1975, J ANIM ECOL, V44, P331, DOI 10.2307/3866; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bullock JM, 2008, J ECOL, V96, P567, DOI 10.1111/j.1365-2745.2008.01382.x; Caswell H., 2001, MATRIX POPULATION MO; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; Crowder LB, 2008, ANNU REV ECOL EVOL S, V39, P259, DOI 10.1146/annurev.ecolsys.39.110707.173406; De Roos AM, 2001, OIKOS, V94, P51, DOI 10.1034/j.1600-0706.2001.11313.x; DEANGELIS DL, 1975, ECOLOGY, V56, P881, DOI 10.2307/1936298; DEMETRIUS L, 2009, PHYSICA A, P651; ELLNER SP, 2006, AM NAT, P410; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; FESTABIANCHET M, 2003, J ANIM ECOL, P640; Field JC, 2006, PROG OCEANOGR, V68, P238, DOI 10.1016/j.pocean.2006.02.010; Forsyth DM, 2006, ECOLOGY, V87, P297, DOI 10.1890/05-0709; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; GAUZE GF, 1934, STRUGGLE EXISTENCE, pR9; Getz W. M., 1989, Population harvesting: demographic models of fish, forest, and animal resources.; Getz Wayne M., 1999, Natural Resource Modeling, V12, P197; Getz WM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000209; Getz Wayne M., 1994, Lecture Notes in Biomathematics, V100, P411; Getz WM, 1999, ANN ZOOL FENN, V36, P11; Getz WM, 1996, ECOLOGY, V77, P2014, DOI 10.2307/2265697; Getz WM, 1998, BIOSCIENCE, V48, P540, DOI 10.2307/1313316; GETZ WM, 1991, NAT RESOUR MODEL, V5, P623; GETZ WM, 1993, EVOLUTIONARY ECOLOGY, P287; GETZ WM, 1984, J THEOR BIOL, P623; GETZ WM, 2010, ECOLOGY LETT; Ginzburg L. R., 2004, ECOLOGICAL ORBITS PL; Ginzburg LR, 2010, BIOL LETTERS, V6, P850, DOI 10.1098/rsbl.2010.0452; GINZBURG LR, 1986, J THEOR BIOL, P385; GINZBURG LR, 1998, J ANIM ECOL, P325; Gross J. E., 2010, DYNAMICS LARGE HERBI, P117; GROVER JP, 2003, AM NAT, P29; GURNEY WSC, 1998, ECOLOGICAL DYNAMICS, pR13; Gutierrez A. P., 1996, Applied population ecology: a supply-demand approach.; Hamel S, 2009, ECOLOGY, V90, P1981, DOI 10.1890/08-0596.1; Haque M, 2009, B MATH BIOL, V71, P430, DOI 10.1007/s11538-008-9368-4; Helle T, 2008, ECOGRAPHY, V31, P221, DOI 10.1111/j.0906-7590.2008.4912.x; HILKER FM, 2008, J THEOR BIOL, P299; Hobbs N. T., 2010, DYNAMICS LARGE HERBI, P141; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Husseman JS, 2003, OIKOS, V101, P591, DOI 10.1034/j.1600-0706.2003.12230.x; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; INCHAUSTI P, 1998, J ANIM ECOL, P180; Inchausti P, 2009, PHILOS T R SOC B, V364, P1117, DOI 10.1098/rstb.2008.0292; IVES AR, 1985, J THEOR BIOL, P65; JOHST K, 2008, POPULATION ECOLOGY, P79; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; KOOIJMAN SALM, 1989, FUNCT ECOL, V3, P325, DOI 10.2307/2389373; KOT M, 1984, THEORETICAL POPULATI, P340; Kuwamura M, 2009, J MATH BIOL, V58, P459, DOI 10.1007/s00285-008-0203-1; LAMBIN X, 2006, J ANIM ECOL, P340; LANDE R, 2003, STOCHASTIC POPULATIO, pR10; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; LESLIE PH, 1948, BIOMETRIKA, V35, P213, DOI 10.2307/2332342; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; LINDSTROM J, 2002, ECOL LETT, P338; Lotka A. J., 1925, P460; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1973, STABILITY COMPLEXITY, pR9; McGill BJ, 2007, ANNU REV ECOL EVOL S, V38, P403, DOI 10.1146/annurev.ecolsys.36.091704.175517; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; MOUGI A, 2009, THEORETICAL ECOLOGY, P33; MOYES K, 2009, J ANIM ECOL, P406; Mueller T, 2008, OIKOS, V117, P654, DOI 10.1111/j.0030-1299.2008.16291.x; Murdoch W. W., 2003, CONSUMER RESOURCE DY, p[xiii, 462]; Murdoch WW, 2002, NATURE, V417, P541, DOI 10.1038/417541a; NICHOLSON A. J., 1935, Proceedings of the Zoological Society of London, P551; NICHOLSON AJ, 1933, J ANIM ECOL, P132; NISBET RM, 2000, J ANIM ECOL, P913; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; Olff H, 2009, PHILOS T R SOC B, V364, P1755, DOI 10.1098/rstb.2008.0222; Owen-Smith N., 2008, RESOURCE ECOLOGY SPA, P159, DOI DOI 10.1007/978-1-4020-6850-8_14; Owen-Smith RN., 2002, CAMB ST ECO, DOI 10.1017/CBO9780511525605; Owens IPF, 2006, TRENDS ECOL EVOL, V21, P356, DOI 10.1016/j.tree.2006.03.014; OWENSMITH N, 1987, ECOLOGY, V68, P319, DOI 10.2307/1939263; OWENSMITH N, 2002, ECOLOGICAL MODELLING, P153; PARKER KL, 2009, FUNCTIONAL ECOLOGY, P57; PONTRYAGIN LS, 1964, MATH THEORY OPTIMAL, V340, pR7; Power ME, 2002, ECOL RES, V17, P451, DOI 10.1046/j.1440-1703.2002.00503.x; RAMOSJILIBERTO R, 2000, ECOLOGICAL MODELLING, P221; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; Ryan SJ, 2007, BEHAV ECOL, V18, P635, DOI 10.1093/beheco/arm028; SCHULTZ JC, 1983, ACS SYM SER, V208, P37; SIMARD MA, 2008, J ANIM ECOL, P678; STREIFER W, 1973, ECOLOGY, V54, P392, DOI 10.2307/1934347; THOMPSON W. R., 1929, PARASILOLOGY, V21, P180, DOI 10.1017/S0031182000022885; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; VADASZ P, 2010, MICROB ECOL, P233; van der Putten WH, 2009, OECOLOGIA, V161, P1, DOI 10.1007/s00442-009-1351-8; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Weladji RB, 2010, OECOLOGIA, V162, P261, DOI 10.1007/s00442-009-1443-5; White TCR, 2008, BIOL REV, V83, P227, DOI 10.1111/j.1469-185X.2008.00041.x; Wilmers CC, 2005, PLOS BIOL, V3, P571, DOI 10.1371/journal.pbio.0030092; WILMERS CC, 2004, ECOLOGICAL MODELLING, P193; WILMERS CC, 2003, J ANIM ECOL, P909; WILMERS CC, 2003, ECOL LETT, P996; Wilmers CC, 2007, J ANIM ECOL, V76, P1037, DOI 10.1111/j.1365-2656.2007.01289.x; WILSON DS, 1977, AM NAT, V111, P157, DOI 10.1086/283146; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	121	3	3	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14539	10.1371/journal.pone.0014539	http://dx.doi.org/10.1371/journal.pone.0014539			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283752	gold, Green Published, Green Submitted			2022-12-25	WOS:000286522200002
J	Martellini, JA; Cole, AL; Svoboda, P; Stuchlik, O; Chen, LM; Chai, KX; Gangrade, BK; Sorensen, OE; Pohl, J; Cole, AM				Martellini, Julie A.; Cole, Amy L.; Svoboda, Pavel; Stuchlik, Olga; Chen, Li-Mei; Chai, Karl X.; Gangrade, Bhushan K.; Sorensen, Ole E.; Pohl, Jan; Cole, Alexander M.			HIV-1 Enhancing Effect of Prostatic Acid Phosphatase Peptides Is Reduced in Human Seminal Plasma	PLOS ONE			English	Article							SEMEN-MEDIATED ENHANCEMENT; ANTIMICROBIAL PEPTIDES; SEMENOGELIN-I; INFECTION; DEFENSINS; ANTIGEN; INHIBITOR; SUBSTRATE; FLUID; SEVI	We recently reported that HIV-1 infection can be inhibited by innate antimicrobial components of human seminal plasma (SP). Conversely, naturally occurring peptidic fragments from the SP-derived prostatic acid phosphatase ( PAP) have been reported to form amyloid fibrils called "SEVI'' and enhance HIV-1 infection in vitro. In order to understand the biological consequence of this proviral effect, we extended these studies in the presence of human SP. PAP-derived peptides were agitated to form SEVI and incubated in the presence or absence of SP. While PAP-derived peptides and SEVI alone were proviral, the presence of 1% SP ablated their proviral activity in several different anti-HIV-1 assays. The anti-HIV-1 activity of SP was concentration dependent and was reduced following filtration. Supraphysiological concentrations of PAP peptides and SEVI incubated with diluted SP were degraded within hours, with SP exhibiting proteolytic activity at dilutions as high as 1:200. Sub-physiological concentrations of two prominent proteases of SP, prostate-specific antigen (PSA) and matriptase, could degrade physiological and supraphysiological concentrations of PAP peptides and SEVI. While human SP is a complex biological fluid, containing both antiviral and proviral factors, our results suggest that PAP peptides and SEVI may be subject to naturally occurring proteolytic components capable of reducing their proviral activity.	[Martellini, Julie A.; Cole, Amy L.; Chen, Li-Mei; Chai, Karl X.; Cole, Alexander M.] Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Biomol Sci Ctr,Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Svoboda, Pavel; Pohl, Jan] Emory Univ, Microchem & Prote Facil, Atlanta, GA 30322 USA; [Svoboda, Pavel; Stuchlik, Olga; Pohl, Jan] Ctr Dis Control & Prevent, Biotechnol Core Facil Branch, Div Safety Res, Atlanta, GA USA; [Gangrade, Bhushan K.] Ctr Reprod Med, Orlando, FL USA; [Sorensen, Ole E.] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden	State University System of Florida; University of Central Florida; Emory University; Centers for Disease Control & Prevention - USA; Lund University	Martellini, JA (corresponding author), Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Biomol Sci Ctr,Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	acole@mail.ucf.edu		Sorensen, Ole E./0000-0001-8681-6921	National Institutes of Health [R01 AI052017, U19 AI065430]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052017, U19AI065430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was supported by the National Institutes of Health: Grants R01 AI052017; and, U19 AI065430 (Project 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgeon F, 2004, BIOL REPROD, V70, P768, DOI 10.1095/biolreprod.103.022533; Brillard-Bourdet M, 2002, EUR J BIOCHEM, V269, P390, DOI 10.1046/j.0014-2956.2001.02667.x; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Chen MQ, 2010, MOL CELL BIOCHEM, V337, P259, DOI 10.1007/s11010-009-0307-y; CHRISTOPHERHENN.J, 2008, ANIM HEALTH RES REV, P1; Cole AM, 2003, EXPERT OPIN THER TAR, V7, P329, DOI 10.1517/eott.7.3.329.22436; Com E, 2003, BIOL REPROD, V68, P95, DOI 10.1095/biolreprod.102.005389; Edstrom AML, 2008, J IMMUNOL, V181, P3413, DOI 10.4049/jimmunol.181.5.3413; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 1997, SEMIN HEMATOL, V34, P343; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hauber I, 2009, P NATL ACAD SCI USA, V106, P9033, DOI 10.1073/pnas.0811827106; KELLY RW, 1995, HUM REPROD, V10, P1686, DOI 10.1093/oxfordjournals.humrep.a136156; Kim KA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-55; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; LILJA H, 1985, FEBS LETT, V182, P181, DOI 10.1016/0014-5793(85)81179-0; LILJA H, 1993, WORLD J UROL, V11, P188; LILJA H, 1988, SCAND J CLIN LAB INV, V48, P13; Malm J, 2000, PROSTATE, V45, P132, DOI 10.1002/1097-0045(20001001)45:2<132::AID-PROS7>3.0.CO;2-3; Mangoni ME, 1996, FEBS LETT, V383, P93, DOI 10.1016/0014-5793(96)00236-0; MARDH PA, 1975, SCAND J UROL NEPHROL, V9, P17, DOI 10.3109/00365597509139907; Martellini JA, 2009, FASEB J, V23, P3609, DOI 10.1096/fj.09-131961; MOULAEI T, 2010, PROTEIN SCI; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Robert M, 1997, BIOCHEMISTRY-US, V36, P3811, DOI 10.1021/bi9626158; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Sorensen OE, 2003, J BIOL CHEM, V278, P28540, DOI 10.1074/jbc.M301608200; TAYLOR PW, 1952, SURG GYNECOL OBSTET, V94, P662; von Horsten HH, 2002, BIOL REPROD, V67, P804, DOI 10.1095/biolreprod.102.004564; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Ye ZQ, 2009, BIOCHEMISTRY-US, V48, P11582, DOI 10.1021/bi901709j; YU JX, 1994, J BIOL CHEM, V269, P18843; Zhao H, 2008, PEPTIDES, V29, P505, DOI 10.1016/j.peptides.2008.01.009	35	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16285	10.1371/journal.pone.0016285	http://dx.doi.org/10.1371/journal.pone.0016285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283773	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200047
J	Santiago, C; Ruiz, JR; Rodriguez-Romo, G; Fiuza-Luces, C; Yvert, T; Gonzalez-Freire, M; Gomez-Gallego, F; Moran, M; Lucia, A				Santiago, Catalina; Ruiz, Jonatan R.; Rodriguez-Romo, Gabriel; Fiuza-Luces, Carmen; Yvert, Thomas; Gonzalez-Freire, Marta; Gomez-Gallego, Felix; Moran, Maria; Lucia, Alejandro			The K153R Polymorphism in the Myostatin Gene and Muscle Power Phenotypes in Young, Non-Athletic Men	PLOS ONE			English	Article							JUMP PERFORMANCE; VERTICAL JUMP; STRENGTH; GENOTYPE; GROWTH; SARCOPENIA; REGULATOR; HUMANS; CATTLE; MICE	The Lys(K) 153Arg(R) polymorphism in exon 2 (rs1805086, 2379 A>G replacement) of the myostatin (MSTN) gene is a candidate to influence skeletal muscle phenotypes. We examined the association between the MSTN K153R polymorphism and 'explosive' leg power, assessed during sprint (30 m) and stationary jumping tests [squat (SJ) and counter-movement jumps (CMJ)] in non-athletic young adults (University students) [n = 281 (214 men); age: 21-32 years]. We also genotyped the MSTN exonic variants E164K (rs35781413), I225T, and P198A, yet no subject carried any of these variant MSTN alleles. As for the K153R polymorphism, we found only one woman with the KR genotype; thus, we presented the results only for men. The results of a one-way ANCOVA (with age, weight and height entered as covariates) showed that men with the KR genotype (n = 15) had a worse performance in vertical jumps compared with those with the KK genotype [SJ: vertical displacement of center of gravity (CG) of 35.17 +/- 1.42 vs. 39.06 +/- 0.39 cm, respectively, P = 0.009; CMJ: vertical displacement of CG of 36.44 +/- 1.50 vs. 40.63 +/- 0.41 cm, respectively, P = 0.008]. The results persisted after adjusting for multiple comparisons according to Bonferroni. Performance in 30 m sprint tests did however not differ by K153R genotypes. In summary, the MSTN K153R polymorphism is associated with the ability to produce 'peak' power during muscle contractions, as assessed with vertical jump tests, in young non-athletic men. Although more research is still needed, this genetic variation is among the numerous candidates to explain, alone or in combination with other polymorphisms, individual variations in muscle phenotypes.	[Santiago, Catalina; Fiuza-Luces, Carmen; Yvert, Thomas; Gonzalez-Freire, Marta; Gomez-Gallego, Felix; Lucia, Alejandro] Univ Europea Madrid, Dept Biomed, Madrid, Spain; [Ruiz, Jonatan R.] Karolinska Inst, Unit Prevent Nutr, Dept Biosci & Nutr, Novum, Stockholm, Sweden; [Rodriguez-Romo, Gabriel] Univ Politecn Madrid, INEF, Madrid, Spain; [Moran, Maria] Hosp Univ 12 Octubre, Madrid, Spain	European University of Madrid; Karolinska Institutet; Universidad Politecnica de Madrid; Facultad de Ciencias de la Actividad Fisica del Deporte (INEF); Hospital Universitario 12 de Octubre	Santiago, C (corresponding author), Univ Europea Madrid, Dept Biomed, Madrid, Spain.	alejandro.lucia@uem.es	Santiago, Catalina/P-8177-2019; Lucia, Alejandro/M-2759-2014; Gonzalez-Freire, Marta/ABG-1197-2020; Gomez-Gallego, Felix/H-6925-2013; Gomez-Gallego, Felix/AAD-9617-2020; Rodriguez-Romo, Gabriel/AAD-1603-2022; Moran, Maria/HHS-1798-2022; RUIZ, JONATAN R/M-1338-2015; Santiago, Catalina/K-6803-2014	Santiago, Catalina/0000-0003-3852-8217; Lucia, Alejandro/0000-0002-3025-2060; Gomez-Gallego, Felix/0000-0002-1968-1761; Rodriguez-Romo, Gabriel/0000-0003-3111-6340; RUIZ, JONATAN R/0000-0002-7548-7138; Santiago, Catalina/0000-0003-3852-8217; Gonzalez-Freire, Marta/0000-0001-9741-2826; Lucia, Alejandro/0000-0002-5565-0997; Fiuza-Luces, Carmen/0000-0001-8131-7007; Yvert, Thomas/0000-0002-9451-9799	Consejo Superior de Deportes (CSD) [UPR10/08]; Fondo de Investigaciones Sanitarias (FIS) [PS09/00194]; Swedish Council for Working Life and Social Research (FAS)	Consejo Superior de Deportes (CSD); Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was funded by the Consejo Superior de Deportes (CSD, ref # UPR10/08), Fondo de Investigaciones Sanitarias (FIS, ref. # PS09/00194), and the Swedish Council for Working Life and Social Research (FAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz PE, 2009, J STRENGTH COND RES, V23, P480, DOI 10.1519/JSC.0b013e318198f92c; Ashley C.D., 1994, J STRENGTH CONDITION, V1, P5, DOI [10.1519/1533-4287(1994)0082.3.CO;2, DOI 10.1519/1533-4287(1994)0082.3.CO;2]; BOSCO C, 1983, EUR J APPL PHYSIOL O, V51, P357, DOI 10.1007/BF00429072; Brown L.E., 2001, J EXERC PHYSL ONLINE, V4, P1, DOI DOI 10.4236/JEP.2013.46A001; Cavagna G A, 1977, Exerc Sport Sci Rev, V5, P89; Corsi AM, 2002, J AM GERIATR SOC, V50, P1463, DOI 10.1046/j.1532-5415.2002.50376.x; Fedoruk MN, 2008, SCAND J MED SCI SPOR, V18, P123, DOI 10.1111/j.1600-0838.2007.00759.x; Ferrell RE, 1999, GENOMICS, V62, P203, DOI 10.1006/geno.1999.5984; Gonzalez-Freire M, 2010, AGE, V32, P405, DOI 10.1007/s11357-010-9139-7; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Ham DJ, 2007, J STRENGTH COND RES, V21, P967; Hill EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008645; HOLM S, 1979, SCAND J STAT, V6, P65; Huygens W, 2004, PHYSIOL GENOMICS, V17, P264, DOI 10.1152/physiolgenomics.00224.2003; Ivey FM, 2000, J GERONTOL A-BIOL, V55, pB152, DOI 10.1093/gerona/55.3.B152; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Juffer P, 2009, INT J SPORTS MED, V30, P387, DOI 10.1055/s-0028-1105931; Kostek MA, 2009, MED SCI SPORT EXER, V41, P1063, DOI 10.1249/MSS.0b013e3181930337; Kubo K, 1999, J APPL PHYSIOL, V87, P2090, DOI 10.1152/jappl.1999.87.6.2090; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Rios R, 2002, AM J PHYSIOL-CELL PH, V282, pC993, DOI 10.1152/ajpcell.00372.2001; SANTIAGO C, 2009, SCAND J MED SCI SPOR; Saunders MA, 2006, AM J HUM GENET, V79, P1089, DOI 10.1086/509707; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Seibert MJ, 2001, J AM GERIATR SOC, V49, P1093, DOI 10.1046/j.1532-5415.2001.49214.x; Siriett V, 2006, J CELL PHYSIOL, V209, P866, DOI 10.1002/jcp.20778; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Thomis MAI, 2004, EUR J APPL PHYSIOL, V92, P267, DOI 10.1007/s00421-004-1093-6; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Young WB, 2001, J STRENGTH COND RES, V15, P6	37	36	37	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16323	10.1371/journal.pone.0016323	http://dx.doi.org/10.1371/journal.pone.0016323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283721	Green Submitted, gold, Green Published			2022-12-25	WOS:000286522200050
J	Borde, C; Barnay-Verdier, S; Gaillard, C; Hocini, H; Marechal, V; Gozlan, J				Borde, Chloe; Barnay-Verdier, Stephanie; Gaillard, Claire; Hocini, Hakim; Marechal, Vincent; Gozlan, Joel			Stepwise Release of Biologically Active HMGB1 during HSV-2 Infection	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; GROUP BOX-1 PROTEIN; HIGH-MOBILITY-GROUP-BOX-1 PROTEIN; HIV-1 REPLICATION; IMMUNE-RESPONSES; DENDRITIC CELLS; GENITAL HERPES; TISSUE-DAMAGE; TYPE-2; INDUCTION	Background: High mobility group box 1 protein (HMGB1) is a major endogenous danger signal that triggers inflammation and immunity during septic and aseptic stresses. HMGB1 recently emerged as a key soluble factor in the pathogenesis of various infectious diseases, but nothing is known of its behaviour during herpesvirus infection. We therefore investigated the dynamics and biological effects of HMGB1 during HSV-2 infection of epithelial HEC-1 cells. Methodology/Principal Findings: Despite a transcriptional shutdown of HMGB1 gene expression during infection, the intracellular pool of HMGB1 protein remained unaffected, indicating its remarkable stability. However, the dynamics of HMGB1 was deeply modified in infected cells. Whereas viral multiplication was concomitant with apoptosis and HMGB1 retention on chromatin, a subsequent release of HMGB1 was observed in response to HSV-2 mediated necrosis. Importantly, extracellular HMGB1 was biologically active. Indeed, HMGB1-containing supernatants from HSV-2 infected cells induced the migration of fibroblasts from murine or human origin, and reactivated HIV-1 from latently infected T lymphocytes. These effects were specifically linked to HMGB1 since they were blocked by glycyrrhizin or by a neutralizing anti-HMGB1 antibody, and were mediated through TLR2 and the receptor for Advanced Glycation End-products (RAGE). Finally, we show that genital HSV-2 active infections also promote HMGB1 release in vivo, strengthening the clinical relevance of our experimental data. Conclusions: These observations target HMGB1 as an important actor during HSV-2 genital infection, notably in the setting of HSV-HIV co-infection.	[Borde, Chloe; Barnay-Verdier, Stephanie; Gaillard, Claire; Marechal, Vincent; Gozlan, Joel] Univ Paris 05, Univ Paris 06, INSERM, Ctr Rech Cordeliers,UMRS872, Paris, France; [Hocini, Hakim] Hop Henri Mondor, INSERM, Inst Mondor Rech Biomed, U955, F-94010 Creteil, France; [Gozlan, Joel] Hop St Antoine, Serv Bacteriol Virol, F-75571 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Borde, C (corresponding author), Univ Paris 05, Univ Paris 06, INSERM, Ctr Rech Cordeliers,UMRS872, Paris, France.	joel.gozlan@sat.aphp.fr	GOZLAN, Joël/P-6014-2017; marechal, vincent/P-7719-2017	Barnay-Verdier, Stephanie/0000-0002-4615-3059	Ministere de l'Enseignement Superieur et de la Recherche Francais; Reseau Herpesvirus et Cancer; La Ligue contre le Cancer; SIDACTION; ANRS	Ministere de l'Enseignement Superieur et de la Recherche Francais; Reseau Herpesvirus et Cancer; La Ligue contre le Cancer(Ligue nationale contre le cancer); SIDACTION; ANRS(ANRSFrench National Research Agency (ANR))	C. Borde received a PhD fellowship from the Ministere de l'Enseignement Superieur et de la Recherche Francais, from the Reseau Herpesvirus et Cancer and from La Ligue contre le Cancer. This work was partly supported by SIDACTION and ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; BARQASHO B, J GEN VIROL; BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Chen LC, 2008, J INFECTION, V56, P143, DOI 10.1016/j.jinf.2007.10.008; de Jong MAWP, 2010, J IMMUNOL, V185, P1633, DOI 10.4049/jimmunol.0904137; ERLICH KS, 1987, CLIN LAB MED, V7, P759, DOI 10.1016/S0272-2712(18)30715-7; Gaillard Claire, 2000, BMC Biochemistry, V1, P1; Gaillard C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002855; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Han JY, 2009, J VIROL, V83, P2765, DOI 10.1128/JVI.02088-08; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jerome KR, 2001, ARCH VIROL, V146, P2219, DOI 10.1007/s007050170032; Kamau E, 2009, J GEN VIROL, V90, P1827, DOI 10.1099/vir.0.009027-0; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; KUCERA LS, 1990, AIDS RES HUM RETROV, V6, P641, DOI 10.1089/aid.1990.6.641; LeGoff J, 2007, AIDS, V21, P1569, DOI 10.1097/QAD.0b013e32825a69bd; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotfi R, 2009, J IMMUNOL, V183, P5023, DOI 10.4049/jimmunol.0900504; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Matis J, 2001, ACTA VIROL, V45, P269; Mayaud P, 2009, J INFECT DIS, V200, P216, DOI 10.1086/599991; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; NGUYENMLAB AJ, 2009, VIRUSES, V1, P965; Nowak P, 2006, CYTOKINE, V34, P17, DOI 10.1016/j.cyto.2006.03.010; Pachot A, 2005, CLIN IMMUNOL, V114, P61, DOI 10.1016/j.clim.2004.08.015; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Patel AR, 2009, INT J DERMATOL, V48, P36, DOI 10.1111/j.1365-4632.2009.03788.x; Popovic PJ, 2006, J IMMUNOL, V177, P8701, DOI 10.4049/jimmunol.177.12.8701; Rasmussen SB, 2009, J GEN VIROL, V90, P74, DOI 10.1099/vir.0.005389-0; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sorensen LN, 2008, J IMMUNOL, V181, P8604, DOI 10.4049/jimmunol.181.12.8604; Sunden-Cullberg J, 2006, CURR OPIN INFECT DIS, V19, P231, DOI 10.1097/01.qco.0000224816.96986.67; Taddeo B, 2002, P NATL ACAD SCI USA, V99, P17031, DOI 10.1073/pnas.252588599; Thapa M, 2008, Open Immunol J, V1, P33, DOI 10.2174/1874226200801010033; Thierry S, 2007, AIDS, V21, P283, DOI 10.1097/QAD.0b013e3280115b50; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Urbonaviciute V, 2009, AUTOIMMUNITY, V42, P305, DOI 10.1080/08916930902831803; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Van de Perre P, 2008, LANCET INFECT DIS, V8, P490, DOI 10.1016/S1473-3099(08)70181-6; Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; YANG HLJ, 2010, ADDITION DITHIOTHREI; Zhang X, 2009, MUCOSAL IMMUNOL, V2, P129, DOI 10.1038/mi.2008.81	54	41	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16145	10.1371/journal.pone.0016145	http://dx.doi.org/10.1371/journal.pone.0016145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283827	Green Published, Green Submitted, gold			2022-12-25	WOS:000286520600025
J	Ward, JR; Heath, PR; Catto, JW; Whyte, MKB; Milo, M; Renshaw, SA				Ward, Jon R.; Heath, Paul R.; Catto, James W.; Whyte, Moira K. B.; Milo, Marta; Renshaw, Stephen A.			Regulation of Neutrophil Senescence by MicroRNAs	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; CELL-DEATH; APOPTOSIS; CANCER; SURVIVAL; INFLAMMATION; ACTIVATION	Neutrophils are rapidly recruited to sites of tissue injury or infection, where they protect against invading pathogens. Neutrophil functions are limited by a process of neutrophil senescence, which renders the cells unable to respond to chemoattractants, carry out respiratory burst, or degranulate. In parallel, aged neutrophils also undergo spontaneous apoptosis, which can be delayed by factors such as GMCSF. This is then followed by their subsequent removal by phagocytic cells such as macrophages, thereby preventing unwanted inflammation and tissue damage. Neutrophils translate mRNA to make new proteins that are important in maintaining functional longevity. We therefore hypothesised that neutrophil functions and lifespan might be regulated by microRNAs expressed within human neutrophils. Total RNA from highly purified neutrophils was prepared and subjected to microarray analysis using the Agilent human miRNA microarray V3. We found human neutrophils expressed a selected repertoire of 148 microRNAs and that 6 of these were significantly upregulated after a period of 4 hours in culture, at a time when the contribution of apoptosis is negligible. A list of predicted targets for these 6 microRNAs was generated from http://mirecords.biolead.org and compared to mRNA species downregulated over time, revealing 83 genes targeted by at least 2 out of the 6 regulated microRNAs. Pathway analysis of genes containing binding sites for these microRNAs identified the following pathways: chemokine and cytokine signalling, Ras pathway, and regulation of the actin cytoskeleton. Our data suggest that microRNAs may play a role in the regulation of neutrophil senescence and further suggest that manipulation of microRNAs might represent an area of future therapeutic interest for the treatment of inflammatory disease.	[Ward, Jon R.; Whyte, Moira K. B.; Renshaw, Stephen A.] Univ Sheffield, Sch Med & Biomed Sci, MRC Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England; [Ward, Jon R.; Whyte, Moira K. B.; Renshaw, Stephen A.] Univ Sheffield, Sch Med & Biomed Sci, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Heath, Paul R.] Univ Sheffield, Sch Med & Biomed Sci, Dept Neurosci, Sheffield, S Yorkshire, England; [Milo, Marta] Univ Sheffield, Sch Med & Biomed Sci, NIHR Cardiovasc Biomed Res Unit, Sheffield, S Yorkshire, England; [Catto, James W.] Univ Sheffield, Sch Med & Biomed Sci, Dept Oncol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Ward, JR (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, MRC Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England.	s.a.renshaw@sheffield.ac.uk	Heath, Paul/B-4778-2009; Renshaw, Steve/E-6192-2010	Renshaw, Steve/0000-0003-1790-1641; catto, james/0000-0003-2787-8828	MRC [G0701932]; MRC [G108/595] Funding Source: UKRI; Medical Research Council [G0701932, G108/595] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by an MRC Senior Clinical Fellowship to SAR (reference number: G0701932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; COLOTTA F, 1992, BLOOD, V80, P2012; COWBURN AS, 2010, AM J RESP CELL MOL B; CRONKITE EP, 1964, NEW ENGL J MED, V270, P1347, DOI 10.1056/NEJM196406182702506; Davidson-Moncada J, 2010, ANN NY ACAD SCI, V1183, P183, DOI 10.1111/j.1749-6632.2009.05121.x; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kobayashi SD, 2005, J LEUKOCYTE BIOL, V78, P1408, DOI 10.1189/jlb.0605289; Kobayashi SD, 2002, P NATL ACAD SCI USA, V99, P6901, DOI 10.1073/pnas.092148299; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liles WC, 1996, J EXP MED, V184, P429, DOI 10.1084/jem.184.2.429; Lum JJ, 2005, J IMMUNOL, V175, P1232, DOI 10.4049/jimmunol.175.2.1232; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Prince LR, 2004, AM J PATHOL, V165, P1819, DOI 10.1016/S0002-9440(10)63437-2; Radom-Aizik S, 2010, J APPL PHYSIOL, V109, P252, DOI 10.1152/japplphysiol.01291.2009; Renshaw SA, 2003, J IMMUNOL, V170, P1027, DOI 10.4049/jimmunol.170.2.1027; Sabroe I, 2004, BIOCHEM SOC T, V32, P468, DOI 10.1042/BST0320468; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Slezak S, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-39; Stringer RE, 1996, BRIT J HAEMATOL, V92, P169, DOI 10.1046/j.1365-2141.1996.00307.x; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Ward JR, 2009, IMMUNOLOGY, V128, P58, DOI 10.1111/j.1365-2567.2009.03071.x; Watson RWG, 1996, J IMMUNOL, V156, P3986; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042; WHYTE MKB, 1993, J IMMUNOL, V150, P5124; Whyte MKB, 1997, J LEUKOCYTE BIOL, V62, P195, DOI 10.1002/jlb.62.2.195; Xia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207	54	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15810	10.1371/journal.pone.0015810	http://dx.doi.org/10.1371/journal.pone.0015810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283524	gold, Green Accepted, Green Published			2022-12-25	WOS:000286520600013
J	Zheng, H; Chu, J; Zhang, YH; Loh, HH; Law, PY				Zheng, Hui; Chu, Ji; Zhang, Yuhan; Loh, Horace H.; Law, Ping-Yee			Modulating mu-Opioid Receptor Phosphorylation Switches Agonist-dependent Signaling as Reflected in PKC epsilon Activation and Dendritic Spine Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTINS; LIPID RAFTS; KINASE-C; MORPHINE; INTERNALIZATION; DESENSITIZATION; TOLERANCE; MEMBRANE; BINDING	A new role of G protein-coupled receptor (GPCR) phosphorylation was demonstrated in the current studies by using the mu-opioid receptor (OPRM1) as a model. Morphine induces a low level of receptor phosphorylation and uses the PKC epsilon pathway to induce ERK phosphorylation and receptor desensitization, whereas etorphine, fentanyl, and [D-Ala(2), N-Me-Phe(4), Gly(5)-ol]-enkephalin (DAMGO) induce extensive receptor phosphorylation and use the beta-arrestin2 pathway. Blocking OPRM1 phosphorylation (by mutating Ser(363), Thr(370) and Ser(375) to Ala) enabled etorphine, fentanyl, and DAMGO to use the PKC epsilon pathway. This was not due to the decreased recruitment of beta-arrestin2 to the receptor signaling complex, because these agonists were unable to use the PKC epsilon pathway when beta-arrestin2 was absent. In addition, overexpressing G protein-coupled receptor kinase 2 (GRK2) decreased the ability of morphine to activate PKC epsilon, whereas overexpressing dominant-negative GRK2 enabled etorphine, fentanyl, and DAMGO to activate PKC epsilon. Furthermore, by overexpressing wild-type OPRM1 and a phosphorylation-deficient mutant in primary cultures of hippocampal neurons, we demonstrated that receptor phosphorylation contributes to the differential effects of agonists on dendritic spine stability. Phosphorylation blockage made etorphine, fentanyl, and DAMGO function as morphine in the primary cultures. Therefore, agonist-dependent phosphorylation of GPCR regulates the activation of the PKC pathway and the subsequent responses.	[Zheng, Hui; Chu, Ji; Zhang, Yuhan; Loh, Horace H.; Law, Ping-Yee] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Zheng, Hui] Chinese Acad Sci, Stem Cell & Canc Biol Grp, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol,Guangzhou Inst Biomed & Hl, Guangzhou 510530, Guangdong, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Zheng, H (corresponding author), 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	zhenhui2055@hotmail.com		Law, Ping-Yee/0000-0002-5364-1093; Zheng, Hui/0000-0001-6801-0529	National Institutes of Health [DA007339, DA016674, DA000564, DA011806]; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000513, R56DA000564, R01DA016674, K05DA070554, R01DA000564, R01DA007339, P50DA011806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA007339, DA016674, DA000564, and DA011806.	Cen B, 2001, MOL PHARMACOL, V59, P758, DOI 10.1124/mol.59.4.758; Chae JH, 2004, MOL CELLS, V18, P271; CHAKRABARTI S, 1995, MOL BRAIN RES, V30, P269, DOI 10.1016/0169-328X(95)00014-J; Chu J, 2008, CELL SIGNAL, V20, P1616, DOI 10.1016/j.cellsig.2008.05.004; Chu J, 2010, CELL SIGNAL, V22, P684, DOI 10.1016/j.cellsig.2009.12.003; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; El Kouhen R, 2001, J BIOL CHEM, V276, P12774, DOI 10.1074/jbc.M009571200; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kobayashi H, 2005, CELL SIGNAL, V17, P1248, DOI 10.1016/j.cellsig.2004.12.014; Koch T, 2005, MOL PHARMACOL, V67, P280, DOI 10.1124/mol.104.004994; Kozasa T, 1996, J BIOL CHEM, V271, P12562, DOI 10.1074/jbc.271.21.12562; Lan HX, 2009, MOL PHARMACOL, V75, P113, DOI 10.1124/mol.108.050534; Law PY, 2004, NEUROPHARMACOLOGY, V47, P300, DOI 10.1016/j.neuropharm.2004.07.013; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Li JL, 2003, J BIOL CHEM, V278, P30219, DOI 10.1074/jbc.M302385200; Liao D, 2005, P NATL ACAD SCI USA, V102, P1725, DOI 10.1073/pnas.0406797102; Liao D, 2007, MOL CELL NEUROSCI, V35, P456, DOI 10.1016/j.mcn.2007.04.007; Lin H, 2009, NEUROPSYCHOPHARMACOL, V34, P2097, DOI 10.1038/npp.2009.34; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Macey TA, 2005, J NEUROCHEM, V93, P128, DOI 10.1111/j.1471-4159.2004.02998.x; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; ROERIG SC, 1992, MOL PHARMACOL, V41, P822; Smith FL, 2007, PAIN, V127, P129, DOI 10.1016/j.pain.2006.08.009; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Xu C, 2010, J CELL SCI, V123, P4259, DOI 10.1242/jcs.073742; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zheng H, 2008, P NATL ACAD SCI USA, V105, P9421, DOI 10.1073/pnas.0802253105; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842; Zheng H, 2010, J BIOL CHEM, V285, P21994, DOI 10.1074/jbc.M110.112607; Zheng H, 2010, J NEUROSCI, V30, P8102, DOI 10.1523/JNEUROSCI.6069-09.2010; Zheng H, 2010, IUBMB LIFE, V62, P112, DOI 10.1002/iub.293; Zheng H, 2010, MOL PHARMACOL, V77, P102, DOI 10.1124/mol.109.060848	42	35	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.177089	http://dx.doi.org/10.1074/jbc.M110.177089			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21292762	hybrid, Green Published			2022-12-25	WOS:000289077500083
J	Santi, SA; Lee, H				Santi, Stacey A.; Lee, Hoyun			Ablation of Akt2 Induces Autophagy through Cell Cycle Arrest, the Downregulation of p70S6K, and the Deregulation of Mitochondria in MDA-MB231 Cells	PLOS ONE			English	Article							MALIGNANT GLIOMA-CELLS; KINASE INHIBITOR P27(KIP1); ACTIVATED PROTEIN-KINASE; OVARIAN-CANCER CELLS; BREAST-CANCER; DEPENDENT PHOSPHORYLATION; INSULIN-RESISTANCE; ENERGY-METABOLISM; AMP KINASE; PATHWAY	Background: Akt/PKB is a promising anticancer therapeutic target, since abnormally elevated Akt activity is directly correlated to tumor development, progression, poor prognosis and resistance to cancer therapies. Currently, the unique role of each Akt isoform and their relevance to human breast cancer are poorly understood. Methodology/Principal Findings: We previously found that Akt1, 2 and 3 are localized at specific subcellular compartments (the cytoplasm, mitochondria and nucleus, respectively), raising the possibility that each isoform may have unique functions and employ different regulation mechanisms. By systematically studying Akt-ablated MDA-MB231 breast cancer cells with isoform-specific siRNA, we here show that Akt2 is the most relevant isoform to cell proliferation and survival in our cancer model. Prolonged ablation of Akt2 with siRNA resulted in cell-cycle arrest in G0/G1 by downregulating Cdk2 and cyclin D, and upregulating p27. The analysis of the Akt downstream signaling pathways suggested that Akt2 specifically targets and activates the p70S6K signaling pathway. We also found that Akt2 ablation initially resulted in an increase in the mitochondrial volume concomitantly with the upregulation of PGC-1 alpha, a regulator of mitochondrial biogenesis. Prolonged ablation of Akt2, but not Akt1 or Akt3, eventually led to cell death by autophagy of the mitochondria (i.e., mitophagy). Conclusions/Significance: Collectively, our data demonstrates that Akt2 augments cell proliferation by facilitating cell cycle progression through the upregulation of the cell cycle engine, and protects a cell from pathological autophagy by modulating mitochondrial homeostasis. Our data, thus, raises the possibility that Akt2 can be an effective anticancer target for the control of (breast) cancer.	[Santi, Stacey A.; Lee, Hoyun] Sudbury Reg Hosp, Reg Canc Program, Tumor Biol Grp, Sudbury, ON, Canada; [Santi, Stacey A.; Lee, Hoyun] Univ Ottawa, Sch Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada; [Lee, Hoyun] No Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada	Health Sciences North; University of Ottawa; Northern Ontario School of Medicine	Santi, SA (corresponding author), Sudbury Reg Hosp, Reg Canc Program, Tumor Biol Grp, Sudbury, ON, Canada.	hlee@hrsrh.on.ca			Canadian Breast Cancer Foundation (CBCF, Ontario Chapter); Northern Cancer Research Foundation (NCRF); University of Ottawa	Canadian Breast Cancer Foundation (CBCF, Ontario Chapter); Northern Cancer Research Foundation (NCRF); University of Ottawa	This work was supported, in part, by a research grant from the Canadian Breast Cancer Foundation (CBCF, Ontario Chapter) and Northern Cancer Research Foundation (NCRF) to H.L. S.S. was a recipient of an NCRF bursary and a University of Ottawa Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Arboleda MJ, 2003, CANCER RES, V63, P196; Bacqueville D, 1998, BIOCHEM BIOPH RES CO, V244, P630, DOI 10.1006/bbrc.1997.7885; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Caldon CE, 2006, J CELL BIOCHEM, V97, P261, DOI 10.1002/jcb.20690; Cheng JQ, 1997, ONCOGENE, V14, P2793, DOI 10.1038/sj.onc.1201121; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cristiano BE, 2006, CANCER RES, V66, P11718, DOI 10.1158/0008-5472.CAN-06-1968; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Fujiwara K, 2007, INT J ONCOL, V31, P753; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hembruff SL, 2005, ANAL BIOCHEM, V345, P237, DOI 10.1016/j.ab.2005.07.014; HERONMILHAVET L, 2006, MOL CELL BIOL; Hickson-Bick DLM, 2008, J MOL CELL CARDIOL, V44, P411, DOI 10.1016/j.yjmcc.2007.10.013; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Jin J, 2005, ONCOGENE, V24, P5459, DOI 10.1038/sj.onc.1208704; Jun T., 1999, SCI STKE, V1999, pPE1; Kim EH, 2007, CANCER RES, V67, P6314, DOI 10.1158/0008-5472.CAN-06-4217; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kossatz U, 2006, EMBO J, V25, P5159, DOI 10.1038/sj.emboj.7601388; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; MENG Q, 2006, CELL SIGNAL; Munafo DB, 2001, J CELL SCI, V114, P3619; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; NOSKE A, 2006, CANC LETT; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rassidakis GZ, 2005, BLOOD, V105, P827, DOI 10.1182/blood-2004-06-2125; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rivard N, 1996, J BIOL CHEM, V271, P18337, DOI 10.1074/jbc.271.31.18337; Rosner M, 2006, MUTAT RES-REV MUTAT, V613, P10, DOI 10.1016/j.mrrev.2006.03.001; Santi SA, 2010, AM J PHYSIOL-CELL PH, V298, pC580, DOI 10.1152/ajpcell.00375.2009; Shapira M, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1533; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Sithanandam G, 2005, ONCOGENE, V24, P1847, DOI 10.1038/sj.onc.1208381; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Veilleux A, 2010, MOL ENDOCRINOL, V24, P766, DOI 10.1210/me.2009-0328; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang G, 1999, ONCOGENE, V18, P5204, DOI 10.1038/sj.onc.1202912; YANG W, 2010, CELL SIGNAL; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	63	54	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14614	10.1371/journal.pone.0014614	http://dx.doi.org/10.1371/journal.pone.0014614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297943	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300006
J	Mammi, C; Pastore, D; Lombardo, MF; Ferrelli, F; Caprio, M; Consoli, C; Tesauro, M; Gatta, L; Fini, M; Federici, M; Sbraccia, P; Donadel, G; Bellia, A; Rosano, GM; Fabbri, A; Lauro, D				Mammi, Caterina; Pastore, Donatella; Lombardo, Marco F.; Ferrelli, Francesca; Caprio, Massimiliano; Consoli, Claudia; Tesauro, Manfredi; Gatta, Lucia; Fini, Massimo; Federici, Massimo; Sbraccia, Paolo; Donadel, Giulia; Bellia, Alfonso; Rosano, Giuseppe M.; Fabbri, Andrea; Lauro, Davide			Sildenafil Reduces Insulin-Resistance in Human Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CA2+-INDEPENDENT ACTIVATION; PULMONARY-HYPERTENSION; CARDIOVASCULAR-DISEASE; ORAL SILDENAFIL; PHOSPHORYLATION; AKT; INHIBITORS; PHOSPHATASE; DYSFUNCTION	Background: The efficacy of Phosphodiesterase 5 (PDE5) inhibitors to re-establish endothelial function is reduced in diabetic patients. Recent evidences suggest that therapy with PDE5 inhibitors, i.e. sildenafil, may increase the expression of nitric oxide synthase (NOS) proteins in the heart and cardiomyocytes. In this study we analyzed the effect of sildenafil on endothelial cells in insulin resistance conditions in vitro. Methodology/Principal Findings: Human umbilical vein endothelial cells (HUVECs) were treated with insulin in presence of glucose 30 mM (HG) and glucosamine 10 mM (Gluc-N) with or without sildenafil. Insulin increased the expression of PDE5 and eNOS mRNA assayed by Real time-PCR. Cytofluorimetric analysis showed that sildenafil significantly increased NO production in basal condition. This effect was partially inhibited by the PI3K inhibitor LY 294002 and completely inhibited by the NOS inhibitor L-NAME. Akt-1 and eNOS activation was reduced in conditions mimicking insulin resistance and completely restored by sildenafil treatment. Conversely sildenafil treatment can counteract this noxious effect by increasing NO production through eNOS activation and reducing oxidative stress induced by hyperglycaemia and glucosamine. Conclusions/Significance: These data indicate that sildenafil might improve NOS activity of endothelial cells in insulin resistance conditions and suggest the potential therapeutic use of sildenafil for improving vascular function in diabetic patients.	[Mammi, Caterina; Caprio, Massimiliano] IRCCS San Raffaele Pisana, Ctr Clin & Basic Res, Rome, Italy; [Pastore, Donatella; Lombardo, Marco F.; Ferrelli, Francesca; Tesauro, Manfredi; Federici, Massimo; Sbraccia, Paolo; Donadel, Giulia; Bellia, Alfonso; Fabbri, Andrea; Lauro, Davide] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Consoli, Claudia; Gatta, Lucia; Fini, Massimo; Rosano, Giuseppe M.] San Raffaele Sulmona, Laquila, Italy; [Fabbri, Andrea] Univ Roma Tor Vergata, Osped S Eugenio & CTO A Alesini, Dept Internal Med, Unit Endocrinol, Rome, Italy	Center Clinical & Basic Research; IRCCS San Raffaele Pisana; University of Rome Tor Vergata; Sant'Eugenio Hospital; University of Rome Tor Vergata	Mammi, C (corresponding author), IRCCS San Raffaele Pisana, Ctr Clin & Basic Res, Rome, Italy.	d.lauro@med.uniroma2.it	Federici, Massimo/G-9940-2012; bellia, alfonso/AIA-9860-2022; Lauro, Davide/K-4683-2018; Rosano, Giuseppe M. C./K-8718-2018; Fini, Massimo/AAA-9948-2021; Donadel, Giulia/M-1900-2019; Caprio, Massimiliano/J-3020-2012; Gatta, Lucia/I-9985-2018	Federici, Massimo/0000-0003-4989-5194; Rosano, Giuseppe M. C./0000-0003-4023-2263; Donadel, Giulia/0000-0002-2454-5940; Caprio, Massimiliano/0000-0003-0722-7163; Gatta, Lucia/0000-0002-9232-2693; mammi, caterina/0000-0002-2687-4422; Lauro, Davide/0000-0002-8597-4415	University Tor Vergata; Ministero dell'Universita e della Ricerca; Department of Health (Tremoli); Fondazione Roma - Rome Foundation [2008-2009]	University Tor Vergata; Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Department of Health (Tremoli); Fondazione Roma - Rome Foundation(Fondazione Roma)	This work has been funded by Institutional funding from University Tor Vergata, PRIN 2007 (Progetti Ricerca Interesse Nazionale) Ministero dell'Universita e della Ricerca, 2007, to A. F.) and by Department of Health RF 2007 (Tremoli), Fondazione Roma - Rome Foundation Research Grant 2008-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2000, Heart, V84, pE4, DOI 10.1136/heart.84.2.e4; ALVARADOVASQUEZ N, 2007, DIABETES METAB RES R; Ayala JE, 2007, DIABETES, V56, P1025, DOI 10.2337/db06-0883; Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Bivalacqua TJ, 2009, J UROLOGY, V181, P899, DOI 10.1016/j.juro.2008.10.062; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; Chou SH, 2006, EXP BIOL MED, V231, P954; Deedwania PC, 2004, CARDIOL CLIN, V22, pXI, DOI 10.1016/j.ccl.2004.07.004; Desouza C, 2002, DIABETES CARE, V25, P1336, DOI 10.2337/diacare.25.8.1336; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Favot L, 2003, THROMB HAEMOSTASIS, V90, P334, DOI 10.1160/TH03-02-0084; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Fleming I, 1999, P NATL ACAD SCI USA, V96, P1123, DOI 10.1073/pnas.96.3.1123; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Francis SH, 2003, INT J IMPOT RES, V15, P369, DOI 10.1038/sj.ijir.3901040; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Hsueh WA, 2004, AM J MED, V117, P109, DOI 10.1016/j.amjmed.2004.02.042; Katz SD, 2000, J AM COLL CARDIOL, V36, P845, DOI 10.1016/S0735-1097(00)00790-7; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Luedders DW, 2006, J CARDIOVASC PHARM, V47, P365; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Michelakis E, 2002, CIRCULATION, V105, P2398, DOI 10.1161/01.CIR.0000016641.12984.DC; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Milara J, 2010, EUR J PHARM SCI, V39, P363, DOI 10.1016/j.ejps.2010.01.005; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Nelson BA, 2002, AM J PHYSIOL-ENDOC M, V282, pE497, DOI 10.1152/ajpendo.00438.2001; Park K, 2008, EUR UROL, V53, P1282, DOI 10.1016/j.eururo.2008.01.032; Prasad S, 2000, NEW ENGL J MED, V343, P1342, DOI 10.1056/NEJM200011023431814; Puerta E, 2009, J NEUROCHEM, V108, P755, DOI 10.1111/j.1471-4159.2008.05825.x; Reffelmann T, 2003, CIRCULATION, V108, P239, DOI 10.1161/01.CIR.0000081166.87607.E2; Salt IP, 2003, J BIOL CHEM, V278, P18791, DOI 10.1074/jbc.M210618200; Sebkhi A, 2003, CIRCULATION, V107, P3230, DOI 10.1161/01.CIR.0000074226.20466.B1; Song P, 2007, CIRCULATION, V116, P1585, DOI 10.1161/CIRCULATIONAHA.107.716498; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; Wilkens H, 2001, CIRCULATION, V104, P1218, DOI 10.1161/hc3601.096826; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59	39	36	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14542	10.1371/journal.pone.0014542	http://dx.doi.org/10.1371/journal.pone.0014542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297971	Green Published, Green Submitted, gold			2022-12-25	WOS:000286664100001
J	Becker, A; Chao, DY; Zhang, X; Salt, DE; Baxter, I				Becker, Anthony; Chao, Dai-Yin; Zhang, Xu; Salt, David E.; Baxter, Ivan			Bulk Segregant Analysis Using Single Nucleotide Polymorphism Microarrays	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ARABIDOPSIS-THALIANA; MARKERS; GENOME; IDENTIFICATION; ASSOCIATION; INTERVAL; LINES	Bulk segregant analysis (BSA) using microarrays, and extreme array mapping (XAM) have recently been used to rapidly identify genomic regions associated with phenotypes in multiple species. These experiments, however, require the identification of single feature polymorphisms (SFP) between the cross parents for each new combination of genotypes, which raises the cost of experiments. The availability of the genomic polymorphism data in Arabidopsis thaliana, coupled with the efficient designs of Single Nucleotide Polymorphism (SNP) genotyping arrays removes the requirement for SFP detection and lowers the per array cost, thereby lowering the overall cost per experiment. To demonstrate that these approaches would be functional on SNP arrays and determine confidence intervals, we analyzed hybridizations of natural accessions to the Arabidopsis ATSNPTILE array and simulated BSA or XAM given a variety of gene models, populations, and bulk selection parameters. Our results show a striking degree of correlation between the genotyping output of both methods, which suggests that the benefit of SFP genotyping in context of BSA can be had with the cheaper, more efficient SNP arrays. As a final proof of concept, we hybridized the DNA from bulks of an F2 mapping population of a Sulfur and Selenium ionomics mutant to both the Arabidopsis ATTILE1R and ATSNPTILE arrays, which produced almost identical results. We have produced R scripts that prompt the user for the required parameters and perform the BSA analysis using the ATSNPTILE1 array and have provided them as supplemental data files.	[Becker, Anthony; Baxter, Ivan] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Chao, Dai-Yin; Salt, David E.] Purdue Univ, Ctr Plant Environm Stress Physiol, W Lafayette, IN 47907 USA; [Zhang, Xu] Univ Chicago, Dept Genet, Chicago, IL 60637 USA; [Baxter, Ivan] ARS, Plant Genet Res Unit, USDA, St Louis, MO USA	Donald Danforth Plant Science Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Chicago; United States Department of Agriculture (USDA)	Becker, A (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	ibaxter@danforthcenter.org	Baxter, Ivan R/A-1052-2009; Becker, Anthony/AAS-1402-2020; Chao, Daiyin/A-5213-2013	Baxter, Ivan R/0000-0001-6680-1722; ?, ??/0000-0003-2832-4800	National Institutes of Health [R01 GM078536]; National Science Foundation [IOS-0419695]; United States Department of Agriculture-Agricultural Research Service [CRIS 21000-028]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536] Funding Source: NIH RePORTER; Direct For Biological Sciences [0851838] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors acknowledge the support of National Institutes of Health grant # R01 GM078536 (www.nih.gov) to DES and IB; National Science Foundation grant # IOS-0419695 (www.nsf.gov) to DES. AB was a participant in the Donald Danforth Plant Science Center Research Experience for Undergraduates program, NSF DBI-0851838. IB is supported by United States Department of Agriculture-Agricultural Research Service CRIS 21000-028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Baxter I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000492; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; BRAUER MJ, 2006, GENETICS, V106; Hazen SP, 2005, PLANT PHYSIOL, V138, P990, DOI 10.1104/pp.105.061408; Kaczorowski KA, 2008, PLANT GENOME-US, V1, P89, DOI 10.3835/plantgenome2008.04.0207; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; Smemo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000287; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032; Zhu T, 2007, TRENDS PLANT SCI, V12, P196, DOI 10.1016/j.tplants.2007.03.013	17	29	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15993	10.1371/journal.pone.0015993	http://dx.doi.org/10.1371/journal.pone.0015993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21297997	Green Published, gold, Green Submitted			2022-12-25	WOS:000286663900020
J	Christofferson, RC; Mores, CN				Christofferson, Rebecca C.; Mores, Christopher N.			Estimating the Magnitude and Direction of Altered Arbovirus Transmission Due to Viral Phenotype	PLOS ONE			English	Article							WEST-NILE-VIRUS; CULEX-PIPIENS DIPTERA; VECTOR COMPETENCE; AEDES-AEGYPTI; DENGUE VIRUS; LABORATORY TRANSMISSION; JAPANESE ENCEPHALITIS; VERTICAL TRANSMISSION; MALARIA TRANSMISSION; EXTRINSIC INCUBATION	Vectorial capacity is a measure of the transmission potential of a vector borne pathogen within a susceptible population. Vector competence, a component of the vectorial capacity equation, is the ability of an arthropod to transmit an infectious agent following exposure to that agent. Comparisons of arbovirus strain-specific vector competence estimates have been used to support observed or hypothesized differences in transmission capability. Typically, such comparisons are made at a single time point during the extrinsic incubation period, the time in days it takes for the virus to replicate and disseminate to the salivary glands. However, vectorial capacity includes crucial parameters needed to effectively evaluate transmission capability, though often this is based on the discrete vector competence values. Utilization of the rate of change of vector competence over a range of days gives a more accurate measurement of the transmission potential. Accordingly, we investigated the rate of change in vector competence of dengue virus in Aedes aegypti mosquitoes and the resulting vectorial capacity curves. The areas under the curves represent the effective vector competence and the cumulative transmission potentials of arboviruses within a population of mosquitoes. We used the calculated area under the curve for each virus strain and the corresponding variance estimates to test for differences in cumulative transmission potentials between strains of dengue virus based on our dynamic model. To further characterize differences between dengue strains, we devised a displacement index interpreted as the capability of a newly introduced strain to displace the established, dominant circulating strain. The displacement index can be used to better understand the transmission dynamics in systems where multiple strains/serotypes circulate or even multiple arbovirus species. The use of a rate of a rate of change based model of vectorial capacity and the informative calculations of the displacement index will lead to better measurements of the differences in transmission potential of arboviruses.	[Christofferson, Rebecca C.; Mores, Christopher N.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Christofferson, RC (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	cmores@lsu.edu		Mores, Christopher/0000-0001-6678-9049	National Institutes of Health [5P20RR020159]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by National Institutes of Health award #5P20RR020159. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2008, AM J TROP MED HYG, V79, P688, DOI 10.4269/ajtmh.2008.79.688; Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769; Armstrong PM, 2003, AM J TROP MED HYG, V68, P539, DOI 10.4269/ajtmh.2003.68.539; Arunachalam N, 2008, INDIAN J MED RES, V127, P395; Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85; Black William C. IV, 1996, P393; BOROMISA RD, 1987, J AM MOSQUITO CONTR, V3, P378; Chisenhall DM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-106; CLARKE DK, 1993, J VIROL, V67, P222, DOI 10.1128/JVI.67.1.222-228.1993; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; DILL GM, 1978, COMPUTER ANAL SUGARC, P31; Dye C., 1995, P260, DOI 10.1017/CBO9780511629396.010; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; DYE C, 1986, Parasitology Today, V2, P203; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; GARRETTJONES C, 1969, B WORLD HEALTH ORGAN, V40, P531; Ghosh AK, 2002, INSECT BIOCHEM MOLEC, V32, P1325, DOI 10.1016/S0965-1748(02)00095-4; Gunther J, 2007, INTERVIROLOGY, V50, P347, DOI 10.1159/000107272; Hardy J. L., 1988, The arboviruses: epidemiology and ecology. Volume I., P87; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537; Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; KRAMER LD, 1983, AM J TROP MED HYG, V32, P1130, DOI 10.4269/ajtmh.1983.32.1130; Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Moncayo AC, 2004, EMERG INFECT DIS, V10, P1790, DOI 10.3201/eid1010.030846; Mores CN, 2007, VECTOR-BORNE ZOONOT, V7, P279, DOI 10.1089/vbz.2006.0557; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; Moutailler S, 2009, TROP MED INT HEALTH, V14, P1105, DOI 10.1111/j.1365-3156.2009.02320.x; Pesko K, 2009, J MED ENTOMOL, V46, P395, DOI 10.1603/033.046.0228; Rattanarithikul R, 1996, AM J TROP MED HYG, V54, P114, DOI 10.4269/ajtmh.1996.54.114; Reifenberg JM, 1997, MED VET ENTOMOL, V11, P246, DOI 10.1111/j.1365-2915.1997.tb00402.x; Reisen W. K., 1989, Bulletin of the Society for Vector Ecology, V14, P39; Richards SL, 2007, VECTOR-BORNE ZOONOT, V7, P629, DOI 10.1089/vbz.2007.0101; Sithiprasasna Ratana, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P505; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Turell MJ, 2006, J MED ENTOMOL, V43, P1076, DOI 10.1603/0022-2585(2006)43[1076:LTOJEW]2.0.CO;2; Turell MJ, 2006, J MED ENTOMOL, V43, P296, DOI 10.1603/0022-2585(2006)043[0296:LTOJEA]2.0.CO;2; TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176; Vaidyanathan R, 2007, VECTOR-BORNE ZOONOT, V7, P193, DOI 10.1089/vbz.2006.0589; VANDENHURK AF, 2009, VECTOR BORNE ZOONOTI; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319	49	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16298	10.1371/journal.pone.0016298	http://dx.doi.org/10.1371/journal.pone.0016298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298018	Green Submitted, Green Published, gold			2022-12-25	WOS:000286663900029
J	Waltert, M; Bobo, KS; Kaupa, S; Montoya, ML; Nsanyi, MS; Fermon, H				Waltert, Matthias; Bobo, Kadiri Serge; Kaupa, Stefanie; Leija Montoya, Marcela; Nsanyi, Moses Sainge; Fermon, Heleen			Assessing Conservation Values: Biodiversity and Endemicity in Tropical Land Use Systems	PLOS ONE			English	Article							SPECIES RICHNESS; AGROFORESTRY SYSTEMS; FOREST CONVERSION; DIVERSITY; FARMLAND; PLANTS; BIRDS; TAXA; ASSEMBLAGES; BUTTERFLIES	Despite an increasing amount of data on the effects of tropical land use on continental forest fauna and flora, it is debatable whether the choice of the indicator variables allows for a proper evaluation of the role of modified habitats in mitigating the global biodiversity crisis. While many single-taxon studies have highlighted that species with narrow geographic ranges especially suffer from habitat modification, there is no multi-taxa study available which consistently focuses on geographic range composition of the studied indicator groups. We compiled geographic range data for 180 bird, 119 butterfly, 204 tree and 219 understorey plant species sampled along a gradient of habitat modification ranging from near-primary forest through young secondary forest and agroforestry systems to annual crops in the southwestern lowlands of Cameroon. We found very similar patterns of declining species richness with increasing habitat modification between taxon-specific groups of similar geographic range categories. At the 8 km 2 spatial level, estimated richness of endemic species declined in all groups by 21% (birds) to 91% (trees) from forests to annual crops, while estimated richness of widespread species increased by +101% (trees) to +275% (understorey plants), or remained stable (-2%, butterflies). Even traditional agroforestry systems lost estimated endemic species richness by -18% (birds) to -90% (understorey plants). Endemic species richness of one taxon explained between 37% and 57% of others (positive correlations) and taxon-specific richness in widespread species explained up to 76% of variation in richness of endemic species (negative correlations). The key implication of this study is that the range size aspect is fundamental in assessments of conservation value via species inventory data from modified habitats. The study also suggests that even ecologically friendly agricultural matrices may be of much lower value for tropical conservation than indicated by mere biodiversity value.	[Waltert, Matthias; Fermon, Heleen] Univ Gottingen, Dept Conservat Biol, Gottingen, Germany; [Bobo, Kadiri Serge] Univ Dschang, Dept Forestry, Dschang, Cameroon; [Leija Montoya, Marcela] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Nuevo Leon, Mexico; [Nsanyi, Moses Sainge] Univ Buea, Fac Sci, Dept Plant & Anim Sci, CTFS,KFDP,Bot Programme, Buea, Cameroon	University of Gottingen; Universidad Autonoma de Nuevo Leon	Waltert, M (corresponding author), Univ Gottingen, Dept Conservat Biol, Gottingen, Germany.	mwalter@gwdg.de	Waltert, Matthias/E-9134-2010	Waltert, Matthias/0000-0001-7053-0291	German Academic Exchange Service (DAAD); German Society for Tropical Ornithology (GTO); African Nature e.V.; Volkswagen Foundation, Hanover, Germany	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Society for Tropical Ornithology (GTO); African Nature e.V.; Volkswagen Foundation, Hanover, Germany(Volkswagen)	This study was supported financially by the German Academic Exchange Service (DAAD), the German Society for Tropical Ornithology (GTO), African Nature e.V., and the Volkswagen Foundation, Hanover, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barlow J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009609; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Bobo KS, 2006, BIODIVERS CONSERV, V15, P4097, DOI 10.1007/s10531-005-3368-6; Bobo KS, 2006, J INSECT CONSERV, V10, P29, DOI 10.1007/s10841-005-8564-x; Borrow N, 2001, BIRDS W AFRICA; Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.2307/176597; Brown LH, 1982, BIRDS AFRICA, V1; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Chazdon RL, 1998, MAN BIOSPH, V20, P285; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; COLWELL RK, 2000, ESTIMATES STAT ESTIM; D'Abrera B, 1980, BUTTERFLIES AFROTROP, P593; D'Abrera B., 1997, BUTTERFLIES AFROTROP; Davis S.D., 1994, CTR PLANT DIVERSITY, V1; de Vries P.J., 1988, Journal of Research on the Lepidoptera, V26, P98; DeVries PJ, 1987, BUTTERFLIES COSTA RI; Dunn RR, 2005, GLOBAL ECOL BIOGEOGR, V14, P359, DOI 10.1111/j.1466-822x.2005.00155.x; Fermon H, 2000, J INSECT CONSERV, V4, P173, DOI 10.1023/A:1009638808635; Fishpool L. D., 2001, IMPORTANT BIRD AREAS; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Harvey CA, 2007, BIODIVERS CONSERV, V16, P2257, DOI 10.1007/s10531-007-9194-2; HECQ J, 1997, EUPHAEDRA LAMBILLION; HELTSHE JF, 1983, BIOMETRICS, V39, P1, DOI 10.2307/2530802; Hughes JB, 2002, ECOL LETT, V5, P121, DOI 10.1046/j.1461-0248.2002.00294.x; Keith S., 1992, BIRDS AFRICA, V4; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; Klein AM, 2002, CONSERV BIOL, V16, P1003, DOI 10.1046/j.1523-1739.2002.00499.x; Larsen TB, 1997, KORUP BUTTERFLIES BI; Larson TB, 2005, BUTTERFLIES W AFRICA, V1-2; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lewis OT, 1998, BIOL CONSERV, V85, P113, DOI 10.1016/S0006-3207(97)00136-5; Nichols J. D., 1996, MEASURING MONITORING, P226; Nichols JD, 1998, CONSERV BIOL, V12, P1390, DOI 10.1046/j.1523-1739.1998.97331.x; Oates J.F., 1996, AFRICAN PRIMATES STA; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Perfecto I, 2003, BIODIVERS CONSERV, V12, P1239, DOI 10.1023/A:1023039921916; Rodewald P.G., 1994, BIRD CONSERV INT, V4, P1, DOI DOI 10.1017/S095927090000263X; Rydon A., 1964, J LEPID SOC, V18, P51; Scales BR, 2008, ENVIRON CONSERV, V35, P160, DOI 10.1017/S0376892908004840; Schroth G, 2004, AGROFORESTRY BIODIVE; Schulze CH, 2004, ECOL APPL, V14, P1321, DOI 10.1890/02-5409; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; THOMAS CD, 1991, BIOL CONSERV, V55, P269, DOI 10.1016/0006-3207(91)90032-5; Umetsu F, 2007, LANDSCAPE ECOL, V22, P517, DOI 10.1007/s10980-006-9041-y; Waltert M, 2005, ECOL APPL, V15, P1351, DOI 10.1890/04-1002; Waltert M, 2004, CONSERV BIOL, V18, P1339, DOI 10.1111/j.1523-1739.2004.00127.x; Waltert M, 2002, ORYX, V36, P257, DOI 10.1017/S0030605302000479; Weist M, 2010, MAMM BIOL, V75, P567, DOI 10.1016/j.mambio.2009.09.004; White F., 1983, VEGETATION AFRICA DE	52	42	45	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16238	10.1371/journal.pone.0016238	http://dx.doi.org/10.1371/journal.pone.0016238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298054	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000286663900025
J	Amanso, AM; Debbas, V; Laurindo, FRM				Amanso, Angelica M.; Debbas, Victor; Laurindo, Francisco R. M.			Proteasome Inhibition Represses Unfolded Protein Response and Nox4, Sensitizing Vascular Cells to Endoplasmic Reticulum Stress-Induced Death	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NADPH OXIDASE ACTIVITY; OXIDATIVE STRESS; ER STRESS; NAD(P)H OXIDASE; MITOCHONDRIAL DYSFUNCTION; DISULFIDE-ISOMERASE; SIGNAL-TRANSDUCTION; CARCINOMA-CELLS; MESSENGER-RNA	Background: Endoplasmic reticulum (ER) stress has pathophysiological relevance in vascular diseases and merges with proteasome function. Proteasome inhibition induces cell stress and may have therapeutic implications. However, whether proteasome inhibition potentiates ER stress-induced apoptosis and the possible mechanisms involved in this process are unclear. Methodology/Principal Findings: Here we show that proteasome inhibition with MG132, per se at non-lethal levels, sensitized vascular smooth muscle cells to caspase-3 activation and cell death during ER stress induced by tunicamycin (Tn). This effect was accompanied by suppression of both proadaptive (KDEL chaperones) and proapoptotic (CHOP/GADD153) unfolded protein response markers, although, intriguingly, the splicing of XBP1 was markedly enhanced and sustained. In parallel, proteasome inhibition completely prevented ER stress-induced increase in NADPH oxidase activity, as well as increases in Nox4 isoform and protein disulfide isomerase mRNA expression. Increased Akt phosphorylation due to proteasome inhibition partially offset the proapoptotic effect of Tn or MG132. Although proteasome inhibition enhanced oxidative stress, reactive oxygen species scavenging had no net effect on sensitization to Tn or MG132-induced cell death. Conclusion/Relevance: These data indicate unfolded protein response-independent pathways whereby proteasome inhibition sensitizes vascular smooth muscle to ER stress-mediated cell death. This may be relevant to understand the therapeutic potential of such compounds in vascular disease associated with increased neointimal hyperplasia.	[Amanso, Angelica M.; Debbas, Victor; Laurindo, Francisco R. M.] Univ Sao Paulo, Sch Med, Vasc Biol Lab, Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo	Amanso, AM (corresponding author), Univ Sao Paulo, Sch Med, Vasc Biol Lab, Heart Inst InCor, Sao Paulo, Brazil.	francisco.laurindo@incor.usp.br	Debbas, Victor/J-9475-2012; Laurindo, Francisco R/J-6575-2015		Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/13683-0, 09/54764-6]; Instituto Nacional de Ciencia e Tecnologia de Processos Redox em BioMedicina (Redoxoma, CNPq); Fundacao Zerbini	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em BioMedicina (Redoxoma, CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Zerbini	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Processes 04/13683-0 and 09/54764-6), Instituto Nacional de Ciencia e Tecnologia de Processos Redox em BioMedicina (Redoxoma, CNPq) and Fundacao Zerbini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chade AR, 2005, J AM SOC NEPHROL, V16, P1005, DOI 10.1681/ASN.2004080674; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; Dickhout JG, 2006, CIRCULATION, V114, P1796, DOI 10.1161/CIRCULATIONAHA.106.656744; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dreger H, 2010, CARDIOVASC RES, V85, P395, DOI 10.1093/cvr/cvp279; Egger L, 2007, CELL DEATH DIFFER, V14, P1172, DOI 10.1038/sj.cdd.4402125; Feng B, 2010, J CARDIOVASC PHARM, V55, P129, DOI 10.1097/FJC.0b013e3181c87f8e; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; Herrmann J, 2007, CIRC RES, V101, P865, DOI 10.1161/CIRCRESAHA.107.152959; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Laurindo FRM, 2008, ANTIOXID REDOX SIGN, V10, P1101, DOI 10.1089/ars.2007.2011; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Ling YH, 2003, CLIN CANCER RES, V9, P1145; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Ludwig A, 2008, CIRC RES, V102, pE37, DOI 10.1161/CIRCRESAHA.107.168963; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; Meiners S, 2002, CIRCULATION, V105, P483, DOI 10.1161/hc0402.102951; OLEJNICZAK SH, 2010, BLOOD           1007; Papa L, 2008, APOPTOSIS, V13, P588, DOI 10.1007/s10495-008-0182-0; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; Price J, 2010, J CELL PHYSIOL, V222, P502, DOI 10.1002/jcp.22001; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Segref A, 2009, EMBO REP, V10, P44, DOI 10.1038/embor.2008.229; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Van Herck JL, 2010, BASIC RES CARDIOL, V105, P39, DOI 10.1007/s00395-009-0054-y; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Willis MS, 2010, CIRC RES, V106, P463, DOI 10.1161/CIRCRESAHA.109.208801; Wosniak J, 2009, ANTIOXID REDOX SIGN, V11, P1265, DOI 10.1089/ars.2009.2392; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Yamamoto N, 2007, J BIOL CHEM, V282, P4364, DOI 10.1074/jbc.M603712200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang L, 2008, FREE RADICAL BIO MED, V45, P679, DOI 10.1016/j.freeradbiomed.2008.05.019	54	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14591	10.1371/journal.pone.0014591	http://dx.doi.org/10.1371/journal.pone.0014591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21297867	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800004
J	Boxall, R; Porteous, DJ; Thomson, PA				Boxall, Ruth; Porteous, David J.; Thomson, Pippa A.			DISC1 and Huntington's Disease - Overlapping Pathways of Vulnerability to Neurological Disorder?	PLOS ONE			English	Article							R6/2 MOUSE MODEL; GENE-TRANSCRIPTION; SCHIZOPHRENIA; ASSOCIATION; DISRUPTED-IN-SCHIZOPHRENIA-1; PSYCHOPATHOLOGY; SUSCEPTIBILITY; SYMPTOMS; PROTEINS; DEFICITS	We re-annotated the interacting partners of the neuronal scaffold protein DISC1 using a knowledge-based approach that incorporated recent protein interaction data and published literature to. This revealed two highly connected networks. These networks feature cellular function and maintenance, and cell signaling. Of potentially greatest interest was the novel finding of a high degree of connectivity between the DISC1 scaffold protein, linked to psychiatric illness, and huntingtin, the protein which is mutated in Huntington's disease. The potential link between DISC1, huntingtin and their interacting partners may open new areas of research into the effects of pathway dysregulation in severe neurological disorders.	[Boxall, Ruth; Porteous, David J.; Thomson, Pippa A.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Genet Sect,Mol Med Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh	Boxall, R (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Genet Sect,Mol Med Ctr, Edinburgh, Midlothian, Scotland.	Pippa.Thomson@ed.ac.uk	Porteous, David/AAA-3446-2021; Porteous, David J/C-7289-2013	Porteous, David/0000-0003-1249-6106; Porteous, David J/0000-0003-1249-6106; Boxall, Ruth/0000-0003-0356-3549	MRC; RCUK [GR/T27983/01]; Medical Research Council [G0700704B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RCUK(UK Research & Innovation (UKRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	RB is funded by an MRC 4 year PhD award. PAT is partially funded by an RCUK fellowship (GR/T27983/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Bradshaw NJ, 2008, BIOCHEM BIOPH RES CO, V377, P1091, DOI 10.1016/j.bbrc.2008.10.120; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007; Chen TC, 2009, J PROTEOME RES, V8, P4943, DOI 10.1021/pr900325f; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Datta SR, 2010, MOL PSYCHIATR, V15, P615, DOI 10.1038/mp.2008.128; DeMarch Z, 2008, NEUROBIOL DIS, V30, P375, DOI 10.1016/j.nbd.2008.02.010; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Gargiulo M, 2009, EUR J HUM GENET, V17, P165, DOI 10.1038/ejhg.2008.146; Giampa C, 2009, EUR J NEUROSCI, V29, P902, DOI 10.1111/j.1460-9568.2009.06649.x; Grote HE, 2005, EUR J NEUROSCI, V22, P2081, DOI 10.1111/j.1460-9568.2005.04365.x; Gurling HMD, 2006, ARCH GEN PSYCHIAT, V63, P844, DOI 10.1001/archpsyc.63.8.844; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Humbert S, 2010, EMBO REP, V11, P899, DOI 10.1038/embor.2010.182; Jason GW, 1997, ARCH NEUROL-CHICAGO, V54, P1081, DOI 10.1001/archneur.1997.00550210019008; Kirkwood SC, 2001, ARCH NEUROL-CHICAGO, V58, P273, DOI 10.1001/archneur.58.2.273; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2005, MOL CELL NEUROSCI, V30, P477, DOI 10.1016/j.mcn.2005.08.021; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Moens LN, 2010, AM J MED GENET B, V153B, P1240, DOI 10.1002/ajmg.b.31088; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Peavy GM, 2010, MOVEMENT DISORD, V25, P1163, DOI 10.1002/mds.22953; Perlis RH, 2010, AM J PSYCHIAT, V167, P574, DOI 10.1176/appi.ajp.2009.09070973; Sack GH, 2010, J BIOENERG BIOMEMBR, V42, P189, DOI 10.1007/s10863-010-9291-x; Sawa A, 2001, J MOL MED, V79, P375, DOI 10.1007/s001090100223; Sawamura N, 2008, MOL PSYCHIATR, V13, P1138, DOI 10.1038/mp.2008.101; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; SHIWACH R, 1994, ACTA PSYCHIAT SCAND, V90, P241, DOI 10.1111/j.1600-0447.1994.tb01587.x; Slaughter J R, 2001, CNS Spectr, V6, P306; Tomppo L, 2009, BIOL PSYCHIAT, V65, P1055, DOI 10.1016/j.biopsych.2009.01.014; Tsuang D, 1998, AM J MED GENET, V81, P323, DOI 10.1002/(SICI)1096-8628(19980710)81:4<323::AID-AJMG9>3.3.CO;2-M; van Duijn E, 2007, J NEUROPSYCH CLIN N, V19, P441, DOI 10.1176/appi.neuropsych.19.4.441; Verny C, 2007, EUR J NEUROL, V14, P1344, DOI 10.1111/j.1468-1331.2007.01975.x; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Yohrling GJ, 2003, MOL CELL NEUROSCI, V23, P28, DOI 10.1016/S1044-7431(03)00032-0; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	45	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16263	10.1371/journal.pone.0016263	http://dx.doi.org/10.1371/journal.pone.0016263			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298101	gold, Green Submitted, Green Published			2022-12-25	WOS:000286662800020
J	Rickabaugh, TM; Kilpatrick, RD; Hultin, LE; Hultin, PM; Hausner, MA; Sugar, CA; Althoff, KN; Margolick, JB; Rinaldo, CR; Detels, R; Phair, J; Effros, RB; Jamieson, BD				Rickabaugh, Tammy M.; Kilpatrick, Ryan D.; Hultin, Lance E.; Hultin, Patricia M.; Hausner, Mary Ann; Sugar, Catherine A.; Althoff, Keri N.; Margolick, Joseph B.; Rinaldo, Charles R.; Detels, Roger; Phair, John; Effros, Rita B.; Jamieson, Beth D.			The Dual Impact of HIV-1 Infection and Aging on Naive CD4(+) T-Cells: Additive and Distinct Patterns of Impairment	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; MARKED INCREASE; MORTALITY-RATES; ANAL CANCER; IN-VIVO; AT-RISK; AIDS; AGE; RESTORATION	HIV-1-infected adults over the age of 50 years progress to AIDS more rapidly than adults in their twenties or thirties. In addition, HIV-1-infected individuals receiving antiretroviral therapy (ART) present with clinical diseases, such as various cancers and liver disease, more commonly seen in older uninfected adults. These observations suggest that HIV-1 infection in older persons can have detrimental immunological effects that are not completely reversed by ART. As naive T-cells are critically important in responses to neoantigens, we first analyzed two subsets (CD45RA(+)CD31(+) and CD45RA(+)CD31(-)) within the naive CD4(+) T-cell compartment in young (20-32 years old) and older (39-58 years old), ART-naive, HIV-1 seropositive individuals within 1-3 years of infection and in age-matched seronegative controls. HIV-1 infection in the young cohort was associated with lower absolute numbers of, and shorter telomere lengths within, both CD45RA(+)CD31(+)CD4(+) and CD45RA(+)CD31(-)CD4(+) T-cell subsets in comparison to age-matched seronegative controls, changes that resembled seronegative individuals who were decades older. Longitudinal analysis provided evidence of thymic emigration and reconstitution of CD45RA(+)CD31(+)CD4(+) T-cells two years post-ART, but minimal reconstitution of the CD45RA(+)CD31(-)CD4(+) subset, which could impair de novo immune responses. For both ART-naive and ART-treated HIV-1-infected adults, a renewable pool of thymic emigrants is necessary to maintain CD4(+) T-cell homeostasis. Overall, these results offer a partial explanation both for the faster disease progression of older adults and the observation that viral responders to ART present with clinical diseases associated with older adults.	[Rickabaugh, Tammy M.; Kilpatrick, Ryan D.; Hultin, Lance E.; Hausner, Mary Ann; Effros, Rita B.; Jamieson, Beth D.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Dept Med, Los Angeles, CA 90095 USA; [Effros, Rita B.] Univ Calif Los Angeles, UCLA AIDS Inst, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Sugar, Catherine A.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Althoff, Keri N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Margolick, Joseph B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Kilpatrick, Ryan D.; Hultin, Patricia M.; Detels, Roger] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA; [Phair, John] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; Northwestern University; Feinberg School of Medicine	Rickabaugh, TM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Dept Med, Los Angeles, CA 90095 USA.	jamieson@mednet.ucla.edu	Serei, Virian D/B-4616-2015; Althoff, Keri N/HGC-5595-2022	Althoff, Keri/0000-0002-5068-6595; Kilpatrick, Ryan/0000-0003-1388-3669	NIAID [5RO1-AI-058845]; NIA [1RO1-AG-030327]; National Institutes of Health [CA-16042, AI-28697]; National Cancer Institute [5 T32 CA009120]; National Institute of Allergy and Infectious Diseases; National Cancer Institute and the National Heart, Lung and Blood Institute [UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; NATIONAL CANCER INSTITUTE [T32CA009120, P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035040, U01AI035042, U01AI037613, U01AI035039, U01AI035043, R01AI058845, U01AI035041, U01AI037984, P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030327, R01AG032422] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute and the National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Heart Lung & Blood Institute (NHLBI)); JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIAID Grant 5RO1-AI-058845 and NIA Grant 1RO1-AG-030327 awarded to B. D. Jamieson, P. I. T. M. Rickabaugh was also supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award, 5 T32 CA009120, from the National Cancer Institute. The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute and the National Heart, Lung and Blood Institute: UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041. Flow cytometry was performed in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility that is supported by National Institutes of Health awards CA-16042 and AI-28697, and by the JCCC, the UCLA AIDS Institute, and the David Geffen School of Medicine at UCLA. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbatecola AM, 2004, J AM GERIATR SOC, V52, P399, DOI 10.1111/j.1532-5415.2004.52112.x; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Arnold DM, 2006, BLOOD, V108, P460, DOI 10.1182/blood-2005-11-4407; Aspinall R, 2000, J CLIN IMMUNOL, V20, P250, DOI 10.1023/A:1006611518223; Azevedo RI, 2009, BLOOD, V113, P2999, DOI 10.1182/blood-2008-07-166223; Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Bar-Or D, 2001, BIOCHEM BIOPH RES CO, V282, P356, DOI 10.1006/bbrc.2001.4533; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V284, pE481, DOI 10.1152/ajpendo.00319.2002; Bestilny LJ, 2000, AIDS, V14, P771, DOI 10.1097/00002030-200005050-00002; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chattopadhyay PK, 2006, AIDS RES HUM RETROV, V22, P501, DOI 10.1089/aid.2006.22.501; D'Souza G, 2008, JAIDS-J ACQ IMM DEF, V48, P491, DOI 10.1097/QAI.0b013e31817aebfe; Darby SC, 1996, LANCET, V347, P1573, DOI 10.1016/S0140-6736(96)91073-9; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Dorrucci M, 2001, J ACQ IMMUN DEF SYND, V26, P377, DOI 10.1097/00126334-200104010-00016; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Effros RB, 2000, MECH AGEING DEV, V121, P161; Efron B., 1994, INTRO BOOTSTRAP; Engels EA, 2010, JAIDS-J ACQ IMM DEF, V54, P78, DOI 10.1097/01.qai.0000371677.48743.8d; Fausto A, 2006, BONE, V38, P893, DOI 10.1016/j.bone.2005.11.001; Fulop T, 2006, MECH AGEING DEV, V127, P526, DOI 10.1016/j.mad.2006.01.025; Herndler-Brandstetter D, 2006, WIEN MED WOCHENSCHR, V156, P130, DOI 10.1007/s10354-006-0267-8; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hooshyar D, 2007, AIDS, V21, P2093, DOI 10.1097/QAD.0b013e3282e9a664; Hsue PY, 2008, AIDS, V22, P825, DOI 10.1097/QAD.0b013e3282f7cd42; Hultdin M, 1998, NUCLEIC ACIDS RES, V26, P3651, DOI 10.1093/nar/26.16.3651; Hultin L, 2006, MANUAL OF MOLECULAR AND CLINICAL LABORATORY IMMUNOLOGY, 7TH EDITION, P147; Iyer SB, 1998, CYTOMETRY, V33, P206, DOI 10.1002/(SICI)1097-0320(19981001)33:2<206::AID-CYTO15>3.0.CO;2-Y; IYER SB, 1997, 233496 BDIS; Jamieson BD, 1999, IMMUNITY, V10, P569, DOI 10.1016/S1074-7613(00)80056-4; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kohler S, 2005, EUR J IMMUNOL, V35, P1987, DOI 10.1002/eji.200526181; Lange CG, 2002, CLIN IMMUNOL, V102, P154, DOI 10.1006/clim.2001.5164; Lucas GM, 2007, AIDS, V21, P2435, DOI 10.1097/QAD.0b013e32827038ad; MASCOLINI M, 2010, RES INITIATIVE TREAT, V15, P1; Nichols WS, 1999, SCAND J IMMUNOL, V49, P302, DOI 10.1046/j.1365-3083.1999.00505.x; Pham T, 2003, CLIN DIAGN LAB IMMUN, V10, P323, DOI 10.1128/CDLI.10.2.323-328.2003; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; PLAEGERMARSHALL S, 1993, J ACQ IMMUN DEF SYND, V6, P984; Pommier JP, 1997, VIROLOGY, V231, P148, DOI 10.1006/viro.1997.8512; RABIN RL, 1995, J CLIN INVEST, V95, P2054, DOI 10.1172/JCI117891; Richardson MW, 2000, BIOMED PHARMACOTHER, V54, P21, DOI 10.1016/S0753-3322(00)88637-0; Robertson JD, 2000, BRIT J HAEMATOL, V109, P272, DOI 10.1046/j.1365-2141.2000.01970.x; RODRIGUEZ B, 2010, CLIN IMMUNOL; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; ROSENBERG PS, 1994, AIDS, V8, P803, DOI 10.1097/00002030-199406000-00013; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Sergio G, 2008, INFLAMM RES, V57, P558, DOI 10.1007/s00011-008-7243-2; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Teixeira L, 2001, AIDS, V15, P1749, DOI 10.1097/00002030-200109280-00002; Thomas J, 2003, JAIDS-J ACQ IMM DEF, V33, P281, DOI 10.1097/00126334-200307010-00001; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Vignoli M, 1998, AIDS, V12, P999, DOI 10.1097/00002030-199809000-00005; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Vrisekoop N, 2008, J IMMUNOL, V181, P1573, DOI 10.4049/jimmunol.181.2.1573; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Webster RG, 2000, VACCINE, V18, P1686, DOI 10.1016/S0264-410X(99)00507-1; Whisler RL, 1996, CELL IMMUNOL, V168, P201, DOI 10.1006/cimm.1996.0067; Wolthers KC, 1999, AIDS RES HUM RETROV, V15, P1053, DOI 10.1089/088922299310340; Zanni F, 2003, EXP GERONTOL, V38, P981, DOI 10.1016/S0531-5565(03)00160-8; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725	71	57	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16459	10.1371/journal.pone.0016459	http://dx.doi.org/10.1371/journal.pone.0016459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298072	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000286662800044
J	Welsh, J; Zinser, LN; Mianecki-Morton, L; Martin, J; Waltz, SE; James, H; Zinser, GM				Welsh, JoEllen; Zinser, Lindsay N.; Mianecki-Morton, Laurel; Martin, Jamie; Waltz, Susan E.; James, Howard; Zinser, Glendon M.			Age-Related Changes in the Epithelial and Stromal Compartments of the Mammary Gland in Normocalcemic Mice Lacking the Vitamin D-3 Receptor	PLOS ONE			English	Article							MINERAL ION HOMEOSTASIS; BREAST-CANCER CELLS; ADIPOSE-TISSUE; KNOCKOUT MICE; 1,25-DIHYDROXYVITAMIN D-3; INDUCED TUMORIGENESIS; DIETARY CALCIUM; ABLATED MICE; MUTANT MICE; GROWTH	The vitamin D-3 receptor (VDR) serves as a negative growth regulator during mammary gland development via suppression of branching morphogenesis during puberty and modulation of differentiation and apoptosis during pregnancy, lactation and involution. To assess the role of the VDR in the aging mammary gland, we utilized 12, 14, and 16 month old VDR knockout (KO) and wild type (WT) mice for assessment of integrity of the epithelial and stromal compartments, steroid hormone levels and signaling pathways. Our data indicate that VDR ablation is associated with ductal ectasia of the primary mammary ducts, loss of secondary and tertiary ductal branches and atrophy of the mammary fat pad. In association with loss of the white adipose tissue compartment, smooth muscle actin staining is increased in glands from VDR KO mice, suggesting a change in the stromal microenviroment. Activation of caspase-3 and increased Bax expression in mammary tissue of VDR KO mice suggests that enhanced apoptosis may contribute to loss of ductal branching. These morphological changes in the glands of VDR KO mice are associated with ovarian failure and reduced serum 17 beta-estradiol. VDR KO mice also exhibit progressive loss of adipose tissue stores, hypoleptinemia and increased metabolic rate with age. These developmental studies indicate that, under normocalcemic conditions, loss of VDR signaling is associated with age-related estrogen deficiency, disruption of epithelial ductal branching, abnormal energy expenditure and atrophy of the mammary adipose compartment.	[Welsh, JoEllen] SUNY Albany, Canc Res Ctr, Rensselaer, NY USA; [Zinser, Lindsay N.] Cincinnati VA Med Ctr, Cincinnati, OH USA; [Mianecki-Morton, Laurel] Univ Michigan, Ann Arbor, MI 48109 USA; [Martin, Jamie] Brown Univ, Hasbro Childrens Hosp, Providence, RI 02912 USA; [Waltz, Susan E.; Zinser, Glendon M.] Univ Cincinnati, Cincinnati, OH USA; [Waltz, Susan E.; James, Howard] Cincinnati Shriners Hosp, Cincinnati, OH USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University of Michigan System; University of Michigan; Brown University; Hasbro Children's Hospital; University of Cincinnati	Welsh, J (corresponding author), SUNY Albany, Canc Res Ctr, Rensselaer, NY USA.	zinserg@ucmail.uc.edu		Waltz, Susan/0000-0003-3572-4642	National Institutes of Health [CA69700, CA100002]; DOD [DAMD17-00-1-0644]; Susan G. Komen Breast Cancer Foundation [PDF0403052]; BIRCWH [HD051953-01]; Shriners Hospital for Children [8950]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051953] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA069700, R01CA100002] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); BIRCWH; Shriners Hospital for Children; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This research was supported by grants from the National Institutes of Health (CA69700, JW) and (CA100002, SEW), DOD Breast Cancer Research Program (DAMD17-00-1-0644, JW), a post-doctoral award to GMZ from the Susan G. Komen Breast Cancer Foundation (PDF0403052), a BIRCWH fellowship award to GMZ (HD051953-01), and a grant from Shriners Hospital for Children (#8950, SEW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Bruce D, 2009, INT IMMUNOL, V21, P113, DOI 10.1093/intimm/dxn129; Cooke PS, 2001, MOL CELL ENDOCRINOL, V178, P147, DOI 10.1016/S0303-7207(01)00414-2; Couldrey C, 2002, DEV DYNAM, V223, P459, DOI 10.1002/dvdy.10065; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; ERBEN RG, HEMATOL ONCOL; Eriksen EF, 2002, BIOGERONTOLOGY, V3, P73, DOI 10.1023/A:1015263514765; Fendrick JL, 1998, J MAMMARY GLAND BIOL, V3, P7, DOI 10.1023/A:1018766000275; Froicu M, 2006, IMMUNOLOGY, V117, P310, DOI 10.1111/j.1365-2567.2005.02290.x; Froicu M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-5; Haslam Sandra Z, 2005, Breast Dis, V24, P71; Haslam SZ, 2002, J MAMMARY GLAND BIOL, V7, P93, DOI 10.1023/A:1015726608146; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Johnson JA, 1996, HISTOCHEM CELL BIOL, V105, P7, DOI 10.1007/BF01450873; Johnson LE, 2001, J NUTR, V131, P1787, DOI 10.1093/jn/131.6.1787; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Kanazawa T, 1999, CELL BIOL INT, V23, P481, DOI 10.1006/cbir.1999.0406; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Keisala T, 2009, J STEROID BIOCHEM, V115, P91, DOI 10.1016/j.jsbmb.2009.03.007; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Lamote I, 2004, STEROIDS, V69, P145, DOI 10.1016/j.steroids.2003.12.008; LANDSKRONEREIGE.S, DEV BIOL, V344, P968; LEFEBVRE MF, 1995, BREAST CANCER RES TR, V33, P189, DOI 10.1007/BF00665943; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Metcalfe AD, 1999, J CELL SCI, V112, P1771; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Narvaez CJ, 2001, J BIOL CHEM, V276, P9101, DOI 10.1074/jbc.M006876200; Neville MC, 1998, J MAMMARY GLAND BIOL, V3, P109, DOI 10.1023/A:1018786604818; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Parra P, 2008, J NUTR BIOCHEM, V19, P109, DOI 10.1016/j.jnutbio.2007.01.009; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; SimboliCampbell M, 1996, J STEROID BIOCHEM, V58, P367, DOI 10.1016/0960-0760(96)00055-6; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; WONG KE, 2009, AM J PHYSL ENDOCRINO; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zinser G, 2002, DEVELOPMENT, V129, P3067; Zinser GM, 2005, J STEROID BIOCHEM, V97, P153, DOI 10.1016/j.jsbmb.2005.06.024; Zinser GM, 2004, MOL ENDOCRINOL, V18, P2208, DOI 10.1210/me.2003-0469; Zinser GM, 2003, MOL CELL ENDOCRINOL, V200, P67, DOI 10.1016/S0303-7207(02)00416-1; Zinser GM, 2002, CARCINOGENESIS, V23, P2103, DOI 10.1093/carcin/23.12.2103; Zou J, 2008, AUDIOL NEURO-OTOL, V13, P219, DOI 10.1159/000115431	43	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16479	10.1371/journal.pone.0016479	http://dx.doi.org/10.1371/journal.pone.0016479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298063	Green Published, Green Submitted, gold			2022-12-25	WOS:000286662800045
J	Lee, G; Origanti, S; White, LS; Sun, JW; Stappenbeck, TS; Piwnica-Worms, H				Lee, Gwanghee; Origanti, Sofia; White, Lynn S.; Sun, Jinwu; Stappenbeck, Thaddeus S.; Piwnica-Worms, Helen			Contributions Made by CDC25 Phosphatases to Proliferation of Intestinal Epithelial Stem and Progenitor Cells	PLOS ONE			English	Article							PROTEIN PHOSPHATASE; CANCER; DEPHOSPHORYLATION; ACTIVATION; MICE; RECOMBINATION; EXPRESSION; MATURATION; IRINOTECAN; P34CDC2	The CDC25 protein phosphatases drive cell cycle advancement by activating cyclin-dependent protein kinases (CDKs). Humans and mice encode three family members denoted CDC25A, -B and -C and genes encoding these family members can be disrupted individually with minimal phenotypic consequences in adult mice. However, adult mice globally deleted for all three phosphatases die within one week after Cdc25 disruption. A severe loss of absorptive villi due to a failure of crypt epithelial cells to proliferate was observed in the small intestines of these mice. Because the Cdc25s were globally deleted, the small intestinal phenotype and loss of animal viability could not be solely attributed to an intrinsic defect in the inability of small intestinal stem and progenitor cells to divide. Here, we report the consequences of deleting different combinations of Cdc25s specifically in intestinal epithelial cells. The phenotypes arising in these mice were then compared with those arising in mice globally deleted for the Cdc25s and in mice treated with irinotecan, a chemotherapeutic agent commonly used to treat colorectal cancer. We report that the phenotypes arising in mice globally deleted for the Cdc25s are due to the failure of small intestinal stem and progenitor cells to proliferate and that blocking cell division by inhibiting the cell cycle engine (through Cdc25 loss) versus by inducing DNA damage (via irinotecan) provokes a markedly different response of small intestinal epithelial cells. Finally, we demonstrate that CDC25A and CDC25B but not CDC25C compensate for each other to maintain the proliferative capacity of intestinal epithelial stem and progenitor cells.	[Lee, Gwanghee; Origanti, Sofia; White, Lynn S.; Sun, Jinwu; Piwnica-Worms, Helen] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Origanti, Sofia; White, Lynn S.; Piwnica-Worms, Helen] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO USA; [Sun, Jinwu] Washington Univ, Sch Med, Mol Imaging Ctr, St Louis, MO USA; [Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Piwnica-Worms, Helen] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Origanti, Sofia; White, Lynn S.; Piwnica-Worms, Helen] Howard Hughes Med Inst, Chevy Chase, MD USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute	Lee, G (corresponding author), Genentech Inc, Dept Physiol Chem, San Francisco, CA USA.	hpiwnica@wustl.edu	Piwnica-Worms, Helen/C-5214-2012	Origanti, Sofia/0000-0002-6953-0160	Cancer Biology Pathway program; National Cancer Institute Cancer Center [P30 CA91842]; Pew Scholars Program in the Biomedical Sciences; Crohn's Colitis Fund of America; National Institutes of Health;  [P50 CA94056]; NATIONAL CANCER INSTITUTE [P30CA091842, P50CA094056] Funding Source: NIH RePORTER	Cancer Biology Pathway program; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pew Scholars Program in the Biomedical Sciences; Crohn's Colitis Fund of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	G.L. was supported in part by the Cancer Biology Pathway program administered through the Siteman Cancer Center. The Siteman Cancer Center is supported in part by an National Cancer Institute Cancer Center Support Grant P30 CA91842. This work was supported by grants from the Pew Scholars Program in the Biomedical Sciences and the Crohn's Colitis Fund of America to T.S.S. and from the National Institutes of Health to H.P.-W. S.O. is an Associate and H.P.-W. is an Investigator of the Howard Hughes Medical Institute. J.S. was supported in part by P50 CA94056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2008, PLOS BIOL, V6, P1746, DOI 10.1371/journal.pbio.0060191; Alimonti A, 2004, CANCER TREAT REV, V30, P555, DOI 10.1016/j.ctrv.2004.05.002; Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Aressy B, 2008, ANTI-CANCER AGENT ME, V8, P818, DOI 10.2174/187152008786847756; Chen MS, 2001, MOL CELL BIOL, V21, P3853, DOI 10.1128/MCB.21.12.3853-3861.2001; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Fuchs C, 2006, CANCER TREAT REV, V32, P491, DOI 10.1016/j.ctrv.2006.07.001; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; HONDA R, 1993, FEBS LETT, V318, P331, DOI 10.1016/0014-5793(93)80540-B; Kohn EA, 2002, J BIOL CHEM, V277, P26553, DOI 10.1074/jbc.M202040200; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lee G, 2009, P NATL ACAD SCI USA, V106, P4701, DOI 10.1073/pnas.0900751106; LEE MS, 1992, MOL BIOL CELL, V3, pA188; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; SEBASTIAN B, 1993, P NATL ACAD SCI USA, V90, P3521, DOI 10.1073/pnas.90.8.3521; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Turowski P, 2003, MOL BIOL CELL, V14, P2984, DOI 10.1091/mbc.E02-08-0515; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Zamboni WC, 1998, CLIN CANCER RES, V4, P743	29	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15561	10.1371/journal.pone.0015561	http://dx.doi.org/10.1371/journal.pone.0015561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283624	gold, Green Published, Green Submitted			2022-12-25	WOS:000286661400008
J	Friberg, U; Miller, PM; Stewart, AD; Rice, WR				Friberg, Urban; Miller, Paige M.; Stewart, Andrew D.; Rice, William R.			Mechanisms Promoting the Long-Term Persistence of a Wolbachia Infection in a Laboratory-Adapted Population of Drosophila melanogaster	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; UNIDIRECTIONAL INCOMPATIBILITY; ANTAGONISTIC COEVOLUTION; SIMULANS; DYNAMICS; EVOLUTION; MOSQUITOS; SELECTION; INSECTS; STRAINS	Intracellular bacteria of the genus Wolbachia are widespread endosymbionts across diverse insect taxa. Despite this prevalence, our understanding of how Wolbachia persists within populations is not well understood. Cytoplasmic incompatibility (CI) appears to be an important phenotype maintaining Wolbachia in many insects, but it is believed to be too weak to maintain Wolbachia in Drosophila melanogaster, suggesting that Wolbachia must also have other effects on this species. Here we estimate the net selective effect of Wolbachia on its host in a laboratory-adapted population of D. melanogaster, to determine the mechanisms leading to its persistence in the laboratory environment. We found i) no significant effects of Wolbachia infection on female egg-to-adult survival or adult fitness, ii) no reduced juvenile survival in males, iii) substantial levels of CI, and iv) a vertical transmission rate of Wolbachia higher than 99%. The fitness of cured females was, however, severely reduced (a decline of 37%) due to CI in offspring. Taken together these findings indicate that Wolbachia is maintained in our laboratory environment due to a combination of a nearly perfect transmission rate and substantial CI. Our results show that there would be strong selection against females losing their infection and producing progeny free from Wolbachia.	[Friberg, Urban] Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden; [Friberg, Urban; Miller, Paige M.; Stewart, Andrew D.; Rice, William R.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	Uppsala University; University of California System; University of California Santa Barbara	Friberg, U (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden.	Urban.Friberg@ebc.uu.se	Friberg, Urban/C-9412-2015	Friberg, Urban/0000-0001-6112-9586; Miller, Paige/0000-0002-5419-8601	National Science Foundation [DEB-0128780, DEB-0111613]; National Institutes of Health [1R01HD057974-01]; Wenner-Gren Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057974] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was funded by the National Science Foundation [DEB-0128780 and DEB-0111613]; National Institutes of Health [1R01HD057974-01]; the Wenner-Gren Foundations (http://www.swgc.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist Goran, 2005, pUnpaginated; Bourtzis K., 1994, Insect Molecular Biology, V3, P131, DOI 10.1111/j.1365-2583.1994.tb00160.x; Bourtzis K, 1996, GENETICS, V144, P1063; CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Clark ME, 2005, GENETICS, V170, P1667, DOI 10.1534/genetics.104.038901; Clark ME, 2002, MECH DEVELOP, V111, P3, DOI 10.1016/S0925-4773(01)00594-9; FINE PEM, 1978, J INVERTEBR PATHOL, V31, P10, DOI 10.1016/0022-2011(78)90102-7; Friberg U, 2008, J EVOLUTION BIOL, V21, P1798, DOI 10.1111/j.1420-9101.2008.01581.x; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Harcombe W, 2004, J INVERTEBR PATHOL, V87, P45, DOI 10.1016/j.jip.2004.07.003; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; HOFFMANN AA, 1988, GENETICS, V119, P435; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; HOFFMANN AA, 1994, GENETICS, V136, P993; Hoffmann AA, 1998, GENETICS, V148, P221; HOFFMANN AA, 1990, GENETICS, V126, P933; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Linder JE, 2005, J EVOLUTION BIOL, V18, P568, DOI 10.1111/j.1420-9101.2004.00872.x; Montenegro H, 2006, GENETICA, V127, P207, DOI 10.1007/s10709-005-3766-4; Olsen K, 2001, HEREDITY, V86, P731, DOI 10.1046/j.1365-2540.2001.00892.x; PROUT T, 1994, EVOLUTION, V48, P909, DOI 10.1111/j.1558-5646.1994.tb01371.x; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Rice WR, 2006, PHILOS T R SOC B, V361, P287, DOI 10.1098/rstb.2005.1787; RICE WR, 1990, BIOMETRICS, V46, P303, DOI 10.2307/2531435; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rice WR, 2005, P NATL ACAD SCI USA, V102, P6527, DOI 10.1073/pnas.0501889102; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; SOLIGNAC M, 1994, CR ACAD SCI III-VIE, V317, P461; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; TURELLI M, 1992, GENETICS, V132, P713; TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x; TURELLI M, 1995, GENETICS, V140, P1319; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren JH, 1997, INFLUENTIAL PASSENGERS, P1; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969	42	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16448	10.1371/journal.pone.0016448	http://dx.doi.org/10.1371/journal.pone.0016448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283625	gold, Green Submitted, Green Published			2022-12-25	WOS:000286523400037
J	Hansson, J; Vasan, RS; Arnlov, J; Ingelsson, E; Lind, L; Larsson, A; Michaelsson, K; Sundstrom, J				Hansson, Jonas; Vasan, Ramachandran S.; Arnlov, Johan; Ingelsson, Erik; Lind, Lars; Larsson, Anders; Michaelsson, Karl; Sundstrom, Johan			Biomarkers of Extracellular Matrix Metabolism (MMP-9 and TIMP-1) and Risk of Stroke, Myocardial Infarction, and Cause-Specific Mortality: Cohort Study	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; PLASMA TISSUE INHIBITOR; LONG-TERM SURVIVAL; E-DEFICIENT MICE; METALLOPROTEINASE INHIBITION; CARDIOVASCULAR-DISEASE; INDEPENDENT PREDICTOR; LUNG-CANCER; MATRIX-METALLOPROTEINASE-9; SERUM	Objective: Turnover of the extracellular matrix in all solid organs is governed mainly by a balance between the degrading matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). An altered extracellular matrix metabolism has been implicated in a variety of diseases. We investigated relations of serum levels of MMP-9 and TIMP-1 to mortality risk from an etiological perspective. Design: The prospective Uppsala Longitudinal Study of Adult Men (ULSAM) cohort, followed from 1991-1995 for up to 18.1 years. A random population-based sample of 1,082 71-year-old men, no loss to follow-up. Endpoints were all-cause (n = 628), cardiovascular (n = 230), non-cardiovascular (n = 398) and cancer mortality (n = 178), and fatal or non-fatal myocardial infarction (n = 138) or stroke (n = 163). Results: Serum MMP-9 and TIMP-1 levels were associated with risk of all-cause mortality (Cox proportional hazard ratio [HR] per standard deviation 1.10, 95% confidence interval [CI] 1.03-1.19; and 1.11, 1.02-1.20; respectively). TIMP-1 levels were mainly related to risks of cardiovascular mortality and stroke (HR per standard deviation 1.22, 95% CI 1.09-1.37; and 1.18, 1.04-1.35; respectively). All relations except those of TIMP-1 to stroke risk were attenuated by adjustment for cardiovascular disease risk factors. Relations in a subsample without cardiovascular disease or cancer were similar to those in the total sample. Conclusion: In this community-based cohort of elderly men, serum MMP-9 and TIMP-1 levels were related to mortality risk. An altered extracellular matrix metabolism may be involved in several detrimental pathways, and circulating MMP-9 or TIMP-1 levels may be relevant markers thereof.	[Hansson, Jonas; Lind, Lars; Sundstrom, Johan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Vasan, Ramachandran S.; Larsson, Anders] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Vasan, Ramachandran S.; Larsson, Anders] Boston Univ, Sch Med, Cardiol Sect, Boston Med Ctr, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Larsson, Anders] Boston Univ, Sch Med, Sect Prevent Med, Boston Med Ctr, Boston, MA 02118 USA; [Arnlov, Johan] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Sci, Falun, Sweden; [Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Michaelsson, Karl; Sundstrom, Johan] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden	Uppsala University; Framingham Heart Study; Boston Medical Center; Boston University; Boston Medical Center; Boston University; Uppsala University; Dalarna University; Karolinska Institutet; Uppsala University; Uppsala University	Hansson, J (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	johan.sundstrom@medsci.uu.se	Larsson, Agneta/AAT-9546-2020; Michaelsson, Karl/AAM-9094-2021; Sundström, Johan/A-6286-2009; Ärnlöv, Johan/AAF-2746-2019; Sundstrom, Johan/R-2139-2019	Larsson, Agneta/0000-0002-8692-249X; Sundström, Johan/0000-0003-2247-8454; Ärnlöv, Johan/0000-0002-6933-4637; Sundstrom, Johan/0000-0003-2247-8454; Michaelsson, Karl/0000-0003-2815-1217; Ramachandran, Vasan/0000-0001-7357-5970	Swedish Research Council (vr.se) [522-2007-5942]; Swedish Heart Lung Foundation (hjart-lungfonden.se) [20041151]	Swedish Research Council (vr.se)(Swedish Research Council); Swedish Heart Lung Foundation (hjart-lungfonden.se)(Swedish Heart-Lung Foundation)	The study was funded by the Swedish Research Council (vr.se), grant 522-2007-5942, and the Swedish Heart Lung Foundation (hjart-lungfonden.se), grant 20041151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Belvisi MG, 2003, INFLAMM RES, V52, P95, DOI 10.1007/s000110300020; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Byberg L, 1998, ARTERIOSCL THROM VAS, V18, P258, DOI 10.1161/01.ATV.18.2.258; Castellanos M, 2003, STROKE, V34, P40, DOI 10.1161/01.STR.0000046764.57344.31; Cavusoglu E, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.02.029; Chancey AL, 2002, CIRCULATION, V105, P1983, DOI 10.1161/01.CIR.0000014686.73212.DA; Creemers EEJM, 2003, AM J PHYSIOL-HEART C, V284, pH364, DOI 10.1152/ajpheart.00511.2002; Dorman Gyorgy, 2007, Recent Pat Cardiovasc Drug Discov, V2, P186, DOI 10.2174/157489007782418964; Eldrup N, 2006, CIRCULATION, V114, P1847, DOI 10.1161/CIRCULATIONAHA.105.593483; Fong KM, 1996, CLIN CANCER RES, V2, P1369; Frantz S, 2008, EUR J HEART FAIL, V10, P388, DOI 10.1016/j.ejheart.2008.02.015; Garvin P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001774; George J, 2005, AM HEART J, V150, P484, DOI 10.1016/j.ahj.2004.11.016; HANSSON J, 2009, EUR J CARDIOVASC PRE; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; JEFFERIS BJ, ATHEROSCLEROSIS, V208, P557; Jung K, 2008, ARTERIOSCL THROM VAS, V28, pE15, DOI 10.1161/ATVBAHA.107.158790; Klein G, 2004, CRIT REV ONCOL HEMAT, V50, P87, DOI 10.1016/j.critevonc.2003.09.001; Lijnen HR, 2003, PATHOPHYSIOL HAEMO T, V33, P275, DOI 10.1159/000083814; Lubos E, 2006, EUR HEART J, V27, P150, DOI 10.1093/eurheartj/ehi582; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; Montaner J, 2003, STROKE, V34, P2851, DOI 10.1161/01.STR.0000098648.54429.1C; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; Montaner J, 2001, STROKE, V32, P1759, DOI 10.1161/01.STR.32.8.1759; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Peterson JT, 2001, CIRCULATION, V103, P2303; Rouet-Benzineb P, 1999, EUR J HEART FAIL, V1, P337, DOI 10.1016/S1388-9842(99)00048-3; Rouis M, 1999, CIRCULATION, V100, P533, DOI 10.1161/01.CIR.100.5.533; Rouy D, 2005, ANAL BIOCHEM, V338, P294, DOI 10.1016/j.ab.2004.10.052; Silence J, 2002, CIRC RES, V90, P897, DOI 10.1161/01.RES.0000016501.56641.83; Spinale FG, 1999, CIRC RES, V85, P364, DOI 10.1161/01.RES.85.4.364; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sundstrom J, 2004, EUR HEART J, V25, P1509, DOI 10.1016/j.ehj.2004.05.029; Sundstrom J, 2004, CIRCULATION, V109, P2850, DOI 10.1161/01.CIR.0000129318.79570.84; Sundstrom J, 2006, CURR OPIN LIPIDOL, V17, P45, DOI 10.1097/01.mol.0000203891.34890.b5; Tuomainen AM, 2007, ARTERIOSCL THROM VAS, V27, P2722, DOI 10.1161/ATVBAHA.107.154831; Turunen MP, 2002, MOL THER, V6, P306, DOI 10.1006/mthe.2002.0668; VELAGALETI RS, ARTERIOSCLER THROMB; West MJ, 2008, EUR HEART J, V29, P923, DOI 10.1093/eurheartj/ehn007; Wu ZS, 2008, INT J CANCER, V122, P2050, DOI 10.1002/ijc.23337; Ylisirnio S, 2000, ANTICANCER RES, V20, P1311; Yoshikawa T, 2009, GASTRIC CANCER, V12, P31, DOI 10.1007/s10120-008-0494-3; Yukawa N, 2007, ONCOLOGY-BASEL, V72, P205, DOI 10.1159/000112827	45	77	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16185	10.1371/journal.pone.0016185	http://dx.doi.org/10.1371/journal.pone.0016185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283828	gold, Green Published, Green Submitted			2022-12-25	WOS:000286520600027
J	Ho, PC; Chang, KC; Chuang, YS; Wei, LN				Ho, Ping-Chih; Chang, Kun-Che; Chuang, Ya-Shan; Wei, Li-Na			Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production	FASEB JOURNAL			English	Article						3 '-UTR; simvastatin; high-fat diet; sepsis; NF-kappa B	REPRESSIVE ACTIVITY; COREPRESSOR RIP140; GENE-EXPRESSION; MOLECULAR INTERACTION; METABOLIC DISEASES; KAPPA-B; NUCLEAR; PHOSPHORYLATION; MIR-33; DIET	Receptor interacting protein 140 (RIP140) is a nuclear receptor coregulator that affects a wide spectrum of biological processes. It is unclear whether and how the expression level of RIP140 can be modulated and whether RIP140 is involved in inflammatory diseases. Here, we examine how intracellular cholesterol regulates RIP140 expression, and we evaluate the effect of RIP140 expression on macrophage proinflammatory potential. Macrophages treated with modified low-density lipoprotein express higher RIP140 mRNA and protein levels. Consistently, simvastatin reduces RIP140 levels, which can be reversed by mevalonate. Moreover, a high-fat diet elevates RIP140 but lowers miR-33 levels in peritoneal macrophages, and increases the production of IL-1 beta and TNF-alpha in macrophages. Mechanistically, miR-33 targets RIP140 mRNA by recognizing its target located in a highly conserved sequence of the 3'-untranslated region (3'-UTR) of RIP140 mRNA. Consequentially, miR-33 reduces RIP140 coactivator activity for NF-kappa B, which is supported by the reduction in NF-kappa B reporter activity and the inflammatory potential in macrophages. This study uncovers a cholesterol-miR-33-RIP140 regulatory pathway that modulates the proinflammatory potential in macrophages in response to an alteration in the intracellular cholesterol status, and identifies RIP140 as a direct target of miR-33 that mediates simvastatin-triggered anti-inflammation.-Ho, P.-C.; Chang, K.-C., Chuang, Y.-S., Wei, L.-N. Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J. 25, 1758-1766 (2011). www.fasebj.org	[Ho, Ping-Chih; Chang, Kun-Che; Chuang, Ya-Shan; Wei, Li-Na] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Wei, LN (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	weixx009@umn.edu		Chang, Kun-Che/0000-0002-0871-5612; Ho, Ping-Chih/0000-0003-3078-3774	U.S. National Institutes of Health [DK60521, DK060521-07S1, DK54733, DK054733-09S1, DA11190, K02-DA13926]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060521, R01DK054733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011190, K02DA013926, P50DA011806] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Y.-C. Tsui for help with the septic shock model and animal handling. The authors also thank F.A. Beyan and A. Smith for technical help. This study was supported in part by U.S. National Institutes of Health grants DK60521, DK060521-07S1, DK54733, DK054733-09S1, DA11190, and K02-DA13926; a Distinguished McKnight University Professorship (L.-N.W.); and an American Heart Association predoctoral fellowship (P.-C.H.).	CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen YX, 2004, MOL CELL ENDOCRINOL, V226, P43, DOI 10.1016/j.mce.2004.07.001; Chen YX, 2002, MOL ENDOCRINOL, V16, P2528, DOI 10.1210/me.2002-0124; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; El Gazzar M, 2010, J BIOL CHEM, V285, P20940, DOI 10.1074/jbc.M110.115063; Fritah A, 2010, AM J PHYSIOL-ENDOC M, V299, pE335, DOI 10.1152/ajpendo.00243.2010; Gao F, 2008, BRIT J ANAESTH, V100, P288, DOI 10.1093/bja/aem406; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gupta P, 2005, MOL CELL PROTEOMICS, V4, P1776, DOI 10.1074/mcp.M500236-MCP200; Gupta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002658; Hernandez-Presa MA, 2003, CARDIOVASC RES, V57, P168, DOI 10.1016/S0008-6363(02)00619-3; Ho PC, 2008, CELL SIGNAL, V20, P1911, DOI 10.1016/j.cellsig.2008.07.001; Ho PC, 2009, CELL METAB, V10, P516, DOI 10.1016/j.cmet.2009.09.012; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huq MDM, 2007, NAT CHEM BIOL, V3, P161, DOI 10.1038/nchembio861; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Huq MDM, 2009, J PROTEOME RES, V8, P1156, DOI 10.1021/pr800569c; Huq MDM, 2005, PROTEOMICS, V5, P2157, DOI 10.1002/pmic.200401090; Lee CH, 1998, MOL CELL BIOL, V18, P6745, DOI 10.1128/MCB.18.11.6745; Lefevre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012828; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Naura AS, 2009, LAB INVEST, V89, P1243, DOI 10.1038/labinvest.2009.98; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Park SW, 2005, MOL CELL PROTEOMICS, V4, P300, DOI 10.1074/mcp.M400195-MCP200; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; REDMOND HP, 1991, ANN SURG, V214, P502, DOI 10.1097/00000658-199110000-00014; Rivera Chantal A., 2010, BMC Physiology, V10, P20, DOI 10.1186/1472-6793-10-20; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Schonbeck U, 2004, CIRCULATION, V109, P18, DOI 10.1161/01.CIR.0000129505.34151.23; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Vachharajani Vidula, 2006, J Intensive Care Med, V21, P287, DOI 10.1177/0885066606290670; White R, 2000, NAT MED, V6, P1368, DOI 10.1038/82183; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zschiedrich I, 2008, BLOOD, V112, P264, DOI 10.1182/blood-2007-11-121699	50	62	69	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2011	25	5					1758	1766		10.1096/fj.10-179267	http://dx.doi.org/10.1096/fj.10-179267			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21285396	Green Published			2022-12-25	WOS:000290023800031
J	Ortega, E; Buey, RM; Sonnenberg, A; de Pereda, JM				Ortega, Esther; Buey, Ruben M.; Sonnenberg, Arnoud; de Pereda, Jose M.			The Structure of the Plakin Domain of Plectin Reveals a Non-canonical SH3 Domain Interacting with Its Fourth Spectrin Repeat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING DOMAIN; INTEGRIN BETA-4 SUBUNIT; INTERMEDIATE-FILAMENTS; EPIDERMOLYSIS-BULLOSA; CRYSTAL-STRUCTURE; DIFFRACTION DATA; PROTEINS; ASSOCIATION; INSIGHTS; PROGRAM	Plectin belongs to the plakin family of cytoskeletal crosslinkers, which is part of the spectrin superfamily. Plakins contain an N-terminal conserved region, the plakin domain, which is formed by an array of spectrin repeats (SR) and a Src-homology 3 (SH3), and harbors binding sites for junctional proteins. We have combined x-ray crystallography and small angle x-ray scattering (SAXS) to elucidate the structure of the central region of the plakin domain of plectin, which corresponds to the SR3, SR4, SR5, and SH3 domains. The crystal structures of the SR3-SR4 and SR4-SR5-SH3 fragments were determined to 2.2 and 2.95 angstrom resolution, respectively. The SH3 of plectin presents major alterations as compared with canonical Pro-rich binding SH3 domains, suggesting that plectin does not recognize Pro-rich motifs. In addition, the SH3 binding site is partially occluded by an intramolecular contact with the SR4. Residues of this pseudo-binding site and the SR4/SH3 interface are conserved within the plakin family, suggesting that the structure of this part of the plectin molecule is similar to that of other plakins. We have created a model for the SR3-SR4-SR5-SH3 region, which agrees well with SAXS data in solution. The three SRs form a semi-flexible rod that is not altered by the presence of the SH3 domain, and it is similar to those found in spectrins. The flexibility of the plakin domain, in analogy with spectrins, might contribute to the role of plakins in maintaining the stability of tissues subject to mechanical stress.	[Ortega, Esther; Buey, Ruben M.; de Pereda, Jose M.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain; [Buey, Ruben M.] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Sonnenberg, Arnoud] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Netherlands Cancer Institute	de Pereda, JM (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Campus Unamuno, E-37007 Salamanca, Spain.	pereda@usal.es	Martinez-Buey, Ruben/K-4296-2014; de Pereda, Jose M/F-1733-2010; de Pereda, Jose M/AAE-5226-2022; Ortega, Esther/AAB-1836-2020	Martinez-Buey, Ruben/0000-0003-1263-0221; de Pereda, Jose M/0000-0002-8912-6739; de Pereda, Jose M/0000-0002-8912-6739; 	Spanish Ministry of Science and Innovation [BES-2007-16463]; European Regional Development Fund [BFU2006-01929, BFU2009-08389]; Netherlands Science Foundation; Dutch Cancer Society; FEBS; Juan de la Cierva Program	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Netherlands Science Foundation(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); FEBS; Juan de la Cierva Program	This work was supported by the Spanish Ministry of Science and Innovation and the European Regional Development Fund (Grants BFU2006-01929 and BFU2009-08389, to J. M. dP.). This work was also supported by grants from the Netherlands Science Foundation and the Dutch Cancer Society (to A. S.).; Recipient of a fellowship from the Spanish Ministry of Science and Innovation (BES-2007-16463).; Recipient of an FEBS fellowship and a contract from the Juan de la Cierva Program.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Afonine PV, 2005, CCP4 NEWSL, V42; Alonso-Garcia N, 2009, ACTA CRYSTALLOGR D, V65, P858, DOI 10.1107/S0907444909018745; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baines AJ, 2003, CELL MOL BIOL LETT, V8, P195; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de la Torre JG, 2000, BIOPHYS J, V78, p401A; de Pereda JM, 2009, CELL ADHES MIGR, V3, P361, DOI 10.4161/cam.3.4.9525; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Eger A, 1997, J CELL SCI, V110, P1307; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOISNER R, 1988, J CELL BIOL, V106, P723, DOI 10.1083/jcb.106.3.723; Fontao L, 2001, J CELL SCI, V114, P2065; Garcia-Alvarez B, 2003, STRUCTURE, V11, P615, DOI 10.1016/S0969-2126(03)00090-X; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; HERRMANN H, 1987, J BIOL CHEM, V262, P1320; Hijikata T, 2008, J CELL SCI, V121, P2062, DOI 10.1242/jcs.021634; Ipsaro JJ, 2010, BLOOD, V115, P4093, DOI 10.1182/blood-2009-11-255604; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Jefferson JJ, 2007, J MOL BIOL, V366, P244, DOI 10.1016/j.jmb.2006.11.036; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Koster J, 2003, J CELL SCI, V116, P387, DOI 10.1242/jcs.00241; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Litjens SHM, 2005, J BIOL CHEM, V280, P22270, DOI 10.1074/jbc.M411818200; Litjens SHM, 2003, MOL BIOL CELL, V14, P4039, DOI 10.1091/mbc.E03-05-0268; Lunter PC, 2002, BIOCHEM BIOPH RES CO, V296, P904, DOI 10.1016/S0006-291X(02)02007-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Musacchio A, 2003, ADV PROTEIN CHEM, V61, P211; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pascual J, 1997, BIOESSAYS, V19, P811, DOI 10.1002/bies.950190911; Pascual J, 1996, FEBS LETT, V383, P201, DOI 10.1016/0014-5793(96)00251-7; Pascual J, 1997, J MOL BIOL, V273, P740, DOI 10.1006/jmbi.1997.1344; Pfendner E, 2005, EXP DERMATOL, V14, P241, DOI 10.1111/j.0906-6705.2005.00324.x; Reipert S, 1999, EXP CELL RES, V252, P479, DOI 10.1006/excr.1999.4626; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Rezniczek GA, 2010, DERMATOL CLIN, V28, P33, DOI 10.1016/j.det.2009.10.004; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schroder R, 1999, EUR J CELL BIOL, V78, P288, DOI 10.1016/S0171-9335(99)80062-4; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; SEIFERT GJ, 1992, EUR J CELL BIOL, V59, P138; Sevcik J, 2004, EUR J BIOCHEM, V271, P1873, DOI 10.1111/j.1432-1033.2004.04095.x; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Sonnenberg A, 2007, J MOL BIOL, V368, P1379, DOI 10.1016/j.jmb.2007.02.090; Spurny R, 2007, J BIOL CHEM, V282, P8175, DOI 10.1074/jbc.M608473200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VIRATA MLA, 1992, P NATL ACAD SCI USA, V89, P544, DOI 10.1073/pnas.89.2.544; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	67	37	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.197467	http://dx.doi.org/10.1074/jbc.M110.197467			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288893	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000289077500057
J	Frandsen, RJN; Schutt, C; Lund, BW; Staerk, D; Nielsen, J; Olsson, S; Giese, H				Frandsen, Rasmus J. N.; Schutt, Claes; Lund, Birgitte W.; Staerk, Dan; Nielsen, John; Olsson, Stefan; Giese, Henriette			Two Novel Classes of Enzymes Are Required for the Biosynthesis of Aurofusarin in Fusarium graminearum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; POLYKETIDE SYNTHASE GENES; FASCICLIN-LIKE PROTEIN; NIDULANS-WA-GENE; GIBBERELLA-ZEAE; SUBCELLULAR-LOCALIZATION; ASPERGILLUS-NIDULANS; FUNCTIONAL EXPRESSION; SCYTALONE DEHYDRATASE; FILAMENTOUS FUNGI	Previous studies have reported the functional characterization of 9 out of 11 genes found in the gene cluster responsible for biosynthesis of the polyketide pigment aurofusarin in Fusarium graminearum. Here we reanalyze the function of a putative aurofusarin pump (AurT) and the two remaining orphan genes, aurZ and aurS. Targeted gene replacement of aurZ resulted in the discovery that the compound YWA1, rather than nor-rubrofusarin, is the primary product of F. graminearum polyketide synthase 12 (FgPKS12). AurZ is the first representative of a novel class of dehydratases that act on hydroxylated gamma-pyrones. Replacement of the aurS gene resulted in accumulation of rubrofusarin, an intermediate that also accumulates when the GIP1, aurF, or aurO genes in the aurofusarin cluster are deleted. Based on the shared phenotype and predicted subcellular localization, we propose that AurS is a member of an extracellular enzyme complex (GIP1-AurF-AurO-AurS) responsible for converting rubrofusarin into aurofusarin. This implies that rubrofusarin, rather than aurofusarin, is pumped across the plasma membrane. Replacement of the putative aurofusarin pump aurT increased the rubrofusarin-to-aurofusarin ratio, supporting that rubrofusarin is normally pumped across the plasma membrane. These results provide functional information on two novel classes of proteins and their contribution to polyketide pigment biosynthesis.	[Frandsen, Rasmus J. N.] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Frandsen, Rasmus J. N.; Olsson, Stefan] Univ Copenhagen, Dept Agr & Ecol, Fac Life Sci, DK-1870 Frederiksberg, Denmark; [Schutt, Claes; Lund, Birgitte W.; Staerk, Dan; Nielsen, John] Univ Copenhagen, Dept Basic Sci & Environm, Fac Life Sci, DK-1870 Frederiksberg, Denmark; [Giese, Henriette] Univ Aarhus, Fac Agr Sci, DK-8000 Aarhus, Denmark	Technical University of Denmark; University of Copenhagen; University of Copenhagen; Aarhus University	Frandsen, RJN (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark.	rasf@bio.dtu.dk	Staerk, Dan/X-6110-2018; Olsson, Stefan/I-5889-2019; Olsson, Stefan/H-2617-2014	Staerk, Dan/0000-0003-0074-298X; Olsson, Stefan/0000-0003-1931-9081; Olsson, Stefan/0000-0003-1931-9081; Nielsen, John/0000-0002-2854-8188; Frandsen, Rasmus John Normand/0000-0002-3799-6062; Giese, Henriette/0000-0002-5284-4155	Danish Ministry for Food, Agriculture and Fisheries; Danish Research Council for Technology and Production Sciences [274-06-0371]	Danish Ministry for Food, Agriculture and Fisheries; Danish Research Council for Technology and Production Sciences	This work was supported by a grant from the Danish Ministry for Food, Agriculture and Fisheries and by The Danish Research Council for Technology and Production Sciences (Grant 274-06-0371).	Adams MA, 2005, J BIOL CHEM, V280, P8358, DOI 10.1074/jbc.M412637200; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bailey TL, 1994, P 2 INT C INT SYST M; Basarab GS, 1999, BIOCHEMISTRY-US, V38, P6012, DOI 10.1021/bi982952b; Bell AA, 2003, PEST MANAG SCI, V59, P736, DOI 10.1002/ps.713; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bills CE, 1931, J BIOL CHEM, V93, P775; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Engh I, 2007, FEMS MICROBIOL LETT, V275, P62, DOI 10.1111/j.1574-6968.2007.00867.x; Evers ME, 2004, ADV BIOCHEM ENG BIOT, V88, P111, DOI 10.1007/b99259; Frandsen RJN, 2006, MOL MICROBIOL, V61, P1069, DOI 10.1111/j.1365-2958.2006.05295.x; Frandsen RJN, 2010, EUKARYOT CELL, V9, P1225, DOI 10.1128/EC.00031-10; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Grocholski T, 2010, BIOCHEMISTRY-US, V49, P934, DOI 10.1021/bi901985b; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Hong SY, 2008, APPL ENVIRON MICROB, V74, P6385, DOI 10.1128/AEM.01185-08; Hong SY, 2009, MYCOL RES, V113, P591, DOI 10.1016/j.mycres.2009.01.013; Hoppert M, 2001, ARCH MICROBIOL, V176, P285, DOI 10.1007/s002030100324; HUBER O, 1994, EMBO J, V13, P4212, DOI 10.1002/j.1460-2075.1994.tb06741.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jordan DB, 2000, BIOCHEMISTRY-US, V39, P2276, DOI 10.1021/bi991839y; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kawamoto T, 1998, BBA-GENE STRUCT EXPR, V1395, P288, DOI 10.1016/S0167-4781(97)00172-3; Kim JE, 2000, J BIOL CHEM, V275, P30907, DOI 10.1074/jbc.M002752200; Kim JE, 2005, APPL ENVIRON MICROB, V71, P1701, DOI 10.1128/AEM.71.4.1701-1708.2005; Kim JE, 2008, PLANT PATHOLOGY J, V24, P8, DOI 10.5423/PPJ.2008.24.1.008; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Lemieux M. Joanne, 2005, Journal of Structural and Functional Genomics, V6, P245, DOI 10.1007/s10969-005-9004-6; LENDENFELD T, 1993, J BIOL CHEM, V268, P665; Liu TB, 2009, J ZHEJIANG UNIV-SC B, V10, P434, DOI 10.1631/jzus.B0920017; Lysoe E, 2006, APPL ENVIRON MICROB, V72, P3924, DOI 10.1128/AEM.00963-05; Malz S, 2005, FUNGAL GENET BIOL, V42, P420, DOI 10.1016/j.fgb.2005.01.010; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Marin M, 2009, J BIOL CHEM, V284, P32709, DOI 10.1074/jbc.M109.024604; MAYORGA ME, 1990, GENETICS, V126, P73; Miyazaki Y, 2007, CURR GENET, V51, P367, DOI 10.1007/s00294-007-0133-2; Nielsen NJ, 2010, J AGR FOOD CHEM, V58, P5509, DOI 10.1021/jf903988f; Pain A, 2004, FUNGAL GENET BIOL, V41, P443, DOI 10.1016/j.fgb.2003.12.003; Pruess LM, 1932, J BIOL CHEM, V97, P483; Roze LV, 2011, FUNGAL GENET BIOL, V48, P35, DOI 10.1016/j.fgb.2010.05.006; Sato K, 2004, ARCH BIOCHEM BIOPHYS, V424, P1, DOI 10.1016/j.abb.2004.01.014; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Song ZS, 2004, CHEMBIOCHEM, V5, P1196, DOI 10.1002/cbic.200400138; STANDFORTH SP, 2006, NATURAL PRODUCT CHEM, P38; Thompson JE, 1998, ANAL BIOCHEM, V256, P1, DOI 10.1006/abio.1997.2489; Tobiasen C, 2007, CURR GENET, V51, P43, DOI 10.1007/s00294-006-0103-0; van de Kamp M, 1999, ANTON LEEUW INT J G, V75, P41, DOI 10.1023/A:1001775932202; Varga J, 2005, ACTA BIOL HUNG, V56, P375, DOI 10.1556/ABiol.56.2005.3-4.19; Watanabe A, 1999, TETRAHEDRON LETT, V40, P91, DOI 10.1016/S0040-4039(98)80027-0; Watanabe A, 2002, TETRAHEDRON LETT, V43, P843, DOI 10.1016/S0040-4039(01)02251-1; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	58	55	67	2	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10419	10428		10.1074/jbc.M110.179853	http://dx.doi.org/10.1074/jbc.M110.179853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21296881	hybrid, Green Published			2022-12-25	WOS:000288547000058
J	Azzolin, L; Antolini, N; Calderan, A; Ruzza, P; Sciacovelli, M; Marin, O; Mammi, S; Bernardi, P; Rasola, A				Azzolin, Luca; Antolini, Nicola; Calderan, Andrea; Ruzza, Paolo; Sciacovelli, Marco; Marin, Oriano; Mammi, Stefano; Bernardi, Paolo; Rasola, Andrea			Antamanide, a Derivative of Amanita phalloides, Is a Novel Inhibitor of the Mitochondrial Permeability Transition Pore	PLOS ONE			English	Article							CYCLOSPORINE-A; CYCLOPHILIN-D; MUSCULAR-DYSTROPHY; IMMUNOSUPPRESSIVE ACTIVITY; LIVER-MITOCHONDRIA; OXIDATIVE STRESS; POTENT INHIBITOR; INNER MEMBRANE; CANCER-CELLS; DEATH	Antamanide is a cyclic decapeptide derived from the fungus Amanita phalloides. Here we show that antamanide inhibits the mitochondrial permeability transition pore, a central effector of cell death induction, by targeting the pore regulator cyclophilin D. Indeed, (i) permeability transition pore inhibition by antamanide is not additive with the cyclophilin D-binding drug cyclosporin A, (ii) the inhibitory action of antamanide on the pore requires phosphate, as previously shown for cyclosporin A; (iii) antamanide is ineffective in mitochondria or cells derived from cyclophilin D null animals, and (iv) abolishes CyP-D peptidyl-prolyl cis-trans isomerase activity. Permeability transition pore inhibition by antamanide needs two critical residues in the peptide ring, Phe6 and Phe9, and is additive with ubiquinone 0, which acts on the pore in a cyclophilin D-independent fashion. Antamanide also abrogates mitochondrial depolarization and the ensuing cell death caused by two well-characterized pore inducers, clotrimazole and a hexokinase II N-terminal peptide. Our findings have implications for the comprehension of cyclophilin D activity on the permeability transition pore and for the development of novel pore-targeting drugs exploitable as cell death inhibitors.	[Azzolin, Luca; Sciacovelli, Marco; Bernardi, Paolo; Rasola, Andrea] Univ Padua, Dept Biomed Sci, Padua, Italy; [Azzolin, Luca; Sciacovelli, Marco; Bernardi, Paolo; Rasola, Andrea] CNR, Inst Neurosci, Padua, Italy; [Antolini, Nicola; Calderan, Andrea; Ruzza, Paolo; Mammi, Stefano] Univ Padua, Dept Chem Sci, Padua, Italy; [Antolini, Nicola; Calderan, Andrea; Ruzza, Paolo; Mammi, Stefano] CNR, Inst Biomol Chem, Padua, Italy; [Marin, Oriano] Univ Padua, Dept Biol Chem, Padua, Italy; [Marin, Oriano; Bernardi, Paolo] Univ Padua, Venetian Inst Mol Med, Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; Veneto Institute Molecular Medicine	Azzolin, L (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	andrea.rasola@unipd.it	Sciacovelli, Marco/AAJ-1145-2020; Bernardi, Paolo/C-3656-2008; Azzolin, Luca/K-8012-2016; Ruzza, Paolo/N-6030-2015	Bernardi, Paolo/0000-0001-9187-3736; Azzolin, Luca/0000-0002-2425-6153; Ruzza, Paolo/0000-0002-5596-9295; Rasola, Andrea/0000-0003-4522-3008; CALDERAN, ANDREA/0000-0003-4763-0782	Progetti di Ricerca di Interesse Nazionale del Ministero dell'Universita e della Ricerca; Associazione Italiana Ricerca sul Cancro [8722]; Progetti di Ateneo dell'Universita di Padova	Progetti di Ricerca di Interesse Nazionale del Ministero dell'Universita e della Ricerca; Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Progetti di Ateneo dell'Universita di Padova	This work was made possible by grants from Progetti di Ricerca di Interesse Nazionale del Ministero dell'Universita e della Ricerca (to P. B.), from Associazione Italiana Ricerca sul Cancro (P. B., project number 8722), and from Progetti di Ateneo dell'Universita di Padova (A. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodeo P, 1998, J PEPT RES, V51, P180; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Choi KJ, 2007, CANCER RES, V67, P3654, DOI 10.1158/0008-5472.CAN-06-1759; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; CONNERN CP, 1992, BIOCHEM J, V284, P381, DOI 10.1042/bj2840381; CONNERN CP, 1994, BIOCHEM J, V302, P321, DOI 10.1042/bj3020321; CROMPTON M, 1988, BIOCHEM J, V255, P357; DAVIDSON AM, 1990, BIOCHEM J, V268, P147, DOI 10.1042/bj2680147; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Fassetta M, 2006, CELL SIGNAL, V18, P1967, DOI 10.1016/j.cellsig.2006.03.005; Fehrenbach T, 2003, N-S ARCH PHARMACOL, V368, P415, DOI 10.1007/s00210-003-0814-4; FLOERSHEIM GL, 1976, N-S ARCH PHARMACOL, V293, P171, DOI 10.1007/BF00499223; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; Gallay PA, 2009, CLIN LIVER DIS, V13, P403, DOI 10.1016/j.cld.2009.05.002; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Gramaglia D, 2004, CELL DEATH DIFFER, V11, P342, DOI 10.1038/sj.cdd.4401326; Hamilton GS, 1998, J MED CHEM, V41, P5119, DOI 10.1021/jm980307x; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Howard BA, 2005, CANCER RES, V65, P8853, DOI 10.1158/0008-5472.CAN-05-1219; Letschert K, 2006, TOXICOL SCI, V91, P140, DOI 10.1093/toxsci/kfj141; Li ZY, 2008, MOL CELL PROTEOMICS, V7, P1810, DOI 10.1074/mcp.M700544-MCP200; Maraldi NM, 2009, ADV ENZYME REGUL, V49, P197, DOI 10.1016/j.advenzreg.2008.12.009; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; MUNTER K, 1986, BIOCHIM BIOPHYS ACTA, V860, P91, DOI 10.1016/0005-2736(86)90502-X; Nicholson LK, 2007, MOL CELL, V25, P483, DOI 10.1016/j.molcel.2007.02.005; NIELSEN O, 1986, ACTA PHARMACOL TOX, V59, P249; Norenberg MD, 2007, NEUROCHEM INT, V50, P983, DOI 10.1016/j.neuint.2007.02.008; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; Qadir M, 2005, CLIN CANCER RES, V11, P2320, DOI 10.1158/1078-0432.CCR-04-1725; Rasola A, 2001, CYTOMETRY, V45, P151, DOI 10.1002/1097-0320(20011001)45:2<151::AID-CYTO1157>3.0.CO;2-I; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; Reutenauer J, 2008, BRIT J PHARMACOL, V155, P574, DOI 10.1038/bjp.2008.285; Rezzani R, 2006, HISTOL HISTOPATHOL, V21, P301, DOI 10.14670/HH-21.301; Rigoni M, 2008, J BIOL CHEM, V283, P34013, DOI 10.1074/jbc.M803243200; Ruzza P, 1999, J PEPT RES, V53, P442, DOI 10.1034/j.1399-3011.1999.00018.x; SIEMION IZ, 1992, PEPTIDES, V13, P1233, DOI 10.1016/0196-9781(92)90034-Z; Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; WELBOURN R, 1991, J APPL PHYSIOL, V70, P1364, DOI 10.1152/jappl.1991.70.3.1364; WIECZOREK Z, 1993, PEPTIDES, V14, P1, DOI 10.1016/0196-9781(93)90003-Y; WIELAND T, 1984, P NATL ACAD SCI-BIOL, V81, P5232, DOI 10.1073/pnas.81.16.5232; WIELAND T, 1968, ANGEW CHEM INT EDIT, V7, P204, DOI 10.1002/anie.196802041; Zheng JM, 2008, CANCER RES, V68, P7769, DOI 10.1158/0008-5472.CAN-08-0639	53	36	40	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16280	10.1371/journal.pone.0016280	http://dx.doi.org/10.1371/journal.pone.0016280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297983	Green Submitted, Green Published, gold			2022-12-25	WOS:000286664100017
J	Lorenz, WA; Clote, P				Lorenz, William A.; Clote, Peter			Computing the Partition Function for Kinetically Trapped RNA Secondary Structures	PLOS ONE			English	Article							NEAREST-NEIGHBOR PARAMETERS; WEB SERVER; STRUCTURE PREDICTION; FOLDING KINETICS; ALGORITHM; OLIGORIBONUCLEOTIDES; STABILITY; RESPECT; BINDING	An RNA secondary structure is locally optimal if there is no lower energy structure that can be obtained by the addition or removal of a single base pair, where energy is defined according to the widely accepted Turner nearest neighbor model. Locally optimal structures form kinetic traps, since any evolution away from a locally optimal structure must involve energetically unfavorable folding steps. Here, we present a novel, efficient algorithm to compute the partition function over all locally optimal secondary structures of a given RNA sequence. Our software, RNALOCOPT runs in O(n(3)) time and O(n(2)) space. Additionally, RNALOCOPT samples a user-specified number of structures from the Boltzmann subensemble of all locally optimal structures. We apply RNALOCOPT to show that (1) the number of locally optimal structures is far fewer than the total number of structures - indeed, the number of locally optimal structures approximately equal to the square root of the number of all structures, (2) the structural diversity of this subensemble may be either similar to or quite different from the structural diversity of the entire Boltzmann ensemble, a situation that depends on the type of input RNA, (3) the (modified) maximum expected accuracy structure, computed by taking into account base pairing frequencies of locally optimal structures, is a more accurate prediction of the native structure than other current thermodynamics-based methods. The software RNALOCOPT constitutes a technical breakthrough in our study of the folding landscape for RNA secondary structures. For the first time, locally optimal structures (kinetic traps in the Turner energy model) can be rapidly generated for long RNA sequences, previously impossible with methods that involved exhaustive enumeration. Use of locally optimal structure leads to state-of-the-art secondary structure prediction, as benchmarked against methods involving the computation of minimum free energy and of maximum expected accuracy. Web server and source code available at http://bioinformatics.bc.edu/clotelab/RNAlocopt/.	[Lorenz, William A.] Denison Univ, Dept Math & Comp Sci, Granville, OH 43023 USA; [Clote, Peter] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Denison University; Boston College	Lorenz, WA (corresponding author), Denison Univ, Dept Math & Comp Sci, Granville, OH 43023 USA.	clote@bc.edu			National Science Foundation [DBI-0543506, DMS-0817971]; Division Of Mathematical Sciences [0817971] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Research was supported by the National Science Foundation under grants DBI-0543506 and DMS-0817971. Additional support was provided PC in the form of a Chair of Excellence by the Digiteo Foundation. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; BANERJEE AR, 1993, BIOCHEMISTRY-US, V32, P153, DOI 10.1021/bi00052a021; Chen SJ, 2008, ANNU REV BIOPHYS, V37, P197, DOI 10.1146/annurev.biophys.37.032807.125957; Clote P, 2005, J COMPUT BIOL, V12, P83, DOI 10.1089/cmb.2005.12.83; Clote P, 2005, NUCLEIC ACIDS RES, V33, pW600, DOI 10.1093/nar/gki382; Clote P, 2006, J COMPUT BIOL, V13, P1640, DOI 10.1089/cmb.2006.13.1640; Clote Peter, 2009, Journal of Bioinformatics and Computational Biology, V7, P869, DOI 10.1142/S0219720009004333; Danilova Ludmlla V., 2006, Journal of Bioinformatics and Computational Biology, V4, P589, DOI 10.1142/S0219720006001904; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Ding Y, 2005, RNA, V11, P1157, DOI 10.1261/rna.2500605; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dotu I, 2010, NUCLEIC ACIDS RES, V38, P1711, DOI 10.1093/nar/gkp1054; Flamm C, 2000, RNA, V6, P325, DOI 10.1017/S1355838200992161; Flamm C., 2007, Foundations of Genetic Algorithms, P194; Flamm C, 2002, Z PHYS CHEM, V216, P155, DOI 10.1524/zpch.2002.216.2.155; Franch T, 1997, J MOL BIOL, V273, P38, DOI 10.1006/jmbi.1997.1294; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gillespie D., 1977, J COMPUT PHYS, V22, P2340; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; HE L, 1991, BIOCHEMISTRY-US, V30, P11124, DOI 10.1021/bi00110a015; Heilman-Miller SL, 2003, RNA, V9, P722, DOI 10.1261/rna.5200903; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; HOFACKER IL, 2010, RNA; Isambert H, 2009, METHODS, V49, P189, DOI 10.1016/j.ymeth.2009.06.005; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; Kiryu H, 2007, BIOINFORMATICS, V23, P434, DOI 10.1093/bioinformatics/btl636; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; LECUYER KA, 1993, BIOCHEMISTRY-US, V32, P5301, DOI 10.1021/bi00071a004; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Lyngso RB, 2000, J COMPUT BIOL, V7, P409, DOI 10.1089/106652700750050862; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mathews DH, 2002, BIOCHEMISTRY-US, V41, P869, DOI 10.1021/bi011441d; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Morgan SR, 1998, J PHYS A-MATH GEN, V31, P3153, DOI 10.1088/0305-4470/31/14/005; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; PERITZ AE, 1991, BIOCHEMISTRY-US, V30, P6428, DOI 10.1021/bi00240a013; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Shapiro BA, 2001, J MOL BIOL, V312, P27, DOI 10.1006/jmbi.2001.4931; Stadler P. F., 2003, Genetic Programming and Evolvable Machines, V4, P7, DOI 10.1023/A:1021821009420; STEIN PR, 1979, DISCRETE MATH, V26, P261, DOI 10.1016/0012-365X(79)90033-5; Tang XY, 2008, J MOL BIOL, V381, P1055, DOI 10.1016/j.jmb.2008.02.007; Tang XY, 2005, J COMPUT BIOL, V12, P862, DOI 10.1089/cmb.2005.12.862; Taufer M, 2009, NUCLEIC ACIDS RES, V37, pD127, DOI 10.1093/nar/gkn806; THACHUK C, 2010, PAC S BIOCOMPUT; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; Waldispuhl J, 2007, J COMPUT BIOL, V14, P190, DOI 10.1089/cmb.2006.0012; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218; Wiese KC, 2005, IEEE T NANOBIOSCI, V4, P212, DOI 10.1109/TNB.2005.853646; Wolfinger MT, 2004, J PHYS A-MATH GEN, V37, P4731, DOI 10.1088/0305-4470/37/17/005; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; Xayaphoummine A, 2005, NUCLEIC ACIDS RES, V33, pW605, DOI 10.1093/nar/gki447; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529; Zar JH, 1999, BIOSTATISTICAL ANAL; Zuker Michael, 1986, LECT MATH LIFE SCI, P87	60	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16178	10.1371/journal.pone.0016178	http://dx.doi.org/10.1371/journal.pone.0016178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297972	gold, Green Published, Green Submitted			2022-12-25	WOS:000286664100014
J	Sobhani, I; Tap, J; Roudot-Thoraval, F; Roperch, JP; Letulle, S; Langella, P; Corthier, G; Jeanne, TVN; Furet, JP				Sobhani, Iradj; Tap, Julien; Roudot-Thoraval, Francoise; Roperch, Jean P.; Letulle, Sophie; Langella, Philippe; Corthier, Gerard; Jeanne Tran Van Nhieu; Furet, Jean P.			Microbial Dysbiosis in Colorectal Cancer (CRC) Patients	PLOS ONE			English	Article							PROMOTES COLON TUMORIGENESIS; 16S RIBOSOMAL-RNA; HUMAN GUT; GASTROINTESTINAL-TRACT; INTESTINAL MICROBIOTA; QUANTITATIVE PCR; FECAL MICROBIOTA; IMMUNE-RESPONSE; DIFFERENTIATION; COMMUNITIES	The composition of the human intestinal microbiota is linked to health status. The aim was to analyze the microbiota of normal and colon cancer patients in order to establish cancer-related dysbiosis. Patients and Methods: Stool bacterial DNA was extracted prior to colonoscopy from 179 patients: 60 with colorectal cancer, and 119 with normal colonoscopy. Bacterial genes obtained by pyrosequencing of 12 stool samples (6 Normal and 6 Cancer) were subjected to a validated Principal Component Analysis (PCA) test. The dominant and subdominant bacterial population (C. leptum, C. coccoides, Bacteroides/Prevotella, Lactobacillus/Leuconostoc/Pediococcus groups, Bifidobacterium genus, and E. coli, and Faecalibacterium prausnitzii species) were quantified in all individuals using qPCR and specific IL17 producer cells in the intestinal mucosa were characterized using immunohistochemistry. Findings: Pyrosequencing (Minimal sequence 200 nucleotide reads) revealed 80% of all sequences could be assigned to a total of 819 taxa based on default parameter of Classifier software. The phylogenetic core in Cancer individuals was different from that in Normal individuals according to the PCA analysis, with trends towards differences in the dominant and subdominant families of bacteria. Consequently, All-bacteria [log(10) (bacteria/g of stool)] in Normal, and Cancer individuals were similar [11.88 +/- 0.35, and 11.80 +/- 0.56, respectively, (P = 0.16)], according to qPCR values whereas among all dominant and subdominant species only those of Bacteroides/Prevotella were higher (All bacteria-specific bacterium; P = 0.009) in Cancer (-1.04 +/- 0.55) than in Normal (-1.40 +/- 0.83) individuals. IL17 immunoreactive cells were significantly expressed more in the normal mucosa of cancer patients than in those with normal colonoscopy. Conclusion: This is the first large series to demonstrate a composition change in the microbiota of colon cancer patients with possible impact on mucosal immune response. These data open new filed for mass screening and pathophysiology investigations.	[Sobhani, Iradj; Roperch, Jean P.] APHP, Dept Gastroenterol, Creteil, France; [Sobhani, Iradj; Roperch, Jean P.] Univ Paris Est Creteil, UPEC, Creteil, France; [Tap, Julien; Langella, Philippe; Corthier, Gerard; Furet, Jean P.] INRA, UMR1319, Micalis Inst, Jouy En Josas, France; [Roudot-Thoraval, Francoise; Jeanne Tran Van Nhieu] Univ Paris 12, Creteil, France; [Letulle, Sophie] Grp Hosp Henri Mondor, INSERM, CIC 006, Creteil, France; [Jeanne Tran Van Nhieu] APHP, Dept Pathol, Creteil, France; [Sobhani, Iradj; Roperch, Jean P.] APHP, LIC EA4393, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Sobhani, I (corresponding author), APHP, Dept Gastroenterol, Creteil, France.	iradj.sobhani@hmn.aphp.fr	VAN NHIEU, Jeanne TRAN/R-5235-2018; Tap, Julien/E-5760-2010; Langella, Philippe/N-8368-2017; SOBHANI, Iradj/A-3973-2013	Tap, Julien/0000-0001-8998-5413; Langella, Philippe/0000-0001-5960-4341; 	Canceropole Ile de France, CoMiCa; LNCC (French National League against Cancer), CCR INSERM Promotion	Canceropole Ile de France, CoMiCa; LNCC (French National League against Cancer), CCR INSERM Promotion	Canceropole Ile de France, CoMiCa 2007-2010 project, (Charles Debray association-ACD); LNCC (French National League against Cancer), CCR INSERM Promotion (2004-2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloulou N, 2008, CANCER RES, V68, P9413, DOI 10.1158/0008-5472.CAN-08-0909; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Dicksved J, 2009, J MED MICROBIOL, V58, P509, DOI 10.1099/jmm.0.007302-0; Dove WF, 1997, CANCER RES, V57, P812; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Ott SJ, 2004, J CLIN MICROBIOL, V42, P2566, DOI 10.1128/JCM.42.6.2566-2572.2004; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sears CL, 2008, CLIN INFECT DIS, V47, P797, DOI 10.1086/591130; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Sobhani I, 2009, GUT, V58, P743, DOI 10.1136/gut.2008.175521; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yang X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006074; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	33	537	577	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16393	10.1371/journal.pone.0016393	http://dx.doi.org/10.1371/journal.pone.0016393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21297998	Green Published, gold			2022-12-25	WOS:000286663900045
J	Sorbye, SW; Kilvaer, T; Valkov, A; Donnem, T; Smeland, E; Al-Shibli, K; Bremnes, RM; Busund, LT				Sorbye, Sveinung W.; Kilvaer, Thomas; Valkov, Andrej; Donnem, Tom; Smeland, Eivind; Al-Shibli, Khalid; Bremnes, Roy M.; Busund, Lill-Tove			Prognostic Impact of Lymphocytes in Soft Tissue Sarcomas	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; CELL LUNG-CARCINOMA; CD8(+) T-CELLS; OVARIAN-CANCER; IMMUNE-RESPONSE; SURVIVAL; DISEASE; OUTCOMES; RELAPSE; SIZE	Purpose: The purpose of this study was to clarify the prognostic significance of lymphocyte infiltration in soft tissue sarcomas (STS). Prognostic markers in potentially curable STS should guide therapy after surgical resection. The immune status at the time of resection may be important, but the prognostic significance of tumor infiltrating lymphocytes is controversial as the immune system has conflicting roles during cancer development. Experimental Design: Tissue microarrays from 249 patients with STS were constructed from duplicate cores of viable and representative neoplastic tumor areas. Immunohistochemistry was used to evaluate the CD3+, CD4+, CD8+, CD20+ and CD45+ lymphocytes in tumors. Results: In univariate analyses, increased numbers of CD4+ (P = 0.008) and CD20+ (P = 0.006) lymphocytes in tumor correlated significantly with an improved disease-specific survival (DSS) in patients with wide resection margins (n = 108). In patients with non-wide resection margins (n = 141) increased numbers of CD3+ (P = 0.028) lymphocytes in tumor correlated significantly with shorter DSS. In multivariate analyses, a high number of CD20+ lymphocytes (HR = 5.5, CI 95% = 1.6-18.6, P = 0.006) in the tumor was an independent positive prognostic factor for DSS in patients with wide resections margins. Conclusions: High density of CD20+ lymphocytes in STS with wide resection margins is an independent positive prognostic indicator for these patients. Further research is needed to define if CD20+ cells can modify tumors in a way that reduces disease progression and metastatic potential.	[Sorbye, Sveinung W.; Valkov, Andrej; Busund, Lill-Tove] Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway; [Sorbye, Sveinung W.; Kilvaer, Thomas; Valkov, Andrej; Al-Shibli, Khalid; Busund, Lill-Tove] Univ Tromso, Inst Med Biol, Tromso, Norway; [Donnem, Tom; Smeland, Eivind; Bremnes, Roy M.] Univ Hosp N Norway, Dept Oncol, Tromso, Norway; [Donnem, Tom; Bremnes, Roy M.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Al-Shibli, Khalid] Nordland Cent Hosp, Dept Pathol, Bodo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Sorbye, SW (corresponding author), Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway.	sveinung.sorbye@unn.no	Kilvaer, Thomas/AAI-7418-2020; Sorbye, Sveinung Wergeland/AAE-7208-2020	Kilvaer, Thomas/0000-0003-1669-0117; Sorbye, Sveinung Wergeland/0000-0002-8250-3992	Northern Norway Regional Health Authority	Northern Norway Regional Health Authority	The work was supported by the Northern Norway Regional Health Authority (Helse Nord RHF, http://www.helse-nord.no/?lang=en_US). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Ancuta E, 2009, ROM J MORPHOL EMBRYO, V50, P651; Costello Regis T., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P83; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Dickinson IC, 2006, ANZ J SURG, V76, P104, DOI 10.1111/j.1445-2197.2006.03615.x; Dong HP, 2006, AM J CLIN PATHOL, V125, P451, DOI 10.1309/15B66DQMFYYM78CJ; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Eerola AK, 2000, CLIN CANCER RES, V6, P1875; Enarsson K, 2007, EUR J IMMUNOL, V37, P282, DOI 10.1002/eji.200636183; Engellau J, 2004, CANCER-AM CANCER SOC, V100, P2233, DOI 10.1002/cncr.20254; Gimotty PA, 2007, DIS MARKERS, V23, P445, DOI 10.1155/2007/508350; GUSTAFSON P, 1994, ACTA ORTHOP SCAND, V65, P1; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; Hong C, 2006, J IMMUNOL, V177, P6747, DOI 10.4049/jimmunol.177.10.6747; Kallioniemi OP, 2001, HUM MOL GENET, V10, P657, DOI 10.1093/hmg/10.7.657; Karja V, 2005, ANTICANCER RES, V25, P4435; Kiatisevi Piya, 2006, Journal of the Medical Association of Thailand, V89, P334; Koea JB, 2003, ANN SURG ONCOL, V10, P432, DOI 10.1245/ASO.2003.05.014; Kondratiev S, 2004, CLIN CANCER RES, V10, P4450, DOI 10.1158/1078-0432.CCR-0732-3; Mendenhall WM, 2005, CANCER-AM CANCER SOC, V104, P669, DOI 10.1002/cncr.21264; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Mukai S, 1999, CANCER RES, V59, P5245; Naito Y, 1998, CANCER RES, V58, P3491; Nelson BH, 2008, IMMUNOL REV, V222, P101, DOI 10.1111/j.1600-065X.2008.00614.x; Nocito A, 2001, INT J CANCER, V94, P1, DOI 10.1002/ijc.1385; Oshikiri T, 2003, J SURG ONCOL, V84, P224, DOI 10.1002/jso.10321; Ottaiano A, 2005, ANTICANCER RES, V25, P4519; Pelletier MP, 2001, CAN J SURG, V44, P180; Pretscher D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-292; RANEY RB, 1983, CANCER-AM CANCER SOC, V52, P44, DOI 10.1002/1097-0142(19830701)52:1<44::AID-CNCR2820520110>3.0.CO;2-V; Raspollini MR, 2005, ANN ONCOL, V16, P590, DOI 10.1093/annonc/mdi112; Schumacher K, 2001, CANCER RES, V61, P3932; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; SIKORA K, 1983, BRIT J CANCER, V47, P135, DOI 10.1038/bjc.1983.16; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Staibano S, 2006, INT J IMMUNOPATH PH, V19, P171; Thornton K, 2008, SURG CLIN N AM, V88, P647, DOI 10.1016/j.suc.2008.03.004; Tomsova M, 2008, GYNECOL ONCOL, V108, P415, DOI 10.1016/j.ygyno.2007.10.016; Wahlin BE, 2007, CLIN CANCER RES, V13, P388, DOI 10.1158/1078-0432.CCR-06-1734; YANG RS, 1995, CANCER-AM CANCER SOC, V76, P1398, DOI 10.1002/1097-0142(19951015)76:8<1398::AID-CNCR2820760815>3.0.CO;2-B; Zagars GK, 2003, INT J RADIAT ONCOL, V57, P739, DOI 10.1016/S0360-3016(03)00714-4; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	43	67	69	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14611	10.1371/journal.pone.0014611	http://dx.doi.org/10.1371/journal.pone.0014611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298041	gold, Green Published, Green Submitted			2022-12-25	WOS:000286663900013
J	Benhamou, S				Benhamou, Simon			Dynamic Approach to Space and Habitat Use Based on Biased Random Bridges	PLOS ONE			English	Article							HOME-RANGE; ANIMAL MOVEMENTS; RESOURCE SELECTION; TELEMETRY DATA; RANDOM-WALK; MODELS; AUTOCORRELATION; DIFFUSION; ESTIMATORS; PREFERENCE	Background: Although habitat use reflects a dynamic process, most studies assess habitat use statically as if an animal's successively recorded locations reflected a point rather than a movement process. By relying on the activity time between successive locations instead of the local density of individual locations, movement-based methods can substantially improve the biological relevance of utilization distribution (UD) estimates (i.e. the relative frequencies with which an animal uses the various areas of its home range, HR). One such method rests on Brownian bridges (BBs). Its theoretical foundation (purely and constantly diffusive movements) is paradoxically inconsistent with both HR settlement and habitat selection. An alternative involves movement-based kernel density estimation (MKDE) through location interpolation, which may be applied to various movement behaviours but lacks a sound theoretical basis. Methodology/Principal Findings: I introduce the concept of a biased random (advective-diffusive) bridge (BRB) and show that the MKDE method is a practical means to estimate UDs based on simplified (isotropically diffusive) BRBs. The equation governing BRBs is constrained by the maximum delay between successive relocations warranting constant within-bridge advection (allowed to vary between bridges) but remains otherwise similar to the BB equation. Despite its theoretical inconsistencies, the BB method can therefore be applied to animals that regularly reorientate within their HRs and adapt their movements to the habitats crossed, provided that they were relocated with a high enough frequency. Conclusions/Significance: Biased random walks can approximate various movement types at short times from a given relocation. Their simplified form constitutes an effective trade-off between too simple, unrealistic movement models, such as Brownian motion, and more sophisticated and realistic ones, such as biased correlated random walks (BCRWs), which are too complex to yield functional bridges. Relying on simplified BRBs proves to be the most reliable and easily usable way to estimate UDs from serially correlated relocations and raw activity information.	CNRS, CEFE, Montpellier, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Benhamou, S (corresponding author), CNRS, CEFE, Montpellier, France.	simon.benhamou@cefe.cnrs.fr						Bar-David S, 2009, ECOLOGY, V90, P2467, DOI 10.1890/08-1532.1; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Benhamou S, 2006, ECOLOGY, V87, P518, DOI 10.1890/05-0495; BENHAMOU S, 1994, ANIM BEHAV, V47, P1423, DOI 10.1006/anbe.1994.1189; BENHAMOU S, 1989, J THEOR BIOL, V139, P379, DOI 10.1016/S0022-5193(89)80216-4; Benhamou S, 2010, ENCY BEHAV NEUROCIEN, V2, P497, DOI DOI 10.1016/B978-0-08-045396-5.00106-8; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Blackwell PG, 1997, ECOL MODEL, V100, P87, DOI 10.1016/S0304-3800(97)00153-1; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Bullard F., 1999, ESTIMATING HOME RANG; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Codling EA, 2010, ECOLOGY, V91, P3106, DOI 10.1890/09-1729.1; CORNELIS D, 2010, SPATIOTEMPORAL UNPUB; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Dettki H, 2008, J WILDLIFE MANAGE, V72, P535, DOI 10.2193/2006-363; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; Fieberg J, 2010, PHILOS T R SOC B, V365, P2233, DOI 10.1098/rstb.2010.0079; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Horne JS, 2006, J WILDLIFE MANAGE, V70, P641, DOI 10.2193/0022-541X(2006)70[641:LCVLSC]2.0.CO;2; Johnson DS, 2008, BIOMETRICS, V64, P968, DOI 10.1111/j.1541-0420.2007.00943.x; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Matthiopoulos J, 2003, ECOL MODEL, V159, P239, DOI 10.1016/S0304-3800(02)00293-4; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Moorcroft PR, 2006, P ROY SOC B-BIOL SCI, V273, P1651, DOI 10.1098/rspb.2005.3439; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Nielson RM, 2009, ECOLOGY, V90, P2956, DOI 10.1890/08-1562.1; Otis DL, 1999, J WILDLIFE MANAGE, V63, P1039, DOI 10.2307/3802819; Ovaskainen O, 2004, ECOLOGY, V85, P242, DOI 10.1890/02-0706; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Silverman B.W., 1986, DENSITY ESTIMATION S; SWIHART RK, 1985, ECOLOGY, V66, P1176, DOI 10.2307/1939170; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; Van Moorter B, 2009, OIKOS, V118, P641, DOI 10.1111/j.1600-0706.2008.17003.x; Worton J. B., 1989, ECOLOGY, V70, P164	38	178	179	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14592	10.1371/journal.pone.0014592	http://dx.doi.org/10.1371/journal.pone.0014592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21297869	gold, Green Published, Green Submitted			2022-12-25	WOS:000286662800005
J	Woodard, A; Wood, DO				Woodard, Andrew; Wood, David O.			Analysis of Convergent Gene Transcripts in the Obligate Intracellular Bacterium Rickettsia prowazekii	PLOS ONE			English	Article							TERMINATION; TYPHUS; RNAS; GLTA	Termination of transcription is an important component of bacterial gene expression. However, little is known concerning this process in the obligate intracellular pathogen and model for reductive evolution, Rickettsia prowazekii. To assess transcriptional termination in this bacterium, transcripts of convergent gene pairs, some containing predicted intrinsic terminators, were analyzed. These analyses revealed that, rather than terminating at a specific site within the intervening region between the convergent genes, most of the transcripts demonstrated either a lack of termination within this region, which generated antisense RNA, or a putative non-site-specific termination that occurred throughout the intervening sequence. Transcripts terminating at predicted intrinsic terminators, as well as at a putative Rho-dependant terminator, were also examined and found to vary based on the rickettsial host environment. These results suggest that transcriptional termination, or lack thereof, plays a role in rickettsial gene regulation.	[Woodard, Andrew; Wood, David O.] Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA	University of South Alabama	Woodard, A (corresponding author), Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA.	dowood@jaguar1.usouthal.edu			National Institute of Allergy and Infectious Disease [AI020384]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020384, R37AI020384, R56AI020384] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institute of Allergy and Infectious Disease grant AI020384 to DOW. http://www.niaid.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Audia JP, 2008, APPL ENVIRON MICROB, V74, P7809, DOI 10.1128/AEM.00896-08; BOZEMAN FM, 1975, NATURE, V255, P545, DOI 10.1038/255545a0; Cai J, 1997, ACTA VIROL, V41, P285; CAI J, 1995, GENE, V163, P115, DOI 10.1016/0378-1119(95)00365-D; CAI J, 1993, J BACTERIOL, V175, P5725, DOI 10.1128/JB.175.17.5725-5727.1993; Cai J, 1996, J BACTERIOL, V178, P5543, DOI 10.1128/jb.178.18.5543-5545.1996; Chao CC, 2004, PROTEOMICS, V4, P1280, DOI 10.1002/pmic.200300775; DING HF, 1993, J BIOL CHEM, V268, P3897; DING HF, 1990, J BACTERIOL, V172, P5624, DOI 10.1128/jb.172.10.5624-5630.1990; Dornenburg JE, 2010, MBIO, V1, DOI 10.1128/mBio.00024-10; Italiani VCS, 2002, MOL MICROBIOL, V44, P181, DOI 10.1046/j.1365-2958.2002.02865.x; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Nelson CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-364; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; Reynolds MG, 2003, EMERG INFECT DIS, V9, P1341; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shaw EI, 1997, J BACTERIOL, V179, P6448, DOI 10.1128/jb.179.20.6448-6452.1997; SHAW EI, 1997, THESIS U S ALABAMA M; Tucker AM, 2005, ANN NY ACAD SCI, V1063, P35, DOI 10.1196/annals.1355.005; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; WINKLER HH, 1976, J BIOL CHEM, V251, P389	23	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16537	10.1371/journal.pone.0016537	http://dx.doi.org/10.1371/journal.pone.0016537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298070	gold, Green Published, Green Submitted			2022-12-25	WOS:000286662800053
J	Galopier, A; Hermann-Le Denmat, S				Galopier, Aurelie; Hermann-Le Denmat, Sylvie			Mitochondria of the Yeasts Saccharomyces cerevisiae and Kluyveromyces lactis Contain Nuclear rDNA-Encoded Proteins	PLOS ONE			English	Article							RNA-POLYMERASE-II; INNER-MEMBRANE; TRANSCRIPTION TERMINATION; SHUTTLE VECTORS; RIBOSOMAL-RNA; COENZYME-Q; DNA; SEQUENCES; SIGNALS; SPACER	In eukaryotes, the nuclear ribosomal DNA (rDNA) is the source of the structural 18S, 5.8S and 25S rRNAs. In hemiascomycetous yeasts, the 25S rDNA sequence was described to lodge an antisense open reading frame (ORF) named TAR1 for Transcript Antisense to Ribosomal RNA. Here, we present the first immuno-detection and sub-cellular localization of the authentic product of this atypical yeast gene. Using specific antibodies against the predicted amino-acid sequence of the Saccharomyces cerevisiae TAR1 product, we detected the endogenous Tar1p polypeptides in S. cerevisiae (Sc) and Kluyveromyces lactis (Kl) species and found that both proteins localize to mitochondria. Protease and carbonate treatments of purified mitochondria further revealed that endogenous Sc Tar1p protein sub-localizes in the inner membrane in a N(in)-C(out) topology. Plasmid-versions of 5` end or 3` end truncated TAR1 ORF were used to demonstrate that neither the N-terminus nor the C-terminus of Sc Tar1p were required for its localization. Also, Tar1p is a presequence-less protein. Endogenous Sc Tar1p was found to be a low abundant protein, which is expressed in fermentable and non-fermentable growth conditions. Endogenous Sc TAR1 transcripts were also found low abundant and consistently 5` flanking regions of TAR1 ORF exhibit modest promoter activity when assayed in a luciferase-reporter system. Using rapid amplification of cDNA ends (RACE) PCR, we also determined that endogenous Sc TAR1 transcripts possess heterogeneous 5` and 3` ends probably reflecting the complex expression of a gene embedded in actively transcribed rDNA sequence. Altogether, our results definitively ascertain that the antisense yeast gene TAR1 constitutes a functional transcription unit within the nuclear rDNA repeats.	[Galopier, Aurelie] Univ Paris 11, Orsay, France; [Galopier, Aurelie; Hermann-Le Denmat, Sylvie] CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France; [Hermann-Le Denmat, Sylvie] Ecole Normale Super, F-75231 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Galopier, A (corresponding author), Univ Paris 11, Orsay, France.	sylvie.hermann-ledenmat@igmors.u-psud.fr			CNRS-ATIP; FRM-INE [INE20071110914]	CNRS-ATIP(Centre National de la Recherche Scientifique (CNRS)); FRM-INE	This work was supported by research projects granted by the CNRS-ATIP Program 2006 (to S.H.L.D) and the FRM-INE Program 2007 (to S.H.L.D; code INE20071110914). (http://www.cnrs.fr/ http://www.frm.org/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Arnold I, 1998, J BIOL CHEM, V273, P1469, DOI 10.1074/jbc.273.3.1469; Baba SW, 2004, J BIOL CHEM, V279, P10052, DOI 10.1074/jbc.M313712200; BALDARI C, 1985, GENE, V35, P27, DOI 10.1016/0378-1119(85)90154-4; Bonawitz ND, 2008, CURR GENET, V54, P83, DOI 10.1007/s00294-008-0203-0; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; CIGAN AM, 1987, GENE, V59, P1; COEHLO PS, 2002, GENE DEV, V16, P2755; COLLART MA, 1997, CURRENT PROTOCOLS MO; CONRADWEBB H, 1995, MOL CELL BIOL, V15, P2420; Davis AJ, 1998, MOL BIOL CELL, V9, P2577, DOI 10.1091/mbc.9.9.2577; de Marcos-Lousa C, 2006, TRENDS BIOCHEM SCI, V31, P259, DOI 10.1016/j.tibs.2006.03.006; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; Ge JH, 2010, RNA, V16, P1078, DOI 10.1261/rna.2060210; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Grentzmann G, 1998, RNA, V4, P479; HAMILTON R, 1987, NUCLEIC ACIDS RES, V15, P3581, DOI 10.1093/nar/15.8.3581; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kumar A, 2002, NAT BIOTECHNOL, V20, P58, DOI 10.1038/nbt0102-58; Li CH, 2006, MOL BIOL CELL, V17, P3848, DOI 10.1091/mbc.E06-03-0205; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; PARIKH VS, 1989, MOL CELL BIOL, V9, P1897, DOI 10.1128/MCB.9.5.1897; PARKIH VS, 1987, SCIENCE, V235, P576; SANTANGELO GM, 1988, MOL CELL BIOL, V8, P4217, DOI 10.1128/MCB.8.10.4217; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Torchet C, 1998, RNA, V4, P1636, DOI 10.1017/S1355838298981511; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Vasilieva L, 2008, MOL CELL, V29, P313, DOI 10.1016/j.molcel.2008.01.011; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WALLIS MG, 1994, EUR J BIOCHEM, V222, P27, DOI 10.1111/j.1432-1033.1994.tb18837.x; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zhao XL, 2008, NAT METHODS, V5, P95, DOI 10.1038/NMETH1142	40	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16325	10.1371/journal.pone.0016325	http://dx.doi.org/10.1371/journal.pone.0016325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283537	Green Published, Green Submitted, gold			2022-12-25	WOS:000286661400043
J	Molokhia, M; Nitsch, D; Patrick, AL; McKeigue, P				Molokhia, Mariam; Nitsch, Dorothea; Patrick, Alan Leslie; McKeigue, Paul			30 Year Patterns of Mortality in Tobago, West Indies, 1976-2005: Impact of Glucose Intolerance and Alcohol Intake	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; RISK; MEN; OBESITY; WOMEN	Objectives: To determine the main predictors of all-cause and cardiovascular (CV) mortality in a rural West Indian population in Plymouth, Tobago over 30 years. Methods: Questionnaire survey for CV risk factors and alcohol consumption patterns administered at baseline in 1976 with 92.5% response rate. 831/832 patients were followed up until 2005 or death. Results: Hypertension (>140/90 mm Hg) was prevalent in 48% of men and 44% of women, and 21% of men and 17% of women had diabetes. Evidence showed most predictors for all cause and cardiovascular mortality having the main effects at ages <60 years, (p-value for interaction<0.01) but no risk factors having sex-specific effects on mortality. The main predictors of all-cause mortality at age <60 years in the fully adjusted model were high sessional alcohol intake (hazard ratio (HR) 2.04, 95% CI 1.10-3.80), severe hypertension >160/95 mm Hg (HR 1.68, 95% CI 1.09-2.60), diabetes (HR 3.28, 95% CI 1.89-5.69), and BMI (HR 1.04, 95% CI 1.00-1.07). The main predictors of cardiovascular mortality were similar in the fully adjusted model: high sessional alcohol intake (HR 2.47 95% CI 1.10-5.57), severe hypertension (HR 2.78 95% CI 1.56-4.95), diabetes (HR 3.68 95% CI 1.77-7.67) and additionally LVH, (HR 5.54 95% CI 1.38-22.26), however BMI did not show independent effects. For men, high sessional alcohol intake explains 27% of all cause mortality, and 40% of cardiovascular mortality at age <60 yrs. In adults aged <60 years, the attributable risk fraction for IGT/Diabetes and all cause mortality and cardiovascular mortality is 28% in women vs. 11% in men, and 22% in women vs. 6% in men respectively. Conclusions: In this Afro-Caribbean population we found that a major proportion of deaths are attributable to high sessional alcohol intake (in males), diabetes, and hypertension and these risk factors primarily operate in those below 60 years.	[Molokhia, Mariam; Nitsch, Dorothea] London Sch Hyg & Trop Med, Div Epidemiol & Populat Hlth, London WC1, England; [Patrick, Alan Leslie] Kavanagh St Med Ctr, Port of Spain, Trinidad, Trinidad Tobago; [McKeigue, Paul] Univ Edinburgh, Publ Hlth Sci Mol Med Ctr, Edinburgh, Midlothian, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh	Molokhia, M (corresponding author), London Sch Hyg & Trop Med, Div Epidemiol & Populat Hlth, London WC1, England.	mariam.molokhia@lshtm.ac.uk		Nitsch, Dorothea/0000-0001-5767-248X	Commonwealth Research Council; National Institutes of Health	Commonwealth Research Council; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The original study was supported by a grant from the Commonwealth Health Research Council, formerly the Commonwealth Research Council. MM is supported by a National Institutes of Health Research postdoctoral fellowship and is an investigator for the FP7 ARITMO project: Investigating Arrhythmogenic Potential of Drugs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM HEART ASS, 2008, AFR AM CARD DIS STAT, P1; Austin M, 2004, W INDIAN MED J, V53, P387; *CENTR STAT OFF GO, 2004, POP VIT STAT REP; Chalmers J, 2008, J HYPERTENS, V26, pS11, DOI 10.1097/01.hjh.0000320754.38732.46; CHATURVEDI N, 1994, DIABETOLOGIA, V37, P765, DOI 10.1007/s001250050177; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Glynn RJ, 2002, HYPERTENSION, V39, P105, DOI 10.1161/hy1201.097199; He J, 1999, J HYPERTENS, V17, pS7; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; KANNEL W B, 1970, Annals of Internal Medicine, V72, P813; LACKLAND DT, 1995, CLIN EXP HYPERTENS, V17, P1091, DOI 10.3109/10641969509033654; MILLER GJ, 1988, INT J EPIDEMIOL, V17, P62, DOI 10.1093/ije/17.1.62; Mourad JJ, 2008, J HYPERTENS, V26, pS257; PATRICK AL, 1985, W INDIAN MED J, V34, P158; PATRICK AL, 1986, W INDIAN MED J, V35, P76; PATRICK AL, 1980, THESIS U LONDON LOND; PATRICK AL, 1995, 3 EUR C CARD; Price GM, 2006, AM J CLIN NUTR, V84, P449; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Shkolnikov VM, 2002, J EPIDEMIOL COMMUN H, V56, P171, DOI 10.1136/jech.56.3.171; Sull JW, 2009, STROKE, V40, P2953, DOI 10.1161/STROKEAHA.109.556027; Wilks R, 1996, CIBA F SYMP, V201, P37	22	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e14588	10.1371/journal.pone.0014588	http://dx.doi.org/10.1371/journal.pone.0014588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283617	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000286661400005
J	Thepparit, C; Sunyakumthorn, P; Guillotte, ML; Popov, VL; Foil, LD; Macaluso, KR				Thepparit, Chutima; Sunyakumthorn, Piyanate; Guillotte, Mark L.; Popov, Vsevolod L.; Foil, Lane D.; Macaluso, Kevin R.			Isolation of a Rickettsial Pathogen from a Non-Hematophagous Arthropod	PLOS ONE			English	Article							CTENOCEPHALIDES-FELIS BOUCHE; LIPOSCELIS-BOSTRYCHOPHILA PSOCOPTERA; SPOTTED-FEVER GROUP; CAT FLEAS; CELL-LINE; TICK; MYCETOME; TYPHUS; GENE; PEST	Rickettsial diversity is intriguing in that some species are transmissible to vertebrates, while others appear exclusive to invertebrate hosts. Of particular interest is Rickettsia felis, identifiable in both stored product insect pests and hematophagous disease vectors. To understand rickettsial survival tactics in, and probable movement between, both insect systems will explicate the determinants of rickettsial pathogenicity. Towards this objective, a population of Liposcelis bostrychophila, common booklice, was successfully used for rickettsial isolation in ISE6 (tick-derived cells). Rickettsiae were also observed in L. bostrychophila by electron microscopy and in paraffin sections of booklice by immunofluorescence assay using anti-R. felis polyclonal antibody. The isolate, designated R. felis strain LSU-Lb, resembles typical rickettsiae when examined by microscopy. Sequence analysis of portions of the Rickettsia specific 17-kDa antigen gene, citrate synthase (gltA) gene, rickettsial outer membrane protein A (ompA) gene, and the presence of the R. felis plasmid in the cell culture isolate confirmed the isolate as R. felis. Variable nucleotide sequences from the isolate were obtained for R. felis-specific pRF-associated putative tldD/pmbA. Expression of rickettsial outer membrane protein B (OmpB) was verified in R. felis (LSU-Lb) using a monoclonal antibody. Additionally, a quantitative real-time PCR assay was used to identify a significantly greater median rickettsial load in the booklice, compared to cat flea hosts. With the potential to manipulate arthropod host biology and infect vertebrate hosts, the dual nature of R. felis provides an excellent model for the study of rickettsial pathogenesis and transmission. In addition, this study is the first isolation of a rickettsial pathogen from a non-hematophagous arthropod.	[Thepparit, Chutima; Sunyakumthorn, Piyanate; Guillotte, Mark L.; Macaluso, Kevin R.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Popov, Vsevolod L.] Univ Texas Med Branch, WHO Collaborating Ctr Trop Dis, Dept Pathol, Galveston, TX USA; [Foil, Lane D.] Louisiana State Univ, Dept Entomol, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; University of Texas System; University of Texas Medical Branch Galveston; Louisiana State University System; Louisiana State University	Thepparit, C (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	kmacaluso@vetmed.lsu.edu	Thepparit, Chutima/GLN-5662-2022	Guillotte, Mark/0000-0002-1826-8879; Thepparit, Chutima/0000-0002-8355-269X	National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI069248, AI069248-S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077784, R21AI069248] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is supported by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (www.nih.gov; AI069248 and AI069248-S1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZAD AF, 1992, P NATL ACAD SCI USA, V89, P43, DOI 10.1073/pnas.89.1.43; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2010, APPL ENVIRON MICROB, V76, P1718, DOI 10.1128/AEM.02988-09; Behar A, 2010, APPL ENVIRON MICROB, V76, P2280, DOI 10.1128/AEM.00026-10; Bouyer DH, 2001, INT J SYST EVOL MICR, V51, P339, DOI 10.1099/00207713-51-2-339; Braendle C, 2003, PLOS BIOL, V1, P70, DOI 10.1371/journal.pbio.0000021; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; CHANG KP, 1973, CAN J MICROBIOL, V19, P1075, DOI 10.1139/m73-171; Fournier PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002289; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; Giorgini M, 2010, APPL ENVIRON MICROB, V76, P2589, DOI 10.1128/AEM.03154-09; HAYES SF, 1979, J BACTERIOL, V137, P605, DOI 10.1128/JB.137.1.605-613.1979; HENDERSON G, 1993, J MED ENTOMOL, V30, P619, DOI 10.1093/jmedent/30.3.619; HINDE R, 1971, J INSECT PHYSIOL, V17, P1791, DOI 10.1016/0022-1910(71)90076-X; Horta MC, 2006, APPL ENVIRON MICROB, V72, P1705, DOI 10.1128/AEM.72.2.1705-1707.2006; ITO S, 1981, RICKETTSIAE RICKETTS, P213; Jiang J, 2004, AM J TROP MED HYG, V70, P351, DOI 10.4269/ajtmh.2004.70.351; Kurtti TJ, 2005, J INVERTEBR PATHOL, V90, P177, DOI 10.1016/j.jip.2005.09.001; Lawrence W, 2000, J VECTOR ECOL, V25, P98; Macaluso KR, 2008, VECTOR-BORNE ZOONOT, V8, P391, DOI 10.1089/vbz.2007.0218; MUNDERLOH UG, 1989, EXP APPL ACAROL, V7, P219, DOI 10.1007/BF01194061; MUNDERLOH UG, 1995, ANNU REV ENTOMOL, V40, P221, DOI 10.1146/annurev.en.40.010195.001253; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Perotti MA, 2006, FASEB J, V20, P2372, DOI 10.1096/fj.06-5870fje; Pornwiroon W, 2007, ISME J, V1, P394, DOI 10.1038/ismej.2007.38; Pornwiroon W, 2006, APPL ENVIRON MICROB, V72, P5589, DOI 10.1128/AEM.00532-06; Raoult D, 2001, EMERG INFECT DIS, V7, P73, DOI 10.3201/eid0701.010112; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Reif KE, 2009, J MED ENTOMOL, V46, P723, DOI 10.1603/033.046.0402; Reif KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002805; REIF KE, 2010, VECTOR BORN IN PRESS; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Siddall ME, 2004, MOL PHYLOGENET EVOL, V30, P178, DOI 10.1016/S1055-7903(03)00184-2; Sunyakumthorn P, 2008, APPL ENVIRON MICROB, V74, P3151, DOI 10.1128/AEM.00025-08; TURNER BD, 1994, INT J PEST MANAGE, V40, P179, DOI 10.1080/09670879409371879; VAUGHAN JA, 1990, ANN NY ACAD SCI, V590, P70, DOI 10.1111/j.1749-6632.1990.tb42209.x; Walker DH, 1997, LAB INVEST, V76, P129; Wedincamp J, 2000, J VECTOR ECOL, V25, P123; Wedincamp J, 2002, J VECTOR ECOL, V27, P96; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; WILLIAMS SG, 1992, J CLIN MICROBIOL, V30, P1758, DOI 10.1128/JCM.30.7.1758-1762.1992; Yusuf M, 2004, J STORED PROD RES, V40, P207, DOI 10.1016/S0022-474X(02)00098-X; Zavala-Castro JE, 2005, AM J TROP MED HYG, V73, P662, DOI 10.4269/ajtmh.2005.73.662; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	45	41	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16396	10.1371/journal.pone.0016396	http://dx.doi.org/10.1371/journal.pone.0016396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283549	Green Submitted, Green Published, gold			2022-12-25	WOS:000286661400047
J	Dixit, P; Mukherjee, PK; Ramachandran, V; Eapen, S				Dixit, Prachy; Mukherjee, Prasun K.; Ramachandran, V.; Eapen, Susan			Glutathione Transferase from Trichoderma virens Enhances Cadmium Tolerance without Enhancing Its Accumulation in Transgenic Nicotiana tabacum	PLOS ONE			English	Article							HEAVY-METAL TOLERANCE; LIPID-PEROXIDATION; S-TRANSFERASES; STRESS; PLANTS; EXPRESSION; GENE; CHLOROPLASTS; SEEDLINGS; ENZYMES	Background: Cadmium (Cd) is a major heavy metal pollutant which is highly toxic to plants and animals. Vast agricultural areas worldwide are contaminated with Cd. Plants take up Cd and through the food chain it reaches humans and causes toxicity. It is ideal to develop plants tolerant to Cd, without enhanced accumulation in the edible parts for human consumption. Glutathione transferases (GST) are a family of multifunctional enzymes known to have important roles in combating oxidative stresses induced by various heavy metals including Cd. Some GSTs are also known to function as glutathione peroxidases. Overexpression/heterologous expression of GSTs is expected to result in plants tolerant to heavy metals such as Cd. Results: Here, we report cloning of a glutathione transferase gene from Trichoderma virens, a biocontrol fungus and introducing it into Nicotiana tabacum plants by Agrobacterium-mediated gene transfer. Transgenic nature of the plants was confirmed by Southern blot hybridization and expression by reverse transcription PCR. Transgene (TvGST) showed single gene Mendelian inheritance. When transgenic plants expressing TvGST gene were exposed to different concentrations of Cd, they were found to be more tolerant compared to wild type plants, with transgenic plants showing lower levels of lipid peroxidation. Levels of different antioxidant enzymes such as glutathione transferase, superoxide dismutase, ascorbate peroxidase, guiacol peroxidase and catalase showed enhanced levels in transgenic plants expressing TvGST compared to control plants, when exposed to Cd. Cadmium accumulation in the plant biomass in transgenic plants were similar or lower than wild-type plants. Conclusion: The results of the present study suggest that transgenic tobacco plants expressing a Trichoderma virens GST are more tolerant to Cd, without enhancing its accumulation in the plant biomass. It should be possible to extend the present results to crop plants for developing Cd tolerance and in limiting Cd availability in the food chain.	[Dixit, Prachy; Mukherjee, Prasun K.; Ramachandran, V.; Eapen, Susan] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Dixit, P (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India.	eapenhome@yahoo.com	Ramachandran, Vidhya/HGA-8671-2022					AEBI H, 1984, METHOD ENZYMOL, V105, P121; Apse MP, 2002, CURR OPIN BIOTECH, V13, P146, DOI 10.1016/S0958-1669(02)00298-7; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; BARTLING D, 1993, EUR J BIOCHEM, V216, P579, DOI 10.1111/j.1432-1033.1993.tb18177.x; BERHANE K, 1994, P NATL ACAD SCI USA, V91, P1480, DOI 10.1073/pnas.91.4.1480; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Cummins I, 1999, PLANT J, V18, P285, DOI 10.1046/j.1365-313X.1999.00452.x; CURTIS CR, 1971, CAN J BOTANY, V49, P333, DOI 10.1139/b71-056; DEGRAEVE N, 1981, MUTAT RES, V86, P115, DOI 10.1016/0165-1110(81)90035-X; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dominguez-Solis JR, 2004, PLANT BIOTECHNOL J, V2, P469, DOI 10.1111/j.1467-7652.2004.00092.x; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Farinati S, 2010, NEW PHYTOL, V185, P964, DOI 10.1111/j.1469-8137.2009.03132.x; Gasic K, 2007, PLANT MOL BIOL, V64, P361, DOI 10.1007/s11103-007-9158-7; HABIG WH, 1981, METHOD ENZYMOL, V77, P735; HALLIWELL B, 1987, CHEM PHYS LIPIDS, V44, P327, DOI 10.1016/0009-3084(87)90056-9; Halliwell B., 1993, FREE RADICALS BIOL M; Hasegawa I, 1997, PLANT SOIL, V196, P277, DOI 10.1023/A:1004222612602; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hegedus A, 2001, PLANT SCI, V160, P1085, DOI 10.1016/S0168-9452(01)00330-2; HOAGLAND D. R., 1938, Annual Report of the Smithsonian Institution, P461; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KATO M, 1987, CAN J BOT, V65, P729, DOI 10.1139/b87-097; Kawashima CG, 2004, BIOTECHNOL LETT, V26, P153, DOI 10.1023/B:BILE.0000012895.60773.ff; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Moons A, 2003, FEBS LETT, V553, P427, DOI 10.1016/S0014-5793(03)01077-9; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Ning HX, 2010, BIOTECHNOL LETT, V32, P557, DOI 10.1007/s10529-009-0178-z; Payton P, 1997, PHOTOSYNTH RES, V52, P233, DOI 10.1023/A:1005873105596; Qi YC, 2010, RUSS J PLANT PHYSL+, V57, P233, DOI 10.1134/S102144371002010X; Ranieri A, 2005, PLANT PHYSIOL BIOCH, V43, P45, DOI 10.1016/j.plaphy.2004.12.004; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Sanita di Toppi L, 1999, J PLANT PHYSIOL, V154, P385, DOI 10.1016/S0176-1617(99)80185-0; SENGUPTA A, 1993, PLANT PHYSIOL, V103, P1067, DOI 10.1104/pp.103.4.1067; Shah Mamta R., 2010, Physiology and Molecular Biology of Plants, V16, P39, DOI 10.1007/s12298-010-0006-x; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Song WY, 2003, NAT BIOTECHNOL, V21, P914, DOI 10.1038/nbt850; WILLIAMSON G, 1987, BIOCHEM SOC T, V15, P1103, DOI 10.1042/bst0151103; Wu Q, 2011, J PLANT PHYSIOL, V168, P167, DOI 10.1016/j.jplph.2010.06.005; Zhao F, 2006, J AGR SCI-CAMBRIDGE, V144, P547, DOI 10.1017/S0021859606006411; Zhao FY, 2009, J INTEGR PLANT BIOL, V51, P942, DOI 10.1111/j.1744-7909.2009.00865.x	46	76	80	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16360	10.1371/journal.pone.0016360	http://dx.doi.org/10.1371/journal.pone.0016360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283689	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522300040
J	Al-Jallad, HF; Myneni, VD; Piercy-Kotb, SA; Chabot, N; Mulani, A; Keillor, JW; Kaartinen, MT				Al-Jallad, Hadil F.; Myneni, Vamsee D.; Piercy-Kotb, Sarah A.; Chabot, Nicolas; Mulani, Amina; Keillor, Jeffrey W.; Kaartinen, Mari T.			Plasma Membrane Factor XIIIA Transglutaminase Activity Regulates Osteoblast Matrix Secretion and Deposition by Affecting Microtubule Dynamics	PLOS ONE			English	Article							COAGULATION-FACTOR-XIII; FIBRONECTIN-BINDING SITE; TISSUE TRANSGLUTAMINASE; CELL-SURFACE; CROSS-LINKING; ASCORBIC-ACID; TARGETED INACTIVATION; SIGNALING PATHWAYS; 3T3 FIBROBLASTS; IN-SITU	Transglutaminase activity, arising potentially from transglutaminase 2 (TG2) and Factor XIIIA (FXIIIA), has been linked to osteoblast differentiation where it is required for type I collagen and fibronectin matrix deposition. In this study we have used an irreversible TG-inhibitor to 'block -and-track' enzyme(s) targeted during osteoblast differentiation. We show that the irreversible TG-inhibitor is highly potent in inhibiting osteoblast differentiation and mineralization and reduces secretion of both fibronectin and type I collagen and their release from the cell surface. Tracking of the dansyl probe by Western blotting and immunofluorescence microscopy demonstrated that the inhibitor targets plasma membrane-associated FXIIIA. TG2 appears not to contribute to crosslinking activity on the osteoblast surface. Inhibition of FXIIIA with NC9 resulted in defective secretory vesicle delivery to the plasma membrane which was attributable to a disorganized microtubule network and decreased microtubule association with the plasma membrane. NC9 inhibition of FXIIIA resulted in destabilization of microtubules as assessed by cellular Glu-tubulin levels. Furthermore, NC9 blocked modification of Glu-tubulin into 150 kDa high-molecular weight Glu-tubulin form which was specifically localized to the plasma membrane. FXIIIA enzyme and its crosslinking activity were colocalized with plasma membrane-associated tubulin, and thus, it appears that FXIIIA crosslinking activity is directed towards stabilizing the interaction of microtubules with the plasma membrane. Our work provides the first mechanistic cues as to how transglutaminase activity could affect protein secretion and matrix deposition in osteoblasts and suggests a novel function for plasma membrane FXIIIA in microtubule dynamics.	[Al-Jallad, Hadil F.; Myneni, Vamsee D.; Piercy-Kotb, Sarah A.; Kaartinen, Mari T.] McGill Univ, Div Biomed Sci, Fac Dent, Montreal, PQ, Canada; [Chabot, Nicolas; Mulani, Amina; Keillor, Jeffrey W.] Univ Montreal, Dept Chem, Fac Arts & Sci, Montreal, PQ H3C 3J7, Canada; [Piercy-Kotb, Sarah A.; Kaartinen, Mari T.] McGill Univ, Fac Med, Dept Med, Div Expt Med, Montreal, PQ, Canada	McGill University; Universite de Montreal; McGill University	Al-Jallad, HF (corresponding author), McGill Univ, Div Biomed Sci, Fac Dent, Montreal, PQ, Canada.	mari.kaartinen@mcgill.ca		Kaartinen, Mari/0000-0003-2999-6502	Canadian Institutes of Health Research (CIHR) [MOP-89827]; Natural Sciences and Engineering Research Council of Canada (NSERC) [184034-2009]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research (CIHR) grant number MOP-89827 (http://www.cihr.ca) and Natural Sciences and Engineering Research Council of Canada (NSERC) grant number 184034-2009 (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyuthan KE, 1996, MOL CELL BIOCHEM, V162, P43; Adany R, 2003, CELL MOL LIFE SCI, V60, P1049, DOI 10.1007/s00018-003-2178-9; AESCHLIMANN D, 1991, J BIOL CHEM, V266, P15308; AESCHLIMANN D, 1993, J CELL BIOL, V120, P1461, DOI 10.1083/jcb.120.6.1461; Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; Aeschlimann Daniel, 1996, Seminars in Thrombosis and Hemostasis, V22, P437; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Al-Jallad HF, 2006, MATRIX BIOL, V25, P135, DOI 10.1016/j.matbio.2005.11.001; Allan VJ, 2000, PRACT APPROACH SER, V218, P1; Bernstein EF, 1996, J AM ACAD DERMATOL, V34, P209, DOI 10.1016/S0190-9622(96)80114-9; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; Cordell PA, 2010, BLOOD, V115, P2674, DOI 10.1182/blood-2009-08-231316; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; de Macedo P, 2002, BIOORGAN MED CHEM, V10, P355, DOI 10.1016/S0968-0896(01)00292-9; Del Duca S, 2009, BIOCHEM J, V418, P651, DOI 10.1042/BJ20081781; DIEGELMA.RF, 1972, P NATL ACAD SCI USA, V69, P892, DOI 10.1073/pnas.69.4.892; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; ECAROTCHARRIER B, 1983, J CELL BIOL, V96, P639, DOI 10.1083/jcb.96.3.639; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Facchiano F, 2006, FRONT BIOSCI, V11, P1758, DOI 10.2741/1921; Faverman L, 2008, FEBS LETT, V582, P1552, DOI 10.1016/j.febslet.2008.03.053; FOLK JE, 1983, ADV ENZYMOL RAMB, V54, P1; Forsprecher J, 2009, AMINO ACIDS, V36, P747, DOI 10.1007/s00726-008-0125-7; Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; FRANCESCHI RT, 1990, J BONE MINER RES, V5, P1157; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; GENTILE V, 1992, J CELL BIOL, V119, P463, DOI 10.1083/jcb.119.2.463; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Hsieh L, 2008, HAEMOPHILIA, V14, P1190, DOI 10.1111/j.1365-2516.2008.01857.x; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Inbal A, 2005, THROMB HAEMOSTASIS, V94, P432, DOI 10.1160/TH05-04-0291; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Johnson KA, 2005, J BIOL CHEM, V280, P15004, DOI 10.1074/jbc.M500962200; Johnson KA, 2003, J BIOL CHEM, V278, P18824, DOI 10.1074/jbc.M301055200; Johnson KA, 2008, J CELL SCI, V121, P2256, DOI 10.1242/jcs.011262; Jones RA, 1997, J CELL SCI, V110, P2461; Kaartinen MT, 1997, J BIOL CHEM, V272, P22736, DOI 10.1074/jbc.272.36.22736; Kaartinen MT, 2002, J BONE MINER RES, V17, P2161, DOI 10.1359/jbmr.2002.17.12.2161; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Keillor JW, 2008, CAN J CHEM, V86, P271, DOI 10.1139/V08-024; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lauer P, 2002, THROMB HAEMOSTASIS, V88, P967, DOI 10.1055/s-0037-1613342; Linder S, 2000, J CELL SCI, V113, P4165; Lorand L, 2005, J THROMB HAEMOST, V3, P1337, DOI 10.1111/j.1538-7836.2005.01213.x; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LYNCH GW, 1987, J BIOL CHEM, V262, P1772; MACCIONI RB, 1986, EXP CELL RES, V167, P266, DOI 10.1016/0014-4827(86)90224-7; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; McKee MD, 2005, CELLS TISSUES ORGANS, V181, P176, DOI 10.1159/000091379; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Muszbek L, 1999, THROMB RES, V94, P271, DOI 10.1016/S0049-3848(99)00023-7; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nabavi N, 2008, J BIOL CHEM, V283, P19678, DOI 10.1074/jbc.M802517200; Nahrendorf M, 2006, CIRCULATION, V113, P1196, DOI 10.1161/CIRCULATIONAHA.105.602094; Nakano Y, 2007, BONE, V41, P549, DOI 10.1016/j.bone.2007.06.011; Nakano Y, 2007, J HISTOCHEM CYTOCHEM, V55, P675, DOI 10.1369/jhc.6A7091.2007; Nakano Y, 2010, J CELL PHYSIOL, V223, P260, DOI 10.1002/jcp.22034; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Nurminskaya M, 2006, FRONT BIOSCI-LANDMRK, V11, P1591, DOI 10.2741/1907; Nurminskaya M, 1998, J CELL BIOL, V142, P1135, DOI 10.1083/jcb.142.4.1135; Nurminskaya M, 2003, DEV BIOL, V263, P139, DOI 10.1016/S0012-1606(03)00445-7; Nurminskaya MV, 2002, J ORTHOPAED RES, V20, P575, DOI 10.1016/S0736-0266(01)00146-2; Nurminskaya MV, 2002, DEV DYNAM, V223, P24, DOI 10.1002/dvdy.1230; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; PAYE M, 1989, HAEMOSTASIS, V19, P274; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; PRINCE CW, 1991, BIOCHEM BIOPH RES CO, V177, P1205, DOI 10.1016/0006-291X(91)90669-X; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; SCHMID I, 1991, CYTOMETRY, V12, P279, DOI 10.1002/cyto.990120312; Schmoranzer J, 2003, MOL BIOL CELL, V14, P1558, DOI 10.1091/mbc.E02-08-0500; Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563; Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740; Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86, DOI 10.1007/s005860100283; SORENSEN ES, 1994, BIOCHEM J, V304, P13, DOI 10.1042/bj3040013; SPERANZA ML, 1987, COLLAGEN REL RES, V7, P115; Tarantino U, 2009, AMINO ACIDS, V36, P679, DOI 10.1007/s00726-008-0133-7; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Tucholski J, 1999, J NEUROCHEM, V73, P1871; Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verhage M, 2007, CURR OPIN CELL BIOL, V19, P402, DOI 10.1016/j.ceb.2007.05.002; WANG D, 1999, J BONE MINER RES, V9, P843; Wolff J, 2009, BBA-BIOMEMBRANES, V1788, P1415, DOI 10.1016/j.bbamem.2009.03.013; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Zemskov EA, 2007, J CELL SCI, V120, P3188, DOI 10.1242/jcs.010397; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022	101	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15893	10.1371/journal.pone.0015893	http://dx.doi.org/10.1371/journal.pone.0015893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283799	gold, Green Published, Green Submitted			2022-12-25	WOS:000286522200017
J	Etchuuya, R; Ito, M; Kitano, S; Shigi, F; Sobue, R; Maeda, S				Etchuuya, Rika; Ito, Miki; Kitano, Seiko; Shigi, Fukiko; Sobue, Rina; Maeda, Sumio			Cell-to-Cell Transformation in Escherichia coli: A Novel Type of Natural Transformation Involving Cell-Derived DNA and a Putative Promoting Pheromone	PLOS ONE			English	Article							GENETIC-TRANSFORMATION; PLASMID TRANSFORMATION; NONCONJUGATIVE PLASMIDS; HORIZONTAL TRANSFER; COLONY BIOFILM; COMPETENCE; COMPLEMENTATION; EXPRESSION; RESISTANCE; SECRETION	Escherichia coli is not assumed to be naturally transformable. However, several recent reports have shown that E. coli can express modest genetic competence in certain conditions that may arise in its environment. We have shown previously that spontaneous lateral transfer of non-conjugative plasmids occurs in a colony biofilm of mixed E. coli strains (a set of a donor strain harbouring a plasmid and a plasmid-free recipient strain). In this study, with high-frequency combinations of strains and a plasmid, we constructed the same lateral plasmid transfer system in liquid culture. Using this system, we demonstrated that this lateral plasmid transfer was DNase-sensitive, indicating that it is a kind of transformation in which DNase-accessible extracellular naked DNA is essential. However, this transformation did not occur with purified plasmid DNA and required a direct supply of plasmid from co-existing donor cells. Based on this feature, we have termed this transformation type as 'cell-to-cell transformation'. Analyses using medium conditioned with the high-frequency strain revealed that this strain released a certain factor(s) that promoted cell-to-cell transformation and arrested growth of the other strains. This factor is heat-labile and protease-sensitive, and its roughly estimated molecular mass was between similar to 9 kDa and similar to 30 kDa, indicating that it is a polypeptide factor. Interestingly, this factor was effective even when the conditioned medium was diluted 10(-5)-10(-6), suggesting that it acts like a pheromone with high bioactivity. Based on these results, we propose that cell-to-cell transformation is a novel natural transformation mechanism in E. coli that requires cell-derived DNA and is promoted by a peptide pheromone. This is the first evidence that suggests the existence of a peptide pheromone-regulated transformation mechanism in E. coli and in Gram-negative bacteria.	[Etchuuya, Rika; Ito, Miki; Kitano, Seiko; Shigi, Fukiko; Sobue, Rina; Maeda, Sumio] Nara Womens Univ, Fac Human Life & Environm, Nara 630, Japan	Nara Womens University	Etchuuya, R (corresponding author), Nara Womens Univ, Fac Human Life & Environm, Nara 630, Japan.	smaeda@cc.nara-wu.ac.jp			Japan Society for the Promotion of Science [19580089]; Institute for Fermentation, Osaka, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute for Fermentation, Osaka, Japan(Institute for Fermentation (IFO))	This work was supported by a Grant-In-Aid for Scientific Research (no. 19580089) from the Japan Society for the Promotion of Science and in part by a grant from the Institute for Fermentation, Osaka, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2009, WORLD J MICROB BIOT, V25, P1865, DOI 10.1007/s11274-009-0070-y; Averhoff B, 2003, ARCH MICROBIOL, V180, P385, DOI 10.1007/s00203-003-0616-6; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bauer F, 1999, SYST APPL MICROBIOL, V22, P161, DOI 10.1016/S0723-2020(99)80061-7; Baur B, 1996, APPL ENVIRON MICROB, V62, P3673, DOI 10.1128/AEM.62.10.3673-3678.1996; Blokesch M, 2008, J BACTERIOL, V190, P7232, DOI 10.1128/JB.00959-08; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Bushman F., 2002, LATERAL DNA TRANSFER; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; Carmen John C., 2004, Journal of Infection and Chemotherapy, V10, P193; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Claverys JP, 2007, MOL MICROBIOL, V64, P1423, DOI 10.1111/j.1365-2958.2007.05757.x; DANNER DB, 1980, GENE, V11, P311, DOI 10.1016/0378-1119(80)90071-2; Dirix G, 2004, PEPTIDES, V25, P1425, DOI 10.1016/j.peptides.2003.10.028; Draghi JA, 2006, MICROBIOL-SGM, V152, P2683, DOI 10.1099/mic.0.29013-0; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Duggan PS, 2000, FEMS MICROBIOL LETT, V191, P71, DOI 10.1111/j.1574-6968.2000.tb09321.x; EKINS C, 1991, J BACTERIOL, V173, P3911; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; FOUTS KE, 1982, J BACTERIOL, V149, P106, DOI 10.1128/JB.149.1.106-113.1982; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Hong XK, 1996, MOL MICROBIOL, V21, P953, DOI 10.1046/j.1365-2958.1996.591419.x; Ishimoto Y, 2008, WORLD J MICROB BIOT, V24, P2731, DOI 10.1007/s11274-008-9761-z; Keese Paul, 2008, Environmental Biosafety Research, V7, P123, DOI 10.1051/ebr:2008014; Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P978, DOI 10.1016/j.fct.2008.06.012; Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P969, DOI 10.1016/j.fct.2008.02.007; Koch B, 2005, MICROBIOL-SGM, V151, P3589, DOI 10.1099/mic.0.27954-0; Kolodkin-Gal A, 2008, J BACTERIOL, V190, P3169, DOI 10.1128/JB.01918-07; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Maeda S, 2006, FEMS MICROBIOL LETT, V255, P115, DOI 10.1111/j.1574-6968.2005.00072.x; Maeda S, 2004, FEMS MICROBIOL LETT, V236, P61, DOI 10.1111/j.1574-6968.2004.tb09627.x; Maeda S., 2003, MICROBES ENV, V18, P100, DOI 10.1264/jsme2.18.100; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; Manen D, 1997, GENE, V186, P197, DOI 10.1016/S0378-1119(96)00702-0; Neidhardt, 1996, ESCHERICHIA COLIAND, V2, P2460; Panja S, 2008, BIOMACROMOLECULES, V9, P2501, DOI 10.1021/bm8005215; Perez-Conesa D, 2006, J FOOD PROTECT, V69, P2947, DOI 10.4315/0362-028X-69.12.2947; Pontiroli A, 2009, APPL ENVIRON MICROB, V75, P3314, DOI 10.1128/AEM.02632-08; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Sambrook J, 1989, MOL CLONING LABORATO; SINGER M, 1989, MICROBIOL REV, V53, P1; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; Sun DC, 2006, FEMS MICROBIOL LETT, V265, P249, DOI 10.1111/j.1574-6968.2006.00503.x; Sun DC, 2009, J BACTERIOL, V191, P713, DOI 10.1128/JB.01130-08; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Tsen SD, 2002, J BIOMED SCI, V9, P246, DOI 10.1159/000059425; van Schaik EJ, 2005, J BACTERIOL, V187, P1455, DOI 10.1128/JB.187.4.1455-1464.2005; Wang XJ, 2007, CURR MICROBIOL, V54, P450, DOI 10.1007/s00284-006-0617-1; Wang Y, 2002, J BACTERIOL, V184, P3442, DOI 10.1128/JB.184.13.3442-3449.2002; Woegerbauer M, 2002, APPL ENVIRON MICROB, V68, P440, DOI 10.1128/AEM.68.1.440-443.2002; Zahrl D, 2006, J BACTERIOL, V188, P6611, DOI 10.1128/JB.00632-06	60	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16355	10.1371/journal.pone.0016355	http://dx.doi.org/10.1371/journal.pone.0016355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283723	gold, Green Submitted, Green Published			2022-12-25	WOS:000286522200055
J	Li, Y; Fu, L; Wong, AMG; Fan, YH; Li, MX; Bei, JX; Jia, WH; Zeng, YX; Chan, D; Cheung, KMC; Sham, P; Chua, D; Guan, XY; Song, YQ				Li, Yan; Fu, Li; Wong, Alissa Michelle Go; Fan, Yan-Hui; Li, Miao-Xin; Bei, Jin-Xin; Jia, Wei-Hua; Zeng, Yi-Xin; Chan, Danny; Cheung, Kenneth M. C.; Sham, Pak; Chua, Daniel; Guan, Xin-Yuan; Song, You-Qiang			Identification of Genes with Allelic Imbalance on 6p Associated with Nasopharyngeal Carcinoma in Southern Chinese	PLOS ONE			English	Article							SUSCEPTIBILITY LOCUS; POLYMORPHISM; EXPRESSION; RECEPTOR; HOMOZYGOSITY; METASTASIS; ESTROGEN; LINKAGE; NEDD9; CELLS	Nasopharyngeal carcinoma (NPC) is a malignancy of epithelial origin. The etiology of NPC is complex and includes multiple genetic and environmental factors. We employed case-control analysis to study the association of chromosome 6p regions with NPC. In total, 360 subjects and 360 healthy controls were included, and 233 single nucleotide polymorphisms (SNPs) on 6p were examined. Significant single-marker associations were found for SNPs rs2267633 (p = 4.49 x 10(-5)), rs2076483 (most significant, p = 3.36 x 10(-5)), and rs29230 (p = 1.43 x 10(-4)). The highly associated genes were the gamma-amino butyric acid B receptor 1 (GABBR1), human leukocyte antigen (HLA-A), and HLA complex group 9 (HCG9). Haplotypic associations were found for haplotypes AAA (located within GABBR1, p-value = 6.46 x 10(-5)) and TT (located within HLA-A, p = 0.0014). Further investigation of the homozygous genotype frequencies between cases and controls suggested that micro-deletion regions occur in GABBR1 and neural precursor cell expressed developmentally down-regulated 9 (NEDD9). Quantitative real-time polymerase chain reaction (qPCR) using 11 pairs of NPC biopsy samples confirmed the significant decline in GABBR1 and NEDD9 mRNA expression in the cancer tissues compared to the adjacent non-tumor tissue (p<0.05). Our study demonstrates that multiple chromosome 6p susceptibility loci contribute to the risk of NPC, possibly though GABBR1 and NEDD9 loss of function.	[Li, Yan; Fan, Yan-Hui; Li, Miao-Xin; Chan, Danny; Song, You-Qiang] Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Fu, Li; Wong, Alissa Michelle Go; Chua, Daniel; Guan, Xin-Yuan] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Bei, Jin-Xin; Jia, Wei-Hua; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Bei, Jin-Xin; Jia, Wei-Hua; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Cheung, Kenneth M. C.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak] Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Chan, Danny; Sham, Pak; Song, You-Qiang] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong; University of Hong Kong; University of Hong Kong	Li, Y (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	xyguan@hku.hk; songy@hku.hk	Song, You-qiang/C-4401-2009; Bei, Jin-Xin/AAO-1259-2020; Fu, Li/F-7182-2010; Fan, Yanhui/J-4659-2016; Song, You-Qiang/E-5207-2011; /A-3639-2009; Chan, Danny/C-4203-2009; Guan, Xin-Yuan/A-3639-2009	Fu, Li/0000-0003-2643-6278; Fan, Yanhui/0000-0001-9677-3777; /0000-0003-1874-9805; Wong, Alissa/0000-0001-7858-1368; Song, You-Qiang/0000-0001-9407-2256; Cheung, Kenneth/0000-0001-8304-0419; Chan, Danny/0000-0003-3824-5778; Guan, Xin-Yuan/0000-0002-4485-6017	Research Fund for the Control of Infectious Diseases (RFCID) [08070652]; AO Foundation (AOSPINE) [AOSBRC-07-02]	Research Fund for the Control of Infectious Diseases (RFCID); AO Foundation (AOSPINE)	The study is supported by a grant from the Research Fund for the Control of Infectious Diseases (RFCID: http://www.fhb.gov.hk/grants/english/funds/funds_rfcid/funds_rfcid_abt/funds_rfcid_abt.html) (no. 08070652, YQS) and AO Foundation (AOSPINE (AOSBRC-07-02; http://www.aospine.org/history.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Buterin T, 2006, CARCINOGENESIS, V27, P1567, DOI [10.1093/carcin/bci339, 10.1093/carcin/bgi339]; Chan ATC, 2002, ANN ONCOL, V13, P1007, DOI 10.1093/annonc/mdf179; Chen Shuang-ling, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P305; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Deng L, 2002, ACTA BIOCH BIOPH SIN, V34, P16; Dutt A, 2007, CURR OPIN ONCOL, V19, P43, DOI 10.1097/CCO.0b013e328011a8c1; HO JHC, 1978, INT J RADIAT ONCOL, V4, P182; [黄腾波 Huang Tengbo], 2002, [中华医学遗传学杂志, Chinese Journal of Medical Genetics], V19, P134; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; LANIER A, 1980, CANCER-AM CANCER SOC, V46, P2100, DOI 10.1002/1097-0142(19801101)46:9<2100::AID-CNCR2820460932>3.0.CO;2-G; LERMAN MI, 1987, CARCINOGENESIS, V8, P121, DOI 10.1093/carcin/8.1.121; LU SJ, 1990, NATURE, V346, P470, DOI 10.1038/346470a0; McDermott AL, 2001, CLIN OTOLARYNGOL, V26, P82, DOI 10.1046/j.1365-2273.2001.00449.x; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Merrill RA, 2004, DEV DYNAM, V231, P564, DOI 10.1002/dvdy.20159; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Nazar-Stewart V, 1999, CANCER EPIDEM BIOMAR, V8, P547; Ooi EE, 1997, INT J CANCER, V74, P229; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Schuller HM, 2008, CANCER-AM CANCER SOC, V112, P767, DOI 10.1002/cncr.23231; Sheu JJC, 2009, CANCER EPIDEM BIOMAR, V18, P2709, DOI 10.1158/1055-9965.EPI-09-0349; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Song LB, 2006, CANCER LETT, V242, P258, DOI 10.1016/j.canlet.2005.11.013; Tai ALS, 2006, CANCER RES, V66, P4133, DOI 10.1158/0008-5472.CAN-05-2775; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Xiong W, 2004, CANCER RES, V64, P1972, DOI 10.1158/0008-5472.CAN-03-3253; Zheng MZ, 2002, J BIOL CHEM, V277, P39599, DOI 10.1074/jbc.M202263200; Zhou XF, 2007, COMP FUNCT GENOM, DOI 10.1155/2007/57513	36	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14562	10.1371/journal.pone.0014562	http://dx.doi.org/10.1371/journal.pone.0014562			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283797	gold, Green Published			2022-12-25	WOS:000286522200005
J	Saridaki, Z; Tzardi, M; Papadaki, C; Sfakianaki, M; Pega, F; Kalikaki, A; Tsakalaki, E; Trypaki, M; Messaritakis, I; Stathopoulos, E; Mavroudis, D; Georgoulias, V; Souglakos, J				Saridaki, Zacharenia; Tzardi, Maria; Papadaki, Chara; Sfakianaki, Maria; Pega, Fraga; Kalikaki, Aristea; Tsakalaki, Eleftheria; Trypaki, Maria; Messaritakis, Ippokratis; Stathopoulos, Efstathios; Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John			Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in >= 2(nd) Line Cetuximab-Based Therapy of Colorectal Cancer Patients	PLOS ONE			English	Article							GENE COPY NUMBER; PLUS IRINOTECAN; PREDICTS; FLUOROURACIL; LEUCOVORIN; RESISTANCE; SURVIVAL; EFFICACY; BENEFIT; EGFR	Background: To investigate the predictive significance of KRAS, BRAF, PIK3CA mutational status, AREG- EREG mRNA expression, PTEN protein expression and skin rash in metastatic colorectal cancer (mCRC) patients treated with cetuximab containing salvage chemotherapy. Methods: Primary tumors from 112 mCRC patients were analyzed. The worst skin toxicity during treatment was recorded. Results: KRAS, BRAF and PIK3CA mutations were present in 37 (33%), 8 (7.2%) and 11 (9.8%) cases, respectively, PTEN was lost in 21 (19.8%) cases, AREG and EREG were overexpressed in 48 (45%) and 51 (49%) cases. In the whole study population, time to tumor progression (TTP) and overall survival (OS) was significantly lower in patients with KRAS (p = 0.001 and p = 0.026, respectively) or BRAF (p = 0.001 and p<0.0001, respectively) mutant tumors, downregulation of AREG (p = 0.018 and p = 0.013, respectively) or EREG (p = 0.002 and p = 0.004, respectively) and grade 0-1 skin rash (p<0.0001 and p<0.0001, respectively). In KRAS wt patients TTP and OS was significantly lower in patients with BRAF (p = 0.0001 and p<0.0001, respectively) mutant tumors, downregulation of AREG (p = 0.021 and p = 0.004, respectively) or EREG (p = 0.0001 and p<0.0001, respectively) and grade 0-1 skin rash (p<0.0001 and p<0.0001, respectively). TTP was significantly lower in patients with PIK3CA mutations (p = 0.01) or lost PTEN (p = 0.002). Multivariate analysis revealed KRAS (Hazard Ratio [HR] 4.3, p<0.0001), BRAF mutation (HR: 5.1, p<0.0001), EREG low expression (HR: 1.6, p = 0.021) and absence of severe/moderate skin rash (HR: 4.0, p<0.0001) as independent prognostic factors for decreased TTP. Similarly, KRAS (HR 2.9, p = 0.01), BRAF mutation (HR: 3.0, p = 0.001), EREG low expression (HR: 1.7, p = 0.021), absecence of severe/moderate skin rash (HR: 3.7, p<0.0001) and the presence of undifferantited tumours (HR: 2.2, p = 0.001) were revealed as independent prognostic factors for decreased OS. Conclusions: These results underscore that KRAS-BRAF mutations and EREG expression can be used as biomarkers to further select patients undergoing anti-EGFR treatment.	[Saridaki, Zacharenia; Papadaki, Chara; Sfakianaki, Maria; Pega, Fraga; Kalikaki, Aristea; Tsakalaki, Eleftheria; Trypaki, Maria; Messaritakis, Ippokratis; Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John] Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Crete, Greece; [Saridaki, Zacharenia; Mavroudis, Dimitris; Georgoulias, Vassilis; Souglakos, John] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Crete, Greece; [Tzardi, Maria; Stathopoulos, Efstathios] Univ Gen Hosp, Pathol Lab, Iraklion, Crete, Greece	University of Crete; University Hospital of Heraklion; University Hospital of Heraklion	Saridaki, Z (corresponding author), Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Crete, Greece.	georgsec@med.uoc.gr	Messaritakis, Ippokratis/H-6668-2019	PAPADAKI, CHARA/0000-0002-4591-3757; Pega, Fraga/0000-0002-2794-3565; Messaritakis, Ippokratis/0000-0003-1877-500X	Cretan Association for Biomedical Research (CABR)	Cretan Association for Biomedical Research (CABR)	Dr. Z. Saridaki is a recipient of a Cretan Association for Biomedical Research (CABR) research fellowship. No current external funding sources for this study.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; DE RW, 2010, LANCET ONCOL; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Douillard J, 2010, J CLIN ONCOL, V28; DOUILLARD J, 2009, ANNONCOL SUPP; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Jacobs B, 2009, J CLIN ONCOL, V27, P5068, DOI 10.1200/JCO.2008.21.3744; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Lurkin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008802; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Papadaki C, 2009, CLIN CANCER RES, V15, P3827, DOI 10.1158/1078-0432.CCR-08-3027; Perrone F, 2009, ANN ONCOL, V20, P84, DOI 10.1093/annonc/mdn541; Prenen Hans, 2009, Eur J Cancer, V45 Suppl 1, P70, DOI 10.1016/S0959-8049(09)70018-8; Prenen H, 2009, CLIN CANCER RES, V15, P3184, DOI 10.1158/1078-0432.CCR-08-2961; Razis E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-234; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Saridaki Z, 2010, BRIT J CANCER, V102, P1762, DOI 10.1038/sj.bjc.6605694; Saridaki Z, 2010, WORLD J GASTROENTERO, V16, P1177, DOI 10.3748/wjg.v16.i10.1177; Sartore-Bianchi A, 2007, J CLIN ONCOL, V25, P3238, DOI 10.1200/JCO.2007.11.5956; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Segaert Siegfried, 2009, Eur J Cancer, V45 Suppl 1, P295, DOI 10.1016/S0959-8049(09)70044-9; Souglakos J, 2009, BRIT J CANCER, V101, P465, DOI 10.1038/sj.bjc.6605164; Tabernero J, 2010, J CLIN ONCOL, V28, P1181, DOI 10.1200/JCO.2009.22.6043; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Torres J, 2001, EUR J CANCER, V37, P114, DOI 10.1016/S0959-8049(00)00366-X; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wong R, 2008, J CLIN ONCOL, V26, P5668, DOI 10.1200/JCO.2008.19.5024; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	45	105	117	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15980	10.1371/journal.pone.0015980	http://dx.doi.org/10.1371/journal.pone.0015980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283802	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522200019
J	Kim, YK; Wassef, L; Chung, S; Jiang, HF; Wyss, A; Blaner, WS; Quadro, L				Kim, Youn-Kyung; Wassef, Lesley; Chung, Stacey; Jiang, Hongfeng; Wyss, Adrian; Blaner, William S.; Quadro, Loredana			beta-Carotene and its cleavage enzyme beta-carotene-15,15 '-oxygenase (CMOI) affect retinoid metabolism in developing tissues	FASEB JOURNAL			English	Article						provitamin A; lecithin:retinol acyltransferase; LRAT; embryonic vitamin A deficiency	VITAMIN-A; EMBRYONIC-DEVELOPMENT; ACYLTRANSFERASE LRAT; ENDOGENOUS RETINOIDS; PROVITAMIN-A; ACID; LECITHIN; MOUSE; MICE; IDENTIFICATION	The mammalian embryo relies on maternal circulating retinoids (vitamin A derivatives) for development. beta-Carotene is the major human dietary provitamin A. beta-Carotene-15,15'-oxygenase (CMOI) has been proposed as the main enzyme generating retinoid from beta-carotene in vivo. CMOI is expressed in embryonic tissues, suggesting that beta-carotene provides retinoids locally during development. We performed loss of CMOI function studies in mice lacking retinol-binding protein (RBP), an established model of embryonic vitamin A deficiency (VAD). We show that, unexpectedly, lack of CMOI in the developing tissues further exacerbates the severity of VAD and thus the embryonic malformations of RBP(-/-) mice. Since beta-carotene was not present in any of the mouse diets, we unveiled a novel action of CMOI independent from its beta-carotene cleavage activity. We also show for the first time that CMOI exerts an additional function on retinoid metabolism by influencing retinyl ester formation via modulation of lecithin: retinol acyltransferase (LRAT) activity, at least in developing tissues. Finally, we demonstrate unequivocally that beta-carotene can serve as an alternative vitamin A source for the in situ synthesis of retinoids in developing tissues by the action of CMOI.-Kim, Y.-K., Wassef, L., Chung, S., Jiang, H., Wyss, A., Blaner, W. S., Quadro, L. beta-Carotene and its cleavage enzyme beta-carotene-15,15'-oxygenase (CMOI) affect retinoid metabolism in developing tissues. FASEB J. 25, 1641-1652 (2011). www.fasebj.org	[Kim, Youn-Kyung; Wassef, Lesley; Chung, Stacey; Quadro, Loredana] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Kim, Youn-Kyung; Wassef, Lesley; Chung, Stacey; Quadro, Loredana] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Jiang, Hongfeng; Blaner, William S.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA; [Wyss, Adrian] DSM Nutr Prod, Basel, Switzerland	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Columbia University; DSM NV	Quadro, L (corresponding author), Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.	quadro@aesop.rutgers.edu	jiang, hongfeng/I-6188-2013		U.S. National Institutes of Health (NIH) [R01HD057493, R01HD057493-02S1]; U.S. Department of Agriculture Cooperative State Research, Education, and Extension Service, Bioactive Food Components for Optimal Health [2006-35200-16580]; NIH [R01DK079221, RC2AA019413]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019413] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture Cooperative State Research, Education, and Extension Service, Bioactive Food Components for Optimal Health(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants R01HD057493 and R01HD057493-02S1 from the U.S. National Institutes of Health (NIH) and partially by National Research Initiative grant 2006-35200-16580 from the U.S. Department of Agriculture Cooperative State Research, Education, and Extension Service, Bioactive Food Components for Optimal Health (31.0) Program to L. Q. In addition, W. S. B. and H. J were supported by grants R01DK079221 and RC2AA019413 from NIH.	Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; Dimenstein R, 1996, BIOL NEONATE, V69, P230, DOI 10.1159/000244315; Engelking LJ, 2006, J CLIN INVEST, V116, P2356, DOI 10.1172/JCI28988; ERDMAN JW, 1993, ANN NY ACAD SCI, V691, P76, DOI 10.1111/j.1749-6632.1993.tb26159.x; Fortuna VA, 2001, J NUTR BIOCHEM, V12, P610, DOI 10.1016/S0955-2863(01)00179-6; Glise D, 1998, IN VIVO, V12, P447; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kim YK, 2008, J BIOL CHEM, V283, P5611, DOI 10.1074/jbc.M708885200; Kim YK, 2010, METHODS MOL BIOL, V652, P263, DOI 10.1007/978-1-60327-325-1_15; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; Lindqvist A, 2007, J NUTR, V137, P2346, DOI 10.1093/jn/137.11.2346; Marceau G, 2007, VITAM HORM, V75, P97, DOI 10.1016/S0083-6729(06)75004-X; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; NAPOLI JL, 1988, J BIOL CHEM, V263, P17372; Niederreither K, 2002, P NATL ACAD SCI USA, V99, P16111, DOI 10.1073/pnas.252626599; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Pasqualetti M, 2001, NAT GENET, V29, P34, DOI 10.1038/ng702; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 2004, AM J PHYSIOL-ENDOC M, V286, pE844, DOI 10.1152/ajpendo.00556.2003; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Ross AC, 2010, METHODS MOL BIOL, V652, P295, DOI 10.1007/978-1-60327-325-1_17; Scaife AR, 2006, BRIT J NUTR, V95, P771, DOI 10.1079/BJN20051718; SHINGLETON JL, 1989, BIOCHEMISTRY-US, V28, P9647, DOI 10.1021/bi00451a016; Shmarakov I, 2010, ARCH BIOCHEM BIOPHYS, V504, P3, DOI 10.1016/j.abb.2010.05.010; Ulven SM, 2000, DEV BIOL, V220, P379, DOI 10.1006/dbio.2000.9634; van Helden YGJ, 2010, CELL MOL LIFE SCI, V67, P2039, DOI 10.1007/s00018-010-0341-7; VOGEL S, 1999, HANDB EXP PHARM, V139, P31; von Lintig J, 2005, BBA-MOL BASIS DIS, V1740, P122, DOI 10.1016/j.bbadis.2004.11.010; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Wang XD, 1996, J BIOL CHEM, V271, P26490, DOI 10.1074/jbc.271.43.26490; WANG XD, 1992, ARCH BIOCHEM BIOPHYS, V293, P298, DOI 10.1016/0003-9861(92)90399-H; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Yeum KJ, 2002, ANNU REV NUTR, V22, P483, DOI 10.1146/annurev.nutr.22.010402.102834; Yeum KJ, 1998, J AM COLL NUTR, V17, P442, DOI 10.1080/07315724.1998.10718791; Zolfaghari R, 2000, J LIPID RES, V41, P2024	42	48	51	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2011	25	5					1641	1652		10.1096/fj.10-175448	http://dx.doi.org/10.1096/fj.10-175448			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21285397	Green Published			2022-12-25	WOS:000290023800021
J	Place, TL; Fitzgerald, MP; Venkataraman, S; Vorrink, SU; Case, AJ; Teoh, MLT; Domann, FE				Place, Trenton L.; Fitzgerald, Matthew P.; Venkataraman, Sujatha; Vorrink, Sabine U.; Case, Adam J.; Teoh, Melissa L. T.; Domann, Frederick E.			Aberrant Promoter CpG Methylation Is a Mechanism for Impaired PHD3 Expression in a Diverse Set of Malignant Cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; PROLYL-HYDROXYLASES; PROLINE HYDROXYLATION; OXYGEN SENSOR; HIF-ALPHA; HIF-1-ALPHA; FACTOR-1; HIF-2-ALPHA; STABILITY; THERAPY	Background: The prolyl-hydroxylase domain family of enzymes (PHD1-3) plays an important role in the cellular response to hypoxia by negatively regulating HIF-alpha proteins. Disruption of this process can lead to up-regulation of factors that promote tumorigenesis. We observed decreased basal expression of PHD3 in prostate cancer tissue and tumor cell lines representing diverse tissues of origin. Furthermore, some cancer lines displayed a failure of PHD3 mRNA induction when introduced to a hypoxic environment. This study explores the mechanism by which malignancies neither basally express PHD3 nor induce PHD3 under hypoxic conditions. Methodology/Principal Findings: Using bisulfite sequencing and methylated DNA enrichment procedures, we identified human PHD3 promoter hypermethylation in prostate, breast, melanoma and renal carcinoma cell lines. In contrast, non-transformed human prostate and breast epithelial cell lines contained PHD3 CpG islands that were unmethylated and responded normally to hypoxia by upregulating PHD3 mRNA. Only treatment of cells lines containing PHD3 promoter hypermethylation with the demethylating drug 5-aza-2 '-deoxycytidine significantly increased the expression of PHD3. Conclusions/Significance: We conclude that expression of PHD3 is silenced by aberrant CpG methylation of the PHD3 promoter in a subset of human carcinoma cell lines of diverse origin and that this aberrant cytosine methylation status is the mechanism by which these cancer cell lines fail to upregulate PHD3 mRNA. We further show that a loss of PHD3 expression does not correlate with an increase in HIF-1 alpha protein levels or an increase in the transcriptional activity of HIF, suggesting that loss of PHD3 may convey a selective advantage in some cancers by affecting pathway(s) other than HIF.	[Place, Trenton L.; Domann, Frederick E.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA; [Fitzgerald, Matthew P.; Case, Adam J.; Teoh, Melissa L. T.; Domann, Frederick E.] Univ Iowa, Free Radical & Radiat Biol Program, Iowa City, IA USA; [Fitzgerald, Matthew P.; Case, Adam J.; Teoh, Melissa L. T.; Domann, Frederick E.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA USA; [Venkataraman, Sujatha] Univ Colorado Denver, Aurora, CO USA; [Vorrink, Sabine U.; Domann, Frederick E.] Univ Iowa, Human Toxicol Program, Iowa City, IA USA; [Domann, Frederick E.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Domann, Frederick E.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Iowa; University of Iowa; University of Iowa	Place, TL (corresponding author), Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA.	frederick-domann@uiowa.edu		Case, Adam/0000-0003-3404-1428; Domann, Frederick/0000-0002-0489-2179	National Institutes of Health (NIH) [R01CA115438, R01CA073612]; DOD [W81XWH-08-1-0112]; Susan G. Komen for the Cure [KG080437]; NIH Cancer Center [P30CA086862]; NIEHS [2P42ES013661]; NIH [T32GM073610]; NATIONAL CANCER INSTITUTE [P30CA086862, R01CA115438, R01CA073612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073610] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants R01CA115438 (FED), R01CA073612 (FED), DOD grant W81XWH-08-1-0112 (AJC), and the Susan G. Komen for the Cure grant KG080437 (MLT). SV received a project development grant from NIH Cancer Center Support, grant P30CA086862. SUV received partial salary support from NIEHS 2P42ES013661, and AJC received partial salary support from NIH T32GM073610. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; CYR A, ANTIOXID REDOX SIGNA; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Domann FE, 2004, AM J PATHOL, V164, P1883, DOI 10.1016/S0002-9440(10)63748-0; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FU J, J BIOL CHEM, V285, P8927; HATZIMICHAEL E, 2009, EUR J HAEMATOL; HENZE AT, CANC RES, V70, P357; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; HUANG KT, HISTOPATHOLOGY; Huang LE, 2003, J BIOL CHEM, V278, P19575, DOI 10.1074/jbc.R200030200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kim A, 2009, CARCINOGENESIS, V30, P927, DOI 10.1093/carcin/bgp072; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Lipscomb EA, 2001, J BIOL CHEM, V276, P5085, DOI 10.1074/jbc.M008407200; LIU Y, BIOCH BIOPHYS RES CO, V401, P231; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; MAIER HJ, CANC LETT, V295, P214; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; PASANEN A, INT J BIOCH CELL BIO, V42, P1189; Rose SL, 2006, GYNECOL ONCOL, V102, P319, DOI 10.1016/j.ygyno.2005.12.025; Salnikow K, 1999, CARCINOGENESIS, V20, P1819, DOI 10.1093/carcin/20.9.1819; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Szyf M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P533, DOI 10.1007/s10541-005-0147-7; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; XUE J, 2009, GASTROENTEROLOGY; Yan M, 2009, BRIT J CANCER, V101, P1168, DOI 10.1038/sj.bjc.6605287; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	39	37	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14617	10.1371/journal.pone.0014617	http://dx.doi.org/10.1371/journal.pone.0014617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297970	gold, Green Published, Green Submitted			2022-12-25	WOS:000286664100004
J	Evans, D; McGreevy, P				Evans, David; McGreevy, Paul			An Investigation of Racing Performance and Whip Use by Jockeys in Thoroughbred Races	PLOS ONE			English	Article								Concerns have been expressed concerning animal-welfare issues associated with whip use during Thoroughbred races. However, there have been no studies of relationships between performance and use of whips in Thoroughbred racing. Our aim was to describe whip use and the horses' performance during races, and to investigate associations between whip use and racing performance. Under the Australian Racing Board (ARB) rules, only horses that are in contention can be whipped, so we expected that whippings would be associated with superior performance, and those superior performances would be explained by an effect of whipping on horse velocities in the final 400 m of the race. We were also interested to determine whether performance in the latter sections of a race was associated with performance in the earlier sections of a race. Measurements of whip strikes and sectional times during each of the final three 200 metre (m) sections of five races were analysed. Jockeys in more advanced placings at the final 400 and 200 m positions in the races whipped their horses more frequently. Horses, on average, achieved highest speeds in the 600 to 400 m section when there was no whip use, and the increased whip use was most frequent in the final two 200 m sections when horses were fatigued. This increased whip use was not associated with significant variation in velocity as a predictor of superior placing at the finish.	[Evans, David; McGreevy, Paul] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Evans, D (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	paul.mcgreevy@sydney.edu.au		McGreevy, Paul/0000-0001-7220-8378				Australian Racing Board, 2009, AUSTR RUL RAC; Brisbane Racing Club, 2010, TRACK RAT; British Horseracing Authority, 2009, RAC MAN B SCH 6 CAUS; Deuel N.R., 1987, P EQ NUTR PHYS S, V10, P487; HARRIS RC, 1987, J APPL PHYSIOL, V63, P12, DOI 10.1152/jappl.1987.63.1.12; Jones B, 2010, J VET BEHAV, V5, P196, DOI 10.1016/j.jveb.2010.04.001; McGreevy PD, 2007, J VET BEHAV, V2, P108, DOI 10.1016/j.jveb.2007.05.003; McLean A., 2008, ACAD HORSE TRAINING; Racing Victoria, 2009, PADD WHIP SPEC	9	33	33	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15622	10.1371/journal.pone.0015622	http://dx.doi.org/10.1371/journal.pone.0015622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21283587	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900015
J	Huang, Y; Morozov, A				Huang, Ying; Morozov, Alexei			Hippocampal Deletion of BDNF Gene Attenuates Gamma Oscillations in Area CA1 by Up-Regulating 5-HT3 Receptor	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; IN-VITRO; GABAERGIC TRANSMISSION; INTERNEURON NETWORKS; PREFRONTAL CORTEX; CA2+ OSCILLATIONS; MESSENGER-RNA; BEHAVING RAT; BRAIN; SEROTONIN	Background: Pyramidal neurons in the hippocampal area CA3 express high levels of BDNF, but how this BDNF contributes to oscillatory properties of hippocampus is unknown. Methodology/Principal Findings: Here we examined carbachol-induced gamma oscillations in hippocampal slices lacking BDNF gene in the area CA3. The power of oscillations was reduced in the hippocampal area CA1, which coincided with increases in the expression and activity of 5-HT3 receptor. Pharmacological block of this receptor partially restored power of gamma oscillations in slices from KO mice, but had no effect in slices from WT mice. Conclusion/Significance: These data suggest that BDNF facilitates gamma oscillations in the hippocampus by attenuating signaling through 5-HT3 receptor. Thus, BDNF modulates hippocampal oscillations through serotonergic system.	[Huang, Ying; Morozov, Alexei] NIMH, Unit Behav Genet, Mol Pathophysiol Lab, NIH, Bethesda, MD 20892 USA; [Huang, Ying] Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Fudan University	Huang, Y (corresponding author), NIMH, Unit Behav Genet, Mol Pathophysiol Lab, NIH, Bethesda, MD 20892 USA.	morozova@mail.nih.gov			National Institutes of Health National Institute of Mental Health	National Institutes of Health National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by the National Institutes of Health National Institute of Mental Health Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin I, 2008, J PHYSIOL-LONDON, V586, P1885, DOI 10.1113/jphysiol.2007.148627; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Berghuis P, 2004, EUR J NEUROSCI, V20, P1290, DOI 10.1111/j.1460-9568.2004.03561.x; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Bookout A. L., 2006, CURRENT PROTOCOLS MO; BRAGIN A, 1995, J NEUROSCI, V15, P47; Choi IS, 2007, J NEUROCHEM, V103, P2342, DOI 10.1111/j.1471-4159.2007.04945.x; Conner JM, 1997, J NEUROSCI, V17, P2295; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; FARZAN F, BRAIN, V133, P1505; Ferezou I, 2002, J NEUROSCI, V22, P7389; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Fujisawa S, 2004, BIOPHYS J, V86, P1820, DOI 10.1016/S0006-3495(04)74249-6; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Holm MM, 2009, J NEUROSCI, V29, P12412, DOI 10.1523/JNEUROSCI.2978-09.2009; Hughes JR, 2008, EPILEPSY BEHAV, V13, P25, DOI 10.1016/j.yebeh.2008.01.011; Itami C, 2007, J NEUROSCI, V27, P2241, DOI 10.1523/JNEUROSCI.3345-06.2007; Jin X, 2003, J NEUROSCI, V23, P5662; Kahana MJ, 2006, J NEUROSCI, V26, P1669, DOI 10.1523/JNEUROSCI.3737-05c.2006; Macor JE, 2001, BIOORG MED CHEM LETT, V11, P319, DOI 10.1016/S0960-894X(00)00670-3; MAMOUNAS LA, 1991, J COMP NEUROL, V314, P558, DOI 10.1002/cne.903140312; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Nakajo Y, 2008, BRAIN RES, V1241, P103, DOI 10.1016/j.brainres.2008.08.080; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Numakawa T, 2002, J BIOL CHEM, V277, P6520, DOI 10.1074/jbc.M109139200; Ongur D, 2010, PSYCHIAT RES-NEUROIM, V183, P59, DOI 10.1016/j.pscychresns.2010.04.008; Papke RL, 2004, BIOORG MED CHEM LETT, V14, P1849, DOI 10.1016/j.bmcl.2003.09.104; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Popescu AT, 2009, NAT NEUROSCI, V12, P801, DOI 10.1038/nn.2305; Puig MV, 2010, J NEUROSCI, V30, P2211, DOI 10.1523/JNEUROSCI.3335-09.2010; ROPERT N, 1991, J PHYSIOL-LONDON, V441, P121, DOI 10.1113/jphysiol.1991.sp018742; Sakai N, 1997, BRAIN RES, V778, P318, DOI 10.1016/S0006-8993(97)01052-4; Sakata K, 2009, P NATL ACAD SCI USA, V106, P5942, DOI 10.1073/pnas.0811431106; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; TECOTT LH, 1993, P NATL ACAD SCI USA, V90, P1430, DOI 10.1073/pnas.90.4.1430; Traub RD, 1997, J COMPUT NEUROSCI, V4, P141, DOI 10.1023/A:1008839312043; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Turner TJ, 2004, NEUROSCIENCE, V129, P703, DOI 10.1016/j.neuroscience.2004.08.020; van Deursen JA, 2008, J NEURAL TRANSM, V115, P1301, DOI 10.1007/s00702-008-0083-y; van Vugt MK, 2010, J NEUROSCI, V30, P2694, DOI 10.1523/JNEUROSCI.0567-09.2010; Whittington MA, 2000, PHARMACOL THERAPEUT, V86, P171, DOI 10.1016/S0163-7258(00)00038-3; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Yamada MK, 2002, J NEUROSCI, V22, P7580; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9	50	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16480	10.1371/journal.pone.0016480	http://dx.doi.org/10.1371/journal.pone.0016480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298058	Green Submitted, Green Published, gold			2022-12-25	WOS:000286662800046
J	Marzoli, D; Palumbo, R; Di Domenico, A; Penolazzi, B; Garganese, P; Tommasi, L				Marzoli, Daniele; Palumbo, Rocco; Di Domenico, Alberto; Penolazzi, Barbara; Garganese, Patrizia; Tommasi, Luca			The Relation between Self-Reported Empathy and Motor Identification with Imagined Agents	PLOS ONE			English	Article							VISUAL PERSPECTIVE-TAKING; GENDER-DIFFERENCES; SEX-DIFFERENCES; EMOTIONAL CONTAGION; FUNCTIONAL-ANATOMY; MIMICRY REACTIONS; EMBODIED EMPATHY; MENTAL ROTATION; SPATIAL ABILITY; MIRROR SYSTEM	Background: In a previous study, we found that when required to imagine another person performing an action, participants reported a higher correspondence between their own handedness and the hand used by the imagined person when the agent was seen from the back compared to when the agent was seen from the front. This result was explained as evidence of a greater involvement of motor areas in the back-view perspective, possibly indicating a greater proneness to put oneself in the agent's shoes in such a condition. In turn, the proneness to put oneself in another's shoes could also be considered as a cue of greater identification with the other, that is a form of empathy. If this is the case, the proportion of lateral matches vs mismatches should be different for subjects with high and low self-reported empathy. In the present study, we aimed at testing this hypothesis. Methodology/Principal Findings: Participants were required to imagine a person performing a single manual action in a back view and to indicate the hand used by the imagined person during movement execution. Consistent with our hypothesis, the proportion of matching between the handedness of participants and the handedness of agents imagined was higher for participants scoring high in a self-report measure of empathy. Importantly, this relationship was specific for females. Conclusions/Significance: At least for females, our data seem to corroborate the idea of a link between self-reported empathy and motor identification with imagined agents. This sex-specific result is consistent with neuroimaging studies indicating a stronger involvement of action representations during emotional and empathic processing in females than in males. In sum, our findings underline the possibility of employing behavioral research as a test-bed for theories deriving from functional studies suggesting a link between empathic processing and the activation of motor-related areas.	[Marzoli, Daniele] Univ Ferrara, Dept Biomed Sci & Adv Therapy, I-44100 Ferrara, Italy; [Marzoli, Daniele; Palumbo, Rocco; Di Domenico, Alberto; Penolazzi, Barbara; Garganese, Patrizia; Tommasi, Luca] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Penolazzi, Barbara] Univ Alma Mater Studiorum, Dept Psychol, Bologna, Italy	University of Ferrara; G d'Annunzio University of Chieti-Pescara; University of Bologna	Marzoli, D (corresponding author), Univ Ferrara, Dept Biomed Sci & Adv Therapy, I-44100 Ferrara, Italy.	d.marzoli@unich.it	Palumbo, Rocco/M-3593-2019; Di Domenico, Alberto/O-2111-2015; Palumbo, Rocco/R-6572-2017; Di Domenico, Alberto/AIB-7965-2022; Tommasi, Luca/F-3638-2012; Palumbo, Rocco/H-7375-2014	Palumbo, Rocco/0000-0002-2385-5840; Di Domenico, Alberto/0000-0002-9962-2891; Palumbo, Rocco/0000-0002-2385-5840; Di Domenico, Alberto/0000-0002-9962-2891; Palumbo, Rocco/0000-0002-2385-5840; Tommasi, Luca/0000-0003-0664-714X; PENOLAZZI, Barbara/0000-0001-8717-6233	Commission of the European Communities [28806]	Commission of the European Communities(European Commission)	This research is part of the project EDCBNL (Evolution and Development of Cognitive, Behavioural and Neural Lateralization, 2006-2009) supported by the Commission of the European Communities within the framework of the specific research and technological development program 'Integrating and strengthening the European Research Area' initiative 'What it means to be human' through a financial grant to Luca Tommasi, grant number 28806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiero P., 2006, TPM, V13, P107; Arzy S, 2006, J NEUROSCI, V26, P8074, DOI 10.1523/JNEUROSCI.0745-06.2006; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Avenanti A, 2006, NEUROIMAGE, V32, P316, DOI 10.1016/j.neuroimage.2006.03.010; Avenanti A, 2009, NEUROIMAGE, V44, P275, DOI 10.1016/j.neuroimage.2008.08.001; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Blanke O, 2005, J NEUROSCI, V25, P550, DOI 10.1523/JNEUROSCI.2612-04.2005; Blanke O, 2010, BRAIN TOPOGR, V23, P321, DOI 10.1007/s10548-010-0138-x; Bufalari I, 2007, CEREB CORTEX, V17, P2553, DOI 10.1093/cercor/bhl161; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng YW, 2006, NEUROREPORT, V17, P1115, DOI 10.1097/01.wnr.0000223393.59328.21; Cheng YW, 2007, NEUROREPORT, V18, P887, DOI 10.1097/WNR.0b013e3280ebb486; Cheng YW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002113; Costantini M, 2008, EUR J NEUROSCI, V28, P1222, DOI 10.1111/j.1460-9568.2008.06406.x; Dabbs JM, 1998, EVOL HUM BEHAV, V19, P89, DOI 10.1016/S1090-5138(97)00107-4; Davis M., 1996, EMPATHY SOCIAL PSYCH; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85, DOI DOI 10.1037/0022-3514.44.1.113; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Derntl B, 2010, PSYCHONEUROENDOCRINO, V35, P67, DOI 10.1016/j.psyneuen.2009.10.006; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Fukushima H, 2006, SOC COGN AFFECT NEUR, V1, P149, DOI 10.1093/scan/nsl020; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallese V, 2001, J CONSCIOUSNESS STUD, V8, P33; Gardner MR, 2010, BRAIN COGNITION, V73, P35, DOI 10.1016/j.bandc.2010.02.002; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hamilton AFD, 2009, COGNITION, V113, P37, DOI 10.1016/j.cognition.2009.07.007; Han SH, 2008, BRAIN RES, V1196, P85, DOI 10.1016/j.brainres.2007.12.062; Harenski CL, 2008, SOC COGN AFFECT NEUR, V3, P313, DOI 10.1093/scan/nsn026; HOFFMAN ML, 1977, PSYCHOL BULL, V84, P712, DOI 10.1037/0033-2909.84.4.712; Hooker CI, 2008, SOC COGN AFFECT NEUR, V3, P204, DOI 10.1093/scan/nsn019; Hooker CI, 2010, BRAIN RES, V1308, P100, DOI 10.1016/j.brainres.2009.10.006; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Ionta S, 2009, EXP BRAIN RES, V195, P207, DOI 10.1007/s00221-009-1770-0; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; Kaiser S, 2008, NEUROPSYCHOLOGIA, V46, P2524, DOI 10.1016/j.neuropsychologia.2008.04.013; Langdon R, 2001, COGNITION, V82, P1, DOI 10.1016/S0010-0277(01)00139-1; LAWTON CA, 1994, SEX ROLES, V30, P765, DOI 10.1007/BF01544230; Leiberg S, 2006, PROG BRAIN RES, V156, P419, DOI 10.1016/S0079-6123(06)56023-6; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Lewis JW, 2006, J COGNITIVE NEUROSCI, V18, P1314, DOI 10.1162/jocn.2006.18.8.1314; LUNDQVIST LO, 1995, SCAND J PSYCHOL, V36, P130, DOI 10.1111/j.1467-9450.1995.tb00974.x; Marzoli D, 2011, BRAIN COGNITION, V75, P51, DOI 10.1016/j.bandc.2010.10.002; Mehrabian A, 1997, AGGRESSIVE BEHAV, V23, P433, DOI 10.1002/(SICI)1098-2337(1997)23:6<433::AID-AB3>3.0.CO;2-H; Meneghini AM, 2006, RICERCHE PSICOLOGIA, V29, P123; Minio-Paluello I, 2006, SOC NEUROSCI, V1, P320, DOI 10.1080/17470910601035954; Minio-Paluello I, 2009, BIOL PSYCHIAT, V65, P55, DOI 10.1016/j.biopsych.2008.08.006; Mohr C, 2010, BRIT J PSYCHOL, V101, P277, DOI 10.1348/000712609X457450; Nummenmaa L, 2008, NEUROIMAGE, V43, P571, DOI 10.1016/j.neuroimage.2008.08.014; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, J EXP PSYCHOL GEN, V116, P172, DOI 10.1037/0096-3445.116.2.172; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; Pelgrims B, 2009, CEREB CORTEX, V19, P2298, DOI 10.1093/cercor/bhn248; Pfeifer JH, 2008, NEUROIMAGE, V39, P2076, DOI 10.1016/j.neuroimage.2007.10.032; Proverbio AM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-56; Proverbio AM, 2009, NEUROPSYCHOLOGIA, V47, P2374, DOI 10.1016/j.neuropsychologia.2008.10.030; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; SALMASO D, 1985, CORTEX, V21, P533, DOI 10.1016/S0010-9452(58)80003-9; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Schaefer M, 2009, HUM BRAIN MAPP, V30, P2722, DOI 10.1002/hbm.20701; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Seurinck R, 2004, NEUROIMAGE, V23, P1440, DOI 10.1016/j.neuroimage.2004.08.010; Shimada S, 2010, NEUROPSYCHOLOGIA, V48, P1930, DOI 10.1016/j.neuropsychologia.2010.03.012; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Sirigu A, 2001, J COGNITIVE NEUROSCI, V13, P910, DOI 10.1162/089892901753165827; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Solodkin A, 2001, EUR J NEUROL, V8, P425, DOI 10.1046/j.1468-1331.2001.00242.x; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Sonnby-Borgstrom M, 2003, J NONVERBAL BEHAV, V27, P3, DOI 10.1023/A:1023608506243; Sonnby-Borgstrom M, 2008, SCAND J PSYCHOL, V49, P111, DOI 10.1111/j.1467-9450.2008.00626.x; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Thakkar KN, 2010, COGN NEUROPSYCHIATRY, V15, P477, DOI 10.1080/13546801003711350; Thakkar KN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005864; Wild B, 2003, PSYCHIAT RES-NEUROIM, V123, P17, DOI 10.1016/S0925-4927(03)00006-4; Willems RM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.039.2009; Yang CY, 2009, BRAIN RES, V1251, P176, DOI 10.1016/j.brainres.2008.11.062	84	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14595	10.1371/journal.pone.0014595	http://dx.doi.org/10.1371/journal.pone.0014595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JL	21298089	Green Submitted, gold, Green Published			2022-12-25	WOS:000286662800007
J	Dwivedi, P; Thompson, A; Xie, ZH; Kashleva, H; Ganguly, S; Mitchell, AP; Dongari-Bagtzoglou, A				Dwivedi, Prabhat; Thompson, Angela; Xie, Zhihong; Kashleva, Helena; Ganguly, Shantanu; Mitchell, Aaron P.; Dongari-Bagtzoglou, Anna			Role of Bcr1-Activated Genes Hwp1 and Hyr1 in Candida Albicans Oral Mucosal Biofilms and Neutrophil Evasion	PLOS ONE			English	Article							TRANSGLUTAMINASE SUBSTRATE; MODEL; MANIFESTATIONS; RESPONSES; ADHESIN; GOVERN; THRUSH; ALS3P	Candida albicans triggers recurrent infections of the oropharyngeal mucosa that result from biofilm growth. Prior studies have indicated that the transcription factor Bcr1 regulates biofilm formation in a catheter model, both in vitro and in vivo. We thus hypothesized that Bcr1 plays similar roles in the formation of oral mucosal biofilms and tested this hypothesis in a mouse model of oral infection. We found that a bcr1/bcr1 mutant did not form significant biofilm on the tongues of immunocompromised mice, in contrast to reference and reconstituted strains that formed pseudomembranes covering most of the tongue dorsal surface. Overexpression of HWP1, which specifies an epithelial adhesin that is under the transcriptional control of Bcr1, partly but significantly rescued the bcr1/bcr1 biofilm phenotype in vivo. Since HWP1 overexpression only partly reversed the biofilm phenotype, we investigated whether additional mechanisms, besides adhesin down-regulation, were responsible for the reduced virulence of this mutant. We discovered that the bcr1/bcr1 mutant was more susceptible to damage by human leukocytes when grown on plastic or on the surface of a human oral mucosa tissue analogue. Overexpression of HYR1, but not HWP1, significantly rescued this phenotype. Furthermore a hyr1/hyr1 mutant had significantly attenuated virulence in the mouse oral biofilm model of infection. These discoveries show that Bcr1 is critical for mucosal biofilm infection via regulation of epithelial cell adhesin and neutrophil function.	[Dwivedi, Prabhat] Univ Texas, Dept Microbiol, Houston, TX 77030 USA; [Thompson, Angela; Xie, Zhihong; Kashleva, Helena; Dongari-Bagtzoglou, Anna] Univ Connecticut, Sch Dent Med, Div Periodontol, Farmington, CT 06032 USA; [Ganguly, Shantanu; Mitchell, Aaron P.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	University of Texas System; University of Connecticut; Carnegie Mellon University	Dwivedi, P (corresponding author), Univ Texas, Dept Microbiol, Houston, TX 77030 USA.	adongari@uchc.edu	XIE, Zhihong/B-2968-2011	Mitchell, Aaron/0000-0002-0868-4000	National Institutes of Health [RO1DE013986, RO1DE013986-08S1, R01AI067703]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	These studies were supported by National Institutes of Health grants RO1DE013986, RO1DE013986-08S1 (ADB) and R01AI067703 (APM). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Blankenship JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000752; Brent NB, 2001, CLIN PEDIATR, V40, P503, DOI 10.1177/000992280104000905; Cheng SJ, 2003, MOL MICROBIOL, V48, P1275, DOI 10.1046/j.1365-2958.2003.03521.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Coogan M M, 2006, Adv Dent Res, V19, P130; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Deconinck S, 2003, BRIT J GEN PRACT, V53, P130; Dongari-Bagtzoglou A, 2005, MED MYCOL, V43, P545, DOI 10.1080/13693780500064557; Dongari-Bagtzoglou A, 2006, NAT PROTOC, V1, P2012, DOI 10.1038/nprot.2006.323; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Fonseca R, 2000, QUINTESSENCE INT, V31, P419; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Green CB, 2004, MICROBIOL-SGM, V150, P267, DOI 10.1099/mic.0.26699-0; Harriott MM, 2010, MICROBIOL-SGM, V156, P3635, DOI 10.1099/mic.0.039354-0; HOLMSTRUP P, 1990, ACTA ODONTOL SCAND, V48, P57, DOI 10.3109/00016359009012734; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; Luo G, 2010, J INFECT DIS, V201, P1718, DOI 10.1086/652407; Nett JE, 2010, INFECT IMMUN, V78, P3650, DOI 10.1128/IAI.00480-10; Nicolatou-Galitis O, 2001, J ORAL PATHOL MED, V30, P471, DOI 10.1034/j.1600-0714.2001.030008471.x; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Passalacqua G, 2000, ALLERGY, V55, P16, DOI 10.1034/j.1398-9995.2000.00370.x; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Richard ML, 2005, EUKARYOT CELL, V4, P1493, DOI 10.1128/EC.4.8.1493-1502.2005; Ricicova M, 2010, MICROBIOL-SGM, V156, P909, DOI 10.1099/mic.0.033530-0; Scaramuzzino DA, 2000, INFECT IMMUN, V68, P2880, DOI 10.1128/IAI.68.5.2880-2887.2000; Schaller M, 2004, MICROBIOL-SGM, V150, P2807, DOI 10.1099/mic.0.27169-0; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Sundstrom P, 2002, J INFECT DIS, V185, P521, DOI 10.1086/338836; THOMAS D, 2006, PROTEOMICS, V6, P1; Tsuchimori N, 2000, INFECT IMMUN, V68, P1997, DOI 10.1128/IAI.68.4.1997-2002.2000; Villar CC, 2004, ORAL MICROBIOL IMMUN, V19, P262, DOI 10.1111/j.1399-302X.2004.00150.x; Zhao X, 2006, MICROBIOL-SGM, V152, P2287, DOI 10.1099/mic.0.28959-0; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0	39	66	70	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16218	10.1371/journal.pone.0016218	http://dx.doi.org/10.1371/journal.pone.0016218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283544	gold, Green Published, Green Submitted			2022-12-25	WOS:000286661400035
J	Waller, RG; Scanlon, KM; Robinson, LF				Waller, Rhian G.; Scanlon, Kathryn M.; Robinson, Laura F.			Cold-Water Coral Distributions in the Drake Passage Area from Towed Camera Observations - Initial Interpretations	PLOS ONE			English	Article							BIOLOGY; DEEP; REGION; REEFS	Seamounts are unique deep-sea features that create habitats thought to have high levels of endemic fauna, productive fisheries and benthic communities vulnerable to anthropogenic impacts. Many seamounts are isolated features, occurring in the high seas, where access is limited and thus biological data scarce. There are numerous seamounts within the Drake Passage (Southern Ocean), yet high winds, frequent storms and strong currents make seafloor sampling particularly difficult. As a result, few attempts to collect biological data have been made, leading to a paucity of information on benthic habitats or fauna in this area, particularly those on primarily hard-bottom seamounts and ridges. During a research cruise in 2008 six locations were examined (two on the Antarctic margin, one on the Shackleton Fracture Zone, and three on seamounts within the Drake Passage), using a towed camera with onboard instruments to measure conductivity, temperature, depth and turbidity. Dominant fauna and bottom type were categorized from 200 randomized photos from each location. Cold-water corals were present in high numbers in habitats both on the Antarctic margin and on the current swept seamounts of the Drake Passage, though the diversity of orders varied. Though the Scleractinia (hard corals) were abundant on the sedimented margin, they were poorly represented in the primarily hard-bottom areas of the central Drake Passage. The two seamount sites and the Shackleton Fracture Zone showed high numbers of stylasterid (lace) and alcyonacean (soft) corals, as well as large numbers of sponges. Though data are preliminary, the geological and environmental variability (particularly in temperature) between sample sites may be influencing cold-water coral biogeography in this region. Each area observed also showed little similarity in faunal diversity with other sites examined for this study within all phyla counted. This manuscript highlights how little is understood of these isolated features, particularly in Polar regions.	[Waller, Rhian G.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Scanlon, Kathryn M.] US Geol Survey, Woods Hole, MA 02543 USA; [Robinson, Laura F.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA	University of Hawaii System; University of Hawaii Manoa; United States Department of the Interior; United States Geological Survey; Woods Hole Oceanographic Institution	Waller, RG (corresponding author), Univ Maine, Darling Marine Ctr, Sch Marine Sci, Walpole, ME 04573 USA.	rhian.waller@maine.edu		Robinson, Laura/0000-0001-6811-0140	National Science Foundation [ANT0636787]; CenSeam; University of Hawaii at Manoa; Office of Polar Programs (OPP) [1127582] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); CenSeam; University of Hawaii at Manoa; Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by the National Science Foundation's Antarctic Earth Sciences Program (ANT0636787 awarded to LFR and RGW) and a CenSeam minigrant (awarded to RGW), and RGW is supported by a SOEST Young Investigator Fellowship from the University of Hawaii at Manoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker PF, 2004, EARTH-SCI REV, V66, P143, DOI 10.1016/j.earscirev.2003.10.003; CAIRNS SD, 1990, SYNOPSIS ANTARCTIC B, V1; Cairns Stephen D., 1992, Scientia Marina, V56, P125; Clarke A, 2005, TRENDS ECOL EVOL, V20, P1, DOI 10.1016/j.tree.2004.10.004; CLARKE A, 1989, GEOLOGICAL SOC SPECI, V47, P253; Cook SE, 2008, MAR ENVIRON RES, V66, pS80, DOI 10.1016/j.marenvres.2008.09.002; Daniel J., 2003, EOS T AM GEOPHYS UN, V84, P69, DOI [DOI 10.1029/2003E0080001, 10.1029/2003EO080001, DOI 10.1029/2003EO080001]; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; GRIGG RW, 1984, PSZNI MAR ECOL, V5, P57, DOI 10.1111/j.1439-0485.1984.tb00307.x; Haussermann V, 2007, POLAR BIOL, V30, P487, DOI 10.1007/s00300-006-0207-5; HEIFETZ J, 2007, DEEP SEA CORAL DISTR; Huber Brian T., 1992, Antarctic Research Series, V56, P31; Kleypas J., 2006, IMPACTS OCEAN ACIDIF; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Lipps J., 1982, ENV DEEP SEA, P324; Livermore R, 2005, EARTH PLANET SC LETT, V236, P459, DOI 10.1016/j.epsl.2005.03.027; MacIntyre I.G., 2000, ATOLL RES BULL, V466, P1; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; ROGERS AD, 2007, SEAMOUNTS ECOLOGY FI, P141; Rutzler K., 2002, Acta Geologica Hispanica, V37, P61; Stocks K. I., 2007, SEAMOUNTS ECOLOGY FI, P255; STOCKS KI, 2004, P COL OC DAT S BRUSS, P77; Thomson MRA, 2004, DEEP-SEA RES PT II, V51, P1467, DOI 10.1016/j.dsr2.2004.06.021; Wilson RR, 1987, GEOPHYS MONOGR SER, P355, DOI DOI 10.1029/GM043P0355	26	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16153	10.1371/journal.pone.0016153	http://dx.doi.org/10.1371/journal.pone.0016153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283585	gold, Green Published, Green Submitted			2022-12-25	WOS:000286661400030
J	Ho, MCW; Schiller, BJ; Akbari, OS; Bae, E; Drewell, RA				Ho, Margaret C. W.; Schiller, Benjamin J.; Akbari, Omar S.; Bae, Esther; Drewell, Robert A.			Disruption of the Abdominal-B Promoter Tethering Element Results in a Loss of Long-Range Enhancer-Directed Hox Gene Expression in Drosophila	PLOS ONE			English	Article							BITHORAX-COMPLEX; ANTENNAPEDIA COMPLEX; REGULATORY LANDSCAPE; MELANOGASTER; BOUNDARIES; EMBRYO; REGION; DOMAIN; LOCUS; DNA	There are many examples within gene complexes of transcriptional enhancers interacting with only a subset of target promoters. A number of molecular mechanisms including promoter competition, insulators and chromatin looping are thought to play a role in regulating these interactions. At the Drosophila bithorax complex (BX-C), the IAB5 enhancer specifically drives gene expression only from the Abdominal-B (Abd-B) promoter, even though the enhancer and promoter are 55 kb apart and are separated by at least three insulators. In previous studies, we discovered that a 255 bp cis-regulatory module, the promoter tethering element (PTE), located 59 of the Abd-B transcriptional start site is able to tether IAB5 to the Abd-B promoter in transgenic embryo assays. In this study we examine the functional role of the PTE at the endogenous BX-C using transposon-mediated mutagenesis. Disruption of the PTE by P element insertion results in a loss of enhancer-directed Abd-B expression during embryonic development and a homeotic transformation of abdominal segments. A partial deletion of the PTE and neighboring upstream genomic sequences by imprecise excision of the P element also results in a similar loss of Abd-B expression in embryos. These results demonstrate that the PTE is an essential component of the regulatory network at the BX-C and is required in vivo to mediate specific long-range enhancer-promoter interactions.	[Ho, Margaret C. W.; Schiller, Benjamin J.; Akbari, Omar S.; Drewell, Robert A.] Harvey Mudd Coll, Dept Biol, Claremont, CA 91711 USA; [Bae, Esther] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA	Claremont Colleges; Harvey Mudd College; Western University of Health Sciences	Ho, MCW (corresponding author), Harvey Mudd Coll, Dept Biol, Claremont, CA 91711 USA.	drewell@hmc.edu		Akbari, Omar/0000-0002-6853-9884; Ho, Margaret/0000-0002-2007-2226	National Institutes of Health [NIH-HD54977]; National Science Foundation [IOS-0845103]; Howard Hughes Medical Institute [520051213]; Merck-American Association for the Advancement of Science (AAAS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD054977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Merck-American Association for the Advancement of Science (AAAS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The research in this paper was supported by funding to R.A.D. from the National Institutes of Health (NIH-HD54977) and the National Science Foundation (IOS-0845103) and a Howard Hughes Medical Institute Undergraduate Science Education Program grant (520051213) to the Biology department at Harvey Mudd College. M.C.W.H. received support from the Merck-American Association for the Advancement of Science (AAAS) Undergraduate Science Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari OS, 2007, FLY, V1, P337, DOI 10.4161/fly.5607; Akbari OS, 2008, DEVELOPMENT, V135, P123, DOI 10.1242/dev.010744; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; BOULET AM, 1991, DEVELOPMENT, V111, P393; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Calhoun VC, 2003, P NATL ACAD SCI USA, V100, P9878, DOI 10.1073/pnas.1233791100; Calhoun VC, 2002, P NATL ACAD SCI USA, V99, P9243, DOI 10.1073/pnas.142291299; Cande JD, 2009, DEVELOPMENT, V136, P3153, DOI 10.1242/dev.038034; CAPLAN AI, 1978, SCIENCE, V201, P120, DOI 10.1126/science.351805; CASANOVA J, 1986, CELL, V47, P627, DOI 10.1016/0092-8674(86)90627-6; Celniker SE, 2007, BIOESSAYS, V29, P7, DOI 10.1002/bies.20520; Chopra VS, 2009, GENE DEV, V23, P1505, DOI 10.1101/gad.1807309; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; de Navas L, 2006, MECH DEVELOP, V123, P860, DOI 10.1016/j.mod.2006.07.010; DELORENZI M, 1990, DEVELOPMENT, V108, P323; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; Estrada B, 2002, DEVELOPMENT, V129, P5195; Fujioka M, 2009, DEVELOPMENT, V136, P3077, DOI 10.1242/dev.036467; GYURKOVICS H, 1990, EMBO J, V9, P2579, DOI 10.1002/j.1460-2075.1990.tb07439.x; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Ho MCW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000709; KARCH F, 1994, NUCLEIC ACIDS RES, V22, P3138, DOI 10.1093/nar/22.15.3138; KARCH F, 1985, CELL, V43, P81, DOI 10.1016/0092-8674(85)90014-5; Kellum R, 1998, CURR BIOL, V8, pR521, DOI 10.1016/S0960-9822(07)00337-5; Kwon D, 2009, DEVELOPMENT, V136, P3067, DOI 10.1242/dev.036426; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lin O, 2003, DEVELOPMENT, V130, P519, DOI 10.1242/dev.00227; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3237, DOI 10.1073/pnas.0605730104; MACIAS A, 1990, DEVELOPMENT, V110, P1197; MARTIN CH, 1995, P NATL ACAD SCI USA, V92, P8398, DOI 10.1073/pnas.92.18.8398; MASTRANGELO IA, 1991, P NATL ACAD SCI USA, V88, P5670, DOI 10.1073/pnas.88.13.5670; Mihaly J, 1998, CELL MOL LIFE SCI, V54, P60, DOI 10.1007/s000180050125; Mihaly J, 2006, DEVELOPMENT, V133, P2983, DOI 10.1242/dev.02451; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; Perez-Lluch S, 2008, NUCLEIC ACIDS RES, V36, P6926, DOI 10.1093/nar/gkn818; Ronshaugen M, 2004, DEV CELL, V7, P925, DOI 10.1016/j.devcel.2004.11.001; SANCHEZHERRERO E, 1988, EMBO J, V7, P2163, DOI 10.1002/j.1460-2075.1988.tb03055.x; Sipos L, 2005, FEBS J, V272, P3253, DOI 10.1111/j.1742-4658.2005.04757.x; Sipos L, 1998, GENETICS, V149, P1031; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; ZELLER RW, 1995, P NATL ACAD SCI USA, V92, P2989, DOI 10.1073/pnas.92.7.2989; Zhou JM, 1999, DEVELOPMENT, V126, P3057	48	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16283	10.1371/journal.pone.0016283	http://dx.doi.org/10.1371/journal.pone.0016283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283702	Green Submitted, gold, Green Published			2022-12-25	WOS:000286522300030
J	Tang, CSM; Tang, WK; So, MT; Miao, XP; Leung, BMC; Yip, BHK; Leon, TYY; Ngan, ESW; Lui, VCH; Chen, Y; Chan, IHY; Chung, PHY; Liu, XL; Wu, XZ; Wong, KKY; Sham, PC; Cherny, SS; Tam, PKH; Garcia-Barcelo, MM				Tang, Clara Sze-Man; Tang, Wai-Kiu; So, Man-Ting; Miao, Xiao-Ping; Leung, Brian Man-Chun; Yip, Benjamin Hon-Kei; Leon, Thomas Yuk-Yu; Ngan, Elly Sau-Wai; Lui, Vincent Chi-Hang; Chen, Yan; Chan, Ivy Hau-Yee; Chung, Patrick Ho-Yu; Liu, Xue-Lai; Wu, Xuan-Zhao; Wong, Kenneth Kak-Yuen; Sham, Pak-Chung; Cherny, Stacey S.; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce			Fine Mapping of the NRG1 Hirschsprung's Disease Locus	PLOS ONE			English	Article							RET PROTOONCOGENE; NERVOUS-SYSTEM; MUTATIONS; GENE; NEUREGULIN-1; EXPRESSION; SCHIZOPHRENIA; ASSOCIATION; MAINTENANCE; COMMON	The primary pathology of Hirschsprung's disease (HSCR, colon aganglionosis) is the absence of ganglia in variable lengths of the hindgut, resulting in functional obstruction. HSCR is attributed to a failure of migration of the enteric ganglion precursors along the developing gut. RET is a key regulator of the development of the enteric nervous system (ENS) and the major HSCR-causing gene. Yet the reduced penetrance of RET DNA HSCR-associated variants together with the phenotypic variability suggest the involvement of additional genes in the disease. Through a genome-wide association study, we uncovered a similar to 350 kb HSCR-associated region encompassing part of the neuregulin-1 gene (NRG1). To identify the causal NRG1 variants contributing to HSCR, we genotyped 243 SNPs variants on 343 ethnic Chinese HSCR patients and 359 controls. Genotype analysis coupled with imputation narrowed down the HSCR-associated region to 21 kb, with four of the most associated SNPs (rs10088313, rs10094655, rs4624987, and rs3884552) mapping to the NRG1 promoter. We investigated whether there was correlation between the genotype at the rs10088313 locus and the amount of NRG1 expressed in human gut tissues (40 patients and 21 controls) and found differences in expression as a function of genotype. We also found significant differences in NRG1 expression levels between diseased and control individuals bearing the same rs10088313 risk genotype. This indicates that the effects of NRG1 common variants are likely to depend on other alleles or epigenetic factors present in the patients and would account for the variability in the genetic predisposition to HSCR.	[Tang, Clara Sze-Man; Yip, Benjamin Hon-Kei; Sham, Pak-Chung; Cherny, Stacey S.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Tang, Clara Sze-Man; Tang, Wai-Kiu; So, Man-Ting; Leung, Brian Man-Chun; Yip, Benjamin Hon-Kei; Leon, Thomas Yuk-Yu; Ngan, Elly Sau-Wai; Lui, Vincent Chi-Hang; Chen, Yan; Chan, Ivy Hau-Yee; Chung, Patrick Ho-Yu; Liu, Xue-Lai; Wong, Kenneth Kak-Yuen; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak-Chung] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Ngan, Elly Sau-Wai; Lui, Vincent Chi-Hang; Sham, Pak-Chung; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Wu, Xuan-Zhao] Guiyang Med Coll Affiliated Hosp, Dept Surg, Guiyang, Peoples R China; [Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat,Minist Educ Key Lab Envi, Wuhan 430074, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Guizhou Medical University; Huazhong University of Science & Technology	Tang, CSM (corresponding author), Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	cherny@hku.hk; mmgarcia@hku.hk	Yip, Benjamin/AAC-7845-2019; Chen, Yan/C-4228-2009; Wong, Kenneth K. Y./B-9920-2008; YIP, Benjamin HK/I-2336-2013; Chen, Yan/N-7489-2019; Ngan, Elly/N-1543-2019; Cherny, Stacey S/B-3315-2008; miao, xiaoping/C-4336-2011; /C-4405-2009; /C-4359-2009	Yip, Benjamin/0000-0002-4749-7611; Chen, Yan/0000-0002-2354-230X; Chen, Yan/0000-0002-2354-230X; Ngan, Elly/0000-0002-0022-7999; Cherny, Stacey S/0000-0002-0269-3352; miao, xiaoping/0000-0002-6818-9722; /0000-0001-6231-3035; /0000-0002-1758-8854; CHUNG, Patrick Ho Yu/0000-0003-2382-5681; Tang, Clara/0000-0003-0265-2638	Hong Kong Research Grants Council [HKU 765609M]; University of Hong Kong [200911159071, 200811159006]; University of Hong Kong Genomics Strategic Research Theme	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong); University of Hong Kong Genomics Strategic Research Theme	This work was supported by research grants from the Hong Kong Research Grants Council HKU 765609M to MGB and from The University of Hong Kong Seed Funding 200911159071 and 200811159006 to PT and MGB respectively. Support was also obtained from The University of Hong Kong Genomics Strategic Research Theme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; Ao SI, 2005, BIOINFORMATICS, V21, P1735, DOI 10.1093/bioinformatics/bti201; Britsch S, 2007, V190; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Brooks AS, 2005, AM J HUM GENET, V77, P120, DOI 10.1086/431244; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Chen SZ, 2003, NAT NEUROSCI, V6, P1186, DOI 10.1038/nn1139; Crone SA, 2003, NEURON, V37, P29, DOI 10.1016/S0896-6273(02)01128-5; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P526, DOI 10.1111/j.1469-1809.2007.00347.x; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Hofstra RMW, 2000, HUM MUTAT, V15, P418, DOI 10.1002/(SICI)1098-1004(200005)15:5<418::AID-HUMU3>3.0.CO;2-2; Hofstra RMW, 1999, AM J HUM GENET, V64, P304, DOI 10.1086/302184; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Paratore C, 2002, HUM MOL GENET, V11, P3075, DOI 10.1093/hmg/11.24.3075; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; TANG CS, 2010, HUM GENET; Torfs C., 1998, EPIDEMIOLOGICAL STUD; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012	31	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16181	10.1371/journal.pone.0016181	http://dx.doi.org/10.1371/journal.pone.0016181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283760	Green Published, gold			2022-12-25	WOS:000286522200033
J	Paradise, RK; Lauffenburger, DA; Van Vliet, KJ				Paradise, Ranjani K.; Lauffenburger, Douglas A.; Van Vliet, Krystyn J.			Acidic Extracellular pH Promotes Activation of Integrin alpha(v)beta(3)	PLOS ONE			English	Article							CELL-MIGRATION SPEED; HUMAN-MELANOMA CELLS; CONFORMATIONAL FLEXIBILITY; LIGAND RECOGNITION; INTRACELLULAR PH; INTERSTITIAL PH; BINDING-SITES; OUTSIDE-IN; III DOMAIN; ADHESION	Acidic extracellular pH is characteristic of the cell microenvironment in several important physiological and pathological contexts. Although it is well established that acidic extracellular pH can have profound effects on processes such as cell adhesion and migration, the underlying molecular mechanisms are largely unknown. Integrin receptors physically connect cells to the extracellular matrix, and are thus likely to modulate cell responses to extracellular conditions. Here, we examine the role of acidic extracellular pH in regulating activation of integrin alpha(v)beta(3). Through computational molecular dynamics simulations, we find that acidic extracellular pH promotes opening of the alpha(v)beta(3) headpiece, indicating that acidic pH can thereby facilitate integrin activation. This prediction is consistent with our flow cytometry and atomic force microscope-mediated force spectroscopy assays of integrin alpha(v)beta(3) on live cells, which both demonstrate that acidic pH promotes activation at the intact cell surface. Finally, quantification of cell morphology and migration measurements shows that acidic extracellular pH affects cell behavior in a manner that is consistent with increased integrin activation. Taken together, these computational and experimental results suggest a new and complementary mechanism of integrin activation regulation, with associated implications for cell adhesion and migration in regions of altered pH that are relevant to wound healing and cancer.	[Paradise, Ranjani K.; Lauffenburger, Douglas A.; Van Vliet, Krystyn J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Van Vliet, Krystyn J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Paradise, RK (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	krystyn@mit.edu			National Institute of Biomedical Imaging and Bioengineering [T32EB006348]; MIT; NIH [U54-GM069668]; NSF; Singapore-MIT Alliance for Research & Technology (SMART) Biosystems & Micromechanics (BioSyM) Interdisciplinary Research Group; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069668] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); MIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Singapore-MIT Alliance for Research & Technology (SMART) Biosystems & Micromechanics (BioSyM) Interdisciplinary Research Group; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by Award Number T32EB006348 from the National Institute of Biomedical Imaging and Bioengineering and the MIT Collamore-Rogers Fellowship (RKP), the NIH Cell Migration Consortium Grant U54-GM069668 (DAL and RKP), the NSF CAREER Award (KJVV and RKP), and the Singapore-MIT Alliance for Research & Technology (SMART) Biosystems & Micromechanics (BioSyM) Interdisciplinary Research Group (KJVV and RKP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexov EG, 1997, BIOPHYS J, V72, P2075, DOI 10.1016/S0006-3495(97)78851-9; BAJT ML, 1994, J BIOL CHEM, V269, P20913; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; DICKINSON RB, 1993, AICHE J; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Dunn G A, 1983, Agents Actions Suppl, V12, P14; Faff L, 2000, BRAIN RES, V853, P22, DOI 10.1016/S0006-8993(99)02221-0; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; GRINSTEIN S, 1993, EMBO J, V12, P5209, DOI 10.1002/j.1460-2075.1993.tb06216.x; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Harms BD, 2005, BIOPHYS J, V88, P1479, DOI 10.1529/biophysj.104.047365; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KATO Y, 1992, J BIOL CHEM, V267, P11424; Koide A, 2001, BIOCHEMISTRY-US, V40, P10326, DOI 10.1021/bi010916y; Krishnan R, 2009, J MOL MODEL, V15, P1383, DOI 10.1007/s00894-009-0504-3; Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; Mallik B, 2008, BIOTECHNOL PROGR, V24, P48, DOI 10.1021/bp0700915; MARTIN GR, 1994, CANCER RES, V54, P5670; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mould AP, 2003, J BIOL CHEM, V278, P51622, DOI 10.1074/jbc.M306655200; Mould AP, 2004, CURR OPIN CELL BIOL, V16, P544, DOI 10.1016/j.ceb.2004.07.003; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; Palecek SP, 1998, J CELL SCI, V111, P929; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Serrano CV, 1996, AM J PHYSIOL-CELL PH, V271, pC962, DOI 10.1152/ajpcell.1996.271.3.C962; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Stock C, 2007, CELL PHYSIOL BIOCHEM, V20, P679, DOI 10.1159/000107550; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tan J, 2005, BIOMATERIALS, V26, P3663, DOI 10.1016/j.biomaterials.2004.09.053; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhang XH, 2004, BIOPHYS J, V87, P3470, DOI 10.1529/biophysj.104.045690	58	93	95	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15746	10.1371/journal.pone.0015746	http://dx.doi.org/10.1371/journal.pone.0015746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283814	Green Published, gold, Green Submitted			2022-12-25	WOS:000286520600010
J	Miller, G; Matthews, SP; Reinheckel, T; Fleming, S; Watts, C				Miller, Gail; Matthews, Stephen P.; Reinheckel, Thomas; Fleming, Stewart; Watts, Colin			Asparagine endopeptidase is required for normal kidney physiology and homeostasis	FASEB JOURNAL			English	Article						legumain; lysosome; proteolysis; kidney proximal tubule; EGF receptor	GROWTH-FACTOR RECEPTOR; CATHEPSIN-L; ANTIGEN PRESENTATION; LYSOSOMAL CYSTEINE; MAMMALIAN LEGUMAIN; DEGRADATION; PROLIFERATION; PROGELATINASE; ACTIVATION; EXPRESSION	Although protein recapture and catabolism is known as a key function of kidney proximal tubular cells (PTCs), to date, no single protease has been shown to be required. Asparagine endopeptidase (AEP) is an unusually specific endosomal and lysosomal cysteine protease, expressed at high levels in the PTCs of the mammalian kidney. We report that mice lacking AEP accumulate a discrete set of proteins in their PTC endosomes and lysosomes, which indicates a defect in the normal catabolism of proteins captured from the filtrate. Moreover, the mice develop progressive kidney pathology, including hyperplasia of PTCs, interstitial fibrosis, development of glomerular cysts, and renal pelvis dilation. By 6 mo of age, the glomerular filtration rate in AEP-null mice dropped by almost a factor of 2, and the mice developed proteinuria. We also show that EGF receptor levels are significantly higher in AEP-null PTCs, which likely explains the hyperplasia, and we show that chemical inhibition of AEP activity suppresses down-regulation of the EGF receptor in vitro. Thus, AEP is required for normal protein catabolism by PTCs, and its loss induces proliferative and other abnormalities in the murine kidney, at least in part through defective regulation of the EGF receptor.-Miller, G., Matthews, S. P., Reinheckel, R., Fleming, S., Watts, C. Asparagine endopeptidase is required for normal kidney physiology and homeostasis. FASEB J. 25, 1606-1617 (2011). www.fasebj.org	[Miller, Gail; Matthews, Stephen P.; Watts, Colin] Univ Dundee, Coll Life Sci, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland; [Fleming, Stewart] Univ Dundee, Ninewells Hosp, Dept Mol Pathol, Dundee DD1 5EH, Scotland; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Zellforsch, Freiburg, Germany	University of Dundee; University of Dundee; University of Freiburg	Watts, C (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland.	c.watts@dundee.ac.uk	Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Watts, Colin/0000-0001-6183-2087; Matthews, Stephen/0000-0003-3556-962X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank Kathe Young, Calum Thomson, and John James for performing immunohistochemistry, histology staining, and electron microscopy. The authors thank Alan Prescott and John Lucocq for assistance and advice on fluorescence and electron microscopy. The authors thank Kenneth Beattie and Douglas Lamont for peptide mass fingerprinting and Doreen Keane and Keith Burling (Core Biochemical Assay Laboratory, Addenbrooke's Hospital, Cambridge, UK) for technical assistance. This work was supported by a Wellcome Trust program grant to C. W.	Antoniou AN, 2000, IMMUNITY, V12, P391, DOI 10.1016/S1074-7613(00)80191-0; Chan CB, 2009, P NATL ACAD SCI USA, V106, P468, DOI 10.1073/pnas.0809824105; Chen JM, 2001, BIOL CHEM, V382, P777, DOI 10.1515/BC.2001.093; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Costantino CM, 2008, J IMMUNOL, V180, P2876, DOI 10.4049/jimmunol.180.5.2876; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Kawashima A, 1998, KIDNEY INT, V54, P275, DOI 10.1046/j.1523-1755.1998.00958.x; Khoudoli G.A., 2004, PROTEOME SCI, V2, P6, DOI DOI 10.1186/1477-5956-2-6; KOLDOVSKY O, 1971, BIOCHEM J, V125, P697, DOI 10.1042/bj1250697; Liu C, 2003, CANCER RES, V63, P2957; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Loak K, 2003, BIOL CHEM, V384, P1239, DOI 10.1515/BC.2003.136; Maehr R, 2005, J IMMUNOL, V174, P7066, DOI 10.4049/jimmunol.174.11.7066; Manoury B, 2003, IMMUNITY, V18, P489, DOI 10.1016/S1074-7613(03)00085-2; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Matthews SP, 2010, J IMMUNOL, V184, P2423, DOI 10.4049/jimmunol.0901486; Mattock KL, 2010, ATHEROSCLEROSIS, V208, P83, DOI 10.1016/j.atherosclerosis.2009.07.022; Moch H, 1997, HUM PATHOL, V28, P1255; Morita Y, 2007, FEBS LETT, V581, P1417, DOI 10.1016/j.febslet.2007.02.064; Moss CX, 2007, EMBO J, V26, P2137, DOI 10.1038/sj.emboj.7601660; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Patel N, 2009, J CLIN INVEST, V119, P1964, DOI 10.1172/JCI37977; Reinheckel T, 2005, J CELL SCI, V118, P3387, DOI 10.1242/jcs.02469; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Sarandeses CS, 2003, J BIOL CHEM, V278, P13286, DOI 10.1074/jbc.M213005200; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; STOCKLIN E, 1993, J CELL BIOL, V122, P199, DOI 10.1083/jcb.122.1.199; Tagboto S, 2007, BMC CLIN PATHOL, V7, DOI 10.1186/1472-6890-7-5; Terzi F, 2000, J CLIN INVEST, V106, P225, DOI 10.1172/JCI8315; TERZI F, 2007, DRUG DISC TODAY DIS, V4, P47; Thomasson M, 2003, BRIT J CANCER, V89, P1285, DOI 10.1038/sj.bjc.6601208; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Watts C, 2005, IMMUNOL REV, V207, P218, DOI 10.1111/j.0105-2896.2005.00312.x; Watts C, 2003, BIOCHEM SOC SYMP, V70, P31, DOI 10.1042/bss0700031; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119	41	53	55	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1606	1617		10.1096/fj.10-172312	http://dx.doi.org/10.1096/fj.10-172312			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21292981				2022-12-25	WOS:000290023800018
J	Bacik, JP; Whitworth, GE; Stubbs, KA; Yadav, AK; Martin, DR; Bailey-Elkin, BA; Vocadlo, DJ; Mark, BL				Bacik, John-Paul; Whitworth, Garrett E.; Stubbs, Keith A.; Yadav, Anuj K.; Martin, Dylan R.; Bailey-Elkin, Ben A.; Vocadlo, David J.; Mark, Brian L.			Molecular Basis of 1,6-Anhydro Bond Cleavage and Phosphoryl Transfer by Pseudomonas aeruginosa 1,6-Anhydro-N-acetylmuramic Acid Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; LEVOGLUCOSAN KINASE; ASPERGILLUS-NIGER; PROVIDES INSIGHT; MUREIN; IDENTIFICATION; MECHANISM	Anhydro-N-acetylmuramic acid kinase (AnmK) catalyzes the ATP-dependent conversion of the Gram-negative peptidoglycan (PG) recycling intermediate 1,6-anhydro-N-acetylmuramic acid (anhMurNAc) to N-acetylmuramic acid-6-phosphate (MurNAc-6-P). Here we present crystal structures of Pseudomonas aeruginosa AnmK in complex with its natural substrate, anhMurNAc, and a product of the reaction, ADP. AnmK is homodimeric, with each subunit comprised of two subdomains that are separated by a deep active site cleft, which bears similarity to the ATPase core of proteins belonging to the hexokinase-hsp70-actin superfamily of proteins. The conversion of anhMurNAc to MurNAc-6-P involves both cleavage of the 1,6-anhydro ring of anhMurNAc along with addition of a phosphoryl group to O6 of the sugar, and thus represents an unusual enzymatic mechanism involving the formal addition of H3PO4 to anhMurNAc. The structural complexes and NMR analysis of the reaction suggest that a water molecule, activated by Asp-182, attacks the anomeric carbon of anhMurNAc, aiding cleavage of the 1,6-anhydro bond and facilitating the capture of the gamma phosphate of ATP by O6 via an in-line phosphoryl transfer. AnmK is active only against anhMurNAc and not the metabolically related 1,6-anhydro-N-acetylmuramyl peptides, suggesting that the cytosolic N-acetyl-anhydromuramyl-L-alanine amidase AmpD must first remove the stem peptide from these PG muropeptide catabolites before anhMurNAc can be acted upon by AnmK. Our studies provide the foundation for a mechanistic model for the dual activities of AnmK as a hydrolase and a kinase of an unusual heterocyclic monosaccharide.	[Bacik, John-Paul; Martin, Dylan R.; Bailey-Elkin, Ben A.; Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Whitworth, Garrett E.; Stubbs, Keith A.; Yadav, Anuj K.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Stubbs, Keith A.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Dept Chem M313, Crawley, WA 6009, Australia	University of Manitoba; Simon Fraser University; University of Western Australia	Mark, BL (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	brian_mark@umanitoba.ca	Stubbs, Keith/H-5909-2014; Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Mark, Brian/0000-0002-7344-1355; Bacik, John-Paul/0000-0001-9315-5332; Stubbs, Keith/0000-0001-6899-402X	Canadian Institutes of Health Research; Canadian Cystic Fibrosis Foundation; Manitoba Health Research Council (MHRC); NSERC; National Research Council; University of Saskatchewan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation; Manitoba Health Research Council (MHRC); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council; University of Saskatchewan	This work was funded by Canadian Institutes of Health Research and Canadian Cystic Fibrosis Foundation Grants (to B. L. M. and D. J. V.).; Supported by a postdoctoral fellowship from the Manitoba Health Research Council (MHRC).; Supported by a postgraduate scholarship (PGS-D) from NSERC.; We thank V. Larmour for technical assistance and S. Labiuk and the staff of the Canadian Light Source (CLS) beam-line 08ID-1 for assistance with data collection. The CLS is supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), National Research Council, the Canadian Institutes of Health Research (CIHR), and the University of Saskatchewan. K. A. S. thanks the Australian Research Council.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balcewich MD, 2010, J MOL BIOL, V400, P998, DOI 10.1016/j.jmb.2010.05.040; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng QM, 2000, J BACTERIOL, V182, P4836, DOI 10.1128/JB.182.17.4836-4840.2000; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ganguli ARS, 2005, TETRAHEDRON-ASYMMETR, V16, P411, DOI 10.1016/j.tetasy.2004.11.053; GOODELL EW, 1985, J BACTERIOL, V163, P305, DOI 10.1128/JB.163.1.305-310.1985; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Grueninger D, 2006, J MOL BIOL, V359, P787, DOI 10.1016/j.jmb.2006.04.013; Hawley J, 2002, EUR J ORG CHEM, V2002, P1925, DOI 10.1002/1099-0690(200206)2002:12<1925::AID-EJOC1925>3.0.CO;2-9; Hoffmann D, 2010, ENVIRON SCI TECHNOL, V44, P694, DOI 10.1021/es902476f; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jacobs C, 1997, CELL, V88, P823, DOI 10.1016/S0092-8674(00)81928-5; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kubasch N, 2002, EUR J ORG CHEM, V2002, P2710, DOI 10.1002/1099-0690(200208)2002:16<2710::AID-EJOC2710>3.0.CO;2-8; Lee MJ, 2009, J AM CHEM SOC, V131, P8742, DOI 10.1021/ja9025566; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimasu H, 2007, J BIOL CHEM, V282, P9923, DOI 10.1074/jbc.M610678200; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; PAULSEN H, 1986, LIEBIGS ANN CHEM, P664; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Uehara T, 2006, J BACTERIOL, V188, P1660, DOI 10.1128/JB.188.4.1660-1662.2006; Uehara T, 2005, J BACTERIOL, V187, P3643, DOI 10.1128/JB.187.11.3643-3649.2005; VANBOECKEL CAA, 1983, RECL TRAV CHIM PAY B, V102, P415; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Votsch W, 2000, J BIOL CHEM, V275, P39032, DOI 10.1074/jbc.M004797200; Weihofen WA, 2006, J MOL BIOL, V364, P388, DOI 10.1016/j.jmb.2006.08.085; Xie HJ, 2005, FEMS MICROBIOL LETT, V251, P313, DOI 10.1016/j.femsle.2005.08.024; Zhuang XL, 2002, PROTEIN EXPRES PURIF, V26, P71, DOI 10.1016/S1046-5928(02)00501-6; Zhuang XL, 2001, BIORESOURCE TECHNOL, V79, P63, DOI 10.1016/S0960-8524(01)00023-2	42	21	21	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.198317	http://dx.doi.org/10.1074/jbc.M110.198317			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288904	hybrid, Green Published			2022-12-25	WOS:000289077500042
J	Blackman, BE; Horner, K; Heidmann, J; Wang, D; Richter, W; Rich, TC; Conti, M				Blackman, Brigitte E.; Horner, Kathleen; Heidmann, Julia; Wang, Dan; Richter, Wito; Rich, Thomas C.; Conti, Marco			PDE4D and PDE4B Function in Distinct Subcellular Compartments in Mouse Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; CAMP-SPECIFIC PHOSPHODIESTERASES; NUCLEOTIDE-GATED CHANNELS; PROTEIN-KINASE; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTORS; ADENYLYL-CYCLASE; CYCLIC-AMP; CROSS-TALK; ACTIVATION	Signaling through cAMP regulates most cellular functions. The spatiotemporal control of cAMP is, therefore, crucial for differential regulation of specific cellular targets. Here we investigated the consequences of PDE4B or PDE4D gene ablation on cAMP signaling at a subcellular level using mouse embryonic fibroblasts. PDE4B ablation had no effect on the global or bulk cytosol accumulation of cAMP but increased both basal and hormone-dependent cAMP in a near-membrane pool. Conversely, PDE4D ablation enhanced agonist-induced cAMP accumulation in the bulk cytosol as well as at the plasma membrane. Both PDE4B and PDE4D ablation significantly modified the time course and the level of isoproterenol-induced phosphorylation of vasodilator-stimulated phosphoprotein, a membrane cytoskeletal component. A second membrane response through Toll-like receptor signaling, however, was only affected by PDE4B ablation. PDE4D but not PDE4B ablation significantly prolonged cAMP-response element-binding protein-mediated transcription. These findings demonstrate that PDE4D and PDE4B have specialized functions in mouse embryonic fibroblasts with PDE4B controlling cAMP in a discrete subdomain near the plasma membrane.	[Blackman, Brigitte E.; Horner, Kathleen; Heidmann, Julia; Wang, Dan; Richter, Wito; Conti, Marco] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Rich, Thomas C.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Rich, Thomas C.] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA	University of California System; University of California San Francisco; University of South Alabama; University of South Alabama	Conti, M (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, 513 Parnassus Ave,Box 0556, San Francisco, CA 94143 USA.	ContiM@obgyn.ucsf.edu		Richter, Wito/0000-0001-5588-9060	National Institutes of Health [HL092788]; Leducq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL092788. This work was also supported by a grant from the Leducq Foundation.	Abrahamsen H, 2004, J IMMUNOL, V173, P4847, DOI 10.4049/jimmunol.173.8.4847; An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Arp J, 2003, MOL CELL BIOL, V23, P8042, DOI 10.1128/MCB.23.22.8042-8057.2003; Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; BEAVO JA, 1974, P NATL ACAD SCI USA, V71, P3580, DOI 10.1073/pnas.71.9.3580; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Bruss MD, 2008, J BIOL CHEM, V283, P22430, DOI 10.1074/jbc.M803306200; Chen HJ, 2008, J BIOL CHEM, V283, P4439, DOI 10.1074/jbc.M709439200; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; Houslay MD, 2001, PROG NUCLEIC ACID RE, V69, P249, DOI 10.1016/S0079-6603(01)69049-4; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Jin SLC, 1998, J BIOL CHEM, V273, P19672, DOI 10.1074/jbc.273.31.19672; Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Oliveira RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011725; Padron A, 2007, MOL ENDOCRINOL, V21, P49, DOI 10.1210/me.2006-0075; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Richter W, 2002, J BIOL CHEM, V277, P40212, DOI 10.1074/jbc.M203585200; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; Willoughby D, 2007, J BIOL CHEM, V282, P34235, DOI 10.1074/jbc.M706765200; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Zaccolo M, 2006, BIOCHEM SOC T, V34, P495, DOI 10.1042/BST0340495; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	48	41	42	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.203604	http://dx.doi.org/10.1074/jbc.M110.203604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288894	hybrid, Green Published			2022-12-25	WOS:000289077500071
J	Ideo, H; Matsuzaka, T; Nonaka, T; Seko, A; Yamashita, K				Ideo, Hiroko; Matsuzaka, Tsutomu; Nonaka, Takamasa; Seko, Akira; Yamashita, Katsuko			Galectin-8-N-domain Recognition Mechanism for Sialylated and Sulfated Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL CARBOHYDRATE-RECOGNITION; RAY CRYSTAL-STRUCTURE; BINDING; GALECTINS; PROTEIN; LECTIN; DOMAIN; SPECIFICITY; REFINEMENT; MODULATOR	Galectin-8 has much higher affinity for 3'-O-sulfated or 3'-O-sialylated glycoconjugates and a Lewis X-containing glycan than for oligosaccharides terminating in Gal beta 1 -> 33/4GlcNAc, and this specificity is mainly attributed to the N-terminal carbohydrate recognition domain (N-domain, CRD) (Ideo, H., Seko, A., Ishizuka, I., and Yamashita, K. (2003) Glycobiology 13, 713-723). In this study, we elucidated the crystal structures of the human galectin-8-N-domain (-8N) in the absence or presence of 4 ligands. The apo molecule forms a dimer, which is different from the canonical 2-fold symmetric dimer observed for galectin- 1 and -2. In a galectin-8N-lactose complex, the lactose-recognizing amino acids are highly conserved among the galectins. However, Arg(45), Gln(47), Arg(59), and the long loop region between the S3 and S4 beta-strands are unique to galectin-8N. These amino acids directly or indirectly interact with the sulfate or sialic acid moieties of 3'-sialyl-and 3'-sulfolactose complexed with galectin- 8N. Furthermore, in the LNF-III-galectin-8N complex, van der Waals interactions occur between the alpha 1-3-branched fucose and galactose and between galactose and Tyr(141), and these interactions increase the affinity toward galectin-8N. Based on the findings of these x-ray crystallographic analyses, a mutagenesis study using surface plasmon resonance showed that Arg(45), Gln(47), and Arg(59) of galectin-8N are indispensable and coordinately contribute to the strong binding of galectins-8N to sialylated and sulfated oligosaccharides. Arg(59) is the most critical amino acid for binding in the S3-S4 loop region.	[Matsuzaka, Tsutomu; Nonaka, Takamasa] Iwate Med Univ, Sch Pharm, Yahaba, Iwate 0283694, Japan; [Ideo, Hiroko; Seko, Akira; Yamashita, Katsuko] Tokyo Inst Technol, Innovat Res Initiat, Yokohama, Kanagawa 2268503, Japan	Iwate Medical University; Tokyo Institute of Technology	Nonaka, T (corresponding author), 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	tnonaka@iwate-med.ac.jp; kyamashi@bio.titech.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) in Japan	New Energy and Industrial Technology Development Organization (NEDO) in Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the New Energy and Industrial Technology Development Organization (NEDO) in Japan.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Arbel-Goren R, 2005, J BIOL CHEM, V280, P19105, DOI 10.1074/jbc.M502060200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BRENNAN MJ, 1991, J BIOL CHEM, V266, P18827; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Carcamo C, 2006, EXP CELL RES, V312, P374, DOI 10.1016/j.yexcr.2005.10.025; Cooper DNW, 1999, GLYCOBIOLOGY, V9, P979, DOI 10.1093/glycob/9.10.979; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Hadari YR, 1997, TRENDS GLYCOSCI GLYC, V9, P103, DOI 10.4052/tigg.9.103; HADARI YR, 1995, J BIOL CHEM, V270, P3447, DOI 10.1074/jbc.270.7.3447; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HIRABAYASHI J, 1994, GLYCOCONJUGATE J, V11, P437, DOI 10.1007/BF00731280; Honke K, 2001, J BIOL CHEM, V276, P267, DOI 10.1074/jbc.M005666200; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Ideo H, 2002, GLYCOBIOLOGY, V12, P199, DOI 10.1093/glycob/12.3.199; Ideo H, 2007, J BIOL CHEM, V282, P21081, DOI 10.1074/jbc.M703770200; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Leonidas DD, 1998, BIOCHEMISTRY-US, V37, P13930, DOI 10.1021/bi981056x; Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2006, J BIOL CHEM, V281, P35884, DOI 10.1074/jbc.M606648200; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Seko A, 2005, GLYCOBIOLOGY, V15, P943, DOI 10.1093/glycob/cwi082; Seko A, 2002, JPN J CANCER RES, V93, P507, DOI 10.1111/j.1349-7006.2002.tb01285.x; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Suzuki T, 1996, BIOCHEM J, V318, P389, DOI 10.1042/bj3180389; Swaminathan GJ, 1999, BIOCHEMISTRY-US, V38, P13837, DOI 10.1021/bi990756e; Teneberg S, 1997, J BIOL CHEM, V272, P19067, DOI 10.1074/jbc.272.30.19067; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein C., 2006, MACROMOLECULAR CRYST, V2, P215; Warren L, 1976, BIOL ROLES SIALIC AC, P103; Zick Y, 2002, GLYCOCONJUGATE J, V19, P517, DOI 10.1023/B:GLYC.0000014081.55445.af	41	91	93	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11346	11355		10.1074/jbc.M110.195925	http://dx.doi.org/10.1074/jbc.M110.195925			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21288902	hybrid, Green Published			2022-12-25	WOS:000288797100047
J	Pontarin, G; Ferraro, P; Rampazzo, C; Kollberg, G; Holme, E; Reichard, P; Bianchi, V				Pontarin, Giovanna; Ferraro, Paola; Rampazzo, Chiara; Kollberg, Gittan; Holme, Elisabeth; Reichard, Peter; Bianchi, Vera			Deoxyribonucleotide Metabolism in Cycling and Resting Human Fibroblasts with a Missense Mutation in p53R2, a Subunit of Ribonucleotide Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-DNA DEPLETION; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY; THYMIDINE KINASE; RENAL-FAILURE; CANCER CELLS; DNTP POOLS; IN-VITRO; DAMAGE; GENE; REPAIR	Ribonucleotide reduction provides deoxynucleotides for nuclear and mitochondrial (mt) DNA replication and DNA repair. In cycling mammalian cells the reaction is catalyzed by two proteins, R1 and R2. A third protein, p53R2, with the same function as R2, occurs in minute amounts. In quiescent cells, p53R2 replaces the absent R2. In humans, genetic inactivation of p53R2 causes early death with mtDNA depletion, especially in muscle. We found that cycling fibroblasts from a patient with a lethal mutation in p53R2 contained a normal amount of mtDNA and showed normal growth, ribonucleotide reduction, and deoxynucleoside triphosphate (dNTP) pools. However, when made quiescent by prolonged serum starvation the mutant cells strongly down-regulated ribonucleotide reduction, decreased their dCTP and dGTP pools, and virtually abolished the catabolism of dCTP in substrate cycles. mtDNA was not affected. Also, nuclear DNA synthesis and the cell cycle-regulated enzymes R2 and thymidine kinase 1 decreased strongly, but the mutant cell populations retained unexpectedly larger amounts of the two enzymes than the controls. This difference was probably due to their slightly larger fraction of S phase cells and therefore not induced by the absence of p53R2 activity. We conclude that loss of p53R2 affects ribonucleotide reduction only in resting cells and leads to a decrease of dNTP catabolism by substrate cycles that counterweigh the loss of anabolic activity. We speculate that this compensatory mechanism suffices to maintain mtDNA in fibroblasts but not in muscle cells with a larger content of mtDNA necessary for their high energy requirements.	[Pontarin, Giovanna; Ferraro, Paola; Rampazzo, Chiara; Reichard, Peter; Bianchi, Vera] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Kollberg, Gittan; Holme, Elisabeth] Sahlgrens Univ Hosp, Dept Clin Chem, SE-41345 Gothenburg, Sweden	University of Padua; Sahlgrenska University Hospital	Bianchi, V (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.	vbianchi@bio.unipd.it			Italian Telethon [GGP09019]; Italian Association for Cancer Research [1091]; Fondazione Cariparo; University of Padova	Italian Telethon(Fondazione Telethon); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariparo(Fondazione Cariparo); University of Padova	This work was supported by Italian Telethon Grant GGP09019, Italian Association for Cancer Research Grant 1091, the Fondazione Cariparo, and the University of Padova Strategic Projects 2008 (to V. B.).	Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chen YL, 2010, J BIOL CHEM, V285, P27327, DOI 10.1074/jbc.M110.137042; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Devlin HL, 2008, MOL CANCER RES, V6, P808, DOI 10.1158/1541-7786.MCR-07-2027; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Gallinaro L, 2002, J BIOL CHEM, V277, P35080, DOI 10.1074/jbc.M203755200; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Hu CM, 2007, J BIOMED SCI, V14, P491, DOI 10.1007/s11373-007-9175-1; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014; KOSHLAND DE, 1984, TRENDS BIOCHEM SCI, V9, P155, DOI 10.1016/0968-0004(84)90125-7; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; Lin ZP, 2007, BIOCHEM PHARMACOL, V73, P760, DOI 10.1016/j.bcp.2006.11.014; Lin ZP, 2004, J BIOL CHEM, V279, P27030, DOI 10.1074/jbc.M402056200; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200; Powell DR, 2005, PEDIATR NEPHROL, V20, P432, DOI 10.1007/s00467-004-1696-5; Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tsai MH, 2006, ONCOGENE, V25, P622, DOI 10.1038/sj.onc.1209082; Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009	42	26	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11132	11140		10.1074/jbc.M110.202283	http://dx.doi.org/10.1074/jbc.M110.202283			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21297166	Green Published, hybrid			2022-12-25	WOS:000288797100024
J	Ellrichmann, G; Petrasch-Parwez, E; Lee, DH; Reick, C; Arning, L; Saft, C; Gold, R; Linker, RA				Ellrichmann, Gisa; Petrasch-Parwez, Elisabeth; Lee, De-Hyung; Reick, Christiane; Arning, Larissa; Saft, Carsten; Gold, Ralf; Linker, Ralf A.			Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; INTRACELLULAR CALCIUM; MUTANT HUNTINGTIN; DIMETHYL-FUMARATE; OXIDATIVE DAMAGE; MOTOR DEFICITS; IN-VIVO; MICE; EXPRESSION; NEURODEGENERATION	Huntington's disease (HD) is an autosomal dominantly inherited progressive neurodegenerative disease. The exact sequel of events finally resulting in neurodegeneration is only partially understood and there is no established protective treatment so far. Some lines of evidence speak for the contribution of oxidative stress to neuronal tissue damage. The fumaric acid ester dimethylfumarate (DMF) is a new disease modifying therapy currently in phase III studies for relapsing-remitting multiple sclerosis. DMF potentially exerts neuroprotective effects via induction of the transcription factor "nuclear factor E2-related factor 2'' (Nrf2) and detoxification pathways. Thus, we investigated here the therapeutic efficacy of DMF in R6/2 and YAC128 HD transgenic mice which mimic many aspects of HD and are characterized by an enhanced generation of free radicals in neurons. Treatment with DMF significantly prevented weight loss in R6/2 mice between postnatal days 80-90. At the same time, DMF treatment led to an attenuated motor impairment as measured by the clasping score. Average survival in the DMF group was 100.5 days vs. 94.0 days in the placebo group. In the histological analysis on day 80, DMF treatment resulted in a significant preservation of morphologically intact neurons in the striatum as well as in the motor cortex. DMF treatment resulted in an increased Nrf2 immunoreactivity in neuronal subpopulations, but not in astrocytes. These beneficial effects were corroborated in YAC128 mice which, after one year of DMF treatment, also displayed reduced dyskinesia as well as a preservation of neurons. In conclusion, DMF may exert beneficial effects in mouse models of HD. Given its excellent side effect profile, further studies with DMF as new therapeutic approach in HD and other neurodegenerative diseases are warranted.	[Ellrichmann, Gisa; Lee, De-Hyung; Reick, Christiane; Saft, Carsten; Gold, Ralf; Linker, Ralf A.] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, D-4630 Bochum, Germany; [Petrasch-Parwez, Elisabeth] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-4630 Bochum, Germany; [Arning, Larissa] Ruhr Univ Bochum, Dept Human Genet, D-4630 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Ellrichmann, G (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, D-4630 Bochum, Germany.	ralf.linker@uk-erlangen.de	Linker, Ralf/AAD-8884-2020	Saft, Carsten/0000-0002-3983-7292				Ang ET, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00025; Begleiter A, 2003, CANCER EPIDEM BIOMAR, V12, P566; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Clarke KA, 1999, PHYSIOL BEHAV, V66, P723, DOI 10.1016/S0031-9384(98)00343-6; Clifford JJ, 2002, NEUROSCIENCE, V109, P81, DOI 10.1016/S0306-4522(01)00409-2; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dedeoglu A, 2002, J NEUROSCI, V22, P8942; deJong P, 1996, EUR J IMMUNOL, V26, P2067, DOI 10.1002/eji.1830260916; Duffy S, 1998, J NEUROCHEM, V71, P69; Fernandez-Checa JC, 2010, CNS NEUROL DISORD-DR, V9, P439, DOI 10.2174/187152710791556113; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gil JM, 2009, BRAIN RES REV, V59, P410, DOI 10.1016/j.brainresrev.2008.12.001; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Iannicola C, 2000, J NEUROCHEM, V75, P830, DOI 10.1046/j.1471-4159.2000.0750830.x; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Keene CD, 2002, P NATL ACAD SCI USA, V99, P10671, DOI 10.1073/pnas.162362299; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kumar P, 2010, PHARMACOL REP, V62, P1; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; LINKER RA, BRAIN IN PRESS; Linker Ralf A, 2008, Expert Rev Neurother, V8, P1683, DOI 10.1586/14737175.8.11.1683; Loewe R, 2002, J IMMUNOL, V168, P4781, DOI 10.4049/jimmunol.168.9.4781; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masuda N, 2008, NEUROBIOL DIS, V30, P293, DOI 10.1016/j.nbd.2008.01.014; Menalled LB, 2002, J NEUROSCI, V22, P8266; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009793; Moharregh-Khiabani D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011769; Mrowietz U, 1999, BRIT J DERMATOL, V141, P424; Ockenfels HM, 1998, BRIT J DERMATOL, V139, P390; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Petrasch-Parwez E, 2007, J COMP NEUROL, V501, P716, DOI 10.1002/cne.21272; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Schmidt TJ, 2007, BIOORGAN MED CHEM, V15, P333, DOI 10.1016/j.bmc.2006.09.053; SCHWECKENDIEK W, 1959, Med Monatsschr, V13, P103; Sebok B, 1998, EUR J DERMATOL, V8, P29; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Smith DL, 2003, ANN NEUROL, V54, P186, DOI 10.1002/ana.10614; Smith KM, 2006, BBA-MOL BASIS DIS, V1762, P616, DOI 10.1016/j.bbadis.2006.03.004; Stack C, 2010, FREE RADICAL BIO MED, V49, P147, DOI 10.1016/j.freeradbiomed.2010.03.017; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Su JYC, 1999, NEUROSCI LETT, V273, P109, DOI 10.1016/S0304-3940(99)00634-5; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Thiessen A, 2010, NEUROSCI LETT, V475, P56, DOI 10.1016/j.neulet.2010.03.048; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vandermeeren M, 1997, BIOCHEM BIOPH RES CO, V234, P19, DOI 10.1006/bbrc.1997.6570; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wierinckx A, 2005, J NEUROIMMUNOL, V166, P132, DOI 10.1016/j.jneuroim.2005.05.013; Yu ZX, 2003, J NEUROSCI, V23, P2193	69	111	133	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16172	10.1371/journal.pone.0016172	http://dx.doi.org/10.1371/journal.pone.0016172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297955	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300039
J	Overman, AR; Scholtz, RV				Overman, Allen R.; Scholtz, Richard V., III			Model of Yield Response of Corn to Plant Population and Absorption of Solar Energy	PLOS ONE			English	Article							GRAIN-YIELD; DENSITY	Biomass yield of agronomic crops is influenced by a number of factors, including crop species, soil type, applied nutrients, water availability, and plant population. This article is focused on dependence of biomass yield (Mg ha(-1) and g plant(-1)) on plant population (plants m(-2)). Analysis includes data from the literature for three independent studies with the warm-season annual corn (Zea mays L.) grown in the United States. Data are analyzed with a simple exponential mathematical model which contains two parameters, viz. Y(m) (Mg ha(-1)) for maximum yield at high plant population and c (m(2) plant(-1)) for the population response coefficient. This analysis leads to a new parameter called characteristic plant population, x(c) = 1/c (plants m(-2)). The model is shown to describe the data rather well for the three field studies. In one study measurements were made of solar radiation at different positions in the plant canopy. The coefficient of absorption of solar energy was assumed to be the same as c and provided a physical basis for the exponential model. The three studies showed no definitive peak in yield with plant population, but generally exhibited asymptotic approach to maximum yield with increased plant population. Values of xc were very similar for the three field studies with the same crop species.	[Overman, Allen R.; Scholtz, Richard V., III] Univ Florida, Agr & Biol Engn Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Overman, AR (corresponding author), Univ Florida, Agr & Biol Engn Dept, Gainesville, FL 32611 USA.	rscholtz@ufl.edu	Scholtz, Richard/F-9513-2011	Scholtz, Richard/0000-0001-8989-0131	Florida Experiment Station; Marston Science Library staff; University of Florida	Florida Experiment Station; Marston Science Library staff; University of Florida(University of Florida)	The funding of this analysis was provided by the Florida Experiment Station. The authors express appreciation to Amy G. Buhler, Marston Science Library staff, for assistance with funding for the publishing costs of this article as part of the commitment of the University of Florida to open access publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Publication of this article was funded in part by the University of Florida Open-Access publishing Fund. The authors express appreciation to Amy G. Buhler, Marston Science Library staff. We also thank students in the graduate course ABE 6933 Mathematical and Statistical Characteristics of Nonlinear Regression Models for many helpful oral and written review comments on the manuscript.	Cox WJ, 1997, J PROD AGRIC, V10, P405, DOI 10.2134/jpa1997.0405; Cusicanqui JA, 1999, AGRON J, V91, P911, DOI 10.2134/agronj1999.916911x; HASHEMIDEZFOULI A, 1992, AGRON J, V84, P547, DOI 10.2134/agronj1992.00021962008400040001x; HAWKINS BS, 1972, RES B U GEORGIA AGR, V101; KITTRELL BU, 1975, TOBACCO SCI, V19, P119; MCKEE CG, 1978, TOBACCO SCI, V22, P94; Overman AR, 2006, COMMUN SOIL SCI PLAN, V37, P1157, DOI 10.1080/00103620600623350; OVERMAN AR, 2002, MATH MODELS PLANT GR; PRINE GM, 1977, SOIL CROP SCI SOC FL, V36, P157; Ratkowsky D., 1983, NONLINEAR REGRESSION; RHOADS FM, 1979, SOIL CROP SCI SOC FL, V38, P78; SCARSBROOK CE, 1973, ALABAMA AGR EXPT STA, V450; WURR DCE, 1993, J AGR SCI, V120, P63, DOI 10.1017/S0021859600073597	13	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16117	10.1371/journal.pone.0016117	http://dx.doi.org/10.1371/journal.pone.0016117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297960	Green Submitted, gold, Green Published			2022-12-25	WOS:000286834300034
J	Ng, OT; Lin, L; Laeyendecker, O; Quinn, TC; Sun, YJ; Lee, CC; Leo, YS				Ng, Oon Tek; Lin, Li; Laeyendecker, Oliver; Quinn, Thomas C.; Sun, Yong Jiang; Lee, Cheng Chuan; Leo, Yee Sin			Increased Rate of CD4+T-Cell Decline and Faster Time to Antiretroviral Therapy in HIV-1 Subtype CRF01_AE Infected Seroconverters in Singapore	PLOS ONE			English	Article							DISEASE PROGRESSION; VIRAL SUBTYPE; THAILAND; UGANDA; HEALTH; IMPACT	Background: It remains controversial as to whether HIV-1 subtypes influence disease progression. Singapore offers a unique opportunity to address this issue due to the presence of co-circulating subtypes. We compared subtype CRF01_AE and non-CRF01_AE infected patients, with regards to estimated annual rate of CD4+ T-cell loss and time from estimated data of seroconversion (EDS) to antiretroviral therapy (ART). Methods: We recruited ART-naive patients with known dates of seroconversion between October 2002 and December 2007 at the Singapore Communicable Disease Centre, the national reference treatment centre. Multilevel mixed-effects models were used to analyse the rate of CD4+ T-cell decline. Time from EDS to ART was analyzed with the Kaplan-Meier survival method and compared with Cox proportional hazards models. Results: 54 patients with previously assigned HIV-1 subtypes (24 CRF01_AE, 17 B, 8 B', 1 CRF33_01B, 3 CRF34_01B and 1 G) were observed for 89 patient-years. Subtype CRF01_AE and non-CRF01_AE infected patients did not differ in age, gender, risk factor, rate of symptomatic seroconversion, baseline CD4+ T-cell count, log(10) viral load or haemoglobin concentration. The estimated annual rate of CD4+ T-cell loss was 58 cells/mm(3)/year (95% CI: 7 to 109; P = 0.027) greater in subtype CRF01_AE infected patients compared to non-CRF01_AE patients, after adjusting for age, baseline CD4+ T-cell count and baseline log(10) viral load. The median time from EDS to ART was 1.8 years faster comparing CRF01_AE to non-CRF01_AE infected patient with a 2.5 times (95% CI: 1.2-5.0; P = 0.013) higher hazard for ART initiation, after controlling for age, baseline CD4+ T-cell count and baseline log(10) viral load. Conclusions: Infecting subtype significantly impacted the rate of CD4+ T-cell loss and time to treatment in this cohort. Studies to understand the biological basis for this difference could further our understanding of HIV pathogenesis.	[Ng, Oon Tek; Laeyendecker, Oliver; Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Ng, Oon Tek; Lin, Li; Sun, Yong Jiang; Lee, Cheng Chuan; Leo, Yee Sin] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Laeyendecker, Oliver; Quinn, Thomas C.] NIAID, Immunoregulat Lab, Div Intramural Res, NIH, Baltimore, MD USA	Johns Hopkins University; Tan Tock Seng Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA)	Ng, OT (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA.	oong@jhsph.edu	Laeyendecker, Oliver B/B-9331-2009	Laeyendecker, Oliver/0000-0002-6429-4760	Singapore National Medical Research Training Fellowship [MH 95:03/8-169]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361] Funding Source: NIH RePORTER	Singapore National Medical Research Training Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A Singapore National Medical Research Training Fellowship grant (MH 95:03/8-169) provided salary support for OT Ng. Additional support was provided by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Hu DJ, 2001, AIDS, V15, P683, DOI 10.1097/00002030-200104130-00003; Joint United Nations Program on HIV/AIDS (UNAIDS) WHOW, 2007, AIDS EP UPD; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Keller M, 2009, AIDS, V23, P731, DOI 10.1097/QAD.0b013e328326f77f; Kiwanuka N, 2009, J ACQUIRED IMMUNE DE; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lee CC, 2009, HIV MED, V10, P370, DOI 10.1111/j.1468-1293.2009.00698.x; Nelson KE, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000299410.37152.17; Rangsin R, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000299409.29528.23; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Touloumi G, 2003, JAIDS-J ACQ IMM DEF, V34, P76, DOI 10.1097/00126334-200309010-00012; *US DEP HHS, GUID US ANT AG HIV 1; WHO, 2008, WHO STAT INF SYST CO	18	42	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15738	10.1371/journal.pone.0015738	http://dx.doi.org/10.1371/journal.pone.0015738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298051	gold, Green Submitted, Green Published			2022-12-25	WOS:000286663900017
J	Van Hout, AJM; Eens, M; Pinxten, R				Van Hout, Alain J. -M.; Eens, Marcel; Pinxten, Rianne			Carotenoid Supplementation Positively Affects the Expression of a Non-Visual Sexual Signal	PLOS ONE			English	Article							MALE EUROPEAN STARLINGS; OXIDATION HANDICAP HYPOTHESIS; STURNUS-VULGARIS; TESTOSTERONE; AVAILABILITY; ANTIOXIDANTS; SONG; STRESS; COLORATION; PERFORMANCE	Carotenoids are a class of pigments which are widely used by animals for the expression of yellow-to-red colour signals, such as bill or plumage colour. Since they also have been shown to promote immunocompetence and to function as antioxidants, many studies have investigated a potential allocation trade-off with respect to carotenoid-based signals within the context of sexual selection. Although an effect of carotenoids on non-visual (e.g. acoustic) signals involved in sexual selection has been hypothesized, this has to date not been investigated. First, we examined a potential effect of dietary carotenoid supplementation on overall song rate during the non-breeding season in captive male European starlings (Sturnus vulgaris). After only 3-7 days, we found a significant (body-mass independent) positive effect of carotenoid availability on overall song rate. Secondly, as a number of studies suggest that carotenoids could affect the modulation of sexual signals by plasma levels of the steroid hormone testosterone (T), we used the same birds to subsequently investigate whether carotenoid availability affects the increase in (nestbox-oriented) song rate induced by experimentally elevated plasma T levels. Our results suggest that carotenoids may enhance the positive effect of elevated plasma T levels on nestbox-oriented song rate. Moreover, while non-supplemented starlings responded to T-implantation with an increase in both overall song rate and nestbox-oriented song, carotenoid-supplemented starlings instead shifted song production towards (reproductively relevant) nestbox-oriented song, without increasing overall song rate. Given that song rate is an acoustic signal rather than a visual signal, our findings therefore indicate that the role of carotenoids in (sexual) signalling need not be dependent on their function as pigments.	[Van Hout, Alain J. -M.; Eens, Marcel; Pinxten, Rianne] Univ Antwerp, Res Grp Ethol, Antwerp, Belgium	University of Antwerp	Van Hout, AJM (corresponding author), Univ Antwerp, Res Grp Ethol, Antwerp, Belgium.	alain.vanhout@ua.ac.be	Eens, Marcel/AAC-8466-2020		FWO Flanders (Belgium) [G.0130.07]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); University of Antwerp; FWO-Flanders	FWO Flanders (Belgium)(FWO); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); University of Antwerp; FWO-Flanders(FWO)	This study was supported by a research project (G.0130.07) to ME from FWO Flanders (Belgium). Alain Van Hout was funded by a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). Marcel Eens and Rianne Pinxten were funded by the University of Antwerp and supported by FWO-Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absil P, 2003, BEHAV BRAIN RES, V143, P15, DOI 10.1016/S0166-4328(03)00006-8; Aguilera E, 2007, NATURWISSENSCHAFTEN, V94, P895, DOI 10.1007/s00114-007-0268-5; Alonso-Alvarez C, 2008, J EVOLUTION BIOL, V21, P1789, DOI 10.1111/j.1420-9101.2008.01591.x; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Barnett CA, 2007, BEHAV ECOL SOCIOBIOL, V61, P579, DOI 10.1007/s00265-006-0286-x; Bertrand S, 2006, J EXP BIOL, V209, P4414, DOI 10.1242/jeb.02540; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Buchanan KL, 2001, P ROY SOC B-BIOL SCI, V268, P1337, DOI 10.1098/rspb.2001.1669; Senar JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010716; Catchpole C., 1995, BIRD SONG BIOL THEME; Catoni C, 2008, ANIM BEHAV, V76, P1107, DOI 10.1016/j.anbehav.2008.05.027; Costantini D, 2008, FUNCT ECOL, V22, P367, DOI 10.1111/j.1365-2435.2007.01366.x; Costantini D, 2007, J COMP PHYSIOL B, V177, P723, DOI 10.1007/s00360-007-0169-0; De Ridder E, 2000, BEHAV ECOL SOCIOBIOL, V49, P24, DOI 10.1007/s002650000266; Duffy DL, 2002, P ROY SOC B-BIOL SCI, V269, P847, DOI 10.1098/rspb.2002.1956; EENS M, 1991, BEHAVIOUR, V116, P210, DOI 10.1163/156853991X00049; Eens M, 1996, ANIM BEHAV, V51, P1141, DOI 10.1006/anbe.1996.0115; Hasselquist D, 2008, J AVIAN BIOL, V39, P384, DOI 10.1111/j.0908-8857.2008.04427.x; Hill GE, 2009, J EXP BIOL, V212, P1225, DOI 10.1242/jeb.026963; Huggins KA, 2010, NATURWISSENSCHAFTEN, V97, P637, DOI 10.1007/s00114-010-0679-6; Larcombe SD, 2008, J EXP BIOL, V211, P2859, DOI 10.1242/jeb.017970; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Martinez-Padilla J, 2010, J EVOLUTION BIOL, V23, P902, DOI 10.1111/j.1420-9101.2010.01956.x; McGraw KJ, 2006, PHYSIOL BEHAV, V87, P103, DOI 10.1016/j.physbeh.2005.09.001; MOUNTJOY DJ, 1991, BEHAV ECOL SOCIOBIOL, V28, P97; Navarro C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1057, DOI 10.1007/s00265-010-0920-5; Noguera JC, 2010, BEHAV ECOL, V21, P479, DOI 10.1093/beheco/arq005; ONeill CA, 1996, J APPL PHYSIOL, V81, P1197, DOI 10.1152/jappl.1996.81.3.1197; Perez C, 2008, BEHAV ECOL, V19, P967, DOI 10.1093/beheco/arn053; Pike TW, 2007, BEHAV ECOL, V18, P1100, DOI 10.1093/beheco/arm084; Pike TW, 2007, BIOL LETTERS, V3, P353, DOI 10.1098/rsbl.2007.0072; Pinxten R, 2002, HORM BEHAV, V42, P307, DOI 10.1006/hbeh.2002.1824; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; Van Hout AJM, 2009, HORM BEHAV, V56, P564, DOI 10.1016/j.yhbeh.2009.09.010; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Wikelski M, 1999, J COMP PHYSIOL A, V185, P463, DOI 10.1007/s003590050407	37	18	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16326	10.1371/journal.pone.0016326	http://dx.doi.org/10.1371/journal.pone.0016326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283591	Green Submitted, Green Published, gold			2022-12-25	WOS:000286661400044
J	Goler-Baron, V; Assaraf, YG				Goler-Baron, Vicky; Assaraf, Yehuda G.			Structure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance	PLOS ONE			English	Article							HEREDITARY FOLATE MALABSORPTION; INTRACELLULAR TRAFFICKING; PROTEIN BCRP/ABCG2; ABC TRANSPORTERS; MOLECULAR-BASIS; TIGHT JUNCTION; CELL-LINE; CANCER; MEMBRANE; BCRP	Multidrug resistance (MDR) is a major impediment to curative cancer chemotherapy. The ATP-Binding Cassette transporters ABCG2, ABCB1 and ABCC2 form a unique defense network against multiple structurally and functionally distinct chemotherapeutics, thereby resulting in MDR. Thus, deciphering novel mechanisms of MDR and their overcoming is a major goal of cancer research. Recently we have shown that overexpression of ABCG2 in the membrane of novel extracellular vesicles (EVs) in breast cancer cells results in mitoxantrone resistance due to its dramatic sequestration in EVs. However, nothing is known about EVs structure, biogenesis and their ability to concentrate multiple antitumor agents. To this end, we here found that EVs are structural and functional homologues of bile canaliculi, are apically localized, sealed structures reinforced by an actin-based cytoskeleton and secluded from the extracellular milieu by the tight junction proteins occludin and ZO-1. Apart from ABCG2, ABCB1 and ABCC2 were also selectively targeted to the membrane of EVs. Moreover, Ezrin-Radixin-Moesin protein complex selectively localized to the border of the EVs membrane, suggesting a key role for the tethering of MDR pumps to the actin cytoskeleton. The ability of EVs to concentrate and sequester different antitumor drugs was also explored. Taking advantage of the endogenous fluorescence of anticancer drugs, we found that EVs-forming breast cancer cells display high level resistance to topotecan, imidazoacridinones and methotrexate via efficient intravesicular drug concentration hence sequestering them away from their cellular targets. Thus, we identified a new modality of anticancer drug compartmentalization and resistance in which multiple chemotherapeutics are actively pumped from the cytoplasm and highly concentrated within the lumen of EVs via a network of MDR transporters differentially targeted to the EVs membrane. We propose a composite model for the structure and function of MDR pump-rich EVs in cancer cells and their ability to confer multiple anticancer drug resistance.	[Goler-Baron, Vicky; Assaraf, Yehuda G.] Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Goler-Baron, V (corresponding author), Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il		Assaraf, Yehuda G./0000-0001-6692-8221	Fred Wyszkowski Cancer Research Fund	Fred Wyszkowski Cancer Research Fund	This study was supported by the Fred Wyszkowski Cancer Research Fund to Y.G.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 1999, CANCER RES, V59, P4237; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Boll M, 2002, J BIOL CHEM, V277, P22966, DOI 10.1074/jbc.M200374200; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; Delacour D, 2006, CELL MOL LIFE SCI, V63, P2491, DOI 10.1007/s00018-006-6210-8; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Ifergan I, 2005, CANCER RES, V65, P10952, DOI 10.1158/0008-5472.CAN-05-2021; Ifergan I, 2004, J BIOL CHEM, V279, P25527, DOI 10.1074/jbc.M401725200; Ifergan I, 2009, BIOCHEM BIOPH RES CO, V380, P5, DOI 10.1016/j.bbrc.2008.12.168; IHRKE G, 1993, J CELL BIOL, V123, P1761, DOI 10.1083/jcb.123.6.1761; Kikuchi S, 2002, NAT GENET, V31, P320, DOI 10.1038/ng905; Kipp H, 2000, SEMIN LIVER DIS, V20, P339, DOI 10.1055/s-2000-9388; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Li N, 2009, MOL PHARMACEUT, V6, P1180, DOI 10.1021/mp900044x; Maliepaard M, 2001, CLIN CANCER RES, V7, P935; Martinez-Augustin O, 2009, INFLAMM BOWEL DIS, V15, P114, DOI 10.1002/ibd.20579; Mohrmann K, 2005, CANCER CHEMOTH PHARM, V56, P344, DOI 10.1007/s00280-005-1004-5; Nelson WJ, 2004, NAT CELL BIOL, V6, P282, DOI 10.1038/ncb0404-282; Nies AT, 2002, EUR J BIOCHEM, V269, P1866, DOI 10.1046/j.1432-1033.2002.02832.x; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Orban TI, 2008, BIOCHEM BIOPH RES CO, V367, P667, DOI 10.1016/j.bbrc.2007.12.172; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Robey RW, 2007, CANCER METAST REV, V26, P39, DOI 10.1007/s10555-007-9042-6; Rodrigues AC, 2006, BBA-GEN SUBJECTS, V1760, P1866, DOI 10.1016/j.bbagen.2006.08.003; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Shitara Y, 2006, EUR J PHARM SCI, V27, P425, DOI 10.1016/j.ejps.2005.12.003; STJOHNSTON D, CELL, V141, P757; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; TAYLOR CW, 1991, BRIT J CANCER, V63, P923, DOI 10.1038/bjc.1991.202; Tian X, 2007, ANTIMICROB AGENTS CH, V51, P3230, DOI 10.1128/AAC.00082-07; Wakabayashi Y, 2004, MOL BIOL CELL, V15, P3485, DOI 10.1091/mbc.E03-10-0737; Wakabayashi Y, 2006, J BIOL CHEM, V281, P27669, DOI 10.1074/jbc.R600013200; Zegers MMP, 1998, MOL BIOL CELL, V9, P1939, DOI 10.1091/mbc.9.7.1939	40	67	68	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16007	10.1371/journal.pone.0016007	http://dx.doi.org/10.1371/journal.pone.0016007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283667	Green Published, Green Submitted, gold			2022-12-25	WOS:000286523400010
J	Skrlj, N; Vranac, T; Popovic, M; Serbec, VC; Dolinar, M				Skrlj, Nives; Vranac, Tanja; Popovic, Mara; Serbec, Vladka Curin; Dolinar, Marko			Specific Binding of the Pathogenic Prion Isoform: Development and Characterization of a Humanized Single-Chain Variable Antibody Fragment	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; PRPSC REPLICATION; PROTEIN PEPTIDE; IN-VITRO; DISEASE; IMMUNOTHERAPY; DOMAINS; SCRAPIE; CELLS; MOUSE	Murine monoclonal antibody V5B2 which specifically recognizes the pathogenic form of the prion protein represents a potentially valuable tool in diagnostics or therapy of prion diseases. As murine antibodies elicit immune response in human, only modified forms can be used for therapeutic applications. We humanized a single-chain V5B2 antibody using variable domain resurfacing approach guided by computer modelling. Design based on sequence alignments and computer modelling resulted in a humanized version bearing 13 mutations compared to initial murine scFv. The humanized scFv was expressed in a dedicated bacterial system and purified by metal-affinity chromatography. Unaltered binding affinity to the original antigen was demonstrated by ELISA and maintained binding specificity was proved by Western blotting and immunohistochemistry. Since monoclonal antibodies against prion protein can antagonize prion propagation, humanized scFv specific for the pathogenic form of the prion protein might become a potential therapeutic reagent.	[Skrlj, Nives; Serbec, Vladka Curin; Dolinar, Marko] Univ Ljubljana, Chair Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Vranac, Tanja; Serbec, Vladka Curin] Blood Transfus Ctr Slovenia, Dept Prod Diagnost Reagents & Res, Ljubljana, Slovenia; [Popovic, Mara] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Skrlj, N (corresponding author), Univ Ljubljana, Chair Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia.	marko.dolinar@fkkt.uni-lj.si		Dolinar, Marko/0000-0002-4726-8077	Slovenian Research Agency [L3-0206]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency Ph.D. grant for NS and grant L3-0206 to VCS, MD, and TV. DiaMed Benelux (http://diamed.be/) was co-financing the project L3-0206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrenne C, 2009, J NEUROIMMUNOL, V209, P50, DOI 10.1016/j.jneuroim.2009.01.025; Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Beringue V, 2004, J BIOL CHEM, V279, P39671, DOI 10.1074/jbc.M402270200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boado RJ, 2010, MOL PHARMACEUT, V7, P237, DOI 10.1021/mp900235k; Caldas C, 2003, MOL IMMUNOL, V39, P941, DOI 10.1016/S0161-5890(03)00022-1; Campana V, 2009, BIOCHEM J, V418, P507, DOI 10.1042/BJ20081541; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Delagrave S, 1999, PROTEIN ENG, V12, P357, DOI 10.1093/protein/12.4.357; Donofrio G, 2005, J VIROL, V79, P8330, DOI 10.1128/JVI.79.13.8330-8338.2005; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Flego M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-38; Furrer E, 2009, J NEUROIMMUNOL, V215, P65, DOI 10.1016/j.jneuroim.2009.08.005; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Horiuchi M, 2009, VIROLOGY, V394, P200, DOI 10.1016/j.virol.2009.08.025; Jones M, 2009, BRAIN PATHOL, V19, P293, DOI 10.1111/j.1750-3639.2008.00181.x; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat EA, 1991, SEQUENCES PROTEINS I; KNAPPIK A, 1995, PROTEIN ENG, V8, P81, DOI 10.1093/protein/8.1.81; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Koren S, 2008, APPL MICROBIOL BIOT, V78, P1071, DOI 10.1007/s00253-008-1386-5; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li BH, 2007, BIOCHEM BIOPH RES CO, V357, P951, DOI 10.1016/j.bbrc.2007.04.039; Ludewigs H, 2007, EXPERT REV ANTI-INFE, V5, P613, DOI 10.1586/14787210.5.4.613; Luo GX, 2003, J IMMUNOL METHODS, V275, P31, DOI 10.1016/S0022-1759(02)00542-2; MICHAEL SF, 1994, BIOTECHNIQUES, V16, P410; Mirick GR, 2004, Q J NUCL MED MOL IM, V48, P251; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; Muzard J, 2009, FEBS J, V276, P4207, DOI 10.1111/j.1742-4658.2009.07129.x; PADLAN EA, 1991, MOL IMMUNOL, V28, P489, DOI 10.1016/0161-5890(91)90163-E; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; PEDERSEN JT, 1994, J MOL BIOL, V235, P959, DOI 10.1006/jmbi.1994.1050; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Roguska MA, 1996, PROTEIN ENG, V9, P895, DOI 10.1093/protein/9.10.895; Sadowski MJ, 2009, NEUROBIOL DIS, V34, P267, DOI 10.1016/j.nbd.2009.01.013; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Serbec VC, 2004, J BIOL CHEM, V279, P3694, DOI 10.1074/jbc.M310868200; Sigurdsson EM, 2003, NEUROSCI LETT, V336, P185, DOI 10.1016/S0304-3940(02)01192-8; Skrlj N, 2010, APPL BIOCHEM BIOTECH, V160, P1808, DOI 10.1007/s12010-009-8699-4; Skrlj N, 2009, PROTEIN EXPRES PURIF, V64, P198, DOI 10.1016/j.pep.2008.10.019; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Ulrih NP, 2006, BIOCHEM BIOPH RES CO, V344, P1320, DOI 10.1016/j.bbrc.2006.04.046; Venturini AC, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-16; Verma R, 1998, J IMMUNOL METHODS, V216, P165, DOI 10.1016/S0022-1759(98)00077-5; Vranac T, 2006, PEPTIDES, V27, P2695, DOI 10.1016/j.peptides.2006.05.026; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; White AR, 2003, J NEUROCHEM, V87, P801, DOI 10.1046/j.1471-4159.2003.02064.x; Wuertzer CA, 2008, MOL THER, V16, P481, DOI 10.1038/sj.mt.6300387; Zhang W, 2005, MOL IMMUNOL, V42, P1445, DOI 10.1016/j.molimm.2005.01.015	57	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15783	10.1371/journal.pone.0015783	http://dx.doi.org/10.1371/journal.pone.0015783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283753	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522200013
J	White, BR; Bauer, AQ; Snyder, AZ; Schlaggar, BL; Lee, JM; Culver, JP				White, Brian R.; Bauer, Adam Q.; Snyder, Abraham Z.; Schlaggar, Bradley L.; Lee, Jin-Moo; Culver, Joseph P.			Imaging of Functional Connectivity in the Mouse Brain	PLOS ONE			English	Article							RAT SOMATOSENSORY CORTEX; RESTING-STATE; DEFAULT NETWORK; VISUAL-CORTEX; BLOOD-FLOW; NEURODEGENERATIVE DISEASES; HEMOGLOBIN CONCENTRATION; STRUCTURAL CONNECTIVITY; HEMODYNAMIC-RESPONSE; NEURONAL-ACTIVITY	Functional neuroimaging (e.g., with fMRI) has been difficult to perform in mice, making it challenging to translate between human fMRI studies and molecular and genetic mechanisms. A method to easily perform large-scale functional neuroimaging in mice would enable the discovery of functional correlates of genetic manipulations and bridge with mouse models of disease. To satisfy this need, we combined resting-state functional connectivity mapping with optical intrinsic signal imaging (fcOIS). We demonstrate functional connectivity in mice through highly detailed fcOIS mapping of resting-state networks across most of the cerebral cortex. Synthesis of multiple network connectivity patterns through iterative parcellation and clustering provides a comprehensive map of the functional neuroarchitecture and demonstrates identification of the major functional regions of the mouse cerebral cortex. The method relies on simple and relatively inexpensive camera-based equipment, does not require exogenous contrast agents and involves only reflection of the scalp (the skull remains intact) making it minimally invasive. In principle, fcOIS allows new paradigms linking human neuroscience with the power of molecular/genetic manipulations in mouse models.	[White, Brian R.; Culver, Joseph P.] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [White, Brian R.; Bauer, Adam Q.; Snyder, Abraham Z.; Schlaggar, Bradley L.; Culver, Joseph P.] Washington Univ, Dept Radiol, St Louis, MO USA; [Snyder, Abraham Z.; Schlaggar, Bradley L.; Lee, Jin-Moo] Washington Univ, Dept Neurol, St Louis, MO USA; [Schlaggar, Bradley L.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO USA; [Schlaggar, Bradley L.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Culver, Joseph P.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	White, BR (corresponding author), Washington Univ, Dept Phys, St Louis, MO 63130 USA.	culverj@mir.wustl.edu	Schlaggar, Bradley/AAZ-4153-2020; Bullmore, Ed/C-1706-2012; White, Brian/C-8269-2019; Lee, Jin-Moo/K-2024-2015	Bullmore, Ed/0000-0002-8955-8283; White, Brian/0000-0001-5196-2339; Lee, Jin-Moo/0000-0002-3979-0906	NIH [R01-EB008085, R01-EB009233, T90-DA022871, P01-NS32636]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008085, R01EB009233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS032636, R01NS084028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by NIH grants R01-EB008085 (J.P.C.), R01-EB009233 (J.P.C.), T90-DA022871 (Imaging Science Fellowship, B.R.W.), and P01-NS32636 (L.J-M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SA, 2007, NMR BIOMED, V20, P200, DOI 10.1002/nbm.1167; ARRIDGE SR, 1992, PHYS MED BIOL, V37, P1531, DOI 10.1088/0031-9155/37/7/005; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bouchard MB, 2009, OPT EXPRESS, V17, P15670, DOI 10.1364/OE.17.015670; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Culver JP, 2005, NEUROIMAGE, V27, P947, DOI 10.1016/j.neuroimage.2005.05.052; Culver JP, 2003, J CEREBR BLOOD F MET, V23, P911, DOI 10.1097/01.WCB.0000076703.71231.BB; Devor A, 2005, P NATL ACAD SCI USA, V102, P3822, DOI 10.1073/pnas.0407789102; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Dunn AK, 2005, NEUROIMAGE, V27, P279, DOI 10.1016/j.neuroimage.2005.04.024; Dunn AK, 2003, OPT LETT, V28, P28, DOI 10.1364/OL.28.000028; Evans A.C., 1993, NUCL SCI S MED IM C, P1813, DOI DOI 10.1109/NSSMIC.1993.373602; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Franceschini MA, 2010, NEUROIMAGE, V51, P1367, DOI 10.1016/j.neuroimage.2010.03.060; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hillman EMC, 2007, NEUROIMAGE, V35, P89, DOI 10.1016/j.neuroimage.2006.11.032; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1738, DOI 10.1016/j.neuroimage.2007.05.061; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Leingartner A, 2007, P NATL ACAD SCI USA, V104, P4153, DOI 10.1073/pnas.0611723104; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Martin C, 2006, NEUROIMAGE, V32, P33, DOI 10.1016/j.neuroimage.2006.02.021; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054; Prahl S, 2002, OPTICAL ABSORPTION H; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sheth SA, 2004, J NEUROSCI, V24, P634, DOI 10.1523/JNEUROSCI.4526-03.2004; SMYSER CD, 2010, CEREBRAL CO IN PRESS; Strome EM, 2007, MOL IMAGING BIOL, V9, P186, DOI 10.1007/s11307-007-0093-4; TALARAICH J, 1988, COPLANAR STEREOTACTI; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; White BR, 2009, NEUROIMAGE, V47, P148, DOI 10.1016/j.neuroimage.2009.03.058; Williams KA, 2010, MAGN RESON IMAGING, V28, P995, DOI 10.1016/j.mri.2010.03.007; Woolsey TA, 1996, CEREB CORTEX, V6, P647, DOI 10.1093/cercor/6.5.647; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063	60	161	164	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16322	10.1371/journal.pone.0016322	http://dx.doi.org/10.1371/journal.pone.0016322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283729	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200049
J	Luque, RM; Lin, Q; Cordoba-Chacon, J; Subbaiah, PV; Buch, T; Waisman, A; Vankelecom, H; Kineman, RD				Luque, Raul M.; Lin, Qing; Cordoba-Chacon, Jose; Subbaiah, Papasani V.; Buch, Thorsten; Waisman, Ari; Vankelecom, Hugo; Kineman, Rhonda D.			Metabolic Impact of Adult-Onset, Isolated, Growth Hormone Deficiency (AOiGHD) Due to Destruction of Pituitary Somatotropes	PLOS ONE			English	Article							INCREASED INSULIN SENSITIVITY; DIET-INDUCED OBESITY; RECEPTOR GENE; FACTOR-I; HYPOTHALAMIC EXPRESSION; REPLACEMENT THERAPY; GLUCOSE; INHIBITION; MOUSE; LIVER	Growth hormone (GH) inhibits fat accumulation and promotes protein accretion, therefore the fall in GH observed with weight gain and normal aging may contribute to metabolic dysfunction. To directly test this hypothesis a novel mouse model of adult onset-isolated GH deficiency (AOiGHD) was generated by cross breeding rat GH promoter-driven Cre recombinase mice (Cre) with inducible diphtheria toxin receptor mice (iDTR) and treating adult Cre(+/-), iDTR(+/-) offspring with DT to selectively destroy the somatotrope population of the anterior pituitary gland, leading to a reduction in circulating GH and IGF-I levels. DT-treated Cre(-/-), iDTR(+/-) mice were used as GH-intact controls. AOiGHD improved whole body insulin sensitivity in both low-fat and high-fat fed mice. Consistent with improved insulin sensitivity, indirect calorimetry revealed AOiGHD mice preferentially utilized carbohydrates for energy metabolism, as compared to GH-intact controls. In high-fat, but not low-fat fed AOiGHD mice, fat mass increased, hepatic lipids decreased and glucose clearance and insulin output were impaired. These results suggest the age-related decline in GH helps to preserve systemic insulin sensitivity, and in the context of moderate caloric intake, prevents the deterioration in metabolic function. However, in the context of excess caloric intake, low GH leads to impaired insulin output, and thereby could contribute to the development of diabetes.	[Luque, Raul M.; Lin, Qing; Kineman, Rhonda D.] Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL USA; [Luque, Raul M.; Lin, Qing; Subbaiah, Papasani V.; Kineman, Rhonda D.] Univ Illinois, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL USA; [Luque, Raul M.; Cordoba-Chacon, Jose] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Luque, Raul M.; Cordoba-Chacon, Jose] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Cordoba, Spain; [Buch, Thorsten] Univ Zurich Hosp, Dept Pathol, Inst Expt Immunol, Neuroimmunol Div, CH-8091 Zurich, Switzerland; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Biol, Mainz, Germany; [Vankelecom, Hugo] Katholieke Univ Leuven, Lab Tissue Plast, Dept Mol Cell Biol, Leuven, Belgium	US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Zurich; University Zurich Hospital; Institute of Molecular Biology (IMB); Johannes Gutenberg University of Mainz; KU Leuven	Luque, RM (corresponding author), Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL USA.	Kineman@uic.edu	Cordoba-Chacon, Jose/AAH-5753-2019; Waisman, Ari/C-7383-2015; Subbaiah, Papasani/U-1104-2019; Kineman, Rhonda D/H-2221-2011; Buch, Thorsten/P-1659-2019; Raul, Luque Huertas/M-6948-2018	Cordoba-Chacon, Jose/0000-0001-8787-2706; Waisman, Ari/0000-0003-4304-8234; Kineman, Rhonda D/0000-0001-7322-1152; Buch, Thorsten/0000-0002-2236-9074; Vankelecom, Hugo/0000-0002-2251-7284; Luque, Raul M./0000-0002-7585-1913	Department of Veterans Affairs; Veterans Health Administration; Office of Research and Development; NIH [AG-031465, HL68585, DK78165]; Programa Ramon y Cajal [RYC-2007-00186]; del Ministerio de Educacion y Ciencia e Innovacion [JC2008-00220, BFU2008-01136/BFI]; Fondo de Investigacion sanitaria del, Spain [ISCIII FI06/00804]; Fund for Scientific Research (F.W.O.)-Flanders (Belgium); Research Fund of the K.U.Leuven; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL068585, R01HL068585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088133, R21DK078165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG031465] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Programa Ramon y Cajal(Spanish Government); del Ministerio de Educacion y Ciencia e Innovacion(German Research Foundation (DFG)); Fondo de Investigacion sanitaria del, Spain; Fund for Scientific Research (F.W.O.)-Flanders (Belgium)(FWO); Research Fund of the K.U.Leuven; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development Merit Award and NIH AG-031465 (to RDK); Grants from Programa Ramon y Cajal RYC-2007-00186, Programa Jose Castillejo JC2008-00220 and BFU2008-01136/BFI del Ministerio de Educacion y Ciencia e Innovacion (to RML) and Fondo de Investigacion sanitaria del ISCIII FI06/00804 (to JCC), Spain; NIH HL68585 and DK78165 (to PVS); Fund for Scientific Research (F.W.O.)-Flanders (Belgium) and the Research Fund of the K.U.Leuven (to HV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attallah H, 2006, GROWTH HORM IGF RES, V16, pS62, DOI 10.1016/j.ghir.2006.03.004; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOYLE PJ, 1992, DIABETOLOGIA, V35, P372, DOI 10.1007/BF00401205; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Christ ER, 2003, CLIN ENDOCRINOL, V58, P309, DOI 10.1046/j.1365-2265.2003.01714.x; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; del Rincon JP, 2007, DIABETES, V56, P1638, DOI 10.2337/db06-0299; DELEHAYEZERVAS MC, 1994, J CLIN ENDOCR METAB, V78, P1473; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Frick F, 2001, AM J PHYSIOL-ENDOC M, V281, pE1230, DOI 10.1152/ajpendo.2001.281.6.E1230; Giovannini S, 2008, MECH AGEING DEV, V129, P593, DOI 10.1016/j.mad.2008.08.001; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Groop L, 2005, HORM RES, V64, P45, DOI 10.1159/000089317; Guo YB, 2005, ENDOCRINOLOGY, V146, P2602, DOI 10.1210/en.2004-1203; Hersch EC, 2008, CLIN INTERV AGING, V3, P121; Imrie H, 2009, ENDOCRINOLOGY, V150, P4575, DOI 10.1210/en.2008-1641; Jensen J, 2005, J ENDOCRINOL, V187, P25, DOI 10.1677/joe.1.06086; Jorgensen JOL, 2004, HORM RES, V62, P51, DOI 10.1159/000080499; Kanety H, 2009, EUR J ENDOCRINOL, V161, P837, DOI 10.1530/EJE-09-0419; Kappeler L, 2009, ENDOCRINOLOGY, V150, P314, DOI 10.1210/en.2008-0981; Lanes Roberto, 2004, Pediatr Endocrinol Rev, V2, P209; Lindberg K, 2005, J MOL ENDOCRINOL, V35, P231, DOI 10.1677/jme.1.01840; Liu JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE405, DOI 10.1152/ajpendo.00423.2003; Loh DH, 2008, NEUROENDOCRINOLOGY, V88, P246, DOI 10.1159/000140676; Luque RM, 2006, ENDOCRINOLOGY, V147, P2754, DOI 10.1210/en.2005-1549; Luque RM, 2007, ENDOCRINOLOGY, V148, P300, DOI 10.1210/en.2006-0592; Luque RM, 2007, ENDOCRINOLOGY, V148, P4601, DOI 10.1210/en.2007-0500; Luque RM, 2007, ENDOCRINOLOGY, V148, P1946, DOI 10.1210/en.2006-1542; Mauras N, 2000, J CLIN ENDOCR METAB, V85, P1686, DOI 10.1210/jc.85.4.1686; Oliveira JLM, 2006, J CLIN ENDOCR METAB, V91, P2093, DOI 10.1210/jc.2005-2571; NIELSEN JH, 1989, MOL ENDOCRINOL, V3, P165, DOI 10.1210/mend-3-1-165; NIELSEN JH, 1990, BIOMED BIOCHIM ACTA, V49, P1151; Pereira RMC, 2007, J CLIN ENDOCR METAB, V92, P2353, DOI 10.1210/jc.2007-0092; Riachi M, 2004, CAN J PHYSIOL PHARM, V82, P1075, DOI [10.1139/y04-117, 10.1139/Y04-117]; Rosenfalck AM, 2000, J CLIN ENDOCR METAB, V85, P4173, DOI 10.1210/jc.85.11.4173; Sasaki-Suzuki N, 2009, J BIOL CHEM, V284, P6061, DOI 10.1074/jbc.M808282200; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Segerlantz M, 2001, J CLIN ENDOCR METAB, V86, P5813, DOI 10.1210/jc.86.12.5813; Segerlantz M, 2003, EUR J ENDOCRINOL, V149, P511, DOI 10.1530/eje.0.1490511; Short KR, 2008, J CLIN ENDOCR METAB, V93, P597, DOI 10.1210/jc.2007-1814; TRIMBLE ER, 1980, J CLIN ENDOCR METAB, V51, P626, DOI 10.1210/jcem-51-3-626; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venken K, 2007, J BONE MINER RES, V22, P72, DOI 10.1359/JBMR.060911; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; Williams TD, 2003, CLIN EXP PHARMACOL P, V30, P769, DOI 10.1046/j.1440-1681.2003.t01-1-03808.x; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yuen KCJ, 2007, DIABETES OBES METAB, V9, P11, DOI 10.1111/j.1463-1326.2006.00591.x; Yuen KCJ, 2006, GROWTH HORM IGF RES, V16, pS55, DOI 10.1016/j.ghir.2006.03.001	50	60	63	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15767	10.1371/journal.pone.0015767	http://dx.doi.org/10.1371/journal.pone.0015767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283519	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000286520600011
J	Butler, JS; Zurita-Lopez, CI; Clarke, SG; Bedford, MT; Dent, SYR				Butler, Jill S.; Zurita-Lopez, Cecilia I.; Clarke, Steven G.; Bedford, Mark T.; Dent, Sharon Y. R.			Protein-arginine Methyltransferase 1 (PRMT1) Methylates Ash2L, a Shared Component of Mammalian Histone H3K4 Methyltransferase Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; N-METHYLTRANSFERASE; IN-VIVO; SYMMETRIC DIMETHYLARGININE; TRANSCRIPTIONAL REGULATION; SUBSTRATE-SPECIFICITY; CELL-PROLIFERATION; DNA METHYLATION; GENE EZH2; MLL	Multiple enzymes and enzymatic complexes coordinately regulate the addition and removal of post-translational modifications on histone proteins. The oncoprotein Ash2L is a component of the mixed lineage leukemia (MLL) family members 1-4, Setd1A, and Setd1B mammalian histone H3K4 methyltransferase complexes and is essential to maintain global trimethylation of histone H3K4. However, regulation of these complexes at the level of expression and activity remains poorly understood. In this report, we demonstrate that Ash2L is methylated on arginine residues both in vitro and in cells. We found that both protein-arginine methyltransferases 1 and 5 methylate Arg-296 within Ash2L. These findings are the first to demonstrate that post-translational modifications occur on the Ash2L protein and provide a novel example of cross-talk between chromatin-modifying enzyme complexes.	[Butler, Jill S.; Bedford, Mark T.; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr Sci Pk, Virginia Harris Cockrell Canc Res Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Butler, Jill S.; Bedford, Mark T.; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Butler, Jill S.; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA; [Zurita-Lopez, Cecilia I.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles	Dent, SYR (corresponding author), Univ Texas MD Anderson Canc Ctr Sci Pk, Virginia Harris Cockrell Canc Res Ctr, Dept Mol Carcinogenesis, POB 389, Smithville, TX 78957 USA.	sroth@mdanderson.org	Bedford, Mark T/E-7856-2011; Zurita-Lopez, Cecilia I./AAC-6509-2020; Dent, Sharon YR/F-1746-2011	Dent, Sharon YR/0000-0002-4824-3269; Napierala, Jill/0000-0002-5141-0822	National Institutes of Health [T32 CA00929930, T32 CA929931A1, GM026020, F31 GM078761]; Cancer Prevention Research Institute of Texas; Welch Foundation; NATIONAL CANCER INSTITUTE [R21CA092993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, F31GM078761, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Training Grants T32 CA00929930 and T32 CA929931A1 (to J. S. B.) and Grants GM026020 (to S. G. C.) and F31 GM078761 (to C. I. Z.-L.). This work was also supported by the Cancer Prevention Research Institute of Texas and the Welch Foundation (to S. Y. R. D.).	Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Faber J, 2009, BLOOD, V113, P2375, DOI 10.1182/blood-2007-09-113597; Fisk JC, 2010, EUKARYOT CELL, V9, P866, DOI 10.1128/EC.00018-10; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; HARLOW E, 1999, USING ANTIBODIES LAB, P77; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Ikegawa S, 1999, CYTOGENET CELL GENET, V84, P167, DOI 10.1159/000015248; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; SHEARN A, 1971, P NATL ACAD SCI USA, V68, P2594, DOI 10.1073/pnas.68.10.2594; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; Tan CC, 2008, P NATL ACAD SCI USA, V105, P7472, DOI 10.1073/pnas.0711896105; Tan CP, 2006, MOL CELL BIOL, V26, P7224, DOI 10.1128/MCB.00473-06; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang JH, 2001, J MOL MED, V79, P399, DOI 10.1007/s001090100222; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	68	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.202416	http://dx.doi.org/10.1074/jbc.M110.202416			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285357	hybrid, Green Published			2022-12-25	WOS:000289077500038
J	Delgado-Olguin, P; Brand-Arzamendi, K; Scott, IC; Jungblut, B; Stainier, DY; Bruneau, BG; Recillas-Targa, F				Delgado-Olguin, Paul; Brand-Arzamendi, Koroboshka; Scott, Ian C.; Jungblut, Benno; Stainier, Didier Y.; Bruneau, Benoit G.; Recillas-Targa, Felix			CTCF Promotes Muscle Differentiation by Modulating the Activity of Myogenic Regulatory Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SARCOGLYCAN PROMOTER; DNA-BINDING; ZEBRAFISH GASTRULATION; EXTENSION MOVEMENTS; SKELETAL MYOGENESIS; GENE-EXPRESSION; DISTINCT ROLES; PROTEIN CTCF; HUMAN GENOME; MYOD	CTCF nuclear factor regulates many aspects of gene expression, largely as a transcriptional repressor or via insulator function. Its roles in cellular differentiation are not clear. Here we show an unexpected role for CTCF in myogenesis. Ctcf is expressed in myogenic structures during mouse and zebrafish development. Gain-and loss-of-function approaches in C2C12 cells revealed CTCF as a modulator of myogenesis by regulating muscle-specific gene expression. We addressed the functional connection between CTCF and myogenic regulatory factors (MRFs). CTCF enhances the myogenic potential of MyoD and myogenin and establishes direct interactions with MyoD, indicating that CTCF regulates MRF-mediated muscle differentiation. Indeed, CTCF modulates functional interactions between MyoD and myogenin in co-activation of muscle-specific gene expression and facilitates MyoD recruitment to a muscle-specific promoter. Finally, ctcf loss-of-function experiments in zebrafish embryos revealed a critical role of CTCF in myogenic development and linked CTCF to broader aspects of development via regulation of Wnt signaling. We conclude that CTCF modulates MRF functional interactions in the orchestration of myogenesis.	[Delgado-Olguin, Paul; Bruneau, Benoit G.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Brand-Arzamendi, Koroboshka; Stainier, Didier Y.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Stainier, Didier Y.; Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Delgado-Olguin, Paul; Recillas-Targa, Felix] Univ Nacl Autonoma Mexico, Dept Mol Genet, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Brand-Arzamendi, Koroboshka; Scott, Ian C.] Univ Toronto, Hosp Sick Children, Dept Mol & Med Genet, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Brand-Arzamendi, Koroboshka; Jungblut, Benno] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidad Nacional Autonoma de Mexico; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Max Planck Society	Bruneau, BG (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	bbruneau@gladstone.ucsf.edu; frecilla@ifc.unam.mx	Olguin, Paul Delgado/H-9293-2019	Olguin, Paul Delgado/0000-0002-5355-247X; Stainier, Didier/0000-0002-0382-0026; Bruneau, Benoit/0000-0002-0804-7597; Scott, Ian/0000-0001-6665-1410	National Institutes of Health [HL54737]; Direccion General de Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico [IX230104, IN209403, IN214407]; Consejo Nacional de Ciencia y Tecnologia [42653-Q, 58767]; Third World Academy of Sciences [01-055 RG/BIO/LA]; J. David Gladstone Institutes; California Institute of Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direccion General de Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Third World Academy of Sciences; J. David Gladstone Institutes(University of California System); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL54737 (to D. Y. S.). This work was also supported by Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico Grants IX230104, IN209403, and IN214407; Consejo Nacional de Ciencia y Tecnologia Grants 42653-Q and 58767; and Third World Academy of Sciences Grant 01-055 RG/BIO/LA (to F.R.-T.); and the J. David Gladstone Institutes (to B. G. B.).; Supported by the California Institute of Regenerative Medicine.	Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Borello U, 2006, DEVELOPMENT, V133, P3723, DOI 10.1242/dev.02517; Bruneau BG, 2001, MOL CELL BIOL, V21, P1730, DOI 10.1128/MCB.21.5.1730-1736.2001; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; Delgado MD, 1999, FEBS LETT, V444, P5, DOI 10.1016/S0014-5793(99)00013-7; Delgado-Olguin P, 2004, BIOCHEM BIOPH RES CO, V319, P1032, DOI 10.1016/j.bbrc.2004.05.074; Delgado-Olguin P, 2008, BBA-GENE REGUL MECH, V1779, P74, DOI 10.1016/j.bbagrm.2007.09.002; Delgado-Olguin P, 2006, BBA-GENE STRUCT EXPR, V1759, P240, DOI 10.1016/j.bbaexp.2006.04.007; Dilworth FJ, 2004, P NATL ACAD SCI USA, V101, P11593, DOI 10.1073/pnas.0404192101; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Geetha-Loganathan P, 2005, DEV BIOL, V288, P221, DOI 10.1016/j.ydbio.2005.09.035; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Heidt AB, 2007, MOL CELL BIOL, V27, P5910, DOI 10.1128/MCB.01700-06; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Kim CH, 2008, MOL CELL BIOL, V28, P2941, DOI 10.1128/MCB.01682-07; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; OTT MO, 1991, DEVELOPMENT, V111, P1097; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pugacheva EM, 2006, GENE, V375, P26, DOI 10.1016/j.gene.2006.01.036; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Recillas-Targa F, 2006, J CELL MOL MED, V10, P554, DOI 10.1111/j.1582-4934.2006.tb00420.x; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Seo J, 2010, J CELL BIOCHEM, V110, P1022, DOI 10.1002/jcb.22616; Soshnikova N, 2010, DEV CELL, V19, P819, DOI 10.1016/j.devcel.2010.11.009; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; STAINIER DYR, 1990, P NATL ACAD SCI USA, V87, P923, DOI 10.1073/pnas.87.3.923; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Weinberg ES, 1996, DEVELOPMENT, V122, P271; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yin CY, 2007, DEV BIOL, V304, P141, DOI 10.1016/j.ydbio.2006.12.030; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	60	35	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.164574	http://dx.doi.org/10.1074/jbc.M110.164574			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288905	Green Published, hybrid			2022-12-25	WOS:000289077500062
J	Schmid, AW; Condemi, E; Tuchscherer, G; Chiappe, D; Mutter, M; Vogel, H; Moniatte, M; Tsybin, YO				Schmid, Adrien W.; Condemi, Enrico; Tuchscherer, Gabriele; Chiappe, Diego; Mutter, Manfred; Vogel, Horst; Moniatte, Marc; Tsybin, Yury O.			Tissue Transglutaminase-mediated Glutamine Deamidation of beta-Amyloid Peptide Increases Peptide Solubility, Whereas Enzymatic Cross-linking and Peptide Fragmentation May Serve as Molecular Triggers for Rapid Peptide Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE BRAIN; LONG-TERM POTENTIATION; ALPHA-SYNUCLEIN; ASPARAGINE DEAMIDATION; SYNAPTIC PLASTICITY; CEREBROSPINAL-FLUID; PARKINSONS-DISEASE; MASS-SPECTROMETRY; SER(26) RESIDUE; BINDING DOMAIN	Tissue transglutaminase (TGase) has been implicated in a number of cellular processes and disease states, where the enzymatic actions of TGase may serve in both, cell survival and apoptosis. To date, the precise functional properties of TGase in cell survival or cell death mechanisms still remain elusive. TGase-mediated cross-linking has been reported to account for the formation of insoluble lesions in conformational diseases. We report here that TGase induces intramolecular cross-linking of beta-amyloid peptide (A beta), resulting in structural changes of monomeric A beta. Using high resolution mass spectrometry (MS) of cross-linkedA beta peptides, we observed a shift in mass, which is, presumably associated with the loss of NH3 due to enzymatic transamidation activity and hence intramolecular peptide cross-linking. We have observed that a large population of A beta monomers contained an 0.984 Da increase in mass at a glutamine residue, indicating that glutamine 15 serves as an indispensable substrate in TGase-mediated deamidation to glutamate 15. We provide strong analytical evidence on TGase-mediated A beta peptide dimerization, through covalent intermolecular cross-linking and hence the formation of A beta(1-40) dimers. Our in depth analyses indicate that TGase-induced post-translational modifications of A beta peptide may serve as an important seed for aggregation.	[Schmid, Adrien W.; Chiappe, Diego; Moniatte, Marc] Ecole Polytech Fed Lausanne, Prote Core Facil, CH-1015 Lausanne, Switzerland; Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Schmid, Adrien W.; Chiappe, Diego; Moniatte, Marc] Ecole Polytech Fed Lausanne, AI 0151, Stn 15, Prote Core Facil, CH-1015 Lausanne, Switzerland; [Condemi, Enrico; Tuchscherer, Gabriele; Vogel, Horst] Ecole Polytech Fed Lausanne, Stn 6, Lab Phys Chem Polymers & Membranes, CH-1015 Lausanne, Switzerland; [Mutter, Manfred] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Tsybin, Yury O.] Ecole Polytech Fed Lausanne, Biomol Mass Spectrometry Lab, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Schmid, AW (corresponding author), Ecole Polytech Fed Lausanne, AI 0151, Stn 15, Prote Core Facil, CH-1015 Lausanne, Switzerland.	adrien.schmid@epfl.ch	Vogel, Horst/AAJ-5490-2021; Schmid, Adrien/CAG-1527-2022; Tsybin, Yury/AAN-9764-2020; Tsybin, Yury O/A-2446-2011	Tsybin, Yury/0000-0001-7533-0774; Schmid, Adrien W./0000-0001-6671-7950; Moniatte, Marc/0000-0003-2235-4523	Biomedizin-Naturwissenschaft-Forschung (University of Bern, Switzerland); Ecole Polytechnique Federale Lausanne, Switzerland; Swiss National Science Foundation [200021-125147/1]; University of Bern, Switzerland	Biomedizin-Naturwissenschaft-Forschung (University of Bern, Switzerland); Ecole Polytechnique Federale Lausanne, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Bern, Switzerland	This work was supported by the Biomedizin-Naturwissenschaft-Forschung (University of Bern, Switzerland), Proteomics Core Facility (Ecole Polytechnique Federale Lausanne, Switzerland), Ecole Polytechnique Federale Lausanne, Switzerland, and Swiss National Science Foundation project Grant 200021-125147/1 (to Y. O. T.).; We are grateful to Dr. Manfredo Quadroni and Dr. Patrice Waridel (Protein Analysis Facility, University of Lausanne) for preliminary analyses on Orbitrap. We thank Romain Hamelin (PCF) for help with Scaffold and MASCOT profiling. We thank Prof. Dominic Walsh (Conway Institute, University College of Dublin) for critical review and discussion on the preliminary data and the BNF program at the University of Bern, Switzerland, for financial support.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Andringa G, 2004, FASEB J, V18, P932, DOI 10.1096/fj.03-0829fje; Bonelli RM, 2002, NEUROBIOL DIS, V11, P106, DOI 10.1006/nbdi.2002.0535; Boros S, 2008, EXP EYE RES, V86, P383, DOI 10.1016/j.exer.2007.11.011; CHAN WC, 2000, FMOC SOLID PHASE PEP, P1; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Dorum S, 2009, J PROTEOME RES, V8, P1748, DOI 10.1021/pr800960n; DUDEK SM, 1994, BRAIN RES, V651, P129, DOI 10.1016/0006-8993(94)90688-2; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Fantini J, 2003, CELL MOL LIFE SCI, V60, P1027, DOI 10.1007/s00018-003-3003-1; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Fornelli L, 2011, CHEM-EUR J, V17, P486, DOI 10.1002/chem.201002483; Halverson RA, 2005, J NEUROSCI, V25, P1226, DOI 10.1523/JNEUROSCI.3263-04.2005; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; Hebbar S, 2008, J LIPID RES, V49, P1077, DOI 10.1194/jlr.M700543-JLR200; IKURA K, 1993, FEBS LETT, V326, P109, DOI 10.1016/0014-5793(93)81772-R; Jeitner TM, 2009, J NEUROCHEM, V109, P160, DOI 10.1111/j.1471-4159.2009.05843.x; Johnson GVW, 1997, BRAIN RES, V751, P323, DOI 10.1016/S0006-8993(96)01431-X; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Kaneko I, 2001, NEUROSCIENCE, V104, P1003, DOI 10.1016/S0306-4522(01)00155-5; Kim SY, 1999, J BIOL CHEM, V274, P30715, DOI 10.1074/jbc.274.43.30715; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Kubo T, 2003, J NEUROPATH EXP NEUR, V62, P248, DOI 10.1093/jnen/62.3.248; Lam HT, 2007, J PROTEOME RES, V6, P1666, DOI 10.1021/pr0606023; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li HY, 2010, BIOCHEMISTRY-US, V49, P6358, DOI 10.1021/bi100773g; Li XJ, 2010, ANAL CHEM, V82, P3606, DOI 10.1021/ac9028467; Maggio N, 2001, BRAIN RES BULL, V56, P173, DOI 10.1016/S0361-9230(01)00649-9; MILHAUD PG, 1980, BIOCHIM BIOPHYS ACTA, V630, P476, DOI 10.1016/0304-4165(80)90002-1; Mishizen-Eberz AJ, 2003, J NEUROCHEM, V86, P836, DOI 10.1046/j.1471-4159.2003.01878.x; Mishra S, 2007, J BIOL CHEM, V282, P18108, DOI 10.1074/jbc.M607413200; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nemes Z, 2009, J BIOL CHEM, V284, P27252, DOI 10.1074/jbc.M109.033969; Nilsson MR, 2002, PROTEIN SCI, V11, P342, DOI 10.1110/ps.48702; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Oliverio S, 1997, MOL CELL BIOL, V17, P6040, DOI 10.1128/MCB.17.10.6040; Palmblad M, 2002, J BIOL CHEM, V277, P19506, DOI 10.1074/jbc.M112218200; Pittenauer E, 2006, J MASS SPECTROM, V41, P421, DOI 10.1002/jms.1032; Portelius E, 2006, NEUROSCI LETT, V409, P215, DOI 10.1016/j.neulet.2006.09.044; Portelius E, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-2; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Sandmeier E, 1999, BIOCHEM BIOPH RES CO, V261, P578, DOI 10.1006/bbrc.1999.1056; Schmid AW, 2008, BRAIN RES, V1197, P135, DOI 10.1016/j.brainres.2007.11.056; Schmid AW, 2009, J BIOL CHEM, V284, P13128, DOI 10.1074/jbc.M809067200; SELKOE DJ, 1982, P NATL ACAD SCI-BIOL, V79, P6070, DOI 10.1073/pnas.79.19.6070; Sergeant N, 2003, J NEUROCHEM, V85, P1581, DOI 10.1046/j.1471-4159.2003.01818.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shimmyo Y, 2008, J NEUROSCI RES, V86, P368, DOI 10.1002/jnr.21476; TOMIYAMA T, 1994, J BIOL CHEM, V269, P10205; Wakshlag JJ, 2006, PROTEIN J, V25, P83, DOI 10.1007/s10930-006-0009-1; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Wang DS, 2008, J ALZHEIMERS DIS, V13, P53; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Warren CM, 2010, J PROTEOMICS, V73, P1551, DOI 10.1016/j.jprot.2010.03.016; Watanabe A, 1999, J BIOL CHEM, V274, P7368, DOI 10.1074/jbc.274.11.7368; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilhelmus MMM, 2009, BRAIN PATHOL, V19, P612, DOI 10.1111/j.1750-3639.2008.00197.x; Yang HQ, 2010, ELECTROPHORESIS, V31, P1764, DOI 10.1002/elps.201000027; Zhang W, 1998, ACTA NEUROPATHOL, V96, P395, DOI 10.1007/s004010050910	64	32	34	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.176149	http://dx.doi.org/10.1074/jbc.M110.176149			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21300794	Green Published, hybrid			2022-12-25	WOS:000289077500033
J	Palam, LR; Baird, TD; Wek, RC				Palam, Lakshmi Reddy; Baird, Thomas D.; Wek, Ronald C.			Phosphorylation of eIF2 Facilitates Ribosomal Bypass of an Inhibitory Upstream ORF to Enhance CHOP Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; OPEN READING FRAMES; EUKARYOTIC INITIATION-FACTOR-2; OXIDATIVE STRESS; MAMMALIAN-CELLS; GENE-EXPRESSION; MESSENGER-RNAS; REINITIATION; TRANSCRIPTION	In response to different environmental stresses, phosphorylation of eukaryotic initiation factor-2 (eIF2) rapidly reduces protein synthesis, which lowers energy expenditure and facilitates reprogramming of gene expression to remediate stress damage. Central to the changes in gene expression, eIF2 phosphorylation also enhances translation of ATF4, a transcriptional activator of genes subject to the integrated stress response (ISR). The ISR increases the expression of genes important for alleviating stress or alternatively triggering apoptosis. One ISR target gene encodes the transcriptional regulator CHOP whose accumulation is critical for stress-induced apoptosis. In this study, we show that eIF2 phosphorylation induces preferential translation of CHOP by a mechanism involving a single upstream ORF (uORF) located in the 5'-leader of the CHOP mRNA. In the absence of stress and low eIF2 phosphorylation, translation of the uORF serves as a barrier that prevents translation of the downstream CHOP coding region. Enhanced eIF2 phosphorylation during stress facilitates ribosome bypass of the uORF due to its poor start site context, and instead it allows scanning ribosomes to translate CHOP. This new mechanism of translational control explains how expression of CHOP and the fate of cells are tightly linked to the levels of phosphorylated eIF2 and stress damage.	[Palam, Lakshmi Reddy; Baird, Thomas D.; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Wek, RC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iupui.edu	palam, lakshmi reddy/H-4902-2015	Baird, Thomas/0000-0002-0280-9984	National Institutes of Health [GM49164, GM64350]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049164, R01GM064350, R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM49164 and GM64350 (to R. C. W.).	ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; Chen YJ, 2010, NUCLEIC ACIDS RES, V38, P764, DOI 10.1093/nar/gkp1034; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Do AND, 2009, PHYSIOL GENOMICS, V38, P328, DOI 10.1152/physiolgenomics.90396.2008; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Ivanov IP, 2010, P NATL ACAD SCI USA, V107, P18056, DOI 10.1073/pnas.1009269107; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Spirin AS, 2009, BIOCHEMISTRY-US, V48, P10688, DOI 10.1021/bi901379a; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2009, CELL METAB, V10, P1, DOI 10.1016/j.cmet.2009.06.005; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	44	256	273	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10939	10949		10.1074/jbc.M110.216093	http://dx.doi.org/10.1074/jbc.M110.216093			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21285359	Green Published, hybrid			2022-12-25	WOS:000288797100006
J	Luque, SP; Fried, R				Luque, Sebastian P.; Fried, Roland			Recursive Filtering for Zero Offset Correction of Diving Depth Time Series with GNU R Package diveMove	PLOS ONE			English	Article							LEATHERBACK TURTLES; DERMOCHELYS-CORIACEA; BEHAVIOR; MIGRATION; PENGUINS	Zero offset correction of diving depth measured by time-depth recorders is required to remove artifacts arising from temporal changes in accuracy of pressure transducers. Currently used methods for this procedure are in the proprietary software domain, where researchers cannot study it in sufficient detail, so they have little or no control over how their data were changed. GNU R package diveMove implements a procedure in the Free Software domain that consists of recursively smoothing and filtering the input time series using moving quantiles. This paper describes, demonstrates, and evaluates the proposed method by using a "perfect" data set, which is subsequently corrupted to provide input for the proposed procedure. The method is evaluated by comparing the corrected time series to the original, uncorrupted, data set from an Antarctic fur seal (Arctocephalus gazella Peters, 1875). The Root Mean Square Error of the corrected data set, relative to the "perfect" data set, was nearly identical to the magnitude of noise introduced into the latter. The method, thus, provides a flexible, reliable, and efficient mechanism to perform zero offset correction for analyses of diving behaviour. We illustrate applications of the method to data sets from four species with large differences in diving behaviour, measured using different sampling protocols and instrument characteristics.	[Luque, Sebastian P.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Fried, Roland] Tech Univ Dortmund, Fak Stat, Dortmund, Germany	University of Manitoba; Dortmund University of Technology	Luque, SP (corresponding author), Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada.	spluque@gmail.com	Fried, Roland/AAB-9091-2020	LUQUE, SONIA/0000-0002-3215-320X	Institut Polaire Francais Paul Emile Victor (IPEV); Centre National de la Recherche Scientifique	Institut Polaire Francais Paul Emile Victor (IPEV); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This research was funded by grants from Institut Polaire Francais Paul Emile Victor (IPEV) and Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Eguchi T, 2005, MAR MAMMAL SCI, V21, P283, DOI 10.1111/j.1748-7692.2005.tb01228.x; Elliott KH, 2010, AQUAT BIOL, V8, P221, DOI 10.3354/ab00236; Fossette S, 2007, MAR ECOL PROG SER, V338, P233, DOI 10.3354/meps338233; Hays GC, 2004, ANIM BEHAV, V67, P733, DOI 10.1016/j.anbehav.2003.08.011; Hooker SK, 2001, MAMMAL REV, V31, P81, DOI 10.1046/j.1365-2907.2001.00080.x; Houghton JDR, 2008, J EXP BIOL, V211, P2566, DOI 10.1242/jeb.020065; Hull CL, 2000, CAN J ZOOL, V78, P333, DOI 10.1139/cjz-78-3-333; Laidre KL, 2002, CAN J ZOOL, V80, P624, DOI 10.1139/Z02-041; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; Scheffer A, 2010, PROG OCEANOGR, V86, P232, DOI 10.1016/j.pocean.2010.04.008; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; Spence-Bailey LM, 2007, J COMP PHYSIOL B, V177, P483, DOI 10.1007/s00360-007-0146-7; Tuszynski J., 2009, CATOOLS TOOLS MOVING; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101	15	41	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e15850	10.1371/journal.pone.0015850	http://dx.doi.org/10.1371/journal.pone.0015850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297976	Green Published, Green Submitted, gold			2022-12-25	WOS:000286664100011
J	Zhu, DL; Shi, JP; Zhang, YD; Wang, BR; Liu, W; Chen, ZC; Tong, QA				Zhu, Donglin; Shi, Jingping; Zhang, Yingdong; Wang, Bianrong; Liu, Wei; Chen, Zhicong; Tong, Qiang			Central Angiotensin II Stimulation Promotes beta Amyloid Production in Sprague Dawley Rats	PLOS ONE			English	Article							AT(1) RECEPTOR EXPRESSION; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; PRECURSOR PROTEIN; ALPHA-SECRETASE; UP-REGULATION; PARAVENTRICULAR NUCLEUS; COGNITIVE IMPAIRMENT; STRESS INCREASES; TAU PATHOLOGY	Background: Stress and various stress hormones, including catecholamines and glucocorticoids, have recently been implicated in the pathogenesis of Alzheimer's disease (AD), which represents the greatest unresolved medical challenge in neurology. Angiotensin receptor blockers have shown benefits in AD and prone-to-AD animals. However, the mechanisms responsible for their efficacy remain unknown, and no studies have directly addressed the role of central angiotensin II (Ang II), a fundamental stress hormone, in the pathogenesis of AD. The present study focused on the role of central Ang II in amyloidogenesis, the critical process in AD neuropathology, and aimed to provide direct evidence for the role of this stress hormone in the pathogenesis of AD. Methodology/Principal Findings: Increased central Ang II levels during stress response were modeled by intracerebroventricular (ICV) administration of graded doses of Ang II (6 ng/hr low dose, 60 ng/hr medium dose, and 600 ng/hr high dose, all delivered at a rate of 0.25 mu l/hr) to male Sprague Dawley rats (280-310 g) via osmotic pumps. After 1 week of continuous Ang II infusion, the stimulation of Ang II type 1 receptors was accompanied by the modulation of amyloid precursor protein, alpha-, beta- and gamma-secretase, and increased beta amyloid production. These effects could be completely abolished by concomitant ICV infusion of losartan, indicating that central Ang II played a causative role in these alterations. Conclusions/Significance: Central Ang II is essential to the stress response, and the results of this study suggest that increased central Ang II levels play an important role in amyloidogenesis during stress, and that central Ang II-directed stress prevention and treatment might represent a novel anti-AD strategy.	[Zhu, Donglin; Shi, Jingping; Zhang, Yingdong; Liu, Wei; Chen, Zhicong; Tong, Qiang] Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurol, Nanjing, Peoples R China; [Wang, Bianrong] Nanjing Univ, Sch Med, Dept Neurol, Nanjing 210008, Peoples R China	Nanjing Medical University; Nanjing University	Zhu, DL (corresponding author), Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurol, Nanjing, Peoples R China.	profshijp@yahoo.com.cn	Shi, Jing/HHS-6413-2022		Medical Science and Technology Development Foundation, Nanjing Department of Health [ZKX08035]	Medical Science and Technology Development Foundation, Nanjing Department of Health	This study is supported by Key Project of Medical Science and Technology Development Foundation, Nanjing Department of Health (NO.ZKX08035, http://www.njh.gov.cn/html/list_83.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA G, 1995, J NEUROENDOCRINOL, V7, P775, DOI 10.1111/j.1365-2826.1995.tb00714.x; Armando I, 2001, ENDOCRINOLOGY, V142, P3880, DOI 10.1210/en.142.9.3880; BARNES JM, 1989, BRAIN RES, V491, P136, DOI 10.1016/0006-8993(89)90095-4; BARNES JM, 1990, BRAIN RES, V507, P341, DOI 10.1016/0006-8993(90)90294-L; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Carter DB, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-6; CASTREN E, 1988, ENDOCRINOLOGY, V122, P370, DOI 10.1210/endo-122-1-370; Chan SHH, 2007, J HYPERTENS, V25, P1845, DOI 10.1097/HJH.0b013e328217b286; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Danielyan L, 2010, REJUV RES, V13, P195, DOI 10.1089/rej.2009.0944; Das U N, 2005, J Assoc Physicians India, V53, P472; de la Torre JC, 2010, J ALZHEIMERS DIS, V20, P687, DOI 10.3233/JAD-2010-091580; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Fogari R, 2003, J HUM HYPERTENS, V17, P781, DOI 10.1038/sj.jhh.1001613; Frykman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008948; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Hamdi HK, 2004, BIOCHEM BIOPH RES CO, V318, P187, DOI 10.1016/j.bbrc.2004.04.004; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Huttunen HJ, 2007, FEBS LETT, V581, P1688, DOI 10.1016/j.febslet.2007.03.056; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kuo LH, 2008, MOL BIOL CELL, V19, P4201, DOI 10.1091/mbc.E07-09-0987; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lahiri Debomoy K., 2006, Current Alzheimer Research, V3, P475, DOI 10.2174/156720506779025224; Lee S, 2008, BRAIN RES, V1207, P19, DOI 10.1016/j.brainres.2008.02.016; Lee Sebum, 2010, Front Biosci (Elite Ed), V2, P22, DOI 10.2741/e61; Leong DS, 2002, NEUROENDOCRINOLOGY, V75, P227, DOI 10.1159/000054714; Li WZ, 2010, EUR J PHARMACOL, V628, P108, DOI 10.1016/j.ejphar.2009.11.045; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Liu L, 2008, NEUROBIOL DIS, V31, P46, DOI 10.1016/j.nbd.2008.03.005; Lu J, 2008, BRAIN RES, V1219, P127, DOI 10.1016/j.brainres.2008.04.057; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mitra AK, 2010, AM J PHYSIOL-CELL PH, V299, pC561, DOI 10.1152/ajpcell.00127.2010; Mitsuda N, 2001, J BIOL CHEM, V276, P9688, DOI 10.1074/jbc.M006153200; Moellenhoff E, 2001, AM J PHYSIOL-REG I, V280, pR1095, DOI 10.1152/ajpregu.2001.280.4.R1095; Mogi M, 2008, BIOCHEM BIOPH RES CO, V375, P446, DOI 10.1016/j.bbrc.2008.08.032; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nishida Y, 2009, J BIOL CHEM, V284, P33400, DOI 10.1074/jbc.M109.054056; Pan YX, 2007, HYPERTENSION, V49, P519, DOI 10.1161/01.HYP.0000256955.74461.93; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Peng JF, 2001, REGUL PEPTIDES, V97, P91, DOI 10.1016/S0167-0115(00)00218-4; Poon IO, 2008, PHARMACOTHERAPY, V28, P366, DOI 10.1592/phco.28.3.366; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Quiroz-Baez R, 2009, NEUROCHEM INT, V55, P662, DOI 10.1016/j.neuint.2009.06.012; Raghavendra V, 2001, NEUROPEPTIDES, V35, P65, DOI 10.1054/npep.2000.0845; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; Saavedra JM, 2005, CELL MOL NEUROBIOL, V25, P485, DOI 10.1007/s10571-005-4011-5; Saavedra JM, 2007, STRESS, V10, P185, DOI 10.1080/10253890701350735; Saavedra JM, 2006, J HYPERTENS, V24, pS131, DOI 10.1097/01.hjh.0000220418.09021.ee; Salloway S, 2009, CLEV CLIN J MED, V76, P49, DOI 10.3949/ccjm.76a.072178; Savaskan E, 2001, NEUROBIOL AGING, V22, P541, DOI 10.1016/S0197-4580(00)00259-1; Savaskan E, 1991, DEMENT GERIATR COGN, V2, P314; Shelton CC, 2009, P NATL ACAD SCI USA, V106, P20228, DOI 10.1073/pnas.0910757106; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506; SUMNERS C, 1983, AM J PHYSIOL, V244, pR257, DOI 10.1152/ajpregu.1983.244.2.R257; Sumners C, 2002, CLIN EXP PHARMACOL P, V29, P483, DOI 10.1046/j.1440-1681.2002.03660.x; Takeda S, 2009, HYPERTENSION, V54, P1345, DOI 10.1161/HYPERTENSIONAHA.109.138586; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tan ZS, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt29; Tedesco MA, 1999, AM J HYPERTENS, V12, p117A; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Tota S, 2009, BEHAV BRAIN RES, V199, P235, DOI 10.1016/j.bbr.2008.11.044; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Wei SG, 2008, HYPERTENSION, V52, P679, DOI 10.1161/HYPERTENSIONAHA.108.113639; Wei SG, 2009, AM J PHYSIOL-HEART C, V296, pH1425, DOI 10.1152/ajpheart.00942.2008; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Wray S, 2009, J NEUROSCI, V29, P9665, DOI 10.1523/JNEUROSCI.2234-09.2009; Yan RQ, 2001, J BIOL CHEM, V276, P34019, DOI 10.1074/jbc.M105583200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang G, 1996, BIOL SIGNAL, V5, P1; Yang Gang, 1993, Biological Signals, V2, P166; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039; Yu NN, 2010, BRAIN RES, V1317, P305, DOI 10.1016/j.brainres.2009.12.087; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426; Zimmerman MC, 2002, CIRC RES, V91, P1038, DOI 10.1161/01.RES.0000043501.47934.FA; Zou L, 2007, CELL RES, V17, P389, DOI 10.1038/cr.2007.5	89	76	78	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16037	10.1371/journal.pone.0016037	http://dx.doi.org/10.1371/journal.pone.0016037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297982	gold, Green Submitted, Green Published			2022-12-25	WOS:000286664100012
J	Sun, XY; Hayashi, Y; Xu, S; Kanou, Y; Takagishi, Y; Tang, YP; Murata, Y				Sun, Xiao-yang; Hayashi, Yoshitaka; Xu, Sai; Kanou, Yasuhiko; Takagishi, Yoshiko; Tang, Ya-ping; Murata, Yoshiharu			Inactivation of the Rcan2 Gene in Mice Ameliorates the Age- and Diet-Induced Obesity by Causing a Reduction in Food Intake	PLOS ONE			English	Article							THYROID-HORMONE; ENERGY-EXPENDITURE; CALCINEURIN; LEPTIN; FAT; ZAKI-4; FAMILY; HYPOTHALAMUS; EXPRESSION; REGULATORS	Obesity is a serious international health problem that increases the risk of several diet-related chronic diseases. The genetic factors predisposing to obesity are little understood. Rcan2 was originally identified as a thyroid hormone-responsive gene. In the mouse, two splicing variants that harbor distinct tissue-specific expression patterns have been identified: Rcan2-3 is expressed predominately in the brain, whereas Rcan2-1 is expressed in the brain and other tissues such as the heart and skeletal muscle. Here, we show that Rcan2 plays an important role in the development of age-and diet-induced obesity. We found that although the loss of Rcan2 function in mice slowed growth in the first few weeks after birth, it also significantly ameliorated age-and diet-induced obesity in the mice by causing a reduction in food intake rather than increased energy expenditure. Rcan2 expression was most prominent in the ventromedial, dorsomedial and paraventricular hypothalamic nuclei governing energy balance. Fasting and refeeding experiment showed that only Rcan2-3 mRNA expression is upregulated in the hypothalamus by fasting, and loss of Rcan2 significantly attenuates the hyperphagic response to starvation. Using double-mutant (Lep(ob/ob) Rcan2(-/-)) mice, we were also able to demonstrate that Rcan2 and leptin regulate body weight through different pathways. Our findings indicate that there may be an Rcan2-dependent mechanism which regulates food intake and promotes weight gain through a leptin-independent pathway. This study provides novel information on the control of body weight in mice and should improve our understanding of the mechanisms of obesity in humans.	[Sun, Xiao-yang; Hayashi, Yoshitaka; Xu, Sai; Kanou, Yasuhiko; Takagishi, Yoshiko; Murata, Yoshiharu] Nagoya Univ, Environm Med Res Inst, Dept Genet, Div Stress Adaptat & Recognit, Nagoya, Aichi 464, Japan; [Tang, Ya-ping] Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA USA	Nagoya University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Sun, XY (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Genet, Div Stress Adaptat & Recognit, Nagoya, Aichi 464, Japan.	ymurata@riem.nagoya-u.ac.jp	Tang, Ya-Ping/A-1035-2011; Hayashi, Yoshitaka/I-6168-2014	Hayashi, Yoshitaka/0000-0002-7557-4303; Tang, Ya-Ping/0000-0002-0445-4072	Ministry of Education, Science, Sports and Culture, Japan [14370324]	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in-Aid for Scientific Research (B) No. 14370324 and by the 21st Century COE program "Integrated Molecular Medicine for Neuronal and Neoplastic Disorders" from the Ministry of Education, Science, Sports and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; Cao X, 2002, BIOCHEM J, V367, P459, DOI 10.1042/BJ20011797; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Ebling FJP, 2008, J NEUROENDOCRINOL, V20, P827, DOI 10.1111/j.1365-2826.2008.01721.x; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; HimmsHagen J, 1997, SCIENCE, V276, P1132, DOI 10.1126/science.276.5315.1132; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; LISSNER L, 1995, EUR J CLIN NUTR, V49, P79; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Miyazaki T, 1996, J BIOL CHEM, V271, P14567, DOI 10.1074/jbc.271.24.14567; Mizuno Y, 2004, EUR J ENDOCRINOL, V150, P371, DOI 10.1530/eje.0.1500371; Morgan PJ, 2006, PROG BRAIN RES, V153, P325, DOI 10.1016/S0079-6123(06)53019-5; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Sola C, 1999, J NEUROSCI RES, V57, P651, DOI 10.1002/(SICI)1097-4547(19990901)57:5<651::AID-JNR7>3.0.CO;2-G; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; WILDING JPH, 1993, ENDOCRINOLOGY, V132, P1939, DOI 10.1210/en.132.5.1939; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	35	16	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14605	10.1371/journal.pone.0014605	http://dx.doi.org/10.1371/journal.pone.0014605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298050	Green Submitted, Green Published, gold			2022-12-25	WOS:000286663900009
J	Vigan-Womas, I; Guillotte, M; Juillerat, A; Vallieres, C; Lewit-Bentley, A; Tall, A; Baril, L; Bentley, GA; Mercereau-Puijalon, O				Vigan-Womas, Ines; Guillotte, Micheline; Juillerat, Alexandre; Vallieres, Cindy; Lewit-Bentley, Anita; Tall, Adama; Baril, Laurence; Bentley, Graham A.; Mercereau-Puijalon, Odile			Allelic Diversity of the Plasmodium falciparum Erythrocyte Membrane Protein 1 Entails Variant-Specific Red Cell Surface Epitopes	PLOS ONE			English	Article							CROSS-REACTIVE ANTIBODIES; PREGNANCY-ASSOCIATED MALARIA; SEVERE CHILDHOOD MALARIA; CHONDROITIN SULFATE-A; VAR GENE-EXPRESSION; INFECTED ERYTHROCYTES; FUNCTIONAL SPECIALIZATION; ACQUIRED-IMMUNITY; CLINICAL MALARIA; CEREBRAL MALARIA	The clonally variant Plasmodium falciparum PfEMP1 adhesin is a virulence factor and a prime target of humoral immunity. It is encoded by a repertoire of functionally differentiated var genes, which display architectural diversity and allelic polymorphism. Their serological relationship is key to understanding the evolutionary constraints on this gene family and rational vaccine design. Here, we investigated the Palo Alto/VarO and IT4/R29 and 3D7/PF13_003 parasites lines. VarO and R29 form rosettes with uninfected erythrocytes, a phenotype associated with severe malaria. They express an allelic Cys2/group A NTS-DBL1 alpha(1) PfEMP1 domain implicated in rosetting, whose 3D7 ortholog is encoded by PF13_0003. Using these three recombinant NTS-DBL1 alpha(1) domains, we elicited antibodies in mice that were used to develop monovariant cultures by panning selection. The 3D7/PF13_0003 parasites formed rosettes, revealing a correlation between sequence identity and virulence phenotype. The antibodies cross-reacted with the allelic domains in ELISA but only minimally with the Cys4/group B/C PFL1955w NTS-DBL1 alpha. By contrast, they were variant-specific in surface seroreactivity of the monovariant-infected red cells by FACS analysis and in rosette-disruption assays. Thus, while ELISA can differentiate serogroups, surface reactivity assays define the more restrictive serotypes. Irrespective of cumulated exposure to infection, antibodies acquired by humans living in a malaria-endemic area also displayed a variant-specific surface reactivity. Although seroprevalence exceeded 90% for each rosetting line, the kinetics of acquistion of surface-reactive antibodies differed in the younger age groups. These data indicate that humans acquire an antibody repertoire to non-overlapping serotypes within a serogroup, consistent with an antibody-driven diversification pressure at the population level. In addition, the data provide important information for vaccine design, as production of a vaccine targeting rosetting PfEMP1 adhesins will require engineering to induce variant-transcending responses or combining multiple serotypes to elicit a broad spectrum of immunity.	[Vigan-Womas, Ines; Guillotte, Micheline; Vallieres, Cindy; Mercereau-Puijalon, Odile] Inst Pasteur, Unite Immunol Mol Parasites, Paris, France; [Vigan-Womas, Ines; Guillotte, Micheline; Vallieres, Cindy; Mercereau-Puijalon, Odile] CNRS, URA 2581, Paris, France; [Juillerat, Alexandre; Lewit-Bentley, Anita; Bentley, Graham A.] Inst Pasteur, Unite Immunol Struct, Paris, France; [Juillerat, Alexandre; Lewit-Bentley, Anita; Bentley, Graham A.] CNRS, URA 2185, Paris, France; [Tall, Adama; Baril, Laurence] Inst Pasteur, Unite Epidemiol Maladies Infectieuses, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Vigan-Womas, I (corresponding author), Inst Pasteur, Unite Immunol Mol Parasites, Paris, France.	odile.puijalon@pasteur.fr	Ines, VIGAN-WOMAS/I-8604-2012; Vallieres, Cindy/AAV-3381-2020; Mercereau-Puijalon, Odile/AAA-2242-2020; Ines, VIGAN-WOMAS/A-7846-2017	Ines, VIGAN-WOMAS/0000-0001-7848-9297; Vallieres, Cindy/0000-0001-6409-1296; Ines, VIGAN-WOMAS/0000-0001-7848-9297; Baril, Laurence/0000-0003-2346-883X	French National Research Agency (Agence Nationale de la Recherche) [ANR-07-MIME-021-0]; European Union [FP7/2007-2013, Nu 242095 (Evimalar)]	French National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); European Union(European Commission)	This work was supported by the French National Research Agency (Agence Nationale de la Recherche, Programme Microbiologie, Immunologie et Maladies Emergentes, grant ANR-07-MIME-021-0), which provided a fellowship to A. J.. The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement Nu 242095 (Evimalar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Beeson JG, 2008, J INFECT DIS, V197, P1350, DOI 10.1086/586905; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Bir N, 2006, INFECT IMMUN, V74, P5955, DOI 10.1128/IAI.00481-06; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Chattopadhyay R, 2003, INFECT IMMUN, V71, P597, DOI 10.1128/IAI.71.2.597-604.2003; Contamin H, 1996, AM J TROP MED HYG, V54, P632, DOI 10.4269/ajtmh.1996.54.632; Costa FTM, 2003, J INFECT DIS, V188, P153, DOI 10.1086/375800; DeLano W., 2006, PYMOL MOL GRAPHICS S; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Doumbo OK, 2009, AM J TROP MED HYG, V81, P987, DOI 10.4269/ajtmh.2009.09-0406; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giha HA, 2000, IMMUNOL LETT, V71, P117, DOI 10.1016/S0165-2478(99)00173-X; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Hviid L, 2003, INFECT IMMUN, V71, P2296, DOI 10.1128/IAI.71.4.2296.2003; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Joergensen L, 2007, J IMMUNOL, V178, P428, DOI 10.4049/jimmunol.178.1.428; Joergensen L, 2006, INFECT IMMUN, V74, P6778, DOI 10.1128/IAI.01187-06; Juillerat A, 2010, MOL BIOCHEM PARASIT, V170, P84, DOI 10.1016/j.molbiopara.2009.12.008; Kinyanjui SM, 2004, J INFECT DIS, V190, P1527, DOI 10.1086/424675; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Mackintosh CL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-155; Magistrado PA, 2007, INFECT IMMUN, V75, P2415, DOI 10.1128/IAI.00951-06; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; Mayor A, 2009, INFECT IMMUN, V77, P3857, DOI 10.1128/IAI.00049-09; Mercereau-Puijalon O, 2008, TRANSFUS CLIN BIOL, V15, P62, DOI 10.1016/j.tracli.2008.04.003; Moll K, 2007, INFECT IMMUN, V75, P211, DOI 10.1128/IAI.00749-06; Montgomery J, 2007, MOL MICROBIOL, V65, P959, DOI 10.1111/j.1365-2958.2007.05837.x; NEWBOLD CI, 1992, EXP PARASITOL, V75, P281, DOI 10.1016/0014-4894(92)90213-T; Nielsen MA, 2004, INFECT IMMUN, V72, P3531, DOI 10.1128/IAI.72.6.3531-3535.2004; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Noranate N, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-219; Normark J, 2007, P NATL ACAD SCI US; Oguariri RM, 2003, PARASITOL RES, V90, P467, DOI 10.1007/s00436-003-0884-8; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; ROWE A, 1994, EXP PARASITOL, V79, P506, DOI 10.1006/expr.1994.1111; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Staalso T, 1998, IMMUNOL LETT, V60, P121, DOI 10.1016/S0165-2478(97)00143-0; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Ward CP, 1999, MOL BIOCHEM PARASIT, V102, P167, DOI 10.1016/S0166-6851(99)00106-1; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106	61	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16544	10.1371/journal.pone.0016544	http://dx.doi.org/10.1371/journal.pone.0016544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298021	Green Submitted, Green Published, gold			2022-12-25	WOS:000286663900067
J	Pol, D; Garrido, A; Cerda, IA				Pol, Diego; Garrido, Alberto; Cerda, Ignacio A.			A New Sauropodomorph Dinosaur from the Early Jurassic of Patagonia and the Origin and Evolution of the Sauropod-type Sacrum	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; ANATOMY; SAURISCHIA; VERTEBRAE; ONTOGENY; GERMANY; TAXA	Background: The origin of sauropod dinosaurs is one of the major landmarks of dinosaur evolution but is still poorly understood. This drastic transformation involved major skeletal modifications, including a shift from the small and gracile condition of primitive sauropodomorphs to the gigantic and quadrupedal condition of sauropods. Recent findings in the Late Triassic-Early Jurassic of Gondwana provide critical evidence to understand the origin and early evolution of sauropods. Methodology/Principal Findings: A new sauropodomorph dinosaur, Leonerasaurus taquetrensis gen. et sp. nov., is described from the Las Leoneras Formation of Central Patagonia (Argentina). The new taxon is diagnosed by the presence of anterior unserrated teeth with a low spoon-shaped crown, amphicoelous and acamerate vertebral centra, four sacral vertebrae, and humeral deltopectoral crest low and medially deflected along its distal half. The phylogenetic analysis depicts Leonerasaurus as one of the closest outgroups of Sauropoda, being the sister taxon of a clade of large bodied taxa composed of Melanorosaurus and Sauropoda. Conclusions/Significance: The dental and postcranial anatomy of Leonerasaurus supports its close affinities with basal sauropods. Despite the small size and plesiomorphic skeletal anatomy of Leonerasaurus, the four vertebrae that compose its sacrum resemble that of the large-bodied primitive sauropods. This shows that the appearance of the sauropod-type of sacrum predated the marked increase in body size that characterizes the origins of sauropods, rejecting a causal explanation and evolutionary linkage between this sacral configuration and body size. Alternative phylogenetic placements of Leonerasaurus as a basal anchisaurian imply a convergent acquisition of the sauropod-type sacrum in the new small-bodied taxon, also rejecting an evolutionary dependence of sacral configuration and body size in sauropodomorphs. This and other recent discoveries are showing that the characteristic sauropod body plan evolved gradually, with a step-wise pattern of character appearance.	[Pol, Diego] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Argentina; [Garrido, Alberto] Museo Prov Ciencias Nat Prof Dr Juan A Olsache, Zapala, Argentina; [Cerda, Ignacio A.] Univ Nacjonal Comahue, CONICET, INBIOMA, Museo Geol & Paleontol, Neuquen, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Pol, D (corresponding author), Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Argentina.	dpol@mef.org.ar	Pol, Diego/A-8007-2008	Pol, Diego/0000-0002-9690-7517	Fundacion Egidio Feruglio; Paleontological Exploration of Patagonia; Fundacion Antorchas; University of Louisville; Agencia Nacional de Promocion de Ciencia y Tecnica [PICT 1756, DFGRA1012/9-1]	Fundacion Egidio Feruglio; Paleontological Exploration of Patagonia; Fundacion Antorchas; University of Louisville; Agencia Nacional de Promocion de Ciencia y Tecnica	Fieldwork was funded by the Fundacion Egidio Feruglio and the Paleontological Exploration of Patagonia, Fundacion Antorchas, and University of Louisville to Guillermo Rougier. Research was funded by the Agencia Nacional de Promocion de Ciencia y Tecnica, PICT 1756 and DFGRA1012/9-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2008, GEODIVERSITAS, V30, P345; Aragon E, 2003, J S AM EARTH SCI, V16, P91, DOI 10.1016/S0895-9811(03)00046-4; Barrett PM, 2007, ZOOL J LINN SOC-LOND, V150, P319, DOI 10.1111/j.1096-3642.2007.00290.x; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Benton MJ, 2000, J VERTEBR PALEONTOL, V20, P77, DOI 10.1671/0272-4634(2000)020[0077:AASOTP]2.0.CO;2; Bonaparte J.F., 1986, P247; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; BONETTI MIR, 1963, REV MUSEO ARG CIENC, V1, P23; Bonnan MF, 2007, SPEC PAP PALAEONTOL, P157; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Carreira-Perpinan MA., 2005, ADV NEURAL INF PROCE, V17, P225; Castanet J., 1993, BONE, P245; Charig A. J., 1965, Proceedings of the Linnean Society of London, V176, P197; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; CODDINGTON J, 1994, CLADISTICS, V10, P415; Colbert E. H., 1964, American Museum Novitates, VNo. 2181, P1; Escapa I, 2008, AMEGHINIANA, V45, P633; Figari E.G., 1993, 12 C GEOL ARG C EXPL, P66; Franzese J, 2003, J S AM EARTH SCI, V16, P81, DOI 10.1016/S0895-9811(03)00020-8; Galton P.M., 1990, P320; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Galton Peter M., 2000, Journal of Vertebrate Paleontology, V20, p43A; Galton PM, 1999, NEUES JAHRB GEOL P-A, V213, P19, DOI 10.1127/njgpa/213/1999/19; Galton PM, 2000, NEUES JAHRB GEOL P-A, V216, P233; Galton PM, 2005, LIFE O PAST, P1; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff P, 2008, CLADISTICS, V24, P91; Herbst R., 1968, AMEGHINIANA, V5, P183; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Kearney M, 2002, SYST BIOL, V51, P369, DOI 10.1080/10635150252899824; Kutty TS, 2007, J PALEONTOL, V81, P1218, DOI 10.1666/04-074.1; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Langer Max Cardoso, 2003, Paleobios, V23, P1; Macdonald D, 2003, MAR PETROL GEOL, V20, P287, DOI 10.1016/S0264-8172(03)00045-X; McIntosh J.S., 1990, P345; Miall A.D., 1996, GEOLOGY FLUVIAL DEPO; Moser Markus, 2003, Zitteliana Reihe B, V24, P5; Muller J, 2010, P NATL ACAD SCI USA, V107, P2118, DOI 10.1073/pnas.0912622107; Nakayama C., 1973, 5 C GEOL ARG BUEN AI, V3, P269; NIETO DS, 2004, SERVICIO GEOLOGICO M, V265, P72; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; NULLO FE, 1983, SERVICIO GEOLOOGICO, V199; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; PAGE R, 2000, GEOLOGIA ARGENTINA, P460; Pine S, 2007, J VERTEBR PALEONTOL, V27, p130A; Pol Diego, 2007, Historical Biology, V19, P125, DOI 10.1080/08912960601140085; Pol D, 2007, SPEC PAP PALAEONTOL, P223; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; SERENO CP, 2005, STEM ARCHOSAURIA TAX; Sereno PC, 2007, SPEC PAP PALAEONTOL, P261; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Smith ND, 2007, ACTA PALAEONTOL POL, V52, P657; SPALLETTI LA, 1988, REV ASOC GEOL ARGENT, V43, P544; Tang F., 2001, COMPLETE SAUROPOD JI, P128; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Upchurch P, 2007, GEOL MAG, V144, P247, DOI 10.1017/S0016756806003062; Upchurch P, 2007, SPEC PAP PALAEONTOL, P57; WALKER RG, 1984, GEOSCIENCE CANADA RE, V1, P71; Wilkinson M, 2000, SYST BIOL, V49, P754, DOI 10.1080/106351500750049815; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; WILSON JA, 1998, SOC VERTEBRATE PALEO, V5, P1, DOI DOI 10.2307/3889325; Wilson JA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P15; Yadagiri P, 2001, J VERTEBR PALEONTOL, V21, P242, DOI 10.1671/0272-4634(2001)021[0242:TOOKYA]2.0.CO;2; Yates Adam M., 2007, Historical Biology, V19, P93, DOI 10.1080/08912960600866953; Yates AM, 2007, SPEC PAP PALAEONTOL, P9; Yates Adam M., 2004, Postilla, V230, P1; Yates AM, 2010, PALAEONTOLOGY, V53, P739, DOI 10.1111/j.1475-4983.2010.00952.x; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; Yates AM, 2003, P ROY SOC B-BIOL SCI, V270, P1753, DOI 10.1098/rspb.2003.2417; Yates AM, 2003, PALAEONTOLOGY, V46, P317, DOI 10.1111/j.0031-0239.2003.00301.x	77	59	61	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14572	10.1371/journal.pone.0014572	http://dx.doi.org/10.1371/journal.pone.0014572			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298087	Green Published, gold			2022-12-25	WOS:000286662800002
J	Pernice, M; Dunn, SR; Miard, T; Dufour, S; Dove, S; Hoegh-Guldberg, O				Pernice, Mathieu; Dunn, Simon R.; Miard, Thomas; Dufour, Sylvie; Dove, Sophie; Hoegh-Guldberg, Ove			Regulation of Apoptotic Mediators Reveals Dynamic Responses to Thermal Stress in the Reef Building Coral Acropora millepora	PLOS ONE			English	Article							SYMBIOTIC SEA-ANEMONE; GENE-EXPRESSION; CELL-DEATH; OXIDATIVE STRESS; BCL-2; MECHANISMS; EVOLUTION; RELEASE; SUSCEPTIBILITY; BIOCHEMISTRY	Background: Mass coral bleaching is increasing in scale and frequency across the world's coral reefs and is being driven primarily by increased levels of thermal stress arising from global warming. In order to understand the impacts of projected climate change upon corals reefs, it is important to elucidate the underlying cellular mechanisms that operate during coral bleaching and subsequent mortality. In this respect, increased apoptotic cell death activity is an important cellular process that is associated with the breakdown of the mutualistic symbiosis between the cnidarian host and their dinoflagellate symbionts. Methodology/Principal Findings: The present study reports the impacts of different stressors (colchicine and heat stress) on three phases of apoptosis: (i) the potential initiation by differential expression of Bcl-2 members, (ii) the execution of apoptotic events by activation of caspase 3-like proteases and (iii) and finally, the cell disposal indicated by DNA fragmentation in the reef building coral Acropora millepora. In corals incubated with colchicine, an increase in caspase 3-like activity and DNA fragmentation was associated with a relative down-regulation of Bcl-2, suggesting that the initiation of apoptosis may be mediated by the suppression of an anti-apoptotic mechanism. In contrast, in the early steps of heat stress, the induction of caspase-dependent apoptosis was related to a relative up-regulation of Bcl-2 consecutively followed by a delayed decrease in apoptosis activity. Conclusions/Significance: In the light of these results, we propose a model of heat stress in coral hosts whereby increasing temperatures engage activation of caspase 3-dependent apoptosis in cells designated for termination, but also the onset of a delayed protective response involving overexpression of Bcl-2 in surviving cells. This mitigating response to thermal stress could conceivably be an important regulatory mechanism for cell survival in corals exposed to sudden environmental changes.	[Pernice, Mathieu; Dunn, Simon R.; Miard, Thomas; Dove, Sophie; Hoegh-Guldberg, Ove] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, Global Change Inst, Coral Reef Ecosyst Lab, St Lucia, Qld, Australia; [Pernice, Mathieu; Dufour, Sylvie] UMR 7208 Biol Organismes & Ecosyst Aquat MNHN CNR, Paris, France	University of Queensland; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Pernice, M (corresponding author), Univ Queensland, ARC Ctr Excellence Coral Reef Studies, Global Change Inst, Coral Reef Ecosyst Lab, St Lucia, Qld, Australia.	m.pernice@uq.edu.au	Pernice, Mathieu/AAU-9285-2020; Hoegh-Guldberg, Ove/ABA-5420-2020; Dove, Sophie/I-7873-2013; Hoegh-Guldberg, Ove/H-6169-2011	Pernice, Mathieu/0000-0002-3431-2104; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Dove, Sophie/0000-0003-1823-8634; Hoegh-Guldberg, Ove/0000-0001-7510-6713	Marie Curie International Outgoing Fellowship; Australian Research Council Centre for Excellence for Coral Reef Studies	Marie Curie International Outgoing Fellowship(European Commission); Australian Research Council Centre for Excellence for Coral Reef Studies(Australian Research Council)	This work was supported by a Marie Curie International Outgoing Fellowship and the Australian Research Council Centre for Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, J EXP MAR BIOL ECOL, V364, P63, DOI 10.1016/j.jembe.2008.06.032; Ainsworth TD, 2007, MAR BIOL, V151, P19, DOI 10.1007/s00227-006-0449-3; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Berkelmans R, 2002, MAR ECOL PROG SER, V229, P73, DOI 10.3354/meps229073; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Bythell JC, 2002, LETT APPL MICROBIOL, V34, P359, DOI 10.1046/j.1472-765X.2002.01097.x; Cikala M, 1999, CURR BIOL, V9, P959, DOI 10.1016/S0960-9822(99)80423-0; Coffroth MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013258; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; D'Alessio M, 2004, FASEB J, V18, P1609, DOI 10.1096/fj.04-1813fje; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Dunn SR, 2007, BIOL BULL-US, V212, P250, DOI 10.2307/25066607; Dunn SR, 2006, J MOL EVOL, V63, P95, DOI 10.1007/s00239-005-0236-7; Dunn SR, 2009, ENVIRON MICROBIOL, V11, P268, DOI 10.1111/j.1462-2920.2008.01774.x; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; DUNN SR, 2002, P 9 INT COR REEF S B, V1, P145; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Gorman AM, 1999, EUR J NEUROSCI, V11, P1067, DOI 10.1046/j.1460-9568.1999.00512.x; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Kowaltowski AJ, 2005, ANTIOXID REDOX SIGN, V7, P508, DOI 10.1089/ars.2005.7.508; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Mayfield AB, 2009, MOL ECOL RESOUR, V9, P462, DOI 10.1111/j.1755-0998.2008.02349.x; Merle PL, 2007, FREE RADICAL BIO MED, V42, P236, DOI 10.1016/j.freeradbiomed.2006.10.038; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Middlebrook R, 2010, J EXP BIOL, V213, P1026, DOI 10.1242/jeb.031633; Moya A, 2008, MAR BIOTECHNOL, V10, P653, DOI 10.1007/s10126-008-9101-1; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Pankow S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000782; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plantivaux A, 2004, FREE RADICAL BIO MED, V37, P1170, DOI 10.1016/j.freeradbiomed.2004.06.043; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Rodriguez-Lanetty M, 2008, J BIOCHEM BIOPH METH, V70, P985, DOI 10.1016/j.jbbm.2007.08.005; Rozen S, 2000, Methods Mol Biol, V132, P365; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sandau KB, 2000, CELL DEATH DIFFER, V7, P118, DOI 10.1038/sj.cdd.4400615; Seneca FO, 2010, MAR BIOTECHNOL, V12, P594, DOI 10.1007/s10126-009-9247-5; Setroikromo R, 2007, CELL STRESS CHAPERON, V12, P320, DOI 10.1379/CSC-279.1; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Sullivan JC, 2006, NUCLEIC ACIDS RES, V34, pD495, DOI 10.1093/nar/gkj020; Sunagawa S, 2008, COMP BIOCHEM PHYS B, V151, P133, DOI 10.1016/j.cbpb.2008.06.007; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wiens M, 2000, J MOL EVOL, V50, P520, DOI 10.1007/s002390010055; Wiens M, 2001, CELL DEATH DIFFER, V8, P887, DOI 10.1038/sj.cdd.4400906; Zmasek CM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r226	62	61	61	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16095	10.1371/journal.pone.0016095	http://dx.doi.org/10.1371/journal.pone.0016095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283671	Green Published, gold			2022-12-25	WOS:000286523400017
J	Yoon, M; Kopp, SJ; Taylor, JM; Storti, CS; Spear, PG; Muller, WJ				Yoon, Miri; Kopp, Sarah J.; Taylor, Joann M.; Storti, Christopher S.; Spear, Patricia G.; Muller, William J.			Functional Interaction between Herpes Simplex Virus Type 2 gD and HVEM Transiently Dampens Local Chemokine Production after Murine Mucosal Infection	PLOS ONE			English	Article							T-LYMPHOCYTE ATTENUATOR; 3-O-SULFATED HEPARAN-SULFATE; NECROSIS-FACTOR-ALPHA; FEMALE GENITAL-TRACT; ENTRY MEDIATOR; GLYCOPROTEIN-D; B-LYMPHOCYTE; CELL ENTRY; KAPPA-B; PSEUDORABIES VIRUS	Herpes virus entry mediator (HVEM) is one of two principal receptors mediating herpes simplex virus (HSV) entry into murine and human cells. It functions naturally as an immune signaling co-receptor, and may participate in enhancing or repressing immune responses depending on the natural ligand used. To investigate whether engagement of HVEM by HSV affects the in vivo response to HSV infection, we generated recombinants of HSV-2(333) that expressed wild-type gD (HSV-2/gD) or mutant gD able to bind to nectin-1 (the other principal entry receptor) but not HVEM. Replication kinetics and yields of the recombinant strains on Vero cells were indistinguishable from those of wild-type HSV-2(333). After intravaginal inoculation with mutant or wild-type virus, adult female C57BL/6 mice developed vaginal lesions and mortality in similar proportions, and mucosal viral titers were similar or lower for mutant strains at different times. Relative to HSV-2/gD, percentages of HSV-specific CD8(+) T-cells were similar or only slightly reduced after infection with the mutant strain HSV-2/gD-Delta 7-15, in all tissues up to 9 days after infection. Levels of HSV-specific CD4(+) T-cells five days after infection also did not differ after infection with either strain. Levels of the cytokine IL-6 and of the chemokines CXCL9, CXCL10, and CCL4 were significantly lower in vaginal washes one day after infection with HSV-2/gD compared with HSV-2/gD-Delta 7-15. We conclude that the interaction of HSV gD with HVEM may alter early innate events in the murine immune response to infection, without significantly affecting acute mortality, morbidity, or initial T-cell responses after lethal challenge.	[Yoon, Miri; Kopp, Sarah J.; Taylor, Joann M.; Spear, Patricia G.] Northwestern Univ, Dept Microbiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Kopp, Sarah J.; Storti, Christopher S.; Muller, William J.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Yoon, M (corresponding author), Northwestern Univ, Dept Microbiol, Feinberg Sch Med, Chicago, IL 60611 USA.	wjmuller@northwestern.edu		Muller, William J/0000-0001-7690-0695	Midwest Sexually Transmitted Infections and Topical Microbicides (STI-TM) Cooperative Research Center [U19 AI031494]; Midwest STI-TM Cooperative Research Center; Department of Pediatrics, Feinberg School of Medicine; Children's Memorial Research Center at Northwestern University; Infectious Diseases Society of America Education and Research Foundation/National Foundation for Infectious Diseases; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089942, U19AI031494] Funding Source: NIH RePORTER	Midwest Sexually Transmitted Infections and Topical Microbicides (STI-TM) Cooperative Research Center; Midwest STI-TM Cooperative Research Center; Department of Pediatrics, Feinberg School of Medicine; Children's Memorial Research Center at Northwestern University; Infectious Diseases Society of America Education and Research Foundation/National Foundation for Infectious Diseases; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants through the Midwest Sexually Transmitted Infections and Topical Microbicides (STI-TM) Cooperative Research Center U19 AI031494 (to PGS), a Midwest STI-TM Cooperative Research Center Developmental Award (to MY), and from a Child Health Research Career Development Award through the Department of Pediatrics, Feinberg School of Medicine, and Children's Memorial Research Center at Northwestern University (to WJM), a Midwest STI-TM Cooperative Research Center Developmental Award (to WJM), and an Infectious Diseases Society of America Education and Research Foundation/National Foundation for Infectious Diseases Young Investigator Award (to WJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS BJ, 1985, CELL, V40, P795, DOI 10.1016/0092-8674(85)90339-3; Bachmann MF, 2006, NAT REV IMMUNOL, V6, P159, DOI 10.1038/nri1776; Barabitskaja O, 2006, J LEUKOCYTE BIOL, V79, P378, DOI 10.1189/jlb.0505255; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Connolly SA, 2003, J VIROL, V77, P8127, DOI 10.1128/JVI.77.14.8127-8140.2003; Croft M, 2005, TRENDS IMMUNOL, V26, P292, DOI 10.1016/j.it.2005.03.010; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gierynska M, 2002, J VIROL, V76, P6568, DOI 10.1128/JVI.76.13.6568-6576.2002; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Harrop JA, 1998, J IMMUNOL, V161, P1786; Hosokawa Y, 2010, MOL IMMUNOL, V47, P666, DOI 10.1016/j.molimm.2009.10.018; Kovacs SK, 2009, CURR EYE RES, V34, P896, DOI 10.3109/02713680903184250; Krieg C, 2005, J IMMUNOL, V175, P6420, DOI 10.4049/jimmunol.175.10.6420; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lasaro MO, 2008, NAT MED, V14, P205, DOI 10.1038/nm1704; Lasaro MO, 2005, MICROBES INFECT, V7, P1541, DOI 10.1016/j.micinf.2005.05.024; LeBlanc RA, 1999, J VIROL, V73, P8145, DOI 10.1128/JVI.73.10.8145-8151.1999; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; MacLeod IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009560; Manoj S, 2004, P NATL ACAD SCI USA, V101, P12414, DOI 10.1073/pnas.0404211101; Marsters SA, 1997, J BIOL CHEM, V272, P14029, DOI 10.1074/jbc.272.22.14029; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; MILLIGAN GN, 1995, VIROLOGY, V206, P234, DOI 10.1016/S0042-6822(95)80038-7; MILLIGAN GN, 1995, VIROLOGY, V212, P481, DOI 10.1006/viro.1995.1506; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Murphy TL, 2010, ANNU REV IMMUNOL, V28, P389, DOI 10.1146/annurev-immunol-030409-101202; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nicola AV, 1998, J VIROL, V72, P3595, DOI 10.1128/JVI.72.5.3595-3601.1998; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; PAPAIOANNOU VE, 1993, LAB ANIM SCI, V43, P189; PARR MB, 1994, LAB INVEST, V70, P369; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; Salazar-Mather TP, 2006, CURR TOP MICROBIOL, V303, P29, DOI 10.1007/978-3-540-33397-5_2; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; Sedy JR, 2008, NAT REV IMMUNOL, V8, P861, DOI 10.1038/nri2434; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Shukla D, 1999, J VIROL, V73, P4493, DOI 10.1128/JVI.73.5.4493-4497.1999; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Spear PG, 2000, VIROLOGY, V275, P1, DOI 10.1006/viro.2000.0529; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Stiles KM, 2010, J VIROL, V84, P11646, DOI 10.1128/JVI.01550-10; Sun YL, 2009, J IMMUNOL, V183, P1946, DOI 10.4049/jimmunol.0801866; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Taylor JM, 2007, CELL HOST MICROBE, V2, P19, DOI 10.1016/j.chom.2007.06.005; Thapa M, 2008, J VIROL, V82, P10295, DOI 10.1128/JVI.00931-08; Thapa M, 2008, J IMMUNOL, V180, P1098, DOI 10.4049/jimmunol.180.2.1098; Thapa M, 2009, J VIROL, V83, P9486, DOI 10.1128/JVI.00854-09; Vanderlugt CL, 2000, J IMMUNOL, V164, P670, DOI 10.4049/jimmunol.164.2.670; Wallace ME, 1999, J VIROL, V73, P7619, DOI 10.1128/JVI.73.9.7619-7626.1999; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; WESTMORELAND D, 1976, J VIROL, V18, P92, DOI 10.1128/JVI.18.1.92-102.1976; Yoon M, 2004, P NATL ACAD SCI USA, V101, P17252, DOI 10.1073/pnas.0407892101; Yoon M, 2003, J VIROL, V77, P9221, DOI 10.1128/JVI.77.17.9221-9231.2003; Zago A, 2003, J VIROL, V77, P9695, DOI 10.1128/JVI.77.17.9695-9699.2003	64	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16122	10.1371/journal.pone.0016122	http://dx.doi.org/10.1371/journal.pone.0016122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283640	Green Published, Green Submitted, gold			2022-12-25	WOS:000286523400020
J	Suwanwela, J; Lee, J; Lin, A; Ucer, TC; Devlin, H; Sinsheimer, J; Garrett, NR; Nishimura, I				Suwanwela, Jaijam; Lee, Jaehoon; Lin, Audrey; Ucer, T. Cemal; Devlin, Hugh; Sinsheimer, Janet; Garrett, Neal R.; Nishimura, Ichiro			A Genetic Association Study of Single Nucleotide Polymorphisms in FGFR1OP2/wit3.0 and Long-Term Atrophy of Edentulous Mandible	PLOS ONE			English	Article							ALVEOLAR BONE-RESORPTION; TOOTH EXTRACTION; RESIDUAL RIDGE; COMPLETE DENTURES; MINERAL DENSITY; ORAL FINDINGS; OSTEOPOROSIS; OVARIECTOMY; HEIGHT; MUCOSA	Background: After dental extraction, the external surface of alveolar bone undergoes resorption at various rates, and a group of patients develop excessive jawbone atrophy. Oral mucosa overlying the atrophied jawbone is unusually thin; therefore, we have hypothesized that excessive jawbone atrophy may be associated with abnormal oral mucosa contraction. FGFR1OP2/wit3.0, a cytoskeleton molecule initially identified in oral wound fibroblasts, has been shown to induce oral mucosa contraction after dental extraction. This study examined the genetic association between single nucleotide polymorphisms (SNPs) of FGFR1OP2/wit3.0 and excessive atrophy of edentulous mandible. Methods and Findings: First, the expression of FGFR1OP2/wit3.0 was determined in gingival tissues of 8 subjects before and after dental extraction. In situ hybridization revealed that all subject increased FGFR1OP2/wit3.0 expression in the postoperative oral mucosa tissues; however, significantly high levels of FGFR1OP2/wit3.0 were observed in 3 out of 8 subjects. In a separate study, 20 long-term edentulous subjects (66.4+/-9.4 years) were recruited. Tag-SNPs in the FGFR1OP2/wit3.0 allele were determined by Taqman-based polymerase chain reaction. The mandibular bone height was determined following the American College of Prosthodontists (ACP) protocol. Subjects with minor allele of rs840869 or rs859024 were found in the highly atrophied group by the ACP classification (Chi square test, p = 0.0384 and p = 0.0565, respectively; Fisher's Exact, p = 0.0515 and p = 0.2604, respectively). The linear regression analysis indicated a suggestive association between rs859024 and the decreased bone heights (Mann-Whitney, p = 0.06). The average bone height of the subjects with rs840869 or rs859024 minor alleles (10.6+/-3.2 mm and 9.6+/-3.2 mm, respectively) was significantly smaller than that of those subjects with the major alleles (14.2+/-4.5 mm, p<0.05). Conclusions: The patients with the minor allele of rs840869 or rs859024 were associated with excessive atrophy of edentulous mandible. This study may provide the basis for a genetic marker identifying susceptible individuals to develop jawbone atrophy after dental extraction.	[Suwanwela, Jaijam; Lee, Jaehoon; Lin, Audrey; Garrett, Neal R.; Nishimura, Ichiro] Univ Calif Los Angeles, Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA 90024 USA; [Suwanwela, Jaijam; Nishimura, Ichiro] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90024 USA; [Suwanwela, Jaijam] Chulalongkorn Univ, Dept Prosthodont, Fac Dent, Bangkok, Thailand; [Lee, Jaehoon] Yonsei Univ, Coll Dent, Dept Prosthodont, Seoul 120749, South Korea; [Ucer, T. Cemal; Devlin, Hugh] Univ Manchester, Sch Dent, Manchester, Lancs, England; [Sinsheimer, Janet] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Sinsheimer, Janet] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Chulalongkorn University; Yonsei University; Yonsei University Health System; University of Manchester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Suwanwela, J (corresponding author), Univ Calif Los Angeles, Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA 90024 USA.	inishimura@dentistry.ucla.edu	DEVLIN, HUGH/G-6077-2010	DEVLIN, HUGH/0000-0002-5120-747X; Lee, Jae Hoon/0000-0003-2281-8885	UCLA; National Center for Research Resources, National Institutes of Health (NCRR/NIH) [C06 RR014529]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014529] Funding Source: NIH RePORTER	UCLA(University of California System); National Center for Research Resources, National Institutes of Health (NCRR/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported, in part, by UCLA Academic Senate Grant. This investigation was conducted in part in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR014529 from the National Center for Research Resources, National Institutes of Health (NCRR/NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beltran-Aguilar Eugenio D., 2005, Morbidity and Mortality Weekly Report, V54, P1; Bollen AM, 2004, OSTEOPOROSIS INT, V15, P970, DOI 10.1007/s00198-004-1695-1; Carlsson GE, 1998, J PROSTHET DENT, V79, P17, DOI 10.1016/S0022-3913(98)70188-X; Devlin H, 1997, J BONE MINER RES, V12, P2061, DOI 10.1359/jbmr.1997.12.12.2061; DEVLIN H, 1994, J PROSTHET DENT, V71, P478, DOI 10.1016/0022-3913(94)90186-4; Fickl S, 2008, J CLIN PERIODONTOL, V35, P356, DOI 10.1111/j.1600-051X.2008.01209.x; Grand EK, 2004, GENE CHROMOSOME CANC, V40, P78, DOI 10.1002/gcc.20023; Horner K, 1998, DENTOMAXILLOFAC RAD, V27, P17, DOI 10.1038/sj.dmfr.4600307; HSIEH YD, 1995, ARCH ORAL BIOL, V40, P529, DOI 10.1016/0003-9969(94)00197-J; Jahangiri L, 1998, J PROSTHET DENT, V80, P224, DOI 10.1016/S0022-3913(98)70116-7; Kingsmill VJ, 1999, CRIT REV ORAL BIOL M, V10, P384, DOI 10.1177/10454411990100030801; KLEMETTI E, 1993, SCAND J DENT RES, V101, P166; KRAJICEK DD, 1984, J PROSTHET DENT, V52, P682, DOI 10.1016/0022-3913(84)90141-0; KRIBBS PJ, 1983, J PROSTHET DENT, V50, P719, DOI 10.1016/0022-3913(83)90215-9; KRIBBS PJ, 1983, J PROSTHET DENT, V50, P576, DOI 10.1016/0022-3913(83)90584-X; LI XH, 1994, J PROSTHET DENT, V72, P324, DOI 10.1016/0022-3913(94)90348-4; Lin A, 2010, CELL ADHES MIGR, V4, P396, DOI 10.4161/cam.4.3.11917; Lin A, 2010, AM J PATHOL, V176, P108, DOI 10.2353/ajpath.2010.090256; Luvizuto ER, 2010, BONE, V46, P1021, DOI 10.1016/j.bone.2009.12.016; McGarry T J, 1999, J Prosthodont, V8, P27, DOI 10.1111/j.1532-849X.1999.tb00005.x; Mulot C, 2005, J BIOMED BIOTECHNOL, P291, DOI 10.1155/JBB.2005.291; Nasser M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006087; Pereira MC, 2007, J ORAL MAXIL SURG, V65, P2248, DOI 10.1016/j.joms.2006.11.040; SCHROEDER HE, 1986, CELL TISSUE RES, V243, P661; SHOJI K, 2010, ARCH ORAL BIOL; Simpson H E, 1969, Br Dent J, V126, P550; Sukotjo C, 2003, J BIOL CHEM, V278, P51527, DOI 10.1074/jbc.M309616200; Sukotjo C, 2002, J DENT RES, V81, P229, DOI 10.1177/154405910208100402; TURCK D, 1965, J PROSTHET DENT, V15, P419, DOI 10.1016/S0022-3913(65)80010-5; Van der Weijden F, 2009, J CLIN PERIODONTOL, V36, P1048, DOI 10.1111/j.1600-051X.2009.01482.x; WARD VJ, 1977, J ORAL REHABIL, V4, P83, DOI 10.1111/j.1365-2842.1977.tb00969.x; WATSON IB, 1982, J PROSTHET DENT, V47, P133, DOI 10.1016/0022-3913(82)90176-7	34	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16204	10.1371/journal.pone.0016204	http://dx.doi.org/10.1371/journal.pone.0016204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283824	Green Published, gold, Green Submitted			2022-12-25	WOS:000286520600030
J	Bernatik, O; Ganji, RS; Dijksterhuis, JP; Konik, P; Cervenka, I; Polonio, T; Krejci, P; Schulte, G; Bryja, V				Bernatik, Ondrej; Ganji, Ranjani Sri; Dijksterhuis, Jacomijn P.; Konik, Peter; Cervenka, Igor; Polonio, Tilman; Krejci, Pavel; Schulte, Gunnar; Bryja, Vitezslav			Sequential Activation and Inactivation of Dishevelled in the Wnt/beta-Catenin Pathway by Casein Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; I-EPSILON; WNT; PHOSPHORYLATION; PROTEINS; DVL; LRP6; AXIN; UBIQUITINATION; MECHANISM	Dishevelled (Dvl) is a key component in the Wnt/beta-catenin signaling pathway. Dvl can multimerize to form dynamic protein aggregates, which are required for the activation of downstream signaling. Upon pathway activation by Wnts, Dvl becomes phosphorylated to yield phosphorylated and shifted (PS) Dvl. Both activation of Dvl in Wnt/beta-catenin signaling and Wnt-induced PS-Dvl formation are dependent on casein kinase 1 (CK1) delta/epsilon activity. However, the overexpression of CK1 was shown to dissolve Dvl aggregates, and endogenous PS-Dvl forms irrespective of whether or not the activating Wnt triggers the Wnt/beta-catenin pathway. Using a combination of gain-of-function, loss-of-function, and domain mapping approaches, we attempted to solve this discrepancy regarding the role of CK1 epsilon in Dvl biology. We analyzed mutual interaction of CK1 delta/epsilon and two other Dvl kinases, CK2 and PAR1, in the Wnt/beta-catenin pathway. We show that CK2 acts as a constitutive kinase whose activity is required for the further action of CK1 epsilon. Furthermore, we demonstrate that the two consequences of CK1 epsilon phosphorylation are separated both spatially and functionally; first, CK1 epsilon-mediated induction of TCF/LEF-driven transcription (associated with dynamic recruitment of Axin1) is mediated via a PDZ-proline-rich region of Dvl. Second, CK1 epsilon-mediated formation of PS-Dvl is mediated by the Dvl3 C terminus. Furthermore, we demonstrate with several methods that PS-Dvl has decreased ability to polymerize with other Dvls and could, thus, act as the inactive signaling intermediate. We propose a multistep and multikinase model for Dvl activation in the Wnt/beta-catenin pathway that uncovers a built-in de-activation mechanism that is triggered by activating phosphorylation of Dvl by CK1 delta/epsilon.	[Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Dijksterhuis, Jacomijn P.; Polonio, Tilman; Schulte, Gunnar] Karolinska Inst, Sect Receptor Biol & Signaling, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Konik, Peter] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Krejci, Pavel; Bryja, Vitezslav] ASCR, Dept Cytokinet, Inst Biophys, Brno 61265, Czech Republic; [Krejci, Pavel] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA	Masaryk University Brno; Karolinska Institutet; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Cedars Sinai Medical Center	Bryja, V (corresponding author), Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic.	bryja@sci.muni.cz	Krejčí, Pavel/I-4285-2014; Bryja, Vít?zslav/H-1925-2014; Bryja, Vítězslav/P-4217-2019; Ganji, Ranjani/AGD-5702-2022	Bryja, Vít?zslav/0000-0002-9136-5085; Bryja, Vítězslav/0000-0002-9136-5085; Dijksterhuis, Jacomijn/0000-0002-9214-6255; Bernatik, Ondrej/0000-0002-2188-332X; Krejci, Pavel/0000-0003-0618-9134; Schulte, Gunnar/0000-0002-2700-7013	Czech Science Foundation [301/09/0587, 204/09/H058, 204/09/0498, 204/09/J030]; Knut and Alice Wallenberg Foundation [KAW2008.0149]; Swedish Research Council [K2008-68P-20810-01-4, K2008-68X-20805-01-4]; Swedish Cancer Society [CAN 2008/539]; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Ministry of Education, Youth, and Sports of the Czech Republic [MSM0021622430]; Academy of Sciences of the Czech Republic [KJB501630801, AVOZ50040507, AVOZ50040702]; EMBO Installation grant	Czech Science Foundation(Grant Agency of the Czech Republic); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); EMBO Installation grant	Supported by Czech Science Foundation Grant 301/09/0587.; Supported by Knut and Alice Wallenberg Foundation Grant KAW2008.0149, Swedish Research Council Grants K2008-68P-20810-01-4 and K2008-68X-20805-01-4, Swedish Cancer Society Grant CAN 2008/539, and The Swedish Foundation for International Cooperation in Research and Higher Education (STINT).; Supported by Ministry of Education, Youth, and Sports of the Czech Republic Grant MSM0021622430, Academy of Sciences of the Czech Republic Grants KJB501630801, AVOZ50040507, and AVOZ50040702, Czech Science Foundation Grants 204/09/H058, 204/09/0498, and 204/09/J030, and an EMBO Installation grant. To whom correspondence should be addressed: Institute of Experimental Biology, Faculty of Science, Masaryk University, Kotlarska 2, 61137 Brno, Czech Republic. Tel.: 420-549493291; Fax: 420-541211214; E-mail: bryja@sci.muni.cz.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Bryja V, 2008, EMBO REP, V9, P1244, DOI 10.1038/embor.2008.193; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Dominguez I, 2005, MOL CELL BIOCHEM, V274, P125, DOI 10.1007/s11010-005-3073-5; Foldynova-Trantirkova S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2581; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao Y, 2006, J BIOL CHEM, V281, P18394, DOI 10.1074/jbc.M601112200; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Itoh K, 2005, J BIOL, V4; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Klimowski LK, 2006, FEBS J, V273, P4594, DOI 10.1111/j.1742-4658.2006.05462.x; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; Lee YN, 2008, CELL SIGNAL, V20, P443, DOI 10.1016/j.cellsig.2007.11.005; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Malanchi I, 2009, CURR OPIN ONCOL, V21, P41, DOI 10.1097/CCO.0b013e32831d1faf; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Ossipova O, 2005, DEV CELL, V8, P829, DOI 10.1016/j.devcel.2005.04.011; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Song DH, 2000, J BIOL CHEM, V275, P23790, DOI 10.1074/jbc.M909107199; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	46	78	79	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10396	10410		10.1074/jbc.M110.169870	http://dx.doi.org/10.1074/jbc.M110.169870			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21285348	Green Published, hybrid			2022-12-25	WOS:000288547000056
J	Yang, AC; Fuh, JL; Huang, NE; Shia, BC; Peng, CK; Wang, SJ				Yang, Albert C.; Fuh, Jong-Ling; Huang, Norden E.; Shia, Ben-Chang; Peng, Chung-Kang; Wang, Shuu-Jiun			Temporal Associations between Weather and Headache: Analysis by Empirical Mode Decomposition	PLOS ONE			English	Article							NONSTATIONARY TIME-SERIES; POPULATION-BASED SURVEY; BAROMETRIC-PRESSURE; MIGRAINE HEADACHE; CHINOOK WINDS	Background: Patients frequently report that weather changes trigger headache or worsen existing headache symptoms. Recently, the method of empirical mode decomposition (EMD) has been used to delineate temporal relationships in certain diseases, and we applied this technique to identify intrinsic weather components associated with headache incidence data derived from a large-scale epidemiological survey of headache in the Greater Taipei area. Methodology/Principal Findings: The study sample consisted of 52 randomly selected headache patients. The weather time-series parameters were detrended by the EMD method into a set of embedded oscillatory components, i.e. intrinsic mode functions (IMFs). Multiple linear regression models with forward stepwise methods were used to analyze the temporal associations between weather and headaches. We found no associations between the raw time series of weather variables and headache incidence. For decomposed intrinsic weather IMFs, temperature, sunshine duration, humidity, pressure, and maximal wind speed were associated with headache incidence during the cold period, whereas only maximal wind speed was associated during the warm period. In analyses examining all significant weather variables, IMFs derived from temperature and sunshine duration data accounted for up to 33.3% of the variance in headache incidence during the cold period. The association of headache incidence and weather IMFs in the cold period coincided with the cold fronts. Conclusions/Significance: Using EMD analysis, we found a significant association between headache and intrinsic weather components, which was not detected by direct comparisons of raw weather data. Contributing weather parameters may vary in different geographic regions and different seasons.	[Yang, Albert C.] Chu Tung Vet Hosp, Dept Psychiat, Hsin Chu Cty, Taiwan; [Yang, Albert C.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Yang, Albert C.; Huang, Norden E.; Peng, Chung-Kang] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Fuh, Jong-Ling; Wang, Shuu-Jiun] Taipei Vet Gen Hosp, Dept Neurol, Neurol Inst, Taipei, Taiwan; [Fuh, Jong-Ling; Wang, Shuu-Jiun] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Huang, Norden E.] Natl Cent Univ, Res Ctr Adapt Data Anal, Chungli 32054, Taiwan; [Shia, Ben-Chang] Fu Jen Catholic Univ, Dept Stat & Informat Sci, Taipei Cty, Taiwan; [Peng, Chung-Kang] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Margret & HA Rey Inst Nonlinear Dynam Med,Beth Is, Boston, MA USA	National Yang Ming Chiao Tung University; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Central University; Fu Jen Catholic University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Wang, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, Neurol Inst, Taipei, Taiwan.	sjwang@vghtpe.gov.tw	Peng, Chung-Kang/E-1489-2011; Peng, Chung-Kang/N-1308-2019	Peng, Chung-Kang/0000-0003-3666-9833; Peng, Chung-Kang/0000-0003-3666-9833; Fuh, Jong-Ling/0000-0001-9135-3351; Yang, Albert Chih-Chieh/0000-0003-2794-9649; Wang, Shuu-Jiun/0000-0001-5179-5358	Taipei-Veterans General Hospital [V97A-061, V100C-059, V100C-087, VGHUST 100-G7-1-1, VGHUST 100-G7-1-3]; National Science Council (NSC) of Taiwan [NSC 96-2314-B-075-075, 98-2314-B-010-019-MY2, NSC 99-2911-I-008-100]; Ministry of Education, Taipei, Taiwan	Taipei-Veterans General Hospital(Taipei Veterans General Hospital); National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taipei, Taiwan	The study was supported in part by a grant from Taipei-Veterans General Hospital (V97A-061, V100C-059, V100C-087, VGHUST 100-G7-1-1, VGHUST 100-G7-1-3), the National Science Council (NSC) of Taiwan (NSC 96-2314-B-075-075, 98-2314-B-010-019-MY2), NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 99-2911-I-008-100), and the Ministry of Education (Aim for the Top University Plan), Taipei, Taiwan. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekkelund SI, 2008, CEPHALALGIA, V28, P1277, DOI 10.1111/j.1468-2982.2008.01676.x; *CENTR WEATH BUR, 1997, AGR B; Cooke LJ, 2000, NEUROLOGY, V54, P302, DOI 10.1212/WNL.54.2.302; CULL RE, 1981, HEADACHE, V21, P102, DOI 10.1111/j.1526-4610.1981.hed2103102.x; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Djuric D., 1994, WEATHER ANAL; GOMERSALL J D, 1973, International Journal of Biometeorology, V17, P285, DOI 10.1007/BF01804622; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; *INT WOM RIGHTS AC, 1988, CONV EL ALL FORMS DI, P1; Kaniecki R, 2003, JAMA-J AM MED ASSOC, V289, P1430, DOI 10.1001/jama.289.11.1430; Lo MT, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061924; Mukamal KJ, 2009, NEUROLOGY, V72, P922, DOI 10.1212/01.wnl.0000344152.56020.94; Novak V, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-39; OSTERMAN PO, 1981, INT J BIOMETEOROL, V25, P39, DOI 10.1007/BF02184436; Piorecky J, 1997, HEADACHE, V37, P153, DOI 10.1046/j.1526-4610.1997.3703153.x; Prince PB, 2004, HEADACHE, V44, P596, DOI 10.1111/j.1526-4610.2004.446008.x; Raskin N, 1988, HEADACHE; RUSSELL MB, 1992, CEPHALALGIA, V12, P369, DOI 10.1111/j.1468-2982.1992.00369.x; SCHULMAN J, 1980, INT J BIOMETEOROL, V24, P263, DOI 10.1007/BF02249796; Sweeney-Reed CM, 2007, J COMPUT NEUROSCI, V23, P79, DOI 10.1007/s10827-007-0020-3; Vaitl D, 2001, HEADACHE, V41, P845, DOI 10.1046/j.1526-4610.2001.041009845.x; Villeneuve PJ, 2006, HEADACHE, V46, P64, DOI 10.1111/j.1526-4610.2006.00322.x; Wang SJ, 2000, CEPHALALGIA, V20, P566, DOI 10.1046/j.1468-2982.2000.00085.x; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Zivadinov R, 2003, CEPHALALGIA, V23, P336, DOI 10.1046/j.1468-2982.2003.00544.x	27	34	34	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14612	10.1371/journal.pone.0014612	http://dx.doi.org/10.1371/journal.pone.0014612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297940	Green Submitted, gold, Green Published			2022-12-25	WOS:000286834300004
J	Aira, M; Dominguez, J				Aira, Manuel; Dominguez, Jorge			Earthworm Effects without Earthworms: Inoculation of Raw Organic Matter with Worm-Worked Substrates Alters Microbial Community Functioning	PLOS ONE			English	Article							EISENIA-FOETIDA OLIGOCHAETA; LUMBRICUS-TERRESTRIS; BIOMASS; SOIL; CARBON; GUT; MINERALIZATION; DECOMPOSITION; RESPIRATION; BIOVOLUME	Background: Earthworms are key organisms in organic matter decomposition because of the interactions they establish with soil microorganisms. They enhance decomposition rates through the joint action of direct effects (i.e. effects due to direct earthworm activity such as digestion, burrowing, etc) and indirect effects (i.e. effects derived from earthworm activities such as cast ageing). Here we test whether indirect earthworm effects affect microbial community functioning in the substrate, as when earthworms are present (i.e., direct effects). Methodology/Principal Findings: To address these questions we inoculated fresh organic matter (pig manure) with worm-worked substrates (vermicompost) produced by three different earthworm species. Two doses of each vermicompost were used (2.5 and 10%). We hypothesized that the presence of worm-worked material in the fresh organic matter will result in an inoculum of different microorganisms and nutrients. This inoculum should interact with microbial communities in fresh organic matter, thus promoting modifications similar to those found when earthworms are present. Inoculation of worm-worked substrates provoked significant increases in microbial biomass and enzyme activities (beta-glucosidase, cellulase, phosphatase and protease). These indirect effects were similar to, although lower than, those obtained in pig manure with earthworms (direct and indirect earthworm effects). In general, the effects were not dose-dependent, suggesting the existence of a threshold at which they were triggered. Conclusion/Significance: Our data reveal that the relationships between earthworms and microorganisms are far from being understood, and suggest the existence of several positive feedbacks during earthworm activity as a result of the interactions between direct and indirect effects, since their combination produces stronger modifications to microbial biomass and enzyme activity.	[Aira, Manuel; Dominguez, Jorge] Univ Vigo, Fac Biol, Dept Ecol & Biol Anim, Vigo 36310, Spain	Universidade de Vigo	Aira, M (corresponding author), Univ Vigo, Fac Biol, Dept Ecol & Biol Anim, Vigo 36310, Spain.	aira@uvigo.es	Aira, Manuel/B-4506-2016; Domínguez, Jorge/T-7647-2019; Domínguez, Jorge/M-2046-2014	Aira, Manuel/0000-0002-2513-4609; Domínguez, Jorge/0000-0002-4313-8582; Domínguez, Jorge/0000-0002-4313-8582	Parga Pondal Fellow Program; Xunta de Galicia [07MRU023383PR]; Spanish Ministerio de Ciencia e Innovacion [CTM2009-08477]	Parga Pondal Fellow Program; Xunta de Galicia(Xunta de GaliciaEuropean Commission); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Manuel Aira is financially supported by Parga Pondal Fellow Program. This research was financially supported by the Xunta de Galicia (Project No. 07MRU023383PR) and the Spanish Ministerio de Ciencia e Innovacion (CTM2009-08477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2006, EUR J SOIL BIOL, V42, pS127, DOI 10.1016/j.ejsobi.2006.07.039; Aira M, 2009, J HAZARD MATER, V162, P1404, DOI 10.1016/j.jhazmat.2008.06.031; Aira M, 2008, SOIL BIOL BIOCHEM, V40, P2511, DOI 10.1016/j.soilbio.2008.06.010; Aira M, 2007, SCI TOTAL ENVIRON, V385, P252, DOI 10.1016/j.scitotenv.2007.06.031; Aira M, 2007, MICROB ECOL, V54, P662, DOI 10.1007/s00248-007-9223-4; Aira M, 2007, J ENVIRON QUAL, V36, P448, DOI 10.2134/jeq2006.0262; Aira M, 2010, APPL SOIL ECOL, V46, P143, DOI 10.1016/j.apsoil.2010.06.001; Aira M, 2010, BIORESOURCE TECHNOL, V101, P7173, DOI 10.1016/j.biortech.2010.03.137; Aira M, 2006, MICROB ECOL, V52, P738, DOI 10.1007/s00248-006-9109-x; Alef K., 1995, METHODS APPL SOIL MI, P335; [Anonymous], 1996, SOIL MICROBIOLOGY BI; Ball BA, 2009, SOIL BIOL BIOCHEM, V41, P1155, DOI 10.1016/j.soilbio.2009.02.025; Benitez E, 2000, BIOL FERT SOILS, V31, P489, DOI 10.1007/s003740000197; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Depkat-Jakob PS, 2010, APPL ENVIRON MICROB, V76, P6205, DOI 10.1128/AEM.01373-10; Dominguez J, 2004, ECOSYSTEMS, V7, P672, DOI 10.1007/s10021-004-0150-7; Dominguez J, 2010, MICROBES AT WORK: FROM WASTES TO RESOURCES, P93, DOI 10.1007/978-3-642-04043-6_5; EDWARDS CA, 1996, BIOL ECOLOGY EARTHWO, P440; EIVAZI F, 1977, SOIL BIOL BIOCHEM, V9, P167, DOI 10.1016/0038-0717(77)90070-0; EIVAZI F, 1988, SOIL BIOL BIOCHEM, V20, P601, DOI 10.1016/0038-0717(88)90141-1; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; JUMA NG, 1978, SOIL SCI, V126, P101, DOI 10.1097/00010694-197808000-00006; Knapp BA, 2009, SOIL BIOL BIOCHEM, V41, P2299, DOI 10.1016/j.soilbio.2009.08.011; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; LADD J N, 1972, Soil Biology and Biochemistry, V4, P19, DOI 10.1016/0038-0717(72)90038-7; Lavelle P., 2001, SOIL ECOLOGY; Lores M, 2006, SOIL BIOL BIOCHEM, V38, P2993, DOI 10.1016/j.soilbio.2006.05.001; Mikola J, 1998, OIKOS, V82, P158, DOI 10.2307/3546926; Monroy F, 2008, APPL SOIL ECOL, V39, P127, DOI 10.1016/j.apsoil.2007.11.011; Nechitaylo TY, 2010, MICROB ECOL, V59, P574, DOI 10.1007/s00248-009-9604-y; R Development Core Team, 2007, R LANG ENV STAT COMP; Sampedro L, 2008, APPL SOIL ECOL, V38, P91, DOI 10.1016/j.apsoil.2007.10.008; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; SCHINNER F, 1990, SOIL BIOL BIOCHEM, V22, P511, DOI 10.1016/0038-0717(90)90187-5; Schmidt SK, 2007, ECOLOGY, V88, P1379, DOI 10.1890/06-0164; Singleton DR, 2003, SOIL BIOL BIOCHEM, V35, P1547, DOI 10.1016/S0038-0717(03)00244-X; SINSABAUGH RL, 1994, SOIL BIOL BIOCHEM, V26, P1305, DOI 10.1016/0038-0717(94)90211-9; SINSABAUGH RL, 1994, BIOL FERT SOILS, V17, P69, DOI 10.1007/BF00418675; SINSABAUGH RL, 1993, ECOLOGY, V74, P1594, DOI 10.2307/1940087; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Thakuria D, 2010, ISME J, V4, P357, DOI 10.1038/ismej.2009.124; Tiunov AV, 1999, SOIL BIOL BIOCHEM, V31, P2039, DOI 10.1016/S0038-0717(99)00127-3; Tiunov AV, 2000, SOIL BIOL BIOCHEM, V32, P265, DOI 10.1016/S0038-0717(99)00165-0; Tiunov AV, 2004, OECOLOGIA, V138, P83, DOI 10.1007/s00442-003-1391-4; Tripathi G, 2004, BIORESOURCE TECHNOL, V92, P275, DOI 10.1016/j.biortech.2003.09.005; Vivas A, 2009, BIORESOURCE TECHNOL, V100, P1319, DOI 10.1016/j.biortech.2008.08.014; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; Zhang BG, 2000, SOIL BIOL BIOCHEM, V32, P2055, DOI 10.1016/S0038-0717(00)00111-5	48	39	41	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16354	10.1371/journal.pone.0016354	http://dx.doi.org/10.1371/journal.pone.0016354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298016	Green Published, gold, Green Submitted			2022-12-25	WOS:000286663900039
J	Kleger, A; Loebnitz, C; Pusapati, GV; Armacki, M; Muller, M; Tumpel, S; Illing, A; Hartmann, D; Brunner, C; Liebau, S; Rudolph, KL; Adler, G; Seufferlein, T				Kleger, Alexander; Loebnitz, Christiane; Pusapati, Ganesh V.; Armacki, Milena; Mueller, Martin; Tuempel, Stefan; Illing, Anett; Hartmann, Daniel; Brunner, Cornelia; Liebau, Stefan; Rudolph, Karl L.; Adler, Guido; Seufferlein, Thomas			Protein Kinase D2 Is an Essential Regulator of Murine Myoblast Differentiation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANS-GOLGI NETWORK; SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; CCKB/GASTRIN RECEPTOR; MOUSE EMBRYOGENESIS; C2C12 MYOBLASTS; PAX7 EXPRESSION; SATELLITE CELLS; UP-REGULATION	Muscle differentiation is a highly conserved process that occurs through the activation of quiescent satellite cells whose progeny proliferate, differentiate, and fuse to generate new myofibers. A defined pattern of myogenic transcription factors is orchestrated during this process and is regulated via distinct signaling cascades involving various intracellular signaling pathways, including members of the protein kinase C (PKC) family. The protein kinase D (PKD) isoenzymes PKD1, -2, and -3, are prominent downstream targets of PKCs and phospholipase D in various biological systems including mouse and could hence play a role in muscle differentiation. In the present study, we used a mouse myoblast cell line (C2C12) as an in vitro model to investigate the role of PKDs, in particular PKD2, in muscle stem cell differentiation. We show that C2C12 cells express all PKD isoforms with PKD2 being highly expressed. Furthermore, we demonstrate that PKD2 is specifically phosphorylated/activated during the initiation of mouse myoblast differentiation. Selective inhibition of PKCs or PKDs by pharmacological inhibitors blocked myotube formation. Depletion of PKD2 by shRNAs resulted in a marked inhibition of myoblast cell fusion. PKD2-depleted cells exhibit impaired regulation of muscle development-associated genes while the proliferative capacity remains unaltered. Vice versa forced expression of PKD2 increases myoblast differentiation. These findings were confirmed in primary mouse satellite cells where myotube fusion was also decreased upon inhibition of PKDs. Active PKD2 induced transcriptional activation of myocyte enhancer factor 2D and repression of Pax3 transcriptional activity. In conclusion, we identify PKDs, in particular PKD2, as a major mediator of muscle cell differentiation in vitro and thereby as a potential novel target for the modulation of muscle regeneration.	[Kleger, Alexander; Loebnitz, Christiane; Pusapati, Ganesh V.; Mueller, Martin; Adler, Guido] Univ Ulm, Dept Internal Med 1, D-7900 Ulm, Germany; [Kleger, Alexander; Tuempel, Stefan; Illing, Anett; Hartmann, Daniel; Rudolph, Karl L.] Univ Ulm, Inst Mol Med, D-7900 Ulm, Germany; [Kleger, Alexander; Tuempel, Stefan; Illing, Anett; Hartmann, Daniel; Rudolph, Karl L.] Univ Ulm, Max Planck Res Dept Stem Cell Aging, D-7900 Ulm, Germany; [Hartmann, Daniel] Tech Univ Munich, Dept Surg, Munich, Germany; [Brunner, Cornelia] Univ Ulm, Inst Physiol Chem, D-7900 Ulm, Germany; [Liebau, Stefan] Univ Ulm, Inst Anat & Cell Biol, D-7900 Ulm, Germany; [Armacki, Milena; Seufferlein, Thomas] Univ Halle Wittenberg, Dept Internal Med 1, Halle, Germany	Ulm University; Ulm University; Max Planck Society; Ulm University; Technical University of Munich; Ulm University; Ulm University; Martin Luther University Halle Wittenberg	Kleger, A (corresponding author), Univ Ulm, Dept Internal Med 1, D-7900 Ulm, Germany.	thomas.seufferlein@uk-halle.de	Liebau, Stefan/C-3374-2015; Brunner, Cornelia/H-8893-2018; Seufferlein, Thomas TW/P-7147-2018; Brunner, Cornelia/L-1291-2013	Liebau, Stefan/0000-0003-0721-8187; Brunner, Cornelia/0000-0002-6456-5508; Kleger, Alexander/0000-0003-0592-5232; Rudolph, Karl Lenhard/0000-0002-4839-2862; Hartmann, Daniel/0000-0003-4366-8986; Pusapati, Ganesh/0000-0002-1406-2566	Medical Faculty of Ulm University [L.SBR.0011]; Graduate College 1041 of Ulm University [1041]; Deutsche Forschungsgemeinschaft (DFG) [SFB 518]	Medical Faculty of Ulm University; Graduate College 1041 of Ulm University; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	A.K. is supported by a fellowship provided by the Medical Faculty of Ulm University (Bausteinprogramm, L.SBR.0011). C. L. was supported by a fellowship of the Graduate College 1041 of Ulm University. The main part of this study was funded by the Deutsche Forschungsgemeinschaft (DFG) ( T. S., SFB 518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold HH, 2000, CURR TOP DEV BIOL, V48, P129; Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Braun T, 1996, EMBO J, V15, P310, DOI 10.1002/j.1460-2075.1996.tb00361.x; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Czifra G, 2006, CELL SIGNAL, V18, P1461, DOI 10.1016/j.cellsig.2005.11.007; Diel P, 2008, J MOL ENDOCRINOL, V40, P231, DOI 10.1677/JME-07-0175; Donati C, 2004, FASEB J, V18, P449, DOI 10.1096/fj.04-1780fje; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Faenza I, 2007, ENDOCRINOLOGY, V148, P1108, DOI 10.1210/en.2006-1003; Fanzani A, 2006, FEBS J, V273, P3709, DOI 10.1111/j.1742-4658.2006.05380.x; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Gaboardi GC, 2010, CELL SIGNAL, V22, P629, DOI 10.1016/j.cellsig.2009.11.017; Geng J, 2009, BIOCHEM BIOPH RES CO, V388, P517, DOI 10.1016/j.bbrc.2009.08.025; Gentile MA, 2010, J MOL ENDOCRINOL, V44, P55, DOI 10.1677/JME-09-0048; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; Kleger A, 2007, CELL SIGNAL, V19, P367, DOI 10.1016/j.cellsig.2006.07.015; Kuisk IR, 1996, DEV BIOL, V174, P1, DOI 10.1006/dbio.1996.0046; LEE SJ, 1995, BIOCHEM BIOPH RES CO, V206, P194, DOI 10.1006/bbrc.1995.1027; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meacci E, 2008, J CELL PHYSIOL, V214, P210, DOI 10.1002/jcp.21187; Mirandola P, 2006, BLOOD, V107, P508, DOI 10.1182/blood-2005-07-2676; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; NAIDU PS, 1995, MOL CELL BIOL, V15, P2707; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; Oster H, 2006, GENE EXPR PATTERNS, V6, P400, DOI 10.1016/j.modgep.2005.09.006; Prelle K, 2000, BIOCHEM BIOPH RES CO, V277, P631, DOI 10.1006/bbrc.2000.3737; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Pusapati GV, 2010, MOL BIOL CELL, V21, P1011, DOI 10.1091/mbc.E09-09-0814; Qiang YW, 2004, BLOOD, V103, P301, DOI 10.1182/blood-2003-06-2066; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Sturany S, 2002, J BIOL CHEM, V277, P29431, DOI 10.1074/jbc.M200934200; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; von Blume J, 2007, EMBO J, V26, P4619, DOI 10.1038/sj.emboj.7601891; von Wicher G, 2008, CELL SIGNAL, V20, P925, DOI 10.1016/j.cellsig.2008.01.003; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wang HX, 2008, MOL BIOL CELL, V19, P1519, DOI 10.1091/mbc.E07-08-0817; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; YOUNG AP, J CELL SCI; Young AP, 2010, J CELL SCI, V123, P2632, DOI 10.1242/jcs.061606; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhu SK, 2004, CIRC RES, V94, P617, DOI 10.1161/01.RES.0000118599.25944.D5; Zhukova E, 2001, J CELL PHYSIOL, V189, P291, DOI 10.1002/jcp.10018; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	60	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14599	10.1371/journal.pone.0014599	http://dx.doi.org/10.1371/journal.pone.0014599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298052	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900004
J	Nahum, L; Gabriel, D; Schnider, A				Nahum, Louis; Gabriel, Damien; Schnider, Armin			Human Processing of Behaviorally Relevant and Irrelevant Absence of Expected Rewards: A High-Resolution ERP Study	PLOS ONE			English	Article							HUMAN ORBITOFRONTAL CORTEX; SPONTANEOUS CONFABULATIONS; PREFRONTAL CORTEX; HUMAN BRAIN; NEURONAL-ACTIVITY; MONETARY REWARD; ONGOING REALITY; FRONTAL-CORTEX; MEMORY TRACES; POTENTIALS	Acute lesions of the posterior medial orbitofrontal cortex (OFC) in humans may induce a state of reality confusion marked by confabulation, disorientation, and currently inappropriate actions. This clinical state is strongly associated with an inability to abandon previously valid anticipations, that is, extinction capacity. In healthy subjects, the filtering of memories according to their relation with ongoing reality is associated with activity in posterior medial OFC (area 13) and electrophysiologically expressed at 220-300 ms. These observations indicate that the human OFC also functions as a generic reality monitoring system. For this function, it is presumably more important for the OFC to evaluate the current behavioral appropriateness of anticipations rather than their hedonic value. In the present study, we put this hypothesis to the test. Participants performed a reversal learning task with intermittent absence of reward delivery. High-density evoked potential analysis showed that the omission of expected reward induced a specific electrocortical response in trials signaling the necessity to abandon the hitherto reward predicting choice, but not when omission of reward had no such connotation. This processing difference occurred at 200-300 ms. Source estimation using inverse solution analysis indicated that it emanated from the posterior medial OFC. We suggest that the human brain uses this signal from the OFC to keep thought and behavior in phase with reality.	[Nahum, Louis; Gabriel, Damien; Schnider, Armin] Univ Geneva, Sch Med, Dept Clin Neurosci & Dermatol, Lab Cognit Neurorehabil, CH-1211 Geneva, Switzerland; [Schnider, Armin] Univ Hosp Geneva, Dept Clin Neurosci, Div Neurorehabil, Geneva, Switzerland	University of Geneva; University of Geneva	Nahum, L (corresponding author), Univ Geneva, Sch Med, Dept Clin Neurosci & Dermatol, Lab Cognit Neurorehabil, CH-1211 Geneva, Switzerland.	armin.schnider@hcuge.ch		gabriel, damien/0000-0001-5413-3640	Swiss National Science Foundation [320030-132447]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the Swiss National Science Foundation to AS (grant no. 320030-132447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo F, 2000, NEUROPSYCHOLOGIA, V38, P1342, DOI 10.1016/S0028-3932(00)00046-4; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; BUTTER CM, 1969, PHYSIOL BEHAV, V4, P163, DOI 10.1016/0031-9384(69)90075-4; Chase H.W., 2010, J COGN NEUROSCI; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Elliott R, 2010, CEREB CORTEX, V20, P198, DOI 10.1093/cercor/bhp092; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Ghahremani DG, 2010, CEREB CORTEX, V20, P1843, DOI 10.1093/cercor/bhp247; Gilboa A, 2006, BRAIN, V129, P1399, DOI 10.1093/brain/awl093; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; James C, 2009, HIPPOCAMPUS, V19, P371, DOI 10.1002/hipo.20526; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; KRZANOWSKI WJ, 1988, BIOMETRICS, V44, P23, DOI 10.2307/2531893; Lantz G, 2001, BRAIN TOPOGR, V14, P139, DOI 10.1023/A:1012996930489; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Lehmann S, 2007, NEUROPSYCHOLOGIA, V45, P1757, DOI 10.1016/j.neuropsychologia.2006.12.018; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Menendez RGD, 2004, NEUROIMAGE, V21, P527, DOI 10.1016/j.neuroimage.2003.09.051; Metcalf K, 2007, COGN NEUROPSYCHOL, V24, P23, DOI 10.1080/02643290600694901; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; Michel CM, 1999, NEWS PHYSIOL SCI, V14, P206; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Michel CM., 2009, ELECT NEUROIMAGING, P111; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Murray MM, 2008, NEUROIMAGE, V39, P847, DOI 10.1016/j.neuroimage.2007.09.002; Nahum L, 2010, HIPPOCAMPUS; Nahum L, 2010, CORTEX; Nahum L, 2009, HUM BRAIN MAPP, V30, P2120, DOI 10.1002/hbm.20654; Nahum L, 2009, BIOL PSYCHIAT, V65, P966, DOI 10.1016/j.biopsych.2009.01.007; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Ouyang M, 2005, P NATL ACAD SCI USA, V102, P9347, DOI 10.1073/pnas.0502315102; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; PAVLOV P, 1927, CONDITIONED REFLEXES; Pegna AJ, 2002, NEUROREPORT, V13, P965, DOI 10.1097/00001756-200205240-00013; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Ptak R, 2001, NEUROLOGY, V56, P1597, DOI 10.1212/WNL.56.11.1597; Ramnani N, 2004, NEUROIMAGE, V23, P777, DOI 10.1016/j.neuroimage.2004.07.028; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; ROSENKILDE CE, 1981, BRAIN RES, V209, P375, DOI 10.1016/0006-8993(81)90160-8; Schnider A, 2000, J NEUROSCI, V20, P5880, DOI 10.1523/JNEUROSCI.20-15-05880.2000; Schnider A, 1999, NAT NEUROSCI, V2, P677, DOI 10.1038/10236; Schnider A, 2000, NEUROLOGY, V55, P74, DOI 10.1212/WNL.55.1.74; Schnider A, 2003, NAT REV NEUROSCI, V4, P662, DOI 10.1038/nrn1179; Schnider A, 2010, NEUROSCIENCE, V167, P583, DOI 10.1016/j.neuroscience.2010.02.044; Schnider A, 2002, CEREB CORTEX, V12, P54, DOI 10.1093/cercor/12.1.54; Schnider A, 1996, BRAIN, V119, P1365, DOI 10.1093/brain/119.4.1365; Schnider A, 1996, BRAIN, V119, P1627, DOI 10.1093/brain/119.5.1627; Schnider A., 2008, CONFABULATING MIND B; Schnider A, 2008, NEUROLOGIE COMPORTEM; Schnider A, 2007, NEUROIMAGE, V35, P1348, DOI 10.1016/j.neuroimage.2007.01.047; Schnider A, 2005, NEUROPSYCHOLOGIA, V43, P316, DOI 10.1016/j.neuropsychologia.2004.07.003; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Schultz W., 2006, ORBITOFRONTAL CORTEX, P173; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Stenger V. A., 2006, ORBITOFRONTAL CORTEX, P423; Tanaka SC, 2008, J NEUROSCI, V28, P6750, DOI 10.1523/JNEUROSCI.1808-08.2008; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Treyer V, 2003, J COGNITIVE NEUROSCI, V15, P610, DOI 10.1162/089892903321662985; VAUGHAN HG, 1982, ANN NY ACAD SCI, V388, P125, DOI 10.1111/j.1749-6632.1982.tb50788.x; Willis ML, 2010, NEUROIMAGE, V50, P329, DOI 10.1016/j.neuroimage.2009.11.071	78	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16173	10.1371/journal.pone.0016173	http://dx.doi.org/10.1371/journal.pone.0016173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JV	21298049	Green Submitted, Green Published, gold			2022-12-25	WOS:000286663900024
J	Shan, JF; Javitch, JA; Shi, L; Weinstein, H				Shan, Jufang; Javitch, Jonathan A.; Shi, Lei; Weinstein, Harel			The Substrate-Driven Transition to an Inward-Facing Conformation in the Functional Mechanism of the Dopamine Transporter	PLOS ONE			English	Article							CYSTEINE-SCANNING MUTAGENESIS; HUMAN NOREPINEPHRINE TRANSPORTER; HUMAN-NORADRENALINE-TRANSPORTER; STEERED MOLECULAR-DYNAMICS; RAT SEROTONIN TRANSPORTER; TRANSMEMBRANE DOMAIN-I; NEUROTRANSMITTER TRANSPORTERS; BINDING-SITE; BACTERIAL HOMOLOG; COCAINE BINDING	Background: The dopamine transporter (DAT), a member of the neurotransmitter: Na+ symporter (NSS) family, terminates dopaminergic neurotransmission and is a major molecular target for psychostimulants such as cocaine and amphetamine, and for the treatment of attention deficit disorder and depression. The crystal structures of the prokaryotic NSS homolog of DAT, the leucine transporter LeuT, have provided critical structural insights about the occluded and outward-facing conformations visited during the substrate transport, but only limited clues regarding mechanism. To understand the transport mechanism in DAT we have used a homology model based on the LeuT structure in a computational protocol validated previously for LeuT, in which steered molecular dynamics (SMD) simulations guide the substrate along a pathway leading from the extracellular end to the intracellular (cytoplasmic) end. Methodology/Principal Findings: Key findings are (1) a second substrate binding site in the extracellular vestibule, and (2) models of the conformational states identified as occluded, doubly occupied, and inward-facing. The transition between these states involve a spatially ordered sequence of interactions between the two substrate-binding sites, followed by rearrangements in structural elements located between the primary binding site and the cytoplasmic end. These rearrangements are facilitated by identified conserved hinge regions and a reorganization of interaction networks that had been identified as gates. Conclusions/Significance: Computational simulations supported by information available from experiments in DAT and other NSS transporters have produced a detailed mechanistic proposal for the dynamic changes associated with substrate transport in DAT. This allosteric mechanism is triggered by the binding of substrate in the S2 site in the presence of the substrate in the S1 site. Specific structural elements involved in this mechanism, and their roles in the conformational transitions illuminated here describe, a specific substrate-driven allosteric mechanism that is directly amenable to experiment as shown previously for LeuT.	[Shan, Jufang; Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Cornell University; Cornell University; Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University	Shan, JF (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA.	les2007@med.cornell.edu; haw2002@med.cornell.edu	Shi, Lei/AAV-1321-2020; WEINSTEIN, HAREL/O-8245-2019	Shi, Lei/0000-0002-4137-096X; WEINSTEIN, HAREL/0000-0003-3473-9818; Javitch, Jonathan/0000-0001-7395-2967	National Institutes of Health, National Institute on Drug Abuse [DA012408, DA023694, DA022413, DA17293]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017293, R00DA023694, P01DA012408, K05DA022413] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants from the National Institute on Drug Abuse (DA012408, DA023694, DA022413, and DA17293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Ben-Yona A, 2009, J BIOL CHEM, V284, P9727, DOI 10.1074/jbc.M809423200; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Burgess KSD, 1999, J NEUROCHEM, V73, P656, DOI 10.1046/j.1471-4159.1999.0730656.x; Case D, 2006, AMBER 9; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Crawley MJ., 2007, R BOOK; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Damm KL, 2006, BIOPHYS J, V90, P4558, DOI 10.1529/biophysj.105.066654; Dar DE, 2005, BIOCHEM PHARMACOL, V70, P461, DOI 10.1016/j.bcp.2005.04.032; Dodd JR, 2005, J BIOL CHEM, V280, P32649, DOI 10.1074/jbc.M506723200; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Elling CE, 1997, FOLD DES, V2, pS76, DOI 10.1016/S1359-0278(97)00068-0; Enkavi G, 2010, BIOCHEMISTRY-US, V49, P1105, DOI 10.1021/bi901412a; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gedeon PC, 2010, PROTEINS, V78, P797, DOI 10.1002/prot.22601; Goldberg NR, 2003, EUR J PHARMACOL, V479, P3, DOI 10.1016/j.ejphar.2003.08.052; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; Gouaux E, 2009, PHILOS T R SOC B, V364, P149, DOI 10.1098/rstb.2008.0181; Gracia L., 2005, RMSDTT RMSD TRAJECTO; Gua Y, 2009, P NATL ACAD SCI USA, V106, P2589, DOI 10.1073/pnas.0812299106; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Huang X, 2007, BIOPHYS J, V93, P3627, DOI 10.1529/biophysj.107.110924; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Itokawa M, 2000, MOL PHARMACOL, V57, P1093; Itokawa M, 2002, MOL BRAIN RES, V108, P71, DOI 10.1016/S0169-328X(02)00515-6; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Javitch JA, 1998, METHOD ENZYMOL, V296, P331; Jensen MO, 2007, BIOPHYS J, V93, P92, DOI 10.1529/biophysj.107.103994; Kamdar G, 2001, J BIOL CHEM, V276, P4038, DOI 10.1074/jbc.M008483200; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; KITAYAMA S, 1993, SYNAPSE, V15, P58, DOI 10.1002/syn.890150107; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lei S, 2002, J BIOL CHEM, V277, P40989, DOI 10.1074/jbc.M206801200; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Lin ZC, 2000, FASEB J, V14, P715, DOI 10.1096/fasebj.14.5.715; Lin ZC, 2003, J BIOL CHEM, V278, P20162, DOI 10.1074/jbc.M209584200; Lin ZC, 2005, J NEUROCHEM, V94, P276, DOI 10.1111/j.1471-4159.2005.03196.x; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Mezei M, 2010, J COMPUT CHEM, V31, P2658, DOI 10.1002/jcc.21551; MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0; Norregaard L, 2003, J BIOL CHEM, V278, P30587, DOI 10.1074/jbc.M303854200; Norregaard L, 2000, BIOCHEMISTRY-US, V39, P15836, DOI 10.1021/bi0018335; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Noskov SY, 2008, PROTEINS, V73, P851, DOI 10.1002/prot.22108; Ota N, 2005, J MOL BIOL, V351, P345, DOI 10.1016/j.jmb.2005.05.043; Paczkowski FA, 2004, J NEUROCHEM, V88, P203, DOI 10.1046/j.1471-4159.2003.02149.x; Paczkowski FA, 2002, PHARMACOGENETICS, V12, P165, DOI 10.1097/00008571-200203000-00010; Penado KMY, 1998, J BIOL CHEM, V273, P28098, DOI 10.1074/jbc.273.43.28098; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plenge P, 2005, NEUROSCI LETT, V383, P203, DOI 10.1016/j.neulet.2005.04.028; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rudnick G, 1998, J BIOENERG BIOMEMBR, V30, P173, DOI 10.1023/A:1020573325823; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Sato Y, 2004, J BIOL CHEM, V279, P22926, DOI 10.1074/jbc.M312194200; Sen N, 2005, NEUROPHARMACOLOGY, V49, P780, DOI 10.1016/j.neuropharm.2005.08.014; Shi L, 2010, PHIL PA 10 IEEE INT; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Singh R, 2002, J PEPT RES, V60, P357, DOI 10.1034/j.1399-3011.2002.21065.x; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sonders MS, 2005, CURR OPIN NEUROBIOL, V15, P296, DOI 10.1016/j.conb.2005.05.009; Sucic S, 2005, J NEUROCHEM, V94, P1620, DOI 10.1111/j.1471-4159.2005.03316.x; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sur C, 1997, BIOCHEM BIOPH RES CO, V241, P68, DOI 10.1006/bbrc.1997.7771; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; Visiers I, 2002, METHOD ENZYMOL, V343, P329; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	96	96	98	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16350	10.1371/journal.pone.0016350	http://dx.doi.org/10.1371/journal.pone.0016350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298009	Green Submitted, Green Published, gold			2022-12-25	WOS:000286663900038
J	Ditt, V; Lusebrink, J; Tillmann, RL; Schildgen, V; Schildgen, O				Ditt, Vanessa; Luesebrink, Jessica; Tillmann, Ramona Liza; Schildgen, Verena; Schildgen, Oliver			Respiratory Infections by HMPV and RSV Are Clinically Indistinguishable but Induce Different Host Response in Aged Individuals	PLOS ONE			English	Article							HUMAN METAPNEUMOVIRUS INFECTION; NF-KAPPA-B; SYNCYTIAL VIRUS; BALB/C MICE; NONSTRUCTURAL PROTEINS; IMMUNE-RESPONSE; NS1; IMMUNOSENESCENCE; CHILDREN; DISEASE	Background: Human metapneumovirus and respiratory syncytial virus can cause severe respiratory diseases, especially in infants, young children, and the elderly. So far it remains unclear why infections in the elderly become life threatening despite the presence of neutralizing antibodies in the serum, and to which extent double infections worsen the clinical course. Methods: Young and aged BALB/c-mice were infected with RSV or/and HMPV. Appearance of the mice was observed during course of infection. On day 5 p.i. animals were dispatched by cervical dislocation and levels of TNF-alpha and NF-kappa B were determined. Results: The observation of activity, weight and appearance of the different mice showed no differences among the tested groups. Despite this, the immunologic response depends on the animals' age and the virus they were infected with. In young animals, NF-kappa B levels were elevated if infected with HMPV and HMPV/RSV but remained low in RSV infections, whereas in aged animals the opposite was observed: solely RSV-infected animals showed elevated levels of NF-kappa B. TNF-alpha was slightly elevated in HMPV-infected young and old animals, but only in young animals this elevation was significant. Conclusions: Contrary to other studies, no weight loss or change in activity despite productive lung infection with the different viruses were observed. This may be due to the weaker anaesthesia or the lesser volume of virus solution used, leading to less stress in the animals. The observed differences in TNF-alpha and NF-kappa B elevation lead to the assumption that young and old individuals have different mechanisms to react against the viruses.	[Ditt, Vanessa; Luesebrink, Jessica; Tillmann, Ramona Liza; Schildgen, Verena; Schildgen, Oliver] Univ Bonn, Inst Virol, D-5300 Bonn, Germany	University of Bonn	Ditt, V (corresponding author), Kliniken Stadt Koln gGmbH, Inst Pathol, Cologne, Germany.	schildgeno@kliniken-koeln.de	Schildgen, Oliver/D-5327-2014	Schildgen, Oliver/0000-0003-4297-9627	European Commission [LSHM-CT-2006-037276]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the European Commission (RespViruses, LSHM-CT-2006-037276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2005, J VIROL, V79, P5971, DOI 10.1128/JVI.79.10.5971-5978.2005; Alvarez R, 2004, J VIROL, V78, P14003, DOI 10.1128/JVI.78.24.14003-14011.2004; Bitko V, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-28; Bitko V, 2007, J VIROL, V81, P1786, DOI 10.1128/JVI.01420-06; Darniot M, 2005, VACCINE, V23, P4473, DOI 10.1016/j.vaccine.2005.04.027; Darniot M, 2009, J VIROL, V83, P3323, DOI 10.1128/JVI.02198-08; DARNIOT M, 2009, J VIROL; de Graaf M, 2008, J GEN VIROL, V89, P2933, DOI 10.1099/vir.0.2008/006957-0; Elliott J, 2007, J VIROL, V81, P3428, DOI 10.1128/JVI.02303-06; Huck B, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-6; LING Z, 2009, J VIROL; Ling Z, 2008, PROTEIN EXPRES PURIF, V57, P261, DOI 10.1016/j.pep.2007.09.017; Ling Z, 2009, J VIROL, V83, P3734, DOI 10.1128/JVI.02434-08; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; Louie JK, 2007, J INFECT DIS, V196, P705, DOI 10.1086/519846; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Mok H, 2008, J VIROL, V82, P11410, DOI 10.1128/JVI.01688-08; Moore EC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-116; Muller A, 2007, EUR J MED RES, V12, P183; Munir S, 2008, J VIROL, V82, P8780, DOI 10.1128/JVI.00630-08; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Pawelec G, 2004, TRENDS IMMUNOL, V25, P406, DOI 10.1016/j.it.2004.05.006; Ruohola A, 2009, EMERG INFECT DIS, V15, P344, DOI 10.3201/eid1502.081468; Schildgen O, 2005, J VIROL, V79, P7273, DOI 10.1128/JVI.79.11.7273-7278.2005; Schildgen O, 2005, EMERG INFECT DIS, V11, P467, DOI 10.3201/eid1103.040676; Schildgen V, 2010, J VIROL METHODS, V163, P74, DOI 10.1016/j.jviromet.2009.08.024; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Spetch L, 2008, J GEN VIROL, V89, P2709, DOI 10.1099/vir.0.2008/003301-0; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Swedan S, 2009, J VIROL, V83, P9682, DOI 10.1128/JVI.00715-09; Tillmann RL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001357; van den Hoogen BG, 2007, CLIN INFECT DIS, V44, P1159, DOI 10.1086/513295; Van den Hoogen BG, 2004, PEDIATR INFECT DIS J, V23, pS25, DOI 10.1097/01.inf.0000108190.09824.e8; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Velayudhan BT, 2006, EMERG INFECT DIS, V12, P1853; von Linstow ML, 2008, EUR J PEDIATR, V167, P1125, DOI 10.1007/s00431-007-0643-4; Wilkesmann A, 2006, EUR J PEDIATR, V165, P467, DOI 10.1007/s00431-006-0105-4	37	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16314	10.1371/journal.pone.0016314	http://dx.doi.org/10.1371/journal.pone.0016314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298115	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800025
J	Lerdsamran, H; Pittayawonganon, C; Pooruk, P; Mungaomklang, A; Iamsirithaworn, S; Thongcharoen, P; Kositanont, U; Auewarakul, P; Chokephaibulkit, K; Oota, S; Pongkankham, W; Silaporn, P; Komolsiri, S; Noisumdaeng, P; Chotpitayasunondh, T; Sangsajja, C; Wiriyarat, W; Louisirirotchanakul, S; Puthavathana, P				Lerdsamran, Hatairat; Pittayawonganon, Chakrarat; Pooruk, Phisanu; Mungaomklang, Anek; Iamsirithaworn, Sopon; Thongcharoen, Prasert; Kositanont, Uraiwan; Auewarakul, Prasert; Chokephaibulkit, Kulkanya; Oota, Sineenat; Pongkankham, Warin; Silaporn, Patummal; Komolsiri, Supaloek; Noisumdaeng, Pirom; Chotpitayasunondh, Tawee; Sangsajja, Chariya; Wiriyarat, Witthawat; Louisirirotchanakul, Suda; Puthavathana, Pilaipan			Serological Response to the 2009 Pandemic Influenza A (H1N1) Virus for Disease Diagnosis and Estimating the Infection Rate in Thai Population	PLOS ONE			English	Article							H5N1 VIRUS; HA2 GLYCOPOLYPEPTIDE; ANTIBODY-RESPONSES; VACCINE; HEMAGGLUTININ; INHIBITION; PROTECTION; STRAIN	Background: Individuals infected with the 2009 pandemic virus A(H1N1) developed serological response which can be measured by hemagglutination-inhibition (HI) and microneutralization (microNT) assays. Methodology/Principal Findings: MicroNT and HI assays for specific antibody to the 2009 pandemic virus were conducted in serum samples collected at the end of the first epidemic wave from various groups of Thai people: laboratory confirmed cases, blood donors and health care workers (HCW) in Bangkok and neighboring province, general population in the North and the South, as well as archival sera collected at pre- and post-vaccination from vaccinees who received influenza vaccine of the 2006 season. This study demonstrated that goose erythrocytes yielded comparable HI antibody titer as compared to turkey erythrocytes. In contrast to the standard protocol, our investigation found out the necessity to eliminate nonspecific inhibitor present in the test sera by receptor destroying enzyme (RDE) prior to performing microNT assay. The investigation in pre-pandemic serum samples showed that HI antibody was more specific to the 2009 pandemic virus than NT antibody. Based on data from pre-pandemic sera together with those from the laboratory confirmed cases, HI antibody titers >= 40 for adults and > 20 for children could be used as the cut-off level to differentiate between the individuals with or without past infection by the 2009 pandemic virus. Conclusions/Significance: Based on the cut-off criteria, the infection rates of 7 and 12.8% were estimated in blood donors and HCW, respectively after the first wave of the 2009 influenza pandemic. Among general population, the infection rate of 58.6% was found in children versus 3.1% in adults.	[Lerdsamran, Hatairat; Pooruk, Phisanu; Thongcharoen, Prasert; Kositanont, Uraiwan; Auewarakul, Prasert; Komolsiri, Supaloek; Noisumdaeng, Pirom; Louisirirotchanakul, Suda; Puthavathana, Pilaipan] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand; [Pittayawonganon, Chakrarat; Iamsirithaworn, Sopon; Silaporn, Patummal] Minist Publ Hlth, Dept Dis Control, Bur Epidemiol, Nonthaburi, Thailand; [Mungaomklang, Anek] Minist Publ Hlth, Maharat Nakhonratchasima Hosp, Nakhon Ratchasima, Thailand; [Chokephaibulkit, Kulkanya] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pediat, Bangkok 10700, Thailand; [Oota, Sineenat] Thai Red Cross Soc, Natl Blood Ctr, Bangkok, Thailand; [Pongkankham, Warin] Royal Thai Navy, Naval Med Dept, Div Prevent Med, Chon Buri, Thailand; [Chotpitayasunondh, Tawee] Minist Publ Hlth, Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Sangsajja, Chariya] Minist Publ Hlth, Bamrasnaradura Infect Dis Inst, Nonthaburi, Thailand; [Wiriyarat, Witthawat] Mahidol Univ, Fac Vet Sci, Nakhon Pathom, Thailand	Mahidol University; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Mahidol University; Thai Red Cross Society; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Mahidol University	Lerdsamran, H (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand.	siput@mahidol.ac.th	Auewarakul, Prasert/D-6015-2011	Tripp, Ralph/0000-0002-2924-9956; Auewarakul, Prasert/0000-0002-4745-4291	National Science and Technology Development Agency; Thailand Research Fund for Senior Research Scholar; Mahidol University	National Science and Technology Development Agency; Thailand Research Fund for Senior Research Scholar; Mahidol University	This study was supported by the National Science and Technology Development Agency, the Thailand Research Fund for Senior Research Scholar and the Mahidol University Research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auewarakul P, 2007, VACCINE, V25, P659, DOI 10.1016/j.vaccine.2006.08.026; Chan M., WORLD NOW START 2009; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chen MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012474; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dejpichai R, 2009, EMERG INFECT DIS, V15, P756, DOI 10.3201/eid1505.080316; Eichelberger M, 2008, VACCINE, V26, P4299, DOI 10.1016/j.vaccine.2008.06.012; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gocnik M, 2008, J GEN VIROL, V89, P958, DOI 10.1099/vir.0.83524-0; Gocnik M, 2007, J GEN VIROL, V88, P951, DOI 10.1099/vir.0.82563-0; HAJJAR LA, 2010, ANN ONCOL; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hinjoy S, 2008, EMERG INFECT DIS, V14, P499, DOI 10.3201/eid1403.070662; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Kitphati R, 2009, CLIN VACCINE IMMUNOL, V16, P978, DOI 10.1128/CVI.00062-09; Kositanont U, 2010, VIRAL IMMUNOL, V23, P329, DOI 10.1089/vim.2009.0082; Louisirirotchanakul S, 2007, J CLIN MICROBIOL, V45, P2284, DOI 10.1128/JCM.00921-07; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miller M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006708; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Ndifon W, 2009, VACCINE, V27, P2447, DOI 10.1016/j.vaccine.2009.02.047; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Reed C, 2010, LANCET, V375, P1062, DOI 10.1016/S0140-6736(09)62194-2; Ross T, 2010, PLOS CURR, V2, DOI DOI 10.1371/CURRENTS.RRN1148; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; WHO, 2009, CDC PROT REALT RT PC; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2009, ASS SEV INFL PAND	34	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16164	10.1371/journal.pone.0016164	http://dx.doi.org/10.1371/journal.pone.0016164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283570	gold, Green Submitted, Green Published			2022-12-25	WOS:000286661400031
J	Zuniga, L; Marquez, V; Gonzalez-Nilo, FD; Chipot, C; Cid, LP; Sepulveda, FV; Niemeyer, MI				Zuniga, Leandro; Marquez, Valeria; Gonzalez-Nilo, Fernando D.; Chipot, Christophe; Pablo Cid, L.; Sepulveda, Francisco V.; Isabel Niemeyer, Maria			Gating of a pH-Sensitive K-2P Potassium Channel by an Electrostatic Effect of Basic Sensor Residues on the Selectivity Filter	PLOS ONE			English	Article							DOMAIN K+ CHANNELS; MOLECULAR-DYNAMICS SIMULATIONS; 2-PORE DOMAIN; FUNCTIONAL-CHARACTERISTICS; EXTRACELLULAR HISTIDINE; CRYSTAL-STRUCTURE; PORE; MECHANISM; TASK2; INACTIVATION	K+ channels share common selectivity characteristics but exhibit a wide diversity in how they are gated open. Leak K-2P K+ channels TASK-2, TALK-1 and TALK-2 are gated open by extracellular alkalinization. The mechanism for this alkalinization-dependent gating has been proposed to be the neutralization of the side chain of a single arginine (lysine in TALK-2) residue near the pore of TASK-2, which occurs with the unusual pK(a) of 8.0. We now corroborate this hypothesis by transplanting the TASK-2 extracellular pH (pH(o)) sensor in the background of a pH(o)-insensitive TASK-3 channel, which leads to the restitution of pH(o)-gating. Using a concatenated channel approach, we also demonstrate that for TASK-2 to open, pH(o) sensors must be neutralized in each of the two subunits forming these dimeric channels with no apparent cross-talk between the sensors. These results are consistent with adaptive biasing force analysis of K+ permeation using a model selectivity filter in wild-type and mutated channels. The underlying free-energy profiles confirm that either a doubly or a singly charged pH(o) sensor is sufficient to abolish ion flow. Atomic detail of the associated mechanism reveals that, rather than a collapse of the pore, as proposed for other K-2P channels gated at the selectivity filter, an increased height of the energetic barriers for ion translocation accounts for channel blockade at acid pHo. Our data, therefore, strongly suggest that a cycle of protonation/deprotonation of pH(o)-sensing arginine 224 side chain gates the TASK-2 channel by electrostatically tuning the conformational stability of its selectivity filter.	[Zuniga, Leandro; Pablo Cid, L.; Sepulveda, Francisco V.; Isabel Niemeyer, Maria] Ctr Estudios Cient, Valdivia, Chile; [Sepulveda, Francisco V.] CECS CIN, Ctr Ingn Innovac, Valdivia, Chile; [Marquez, Valeria; Gonzalez-Nilo, Fernando D.] Univ Talca, Ctr Bioinformat & Simulac Mol, Talca, Chile; [Chipot, Christophe] Univ Illinois, Beckman Inst, Urbana, IL USA; [Chipot, Christophe] Univ Nancy, Unite Mixte Rech CNRS UHP 7565, Equipe Dynam Assemblages Membranaires, Vandoeuvre Les Nancy, France	Universidad de Talca; University of Illinois System; University of Illinois Urbana-Champaign; Universite de Lorraine	Zuniga, L (corresponding author), Univ Concepcion, Dept Fisiol, Concepcion, Chile.	fsepulveda@cecs.cl	González Nilo, Fernando Danilo/M-5368-2017; González-Nilo, Fernando/M-5671-2016	González Nilo, Fernando Danilo/0000-0001-6857-3575; González-Nilo, Fernando/0000-0001-6857-3575; Sepulveda Valenzuela, Francisco Leandro/0000-0003-0022-6598; Cid, Pablo/0000-0003-0394-0498	Fondecyt [1090478]; Conicyt [ACT/24]; Conicyt Base Financing Program; Gobierno Regional de Los Rios; Conicyt fund CIN	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Conicyt Base Financing Program; Gobierno Regional de Los Rios; Conicyt fund CIN	Supported by grants Fondecyt (http://www.conicyt.cl/573/propertyvalue-2229.html) 1090478 and Conicyt (http://www.conicyt.cl/573/channel.html) ACT/24. CECS is funded by Conicyt Base Financing Program. The Gobierno Regional de Los Rios (http://www.goredelosrios.cl/) and Conicyt fund CIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Barriere H, 2003, J GEN PHYSIOL, V122, P177, DOI 10.1085/jgp.200308820; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100; Cid LP, 2000, AM J PHYSIOL-CELL PH, V279, pC1198, DOI 10.1152/ajpcell.2000.279.4.C1198; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Cohen A, 2008, J BIOL CHEM, V283, P19448, DOI 10.1074/jbc.M801273200; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; DIAZ M, 1995, PFLUG ARCH EUR J PHY, V430, P168, DOI 10.1007/BF00374647; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Niemeyer MI, 2010, J BIOL CHEM, V285, P16467, DOI 10.1074/jbc.M110.107060; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang DW, 2004, BIOCHEM BIOPH RES CO, V315, P836, DOI 10.1016/j.bbrc.2004.01.137; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Morton MJ, 2005, P NATL ACAD SCI USA, V102, P16102, DOI 10.1073/pnas.0506870102; Niemeyer M. I., 2006, BIOCHEM SOC T, V34, P903; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; Niemeyer MI, 2003, MOL MEMBR BIOL, V20, P185, DOI 10.1080/0968768031000084181; Niemeyer MI, 2001, J BIOL CHEM, V276, P43166, DOI 10.1074/jbc.M107192200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Rodriguez-Gomez D, 2004, J CHEM PHYS, V120, P3563, DOI 10.1063/1.1642607; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stansfeld PJ, 2008, BIOCHEMISTRY-US, V47, P7414, DOI 10.1021/bi800475j; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Warth R, 2004, P NATL ACAD SCI USA, V101, P8215, DOI 10.1073/pnas.0400081101; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yuill KH, 2007, PFLUG ARCH EUR J PHY, V455, P333, DOI 10.1007/s00424-007-0282-7; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	52	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16141	10.1371/journal.pone.0016141	http://dx.doi.org/10.1371/journal.pone.0016141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283586	Green Published, gold			2022-12-25	WOS:000286661400027
J	Kim, JH; Karpyak, VM; Biernacka, JM; Nam, HW; Lee, MR; Preuss, UW; Zill, P; Yoon, G; Colby, C; Mrazek, DA; Choi, DS				Kim, Jeong-Hyun; Karpyak, Victor M.; Biernacka, Joanna M.; Nam, Hyung Wook; Lee, Moonnoh R.; Preuss, Ulrich W.; Zill, Peter; Yoon, Gihyun; Colby, Colin; Mrazek, David A.; Choi, Doo-Sup			Functional Role of the Polymorphic 647 T/C Variant of ENT1 (SLC29A1) and Its Association with Alcohol Withdrawal Seizures	PLOS ONE			English	Article							EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; REGULATES ETHANOL INTOXICATION; INDUCED MOTOR INCOORDINATION; KINASE-C-EPSILON; GLUTAMATERGIC NEUROTRANSMISSION; EXTRACELLULAR ADENOSINE; SENSITIVITY; MICE; RECEPTORS; DETERMINANTS	Background: Adenosine is involved in several neurological and behavioral disorders including alcoholism. In cultured cell and animal studies, type 1 equilibrative nucleoside transporter (ENT1, slc29a1), which regulates adenosine levels, is known to regulate ethanol sensitivity and preference. Interestingly, in humans, the ENT1 (SLC29A1) gene contains a non-synonymous single nucleotide polymorphism (647 T/C; rs45573936) that might be involved in the functional change of ENT1. Principal Findings: Our functional analysis showed that prolonged ethanol exposure increased adenosine uptake activity of mutant cells (ENT1-216Thr) compared to wild-type (ENT1-216Ile) transfected cells, which might result in reduced extracellular adenosine levels. We found that mice lacking ENT1 displayed increased propensity to ethanol withdrawal seizures compared to wild-type littermates. We further investigated a possible association of the 647C variant with alcoholism and the history of alcohol withdrawal seizures in subjects of European ancestry recruited from two independent sites. Analyses of the combined data set showed an association of the 647C variant and alcohol dependence with withdrawal seizures at the nominally significant level. Conclusions: Together with the functional data, our findings suggest a potential contribution of a genetic variant of ENT1 to the development of alcoholism with increased risk of alcohol withdrawal-induced seizures in humans.	[Kim, Jeong-Hyun; Nam, Hyung Wook; Lee, Moonnoh R.; Choi, Doo-Sup] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Coll Med, Rochester, MN USA; [Karpyak, Victor M.; Biernacka, Joanna M.; Mrazek, David A.; Choi, Doo-Sup] Mayo Clin, Dept Psychiat, Coll Med, Rochester, MN USA; [Biernacka, Joanna M.; Colby, Colin] Mayo Clin, Dept Hlth Sci Res, Coll Med, Rochester, MN USA; [Preuss, Ulrich W.] Univ Halle Wittenberg, Dept Psychiat Psychotherapy & Psychosomat, Halle, Germany; [Zill, Peter] Univ Munich, Sect Psychiat Genet & Neurochem, Munich, Germany; [Yoon, Gihyun] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Martin Luther University Halle Wittenberg; University of Munich; University of Minnesota System; University of Minnesota Twin Cities	Kim, JH (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.	choids@mayo.edu	Karpyak, Victor M./AGJ-2595-2022; Choi, Doo-Sup/G-9474-2012	Karpyak, Victor M./0000-0002-9552-6130; Choi, Doo-Sup/0000-0002-6796-9938	Mayo Clinic; National Institutes of Health [AA015164, AA018779, AA017830-Project 1]; Ludwig-Maximilians-University, Munich, Germany; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017830, R01AA018779, R01AA015164] Funding Source: NIH RePORTER	Mayo Clinic; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig-Maximilians-University, Munich, Germany; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Samuel Johnson Genomics of Addiction Program at Mayo Clinic (VMK, JMB, DAM, DSC), and in part by the National Institutes of Health grant AA015164, AA018779, and AA017830-Project 1 (DSC). The study in Germany was supported by the FoFoLe Program of the Ludwig-Maximilians-University, Munich, Germany (UWP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLARIN M, 1991, ACTA PHYSIOL SCAND, V142, P97, DOI 10.1111/j.1748-1716.1991.tb09133.x; Becker HC, 1997, PHARMACOL BIOCHEM BE, V57, P179, DOI 10.1016/S0091-3057(96)00303-6; Boison D, 2005, NEUROSCIENTIST, V11, P25, DOI 10.1177/1073858404269112; Boison D, 2008, CURR OPIN PHARMACOL, V8, P2, DOI 10.1016/j.coph.2007.09.002; Boison D, 2006, TRENDS PHARMACOL SCI, V27, P652, DOI 10.1016/j.tips.2006.10.008; Bone DBJ, 2007, MOL MEMBR BIOL, V24, P294, DOI 10.1080/09687860701210617; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Chen JH, 2010, BEHAV BRAIN RES, V208, P636, DOI 10.1016/j.bbr.2010.01.011; Choi DS, 2008, J NEUROSCI, V28, P11890, DOI 10.1523/JNEUROSCI.3156-08.2008; Choi DS, 2004, NAT NEUROSCI, V7, P855, DOI 10.1038/nn1288; Choi DS, 2002, J NEUROSCI, V22, P9905; CHOI DS, 2009, PHARMACOL THERAPEUT, P817; Coe I, 2002, FEBS LETT, V517, P201, DOI 10.1016/S0014-5793(02)02622-4; Coe IR, 1996, J PHARMACOL EXP THER, V276, P365; Crusio WE, 2009, GENES BRAIN BEHAV, V8, P1, DOI 10.1111/j.1601-183X.2008.00438.x; DAR MS, 1990, PHARMACOL BIOCHEM BE, V37, P747, DOI 10.1016/0091-3057(90)90558-Y; DAR MS, 1990, J PHARMACOL EXP THER, V255, P1202; DRAGUNOW M, 1991, ANN NEUROL, V29, P575, DOI 10.1002/ana.410290524; Duka T, 2004, ALCOHOL CLIN EXP RES, V28, P233, DOI 10.1097/01.ALC.0000113780.41701.81; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; GORDON AS, 1986, P NATL ACAD SCI USA, V83, P2105, DOI 10.1073/pnas.83.7.2105; Hammond JR, 2000, N-S ARCH PHARMACOL, V361, P373, DOI 10.1007/s002100000214; Harwood HJ, 1998, RECENT DEV ALCOHOL, V14, P307, DOI 10.1007/0-306-47148-5_14; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Kaplan GB, 1999, ALCOHOL, V19, P157, DOI 10.1016/S0741-8329(99)00033-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leabman MK, 2003, P NATL ACAD SCI USA, V100, P5896, DOI 10.1073/pnas.0730857100; Levran O, 2009, GENES BRAIN BEHAV, V8, P531, DOI 10.1111/j.1601-183X.2009.00501.x; LISKOW BI, 1987, J STUD ALCOHOL, V48, P356, DOI 10.15288/jsa.1987.48.356; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MESSING RO, 1991, J BIOL CHEM, V266, P23428; Nagel J, 2002, BEHAV BRAIN RES, V134, P485, DOI 10.1016/S0166-4328(02)00062-1; NAGY LE, 1989, MOL PHARMACOL, V36, P744; NAGY LE, 1990, J BIOL CHEM, V265, P1946; Nam HW, 2010, NEUROSCI LETT, V479, P277, DOI 10.1016/j.neulet.2010.05.079; Osato DH, 2003, PHARMACOGENETICS, V13, P297, DOI 10.1097/00008571-200305000-00010; ROBINS LN, 1984, ARCH GEN PSYCHIAT, V41, P949; ROSSETTI ZL, 1995, EUR J PHARMACOL, V283, P177, DOI 10.1016/0014-2999(95)00344-K; SAPRU MK, 1994, J PHARMACOL EXP THER, V271, P542; Schmidt LG, 2000, EUR PSYCHIAT, V15, P135, DOI 10.1016/S0924-9338(00)00220-0; Schork NJ, 1998, ALCOHOL, V16, P71, DOI 10.1016/S0741-8329(97)00179-1; SCHUCKIT MA, 1995, ADDICTION, V90, P1335, DOI 10.1046/j.1360-0443.1995.901013355.x; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Tsai GC, 1998, ANNU REV MED, V49, P173; Tsai GCE, 1998, AM J PSYCHIAT, V155, P726; Visser F, 2007, J BIOL CHEM, V282, P14148, DOI 10.1074/jbc.M701735200; Wu JH, 2010, ALCOHOL CLIN EXP RES, V34, P1110, DOI 10.1111/j.1530-0277.2010.01187.x	51	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16331	10.1371/journal.pone.0016331	http://dx.doi.org/10.1371/journal.pone.0016331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283641	Green Submitted, gold, Green Published			2022-12-25	WOS:000286523400030
J	Martinez-Marignac, VL; Rodrigue, A; Davidson, D; Couillard, M; Al-Moustafa, AE; Abramovitz, M; Foulkes, WD; Masson, JY; Aloyz, R				Martinez-Marignac, Veronica L.; Rodrigue, Amelie; Davidson, David; Couillard, Martin; Al-Moustafa, Ala-Eddin; Abramovitz, Mark; Foulkes, William D.; Masson, Jean-Yves; Aloyz, Raquel			The Effect of a DNA Repair Gene on Cellular Invasiveness: Xrcc3 Over-Expression in Breast Cancer Cells	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATIONAL REPAIR; MATRIX-METALLOPROTEINASE; CISPLATIN RESISTANCE; LUNG-CANCER; PROTEIN KU; NUDE-MICE; METASTASIS; CARCINOMA; MIGRATION; INVASION	Over-expression of DNA repair genes has been associated with resistance to radiation and DNA-damage induced by chemotherapeutic agents such as cisplatin. More recently, based on the analysis of genome expression profiling, it was proposed that over-expression of DNA repair genes enhances the invasive behaviour of tumour cells. In this study we present experimental evidence utilizing functional assays to test this hypothesis. We assessed the effect of the DNA repair proteins known as X-ray complementing protein 3 (XRCC3) and RAD51, to the invasive behavior of the MCF-7 luminal epithelial-like and BT20 basal-like triple negative human breast cancer cell lines. We report that stable or transient overexpression of XRCC3 but not RAD51 increased invasiveness in both cell lines in vitro. Moreover, XRCC3 over-expressing MCF7 cells also showed a higher tumorigenesis in vivo and this phenotype was associated with increased activity of the metalloproteinase MMP-9 and the expression of known modulators of cell-cell adhesion and metastasis such as CD44, ID-1, DDR1 and TFF1. Our results suggest that in addition to its' role in facilitating repair of DNA damage, XRCC3 affects invasiveness of breast cancer cell lines and the expression of genes associated with cell adhesion and invasion.	[Martinez-Marignac, Veronica L.; Davidson, David; Couillard, Martin; Al-Moustafa, Ala-Eddin; Abramovitz, Mark; Aloyz, Raquel] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Martinez-Marignac, Veronica L.; Davidson, David; Couillard, Martin; Al-Moustafa, Ala-Eddin; Abramovitz, Mark; Aloyz, Raquel] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Foulkes, William D.; Aloyz, Raquel] McGill Univ, Fac Med, Program Canc Genet, Montreal, PQ H3T 1E2, Canada; [Aloyz, Raquel] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Rodrigue, Amelie; Masson, Jean-Yves] Univ Laval, Genome Stabil Lab, Canc Res Ctr, Hotel Dieu Quebec, Quebec City, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; Laval University	Aloyz, R (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.; Aloyz, R (corresponding author), McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada.; Aloyz, R (corresponding author), McGill Univ, Fac Med, Program Canc Genet, Montreal, PQ H3T 1E2, Canada.; Aloyz, R (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ, Canada.	raquel.aloyz@mcgill.ca	Aloyz, Raquel S/N-6606-2013; Foulkes, William D./AAR-9586-2021	Aloyz, Raquel S/0000-0002-6812-497X; Foulkes, William D./0000-0001-7427-4651; Rodrigue, Amelie/0000-0001-9883-7084; Masson, Jean Yves/0000-0002-4403-7169	Weekend to End Breast Cancer-Jewish General Hospital Foundation; CIHR [MOP-86519]; Canadian Breast Cancer Research Alliance	Weekend to End Breast Cancer-Jewish General Hospital Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Alliance	This work was funded by the Weekend to End Breast Cancer-Jewish General Hospital Foundation grant to Raquel Aloyz, a grant from the CIHR (MOP-86519) to Jean Yves Masson. Preliminary results were obtained with funding from the Canadian Breast Cancer Research Alliance to Raquel Aloyz and William D Foulkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloyz R, 2002, CANCER RES, V62, P5457; Amiry N, 2009, ENDOCRINOLOGY, V150, P4473, DOI 10.1210/en.2009-0066; AZZAM HS, 1993, J NATL CANCER I, V85, P1758, DOI 10.1093/jnci/85.21.1758; Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; *CAN CANC SOC STEE, CAN CANC STAT 2010; Crosier M, 2001, AM J PATHOL, V159, P215, DOI 10.1016/S0002-9440(10)61687-2; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; Ganguly A, 2010, MOL VIS, V16, P1292; HARRIS AL, 1985, INT J RADIAT BIOL, V48, P675, DOI 10.1080/09553008514551781; Honrado E, 2005, J CLIN ONCOL, V23, P7503, DOI 10.1200/JCO.2005.01.3698; Hou GP, 2002, CIRC RES, V90, P1147, DOI 10.1161/01.RES.0000022166.74073.F8; Hussain S, 2006, DNA REPAIR, V5, P629, DOI 10.1016/j.dnarep.2006.02.007; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; KUBOTA T, 1993, SURG TODAY, V23, P375, DOI 10.1007/BF00309059; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Liu CY, 2007, LUNG CANCER, V55, P303, DOI 10.1016/j.lungcan.2006.10.019; Loignon M, 2007, CELL CYCLE, V6, P606, DOI 10.4161/cc.6.5.3923; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Mimeault M, 2010, DRUG DISCOV TODAY, V15, P354, DOI 10.1016/j.drudis.2010.03.009; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Muller C, 2005, CELL CYCLE, V4, P438, DOI 10.4161/cc.4.3.1565; Nieborowska-Skorska M, 2006, CANCER RES, V66, P4108, DOI 10.1158/0008-5472.CAN-05-1584; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Park HS, 2007, ONCOL REP, V18, P1435; Paupert J, 2007, EMBO REP, V8, P583, DOI 10.1038/sj.embor.7400976; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Perry JK, 2008, TRENDS ENDOCRIN MET, V19, P74, DOI 10.1016/j.tem.2007.10.003; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Sarasin A, 2010, CURR MOL MED, V10, P413, DOI 10.2174/156652410791317011; Sarasin A, 2008, MUTAT RES-REV MUTAT, V659, P49, DOI 10.1016/j.mrrev.2007.12.002; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x; Sumida T, 2004, CANCER RES, V64, P7886, DOI 10.1158/0008-5472.CAN-04-1155; THEUNISSEN PHMH, 1992, HISTOPATHOLOGY, V20, P251, DOI 10.1111/j.1365-2559.1992.tb00964.x; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZM, 2001, J NATL CANCER I, V93, P1473, DOI 10.1093/jnci/93.19.1473; Wilson JB, 2008, ONCOGENE, V27, P3641, DOI 10.1038/sj.onc.1211034; Xu ZY, 2005, J PHARMACOL EXP THER, V314, P495, DOI 10.1124/jpet.105.084053; Xu ZY, 2002, ANTI-CANCER DRUG, V13, P511, DOI 10.1097/00001813-200206000-00010; YOSHIDA K, 1995, CANCER RES, V55, P4273; Yu Q, 2000, GENE DEV, V14, P163; ZHAI YF, 1992, CANCER IMMUNOL IMMUN, V35, P237, DOI 10.1007/BF01789329	48	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16394	10.1371/journal.pone.0016394	http://dx.doi.org/10.1371/journal.pone.0016394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283680	Green Submitted, Green Published, gold			2022-12-25	WOS:000286523400032
J	Tubio, JMC; Tojo, M; Bassaganyas, L; Escaramis, G; Sharakhov, IV; Sharakhova, MV; Tornador, C; Unger, MF; Naveira, H; Costas, J; Besansky, NJ				Tubio, Jose Manuel C.; Tojo, Marta; Bassaganyas, Laia; Escaramis, Georgia; Sharakhov, Igor V.; Sharakhova, Maria V.; Tornador, Cristian; Unger, Maria F.; Naveira, Horacio; Costas, Javier; Besansky, Nora J.			Evolutionary Dynamics of the Ty3/Gypsy LTR Retrotransposons in the Genome of Anopheles gambiae	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; GENE ASSOCIATIONS; MDG1 LINEAGE; DNA; RECOMBINATION; SEQUENCE; POPULATION; CHROMOSOME; SELECTION; FIXATION	Ty3/gypsy elements represent one of the most abundant and diverse LTR-retrotransposon ( LTRr) groups in the Anopheles gambiae genome, but their evolutionary dynamics have not been explored in detail. Here, we conduct an in silico analysis of the distribution and abundance of the full complement of 1045 copies in the updated AgamP3 assembly. Chromosomal distribution of Ty3/gypsy elements is inversely related to arm length, with densities being greatest on the X, and greater on the short versus long arms of both autosomes. Taking into account the different heterochromatic and euchromatic compartments of the genome, our data suggest that the relative abundance of Ty3/gypsy LTRrs along each chromosome arm is determined mainly by the different proportions of heterochromatin, particularly pericentric heterochromatin, relative to total arm length. Additionally, the breakpoint regions of chromosomal inversion 2La appears to be a haven for LTRrs. These elements are underrepresented more than 7-fold in euchromatin, where 33% of the Ty3/gypsy copies are associated with genes. The euchromatin on chromosome 3R shows a faster turnover rate of Ty3/gypsy elements, characterized by a deficit of proviral sequences and the lowest average sequence divergence of any autosomal region analyzed in this study. This probably reflects a principal role of purifying selection against insertion for the preservation of longer conserved syntenyc blocks with adaptive importance located in 3R. Although some Ty3/gypsy LTRrs show evidence of recent activity, an important fraction are inactive remnants of relatively ancient insertions apparently subject to genetic drift. Consistent with these computational predictions, an analysis of the occupancy rate of putatively older insertions in natural populations suggested that the degenerate copies have been fixed across the species range in this mosquito, and also are shared with the sibling species Anopheles arabiensis.	[Tubio, Jose Manuel C.; Bassaganyas, Laia; Escaramis, Georgia; Tornador, Cristian] Ctr Genom Regulat, Genes & Dis Programme, Barcelona, Spain; [Tubio, Jose Manuel C.; Tojo, Marta] Hosp Univ Santiago de Compostela, Santiago De Compostela, Spain; [Tojo, Marta] Ctr Nacl Genotipado CEGEN, Barcelona, Spain; [Sharakhov, Igor V.; Sharakhova, Maria V.] Virginia Tech, Dept Entomol, Blacksburg, VA USA; [Unger, Maria F.; Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Naveira, Horacio] Univ A Coruna, Dept Biol Celular & Mol, La Coruna, Spain; [Costas, Javier] Complexo Hosp Univ Santiago, Fdn Publ Galega Med Xenom, Santiago De Compostela, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Complexo Hospitalario Universitario de Santiago de Compostela; Virginia Polytechnic Institute & State University; University of Notre Dame; Universidade da Coruna; Complexo Hospitalario Universitario de Santiago de Compostela	Tubio, JMC (corresponding author), Ctr Genom Regulat, Genes & Dis Programme, Barcelona, Spain.	nbesansk@nd.edu	Sharakhov, Igor/B-1972-2008; Tubio, Jose M.C./H-5076-2015; Costas, Javier/B-5016-2008; Tornador, Cristian/S-2197-2018; Naveira, Horacio/I-7802-2019; Escaramis, Georgia/AAR-5586-2020; Naveira, Horacio/H-7249-2014; Escaramis, Georgia/B-2997-2015	Sharakhov, Igor/0000-0003-0752-3747; Tubio, Jose M.C./0000-0003-3540-2459; Costas, Javier/0000-0003-0306-3990; Tornador, Cristian/0000-0002-6437-9270; Naveira, Horacio/0000-0002-3840-1569; Naveira, Horacio/0000-0002-3840-1569; Escaramis, Georgia/0000-0002-5416-3177; BASSAGANYAS, LAIA/0000-0002-4575-0214	National Institutes of Health [AI63508]; Xunta de Galicia (Spain); FSE European funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xunta de Galicia (Spain)(Xunta de Galicia); FSE European funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health grant AI63508 to NJB. JMCT was in part supported by a fellowship from Xunta de Galicia (Spain) and FSE European funds. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Bae YA, 2001, MOL BIOL EVOL, V18, P1474, DOI 10.1093/oxfordjournals.molbev.a003933; Bartolome C, 2004, GENET RES, V83, P91, DOI 10.1017/S0016672304006755; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Blumenstiel JP, 2002, MOL BIOL EVOL, V19, P2211, DOI 10.1093/oxfordjournals.molbev.a004045; BOEKE JD, 1998, 7 ICTV; Caceres M, 2001, GENOME RES, V11, P1353, DOI 10.1101/gr.174001; Charlesworth B, 1997, GENETICS, V147, P1993; CHARLESWORTH B, 1989, ANNU REV GENET, V23, P251, DOI 10.1146/annurev.ge.23.120189.001343; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Costas J, 2001, J MOL EVOL, V53, P165, DOI 10.1007/s002390010206; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Finnegan DJ, 1992, CURR OPIN GENET DEV, V2, P861, DOI 10.1016/S0959-437X(05)80108-X; Franchini LF, 2004, MOL BIOL EVOL, V21, P1323, DOI 10.1093/molbev/msh116; Ganko EW, 2006, J MOL EVOL, V62, P111, DOI 10.1007/s00239-004-0312-4; Giegerich R, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P68; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hua-Van A, 2005, CYTOGENET GENOME RES, V110, P426, DOI 10.1159/000084975; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Jordan IK, 1999, J MOL EVOL, V49, P352, DOI 10.1007/PL00006558; Jordan IK, 1999, GENETICA, V107, P3, DOI 10.1023/A:1004022704701; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Lehmann T, 2000, J HERED, V91, P165, DOI 10.1093/jhered/91.2.165; Lerat E, 2003, GENOME RES, V13, P1889, DOI 10.1101/gr.827603; Malik HS, 1999, J VIROL, V73, P5186, DOI 10.1128/JVI.73.6.5186-5190.1999; Maside X, 2005, GENET RES, V85, P195, DOI 10.1017/S0016672305007548; McDonald JF, 1997, GENETICA, V100, P3, DOI 10.1023/A:1018392117410; MCLAIN DK, 1989, HEREDITY, V62, P257, DOI 10.1038/hdy.1989.36; MONTGOMERY E, 1987, GENET RES, V49, P31, DOI 10.1017/S0016672300026707; Navarro A, 1997, GENETICS, V146, P695; Nuzhdin SV, 1999, GENETICA, V107, P129, DOI 10.1023/A:1003957323876; Petrov DA, 2003, MOL BIOL EVOL, V20, P880, DOI 10.1093/molbev/msg102; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Pombi M, 2006, AM J TROP MED HYG, V75, P901, DOI 10.4269/ajtmh.2006.75.901; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Sharakhova MV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r5; Sharakhova MV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-459; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stump AD, 2007, INSECT MOL BIOL, V16, P703, DOI 10.1111/j.1365-2583.2007.00764.x; Tubio JMC, 2005, MOL BIOL EVOL, V22, P29, DOI 10.1093/molbev/msh251; Tubio JMC, 2004, GENE, V330, P123, DOI [10.1016/S0378-1119(04)00039-3, 10.1016/j.gene.2004.01.012]; Xia A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010592	53	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16328	10.1371/journal.pone.0016328	http://dx.doi.org/10.1371/journal.pone.0016328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283637	Green Submitted, gold, Green Published			2022-12-25	WOS:000286523400029
J	Coyle, DE; Li, J; Baccei, M				Coyle, Dennis E.; Li, Jie; Baccei, Mark			Regional Differentiation of Retinoic Acid-Induced Human Pluripotent Embryonic Carcinoma Stem Cell Neurons	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; RADIAL GLIAL-CELLS; NTERA-2 CELLS; TRANSCRIPTION FACTORS; ECTOPIC EXPRESSION; HNT NEURONS; ES CELLS; TRANSPLANTATION; SPECIFICATION; NEUROGENESIS	The NTERA2 cl D1 (NT2) cell line, derived from human teratocarcinoma, exhibits similar properties as embryonic stem (ES) cells or very early neuroepitheial progenitors. NT2 cells can be induced to become postmitotic central nervous system neurons (NT2N) with retinoic acid. Although neurons derived from pluripotent cells, such as NT2N, have been characterized for their neurotransmitter phenotypes, their potential suitability as a donor source for neural transplantation also depends on their ability to respond to localized environmental cues from a specific region of the CNS. Therefore, our study aimed to characterize the regional transcription factors that define the rostocaudal and dorsoventral identity of NT2N derived from a monolayer differentiation paradigm using quantitative PCR (qPCR). Purified NT2N mainly expressed both GABAergic and glutamatergic phenotypes and were electrically active but did not form functional synapses. The presence of immature astrocytes and possible radial glial cells was noted. The NT2N expressed a regional transcription factor code consistent with forebrain, hindbrain and spinal cord neural progenitors but showed minimal expression of midbrain phenotypes. In the dorsoventral plane NT2N expressed both dorsal and ventral neural progenitors. Of major interest was that even under the influence of retinoic acid, a known caudalization factor, the NT2N population maintained a rostral phenotype subpopulation which expressed cortical regional transcription factors. It is proposed that understanding the regional differentiation bias of neurons derived from pluripotent stem cells will facilitate their successful integration into existing neuronal networks within the CNS.	[Coyle, Dennis E.; Li, Jie; Baccei, Mark] Univ Cincinnati, Dept Anesthesiol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Coyle, DE (corresponding author), Univ Cincinnati, Dept Anesthesiol, Cincinnati, OH 45221 USA.	dennis.coyle@uc.edu			Department of Anesthesiology of the University of Cincinnati	Department of Anesthesiology of the University of Cincinnati	The authors gratefully acknowledge that this work was supported by funding from the Department of Anesthesiology of the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre D, 1996, DEVELOPMENT, V122, P735; Andrews PW, 1998, APMIS, V106, P158, DOI 10.1111/j.1699-0463.1998.tb01331.x; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Andrews PW, 1996, INT J CANCER, V66, P806, DOI 10.1002/(SICI)1097-0215(19960611)66:6<806::AID-IJC17>3.0.CO;2-0; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Bani-Yaghoub M, 1999, NEUROREPORT, V10, P3843, DOI 10.1097/00001756-199912160-00022; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bliss TM, 2006, J NEUROSCI RES, V83, P1004, DOI 10.1002/jnr.20800; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891; Diez del Corral R, 2003, NEURON, V40, P65; Draberova E, 2008, J NEUROPATH EXP NEUR, V67, P341, DOI 10.1097/NEN.0b013e31816a686d; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gajovic S, 1997, DIFFERENTIATION, V62, P187; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Guan KM, 2001, CELL TISSUE RES, V305, P171, DOI 10.1007/s004410100416; Guillemain I, 2000, J COMP NEUROL, V422, P380, DOI 10.1002/1096-9861(20000703)422:3<380::AID-CNE5>3.0.CO;2-C; Hara K, 2008, PROG NEUROBIOL, V85, P318, DOI 10.1016/j.pneurobio.2008.04.005; HARDY M, 1994, J NEUROCHEM, V63, P482; Hartley RS, 1999, J COMP NEUROL, V407, P1, DOI 10.1002/(SICI)1096-9861(19990428)407:1<1::AID-CNE1>3.0.CO;2-Z; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Jain M, 2003, EXP NEUROL, V182, P113, DOI 10.1016/S0014-4886(03)00055-4; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; KOCH P, 2009, PROCNATLACADSCIUSA; Kristensen DM, 2008, MOL CELL ENDOCRINOL, V288, P111, DOI 10.1016/j.mce.2008.02.018; Krizbai IA, 2000, NEUROREPORT, V11, P791, DOI 10.1097/00001756-200003200-00027; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Li YQ, 2010, CELL REPROGRAM, V12, P3, DOI 10.1089/cell.2009.0033; Looijenga LHJ, 2007, ANN NY ACAD SCI, V1120, P187, DOI 10.1196/annals.1411.000; Marin O, 2000, J NEUROSCI, V20, P6063; Megiorni F, 2005, NEUROSCI LETT, V373, P105, DOI 10.1016/j.neulet.2004.09.070; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Misiuta IE, 2006, J NEUROSCI RES, V83, P668, DOI 10.1002/jnr.20718; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Pal R, 2006, CELL PROLIFERAT, V39, P585, DOI 10.1111/j.1365-2184.2006.00400.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; Piper DR, 2000, J NEUROPHYSIOL, V84, P534, DOI 10.1152/jn.2000.84.1.534; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Podrygajlo G, 2009, CELL TISSUE RES, V336, P439, DOI 10.1007/s00441-009-0783-0; Przyborski SA, 2000, EUR J NEUROSCI, V12, P3521, DOI 10.1046/j.1460-9568.2000.00230.x; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sandhu JK, 2002, J NEUROSCI RES, V68, P604, DOI 10.1002/jnr.10236; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; Serra M, 2007, J NEUROSCI RES, V85, P3557, DOI 10.1002/jnr.21451; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Simoes PD, 2007, J NEGAT RESULTS BIOM, V6, DOI 10.1186/1477-5751-6-5; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Squires PE, 1996, EUR J NEUROSCI, V8, P783, DOI 10.1111/j.1460-9568.1996.tb01263.x; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; SZABO G, 1994, MOL CELL BIOL, V14, P7535, DOI 10.1128/MCB.14.11.7535; TIESMAN J, 1988, IN VITRO CELL DEV B, V24, P1209; YOSHIMURA M, 1993, NEUROSCIENCE, V53, P519, DOI 10.1016/0306-4522(93)90216-3; YOUNKIN DP, 1993, P NATL ACAD SCI USA, V90, P2174, DOI 10.1073/pnas.90.6.2174; Zecevic N, 2004, GLIA, V48, P27, DOI 10.1002/glia.20044; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x; Zhao SL, 2004, MOL CELL NEUROSCI, V27, P332, DOI 10.1016/j.mcn.2004.08.002; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	77	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16174	10.1371/journal.pone.0016174	http://dx.doi.org/10.1371/journal.pone.0016174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283767	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522200031
J	Palande, KK; Beekman, R; van der Meeren, LE; Beverloo, HB; Valk, PJM; Touw, IP				Palande, Karishma K.; Beekman, Renee; van der Meeren, Lotte E.; Beverloo, H. Berna; Valk, Peter J. M.; Touw, Ivo P.			The Antioxidant Protein Peroxiredoxin 4 Is Epigenetically Down Regulated in Acute Promyelocytic Leukemia	PLOS ONE			English	Article							COLONY-STIMULATING-FACTOR; ACUTE MYELOID-LEUKEMIA; GENE; METHYLATION; EXPRESSION; MUTATIONS; RECEPTOR; TARGET; PRDX4; RAR	The antioxidant peroxiredoxin (PRDX) protein family comprises 6 members, which are implicated in a variety of cellular responses, including growth factor signal transduction. PRDX4 resides in the endoplasmic reticulum (ER), where it locally controls oxidative stress by reducing H2O2 levels. We recently provided evidence for a regulatory function of PRDX4 in signal transduction from a myeloid growth factor receptor, the granulocyte colony-stimulating factor receptor (G-CSFR). Upon activation, the ligand-induced G-CSFR undergoes endocytosis and routes via the early endosomes where it physically interacts with ER-resident PRDX4. PRDX4 negatively regulates G-CSFR mediated signaling. Here, we investigated whether PRDX4 is affected in acute myeloid leukemia (AML); genomic alterations and expression levels of PRDX4 were investigated. We show that genomic abnormalities involving PRDX4 are rare in AML. However, we find a strong reduction in PRDX4 expression levels in acute promyelocytic leukemia (APL) compared to normal promyelocytes and different molecular subtypes of AML. Subsequently, the possible role of DNA methylation and histone modifications in silencing of PRDX4 in APLs was investigated. We show that the reduced expression is not due to methylation of the CpG island in the promoter region of PRDX4 but correlates with increased trimethylation of histone 3 lysine residue 27 (H3K27me3) and lysine residue 4 (H3K4me3) at the transcriptional start site (TSS) of PRDX4, indicative of a bivalent histone code involved in transcriptional silencing. These findings suggest that the control of G-CSF responses by the antioxidant protein PRDX4 may be perturbed in APL.	[Palande, Karishma K.; Beekman, Renee; van der Meeren, Lotte E.; Valk, Peter J. M.; Touw, Ivo P.] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands; [Beverloo, H. Berna] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Palande, KK (corresponding author), Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands.	i.touw@erasmusmc.nl	Beekman, Renée/AAF-2088-2020; Valk, Peter/AAX-2823-2020	Beekman, Renée/0000-0001-7081-7874; van der Meeren, Lotte Elisabeth/0000-0002-4537-5645	Dutch Cancer Society "KWF kankerbestrijding"; Center for Translational Molecular Medicine (CTMM)	Dutch Cancer Society "KWF kankerbestrijding"(KWF Kankerbestrijding); Center for Translational Molecular Medicine (CTMM)	This work was supported by grants from the Dutch Cancer Society "KWF kankerbestrijding" and by the Center for Translational Molecular Medicine (CTMM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; Freedman MH, 2002, SEMIN HEMATOL, V39, P128, DOI 10.1053/shem.2002.31912; Germeshausen M, 2007, BLOOD, V109, P93, DOI 10.1182/blood-2006-02-004275; Irandoust MI, 2007, EMBO J, V26, P1782, DOI 10.1038/sj.emboj.7601640; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; PEBUSQUE MJ, 1988, BLOOD, V72, P257; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Touw IP, 2007, FRONT BIOSCI-LANDMRK, V12, P800, DOI 10.2741/2103; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Wageningen S, 2008, BLOOD, V111, P1634, DOI 10.1182/blood-2007-04-081125; Verhaak RGW, 2010, CANCER TREAT RES, V145, P67, DOI 10.1007/978-0-387-69259-3_5; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; von Bergh ARM, 2006, GENE CHROMOSOME CANC, V45, P731, DOI 10.1002/gcc.20335; Wang HQ, 2009, FEBS LETT, V583, P1511, DOI 10.1016/j.febslet.2009.04.009; Wolfler A, 2009, TRAFFIC, V10, P1168, DOI 10.1111/j.1600-0854.2009.00928.x; Zhang YM, 2004, GENE CHROMOSOME CANC, V40, P365, DOI 10.1002/gcc.20050; Zhu QS, 2006, BLOOD, V107, P1847, DOI 10.1182/blood-2005-04-1612	26	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16340	10.1371/journal.pone.0016340	http://dx.doi.org/10.1371/journal.pone.0016340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283726	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522200052
J	Hu, LL; Huang, T; Shi, XH; Lu, WC; Cai, YD; Chou, KC				Hu, Lele; Huang, Tao; Shi, Xiaohe; Lu, Wen-Cong; Cai, Yu-Dong; Chou, Kuo-Chen			Predicting Functions of Proteins in Mouse Based on Weighted Protein-Protein Interaction Network and Protein Hybrid Properties	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SECONDARY STRUCTURE; GENE ONTOLOGY; ANNOTATION; DATABASE; CLASSIFICATION; BIOINFORMATICS; MODEL	Background: With the huge amount of uncharacterized protein sequences generated in the post-genomic age, it is highly desirable to develop effective computational methods for quickly and accurately predicting their functions. The information thus obtained would be very useful for both basic research and drug development in a timely manner. Methodology/Principal Findings: Although many efforts have been made in this regard, most of them were based on either sequence similarity or protein-protein interaction (PPI) information. However, the former often fails to work if a query protein has no or very little sequence similarity to any function-known proteins, while the latter had similar problem if the relevant PPI information is not available. In view of this, a new approach is proposed by hybridizing the PPI information and the biochemical/physicochemical features of protein sequences. The overall first-order success rates by the new predictor for the functions of mouse proteins on training set and test set were 69.1% and 70.2%, respectively, and the success rate covered by the results of the top-4 order from a total of 24 orders was 65.2%. Conclusions/Significance: The results indicate that the new approach is quite promising that may open a new avenue or direction for addressing the difficult and complicated problem.	[Hu, Lele; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Hu, Lele; Lu, Wen-Cong] Shanghai Univ, Dept Chem, Coll Sci, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Shi, Xiaohe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Shi, Xiaohe] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Fudan University	Hu, LL (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]	National Basic Research Program of China(National Basic Research Program of China)	This research is supported by the National Basic Research Program of China 2011CB510102, 2011CB510101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Afjehi-Sadat L, 2007, NAT PROTOC, V2, P2318, DOI 10.1038/nprot.2007.317; Aguero-Chapin G, 2008, J CHEM INF MODEL, V48, P2265, DOI 10.1021/ci8001809; Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Arnau V, 2005, BIOINFORMATICS, V21, P364, DOI 10.1093/bioinformatics/bti021; Ashburner M, 2002, NOVART FDN SYMP, V247, P66; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Bork P, 1998, NAT GENET, V18, P313, DOI 10.1038/ng0498-313; Brun C, 2004, GENOME BIOL, V5; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cai YD, 2004, BIOINFORMATICS, V20, P1292, DOI 10.1093/bioinformatics/bth085; Cai YD, 2009, J PROTEOME RES, V8, P999, DOI 10.1021/pr800717y; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Carter DB, 1998, NEUROBIOL AGING, V19, P37, DOI 10.1016/S0197-4580(97)00164-4; Chen Y, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P471; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; Chua HN, 2006, LECT NOTES COMPUT SC, V3916, P1; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Dunn R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-39; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frishman D, 1997, PROTEINS, V27, P329, DOI 10.1002/(SICI)1097-0134(199703)27:3<329::AID-PROT1>3.0.CO;2-8; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Maciag K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100045; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; Mucchielli-Giorgi MH, 1999, BIOINFORMATICS, V15, P176, DOI 10.1093/bioinformatics/15.2.176; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; NISHIKAWA K, 1982, J BIOCHEM-TOKYO, V91, P1821, DOI 10.1093/oxfordjournals.jbchem.a133877; Ofran Y, 2005, DRUG DISCOV TODAY, V10, P1475, DOI 10.1016/S1359-6446(05)03621-4; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Renugopalakrishnan V, 1999, BIOCHEM BIOPH RES CO, V258, P653, DOI 10.1006/bbrc.1999.0667; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruepp A, 2006, NUCLEIC ACIDS RES, V34, pD568, DOI 10.1093/nar/gkj074; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Shen H.-B., 2009, J BIOMED SCI ENG, V2, DOI DOI 10.4236/JBISE.2009.23024; Shen H.B., 2009, OPEN BIOINFORM J, V3, P31, DOI DOI 10.2174/1875036200903010031; Shen HB, 2009, J THEOR BIOL, V256, P441, DOI 10.1016/j.jtbi.2008.10.007; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; SIMMONS LK, 1994, MOL PHARMACOL, V45, P373; Sleator RD, 2010, ARCH MICROBIOL, V192, P151, DOI 10.1007/s00203-010-0549-9; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vlahovicek K, 2002, NUCLEIC ACIDS RES, V30, P273, DOI 10.1093/nar/30.1.273; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xiao X, 2009, J APPL CRYSTALLOGR, V42, P169, DOI 10.1107/S0021889809002751; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; ZHOU GP, 2009, BIOCH BIOPHYSICAL RE, DOI DOI 10.1016/J.BBRC.2009.1009.1084; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	69	237	237	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e14556	10.1371/journal.pone.0014556	http://dx.doi.org/10.1371/journal.pone.0014556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283518	gold, Green Submitted, Green Published			2022-12-25	WOS:000286520600003
J	Feng, YQ; Chelico, L				Feng, Yuqing; Chelico, Linda			Intensity of Deoxycytidine Deamination of HIV-1 Proviral DNA by the Retroviral Restriction Factor APOBEC3G Is Mediated by the Noncatalytic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CYTIDINE DEAMINASE; VIRUS-LIKE PARTICLES; SINGLE-STRANDED-DNA; VIF PROTEIN; DRUG-RESISTANCE; ENZYME APOBEC3G; RNA; HYPERMUTATION; INFECTION; VIRIONS	APOBEC3G is a single-stranded (ss) DNA deaminase that restricts replication of HIV-1 by inducing viral genome mutagenesis through deamination of cytosine to uracil on HIV-1 cDNA. APOBEC3G has polydisperse oligomeric states and deaminates ssDNA processively through jumping and sliding. APOBEC3G has a catalytically inactive N-terminal CD1 domain that mediates processivity and an active C-terminal CD2 domain that catalyzes deaminations. Here, we assess the determinants of APOBEC3G deamination efficiency mediated by the CD1 domain by comparing native APOBEC3G and two CD1 mutants, a monomeric mutant (F126A/W127A) and a clinical mutant associated with high viral loads (H186R). Biochemical assays on ssDNA or partially dsDNA and with a reconstituted HIV replication system demonstrate that both mutants of Apo3G have altered DNA scanning properties in either jumping (F126A/W127A) or sliding (H186R), which results in decreased abilities to induce mutagenesis during reverse transcription. The data reveal a functionality for Apo3G oligomers in deamination and provide the first biochemical characterization of the clinical mutant H186R. The data demonstrate that the balance between the jumping and sliding of Apo3G is needed for efficient mutational inactivation of HIV-1.	[Feng, Yuqing; Chelico, Linda] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Chelico, L (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	linda.chelico@usask.ca		Feng, Yuqing/0000-0002-7156-1628; Chelico, Linda/0000-0003-4673-8978	Natural Sciences and Engineering Research Council of Canada; Saskatchewan Health Research Foundation; College of Medicine at the University of Saskatchewan; University of Saskatchewan; National Institutes of Health [ISI0RR023748-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023748] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Saskatchewan Health Research Foundation; College of Medicine at the University of Saskatchewan; University of Saskatchewan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by a discovery grant from the Natural Sciences and Engineering Research Council of Canada, a new investigator establishment grant from the Saskatchewan Health Research Foundation, and tri-council recognition award from the College of Medicine at the University of Saskatchewan (to L. C.).; Supported by a University of Saskatchewan Summer Student Employment Program-Board of Governors' Scholarship.; We thank Dr. Brian Bandy for the use of the fluorometer, Jason Maley at the Saskatchewan Structural Sciences Centre for assistance with AFM, and Dr. Kerri Kobryn for critical review of the manuscript. The SEC-LX/UV/RI instrumentation was supported by National Institutes of Health Award ISI0RR023748-01.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chelico L, 2009, PHILOS T R SOC B, V364, P583, DOI 10.1098/rstb.2008.0195; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; COFFIN JM, 1997, RETROVIRUSES, P121; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Gifford RJ, 2008, AIDS, V22, P717, DOI 10.1097/QAD.0b013e3282f5e07a; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Harris RS, 2006, NAT STRUCT MOL BIOL, V13, P380, DOI 10.1038/nsmb0506-380; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Hu CL, 2010, J VIROL, V84, P11981, DOI 10.1128/JVI.00723-10; Hultquist JF, 2009, FUTURE VIROL, V4, P605, DOI 10.2217/FVL.09.59; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Khan MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-48; Kim EY, 2010, J VIROL, V84, P10402, DOI 10.1128/JVI.01223-10; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2008, J BIOL CHEM, V283, P17428, DOI 10.1074/jbc.M802121200; Pillai SK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-26; Ratcliff GC, 2001, J AM CHEM SOC, V123, P5632, DOI 10.1021/ja005750n; Rausch JW, 2009, J BIOL CHEM, V284, P7047, DOI 10.1074/jbc.M807258200; Reddy K, 2010, AIDS, V24, P195, DOI 10.1097/QAD.0b013e3283353bba; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; SCHATZ O, 1990, EMBO J, V9, P1171, DOI 10.1002/j.1460-2075.1990.tb08224.x; Shao W, 1997, P NATL ACAD SCI USA, V94, P2243, DOI 10.1073/pnas.94.6.2243; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wlodawer A, 1998, ANNU REV BIOPH BIOM, V27, P249, DOI 10.1146/annurev.biophys.27.1.249; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	68	46	46	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11415	11426		10.1074/jbc.M110.199604	http://dx.doi.org/10.1074/jbc.M110.199604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21300806	hybrid, Green Published			2022-12-25	WOS:000288797100053
J	Wang, Y; Wu, ZY; Li, D; Wang, DA; Wang, XM; Feng, XA; Xia, M				Wang, Yun; Wu, Zeyu; Li, Dan; Wang, Duan; Wang, Xiaoming; Feng, Xiang; Xia, Min			Involvement of Oxygen-regulated Protein 150 in AMP-activated Protein Kinase-mediated Alleviation of Lipid-induced Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; OXIDATIVE-STRESS; CELL-DEATH; HEPATIC LIPOGENESIS; ER STRESS; APOPTOSIS; ORP150; ATHEROSCLEROSIS; METABOLISM; EXPRESSION	Hepatocytes show endoplasmic reticulum (ER) stress when exposed to lipotoxic stimuli such as hyperlipidemia. Recent work has revealed that AMP- activated protein kinase (AMPK) can mitigate ER stress. In this study we investigated the impact of AMPK on lipid-induced ER stress in hepatocytes and its underlying molecular mechanism. Treatment with 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an AMPK agonist, or overexpression of a constitutively active AMPK significantly suppressed lipid-mediated ER stress, leading to marked protection against lipotoxic death. Incubation with AICAR and constitutively active AMPK overexpression induced the expression of an ER-associated chaperone, 150-kDa oxygen-regulated protein (ORP150), at both the mRNA and protein levels in hepatocytes. Forkhead box O1 (FOXO1) was identified as the critical transcription factor regulating ORP150 expression because silencing FOXO1 expression prevented the induction of ORP150 expression by AMPK. In contrast, overexpression of FOXO1-ADA promoted ORP150 expression in hepatocytes. FOXO1 bound directly to the ORP150 promoter, which was enhanced in the presence of AICAR. AMPK acts to activate FOXO1 by increasing its deacetylation and transcriptional activity via silent mating type information regulation 2 homolog 1 (SIRT1). Furthermore, AICAR infusion enhanced ORP150 expression, resulting in the marked amelioration of hepatic ER stress and apoptosis in C57BL/6J mice fed a high fat diet. Our results reveal a novel mechanism by which AMPK regulates ER homeostasis in hepatocytes and suggest that AMPK has a protective role against hypercholesterolemia-related liver damage.	[Wang, Yun; Li, Dan; Wang, Duan; Wang, Xiaoming; Feng, Xiang; Xia, Min] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou 510080, Guangdong, Peoples R China; [Wang, Yun; Li, Dan; Wang, Duan; Wang, Xiaoming; Feng, Xiang; Xia, Min] Sun Yat Sen Univ, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510080, Guangdong, Peoples R China; [Wu, Zeyu] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Surg Vasc Dis, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Xia, M (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, No Campus,74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	xiamin@mail.sysu.edu.cn			National Natural Science Foundation [81072301]; Guangdong Natural Science Foundation [9151012003000002]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [200978]; Sun Yat-Sen University [10ykzd04]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Sun Yat-Sen University	This research was supported by grants from the National Natural Science Foundation (81072301), grants from the Guangdong Natural Science Foundation (9151012003000002), Foundation for the Author of National Excellent Doctoral Dissertation of PR China (200978), and the Fundamental Research Funds for the Central Universities of Sun Yat-Sen University (10ykzd04).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; Bando Y, 2000, AM J PHYSIOL-CELL PH, V278, pC1172, DOI 10.1152/ajpcell.2000.278.6.C1172; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Flamment M, 2010, CURR OPIN LIPIDOL, V21, P239, DOI 10.1097/MOL.0b013e3283395e5c; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kuwabara K, 1996, J BIOL CHEM, V271, P5025; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakamura T, 2008, MOL CELL ENDOCRINOL, V281, P47, DOI 10.1016/j.mce.2007.10.007; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ozawa K, 1999, J BIOL CHEM, V274, P6397, DOI 10.1074/jbc.274.10.6397; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; Qin XM, 2008, HEPATOLOGY, V48, P432, DOI 10.1002/hep.22334; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Sanson M, 2008, CELL DEATH DIFFER, V15, P1255, DOI 10.1038/cdd.2008.36; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Tamatani M, 2001, NAT MED, V7, P317, DOI 10.1038/85463; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsukamoto Y, 1996, J CLIN INVEST, V98, P1930, DOI 10.1172/JCI118994; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	47	50	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11119	11131		10.1074/jbc.M110.203323	http://dx.doi.org/10.1074/jbc.M110.203323			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296878	Green Published, hybrid			2022-12-25	WOS:000288797100023
J	Ramaswamy, R; Sbalzarini, IF; Gonzalez-Segredo, N				Ramaswamy, Rajesh; Sbalzarini, Ivo F.; Gonzalez-Segredo, Nelido			Noise-Induced Modulation of the Relaxation Kinetics around a Non-Equilibrium Steady State of Non-Linear Chemical Reaction Networks	PLOS ONE			English	Article							FLUCTUATIONS; OSCILLATIONS; MODELS	Stochastic effects from correlated noise non-trivially modulate the kinetics of non-linear chemical reaction networks. This is especially important in systems where reactions are confined to small volumes and reactants are delivered in bursts. We characterise how the two noise sources confinement and burst modulate the relaxation kinetics of a non-linear reaction network around a non-equilibrium steady state. We find that the lifetimes of species change with burst input and confinement. Confinement increases the lifetimes of all species that are involved in any non-linear reaction as a reactant. Burst monotonically increases or decreases lifetimes. Competition between burst-induced and confinement-induced modulation may hence lead to a non-monotonic modulation. We quantify lifetime as the integral of the time autocorrelation function (ACF) of concentration fluctuations around a non-equilibrium steady state of the reaction network. Furthermore, we look at the first and second derivatives of the ACF, each of which is affected in opposite ways by burst and confinement. This allows discriminating between these two noise sources. We analytically derive the ACF from the linear Fokker-Planck approximation of the chemical master equation in order to establish a baseline for the burst-induced modulation at low confinement. Effects of higher confinement are then studied using a partial-propensity stochastic simulation algorithm. The results presented here may help understand the mechanisms that deviate stochastic kinetics from its deterministic counterpart. In addition, they may be instrumental when using fluorescence-lifetime imaging microscopy (FLIM) or fluorescence-correlation spectroscopy (FCS) to measure confinement and burst in systems with known reaction rates, or, alternatively, to correct for the effects of confinement and burst when experimentally measuring reaction rates.	[Ramaswamy, Rajesh; Sbalzarini, Ivo F.; Gonzalez-Segredo, Nelido] ETH, Inst Theoret Comp Sci, Zurich, Switzerland; [Ramaswamy, Rajesh; Sbalzarini, Ivo F.; Gonzalez-Segredo, Nelido] ETH, Swiss Inst Bioinformat, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics	Ramaswamy, R (corresponding author), ETH, Inst Theoret Comp Sci, Zurich, Switzerland.	rajeshr@ethz.ch	Sbalzarini, Ivo F/B-2789-2017; Sbalzarini, Ivo F/A-2724-2008	Sbalzarini, Ivo Fabian/0000-0003-4414-4340	Swiss SystemsX.ch initiative [WingX, LipidX-2008/011]	Swiss SystemsX.ch initiative	RR was financed by a grant from the Swiss SystemsX.ch initiative (grant WingX), evaluated by the Swiss National Science Foundation. This project was also supported with a grant from the Swiss SystemsX.ch initiative, grant LipidX-2008/011 to IFS. The funding agency had no role in the conception, design, carrying out, or analysis of the work, nor in the decision to publish or preparation of the manuscript.	Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; Dobrzynski M, 2009, P NATL ACAD SCI USA, V106, P2583, DOI 10.1073/pnas.0803507106; GARDINER CW, 1976, J STAT PHYS, V14, P307, DOI 10.1007/BF01030197; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; Grima R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218103; Grima R, 2008, ESSAYS BIOCHEM, V45, P41, DOI 10.1042/BSE0450041; Kim J, 2007, PLOS COMPUT BIOL, V3, P2190, DOI 10.1371/journal.pcbi.0030218; KURTZ TG, 1972, J CHEM PHYS, V57, P2976, DOI 10.1063/1.1678692; LAKOWICZ JR, 2006, PRINCIPLES FLUORESCE, pCH8, DOI DOI 10.1007/978-0-387-46312-4; Leyvraz F, 2003, PHYS REP, V383, P95, DOI 10.1016/S0370-1573(03)00241-2; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; Mouri K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005131; Nishikawa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011224; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Perc M, 2007, CHEM PHYS LETT, V437, P143, DOI 10.1016/j.cplett.2007.02.003; Qian H, 2002, P NATL ACAD SCI USA, V99, P10376, DOI 10.1073/pnas.152007599; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ramaswamy R, 2010, AIP CONF PROC, V1281, P1338, DOI 10.1063/1.3497968; Ramaswamy R, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3154624; Shibata T, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056218; Shimoni Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005363; Turner MS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168301; VANDONGEN PGJ, 1987, J STAT PHYS, V49, P927, DOI 10.1007/BF01017554; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Zhao YQ, 2008, TRAFFIC, V9, P2253, DOI 10.1111/j.1600-0854.2008.00819.x	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16045	10.1371/journal.pone.0016045	http://dx.doi.org/10.1371/journal.pone.0016045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297975	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000286664100013
J	Chasseigneaux, S; Dinc, L; Rose, C; Chabret, C; Coulpier, F; Topilko, P; Mauger, G; Allinquant, B				Chasseigneaux, Stephanie; Dinc, Levent; Rose, Christiane; Chabret, Claude; Coulpier, Fanny; Topilko, Piotr; Mauger, Gweltas; Allinquant, Bernadette			Secreted Amyloid Precursor Protein beta and Secreted Amyloid Precursor Protein alpha Induce Axon Outgrowth In Vitro through Egr1 Signaling Pathway	PLOS ONE			English	Article							HEPARIN-BINDING DOMAIN; AMINO-TERMINAL REGION; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; BRAIN-DEVELOPMENT; APP BINDS; NEURONS; CELLS; FORM; DIFFERENTIATION	Background: sAPP alpha released after alpha secretase cleavage of Amyloid Precursor Protein (APP) has several functions including the stimulation of neurite outgrowth although detailed morphometric analysis has not been done. Two domains involved in this function have been described and are present in sAPP beta released at the first step of amyloid peptide cleavage, raising the possibility that sAPP beta could also stimulate neurite outgrowth. We investigated the morphological effects of sAPP alpha and sAPP beta on primary neurons and identified a key signaling event required for the changes observed. Methodology/Principal Findings: Final concentrations of 50 to 150 nM bacterial recombinant sAPP alpha or sAPP beta added to primary neuronal cultures after 1 day in vitro decreased cell adhesion 24 hours later and primary dendrite length 96 hours later. 150 nM sAPP alpha and sAPP beta induced a similar increase of axon outgrowth, although this increase was already significant at 100 nM sAPP alpha. These morphological changes induced by sAPPs were also observed when added to differentiated neurons at 5 days in vitro. Real time PCR and immunocytochemistry showed that sAPP alpha and sAPP beta stimulated Egr1 expression downstream of MAPK/ERK activation. Furthermore, in primary neurons from Egr1 -/- mice, sAPPs affected dendritic length but did not induce any increase of axon length. Conclusion/Significance: sAPP alpha and sAPP beta decrease cell adhesion and increase axon elongation. These morphological changes are similar to what has been observed in response to heparan sulfate. The sAPP alpha/sAPP beta stimulated increase in axon growth requires Egr1 signaling. These data suggest that sAPP beta is not deleterious per se. Since sAPP beta and sAPP alpha are present in the embryonic brain, these two APP metabolites might play a role in axon outgrowth during development and in response to brain damage.	[Chasseigneaux, Stephanie; Dinc, Levent; Rose, Christiane; Chabret, Claude; Mauger, Gweltas; Allinquant, Bernadette] INSERM, U894, Paris, France; [Chasseigneaux, Stephanie; Dinc, Levent; Rose, Christiane; Chabret, Claude; Mauger, Gweltas; Allinquant, Bernadette] Univ Paris 05, Paris, France; [Coulpier, Fanny; Topilko, Piotr] Ecole Normale Super, Inst Biol, Dev Biol Sect, INSERM,U1024,CNRS,UMR 8197, F-75231 Paris, France; [Coulpier, Fanny] Ecole Normale Super, Plate Forme Transcriptome INSERM U1024, Inst Biol, CNRS,UMR 8197, F-75231 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Chasseigneaux, S (corresponding author), INSERM, U894, Paris, France.	bernadette.allinquant@inserm.fr	Chasseigneaux, Stephanie/A-4291-2017	Chasseigneaux, Stephanie/0000-0003-2859-371X	Association pour la Recherche sur la Maladie d'Alzheimer; INSERM; Departement de la Recherche Clinique et du Developpement [AP-HP PCR 08006]	Association pour la Recherche sur la Maladie d'Alzheimer; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Departement de la Recherche Clinique et du Developpement	This work was supported by Association pour la Recherche sur la Maladie d'Alzheimer; INSERM; Departement de la Recherche Clinique et du Developpement, AP-HP PCR 08006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; GREENBERG SM, 1995, NEUROSCI LETT, V198, P52, DOI 10.1016/0304-3940(95)11944-R; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hartmann D, 1999, CURR BIOL, V9, P719, DOI 10.1016/S0960-9822(99)80331-5; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hoffmann J, 1999, J HISTOCHEM CYTOCHEM, V47, P373, DOI 10.1177/002215549904700311; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; LAFONT F, 1993, J CELL SCI, V104, P433; LAFONT F, 1992, DEVELOPMENT, V114, P17; LOFFLER J, 1992, J NEUROCHEM, V59, P1316, DOI 10.1111/j.1471-4159.1992.tb08443.x; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; NINOMIYA H, 1994, J NEUROCHEM, V63, P495; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; Pignatelli M, 1999, FEBS LETT, V461, P37, DOI 10.1016/S0014-5793(99)01420-9; PROCHIANTZ A, 1990, PROG BRAIN RES, V86, P331; Rohe M, 2008, J BIOL CHEM, V283, P14826, DOI 10.1074/jbc.M710574200; SALBAUM JM, 1994, J EXP ZOOL, V269, P116, DOI 10.1002/jez.1402690205; SMALL DH, 1994, J NEUROSCI, V14, P2117; SMALL DH, 1992, J NEUROSCI, V12, P4143; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; WILLIAMSON TG, 1995, J NEUROCHEM, V65, P2201; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15	32	68	72	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16301	10.1371/journal.pone.0016301	http://dx.doi.org/10.1371/journal.pone.0016301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298006	gold, Green Published, Green Submitted			2022-12-25	WOS:000286663900031
J	Gheorghe, KR; Thurlings, RM; Westman, M; Boumans, MJ; Malmstrom, V; Trollmo, C; Korotkova, M; Jakobsson, PJ; Tak, PP				Gheorghe, Karina Roxana; Thurlings, Rogier M.; Westman, Marie; Boumans, Maartje J.; Malmstrom, Vivianne; Trollmo, Christina; Korotkova, Marina; Jakobsson, Per-Johan; Tak, Paul-Peter			Prostaglandin E-2 Synthesizing Enzymes in Rheumatoid Arthritis B Cells and the Effects of B Cell Depleting Therapy on Enzyme Expression	PLOS ONE			English	Article							CYCLOOXYGENASE-2 EXPRESSION; SYNOVIAL FIBROBLASTS; ANTIBODY-PRODUCTION; CYCLIC-AMP; LYMPHOCYTES; TISSUE; OSTEOARTHRITIS; INFLAMMATION; VALIDATION; ACTIVATION	Introduction: B cells may play an important role in promoting immune activation in the rheumatoid synovium and can produce prostaglandin E-2 (PGE(2)) when activated. In its turn, PGE(2) formed by cyclooxygenase (COX) and microsomal prostaglandin E-2 synthase 1 (MPGES1) contributes to the rheumatoid arthritis (RA) pathological process. Therapeutic depletion of B cells results in important improvement in controlling disease activity in rheumatoid patients. Therefore we investigated the expression of PGE(2) pathway enzymes in RA B cells and evaluated the effects of B cell depleting therapy on their expression in RA tissue. Methods: B cells expressing MPGES1 and COX-2 were identified by flow cytometry in in vitro stimulated and control mononuclear cells isolated from synovial fluid and peripheral blood of RA patients. Synovial biopsies were obtained from 24 RA patients before and at two consecutive time points after rituximab therapy. Expression of MPGES1, COX-1 and COX-2, as well as interleukin (IL)-1 beta and IL-6, known inducers of MPGES1, was quantified in immunostained biopsy sections using computerized image analysis. Results: Expression of MPGES1 or COX-2 was significantly upregulated upon stimulation of B cells from blood and synovial fluid while control cells displayed no detectable enzymes. In synovial biopsy sections, the expression of MPGES1, COX-1 or COX-2 was resistant to rituximab therapy at 8 or 16 weeks after start of treatment. Furthermore expression of IL-1 beta in the synovial tissue remained unchanged, while IL-6 tended to decrease after therapy. Conclusions: Therapy with B cell depleting agents, although efficient in achieving good clinical and radiographic response in RA patients, leaves important inflammatory pathways in the rheumatoid synovium essentially unaffected.	[Gheorghe, Karina Roxana; Westman, Marie; Malmstrom, Vivianne; Trollmo, Christina; Korotkova, Marina; Jakobsson, Per-Johan] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Thurlings, Rogier M.; Boumans, Maartje J.; Tak, Paul-Peter] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Korotkova, Marina] Actar AB Inc, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Gheorghe, KR (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden.	per-johan.jakobsson@ki.se	Jakobsson, Per-Johan/ABC-5594-2021; Thurlings, R.M./L-4689-2015		Swedish Research Council; Swedish Rheumatism Association; King Gustaf V 80 years Foundation; Swedish Society of Medicine; Marianne and Marcus Wallenberg foundation; Karolinska Institutet Foundation; European Commission; Center for Translational Molecular Medicine (TRACER); Dutch Arthritis Association	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; King Gustaf V 80 years Foundation; Swedish Society of Medicine; Marianne and Marcus Wallenberg foundation; Karolinska Institutet Foundation(Karolinska Institutet); European Commission(European CommissionEuropean Commission Joint Research Centre); Center for Translational Molecular Medicine (TRACER); Dutch Arthritis Association	This study was supported by The Swedish Research Council, The Swedish Rheumatism Association, King Gustaf V 80 years Foundation, The Swedish Society of Medicine, Marianne and Marcus Wallenberg foundation, Karolinska Institutet Foundation and European Commission Sixth Framework Program Autocure, the Center for Translational Molecular Medicine (TRACER), and the Dutch Arthritis Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Soria MA, 2006, ANN RHEUM DIS, V65, P998, DOI 10.1136/ard.2005.046920; Arras M, 2006, AM J RESP CELL MOL, V34, P573, DOI 10.1165/rcmb.2004-0383OC; Bernard MP, 2007, CLIN IMMUNOL, V125, P138, DOI 10.1016/j.clim.2007.07.006; Cantaert T, 2008, J IMMUNOL, V181, P785, DOI 10.4049/jimmunol.181.1.785; DORNER T, PHARM THER, V125, P464; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Haringman JJ, 2005, ARTHRITIS RES THER, V7, pR862, DOI 10.1186/ar1757; Hinz B, 2000, BIOCHEM BIOPH RES CO, V278, P790, DOI 10.1006/bbrc.2000.3885; Inoue H, 2002, BRIT J PHARMACOL, V136, P287, DOI 10.1038/sj.bjp.0704705; Jacobi AM, 2010, CURR OPIN PHARMACOL, V10, P316, DOI 10.1016/j.coph.2010.02.002; Klimiuk PA, 1997, AM J PATHOL, V151, P1311; Korotkova M, 2005, ARTHRITIS RHEUM-US, V52, P3439, DOI 10.1002/art.21390; Kraan MC, 2002, ARTHRITIS RHEUM-US, V46, P2034, DOI 10.1002/art.10556; Kunisch E, 2009, J IMMUNOL, V183, P1328, DOI 10.4049/jimmunol.0900801; LEE H, 2010, J IMMUNOL; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Mongini PKA, 2006, J IMMUNOL, V176, P6736, DOI 10.4049/jimmunol.176.11.6736; Murn J, 2008, J EXP MED, V205, P3091, DOI 10.1084/jem.20081163; Pino MS, 2005, CANCER BIOL THER, V4, P1263, DOI 10.4161/cbt.4.11.2138; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ryan EP, 2005, J IMMUNOL, V174, P2619, DOI 10.4049/jimmunol.174.5.2619; SANO H, 1992, J CLIN INVEST, V89, P97, DOI 10.1172/JCI115591; Sheibanie AF, 2007, ARTHRITIS RHEUM-US, V56, P2608, DOI 10.1002/art.22794; Siegle I, 1998, ARTHRITIS RHEUM-US, V41, P122, DOI 10.1002/1529-0131(199801)41:1<122::AID-ART15>3.3.CO;2-#; Steiner Gunter, 2002, Arthritis Res, V4 Suppl 2, pS1, DOI 10.1186/ar551; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Teng YKO, 2009, ANN RHEUM DIS, V68, P1011, DOI 10.1136/ard.2008.092791; Thurlings RM, 2008, ANN RHEUM DIS, V67, P917, DOI 10.1136/ard.2007.080960; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; ULFGREN AK, 1995, ANN RHEUM DIS, V54, P654, DOI 10.1136/ard.54.8.654; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; Westman M, 2004, ARTHRITIS RHEUM-US, V50, P1774, DOI 10.1002/art.20286; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968	34	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16378	10.1371/journal.pone.0016378	http://dx.doi.org/10.1371/journal.pone.0016378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298002	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900043
J	Courtiol, E; Amat, C; Thevenet, M; Messaoudi, B; Garcia, S; Buonviso, N				Courtiol, Emmanuelle; Amat, Corine; Thevenet, Marc; Messaoudi, Belkacem; Garcia, Samuel; Buonviso, Nathalie			Reshaping of Bulbar Odor Response by Nasal Flow Rate in the Rat	PLOS ONE			English	Article							MAMMALIAN OLFACTORY-BULB; RECEPTOR NEURON INPUT; UNIT-ACTIVITY; AIR-FLOW; SNIFFING BEHAVIOR; RESPIRATORY CYCLE; ANESTHETIZED RAT; SENSORY MAP; PATTERNS; REPRESENTATION	Background: The impact of respiratory dynamics on odor response has been poorly studied at the olfactory bulb level. However, it has been shown that sniffing in the behaving rodent is highly dynamic and varies both in frequency and flow rate. Bulbar odor response could vary with these sniffing parameter variations. Consequently, it is necessary to understand how nasal airflow can modify and shape odor response at the olfactory bulb level. Methodology and Principal Findings: To assess this question, we used a double cannulation and simulated nasal airflow protocol on anesthetized rats to uncouple nasal airflow from animal respiration. Both mitral/tufted cell extracellular unit activity and local field potentials (LFPs) were recorded. We found that airflow changes in the normal range were sufficient to substantially reorganize the response of the olfactory bulb. In particular, cellular odor-evoked activities, LFP oscillations and spike phase-locking to LFPs were strongly modified by nasal flow rate. Conclusion: Our results indicate the importance of reconsidering the notion of odor coding as odor response at the bulbar level is ceaselessly modified by respiratory dynamics.	[Courtiol, Emmanuelle; Amat, Corine; Thevenet, Marc; Messaoudi, Belkacem; Garcia, Samuel; Buonviso, Nathalie] Univ Lyon 1, CNRS, UMR Neurosci Sensorielles 5020, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Courtiol, E (corresponding author), Univ Lyon 1, CNRS, UMR Neurosci Sensorielles 5020, F-69365 Lyon, France.	ecourtiol@olfac.univ-lyon1.fr	Courtiol, Emmanuelle/N-9316-2017; Buonviso, Nathalie/G-8467-2017; amat, corine/O-1089-2017	Courtiol, Emmanuelle/0000-0002-7197-1117; Buonviso, Nathalie/0000-0002-0018-1695; GARCIA, Samuel/0000-0001-6389-9779	Agence Nationale de la Recherche [ANR-07-NEURO-030]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a grant from "Agence Nationale de la Recherche" (#ANR-07-NEURO-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bhalla US, 1997, J COMPUT NEUROSCI, V4, P221, DOI 10.1023/A:1008819818970; Buonviso N, 2003, EUR J NEUROSCI, V17, P1811, DOI 10.1046/j.1460-9568.2003.02619.x; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Cenier T, 2008, EUR J NEUROSCI, V27, P1432, DOI 10.1111/j.1460-9568.2008.06123.x; CHAPUT MA, 1992, EUR J NEUROSCI, V4, P813, DOI 10.1111/j.1460-9568.1992.tb00191.x; Duchamp-Viret P, 2005, J NEUROBIOL, V65, P97, DOI 10.1002/neu.20177; Fontanini A, 2003, J NEUROSCI, V23, P7993; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Garcia Samuel, 2009, Front Neuroinform, V3, P14, DOI 10.3389/neuro.11.014.2009; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; Homma R, 2009, EUR J NEUROSCI, V29, P1027, DOI 10.1111/j.1460-9568.2009.06644.x; Imai T, 2007, CURR OPIN NEUROBIOL, V17, P507, DOI 10.1016/j.conb.2007.08.002; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kent PF, 1996, J NEUROSCI, V16, P345; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kepecs A, 2007, J NEUROPHYSIOL, V98, P205, DOI 10.1152/jn.00071.2007; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Litaudon P, 2003, EUR J NEUROSCI, V17, P2457, DOI 10.1046/j.1460-9568.2003.02654.x; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MOZELL MM, 1970, J GEN PHYSIOL, V56, P46, DOI 10.1085/jgp.56.1.46; MOZELL MM, 1964, NATURE, V203, P1181, DOI 10.1038/2031181a0; Nagao H, 2002, MICROSC RES TECHNIQ, V58, P168, DOI 10.1002/jemt.10146; Neville KR, 2003, J NEUROPHYSIOL, V90, P3921, DOI 10.1152/jn.00475.2003; Oka Y, 2009, J NEUROSCI, V29, P12070, DOI 10.1523/JNEUROSCI.1415-09.2009; ONODA N, 1980, J NEUROPHYSIOL, V44, P29, DOI 10.1152/jn.1980.44.1.29; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; PRITCHARD R, 1961, SCI AM, V204, P72, DOI 10.1038/scientificamerican0661-72; RAVEL N, 1987, EXP BRAIN RES, V65, P623; Roux SG, 2006, J NEUROSCI METH, V152, P173, DOI 10.1016/j.jneumeth.2005.09.004; Roux SG, 2007, J NEUROSCI METH, V160, P135, DOI 10.1016/j.jneumeth.2006.09.001; Schoenfeld TA, 2006, CHEM SENSES, V31, P131, DOI 10.1093/chemse/bjj015; Schoenfeld TA, 2005, TRENDS NEUROSCI, V28, P620, DOI 10.1016/j.tins.2005.09.005; Scott JW, 2006, CHEM SENSES, V31, pA15; Scott-Johnson PE, 2000, CHEM SENSES, V25, P761, DOI 10.1093/chemse/25.6.761; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Tristan C, 2009, EUR J NEUROSCI, V29, P921, DOI 10.1111/j.1460-9568.2009.06651.x; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Wesson DW, 2008, CHEM SENSES, V33, P581, DOI 10.1093/chemse/bjn029; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4	47	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16445	10.1371/journal.pone.0016445	http://dx.doi.org/10.1371/journal.pone.0016445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298064	Green Published, gold			2022-12-25	WOS:000286662800041
J	Ma, XJ; Lin, LG; Qin, GJ; Lu, XP; Fiorotto, M; Dixit, VD; Sun, YX				Ma, Xiaojun; Lin, Ligen; Qin, Guijun; Lu, Xinping; Fiorotto, Marta; Dixit, Vishwa D.; Sun, Yuxiang			Ablations of Ghrelin and Ghrelin Receptor Exhibit Differential Metabolic Phenotypes and Thermogenic Capacity during Aging	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; HORMONE SECRETAGOGUE RECEPTOR; DES-ACYL GHRELIN; GROWTH-HORMONE; FOOD-INTAKE; ENERGY-EXPENDITURE; ADAPTIVE THERMOGENESIS; BODY-COMPOSITION; ACTIVE GHRELIN; HUMAN OBESITY	Background: Obesity is a hallmark of aging in many Western societies, and is a precursor to numerous serious age-related diseases. Ghrelin (Ghrl), via its receptor (growth hormone secretagogue receptor, GHS-R), is shown to stimulate GH secretion and appetite. Surprisingly, our previous studies showed that Ghrl(-/-) mice have impaired thermoregulatory responses to cold and fasting stresses, while Ghsr(-/-) mice are adaptive. Methodology/Principal Findings: To elucidate the mechanism, we analyzed the complete metabolic profiles of younger (3-4 months) and older (10-12 months) Ghrl(-/-) and Ghsr(-/-) mice. Food intake and locomotor activity were comparable for both null mice and their wild-type (WT) counterparts, regardless of age. There was also no difference in body composition between younger null mice and their WT counterparts. As the WT mice aged, as expected, the fat/lean ratio increased and energy expenditure (EE) decreased. Remarkably, however, older Ghsr(-/-) mice exhibited reduced fat/lean ratio and increased EE when compared to older WT mice, thus retaining a youthful lean and high EE phenotype; in comparison, there was no significant difference with EE in Ghrl(-/-) mice. In line with the EE data, the thermogenic regulator, uncoupling protein 1 (UCP1), was significantly up-regulated in brown adipose tissue (BAT) of Ghsr(-/-) mice, but not in Ghrl(-/-) mice. Conclusions: Our data therefore suggest that GHS-R ablation activates adaptive thermogenic function(s) in BAT and increases EE, thereby enabling the retention of a lean phenotype. This is the first direct evidence that the ghrelin signaling pathway regulates fat-burning BAT to affect energy balance during aging. This regulation is likely mediated through an as-yet-unidentified new ligand of GHS-R.	[Ma, Xiaojun; Qin, Guijun] Zhengzhou Univ, Affiliated Hosp 1, Dept Internal Med, Div Endocrinol, Zhengzhou, Peoples R China; [Ma, Xiaojun; Lin, Ligen; Fiorotto, Marta; Sun, Yuxiang] Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat,Baylor Coll Med, Houston, TX 77030 USA; [Lu, Xinping] NIDDKD, Digest Dis Branch, NIH, Bethesda, MD 20892 USA; [Dixit, Vishwa D.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Lab Neuroendocrine Immunol, Baton Rouge, LA USA; [Sun, Yuxiang] Baylor Coll Med, Huffington Ctr Aging, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Zhengzhou University; Baylor College of Medicine; Baylor University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Baylor College of Medicine	Ma, XJ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Internal Med, Div Endocrinol, Zhengzhou, Peoples R China.	yuxiangs@bcm.edu	Lin, Ligen/ABC-1078-2020	Lin, Ligen/0000-0002-6799-5327	USDA/ARS CRIS [6250-51000-055]; NIH/NIA [1R03AG029641-01]; NIH-Diabetes and Endocrinology Research Center at Baylor College of Medicine [P30DK079638]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG029641] Funding Source: NIH RePORTER	USDA/ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-Diabetes and Endocrinology Research Center at Baylor College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are very grateful to the agencies which supported this work: USDA/ARS CRIS fund ARS 6250-51000-055 (YS), NIH/NIA grant 1R03AG029641-01 (YS) and the NIH-Diabetes and Endocrinology Research Center (P30DK079638) at Baylor College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyasu H, 2002, ENDOCRINOLOGY, V143, P3341, DOI 10.1210/en.2002-220225; Bancroft G.D., 1996, THEORY PRACTICE PATH, V4th ed.; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bresciani E, 2006, J ENDOCRINOL INVEST, V29, pRC16, DOI 10.1007/BF03344175; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CANNON B, NAT MED, V16, P965; Carlini VP, 2007, BIOCHEM BIOPH RES CO, V352, P907, DOI 10.1016/j.bbrc.2006.11.112; Cassoni P, 2004, EUR J ENDOCRINOL, V150, P173, DOI 10.1530/eje.0.1500173; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DELHANTY PJ, 1749, PLOS ONE, V5; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; Franco Celina, 2006, Metabolic Syndrome and Related Disorders, V4, P51, DOI 10.1089/met.2006.4.51; Gauna C, 2005, J CLIN ENDOCR METAB, V90, P1055, DOI 10.1210/jc.2004-1069; Hataya Y, 2001, J CLIN ENDOCR METAB, V86, P4552, DOI 10.1210/jc.86.9.4552; Holdstock C, 2003, J CLIN ENDOCR METAB, V88, P3177, DOI 10.1210/jc.2002-021734; Hosoda Hiroshi, 2002, Mol Interv, V2, P494, DOI 10.1124/mi.2.8.494; Jastroch M, 2008, PHYSIOL GENOMICS, V32, P161, DOI 10.1152/physiolgenomics.00183.2007; Justo R, 2005, MITOCHONDRION, V5, P45, DOI 10.1016/j.mito.2004.09.003; Kerckhoffs DAJM, 1998, AM J PHYSIOL-ENDOC M, V274, pE1075, DOI 10.1152/ajpendo.1998.274.6.E1075; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Krems C, 2005, EUR J CLIN NUTR, V59, P255, DOI 10.1038/sj.ejcn.1602066; Lagaud GJ, 2007, BIOCHEM BIOPH RES CO, V357, P264, DOI 10.1016/j.bbrc.2007.03.138; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lopez M., NAT MED, V16, P1001; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Marzullo P, 2004, J CLIN ENDOCR METAB, V89, P936, DOI 10.1210/jc.2003-031328; MATTSON MP, AGEING RES REV, V9, P69; Morley JE, 2001, NUTRITION, V17, P660, DOI 10.1016/S0899-9007(01)00574-3; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Nuotio-Antar AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1517, DOI 10.1152/ajpendo.00522.2007; Obici S, 2002, J CLIN INVEST, V109, P1599, DOI 10.1172/JCI0215258; Palik E, 2007, DIABETES RES CLIN PR, V76, P351, DOI 10.1016/j.diabres.2006.09.005; PFANNENBERG C, DIABETES, V59, P1789; Riis ALD, 2003, J CLIN ENDOCR METAB, V88, P853, DOI 10.1210/jc.2002-021302; Rodriguez A, 2009, INT J OBESITY, V33, P541, DOI 10.1038/ijo.2009.40; Roti E, 2000, INT J OBESITY, V24, pS113, DOI 10.1038/sj.ijo.0801293; Shetty P, 2005, PUBLIC HEALTH NUTR, V8, P994, DOI 10.1079/PHN2005792; Shiiya T, 2002, J CLIN ENDOCR METAB, V87, P240, DOI 10.1210/jc.87.1.240; Shimbara T, 2004, NEUROSCI LETT, V369, P75, DOI 10.1016/j.neulet.2004.07.060; Smith RG, 2005, TRENDS ENDOCRIN MET, V16, P436, DOI 10.1016/j.tem.2005.09.004; St-Onge MP, 2005, CURR OPIN CLIN NUTR, V8, P523; St-Pierre DH, 2004, J CLIN ENDOCR METAB, V89, P5993, DOI 10.1210/jc.2004-0613; STONGE MP, NUTRITION, V26, P152; Sun YX, 2008, ENDOCRINOLOGY, V149, P843, DOI 10.1210/en.2007-0271; Sun YX, 2007, ENDOCRINOLOGY, V148, P1323, DOI 10.1210/en.2006-0782; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Szentirmai E, 2009, P NATL ACAD SCI USA, V106, P14069, DOI 10.1073/pnas.0903090106; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Thielemans L, 2007, J RECEPT SIG TRANSD, V27, P309, DOI 10.1080/10799890701519587; Thompson NM, 2004, ENDOCRINOLOGY, V145, P234, DOI 10.1210/en.2003-0899; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tsubone T, 2005, REGUL PEPTIDES, V130, P97, DOI 10.1016/j.regpep.2005.04.004; Valle A, 2008, REJUV RES, V11, P597, DOI 10.1089/rej.2007.0626; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; WABITSCH M, 1995, METABOLISM, V44, P45, DOI 10.1016/0026-0495(95)90220-1; Wijers SLJ, 2009, OBES REV, V10, P218, DOI 10.1111/j.1467-789X.2008.00538.x; WISKIN AE, ARCH DIS CHILD; Wolthers T, 1996, J CLIN ENDOCR METAB, V81, P1416, DOI 10.1210/jc.81.4.1416; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Yasuda T, 2003, NEUROSCI LETT, V349, P75, DOI 10.1016/S0304-3940(03)00789-4; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	73	53	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16391	10.1371/journal.pone.0016391	http://dx.doi.org/10.1371/journal.pone.0016391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298106	Green Published, Green Submitted, gold			2022-12-25	WOS:000286662800038
J	Rueness, EK; Asmyhr, MG; Sillero-Zubiri, C; Macdonald, DW; Bekele, A; Atickem, A; Stenseth, NC				Rueness, Eli Knispel; Asmyhr, Maria Gulbrandsen; Sillero-Zubiri, Claudio; Macdonald, David W.; Bekele, Afework; Atickem, Anagaw; Stenseth, Nils Chr.			The Cryptic African Wolf: Canis aureus lupaster Is Not a Golden Jackal and Is Not Endemic to Egypt	PLOS ONE			English	Article							CYTOCHROME-B SEQUENCES; MITOCHONDRIAL-DNA; POPULATION; EVOLUTION	The Egyptian jackal (Canis aureus lupaster) has hitherto been considered a large, rare subspecies of the golden jackal (C. aureus). It has maintained its taxonomical status to date, despite studies demonstrating morphological similarities to the grey wolf (C. lupus). We have analyzed 2055 bp of mitochondrial DNA from C. a. lupaster and investigated the similarity to C. aureus and C. lupus. Through phylogenetic comparison with all wild wolf-like canids (based on 726 bp of the Cytochrome b gene) we conclusively (100% bootstrap support) place the Egyptian jackal within the grey wolf species complex, together with the Holarctic wolf, the Indian wolf and the Himalayan wolf. Like the two latter taxa, C. a. lupaster seems to represent an ancient wolf lineage which most likely colonized Africa prior to the northern hemisphere radiation. We thus refer to C. a. lupaster as the African wolf. Furthermore, we have detected C. a. lupaster individuals at two localities in the Ethiopian highlands, extending the distribution by at least 2,500 km southeast. The only grey wolf species to inhabit the African continent is a cryptic species for which the conservation status urgently needs assessment.	[Rueness, Eli Knispel; Asmyhr, Maria Gulbrandsen; Atickem, Anagaw; Stenseth, Nils Chr.] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Sillero-Zubiri, Claudio; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England; [Bekele, Afework] Univ Addis Ababa, Fac Sci, Dept Biol, Addis Ababa, Ethiopia	University of Oslo; University of Oxford; Addis Ababa University	Rueness, EK (corresponding author), Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway.	n.c.stenseth@bio.uio.no	Stenseth, Nils Chr./G-5212-2016	Stenseth, Nils Chr./0000-0002-1591-5399	University of Oslo	University of Oslo	Funding was provided by the University of Oslo (www.uio.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Bardeleben C, 2005, MOL PHYLOGENET EVOL, V37, P815, DOI 10.1016/j.ympev.2005.07.019; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; FERGUSON WW, 1981, MAMMALIA, V45, P459, DOI 10.1515/mamm.1981.45.4.459; HUXLEY TH, 1880, CRANIAL DENTAL CHARA; JANCZEWSKI DN, 1995, MOL BIOL EVOL, V12, P690; JHALA YV, 2008, IUCN 2009 IUCN RED L; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; KRYSTUFEK B, 1990, FOLIA ZOOL, V39, P291; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; MACDONALD DW, 1979, BEHAV ECOL SOCIOBIOL, V5, P17, DOI 10.1007/BF00302692; NASSEF M, 2003, THESIS U LEEDS; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; Sillero-Zubiri C, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P311; Sillero-Zubiri C, 2004, CANIDS FOXES WOLVES; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tiwari J, 2004, CANID NEWS, V7, P5; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Wayne RK, 1997, SYST BIOL, V46, P622, DOI 10.2307/2413498; Wozencraft WC, 2005, MAMMAL SPECIES WORLD, P532; Zachos FE, 2009, BIOCHEM GENET, V47, P241, DOI 10.1007/s10528-009-9221-y	22	78	84	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16385	10.1371/journal.pone.0016385	http://dx.doi.org/10.1371/journal.pone.0016385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298107	Green Published, gold			2022-12-25	WOS:000286662800035
J	King, KY; Lew, JD; Ha, NP; Lin, JS; Ma, X; Graviss, EA; Goodell, MA				King, Katherine Y.; Lew, Justin D.; Ha, Ngan P.; Lin, Jeffery S.; Ma, Xin; Graviss, Edward A.; Goodell, Margaret A.			Polymorphic Allele of Human IRGM1 Is Associated with Susceptibility to Tuberculosis in African Americans	PLOS ONE			English	Article							INTRACELLULAR PATHOGENS; CROHNS-DISEASE; IMMUNITY; GENE; RESISTANCE; GTPASES	An ancestral polymorphic allele of the human autophagy-related gene IRGM1 is associated with altered gene expression and a genetic risk for Crohn's Disease (CD). We used the single nucleotide polymorphism rs10065172C/T as a marker of this polymorphic allele and genotyped 370 African American and 177 Caucasian tuberculosis (TB) cases and 180 African American and 110 Caucasian controls. Among African Americans, the TB cases were more likely to carry the CD-related T allele of rs10065172 (odds ratio of 1.54; 95% confidence interval, 1.17-2.02; P<0.01) compared to controls. Our finding suggests that this CD-related IRGM1 polymorphic allele is also associated with human susceptibility to TB disease among African Americans.	[King, Katherine Y.] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA; [Lew, Justin D.; Ha, Ngan P.; Ma, Xin; Graviss, Edward A.] Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA; [Lin, Jeffery S.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; University of California System; University of California Berkeley; Baylor College of Medicine	King, KY (corresponding author), Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA.	kyk@bcm.edu	King, Katherine/AAI-2436-2021	Goodell, Margaret A./0000-0003-1111-2932; King, Katherine/0000-0002-5093-6005	Simmons Foundation	Simmons Foundation	This work was supported by the Simmons Foundation Collaborative Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CM, 2008, J INFECT DIS, V197, P1713, DOI 10.1086/588384; Bekpen C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000403; CHE N, 2010, CLIN CHIM ACTA, P1; Feng CG, 2008, NAT IMMUNOL, V9, P1279, DOI 10.1038/ni.1653; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Ma X, 2003, J INFECT DIS, V188, P349, DOI 10.1086/376559; Ma X, 2002, INT J TUBERC LUNG D, V6, P818; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Mayer KH, 2010, CLIN INFECT DIS, V50, pS67, DOI 10.1086/651475; McCarroll SA, 2008, NAT GENET; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x	16	64	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16317	10.1371/journal.pone.0016317	http://dx.doi.org/10.1371/journal.pone.0016317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283700	gold, Green Published, Green Submitted			2022-12-25	WOS:000286522300034
J	Shi, M; Liu, ZR; Lv, YG; Zheng, MH; Du, F; Zhao, G; Huang, Y; Chen, JY; Han, H; Ding, YQ				Shi, Ming; Liu, Zhirong; Lv, Yonggang; Zheng, Minhua; Du, Fang; Zhao, Gang; Huang, Ying; Chen, Jiayin; Han, Hua; Ding, Yuqiang			Forced Notch Signaling Inhibits Commissural Axon Outgrowth in the Developing Chick Central Nerve System	PLOS ONE			English	Article							NEURITE OUTGROWTH; SPINAL-CORD; NEURAL DEVELOPMENT; SONIC HEDGEHOG; MOUSE-BRAIN; FLOOR PLATE; GUIDANCE; NEURONS; CELLS; OVEREXPRESSION	Background: A collection of in vitro evidence has demonstrated that Notch signaling plays a key role in the growth of neurites in differentiated neurons. However, the effects of Notch signaling on axon outgrowth in an in vivo condition remain largely unknown. Methodology/Principal Findings: In this study, the neural tubes of HH10-11 chick embryos were in ovo electroporated with various Notch transgenes of activating or inhibiting Notch signaling, and then their effects on commissural axon outgrowth across the floor plate midline in the chick developing central nerve system were investigated. Our results showed that forced expression of Notch intracellular domain, constitutively active form of RBPJ, or full-length Hes1 in the rostral hindbrain, diencephalon and spinal cord at stage HH10-11 significantly inhibited commissural axon outgrowth. On the other hand, inhibition of Notch signaling by ectopically expressing a dominant-negative form of RBPJ promoted commissural axonal growth along the circumferential axis. Further results revealed that these Notch signaling-mediated axon outgrowth defects may be not due to the alteration of axon guidance since commissural axon marker TAG1 was present in the axons in floor plate midline, and also not result from the changes in cell fate determination of commissural neurons since the expression of postmitotic neuron marker Tuj1 and specific commissural markers TAG1 and Pax7 was unchanged. Conclusions/Significance: We first used an in vivo system to provide evidence that forced Notch signaling negatively regulates commissural axon outgrowth.	[Shi, Ming; Liu, Zhirong; Du, Fang; Zhao, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China; [Lv, Yonggang] Fourth Mil Med Univ, Affiliated Hosp 1, Dept Vasc & Endocrine Surg, Xian 710032, Peoples R China; [Zheng, Minhua; Han, Hua] Fourth Mil Med Univ, Dept Med Genet & Dev Biol, Xian 710032, Peoples R China; [Huang, Ying; Chen, Jiayin; Ding, Yuqiang] Tongji Univ, Sch Med, Dept Anat & Neurobiol, Shanghai 200092, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Tongji University	Shi, M (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China.	biomidas@163.com; dingyuqiang@gmail.com	Shi, Ming/B-7829-2012	Ding, Yu-Qiang/0000-0003-1202-4635	Ministry of Science and Technology of China [2006CB943903, 2009ZX09501-030]; National Natural Science Foundation of China [31030034]; Shaanxi Provincial Science and Technology Program, China [2009K01-59]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Science and Technology Program, China	This work was supported by grants from the Ministry of Science and Technology of China (2006CB943903, 2009ZX09501-030), National Natural Science Foundation of China (31030034) and Shaanxi Provincial Science and Technology Program, China (2009K01-59). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; Bhat KMR, 2006, NUCLEIC ACIDS RES, V34, P3819, DOI 10.1093/nar/gkl476; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Crowner D, 2003, CURR BIOL, V13, P967, DOI 10.1016/S0960-9822(03)00325-7; Ferrari-Toninelli G, 2008, NEUROSCIENCE, V154, P946, DOI 10.1016/j.neuroscience.2008.04.025; Ferrari-Toninelli G, 2009, DEV NEUROBIOL, V69, P378, DOI 10.1002/dneu.20710; Franklin JL, 1999, CURR BIOL, V9, P1448, DOI 10.1016/S0960-9822(00)80114-1; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; Guthrie S, 2004, CURR BIOL, V14, pR166, DOI 10.1016/j.cub.2004.01.050; Hansen SM, 2008, CELL MOL LIFE SCI, V65, P3809, DOI 10.1007/s00018-008-8290-0; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Irvin DK, 2004, J NEUROSCI RES, V75, P330, DOI 10.1002/jnr.10843; Jessen U, 2003, J NEUROSCI RES, V71, P1, DOI 10.1002/jnr.10433; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Levy OA, 2002, DEV NEUROSCI-BASEL, V24, P79, DOI 10.1159/000064948; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Maddodi N, 2010, J BIOL CHEM, V285, P242, DOI 10.1074/jbc.M109.068668; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Murakami F, 1997, CELL TISSUE RES, V290, P323, DOI 10.1007/s004410050937; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Otto A, 2006, ANAT EMBRYOL, V211, P293, DOI 10.1007/s00429-006-0083-3; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Saba R, 2003, J NEUROSCI, V23, P1987; Salinas PC, 2003, TRENDS NEUROSCI, V26, P641, DOI 10.1016/j.tins.2003.09.006; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shi M, 2008, MOL CELL NEUROSCI, V39, P529, DOI 10.1016/j.mcn.2008.07.023; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Zhu Y, 2006, DEVELOPMENT, V133, P3837, DOI 10.1242/dev.02564	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14570	10.1371/journal.pone.0014570	http://dx.doi.org/10.1371/journal.pone.0014570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283742	gold, Green Submitted, Green Published			2022-12-25	WOS:000286522300008
J	Wang, GP; Ye, Y; Yang, XQ; Liao, HY; Zhao, CG; Liang, SA				Wang, Guiping; Ye, Yun; Yang, Xiaoqin; Liao, Hongying; Zhao, Canguo; Liang, Shuang			Expression-Based In Silico Screening of Candidate Therapeutic Compounds for Lung Adenocarcinoma	PLOS ONE			English	Article							CELL-CYCLE ARREST; GENE-EXPRESSION; CANCER CELLS; INHIBITION; APOPTOSIS; AKT; GROWTH; HSP90; PROTEIN; CHINA	Background: Lung adenocarcinom (AC) is the most common form of lung cancer. Currently, the number of medical options to deal with lung cancer is very limited. In this study, we aimed to investigate potential therapeutic compounds for lung adenocarcinoma based on integrative analysis. Methodology/Principal Findings: The candidate therapeutic compounds were identified in a two-step process. First, a meta-analysis of two published microarray data was conducted to obtain a list of 343 differentially expressed genes specific to lung AC. In the next step, expression profiles of these genes were used to query the Connectivity-Map (C-MAP) database to identify a list of compounds whose treatment reverse expression direction in various cancer cells. Several compounds in the categories of HSP90 inhibitor, HDAC inhibitor, PPAR agonist, PI3K inhibitor, passed our screening to be the leading candidates. On top of the list, three HSP90 inhibitors, i.e. 17-AAG (also known as tanespimycin), monorden, and alvespimycin, showed significant negative enrichment scores. Cytotoxicity as well as effects on cell cycle regulation and apoptosis were evaluated experimentally in lung adenocarcinoma cell line (A549 or GLC-82) with or without treatment with 17-AAG. In vitro study demonstrated that 17-AAG alone or in combination with cisplatin (DDP) can significantly inhibit lung adenocarcinoma cell growth by inducing cell cycle arrest and apoptosis. Conclusions/Significance: We have used an in silico screening to identify compounds for treating lung cancer. One such compound 17-AAG demonstrated its anti-lung AC activity by inhibiting cell growth and promoting apoptosis and cell cycle arrest.	[Wang, Guiping; Ye, Yun; Yang, Xiaoqin; Liang, Shuang] So Med Univ, Inst Genet Engn, Bioinformat Grp, Guangzhou, Guangdong, Peoples R China; [Wang, Guiping; Zhao, Canguo] Guangzhou Med Univ, Guangzhou, Guangdong, Peoples R China; [Ye, Yun] Guangxi Univ Technol, Dept Biol & Chem Engn, Liuzhou, Peoples R China; [Liao, Hongying] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Southern Medical University - China; Guangzhou Medical University; Guangxi University of Science & Technology; Sun Yat Sen University	Wang, GP (corresponding author), So Med Univ, Inst Genet Engn, Bioinformat Grp, Guangzhou, Guangdong, Peoples R China.	itshuang@gmail.com			Higher Education Agency of GuangDong province	Higher Education Agency of GuangDong province	This research was funded by a special grant from the Higher Education Agency of GuangDong province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Crocetti E, 2002, LUNG CANCER-J IASLC, V35, P215, DOI 10.1016/S0169-5002(01)00335-X; Crowell JA, 2003, J NATL CANCER I, V95, P252, DOI 10.1093/jnci/95.4.252; De Preter K, 2009, CLIN CANCER RES, V15, P3690, DOI 10.1158/1078-0432.CCR-08-2699; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Ebi H, 2009, CANCER RES, V69, P4027, DOI 10.1158/0008-5472.CAN-08-3403; Georgakis GV, 2006, BRIT J HAEMATOL, V135, P68, DOI 10.1111/j.1365-2141.2006.06247.x; Han H, 2007, APOPTOSIS, V12, P2101, DOI 10.1007/s10495-007-0124-2; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Kim WY, 2009, CANCER RES, V69, P1624, DOI 10.1158/0008-5472.CAN-08-0505; Kutalik Z, 2008, NAT BIOTECHNOL, V26, P531, DOI 10.1038/nbt1397; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn610; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Mukhopadhyay NK, 2006, ANN THORAC SURG, V81, P1034, DOI 10.1016/j.athoracsur.2005.06.059; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Okamoto J, 2008, J THORAC ONCOL, V3, P1089, DOI 10.1097/JTO.0b013e3181839693; Pitt SC, 2009, J AM COLL SURGEONS, V209, P82, DOI 10.1016/j.jamcollsurg.2009.03.006; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Rahman KMW, 2006, CANCER RES, V66, P4952, DOI 10.1158/0008-5472.CAN-05-3918; Riedel RF, 2008, MOL CANCER THER, V7, P3141, DOI 10.1158/1535-7163.MCT-08-0642; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; Senju M, 2006, J CANCER RES CLIN, V132, P150, DOI 10.1007/s00432-005-0047-7; Shin SW, 2009, CLIN CANCER RES, V15, P5414, DOI 10.1158/1078-0432.CCR-08-3101; Solit DB, 2003, CANCER RES, V63, P2139; Solit DB, 2002, CLIN CANCER RES, V8, P986; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; Watanabe G, 2009, CANCER CHEMOTH PHARM, V64, P433, DOI 10.1007/s00280-008-0888-2; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Whyte L, 2007, CANCER RES, V67, P12007, DOI 10.1158/0008-5472.CAN-07-2464; Yang L, 2005, EUR J CANCER PREV, V14, P329, DOI 10.1097/00008469-200508000-00004; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yang L, 2004, BRIT J CANCER, V90, P2157, DOI 10.1038/sj.bjc.6601813; Yang Ling, 2003, Asian Pac J Cancer Prev, V4, P23; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	36	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14573	10.1371/journal.pone.0014573	http://dx.doi.org/10.1371/journal.pone.0014573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283735	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522300010
J	Azadniv, M; Bowers, WJ; Topham, DJ; Crispe, IN				Azadniv, Mitra; Bowers, William J.; Topham, David J.; Crispe, Ian N.			CD4+T Cell Effects on CD8+T Cell Location Defined Using Bioluminescence	PLOS ONE			English	Article							CD4(+) T-CELLS; DENDRITIC CELLS; ACUTE INFECTION; NAIVE CELLS; MEMORY; HELP; EXPRESSION; TISSUE; LYMPHOCYTES; RESPONSES	T lymphocytes of the CD8+ class are critical in delivering cytotoxic function and in controlling viral and intracellular infections. These cells are "helped'' by T lymphocytes of the CD4+ class, which facilitate their activation, clonal expansion, full differentiation and the persistence of memory. In this study we investigated the impact of CD4+ T cells on the location of CD8+ T cells, using antibody-mediated CD4+ T cell depletion and imaging the antigen-driven redistribution of bioluminescent CD8+ T cells in living mice. We documented that CD4+ T cells influence the biodistribution of CD8+ T cells, favoring their localization to abdominal lymph nodes. Flow cytometric analysis revealed that this was associated with an increase in the expression of specific integrins. The presence of CD4+ T cells at the time of initial CD8+ T cell activation also influences their biodistribution in the memory phase. Based on these results, we propose the model that one of the functions of CD4+ T cell "help'' is to program the homing potential of CD8+ T cells.	[Azadniv, Mitra; Topham, David J.] Univ Rochester, Med Ctr, David H Smith Ctr Microbiol & Immunol, Aab Inst Biomed Res, Rochester, NY 14642 USA; [Bowers, William J.] Univ Rochester, Med Ctr, Ctr Aging & Dev Biol, Aab Inst Biomed Res,Dept Neurol, Rochester, NY 14642 USA; [Crispe, Ian N.] Seattle Biomed Res Inst, Seattle, WA 98109 USA	University of Rochester; University of Rochester; Center for Infectious Disease Research	Azadniv, M (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Microbiol & Immunol, Aab Inst Biomed Res, Rochester, NY 14642 USA.	nick.crispe@seattlebiomed.org			NIH [AI056356, AI057998]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI057998, P01AI056356] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH grants AI056356 to William Bowers, PhD and AI057998 to Ian N. Crispe, MB BS PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azadniv M, 2007, INT IMMUNOL, V19, P1165, DOI 10.1093/intimm/dxm086; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; BERG EL, 1991, J CELL BIOL, V114, P343, DOI 10.1083/jcb.114.2.343; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bowers WJ, 2000, MOL THER, V1, P294, DOI 10.1006/mthe.2000.0039; Bowers WJ, 2006, MOL THER, V13, P580, DOI 10.1016/j.ymthe.2005.11.011; Bowers WJ, 2001, GENE THER, V8, P111, DOI 10.1038/sj.gt.3301340; BULLER RML, 1987, NATURE, V328, P77, DOI 10.1038/328077a0; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chewning JH, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-44; Curtsinger JM, 1998, J IMMUNOL, V160, P3236; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; de Herve MGD, 2008, J IMMUNOL, V181, P5974, DOI 10.4049/jimmunol.181.9.5974; Dudda JC, 2004, J IMMUNOL, V172, P857, DOI 10.4049/jimmunol.172.2.857; GUERDER S, 1992, J EXP MED, V176, P553, DOI 10.1084/jem.176.2.553; Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Marzo AL, 2004, J IMMUNOL, V173, P969, DOI 10.4049/jimmunol.173.2.969; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Mosmann TR, 2004, NAT IMMUNOL, V5, P564, DOI 10.1038/ni0604-564; PARKER CM, 1992, P NATL ACAD SCI USA, V89, P1924, DOI 10.1073/pnas.89.5.1924; REES MA, 1990, P NATL ACAD SCI USA, V87, P2765, DOI 10.1073/pnas.87.7.2765; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Santos K, 2007, VACCINE, V25, P1634, DOI 10.1016/j.vaccine.2006.11.004; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schuhbauer DMS, 2000, EUR J IMMUNOL, V30, P1255; Shedlock DJ, 2003, J IMMUNOL, V170, P2053, DOI 10.4049/jimmunol.170.4.2053; Shoukry NH, 2004, J IMMUNOL, V172, P483, DOI 10.4049/jimmunol.172.1.483; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Willis RA, 2001, HUM GENE THER, V12, P1867, DOI 10.1089/104303401753153929; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	41	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16222	10.1371/journal.pone.0016222	http://dx.doi.org/10.1371/journal.pone.0016222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283759	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200039
J	Kettern, N; Rogon, C; Limmer, A; Schild, H; Hohfeld, J				Kettern, Nadja; Rogon, Christian; Limmer, Andreas; Schild, Hansjoerg; Hoehfeld, Joerg			The Hsc/Hsp70 Co-Chaperone Network Controls Antigen Aggregation and Presentation during Maturation of Professional Antigen Presenting Cells	PLOS ONE			English	Article							PROTEIN-QUALITY CONTROL; TRANSMEMBRANE CONDUCTANCE REGULATOR; MOLECULAR CHAPERONES; IN-VIVO; UBIQUITINATED PROTEINS; DENDRITIC CELLS; DEGRADATION; PROTEASOME; AUTOPHAGY; CHIP	The maturation of mouse macrophages and dendritic cells involves the transient deposition of ubiquitylated proteins in the form of dendritic cell aggresome-like induced structures (DALIS). Transient DALIS formation was used here as a paradigm to study how mammalian cells influence the formation and disassembly of protein aggregates through alterations of their proteostasis machinery. Co-chaperones that modulate the interplay of Hsc70 and Hsp70 with the ubiquitin-proteasome system (UPS) and the autophagosome-lysosome pathway emerged as key regulators of this process. The chaperone-associated ubiquitin ligase CHIP and the ubiquitin-domain protein BAG-1 are essential for DALIS formation in mouse macrophages and bone-marrow derived dendritic cells (BMDCs). CHIP also cooperates with BAG-3 and the autophagic ubiquitin adaptor p62 in the clearance of DALIS through chaperone-assisted selective autophagy (CASA). On the other hand, the co-chaperone HspBP1 inhibits the activity of CHIP and thereby attenuates antigen sequestration. Through a modulation of DALIS formation CHIP, BAG-1 and HspBP1 alter MHC class I mediated antigen presentation in mouse BMDCs. Our data show that the Hsc/Hsp70 co-chaperone network controls transient protein aggregation during maturation of professional antigen presenting cells and in this way regulates the immune response. Similar mechanisms may modulate the formation of aggresomes and aggresome-like induced structures (ALIS) in other mammalian cell types.	[Kettern, Nadja; Rogon, Christian; Hoehfeld, Joerg] Univ Bonn, Inst Cell Biol, D-5300 Bonn, Germany; [Limmer, Andreas] Univ Hosp Bonn, Inst Mol Med & Expt Immunol, Bonn, Germany; [Schild, Hansjoerg] Johannes Gutenberg Univ Mainz, Inst Immunol, D-6500 Mainz, Germany	University of Bonn; University of Bonn; Johannes Gutenberg University of Mainz	Kettern, N (corresponding author), Univ Bonn, Inst Cell Biol, D-5300 Bonn, Germany.	hoehfeld@uni-bonn.de			Deutsche Forschungsgemeinschaft [SFB 704, SFB 635, DIP K.5.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (SFB 704; SFB 635 and DIP K.5.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Canadien V, 2005, J IMMUNOL, V174, P2471, DOI 10.4049/jimmunol.174.5.2471; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Dikshit P, 2007, BIOCHEM BIOPH RES CO, V357, P761, DOI 10.1016/j.bbrc.2007.04.018; Fassbender M, 2008, MED MICROBIOL IMMUN, V197, P185, DOI 10.1007/s00430-008-0091-4; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Finkbeiner S, 2006, J NEUROSCI, V26, P10349, DOI 10.1523/JNEUROSCI.3829-06.2006; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Heir R, 2006, EMBO REP, V7, P1252, DOI 10.1038/sj.embor.7400823; Herter S, 2005, J IMMUNOL, V175, P891, DOI 10.4049/jimmunol.175.2.891; Jacobs AT, 2009, J BIOL CHEM, V284, P9176, DOI 10.1074/jbc.M808656200; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Munz C, 2010, CURR OPIN IMMUNOL, V22, P89, DOI 10.1016/j.coi.2010.01.016; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schweichel D, 2006, J GENE MED, V8, P1243, DOI 10.1002/jgm.952; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	47	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16398	10.1371/journal.pone.0016398	http://dx.doi.org/10.1371/journal.pone.0016398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283720	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522200060
J	Trompeter, HI; Abbad, H; Iwaniuk, KM; Hafner, M; Renwick, N; Tuschl, T; Schira, J; Muller, HW; Wernet, P				Trompeter, Hans-Ingo; Abbad, Hassane; Iwaniuk, Katharina M.; Hafner, Markus; Renwick, Neil; Tuschl, Thomas; Schira, Jessica; Mueller, Hans Werner; Wernet, Peter			MicroRNAs MiR-17, MiR-20a, and MiR-106b Act in Concert to Modulate E2F Activity on Cell Cycle Arrest during Neuronal Lineage Differentiation of USSC	PLOS ONE			English	Article							SOMATIC STEM-CELL; CORD BLOOD; DISTINCT ROLES; CDK INHIBITORS; FEEDBACK LOOP; EXPRESSION; PROLIFERATION; CANCER; PROGRESSION; APOPTOSIS	Background: MicroRNAs are short (similar to 22 nt) non-coding regulatory RNAs that control gene expression at the post-transcriptional level. Here the functional impact of microRNAs on cell cycle arrest during neuronal lineage differentiation of unrestricted somatic stem cells from human cord blood (USSC) was analyzed. Methodology/Principal Findings: Expression profiling revealed downregulation of microRNAs miR-17, -20a, and -106b in USSC differentiated into neuronal lineage but not in USSC differentiated into osteogenic lineage. Transfection experiments followed by Ki67 immunostainings demonstrated that each of these microRNAs was able to promote proliferation of native USSC and to prevent in part cell cycle arrest during neuronal lineage differentiation of USSC. Bioinformatic target gene predictions followed by experimental target gene validations revealed that miR-17, -20a, and -106b act in a common manner by downregulating an overlapping set of target genes mostly involved in regulation and execution of G(1)/S transition. Pro-proliferative target genes cyclinD1 (CCND1) and E2F1 as well as anti-proliferative targets CDKN1A (p21), PTEN, RB1, RBL1 (p107), RBL2 (p130) were shown as common targets for miR-17, -20a, and -106b. Furthermore, these microRNAs also downregulate WEE1 which is involved in G(2)/M transition. Most strikingly, miR-17, -20a, and -106b were found to promote cell proliferation by increasing the intracellular activity of E2F transcription factors, despite the fact that miR-17, 20a, and -106b directly target the transcripts that encode for this protein family. Conclusions/Significance: Mir-17, -20a, and -106b downregulate a common set of pro-and anti-proliferative target genes to impact cell cycle progression of USSC and increase intracellular activity of E2F transcription factors to govern G(1)/S transition.	[Trompeter, Hans-Ingo; Abbad, Hassane; Iwaniuk, Katharina M.; Wernet, Peter] Univ Dusseldorf, Fac Med, Inst Transplantat Diagnost & Cell Therapeut, Dusseldorf, Germany; [Hafner, Markus; Renwick, Neil; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA; [Schira, Jessica; Mueller, Hans Werner] Univ Dusseldorf, Dept Neurol, Fac Med, Mol Neurobiol Lab, D-4000 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Howard Hughes Medical Institute; Rockefeller University; Heinrich Heine University Dusseldorf	Trompeter, HI (corresponding author), Univ Dusseldorf, Fac Med, Inst Transplantat Diagnost & Cell Therapeut, Dusseldorf, Germany.	peter.wernet@uni-duesseldorf.de	Hafner, Markus/O-7100-2018; Renwick, Neil/V-3980-2019; Renwick, Neil M/A-3744-2012	Hafner, Markus/0000-0002-4336-6518; Renwick, Neil/0000-0001-6695-8236; Renwick, Neil M/0000-0001-6695-8236; Schira-Heinen, Jessica/0000-0002-2184-9746	Deutsche Forschungsgemeinschaft (DFG) [FOR717: WE 505/2-1, MU630/10-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by peer-reviewed grants from the Deutsche Forschungsgemeinschaft (DFG research group FOR717: WE 505/2-1, MU630/10-1) given to Peter Wernet and Hans Werner Muller (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Beveridge NJ, 2009, CELL SIGNAL, V21, P1837, DOI 10.1016/j.cellsig.2009.07.019; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; CHEN D, 2010, J CELL PHYSL; Chen H, 2010, NEUROL RES, V32, P603, DOI 10.1179/174313209X455691; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; CZECH B, NAT REV GENET; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Demir O, 2009, ANAT REC, V292, P1953, DOI 10.1002/ar.20980; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Greschat S, 2008, STEM CELLS DEV, V17, P221, DOI 10.1089/scd.2007.0118; Hafner M., J VIS EXP; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; HARPER JW, 1993, CELL, V75, P805; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; IWANIUK KM, 2010, STEM CELLS IN PRESS; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Robertson Barbara, 2010, Silence, V1, P10, DOI 10.1186/1758-907X-1-10; RUIZ EJ, 2010, CURR BIOL; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stengel KR, 2009, J BIOL CHEM, V284, P19265, DOI 10.1074/jbc.M808740200; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tamrakar S, 2000, FRONT BIOSCI-LANDMRK, V5, pD121, DOI 10.2741/Tamrakar; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wernet P, 2010, EXP HEMATOL, V38, P1099, DOI 10.1016/j.exphem.2010.09.006; Wong P, CANC RES, V70, P3833; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079	66	104	109	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16138	10.1371/journal.pone.0016138	http://dx.doi.org/10.1371/journal.pone.0016138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283765	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522200029
J	Anteau, MJ; Afton, AD				Anteau, Michael J.; Afton, Alan D.			Lipid Catabolism of Invertebrate Predator Indicates Widespread Wetland Ecosystem Degradation	PLOS ONE			English	Article							SPRING CONDITION HYPOTHESIS; SCAUP AYTHYA-AFFINIS; LESSER SCAUP; MISSISSIPPI-RIVER; UPPER-MIDWEST; WESTERN SANDPIPERS; MIGRATION; METABOLITES; CONSISTENT; RESERVES	Animals frequently undergo periods when they accumulate lipid reserves for subsequent energetically expensive activities, such as migration or breeding. During such periods, daily lipid-reserve dynamics (DLD) of sentinel species can quantify how landscape modifications affect function, health, and resilience of ecosystems. Aythya affinis (Eyton 1838; lesser scaup; diving duck) are macroinvertebrate predators; they migrate through an agriculturally dominated landscape in spring where they select wetlands with the greatest food density to refuel and accumulate lipid reserves for subsequent reproduction. We index DLD by measuring plasma-lipid metabolites of female scaup (n = 459) that were refueling at 75 spring migration stopover areas distributed across the upper Midwest, USA. We also indexed DLD for females (n = 44) refueling on a riverine site (Pool 19) south of our upper Midwest study area. We found that mean DLD estimates were significantly (P < 0.05) less than zero in all ecophysiographic regions of the upper Midwest, and the greatest negative value was in the Iowa Prairie Pothole region (-31.6). Mean DLD was 16.8 at Pool 19 and was markedly greater than in any region of the upper Midwest. Our results indicate that females catabolized rather than stored lipid reserves throughout the upper Midwest. Moreover, levels of lipid catabolism are alarming, because scaup use the best quality wetlands available within a given stopover area. Accordingly, these results provide evidence of wetland ecosystem degradation across this large agricultural landscape and document affects that are carried-up through several trophic levels. Interestingly, storing of lipids by scaup at Pool 19 likely reflects similar ecosystem perturbations as observed in the upper Midwest because wetland drainage and agricultural runoff nutrifies the riverine habitat that scaup use at Pool 19. Finally, our results underscore how using this novel technique to monitor DLD, of a carefully selected sentinel species, can index ecosystem health at a landscape scale.	[Anteau, Michael J.] Louisiana State Univ, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; [Afton, Alan D.] Louisiana State Univ, Louisiana Cooperat Fish & Wildlife Res Unit, US Geol Survey, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; United States Department of the Interior; United States Geological Survey	Anteau, MJ (corresponding author), US Geol Survey, No Prairie Wildlife Res Ctr, Jamestown, ND USA.	manteau@usgs.gov		Anteau, Michael/0000-0002-5173-5870	Ducks Unlimited Inc. USA; Federal and Winchester Cartridge Companies; Iowa Department of Natural Resources; IWWR of Ducks Unlimited Canada; Graduate School and the School of Renewable Natural Resources at Louisiana State University; Louisiana Department of Wildlife and Fisheries, Louisiana State University; Minnesota Department of Natural Resources; Minnesota Waterfowl Association; North Dakota Game and Fish Department; Prairie Pothole Joint Venture; Upper Mississippi River and Great Lakes Region Joint Venture; USFWS Regions 3 and 6 HAPET offices; USGS-Louisiana Cooperative Fish and Wildlife Research Unit; USGS-National Wetlands Research Center	Ducks Unlimited Inc. USA; Federal and Winchester Cartridge Companies; Iowa Department of Natural Resources; IWWR of Ducks Unlimited Canada; Graduate School and the School of Renewable Natural Resources at Louisiana State University; Louisiana Department of Wildlife and Fisheries, Louisiana State University; Minnesota Department of Natural Resources; Minnesota Waterfowl Association; North Dakota Game and Fish Department; Prairie Pothole Joint Venture; Upper Mississippi River and Great Lakes Region Joint Venture; USFWS Regions 3 and 6 HAPET offices(US Fish & Wildlife Service); USGS-Louisiana Cooperative Fish and Wildlife Research Unit; USGS-National Wetlands Research Center	The following organizations provided financial or in-kind support: Ducks Unlimited Inc. USA, Federal and Winchester Cartridge Companies, Iowa Department of Natural Resources, IWWR of Ducks Unlimited Canada, IWWR of Ducks Unlimited Canada through the Bonnycastle Fellowship, the Graduate School and the School of Renewable Natural Resources at Louisiana State University, Louisiana Department of Wildlife and Fisheries, Louisiana State University through the Bosch Fellowship, Minnesota Department of Natural Resources, Minnesota Waterfowl Association, North Dakota Game and Fish Department, Prairie Pothole Joint Venture, Upper Mississippi River and Great Lakes Region Joint Venture, USFWS Regions 3 and 6 HAPET offices, USGS-Louisiana Cooperative Fish and Wildlife Research Unit, and USGS-National Wetlands Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFTON AD, 1991, CONDOR, V93, P89, DOI 10.2307/1368610; Afton AD, 2001, J WILDLIFE MANAGE, V65, P781, DOI 10.2307/3803028; AFTON AD, 1991, CAN J ZOOL, V69, P328, DOI 10.1139/z91-053; Anteau M. J., 2006, THESIS LOUISIANA STA THESIS LOUISIANA STA; Anteau MJ, 2008, AUK, V125, P354, DOI 10.1525/auk.2008.06255; Anteau MJ, 2008, WATERBIRDS, V31, P97, DOI 10.1675/1524-4695(2008)31[97:DOLSDS]2.0.CO;2; Anteau MJ, 2008, WETLANDS, V28, P184, DOI 10.1672/07-53.1; Anteau MJ, 2006, CAN J ZOOL, V84, P779, DOI 10.1139/Z06-047; Anteau MJ, 2009, AUK, V126, P873, DOI 10.1525/auk.2009.08193; Anteau MJ, 2009, WETLANDS, V29, P704, DOI 10.1672/08-157.1; Anteau MJ, 2004, AUK, V121, P917, DOI 10.1642/0004-8038(2004)121[0917:NROLSA]2.0.CO;2; ANTEAU MJ, 2010, HYDROBIOLOG IN PRESS; Arzel C, 2006, J ORNITHOL, V147, P167, DOI 10.1007/s10336-006-0054-8; Bartzen BA, 2010, ECOL APPL, V20, P525, DOI 10.1890/08-1650.1; Bellrose F, 1980, DUCKS GEESE SWANS N; Berthold P, 2001, AUK, V2nd; Besser JM, 2004, ENVIRON SCI TECHNOL, V38, P6210, DOI 10.1021/es049715i; Euliss NH, 2008, WETLANDS, V28, P553, DOI 10.1672/07-154.1; Euliss NH, 2006, SCI TOTAL ENVIRON, V361, P179, DOI 10.1016/j.scitotenv.2005.06.007; Euliss NH, 1999, INVERTEBRATES IN FRESHWATER WETLANDS OF NORTH AMERICA, P471; Euliss NH, 2004, WETLANDS, V24, P448, DOI 10.1672/0277-5212(2004)024[0448:TWCACF]2.0.CO;2; Gannes LZ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P1, DOI 10.1086/319315; Gleason RA, 1998, GREAT PLAINS RES, V8, P97; GLEASON RA, 2008, ECOSYSTEM SERVICES D; Goolsby DA, 2001, J ENVIRON QUAL, V30, P329, DOI 10.2134/jeq2001.302329x; Guglielmo CG, 2002, AUK, V119, P437, DOI 10.1642/0004-8038(2002)119[0437:EAISOV]2.0.CO;2; Jenni L, 1996, FUNCT ECOL, V10, P73, DOI 10.2307/2390264; Krapu GL, 2004, J WILDLIFE MANAGE, V68, P332, DOI 10.2193/0022-541X(2004)068[0332:DPOPFW]2.0.CO;2; KRULL JN, 1970, J WILDLIFE MANAGE, V34, P707, DOI 10.2307/3799135; Lyons JE, 2008, OECOLOGIA, V155, P417, DOI 10.1007/s00442-007-0921-x; Morris JD, 2002, SMALL RUMINANT RES, V43, P157, DOI 10.1016/S0921-4488(01)00266-8; Pace RM, 1999, J WILDLIFE MANAGE, V63, P389, DOI 10.2307/3802524; Palmer MA, 2009, SCIENCE, V325, P575, DOI 10.1126/science.1172976; Rabalais NN, 1996, ESTUARIES, V19, P386, DOI 10.2307/1352458; SAS Institute, 2002, SAS STAT US GUID VER, VSixth; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Seaman DAA, 2006, AUK, V123, P563, DOI 10.1642/0004-8038(2006)123[563:LPSDIR]2.0.CO;2; Strand KA, 2008, HYDROBIOLOGIA, V598, P389, DOI 10.1007/s10750-007-9178-y; THOMPSON D, 1973, J WILDLIFE MANAGE, V37, P367, DOI 10.2307/3800128; Williams TD, 1999, AUK, V116, P994, DOI 10.2307/4089679; WILSON DM, 1995, HYDROBIOLOGIA, V304, P209, DOI 10.1007/BF02329315; Zedler JB, 2003, FRONT ECOL ENVIRON, V1, P65, DOI 10.1890/1540-9295(2003)001[0065:WAYSRI]2.0.CO;2; Zimmer KD, 2001, ECOSYSTEMS, V4, P346, DOI 10.1007/s10021-001-0016-1	44	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16029	10.1371/journal.pone.0016029	http://dx.doi.org/10.1371/journal.pone.0016029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283806	Green Published, gold, Green Submitted			2022-12-25	WOS:000286520600020
J	Gao, SB; Babu, R; Lu, YL; Martinez, C; Hao, ZF; Krivanek, AF; Wang, JK; Rong, TZ; Crouch, J; Xu, YB				Gao, Shibin; Babu, Raman; Lu, Yanli; Martinez, Carlos; Hao, Zhuanfang; Krivanek, Alan F.; Wang, Jiankang; Rong, Tingzhao; Crouch, Jonathan; Xu, Yunbi			Revisiting the Hetero-Fertilization Phenomenon in Maize	PLOS ONE			English	Article							SINGLE FERTILIZATION; HETEROFERTILIZATION	Development of a seed DNA-based genotyping system for marker-assisted selection (MAS) has provided a novel opportunity for understanding aberrant reproductive phenomena such as hetero-fertilization (HF) by observing the mismatch of endosperm and leaf genotypes in monocot species. In contrast to conventional approaches using specific morphological markers, this approach can be used for any population derived from diverse parental genotypes. A large-scale experiment was implemented using seven F(2) populations and four three-way cross populations, each with 534 to 1024 individuals. The frequency of HF within these populations ranged from 0.14% to 3.12%, with an average of 1.46%. The highest frequency of HF in both types of population was contributed by the pollen gametes. Using three-way crosses allowed, for the first time, detection of the HF contributed by maternal gametes, albeit at very low frequency (0.14%-0.65%). Four HF events identified from each of two F(2) populations were tested and confirmed using 1032 single nucleotide polymorphic markers. This analysis indicated that only 50% of polymorphic markers can detect a known HF event, and thus the real HF frequency can be inferred by doubling the estimate obtained from using only one polymorphic marker. As expected, 99% of the HF events can be detected by using seven independent markers in combination. Although seed DNA-based analysis may wrongly predict plant genotypes due to the mismatch of endosperm and leaf DNA caused by HF, the relatively low HF frequencies revealed with diverse germplasm in this study indicates that the effect on the accuracy of MAS is limited. In addition, comparative endosperm and leaf DNA analysis of specific genetic stocks could be useful for revealing the relationships among various aberrant fertilization phenomena including haploidy and apomixis.	[Gao, Shibin; Lu, Yanli; Hao, Zhuanfang; Rong, Tingzhao] Sichuan Agr Univ, Maize Res Inst, Yaan, Peoples R China; [Gao, Shibin; Babu, Raman; Lu, Yanli; Martinez, Carlos; Krivanek, Alan F.; Crouch, Jonathan; Xu, Yunbi] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Mexico; [Wang, Jiankang; Xu, Yunbi] Chinese Acad Agr Sci, Natl Key Facil Crop Genet Resources & Improvement, Int Maize & Wheat Improvement Ctr CIMMYT, Inst Crop Sci, Beijing, Peoples R China	Sichuan Agricultural University; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Gao, SB (corresponding author), Sichuan Agr Univ, Maize Res Inst, Yaan, Peoples R China.	y.xu@cgiar.org			Rockefeller Foundation; Bill and Melinda Gates Foundation; Generation Challenge Programme; European Community	Rockefeller Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Generation Challenge Programme; European Community(European Commission)	This research was supported by the Rockefeller Foundation, the Bill and Melinda Gates Foundation, the Generation Challenge Programme, and the European Community. These funders provided financial support to the experiments and research related to this report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belicuas PR, 2007, EUPHYTICA, V156, P95, DOI 10.1007/s10681-007-9356-z; CHANG MT, 1989, GENOME, V32, P232, DOI 10.1139/g89-434; *CIMMYT APPL MOL G, 2003, LAB PROT, P7; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Ford RH, 2000, AM BIOL TEACH, V62, P181, DOI 10.1662/0002-7685(2000)062[0181:IOKCIC]2.0.CO;2; GAO S, 2008, MOL BREEDING, V22, P77; Guignard M.L., 1899, REV G N BOT, V11, P129; Kato A, 1999, J HERED, V90, P276, DOI 10.1093/jhered/90.2.276; Kato A, 1997, SEX PLANT REPROD, V10, P96, DOI 10.1007/s004970050073; Kato A, 2001, GENOME, V44, P1114, DOI 10.1139/gen-44-6-1114; Kiesselbach TA, 1949, RES B, V161; Kraptchev B, 2003, MAYDICA, V48, P271; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; Nawaschin S., 1898, B IMP ACAD SCI, V9, P377; ROBERTSON DS, 1984, J HERED, V75, P457, DOI 10.1093/oxfordjournals.jhered.a109985; SARKAR KR, 1971, J HERED, V62, P118, DOI 10.1093/oxfordjournals.jhered.a108136; Sprague GF, 1929, SCIENCE, V69, P526, DOI 10.1126/science.69.1794.526-a; Sprague GF, 1932, GENETICS, V17, P0358; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2	21	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16101	10.1371/journal.pone.0016101	http://dx.doi.org/10.1371/journal.pone.0016101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283522	Green Published, gold			2022-12-25	WOS:000286520600023
J	Meng, L; Hunt, C; Yaglom, JA; Gabai, VL; Sherman, MY				Meng, L.; Hunt, C.; Yaglom, J. A.; Gabai, V. L.; Sherman, M. Y.			Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis	ONCOGENE			English	Article						Hsp72; HER2; senescence; p21; survivin	NON-ONCOGENE ADDICTION; CANCER-CELLS; INDUCIBLE HEAT-SHOCK-PROTEIN-70; MOLECULAR CHAPERONES; SENESCENCE PATHWAYS; CARCINOMA-CELLS; STRESS; SUPPRESSION; PRINCIPLES; APOPTOSIS	The major heat shock protein Hsp72 is expressed at elevated levels in many human cancers and its expression correlates with tumor progression. Here, we investigated the role of Hsp72 in Her2 oncogene-induced neoplastic transformation and tumorigenesis. Expression of Her2 in untransformed MCF10A mammary epithelial cells caused transformation, as judged by foci formation in culture and tumorigenesis in xenografts. However, expression of Her2 in Hsp72-depleted cells failed to induce transformation. The anti-tumorigenic effects of Hsp72 downregulation were associated with cellular senescence because of accumulation of p21 and depletion of survivin. Accordingly, either knockdown of p21 or expression of survivin reversed this senescence process. Further, we developed an animal model of Hsp72-dependent breast cancer associated with expression of Her2. Knockout (KO) of Hsp72 almost completely suppressed tumorigenesis in the MMTVneu breast cancer mouse model. In young Hsp72 KO mice, expression of Her2 instead of mammary tissue hyperplasia led to suppression of duct development and blocked alveolar budding. These effects were due to massive cell senescence in mammary tissue, which was associated with upregulation of p21 and downregulation of survivin. Therefore, Hsp72 has an essential role in Her2-induced tumorigenesis by regulating oncogene-induced senescence pathways. Oncogene (2011) 30, 2836-2845; doi: 10.1038/onc.2011.5; published online 7 February 2011	[Meng, L.; Yaglom, J. A.; Gabai, V. L.; Sherman, M. Y.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Hunt, C.] Washington Univ, Dept Radiat Oncol, St Louis, MO USA	Boston University; Washington University (WUSTL)	Sherman, MY (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,K-323, Boston, MA 02118 USA.	gabai@bu.edu; sherma1@bu.edu	Gabai, Vladimir L/I-1650-2013	Gabai, Vladimir L/0000-0003-4505-4718; Yaglom, Julia/0000-0002-8723-3506; Sherman, Michael/0000-0003-3345-073X	National Institute of Health [CA081244]; NATIONAL CANCER INSTITUTE [R01CA081244] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institute of Health CA081244. We thank Dr B Park and Dr C Spangenberg for their kind supply of MCF10A cells and HER2-overexpressing retroviral vector.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Gabai VL, 2005, ONCOGENE, V24, P3328, DOI 10.1038/sj.onc.1208495; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Gabai VL, 2009, MOL CELL BIOL, V29, P559, DOI 10.1128/MCB.01041-08; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Muller WJ, 1996, MOL CELL BIOL, V16, P5726; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Tang DL, 2007, J IMMUNOL, V179, P1236, DOI 10.4049/jimmunol.179.2.1236; Tao Y, 2009, CARCINOGENESIS, V30, P175, DOI 10.1093/carcin/bgn256; Trost TM, 2005, CANCER RES, V65, P840; Yaglom JA, 2007, CANCER RES, V67, P2373, DOI 10.1158/0008-5472.CAN-06-3796; Zaarur N, 2006, CANCER RES, V66, P1783, DOI 10.1158/0008-5472.CAN-05-3692	28	67	69	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	25					2836	2845		10.1038/onc.2011.5	http://dx.doi.org/10.1038/onc.2011.5			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	781ZV	21297664	Green Accepted			2022-12-25	WOS:000291977800004
J	Dar, I; Yosha, G; Elfassy, R; Galron, R; Wang, ZQ; Shiloh, Y; Barzilai, A				Dar, Inbal; Yosha, Galit; Elfassy, Ronen; Galron, Ronit; Wang, Zhao-Qi; Shiloh, Yosef; Barzilai, Ari			Investigation of the Functional Link between ATM and NBS1 in the DNA Damage Response in the Mouse Cerebellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; TELANGIECTASIA-LIKE DISORDER; NIGRO-STRIATAL NEURONS; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; DEFICIENT MICE; OXIDATIVE STRESS; PURKINJE-CELLS; MRE11 COMPLEX; MUTANT MICE	Ataxia-telangiectasia (A-T) and Nijmegen breakage syndrome (NBS) are related genomic instability syndromes characterized by neurological deficits. The NBS1 protein that is defective in NBS is a component of the Mre11/RAD50/NBS1 (MRN) complex, which plays a major role in the early phase of the complex cellular response to double strand breaks (DSBs) in the DNA. Among others, Mre11/RAD50/NBS1 is required for timely activation of the protein kinase ATM (A-T, mutated), which is missing or inactivated in patients with A-T. Understanding the molecular pathology of A-T, primarily its cardinal symptom, cerebellar degeneration, requires investigation of the DSB response in cerebellar neurons, particularly Purkinje cells, which are the first to be lost in A-T patients. Cerebellar cultures derived from mice with different mutations in DNA damage response genes is a useful experimental system to study malfunctioning of the damage response in the nervous system. To clarify the interrelations between murine Nbs1 and Atm, we generated a mouse strain with specific disruption of the Nbs1 gene in the central nervous system on the background of general Atm deficiency (Nbs1-CNS-Delta//Atm(-/-)). This genotype exacerbated several features of both conditions and led to a markedly reduced life span, dramatic decline in the number of cerebellar granule neurons with considerable cerebellar disorganization, abolishment of the white matter, severe reduction in glial cell proliferation, and delayed DSB repair in cerebellar tissue. Combined loss of Nbs1 and Atm in the CNS significantly abrogated the DSB response compared with the single mutation genotypes. Importantly, the data indicate that Atm has cellular roles not regulated by Nbs1 in the murine cerebellum.	[Barzilai, Ari] Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Shiloh, Yosef] Tel Aviv Univ, Dept Human Mol Genet & Biochem, David & Inez Myers Lab Canc Genet, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Wang, Zhao-Qi] Fritz Lipmann Inst eV, Leibniz Inst Age Res, D-07745 Jena, Germany; [Wang, Zhao-Qi] Univ Jena, D-07745 Jena, Germany	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena	Barzilai, A (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, Sackler Sch Med, IL-69978 Tel Aviv, Israel.	barzilai@post.tau.ac.il			A-T Children's Project; Israel Science Foundation; U.S.-Israel Binational Science Foundation; German-Israeli Foundation; A-T Medical Research Foundation; Israel Cancer Research Fund; A-T Ease Foundation; Association for International Cancer Research, UK; Deutschen Forschungsgemeinschaft, Germany	A-T Children's Project; Israel Science Foundation(Israel Science Foundation); U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); A-T Medical Research Foundation; Israel Cancer Research Fund; A-T Ease Foundation; Association for International Cancer Research, UK; Deutschen Forschungsgemeinschaft, Germany(German Research Foundation (DFG))	This work was supported by research grants from the A-T Children's Project, the Israel Science Foundation, and the U.S.-Israel Binational Science Foundation (to A. B. and Y. S.) and by The German-Israeli Foundation (to A. B., Z.-Q. W., and Y. S.). Work in the laboratory of Y. S. was supported by research grants from the A-T Medical Research Foundation, The Israel Cancer Research Fund, and the A-T Ease Foundation.; Supported by the Association for International Cancer Research, UK, and by the Deutschen Forschungsgemeinschaft, Germany.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Adelman CA, 2009, MOL CELL BIOL, V29, P483, DOI 10.1128/MCB.01525-08; Allen DR, 2001, GENE DEV, V15, P554, DOI 10.1101/gad.869001; Assaf Y, 2008, EXP NEUROL, V209, P181, DOI 10.1016/j.expneurol.2007.09.021; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Callen E, 2009, MOL CELL, V34, P285, DOI 10.1016/j.molcel.2009.04.025; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chen P, 2003, J NEUROSCI, V23, P11453; Chiesa N, 2000, NEUROSCIENCE, V96, P575, DOI 10.1016/S0306-4522(99)00581-3; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Damjanac M, 2007, BRAIN RES, V1128, P40, DOI 10.1016/j.brainres.2006.05.050; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Delia D, 2004, HUM MOL GENET, V13, P2155, DOI 10.1093/hmg/ddh221; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Eilam R, 2003, NEUROSCIENCE, V121, P83, DOI 10.1016/S0306-4522(03)00322-1; Eilam R, 1998, P NATL ACAD SCI USA, V95, P12653, DOI 10.1073/pnas.95.21.12653; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fernet M, 2005, HUM MOL GENET, V14, P307, DOI 10.1093/hmg/ddi027; Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228; Friesner JD, 2005, MOL BIOL CELL, V16, P2566, DOI 10.1091/mbc.E04-10-0890; GALRON R, 2011, J MOL NEURO IN PRESS; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gueven N, 2006, FREE RADICAL BIO MED, V41, P992, DOI 10.1016/j.freeradbiomed.2006.06.018; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Harlow E, 1988, ANTIBODIES LABORATOR, P471; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Helt CE, 2005, J BIOL CHEM, V280, P1186, DOI 10.1074/jbc.M410873200; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Inamura N, 2000, J NEUROSCI RES, V60, P450, DOI 10.1002/(SICI)1097-4547(20000515)60:4<450::AID-JNR3>3.3.CO;2-G; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Kuljis RO, 1997, P NATL ACAD SCI USA, V94, P12688, DOI 10.1073/pnas.94.23.12688; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Lopez-Contreras AJ, 2010, DNA REPAIR, V9, P1249, DOI 10.1016/j.dnarep.2010.09.012; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lukas J, 2004, CELL, V118, P666, DOI 10.1016/j.cell.2004.09.006; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mladenov E, 2009, RADIAT RES, V171, P397, DOI 10.1667/RR1487.1; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Mount HTJ, 2004, J NEUROCHEM, V88, P1449, DOI 10.1046/j.1471-4159.2003.02278.x; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Nutley BP, 2005, BRIT J CANCER, V93, P1011, DOI 10.1038/sj.bjc.6602823; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Watters D, 1999, J BIOL CHEM, V274, P34277, DOI 10.1074/jbc.274.48.34277; Watters DJ, 2003, REDOX REP, V8, P23, DOI 10.1179/135100003125001206; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	93	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15361	15376		10.1074/jbc.M110.204172	http://dx.doi.org/10.1074/jbc.M110.204172			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21300797	Green Published, hybrid			2022-12-25	WOS:000289788300067
J	Vanhercke, T; Shrestha, P; Green, AG; Singh, SP				Vanhercke, Thomas; Shrestha, Pushkar; Green, Allan G.; Singh, Surinder P.			Mechanistic and Structural Insights into the Regioselectivity of an Acyl-CoA Fatty Acid Desaturase via Directed Molecular Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER-PROTEIN DESATURASE; FUNCTIONAL-CHARACTERIZATION; ACHETA-DOMESTICUS; CRYSTAL-STRUCTURE; HOUSE CRICKET; DELTA-12-DESATURASE; GENE; DIVERSIFICATION; IDENTIFICATION; SPECIFICITY	Membrane-bound fatty acid desaturases and related enzymes play a pivotal role in the biosynthesis of unsaturated and various unusual fatty acids. Structural insights into the remarkable catalytic diversity and wide range of substrate specificities of this class of enzymes remain limited due to the lack of a crystal structure. To investigate the structural basis of the double bond positioning (regioselectivity) of the desaturation reaction in more detail, we relied on a combination of directed evolution in vitro and a powerful yeast complementation assay to screen for Delta x regioselectivity. After two selection rounds, variants of the bifunctional Delta 12/Delta 9-desaturase from the house cricket (Acheta domesticus) exhibited increased Delta 9-desaturation activity on shorter chain fatty acids. This change in specificity was the result of as few as three mutations, some of them near the putative active site. Subsequent analysis of individual substitutions revealed an important role of residue Phe-52 in facilitating Delta 9-desaturation of shorter chain acyl substrates and allowed for the redesign of the cricket Delta 12/Delta 9-desaturase into a 16:0-specific Delta 9-desaturase. Our results demonstrate that a minimal number of mutations can have a profound impact on the regiselectivity of acyl-CoA fatty acid desaturases and include the first biochemical data supporting the acyl-CoA acyl carrier specificity of a desaturase able to carry out Delta 12-desaturation.	[Vanhercke, Thomas; Shrestha, Pushkar; Green, Allan G.; Singh, Surinder P.] CSIRO Plant Ind, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Singh, SP (corresponding author), CSIRO Plant Ind, POB 1600, Canberra, ACT 2601, Australia.	Surinder.Singh@csiro.au	Green, Allan/AAM-6856-2021; singh, surinder/C-9528-2009; Vanhercke, Thomas/B-6647-2011; Shrestha, Pushkar/A-2728-2010; Green, Allan G/C-6572-2008	singh, surinder/0000-0003-4488-8147; Vanhercke, Thomas/0000-0003-1397-7622; Shrestha, Pushkar/0000-0001-9642-6636; Green, Allan/0000-0002-3248-2089	CSIRO Office of the Chief Executive Post-doctoral Fellowship Scheme	CSIRO Office of the Chief Executive Post-doctoral Fellowship Scheme	This work was supported by the CSIRO Office of the Chief Executive Post-doctoral Fellowship Scheme.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BORGESON CE, 1990, BIOCHIM BIOPHYS ACTA, V1047, P135, DOI 10.1016/0005-2760(90)90039-Z; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Cahoon EB, 2005, EUR J LIPID SCI TECH, V107, P239, DOI 10.1002/ejlt.200590020; Cahoon EB, 1997, P NATL ACAD SCI USA, V94, P4872, DOI 10.1073/pnas.94.10.4872; CRIPPS C, 1990, ARCH BIOCHEM BIOPHYS, V278, P46, DOI 10.1016/0003-9861(90)90229-R; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Domergue F, 2005, BIOCHEM J, V389, P483, DOI 10.1042/BJ20050111; Fang S, 2009, MOL BIOL EVOL, V26, P1447, DOI 10.1093/molbev/msp057; Gagne SJ, 2009, BIOCHEMISTRY-US, V48, P12298, DOI 10.1021/bi901605d; GOSTINCAR C, 2001, J MEMBR, V233, P63; Guy JE, 2007, J BIOL CHEM, V282, P19863, DOI 10.1074/jbc.M702520200; Guy JE, 2006, P NATL ACAD SCI USA, V103, P17220, DOI 10.1073/pnas.0607165103; Hashimoto K, 2008, J LIPID RES, V49, P183, DOI 10.1194/jlr.M700377-JLR200; Hoffmann M, 2008, J BIOL CHEM, V283, P22352, DOI 10.1074/jbc.M802377200; Hoffmann M, 2007, J BIOL CHEM, V282, P26666, DOI 10.1074/jbc.M705068200; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hongsthong A, 2004, APPL MICROBIOL BIOT, V66, P74, DOI 10.1007/s00253-004-1655-x; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Libisch B, 2000, BIOCHEM BIOPH RES CO, V279, P779, DOI 10.1006/bbrc.2000.4023; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; Man WC, 2006, J BIOL CHEM, V281, P1251, DOI 10.1074/jbc.M508733200; MCDONOUGH VM, 1992, J BIOL CHEM, V267, P5931; Meesapyodsuk D, 2000, BIOCHEMISTRY-US, V39, P11948, DOI 10.1021/bi000756a; Meesapyodsuk D, 2007, J BIOL CHEM, V282, P20191, DOI 10.1074/jbc.M702196200; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Riddervold MH, 2002, INSECT BIOCHEM MOLEC, V32, P1731, DOI 10.1016/S0965-1748(02)00113-3; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Sayanova O, 2006, J BIOL CHEM, V281, P36533, DOI 10.1074/jbc.M605158200; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 2004, BIOCHEMISTRY-US, V33, P12787; Shanklin J, 2008, ADV PL BIOCH MOL BIO, V1, P29, DOI 10.1016/S1755-0408(07)01002-8; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Vanhercke T, 2005, ANAL BIOCHEM, V339, P9, DOI 10.1016/j.ab.2004.11.032; Whittle E, 2001, J BIOL CHEM, V276, P21500, DOI 10.1074/jbc.M102129200; Whittle EJ, 2008, P NATL ACAD SCI USA, V105, P14738, DOI 10.1073/pnas.0805645105; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhang S, 2007, FEBS LETT, V581, P315, DOI 10.1016/j.febslet.2006.12.031; Zhang XX, 2009, MOL BIOL REP, V36, P567, DOI 10.1007/s11033-008-9215-6; Zhou XR, 2008, INSECT MOL BIOL, V17, P667, DOI 10.1111/j.1365-2583.2008.00841.x	49	31	35	3	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12860	12869		10.1074/jbc.M110.191098	http://dx.doi.org/10.1074/jbc.M110.191098			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21300802	Green Published, hybrid			2022-12-25	WOS:000289282200006
J	Alvarez, S; Blanco, A; Fresno, M; Munoz-Fernandez, MA				Alvarez, Susana; Blanco, Almudena; Fresno, Manuel; Angeles Munoz-Fernandez, Ma			TNF-alpha Contributes to Caspase-3 Independent Apoptosis in Neuroblastoma Cells: Role of NFAT	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TRANSCRIPTION FACTOR NFAT1; ACTIVATED T-CELLS; NERVOUS-SYSTEM; UP-REGULATION; NUCLEAR FACTOR; CALCINEURIN; EXPRESSION; ASTROCYTES; DEATH	There is increasing evidence that soluble factors in inflammatory central nervous system diseases not only regulate the inflammatory process but also directly influence electrophysiological membrane properties of neurons and astrocytes. In this context, the cytokine TNF-alpha (tumor necrosis factor-alpha) has complex injury promoting, as well as protective, effects on neuronal viability. Up-regulated TNF-alpha expression has also been found in various neurodegenerative diseases such as cerebral malaria, AIDS dementia, Alzheimer's disease, multiple sclerosis, and stroke, suggesting a potential pathogenic role of TNF-alpha in these diseases as well. We used the neuroblastoma cells SK-N-MC. Transcriptional activity was measured using luciferase reporter gene assays by using lipofectin. We performed cotransfection experiments of NFAT (nuclear factor of activated T cells) promoter constructed with a dominant negative version of NFAT (dn-NFAT). Cell death was performed by MTT (3-(4,5-dimethylthiazol-2-yl) 5,5-diphenyltetrazolium bromide) and TUNEL assays. NFAT translocation was confirmed by Western blot. Involvement of NFAT in cell death was assessed by using VIVIT. P53, Fas-L, caspase-3, and caspase-9 expressions were carried out by Western blot. The mechanisms involved in TNF-alpha-induced cell death were assessed by using microarray analysis. TNF-alpha causes neuronal cell death in the absence of glia. TNF-alpha treatment results in nuclear translocation of NFAT through activation of calcineurin in a Ca2+ independent manner. We demonstrated the involvement of FasL/Fas, cytochrome c, and caspase-9 but the lack of caspase-3 activation. NB cell death was absolutely reverted in the presence of VIVIT, and partially diminished by anti-Fas treatment. These data demonstrate that TNF-alpha promotes FasL expression through NFAT activation in neuroblastoma cells and this event leads to increased apoptosis through independent caspase-3 activation.	[Alvarez, Susana; Fresno, Manuel] Univ Autonoma Madrid, Ctr Biol Mol, Consejo Super Invest Cient, E-28049 Madrid, Spain; [Blanco, Almudena; Angeles Munoz-Fernandez, Ma] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); General University Gregorio Maranon Hospital	Alvarez, S (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol, Consejo Super Invest Cient, E-28049 Madrid, Spain.	mmunoz.hgugm@madrid.salud.org		, Susana/0000-0001-8573-9370; Munoz-Fernandez/0000-0002-0813-4500; Fresno Escudero, Manuel/0000-0002-9223-5477	Fondos de Investigacion Sanitaria [INTRASALUD PI09/02029, P509102669]; Red Tematica de Investigacion Cooperativa Sanitaria ISCIII [RETIC RD06/0006/0035]; Fundacion para la Investigacion y Prevencion del SIDA en Espana, FIPSE [240800/09]; Fundacion Caja Navarra; RED RICET [RD06/0021]; Programa Nacional de Salud of Spain [SAF2005-02220]; Laboratorios del Dr. Esteve; EU, European Commission [LSH-CT-2004-005033]; Fundacion Ramon Areces; Comunidad Autonoma de Madrid [SAL/2001/2004]; FIS [CD06/00321]; Comunidad de Madrid [S-SAL-0159-2006]	Fondos de Investigacion Sanitaria(Instituto de Salud Carlos III); Red Tematica de Investigacion Cooperativa Sanitaria ISCIII; Fundacion para la Investigacion y Prevencion del SIDA en Espana, FIPSE; Fundacion Caja Navarra; RED RICET; Programa Nacional de Salud of Spain; Laboratorios del Dr. Esteve; EU, European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacion Ramon Areces; Comunidad Autonoma de Madrid(Comunidad de Madrid); FIS(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by grants from Fondos de Investigacion Sanitaria (INTRASALUD PI09/02029, P509102669) Red Tematica de Investigacion Cooperativa Sanitaria ISCIII (RETIC RD06/0006/0035), Fundacion para la Investigacion y Prevencion del SIDA en Espana, FIPSE (240800/09) and Fundacion Caja Navarra to MAM-F; from RED RICET (RD06/0021), Programa Nacional de Salud of Spain (SAF2005-02220), Laboratorios del Dr. Esteve, the 6th EU Framework Programme European Commission (Integrated project EICOSANOX, LSH-CT-2004-005033 and MAIN Network of Excellence) and the Fundacion Ramon Areces to MF; from Comunidad Autonoma de Madrid (SAL/2001/2004) to both MAM-F and MF. SA is supported by a fellowship of FIS (CD06/00321). AB is supported by a fellowship of Comunidad de Madrid S-SAL-0159-2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Assandri R, 1999, J PHYSIOL-LONDON, V516, P343, DOI 10.1111/j.1469-7793.1999.0343v.x; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; de Gregorio R, 2001, J BIOL CHEM, V276, P27003, DOI 10.1074/jbc.M100885200; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Dopp JM, 1997, J NEUROIMMUNOL, V75, P104, DOI 10.1016/S0165-5728(97)00009-X; Figiel I, 2007, BRAIN RES, V1131, P17, DOI 10.1016/j.brainres.2006.10.095; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hamawy MM, 2003, DRUG NEWS PERSPECT, V16, P277, DOI 10.1358/dnp.2003.16.5.829315; Hayashi H, 2009, J BIOL CHEM, V284, P29605, DOI 10.1074/jbc.M109.039560; Herbein G, 2008, TRENDS IMMUNOL, V29, P61, DOI 10.1016/j.it.2007.10.008; Hui KK, 2009, J CELL MOL MED; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; KINOUCHI K, 1991, BIOCHEM BIOPH RES CO, V181, P1532, DOI 10.1016/0006-291X(91)92113-X; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klettner A, 2003, BRIT J PHARMACOL, V138, P1004, DOI 10.1038/sj.bjp.0705132; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lambertsen KL, 2007, NEUROSCIENCE, V144, P934, DOI 10.1016/j.neuroscience.2006.10.046; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Pender MP, 2001, GLIA, V36, P137, DOI 10.1002/glia.1103; Pong K, 2003, CNS NEUROL DISORD-DR, V2, P349, DOI 10.2174/1568007033482652; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reese LC, 2008, AGING CELL, V7, P824, DOI 10.1111/j.1474-9726.2008.00434.x; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sama MA, 2008, J BIOL CHEM, V283, P21953, DOI 10.1074/jbc.M800148200; Sawada M, 2004, CELL DEATH DIFFER, V11, P997, DOI 10.1038/sj.cdd.4401438; SEN S, 1992, FEBS LETT, V307, P122, DOI 10.1016/0014-5793(92)80914-3; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Viviani B, 2004, TOXICOL LETT, V149, P85, DOI 10.1016/j.toxlet.2003.12.022; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189	43	64	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16100	10.1371/journal.pone.0016100	http://dx.doi.org/10.1371/journal.pone.0016100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298033	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900023
J	Gasi, D; van der Korput, HA; Douben, HC; de Klein, A; de Ridder, CM; van Weerden, WM; Trapman, J				Gasi, Delila; van der Korput, Hetty A.; Douben, Hannie C.; de Klein, Annelies; de Ridder, Corrina M.; van Weerden, Wytske M.; Trapman, Jan			Overexpression of Full-Length ETV1 Transcripts in Clinical Prostate Cancer Due to Gene Translocation	PLOS ONE			English	Article							ETS FAMILY; FUSION; HETEROGENEITY; TMPRSS2	ETV1 is overexpressed in a subset of clinical prostate cancers as a fusion transcript with many different partners. However, ETV1 can also be overexpressed as a full-length transcript. Full-length ETV1 protein functions differently from truncated ETV1 produced by fusion genes. In this study we describe the genetic background of full-length ETV1 overexpression and the biological properties of different full-length ETV1 isoforms in prostate cancer. Break-apart FISH showed in five out of six patient samples with overexpression of full-length ETV1 a genomic rearrangement of the gene, indicating frequent translocation. We were able to study the rearrangements in more detail in two tumors. In the first tumor 5'-RACE on cDNA showed linkage of the complete ETV1 transcript to the first exon of a prostate-specific two exon ncRNA gene that maps on chromosome 14 (EST14). This resulted in the expression of both full-length ETV1 transcripts and EST14-ETV1 fusion transcripts. In chromosome spreads of a xenograft derived from the second prostate cancer we observed a complex ETV1 translocation involving a chromosome 7 fragment that harbors ETV1 and fragments of chromosomes 4 and 10. Further studies revealed the overexpression of several different full-length transcripts, giving rise to four protein isoforms with different N-terminal regions. Even the shortest isoform synthesized by full-length ETV1 stimulated in vitro anchorage-independent growth of PNT2C2 prostate cells. This contrasts the lack of activity of even shorter N-truncated ETV1 produced by fusion transcripts. Our findings that in clinical prostate cancer overexpression of full-length ETV1 is due to genomic rearrangements involving different chromosomes and the identification of a shortened biologically active ETV1 isoform are highly relevant for understanding the mechanism of ETV1 function in prostate cancer.	[Gasi, Delila; van der Korput, Hetty A.; Trapman, Jan] Erasmus Univ, Dept Pathol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Douben, Hannie C.; de Klein, Annelies] Erasmus Univ, Dept Clin Genet, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [de Ridder, Corrina M.; van Weerden, Wytske M.] Erasmus Univ, Dept Urol, Med Ctr, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Gasi, D (corresponding author), Erasmus Univ, Dept Pathol, Med Ctr, POB 1738, NL-3000 DR Rotterdam, Netherlands.	j.trapman@erasmusmc.nl	Tandefelt, Delila Gasi/ABI-1558-2020	Gasi Tandefelt, Delila/0000-0002-9490-6588	European Union	European Union(European Commission)	This study was supported by a Marie Curie Grant (Cancure) provided by the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard G, 2008, BRIT J CANCER, V99, P314, DOI 10.1038/sj.bjc.6604472; Eussen BH, 2007, EUR J MED GENET, V50, P112, DOI 10.1016/j.ejmg.2006.10.006; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Hermans KG, 2006, CANCER RES, V66, P10658, DOI 10.1158/0008-5472.CAN-06-1871; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x	14	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16332	10.1371/journal.pone.0016332	http://dx.doi.org/10.1371/journal.pone.0016332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298110	Green Published, Green Submitted, gold			2022-12-25	WOS:000286662800026
J	Matsumoto, Y; Katayama, K; Okamoto, T; Yamada, K; Takashima, N; Nagao, S; Aruga, J				Matsumoto, Yoshifumi; Katayama, Kei-ichi; Okamoto, Takehito; Yamada, Kazuyuki; Takashima, Noriko; Nagao, Soichi; Aruga, Jun			Impaired Auditory-Vestibular Functions and Behavioral Abnormalities of Slitrk6-Deficient Mice	PLOS ONE			English	Article							MOUSE MODELS; EXPRESSION; SLITRK1; HEARING; BRAIN; NEUROTROPHIN-3; ASSOCIATION; RESPONSES; STRAINS	A recent study revealed that Slitrk6, a transmembrane protein containing a leucine-rich repeat domain, has a critical role in the development of the inner ear neural circuit. However, it is still unknown how the absence of Slitrk6 affects auditory and vestibular functions. In addition, the role of Slitrk6 in regions of the central nervous system, including the dorsal thalamus, has not been addressed. To understand the physiological role of Slitrk6, Slitrk6-knockout (KO) mice were subjected to systematic behavioral analyses including auditory and vestibular function tests. Compared to wild-type mice, the auditory brainstem response (ABR) of Slitrk6-KO mice indicated a mid-frequency range (8-16 kHz) hearing loss and reduction of the first ABR wave. The auditory startle response was also reduced. A vestibulo-ocular reflex (VOR) test showed decreased vertical (head movement-induced) VOR gains and normal horizontal VOR. In an open field test, locomotor activity was reduced; the tendency to be in the center region was increased, but only in the first 5 min of the test, indicating altered adaptive responses to a novel environment. Altered adaptive responses were also found in a hole-board test in which head-dip behavior was increased and advanced. Aside from these abnormalities, no clear abnormalities were noted in the mood, anxiety, learning, spatial memory, or fear memory-related behavioral tests. These results indicate that the Slitrk6-KO mouse can serve as a model of hereditary sensorineural deafness. Furthermore, the altered responses of Slitrk6-KO mice to the novel environment suggest a role of Slitrk6 in some cognitive functions.	[Matsumoto, Yoshifumi; Katayama, Kei-ichi; Takashima, Noriko; Aruga, Jun] RIKEN, BSI, Lab Behav & Dev Disorders, Wako, Saitama, Japan; [Okamoto, Takehito; Nagao, Soichi] RIKEN, BSI, Lab Motor Learning Control, Wako, Saitama, Japan; [Yamada, Kazuyuki] RIKEN, BSI, Support Unit Anim Expt, Wako, Saitama, Japan	RIKEN; RIKEN; RIKEN	Matsumoto, Y (corresponding author), RIKEN, BSI, Lab Behav & Dev Disorders, Wako, Saitama, Japan.	jaruga@brain.riken.jp	Aruga, Jun/H-5837-2011; Katayama, Kei-ichi/J-4699-2013	Aruga, Jun/0000-0001-7936-1375; Katayama, Kei-ichi/0000-0003-0527-4644	RIKEN Brain Science Institute (BSI); Japan Society for the Promotion of Science	RIKEN Brain Science Institute (BSI); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was funded by RIKEN Brain Science Institute (BSI) and supported by the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Alitto HJ, 2003, CURR OPIN NEUROBIOL, V13, P440, DOI 10.1016/S0959-4388(03)00096-5; Aruga J, 2003, GENE EXPR PATTERNS, V3, P727, DOI 10.1016/S1567-133X(03)00141-8; Aruga J, 2003, GENE, V315, P87, DOI 10.1016/S0378-1119(03)00715-7; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Bonsch D, 2009, HNO, V57, P371, DOI 10.1007/s00106-008-1832-9; BUTLER AB, 1995, BRAIN BEHAV EVOLUT, V46, P209, DOI 10.1159/000113275; Calabrese DR, 2006, JARO-J ASSOC RES OTO, V7, P151, DOI 10.1007/s10162-006-0031-1; Carnicero E, 2002, NEUROSCI LETT, V321, P149, DOI 10.1016/S0304-3940(01)02501-0; Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf; Hardisty-Hughes RE, 2010, NAT PROTOC, V5, P177, DOI 10.1038/nprot.2009.204; Harrod CG, 2003, BRAIN RES, V972, P75, DOI 10.1016/S0006-8993(03)02505-8; JASTREBOFF PJ, 1979, BIOL CYBERN, V33, P113, DOI 10.1007/BF00355259; Katayama K, 2010, MOL PSYCHIATR, V15, P177, DOI 10.1038/mp.2008.97; Katayama K, 2009, PLOS ONE, V4, pA151, DOI 10.1371/journal.pone.0007786; Katoh A, 1998, P NATL ACAD SCI USA, V95, P7705, DOI 10.1073/pnas.95.13.7705; Korres SG, 2007, MED SCI MONITOR, V13, pCR275; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Miranda DM, 2009, AM J MED GENET B, V150B, P483, DOI 10.1002/ajmg.b.30840; Noushi F, 2005, OTOL NEUROTOL, V26, P528, DOI 10.1097/01.mao.0000169780.84588.a5; Nunez A, 2007, ADV ANAT EMBRYOL CEL, V187, P1; OREILLY RC, OTOL NEUROT IN PRESS; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; PITON A, MOL PSYCHIA IN PRESS; Sakatani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008309; Salvinelli F, 2004, Clin Ter, V155, P395; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Staecker H, 1996, NEUROREPORT, V7, P889, DOI 10.1097/00001756-199603220-00011; Stillman AA, 2009, J COMP NEUROL, V513, P21, DOI 10.1002/cne.21919; Wiener-Vacher SR, 2008, INT J AUDIOL, V47, P578, DOI 10.1080/14992020802334358; Willott James F, 2006, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0821bs34; Zhou XM, 2006, BRAIN RES, V1091, P16, DOI 10.1016/j.brainres.2006.01.107; Zuchner S, 2006, MOL PSYCHIATR, V11, P888, DOI 10.1038/sj.mp.4001865	35	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16497	10.1371/journal.pone.0016497	http://dx.doi.org/10.1371/journal.pone.0016497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298075	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800048
J	Richardson, BD; Ling, LL; Uteshev, VV; Caspary, DM				Richardson, Ben D.; Ling, Lynne L.; Uteshev, Victor V.; Caspary, Donald M.			Extrasynaptic GABA(A) Receptors and Tonic Inhibition in Rat Auditory Thalamus	PLOS ONE			English	Article							MEDIAL GENICULATE-BODY; INFERIOR COLLICULUS; DENTATE GYRUS; NEURONS; PROJECTIONS; SUBUNITS; BINDING; BRAIN; AUTORADIOGRAPHY; AGONISTS	Background: Neural inhibition plays an important role in auditory processing and attentional gating. Extrasynaptic GABA(A) receptors (GABA(A)R), containing alpha(4)and delta GABA(A)R subunits, are thought to be activated by GABA spillover outside of the synapse following release resulting in a tonic inhibitory Cl- current which could account for up to 90% of total inhibition in visual and somatosensory thalamus. However, the presence of this unique type of inhibition has not been identified in auditory thalamus. Methodology/Principal Findings: The present study used gaboxadol, a partially selective potent agonist for delta-subunit containing GABA(A) receptor constructs to elucidate the presence of extrasynaptic GABA(A)Rs using both a quantitative receptor binding assay and patch-clamp electrophysiology in thalamic brain slices. Intense [H-3]gaboxadol binding was found to be localized to the MGB while whole cell recordings from MGB neurons in the presence of gaboxadol demonstrated the expression of delta-subunit containing GABA(A)Rs capable of mediating a tonic inhibitory Cl- current. Conclusions/Significance: Potent tonic inhibitory GABA(A)R responses mediated by extrasynaptic receptors may be important in understanding how acoustic information is processed by auditory thalamic neurons as it ascends to auditory cortex. In addition to affecting cellular behavior and possibly neurotransmission, functional extrasynaptic delta-subunit containing GABA(A)Rs may represent a novel pharmacological target for the treatment of auditory pathologies including temporal processing disorders or tinnitus.	[Richardson, Ben D.; Ling, Lynne L.; Uteshev, Victor V.; Caspary, Donald M.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University	Richardson, BD (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	dcaspary@siumed.edu	Richardson, Ben/GNP-5689-2022; Richardson, Ben/B-2922-2012	Richardson, Ben/0000-0003-0403-4956; 	NIH [DC008532, DC00151]; Merck & Co., Inc. (Rahway, NJ); Merck; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008532, R01DC000151, R56DC000151] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck & Co., Inc. (Rahway, NJ)(Merck & Company); Merck(Merck & Company); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH DC008532 and DC00151 as well as Merck & Co., Inc. (Rahway, NJ). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The binding aspect of the present study results from a research grant from Merck to study gaboxadol as a possible treatment for an auditory disorder and does not alter our adherence to all of the PLoS ONE policies on sharing data and materials. Merck has since dropped any interests in or rights to this drug. There are no proprietary restrictions of any kind on the dissemination of information regarding the findings from these studies. Merck provided the tritiated gaboxadol as part of the grant. None of the authors have any contractual relationship with Merck.	Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Bartlett EL, 2007, J NEUROPHYSIOL, V97, P1005, DOI 10.1152/jn.00593.2006; Bartlett EL, 1999, J NEUROPHYSIOL, V81, P1999, DOI 10.1152/jn.1999.81.5.1999; Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Caspary DM, 2008, J EXP BIOL, V211, P1781, DOI 10.1242/jeb.013581; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Clerici WJ, 1998, J COMP NEUROL, V399, P110, DOI 10.1002/(SICI)1096-9861(19980914)399:1<110::AID-CNE9>3.0.CO;2-4; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Cotillon-Williams N, 2008, J NEUROPHYSIOL, V99, P1137, DOI 10.1152/jn.01159.2007; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Friemel A, 2007, BRAIN RES, V1170, P39, DOI 10.1016/j.brainres.2007.07.031; Herd MB, 2009, EUR J NEUROSCI, V29, P1177, DOI 10.1111/j.1460-9568.2009.06680.x; Hu B, 2003, EXP BRAIN RES, V153, P543, DOI 10.1007/s00221-003-1611-5; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; MILBRANDT JC, 1995, NEUROSCIENCE, V67, P713, DOI 10.1016/0306-4522(95)00082-T; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; PAN HS, 1983, J NEUROSCI, V3, P1189; Paxinos W.C., 1998, RAT BRAIN STEREOTAXI; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; Peruzzi D, 1997, J NEUROSCI, V17, P3766; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; ROUILLER EM, 1985, NEUROSCI LETT, V53, P227, DOI 10.1016/0304-3940(85)90190-9; Storustovu SI, 2006, J PHARMACOL EXP THER, V316, P1351, DOI 10.1124/jpet.105.092403; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Winer JA, 1996, P NATL ACAD SCI USA, V93, P3083, DOI 10.1073/pnas.93.7.3083; Winer JA, 1996, P NATL ACAD SCI USA, V93, P8005, DOI 10.1073/pnas.93.15.8005; Winer JA, 1999, HEARING RES, V130, P42, DOI 10.1016/S0378-5955(98)00217-2; WISDEN W, 1992, J NEUROSCI, V12, P1040; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373	36	38	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16508	10.1371/journal.pone.0016508	http://dx.doi.org/10.1371/journal.pone.0016508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298071	Green Published, Green Submitted, gold			2022-12-25	WOS:000286662800052
J	Hibbert, B; Ma, XL; Pourdjabbar, A; Simard, T; Rayner, K; Sun, JF; Chen, YX; Filion, L; O'Brien, ER				Hibbert, Benjamin; Ma, Xiaoli; Pourdjabbar, Ali; Simard, Trevor; Rayner, Katey; Sun, Jiangfeng; Chen, Yong-Xiang; Filion, Lionel; O'Brien, Edward R.			Pre-Procedural Atorvastatin Mobilizes Endothelial Progenitor Cells: Clues to the Salutary Effects of Statins on Healing of Stented Human Arteries	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; RE-ENDOTHELIALIZATION; INCREASE; THERAPY; DISEASE; NUMBER; NEOVASCULARIZATION; OUTCOMES; REPAIR	Objectives: Recent clinical trials suggest an LDL-independent superiority of intensive statin therapy in reducing target vessel revascularization and peri-procedural myocardial infarctions in patients who undergo percutaneous coronary interventions (PCI). While animal studies demonstrate that statins mobilize endothelial progenitor cells (EPCs) which can enhance arterial repair and attenuate neointimal formation, the precise explanation for the clinical PCI benefits of high dose statin therapy remain elusive. Thus we serially assessed patients undergoing PCI to test the hypothesis that high dose Atorvastatin therapy initiated prior to PCI mobilizes EPCs that may be capable of enhancing arterial repair. Methods and Results: Statin naive male patients undergoing angiography for stent placement were randomized to standard therapy without Atorvastatin (n = 10) or treatment with Atorvastatin 80 mg (n = 10) beginning three days prior to stent implantation. EPCs were defined by flow cytometry (e.g., surface marker profile of CD45dim/34+/133+/117+). As well, we also enumerated cultured angiogenic cells (CACs) by standard in vitro culture assay. While EPC levels did not fluctuate over time for the patients free of Atorvastatin, there was a 3.5-fold increase in EPC levels with high dose Atorvastatin beginning within 3 days of the first dose (and immediately pre-PCI) which persisted at 4 and 24 hours post-PCI (p < 0.05). There was a similar rise in CAC levels as assessed by in vitro culture. CACs cultured in the presence of Atorvastatin failed to show augmented survival or VEGF secretion but displayed a 2-fold increase in adhesion to stent struts (p < 0.05). Conclusions: High dose Atorvastatin therapy pre-PCI improves EPC number and CAC number and function in humans which may in part explain the benefit in clinical outcomes seen in patients undergoing coronary interventions.	[Hibbert, Benjamin; Ma, Xiaoli; Pourdjabbar, Ali; Simard, Trevor; Rayner, Katey; Sun, Jiangfeng; Chen, Yong-Xiang; O'Brien, Edward R.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Filion, Lionel] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa	Hibbert, B (corresponding author), Univ Ottawa, Inst Heart, Ottawa, ON, Canada.	eobrien@ottawaheart.ca	O'Brien, Edward R/J-6621-2013; Rayner, Katey/K-8914-2012	O'Brien, Edward R/0000-0003-1039-9425; Rayner, Katey/0000-0001-6230-426X	Pfizer Canada; University of Ottawa Heart Institute Interventional Cardiology Group	Pfizer Canada(Pfizer); University of Ottawa Heart Institute Interventional Cardiology Group	This work was supported by grants from Pfizer Canada and The University of Ottawa Heart Institute Interventional Cardiology Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C; Banerjee S, 2006, ATHEROSCLEROSIS, V189, P70, DOI 10.1016/j.atherosclerosis.2006.04.026; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Di Sciascio G, 2009, J AM COLL CARDIOL, V54, P558, DOI 10.1016/j.jacc.2009.05.028; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152; Egan CG, 2009, THROMB HAEMOSTASIS, V101, P1138, DOI 10.1160/TH08-11-0723; Fadini GP, 2008, ATHEROSCLEROSIS, V197, P496, DOI 10.1016/j.atherosclerosis.2007.12.039; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db; Gibson CM, 2009, J AM COLL CARDIOL, V54, P2290, DOI 10.1016/j.jacc.2009.09.010; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hibbert B, 2004, AM J PHYSIOL-HEART C, V287, pH518, DOI 10.1152/ajpheart.00002.2004; Hibbert B, 2003, TRENDS CARDIOVAS MED, V13, P322, DOI 10.1016/j.tcm.2003.09.002; Hibbert B, 2009, CARDIOVASC RES, V83, P16, DOI 10.1093/cvr/cvp156; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hristov M, 2007, ATHEROSCLEROSIS, V192, P413, DOI 10.1016/j.atherosclerosis.2006.05.031; Inoue T, 2007, CIRCULATION, V115, P553, DOI 10.1161/CIRCULATIONAHA.106.621714; Kong DL, 2004, CIRCULATION, V110, P2039, DOI 10.1161/01.CIR.0000143161.01901.BD; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Ma XL, 2010, CARDIOVASC RES, V86, P338, DOI 10.1093/cvr/cvq047; Ma XL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001894; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mills NL, 2009, HEART, V95, P2003, DOI 10.1136/hrt.2008.163162; Padfield GJ, 2010, J AM COLL CARDIOL, V55, P1553, DOI 10.1016/j.jacc.2009.10.070; Pasceri V, 2004, CIRCULATION, V110, P674, DOI 10.1161/01.CIR.0000137828.06205.87; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; Schmidt-Lucke C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013790; Schroeter MR, 2009, ATHEROSCLEROSIS, V205, P63, DOI 10.1016/j.atherosclerosis.2008.11.013; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; Sutherland D R, 1996, J Hematother, V5, P213, DOI 10.1089/scd.1.1996.5.213; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wang CH, 2006, J MOL CELL CARDIOL, V41, P34, DOI 10.1016/j.yjmcc.2006.03.006; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Werner C, 2007, DIABETES, V56, P2609, DOI 10.2337/db07-0069; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081; Zentilin L, 2006, BLOOD, V107, P3546, DOI 10.1182/blood-2005-08-3215	40	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16413	10.1371/journal.pone.0016413	http://dx.doi.org/10.1371/journal.pone.0016413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283543	Green Published, Green Submitted, gold			2022-12-25	WOS:000286661400048
J	Teissier, E; Zandomeneghi, G; Loquet, A; Lavillette, D; Lavergne, JP; Montserret, R; Cosset, FL; Bockmann, A; Meier, BH; Penin, F; Pecheur, EI				Teissier, Elodie; Zandomeneghi, Giorgia; Loquet, Antoine; Lavillette, Dimitri; Lavergne, Jean-Pierre; Montserret, Roland; Cosset, Francois-Loic; Boeckmann, Anja; Meier, Beat H.; Penin, Francois; Pecheur, Eve-Isabelle			Mechanism of Inhibition of Enveloped Virus Membrane Fusion by the Antiviral Drug Arbidol	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; MICELLE-BOUND PEPTIDES; TRYPTOPHAN-RICH MOTIF; STATE PROTON-TRANSFER; PHOSPHOLIPID BICELLES; ANTIOXIDANT ACTIVITY; MODEL MEMBRANES; IN-VITRO; B-VIRUS; PROTEIN	The broad-spectrum antiviral arbidol (Arb) inhibits cell entry of enveloped viruses by blocking viral fusion with host cell membrane. To better understand Arb mechanism of action, we investigated its interactions with phospholipids and membrane peptides. We demonstrate that Arb associates with phospholipids in the micromolar range. NMR reveals that Arb interacts with the polar head-group of phospholipid at the membrane interface. Fluorescence studies of interactions between Arb and either tryptophan derivatives or membrane peptides reconstituted into liposomes show that Arb interacts with tryptophan in the micromolar range. Interestingly, apparent binding affinities between lipids and tryptophan residues are comparable with those of Arb IC50 of the hepatitis C virus (HCV) membrane fusion. Since tryptophan residues of membrane proteins are known to bind preferentially at the membrane interface, these data suggest that Arb could increase the strength of virus glycoprotein's interactions with the membrane, due to a dual binding mode involving aromatic residues and phospholipids. The resulting complexation would inhibit the expected viral glycoprotein conformational changes required during the fusion process. Our findings pave the way towards the design of new drugs exhibiting Arb-like interfacial membrane binding properties to inhibit early steps of virus entry, i.e., attractive targets to combat viral infection.	[Teissier, Elodie; Loquet, Antoine; Lavergne, Jean-Pierre; Montserret, Roland; Boeckmann, Anja; Penin, Francois; Pecheur, Eve-Isabelle] Univ Lyon, Inst Biol & Chim Prot, UMR 5086, CNRS,BioSci Gerland Lyon Sud IFR128, Lyon, France; [Zandomeneghi, Giorgia; Meier, Beat H.] ETH, Zurich, Switzerland; [Lavillette, Dimitri; Cosset, Francois-Loic] Univ Lyon, UCB Lyon1, IFR128, Lyon, France; [Lavillette, Dimitri; Cosset, Francois-Loic] INSERM, U758, F-69008 Lyon, France; [Lavillette, Dimitri; Cosset, Francois-Loic] Ecole Normale Super Lyon, F-69364 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Swiss Federal Institutes of Technology Domain; ETH Zurich; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON)	Teissier, E (corresponding author), Univ Lyon, Inst Biol & Chim Prot, UMR 5086, CNRS,BioSci Gerland Lyon Sud IFR128, Lyon, France.	f.penin@ibcp.fr; e.pecheur@ibcp.fr	Böckmann, Anja/AAW-6276-2021; Meier, Beat H/K-4066-2016; Cosset, François-Loïc/M-5862-2019; Zandomeneghi, Giorgia/J-8124-2016; Loquet, Antoine/A-1465-2010	Böckmann, Anja/0000-0001-8149-7941; Meier, Beat H/0000-0002-9107-4464; Cosset, François-Loïc/0000-0001-8842-3726; Zandomeneghi, Giorgia/0000-0001-9452-8751; Loquet, Antoine/0000-0001-7176-7813; Pecheur, Eve/0000-0002-8613-862X; Lavillette, Dimitri/0000-0002-4706-1519	ANRS; European Research Council [ERC-2008-AdG-233130-HEPCENT]	ANRS(ANRSFrench National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission)	Funding was provided by ANRS to E-IP and FP (www.anrs.fr) and European Research Council (ERC-2008-AdG-233130-HEPCENT) to F-LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed-Belkacem A, 2010, GASTROENTEROLOGY, V138, P1112, DOI 10.1053/j.gastro.2009.11.053; Angelova MI, 1999, EUR BIOPHYS J BIOPHY, V28, P142, DOI 10.1007/s002490050193; BERTINI I, 1996, COOR CHEM REV; Besenicar M, 2006, CHEM PHYS LIPIDS, V141, P169, DOI 10.1016/j.chemphyslip.2006.02.010; Boriskin YS, 2008, CURR MED CHEM, V15, P997, DOI 10.2174/092986708784049658; Boriskin YS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-56; Bowles MR, 1997, ANAL BIOCHEM, V244, P133, DOI 10.1006/abio.1996.9888; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Broer R, 2006, J VIROL, V80, P1302, DOI 10.1128/JVI.80.3.1302-1310.2006; Brooks MJ, 2004, CURR OPIN PULM MED, V10, P197, DOI 10.1097/00063198-200405000-00009; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Chai HF, 2006, BIOORGAN MED CHEM, V14, P911, DOI 10.1016/j.bmc.2005.08.041; Chaudhuri S, 2008, LUMINESCENCE, V23, P397, DOI 10.1002/bio.1052; Chaudhuri S, 2009, BIOPHYS CHEM, V139, P29, DOI 10.1016/j.bpc.2008.09.018; Chew CF, 2008, BIOPHYS J, V95, P5627, DOI 10.1529/biophysj.108.139477; Chou JJ, 2002, J AM CHEM SOC, V124, P2450, DOI 10.1021/ja017875d; Claessens MMAE, 2007, LANGMUIR, V23, P6315, DOI 10.1021/la0637622; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; de Foresta B, 1999, BIOPHYS J, V77, P3071, DOI 10.1016/S0006-3495(99)77138-9; Drummer HE, 2007, J GEN VIROL, V88, P1144, DOI 10.1099/vir.0.82567-0; Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; Granseth E, 2005, J MOL BIOL, V346, P377, DOI 10.1016/j.jmb.2004.11.036; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647; Harrison SC, 2008, J CELL BIOL, V183, P177, DOI 10.1083/jcb.200809175; HINMAN RL, 1964, J AM CHEM SOC, V86, P3796, DOI 10.1021/ja01072a040; Kliger Y, 2000, J MOL BIOL, V301, P905, DOI 10.1006/jmbi.2000.4004; Kobayashi M, 2006, J VIROL, V80, P1817, DOI 10.1128/JVI.80.4.1817-1825.2006; Komla-Soukha I, 2006, J VIROL, V80, P4648, DOI 10.1128/JVI.80.10.4648-4655.2006; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Leneva IA, 2009, ANTIVIR RES, V81, P132, DOI 10.1016/j.antiviral.2008.10.009; Marcellin P, 2009, LIVER INT, V29, P1, DOI 10.1111/j.1478-3231.2008.01947.x; Meanwell NA, 2006, CURR OPIN INVEST DR, V7, P727; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; MONTSERRET R, 2010, J BIOL CHEM; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Pecheur EI, 2007, BIOCHEMISTRY-US, V46, P6050, DOI 10.1021/bi700181j; Perez-Berna AJ, 2006, BIOCHEMISTRY-US, V45, P3755, DOI 10.1021/bi0523963; Perrault M, 2009, BIOCHEM J, V423, P303, DOI 10.1042/BJ20091000; Petersen FNR, 2005, BIOPHYS J, V89, P3985, DOI 10.1529/biophysj.105.061804; Pietschmann T, 2009, NATURE, V457, P797, DOI 10.1038/457797a; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Polyak SJ, 2010, P NATL ACAD SCI USA, V107, P5995, DOI 10.1073/pnas.0914009107; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; SANDERS CR, 1994, PROG NUCL MAG RES SP, V26, P421, DOI 10.1016/0079-6565(94)80012-X; Sapay N, 2006, BIOCHEMISTRY-US, V45, P2221, DOI 10.1021/bi0517685; Sapir A, 2008, DEV CELL, V14, P11, DOI 10.1016/j.devcel.2007.12.008; Schrofelbauer B, 2009, BIOCHEM J, V421, P473, DOI 10.1042/BJ20082416; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sellitto G, 2010, BIOORGAN MED CHEM, V18, P6143, DOI 10.1016/j.bmc.2010.06.058; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; van Beek JD, 2007, J MAGN RESON, V187, P19, DOI 10.1016/j.jmr.2007.03.017; Villalain J, 2010, J PHYS CHEM B, V114, P8544, DOI 10.1021/jp102619w; Vold RR, 1997, J BIOMOL NMR, V9, P329, DOI 10.1023/A:1018643312309; von Hahn T, 2008, J BIOL CHEM, V283, P3689, DOI 10.1074/jbc.R700024200; Wagoner J, 2010, HEPATOLOGY, V51, P1912, DOI 10.1002/hep.23587; Yang Jian-Ping, 2009, V510, P295, DOI 10.1007/978-1-59745-394-3_22; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8; Zandomeneghi G, 2003, J BIOMOL NMR, V25, P125, DOI 10.1023/A:1022244025351; Zangger K, 2009, J PHYS CHEM B, V113, P4400, DOI 10.1021/jp808501x	69	94	106	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15874	10.1371/journal.pone.0015874	http://dx.doi.org/10.1371/journal.pone.0015874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283579	Green Published, Green Submitted, gold			2022-12-25	WOS:000286661400016
J	Gu, W; Yang, JK; Lou, ZY; Liang, LM; Sun, YN; Huang, JW; Li, XM; Cao, Y; Meng, ZH; Zhang, KQ				Gu, Wen; Yang, Jinkui; Lou, Zhiyong; Liang, Lianming; Sun, Yuna; Huang, Jingwen; Li, Xuemei; Cao, Yi; Meng, Zhaohui; Zhang, Ke-Qin			Structural Basis of Enzymatic Activity for the Ferulic Acid Decarboxylase (FADase) from Enterobacter sp Px6-4	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRANSCRIPTIONAL ANALYSIS; GENE CLONING; PURIFICATION; 4-VINYLGUAIACOL; TRANSFORMATIONS; DEGRADATION; METABOLISM; EXPRESSION; VANILLIN	Microbial ferulic acid decarboxylase (FADase) catalyzes the transformation of ferulic acid to 4-hydroxy-3-methoxystyrene (4-vinylguaiacol) via non-oxidative decarboxylation. Here we report the crystal structures of the Enterobacter sp. Px6-4 FADase and the enzyme in complex with substrate analogues. Our analyses revealed that FADase possessed a half-opened bottom beta-barrel with the catalytic pocket located between the middle of the core beta-barrel and the helical bottom. Its structure shared a high degree of similarity with members of the phenolic acid decarboxylase (PAD) superfamily. Structural analysis revealed that FADase catalyzed reactions by an "open-closed'' mechanism involving a pocket of 868615 angstrom dimension on the surface of the enzyme. The active pocket could directly contact the solvent and allow the substrate to enter when induced by substrate analogues. Site-directed mutagenesis showed that the E134A mutation decreased the enzyme activity by more than 60%, and Y21A and Y27A mutations abolished the enzyme activity completely. The combined structural and mutagenesis results suggest that during decarboxylation of ferulic acid by FADase, Trp25 and Tyr27 are required for the entering and proper orientation of the substrate while Glu134 and Asn23 participate in proton transfer.	[Gu, Wen; Yang, Jinkui; Liang, Lianming; Huang, Jingwen; Cao, Yi; Meng, Zhaohui; Zhang, Ke-Qin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Key Lab Microbial Resources, Minist Educ, Kunming 650091, Peoples R China; [Lou, Zhiyong] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Sun, Yuna] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100080, Peoples R China; [Li, Xuemei] Yunnan Acad Tobacco Sci, Kunming, Peoples R China; [Cao, Yi] Guizhou Tobacco Res Inst, Guiyang, Peoples R China; [Meng, Zhaohui] Kunming Med Coll, Affiliated Hosp 1, Dept Cardiol, Mol Cardiol Lab, Kunming, Peoples R China	Yunnan University; Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; China National Tobacco Corporation; China National Tobacco Corporation; Kunming Medical University	Gu, W (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Key Lab Microbial Resources, Minist Educ, Kunming 650091, Peoples R China.	zhhmeng@yahoo.cn; kqzhang111@yahoo.com.cn	Liang, Lian-Ming/AAL-3861-2021; zhang, ke/AAH-8217-2019	Yang, Jinkui/0000-0002-3106-2189	National Basic Research Program of China [2007CB411600]; National Natural Science Foundation of China [31060012]; Department of Science and Technology of Yunnan Province [2007C170M, 2007C0001R, 2006C0071M, 2009CI052]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province	This work was supported by the National Basic Research Program of China (approved no. 2007CB411600), the National Natural Science Foundation of China (approved no. 31060012), and by projects from the Department of Science and Technology of Yunnan Province (approved no. 2007C170M, 2007C0001R, 2006C0071M and 2009CI052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARFMANN HA, 1989, Z NATURFORSCH C, V44, P765; Barthelmebs L, 2001, APPL ENVIRON MICROB, V67, P1063, DOI 10.1128/AEM.67.3.1063-1069.2001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cavin JF, 1998, APPL ENVIRON MICROB, V64, P1466; Cavin JF, 1997, APPL ENVIRON MICROB, V63, P1939, DOI 10.1128/AEM.63.5.1939-1944.1997; Cavin JF, 1997, FEMS MICROBIOL LETT, V147, P291, DOI 10.1016/S0378-1097(97)00004-9; Cendron L, 2007, J BIOL CHEM, V282, P18182, DOI 10.1074/jbc.M701297200; DEGRASSI G, 1995, APPL ENVIRON MICROB, V61, P326, DOI 10.1128/AEM.61.1.326-332.1995; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HARTLEY RD, 1989, ACS SYM SER, V399, P137; Huang Z, 1994, J BIOL CHEM, V268, P23594; HUANG ZX, 1993, APPL ENVIRON MICROB, V59, P2244, DOI 10.1128/AEM.59.7.2244-2250.1993; Jurgen R, 1991, US Patent, Patent No. 5017388; Karmakar B, 2000, J BIOTECHNOL, V80, P195, DOI 10.1016/S0168-1656(00)00248-0; LABUDA I, 1992, Patent No. 512825; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li XM, 2008, PROCESS BIOCHEM, V43, P1132, DOI 10.1016/j.procbio.2008.06.006; Lomascolo A, 1999, TRENDS BIOTECHNOL, V17, P282, DOI 10.1016/S0167-7799(99)01313-X; Mathew S, 2006, CRIT REV MICROBIOL, V32, P115, DOI 10.1080/10408410600709628; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muheim A, 1999, APPL MICROBIOL BIOT, V51, P456, DOI 10.1007/s002530051416; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAZARETH S, 1986, CAN J MICROBIOL, V32, P494, DOI 10.1139/m86-090; Nelson DL, 2004, LEHNINGER PRINCIPLES, P190; Nelson DL, 2004, LEHNINGER PRINCIPLES, P75; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Priefert H, 2001, APPL MICROBIOL BIOT, V56, P296, DOI 10.1007/s002530100687; Prim N, 2001, CURR MICROBIOL, V42, P237, DOI 10.1007/s002840010210; RAHOUTI M, 1989, APPL ENVIRON MICROB, V55, P2391, DOI 10.1128/AEM.55.9.2391-2398.1989; Rao FV, 2005, CHEM BIOL, V12, P973, DOI 10.1016/j.chembiol.2005.07.009; Rodriguez H, 2010, PROTEINS, V78, P1662, DOI 10.1002/prot.22684; Rosazza JPN, 1995, J IND MICROBIOL, V15, P457, DOI 10.1007/BF01570016; Walton NJ, 2003, PHYTOCHEMISTRY, V63, P505, DOI 10.1016/S0031-9422(03)00149-3; Walton NJ, 2000, CURR OPIN BIOTECH, V11, P490, DOI 10.1016/S0958-1669(00)00125-7; Washisu S., 1993, Patent Application, Patent No. [5227980, JP5227980]; Yang JK, 2005, BIOTECHNOL LETT, V27, P1123, DOI 10.1007/s10529-005-8461-0; Yoshimoto T., 1990, Japanese Patent, Patent No. [2195871, 2(195) 871]; ZAGO A, 1995, APPL ENVIRON MICROB, V61, P4484, DOI 10.1128/AEM.61.12.4484-4486.1995	40	41	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16262	10.1371/journal.pone.0016262	http://dx.doi.org/10.1371/journal.pone.0016262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283705	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522300024
J	McClatchy, DB; Liao, LJ; Park, SK; Xu, T; Lu, BW; Yates, JR				McClatchy, Daniel B.; Liao, Lujian; Park, Sung Kyu; Xu, Tao; Lu, Bingwen; Yates, John R., III			Differential Proteomic Analysis of Mammalian Tissues Using SILAM	PLOS ONE			English	Article							SCALE PHOSPHORYLATION ANALYSIS; SITE-SPECIFIC PHOSPHORYLATION; TANDEM MASS-SPECTRA; PROTEIN-KINASE CK2; QUANTITATIVE-ANALYSIS; PHOSPHOPROTEOMIC ANALYSIS; NUCLEAR PHOSPHOPROTEINS; DROSOPHILA-MELANOGASTER; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION	Differential expression of proteins between tissues underlies organ-specific functions. Under certain pathological conditions, this may also lead to tissue vulnerability. Furthermore, post-translational modifications exist between different cell types and pathological conditions. We employed SILAM (Stable Isotope Labeling in Mammals) combined with mass spectrometry to quantify the proteome between mammalian tissues. Using (15)N labeled rat tissue, we quantified 3742 phosphorylated peptides in nuclear extracts from liver and brain tissue. Analysis of the phosphorylation sites revealed tissue specific kinase motifs. Although these tissues are quite different in their composition and function, more than 500 protein identifications were common to both tissues. Specifically, we identified an up-regulation in the brain of the phosphoprotein, ZFHX1B, in which a genetic deletion causes the neurological disorder Mowat-Wilson syndrome. Finally, pathway analysis revealed distinct nuclear pathways enriched in each tissue. Our findings provide a valuable resource as a starting point for further understanding of tissue specific gene regulation and demonstrate SILAM as a useful strategy for the differential proteomic analysis of mammalian tissues.	[McClatchy, Daniel B.; Liao, Lujian; Park, Sung Kyu; Xu, Tao; Lu, Bingwen; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute	McClatchy, DB (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	jyates@scripps.edu	Xu, Tao/A-9353-2009		National Institutes of Health [5R01 MH067880-08, P41 RR11823-14]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to acknowledge financial support from the National Institutes of Health grants 5R01 MH067880-08 and P41 RR11823-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAMEDINA J, BIOGERONTOLOGY, V11, P703; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Arnold SE, 2005, PROG BRAIN RES, V147, P319, DOI 10.1016/S0079-6123(04)47023-X; Arnsten AFT, 2005, TRENDS MOL MED, V11, P121, DOI 10.1016/j.molmed.2005.01.006; Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BENBROOK DM, 1990, ONCOGENE, V5, P295; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cantin GT, 2006, J PROTEOME RES, V5, P127, DOI 10.1021/pr050270m; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen KD, 1997, EUR J BIOCHEM, V248, P120, DOI 10.1111/j.1432-1033.1997.t01-1-00120.x; Collin L, 2008, BIOL CELL, V100, P243, DOI 10.1042/BC20070123; Conrads TP, 2001, ANAL CHEM, V73, P2132, DOI 10.1021/ac001487x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Goodlett DR, 2001, RAPID COMMUN MASS SP, V15, P1214, DOI 10.1002/rcm.362; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Haydon CE, 2003, MOL CELL PROTEOMICS, V2, P1055, DOI 10.1074/mcp.M300054-MCP200; HSU JC, 1991, P NATL ACAD SCI USA, V88, P3511, DOI 10.1073/pnas.88.9.3511; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; KREK W, 1992, J CELL BIOL, V116, P43, DOI 10.1083/jcb.116.1.43; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; LEE VMY, 1987, J NEUROSCI, V7, P3474; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Liao LJ, 2008, J PROTEOME RES, V7, P4743, DOI 10.1021/pr8003198; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Lu BW, 2007, ANAL CHEM, V79, P1301, DOI 10.1021/ac061334v; MacCoss MJ, 2005, ANAL CHEM, V77, p295A; MacCoss MJ, 2003, ANAL CHEM, V75, P6912, DOI 10.1021/ac034790h; MATSUDA S, 1991, J BIOL CHEM, V266, P18188; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McClatchy DB, 2007, GENOME RES, V17, P1378, DOI 10.1101/gr.6375007; McClatchy DB, 2007, J PROTEOME RES, V6, P2005, DOI 10.1021/pr060599n; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miquelajauregui A, 2007, P NATL ACAD SCI USA, V104, P12919, DOI 10.1073/pnas.0609863104; Moser K, 2006, J PROTEOME RES, V5, P98, DOI 10.1021/pr0503073; Mowat DR, 2003, J MED GENET, V40, P305, DOI 10.1136/jmg.40.5.305; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Radulescu AE, 2010, TRENDS CELL BIOL, V20, P214, DOI 10.1016/j.tcb.2010.01.003; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; STUURMAN N, 1990, J BIOL CHEM, V265, P5460; TAKEDA J, 1991, ONCOGENE, V6, P1009; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Tsay YG, 2000, ANAL BIOCHEM, V287, P55, DOI 10.1006/abio.2000.4837; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yu LR, 2007, J PROTEOME RES, V6, P4150, DOI 10.1021/pr070152u; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	70	26	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16039	10.1371/journal.pone.0016039	http://dx.doi.org/10.1371/journal.pone.0016039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283754	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522200024
J	Sysi-Aho, M; Koikkalainen, J; Seppanen-Laakso, T; Kaartinen, M; Kuusisto, J; Peuhkurinen, K; Karkkainen, S; Antila, M; Lauerma, K; Reissell, E; Jurkko, R; Lotjonen, J; Helio, T; Oresic, M				Sysi-Aho, Marko; Koikkalainen, Juha; Seppanen-Laakso, Tuulikki; Kaartinen, Maija; Kuusisto, Johanna; Peuhkurinen, Keijo; Karkkainen, Satu; Antila, Margareta; Lauerma, Kirsi; Reissell, Eeva; Jurkko, Raija; Lotjonen, Jyrki; Helio, Tiina; Oresic, Matej			Serum Lipidomics Meets Cardiac Magnetic Resonance Imaging: Profiling of Subjects at Risk of Dilated Cardiomyopathy	PLOS ONE			English	Article							LAMIN-A/C GENE; VARIABLE SELECTION; MUTATIONS; HEART	Dilated cardiomyopathy (DCM), characterized by left ventricular dilatation and systolic dysfunction, constitutes a significant cause for heart failure, sudden cardiac death or need for heart transplantation. Lamin A/C gene (LMNA) on chromosome 1p12 is the most significant disease gene causing DCM and has been reported to cause 7-9% of DCM leading to cardiac transplantation. We have previously performed cardiac magnetic resonance imaging (MRI) to LMNA carriers to describe the early phenotype. Clinically, early recognition of subjects at risk of developing DCM would be important but is often difficult. Thus we have earlier used the MRI findings of these LMNA carriers for creating a model by which LMNA carriers could be identified from the controls at an asymptomatic stage. Some LMNA mutations may cause lipodystrophy. To characterize possible effects of LMNA mutations on lipid profile, we set out to apply global serum lipidomics using Ultra Performance Liquid Chromatography coupled to mass spectrometry in the same LMNA carriers, DCM patients without LMNA mutation and controls. All DCM patients, with or without LMNA mutation, differed from controls in regard to distinct serum lipidomic profile dominated by diminished odd-chain triglycerides and lipid ratios related to desaturation. Furthermore, we introduce a novel approach to identify associations between the molecular lipids from serum and the MR images from the LMNA carriers. The association analysis using dependency network and regression approaches also helped us to obtain novel insights into how the affected lipids might relate to cardiac shape and volume changes. Our study provides a framework for linking serum derived molecular markers not only with clinical endpoints, but also with the more subtle intermediate phenotypes, as derived from medical imaging, of potential pathophysiological relevance.	[Sysi-Aho, Marko; Seppanen-Laakso, Tuulikki; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland; [Koikkalainen, Juha; Lotjonen, Jyrki] VTT Tech Res Ctr Finland, Tampere, Finland; [Lauerma, Kirsi] Univ Helsinki, Cent Hosp, Helsinki Med Imaging Ctr, FIN-00170 Helsinki, Finland; [Kuusisto, Johanna; Peuhkurinen, Keijo; Karkkainen, Satu] Kuopio Univ Hosp, SF-70210 Kuopio, Finland	VTT Technical Research Center Finland; VTT Technical Research Center Finland; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland	Sysi-Aho, M (corresponding author), VTT Tech Res Ctr Finland, Espoo, Finland.	matej.oresic@vtt.fi	Oresic, Matej/K-7673-2016; Oresic, Matej/AAV-3978-2020	Oresic, Matej/0000-0002-2856-9165; Helio, Tiina/0000-0002-9640-9040	Finnish Foundation for Cardiovascular Research; Finnish Medical Foundation; special governmental subsidy for health sciences research [TYH 7106, TYH2009121]; European Commission [201668]	Finnish Foundation for Cardiovascular Research; Finnish Medical Foundation; special governmental subsidy for health sciences research; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors were supported by grants from the Finnish Foundation for Cardiovascular Research (TH), Finnish Medical Foundation (TH), the special governmental subsidy for health sciences research TYH 7106 and TYH2009121 (TH), and the European Commission (ATHEROREMO project, FP7-HEALTH-2007-A contract number 201668) to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castelo R, 2009, J COMPUT BIOL, V16, P213, DOI 10.1089/cmb.2008.08TT; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Garg A, 2009, BBA-MOL CELL BIOL L, V1791, P507, DOI 10.1016/j.bbalip.2008.12.014; Karkkainen S, 2006, HEART, V92, P524, DOI 10.1136/hrt.2004.056721; Karkkainen S, 2004, EUR HEART J, V25, P885, DOI 10.1016/j.ehj.2004.01.020; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Koikkalainen JR, 2008, RADIOLOGY, V249, P88, DOI 10.1148/radiol.2491071584; LIN F, 1993, J BIOL CHEM, V268, P16321; Lotjonen J, 2004, MED IMAGE ANAL, V8, P371, DOI 10.1016/j.media.2004.06.013; Malhotra R, 2009, CURR OPIN CARDIOL, V24, P203, DOI 10.1097/HCO.0b013e32832a11c6; Mestroni L, 2008, J AM COLL CARDIOL, V52, P1261, DOI 10.1016/j.jacc.2008.07.021; Nadeau M, 2010, METABOLISM, V59, P1106, DOI 10.1016/j.metabol.2009.09.034; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Pasotti M, 2008, J AM COLL CARDIOL, V52, P1250, DOI 10.1016/j.jacc.2008.06.044; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; Warensjo E, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-21; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Yamashita T, 2007, COMMUN STAT-THEOR M, V36, P2395, DOI 10.1080/03610920701215639; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	21	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15744	10.1371/journal.pone.0015744	http://dx.doi.org/10.1371/journal.pone.0015744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283746	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522200012
J	Mohammad, HP; Zhang, W; Prevas, HS; Leadem, BR; Zhang, M; Herman, JG; Hooker, CM; Watkins, DN; Karim, B; Huso, DL; Baylin, SB				Mohammad, H. P.; Zhang, W.; Prevas, H. S.; Leadem, B. R.; Zhang, M.; Herman, J. G.; Hooker, C. M.; Watkins, D. N.; Karim, B.; Huso, D. L.; Baylin, S. B.			Loss of a single Hic1 allele accelerates polyp formation in Apc(Delta 716) mice	ONCOGENE			English	Article						Hic1; Min; Polyp; DNA hypermethylation; colon cancer	TUMOR-SUPPRESSOR GENE; MULTIPLE INTESTINAL NEOPLASIA; STEM-CELLS; SOX9; EXPRESSION; CANCER; SIRT1; COLON; IDENTIFICATION; TUMORIGENESIS	Adenomatous polyposis coli (APC) gene mutations have been implicated in familial and sporadic gastrointestinal (GI) cancers. APC mutations are associated with autosomal dominant inheritance of disease in humans. Similarly, mice that contain a single mutant APC gene encoding a protein truncated at residue 716 (Apc(Delta 716)) develop multiple polyps throughout the GI tract as early as 4 weeks after birth. Inactivation of another tumor suppressor gene, Hypermethylated in Cancer 1 (HIC1), often occurs in human colon cancers, among others, via CpG island hypermethylation. Homozygous deletion of Hic1 in mice results in major developmental defects and embryonic lethality. Hic1 heterozygotes have previously been shown to develop tumors of a variety of tissue types. We now report that loss of a single Hic1 allele can promote crypt hyperplasia and neoplasia of the GI tract, and Hic1(+/-), Apc(+/Delta 716) double heterozygotes (DH) develop increased numbers of polyps throughout the GI tract at 60 days. Hic1 expression is absent in polyps from DH mice, with concomitant increased expression of two transcriptional repression targets of Hic1, Sirt1 and Sox9. Together, our data suggest that loss of a gene frequently silenced via epigenetic mechanisms, Hic1, can cooperate with loss of a gene mutated in GI cancer, Apc, to promote tumorigenesis in an in vivo model of multiple intestinal neoplasia. Oncogene (2011) 30, 2659-2669; doi:10.1038/onc.2010.633; published online 7 February 2011	[Baylin, S. B.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Inst Johns Hopkins, Baltimore, MD 21231 USA; [Watkins, D. N.] Monash Univ, Ctr Canc Res, Monash Inst Med Res, Clayton, Vic, Australia; [Karim, B.; Huso, D. L.] Johns Hopkins Univ, Dept Mol & Comparat Pathobiol, Baltimore, MD 21231 USA	Johns Hopkins University; Monash University; Johns Hopkins University	Baylin, SB (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Inst Johns Hopkins, 1650 Orleans St,CRB I 541, Baltimore, MD 21231 USA.	sbaylin@jhmi.edu	zhang, wei/A-7015-2011; Watkins, David N/I-6113-2013		National Cancer Institute [CA043318]; National Institutes of Environmental Health Sciences [ES015226, ES011858]; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA043318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011858, R01ES015226] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Guosheng Liu for technical assistance with dissection, Kimberly Briggs for primers, Robert Beatty for assistance with Hic1<SUP>+/-</SUP> breeding and Kathy Bender for manuscript submission. This work was supported by grants from the National Cancer Institute CA043318 (SBB), National Institutes of Environmental Health Sciences ES015226 and ES011858 (SBB). Additional support was provided by the American Cancer Society (HM and WZ).	Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BARNARD NJ, 1987, J PATHOL, V152, P287, DOI 10.1002/path.1711520407; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Briggs KJ, 2008, GENE DEV, V22, P770, DOI 10.1101/gad.1640908; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Deltour S, 1998, BBA-GENE STRUCT EXPR, V1443, P230, DOI 10.1016/S0167-4781(98)00219-X; Dong SM, 2001, CLIN CANCER RES, V7, P1982; Dupasquier S, 2009, J CELL SCI, V122, P2191, DOI 10.1242/jcs.036483; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Guerardel C, 2001, J BIOL CHEM, V276, P3078, DOI 10.1074/jbc.M008690200; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Lu BJ, 2008, AM J CLIN PATHOL, V130, P897, DOI 10.1309/AJCPW1W8GJBQGCNI; Maekawa M, 2001, CLIN CHEM LAB MED, V39, P121, DOI 10.1515/CCLM.2001.021; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nosho K, 2009, GASTROENTEROLOGY, V137, P1609, DOI 10.1053/j.gastro.2009.08.002; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Polakis P, 2000, GENE DEV, V14, P1837; PONDER BAJ, 1985, NATURE, V313, P689, DOI 10.1038/313689a0; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Stuber E, 1998, GASTROENTEROLOGY, V115, P1205, DOI 10.1016/S0016-5085(98)70092-7; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Valenta T, 2006, EMBO J, V25, P2326, DOI 10.1038/sj.emboj.7601147; Van Rechem C, 2009, J BIOL CHEM, V284, P20927, DOI 10.1074/jbc.M109.022350; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Zhang W, 2010, ONCOGENE, V29, P2467, DOI 10.1038/onc.2010.12	44	21	21	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	23					2659	2669		10.1038/onc.2010.633	http://dx.doi.org/10.1038/onc.2010.633			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778CV	21297660	Green Published, hybrid			2022-12-25	WOS:000291677800006
J	Keller, B; Yang, T; Chen, YQ; Munivez, E; Bertin, T; Zabel, B; Lee, B				Keller, Bettina; Yang, Tao; Chen, Yuqing; Munivez, Elda; Bertin, Terry; Zabel, Bernhard; Lee, Brendan			Interaction of TGF beta and BMP Signaling Pathways during Chondrogenesis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN-2; CHONDROCYTE DIFFERENTIATION; EMBRYONIC-DEVELOPMENT; EXPRESSION PATTERNS; TRANSGENIC MICE; II RECEPTOR; LONG BONES; MOUSE; CARTILAGE	TGF beta and BMP signaling pathways exhibit antagonistic activities during the development of many tissues. Although the crosstalk between BMP and TGF beta signaling pathways is well established in bone development, the relationship between these two pathways is less well defined during cartilage development and postnatal homeostasis. We generated hypomorphic mouse models of cartilage-specific loss of BMP and TGF beta signaling to assess the interaction of these pathways in postnatal growth plate homeostasis. We further used the chondrogenic ATDC5 cell line to test effects of BMP and TGF beta signaling on each other's downstream targets. We found that conditional deletion of Smad1 in chondrocytes resulted in a shortening of the growth plate. The addition of Smad5 haploinsufficiency led to a more severe phenotype with shorter prehypertrophic and hypertrophic zones and decreased chondrocyte proliferation. The opposite growth plate phenotype was observed in a transgenic mouse model of decreased chondrocytic TGF beta signaling that was generated by expressing a dominant negative form of the TGF beta receptor I (Delta T beta RI) in cartilage. Histological analysis demonstrated elongated growth plates with enhanced lhh expression, as well as an increased proliferation rate with altered production of extracellular matrix components. In contrast, in chondrogenic ATDC5 cells, TGF beta was able to enhance BMP signaling, while BMP2 significantly reduces levels of TGF signaling. In summary, our data demonstrate that during endochondral ossification, BMP and TGF beta signaling can have antagonistic effects on chondrocyte proliferation and differentiation in vivo. We also found evidence of direct interaction between the two signaling pathways in a cell model of chondrogenesis in vitro.	[Keller, Bettina; Yang, Tao; Chen, Yuqing; Munivez, Elda; Bertin, Terry; Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lee, Brendan] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Zabel, Bernhard] Univ Hosp Freiburg, Ctr Pediat & Adolescence Med, Freiburg, Germany	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Freiburg	Keller, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	blee@bcm.tmc.edu			Deutsche Forschungsgemeinschaft DFG [Za96/10-2/3]; National Institutes of Health [DE016990, HD22657, ES11253]; Rolanette and Berdon Bone Disease Program of Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011253] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rolanette and Berdon Bone Disease Program of Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Deutsche Forschungsgemeinschaft DFG Za96/10-2/3 (B.Z.), by the National Institutes of Health DE016990 (BL), HD22657 (BL), ES11253 (BL) and by the Rolanette and Berdon Bone Disease Program of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffi MO, 2004, DEV BIOL, V276, P124, DOI 10.1016/j.ydbio.2004.08.027; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen Y, 2002, FEBS LETT, V517, P277, DOI 10.1016/S0014-5793(02)02648-0; Denker AE, 1999, DIFFERENTIATION, V64, P67, DOI 10.1046/j.1432-0436.1999.6420067.x; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Faucheux C, 1997, BIOCHEM BIOPH RES CO, V241, P787, DOI 10.1006/bbrc.1997.7792; FENG XH, 1995, J BIOL CHEM, V270, P24237, DOI 10.1074/jbc.270.41.24237; GATHERER D, 1990, DEVELOPMENT, V110, P445; Giacomini D, 2009, MOL ENDOCRINOL, V23, P1102, DOI 10.1210/me.2008-0425; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hsiao YC, 2004, GENESIS, V39, P122, DOI 10.1002/gene.20038; Izumi N, 2006, AM J PHYSIOL-LUNG C, V290, pL120, DOI 10.1152/ajplung.00171.2005; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mehlhorn AT, 2007, CELL PROLIFERAT, V40, P809, DOI 10.1111/j.1365-2184.2007.00473.x; MILLAN FA, 1991, DEVELOPMENT, V111, P131; Minina E, 2001, DEVELOPMENT, V128, P4523; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Morello R, 2008, J CELL PHYSIOL, V217, P127, DOI 10.1002/jcp.21483; Napierala D, 2008, HUM MOL GENET, V17, P2244, DOI 10.1093/hmg/ddn125; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Pathi S, 1999, DEV BIOL, V209, P239, DOI 10.1006/dbio.1998.9181; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; PELTON RW, 1990, DEVELOPMENT, V110, P609; Pogue R, 2006, CURR TOP DEV BIOL, V76, P1, DOI 10.1016/S0070-2153(06)76001-X; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Sakou T, 1999, J BONE MINER RES, V14, P1145, DOI 10.1359/jbmr.1999.14.7.1145; SANDBERG M, 1988, DEV BIOL, V130, P324, DOI 10.1016/0012-1606(88)90438-1; Seo HS, 2007, DEV BIOL, V310, P304, DOI 10.1016/j.ydbio.2007.07.040; Serra R, 1999, J CELL BIOL, V145, P783, DOI 10.1083/jcb.145.4.783; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Song B, 2009, CYTOKINE GROWTH F R, V20, P379, DOI 10.1016/j.cytogfr.2009.10.010; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Wang SN, 2003, AM J PHYSIOL-RENAL, V284, pF1006, DOI 10.1152/ajprenal.00382.2002; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Yang T, 2010, J CLIN INVEST, V120, P2474, DOI 10.1172/JCI42150; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yew KH, 2005, J BIOL CHEM, V280, P32209, DOI 10.1074/jbc.M505465200; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zhang DH, 2003, J BONE MINER RES, V18, P1593, DOI 10.1359/jbmr.2003.18.9.1593; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; ZHOU G, 1995, J CELL SCI, V108, P3677; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	47	103	111	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16421	10.1371/journal.pone.0016421	http://dx.doi.org/10.1371/journal.pone.0016421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297990	gold, Green Submitted, Green Published			2022-12-25	WOS:000286664100031
J	Berger, T; Pfeifer, B; Hanser, FF; Hintringer, F; Fischer, G; Netzer, M; Trieb, T; Stuehlinger, M; Dichtl, W; Baumgartner, C; Pachinger, O; Seger, M				Berger, Thomas; Pfeifer, Bernhard; Hanser, Friedrich F.; Hintringer, Florian; Fischer, Gerald; Netzer, Michael; Trieb, Thomas; Stuehlinger, Markus; Dichtl, Wolfgang; Baumgartner, Christian; Pachinger, Otmar; Seger, Michael			Single-Beat Noninvasive Imaging of Ventricular Endocardial and Epicardial Activation in Patients Undergoing CRT	PLOS ONE			English	Article							BUNDLE-BRANCH BLOCK; CARDIAC-RESYNCHRONIZATION THERAPY; HEART-FAILURE; MODEL; ELECTROPHYSIOLOGY; ATRIAL	Background: Little is known about the effect of cardiac resynchronization therapy (CRT) on endo-and epicardial ventricular activation. Noninvasive imaging of cardiac electrophysiology (NICE) is a novel imaging tool for visualization of both epi- and endocardial ventricular electrical activation. Methodology/Principal Findings: NICE was performed in ten patients with congestive heart failure (CHF) undergoing CRT and in ten patients without structural heart disease (control group). NICE is a fusion of data from high-resolution ECG mapping with a model of the patient's individual cardiothoracic anatomy created from magnetic resonance imaging. Beat-to-beat endocardial and epicardial ventricular activation sequences were computed during native rhythm as well as during ventricular pacing using a bidomain theory-based heart model to solve the related inverse problem. During right ventricular (RV) pacing control patients showed a deterioration of the ventricular activation sequence similar to the intrinsic activation pattern of CHF patients. Left ventricular propagation velocities were significantly decreased in CHF patients as compared to the control group (1.6 +/- 0.4 versus 2.1 +/- 0.5 m/sec; p<0.05). CHF patients showed right-to-left septal activation with the latest activation epicardially in the lateral wall of the left ventricle. Biventricular pacing resulted in a resynchronization of the ventricular activation sequence and in a marked decrease of total LV activation duration as compared to intrinsic conduction and RV pacing (129 +/- 16 versus 157 +/- 28 and 173 +/- 25 ms; both p<0.05). Conclusions/Significance: Endocardial and epicardial ventricular activation can be visualized noninvasively by NICE. Identification of individual ventricular activation properties may help identify responders to CRT and to further improve response to CRT by facilitating a patient-specific lead placement and device programming.	[Berger, Thomas; Hintringer, Florian; Stuehlinger, Markus; Dichtl, Wolfgang; Pachinger, Otmar] Med Univ Innsbruck, Div Cardiol, Dept Internal Med 3, Innsbruck, Austria; [Pfeifer, Bernhard; Hanser, Friedrich F.; Fischer, Gerald; Netzer, Michael; Baumgartner, Christian; Seger, Michael] Univ Hlth Sci Med Informat & Technol UMIT, Inst Elect Elect & Bioengn, Hall In Tirol, Austria; [Trieb, Thomas] Med Univ Innsbruck, Dept Radiol 1, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Berger, T (corresponding author), Med Univ Innsbruck, Div Cardiol, Dept Internal Med 3, Innsbruck, Austria.	thomas.berger@uki.at	Berger, Thomas U/HGA-3594-2022; Dichtl, Wolfgang/H-7128-2017	Dichtl, Wolfgang/0000-0002-0421-2110; Netzer, Michael/0000-0001-7536-9257; Baumgartner, Christian/0000-0002-3763-5195; Fischer, Gerald/0000-0002-7292-2333; Pfeifer, Bernhard/0000-0003-1507-1015	Austrian Science Fund (FWF, Fonds zur Forderung der wissenschaftlichen Forschung) [START Y144]; Oesterreichische Nationalbank Jubilaumsfond [11183]; European Heart Rhythm Association (European Society of Cardiology)	Austrian Science Fund (FWF, Fonds zur Forderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Oesterreichische Nationalbank Jubilaumsfond; European Heart Rhythm Association (European Society of Cardiology)	This study was financially supported by the Austrian Science Fund (FWF, Fonds zur Forderung der wissenschaftlichen Forschung), Grant START Y144 and by Oesterreichische Nationalbank Jubilaumsfond (Jubilaumsfondsprojekt Nr. 11183). TB received an one year EP-fellowship grant from the European Heart Rhythm Association (European Society of Cardiology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors state, in accordance with their funders, that they agree to the PLoS ONE policies on sharing data and materials.	Agricola E, 2006, HEART, V92, P1390, DOI 10.1136/hrt.2005.082115; Aiba T, 2009, CIRCULATION, V119, P1220, DOI 10.1161/CIRCULATIONAHA.108.794834; Auricchio A, 2004, CIRCULATION, V109, P1133, DOI 10.1161/01.CIR.0000118502.91105.F6; Berger T, 2005, J CARDIOVASC ELECTR, V16, P611, DOI 10.1046/j.1540-8167.2005.40496.x; Berger T, 2006, J AM COLL CARDIOL, V48, P2045, DOI 10.1016/j.jacc.2006.08.019; Breithardt OA, 2003, J AM COLL CARDIOL, V42, P486, DOI 10.1016/S0735-1097(03)00709-5; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cheng LK, 2003, IEEE T BIO-MED ENG, V50, P11, DOI 10.1109/TBME.2002.807326; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Fantoni C, 2005, J CARDIOVASC ELECTR, V16, P112, DOI 10.1046/j.1540-8167.2005.40777.x; Fischer G, 2005, METHOD INFORM MED, V44, P674; Fischer G, 2002, IEEE T BIO-MED ENG, V49, P217, DOI 10.1109/10.983455; Fish JM, 2005, J AM COLL CARDIOL, V46, P2340, DOI 10.1016/j.jacc.2005.08.035; GREENSITE F, 1993, IEEE T BIO-MED ENG, V40, P1210, DOI 10.1109/10.250576; Han CZ, 2008, IEEE T MED IMAGING, V27, P1622, DOI 10.1109/TMI.2008.929094; Hayes JJ, 2006, J AM COLL CARDIOL, V48, P1628, DOI 10.1016/j.jacc.2006.05.071; Huiskamp G, 1997, IEEE T BIO-MED ENG, V44, P433, DOI 10.1109/10.581930; Lambiase PD, 2004, HEART, V90, P44, DOI 10.1136/heart.90.1.44; Modre R, 2003, J CARDIOVASC ELECTR, V14, P712, DOI 10.1046/j.1540-8167.2003.02558.x; Pfeifer B, 2006, METHOD INFORM MED, V45, P19; Ramanathan C, 2004, NAT MED, V10, P422, DOI 10.1038/nm1011; Ritter P, 1999, EUROPACE, V1, P126, DOI 10.1053/eupc.1998.0032; Rodriguez LM, 2003, J CARDIOVASC ELECTR, V14, P135, DOI 10.1046/j.1540-8167.2003.02421.x; Tilg B, 2002, IEEE T MED IMAGING, V21, P1031, DOI 10.1109/TMI.2002.804438	24	31	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16255	10.1371/journal.pone.0016255	http://dx.doi.org/10.1371/journal.pone.0016255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298045	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900026
J	Faucherre, A; Lopez-Schier, H				Faucherre, Adele; Lopez-Schier, Hernan			Delaying Gal4-Driven Gene Expression in the Zebrafish with Morpholinos and Gal80	PLOS ONE			English	Article							TRANSGENE EXPRESSION; NEURAL CIRCUITRY; MOSAIC ANALYSIS; TRAP APPROACH; AMINO-ACIDS; DROSOPHILA; GAL4-VP16; SYSTEM; NOTCH	The modular Gal4/UAS gene expression system has become an indispensable tool in modern biology. Several large-scale gene-and enhancer-trap screens in the zebrafish have generated hundreds of transgenic lines expressing Gal4 in unique patterns. However, the early embryonic expression of the Gal4 severely limits their use for studies on regeneration or behavior because UAS-driven effectors could disrupt normal organogenesis. To overcome this limitation, we explored the use of the Gal4 repressor Gal80 in transient assays and with stable transgenes to temporally control Gal4 activity. We also validated a strategy to delay Gal4-driven gene expression using a morpholino targeted to Gal4. The first approach is limited to transgenes expressing the native Gal4. The morphant approach can also be applied to transgenic lines expressing the Gal4-VP16 fusion protein. It promises to become a standard approach to delay Gal4-driven transgene expression and enhance the genetic toolkit for the zebrafish.	[Faucherre, Adele; Lopez-Schier, Hernan] Ctr Regulac Genom, Lab Sensory Cell Biol & Organogenesis, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Faucherre, A (corresponding author), Ctr Regulac Genom, Lab Sensory Cell Biol & Organogenesis, Barcelona, Spain.	hernanls@crg.es		Faucherre, Adele/0000-0002-6099-3898	AGAUR [2009-SGR-305]; European Research Council [ERC-2007-StG SENSORINEURAL]; European Union; Ministerio de Ciencia e Innovacion of Spain	AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by the AGAUR 2009-SGR-305 and by a grant from the European Research Council (ERC-2007-StG SENSORINEURAL). A. F. was supported by an Intra-European Marie Curie fellowship from the European Union and H. L. S. by the Ramon y Cajal programme of the Ministerio de Ciencia e Innovacion of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169x.2008.01044.x, 10.1111/j.1440-169X.2008.01044.x]; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; BRAND AH, 1993, DEVELOPMENT, V118, P401; Collins RT, 2010, NAT METHODS, V7, P219, DOI [10.1038/NMETH.1423, 10.1038/nmeth.1423]; CROSTON GE, 1992, GENE DEV, V6, P2270, DOI 10.1101/gad.6.12a.2270; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Esengil H, 2007, NAT CHEM BIOL, V3, P154, DOI 10.1038/nchembio858; Faucherre A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004477; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Goll MG, 2009, GENETICS, V182, P747, DOI 10.1534/genetics.109.102079; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koide T, 2009, P NATL ACAD SCI USA, V106, P9884, DOI 10.1073/pnas.0900470106; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Ogura E, 2009, DEV DYNAM, V238, P641, DOI 10.1002/dvdy.21863; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Pujol-Marti J, 2010, DEV DYNAM, V239, P1919, DOI 10.1002/dvdy.22320; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Scheer N, 2001, DEVELOPMENT, V128, P1099; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Scott EK, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.013.2009; Suster ML, 2004, GENESIS, V39, P240, DOI 10.1002/gene.20051; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; Westerfield M, 2007, ZEBRAFISH BOOK; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979	34	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16587	10.1371/journal.pone.0016587	http://dx.doi.org/10.1371/journal.pone.0016587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298067	Green Submitted, Green Published, gold			2022-12-25	WOS:000286662800057
J	Yeo, RA; Gangestad, SW; Liu, JY; Calhoun, VD; Hutchison, KE				Yeo, Ronald A.; Gangestad, Steven W.; Liu, Jingyu; Calhoun, Vince D.; Hutchison, Kent E.			Rare Copy Number Deletions Predict Individual Variation in Intelligence	PLOS ONE			English	Article							HUMAN GENOME; COGNITIVE-ABILITY; EARLY ADULTHOOD; DEVELOPMENTAL INSTABILITY; SEGMENTAL DUPLICATIONS; FLUCTUATING ASYMMETRY; BRAIN-DEVELOPMENT; MENTAL-DISORDERS; GENETIC OVERLAP; YOUNG-CHILDREN	Phenotypic variation in human intellectual functioning shows substantial heritability, as demonstrated by a long history of behavior genetic studies. Many recent molecular genetic studies have attempted to uncover specific genetic variations responsible for this heritability, but identified effects capture little variance and have proven difficult to replicate. The present study, motivated an interest in "mutation load'' emerging from evolutionary perspectives, examined the importance of the number of rare (or infrequent) copy number variations (CNVs), and the total number of base pairs included in such deletions, for psychometric intelligence. Genetic data was collected using the Illumina 1MDuoBeadChip Array from a sample of 202 adult individuals with alcohol dependence, and a subset of these (N = 77) had been administered the Wechsler Abbreviated Scale of Intelligence (WASI). After removing CNV outliers, the impact of rare genetic deletions on psychometric intelligence was investigated in 74 individuals. The total length of the rare deletions significantly and negatively predicted intelligence (r = -.30, p = .01). As prior studies have indicated greater heritability in individuals with relatively higher parental socioeconomic status (SES), we also examined the impact of ethnicity (Anglo/White vs. Other), as a proxy measure of SES; these groups did not differ on any genetic variable. This categorical variable significantly moderated the effect of length of deletions on intelligence, with larger effects being noted in the Anglo/White group. Overall, these results suggest that rare deletions (between 5% and 1% population frequency or less) adversely affect intellectual functioning, and that pleotropic effects might partly account for the association of intelligence with health and mental health status. Significant limitations of this research, including issues of generalizability and CNV measurement, are discussed.	[Yeo, Ronald A.; Gangestad, Steven W.; Hutchison, Kent E.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Liu, Jingyu; Calhoun, Vince D.; Hutchison, Kent E.] Univ New Mexico, Mind Res Network, Albuquerque, NM 87131 USA; [Liu, Jingyu; Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Hutchison, Kent E.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	University of New Mexico; Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico; University of Colorado System; University of Colorado Boulder	Yeo, RA (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	ryeo@unm.edu	Calhoun, Vince D./ACN-9399-2022	Calhoun, Vince D./0000-0001-9058-0747; Gangestad, Steven/0000-0002-8879-4348; Liu, Jingyu/0000-0002-1724-7523	National Institute on Alcoholism and Alcohol Abuse [AA012238, AA013930]; National Institute of Biomedical Imaging and Bioengineering [R01EB005846]; Mind Research Network; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012238, R29AA012238] Funding Source: NIH RePORTER	National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Mind Research Network; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by grants from the National Institute on Alcoholism and Alcohol Abuse (AA012238 and AA013930; KH), the National Institute of Biomedical Imaging and Bioengineering (R01EB005846; VDC) and a grant from the Mind Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDEN R, 2010, USING EVOLUTIONARY T; Arden R, 2009, INTELLIGENCE, V37, P581, DOI 10.1016/j.intell.2009.03.008; Banks GC, 2010, INTELLIGENCE, V38, P393, DOI 10.1016/j.intell.2010.04.003; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2006, J EPIDEMIOL COMMUN H, V60, P872, DOI 10.1136/jech.2005.045039; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; BOURQUE E, 2010, PSYCHOL MED IN PRESS; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; CHEN J, P IEEE BIOI IN PRESS; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Deary IJ, 2006, EUR J HUM GENET, V14, P690, DOI 10.1038/sj.ejhg.5201588; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Der G, 2009, INTELLIGENCE, V37, P573, DOI 10.1016/j.intell.2008.12.002; DONOVAN DM, 1984, ALCOHOL CLIN EXP RES, V8, P470, DOI 10.1111/j.1530-0277.1984.tb05704.x; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; Finn PR, 2004, J ABNORM PSYCHOL, V113, P569, DOI 10.1037/0021-843X.113.4.569; Furlow FB, 1997, P ROY SOC B-BIOL SCI, V264, P823, DOI 10.1098/rspb.1997.0115; Gale CR, 2010, EPIDEMIOLOGY, V21, P70, DOI 10.1097/EDE.0b013e3181c17da8; Gale CR, 2009, INTELLIGENCE, V37, P592, DOI 10.1016/j.intell.2008.09.002; Gangestad SW, 2010, PERS INDIV DIFFER, V49, P289, DOI 10.1016/j.paid.2010.03.005; Gangestad SW, 1999, J EVOLUTION BIOL, V12, P402, DOI 10.1046/j.1420-9101.1999.00039.x; GANGESTAD SW, EVOLUTION H IN PRESS; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; Grant MD, 2010, BEHAV GENET, V40, P438, DOI 10.1007/s10519-010-9351-3; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Harden KP, 2007, BEHAV GENET, V37, P273, DOI 10.1007/s10519-006-9113-4; Hemmingsson T, 2006, INT J EPIDEMIOL, V35, P665, DOI 10.1093/ije/dyi321; Houle D, 2010, P NATL ACAD SCI USA, V107, P1793, DOI 10.1073/pnas.0906195106; Houlihan LM, 2009, GENES BRAIN BEHAV, V8, P238, DOI 10.1111/j.1601-183X.2008.00470.x; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Koenen KC, 2006, J ABNORM PSYCHOL, V115, P787, DOI 10.1037/0021-843X.115.4.787; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Kuntsi J, 2004, AM J MED GENET B, V124B, P41, DOI 10.1002/ajmg.b.20076; Luciano M, 2010, INTELLIGENCE, V38, P304, DOI 10.1016/j.intell.2010.03.002; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Marques-Bonet T, 2009, TRENDS GENET, V25, P443, DOI 10.1016/j.tig.2009.08.002; McCarthy M, 2006, LANCET NEUROL, V5, P907, DOI 10.1016/S1474-4422(06)70594-4; Miller G, 2000, Novartis Found Symp, V233, P260; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Oti M, 2008, TRENDS GENET, V24, P103, DOI 10.1016/j.tig.2007.12.005; Penke L, 2007, EUR J PERSONALITY, V21, P549, DOI 10.1002/per.629; Plomin R, 2004, J PERS SOC PSYCHOL, V86, P112, DOI 10.1037/0022-3514.86.1.112; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Prokosch MD, 2005, INTELLIGENCE, V33, P203, DOI 10.1016/j.intell.2004.07.007; *PSYCH CORP, 2002, WAIS 3 WECHSL AD INT; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sikela JM, 2006, PLOS GENET, V2, P646, DOI 10.1371/journal.pgen.0020080; SKINNER HA, 1982, J ABNORM PSYCHOL, V91, P199, DOI 10.1037/0021-843X.91.3.199; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Toulopoulou T, 2007, SCHIZOPHRENIA BULL, V33, P290; Toulopoulou T, 2007, ARCH GEN PSYCHIAT, V64, P1348, DOI 10.1001/archpsyc.64.12.1348; Tukey JW, 1977, EXPLORATORY DATA ANA; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; VANDONGEN S, EVOLUTION H IN PRESS; Waldron M, 2007, TWIN RES HUM GENET, V10, P440, DOI 10.1375/twin.10.3.440; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Whalley LJ, 2000, NEUROLOGY, V55, P1455, DOI 10.1212/WNL.55.10.1455; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; YEO R, CURRENT ALZ IN PRESS; Yeo RA, 1999, SCHIZOPHR RES, V39, P197, DOI 10.1016/S0920-9964(99)00074-2; Yeo RA, 2007, CURR DIR PSYCHOL SCI, V16, P245, DOI 10.1111/j.1467-8721.2007.00513.x; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	73	37	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16339	10.1371/journal.pone.0016339	http://dx.doi.org/10.1371/journal.pone.0016339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298096	Green Published, Green Submitted, gold			2022-12-25	WOS:000286662800029
J	Zhong, CY; Peng, DH; Ye, WX; Chai, LJ; Qi, JL; Yu, ZN; Ruan, LF; Sun, M				Zhong, Chunying; Peng, Donghai; Ye, Weixing; Chai, Lujun; Qi, Junliang; Yu, Ziniu; Ruan, Lifang; Sun, Ming			Determination of Plasmid Copy Number Reveals the Total Plasmid DNA Amount Is Greater than the Chromosomal DNA Amount in Bacillus thuringiensis YBT-1520	PLOS ONE			English	Article							REAL-TIME PCR; INSECTICIDAL CRYSTAL PROTEIN; ESCHERICHIA-COLI; SEQUENCE-ANALYSIS; GENETIC ELEMENTS; STRAIN YBT-1520; REPLICATION; CEREUS; QUANTIFICATION; GERMINATION	Bacillus thuringiensis is the most widely used bacterial bio-insecticide, and most insecticidal crystal protein-coding genes are located on plasmids. Most strains of B. thuringiensis harbor numerous diverse plasmids, although the plasmid copy numbers (PCNs) of all native plasmids in this host and the corresponding total plasmid DNA amount remains unknown. In this study, we determined the PCNs of 11 plasmids (ranging from 2 kb to 416 kb) in a sequenced B. thuringiensis subsp. kurstaki strain YBT-1520 using real-time qPCR. PCNs were found to range from 1.38 to 172, and were negatively correlated to plasmid size. The amount of total plasmid DNA (similar to 8.7 Mbp) was 1.62-fold greater than the amount of chromosomal DNA (similar to 5.4 Mbp) at the mid-exponential growth stage (OD(600) = 2.0) of the organism. Furthermore, we selected three plasmids with different sizes and replication mechanisms to determine the PCNs over the entire life cycle. We found that the PCNs dynamically shifted at different stages, reaching their maximum during the mid-exponential growth or stationary phases and remaining stable and close to their minimum after the prespore formation stage. The PCN of pBMB2062, which is the smallest plasmid (2062 bp) and has the highest PCN of those tested, varied in strain YBT-1520, HD-1, and HD-136 (172, 115, and 94, respectively). These findings provide insight into both the total plasmid DNA amount of B. thuringiensis and the strong ability of the species to harbor plasmids.	[Zhong, Chunying; Peng, Donghai; Ye, Weixing; Chai, Lujun; Qi, Junliang; Yu, Ziniu; Ruan, Lifang; Sun, Ming] Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Life Sci & Technol, Wuhan, Peoples R China	Huazhong Agricultural University	Zhong, CY (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Life Sci & Technol, Wuhan, Peoples R China.	m98sun@mail.hzau.edu.cn	Ming, Sun/Q-1497-2015; Peng, donghai/O-7259-2016	Ming, Sun/0000-0001-5465-5983; Peng, donghai/0000-0002-4918-2357	National High Technology Research and Development Program (863 Program) of China [2011AA10A203, 2006AA02Z174]; National Basic Research Program (973) of China [2009CB118902]; Genetically Modified Organisms Breeding Major Projects of China [2009ZX08009-032B]; Ministry of Agriculture [2011]; Ministry of Forestry [2006-4-41]; National Natural Science Foundation of China [30870066, 30470026]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); National Basic Research Program (973) of China(National Basic Research Program of China); Genetically Modified Organisms Breeding Major Projects of China; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Ministry of Forestry; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National High Technology Research and Development Program (863 Program) of China Grants (2011AA10A203, 2006AA02Z174), and the National Basic Research Program (973) of China (2009CB118902), and Genetically Modified Organisms Breeding Major Projects of China Grant (2009ZX08009-032B), and China 948 Program of Ministry of Agriculture (2011) and Ministry of Forestry (2006-4-41), and National Natural Science Foundation of China (30870066, 30470026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis Luis A., 1999, Frontiers in Bioscience, V4, pD43, DOI 10.2741/Actis; AGAISSE H, 1995, J BACTERIOL, V177, P6027, DOI 10.1128/jb.177.21.6027-6032.1995; ARONSON AI, 1993, MOL MICROBIOL, V7, P489, DOI 10.1111/j.1365-2958.1993.tb01139.x; Asano K, 1998, EMBO J, V17, P5201, DOI 10.1093/emboj/17.17.5201; BAUM JA, 1995, MOL MICROBIOL, V18, P1, DOI 10.1111/j.1365-2958.1995.mmi_18010001.x; Brantl S, 2000, MOL MICROBIOL, V35, P1469, DOI 10.1046/j.1365-2958.2000.01813.x; BRANTL S, 1994, MOL MICROBIOL, V14, P473, DOI 10.1111/j.1365-2958.1994.tb02182.x; Chattoraj DK, 2000, MOL MICROBIOL, V37, P467, DOI 10.1046/j.1365-2958.2000.01986.x; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; del Solar G, 2000, MOL MICROBIOL, V37, P492, DOI 10.1046/j.1365-2958.2000.02005.x; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Dobrzhanskaya E. O., 2000, Mikrobiologiya, V69, P796; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Grabherr R, 2002, TRENDS BIOTECHNOL, V20, P257, DOI 10.1016/S0167-7799(02)01950-9; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; HOFTE H, 1989, MICROBIOL REV, V53, P242; Hu HJ, 2007, FEMS MICROBIOL LETT, V272, P245, DOI 10.1111/j.1574-6968.2007.00766.x; KALMAN S, 1993, APPL ENVIRON MICROB, V59, P1131, DOI 10.1128/AEM.59.4.1131-1137.1993; KIESELBURG MK, 1984, NAT BIOTECHNOL, V2, P6; Lee CL, 2006, J MICROBIOL METH, V65, P258, DOI 10.1016/j.mimet.2005.07.019; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Lee SJ, 2002, APPL ENVIRON MICROB, V68, P3919, DOI 10.1128/AEM.68.8.3919-3924.2002; Liu C, 2007, PLASMID, V57, P44, DOI 10.1016/j.plasmid.2006.06.002; Liu XJ, 2008, J MICROBIOL BIOTECHN, V18, P1630; MARIN R, 1992, FEMS MICROBIOL LETT, V73, P263; MCDOWELL DG, 1991, PLASMID, V25, P113, DOI 10.1016/0147-619X(91)90022-O; NAKAMURA LK, 1994, INT J SYST BACTERIOL, V44, P125, DOI 10.1099/00207713-44-1-125; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Providenti MA, 2006, J MICROBIOL METH, V65, P476, DOI 10.1016/j.mimet.2005.09.007; Qiu N, 2010, FEMS MICROBIOL LETT, V310, P9, DOI 10.1111/j.1574-6968.2010.02033.x; Reyes-Ramirez A, 2008, APPL ENVIRON MICROB, V74, P125, DOI 10.1128/AEM.02133-07; Rowland SL, 1997, MOL MICROBIOL, V23, P295, DOI 10.1046/j.1365-2958.1997.2141580.x; Schmidt T, 1996, J BIOTECHNOL, V49, P219, DOI 10.1016/0168-1656(96)01519-2; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sedlak M, 2000, J BACTERIOL, V182, P734, DOI 10.1128/JB.182.3.734-741.2000; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; Smajs D, 2008, PLASMID, V59, P1, DOI 10.1016/j.plasmid.2007.08.002; Summers D, 1998, MOL MICROBIOL, V29, P1137, DOI 10.1046/j.1365-2958.1998.01012.x; Sun M, 2000, Wei Sheng Wu Xue Bao, V40, P365; Sun M, 2000, Yi Chuan Xue Bao, V27, P932; Turgeon N, 2008, PLASMID, V60, P118, DOI 10.1016/j.plasmid.2008.05.001; Verheust C, 2003, MICROBIOL-SGM, V149, P2083, DOI 10.1099/mic.0.26307-0; Wagner EGH, 2002, ADV GENET, V46, P361; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; YOSHIKAWA H, 1964, P NATL ACAD SCI USA, V52, P973, DOI 10.1073/pnas.52.4.973	47	35	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16025	10.1371/journal.pone.0016025	http://dx.doi.org/10.1371/journal.pone.0016025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283584	Green Published, gold, Green Submitted			2022-12-25	WOS:000286661400021
J	Ganusov, VV; Barber, DL; De Boer, RJ				Ganusov, Vitaly V.; Barber, Daniel L.; De Boer, Rob J.			Killing of Targets by CD8(+) T Cells in the Mouse Spleen Follows the Law of Mass Action	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEDIATED CYTO-TOXICITY; IN-VIVO; IMMUNODEFICIENCY-VIRUS; VIRAL-INFECTION; CUTTING EDGE; EFFECTOR FUNCTION; RHESUS-MONKEYS; CTL ACTIVITY; LYMPH-NODES	It has been difficult to correlate the quality of CD8(+) T cell responses with protection against viral infections. To investigate the relationship between efficacy and magnitude of T cell responses, we quantify the rate at which individual CD8(+) effector and memory T cells kill target cells in the mouse spleen. Using mathematical modeling, we analyze recent data on the loss of target cells pulsed with three different peptides from the mouse lymphocytic choriomeningitis virus (LCMV) in mouse spleens with varying numbers of epitope-specific CD8(+) T cells. We find that the killing of targets follows the law of mass-action, i.e., the death rate of individual target cells remains proportional to the frequency (or the total number) of specific CD8(+) T cells in the spleen despite the fact that effector cell densities and effector to target ratios vary about a 1000-fold. The killing rate of LCMV-specific CD8(+) T cells is largely independent of T cell specificity and differentiation stage. Our results thus allow one to calculate the critical T cell concentration at which growth of a virus with a given replication rate can be prevented from the start of infection by memory CD8(+) T cell response.	[Ganusov, Vitaly V.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Barber, Daniel L.] NIH, Bethesda, MD 20892 USA; [De Boer, Rob J.] Univ Utrecht, Utrecht, Netherlands	University of Tennessee System; University of Tennessee Knoxville; National Institutes of Health (NIH) - USA; Utrecht University	Ganusov, VV (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	vitaly.ganusov@gmail.com	Barber, Daniel L./V-1190-2019; de Boer, Rob/B-6050-2011	de Boer, Rob/0000-0002-2130-691X; Ganusov, Vitaly/0000-0001-6572-1691	NWO [016.048.603]; Marie Curie Incoming International Fellowship (FP6); U.S. Department of Energy; University of Tennessee; Russian Ministry of Education [NK-550P/2]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009222] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006427] Funding Source: NIH RePORTER	NWO(Netherlands Organization for Scientific Research (NWO)); Marie Curie Incoming International Fellowship (FP6)(European Commission); U.S. Department of Energy(United States Department of Energy (DOE)); University of Tennessee; Russian Ministry of Education(Ministry of Education and Science, Russian Federation); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the VICI grant 016.048.603 from NWO, Marie Curie Incoming International Fellowship (FP6), the U.S. Department of Energy through the LANL/LDRD Program, start-up funds from the University of Tennessee and in part by a grant from the Russian Ministry of Education (NK-550P/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichele P, 1997, IMMUNITY, V6, P519, DOI 10.1016/S1074-7613(00)80340-4; Althaus CL, 2007, J IMMUNOL, V179, P2944, DOI 10.4049/jimmunol.179.5.2944; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Barchet W, 2000, EUR J IMMUNOL, V30, P1356, DOI 10.1002/(SICI)1521-4141(200005)30:5<1356::AID-IMMU1356>3.0.CO;2-K; Berger DP, 2000, VIROLOGY, V266, P257, DOI 10.1006/viro.1999.0074; Blancou P, 2001, P NATL ACAD SCI USA, V98, P13237, DOI 10.1073/pnas.231348598; Bocharov G, 2004, J VIROL, V78, P2247, DOI 10.1128/JVI.78.5.2247-2254.2004; Borghans JAM, 1996, B MATH BIOL, V58, P43, DOI 10.1016/0092-8240(95)00306-1; Budhu S, 2010, J EXP MED, V207, P223, DOI 10.1084/jem.20091279; Byers AM, 2003, J IMMUNOL, V171, P17, DOI 10.4049/jimmunol.171.1.17; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; De Boer RJ, 2001, J VIROL, V75, P10663, DOI 10.1128/JVI.75.22.10663-10669.2001; De Boer RJ, 2007, J VIROL, V81, P2838, DOI 10.1128/JVI.01914-06; Efron B., 1994, INTRO BOOTSTRAP; Ehl S, 1997, EUR J IMMUNOL, V27, P3404, DOI 10.1002/eji.1830271240; Ganusov VV, 2007, J IMMUNOL, V179, P5006, DOI 10.4049/jimmunol.179.8.5006; Ganusov VV, 2008, J VIROL, V82, P11749, DOI 10.1128/JVI.01128-08; Graw F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000466; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Ingulli Elizabeth, 2007, Methods Mol Biol, V380, P365; Jenkins MR, 2009, CELL DEATH DIFFER, V16, P537, DOI 10.1038/cdd.2008.176; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kim SK, 2004, J IMMUNOL, V172, P3139, DOI 10.4049/jimmunol.172.5.3139; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Mempel TR, 2006, IMMUNITY, V25, P867, DOI 10.1016/j.immuni.2006.11.002; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; MERRILL SJ, 1982, MATH BIOSCI, V62, P219, DOI 10.1016/0025-5564(82)90084-0; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Oehen S, 1998, J IMMUNOL, V161, P5338; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; PERELSON AS, 1984, J IMMUNOL, V132, P2190; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Regner M, 2009, J IMMUNOL, V183, P37, DOI 10.4049/jimmunol.0900466; Regoes RR, 2007, P NATL ACAD SCI USA, V104, P1599, DOI 10.1073/pnas.0508830104; Rehr M, 2008, J VIROL, V82, P3391, DOI 10.1128/JVI.02383-07; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Sykulev Y, 1995, P NATL ACAD SCI USA, V92, P11990, DOI 10.1073/pnas.92.26.11990; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Yates A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001301	51	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e15959	10.1371/journal.pone.0015959	http://dx.doi.org/10.1371/journal.pone.0015959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283669	Green Submitted, gold, Green Published			2022-12-25	WOS:000286523400009
J	Dua, R; Zhang, JH; Parry, G; Penuel, E				Dua, Rajiv; Zhang, Jianhuan; Parry, Gordon; Penuel, Elicia			Detection of Hepatocyte Growth Factor (HGF) Ligand-c-MET Receptor Activation in Formalin-Fixed Paraffin Embedded Specimens by a Novel Proximity Assay	PLOS ONE			English	Article							TYROSINE KINASE; LUNG ADENOCARCINOMA; EXPRESSION; CANCER; BREAST; QUANTITATION; INHIBITION; OVEREXPRESSION; MUTATIONS; SURVIVAL	Aberrant activation of membrane receptors frequently occurs in human carcinomas. Detection of phosphorylated receptors is commonly used as an indicator of receptor activation in formalin-fixed paraffin embedded (FFPE) tumor specimens. FFPE is a standard method of specimen preparation used in the histological analysis of solid tumors. Due to variability in FFPE preparations and the labile nature of protein phosphorylation, measurements of phospho-proteins are unreliable and create ambiguities in clinical interpretation. Here, we describe an alternative, novel approach to measure receptor activation by detecting and quantifying ligand-receptor complexes in FFPE specimens. We used hepatocyte growth factor (HGF)-c-MET as our model ligand-receptor system. HGF is the only known ligand of the c-MET tyrosine kinase receptor and HGF binding triggers c-MET phosphorylation. Novel antibody proximity-based assays were developed and used to detect and quantify total c-MET, total HGF, and HGF-c-MET ligand-receptor interactions in FFPE cell line and tumor tissue. In glioma cells, autocrine activation of c-MET by HGF-c-MET increased basal levels of c-MET phosphorylation at tyrosine (Tyr) 1003. Furthermore, HGF-c-MET activation in glioma cell lines was verified by Surface Protein-Protein Interaction by Crosslinking ELISA (SPPICE) assay in corresponding soluble cell lysates. Finally, we profiled levels of c-MET, HGF, and HGF-c-MET complexes in FFPE specimens of human Non-Small Cell Lung Cancer (NSCLC), Gastric Cancer, Head and Neck Squamous Cell, and Head and Neck Non-Squamous Cell carcinomas. This report describes a novel approach for the detection and quantification of ligand-receptor interactions that can be widely applied to measure receptor activation in FFPE preclinical models and archived FFPE human tissue specimens.	[Dua, Rajiv; Zhang, Jianhuan; Parry, Gordon; Penuel, Elicia] Monogram Biosci Inc, Res & Dev, Oncol, San Francisco, CA USA		Dua, R (corresponding author), Monogram Biosci Inc, Res & Dev, Oncol, San Francisco, CA USA.	rdua@monogrambio.com			Monogram Biosciences, Inc.	Monogram Biosciences, Inc.	The study was funded by Monogram Biosciences, Inc. Monogram Biosciences played role in study design, data collection and analysis, preparation of manuscript, and decision to publish this work. No outside funding was received for performing this research work.	Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; CHISTENSEN JG, 2003, CANCER RES, V63, P7345; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Desmedt C, 2009, DIAGN MOL PATHOL, V18, P22, DOI 10.1097/PDM.0b013e31818ebc69; Dua R, 2010, BREAST CANCER RES TR, V122, P685, DOI 10.1007/s10549-009-0592-x; Gotte M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1641; Gordon MS, 2010, CLIN CANCER RES, V16, P699, DOI 10.1158/1078-0432.CCR-09-1365; Gupta A, 2008, CLIN CANCER RES, V14, P7385, DOI 10.1158/1078-0432.CCR-07-5110; Jain A, 2010, CANCER RES, V70, P1989, DOI 10.1158/0008-5472.CAN-09-3326; Jones RJ, 2008, CANCER CHEMOTH PHARM, V61, P23, DOI 10.1007/s00280-007-0440-9; Knowles LM, 2009, CLIN CANCER RES, V15, P3740, DOI 10.1158/1078-0432.CCR-08-3252; Kong DS, 2009, CANCER-AM CANCER SOC, V115, P140, DOI 10.1002/cncr.23972; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Koochekpour S, 1997, CANCER RES, V57, P5391; Larson JS, 2010, PATHOLOG RES INT; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Miyata Y, 2006, CLIN CANCER RES, V12, P4876, DOI 10.1158/1078-0432.CCR-06-0362; Nakamura T, 1997, CANCER RES, V57, P3305; Nakamura Y, 2007, CANCER SCI, V98, P1006, DOI 10.1111/j.1349-7006.2007.00493.x; Pozner-Moulis S, 2007, LAB INVEST, V87, P251, DOI 10.1038/labinvest.3700515; SALGIA R, 2008, P 20 ANN AACR NCI EO; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Shi YN, 2009, DIAGN MOL PATHOL, V18, P11, DOI 10.1097/PDM.0b013e31818cbdb2; Siegfried JM, 1997, CANCER RES, V57, P433; Sperinde J, 2010, CLIN CANCER RES, V16, P4226, DOI 10.1158/1078-0432.CCR-10-0410; Toschi L, 2008, CLIN CANCER RES, V14, P5941, DOI 10.1158/1078-0432.CCR-08-0071; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yap TA, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.3584; Zucali PA, 2008, ANN ONCOL, V19, P1605, DOI 10.1093/annonc/mdn240	34	20	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e15932	10.1371/journal.pone.0015932	http://dx.doi.org/10.1371/journal.pone.0015932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283737	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522300014
J	Kaess, BM; Tomaszewski, M; Braund, PS; Stark, K; Rafelt, S; Fischer, M; Hardwick, R; Nelson, CP; Debiec, R; Huber, F; Kremer, W; Kalbitzer, HR; Rose, LM; Chasman, DI; Hopewell, J; Clarke, R; Burton, PR; Tobin, MD; Hengstenberg, C; Samani, NJ				Kaess, Bernhard M.; Tomaszewski, Maciej; Braund, Peter S.; Stark, Klaus; Rafelt, Suzanne; Fischer, Marcus; Hardwick, Robert; Nelson, Christopher P.; Debiec, Radoslaw; Huber, Fritz; Kremer, Werner; Kalbitzer, Hans Robert; Rose, Lynda M.; Chasman, Daniel I.; Hopewell, Jemma; Clarke, Robert; Burton, Paul R.; Tobin, Martin D.; Hengstenberg, Christian; Samani, Nilesh J.			Large-Scale Candidate Gene Analysis of HDL Particle Features	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CORONARY-ARTERY-DISEASE; MACULAR DEGENERATION; COMMON VARIANTS; BINDING-PROTEIN; SMOOTH-MUSCLE; LIPID-LEVELS; LIPOPROTEIN; FIBULIN-5; LOCI	Background: HDL cholesterol (HDL-C) is an established marker of cardiovascular risk with significant genetic determination. However, HDL particles are not homogenous, and refined HDL phenotyping may improve insight into regulation of HDL metabolism. We therefore assessed HDL particles by NMR spectroscopy and conducted a large-scale candidate gene association analysis. Methodology/Principal Findings: We measured plasma HDL-C and determined mean HDL particle size and particle number by NMR spectroscopy in 2024 individuals from 512 British Caucasian families. Genotypes were 49,094 SNPs in >2,100 cardiometabolic candidate genes/loci as represented on the HumanCVD BeadChip version 2. False discovery rates (FDR) were calculated to account for multiple testing. Analyses on classical HDL-C revealed significant associations (FDR<0.05) only for CETP (cholesteryl ester transfer protein; lead SNP rs3764261: p = 5.6*10(-15)) and SGCD (sarcoglycan delta; rs6877118: p = 8.6*10(-6)). In contrast, analysis with HDL mean particle size yielded additional associations in LIPC (hepatic lipase; rs261332: p = 6.1*10(-9)), PLTP (phospholipid transfer protein, rs4810479: p = 1.7*10(-8)) and FBLN5 (fibulin-5; rs2246416: p = 6.2*10(-6)). The associations of SGCD and Fibulin-5 with HDL particle size could not be replicated in PROCARDIS (n = 3,078) and/or the Women's Genome Health Study (n = 23,170). Conclusions: We show that refined HDL phenotyping by NMR spectroscopy can detect known genes of HDL metabolism better than analyses on HDL-C.	[Kaess, Bernhard M.; Tomaszewski, Maciej; Braund, Peter S.; Rafelt, Suzanne; Hardwick, Robert; Nelson, Christopher P.; Debiec, Radoslaw; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Kaess, Bernhard M.; Stark, Klaus; Fischer, Marcus; Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Huber, Fritz; Kremer, Werner; Kalbitzer, Hans Robert] LipoFIT Analyt GmbH, Regensburg, Germany; [Kremer, Werner; Kalbitzer, Hans Robert] Univ Regensburg, Inst Biophys & Phys Biochem, D-8400 Regensburg, Germany; [Rose, Lynda M.; Chasman, Daniel I.] Brigham & Womens Hosp, Dept Prevent Med, Boston, MA 02115 USA; [Hopewell, Jemma; Clarke, Robert] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Burton, Paul R.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of Leicester; University of Regensburg; University of Regensburg; Harvard University; Brigham & Women's Hospital; University of Oxford; University of Leicester	Kaess, BM (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	christian.hengstenberg@klinik.uni-regensburg.de; njs@le.ac.uk	Hengstenberg, Christian/U-5485-2019; Stark, Klaus/L-7367-2013; Stark, Klaus/D-3813-2009	Stark, Klaus/0000-0002-7832-1942; Stark, Klaus/0000-0002-7832-1942; Hopewell, Jemma/0000-0002-3870-8018; Tomaszewski, Maciej/0000-0001-8215-6567; Debiec, Radoslaw/0000-0003-2292-467X; Tobin, Martin/0000-0002-3596-7874; Kalbitzer, Hans Robert/0000-0002-6514-2355; Nelson, Christopher/0000-0001-8025-2897	British Heart Foundation; National Genome Network (NGFNplus) [01GS0832]; European Union [LSH-2005-037593]; Medical Research Council [G0501942]; Leicester National Institute for Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease; Medical Research Council [MC_U137686857] Funding Source: researchfish; MRC [MC_U137686857, G0501942] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); National Genome Network (NGFNplus); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leicester National Institute for Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Recruitment and genotyping of the GRAPHIC cohort was funded by the British Heart Foundation. Phenotyping and BK's fellowship in Leicester were supported by grants from the National Genome Network (NGFNplus, 01GS0832) and the European Union-sponsored project Cardiogenics (LSH-2005-037593). NJS holds a British Heart Foundation Chair of Cardiology and MDT holds a Medical Research Council Clinician Scientist Fellowship (G0501942). NJS, MT and PRB are supported by the Leicester National Institute for Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease. NMR spectroscopy was performed at LipoFIT GmbH. WK and HRK are employed by the University of Regensburg and co-founders of LipoFIT GmbH; FH is co-founder and CEO of LipoFIT GmbH. With the exception of this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalain JH, 2002, CLIN CHIM ACTA, V326, P97, DOI 10.1016/S0009-8981(02)00288-7; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; ARSENAULT BJ, 2009, ATHEROSCLEROSIS; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; de Souza JA, 2008, ATHEROSCLEROSIS, V197, P84, DOI 10.1016/j.atherosclerosis.2007.08.009; El Harchaoui K, 2009, ANN INTERN MED, V150, P84, DOI 10.7326/0003-4819-150-2-200901200-00006; Freedman DS, 1998, ARTERIOSCL THROM VAS, V18, P1046, DOI 10.1161/01.ATV.18.7.1046; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Kaess B, 2008, J LIPID RES, V49, P715, DOI 10.1194/jlr.M700338-JLR200; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Malek G, 2003, AM J PATHOL, V162, P413, DOI 10.1016/S0002-9440(10)63836-9; Mora S, 2009, CIRCULATION, V119, pE385, DOI 10.1161/CIRCULATIONAHA.108.835587; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Nguyen AD, 2004, CIRC RES, V95, P1067, DOI 10.1161/01.RES.0000149568.85071.FB; OCONNELL DL, 1988, GENET EPIDEMIOL, V5, P323, DOI 10.1002/gepi.1370050504; OTVOS JD, 1991, CLIN CHEM, V37, P377; Pietilainen KH, 2009, OBESITY, V17, P1208, DOI 10.1038/oby.2008.675; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rosenson RS, 2002, AM J CARDIOL, V90, P89, DOI 10.1016/S0002-9149(02)02427-X; Spencer JA, 2005, P NATL ACAD SCI USA, V102, P2946, DOI 10.1073/pnas.0500058102; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Superko HR, 2009, CIRCULATION, V119, P2383, DOI 10.1161/CIRCULATIONAHA.108.809582; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tobin MD, 2008, HYPERTENSION, V51, P1658, DOI 10.1161/HYPERTENSIONAHA.108.112664; Vekic J, 2007, EUR J CLIN INVEST, V37, P715, DOI 10.1111/j.1365-2362.2007.01849.x; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a	36	32	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14529	10.1371/journal.pone.0014529	http://dx.doi.org/10.1371/journal.pone.0014529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283740	gold, Green Submitted, Green Published			2022-12-25	WOS:000286522300002
J	Lorenzo, MN; Ramos, AM; Taboada, JJ; Gimeno, L				Lorenzo, Maria N.; Ramos, Alexandre M.; Taboada, Juan J.; Gimeno, Luis			Changes in Present and Future Circulation Types Frequency in Northwest Iberian Peninsula	PLOS ONE			English	Article							ATMOSPHERIC CIRCULATION; ATLANTIC OSCILLATION; WINTER CLIMATE; WEATHER-TYPE; CLASSIFICATION; TEMPERATURE; PATTERNS; IMPACT; PRECIPITATION; SIMULATIONS	The aim of the work described herein was to study projection scenarios in order to find changes in the synoptic variability of the northwest Iberian Peninsula in the 21st century. To this end, we investigated the changes in the frequency of the different circulation types computed for the study area using three different models used in the IPCC 4(th) assessment report. The circulation types were computed using the procedure known as Lamb circulation types. The control simulation for the late 20th century was evaluated objectively from the results obtained using data from the NCEP/NCAR reanalysis, as to evaluate the ability of the model to reproduce the present climate. We have compared not only seasonal mean sea level pressure fields but also the mean seasonal frequency of circulation types. The results for the end of the 21st century show a decrease in the frequency of cyclonic, W, and SW circulation types in the spring and summer months. This trend also appears in the autumn, with a concomitant increase in the anticyclonic types.	[Lorenzo, Maria N.; Ramos, Alexandre M.; Gimeno, Luis] Univ Vigo, Fac Ciencias, EPhysLab, Orense, Spain; [Taboada, Juan J.] Xunta de Galicia, Meteogalicia, Santiago De Compostela, Spain	Universidade de Vigo	Lorenzo, MN (corresponding author), Univ Vigo, Fac Ciencias, EPhysLab, Orense, Spain.	alexramos@uvigo.es	GIMENO, LUIS/B-8137-2008; Ramos, Alexandre M./A-1998-2009; de las Nieves Lorenzo, María/B-9924-2011	Ramos, Alexandre M./0000-0003-3129-7233; de las Nieves Lorenzo, María/0000-0001-5302-8312; Taboada, Juan/0000-0001-9023-473X; GIMENO, LUIS/0000-0002-0778-3605	Xunta de Galicia [PGIDIT06PXIB383288PR]; Portuguese Science Foundation (FCT) [BD/46000/2008]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology)	This study was supported by 'Xunta de Galicia' under project PGIDIT06PXIB383288PR. Alexandre M. Ramos was supported by the Portuguese Science Foundation (FCT) through Grant BD/46000/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004744; Anagnostopouloua CHR, 2008, INT J CLIMATOL, V28, P185, DOI 10.1002/joc.1521; Buchanan CM, 2002, ATMOS ENVIRON, V36, P5343, DOI 10.1016/S1352-2310(02)00579-4; Cahynova M, 2009, THEOR APPL CLIMATOL, V96, P57, DOI 10.1007/s00704-008-0097-2; Cassou C, 2004, J CLIMATE, V17, P1055, DOI 10.1175/1520-0442(2004)017<1055:NAWCRS>2.0.CO;2; deCastro M, 2008, CLIM RES, V36, P169, DOI 10.3354/cr00742; Demuzere M, 2009, INT J CLIMATOL, V29, P1796, DOI 10.1002/joc.1821; Demuzere M, 2009, ATMOS CHEM PHYS, V9, P2695, DOI 10.5194/acp-9-2695-2009; Fowler HJ, 2002, J HYDROL, V262, P177, DOI 10.1016/S0022-1694(02)00034-3; Garcia-Herrera R, 2007, J HYDROMETEOROL, V8, P483, DOI 10.1175/JHM578.1; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; GOMEZGESTEIRA M, 2011, CLIMATE RES IN PRESS; Goodess CM, 2002, INT J CLIMATOL, V22, P1593, DOI 10.1002/joc.810; Hipel K.W., 2005, TIME SERIES MODELLIN; Hope PK, 2006, CLIM DYNAM, V26, P765, DOI 10.1007/s00382-006-0116-x; HULME M, 1993, CLIM DYNAM, V9, P95, DOI 10.1007/BF00210012; Huth R, 2000, THEOR APPL CLIMATOL, V67, P1, DOI 10.1007/s007040070012; Huth R, 2001, INT J CLIMATOL, V21, P135, DOI 10.1002/joc.605; Huth R, 2008, ANN NY ACAD SCI, V1146, P105, DOI 10.1196/annals.1446.019; James PM, 2008, USE SYNOPTIC REGIME; JONES PD, 1993, INT J CLIMATOL, V13, P655, DOI 10.1002/joc.3370130606; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Karl TR, 2000, GEOPHYS RES LETT, V27, P719, DOI 10.1029/1999GL010877; Kendall M. G., 1975, RANK CORRELATION MET; Kysely J, 2008, GLOBAL PLANET CHANGE, V62, P147, DOI 10.1016/j.gloplacha.2008.01.003; Laaidi K, 2001, INT J BIOMETEOROL, V45, P124, DOI 10.1007/s004840100096; Lamb H.H., 1972, METEOROLOGICAL OFFIC, VXVI, P85; Lopez-Moreno JI, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037956; Lorenzo MN, 2008, INT J CLIMATOL, V28, P1493, DOI 10.1002/joc.1646; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Philipp A, 2010, PHYS CHEM EARTH, V35, P360, DOI 10.1016/j.pce.2009.12.010; Ramos AM, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012194; Santos J, 2009, J APPL STAT, V36, P323, DOI 10.1080/02664760802449159; Schoof JT, 2003, INT J CLIMATOL, V23, P1725, DOI 10.1002/joc.969; Siegismund F, 2001, CLIMATE RES, V18, P39, DOI 10.3354/cr018039; Solomon S., 2007, 2007 CLIMATE CHANGE; Stefan S, 2010, PHYS CHEM EARTH, V35, P523, DOI 10.1016/j.pce.2009.12.008; Stephenson DB, 2006, CLIM DYNAM, V27, P401, DOI 10.1007/s00382-006-0140-x; TRENBERTH KE, 1990, B AM METEOROL SOC, V71, P988, DOI 10.1175/1520-0477(1990)071<0988:ROICCI>2.0.CO;2; Trigo RM, 2008, ANN NY ACAD SCI, V1146, P212, DOI 10.1196/annals.1446.014; van Ulden AP, 2006, ATMOS CHEM PHYS, V6, P863, DOI 10.5194/acp-6-863-2006; Walter K, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000850	42	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16201	10.1371/journal.pone.0016201	http://dx.doi.org/10.1371/journal.pone.0016201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283703	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522300019
J	Tepper, N; Shlomi, T				Tepper, Naama; Shlomi, Tomer			Computational Design of Auxotrophy-Dependent Microbial Biosensors for Combinatorial Metabolic Engineering Experiments	PLOS ONE			English	Article							GLUCOSE-LIMITED GROWTH; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; COMPUTER-MODEL; SINGLE-CELL; GENE; RECONSTRUCTION; FRAMEWORK; PATHWAY; CAPABILITIES	Combinatorial approaches in metabolic engineering work by generating genetic diversity in a microbial population followed by screening for strains with improved phenotypes. One of the most common goals in this field is the generation of a high rate chemical producing strain. A major hurdle with this approach is that many chemicals do not have easy to recognize attributes, making their screening expensive and time consuming. To address this problem, it was previously suggested to use microbial biosensors to facilitate the detection and quantification of chemicals of interest. Here, we present novel computational methods to: (i) rationally design microbial biosensors for chemicals of interest based on substrate auxotrophy that would enable their high-throughput screening; (ii) predict engineering strategies for coupling the synthesis of a chemical of interest with the production of a proxy metabolite for which high-throughput screening is possible via a designed bio-sensor. The biosensor design method is validated based on known genetic modifications in an array of E. coli strains auxotrophic to various amino-acids. Predicted chemical production rates achievable via the biosensor-based approach are shown to potentially improve upon those predicted by current rational strain design approaches. (A Matlab implementation of the biosensor design method is available via http://www.cs.technion.ac.il/similar to tomersh/tools).	[Tepper, Naama; Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Tepper, N (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel.	naamat@cs.technion.ac.il; tomersh@cs.technion.ac.il						Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Baez-Viveros JL, 2004, BIOTECHNOL BIOENG, V87, P516, DOI 10.1002/bit.20159; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; Bailey JE, 1996, BIOTECHNOL BIOENG, V52, P109, DOI 10.1002/(SICI)1097-0290(19961005)52:1<109::AID-BIT11>3.3.CO;2-1; BERG CM, 1979, GENETICS, V93, P309; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; BURKHOLDER PR, 1951, SCIENCE, V114, P459, DOI 10.1126/science.114.2966.459; Chalova VI, 2007, APPL MICROBIOL BIOT, V76, P91, DOI 10.1007/s00253-007-0989-6; Chotani G, 2000, BBA-PROTEIN STRUCT M, V1543, P434, DOI 10.1016/S0167-4838(00)00234-X; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; DIAMONT YCE, 2009, MOL BIOSYST, V5, P1732; DOMACH MM, 1984, BIOTECHNOL BIOENG, V26, P203, DOI 10.1002/bit.260260303; Domach MM, 2000, BIOTECHNOL BIOENG, V67, P827, DOI 10.1002/(SICI)1097-0290(20000320)67:6<827::AID-BIT18>3.0.CO;2-N; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Feist AM, 2010, METAB ENG, V12, P173, DOI 10.1016/j.ymben.2009.10.003; FELL D, 1996, UNDERSTANDING CONTRO; FELL DA, 1986, BIOCHEM J, V238, P781, DOI 10.1042/bj2380781; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gill RT, 2002, P NATL ACAD SCI USA, V99, P7033, DOI 10.1073/pnas.102154799; HANI EK, 1994, J BACTERIOL, V176, P1865, DOI 10.1128/jb.176.7.1865-1871.1994; HEATWOLE VM, 1991, J BACTERIOL, V173, P108, DOI 10.1128/jb.173.1.108-115.1991; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; JIN YSS, 2007, METAB ENG, V9; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Kim MI, 2010, ANAL CHEM, V82, P4072, DOI 10.1021/ac100087r; Lee PC, 2002, APPL MICROBIOL BIOT, V60, P1, DOI 10.1007/s00253-002-1101-x; LEI WCY, 2006, ANAL CHIMICA ACTA, V568; LEWIS NEH, 2010, MOL SYSTEMS BIOL, V6; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Okamoto K, 1997, BIOSCI BIOTECH BIOCH, V61, P1877, DOI 10.1271/bbb.61.1877; Park KS, 2003, NAT BIOTECHNOL, V21, P1208, DOI 10.1038/nbt868; PATIL KR, 2005, BMC BIOINFORMATICS, V6, DOI DOI 10.1186/1471-2105-1186-1308; PAYNE JW, 1977, J APPL BACTERIOL, V42, P165, DOI 10.1111/j.1365-2672.1977.tb00682.x; Pfleger BF, 2007, METAB ENG, V9, P30, DOI 10.1016/j.ymben.2006.08.002; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Santos CNS, 2008, CURR OPIN CHEM BIOL, V12, P168, DOI 10.1016/j.cbpa.2008.01.017; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Schilling CH, 2000, BIOTECHNOL BIOENG, V71, P286, DOI 10.1002/1097-0290(2000)71:4<286::AID-BIT1018>3.0.CO;2-R; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Suthers PF, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.56; Tepper N, 2010, BIOINFORMATICS, V26, P536, DOI 10.1093/bioinformatics/btp704; Van Dien SJ, 2002, BIOTECHNOL BIOENG, V78, P296, DOI 10.1002/bit.10200; VARMA A, 1993, BIOTECHNOL BIOENG, V42, P59, DOI 10.1002/bit.260420109; Wright BE, 1997, MICROBIOL-UK, V143, P847, DOI 10.1099/00221287-143-3-847	55	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16274	10.1371/journal.pone.0016274	http://dx.doi.org/10.1371/journal.pone.0016274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283695	gold, Green Published, Green Submitted			2022-12-25	WOS:000286522300027
J	Farke, AA				Farke, Andrew A.			Anatomy and Taxonomic Status of the Chasmosaurine Ceratopsid Nedoceratops hatcheri from the Upper Cretaceous Lance Formation of Wyoming, USA	PLOS ONE			English	Article							WESTERN CANADA; TRICERATOPS; DINOSAURS; ONTOGENY; SKULL; ORNITHISCHIA; ALBERTA	Background: The validity of Nedoceratops hatcheri, a chasmosaurine ceratopsid dinosaur known from a single skull recovered in the Lance Formation of eastern Wyoming, U.S.A., has been debated for over a century. Some have argued that the taxon is an aberrant Triceratops, and most recently it was proposed that N. hatcheri represents an intermediate ontogenetic stage between "young adult'' and "old adult'' forms of a single taxon previously split into Triceratops and Torosaurus. Methodology/Principal Findings: The holotype skull of Nedoceratops hatcheri was reexamined in order to map reconstructed areas and compare the specimen with other ceratopsids. Although squamosal fenestrae are almost certainly not of taxonomic significance, some other features are unique to N. hatcheri. These include a nasal lacking a recognizable horn, nearly vertical postorbital horncores, and relatively small parietal fenestrae. Thus, N. hatcheri is tentatively considered valid, and closely related to Triceratops spp. The holotype of N. hatcheri probably represents an "old adult,'' based upon bone surface texture and the shape of the horns and epiossifications on the frill. In this study, Torosaurus is maintained as a genus distinct from Triceratops and Nedoceratops. Synonymy of the three genera as ontogenetic stages of a single taxon would require cranial changes otherwise unknown in ceratopsids, including additions of ossifications to the frill and repeated alternation of bone surface texture between juvenile and adult morphotypes. Conclusions/Significance: Triceratops, Torosaurus, and likely Nedoceratops, are all distinct taxa, indicating that species richness for chasmosaurine ceratopsids in the Lance Formation just prior to the Cretaceous-Paleocene extinction was roughly equivalent to that earlier in the Cretaceous.	Raymond M Alf Museum Paleontol, Claremont, CA 91711 USA		Farke, AA (corresponding author), Raymond M Alf Museum Paleontol, Claremont, CA 91711 USA.	afarke@webb.org		Farke, Andrew/0000-0002-6930-2002	National Science Foundation [EAR 0819953]; Division Of Earth Sciences [0819953] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by a grant from the National Science Foundation (EAR 0819953; http://www.nsf.gov/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN BARNUM, 1940, ANN NEW YORK ACAD SCI, V40, P133; Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; COBABE EA, 1987, J PALEONTOL, V61, P148, DOI 10.1017/S0022336000028298; COLBERT EDWIN H., 1947, PROC ACAD NAT SCI PHILADELPHIA, V99, P93; DODSON P, 1988, CAN J EARTH SCI, V25, P926, DOI 10.1139/e88-090; Dodson P, 1997, ENCY DINOSAURS, P473; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Farke Andrew A., 2007, P235; Farke AA, 2010, J VERTEBR PALEONTOL, V30, P1486, DOI 10.1080/02724634.2010.501436; Forster A., 1869, VERHANDLUNGEN NATURH, V25, P135; Forster CA, 1996, J VERTEBR PALEONTOL, V16, P246, DOI 10.1080/02724634.1996.10011312; Forster CA, 1996, J VERTEBR PALEONTOL, V16, P259, DOI 10.1080/02724634.1996.10011313; Forster Catherine A., 1993, Journal of Vertebrate Paleontology, V13, P161; Godfrey SJ, 1995, J VERTEBR PALEONTOL, V15, P726, DOI 10.1080/02724634.1995.10011258; Goodwin Mark B., 2010, P551; Goodwin MB, 2006, J VERTEBR PALEONTOL, V26, P103, DOI 10.1671/0272-4634(2006)26[103:TSKTSN]2.0.CO;2; Hatcher J. B., 1907, MONOGRAPHS US GEOLOG, VXLIX, DOI DOI 10.5962/BHL.TITLE.60500; Hatcher JB, 1905, AM J SCI, V20, P413; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Kirkland James I., 2010, P117; Lambe LM., 1915, CANADA GEOLOGICAL SU, V12, P1; Lehman T.M., 1989, Journal of Vertebrate Paleontology, V9, P137; Lehman TM, 1998, J PALEONTOL, V72, P894, DOI 10.1017/S0022336000027220; Loewen Mark A., 2010, P99; Longrich NR, 2010, J PALEONTOL, V84, P681, DOI 10.1666/09-114.1; LULL RS, 1933, YALE PEABODY MUSEUM, V3, P1; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; MARSH OC, 1898, AM J SCI 4, V6, P92; Marsh OC., 1888, AM J SCI, V36, P477, DOI [10.2475/ajs.s3-36.216.477, DOI 10.2475/AJS.S3-36.216.477.]; Mateus O, 2008, J PALEONTOL, V82, P423, DOI 10.1666/07-069.1; Ostrom J.H., 1986, Zitteliana, V14, P111; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; PADIAN K, 1993, NEW MEXICO MUSEUM NA, V3, P379; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Scannella J.B., 2009, CINCINNATI MUSEUM CT, V3, P148; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Tanke Darren H., 2007, P319; Tsuihiji T, 2010, ANAT REC, V293, P1360, DOI 10.1002/ar.21191; Tumarkin-Deratzian Allison R., 2010, P251; Ukrainsky A.S., 2007, Zoosystematica Rossica, V16, P292; Wu XC, 2007, CAN J EARTH SCI, V44, P1243, DOI 10.1139/e07-011	44	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16196	10.1371/journal.pone.0016196	http://dx.doi.org/10.1371/journal.pone.0016196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283763	gold, Green Submitted, Green Published			2022-12-25	WOS:000286522200036
J	Kissner, TL; Ruthel, G; Alam, S; Ulrich, RG; Fernandez, S; Saikh, KU				Kissner, Teri L.; Ruthel, Gordon; Alam, Shahabuddin; Ulrich, Robert G.; Fernandez, Stefan; Saikh, Kamal U.			Activation of MyD88 Signaling upon Staphylococcal Enterotoxin Binding to MHC Class II Molecules	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; BRUTONS-TYROSINE KINASE; TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; FACTOR-ALPHA GENES; HUMAN-MONOCYTES; T-CELLS; HLA-DR; TRANSCRIPTIONAL ACTIVATION; CYTOKINE EXPRESSION	Ligands binding to Toll-like receptor (TLR), interleukin 1 receptor (IL-1R), or IFN-gamma R1 are known to trigger MyD88-mediated signaling, which activates pro-inflammatory cytokine responses. Recently we reported that staphylococcal enterotoxins (SEA or SEB), which bind to MHC class II molecules on APCs and cross link T cell receptors, activate MyD88-mediated proinflammatory cytokine responses. We also reported that MyD88(-/-) mice were resistant to SE-induced toxic shock and had reduced levels of serum cytokines. In this study, we investigated whether MHC class II-SE interaction by itself is sufficient to activate MyD88 in MHC class II(+) cells and induce downstream pro-inflammatory signaling and production of cytokines such as TNF-alpha and IL-1 beta. Here we report that human monocytes treated with SEA, SEB, or anti-MHC class II monoclonal antibodies up regulated MyD88 expression, induced activation of NF-kB, and increased expression of IL-1R1 accessory protein, TNF-alpha and IL-1 beta. MyD88 immunoprecipitated from cell extracts after SEB stimulation showed a greater proportion of MyD88 phosphorylation compared to unstimulated cells indicating that MyD88 was a component of intracellular signaling. MyD88 downstream proteins such as IRAK4 and TRAF6 were also up regulated in monocytes after SEB stimulation. In addition to monocytes, primary B cells up regulated MyD88 in response to SEA or SEB stimulation. Importantly, in contrast to primary B cells, MHC class II deficient T2 cells had no change of MyD88 after SEA or SEB stimulation, whereas MHC class II-independent activation of MyD88 was elicited by CpG or LPS. Collectively, these results demonstrate that MHC class II utilizes a MyD88-mediated signaling mechanism when in contact with ligands such as SEs to induce pro-inflammatory cytokines.	[Kissner, Teri L.; Ruthel, Gordon; Alam, Shahabuddin; Ulrich, Robert G.; Fernandez, Stefan; Saikh, Kamal U.] USA, Med Res Inst Infect Dis, Dept Immunol, Frederick, MD 21702 USA		Kissner, TL (corresponding author), USA, Med Res Inst Infect Dis, Dept Immunol, Frederick, MD 21702 USA.	kamal.saikh@amedd.army.mil	Ruthel, Gordon/GYU-9133-2022	Ruthel, Gordon/0000-0001-9193-5589	Defense Threat Reduction Agency (DTRA) [CBM.THRTOX.03.10.RD.006]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Defense Threat Reduction Agency (DTRA; WWW.jpras.us) Grant CBM.THRTOX.03.10.RD.006 to Kamal U. Saikh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alugupalli KR, 2007, J IMMUNOL, V178, P3740, DOI 10.4049/jimmunol.178.6.3740; Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Becart S, 2003, J CELL SCI, V116, P2565, DOI 10.1242/jcs.00449; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Buatois V, 2003, J IMMUNOL, V171, P5812, DOI 10.4049/jimmunol.171.11.5812; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; CAMBIER JC, 1991, J IMMUNOL, V146, P2075; CAMBIER JC, 1987, NATURE, V327, P629, DOI 10.1038/327629a0; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; FAASSEN AE, 1995, J IMMUNOL, V155, P1737; FISCHER H, 1989, J IMMUNOL, V142, P3151; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; GORGA JC, 1986, CELL IMMUNOL, V103, P160, DOI 10.1016/0008-8749(86)90077-8; Graves DT, 2000, INFECT IMMUN, V68, P4746, DOI 10.1128/IAI.68.8.4746-4751.2000; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; HAUSCHILDT S, 1993, EUR J IMMUNOL, V23, P2988, DOI 10.1002/eji.1830231139; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kissner TL, 2010, IMMUNOLOGY, V130, P516, DOI 10.1111/j.1365-2567.2010.03249.x; KISSNER TL, 2010, INNATE IMMU IN PRESS; LANE PJL, 1990, J IMMUNOL, V144, P3684; MATSUYAMA S, 1993, EUR J IMMUNOL, V23, P3194, DOI 10.1002/eji.1830231223; MOLLICK JA, 1989, SCIENCE, V244, P817, DOI 10.1126/science.2658055; MOONEY NA, 1990, J IMMUNOL, V145, P2070; MOURAD W, 1990, J EXP MED, V172, P1513, DOI 10.1084/jem.172.5.1513; O'Neill LAJ, 2003, BIOCHEM SOC T, V31, P643, DOI 10.1042/BST0310643; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; PALKAMA T, 1989, SCAND J IMMUNOL, V29, P609; PALKAMA T, 1993, HUM IMMUNOL, V36, P259, DOI 10.1016/0198-8859(93)90133-L; Rich T, 1997, J IMMUNOL, V159, P3792; Saikh KU, 2004, J IMMUNOL, V173, P7426, DOI 10.4049/jimmunol.173.12.7426; Saikh KU, 2003, J INFECT DIS, V188, P1562, DOI 10.1086/379196; Saikh KU, 2001, CLIN EXP IMMUNOL, V126, P447, DOI 10.1046/j.1365-2249.2001.01672.x; SCHOLL P, 1989, P NATL ACAD SCI USA, V86, P4210, DOI 10.1073/pnas.86.11.4210; SPERTINI F, 1992, J IMMUNOL, V149, P65; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TREDE NS, 1991, J IMMUNOL, V146, P2310; Ulrich RG, 1995, TRENDS MICROBIOL, V3, P463, DOI 10.1016/S0966-842X(00)89011-3; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; Xi CX, 2010, J LEUKOCYTE BIOL, V87, P415, DOI 10.1189/jlb.0309125; Zilber MT, 2005, BLOOD, V106, P3074, DOI 10.1182/blood-2004-10-4094	48	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15985	10.1371/journal.pone.0015985	http://dx.doi.org/10.1371/journal.pone.0015985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283748	gold, Green Published, Green Submitted			2022-12-25	WOS:000286522200021
J	Zhou, XA; Takatoh, J; Wang, F				Zhou, Xiang; Takatoh, Jun; Wang, Fan			The Mammalian Class 3 PI3K (PIK3C3) Is Required for Early Embryogenesis and Cell Proliferation	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; EARLY EMBRYONIC LETHALITY; DAB2 ADAPTER PROTEIN; HEART TUBE FORMATION; TRANSCRIPTION FACTOR; VISCERAL ENDODERM; MOUSE EMBRYO; PHOSPHOINOSITIDE 3-KINASE; SACCHAROMYCES-CEREVISIAE; VENTRAL MORPHOGENESIS	The Pik3c3 gene encodes an 887 amino acid lipid kinase, phosphoinositide-3-kinase class 3 (PIK3C3). PIK3C3 is known to regulate various intracellular membrane trafficking events. However, little is known about its functions during early embryogenesis in mammals. To investigate the function of PIK3C3 in vivo, we generated Pik3c3 null mice. We show here that Pik3c3 heterozygous are normal and fertile. In contrast, Pik3c3 homozygous mutants are embryonic lethal and die between E7.5 and E8.5 of embryogenesis. Mutant embryos are poorly developed with no evidence of mesoderm formation, and suffer from severely reduced cell proliferations. Cell proliferation defect is also evident in vitro, where mutant blastocysts in culture fail to give rise to typical colonies formed by inner cell mass. Electron microscopic analysis revealed that epiblast cells in mutant embryos appear normal, whereas the visceral endoderm cells contain larger vesicles inside the lipid droplets. Finally, we provide evidence that mTOR signaling is drastically reduced in Pik3c3 null embryos, which could be a major contributor to the observed proliferation and embryogenesis defects.	[Zhou, Xiang; Takatoh, Jun; Wang, Fan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Zhou, Xiang; Wang, Fan] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University	Zhou, XA (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	f.wang@cellbio.duke.edu		Takatoh, Jun/0000-0002-0976-7684	McKnight Scholar Award; Wings for Life Foundation	McKnight Scholar Award; Wings for Life Foundation	This work is supported by the McKnight Scholar Award and the Wings for Life Foundation to F.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Bielinska M, 1999, INT J DEV BIOL, V43, P183; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; DUNCAN SA, 1994, P NATL ACAD SCI USA, V91, P7598, DOI 10.1073/pnas.91.16.7598; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; GWATKIN RBL, 1966, ANN MED EXP BIOL FEN, V44, P125; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Martin PM, 2001, DEV BIOL, V240, P182, DOI 10.1006/dbio.2001.0461; Maurer ME, 2005, J CELL SCI, V118, P5345, DOI 10.1242/jcs.02650; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Murray JT, 2002, TRAFFIC, V3, P416, DOI 10.1034/j.1600-0854.2002.30605.x; NAESLUND G, 1979, UPSALA J MED SCI, V84, P9, DOI 10.3109/03009737909179136; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Nobukuni T, 2007, CURR OPIN CELL BIOL, V19, P135, DOI 10.1016/j.ceb.2007.02.019; Obara K, 2008, J BIOL CHEM, V283, P23972, DOI 10.1074/jbc.M803180200; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; POWER MA, 1993, ANAT EMBRYOL, V187, P493; Roggo L, 2002, EMBO J, V21, P1673, DOI 10.1093/emboj/21.7.1673; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Skanland SS, 2007, TRAFFIC, V8, P297, DOI 10.1111/j.1600-0854.2006.00527.x; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; TARAVIRAS S, 1994, MECH DEVELOP, V48, P67, DOI 10.1016/0925-4773(94)90017-5; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Zhou X, 2007, P NATL ACAD SCI USA, V104, P5842, DOI 10.1073/pnas.0701402104; Zhou XA, 2010, AUTOPHAGY, V6, P798, DOI 10.4161/auto.6.6.12511; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	66	61	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16358	10.1371/journal.pone.0016358	http://dx.doi.org/10.1371/journal.pone.0016358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283715	Green Published, gold			2022-12-25	WOS:000286522200056
J	Qiu, JZ; Zhang, XR; Luo, MJ; Li, HG; Dong, J; Wang, JF; Leng, BF; Wang, XL; Feng, HH; Ren, WZ; Deng, XM				Qiu, Jiazhang; Zhang, Xiaoran; Luo, Mingjing; Li, Hongen; Dong, Jing; Wang, Jianfeng; Leng, Bingfeng; Wang, Xiaoliang; Feng, Haihua; Ren, Wenzhi; Deng, Xuming			Subinhibitory Concentrations of Perilla Oil Affect the Expression of Secreted Virulence Factor Genes in Staphylococcus aureus	PLOS ONE			English	Article							PLANT ESSENTIAL OILS; ANTIBACTERIAL ACTIVITY	Background: The pathogenicity of staphylococcus aureus is dependent largely upon its ability to secrete a number of virulence factors, therefore, anti-virulence strategy to combat S. aureus-mediated infections is now gaining great interest. It is widely recognized that some plant essential oils could affect the production of staphylococcal exotoxins when used at subinhibitory concentrations. Perilla [Perilla frutescens (L.) Britton], a natural medicine found in eastern Asia, is primarily used as both a medicinal and culinary herb. Its essential oil (perilla oil) has been previously demonstrated to be active against S. aureus. However, there are no data on the influence of perilla oil on the production of S. aureus exotoxins. Methodology/Principal Findings: A broth microdilution method was used to determine the minimum inhibitory concentrations (MICs) of perilla oil against S. aureus strains. Hemolysis, tumour necrosis factor (TNF) release, Western blot, and real-time RT-PCR assays were performed to evaluate the effects of subinhibitory concentrations of perilla oil on exotoxins production in S. aureus. The data presented here show that perilla oil dose-dependently decreased the production of a-toxin, enterotoxins A and B (the major staphylococcal enterotoxins), and toxic shock syndrome toxin 1 (TSST-1) in both methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA). Conclusions/Significance: The production of alpha-toxin, SEA, SEB, and TSST-1 in S. aureus was decreased by perilla oil. These data suggest that perilla oil may be useful for the treatment of S. aureus infections when used in combination with beta-lactam antibiotics, which can increase exotoxins production by S. aureus at subinhibitory concentrations. Furthermore, perilla oil could be rationally applied in food systems as a novel food preservative both to inhibit the growth of S. aureus and to repress the production of exotoxins, particularly staphylococcal enterotoxins.	[Qiu, Jiazhang; Luo, Mingjing; Li, Hongen; Dong, Jing; Wang, Jianfeng; Leng, Bingfeng; Wang, Xiaoliang; Feng, Haihua; Ren, Wenzhi; Deng, Xuming] Jilin Univ, Coll Anim Sci & Vet Med, Inst Zoonosis, Key Lab Zoonosis,Minist Educ, Changchun 130023, Peoples R China; [Zhang, Xiaoran] Jilin Univ, Coll Chem, Changchun 130023, Peoples R China	Jilin University; Jilin University	Qiu, JZ (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Inst Zoonosis, Key Lab Zoonosis,Minist Educ, Changchun 130023, Peoples R China.	rwz1964@163.com; dengxm@jlu.edu.cn			National Nature Science Foundation of China [30972212]; Chinese Postdoctoral Science Foundation [20090461034]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Nature Science Foundation of China (No. 30972212) and the Chinese Postdoctoral Science Foundation (No. 20090461034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit-Vical F, 2006, CHEMOTHERAPY, V52, P288, DOI 10.1159/000095960; Bernardo K, 2004, ANTIMICROB AGENTS CH, V48, P546, DOI 10.1128/AAC.48.2.546-555.2004; CARSON CF, 1995, J ANTIMICROB CHEMOTH, V35, P421, DOI 10.1093/jac/35.3.421; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Cheung AL, 2002, FRONT BIOSCI-LANDMRK, V7, pD1825, DOI 10.2741/cheung; Corpet DE, 2002, NUTR CANCER, V43, P1, DOI 10.1207/S15327914NC431_1; Derakhshan S, 2008, INT J ANTIMICROB AG, V32, P432, DOI 10.1016/j.ijantimicag.2008.05.009; Herbert S, 2001, INFECT IMMUN, V69, P2996, DOI 10.1128/IAI.69.5.2996-3003.2001; Inouye Shigeharu, 2001, Journal of Antimicrobial Chemotherapy, V47, P565, DOI 10.1093/jac/47.5.565; Ito M, 2008, J NAT MED, V62, P387, DOI 10.1007/s11418-008-0262-z; Jones TF, 2002, EMERG INFECT DIS, V8, P82, DOI 10.3201/eid0801.010174; Kalemba D, 2003, CURR MED CHEM, V10, P813, DOI 10.2174/0929867033457719; Koszczol C, 2006, J ANTIMICROB CHEMOTH, V58, P564, DOI 10.1093/jac/dkl291; Kuroda H, 2007, FEMS MICROBIOL LETT, V268, P98, DOI 10.1111/j.1574-6968.2006.00568.x; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; O'Brien GJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-115; Okamoto M, 2000, INTERNAL MED, V39, P107, DOI 10.2169/internalmedicine.39.107; Okuyama H, 2007, LIPIDS, V42, P821, DOI 10.1007/s11745-007-3073-1; Qiu JZ, 2010, APPL ENVIRON MICROB, V76, P5846, DOI 10.1128/AEM.00704-10; Qiu JZ, 2010, FEMS MICROBIOL LETT, V307, P135, DOI 10.1111/j.1574-6968.2010.01973.x; Qiu JZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009736; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Saliba R, 2009, IMMUNOPHARM IMMUNOT, V31, P583, DOI 10.3109/08923970902838672; Sambanthamoorthy K, 2006, MICROBIOL-SGM, V152, P2559, DOI 10.1099/mic.0.29071-0; Senatore F, 2007, FITOTERAPIA, V78, P244, DOI 10.1016/j.fitote.2006.11.010; Smith-Palmer A, 2004, J MED MICROBIOL, V53, P1023, DOI 10.1099/jmm.0.45567-0; Smith-Palmer A, 2001, FOOD MICROBIOL, V18, P463, DOI 10.1006/fmic.2001.0415; Stewart CM, 2002, APPL ENVIRON MICROB, V68, P1864, DOI 10.1128/AEM.68.4.1864-1871.2002; Valero M, 2006, FOOD MICROBIOL, V23, P68, DOI 10.1016/j.fm.2005.01.016; WATANABE S, 1994, J NUTR, V124, P1566, DOI 10.1093/jn/124.9.1566; Yamada K, 2000, BIOFACTORS, V13, P167, DOI 10.1002/biof.5520130127; YAMAMOTO N, 1987, J LIPID RES, V28, P144	32	67	73	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16160	10.1371/journal.pone.0016160	http://dx.doi.org/10.1371/journal.pone.0016160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283822	Green Submitted, Green Published, gold			2022-12-25	WOS:000286520600026
J	Joly, N; Buck, M				Joly, Nicolas; Buck, Martin			Single Chain Forms of the Enhancer Binding Protein PspF Provide Insights into Geometric Requirements for Gene Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA PLUS PROTEIN; ESCHERICHIA-COLI; RNA-POLYMERASE; TRANSCRIPTIONAL ACTIVATION; SIGMA(54) SIGMA(N); STRUCTURAL BASIS; DNA-REPLICATION; ATP-HYDROLYSIS; PROMOTER DNA; PORE LOOPS	Genetic information in the DNA is accessed by the molecular machine RNA polymerase following a highly conserved process, invariably involving the transition between double-stranded and single-stranded DNA states. In the case of the bacterial enhancer-dependent RNA polymerase (which is essential for adaptive responses and bacterial pathogenesis), the DNA melting event depends on specialized hexameric AAA+ ATPase activators. Involvement of such factors in transcription was demonstrated 25 years ago, but why these activators need to be hexameric, whether all the subunits operate identically, what is the contribution of each of the six subunits within the hexamer (structural, functional, or both), and how many active subunits are required for transcription activation remain open questions. Using engineered single-chain polypeptides covalently linking two or three subunits of the activator (allowing the subunit distribution within a hexamer to be fixed), we now show that (i) individual subunits have differential contributions to the activities of the oligomer and (ii) only a fraction of the subunits within the hexameric ATPase is directly required for gene activation. We establish that nucleotide-dependent coordination across three subunits of the hexameric bacterial enhancer binding proteins (bEBPs) is necessary for engagement and remodeling of the closed complex (RPc). Outcomes revealed features of bEBP, distinguishing their mode of action from fully processive AAA+ proteins or from simple bimodal switches. We now propose that the hexamer functions with asymmetric organization, potentially involving a split planar (open ring) or spiral character.	Univ Paris Diderot, Inst Jacques Monod, CNRS UMR 7592, F-75205 Paris 13, France; [Joly, Nicolas; Buck, Martin] Univ London Imperial Coll Sci Technol & Med, Div Biol, London SW7 2AZ, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Imperial College London	Joly, N (corresponding author), Univ Paris Diderot, Inst Jacques Monod, CNRS UMR 7592, Batiment Buffon,15 Rue Helene Brion, F-75205 Paris 13, France.	joly@ijm.univ-paris-diderot.fr; m.buck@imperial.ac.uk	Joly, Nicolas/H-6851-2018	Joly, Nicolas/0000-0003-2731-3827	Biotechnology and Biological Sciences Research Council [BB/G001278/1]; BBSRC [BB/G001278/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/G001278/1.	Barry ER, 2009, P NATL ACAD SCI USA, V106, P1051, DOI 10.1073/pnas.0809192106; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bordes P, 2003, P NATL ACAD SCI USA, V100, P2278, DOI 10.1073/pnas.0537525100; Bose D, 2008, MOL CELL, V32, P337, DOI 10.1016/j.molcel.2008.09.015; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; BUCK M, 1992, NATURE, V358, P422, DOI 10.1038/358422a0; Burrows PC, 2010, P NATL ACAD SCI USA, V107, P9376, DOI 10.1073/pnas.1001188107; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Joly N, 2006, J BIOL CHEM, V281, P34997, DOI 10.1074/jbc.M606628200; Joly N, 2010, J BIOL CHEM, V285, P15178, DOI 10.1074/jbc.M110.103150; Jovanovic G, 1997, MOL MICROBIOL, V25, P473, DOI 10.1046/j.1365-2958.1997.4791844.x; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Model P, 1997, MOL MICROBIOL, V24, P255, DOI 10.1046/j.1365-2958.1997.3481712.x; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Neuwald AF, 1999, GENOME RES, V9, P27; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2008, BIOCHEM SOC T, V36, P68, DOI 10.1042/BST0360068; Rappas M, 2006, J MOL BIOL, V357, P481, DOI 10.1016/j.jmb.2005.12.052; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Schumacher J, 2006, J STRUCT BIOL, V156, P190, DOI 10.1016/j.jsb.2006.01.006; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Wigneshweplaraj SR, 2005, PROG NUCLEIC ACID RE, V79, P339, DOI 10.1016/S0079-6603(04)79007-8; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x	41	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.203554	http://dx.doi.org/10.1074/jbc.M110.203554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21300807	hybrid, Green Published			2022-12-25	WOS:000289077500084
J	Oloo, EO; Yethon, JA; Ochs, MM; Carpick, B; Oomen, R				Oloo, Eliud O.; Yethon, Jeremy A.; Ochs, Martina M.; Carpick, Bruce; Oomen, Raymond			Structure-guided Antigen Engineering Yields Pneumolysin Mutants Suitable for Vaccination against Pneumococcal Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSINS; STREPTOCOCCUS-PNEUMONIAE; PROTEIN CONFORMATION; MOLECULAR-DYNAMICS; TOXIN PNEUMOLYSIN; MEMBRANE-PROTEINS; PORE FORMATION; VACCINES; STABILIZATION; IMMUNIZATION	Pneumolysin (PLY) is a cholesterol-binding, pore-forming protein toxin. It is an important virulence factor of Streptococcus pneumoniae and a key vaccine target against pneumococcal disease. We report a systematic structure-driven approach that solves a long-standing problem for vaccine development in this field: detoxification of PLY with retention of its antigenic integrity. Using three conformational restraint techniques, we rationally designed variants of PLY that lack hemolytic activity and yet induce neutralizing antibodies against the wild-type toxin. These results represent a key milestone toward a broad-spectrum protein-based pneumococcal vaccine and illustrate the value of structural knowledge in formulating effective strategies for antigen optimization.	[Oloo, Eliud O.; Yethon, Jeremy A.; Ochs, Martina M.; Carpick, Bruce; Oomen, Raymond] Sanofi Pasteur, Toronto, ON M2R 3T4, Canada	Sanofi-Aventis	Oloo, EO (corresponding author), Sanofi Pasteur, 38 Sidney St, Cambridge, MA 02139 USA.	eliud.oloo@sanofipasteur.com						ALEXANDER JE, 1994, INFECT IMMUN, V62, P5683, DOI 10.1128/IAI.62.12.5683-5688.1994; [Anonymous], 2003, Weekly Epidemiological Record, V78, P110; Ash WL, 2004, BBA-BIOMEMBRANES, V1666, P158, DOI 10.1016/j.bbamem.2004.04.012; Berman HM, 2009, NUCLEIC ACIDS RES, V37, pD365, DOI 10.1093/nar/gkn790; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERRY AM, 1995, INFECT IMMUN, V63, P1969, DOI 10.1128/IAI.63.5.1969-1974.1995; Black S, 2008, VACCINES, P531; Choi EJ, 2006, PROTEIN ENG DES SEL, V19, P285, DOI 10.1093/protein/gzl007; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Del Giudice G, 1999, SCHWEIZ MED WSCHR, V129, P1744; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; FELDMAN C, 1991, AM J RESP CELL MOL, V5, P416, DOI 10.1165/ajrcmb/5.5.416; FERRANTE A, 1984, INFECT IMMUN, V46, P585, DOI 10.1128/IAI.46.2.585-589.1984; GIANNINI G, 1984, NUCLEIC ACIDS RES, V12, P4063, DOI 10.1093/nar/12.10.4063; Gilbert RJC, 2002, CELL MOL LIFE SCI, V59, P832, DOI 10.1007/s00018-002-8471-1; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kirkham LAS, 2006, INFECT IMMUN, V74, P586, DOI 10.1128/IAI.74.1.586-593.2006; Korchev YE, 1998, BIOCHEM J, V329, P571; Lindahl E, 2008, CURR OPIN STRUC BIOL, V18, P425, DOI 10.1016/j.sbi.2008.02.003; LOCK RA, 1988, MICROB PATHOGENESIS, V5, P461, DOI 10.1016/0882-4010(88)90007-1; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; MITCHELL TJ, 1990, NUCLEIC ACIDS RES, V18, P4010, DOI 10.1093/nar/18.13.4010; Nollmann M, 2004, BIOPHYS J, V86, P3141, DOI 10.1016/S0006-3495(04)74362-3; Paton James C., 2008, P421; PATON JC, 1983, INFECT IMMUN, V40, P548, DOI 10.1128/IAI.40.2.548-552.1983; PATON JC, 1983, INFECT IMMUN, V41, P1212, DOI 10.1128/IAI.41.3.1212-1216.1983; Paton JC, 1996, TRENDS MICROBIOL, V4, P103, DOI 10.1016/0966-842X(96)81526-5; Pletz MW, 2008, INT J ANTIMICROB AG, V32, P199, DOI 10.1016/j.ijantimicag.2008.01.021; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; RAPPUOLI R, 1994, VACCINE, V12, P579, DOI 10.1016/0264-410X(94)90259-3; Reiter Y, 1995, PROTEIN ENG, V8, P1323, DOI 10.1093/protein/8.12.1323; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SAUNDERS FK, 1989, INFECT IMMUN, V57, P2547, DOI 10.1128/IAI.57.8.2547-2552.1989; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Vieille C, 1996, Biotechnol Annu Rev, V2, P1, DOI 10.1016/S1387-2656(08)70006-1; Walz T, 2005, MOL CELL, V18, P393, DOI 10.1016/j.molcel.2005.04.018; Wriggers W, 1997, PROTEINS, V29, P1	47	26	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.191148	http://dx.doi.org/10.1074/jbc.M110.191148			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21296887	Green Published, hybrid			2022-12-25	WOS:000289077500028
J	Tu, QS; Zhang, J; Dong, LQ; Saunders, E; Luo, E; Tang, JA; Chen, JK				Tu, Qisheng; Zhang, Jin; Dong, Lily Q.; Saunders, Eileen; Luo, En; Tang, Jean; Chen, Jake			Adiponectin Inhibits Osteoclastogenesis and Bone Resorption via APPL1-mediated Suppression of Akt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; MINERAL DENSITY; ADIPOSE-TISSUE; PERIODONTAL-DISEASE; INSULIN-RESISTANCE; PLASMA-CONCENTRATIONS; SIGNALING PATHWAY; IN-VIVO; OBESITY	Adiponectin is an adipokine playing an important role in regulating energy homeostasis and insulin sensitivity. However, the effect of adiponectin on bone metabolism shows contradictory results according to different research studies. In this study femurs were isolated from genetically double-labeled mBSP9.0Luc/beta-ACT-EGFP transgenic mice and were transplanted into adiponectin knock-out mice or wild type mice to investigate the effect of temporary exposure to adiponectin deficiency on bone growth and metabolism. We found that the growth of bone explants in adiponectin knock-out mice was significantly retarded. Histological analysis, microcomputed tomography analysis, and tartrate-resistant acid phosphatase staining revealed reduced trabecular bone volume, decreased cortical bone, and increased osteoclast number in bone explants in adiponectin knock-out mice. We then found that adiponectin inhibits RANKL-induced osteoclastogenesis from RAW264.7 cells and down-regulates RANKL-enhanced expressions of osteoclastogenic regulators including NFAT2, TRAF6, cathepsin K, and tartrate-resistant acid phosphatase. Adiponectin also increases osteoclast apoptosis and decreases survival/proliferation of osteoclast precursor cells. Using siRNA specifically targeting APPL1, the first identified adaptor protein of adiponectin signaling, we found that the inhibitory effect of adiponectin on osteoclasts was induced by APPL1-mediated down-regulation of Akt1 activity. In addition, overexpression of Akt1 successfully reversed adiponectin- induced inhibition in RANKL-stimulated osteoclast differentiation. In conclusion, adiponectin is important in maintaining the balance of energy metabolism, inflammatory responses, and bone formation.	[Tu, Qisheng; Zhang, Jin; Saunders, Eileen; Luo, En; Tang, Jean; Chen, Jake] Tufts Univ, Sch Dent Med, Dept Gen Dent, Div Oral Biol, Boston, MA 02111 USA; [Zhang, Jin] Shandong Univ, Sch Dent, Jinan 250012, Shandong, Peoples R China; [Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol Cellular & Struct Biol, San Antonio, TX 78229 USA; [Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78229 USA	Tufts University; Shandong University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Chen, JK (corresponding author), Tufts Univ, Sch Dent Med, Dept Gen Dent, Div Oral Biol, Boston, MA 02111 USA.	jk.chen@tufts.edu		Luo, En/0000-0002-7447-1097; Tu, Qisheng/0000-0003-0639-8761; Chen, Jake/0000-0001-8829-7504	National Institutes of Health [DE14537, DE16710]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014537, R01DE016710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant Grants DE14537 and DE16710 (to J. C.)	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; Araneta MRG, 2009, J BONE MINER RES, V24, P2016, DOI [10.1359/JBMR.090519, 10.1359/jbmr.090519]; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Dacquin R, 2004, J CELL BIOL, V164, P509, DOI 10.1083/jcb.200312135; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Ealey KN, 2008, EXP BIOL MED, V233, P1546, DOI 10.3181/0806-RM-192; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Goulding A, 2005, J BONE MINER RES, V20, P2090, DOI 10.1359/JBMR.050820; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kanazawa I, 2010, METABOLISM, V59, P1252, DOI 10.1016/j.metabol.2009.11.017; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Lee HW, 2009, STEM CELLS, V27, P2254, DOI 10.1002/stem.144; Lenchik L, 2003, BONE, V33, P646, DOI 10.1016/S8756-3282(03)00237-0; Li S, 2008, J CELL PHYSIOL, V215, P204, DOI 10.1002/jcp.21302; Luo XH, 2006, J BONE MINER RES, V21, P1648, DOI 10.1359/JBMR.060707; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; NELSON RG, 1990, DIABETES CARE, V13, P836, DOI 10.2337/diacare.13.8.836; Oh KW, 2005, CLIN ENDOCRINOL, V63, P131, DOI 10.1111/j.1365-2265.2005.02312.x; Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210; Pischon N, 2007, J DENT RES, V86, P400, DOI 10.1177/154405910708600503; Preshaw PM, 2007, PERIODONTOL 2000, V45, P138, DOI 10.1111/j.1600-0757.2007.00221.x; Ravn P, 1999, J BONE MINER RES, V14, P1622, DOI 10.1359/jbmr.1999.14.9.1622; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Saito T, 1998, NEW ENGL J MED, V339, P482, DOI 10.1056/NEJM199808133390717; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Shinoda Y, 2006, J CELL BIOCHEM, V99, P196, DOI 10.1002/jcb.20890; Shishodia S, 2006, ONCOGENE, V25, P1463, DOI 10.1038/sj.onc.1209194; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stolk RP, 1996, BONE, V18, P545, DOI 10.1016/8756-3282(96)00079-8; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Tanaka H, 2004, J STEROID BIOCHEM, V89-90, P343, DOI 10.1016/j.jsbmb.2004.03.021; Tu Q, 2008, J CELL PHYSIOL, V217, P40, DOI 10.1002/jcp.21472; Tu QS, 2009, J CELL PHYSIOL, V218, P135, DOI 10.1002/jcp.21576; Tu QS, 2004, BIOCHEM BIOPH RES CO, V316, P461, DOI 10.1016/j.bbrc.2004.02.068; Valverde P, 2005, J BONE MINER RES, V20, P1669, DOI 10.1359/JBMR.050511; Valverde P, 2008, J BONE MINER RES, V23, P1775, DOI 10.1359/JBMR.080605; Vondracek Sheryl F, 2009, Int J Chron Obstruct Pulmon Dis, V4, P267; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Williams GA, 2009, ENDOCRINOLOGY, V150, P3603, DOI 10.1210/en.2008-1639; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamaguchi N, 2008, FEBS LETT, V582, P451, DOI 10.1016/j.febslet.2007.12.037; Yamaguchi N, 2007, FEMS IMMUNOL MED MIC, V49, P28, DOI 10.1111/j.1574-695X.2006.00164.x; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572; Zillikens MC, 2010, CALCIFIED TISSUE INT, V86, P116, DOI 10.1007/s00223-009-9319-6	64	90	95	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.152405	http://dx.doi.org/10.1074/jbc.M110.152405			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21300805	Green Published, hybrid			2022-12-25	WOS:000289077500067
J	Gu, R; Lu, W; Xie, J; Bai, JA; Xu, BA				Gu, Rong; Lu, Wen; Xie, Jun; Bai, Jian; Xu, Biao			Renalase Deficiency in Heart Failure Model of Rats-A Potential Mechanism Underlying Circulating Norepinephrine Accumulation	PLOS ONE			English	Article							SYMPATHETIC NERVOUS ACTIVITY; ANGIOTENSIN-II; CARDIAC-FAILURE; BLOOD-PRESSURE; ANG-II; ARTERIAL; IMPAIRMENT; OXIDASE; ROLES	Background: Sympathetic overactivity and catecholamine accumulation are important characteristic findings in heart failure, which contribute to its pathophysiology. Here, we identify a potential mechanism underlying norepinephrine accumulation in a rat model of heart failure. Methodology/Principal Findings: Initially, we constructed a rat model of unilateral renal artery stenosis (n = 16) and found that the expression of renalase, a previously identified secreted amine oxidase, was markedly reduced in the ischemic compared to the non-ischemic kidney (protein: 0.295 +/- 0.085 versus 0.765 +/- 0.171, p<0.05). Subsequently, we utilized an isolated perfused rat kidney model to demonstrate that the clearance rate of norepinephrine decreased with reduction of perfusion flow. On the basis of these findings, we hypothesized the reduced renal blood supply which occurs in heart failure would result in impaired synthesis of renalase by the kidney and consequently reduced degradation of circulating norepinephrine. To verify this, we used a rat model of infarction-induced heart failure (n = 12 per group). In these rats, the flow velocity of renal artery, when measured at four weeks, is obviously lower in the operation group. Renal expression of renalase was reduced (protein: 0.476 +/- 0.043 for control, 0.248 +/- 0.029 for operation versus 0.636 +/- 0.151 for sham-operation) and this was associated with an increase in circulating norepinephrine (0.168 +/- 0.016 ng/mL for control, 0.203 +/- 0.019 ng/mL for operation versus 0.138 +/- 0.008 ng/mL for sham-operation). Conclusions/Significance: Renalase expression is influenced by renal blood flow and impaired synthesis of renalase by the kidney may represent a potential mechanism underlying circulating norepinephrine accumulation in heart failure.	[Gu, Rong; Lu, Wen; Xie, Jun; Bai, Jian; Xu, Biao] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Peoples R China	Nanjing University	Gu, R (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Peoples R China.	xubiao@medmail.com.cn	xie, jun/C-2193-2017	xie, jun/0000-0002-9385-3242	National Natural Science Foundation of China [30170370]; Jiangsu Key Laboratory for Molecular Medicine, Nanjing University [2008]; Department of Health, Jiangsu Province of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory for Molecular Medicine, Nanjing University(Nanjing University); Department of Health, Jiangsu Province of China	This work was supported by grants from the National Natural Science Foundation of China [Research Grant Number 30170370]; the Jiangsu Key Laboratory for Molecular Medicine, Nanjing University [Research Grant 2008]; and Department of Health, Jiangsu Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; DIBNERDUNLAP ME, 1989, CIRC RES, V65, P1526, DOI 10.1161/01.RES.65.6.1526; DIBONA GF, 1995, AM J PHYSIOL-REG I, V268, pR112, DOI 10.1152/ajpregu.1995.268.1.R112; DIBONA GF, 1995, AM J PHYSIOL-REG I, V269, pR1189, DOI 10.1152/ajpregu.1995.269.5.R1189; Gao L, 2004, CIRC RES, V95, P937, DOI 10.1161/01.RES.0000146676.04359.64; Ghosh SS, 2009, PEDIATR NEPHROL, V24, P367, DOI 10.1007/s00467-008-0978-8; HASKING GJ, 1986, CIRCULATION, V73, P615, DOI 10.1161/01.CIR.73.4.615; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; KAYE DM, 1995, J AM COLL CARDIOL, V26, P1257, DOI 10.1016/0735-1097(95)00332-0; Li G, 2008, CIRCULATION, V117, P1277, DOI 10.1161/CIRCULATIONAHA.107.732032; Liang CS, 2007, ACTA PHARMACOL SIN, V28, P921, DOI 10.1111/j.1745-7254.2007.00585.x; Magri P, 1998, CIRCULATION, V98, P2849, DOI 10.1161/01.CIR.98.25.2849; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; MEREDITH IT, 1991, NEW ENGL J MED, V325, P618, DOI 10.1056/NEJM199108293250905; Mircoli L, 2002, CIRCULATION, V106, P866, DOI 10.1161/01.CIR.0000024981.48160.6D; Negrao CE, 2008, HEART FAIL REV, V13, P51, DOI 10.1007/s10741-007-9057-7; REID IA, 1992, AM J PHYSIOL, V262, pE763, DOI 10.1152/ajpendo.1992.262.6.E763; Russo LM, 2006, AM J PHYSIOL-RENAL, V291, pF246, DOI 10.1152/ajprenal.00437.2005; Taft David R, 2004, Curr Drug Discov Technol, V1, P97, DOI 10.2174/1570163043484824; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Zhang J, 2009, CIRCULATION, V119, P1776, DOI 10.1161/CIRCULATIONAHA.108.800565; Zhao Q, 2007, J MOL MED, V85, P877, DOI 10.1007/s00109-006-0151-4; Zucker IH, 2004, PROG BIOPHYS MOL BIO, V84, P217, DOI 10.1016/j.pbiomolbio.2003.11.010	23	63	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14633	10.1371/journal.pone.0014633	http://dx.doi.org/10.1371/journal.pone.0014633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297953	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300015
J	Rova, E; Bjorklund, M				Rova, Emma; Bjorklund, Mats			Can Preference for Oviposition Sites Initiate Reproductive Isolation in Callosobruchus maculatus?	PLOS ONE			English	Article							SYMPATRIC SPECIATION; SEED BEETLE; SEXUAL SELECTION; SANTA ROSALIA; HOST RACES; EVOLUTION; POPULATIONS; COLEOPTERA; BRUCHIDAE; SPECIALIZATION	Theory has identified a variety of evolutionary processes that may lead to speciation. Our study includes selection experiments using different host plants and test key predictions concerning models of speciation based on host plant choice, such as the evolution of host use (preference and performance) and assortative mating. This study shows that after only ten generations of selection on different resources/hosts in allopatry, strains of the seed beetle Callosobruchus maculatus develop new resource preferences and show resource-dependent assortative mating when given the possibility to choose mates and resources during secondary contact. The resulting reduced gene flow between the different strains remained for two generations after contact before being overrun by disassortative mating. We show that reduced gene flow can evolve in a population due to a link between host preference and assortative mating, although this result was not found in all lines. However, consistent with models of speciation, assortative mating alone is not sufficient to maintain reproductive isolation when individuals disperse freely between hosts. We conclude that the evolution of reproductive isolation in this system cannot proceed without selection against hybrids. Other possible factors facilitating the evolution of isolation would be longer periods of allopatry, the build up of local adaptation or reduced migration upon secondary contact.	[Rova, Emma; Bjorklund, Mats] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden	Uppsala University	Rova, E (corresponding author), Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden.	emma.rova@ebc.uu.se		Bjorklund, Mats/0000-0001-5436-6989	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the Swedish Research Council. The funders had no deal in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Coyne JA, 2004, SPECIATION, V37; Dobzhansky T., 1937; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; EADY PE, 1991, ECOL ENTOMOL, V16, P45, DOI 10.1111/j.1365-2311.1991.tb00191.x; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Forister ML, 2005, EVOLUTION, V59, P1149, DOI 10.1111/j.0014-3820.2005.tb01051.x; Fox CW, 2004, HEREDITY, V92, P170, DOI 10.1038/sj.hdy.6800383; Fox CW, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P159; FOX CW, 1993, EVOLUTION, V47, P166, DOI [10.2307/2410126, 10.1111/j.1558-5646.1993.tb01207.x]; Fricke C, 2007, EVOLUTION, V61, P440, DOI 10.1111/j.1558-5646.2007.00038.x; Fry JD, 2003, EVOLUTION, V57, P1735; Gavrilets S, 2004, FITNESS LANDSCAPES O; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; Kawecki TJ, 1998, AM NAT, V152, P635, DOI 10.1086/286195; KILIAS G, 1980, EVOLUTION, V34, P730, DOI 10.1111/j.1558-5646.1980.tb04012.x; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Magalhaes S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-182; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; Messina FJ, 2009, ANN ENTOMOL SOC AM, V102, P181, DOI 10.1603/008.102.0121; RICE WR, 1990, EVOLUTION, V44, P1140, DOI 10.1111/j.1558-5646.1990.tb05221.x; Servedio MR, 2009, HEREDITY, V102, P51, DOI 10.1038/hdy.2008.98; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; SMITH JM, 1966, AM NAT, V100, P637, DOI 10.1086/282457; SOANS AB, 1974, AM NAT, V108, P117, DOI 10.1086/282889; UDOVIC D, 1980, AM NAT, V116, P621, DOI 10.1086/283654; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; WASSERMAN SS, 1981, EVOLUTION, V35, P605, DOI 10.1111/j.1558-5646.1981.tb04923.x; WEIR BS, 1996, GENETIC ANAL, V2	31	12	12	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14628	10.1371/journal.pone.0014628	http://dx.doi.org/10.1371/journal.pone.0014628			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297947	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300010
J	Mattiuzzo, M; Vargiu, G; Totta, P; Fiore, M; Ciferri, C; Musacchio, A; Degrassi, F				Mattiuzzo, Marta; Vargiu, Giulia; Totta, Pierangela; Fiore, Mario; Ciferri, Claudio; Musacchio, Andrea; Degrassi, Francesca			Abnormal Kinetochore-Generated Pulling Forces from Expressing a N-Terminally Modified Hec1	PLOS ONE			English	Article							SPINDLE-POLE ORGANIZATION; CULTURED-MAMMALIAN-CELLS; MICROTUBULE ATTACHMENT; NDC80 COMPLEX; CHROMOSOME CONGRESSION; MITOTIC PROGRESSION; CENP-E; FLUORESCENT PROTEIN; CANCER; CHECKPOINT	Background: Highly Expressed in Cancer protein 1 (Hec1) is a constituent of the Ndc80 complex, a kinetochore component that has been shown to have a fundamental role in stable kinetochore-microtubule attachment, chromosome alignment and spindle checkpoint activation at mitosis. HEC1 RNA is found up-regulated in several cancer cells, suggesting a role for HEC1 deregulation in cancer. In light of this, we have investigated the consequences of experimentally-driven Hec1 expression on mitosis and chromosome segregation in an inducible expression system from human cells. Methodology/Principal Findings: Overexpression of Hec1 could never be obtained in HeLa clones inducibly expressing C-terminally tagged Hec1 or untagged Hec1, suggesting that Hec1 cellular levels are tightly controlled. On the contrary, a chimeric protein with an EGFP tag fused to the Hec1 N-terminus accumulated in cells and disrupted mitotic division. EGFP-Hec1 cells underwent altered chromosome segregation within multipolar spindles that originated from centriole splitting. We found that EGFP-Hec1 assembled a mutant Ndc80 complex that was unable to rescue the mitotic phenotypes of Hec1 depletion. Kinetochores harboring EGFP-Hec1 formed persisting lateral microtubule-kinetochore interactions that recruited the plus-end depolymerase MCAK and the microtubule stabilizing protein HURP on K-fibers. In these conditions the plus-end kinesin CENP-E was preferentially retained at kinetochores. RNAi-mediated CENP-E depletion further demonstrated that CENP-E function was required for multipolar spindle formation in EGFP-Hec1 expressing cells. Conclusions/Significance: Our study suggests that modifications on Hec1 N-terminal tail can alter kinetochore-microtubule attachment stability and influence Ndc80 complex function independently from the intracellular levels of the protein. N-terminally modified Hec1 promotes spindle pole fragmentation by CENP-E-mediated plus-end directed kinetochore pulling forces that disrupt the fine balance of kinetochore-and centrosome-associated forces regulating spindle bipolarity. Overall, our findings support a model in which centrosome integrity is influenced by the pathways regulating kinetochore-microtubule attachment stability.	[Mattiuzzo, Marta; Vargiu, Giulia; Totta, Pierangela; Fiore, Mario; Degrassi, Francesca] Natl Res Council Italy, Inst Mol Biol & Pathol, Rome, Italy; [Mattiuzzo, Marta; Musacchio, Andrea] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Ciferri, Claudio] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); IRCCS European Institute of Oncology (IEO); University of California System; University of California Berkeley	Mattiuzzo, M (corresponding author), Natl Res Council Italy, Inst Mol Biol & Pathol, Rome, Italy.	f.degrassi@caspur.it	Totta, Pierangela/I-3251-2018	Totta, Pierangela/0000-0001-7826-4733; Musacchio, Andrea/0000-0003-2362-8784	Italian Association for Cancer Research (AIRC) [IG 4809]; Italian Ministry of Health	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Association for Cancer Research (AIRC, IG 4809) and the Italian Ministry of Health to F. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Bharadwaj R, 2004, J BIOL CHEM, V279, P13076, DOI 10.1074/jbc.M310224200; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; DeLuca JG, 2003, CURR BIOL, V13, P2103, DOI 10.1016/j.cub.2003.10.056; Diaz-Rodriguez E, 2008, P NATL ACAD SCI USA, V105, P16719, DOI 10.1073/pnas.0803504105; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ferretti C, 2010, CELL CYCLE, V9, P4174, DOI 10.4161/cc.9.20.13457; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Harborth J, 2001, J CELL SCI, V114, P4557; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Hayama S, 2006, CANCER RES, V66, P10339, DOI 10.1158/0008-5472.CAN-06-2137; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hori T, 2003, J CELL SCI, V116, P3347, DOI 10.1242/jcs.00645; Huang Y, 2009, CELL CYCLE, V8, P2643, DOI 10.4161/cc.8.16.9366; Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010; Kaneko N, 2009, BIOCHEM BIOPH RES CO, V390, P1235, DOI 10.1016/j.bbrc.2009.10.127; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Manning AL, 2007, CURR BIOL, V17, P260, DOI 10.1016/j.cub.2006.11.071; Mao YH, 2010, CELL CYCLE, V9, P715, DOI 10.4161/cc.9.4.10763; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Perez de Castro I, 2007, CARCINOGENESIS, V28, P899, DOI 10.1093/carcin/bgm019; PUCKEY FR, 2002, DEV CELL, V3, P351; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; TANAKA TU, 2008, CURR OPIN CELL BIOL, V19, P1; Tanenbaum ME, 2008, EMBO J, V27, P3235, DOI 10.1038/emboj.2008.242; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Torosantucci L, 2009, J CELL SCI, V122, P3455, DOI 10.1242/jcs.047944; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Walczak CE, 2003, MOL CELL, V11, P286, DOI 10.1016/S1097-2765(03)00067-4; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Wordeman L, 2005, CURR OPIN CELL BIOL, V17, P82, DOI 10.1016/j.ceb.2004.12.003; Wu GK, 2009, MOL BIOL CELL, V20, P4686, DOI 10.1091/mbc.E08-11-1123; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	67	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16307	10.1371/journal.pone.0016307	http://dx.doi.org/10.1371/journal.pone.0016307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297979	gold, Green Published, Green Submitted			2022-12-25	WOS:000286664100022
J	Ramanathan, A; Savol, AJ; Langmead, CJ; Agarwal, PK; Chennubhotla, CS				Ramanathan, Arvind; Savol, Andrej J.; Langmead, Christopher J.; Agarwal, Pratul K.; Chennubhotla, Chakra S.			Discovering Conformational Sub-States Relevant to Protein Function	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FREE-ENERGY LANDSCAPE; INTRINSIC DYNAMICS; CIS/TRANS ISOMERIZATION; ATOMIC FLUCTUATIONS; FERROCYTOCHROME-C; FORCE-FIELD; T4 LYSOZYME; MOTIONS; ANHARMONICITY	Background: Internal motions enable proteins to explore a range of conformations, even in the vicinity of native state. The role of conformational fluctuations in the designated function of a protein is widely debated. Emerging evidence suggests that sub-groups within the range of conformations (or sub-states) contain properties that may be functionally relevant. However, low populations in these sub-states and the transient nature of conformational transitions between these sub-states present significant challenges for their identification and characterization. Methods and Findings: To overcome these challenges we have developed a new computational technique, quasi-anharmonic analysis (QAA). QAA utilizes higher-order statistics of protein motions to identify sub-states in the conformational landscape. Further, the focus on anharmonicity allows identification of conformational fluctuations that enable transitions between sub-states. QAA applied to equilibrium simulations of human ubiquitin and T4 lysozyme reveals functionally relevant sub-states and protein motions involved in molecular recognition. In combination with a reaction pathway sampling method, QAA characterizes conformational sub-states associated with cis/trans peptidyl-prolyl isomerization catalyzed by the enzyme cyclophilin A. In these three proteins, QAA allows identification of conformational sub-states, with critical structural and dynamical features relevant to protein function. Conclusions: Overall, QAA provides a novel framework to intuitively understand the biophysical basis of conformational diversity and its relevance to protein function.	[Ramanathan, Arvind; Agarwal, Pratul K.] Oak Ridge Natl Lab, Computat Biol Inst, Oak Ridge, TN 37831 USA; [Ramanathan, Arvind; Agarwal, Pratul K.] Oak Ridge Natl Lab, Comp Sci & Math Div, Oak Ridge, TN USA; [Savol, Andrej J.; Chennubhotla, Chakra S.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Savol, Andrej J.] Carnegie Mellon Univ Univ Pittsburgh Ph D Program, Pittsburgh, PA USA; [Langmead, Christopher J.] Carnegie Mellon Univ, Sch Comp Sci, Dept Comp Sci, Pittsburgh, PA 15213 USA; [Ramanathan, Arvind; Langmead, Christopher J.] Carnegie Mellon Univ, Sch Comp Sci, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Ramanathan, A (corresponding author), Oak Ridge Natl Lab, Computat Biol Inst, Oak Ridge, TN 37831 USA.	agarwalpk@ornl.gov; chakracs@pitt.edu	Ramanathan, Arvind/E-5388-2010	Agarwal, Pratul/0000-0002-3848-9492; Langmead, Christopher/0000-0001-7521-6736	National Institutes of Health [1RC2GM093307]; NIH [T32 EB009403]; HHMI-NIBIB Interfaces Initiative; ORNLs Laboratory Directed Research and Development (LDRD); U.S. Department of Energy [DEAC05-00OR22725]; NSF Teragrid;  [R01 GM086238]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086238, RC2GM093307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI-NIBIB Interfaces Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); ORNLs Laboratory Directed Research and Development (LDRD); U.S. Department of Energy(United States Department of Energy (DOE)); NSF Teragrid(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AR was supported by National Institutes of Health 1RC2GM093307 to CJL. AJS was a predoctoral trainee supported by NIH T32 training grant T32 EB009403 as part of the HHMI-NIBIB Interfaces Initiative. PKA acknowledges the support by ORNLs Laboratory Directed Research and Development (LDRD) funds and the computing time allocation from the National Center for Computational Sciences (BIP003). ORNL is managed by UT-Battelle, LLC for the U.S. Department of Energy under Contract No. DEAC05-00OR22725. CSC was partially supported by R01 GM086238 (PI: Bahar, Co-PI: Chennubhotla). CSC is grateful for the simulation time allocated via startup allocation grant on NSF Teragrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-2; Agarwal PK, 2005, J AM CHEM SOC, V127, P15248, DOI 10.1021/ja055251s; Agarwal PK, 2004, BIOCHEMISTRY-US, V43, P10605, DOI 10.1021/bi0495228; Agarwal PK, 2004, PROTEINS, V56, P449, DOI 10.1002/prot.20135; Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Altis A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2746330; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amari S, 1996, ADV NEUR IN, V8, P757; Arora K, 2009, J AM CHEM SOC, V131, P5642, DOI 10.1021/ja9000135; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I., 2003, MATH COMPUTATIONAL B; Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Balsera MA, 1996, J PHYS CHEM-US, V100, P2567, DOI 10.1021/jp9536920; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERWEGER CD, 1995, CHEM PHYS LETT, V232, P429, DOI 10.1016/0009-2614(94)01391-8; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Bowers K.J., 2006, SCALABLE ALGORITHMS; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Cannon WR, 1998, J BIOL CHEM, V273, P26257, DOI 10.1074/jbc.273.41.26257; Cardoso JF, 1999, NEURAL COMPUT, V11, P157, DOI 10.1162/089976699300016863; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Chen Y, 2003, J PHYS CHEM B, V107, P7947, DOI 10.1021/jp022406z; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; ELBER R, 1987, SCIENCE, V235, P318, DOI 10.1126/science.3798113; FAURE P, 1994, NAT STRUCT BIOL, V1, P124, DOI 10.1038/nsb0294-124; Fenimore PW, 2002, P NATL ACAD SCI USA, V99, P16047, DOI 10.1073/pnas.212637899; Ferguson AL, 2010, P NATL ACAD SCI USA, V107, P13597, DOI 10.1073/pnas.1003293107; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f; Golub GH., 2013, MATRIX COMPUTATIONS; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; Hastie T., 2009, UNSUPERVISED LEARNIN; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Hub JS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000480; ICHIYE T, 1987, PROTEINS, V2, P236, DOI 10.1002/prot.340020308; ICHIYE T, 1988, BIOCHEMISTRY-US, V27, P3487, DOI 10.1021/bi00409a054; Jolliffe, 2002, PRINCIPAL COMPONENT; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KAMATH G, 2010, BIOCHEMISTR IN PRESS; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; Kong YF, 2007, STRUCTURE, V15, P611, DOI 10.1016/j.str.2007.04.002; Kong YF, 2009, PROTEINS, V74, P145, DOI 10.1002/prot.22139; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lange OF, 2008, PROTEINS, V70, P1294, DOI 10.1002/prot.21618; Lange OF, 2006, J PHYS CHEM B, V110, P22842, DOI 10.1021/jp062548j; Leitner D. M., 2010, PROTEINS ENERGY HEAT; Maisuradze GG, 2007, PROTEINS, V67, P569, DOI 10.1002/prot.21344; MAO B, 1982, BIOPOLYMERS, V21, P1979, DOI 10.1002/bip.360211005; Markwick PRL, 2007, J AM CHEM SOC, V129, P4724, DOI 10.1021/ja0687668; Materese CK, 2008, P NATL ACAD SCI USA, V105, P10659, DOI 10.1073/pnas.0801850105; Mchaourab HS, 1997, BIOCHEMISTRY-US, V36, P307, DOI 10.1021/bi962114m; McLachlan G. J., 1988, MIXTURE MODELS INFER, V84; Moritsugu K, 2000, PHYS REV LETT, V85, P3970, DOI 10.1103/PhysRevLett.85.3970; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Nabney I.T., 2003, NETLAB ALGORITHMS PA; NORTHRUP SH, 1981, J MOL BIOL, V153, P1087, DOI 10.1016/0022-2836(81)90469-1; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Petsko GA, 2000, CURR OPIN CHEM BIOL, V4, P89, DOI 10.1016/S1367-5931(99)00057-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POST CB, 1986, J AM CHEM SOC, V108, P1317, DOI 10.1021/ja00266a044; POST CB, 1986, J MOL BIOL, V190, P455, DOI 10.1016/0022-2836(86)90015-X; Ramanathan A, 2009, J PHYS CHEM B, V113, P16669, DOI 10.1021/jp9077213; SCHRODER GF, 2004, THESIS U GOTTINGEN; Schwartz SD, 2009, NAT CHEM BIOL, V5, P552, DOI 10.1038/nchembio.202; Shehu A, 2009, PROTEINS, V76, P837, DOI 10.1002/prot.22390; Shirts MR, 2001, PHYS REV LETT, V86, P4983, DOI 10.1103/PhysRevLett.86.4983; Stamati H, 2010, PROTEINS, V78, P223, DOI 10.1002/prot.22526; WEAVER LH, 1987, J MOL BIOL, V193, P189, DOI 10.1016/0022-2836(87)90636-X	82	53	53	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e15827	10.1371/journal.pone.0015827	http://dx.doi.org/10.1371/journal.pone.0015827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297978	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000286664100010
J	Kawashita, E; Tsuji, D; Toyoshima, M; Kanno, Y; Matsuno, H; Itoh, K				Kawashita, Eri; Tsuji, Daisuke; Toyoshima, Masahiro; Kanno, Yosuke; Matsuno, Hiroyuki; Itoh, Kohji			Prostaglandin E2 Reverses Aberrant Production of an Inflammatory Chemokine by Microglia from Sandhoff Disease Model Mice through the cAMP-PKA Pathway	PLOS ONE			English	Article							MOUSE MODELS; TAY-SACHS; EPAC; PROTEIN-1-ALPHA; RECEPTOR; NEURODEGENERATION; PATHOGENESIS; EXPRESSION; CELLS; RAP1	Background: Sandhoff disease (SD) is a neurodegenerative lysosomal beta-hexosaminidase (Hex) deficiency involving excessive accumulation of undegraded substrates, including terminal GlcNAc-oligosaccharides and GM2 ganglioside. Microglia-mediated neuroinflammation contributes to the pathogenesis and progression of SD. Our previous study demonstrated that MIP-1 alpha, a putative pathogenic factor for SD, is up-regulated in microglial cells derived from SD model mice (SD-Mg) through activation of Akt and JNK. Methodology/Principal Findings: In this study, we first demonstrated that prostaglandin E2 (PGE2), which is one of the lipid mediators derived from arachidonic acid and is known to suppress activation of microglia, reduced the aberrant MIP-1 alpha production by SD-Mg to the same level as by WT-Mg. PGE2 also attenuated the activation of Akt and JNK. The inhibition of MIP-1 alpha production and the activation of Akt and JNK occurred through the EP2 and 4/cAMP/PKA signaling pathway in the murine microglia derived from SD model mice. Conclusions/Significance: We propose that PGE2 plays a role as a negative regulator of MIP-1 alpha production in the pathogenesis of SD, and that PGE2-EP2 and 4/cAMP/PKA signaling could be a target pathway for therapy for SD.	[Kawashita, Eri; Tsuji, Daisuke; Toyoshima, Masahiro; Itoh, Kohji] Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Med Res, Dept Med Biotechnol, Tokushima 770, Japan; [Kawashita, Eri; Kanno, Yosuke; Matsuno, Hiroyuki] Doshisha Womens Collage Liberal Arts, Fac Pharmaceut Sci, Dept Clin Pathol Biochem, Kyoto, Japan; [Tsuji, Daisuke; Itoh, Kohji] Natl Inst Biomed Innovat NIBIO, Osaka, Japan	Tokushima University	Kawashita, E (corresponding author), Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Med Res, Dept Med Biotechnol, Tokushima 770, Japan.	kitoh@ph.tokushima-u.ac.jp	Tsuji, Daisuke/F-7085-2013	Tsuji, Daisuke/0000-0002-1528-7820	National Institute of Biomedical Innovation (NIBIO, Osaka, Japan); Grants-in-Aid for Scientific Research [22790318] Funding Source: KAKEN	National Institute of Biomedical Innovation (NIBIO, Osaka, Japan)(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The funding supporting this work is the Program for Promotion of Fundamental Studied Health Sciences of the National Institute of Biomedical Innovation (NIBIO, Osaka, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Caggiano AO, 1999, J NEUROCHEM, V72, P565, DOI 10.1046/j.1471-4159.1999.0720565.x; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Gravel R. A., 2001, METABOLIC MOL BASES, V3, P3827; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Huang JQ, 1997, HUM MOL GENET, V6, P1879, DOI 10.1093/hmg/6.11.1879; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; Jin JJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-2; Jing H, 2004, J BIOL CHEM, V279, P55176, DOI 10.1074/jbc.M409816200; Jing H, 2003, J LEUKOCYTE BIOL, V74, P868, DOI 10.1189/jlb.0303116; Kawashita E, 2009, J NEUROCHEM, V109, P1215, DOI 10.1111/j.1471-4159.2009.06041.x; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Li J, 2008, NEUROSCI LETT, V438, P210, DOI 10.1016/j.neulet.2008.04.054; Liang XB, 2008, ANN NEUROL, V64, P304, DOI 10.1002/ana.21437; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; Matsuoka K, 2010, MOL THER, V18, P1519, DOI 10.1038/mt.2010.113; McCullough L, 2004, J NEUROSCI, V24, P257, DOI 10.1523/JNEUROSCI.4485-03.2004; Myerowitz R, 2002, HUM MOL GENET, V11, P1343, DOI 10.1093/hmg/11.11.1343; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tsuji D, 2005, J NEUROCHEM, V92, P1497, DOI 10.1111/j.1471-4159.2005.02986.x; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wortmann SB, 2009, J INHERIT M IN PRESS; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101	32	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16269	10.1371/journal.pone.0016269	http://dx.doi.org/10.1371/journal.pone.0016269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298000	Green Submitted, Green Published, gold			2022-12-25	WOS:000286663900027
J	Saathoff, AJ; Sarath, G; Chow, EK; Dien, BS; Tobias, CM				Saathoff, Aaron J.; Sarath, Gautam; Chow, Elaine K.; Dien, Bruce S.; Tobias, Christian M.			Downregulation of Cinnamyl-Alcohol Dehydrogenase in Switchgrass by RNA Silencing Results in Enhanced Glucose Release after Cellulase Treatment	PLOS ONE			English	Article							CELL-WALL COMPOSITION; BROWN-MIDRIB MUTANTS; REDUCED LIGNIN; PLANT DEVELOPMENT; PANICUM-VIRGATUM; SATIVA L.; SORGHUM; INHIBITION; ENERGY; TRANSFORMATION	Cinnamyl alcohol dehydrogenase (CAD) catalyzes the last step in monolignol biosynthesis and genetic evidence indicates CAD deficiency in grasses both decreases overall lignin, alters lignin structure and increases enzymatic recovery of sugars. To ascertain the effect of CAD downregulation in switchgrass, RNA mediated silencing of CAD was induced through Agrobacterium mediated transformation of cv. "Alamo'' with an inverted repeat construct containing a fragment derived from the coding sequence of PviCAD2. The resulting primary transformants accumulated less CAD RNA transcript and protein than control transformants and were demonstrated to be stably transformed with between 1 and 5 copies of the TDNA. CAD activity against coniferaldehyde, and sinapaldehyde in stems of silenced lines was significantly reduced as was overall lignin and cutin. Glucose release from ground samples pretreated with ammonium hydroxide and digested with cellulases was greater than in control transformants. When stained with the lignin and cutin specific stain phloroglucinol-HCl the staining intensity of one line indicated greater incorporation of hydroxycinnamyl aldehydes in the lignin.	[Saathoff, Aaron J.; Sarath, Gautam] ARS, Grain Forage & Bioenergy Res Unit, USDA, Lincoln, NE 68508 USA; [Dien, Bruce S.] ARS, Bioenergy Res Unit, USDA, Peoria, IL USA; [Chow, Elaine K.; Tobias, Christian M.] ARS, Genom & Gene Discovery Res Unit, USDA, Albany, CA 94710 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Saathoff, AJ (corresponding author), ARS, Grain Forage & Bioenergy Res Unit, USDA, Lincoln, NE 68508 USA.	christian.tobias@ars.usda.gov	Tobias, Christian/B-6602-2009	Tobias, Christian/0000-0002-7881-750X; Dien, Bruce/0000-0003-3863-6664	Office of Science (BER), U.S. Department of Energy [DE-AI02-09ER64829]; USDA Agricultural Research Service [307, 5325-21000-017-00, 5440-21000-028-00]	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Aaron J. Saathoff was supported in part by the Office of Science (BER), U.S. Department of Energy grant number DE-AI02-09ER64829. This work was supported by the USDA Agricultural Research Service National Program 307 (Bioenergy) involving CRIS numbers: 5325-21000-017-00 and 5440-21000-028-00. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anterola AM, 2002, PHYTOCHEMISTRY, V61, P221, DOI 10.1016/S0031-9422(02)00211-X; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-26; Baucher M, 1999, PLANT MOL BIOL, V39, P437, DOI 10.1023/A:1006182925584; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; BUCHOLTZ DL, 1980, J AGR FOOD CHEM, V28, P1239, DOI 10.1021/jf60232a045; CARVER TLW, 1994, PHYSIOL MOL PLANT P, V44, P261, DOI 10.1016/S0885-5765(05)80029-3; Chabannes M, 2001, PLANT J, V28, P257, DOI 10.1046/j.1365-313X.2001.01140.x; Chen L, 2003, PLANT BIOTECHNOL J, V1, P437, DOI 10.1046/j.1467-7652.2003.00040.x; Corredor DY, 2009, APPL BIOCHEM BIOTECH, V158, P164, DOI 10.1007/s12010-008-8340-y; Dien BS, 2009, BIOENERG RES, V2, P153, DOI 10.1007/s12155-009-9041-2; Du FY, 2010, APPL BIOCHEM BIOTECH, V161, P313, DOI 10.1007/s12010-009-8796-4; Funnell DL, 2006, PLANT DIS, V90, P331, DOI 10.1094/PD-90-0331; Graham RL, 2000, BIOMASS BIOENERG, V18, P309, DOI 10.1016/S0961-9534(99)00098-7; HAWKINS SW, 1994, PLANT PHYSIOL, V104, P75, DOI 10.1104/pp.104.1.75; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horser C, 2002, GENET ENG P, V24, P239; Jacobsen J, 2006, METH MOL B, V343, P171; JUNG HJG, 1992, J SCI FOOD AGR, V59, P169, DOI 10.1002/jsfa.2740590206; Keshwani DR, 2009, BIORESOURCE TECHNOL, V100, P1515, DOI 10.1016/j.biortech.2008.09.035; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson S, 2000, APPL BIOCHEM BIOTECH, V84-6, P617, DOI 10.1385/ABAB:84-86:1-9:617; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Li XJ, 2009, PLANT MOL BIOL, V69, P685, DOI 10.1007/s11103-008-9448-8; Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Marita JM, 2003, J AGR FOOD CHEM, V51, P1313, DOI 10.1021/jf0260592; McLaughlin SB, 2006, ADV AGRON, V90, P267, DOI 10.1016/S0065-2113(06)90007-8; McLaughlin SB, 2002, ENVIRON SCI TECHNOL, V36, P2122, DOI 10.1021/es010963d; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; MOERSCHBACHER BM, 1990, PLANT PHYSIOL, V93, P465, DOI 10.1104/pp.93.2.465; Monti A, 2009, EUR J AGRON, V31, P77, DOI 10.1016/j.eja.2009.04.001; MOORE KJ, 1991, AGRON J, V83, P1073, DOI 10.2134/agronj1991.00021962008300060027x; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Onnerud H, 2002, PLANT CELL, V14, P1953, DOI 10.1105/tpc.001487; Palmer NA, 2008, PLANTA, V229, P115, DOI 10.1007/s00425-008-0814-1; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Pedersen JF, 2005, CROP SCI, V45, P812, DOI 10.2135/cropsci2004.0155; Pilate G, 2002, NAT BIOTECHNOL, V20, P607, DOI 10.1038/nbt0602-607; PILLONEL C, 1991, PLANTA, V185, P538, DOI 10.1007/BF00202964; Ralph J, 2001, PHYTOCHEMISTRY, V57, P993, DOI 10.1016/S0031-9422(01)00109-1; Saathoff AJ, 2010, BIOENERG RE IN PRESS; Saballos A, 2009, GENETICS, V181, P783, DOI 10.1534/genetics.108.098996; Saballos A, 2008, BIOENERG RES, V1, P193, DOI 10.1007/s12155-008-9025-7; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Sarath G, 2008, J IND MICROBIOL BIOT, V35, P343, DOI 10.1007/s10295-007-0296-3; Sarath G, 2007, BIORESOURCE TECHNOL, V98, P2985, DOI 10.1016/j.biortech.2006.10.020; Sattler SE, 2010, PLANT SCI, V178, P229, DOI 10.1016/j.plantsci.2010.01.001; Sattler SE, 2010, J AGR FOOD CHEM, V58, P3611, DOI 10.1021/jf903784j; Sattler SE, 2009, PLANT PHYSIOL, V150, P584, DOI 10.1104/pp.109.136408; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Selig MJ, 2008, BIORESOURCE TECHNOL, V99, P4997, DOI 10.1016/j.biortech.2007.09.064; Smeets EMW, 2009, RENEW SUST ENERG REV, V13, P1230, DOI 10.1016/j.rser.2008.09.006; Somleva MN, 2008, PLANT BIOTECHNOL J, V6, P663, DOI 10.1111/j.1467-7652.2008.00350.x; Somleva MN, 2002, CROP SCI, V42, P2080, DOI 10.2135/cropsci2002.2080; Tobias CM, 2005, PLANTA, V220, P678, DOI 10.1007/s00425-004-1385-4; Vermerris W, 2002, HEREDITY, V88, P450, DOI 10.1038/sj.hdy.6800078; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel KP, 2011, RSC ENERGY ENVIRON S, P341; Vogel KP, 1999, CROP SCI, V39, P276, DOI 10.2135/cropsci1999.0011183X003900010042x; WYRAMBIK D, 1975, EUR J BIOCHEM, V59, P9, DOI 10.1111/j.1432-1033.1975.tb02418.x; Yahiaoui N, 1998, PLANTA, V204, P8, DOI 10.1007/s004250050224; Zhang KW, 2006, PLANT PHYSIOL, V140, P972, DOI 10.1104/pp.105.073007	62	124	129	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16416	10.1371/journal.pone.0016416	http://dx.doi.org/10.1371/journal.pone.0016416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298014	Green Submitted, Green Published, gold			2022-12-25	WOS:000286663900047
J	Schneider, SA; Schrader, C; Wagner, AE; Boesch-Saadatmandi, C; Liebig, J; Rimbach, G; Roeder, T				Schneider, Sebastian A.; Schrader, Charlotte; Wagner, Anika E.; Boesch-Saadatmandi, Christine; Liebig, Juergen; Rimbach, Gerald; Roeder, Thomas			Stress Resistance and Longevity Are Not Directly Linked to Levels of Enzymatic Antioxidants in the Ponerine Ant Harpegnathos saltator	PLOS ONE			English	Article							HONEY-BEE LONGEVITY; LIFE-SPAN; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; SOCIAL INSECTS; DROSOPHILA; WORKERS; GLUTATHIONE; EXPRESSION	Background: The molecular mechanisms of variations in individual longevity are not well understood, even though longevity can be increased substantially by means of diverse experimental manipulations. One of the factors supposed to be involved in the increase of longevity is a higher stress resistance. To test this hypothesis in a natural system, eusocial insects such as bees or ants are ideally suited. In contrast to most other eusocial insects, ponerine ants show a peculiar life history that comprises the possibility to switch during adult life from a normal worker to a reproductive gamergate, therewith increasing their life expectancy significantly. Results: We show that increased resistance against major stressors, such as reactive oxygen species and infection accompanies the switch from a life-history trait with normal lifespan to one with a longer life expectancy. A short period of social isolation was sufficient to enhance stress resistance of workers from the ponerine ant species Harpegnathos saltator significantly. All ant groups with increased stress resistances (reproducing gamergates and socially isolated workers) have lower catalase activities and glutathione levels than normal workers. Therewith, these ants resemble the characteristics of the youngest ants in the colony. Conclusions: Social insects with their specific life history including a switch from normal workers to reproducing gamergates during adult life are well suited for ageing research. The regulation of stress resistance in gamergates seemed to be modified compared to foraging workers in an economic way. Interestingly, a switch towards more stress resistant animals can also be induced by a brief period of social isolation, which may already be associated with a shift to a reproductive trajectory. In Harpegnathos saltator, stress resistances are differently and potentially more economically regulated in reproductive individuals, highlighting the significance of reproduction for an increase in longevity in social insects. As already shown for other organisms with a long lifespan, this trait is not directly coupled to higher levels of enzymatic and non-enzymatic antioxidants.	[Schneider, Sebastian A.; Roeder, Thomas] Univ Kiel, Dept Zoophysiol 2, Kiel, Germany; [Schrader, Charlotte; Wagner, Anika E.; Boesch-Saadatmandi, Christine; Rimbach, Gerald] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany; [Liebig, Juergen] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Liebig, Juergen] Arizona State Univ, Ctr Social Dynam & Complex, Tempe, AZ USA	University of Kiel; University of Kiel; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Schneider, SA (corresponding author), Univ Kiel, Dept Zoophysiol 2, Kiel, Germany.	troeder@zoologie.uni-kiel.de	Wagner, Anika/AAE-3579-2019; Roeder, Thomas/B-9016-2011; Rimbach, Gerald/A-7178-2011	Wagner, Anika/0000-0003-3047-7128; Roeder, Thomas/0000-0002-3489-3834; Rimbach, Gerald/0000-0001-7888-4684; Bosch, Christine/0000-0001-6705-5709	German Federal Ministry of Education and Research; University of Kiel	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); University of Kiel	This work was supported by the Deutsche Forschungsgemeinschaft as part of the Cluster of Excellence: Inflammation at Interfaces, project "Vision Epifood", funded by the German Federal Ministry of Education and Research as well as by a stipend to SAS from the University of Kiel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andziak B, 2005, MECH AGEING DEV, V126, P1206, DOI 10.1016/j.mad.2005.06.009; Andziak B, 2006, AGING CELL, V5, P525, DOI 10.1111/j.1474-9726.2006.00246.x; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Brown-Borg HM, 2007, AGEING RES REV, V6, P28, DOI 10.1016/j.arr.2007.02.005; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Corona M, 2005, MECH AGEING DEV, V126, P1230, DOI 10.1016/j.mad.2005.07.004; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; David JR, 2005, HEREDITY, V94, P3, DOI 10.1038/sj.hdy.6800562; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Habig W H, 1981, Methods Enzymol, V77, P398; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hartmann A, 2003, EVOLUTION, V57, P2424, DOI 10.1111/j.0014-3820.2003.tb00254.x; Hercus MJ, 2003, BIOGERONTOLOGY, V4, P149, DOI 10.1023/A:1024197806855; HOLLDOBLER B, 1991, ANTS; Jemielity S, 2007, AGING CELL, V6, P225, DOI 10.1111/j.1474-9726.2007.00279.x; JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4; Johnson TE, 2002, J INHERIT METAB DIS, V25, P197, DOI 10.1023/A:1015677828407; Kaeberlein M, 2007, CURR GENOMICS, V8, P73, DOI 10.2174/138920207780368196; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; Keller L, 2006, EXP GERONTOL, V41, P553, DOI 10.1016/j.exger.2006.04.002; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Liebig J, 1998, NATURWISSENSCHAFTEN, V85, P133, DOI 10.1007/s001140050470; Liebig J, 2004, ECOL ENTOMOL, V29, P203, DOI 10.1111/j.1365-2311.2004.00583.x; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107; Narasimhan SD, 2009, CURR BIOL, V19, pR657, DOI 10.1016/j.cub.2009.06.013; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Parker JD, 2004, P NATL ACAD SCI USA, V101, P3486, DOI 10.1073/pnas.0400222101; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; PEETERS C, 1995, P NATL ACAD SCI USA, V92, P10977, DOI 10.1073/pnas.92.24.10977; Peeters C, 2000, INSECT SOC, V47, P325, DOI 10.1007/PL00001724; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Rueppell O, 2005, INSECT SOC, V52, P282, DOI 10.1007/s00040-005-0804-2; Salmon AB, 2009, FASEB J, V23, P2317, DOI 10.1096/fj.08-122523; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095; Toivonen JM, 2009, MOL CELL ENDOCRINOL, V299, P39, DOI 10.1016/j.mce.2008.07.005; Tsuji K, 1996, NATURWISSENSCHAFTEN, V83, P577; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; Vermeulen CJ, 2007, EXP GERONTOL, V42, P153, DOI 10.1016/j.exger.2006.09.014; Williams JB, 2008, EXP GERONTOL, V43, P538, DOI 10.1016/j.exger.2008.02.001	53	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14601	10.1371/journal.pone.0014601	http://dx.doi.org/10.1371/journal.pone.0014601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298046	Green Submitted, Green Published, gold			2022-12-25	WOS:000286663900005
J	Maher, LA; Stock, JT; Finney, S; Heywood, JJN; Miracle, PT; Banning, EB				Maher, Lisa A.; Stock, Jay T.; Finney, Sarah; Heywood, James J. N.; Miracle, Preston T.; Banning, Edward B.			A Unique Human-Fox Burial from a Pre-Natufian Cemetery in the Levant (Jordan)	PLOS ONE			English	Article							SOUTHERN LEVANT; ANCIENT DNA; DOGS; DOMESTICATION; EVOLUTION; ORIGIN; OCHRE	New human burials from northern Jordan provide important insights into the appearance of cemeteries and the nature of human-animal relationships within mortuary contexts during the Epipalaeolithic period (c. 23,000-11,600 cal BP) in the Levant, reinforcing a socio-ideological relationship that goes beyond predator-prey. Previous work suggests that archaeological features indicative of social complexity occur suddenly during the latest Epipalaeolithic phase, the Natufian (c. 14,500-11,600 cal BP). These features include sedentism, cemeteries, architecture, food production, including animal domestication, and burials with elaborate mortuary treatments. Our findings from the pre-Natufian (Middle Epipalaeolithic) cemetery of 'Uyun al-Hammam demonstrate that joint human-animal mortuary practices appear earlier in the Epipalaeolithic. We describe the earliest human-fox burial in the Near East, where the remains of dogs have been found associated with human burials at a number of Natufian sites. This is the first time that a fox has been documented in association with human interments pre-dating the Natufian and with a particular suite of grave goods. Analysis of the human and animal bones and their associated artefacts provides critical data on the nature and timing of these newly-developing relationships between people and animals prior to the appearance of domesticated dogs in the Natufian.	[Maher, Lisa A.; Stock, Jay T.] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England; [Finney, Sarah] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Heywood, James J. N.] Univ Cambridge, Dept Paediat, Cambridge, England; [Miracle, Preston T.] Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England; [Banning, Edward B.] Univ Toronto, Dept Anthropol, Toronto, ON M5S 1A1, Canada	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Toronto	Maher, LA (corresponding author), Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England.	l.maher@human-evol.cam.ac.uk	Banning, Edward B./B-1948-2008; Stock, Jay T/B-6453-2011; Heywood, James/A-9785-2016	Banning, Edward B./0000-0002-4281-7639; Stock, Jay T/0000-0003-0147-8631; Heywood, James/0000-0002-2499-3663	Social Sciences and Humanities Research Council of Canada [410-2007-1269]; National Geographic Society Committee for Research and Exploration [8495-08]; Arts and Humanities Research Council [AH/E009484/1]; AHRC [AH/E009484/1] Funding Source: UKRI; Natural Environment Research Council [NER/M/S/2003/00069] Funding Source: researchfish	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); National Geographic Society Committee for Research and Exploration(National Geographic Society); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research is funded by a Social Sciences and Humanities Research Council of Canada Research Grant to L. A. Maher and E. B. Banning (410-2007-1269; http://www.sshrc-crsh.gc.ca/), a National Geographic Society Committee for Research and Exploration Fieldwork Grant to L. A. Maher (8495-08; http://www.nationalgeographic.com/field/grants-programs/cre-fund.html), and an Arts and Humanities Research Council Research Grant to J. T. Stock (AH/E009484/1; http://www.ahrc.ac.uk/Pages/default.aspx). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arensburg B, 1973, PALEORIENT, V1, P201, DOI [10.3406/paleo.1973.4165, DOI 10.3406/PALEO.1973.4165]; Balter M, 2010, SCIENCE, V329, P1465, DOI 10.1126/science.329.5998.1465; Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; Belfer-Cohen A., 1988, PALEORIENT, V14, P297, DOI DOI 10.3406/PALE0.1988.4476; Belfer-Cohen A., 1995, ARCHAEOLOGY DEATH AN, P9; BELFERCOHEN A, 1991, ANNU REV ANTHROPOL, V20, P167, DOI 10.1146/annurev.an.20.100191.001123; Buck C. E., 1999, INTERNET ARCHAEOLOGY, V7; Buikstra JE, 1994, ARKANSAS ARCHEOLOGIC; Byrd BF, 2005, J ARCHAEOL RES, V13, P231, DOI 10.1007/s10814-005-3107-2; BYRD BF, 1995, J ANTHROPOL ARCHAEOL, V14, P251, DOI 10.1006/jaar.1995.1014; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Clutton-Brock Juliet, 1995, P7; Crockford S., 2000, DOGS TIME ARCHAEOLOG, V889; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; DAYAN T, 1994, J ARCHAEOL SCI, V21, P633, DOI 10.1006/jasc.1994.1062; Edwards P., 2002, PALEORIENT, V28, P103, DOI DOI 10.3406/paleo.2002.4741; Garrard A., 2003, B ARCHEOLOGIE ARCHIT, V7, P7; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Goring-Morris A.N., 2005, ARCHAEOLOGICAL PERSP, P89; Goring-Morris A. Nigel, 2002, MAGIC PRACTICES RITU, P67; Goring-Morris AN., 2009, TRANSITIONS PREHISTO, P185; Gray MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-16; Grosman L, 2008, P NATL ACAD SCI USA, V105, P17665, DOI 10.1073/pnas.0806030105; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; HILL A, 1979, PALEOBIOLOGY, V5, P261, DOI 10.1017/S0094837300006552; Hovers E, 2003, CURR ANTHROPOL, V44, P491, DOI 10.1086/375869; KAUFMAN D, 1987, ANTHROPOLOGIE, V91, P335; Kuijt I, 2002, J WORLD PREHIST, V16, P361, DOI 10.1023/A:1022973114090; Kuijt I, 1996, J ANTHROPOL ARCHAEOL, V15, P313, DOI 10.1006/jaar.1996.0012; Kuijt I., 2000, LIFE NEOLITHIC FARMI, P19, DOI DOI 10.1007/0-306-47166-3_2; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; MAHER L, PRELIMINARY IN PRESS; Maher L, 2002, PALEORIENT, V27, P5; MAHER L, 2001, GEOARCHAEOLOGICAL SU, P61; MAHER L, 2005, ANN DEP ANTIQUITIES, V49, P101; Maher LA, 2007, ANN DEP ANTIQUITIES, V51, P263; Morey DF, 2006, J ARCHAEOL SCI, V33, P158, DOI 10.1016/j.jas.2005.07.009; Muheisen M., 1988, BRIT ARCHAEOLOGICAL, Vvol. 396, P353; Nadel D., 1994, PALEORIENT, V20, P113, DOI DOI 10.3406/paleo.1994.4605; O'Farrell V., 1995, THE DOMESTIC DOG; Peters Joris, 2004, Anthropozoologica, V39, P179; RICHTER R, 2011, CAMB ARCHAE IN PRESS; Richter T, 2010, ANTIQUITY, V84, P321, DOI 10.1017/S0003598X00066606; Richter T, 2007, ANN DEP ANTIQUITIES, V51, P313; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Stock JT, 2005, AM J PHYS ANTHROPOL, V128, P453, DOI 10.1002/ajpa.20163; Tchernov E, 1997, J ARCHAEOL SCI, V24, P65, DOI 10.1006/jasc.1995.0096; VALLA F, 1998, ARCHEOLOGIA, V348, P36; Valla Francois R., 2002, B CTR RECHERCHE FRAN, V10, P17; Verhoeven M, 2004, J WORLD PREHIST, V18, P179, DOI 10.1007/s10963-004-4361-9; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; VONHOLDT BM, 2010, NATURE, V10, P1; Weinstein-Evron, 2009, FARMING, V2009, P1, DOI [10.3828/bfarm.2009.1.3, DOI 10.3828/BFARM.2009.1.3]; WRESCHNER EE, 1980, CURR ANTHROPOL, V21, P631, DOI 10.1086/202541	54	54	54	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e15815	10.1371/journal.pone.0015815	http://dx.doi.org/10.1371/journal.pone.0015815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JL	21298094	Green Published, gold			2022-12-25	WOS:000286662800013
J	Biersmith, B; Liu, Z; Bauman, K; Geisbrecht, ER				Biersmith, Bridget; Liu, Ze (Cindy); Bauman, Kenneth; Geisbrecht, Erika R.			The DOCK Protein Sponge Binds to ELMO and Functions in Drosophila Embryonic CNS Development	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE; MYOBLAST FUSION; TYROSINE KINASE; CELL-MIGRATION; RAC ACTIVATION; PH DOMAIN; IDENTIFICATION; GEF; PATHWAY; GTPASE	Cell morphogenesis, which requires rearrangement of the actin cytoskeleton, is essential to coordinate the development of tissues such as the musculature and nervous system during normal embryonic development. One class of signaling proteins that regulate actin cytoskeletal rearrangement is the evolutionarily conserved CDM (C. elegans Ced-5, human DOCK180, Drosophila Myoblast city, or Mbc) family of proteins, which function as unconventional guanine nucleotide exchange factors for the small GTPase Rac. This CDM-Rac protein complex is sufficient for Rac activation, but is enhanced upon the association of CDM proteins with the ELMO/Ced-12 family of proteins. We identified and characterized the role of Drosophila Sponge (Spg), the vertebrate DOCK3/DOCK4 counterpart as an ELMO-interacting protein. Our analysis shows Spg mRNA and protein is expressed in the visceral musculature and developing nervous system, suggesting a role for Spg in later embryogenesis. As maternal null mutants of spg die early in development, we utilized genetic interaction analysis to uncover the role of Spg in central nervous system (CNS) development. Consistent with its role in ELMO-dependent pathways, we found genetic interactions with spg and elmo mutants exhibited aberrant axonal defects. In addition, our data suggests Ncad may be responsible for recruiting Spg to the membrane, possibly in CNS development. Our findings not only characterize the role of a new DOCK family member, but help to further understand the role of signaling downstream of N-cadherin in neuronal development.	[Biersmith, Bridget; Liu, Ze (Cindy); Bauman, Kenneth; Geisbrecht, Erika R.] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA; [Biersmith, Bridget; Liu, Ze (Cindy)] Univ Missouri, Sch Biol Sci, PhD Program, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Biersmith, B (corresponding author), Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA.	geisbrechte@umkc.edu			University of Missouri Research Board (UMRB) Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR053027] Funding Source: NIH RePORTER	University of Missouri Research Board (UMRB) Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the University of Missouri Research Board (UMRB) Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Balagopalan L, 2006, MOL CELL BIOL, V26, P9442, DOI 10.1128/MCB.00016-06; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Brody T, 2002, MECH DEVELOP, V113, P41, DOI 10.1016/S0925-4773(02)00010-2; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chen Q, 2002, J CELL BIOL, V158, P79, DOI 10.1083/jcb.200110151; Chen Q, 2005, J NEUROSCI, V25, P281, DOI 10.1523/JNEUROSCI.3692-04.2005; Chen Q, 2001, AM J PATHOL, V159, P1597, DOI 10.1016/S0002-9440(10)63005-2; Chen Q, 2009, J NEUROSCI, V29, P118, DOI 10.1523/JNEUROSCI.3985-08.2009; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; de Silva MG, 2003, J MED GENET, V40, P733, DOI 10.1136/jmg.40.10.733; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Fritz JL, 2000, DEVELOPMENT, V127, P1991; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Geisbrecht ER, 2008, DEV BIOL, V314, P137, DOI 10.1016/j.ydbio.2007.11.022; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Harris TJC, 2009, CURR TOP DEV BIOL, V89, P55, DOI 10.1016/S0070-2153(09)89003-0; Hayashi S, 1997, P NATL ACAD SCI USA, V94, P242, DOI 10.1073/pnas.94.1.242; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kashiwa A, 2000, J NEUROCHEM, V75, P109, DOI 10.1046/j.1471-4159.2000.0750109.x; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; LU MRK, 2005, ACTIVATION GTPASES D, P73; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Makino Y, 2006, J CELL SCI, V119, P923, DOI 10.1242/jcs.02797; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Miyamoto Y, 2010, CELL SIGNAL, V22, P175, DOI 10.1016/j.cellsig.2009.09.036; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; POSTNER MA, 1992, J CELL BIOL, V119, P1205, DOI 10.1083/jcb.119.5.1205; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Reif K, 2002, TRENDS CELL BIOL, V12, P368, DOI 10.1016/S0962-8924(02)02330-9; RICE TB, 1975, DEV BIOL, V43, P277, DOI 10.1016/0012-1606(75)90027-5; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Starz-Gaiano M, 2004, CURR OPIN GENET DEV, V14, P86, DOI 10.1016/j.gde.2003.12.001; Tosello-Trampont AC, 2007, CELL DEATH DIFFER, V14, P963, DOI 10.1038/sj.cdd.4402094; UEDA S, 2008, J NEUROSCI RES; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yan D, 2006, J MOL BIOL, V357, P755, DOI 10.1016/j.jmb.2006.01.017; Yang L, 2006, NEURON, V52, P595, DOI 10.1016/j.neuron.2006.09.039; Yokoyama N, 2005, BIOCHEMISTRY-US, V44, P8841, DOI 10.1021/bi0500832; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	66	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16120	10.1371/journal.pone.0016120	http://dx.doi.org/10.1371/journal.pone.0016120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283588	Green Published, Green Submitted, gold			2022-12-25	WOS:000286661400026
J	Selman, C; Partridge, L; Withers, DJ				Selman, Colin; Partridge, Linda; Withers, Dominic J.			Replication of Extended Lifespan Phenotype in Mice with Deletion of Insulin Receptor Substrate 1	PLOS ONE			English	Article							NUTRIENT HOMEOSTASIS; CALORIC RESTRICTION; HUMAN LONGEVITY; DWARF MICE; EXTENSION; RAPAMYCIN; PATHWAY	We previously reported that global deletion of insulin receptor substrate protein 1 (Irs1) extends lifespan and increases resistance to several age-related pathologies in female mice. However, no effect on lifespan was observed in male Irs1 null mice. We suggested at the time that the lack of any effect in males might have been due to a sample size issue. While such lifespan studies are essential to our understanding of the aging process, they are generally based on survival curves derived from single experiments, primarily due to time and economic constraints. Consequently, the robustness of such findings as a basis for further investigation has been questioned. We have therefore measured lifespan in a second, separate cohort of Irs1 null female mice, and show that, consistent with our previous finding, global deletion of Irs1 significantly extends lifespan in female mice. In addition, an augmented and completed study demonstrates lifespan extension in male Irs1 null mice. Therefore, we show that reduced IRS1-dependent signalling is a robust mechanism through which mammalian lifespan can be modulated.	[Selman, Colin] Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen, Scotland; [Partridge, Linda] UCL, Dept Genet Evolut & Environm, Inst Healthy Ageing, London, England; [Withers, Dominic J.] Univ London Imperial Coll Sci Technol & Med, Med Res Council Clin Sci Ctr, Metab Signaling Grp, London, England	University of Aberdeen; University of London; University College London; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Selman, C (corresponding author), Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen, Scotland.	c.selman@abdn.ac.uk	Partridge, Linda/E-7342-2015; Partridge, Linda/A-5501-2010; Withers, Dominic J/D-7671-2014	Withers, Dominic J/0000-0002-8009-7521; Selman, Colin/0000-0002-8727-0593; Partridge, Linda/0000-0001-9615-0094	Wellcome Trust; Medical Research Council [MC_U120097114] Funding Source: researchfish; MRC [MC_U120097114] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust (Functional Genomics and Strategic) awards to L.P. and D.J.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austad S, 2008, AGING CELL, V7, P119, DOI 10.1111/j.1474-9726.2008.00374.x; Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bonafe M, 2009, MOL CELL ENDOCRINOL, V299, P118, DOI 10.1016/j.mce.2008.10.038; Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Ladiges W, 2009, AGING CELL, V8, P346, DOI 10.1111/j.1474-9726.2009.00491.x; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Masternak MM, 2009, J GERONTOL A-BIOL, V64, P516, DOI 10.1093/gerona/glp024; PARTRIDGE L, 2010, EXP GERONTOL; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x; SELMAN C, 2010, PHILOS T R IN PRESS; Selman C, 2008, SCIENCE, V320, DOI 10.1126/science.1152366; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Vergara M, 2004, J GERONTOL A-BIOL, V59, P1244, DOI 10.1093/gerona/59.12.1244	26	68	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16144	10.1371/journal.pone.0016144	http://dx.doi.org/10.1371/journal.pone.0016144			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283571	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000286661400029
J	Xie, SS; Li, XY; Liu, T; Cao, JH; Zhong, QA; Zhao, SH				Xie, Sheng-Song; Li, Xin-Yun; Liu, Teng; Cao, Jian-Hua; Zhong, Qiang; Zhao, Shu-Hong			Discovery of Porcine microRNAs in Multiple Tissues by a Solexa Deep Sequencing Approach	PLOS ONE			English	Article							EXPRESSION; GENES; RNAS; IDENTIFICATION; MIR-122; ENCODES; SYSTEM	The domestic pig (Sus scrofa) is an important economic animal for meat production and as a suitable model organism for comparative genomics and biomedical studies. In an effort to gain further identification of miRNAs in the pig, we have applied the Illumina Solexa sequencing technology to carry out an in-depth analysis of the miRNA transcriptome in a pool of equal amounts of RNA from 16 different porcine tissues. From this data set, we identified 437 conserved and 86 candidate novel miRNA/miRNA* in the pig, corresponding to 329 miRNA genes. Compared with all the reported porcine miRNAs, the result showed that 112 conserved and 61 candidate novel porcine miRNA were first reported in this study. Further analysis revealed extensive sequence variations (isomiRs) of porcine miRNAs, including terminal isomiRs at both the 5` and 3` ends and nucleotide variants. Read counts of individual porcine miRNA spanned from a few reads to approximately 405541 reads, confirming the different level of expression of porcine miRNAs. Subsequently, the tissue expression patterns of 8 miRNAs were characterized by Northern blotting. The results showed that miR-145, miR-423-5p, miR-320, miR-26a, and miR-191 are ubiquitously expressed in diverse tissues, while miR-92, miR-200a, and miR-375 were selectively enriched and expressed in special tissues. Meanwhile, the expression of 8 novel porcine-specific miRNAs was validated by stem-loop RT-PCR, and one of these was detected by Northern blotting. Using the porcine miRNA array designed according to our Solexa results, 123 miRNAs were detected expression in porcine liver tissues. A total of 58 miRNAs showed differential expression between the Tongcheng (a Chinese indigenous fatty breed) and Large White pig breeds (a lean type pig). Taken together, our results add new information to existing data on porcine miRNAs and should be useful for investigating the biological functions of miRNAs in pig and other species.	[Xie, Sheng-Song] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China; Huazhong Agr Univ, Minist Agr, Key Lab Swine Genet & Breeding, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Xie, SS (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China.	shzhao@mail.hzau.edu.cn			National High Science and Technology Foundation of China [2010AA10A104, 2008AA101008]; NSFC [U0631005]; National Key Basic Research and Development Program of China [2006CB102105]; Chinese Ministry of Education [IRT0831]	National High Science and Technology Foundation of China; NSFC(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); Chinese Ministry of Education(Ministry of Education, China)	This study was supported by a grant from the the National High Science and Technology Foundation of China "863" (2010AA10A104 and 2008AA101008), the NSFC-Guangdong Key Project (U0631005), National Key Basic Research and Development Program of China (2006CB102105), and the creative team project of the Chinese Ministry of Education (IRT0831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bandiera S, 2010, CLIN GENET, V77, P306, DOI 10.1111/j.1399-0004.2010.01370.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; CHO IS, MOL BIOL REP; Critser John K, 2009, ILAR J, V50, P89; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; FORMAN JJ, CELL CYCLE, V9; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sawera M, 2005, MAMM GENOME, V16, P594, DOI 10.1007/s00335-005-0013-3; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang Y, 2010, J HEPATOL, V53, P57, DOI 10.1016/j.jhep.2009.12.043; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	59	66	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16235	10.1371/journal.pone.0016235	http://dx.doi.org/10.1371/journal.pone.0016235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283541	Green Submitted, Green Published, gold			2022-12-25	WOS:000286661400037
J	Hu, J; De Barro, P; Zhao, H; Wang, J; Nardi, F; Liu, SS				Hu, Jian; De Barro, Paul; Zhao, Hua; Wang, Jia; Nardi, Francesco; Liu, Shu-Sheng			An Extensive Field Survey Combined with a Phylogenetic Analysis Reveals Rapid and Widespread Invasion of Two Alien Whiteflies in China	PLOS ONE			English	Article							BEMISIA-TABACI HEMIPTERA; MITOCHONDRIAL-DNA MARKERS; POLYMERASE CHAIN-REACTION; BIOTYPE-B; HOMOPTERA ALEYRODIDAE; GENNADIUS HEMIPTERA; SHANDONG PROVINCE; GENETIC DIVERSITY; SPECIES COMPLEX; RIBOSOMAL ITS1	Background: To understand the processes of invasions by alien insects is a pre-requisite for improving management. The whitefly Bemisia tabaci is a cryptic species complex that contains some of the most invasive pests worldwide. However, extensive field data to show the geographic distribution of the members of this species complex as well as the invasion by some of its members are scarce. Methodology/Principal Findings: We used field surveys and published data to assess the current diversity and distribution of B. tabaci cryptic species in China and relate the indigenous members to other Asian and Australian members of the complex. The survey covered the 16 provinces where indigenous B. tabaci occur and extends this with published data for the whole of China. We used molecular markers to identify cryptic species. The evolutionary relationships between the different Asian B. tabaci were reconstructed using Bayesian methods. We show that whereas in the past the exotic invader Middle East-Asia Minor 1 was predominant across China, another newer invader Mediterranean is now the dominant species in the Yangtze River Valley and eastern coastal areas, and Middle East-Asia Minor 1 is now predominant only in the south and south eastern coastal areas. Based on mtCO1 we identified four new cryptic species, and in total we have recorded 13 indigenous and two invasive species from China. Diversity was highest in the southern and southeastern provinces and declined to north and west. Only the two invasive species were found in the northern part of the country where they occur primarily in protected cropping. By 2009, indigenous species were mainly found in remote mountainous areas and were mostly absent from extensive agricultural areas. Conclusions/Significance: Invasions by some members of the whitefly B. tabaci species complex can be rapid and widespread, and indigenous species closely related to the invaders are replaced.	[Hu, Jian; Zhao, Hua; Wang, Jia; Liu, Shu-Sheng] Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insects, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [De Barro, Paul] CSIRO Ecosyst Sci, Indooroopilly, Qld, Australia; [Nardi, Francesco] Univ Siena, Dept Evolut Biol, I-53100 Siena, Italy	Ministry of Agriculture & Rural Affairs; Zhejiang University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Siena	Hu, J (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insects, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China.	shshliu@zju.edu.cn	Liu, Shu-Sheng/D-2300-2013; Nardi, Francesco/E-5516-2011; De Barro, Paul J/C-1724-2008	Nardi, Francesco/0000-0003-0271-9855; 	National Basic Research Programme of China [2009CB119203]; National Nature Science Foundation of China [30730061]; Earmarked Fund for Modern Agro-Industry Technology Research System in China	National Basic Research Programme of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-Industry Technology Research System in China	Financial support from the National Basic Research Programme of China (2009CB119203) (http://www.most.gov.cn/), the National Nature Science Foundation of China (30730061) (http://www.nsfc.gov.cn), and the Earmarked Fund for Modern Agro-Industry Technology Research System in China is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Muhammad Z., 2009, Acta Entomologica Sinica, V52, P1132; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; CHEEK S, 1994, PESTIC SCI, V42, P135, DOI 10.1002/ps.2780420211; Cheng XY, 2009, BIOL INVASIONS, V11, P205, DOI 10.1007/s10530-008-9225-2; Chu D, 2007, ENVIRON ENTOMOL, V36, P1290, DOI 10.1603/0046-225X(2007)36[1290:BSADOB]2.0.CO;2; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Crowder DW, 2010, ANIM BEHAV, V79, P579, DOI 10.1016/j.anbehav.2009.11.025; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2000, MOL PHYLOGENET EVOL, V16, P29, DOI 10.1006/mpev.1999.0768; DeBarro PJ, 1997, AUST J ENTOMOL, V36, P149; Delatte H, 2009, BIOL INVASIONS, V11, P1059, DOI 10.1007/s10530-008-9328-9; Ding JQ, 2008, BIOSCIENCE, V58, P317, DOI 10.1641/B580407; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Elbaz M, 2010, B ENTOMOL RES, V100, P581, DOI 10.1017/S0007485309990630; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Guirao P, 1997, B ENTOMOL RES, V87, P587, DOI 10.1017/S0007485300038682; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Horowitz AR, 2003, PHYTOPARASITICA, V31, P94, DOI 10.1007/BF02979772; Hsieh CH, 2006, ANN ENTOMOL SOC AM, V99, P768, DOI 10.1603/0013-8746(2006)99[768:AOBTHA]2.0.CO;2; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Lima LHC, 2000, GENET MOL BIOL, V23, P781, DOI 10.1590/S1415-47572000000400012; Lin K, 2007, CROP PROT, V26, P1831, DOI 10.1016/j.cropro.2007.04.002; Lin W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001208; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Lockwood J.L., 2007, INVASION ECOLOGY, P304; Luan JB, 2008, ENTOMOL EXP APPL, V129, P316, DOI 10.1111/j.1570-7458.2008.00777.x; Luo C, 2010, CROP PROT, V29, P429, DOI 10.1016/j.cropro.2009.10.001; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Ma DY, 2007, CROP PROT, V26, P612, DOI 10.1016/j.cropro.2006.04.027; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Moya A, 2001, MOL ECOL, V10, P891, DOI 10.1046/j.1365-294X.2001.01221.x; Nauen R, 2002, PEST MANAG SCI, V58, P868, DOI 10.1002/ps.557; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Pascual S, 2004, B ENTOMOL RES, V94, P369, DOI 10.1079/BER2003307; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu BL, 2007, PROG NAT SCI-MATER, V17, P645; Rao Q, 2011, B ENTOMOL RES, V101, P81, DOI 10.1017/S0007485310000428; Roques A., 2006, Bulletin OEPP, V36, P490; Rosell RC, 1997, ANN ENTOMOL SOC AM, V90, P575, DOI 10.1093/aesa/90.5.575; Simon B, 2003, B ENTOMOL RES, V93, P259, DOI 10.1079/BER2003233; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sun DB, 2011, B ENTOMOL RES, V101, P211, DOI 10.1017/S0007485310000416; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ueda S, 2009, J APPL ENTOMOL, V133, P355, DOI 10.1111/j.1439-0418.2008.01379.x; WANG P, 2011, INSECT SCI IN PRESS, V18, DOI DOI 10.1017/S0007485310000416; Wang P, 2010, INSECT SCI, V17, P508, DOI 10.1111/j.1744-7917.2010.01353.x; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wilson M, 2007, PEST MANAG SCI, V63, P761, DOI 10.1002/ps.1403; Wu XX, 2003, PROG NAT SCI-MATER, V13, P276, DOI 10.1360/03jz9049; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Xu J., 2009, THESIS ZHEJIANG U HA; Zhang LP, 2005, J APPL ENTOMOL, V129, P121, DOI 10.1111/j.1439-0418.2005.00950.x; Zhou FuCai, 2003, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V24, P71	58	263	331	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16061	10.1371/journal.pone.0016061	http://dx.doi.org/10.1371/journal.pone.0016061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283707	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522300016
J	Barroso, H; Borrego, P; Bartolo, I; Marcelino, JM; Familia, C; Quintas, A; Taveira, N				Barroso, Helena; Borrego, Pedro; Bartolo, Ines; Marcelino, Jose Maria; Familia, Carlos; Quintas, Alexandre; Taveira, Nuno			Evolutionary and Structural Features of the C2, V3 and C3 Envelope Regions Underlying the Differences in HIV-1 and HIV-2 Biology and Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-2; AUTOLOGOUS NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; SWISS-MODEL; MOLECULAR EPIDEMIOLOGY; CORECEPTOR USAGE; SITE VARIATION; SUBTYPE-G; GLYCOPROTEIN; SEQUENCE	Background: Unlike in HIV-1 infection, the majority of HIV-2 patients produce broadly reactive neutralizing antibodies, control viral replication and survive as elite controllers. The identification of the molecular, structural and evolutionary footprints underlying these very distinct immunological and clinical outcomes may lead to the development of new strategies for the prevention and treatment of HIV infection. Methodology/Principal Findings: We performed a side-by-side molecular, evolutionary and structural comparison of the C2, V3 and C3 envelope regions from HIV-1 and HIV-2. These regions contain major antigenic targets and are important for receptor binding. In HIV-2, these regions also have immune modulatory properties. We found that these regions are significantly more variable in HIV-1 than in HIV-2. Within each virus, C3 is the most entropic region followed by either C2 (HIV-2) or V3 (HIV-1). The C3 region is well exposed in the HIV-2 envelope and is under strong diversifying selection suggesting that, like in HIV-1, it may harbour neutralizing epitopes. Notably, however, extreme diversification of C2 and C3 seems to be deleterious for HIV-2 and prevent its transmission. Computer modelling simulations showed that in HIV-2 the V3 loop is much less exposed than C2 and C3 and has a retractile conformation due to a physical interaction with both C2 and C3. The concealed and conserved nature of V3 in the HIV-2 is consistent with its lack of immunodominancy in vivo and with its role in preventing immune activation. In contrast, HIV-1 had an extended and accessible V3 loop that is consistent with its immunodominant and neutralizing nature. Conclusions/Significance: We identify significant structural and functional constrains to the diversification and evolution of C2, V3 and C3 in the HIV-2 envelope but not in HIV-1. These studies highlight fundamental differences in the biology and infection of HIV-1 and HIV-2 and in their mode of interaction with the human immune system and may inform new vaccine and therapeutic interventions against these viruses.	[Barroso, Helena; Borrego, Pedro; Bartolo, Ines; Taveira, Nuno] Fac Farm Lisboa, Ctr Patogenese Mol, URIA, Lisbon, Portugal; [Barroso, Helena; Bartolo, Ines; Familia, Carlos; Quintas, Alexandre; Taveira, Nuno] Inst Super Ciencias Saude Egas Moniz, CiiEM, Caparica, Portugal; [Marcelino, Jose Maria] Inst Higiene & Med Trop, Unidade Tecnol Proteinas & Anticorpos Monoclonais, Lisbon, Portugal; [Taveira, Nuno] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior de Ciencias da Saude Egas Moniz; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Lisboa	Barroso, H (corresponding author), Fac Farm Lisboa, Ctr Patogenese Mol, URIA, Lisbon, Portugal.	ntaveira@ff.ul.pt	Marcelino, José Maria/N-4047-2019; Familia, Carlos/A-4535-2013; Quintas, Alexandre/J-6436-2012; iMed.ULisboa, EEPHIV/B-4222-2014; Borrego, Pedro/H-6968-2013; Bártolo, Inês/A-7477-2014; Taveira, Nuno C/A-6252-2014; Marcelino, Jose/B-3374-2008	Marcelino, José Maria/0000-0002-4597-1535; Familia, Carlos/0000-0001-5059-2487; Quintas, Alexandre/0000-0002-5188-0453; Borrego, Pedro/0000-0002-1949-9484; Bártolo, Inês/0000-0002-2022-8921; Taveira, Nuno C/0000-0003-0176-5585; Marcelino, Jose/0000-0002-4597-1535; Barroso, Helena/0000-0003-4098-5433	Fundo para a Ciencia e Tecnologia, Portugal [PTDCSAU-FCF6767/2006]; European Union; Fundo para a Ciencia e Tecnologia	Fundo para a Ciencia e Tecnologia, Portugal; European Union(European Commission); Fundo para a Ciencia e Tecnologia	This work was supported by projects PTDCSAU-FCF6767/2006 from Fundo para a Ciencia e Tecnologia, Portugal and by Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN), from the European Union. PB and IB are supported by PhD grants from Fundo para a Ciencia e Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes R, 2003, J CLIN MICROBIOL, V41, P3361, DOI 10.1128/JCM.41.7.3361-3367.2003; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barroso Helena, 2005, Infection Genetics and Evolution, V5, P239, DOI 10.1016/j.meegid.2004.07.008; Berry N, 1998, J Hum Virol, V1, P457; Binley J, 2009, CURR OPIN HIV AIDS, V4, P364, DOI 10.1097/COH.0b013e32832e06fe; BIOVIA Discovery Studio, 2008, DISCOVERYSTUDIO 21 I; BJORLING E, 1993, VIROLOGY, V193, P528, DOI 10.1006/viro.1993.1160; BJORLING E, 1991, P NATL ACAD SCI USA, V88, P6082, DOI 10.1073/pnas.88.14.6082; BJORLING E, 1994, J IMMUNOL, V152, P1952; Blaak H, 2006, VIROLOGY, V353, P144, DOI 10.1016/j.virol.2006.05.029; Borrego P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-78; Canducci F, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-4; Cavaleiro R, 2000, AIDS, V14, P2679, DOI 10.1097/00002030-200012010-00007; Cavaleiro R, 2007, EUR J IMMUNOL, V37, P3435, DOI 10.1002/eji.200737511; Chen ZW, 1997, J VIROL, V71, P3953, DOI 10.1128/JVI.71.5.3953-3960.1997; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; Damond F, 2004, AIDS RES HUM RETROV, V20, P666, DOI 10.1089/0889222041217392; Davis KL, 2009, J VIROL, V83, P1240, DOI 10.1128/JVI.01743-08; de Silva TI, 2008, TRENDS MICROBIOL, V16, P588, DOI 10.1016/j.tim.2008.09.003; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; DOUAGI I, 2009, J VIROL; Drylewicz J, 2008, AIDS, V22, P457, DOI 10.1097/QAD.0b013e3282f4ddfc; Esteves A, 2002, AIDS RES HUM RETROV, V18, P313, DOI 10.1089/088922202753519089; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; Garrity RR, 1997, J IMMUNOL, V159, P279; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; GERSTEIN M, 1992, ACTA CRYSTALLOGR A, V48, P271, DOI 10.1107/S0108767391012680; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; HUANG ML, 1991, J VIROL, V65, P5073, DOI 10.1128/JVI.65.9.5073-5079.1991; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Isaka Y, 1999, VIROLOGY, V264, P237, DOI 10.1006/viro.1999.0006; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim YB, 2003, VIROLOGY, V305, P124, DOI 10.1006/viro.2002.1727; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Krachmarov CP, 2006, J VIROL, V80, P7127, DOI 10.1128/JVI.02619-05; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEITNER T, 1995, VIROLOGY, V209, P136, DOI 10.1006/viro.1995.1237; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Lemey P, 2006, AIDS REV, V8, P125; Liang BH, 2007, BIOCHEM CELL BIOL, V85, P259, DOI 10.1139/O06-143; MacNeil A, 2007, J VIROL, V81, P5325, DOI 10.1128/JVI.02625-06; Marcelino JM, 2006, J CLIN MICROBIOL, V44, P607, DOI 10.1128/JCM.44.2.607-611.2006; Marcelino JM, 2010, J VIROL, V84, P12429, DOI 10.1128/JVI.01102-10; Marcelino JM, 2008, AIDS, V22, P2257, DOI 10.1097/QAD.0b013e3283155546; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; MATSUSHITA S, 1995, J VIROL, V69, P3333, DOI 10.1128/JVI.69.6.3333-3340.1995; McKnight A, 1996, J VIROL, V70, P4598, DOI 10.1128/JVI.70.7.4598-4606.1996; MOORE JP, 1994, J VIROL, V68, P6836, DOI 10.1128/JVI.68.11.6836-6847.1994; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Morner A, 1999, VIRUS RES, V59, P49, DOI 10.1016/S0168-1702(98)00133-6; Mota-Miranda A, 2001, AIDS, V15, P2460, DOI 10.1097/00002030-200112070-00018; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Palma AC, 2007, INFECT GENET EVOL, V7, P391, DOI 10.1016/j.meegid.2007.01.009; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinter A, 2007, CURR HIV RES, V5, P542, DOI 10.2174/157016207782418470; Plantier JC, 2001, J CLIN MICROBIOL, V39, P3803, DOI 10.1128/JCM.39.10.3803-3807.2001; Pond SLK, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P419; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D., 2003, CURRENT PROTOCOLS BI; Pybus OG, 2007, MOL BIOL EVOL, V24, P845, DOI 10.1093/molbev/msm001; Qin LZ, 2003, VIROLOGY, V308, P225, DOI [10.1016/S0042-6822(02)00088-0, 10.1016/S0042-3822(02)00088-0]; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rodriguez SK, 2007, J VIROL, V81, P5331, DOI 10.1128/JVI.02789-06; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Rowland-Jones S, 2006, FUTURE MICROBIOL, V1, P427, DOI 10.2217/17460913.1.4.427; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Selvarajah S, 2008, AIDS RES HUM RETROV, V24, P301, DOI 10.1089/aid.2007.0158; Semaille C, 2007, J INFECT DIS, V196, P377, DOI 10.1086/519387; Shi Y, 2005, J GEN VIROL, V86, P3385, DOI 10.1099/vir.0.81259-0; Skar H, 2010, J VIROL, V84, P7412, DOI 10.1128/JVI.02548-09; Skott P, 1999, VIRAL IMMUNOL, V12, P79, DOI 10.1089/vim.1999.12.79; Soares R, 2006, J VIROL, V80, P12425, DOI 10.1128/JVI.01557-06; Soriano V, 2000, J MED VIROL, V61, P111, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;111::AID-JMV18&gt;3.0.CO;2-W; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; TRAINCARD F, 1994, AIDS RES HUM RETROV, V10, P1659, DOI 10.1089/aid.1994.10.1659; Valadas E, 2009, CLIN INFECT DIS, V48, P1166, DOI 10.1086/597504; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yamaguchi J, 2000, AIDS RES HUM RETROV, V16, P925; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	101	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14548	10.1371/journal.pone.0014548	http://dx.doi.org/10.1371/journal.pone.0014548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283793	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200004
J	Jang, Y				Jang, Yikweon			Male Responses to Conspecific Advertisement Signals in the Field Cricket Gryllus rubens (Orthoptera: Gryllidae)	PLOS ONE			English	Article							ALTERNATIVE MATING TACTICS; IN-HOUSE CRICKETS; CALLING-SONG; WING DIMORPHISM; BODY-SIZE; ACOUSTIC COMMUNICATION; ALLOPATRIC POPULATIONS; INTERMALE COMPETITION; FULTONI ORTHOPTERA; FEMALE PREFERENCE	In many species males aggregate and produce long-range advertisement signals to attract conspecific females. The majority of the receivers of these signals are probably other males most of the time, and male responses to competitors' signals can structure the spatial and temporal organization of the breeding aggregation and affect male mating tactics. I quantified male responses to a conspecific advertisement stimulus repeatedly over three age classes in Gryllus rubens (Orthoptera: Gryllidae) in order to estimate the type and frequency of male responses to the broadcast stimulus and to determine the factors affecting them. Factors tested included body size, wing dimorphism, age, and intensity of the broadcast stimulus. Overall, males employed acoustic response more often than positive phonotactic response. As males aged, the frequency of positive phonotactic response decreased but that of the acoustic response increased. That is, males may use positive phonotaxis in the early stages of their adult lives, possibly to find suitable calling sites or parasitize calling males, and then later in life switch to acoustic responses in response to conspecific advertisement signals. Males with smaller body size more frequently exhibited acoustic responses. This study suggests that individual variation, more than any factors measured, is critical for age-dependent male responses to conspecific advertisement signals.	[Jang, Yikweon] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Jang, Yikweon] Ewha Womans Univ, Div EcoSci, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Jang, Y (corresponding author), Ewha Womans Univ, Dept Life Sci, Seoul, South Korea.	jangy@ewha.ac.kr			National Research Foundation of Korea [371-2009-1-C00001]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported financially by a National Research Foundation of Korea grant (371-2009-1-C00001). Funder's website: http://www.nrf.go.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDE.RD, 1968, Q REV BIOL, V43, P1, DOI 10.1086/405628; ALEXANDER RD, 1962, EVOLUTION, V16, P443, DOI 10.1111/j.1558-5646.1962.tb03236.x; Andersson Malte, 1994; ARAK A, 1988, ANIM BEHAV, V36, P416, DOI 10.1016/S0003-3472(88)80012-5; ARAK A, 1990, BEHAV ECOL SOCIOBIOL, V26, P1, DOI 10.1007/BF00174019; Beck CW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000939; Beck CW, 2002, EVOL ECOL RES, V4, P275; Bee MA, 2000, BEHAV ECOL, V11, P169, DOI 10.1093/beheco/11.2.169; Bee MA, 2002, BEHAV ECOL, V13, P109, DOI 10.1093/beheco/13.1.109; Bee MA, 2007, BEHAV ECOL SOCIOBIOL, V61, P955, DOI 10.1007/s00265-006-0324-8; Bell W.J, 1991, SEARCHING BEHAV; Bertram SM, 2000, ANIM BEHAV, V60, P333, DOI 10.1006/anbe.2000.1473; Bertram SM, 2006, ETHOLOGY, V112, P850, DOI 10.1111/j.1439-0310.2006.01234.x; BOAKE CRB, 1994, QUANTITATIVE GENETIC, P3; Bosch J, 1996, ETHOLOGY, V102, P841; Bosch J, 2002, HERPETOLOGICA, V58, P95, DOI 10.1655/0018-0831(2002)058[0095:RTVICF]2.0.CO;2; Brown WD, 2006, ANIM BEHAV, V72, P225, DOI 10.1016/j.anbehav.2006.01.012; Crnokrak P, 1995, ANIM BEHAV, V50, P1475, DOI 10.1016/0003-3472(95)80004-2; Crnokrak P, 1998, EVOLUTION, V52, P1111, DOI 10.1111/j.1558-5646.1998.tb01838.x; Crnokrak P, 1998, ANIM BEHAV, V56, P433, DOI 10.1006/anbe.1998.0741; CRUMP ML, 1988, ANIM BEHAV, V36, P1064, DOI 10.1016/S0003-3472(88)80066-6; DIXON KA, 1986, ANIM BEHAV, V34, P340, DOI 10.1016/S0003-3472(86)80102-6; DOHERTY JA, 1991, J INSECT BEHAV, V4, P67, DOI 10.1007/BF01092552; Falconer D. S., 1996, Introduction to quantitative genetics.; Farris HE, 1997, J INSECT BEHAV, V10, P639, DOI 10.1007/BF02765384; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GRAFE TU, 1995, ETHOLOGY, V101, P67; Gray DA, 1997, ANIM BEHAV, V54, P1553, DOI 10.1006/anbe.1997.0584; Gray DA, 1999, J INSECT BEHAV, V12, P691, DOI 10.1023/A:1020983821436; Gray DA, 2000, P NATL ACAD SCI USA, V97, P14449, DOI 10.1073/pnas.97.26.14449; GREENFIELD MD, 1993, ETHOLOGY, V95, P309, DOI 10.1111/j.1439-0310.1993.tb00480.x; GREENFIELD MD, 1994, ANNU REV ECOL SYST, V25, P97, DOI 10.1146/annurev.es.25.110194.000525; GREENFIELD MD, 1993, NATURE, V364, P618, DOI 10.1038/364618a0; Greenfield MD, 2002, SIGNALERS RECEIVERS; HISSMANN K, 1991, J INSECT BEHAV, V4, P675, DOI 10.1007/BF01048078; Huang Y, 2000, MOL PHYLOGENET EVOL, V17, P48, DOI 10.1006/mpev.2000.0815; Humfeld SC, 2008, ANIM BEHAV, V75, P205, DOI 10.1016/j.anbehav.2007.05.015; Humfeld SC, 2009, ANIM BEHAV, V78, P915, DOI 10.1016/j.anbehav.2009.06.028; Jacot A, 2007, ETHOLOGY, V113, P615, DOI 10.1111/j.1439-0310.2007.01360.x; Jang Y, 2006, J EVOLUTION BIOL, V19, P459, DOI 10.1111/j.1420-9101.2005.01014.x; Jang Y, 1997, J INSECT BEHAV, V10, P87, DOI 10.1007/BF02765476; Jang Y, 2008, BEHAV ECOL SOCIOBIOL, V62, P1397, DOI 10.1007/s00265-008-0568-6; Jang Y, 2007, ETHOLOGY, V113, P87, DOI 10.1111/j.1439-0310.2006.01304.x; Jang Y, 2006, BEHAV ECOL SOCIOBIOL, V60, P150, DOI 10.1007/s00265-005-0151-3; Kiflawi M, 2000, P ROY SOC B-BIOL SCI, V267, P2157, DOI 10.1098/rspb.2000.1263; Kokko H, 1998, EVOL ECOL, V12, P739, DOI 10.1023/A:1006541701002; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P1533, DOI 10.1098/rspb.1996.0224; Leary CJ, 2005, ANIM BEHAV, V70, P663, DOI 10.1016/j.anbehav.2004.12.013; Leonard AS, 2009, BEHAV ECOL, V20, P1175, DOI 10.1093/beheco/arp115; LOPEZ PT, 1988, ANIM BEHAV, V36, P1295, DOI 10.1016/S0003-3472(88)80198-2; Lucas JR, 1996, ANIM BEHAV, V51, P501, DOI 10.1006/anbe.1996.0056; Marshall VT, 2003, ANIM BEHAV, V65, P1223, DOI 10.1006/anbe.2003.2134; Martin SD, 2000, CAN J ZOOL, V78, P706, DOI 10.1139/cjz-78-5-706; Morris GK, 2002, CAN J ZOOL, V80, P271, DOI 10.1139/z02-003; MURRAY AM, 1995, CAN J ZOOL, V73, P1207, DOI 10.1139/z95-144; Naguib M, 1996, BEHAV PROCESS, V38, P163, DOI 10.1016/0376-6357(95)00077-1; Narins PM, 2005, P NATL ACAD SCI USA, V102, P2425, DOI 10.1073/pnas.0406407102; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; NICKLE D A, 1974, Florida Entomologist, V57, P8, DOI 10.2307/3493822; Pfennig KS, 2000, BEHAV ECOL SOCIOBIOL, V48, P69, DOI 10.1007/s002650000205; Prosser MR, 1997, J INSECT BEHAV, V10, P437, DOI 10.1007/BF02765609; RITCHIE MG, 1995, P ROY SOC B-BIOL SCI, V262, P21, DOI 10.1098/rspb.1995.0171; ROMER H, 1986, J COMP PHYSIOL A, V159, P627, DOI 10.1007/BF00612036; Schul J, 2002, P ROY SOC B-BIOL SCI, V269, P1847, DOI 10.1098/rspb.2002.2092; SHELLY TE, 1989, BEHAVIOUR, V109, P200, DOI 10.1163/156853989X00231; SIMMONS LW, 1986, ANIM BEHAV, V34, P567, DOI 10.1016/S0003-3472(86)80126-9; SIMMONS LW, 1992, ANIM BEHAV, V44, P1145, DOI 10.1016/S0003-3472(05)80326-4; SIMMONS LW, 1988, ANIM BEHAV, V36, P380, DOI 10.1016/S0003-3472(88)80009-5; SIMMONS LW, 1993, BEHAV ECOL, V4, P364, DOI 10.1093/beheco/4.4.364; Simmons LW, 1995, BEHAV ECOL, V6, P376, DOI 10.1093/beheco/6.4.376; SMITH CJ, 1987, CAN J ZOOL, V65, P2390, DOI 10.1139/z87-359; Snedden WA, 1998, BEHAV ECOL SOCIOBIOL, V43, P59, DOI 10.1007/s002650050466; SNEDDEN WA, 1992, ANIM BEHAV, V44, P633, DOI 10.1016/S0003-3472(05)80291-X; SOLYMAR BD, 1990, BEHAV ECOL SOCIOBIOL, V26, P73, DOI 10.1007/BF00171576; STOUT J, 1989, NEURAL MECH BEHAV; Tarano Z, 2002, J HERPETOL, V36, P615, DOI 10.1670/0022-1511(2002)036[0615:VRTCCV]2.0.CO;2; Tarano Z, 2002, ANIM BEHAV, V64, P599, DOI 10.1006/anbe.2002.3080; Tarano Z, 2009, ETHOLOGY, V115, P747, DOI 10.1111/j.1439-0310.2009.01664.x; WAGNER WE, 1989, ANIM BEHAV, V38, P1025, DOI 10.1016/S0003-3472(89)80141-1; WAGNER WE, 1989, BEHAV ECOL SOCIOBIOL, V25, P429, DOI 10.1007/BF00300189; Walker TJ, 2000, ANN ENTOMOL SOC AM, V93, P565, DOI 10.1603/0013-8746(2000)093[0565:PRITSO]2.0.CO;2; Walker TJ, 1998, ANN ENTOMOL SOC AM, V91, P175, DOI 10.1093/aesa/91.2.175; WALKER TJ, 1986, ANN ENTOMOL SOC AM, V79, P84, DOI 10.1093/aesa/79.1.84; WALKER TJ, 1987, ANN ENTOMOL SOC AM, V80, P547, DOI 10.1093/aesa/80.5.547; WELLS KD, 1978, ANIM BEHAV, V26, P1051, DOI 10.1016/0003-3472(78)90094-5; ZERA AJ, 1989, OECOLOGIA, V80, P249, DOI 10.1007/BF00380159; ZUK M, 1988, EVOLUTION, V42, P969, DOI 10.1111/j.1558-5646.1988.tb02515.x	87	29	29	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16063	10.1371/journal.pone.0016063	http://dx.doi.org/10.1371/journal.pone.0016063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283758	gold, Green Published, Green Submitted			2022-12-25	WOS:000286522200027
J	Mestre, O; Luo, T; Dos Vultos, T; Kremer, K; Murray, A; Namouchi, A; Jackson, C; Rauzier, J; Bifani, P; Warren, R; Rasolofo, V; Mei, JA; Gao, QA; Gicquel, B				Mestre, Olga; Luo, Tao; Dos Vultos, Tiago; Kremer, Kristin; Murray, Alan; Namouchi, Amine; Jackson, Celine; Rauzier, Jean; Bifani, Pablo; Warren, Rob; Rasolofo, Voahangy; Mei, Jian; Gao, Qian; Gicquel, Brigitte			Phylogeny of Mycobacterium tuberculosis Beijing Strains Constructed from Polymorphisms in Genes Involved in DNA Replication, Recombination and Repair	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISMS; GLOBAL DISSEMINATION; GENOMIC DELETIONS; EVOLUTION; LINEAGE; FAMILY; GENOTYPE	Background: The Beijing family is a successful group of M. tuberculosis strains, often associated with drug resistance and widely distributed throughout the world. Polymorphic genetic markers have been used to type particular M. tuberculosis strains. We recently identified a group of polymorphic DNA repair replication and recombination (3R) genes. It was shown that evolution of M. tuberculosis complex strains can be studied using 3R SNPs and a high-resolution tool for strain discrimination was developed. Here we investigated the genetic diversity and propose a phylogeny for Beijing strains by analyzing polymorphisms in 3R genes. Methodology/Principal Findings: A group of 3R genes was sequenced in a collection of Beijing strains from different geographic origins. Sequence analysis and comparison with the ones of non-Beijing strains identified several SNPs. These SNPs were used to type a larger collection of Beijing strains and allowed identification of 26 different sequence types for which a phylogeny was constructed. Phylogenetic relationships established by sequence types were in agreement with evolutionary pathways suggested by other genetic markers, such as Large Sequence Polymorphisms (LSPs). A recent Beijing genotype (Bmyc10), which included 60% of strains from distinct parts of the world, appeared to be predominant. Conclusions/Significance: We found SNPs in 3R genes associated with the Beijing family, which enabled discrimination of different groups and the proposal of a phylogeny. The Beijing family can be divided into different groups characterized by particular genetic polymorphisms that may reflect pathogenic features. These SNPs are new, potential genetic markers that may contribute to better understand the success of the Beijing family.	[Mestre, Olga; Dos Vultos, Tiago; Murray, Alan; Namouchi, Amine; Jackson, Celine; Rauzier, Jean; Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, Paris, France; [Luo, Tao; Gao, Qian] Fudan Univ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Kremer, Kristin] Natl Inst Publ Hlth & Environm, TB Reference Lab, NL-3720 BA Bilthoven, Netherlands; [Murray, Alan] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Bifani, Pablo] Sci Inst Publ Hlth, Brussels, Belgium; [Warren, Rob] Univ Stellenbosch, MRC Ctr Mol & Cellular Biol, NRF Ctr Excellence Biomed TB Research, Cape Town, South Africa; [Rasolofo, Voahangy] Inst Pasteur Madagascar, Unite TB & Mycobacteries, Antananarivo, Madagascar; [Mei, Jian] Shanghai Municipal CDC, Dept TB Control, Shanghai, Peoples R China	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Fudan University; Netherlands National Institute for Public Health & the Environment; Massey University; Stellenbosch University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Mestre, O (corresponding author), Inst Pasteur, Unite Genet Mycobacterienne, Paris, France.	brigitte.gicquel@pasteur.fr	, 罗涛/AHA-1191-2022; Mestre, Olga/D-7418-2013	Warren, Robin/0000-0001-5741-7358; Mestre, Olga/0000-0002-0993-2248; Bifani, Pablo/0000-0001-9651-6439	European Commission [LSHP-CT-2006-037919, 200973]; Key Project of Chinese National Programs [2008ZX10003-010]	European Commission(European CommissionEuropean Commission Joint Research Centre); Key Project of Chinese National Programs	This work is part of the TB-ADAPT (LSHP-CT-2006-037919) and TB-VIR (Grant agreement nu 200973) projects supported by the European Commission under the Health Cooperation Work Programme of the 6th and 7th Framework Programme, respectively. This work was also supported by the Key Project of Chinese National Programs (2008ZX10003-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; [Anonymous], 2006, EMERG INFECT DIS, P736; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Gutacker MM, 2002, GENETICS, V162, P1533; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Kremer K, 2005, J CLIN MICROBIOL, V43, P314, DOI 10.1128/JCM.43.1.314-320.2005; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Moreland NJ, 2009, BIOCHEMISTRY-US, V48, P699, DOI 10.1021/bi8009554; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Rindi L, 2009, INFECT GENET EVOL, V9, P48, DOI 10.1016/j.meegid.2008.09.006; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; Zhang L, 2008, FEMS MICROBIOL LETT, V282, P22, DOI 10.1111/j.1574-6968.2008.01081.x; 2008, WHO REPORT 2008 GLOB	21	54	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16020	10.1371/journal.pone.0016020	http://dx.doi.org/10.1371/journal.pone.0016020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283803	Green Published, gold			2022-12-25	WOS:000286522200023
J	von Holleben, M; Gohla, A; Janssen, KP; Iritani, BM; Beer-Hammer, S				von Holleben, Max; Gohla, Antje; Janssen, Klaus-Peter; Iritani, Brian M.; Beer-Hammer, Sandra			Immunoinhibitory Adapter Protein Src Homology Domain 3 Lymphocyte Protein 2 (SLy2) Regulates Actin Dynamics and B Cell Spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; SIGNAL-TRANSDUCTION; IMMUNE SYNAPSE; RHO-GTPASES; ACTIVATION; CYTOSKELETON; CORTACTIN; COMPLEX; SH3; HACS1	Appropriate B cell activation is essential for adaptive immunity. In contrast to the molecular mechanisms that regulate positive signaling in immune responses, the counterbalancing negative regulatory pathways remain insufficiently understood. The Src homology domain 3 (SH3)-containing adapter protein SH3 lymphocyte protein 2 (SLy2, also known as hematopoietic adapter-containing SH3 and sterile alpha-motif (SAM) domains 1; HACS1) is strongly up-regulated upon B cell activation and functions as an endogenous immunoinhibitor in vivo, but the underlying molecular mechanisms of SLy2 function have been elusive. We have generated transgenic mice overexpressing SLy2 in B and T cells and have studied the biological effects of elevated SLy2 levels in Jurkat and HeLa cells. Our results demonstrate that SLy2 induces Rac1-dependent membrane ruffle formation and regulates cell spreading and polarization and that the SLy2 SH3 domain is essential for these effects. Using immunoprecipitation and confocal microscopy, we provide evidence that the actin nucleation-promoting factor cortactin is an SH3 domain-directed interaction partner of SLy2. Consistent with an important role of SLy2 for actin cytoskeletal reorganization, we further show that SLy2-transgenic B cells are severely defective in cell spreading. Together, our findings extend our mechanistic understanding of the immunoinhibitory roles of SLy2 in vivo and suggest that the physiological up-regulation of SLy2 observed upon B cell activation functions to counteract excessive B cell spreading.	[von Holleben, Max; Beer-Hammer, Sandra] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Gohla, Antje] Univ Dusseldorf, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Gohla, Antje] Univ Wurzburg, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Gohla, Antje] Univ Wurzburg, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany; [Janssen, Klaus-Peter] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-81675 Munich, Germany; [Iritani, Brian M.] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA; [Beer-Hammer, Sandra] Univ Tubingen, Inst Expt & Clin Pharmacol & Toxicol, Eberhard Karls Univ Hosp & Clin, Dept Pharmacol & Expt Therapy, D-72074 Tubingen, Germany; [Beer-Hammer, Sandra] Univ Tubingen, Interfac Ctr Pharmacogen & Pharmaceut Res, D-72074 Tubingen, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Wurzburg; University of Wurzburg; Technical University of Munich; University of Washington; University of Washington Seattle; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Beer-Hammer, S (corresponding author), Univ Tubingen, Inst Expt & Clin Pharmacol & Toxicol, Eberhard Karls Univ Hosp & Clin, Dept Pharmacol & Expt Therapy, Wilhelmstr 56, D-72074 Tubingen, Germany.	sandra.beer-hammer@uni-tuebingen.de	Beer-Hammer, Sandra/C-7442-2014	Beer-Hammer, Sandra/0000-0001-6049-0257; Iritani, Brian/0000-0003-1903-7850; Gohla, Antje/0000-0002-7442-1487	Deutsche Forschungsgemeinschaft [BE 2813/1-1, 2813/1-2, SFB 728, FOR729, SFB 688, SFB 456]; Forschungskommission of the Heinrich Heine University Duesseldorf; Karls-Eberhard-University Tubingen; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024462] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungskommission of the Heinrich Heine University Duesseldorf; Karls-Eberhard-University Tubingen; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Grants BE 2813/1-1 and 2813/1-2 (to S. B.), SFB 728, FOR729, and SFB 688 (to A. G.), and SFB 456 (to K.-P. J.) from Deutsche Forschungsgemeinschaft and Forschungskommission of the Heinrich Heine University Duesseldorf and Karls-Eberhard-University Tubingen (to S. B.-H.).	Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Batista FD, 2010, IMMUNOL REV, V237, P191, DOI 10.1111/j.1600-065X.2010.00943.x; Beer S, 2001, BBA-GENE STRUCT EXPR, V1520, P89, DOI 10.1016/S0167-4781(01)00242-1; Billadeau DD, 2006, TRAFFIC, V7, P1451, DOI 10.1111/j.1600-0854.2006.00491.x; Brandt S, 2010, INT J BIOCHEM CELL B, V42, P1472, DOI 10.1016/j.biocel.2010.05.004; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Butler B, 2008, NAT IMMUNOL, V9, P887, DOI 10.1038/ni.1630; Claudio J, 2001, ONCOGENE, V20, P5373, DOI 10.1038/sj.onc.1204698; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; HIDAKA M, 1991, BIOCHEM BIOPH RES CO, V180, P1490, DOI 10.1016/S0006-291X(05)81364-6; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rimkus C, 2006, BRIT J CANCER, V95, P1419, DOI 10.1038/sj.bjc.6603452; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Wang DY, 2010, FASEB J, V24, P947, DOI 10.1096/fj.09-140806; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Zeller C, 2003, ONCOGENE, V22, P2972, DOI 10.1038/sj.onc.1206474; Zhu YX, 2004, J EXP MED, V200, P737, DOI 10.1084/jem.20031816	34	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13489	13501		10.1074/jbc.M110.155184	http://dx.doi.org/10.1074/jbc.M110.155184			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21296879	hybrid, Green Published			2022-12-25	WOS:000289282200069
J	Fu, YX; Chang, ACY; Fournier, M; Chang, L; Niessen, K; Karsan, A				Fu, YangXin; Chang, Alex Chia Yu; Fournier, Michele; Chang, Linda; Niessen, Kyle; Karsan, Aly			RUNX3 Maintains the Mesenchymal Phenotype after Termination of the Notch Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL HEART-DEFECTS; RBP-J-KAPPA; CARDIAC DEVELOPMENT; VASCULAR DEVELOPMENT; ENDOTHELIAL-CELLS; TRANSITION; DIFFERENTIATION; ACTIVATION; PATHWAY; GENE	Notch is a critical mediator of endothelial-to-mesenchymal transition (EndMT) during cardiac cushion development. Slug, a transcriptional repressor that is a Notch target, is an important Notch effector of EndMT in the cardiac cushion. Here, we report that the runt-related transcription factor RUNX3 is a novel direct Notch target in the endothelium. Ectopic expression of RUNX3 in endothelium induces Slug expression and EndMT independent of Notch activation. Interestingly, RUNX3 physically interacts with CSL, the Notch-interacting partner in the nucleus, and induces Slug in a CSL-dependent, but Notch-independent manner. Although RUNX3 may not be required for the initial induction of Slug and EndMT by Notch, because RUNX3 has a much longer half-life than Slug, it sustains the expression of Slug thereby maintaining the mesenchymal phenotype. CSL binds to the Runx3 promoter in the atrioventricular canal in vivo, and inhibition of Notch reduces RUNX3 expression in the cardiac cushion of embryonic hearts. Taken together, our results suggest that induction of RUNX3 may be a mechanism to maintain Notch-transformed mesenchymal cells during heart development.	[Fu, YangXin; Fournier, Michele; Karsan, Aly] Univ British Columbia, British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Fu, YangXin; Chang, Alex Chia Yu; Chang, Linda; Niessen, Kyle; Karsan, Aly] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Karsan, A (corresponding author), Univ British Columbia, British Columbia Canc Res Ctr, 675W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	akarsan@bccrc.ca	Karsan, Aly/K-2067-2015	Chang, Alex Chia Yu/0000-0001-9441-4033	Canadian Institutes of Health Research; Heart and Stroke Foundation of British Columbia and Yukon; Genome Canada; Genome British Columbia; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia and Yukon; Genome Canada(Genome Canada); Genome British Columbia; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of British Columbia and Yukon, Genome Canada, and Genome British Columbia.; Supported by a Doctoral Research Award from the Michael Smith Foundation for Health Research.	Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Brennan K, 2002, BIOESSAYS, V24, P405, DOI 10.1002/bies.10089; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Del Monte G, 2007, DEV DYNAM, V236, P2594, DOI 10.1002/dvdy.21246; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Fu YX, 2009, J BIOL CHEM, V284, P19452, DOI 10.1074/jbc.M109.011833; Gao J, 2010, EXP CELL RES, V316, P149, DOI 10.1016/j.yexcr.2009.09.025; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; MacKenzie F, 2004, BLOOD, V104, P1760, DOI 10.1182/blood-2003-12-4244; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Nakagawa M, 2006, BLOOD, V108, P3329, DOI 10.1182/blood-2006-04-019570; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Nigam V, 2009, J MOL CELL CARDIOL, V47, P828, DOI 10.1016/j.yjmcc.2009.08.008; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; OKA C, 1995, DEVELOPMENT, V121, P3291; Sarao R, 1998, TRANSGENIC RES, V7, P421, DOI 10.1023/A:1008837410485; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Van de Walle I, 2009, BLOOD, V113, P2988, DOI 10.1182/blood-2008-06-164871; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	46	30	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11803	11813		10.1074/jbc.M111.222331	http://dx.doi.org/10.1074/jbc.M111.222331			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21288908	Green Published, hybrid			2022-12-25	WOS:000288797100087
J	Burkhardt, J; Vonck, J; Averhoff, B				Burkhardt, Janin; Vonck, Janet; Averhoff, Beate			Structure and Function of PilQ, a Secretin of the DNA Transporter from the Thermophilic Bacterium Thermus thermophilus HB27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; ENTEROPATHOGENIC ESCHERICHIA-COLI; TRANSMISSION ELECTRON-MICROSCOPY; NATURAL GENETIC-TRANSFORMATION; OUTER-MEMBRANE COMPONENTS; FILAMENTOUS PHAGE-PIV; HIGH-MOLECULAR-MASS; N-TERMINAL DOMAIN; NEISSERIA-MENINGITIDIS; PSEUDOMONAS-AERUGINOSA	Secretins are a family of large bacterial outer membrane protein complexes mediating the transport of complex structures, such as type IV pili, DNA and filamentous phage, or various proteins, such as extracellular enzymes and pathogenicity determinants. PilQ of the thermophilic bacterium Thermus thermophilus HB27 is a member of the secretin family required for natural transformation. Here we report the isolation, structural, and functional analyses of a unique PilQ from T. thermophilus. Native PAGE, gel filtration chromatography, and electrophoretic mobility shift analyses indicated that PilQ forms a macromolecular homopolymeric complex that binds dsDNA. Electron microscopy showed that the PilQ complex is 15 nm wide and 34 nm long and consists of an extraordinary stable "cone" and "cup" structure and five ring structures with a large central channel. Moreover, the electron microscopic images together with secondary structure analyses combined with structural data of type II protein secretion system and type III protein secretion system secretins suggest that the individual rings are formed by conserved domains of alternating alpha-helices and alpha-sheets. The unprecedented length of the PilQ complex correlated well with the distance between the inner and outer membrane of T. thermophilus. Indeed, PilQ was found immunologically in both membranes, indicating that the PilQ complex spans the entire cell periphery of T. thermophilus. This is consistent with the hypothesis that PilQ accommodates a PilA4 comprising pseudopilus mediating DNA transport across the outer membrane and periplasmic space in a single-step process.	[Burkhardt, Janin; Averhoff, Beate] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Vonck, Janet] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Max Planck Society	Averhoff, B (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	Averhoff@bio.uni-frankfurt.de		Averhoff, Beate/0000-0003-1460-3649; Vonck, Janet/0000-0001-5659-8863				Assalkhou R, 2007, MICROBIOL-SGM, V153, P1593, DOI 10.1099/mic.0.2006/004200-0; Averhoff B, 2004, J BIOENERG BIOMEMBR, V36, P25, DOI 10.1023/B:JOBB.0000019595.66733.fa; Averhoff B, 2009, FEMS MICROBIOL REV, V33, P611, DOI 10.1111/j.1574-6976.2008.00160.x; Bayan N, 2006, MOL MICROBIOL, V60, P1, DOI 10.1111/j.1365-2958.2006.05084.x; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; Bitter W, 2007, J BACTERIOL, V189, P2967, DOI 10.1128/JB.01583-06; Bose N, 2005, J BACTERIOL, V187, P2225, DOI 10.1128/JB.187.7.2225-2232.2005; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340; Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004; CASTON JR, 1988, FEMS MICROBIOL LETT, V51, P225, DOI 10.1111/j.1574-6968.1988.tb03001.x; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen I, 2006, J BIOL CHEM, V281, P21720, DOI 10.1074/jbc.M604071200; Clock SA, 2008, J BACTERIOL, V190, P980, DOI 10.1128/JB.01347-07; Collins RF, 2005, J BIOL CHEM, V280, P18923, DOI 10.1074/jbc.M411603200; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Collins RF, 2003, J BACTERIOL, V185, P2611, DOI 10.1128/JB.185.8.2611-2617.2003; Collins RF, 2001, J BACTERIOL, V183, P3825, DOI 10.1128/JB.183.13.3825-3832.2001; Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x; Daniel A, 2006, MICROBIOL-SGM, V152, P2405, DOI 10.1099/mic.0.28860-0; DENFERT C, 1989, J BIOL CHEM, V264, P17462; Drake SL, 1997, MOL MICROBIOL, V23, P657, DOI 10.1046/j.1365-2958.1997.2511618.x; FARALDO MM, 1992, J BACTERIOL, V174, P7458, DOI 10.1128/jb.174.22.7458-7462.1992; FERNANDEZHERRERO LA, 1995, J BACTERIOL, V177, P5460, DOI 10.1128/jb.177.19.5460-5466.1995; Friedrich A, 2001, APPL ENVIRON MICROB, V67, P3140, DOI 10.1128/AEM.67.7.3140-3148.2001; Friedrich A, 2003, APPL ENVIRON MICROB, V69, P3695, DOI 10.1128/AEM.69.7.3695-3700.2003; Friedrich A, 2002, APPL ENVIRON MICROB, V68, P745, DOI 10.1128/AEM.68.2.745-755.2002; Fussenegger M, 1997, GENE, V192, P125, DOI 10.1016/S0378-1119(97)00038-3; GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883; Graupner S, 2000, J BACTERIOL, V182, P2184, DOI 10.1128/JB.182.8.2184-2190.2000; Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999; HANCOCK REW, 1978, J BACTERIOL, V136, P381, DOI 10.1128/JB.136.1.381-390.1978; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; Helm RA, 2007, J BACTERIOL, V189, P3198, DOI 10.1128/JB.01833-06; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Johnsborg O, 2007, RES MICROBIOL, V158, P767, DOI 10.1016/j.resmic.2007.09.004; Koomey M, 1998, APMIS, V106, P56; Korotkov KV, 2006, J MOL BIOL, V363, P311, DOI 10.1016/j.jmb.2006.08.037; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x; Koster M, 2000, INT J MED MICROBIOL, V290, P325; KOYAMA Y, 1986, J BACTERIOL, V166, P338, DOI 10.1128/jb.166.1.338-340.1986; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maier B, 2004, P NATL ACAD SCI USA, V101, P10961, DOI 10.1073/pnas.0402305101; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Maier E, 2001, J BACTERIOL, V183, P800, DOI 10.1128/JB.183.2.800-803.2001; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9; Ramer SW, 1996, J BACTERIOL, V178, P6555, DOI 10.1128/jb.178.22.6555-6563.1996; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Rose I, 2011, EXTREMOPHILES, V15, P191, DOI 10.1007/s00792-010-0343-2; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; RUSSEL M, 1993, J BACTERIOL, V175, P3998, DOI 10.1128/JB.175.13.3998-4007.1993; Schmidt SA, 2001, J BACTERIOL, V183, P4848, DOI 10.1128/JB.183.16.4848-4859.2001; Schwarzenlander C, 2009, ENVIRON MICROBIOL, V11, P801, DOI 10.1111/j.1462-2920.2008.01801.x; SEIFERT HS, 1990, J BACTERIOL, V172, P40, DOI 10.1128/JB.172.1.40-46.1990; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Spagnuolo J, 2010, MOL MICROBIOL, V76, P133, DOI 10.1111/j.1365-2958.2010.07085.x; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Thanassi DG, 2002, J MOL MICROB BIOTECH, V4, P11; Tonjum T, 1997, GENE, V192, P155, DOI 10.1016/S0378-1119(97)00018-8; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; van Schaik EJ, 2005, J BACTERIOL, V187, P1455, DOI 10.1128/JB.187.4.1455-1464.2005; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	69	48	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9977	9984		10.1074/jbc.M110.212688	http://dx.doi.org/10.1074/jbc.M110.212688			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21285351	Green Published, hybrid			2022-12-25	WOS:000288547000012
J	Echtermeyer, C; Costa, LD; Rodrigues, FA; Kaiser, M				Echtermeyer, Christoph; Costa, Luciano da Fontoura; Rodrigues, Francisco A.; Kaiser, Marcus			Automatic Network Fingerprinting through Single-Node Motifs	PLOS ONE			English	Article							COMPLEX NETWORKS; ROBUSTNESS; LETHALITY; INTERNET; MODEL	Complex networks have been characterised by their specific connectivity patterns (network motifs), but their building blocks can also be identified and described by node-motifs-a combination of local network features. One technique to identify single node-motifs has been presented by Costa et al. (L. D. F. Costa, F. A. Rodrigues, C. C. Hilgetag, and M. Kaiser, Europhys. Lett., 87, 1, 2009). Here, we first suggest improvements to the method including how its parameters can be determined automatically. Such automatic routines make high-throughput studies of many networks feasible. Second, the new routines are validated in different network-series. Third, we provide an example of how the method can be used to analyse network time-series. In conclusion, we provide a robust method for systematically discovering and classifying characteristic nodes of a network. In contrast to classical motif analysis, our approach can identify individual components (here: nodes) that are specific to a network. Such special nodes, as hubs before, might be found to play critical roles in real-world networks.	[Echtermeyer, Christoph; Kaiser, Marcus] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Costa, Luciano da Fontoura] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Rodrigues, Francisco A.] Univ Sao Paulo, Dept Matemat Aplicada & Estat, Inst Ciencia & Tecnol Polimeros, Inst Ciencias Matemat & Computacao, Sao Carlos, SP, Brazil; [Kaiser, Marcus] Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kaiser, Marcus] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea	Newcastle University - UK; Universidade de Sao Paulo; Universidade de Sao Paulo; Newcastle University - UK; Seoul National University (SNU)	Echtermeyer, C (corresponding author), Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	m.kaiser@newcastle.ac.uk	Kaiser, Marcus/A-7166-2008; da F. Costa, Luciano/H-5475-2011; Rodrigues, Francisco A./E-4418-2011	Kaiser, Marcus/0000-0002-4654-3110; da F. Costa, Luciano/0000-0001-5203-4366; Rodrigues, Francisco A./0000-0002-0145-5571	Engineering and Physical Sciences Research Council (EPSRC) [EP/G03950X/1, EP/E002331/1]; Ministry of Education, Science and Technology [R32-10142]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301303/06-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/00587-5]; FAPESP [2007/50633-9]; Engineering and Physical Sciences Research Council [EP/E002331/1, EP/G03950X/1] Funding Source: researchfish; EPSRC [EP/E002331/1, EP/G03950X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Marcus Kaiser and Christoph Echtermeyer were supported by the Engineering and Physical Sciences Research Council (EPSRC) (EP/G03950X/1), the CARMEN e-science project (http://www.carmen.org.uk) funded by EPSRC (EP/E002331/1), and the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R32-10142). Luciano da F. Costa is grateful to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (301303/06-1) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (05/00587-5) for financial support. Francisco A. Rodrigues is grateful to FAPESP (2007/50633-9) for sponsorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barthelemy M, 2005, J THEOR BIOL, V235, P275, DOI 10.1016/j.jtbi.2005.01.011; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BORDINO I, 2008, 8 INT C DAT MIN ICDM; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Bornholdt S, 2003, HDB GRAPHS NETWORKS; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carmi S, 2007, P NATL ACAD SCI USA, V104, P11150, DOI 10.1073/pnas.0701175104; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Costa LD, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18008; Costa LD, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/48001; Costa LD, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-16; Costa LD, 2006, J STAT PHYS, V125, P845, DOI 10.1007/s10955-006-9130-y; DUDA RO, 2001, PATTERN CLASSIFICATI; Eaton J.W., 2002, GNU OCTAVE MANUAL; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Estrada E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016103; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; GROENING M, 2005, SIMPSONS UNCENSORED; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; GUARE J, 1994, 6 DEGREES SEPARATION; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnson R. A., 2007, APPL MULTIVARIATE ST, V6th; Kaiser M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/5/110; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Kaiser M, 2007, PHILOS T R SOC A, V365, P3033, DOI 10.1098/rsta.2007.0007; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kochen Manfred, 1989, SMALL WORLD; Kuramochi M, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P313, DOI 10.1109/ICDM.2001.989534; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; MacKay D. J. C., 2003, INFORM THEORY INFERE; MAHALANOBIS PC, 1936, P NAT I SCI INDIA, V2, P49; Meloni S, 2009, P NATL ACAD SCI USA, V106, P16897, DOI 10.1073/pnas.0907121106; Middendorf M, 2005, P NATL ACAD SCI USA, V102, P3192, DOI 10.1073/pnas.0409515102; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ozik J, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026108; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Ramasco JJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036122; Ribeiro Pedro, 2009, Proceedings of the 2009 5th IEEE International Conference on e-Science (e-Science 2009), P80, DOI 10.1109/e-Science.2009.20; Rodrigues FA, 2009, MOL BIOSYST, V5, P385, DOI 10.1039/b815702m; Saavedra S, 2008, P NATL ACAD SCI USA, V105, P16466, DOI 10.1073/pnas.0804740105; Schnettler S, 2009, SOC NETWORKS, V31, P165, DOI 10.1016/j.socnet.2008.12.004; SEIDMAN SB, 1983, NETWORK STRUCTURE MI, V5; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Wang J, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/123023; Wasserman S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	69	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15765	10.1371/journal.pone.0015765	http://dx.doi.org/10.1371/journal.pone.0015765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297963	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300025
J	Spingath, EY; Kang, HS; Plummer, T; Blake, DT				Spingath, Elsie Y.; Kang, Hyun Sug; Plummer, Thane; Blake, David T.			Different Neuroplasticity for Task Targets and Distractors	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; PRIMARY SOMATOSENSORY CORTEX; CORTICAL MAP REORGANIZATION; MIDDLE TEMPORAL AREA; ADULT OWL MONKEYS; NUCLEUS BASALIS; DEPENDENT PLASTICITY; DISCRIMINATION TASK; HAND REPRESENTATION; TACTILE STIMULATION	Adult learning-induced sensory cortex plasticity results in enhanced action potential rates in neurons that have the most relevant information for the task, or those that respond strongly to one sensory stimulus but weakly to its comparison stimulus. Current theories suggest this plasticity is caused when target stimulus evoked activity is enhanced by reward signals from neuromodulatory nuclei. Prior work has found evidence suggestive of nonselective enhancement of neural responses, and suppression of responses to task distractors, but the differences in these effects between detection and discrimination have not been directly tested. Using cortical implants, we defined physiological responses in macaque somatosensory cortex during serial, matched, detection and discrimination tasks. Nonselective increases in neural responsiveness were observed during detection learning. Suppression of responses to task distractors was observed during discrimination learning, and this suppression was specific to cortical locations that sampled responses to the task distractor before learning. Changes in receptive field size were measured as the area of skin that had a significant response to a constant magnitude stimulus, and these areal changes paralleled changes in responsiveness. From before detection learning until after discrimination learning, the enduring changes were selective suppression of cortical locations responsive to task distractors, and nonselective enhancement of responsiveness at cortical locations selective for target and control skin sites. A comparison of observations in prior studies with the observed plasticity effects suggests that the non-selective response enhancement and selective suppression suffice to explain known plasticity phenomena in simple spatial tasks. This work suggests that differential responsiveness to task targets and distractors in primary sensory cortex for a simple spatial detection and discrimination task arise from nonselective increases in response over a broad cortical locus that includes the representation of the task target, and selective suppression of responses to the task distractor within this locus.	[Spingath, Elsie Y.; Kang, Hyun Sug; Plummer, Thane; Blake, David T.] Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; [Spingath, Elsie Y.; Kang, Hyun Sug] Med Coll Georgia, Grad Program Neurosci, Augusta, GA 30912 USA; [Plummer, Thane; Blake, David T.] Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Spingath, EY (corresponding author), Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA.	dblake@mcg.edu			NIH [5R01NS055173]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055173] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work funded by NIH grant 5R01NS055173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Beitel RE, 2003, P NATL ACAD SCI USA, V100, P11070, DOI 10.1073/pnas.1334187100; Bender KJ, 2006, J NEUROSCI, V26, P4155, DOI 10.1523/JNEUROSCI.0175-06.2006; Blake David T., 2005, P279, DOI 10.1016/B978-012088382-0/50023-2; Blake DT, 2006, NEURON, V52, P371, DOI 10.1016/j.neuron.2006.08.009; Blake DT, 2005, J NEUROPHYSIOL, V94, P2239, DOI 10.1152/jn.00172.2005; Blake DT, 2002, P NATL ACAD SCI USA, V99, P10114, DOI 10.1073/pnas.092278099; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; CARPENTERHYLAND E, 2010, P NAT ACAD SCI US; deCharms RC, 1999, J NEUROSCI METH, V93, P27, DOI 10.1016/S0165-0270(99)00087-4; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Green DM, 1966, SIGNAL DETECTION THE; Harris JA, 2001, J NEUROSCI, V21, P1056, DOI 10.1523/JNEUROSCI.21-03-01056.2001; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; HSIAO SS, 1993, J NEUROPHYSIOL, V70, P444, DOI 10.1152/jn.1993.70.1.444; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; JOHANSSON R, 1978, J PHYSL; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Killebrew JH, 2007, J NEUROSCI METH, V161, P62, DOI 10.1016/j.jneumeth.2006.10.012; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; MERZENICH MM, 1978, J COMP NEUROL, V181, P41, DOI 10.1002/cne.901810104; Nover H, 2005, J NEUROSCI, V25, P10049, DOI 10.1523/JNEUROSCI.1661-05.2005; Pei YC, 2009, J NEUROPHYSIOL, V102, P1843, DOI 10.1152/jn.00235.2009; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Porro CA, 1996, J NEUROSCI, V16, P7688; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; RICHARDSON RT, 1986, BRAIN RES, V399, P364, DOI 10.1016/0006-8993(86)91529-5; RICHARDSON RT, 1990, J NEUROSCI, V10, P2528; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; SEGUELA P, 1990, NEUROSCIENCE, V35, P249, DOI 10.1016/0306-4522(90)90079-J; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Tsushima Y, 2008, CURR BIOL, V18, pR516, DOI 10.1016/j.cub.2008.04.029; Uka T, 2003, J NEUROSCI, V23, P3515; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Xerri C, 1999, CEREB CORTEX, V9, P264, DOI 10.1093/cercor/9.3.264; XERRI C, 1994, J NEUROSCI, V14, P1710, DOI 10.1523/JNEUROSCI.14-03-01710.1994; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004	49	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15342	10.1371/journal.pone.0015342	http://dx.doi.org/10.1371/journal.pone.0015342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297962	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300022
J	Chen, JA; Guo, SX; Liu, PG				Chen, Juan; Guo, Shun-Xing; Liu, Pei-Gui			Species Recognition and Cryptic Species in the Tuber indicum Complex	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; CHINESE TRUFFLES; SP-NOV; PSEUDOHIMALAYENSE; PSEUDOEXCAVATUM; SPAIN	Morphological delimitation of Asian black truffles, including Tuber himalayense, T. indicum, T. sinense, T. pseudohimalayense, T. formosanum and T. pseudoexcavatum, has remained problematic and even phylogenetic analyses have been controversial. In this study, we combined five years of field investigation in China with morphological study and DNA sequences analyses (ITS, LSU and beta-tubulin) of 131 Tuber specimens to show that T. pseudohimalayense and T. pseudoexcavatum are the same species. T. formosanum is a separate species based on its host plants and geographic distribution, combined with minor morphological difference from T. indicum. T. sinense should be treated as a synonym of T. indicum. Our results demonstrate that the present T. indicum, a single described morphological species, should include at least two separate phylogenetic species. These findings are of high importance for truffle taxonomy and reveal and preserve the richness of truffle diversity.	[Chen, Juan; Liu, Pei-Gui] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Chen, Juan; Guo, Shun-Xing] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100037, Peoples R China; [Chen, Juan; Guo, Shun-Xing] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, JA (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.	pgliu@mail.kib.ac.cn	Chen, Juan/AEX-8536-2022		National Science Foundation of China [30470011, 30770007, 30900004]; National Science Foundation of China; Yunnan Province Government [U0836604]; Yunnan Program of Innovation [2009AC013]; Key Laboratory of Biodiversity and Biogeography; Kunming Institute of Botany; Chinese Academy of Sciences [0806361121, KSCX2-YW-G-025]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province Government; Yunnan Program of Innovation; Key Laboratory of Biodiversity and Biogeography; Kunming Institute of Botany; Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was financed by the National Science Foundation of China (No.30470011, 30770007 and 30900004), the Joint Founds of the National Science Foundation of China and Yunnan Province Government (No.U0836604), Yunnan Program of Innovation to strong provinces by Science & Technology (No. 2009AC013) and Key Laboratory of Biodiversity and Biogeography, Kunming Institute of Botany, Chinese Academy of Sciences (No. 0806361121), as well as the Knowledge Innovation Program of the Chinese Academy of Sciences (No.KSCX2-YW-G-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ceruti A., 2003, SPECIE EUROPEE GENER; CHEN J, 2007, THESIS CHINESE ACAD; Chen J, 2007, MYCOLOGIA, V99, P475, DOI 10.3852/mycologia.99.3.475; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HOLMGREN PK, 2007, INDEX HERBARIORUM; HU HT, 1992, J EXPT FOREST NATL T, V6, P79; Liu B, 1989, J SHANXI U NAT SCI E, V12, P215; MABRU D, 2004, INT J FOOD MICROBIOL, V33, P230; Manjon JL, 2009, MYCOTAXON, V110, P399, DOI 10.5248/110.399; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; Moncalvo JM, 2000, SYST BIOL, V49, P278, DOI 10.1093/sysbio/49.2.278; Moreno G, 1997, MYCOTAXON, V63, P217; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NYLANDER JAA, 2002, MODELTEST; Paolocci F, 1997, FEMS MICROBIOL LETT, V153, P255, DOI 10.1111/j.1574-6968.1997.tb12582.x; PEGLER DN, 1993, BRIT TRUFFLES REVISI; RIOUSSET L, 2001, TRUFFES EUROPE CHINE; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roux C, 1999, FEMS MICROBIOL LETT, V180, P147, DOI 10.1111/j.1574-6968.1999.tb08789.x; Rubini A, 2007, NEW PHYTOL, V174, P256, DOI 10.1111/j.1469-8137.2007.01976.x; Sato H, 2007, AM J BOT, V94, P1630, DOI 10.3732/ajb.94.10.1630; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRAPPE JM, 1979, MYCOTAXON, V9, P297; Wang Y, 1998, CRYPTOGAMIE MYCOL, V19, P113; Wang YJ, 2006, MYCOL RES, V110, P1034, DOI 10.1016/j.mycres.2006.06.013; White T., 1990, PCR PROTOCOLS GUIDE, P315; ZHANG BC, 1988, T BRIT MYCOL SOC, V91, P593, DOI 10.1016/S0007-1536(88)80032-9; Zhang LF, 2005, FEMS MICROBIOL LETT, V245, P85, DOI 10.1016/j.femsle.2005.02.028	31	44	55	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14625	10.1371/journal.pone.0014625	http://dx.doi.org/10.1371/journal.pone.0014625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297969	gold, Green Published, Green Submitted			2022-12-25	WOS:000286664100009
J	Adel-Patient, K; Guimaraes, VD; Paris, A; Drumare, MF; Ah-Leung, S; Lamourette, P; Nevers, MC; Canlet, C; Molina, J; Bernard, H; Creminon, C; Wal, JM				Adel-Patient, Karine; Guimaraes, Valeria D.; Paris, Alain; Drumare, Marie-Francoise; Ah-Leung, Sandrine; Lamourette, Patricia; Nevers, Marie-Claire; Canlet, Cecile; Molina, Jerome; Bernard, Herve; Creminon, Christophe; Wal, Jean-Michel			Immunological and Metabolomic Impacts of Administration of Cry1Ab Protein and MON 810 Maize in Mouse	PLOS ONE			English	Article							BETA-LACTOGLOBULIN; IMMUNE-RESPONSE; BALB/C MICE; MONOCLONAL-ANTIBODIES; ANIMAL-MODELS; IGE; ALLERGENICITY; ALLERGY; IMMUNOASSAYS; CHALLENGE	We have investigated the immunological and metabolomic impacts of Cry1Ab administration to mice, either as a purified protein or as the Cry1Ab-expressing genetically modified (GM) MON810 maize. Humoral and cellular specific immune responses induced in BALB/cJ mice after intra-gastric (i.g.) or intra-peritoneal (i.p.) administration of purified Cry1Ab were analyzed and compared with those induced by proteins of various immunogenic and allergic potencies. Possible unintended effects of the genetic modification on the pattern of expression of maize natural allergens were studied using IgE-immunoblot and sera from maize-allergic patients. Mice were experimentally sensitized (i.g. or i.p. route) with protein extracts from GM or non-GM maize, and then anti-maize proteins and anti-Cry1Ab-induced immune responses were analyzed. In parallel, longitudinal metabolomic studies were performed on the urine of mice treated via the i.g. route. Weak immune responses were observed after i.g. administration of the different proteins. Using the i.p. route, a clear Th2 response was observed with the known allergenic proteins, whereas a mixed Th1/Th2 immune response was observed with immunogenic protein not known to be allergenic and with Cry1Ab. This then reflects protein immunogenicity in the BALB/c Th2-biased mouse strain rather than allergenicity. No difference in natural maize allergen profiles was evidenced between MON810 and its non-GM comparator. Immune responses against maize proteins were quantitatively equivalent in mice treated with MON810 vs the non-GM counterpart and no anti-Cry1Ab-specific immune response was detected in mice that received MON810. Metabolomic studies showed a slight "cultivar'' effect, which represented less than 1% of the initial metabolic information. Our results confirm the immunogenicity of purified Cry1Ab without evidence of allergenic potential. Immunological and metabolomic studies revealed slight differences in mouse metabolic profiles after i.g. administration of MON810 vs its non-GM counterpart, but no significant unintended effect of the genetic modification on immune responses was seen.	[Adel-Patient, Karine; Guimaraes, Valeria D.; Drumare, Marie-Francoise; Ah-Leung, Sandrine; Bernard, Herve; Wal, Jean-Michel] INRA, UR496, Unite Immuno Allergie Alimentaire, Jouy En Josas, France; [Paris, Alain] INRA, UR1204, Paris, France; [Lamourette, Patricia; Nevers, Marie-Claire; Creminon, Christophe] CEA, iBiTeCS, Lab Etude & Rech Immunoanalyse, Gif Sur Yvette, France; [Canlet, Cecile; Molina, Jerome] INRA, UMR1089, F-31931 Toulouse, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; CEA; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Adel-Patient, K (corresponding author), INRA, UR496, Unite Immuno Allergie Alimentaire, Jouy En Josas, France.	Karine.Adel-Patient@cea.fr	Paris, Alain/AAW-6157-2020		French Ministry of Research and Technology	French Ministry of Research and Technology	The authors thank the French Ministry of Research and Technology for financial support (ANR "Impact des OGM''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2005, ALLERGY, V60, P658, DOI 10.1111/j.1398-9995.2005.00767.x; Adel-Patient K, 2003, CLIN EXP ALLERGY, V33, P376, DOI 10.1046/j.1365-2222.2003.01613.x; Adel-Patient K, 2000, J IMMUNOL METHODS, V235, P21, DOI 10.1016/S0022-1759(99)00210-0; Batista R, 2005, J ALLERGY CLIN IMMUN, V116, P403, DOI 10.1016/j.jaci.2005.04.014; Bernard H, 2003, ALLERGY, V58, P1285, DOI 10.1046/j.1398-9995.2003.00300.x; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Codex Alimentarius Commission, 2003, AL 03 34 JOINT FAO W, P47; Coen M, 2008, CHEM RES TOXICOL, V21, P9, DOI 10.1021/tx700335d; Coll A, 2008, PLANT MOL BIOL, V68, P105, DOI 10.1007/s11103-008-9355-z; Dearman RJ, 2009, CLIN EXP ALLERGY, V39, P458, DOI 10.1111/j.1365-2222.2008.03194.x; Dearman RJ, 2007, METHODS, V41, P91, DOI 10.1016/j.ymeth.2006.07.008; Dearman RJ, 2001, TOXICOLOGY, V167, P217, DOI 10.1016/S0300-483X(01)00462-0; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; Dumas ME, 2002, ANAL CHEM, V74, P2261, DOI 10.1021/ac0156870; EFSA Panel on Genetically Modified Organisms (GMO), 2010, SCI OP ASS ALL GM PL, P1700; Eiwegger T, 2006, CLIN EXP ALLERGY, V36, P1281, DOI 10.1111/j.1365-2222.2006.02565.x; Eum SY, 1995, P NATL ACAD SCI USA, V92, P12290, DOI 10.1073/pnas.92.26.12290; FAO/WHO, 2001, EV ALL GEN MOD FOODS; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Goodman RE, 2008, NAT BIOTECHNOL, V26, P73, DOI 10.1038/nbt1343; GRASSI J, 1988, ANAL BIOCHEM, V168, P436, DOI 10.1016/0003-2697(88)90341-7; Guerrero GG, 2004, MOL IMMUNOL, V41, P1177, DOI 10.1016/j.molimm.2004.06.026; Guimaraes V, 2010, J AGR FOOD CHEM, V58, P3222, DOI 10.1021/jf903189j; Hefle SL, 1996, CRIT REV FOOD SCI, V36, pS69, DOI 10.1080/10408399609527760; HOFTE H, 1986, EUR J BIOCHEM, V161, P273, DOI 10.1111/j.1432-1033.1986.tb10443.x; HOLT PG, 1981, INT ARCH ALLER A IMM, V65, P42, DOI 10.1159/000232736; Hourihane JO, 1998, ALLERGY, V53, P84, DOI 10.1111/j.1398-9995.1998.tb04971.x; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Kim JH, 2009, FOOD SCI BIOTECHNOL, V18, P1273; Kim T., 2003, REGULATORY FRAMEWORK, V527, P1; Kimber I, 2003, ENVIRON HEALTH PERSP, V111, P1125; Konig A, 2004, FOOD CHEM TOXICOL, V42, P1047, DOI 10.1016/j.fct.2004.02.019; Kroghsbo S, 2008, TOXICOLOGY, V245, P24, DOI 10.1016/j.tox.2007.12.005; LECADET MM, 1967, CR ACAD SCI D NAT, V265, P1543; MARCELLETTI JF, 1992, CELL IMMUNOL, V143, P405, DOI 10.1016/0008-8749(92)90036-O; Moreno-Fierros L, 2000, MICROBES INFECT, V2, P885, DOI 10.1016/S1286-4579(00)00398-1; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nakajima O, 2007, REGUL TOXICOL PHARM, V47, P90, DOI 10.1016/j.yrtph.2006.08.003; Negroni L, 1998, J IMMUNOL METHODS, V220, P25, DOI 10.1016/S0022-1759(98)00150-1; PRADELLES P, 1985, ANAL CHEM, V57, P1170, DOI 10.1021/ac00284a003; Schmidt-Weber CB, 2007, J ALLERGY CLIN IMMUN, V120, P247, DOI 10.1016/j.jaci.2007.06.039; Stickler M, 2003, ENVIRON HEALTH PERSP, V111, P251, DOI 10.1289/ehp.5707; TAYLOR WA, 1980, IMMUNOLOGY, V39, P583; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Vazquez-Padron RI, 2000, BRAZ J MED BIOL RES, V33, P147, DOI 10.1590/S0100-879X2000000200002	45	39	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16346	10.1371/journal.pone.0016346	http://dx.doi.org/10.1371/journal.pone.0016346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298004	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900037
J	Malmsten, M; Kasetty, G; Pasupuleti, M; Alenfall, J; Schmidtchen, A				Malmsten, Martin; Kasetty, Gopinath; Pasupuleti, Mukesh; Alenfall, Jan; Schmidtchen, Artur			Highly Selective End-Tagged Antimicrobial Peptides Derived from PRELP	PLOS ONE			English	Article							HEPARIN-BINDING PEPTIDES; ANTIBACTERIAL PEPTIDES; HOST-DEFENSE; PSEUDOMONAS-AERUGINOSA; BACTERIAL PATHOGENS; INNATE IMMUNITY; DESIGN; POLYPEPTIDES; INFECTIONS; RESISTANCE	Background: Antimicrobial peptides (AMPs) are receiving increasing attention due to resistance development against conventional antibiotics. Pseudomonas aeruginosa and Staphylococcus aureus are two major pathogens involved in an array of infections such as ocular infections, cystic fibrosis, wound and post-surgery infections, and sepsis. The goal of the study was to design novel AMPs against these pathogens. Methodology and Principal Findings: Antibacterial activity was determined by radial diffusion, viable count, and minimal inhibitory concentration assays, while toxicity was evaluated by hemolysis and effects on human epithelial cells. Liposome and fluorescence studies provided mechanistic information. Protease sensitivity was evaluated after subjection to human leukocyte elastase, staphylococcal aureolysin and V8 proteinase, as well as P. aeruginosa elastase. Highly active peptides were evaluated in ex vivo skin infection models. C-terminal end-tagging by W and F amino acid residues increased antimicrobial potency of the peptide sequences GRRPRPRPRP and RRPRPRPRP, derived from proline arginine-rich and leucine-rich repeat protein (PRELP). The optimized peptides were antimicrobial against a range of Gram-positive S. aureus and Gram-negative P. aeruginosa clinical isolates, also in the presence of human plasma and blood. Simultaneously, they showed low toxicity against mammalian cells. Particularly W-tagged peptides displayed stability against P. aeruginosa elastase, and S. aureus V8 proteinase and aureolysin, and the peptide RRPRPRPRPWWWW-NH2 was effective against various "superbugs'' including vancomycin-resistant enterococci, multi-drug resistant P. aeruginosa, and methicillin-resistant S. aureus, as well as demonstrated efficiency in an ex vivo skin wound model of S. aureus and P. aeruginosa infection. Conclusions/Significance: Hydrophobic C-terminal end-tagging of the cationic sequence RRPRPRPRP generates highly selective AMPs with potent activity against multiresistant bacteria and efficiency in ex vivo wound infection models. A precise "tuning'' of toxicity and proteolytic stability may be achieved by changing tag-length and adding W-or F-amino acid tags.	[Malmsten, Martin] Uppsala Univ, Dept Pharm, Uppsala, Sweden; [Kasetty, Gopinath; Pasupuleti, Mukesh; Schmidtchen, Artur] Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden; [Alenfall, Jan] Dermagen AB, Lund, Sweden	Uppsala University; Lund University	Malmsten, M (corresponding author), Uppsala Univ, Dept Pharm, Uppsala, Sweden.	artur.schmidtchen@med.lu.se	Pasupuleti, Mukesh/AAF-4066-2020; Pasupuleti, Mukesh/H-7605-2013; Pasupuleti, Mukesh/AAD-9977-2020; Schmidtchen, Artur/F-9507-2015	Pasupuleti, Mukesh/0000-0001-6337-6257; 	Swedish Research Council [521-2009-3378, 7480, 621-2003-4022]; Royal Physiographic Society in Lund; Welander-Finsen Foundation; Crafoord Foundation; Osterlund Foundation; Kock Foundation; Marianne and Marcus Wallenberg Foundation; DermaGen AB; Swedish Government Funds for Clinical Research (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society in Lund; Welander-Finsen Foundation; Crafoord Foundation; Osterlund Foundation; Kock Foundation; Marianne and Marcus Wallenberg Foundation; DermaGen AB; Swedish Government Funds for Clinical Research (ALF)	This work was supported by grants from the Swedish Research Council (projects 521-2009-3378, 7480, and 621-2003-4022), the Royal Physiographic Society in Lund, the Welander-Finsen, Crafoord, Osterlund, and Kock Foundations, Marianne and Marcus Wallenberg Foundation, DermaGen AB, and the Swedish Government Funds for Clinical Research (ALF). Dermagen AB (JA) provided data concerning MIC analyses of multi-resistant bacterial isolates (Table 2) and approved the manuscript before submission. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGERBERTH B, 1991, EUR J BIOCHEM, V202, P849, DOI 10.1111/j.1432-1033.1991.tb16442.x; Amyes SGB, 2007, INT J ANTIMICROB AG, V29, pS43, DOI 10.1016/S0924-8579(07)72177-5; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Beisswenger C, 2005, CURR PROTEIN PEPT SC, V6, P255, DOI 10.2174/1389203054065428; Blondelle SE, 2000, BIOPOLYMERS, V55, P74, DOI 10.1002/1097-0282(2000)55:1&lt;74::AID-BIP70&gt;3.0.CO;2-S; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761; Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Fritsche TR, 2008, J ANTIMICROB CHEMOTH, V61, P1092, DOI 10.1093/jac/dkn074; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Jenssen H, 2007, CHEM BIOL DRUG DES, V70, P134, DOI 10.1111/j.1747-0285.2007.00543.x; Kunz AN, 2010, CHEMOTHERAPY, V56, P492, DOI 10.1159/000321018; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Li X, 2006, BBA-BIOMEMBRANES, V1758, P1203, DOI 10.1016/j.bbamem.2006.03.032; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; Malmsten M, 2006, MATRIX BIOL, V25, P294, DOI 10.1016/j.matbio.2006.04.003; Marr AK, 2006, CURR OPIN PHARM; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; McDonnell G, 1999, J MICROBIOL METH, V35, P31, DOI 10.1016/S0167-7012(98)00094-3; Nilsson M, 2008, MOL MICROBIOL, V67, P482, DOI 10.1111/j.1365-2958.2007.05974.x; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; Papareddy P, 2010, J BIOL CHEM, V285, P28387, DOI 10.1074/jbc.M110.127019; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Pasupuleti M, 2008, BIOCHEMISTRY-US, V47, P9057, DOI 10.1021/bi800991e; Pasupuleti M, 2007, J BIOL CHEM, V282, P2520, DOI 10.1074/jbc.M607848200; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007358; Pasupuleti M, 2009, BBA-GEN SUBJECTS, V1790, P800, DOI 10.1016/j.bbagen.2009.03.029; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; PEREIRA HA, 1995, J LEUKOCYTE BIOL, V57, P805, DOI 10.1002/jlb.57.6.805; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Poon VKM, 2004, BURNS, V30, P140, DOI 10.1016/j.burns.2003.09.030; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Ringstad L, 2008, LANGMUIR, V24, P208, DOI 10.1021/la702538k; Ringstad L, 2007, BBA-BIOMEMBRANES, V1768, P715, DOI 10.1016/j.bbamem.2006.11.016; Ringstad L, 2006, LANGMUIR, V22, P5042, DOI 10.1021/la060317y; Ringstad L, 2007, BIOPHYS J, V92, P87, DOI 10.1529/biophysj.106.088161; Rydengard V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000116; Sajjan US, 2001, ANTIMICROB AGENTS CH, V45, P3437, DOI 10.1128/AAC.45.12.3437-3444.2001; Schmidtchen A, 2003, MICROB PATHOGENESIS, V34, P47, DOI 10.1016/S0882-4010(02)00197-3; Schmidtchen A, 2009, J BIOL CHEM, V284, P17584, DOI 10.1074/jbc.M109.011650; Stromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070; Taboureau O, 2006, CHEM BIOL DRUG DES, V68, P48, DOI 10.1111/j.1747-0285.2006.00405.x; Tossi A, 2000, BIOPOLYMERS, V55, P4; Tossi A, 2002, CURR PHARM DESIGN, V8, P743, DOI 10.2174/1381612023395475; Vermeulen H, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005486.pub2; Werthen M, 2004, J ANTIMICROB CHEMOTH, V54, P772, DOI 10.1093/jac/dkh407; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Woodford N, 2009, J INFECTION, V59, pS4, DOI 10.1016/S0163-4453(09)60003-7; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; ZELEZETSKY I, 2006, J BIOL CHEM; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021	68	61	64	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16400	10.1371/journal.pone.0016400	http://dx.doi.org/10.1371/journal.pone.0016400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298015	Green Submitted, Green Published, gold			2022-12-25	WOS:000286663900046
J	Pope, WH; Jacobs-Sera, D; Russell, DA; Peebles, CL; Al-Atrache, Z; Alcoser, TA; Alexander, LM; Alfano, MB; Alford, ST; Amy, NE; Anderson, MD; Anderson, AG; Ang, AAS; Ares, M; Barber, AJ; Barker, LP; Barrett, JM; Barshop, WD; Bauerle, CM; Bayles, IM; Belfield, KL; Best, AA; Borjon, A; Bowman, CA; Boyer, CA; Bradley, KW; Bradley, VA; Broadway, LN; Budwal, K; Busby, KN; Campbell, IW; Campbell, AM; Carey, A; Caruso, SM; Chew, RD; Cockburn, CL; Cohen, LB; Corajod, JM; Cresawn, SG; Davis, KR; Deng, LS; Denver, DR; Dixon, BR; Ekram, S; Elgin, SCR; Engelsen, AE; English, BEV; Erb, ML; Estrada, C; Filliger, LZ; Findley, AM; Forbes, L; Forsyth, MH; Fox, TM; Fritz, MJ; Garcia, R; George, ZD; Georges, AE; Gissendanner, CR; Goff, S; Goldstein, R; Gordon, KC; Green, RD; Guerra, SL; Guiney-Olsen, KR; Guiza, BG; Haghighat, L; Hagopian, GV; Harmon, CJ; Harmson, JS; Hartzog, GA; Harvey, SE; He, SP; He, KJ; Healy, KE; Higinbotham, ER; Hildebrandt, EN; Ho, JH; Hogan, GM; Hohenstein, VG; Holz, NA; Huang, VJ; Hufford, EL; Hynes, PM; Jackson, AS; Jansen, EC; Jarvik, J; Jasinto, PG; Jordan, TC; Kasza, T; Katelyn, MA; Kelsey, JS; Kerrigan, LA; Khaw, D; Kim, J; Knutter, JZ; Ko, CC; Larkin, GV; Laroche, JR; Latif, A; Leuba, KD; Leuba, SI; Lewis, LO; Loesser-Casey, KE; Long, CA; Lopez, AJ; Lowery, N; Lu, TQ; Mac, V; Masters, IR; McCloud, JJ; McDonough, MJ; Medenbach, AJ; Menon, A; Miller, R; Morgan, BK; Ng, PC; Nguyen, E; Nguyen, KT; Nguyen, ET; Nicholson, KM; Parnell, LA; Peirce, CE; Perz, AM; Peterson, LJ; Pferdehirt, RE; Philip, SV; Pogliano, K; Pogliano, J; Polley, T; Puopolo, EJ; Rabinowitz, HS; Resiss, MJ; Rhyan, CN; Robinson, YM; Rodriguez, LL; Rose, AC; Rubin, JD; Ruby, JA; Saha, MS; Sandoz, JW; Savitskaya, J; Schipper, DJ; Schnitzler, CE; Schott, AR; Segal, JB; Shaffer, CD; Sheldon, KE; Shepard, EM; Shepardson, JW; Shroff, MK; Simmons, JM; Simms, EF; Simpson, BM; Sinclair, KM; Sjoholm, RL; Slette, IJ; Spaulding, BC; Straub, CL; Stukey, J; Sughrue, T; Tang, TY; Tatyana, LM; Taylor, SB; Taylor, BJ; Temple, LM; Thompson, JV; Tokarz, MP; Trapani, SE; Troum, AP; Tsay, J; Tubbs, AT; Walton, JM; Wang, DH; Wang, HN; Warner, JR; Weisser, EG; Wendler, SC; Weston-Hafer, KA; Whelan, HM; Williamson, KE; Willis, AN; Wirtshafter, HS; Wong, TW; Wu, PL; Yang, YJ; Yee, BC; Zaidins, DA; Zhang, B; Zuniga, MY; Hendrix, RW; Hatfull, GF				Pope, Welkin H.; Jacobs-Sera, Deborah; Russell, Daniel A.; Peebles, Craig L.; Al-Atrache, Zein; Alcoser, Turi A.; Alexander, Lisa M.; Alfano, Matthew B.; Alford, Samantha T.; Amy, Nichols E.; Anderson, Marie D.; Anderson, Alexander G.; Ang, Andrew A. S.; Ares, Manuel, Jr.; Barber, Amanda J.; Barker, Lucia P.; Barrett, Jonathan M.; Barshop, William D.; Bauerle, Cynthia M.; Bayles, Ian M.; Belfield, Katherine L.; Best, Aaron A.; Borjon, Agustin, Jr.; Bowman, Charles A.; Boyer, Christine A.; Bradley, Kevin W.; Bradley, Victoria A.; Broadway, Lauren N.; Budwal, Keshav; Busby, Kayla N.; Campbell, Ian W.; Campbell, Anne M.; Carey, Alyssa; Caruso, Steven M.; Chew, Rebekah D.; Cockburn, Chelsea L.; Cohen, Lianne B.; Corajod, Jeffrey M.; Cresawn, Steven G.; Davis, Kimberly R.; Deng, Lisa; Denver, Dee R.; Dixon, Breyon R.; Ekram, Sahrish; Elgin, Sarah C. R.; Engelsen, Angela E.; English, Belle E. V.; Erb, Marcella L.; Estrada, Crystal; Filliger, Laura Z.; Findley, Ann M.; Forbes, Lauren; Forsyth, Mark H.; Fox, Tyler M.; Fritz, Melissa J.; Garcia, Roberto; George, Zindzi D.; Georges, Anne E.; Gissendanner, Christopher R.; Goff, Shannon; Goldstein, Rebecca; Gordon, Kobie C.; Green, Russell D.; Guerra, Stephanie L.; Guiney-Olsen, Krysta R.; Guiza, Bridget G.; Haghighat, Leila; Hagopian, Garrett V.; Harmon, Catherine J.; Harmson, Jeremy S.; Hartzog, Grant A.; Harvey, Samuel E.; He, Siping; He, Kevin J.; Healy, Kaitlin E.; Higinbotham, Ellen R.; Hildebrandt, Erin N.; Ho, Jason H.; Hogan, Gina M.; Hohenstein, Victoria G.; Holz, Nathan A.; Huang, Vincent J.; Hufford, Ericka L.; Hynes, Peter M.; Jackson, Arrykka S.; Jansen, Erica C.; Jarvik, Jonathan; Jasinto, Paul G.; Jordan, Tuajuanda C.; Kasza, Tomas; Katelyn, Murray A.; Kelsey, Jessica S.; Kerrigan, Larisa A.; Khaw, Daryl; Kim, Junghee; Knutter, Justin Z.; Ko, Ching-Chung; Larkin, Gail V.; Laroche, Jennifer R.; Latif, Asma; Leuba, Kohana D.; Leuba, Sequoia I.; Lewis, Lynn O.; Loesser-Casey, Kathryn E.; Long, Courtney A.; Lopez, A. Javier; Lowery, Nicholas; Lu, Tina Q.; Mac, Victor; Masters, Isaac R.; McCloud, Jazmyn J.; McDonough, Molly J.; Medenbach, Andrew J.; Menon, Anjali; Miller, Rachel; Morgan, Brandon K.; Ng, Patrick C.; Nguyen, Elvis; Nguyen, Katrina T.; Nguyen, Emilie T.; Nicholson, Kaylee M.; Parnell, Lindsay A.; Peirce, Caitlin E.; Perz, Allison M.; Peterson, Luke J.; Pferdehirt, Rachel E.; Philip, Seegren V.; Pogliano, Kit; Pogliano, Joe; Polley, Tamsen; Puopolo, Erica J.; Rabinowitz, Hannah S.; Resiss, Michael J.; Rhyan, Corwin N.; Robinson, Yetta M.; Rodriguez, Lauren L.; Rose, Andrew C.; Rubin, Jeffrey D.; Ruby, Jessica A.; Saha, Margaret S.; Sandoz, James W.; Savitskaya, Judith; Schipper, Dale J.; Schnitzler, Christine E.; Schott, Amanda R.; Segal, J. Bradley; Shaffer, Christopher D.; Sheldon, Kathryn E.; Shepard, Erica M.; Shepardson, Jonathan W.; Shroff, Madav K.; Simmons, Jessica M.; Simms, Erika F.; Simpson, Brandy M.; Sinclair, Kathryn M.; Sjoholm, Robert L.; Slette, Ingrid J.; Spaulding, Blaire C.; Straub, Clark L.; Stukey, Joseph; Sughrue, Trevor; Tang, Tin-Yun; Tatyana, Lyons M.; Taylor, Stephen B.; Taylor, Barbara J.; Temple, Louise M.; Thompson, Jasper V.; Tokarz, Michael P.; Trapani, Stephanie E.; Troum, Alexander P.; Tsay, Jonathan; Tubbs, Anthony T.; Walton, Jillian M.; Wang, Danielle H.; Wang, Hannah; Warner, John R.; Weisser, Emilie G.; Wendler, Samantha C.; Weston-Hafer, Kathleen A.; Whelan, Hilary M.; Williamson, Kurt E.; Willis, Angelica N.; Wirtshafter, Hannah S.; Wong, Theresa W.; Wu, Phillip; Yang, Yun Jeong; Yee, Brandon C.; Zaidins, David A.; Zhang, Bo; Zuniga, Melina Y.; Hendrix, Roger W.; Hatfull, Graham F.			Expanding the Diversity of Mycobacteriophages: Insights into Genome Architecture and Evolution	PLOS ONE			English	Article							TRANSFER-RNA GENES; PHAGE GENOMICS; TMRNA GENES; BACTERIOPHAGES; VIRUSES; TRANSFORMATION; TUBERCULOSIS; RECOGNITION; INTEGRATION; SEQUENCES	Mycobacteriophages are viruses that infect mycobacterial hosts such as Mycobacterium smegmatis and Mycobacterium tuberculosis. All mycobacteriophages characterized to date are dsDNA tailed phages, and have either siphoviral or myoviral morphotypes. However, their genetic diversity is considerable, and although sixty-two genomes have been sequenced and comparatively analyzed, these likely represent only a small portion of the diversity of the mycobacteriophage population at large. Here we report the isolation, sequencing and comparative genomic analysis of 18 new mycobacteriophages isolated from geographically distinct locations within the United States. Although no clear correlation between location and genome type can be discerned, these genomes expand our knowledge of mycobacteriophage diversity and enhance our understanding of the roles of mobile elements in viral evolution. Expansion of the number of mycobacteriophages grouped within Cluster A provides insights into the basis of immune specificity in these temperate phages, and we also describe a novel example of apparent immunity theft. The isolation and genomic analysis of bacteriophages by freshman college students provides an example of an authentic research experience for novice scientists.	[Al-Atrache, Zein; Alcoser, Turi A.; Alexander, Lisa M.; Bayles, Ian M.; Budwal, Keshav; Campbell, Ian W.; Cohen, Lianne B.; English, Belle E. V.; Filliger, Laura Z.; Fox, Tyler M.; Guerra, Stephanie L.; He, Siping; Healy, Kaitlin E.; Jarvik, Jonathan; Jasinto, Paul G.; Lopez, A. Javier; Medenbach, Andrew J.; Pferdehirt, Rachel E.; Resiss, Michael J.; Savitskaya, Judith; Sheldon, Kathryn E.; Shroff, Madav K.; Thompson, Jasper V.; Wirtshafter, Hannah S.; Zaidins, David A.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Forsyth, Mark H.; Gordon, Kobie C.; Harvey, Samuel E.; Jackson, Arrykka S.; McDonough, Molly J.; Perz, Allison M.; Saha, Margaret S.; Walton, Jillian M.; Whelan, Hilary M.; Williamson, Kurt E.] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA; [Barber, Amanda J.; Best, Aaron A.; Chew, Rebekah D.; Corajod, Jeffrey M.; Georges, Anne E.; Harmon, Catherine J.; Hildebrandt, Erin N.; Jansen, Erica C.; Knutter, Justin Z.; Laroche, Jennifer R.; Long, Courtney A.; Peirce, Caitlin E.; Peterson, Luke J.; Rose, Andrew C.; Schipper, Dale J.; Simmons, Jessica M.; Sjoholm, Robert L.; Slette, Ingrid J.; Stukey, Joseph; Willis, Angelica N.] Hope Coll, A Paul Schaap Sci Ctr, Dept Biol, Holland, MI 49423 USA; [Barker, Lucia P.; Bradley, Kevin W.; Jordan, Tuajuanda C.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Amy, Nichols E.; Barrett, Jonathan M.; Bradley, Victoria A.; Cockburn, Chelsea L.; Cresawn, Steven G.; Green, Russell D.; Katelyn, Murray A.; Masters, Isaac R.; Philip, Seegren V.; Schott, Amanda R.; Sinclair, Kathryn M.; Tatyana, Lyons M.; Taylor, Stephen B.; Temple, Louise M.; Trapani, Stephanie E.; Troum, Alexander P.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [Carey, Alyssa; Denver, Dee R.; Forbes, Lauren; Garcia, Roberto; Goff, Shannon; Khaw, Daryl; Kim, Junghee; Lowery, Nicholas; Menon, Anjali; Miller, Rachel; Nguyen, Elvis; Polley, Tamsen; Puopolo, Erica J.; Schnitzler, Christine E.; Shepardson, Jonathan W.; Taylor, Barbara J.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Anderson, Marie D.; Bauerle, Cynthia M.; Dixon, Breyon R.; George, Zindzi D.; McCloud, Jazmyn J.; Parnell, Lindsay A.; Robinson, Yetta M.; Spaulding, Blaire C.; Zuniga, Melina Y.] Spelman Coll, Dept Biol, Atlanta, GA 30314 USA; [Ang, Andrew A. S.; Busby, Kayla N.; Ekram, Sahrish; Erb, Marcella L.; Estrada, Crystal; Guiza, Bridget G.; Haghighat, Leila; He, Kevin J.; Ho, Jason H.; Lu, Tina Q.; Nguyen, Katrina T.; Nguyen, Emilie T.; Pogliano, Kit; Pogliano, Joe; Segal, J. Bradley; Tang, Tin-Yun; Tsay, Jonathan; Wang, Danielle H.; Wang, Hannah; Wong, Theresa W.; Wu, Phillip; Yang, Yun Jeong] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ares, Manuel, Jr.; Borjon, Agustin, Jr.; Davis, Kimberly R.; Hagopian, Garrett V.; Hartzog, Grant A.; Holz, Nathan A.; Kasza, Tomas; Mac, Victor; Nicholson, Kaylee M.; Rodriguez, Lauren L.; Rubin, Jeffrey D.; Ruby, Jessica A.; Shepard, Erica M.; Straub, Clark L.; Sughrue, Trevor; Yee, Brandon C.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Broadway, Lauren N.; Engelsen, Angela E.; Findley, Ann M.; Gissendanner, Christopher R.; Harmson, Jeremy S.; Hogan, Gina M.; Hufford, Ericka L.; Morgan, Brandon K.; Warner, John R.] NE Louisiana Univ, Dept Biol, Monroe, LA 71209 USA; [Al-Atrache, Zein; Alfano, Matthew B.; Belfield, Katherine L.; Boyer, Christine A.; Campbell, Anne M.; Guiney-Olsen, Krysta R.; Higinbotham, Ellen R.; Kerrigan, Larisa A.; Larkin, Gail V.; Latif, Asma; Lewis, Lynn O.; Loesser-Casey, Kathryn E.; Simpson, Brandy M.; Tokarz, Michael P.; Wendler, Samantha C.] Univ Mary Washington, Dept Biol Sci, Fredericksburg, VA USA; [Caruso, Steven M.; Goldstein, Rebecca; Kelsey, Jessica S.; Sandoz, James W.] Univ Maryland, Dept Biol Sci, Baltimore, MD 21201 USA; [Pope, Welkin H.; Jacobs-Sera, Deborah; Russell, Daniel A.; Peebles, Craig L.; Bowman, Charles A.; Fritz, Melissa J.; Hohenstein, Victoria G.; Ko, Ching-Chung; Leuba, Kohana D.; Leuba, Sequoia I.; Hendrix, Roger W.; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Alford, Samantha T.; Anderson, Alexander G.; Barshop, William D.; Deng, Lisa; Elgin, Sarah C. R.; Huang, Vincent J.; Hynes, Peter M.; Ng, Patrick C.; Rabinowitz, Hannah S.; Rhyan, Corwin N.; Shaffer, Christopher D.; Simms, Erika F.; Tubbs, Anthony T.; Weisser, Emilie G.; Weston-Hafer, Kathleen A.; Zhang, Bo] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Carnegie Mellon University; William & Mary; Hope College; Howard Hughes Medical Institute; James Madison University; Oregon State University; Spelman College; University of California System; University of California San Diego; University of California System; University of California Santa Cruz; University of Louisiana System; University of Louisiana Monroe; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Pope, WH (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	gfh@pitt.edu	Slette, Ingrid J/AAL-8634-2020; Schnitzler, Christine/G-8733-2013; Caruso, Steven M/AAF-2169-2020	Slette, Ingrid J/0000-0002-7707-3246; Caruso, Steven M/0000-0001-9166-9137; Wirtshafter, Hannah/0000-0003-4684-7074; Rubin, Jeffrey/0000-0001-9168-4361; Tubbs, Anthony/0000-0002-5605-8231; Yuen, Lisa/0000-0002-3900-416X; Jansen, Erica/0000-0002-3364-3729; Barshop, William/0000-0001-9517-2339; Tang, Tin-Yun/0000-0003-2030-9518; Belfield, Katherine/0000-0001-5893-0882; Leuba, Sequoia/0000-0002-6585-2824; Schnitzler, Christine/0000-0002-5001-6524; Forsyth, Mark/0000-0001-8653-6508; Busby, Kayla/0000-0002-3360-9707; Lin, Hilary/0000-0002-3006-9741; Saha, Margaret/0000-0003-0096-2667; Elgin, Sarah C. R./0000-0002-5176-2510; Pogliano, Kit/0000-0002-7868-3345; Holland, Laura/0000-0002-5726-0087; Seegren, Philip/0000-0002-7153-4670; Vallespir Lowery, Nick/0000-0001-7887-4179; Ko, Ching-Chung/0000-0002-8950-7128	National Institutes of Health [GM51975]; Howard Hughes Medical Institute; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057045] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0821202] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Institutes of Health Grant GM51975; Howard Hughes Medical Institute. The University of Pittsburgh was supported through a Professor's grant from HHMI. The Science Education Alliance (SEA) program at HHMI also supported the 12 participating institutions in offering a research-based course for freshman undergraduates. HHMI participated in course design and implementation, and designed tools for data analysis.	Bandhu A, 2010, BIOCHEMISTRY-US, V49, P4235, DOI 10.1021/bi9020956; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Brown KL, 1997, EMBO J, V16, P5914, DOI 10.1093/emboj/16.19.5914; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Calendar R., 2006, BACTERIOPHAGES; Caruso SM, 2009, CBE-LIFE SCI EDUC, V8, P278, DOI 10.1187/cbe.09-07-0052; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Derbyshire V, 1998, P NATL ACAD SCI USA, V95, P1356, DOI 10.1073/pnas.95.4.1356; DONNELLYWU MK, 1993, MOL MICROBIOL, V7, P407, DOI 10.1111/j.1365-2958.1993.tb01132.x; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; Ford ME, 1998, J MOL BIOL, V279, P143, DOI 10.1006/jmbi.1997.1610; Fraser JS, 2006, J MOL BIOL, V359, P496, DOI 10.1016/j.jmb.2006.03.043; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; Hanauer DI, 2009, MENTOR ACAD IND, V2, P1, DOI 10.1007/978-0-387-89649-6_1; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; Hatfull G. F., 2006, BACTERIOPHAGES, P602; Hatfull GF, 2008, RES MICROBIOL, V159, P332, DOI 10.1016/j.resmic.2008.04.008; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Hendrix RW, 2003, CURR OPIN MICROBIOL, V6, P506, DOI 10.1016/j.mib.2003.09.004; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Henry M, 2010, GENE, V453, P9, DOI 10.1016/j.gene.2009.12.007; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Jain S, 2000, MOL MICROBIOL, V38, P971, DOI 10.1046/j.1365-2958.2000.02184.x; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kumar V, 2008, TUBERCULOSIS, V88, P616, DOI 10.1016/j.tube.2008.02.007; Kwan T, 2006, J BACTERIOL, V188, P1184, DOI 10.1128/JB.188.3.1184-1187.2006; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martinsohn JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000065; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Perler FB, 2006, IUBMB LIFE, V58, P63, DOI 10.1080/15216540500531739; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Sampson T, 2009, MICROBIOL-SGM, V155, P2962, DOI 10.1099/mic.0.030486-0; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; SOLOFF BL, 1978, J VIROL, V25, P253, DOI 10.1128/JVI.25.1.253-262.1978; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Sulakvelidze Andrew M. Kropinski Alexander, 2007, V394, P133, DOI 10.1007/978-1-59745-512-1_9; Summer EJ, 2007, CURR OPIN MICROBIOL, V10, P410, DOI 10.1016/j.mib.2007.05.016; SUSSKIND MM, 1978, MICROBIOL REV, V42, P385, DOI 10.1128/MMBR.42.2.385-413.1978; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tori K, 2010, J BIOL CHEM, V285, P2515, DOI 10.1074/jbc.M109.069567; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Xu J, 2004, MOL CELL, V16, P11, DOI 10.1016/j.molcel.2004.09.006	53	102	107	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16329	10.1371/journal.pone.0016329	http://dx.doi.org/10.1371/journal.pone.0016329			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298013	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000286663900036
J	Deiuliis, J; Shah, Z; Shah, N; Needleman, B; Mikami, D; Narula, V; Perry, K; Hazey, J; Kampfrath, T; Kollengode, M; Sun, QH; Satoskar, AR; Lumeng, C; Moffatt-Bruce, S; Rajagopalan, S				Deiuliis, Jeffrey; Shah, Zubair; Shah, Nilay; Needleman, Bradley; Mikami, Dean; Narula, Vimal; Perry, Kyle; Hazey, Jeffrey; Kampfrath, Thomas; Kollengode, Madhukar; Sun, Qinghua; Satoskar, Abhay R.; Lumeng, Carey; Moffatt-Bruce, Susan; Rajagopalan, Sanjay			Visceral Adipose Inflammation in Obesity Is Associated with Critical Alterations in Tregulatory Cell Numbers	PLOS ONE			English	Article							REGULATORY T-CELLS; INSULIN-RESISTANCE; DENDRITIC CELLS; MACROPHAGE POLARIZATION; TISSUE INFLAMMATION; DISTINCT SUBSETS; MONOCYTE SUBSETS; BLOOD MONOCYTES; HOMING RECEPTOR; UP-REGULATION	Background: The development of insulin resistance (IR) in mouse models of obesity and type 2 diabetes mellitus (DM) is characterized by progressive accumulation of inflammatory macrophages and subpopulations of T cells in the visceral adipose. Regulatory T cells (Tregs) may play a critical role in modulating tissue inflammation via their interactions with both adaptive and innate immune mechanisms. We hypothesized that an imbalance in Tregs is a critical determinant of adipose inflammation and investigated the role of Tregs in IR/obesity through coordinated studies in mice and humans. Methods and Findings: Foxp3-green fluorescent protein (GFP) "knock-in'' mice were randomized to a high-fat diet intervention for a duration of 12 weeks to induce DIO/IR. Morbidly obese humans without overt type 2 DM (n = 13) and lean controls (n = 7) were recruited prospectively for assessment of visceral adipose inflammation. DIO resulted in increased CD3(+) CD4(+), and CD3(+) CD8(+) cells in visceral adipose with a striking decrease in visceral adipose Tregs. Treg numbers in visceral adipose inversely correlated with CD11b(+) CD11c(+) adipose tissue macrophages (ATMs). Splenic Treg numbers were increased with up-regulation of homing receptors CXCR3 and CCR7 and marker of activation CD44. In-vitro differentiation assays showed an inhibition of Treg differentiation in response to conditioned media from inflammatory macrophages. Human visceral adipose in morbid obesity was characterized by an increase in CD11c(+) ATMs and a decrease in foxp3 expression. Conclusions: Our experiments indicate that obesity in mice and humans results in adipose Treg depletion. These changes appear to occur via reduced local differentiation rather than impaired homing. Our findings implicate a role for Tregs as determinants of adipose inflammation.	[Deiuliis, Jeffrey; Shah, Zubair; Kampfrath, Thomas; Kollengode, Madhukar; Sun, Qinghua; Rajagopalan, Sanjay] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Shah, Nilay; Needleman, Bradley; Mikami, Dean; Narula, Vimal; Perry, Kyle; Hazey, Jeffrey; Moffatt-Bruce, Susan] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Satoskar, Abhay R.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Lumeng, Carey] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan	Deiuliis, J (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	deiuliis.1@osu.edu	Sun, Qinghua/E-4167-2011; Perry, Kyle/E-3853-2011; Narula, Vimal/E-3736-2011; Mikami, MD, Dean/E-3676-2011; Satoskar, Abhay/AAB-7748-2019; Needleman, Bradley/E-3743-2011	Needleman, Bradley/0000-0002-9186-4028; Perry, Kyle/0000-0003-4391-3259; Lumeng, Carey/0000-0003-0303-6204; Moffatt-Bruce, Susan/0000-0002-0999-5505; Deiuliis, Jeffrey/0000-0002-5665-8894; Narula, Vimal/0000-0003-1261-2736	National Institute of Diabetes And Digestive And Kidney Diseases [F32DK083903]; NIEHS [R01, KO1, ES016588]; NIDDK [ES015146, R21, DK088522]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK078851, R21DK088522, R01DK090262, F32DK083903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015146, K01ES016588] Funding Source: NIH RePORTER	National Institute of Diabetes And Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project described was supported by Award Number F32DK083903 from the National Institute of Diabetes And Digestive And Kidney Diseases awarded to Dr. Deiuliis. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Diabetes And Digestive And Kidney Diseases or the National Institutes of Health. Dr. Rajagopalan is supported by an R01 award from the NIEHS "Air Pollution and Vascular Mechanisms'' (ES015146) and R21 award NIDDK "T Regulatory Cells as Determinants of Inflammation in Adipose Tissue'' (DK088522) grants. Dr. Sun is supported by an NIEHS KO1 award "Air Pollution and Microvascular Dysfunction: Leukocyte Dependent NAD(P)H Oxidase" (ES016588). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baaten BJ, IMMUNITY, V32, P104; Barbi J, 2009, FASEB J, V23, P3990, DOI 10.1096/fj.09-138057; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Chai JG, 2008, J IMMUNOL, V180, P858, DOI 10.4049/jimmunol.180.2.858; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DIAZ YR, J INFECT DIS, V202, P406; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Forster-Horvath C, 2001, EUR J IMMUNOL, V31, P600, DOI 10.1002/1521-4141(200102)31:2<600::AID-IMMU600>3.0.CO;2-8; FOX SB, 1994, CANCER RES, V54, P4539; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; ILAN Y, P NATL ACAD SCI US, V107, P9765; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SCREATON GR, 1993, J BIOL CHEM, V268, P12235; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Tosello V, 2008, CLIN IMMUNOL, V126, P291, DOI 10.1016/j.clim.2007.11.008; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; WENTWORTH JM, 2010, PROINFLAMMATORY CD 1; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379	45	217	224	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16376	10.1371/journal.pone.0016376	http://dx.doi.org/10.1371/journal.pone.0016376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298111	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800033
J	Dulin, JN; Moore, ML; Gates, KW; Queen, JH; Grill, RJ				Dulin, Jennifer N.; Moore, Meredith L.; Gates, Kevin W.; Queen, Joanna H.; Grill, Raymond J.			Spinal Cord Injury Causes Sustained Disruption of the Blood-Testis Barrier in the Rat	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; TESTICULAR MAST-CELLS; EXOGENOUS TESTOSTERONE; SEMINIFEROUS TUBULES; TIGHT JUNCTIONS; SEMINAL PLASMA; SERTOLI-CELL; SPERMATOGENESIS; CYTOKINES	There is a high incidence of infertility in males following traumatic spinal cord injury (SCI). Quality of semen is frequently poor in these patients, but the pathophysiological mechanism(s) causing this are not known. Blood-testis barrier (BTB) integrity following SCI has not previously been examined. The objective of this study was to characterize the effects of spinal contusion injury on the BTB in the rat. 63 adult, male Sprague Dawley rats received SCI (n = 28), laminectomy only (n = 7) or served as uninjured, age-matched controls (n = 28). Using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), BTB permeability to the vascular contrast agent gadopentate dimeglumine (Gd) was assessed at either 72 hours-, or 10 months post-SCI. DCE-MRI data revealed that BTB permeability to Gd was greater than controls at both 72 h and 10 mo post-SCI. Histological evaluation of testis tissue showed increased BTB permeability to immunoglobulin G at both 72 hours- and 10 months post-SCI, compared to age-matched sham-operated and uninjured controls. Tight junctional integrity within the seminiferous epithelium was assessed; at 72 hours post-SCI, decreased expression of the tight junction protein occludin was observed. Presence of inflammation in the testes was also examined. High expression of the proinflammatory cytokine interleukin-1 beta was detected in testis tissue. CD68(+) immune cell infiltrate and mast cells were also detected within the seminiferous epithelium of both acute and chronic SCI groups but not in controls. In addition, extensive germ cell apoptosis was observed at 72 h post-SCI. Based on these results, we conclude that SCI is followed by compromised BTB integrity by as early as 72 hours post-injury in rats and is accompanied by a substantial immune response within the testis. Furthermore, our results indicate that the BTB remains compromised and testis immune cell infiltration persists for months after the initial injury.	[Dulin, Jennifer N.; Queen, Joanna H.; Grill, Raymond J.] Univ Texas Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA; [Moore, Meredith L.; Gates, Kevin W.] Univ Texas Med Sch Houston, Dept Neurosurg, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Dulin, JN (corresponding author), Univ Texas Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA.	raymond.j.grill@uth.tmc.edu		Dulin, Jennifer/0000-0001-5767-4290	National Institute of Neurological Disorders and Stroke (NINDS) [R01NS049409]; Paralyzed Veterans of America [2511]; Mission Connect; The Institute for Rehabilitation and Research (TIRR) Foundation; The Gillson-Longenbaugh Foundation; National Institutes of Health [T32, 5TL1RR024147]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049409] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Paralyzed Veterans of America; Mission Connect; The Institute for Rehabilitation and Research (TIRR) Foundation; The Gillson-Longenbaugh Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) R01NS049409, Paralyzed Veterans of America #2511, and Mission Connect, a project of The Institute for Rehabilitation and Research (TIRR) Foundation and The Gillson-Longenbaugh Foundation. JND is supported by the National Institutes of Health T32 training grant 5TL1RR024147. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Al-Sadi R, 2009, FRONT BIOSCI-LANDMRK, V14, P2765, DOI 10.2741/3413; Guazzone VA, 2009, MICROSC RES TECHNIQ, V72, P620, DOI 10.1002/jemt.20704; Apodaca G, 2003, AM J PHYSIOL-RENAL, V284, pF966, DOI 10.1152/ajprenal.00359.2002; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; Basu S, 2004, J ANDROL, V25, P250; BERETTA G, 1987, Acta Europaea Fertilitatis, V18, P203; Brackett NL, 1998, J UROLOGY, V159, P844, DOI 10.1016/S0022-5347(01)63749-2; Brackett NL, 1996, PHYS THER, V76, P1221, DOI 10.1093/ptj/76.11.1221; Chow SH, 2000, NEUROENDOCRINOLOGY, V72, P37, DOI 10.1159/000054569; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; DeForge D, 2005, SPINAL CORD, V43, P693, DOI 10.1038/sj.sc.3101769; FARGHALI H, 1991, MAGNET RESON MED, V22, P81, DOI 10.1002/mrm.1910220109; Gerdprasert O, 2002, CELL TISSUE RES, V308, P277, DOI 10.1007/s00441-002-0547-6; Grill RJ, 2005, EXP NEUROL, V196, P1, DOI 10.1016/j.expneurol.2005.08.005; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Griswold M D, 1988, Int Rev Cytol, V110, P133; Hedger MP, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1195; Hedger MP, 2002, J REPROD IMMUNOL, V57, P19, DOI 10.1016/S0165-0378(02)00016-5; Herrera JJ, 2010, J NEUROTRAUM, V27, P423, DOI 10.1089/neu.2009.0997; HIRSCH IH, 1990, ARCH ANDROLOGY, V25, P69, DOI 10.3109/01485019008987596; HIRSCH IH, 1992, UROLOGY, V39, P243, DOI 10.1016/0090-4295(92)90298-B; Huang HFS, 2004, J ANDROL, V25, P95; Huang HFS, 2004, J SPINAL CORD MED, V27, P55, DOI 10.1080/10790268.2004.11753731; Hussein MR, 2005, FERTIL STERIL, V83, P1447, DOI 10.1016/j.fertnstert.2004.11.062; JOHNSON AR, 1974, J PHARMACOL EXP THER, V189, P221; JONES WR, 1994, HUM REPROD, V9, P828, DOI 10.1093/oxfordjournals.humrep.a138603; Kashiwabara S, 2002, SCIENCE, V298, P1999, DOI 10.1126/science.1074632; Kim KN, 2004, INVEST RADIOL, V39, P445, DOI 10.1097/01.rli.0000129466.33263.8c; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; Li MWM, 2006, J ENDOCRINOL, V190, P313, DOI 10.1677/joe.1.06781; Li MWM, 2009, CYTOKINE GROWTH F R, V20, P329, DOI 10.1016/j.cytogfr.2009.07.007; Lui WY, 2009, J MOL ENDOCRINOL, V43, P43, DOI 10.1677/JME-08-0174; Luna JD, 1997, J NEUROSCI RES, V49, P268, DOI 10.1002/(SICI)1097-4547(19970801)49:3<268::AID-JNR2>3.0.CO;2-A; LUSTIG L, 1982, J REPROD IMMUNOL, V4, P79, DOI 10.1016/0165-0378(82)90039-0; Lysiak Jeffrey J, 2004, Reprod Biol Endocrinol, V2, P9, DOI 10.1186/1477-7827-2-9; Lysiak JJ, 2003, BIOL REPROD, V69, P202, DOI 10.1095/biolreprod.102.013318; Lysiak JJ, 2001, BIOL REPROD, V65, P718, DOI 10.1095/biolreprod65.3.718; MALLIDIS C, 1994, LANCET, V343, P1072, DOI 10.1016/S0140-6736(94)90183-X; Meineke V, 2000, FERTIL STERIL, V74, P239, DOI 10.1016/S0015-0282(00)00626-9; Moffit JS, 2007, TOXICOL PATHOL, V35, P719, DOI 10.1080/01926230701481931; Moroi S, 1998, AM J PHYSIOL-CELL PH, V274, pC1708, DOI 10.1152/ajpcell.1998.274.6.C1708; Mruk DD, 2010, PHILOS T R SOC B, V365, P1621, DOI 10.1098/rstb.2010.0010; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; O'Bryan MK, 2000, ENDOCRINOLOGY, V141, P238, DOI 10.1210/en.141.1.238; Padron OF, 1997, FERTIL STERIL, V67, P1115, DOI 10.1016/S0015-0282(97)81448-3; Patel CB, 2009, J NEUROTRAUM, V26, P1005, DOI 10.1089/neu.2008.0860; Prussin C, 2006, J ALLERGY CLIN IMMUN, V117, pS450, DOI 10.1016/j.jaci.2005.11.016; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Saari T, 1996, J REPROD IMMUNOL, V31, P65, DOI 10.1016/0165-0378(96)00962-X; Sarkar O, 2008, BIOL REPROD, V78, P445, DOI 10.1095/biolreprod.107.064501; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Setchell BP, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P771; Su LL, 2009, INT J BIOCHEM CELL B, V41, P2578, DOI 10.1016/j.biocel.2009.08.015; Theas MS, 2008, HUM REPROD, V23, P1865, DOI 10.1093/humrep/den240; Tung K S, 1991, Monogr Pathol, P308; TUNG KSK, 1977, TESTIS, P491; Wang SL, 2005, J ANDROL, V26, P592, DOI 10.2164/jandrol.04168; Wong CH, 2007, FASEB J, V21, P438, DOI 10.1096/fj.05-4144com; Yamanaka K, 2000, HUM REPROD, V15, P1543, DOI 10.1093/humrep/15.7.1543	61	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16456	10.1371/journal.pone.0016456	http://dx.doi.org/10.1371/journal.pone.0016456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298060	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800043
J	Chansard, M; Wang, JA; Hong, CT; Neumayer, G; Shim, SY; Park, YU; Belzil, C; Hoa, TL; Park, SK; Minh, DN				Chansard, Mathieu; Wang, Jian; Hong Chi Tran; Neumayer, Gernot; Shim, Su Yeon; Park, Young-Un; Belzil, Camille; Hoa Thi Le; Park, Sang Ki; Minh Dang Nguyen			The Cytoskeletal Protein Ndel1 Regulates Dynamin 2 GTPase Activity	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; RECEPTOR-MEDIATED ENDOCYTOSIS; CYTOPLASMIC DYNEIN; NEURONAL MIGRATION; NEURITE OUTGROWTH; MEMBRANE FISSION; MAMMALIAN-CELLS; HOMOLOGY DOMAIN; ACTIN; LIS1	Cytoskeleton dynamics, membranes trafficking and positioning are essential for the proper functioning of any mammalian cell. The identification of the molecules and mechanisms that allow these cellular processes to interface is vital for understanding cell behaviors. Ndel1, the mammalian homolog of the Aspergillus nidulans NudE, organizes the cytoskeleton and regulates molecular motors, thereby impacting on the positioning of membranes. Hypothetically, Ndel1 can act in concert with enzymes controlling membrane trafficking (vesicle-mediated transport) per se, but this idea has never been investigated. We now report that a pool of Ndel1 associates directly with Dynamin 2 (Dyn2), a large cytosolic GTPase involved in the trafficking of the AMPA receptor subunit GluR1. In vitro, Ndel1 enhances Dyn2 GTPase activity in its unassembled and assembled forms, without promoting oligomerization of the enzyme. In cells, gain and loss of function of Ndel1 recapitulate the effects of overexpression of Dyn2 and Dyn2 dominant negative with reduced GTPase activity on the intracellular localization of GluR1, respectively, without affecting the stability of microtubules. Together, these results indicate that Ndel1 regulates Dyn2 GTPase activity and impacts GluR1-containing membranes distribution in a manner reminiscent of Dyn2.	[Chansard, Mathieu; Wang, Jian; Hong Chi Tran; Neumayer, Gernot; Shim, Su Yeon; Belzil, Camille; Hoa Thi Le; Minh Dang Nguyen] Univ Calgary, Dept Clin Neurosci Cell Biol & Anat, Hotchkiss Brain Inst, Calgary, AB, Canada; [Chansard, Mathieu; Wang, Jian; Hong Chi Tran; Neumayer, Gernot; Shim, Su Yeon; Belzil, Camille; Hoa Thi Le; Minh Dang Nguyen] Univ Calgary, Dept Biochem & Mol Biol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Park, Young-Un; Park, Sang Ki] Pohang Univ Sci & Technol, Div Mol & Life Sci, Dept Life Sci, Pohang, South Korea; [Park, Young-Un] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea	University of Calgary; University of Calgary; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Chansard, M (corresponding author), Univ Calgary, Dept Clin Neurosci Cell Biol & Anat, Hotchkiss Brain Inst, Calgary, AB, Canada.	mdnguyen@ucalgary.ca	wang, jian/GVS-0711-2022		Canadian Institutes of Health Research (CIHR) [733371]; Alberta Heritage Foundation for Medical Research (AHFMR) [732626]; Multiple Sclerosis Society of Canada; Brain Research Center [2010K000812]; Korean Ministry of Education, Science and Technology [331-2007-1-C00213, 3-200900000001605, 20090076351]; Human Frontier Science Program Organization (HFSPO); Brenda Strafford Foundation Chair in Alzheimer research [791959]; Hotchkiss Brain Institute (HBI); Austrian Academy of Sciences at the Institute of Biochemistry and Molecular Biology/University of Calgary	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Multiple Sclerosis Society of Canada; Brain Research Center; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); Brenda Strafford Foundation Chair in Alzheimer research; Hotchkiss Brain Institute (HBI); Austrian Academy of Sciences at the Institute of Biochemistry and Molecular Biology/University of Calgary	This work was supported by operating grants from the Canadian Institutes of Health Research (CIHR, 733371), the Alberta Heritage Foundation for Medical Research (AHFMR, 732626), the Multiple Sclerosis Society of Canada (to MDN), a grant from the Brain Research Center of the 21C Frontier Research Program (2010K000812) and the grants 331-2007-1-C00213, 3-200900000001605 and 20090076351 from the Korean Ministry of Education, Science and Technology (to SKP). MDN holds a Career Development Award from the Human Frontier Science Program Organization (HFSPO), a New Investigator Award from the CIHR, a scholarship from the AHFMR and the Brenda Strafford Foundation Chair in Alzheimer research (791959). MC is supported by a Hotchkiss Brain Institute (HBI) post-doctoral fellowship. GN is a recipient of a DOC-fellowship of the Austrian Academy of Sciences at the Institute of Biochemistry and Molecular Biology/University of Calgary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Cao H, 2000, J CELL SCI, V113, P1993; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Fabrizi GM, 2007, NEUROLOGY, V69, P291, DOI 10.1212/01.wnl.0000265820.51075.61; Fabrizi GM, 2007, BRAIN, V130, P394, DOI 10.1093/brain/awl284; Hinshaw JE, 2006, NAT CELL BIOL, V8, P432, DOI 10.1038/ncb0506-432; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LIU JP, 1995, ENDOCR REV, V16, P590, DOI 10.1210/er.16.5.590; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Ribeiro CMP, 2000, CELL CALCIUM, V27, P175, DOI 10.1054/ceca.2000.0108; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.e04-08-0734; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Shim SY, 2008, J BIOL CHEM, V283, P12232, DOI 10.1074/jbc.M710200200; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; TOOZE SA, 1992, METHOD ENZYMOL, V219, P81; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yao Q, 2005, J MOL BIOL, V348, P491, DOI 10.1016/j.jmb.2005.02.003; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	61	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e14583	10.1371/journal.pone.0014583	http://dx.doi.org/10.1371/journal.pone.0014583			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283621	Green Published, gold, Green Submitted			2022-12-25	WOS:000286661400002
J	Fontainhas, AM; Wang, MH; Liang, KJ; Chen, S; Mettu, P; Damani, M; Fariss, RN; Li, W; Wong, WT				Fontainhas, Aurora M.; Wang, Minhua; Liang, Katharine J.; Chen, Shan; Mettu, Pradeep; Damani, Mausam; Fariss, Robert N.; Li, Wei; Wong, Wai T.			Microglial Morphology and Dynamic Behavior Is Regulated by Ionotropic Glutamatergic and GABAergic Neurotransmission	PLOS ONE			English	Article							IN-VIVO; PANNEXIN HEMICHANNELS; CULTURED MICROGLIA; CELL COMMUNICATION; RETINAL MICROGLIA; EXTRACELLULAR ATP; P2Y RECEPTORS; MOUSE RETINA; TASTE-BUDS; BRAIN	Purpose: Microglia represent the primary resident immune cells in the CNS, and have been implicated in the pathology of neurodegenerative diseases. Under basal or "resting'' conditions, microglia possess ramified morphologies and exhibit dynamic surveying movements in their processes. Despite the prominence of this phenomenon, the function and regulation of microglial morphology and dynamic behavior are incompletely understood. We investigate here whether and how neurotransmission regulates "resting'' microglial morphology and behavior. Methods: We employed an ex vivo mouse retinal explant system in which endogenous neurotransmission and dynamic microglial behavior are present. We utilized live-cell time-lapse confocal imaging to study the morphology and behavior of GFP-labeled retinal microglia in response to neurotransmitter agonists and antagonists. Patch clamp electrophysiology and immunohistochemical localization of glutamate receptors were also used to investigate direct-versus-indirect effects of neurotransmission by microglia. Results: Retinal microglial morphology and dynamic behavior were not cell-autonomously regulated but are instead modulated by endogenous neurotransmission. Morphological parameters and process motility were differentially regulated by different modes of neurotransmission and were increased by ionotropic glutamatergic neurotransmission and decreased by ionotropic GABAergic neurotransmission. These neurotransmitter influences on retinal microglia were however unlikely to be directly mediated; local applications of neurotransmitters were unable to elicit electrical responses on microglia patch-clamp recordings and ionotropic glutamatergic receptors were not located on microglial cell bodies or processes by immunofluorescent labeling. Instead, these influences were mediated indirectly via extracellular ATP, released in response to glutamatergic neurotransmission through probenecid-sensitive pannexin hemichannels. Conclusions: Our results demonstrate that neurotransmission plays an endogenous role in regulating the morphology and behavior of "resting'' microglia in the retina. These findings illustrate a mode of constitutive signaling between the neural and immune compartments of the CNS through which immune cells may be regulated in concert with levels of neural activity.	[Fontainhas, Aurora M.; Wang, Minhua; Liang, Katharine J.; Mettu, Pradeep; Damani, Mausam; Wong, Wai T.] NEI, Unit Neuron Glia Interact Retinal Dis, NIH, Bethesda, MD 20892 USA; [Chen, Shan; Li, Wei] NEI, Unit Retinal Neurophysiol, Bethesda, MD 20892 USA; [Fariss, Robert N.] NEI, Off Sci Director, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Fontainhas, AM (corresponding author), NEI, Unit Neuron Glia Interact Retinal Dis, NIH, Bethesda, MD 20892 USA.	wongw@nei.nih.gov	Fariss, Robert/ABI-1771-2020; Wong, Wai/B-6118-2017	Wong, Wai/0000-0003-0681-4016; Fariss, Robert/0000-0003-3227-7170	National Eye Institute; Prevention of Blindness Society of Metropolitan Washington; NATIONAL EYE INSTITUTE [ZICEY000459, ZIAEY000463] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Prevention of Blindness Society of Metropolitan Washington; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work has been supported by the National Eye Institute Intramural Research Program and a grant from the Prevention of Blindness Society of Metropolitan Washington (www.youreyes.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dvoriantchikova G, 2006, FEBS LETT, V580, P2178, DOI 10.1016/j.febslet.2006.03.026; Eter N, 2008, INVEST OPHTH VIS SCI, V49, P3649, DOI 10.1167/iovs.07-1322; Farber K, 2005, BRAIN RES REV, V48, P133, DOI 10.1016/j.brainresrev.2004.12.003; Gottlieb M, 1997, J CEREBR BLOOD F MET, V17, P290, DOI 10.1097/00004647-199703000-00006; Hagino Y, 2004, GLIA, V47, P68, DOI 10.1002/glia.20034; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kawamura M, 2010, J NEUROSCI, V30, P3886, DOI 10.1523/JNEUROSCI.0055-10.2010; Kurth-Nelson ZL, 2009, J NEUROSCI, V29, P11339, DOI 10.1523/JNEUROSCI.2493-09.2009; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee JE, 2008, INVEST OPHTH VIS SCI, V49, P4169, DOI 10.1167/iovs.08-2076; Li W, 2002, J COMP NEUROL, V448, P230, DOI 10.1002/cne.10189; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; Liu GJ, 2009, EUR J NEUROSCI, V29, P1108, DOI 10.1111/j.1460-9568.2009.06659.x; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Newman EA, 2004, GLIA, V47, P268, DOI 10.1002/glia.20030; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Noda M, 2000, J NEUROSCI, V20, P251, DOI 10.1523/JNEUROSCI.20-01-00251.2000; NORENBERG W, 1994, J PHYSIOL-LONDON, V475, P15; Ohsawa K, 2007, GLIA, V55, P604, DOI 10.1002/glia.20489; Paques M, 2010, GLIA, V58, P1663, DOI 10.1002/glia.21037; Perez-Leon J, 2003, INVEST OPHTH VIS SCI, V44, P1376, DOI 10.1167/iovs.02-0702; PERRY VH, 1989, NEUROSCIENCE, V31, P453, DOI 10.1016/0306-4522(89)90387-4; Pocock JM, 2007, TRENDS NEUROSCI, V30, P527, DOI 10.1016/j.tins.2007.07.007; POW DV, 1989, NEUROSCIENCE, V33, P567, DOI 10.1016/0306-4522(89)90409-0; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Ray A, 2006, CEREBELLUM, V5, P189, DOI 10.1080/14734220500530082; Reigada D, 2008, NEUROSCIENCE, V157, P396, DOI 10.1016/j.neuroscience.2008.08.036; Roumier A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002595; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Wollmer MA, 2001, J NEUROIMMUNOL, V115, P19, DOI 10.1016/S0165-5728(01)00257-0; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Wu LJ, 2008, J NEUROPHYSIOL, V99, P2026, DOI 10.1152/jn.01210.2007; Wu LJ, 2007, GLIA, V55, P810, DOI 10.1002/glia.20500; Xiang ZH, 2006, J NEUROSCI RES, V83, P91, DOI 10.1002/jnr.20709; Yamada J, 2006, BIOCHEM BIOPH RES CO, V349, P913, DOI 10.1016/j.bbrc.2006.08.126	56	227	231	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15973	10.1371/journal.pone.0015973	http://dx.doi.org/10.1371/journal.pone.0015973			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283568	Green Published, Green Submitted, gold			2022-12-25	WOS:000286661400019
J	An, HB; Lu, XY; Liu, D; Yarbrough, WG				An, Hanbing; Lu, Xinyuan; Liu, Dan; Yarbrough, Wendell G.			LZAP Inhibits p38 MAPK (p38) Phosphorylation and Activity by Facilitating p38 Association with the Wild-Type p53 Induced Phosphatase 1 (WIP1)	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELL-CYCLE CHECKPOINTS; NF-KAPPA-B; TUMOR-SUPPRESSOR; BINDING PROTEIN; BAX TRANSLOCATION; INDUCED APOPTOSIS; UV-RADIATION; EXPRESSION; PATHWAY	LZAP (Cdk5rap3, C53) is a putative tumor suppressor that inhibits RelA, Chk1 and Chk2 and activates p53. LZAP is lost in a portion of human head and neck squamous cell carcinoma and experimental loss of LZAP expression is associated with enhanced invasion, xenograft tumor growth and angiogenesis. p38 MAPK can increase or decrease proliferation and cell death depending on cellular context. LZAP has no known enzymatic activity, implying that its biological functions are likely mediated by its protein-protein interactions. To gain further insight into LZAP activities, we searched for LZAP-associated proteins (LAPs). Here we show that the LZAP binds p38, alters p38 cellular localization, and inhibits basal and cytokine-stimulated p38 activity. Expression of LZAP inhibits p38 phosphorylation in a dose-dependent fashion while loss of LZAP enhances phosphorylation and activation with resultant phosphorylation of p38 downstream targets. Mechanistically, the ability of LZAP to alter p38 phosphorylation depended, at least partially, on the p38 phosphatase, Wip1. Expression of LZAP increased both LZAP and Wip1 binding to p38. Taken together, these data suggest that LZAP activity includes inhibition of p38 phosphorylation and activation.	[An, Hanbing; Yarbrough, Wendell G.] Vanderbilt Univ, Dept Otolaryngol, Nashville, TN 37235 USA; [Lu, Xinyuan; Liu, Dan; Yarbrough, Wendell G.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN USA; [An, Hanbing; Lu, Xinyuan; Liu, Dan; Yarbrough, Wendell G.] Vanderbilt Univ, Barry Baker Lab Head & Neck Oncol, Nashville, TN USA; [Yarbrough, Wendell G.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	An, HB (corresponding author), Vanderbilt Univ, Dept Otolaryngol, Nashville, TN 37235 USA.	wendell.yarbrough@vanderbilt.edu			NIH/NIDCR; Ingram Professorship; Vanderbilt Ingram Cancer Center; Department of Otolaryngology; Vanderbilt Bill Wilkerson Center; National Institute of Dental and Craniofacial Research [2R01 DE013173];  [2R56 DE013173-10];  [09/01/10]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE013173] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Ingram Professorship; Vanderbilt Ingram Cancer Center; Department of Otolaryngology; Vanderbilt Bill Wilkerson Center; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); ; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was funded by 2R56 DE013173-10, 09/01/10 to 08/31/11, NIH/NIDCR: "Tumor suppressor qualities and mechanisms of LZAP activity. Identify molecular differences in HNSCC related to HPV status." (http://www.nidcr.nih.gov/.) These studies are supported by an endowment to the Barry Baker Laboratories for Head and Neck Oncology, by funds supplied through the Ingram Professorship (WGY), and through funds supplied by the Vanderbilt Ingram Cancer Center, the Department of Otolaryngology, and the Vanderbilt Bill Wilkerson Center for Otolaryngology and Communication Sciences and through grant # 2R01 DE013173 from the National Institute of Dental and Craniofacial Research to Dr. Yarbrough. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Chew J, 2009, NAT CELL BIOL, V11, P659, DOI 10.1038/ncb1873; Ching YP, 2000, GENE, V242, P285, DOI 10.1016/S0378-1119(99)00499-0; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Esteva FJ, 2004, CANCER-AM CANCER SOC, V100, P499, DOI 10.1002/cncr.11940; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fu J, 2006, J CELL SCI, V119, P115, DOI 10.1242/jcs.02699; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Ishikawa Y, 2003, MOL CELL NEUROSCI, V24, P451, DOI 10.1016/S1044-7431(03)00203-3; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Jiang H, 2009, CELL RES, V19, P458, DOI 10.1038/cr.2009.14; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2004, MOL CELL, V15, P621, DOI 10.1016/j.molcel.2004.08.007; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Mayor F, 2007, CELL CYCLE, V6, P528, DOI 10.4161/cc.6.5.3920; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pomerance M, 2006, J PATHOL, V209, P298, DOI 10.1002/path.1975; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Spaziani A, 2006, J BIOL CHEM, V281, P10983, DOI 10.1074/jbc.M512536200; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wang JL, 2006, BIOCHEM J, V393, P489, DOI 10.1042/BJ20050960; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619; Xia Y, 2009, J BIOL CHEM, V284, P17428, DOI 10.1074/jbc.M109.007823; Yarbrough WG, 2002, CANCER RES, V62, P1171; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2	41	18	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16427	10.1371/journal.pone.0016427	http://dx.doi.org/10.1371/journal.pone.0016427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283629	Green Published, Green Submitted, gold			2022-12-25	WOS:000286523400034
J	Jain, A; McKeon, RJ; Brady-Kalnay, SM; Bellamkonda, RV				Jain, Anjana; McKeon, Robert J.; Brady-Kalnay, Susann M.; Bellamkonda, Ravi V.			Sustained Delivery of Activated Rho GTPases and BDNF Promotes Axon Growth in CSPG-Rich Regions Following Spinal Cord Injury	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; MYELIN-ASSOCIATED GLYCOPROTEIN; NEURITE OUTGROWTH; FUNCTIONAL RECOVERY; NERVOUS-SYSTEM; GLIAL SCAR; ADULT-RAT; REGENERATION; REPAIR; INHIBITION	Background: Spinal cord injury (SCI) often results in permanent functional loss. This physical trauma leads to secondary events, such as the deposition of inhibitory chondroitin sulfate proteoglycan (CSPG) within astroglial scar tissue at the lesion. Methodology/Principal Findings: We examined whether local delivery of constitutively active (CA) Rho GTPases, Cdc42 and Rac1 to the lesion site alleviated CSPG-mediated inhibition of regenerating axons. A dorsal over-hemisection lesion was created in the rat spinal cord and the resulting cavity was conformally filled with an in situ gelling hydrogel combined with lipid microtubes that slowly released constitutively active (CA) Cdc42, Rac1, or Brain-derived neurotrophic factor (BDNF). Treatment with BDNF, CA-Cdc42, or CA-Rac1 reduced the number of GFAP-positive astrocytes, as well as CSPG deposition, at the interface of the implanted hydrogel and host tissue. Neurofilament 160kDa positively stained axons traversed the glial scar extensively, entering the hydrogel-filled cavity in the treatments with BDNF and CA-Rho GTPases. The treated animals had a higher percentage of axons from the corticospinal tract that traversed the CSPG-rich regions located proximal to the lesion site. Conclusion: Local delivery of CA-Cdc42, CA-Rac1, and BDNF may have a significant therapeutic role in overcoming CSPG-mediated regenerative failure after SCI.	[Jain, Anjana; Bellamkonda, Ravi V.] Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [McKeon, Robert J.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Brady-Kalnay, Susann M.] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Brady-Kalnay, Susann M.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; Case Western Reserve University; Case Western Reserve University	Jain, A (corresponding author), Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.	ravi@gatech.edu			National Institutes of Health (NINDS) [R01 NS43486]; GTEC an NSF Engineering Research Center based at Georgia Tech/Emory [EEC - 9731643]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043486] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); GTEC an NSF Engineering Research Center based at Georgia Tech/Emory; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from National Institutes of Health R01 NS43486 (NINDS, R.V.B.) and GTEC an NSF Engineering Research Center based at Georgia Tech/Emory, (EEC - 9731643, Nerem). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; DAVID S, 2003, ANN REV NEUROSCI; Dergham P, 2002, J NEUROSCI, V22, P6570; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 1999, BRIT J CANCER, V80, P25; Hoke A, 1996, PROG BRAIN RES, V108, P149, DOI 10.1016/S0079-6123(08)62538-8; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Jain A, 2004, J NEUROSCI RES, V77, P299, DOI 10.1002/jnr.20161; Jin Z, 1997, J NEUROSCI, V17, P6256; King VR, 2004, NEUROSCIENCE, V126, P173, DOI 10.1016/j.neuroscience.2004.03.035; Kosako H, 1997, J BIOL CHEM, V272, P10333; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Major DL, 2007, MOL CELL NEUROSCI, V34, P453, DOI 10.1016/j.mcn.2006.11.022; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Meilander NJ, 2003, J CONTROL RELEASE, V88, P321, DOI 10.1016/S0168-3659(03)00007-5; Meilander NJ, 2001, J CONTROL RELEASE, V71, P141, DOI 10.1016/S0168-3659(01)00214-0; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Niederost B, 2002, J NEUROSCI, V22, P10368; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Novikova LN, 2000, EUR J NEUROSCI, V12, P776, DOI 10.1046/j.1460-9568.2000.00978.x; Oudega M, 1999, BRAIN RES, V818, P431, DOI 10.1016/S0006-8993(98)01314-6; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Soga N, 2001, EXP CELL RES, V269, P73, DOI 10.1006/excr.2001.5295; Winton MJ, 2002, J BIOL CHEM, V277, P32820, DOI 10.1074/jbc.M201195200; Zhou LJ, 2003, J NEUROSCI RES, V74, P221, DOI 10.1002/jnr.10718; Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951; Zuo J, 2002, EXP NEUROL, V176, P221, DOI 10.1006/exnr.2002.7922	32	57	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16135	10.1371/journal.pone.0016135	http://dx.doi.org/10.1371/journal.pone.0016135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283639	Green Published, gold, Green Submitted			2022-12-25	WOS:000286523400023
J	Magbanua, ZV; Ozkan, S; Bartlett, BD; Chouvarine, P; Saski, CA; Liston, A; Cronn, RC; Nelson, CD; Peterson, DG				Magbanua, Zenaida V.; Ozkan, Seval; Bartlett, Benjamin D.; Chouvarine, Philippe; Saski, Christopher A.; Liston, Aaron; Cronn, Richard C.; Nelson, C. Dana; Peterson, Daniel G.			Adventures in the Enormous: A 1.8 Million Clone BAC Library for the 21.7 Gb Genome of Loblolly Pine	PLOS ONE			English	Article							ARTIFICIAL CHROMOSOME LIBRARIES; REPEAT TRANSPOSABLE ELEMENTS; WOOD PROPERTY TRAITS; TAEDA L.; HIGH-THROUGHPUT; WATER-DEFICIT; CONSTRUCTION; GENE; IDENTIFICATION; INTEGRATION	Loblolly pine (LP; Pinus taeda L.) is the most economically important tree in the U. S. and a cornerstone species in southeastern forests. However, genomics research on LP and other conifers has lagged behind studies on flowering plants due, in part, to the large size of conifer genomes. As a means to accelerate conifer genome research, we constructed a BAC library for the LP genotype 7-56. The LP BAC library consists of 1,824,768 individually-archived clones making it the largest single BAC library constructed to date, has a mean insert size of 96 kb, and affords 7.6X coverage of the 21.7 Gb LP genome. To demonstrate the efficacy of the library in gene isolation, we screened macroarrays with overgos designed from a pine EST anchored on LP chromosome 10. A positive BAC was sequenced and found to contain the expected full-length target gene, several gene-like regions, and both known and novel repeats. Macroarray analysis using the retrotransposon IFG-7 (the most abundant repeat in the sequenced BAC) as a probe indicates that IFG-7 is found in roughly 210,557 copies and constitutes about 5.8% or 1.26 Gb of LP nuclear DNA; this DNA quantity is eight times the Arabidopsis genome. In addition to its use in genome characterization and gene isolation as demonstrated herein, the BAC library should hasten whole genome sequencing of LP via next-generation sequencing strategies/technologies and facilitate improvement of trees through molecular breeding and genetic engineering. The library and associated products are distributed by the Clemson University Genomics Institute (www.genome.clemson.edu).	[Magbanua, Zenaida V.; Ozkan, Seval; Bartlett, Benjamin D.; Chouvarine, Philippe; Peterson, Daniel G.] Mississippi State Univ, Mississippi Genome Explorat Lab, Mississippi State, MS 39762 USA; [Magbanua, Zenaida V.; Ozkan, Seval; Bartlett, Benjamin D.; Chouvarine, Philippe; Peterson, Daniel G.] Mississippi State Univ, Dept Plant & Soil Sci, Mississippi State, MS 39762 USA; [Magbanua, Zenaida V.; Chouvarine, Philippe; Peterson, Daniel G.] Mississippi State Univ, Sci & Biotechnol Inst, Mississippi State, MS 39762 USA; [Magbanua, Zenaida V.; Chouvarine, Philippe; Peterson, Daniel G.] Mississippi State Univ, Inst Digital Biol, Mississippi State, MS 39762 USA; [Saski, Christopher A.] Clemson Univ, Clemson Univ Genom Inst, Clemson, SC USA; [Liston, Aaron; Cronn, Richard C.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Cronn, Richard C.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [Nelson, C. Dana] US Forest Serv, So Inst Forest Genet, Saucier, MS USA	Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University; Clemson University; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Magbanua, ZV (corresponding author), Mississippi State Univ, Mississippi Genome Explorat Lab, Mississippi State, MS 39762 USA.	zvm2@msstate.edu		Cronn, Richard/0000-0001-5342-3494; Peterson, Daniel/0000-0002-0274-5968	National Science Foundation [DBI-0421717, MCB-0841821]; U.S. Department of Agriculture [ARS-58-6402-7-241, CSREES-2009-34609-20222]; Div Of Molecular and Cellular Bioscience [0841821] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (DBI-0421717 to DGP and CDN; MCB-0841821 to DGP) and U.S. Department of Agriculture (ARS-58-6402-7-241 to DGP; CSREES-2009-34609-20222 to ZVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auckland L, 2002, CONIFER MICROSATELLI; Baig MNR, 2009, GENOME, V52, P484, DOI [10.1139/G09-017, 10.1139/g09-017]; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bennett M. D., 2003, PLANT DNA C VALUES D; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berube Y, 2007, TREE GENET GENOMES, V3, P251, DOI 10.1007/s11295-006-0061-1; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Brown GR, 2003, GENETICS, V164, P1537; Brown GR, 2001, GENETICS, V159, P799; Cairney J, 2006, PLANT MOL BIOL, V62, P485, DOI 10.1007/s11103-006-9035-9; CAPEL J, 1993, NUCLEIC ACIDS RES, V21, P2369, DOI 10.1093/nar/21.10.2369; Cavagnaro PF, 2009, MOL GENET GENOMICS, V281, P273, DOI 10.1007/s00438-008-0411-9; Chagne D, 2003, MOL BREEDING, V12, P185, DOI 10.1023/A:1026318327911; Chester M, 2010, CYTOGENET GENOME RES, V129, P35, DOI 10.1159/000312959; Coyne CJ, 2007, GENOME, V50, P871, DOI 10.1139/G07-063; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farjon A, 2008, NATURAL HIST CONIFER; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Frederick WJ, 2008, BIORESOURCE TECHNOL, V99, P5051, DOI 10.1016/j.biortech.2007.08.086; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Gough CM, 2004, TREE PHYSIOL, V24, P845, DOI 10.1093/treephys/24.7.845; Guimaraes PM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-14; Gutman W, 2008, CELL MOL BIOL LETT, V13, P74, DOI 10.2478/s11658-007-0038-6; Hawkins JS, 2008, PLANT SCI, V174, P557, DOI 10.1016/j.plantsci.2008.03.015; Hoekstra FA, 2001, CRYOBIOLOGY, V43, P140, DOI 10.1006/cryo.2001.2358; HOLST L, 1971, ANN MATH STAT, V42, P1671, DOI 10.1214/aoms/1177693165; Islam-Faridi MN, 2007, GENOME, V50, P241, DOI 10.1139/G06-153; Jacobs G, 2009, GENETICA, V135, P157, DOI 10.1007/s10709-008-9265-7; Kaufmann H, 2003, MOL GENET GENOMICS, V268, P666, DOI 10.1007/s00438-002-0784-0; Kossack DS, 1999, PLANT MOL BIOL, V39, P417, DOI 10.1023/A:1006115732620; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.07816.108, 10.1101/gr.078196.108]; LORENZ WW, 2006, TREE PHYSL, V26; Luo MZ, 2001, GENOME, V44, P154, DOI 10.1139/gen-44-2-154; McKeand S, 2003, J FOREST, V101, P32; MURRAY B, 2003, GYMNOSPERM DNA C VAL; NEALE DB, 1996, GENOME MAPPING PLANT, P309; Nilmalgoda SD, 2003, GENOME, V46, P870, DOI 10.1139/G03-067; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; Peterson DG, 2002, GENOME RES, V12, P795, DOI 10.1101/gr.226102; Peterson DG, 2000, J AGR GENOMICS, V5; Philippe C, 2008, ANAL BIOCHEM, V373, P78, DOI 10.1016/j.ab.2007.08.008; Plomion C., 2007, V7, P29; Rocheta M, 2007, PLANTA, V225, P551, DOI 10.1007/s00425-006-0370-5; Sambrook J., 1999, MOL CLONING LAB MANU; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sewell MM, 1999, GENETICS, V151, P321; Shan XY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S2-S9; Shi BJ, 2009, THEOR APPL GENET, V119, P695, DOI 10.1007/s00122-009-1080-8; SMITH AM, 2010, NUCL ACIDS RES ADV; Steuernagel B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-547; Talia P, 2010, GENOME, V53, P172, DOI [10.1139/G09-097, 10.1139/g09-097]; Terol J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-423; Tu ZJ, 2001, P NATL ACAD SCI USA, V98, P1699, DOI 10.1073/pnas.041593198; Wang WM, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-10; Yu Q, 2005, CAN J FOREST RES, V35, P1723, DOI 10.1139/X05-103; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang HB, 2001, PLANT PHYSIOL BIOCH, V39, P195, DOI 10.1016/S0981-9428(00)01236-5	62	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16214	10.1371/journal.pone.0016214	http://dx.doi.org/10.1371/journal.pone.0016214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283709	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522300020
J	Fujioka, Y; Tsuda, M; Hattori, T; Sasaki, J; Sasaki, T; Miyazaki, T; Ohba, Y				Fujioka, Yoichiro; Tsuda, Masumi; Hattori, Tomoe; Sasaki, Junko; Sasaki, Takehiko; Miyazaki, Tadaaki; Ohba, Yusuke			The Ras-PI3K Signaling Pathway Is Involved in Clathrin-Independent Endocytosis and the Internalization of Influenza Viruses	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; A-VIRUS; NS1 PROTEIN; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL-3-KINASE PI3K; TRANSCRIPTION FACTOR-8; MEDIATED ENDOCYTOSIS; NEGATIVE REGULATION; DENGUE VIRUS; RAS BINDING	Background: Influenza virus infection causes highly contagious, severe respiratory disorders and gives rise to thousands of deaths every year; however, the efficacy of currently approved defense strategies, including vaccines and neuraminidase inhibitors, is limited because the virus frequently acquires resistance via antigen drift and reassortment. It is therefore important to establish a novel, effective therapeutic strategy that is effective irrespective of viral subtype. Methodology/Principal Findings: Here, we identify the Ras-phosphoinositide 3-kinase (PI3K) signaling pathway as a host-cell regulatory mechanism for influenza virus entry. The binding of Ras to PI3K is specifically involved in clathrinin-dependent endocytosis, endosomal maturation, and intracellular transport of viruses, which result in decreased infectious efficacy of different subtypes of influenza viruses in cells lacking the Ras-PI3K interaction. Moreover, influenza virus infection indeed triggered Ras activation and subsequent PI3K activation in early endosomes. Conclusions/Significance: Taken together, these results demonstrate that the Ras-PI3K signaling axis acts as a host-oriented mechanism for viral internalization. Given that virus incorporation is a process conserved among virus subtypes and species, this signaling pathway may provide a target for potent, well-tolerated prophylactics and therapeutics against a broad range of viruses.	[Fujioka, Yoichiro; Tsuda, Masumi; Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Lab Pathophysiol & Signal Transduct, Sapporo, Hokkaido, Japan; [Hattori, Tomoe; Miyazaki, Tadaaki] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Sapporo, Hokkaido, Japan; [Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Sch Med, Div Microbiol, Dept Pathol & Immunol, Akita 010, Japan	Hokkaido University; Hokkaido University; Akita University	Fujioka, Y (corresponding author), Hokkaido Univ, Grad Sch Med, Lab Pathophysiol & Signal Transduct, Sapporo, Hokkaido, Japan.	yohba@med.hokudai.ac.jp	Ohba, Yusuke/E-7944-2011; Fujioka, Yoichiro/AAF-3313-2019; Miyazaki, Tadaaki/D-9368-2012	Fujioka, Yoichiro/0000-0002-5760-9357; Sasaki, Takehiko/0000-0003-1837-3748	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Japan Science and Technology Agency; Takeda Science Foundation; Akiyama Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Akiyama Foundation	This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the Japan Society for the Promotion of Science and by grants from the Japan Science and Technology Agency, the Takeda Science Foundation, and the Akiyama Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Awad AE, 2010, AM J PHYSIOL-CELL PH, V298, pC679, DOI 10.1152/ajpcell.00351.2009; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chen C, 2008, P NATL ACAD SCI USA, V105, P11790, DOI 10.1073/pnas.0803711105; Coombes BK, 2002, CELL MICROBIOL, V4, P447, DOI 10.1046/j.1462-5822.2002.00203.x; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; Ehrhardt C, 2007, J VIROL, V81, P12097, DOI 10.1128/JVI.01216-07; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Frey RS, 2006, J BIOL CHEM, V281, P16128, DOI 10.1074/jbc.M508810200; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hale BG, 2008, J BIOL CHEM, V283, P1372, DOI 10.1074/jbc.M708862200; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Inuzuka T, 2009, CANCER RES, V69, P1678, DOI 10.1158/0008-5472.CAN-08-3620; Inuzuka T, 2009, BIOCHEM BIOPH RES CO, V379, P510, DOI 10.1016/j.bbrc.2008.12.101; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Li Y, 2008, J BIOL CHEM, V283, P23397, DOI 10.1074/jbc.M802737200; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Luo J, 2005, CELL CYCLE, V4, P1309, DOI 10.4161/cc.4.10.2062; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ohba Y, 2003, EMBO J, V22, P859, DOI 10.1093/emboj/cdg087; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Puri KD, 2005, BLOOD, V106, P150, DOI 10.1182/blood-2005-01-0023; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sieczkarski SB, 2003, J VIROL, V77, P460, DOI 10.1128/JVI.77.1.460-469.2003; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Tsutsumi K, 2009, CELL SIGNAL, V21, P1672, DOI 10.1016/j.cellsig.2009.07.004; Upham JP, 2010, J VIROL, V84, P3730, DOI 10.1128/JVI.02148-09; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	50	53	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16324	10.1371/journal.pone.0016324	http://dx.doi.org/10.1371/journal.pone.0016324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283725	Green Published, gold			2022-12-25	WOS:000286522200051
J	Naor, A; Lazary, R; Barzel, A; Papke, RT; Gophna, U				Naor, Adit; Lazary, Rona; Barzel, Adi; Papke, R. Thane; Gophna, Uri			In Vivo Characterization of the Homing Endonuclease within the polB Gene in the Halophilic Archaeon Haloferax volcanii	PLOS ONE			English	Article							RECOMBINATION	Inteins are parasitic genetic elements, analogous to introns that excise themselves at the protein level by self-splicing, allowing the formation of functional non-disrupted proteins. Many inteins contain a homing endonuclease (HEN) gene, and rely on its activity for horizontal propagation. In the halophilic archaeon, Haloferax volcanii, the gene encoding DNA polymerase B (polB) contains an intein with an annotated but uncharacterized HEN. Here we examine the activity of the polB HEN in vivo, within its natural archaeal host. We show that this HEN is highly active, and able to insert the intein into both a chromosomal target and an extra-chromosomal plasmid target, by gene conversion. We also demonstrate that the frequency of its incorporation depends on the length of the flanking homologous sequences around the target site, reflecting its dependence on the homologous recombination machinery. Although several evolutionary models predict that the presence of an intein involves a change in the fitness of the host organism, our results show that a strain deleted for the intein sequence shows no significant changes in growth rate compared to the wild type.	[Naor, Adit; Lazary, Rona; Barzel, Adi; Gophna, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Papke, R. Thane] Univ Connecticut, Dept Mol Cell Biol, Storrs, CT USA	Tel Aviv University; University of Connecticut	Naor, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	urigo@tauex.tau.ac.il	Gophna, Uri/AAS-8376-2020	Gophna, Uri/0000-0001-5129-5652; Papke, Robertson/0000-0003-1371-2341	Biational Science Foundation (BSF) [2007043]; James S. McDonnell Foundation; Israeli Ministry of Health; National Science Foundation [DEB-0919290, DEB-0830024]; University of Connecticut Research Foundation; Division Of Environmental Biology [0830024] Funding Source: National Science Foundation	Biational Science Foundation (BSF)(US-Israel Binational Science Foundation); James S. McDonnell Foundation; Israeli Ministry of Health; National Science Foundation(National Science Foundation (NSF)); University of Connecticut Research Foundation; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the Biational Science Foundation (BSF) grant number 2007043. UG is supported by the James S. McDonnell Foundation and the Israeli Ministry of Health. RTP acknowledges National Science Foundation awards DEB-0919290, DEB-0830024 and the University of Connecticut Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 1995, P NATL ACAD SCI USA, V92, P12285, DOI 10.1073/pnas.92.26.12285; Agmon N, 2009, NUCLEIC ACIDS RES, V37, P5081, DOI 10.1093/nar/gkp495; Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; CLINE SW, 1989, CAN J MICROBIOL, V35, P148, DOI 10.1139/m89-022; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Gogarten JP, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-94; Kurokawa S, 2005, FEBS J, V272, P2487, DOI 10.1111/j.1742-4658.2005.04669.x; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Miyake T, 2003, J BIOL CHEM, V278, P39632, DOI 10.1074/jbc.M302084200; Norais C, 2007, PLOS GENET, V3, P729, DOI 10.1371/journal.pgen.0030077; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Pietrokovski S, 2001, TRENDS GENET, V17, P465, DOI 10.1016/S0168-9525(01)02365-4; Scalley-Kim M, 2007, J MOL BIOL, V372, P1305, DOI 10.1016/j.jmb.2007.07.052; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063	18	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15833	10.1371/journal.pone.0015833	http://dx.doi.org/10.1371/journal.pone.0015833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283796	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522200015
J	Escobar, PR; Gernandt, DS; Pinero, D; Garcillan, PP				Rosas Escobar, Patricia; Gernandt, David S.; Pinero, Daniel; Garcillan, Pedro P.			Plastid DNA Diversity Is Higher in the Island Endemic Guadalupe Cypress than in the Continental Tecate Cypress	PLOS ONE			English	Article							GENETIC DIVERSITY; PERIPHERAL-POPULATIONS; CHLOROPLAST; CUPRESSACEAE; CONSEQUENCES; DIVERGENCE; CALIFORNIA; RARE; MITOCHONDRIAL; POLYMORPHISM	Background: Callitropsis guadalupensis (Guadalupe cypress) is endemic to Guadalupe Island, Mexico, where it is the dominant species of the only forest. The species has suffered declining numbers following the introduction of goats to the island over 150 years ago. Callitropsis guadalupensis is closely related to Callitropsis forbesii (Tecate cypress), distributed in small isolated populations in mainland Baja California and southern California. The objective of the present study was to compare the genetic diversity of the island endemic to the continental species. Methodology/Principal Findings: We measured genetic diversity in Callitropsis guadalupensis (n = 54) from Guadalupe Island and in Callitropsis forbesii (n = 100) from five populations in mainland Baja California. The plastid DNA trnS-trnG spacer and the trnL-trnF region were chosen for characterization. Thirty-four haplotypes were observed, of which six were shared between both species. One of these haplotypes was also shared with three other species, Callitropsis lusitanica, Callitropsis montana, and Callitropsis stephensonii. Haplotype diversity (h) and nucleotide diversity (pi) were significantly higher for Callitropsis guadalupensis (h = 0.698, pi = 0.00071) than for Callitropsis forbesii (h = 0.337, pi = 0.00024). Conclusions/Significance: Callitropsis guadalupensis shows no evidence of a founder effect or of a genetic bottleneck, and can be added to a growing list of insular species with higher genetic diversity than their mainland relatives.	[Rosas Escobar, Patricia] Univ Autonoma Baja California, Fac Ciencias, Ensenada, Baja California, Mexico; [Rosas Escobar, Patricia] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico; [Gernandt, David S.] Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City 04510, DF, Mexico; [Pinero, Daniel] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico; [Garcillan, Pedro P.] Ctr Invest Biol Noroeste, La Paz, Baja California, Mexico	Universidad Autonoma de Baja California; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA	Escobar, PR (corresponding author), Univ Autonoma Baja California, Fac Ciencias, Ensenada, Baja California, Mexico.	dgernandt@ibiologia.unam.mx		Pinero, Daniel/0000-0002-2509-2445	Secretaria de Medio Ambiente y Recursos Naturales-Consejo Nacional de Ciencia y Tecnologia, Mexico [2004-C01-122]	Secretaria de Medio Ambiente y Recursos Naturales-Consejo Nacional de Ciencia y Tecnologia, Mexico	This study was supported by the Secretaria de Medio Ambiente y Recursos Naturales-Consejo Nacional de Ciencia y Tecnologia (2004-C01-122), Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RP, 2009, PHYTOLOGIA, V91, P160; Ann W, 2007, MOL BIOL EVOL, V24, P90, DOI 10.1093/molbev/msl131; Arnaud-Haond S, 2006, MOL ECOL, V15, P3515, DOI 10.1111/j.1365-294X.2006.02997.x; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; AXELROD DI, 1958, BOT REV, V24, P433, DOI 10.1007/BF02872570; Cheng YP, 2005, MOL ECOL, V14, P2075, DOI 10.1111/j.1365-294X.2005.02567.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; De Gouvenain RC, 2006, SOUTHWEST NAT, V51, P447, DOI 10.1894/0038-4909(2006)51[447:ABFRIA]2.0.CO;2; Delgado P, 1999, AM J BOT, V86, P669, DOI 10.2307/2656576; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Dunn AT, 1987, CONSERVATION MANAGEM, P367; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; ENGEL CG, 1961, AAPG BULL, V45, P1799; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Farjon A., 1999, CONIFERS STATUS SURV; Farjon A, 2005, MONOGRAPH CUPRESSACE; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Furches MS, 2009, CONSERV GENET, V10, P115, DOI 10.1007/s10592-008-9531-3; Garcillan P.P., 2009, P 7 CAL ISL S I WILD, P177; Gernandt DS, 2009, SYST BOT, V34, P481, DOI 10.1600/036364409789271290; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hamrick J. L., 1996, P281; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Helenurm K, 2005, ANN BOT-LONDON, V95, P1221, DOI 10.1093/aob/mci135; Helenurm K, 2001, J HERED, V92, P427, DOI 10.1093/jhered/92.5.427; Hoelzel AR, 2002, J EVOLUTION BIOL, V15, P567, DOI 10.1046/j.1420-9101.2002.00419.x; HONG YP, 1993, MOL PHYLOGENET EVOL, V2, P322, DOI 10.1006/mpev.1993.1031; Huang SF, 2004, J BIOGEOGR, V31, P1251, DOI 10.1111/j.1365-2699.2004.01082.x; Huang SSF, 2002, MOL ECOL, V11, P2349, DOI 10.1046/j.1365-294X.2002.01624.x; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Hwang SY, 2003, MOL ECOL, V12, P2689, DOI 10.1046/j.1365-294X.2003.01935.x; *IUCN, 2006, 2006 IUCN RED LIST T; Jaramillo-Correa JP, 2008, MOL ECOL, V17, P2476, DOI 10.1111/j.1365-294X.2008.03762.x; Junak S., 2005, ISLA GUADALUPE RESTA, P83; KAHRU A, 2005, J EVOLUTION BIOL, V19, P167; Kondo T, 1998, BREEDING SCI, V48, P177; Lammi A, 1999, CONSERV BIOL, V13, P1069, DOI 10.1046/j.1523-1739.1999.98278.x; LEDIG FT, 1983, EVOLUTION, V37, P79, DOI 10.1111/j.1558-5646.1983.tb05515.x; Ledig FT, 2002, CONSERV GENET, V3, P113, DOI 10.1023/A:1015297621884; LESICA P, 1992, CONSERV BIOL, V6, P135, DOI 10.1046/j.1523-1739.1992.610135.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liston A, 2007, MOL ECOL, V16, P3926, DOI 10.1111/j.1365-294X.2007.03461.x; Little DP, 2006, SYST BOT, V31, P461, DOI 10.1600/036364406778388638; Minnich RA, 1997, INT J WILDLAND FIRE, V7, P221, DOI 10.1071/WF9970221; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Moran R., 1996, MEMOIRS CALIFORNIA A, V19; Muller Kai, 2005, Appl Bioinformatics, V4, P65; NEALE DB, 1991, CAN J FOREST RES, V21, P717, DOI 10.1139/x91-100; NEALE DB, 1989, P NATL ACAD SCI USA, V86, P9347, DOI 10.1073/pnas.86.23.9347; Nei M., 1987, MOL EVOLUTIONARY GEN; Oberbauer T., 2005, P 6 CAL ISL S, P143; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rasmussen KK, 2008, CONSERV GENET, V9, P1533, DOI 10.1007/s10592-007-9492-y; Rehfeldt GE, 1997, AM J BOT, V84, P190, DOI 10.2307/2446080; *SEMARNAT, 2002, NOM059ECOL2001 SEMAR; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; SPENGER C, 1985, FREMONTIA, V13, P8; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TSUMURA Y, 1993, CAN J FOREST RES, V23, P859, DOI 10.1139/x93-112; Vogl RJ., 1977, TERRESTRIAL VEGETATI, P295; Wang DL, 2004, BIOCHEM SYST ECOL, V32, P797, DOI 10.1016/j.bse.2003.12.003; Weber DS, 2004, J HERED, V95, P144, DOI 10.1093/jhered/esh018; Whittall JB, 2010, MOL ECOL, V19, P100, DOI 10.1111/j.1365-294X.2009.04474.x; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zedler PH, 1981, FOREST SUCCESSION CO, P406; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x	75	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16133	10.1371/journal.pone.0016133	http://dx.doi.org/10.1371/journal.pone.0016133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283771	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522200028
J	Smith, AL; Friedman, DB; Yu, HP; Carnahan, RH; Reynolds, AB				Smith, Andrew L.; Friedman, David B.; Yu, Huapeng; Carnahan, Robert H.; Reynolds, Albert B.			ReCLIP (Reversible Cross-Link Immuno-Precipitation): An Efficient Method for Interrogation of Labile Protein Complexes	PLOS ONE			English	Article							P120 CATENIN; BETA(1) INTEGRINS; EPITHELIAL-CELLS; IDENTIFICATION; ADHESION; CD98; PHOSPHORYLATION; P120-CATENIN; P120(CTN); RECEPTOR	The difficulty of maintaining intact protein complexes while minimizing non-specific background remains a significant limitation in proteomic studies. Labile interactions, such as the interaction between p120-catenin and the E-cadherin complex, are particularly challenging. Using the cadherin complex as a model-system, we have developed a procedure for efficient recovery of otherwise labile protein-protein interactions. We have named the procedure "ReCLIP'' (Reversible Cross-Link Immuno-Precipitation) to reflect the primary elements of the method. Using cell-permeable, thiol-cleavable crosslinkers, normally labile interactions (i.e. p120 and E-cadherin) are stabilized in situ prior to isolation. After immunoprecipitation, crosslinked binding partners are selectively released and all other components of the procedure (i.e. beads, antibody, and p120 itself) are discarded. The end result is extremely efficient recovery with exceptionally low background. ReCLIP therefore appears to provide an excellent alternative to currently available affinity-purification approaches, particularly for studies of labile complexes.	[Smith, Andrew L.; Yu, Huapeng; Carnahan, Robert H.; Reynolds, Albert B.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37240 USA; [Friedman, David B.] Vanderbilt Univ, Dept Biochem, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Smith, AL (corresponding author), Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37240 USA.	al.reynolds@vanderbilt.edu	Carnahan, Robert H/N-7429-2013	Carnahan, Robert H/0000-0001-5230-1532; Yu, Huapeng/0000-0002-6669-7459	National Institutes of Health [RO1 CA55724, RO1 CA111947]; Vanderbilt GI SPORE [50 CA95103]; Vanderbilt Cancer Center [P30-CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485, P50CA095103, R01CA055724, R01CA111947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt GI SPORE; Vanderbilt Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Institutes of Health Grants RO1 CA55724 and RO1 CA111947 to A.B. Reynolds, Vanderbilt GI SPORE (50 CA95103) to R.J. Coffey, and the Vanderbilt Cancer Center Support grant (P30-CA068485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Baldwin MA, 2004, MOL CELL PROTEOMICS, V3, P1, DOI 10.1074/mcp.R300012-MCP200; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Cai S, 2005, J CELL SCI, V118, P889, DOI 10.1242/jcs.01674; CAMERON CM, 1985, BIOCHIM BIOPHYS ACTA, V841, P254, DOI 10.1016/0304-4165(85)90066-2; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Casula S, 2009, BLOOD CELL MOL DIS, V42, P233, DOI 10.1016/j.bcmd.2009.01.021; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; GUMBINER BM, 1993, J CELL SCI, P155; HAYNES BF, 1981, J IMMUNOL, V126, P1409; Henderson NC, 2004, J BIOL CHEM, V279, P54731, DOI 10.1074/jbc.M408700200; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Kim SM, 2008, EXP MOL MED, V40, P261, DOI 10.3858/emm.2008.40.3.261; KISS A, 2008, MOL BIOL CELL; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Nakamura E, 1999, J BIOL CHEM, V274, P3009, DOI 10.1074/jbc.274.5.3009; Nesvizhskii AI, 2006, MOL CELL PROTEOMICS, V5, P652, DOI 10.1074/mcp.M500319-MCP200; Nguyen HTT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003895; Norvell SM, 1998, J CELL SCI, V111, P1305; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Salazar G, 2009, J BIOL CHEM, V284, P1790, DOI 10.1074/jbc.M805991200; Studdert CA, 2007, METHOD ENZYMOL, V423, P414, DOI 10.1016/S0076-6879(07)23019-8; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Troyanovsky RB, 2003, MOL CELL BIOL, V23, P7965, DOI 10.1128/MCB.23.22.7965-7972.2003; Vretou E, 2008, MICROB PATHOGENESIS, V45, P265, DOI 10.1016/j.micpath.2008.06.007; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wu J, 1998, HYBRIDOMA, V17, P175, DOI 10.1089/hyb.1998.17.175; Xia XB, 2006, EXP CELL RES, V312, P3336, DOI 10.1016/j.yexcr.2006.07.007; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Zent R, 2000, J BIOL CHEM, V275, P5059, DOI 10.1074/jbc.275.7.5059; Zhang L, 2007, BIOCHEM BIOPH RES CO, V361, P611, DOI 10.1016/j.bbrc.2007.07.089; ZHOU M, 1993, BIOCHEMISTRY-US, V32, P8193, DOI 10.1021/bi00083a020	44	49	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16206	10.1371/journal.pone.0016206	http://dx.doi.org/10.1371/journal.pone.0016206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283770	gold, Green Submitted, Green Published			2022-12-25	WOS:000286522200037
J	Sousa, AGP; Lopes, NH; Hueb, WA; Krieger, JE; Pereira, AC				Sousa, Andre Gustavo P.; Lopes, Neuza H.; Hueb, Whady A.; Krieger, Jose Eduardo; Pereira, Alexandre C.			Genetic Variants of Diabetes Risk and Incident Cardiovascular Events in Chronic Coronary Artery Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CONTROLLED CLINICAL-TRIAL; 3 THERAPEUTIC STRATEGIES; MASS-II; FOLLOW-UP; ANGIOPLASTY; SURGERY; LOCI; MEDICINE; REPLICATION	Objective: To determine whether information from genetic risk variants for diabetes is associated with cardiovascular events incidence. Methods: From the about 30 known genes associated with diabetes, we genotyped single-nucleotide polymorphisms at the 10 loci most associated with type-2 diabetes in 425 subjects from the MASS-II Study, a randomized study in patients with multi-vessel coronary artery disease. The combined genetic information was evaluated by number of risk alleles for diabetes. Performance of genetic models relative to major cardiovascular events incidence was analyzed through Kaplan-Meier curve comparison and Cox Hazard Models and the discriminatory ability of models was assessed for cardiovascular events by calculating the area under the ROC curve. Results: Genetic information was able to predict 5-year incidence of major cardiovascular events and overall-mortality in non-diabetic individuals, even after adjustment for potential confounders including fasting glycemia. Non-diabetic individuals with high genetic risk had a similar incidence of events then diabetic individuals (cumulative hazard of 33.0 versus 35.1% of diabetic subjects). The addition of combined genetic information to clinical predictors significantly improved the AUC for cardiovascular events incidence (AUC = 0.641 versus 0.610). Conclusions: Combined information of genetic variants for diabetes risk is associated to major cardiovascular events incidence, including overall mortality, in non-diabetic individuals with coronary artery disease.	[Sousa, Andre Gustavo P.; Krieger, Jose Eduardo; Pereira, Alexandre C.] Univ Sao Paulo, Sch Med, Inst Heart, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; [Sousa, Andre Gustavo P.] Univ Fed Rio Grande do Norte, Dept Clin Med, BR-59072970 Natal, RN, Brazil; [Lopes, Neuza H.; Hueb, Whady A.] Univ Sao Paulo, Sch Med, Inst Heart, Coronary Artery Dis Serv, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio Grande do Norte; Universidade de Sao Paulo	Sousa, AGP (corresponding author), Univ Sao Paulo, Sch Med, Inst Heart, Lab Genet & Mol Cardiol, Sao Paulo, Brazil.	agpsousa@ig.com.br	Krieger, Jose E/C-3117-2011; Pereira, Alexandre/HHN-1038-2022; Hueb, Whady/A-7919-2013	Krieger, Jose E/0000-0001-5464-1792; Hueb, Whady/0000-0002-3166-6054	FAPESP [2007/54138-2]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (www.fapesp.br) grant number 2007/54138-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman EL, 1996, NEW ENGL J MED, V335, P217; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475; *IDF, 2004, INT DIAB FED DIAB AT; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Miyake K, 2009, J HUM GENET, V54, P236, DOI 10.1038/jhg.2009.17; Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901; Pereira AC, 2006, J AM COLL CARDIOL, V48, P948, DOI 10.1016/j.jacc.2005.11.094; Qiao Q, 2003, DIABETES CARE, V26, P688; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schettert IT, 2006, THROMB RES, V118, P679, DOI 10.1016/j.thromres.2005.11.009; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sousa AGP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007697; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	26	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16341	10.1371/journal.pone.0016341	http://dx.doi.org/10.1371/journal.pone.0016341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283728	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200053
J	Sato, Y; Endo, H; Okuyama, H; Takeda, T; Iwahashi, H; Imagawa, A; Yamagata, K; Shimomura, I; Inoue, M				Sato, Yoshifumi; Endo, Hiroko; Okuyama, Hiroaki; Takeda, Takaaki; Iwahashi, Hiromi; Imagawa, Akihisa; Yamagata, Kazuya; Shimomura, Iichiro; Inoue, Masahiro			Cellular Hypoxia of Pancreatic beta-Cells Due to High Levels of Oxygen Consumption for Insulin Secretion in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ENDOPLASMIC-RETICULUM; INTRACELLULAR OXYGEN; GLUCOSE; METABOLISM; SYSTEM; LINE; STABILIZATION; HIF-2-ALPHA; RESPIRATION	Cellular oxygen consumption is a determinant of intracellular oxygen levels. Because of the high demand of mitochondrial respiration during insulin secretion, pancreatic beta-cells consume large amounts of oxygen in a short time period. We examined the effect of insulin secretion on cellular oxygen tension in vitro. We confirmed that Western blotting of pimonidazole adduct was more sensitive than immunostaining for detection of cellular hypoxia in vitro and in vivo. The islets of the diabetic mice but not those of normal mice were hypoxic, especially when a high dose of glucose was loaded. In MIN6 cells, a pancreatic beta-cell line, pimonidazole adduct formation and stabilization of hypoxia-inducible factor- 1 alpha (HIF-1 alpha) were detected under mildly hypoxic conditions. Inhibition of respiration rescued the cells from becoming hypoxic. Glucose stimulation decreased cellular oxygen levels in parallel with increased insulin secretion and mitochondrial respiration. The cellular hypoxia by glucose stimulation was also observed in the isolated islets from mice. The MIN6 cells overexpressing HIF-1 alpha were resistant to becoming hypoxic after glucose stimulation. Thus, glucose-stimulated beta-cells can become hypoxic by oxygen consumption, especially when the oxygen supply is impaired.	[Sato, Yoshifumi; Endo, Hiroko; Okuyama, Hiroaki; Takeda, Takaaki; Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Higashinari Ku, Osaka 5378511, Japan; [Sato, Yoshifumi; Iwahashi, Hiromi; Imagawa, Akihisa; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan; [Yamagata, Kazuya] Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto 8608556, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University; Kumamoto University	Inoue, M (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	inoue-ma2@mc.pref.osaka.jp	Sato, Yoshifumi/GYQ-7230-2022	Sato, Yoshifumi/0000-0003-0697-1476	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science.	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Arteel GE, 1998, EUR J BIOCHEM, V253, P743, DOI 10.1046/j.1432-1327.1998.2530743.x; Bracken CP, 2006, J BIOL CHEM, V281, P22575, DOI 10.1074/jbc.M600288200; Brown ST, 2008, AM J PHYSIOL-CELL PH, V294, pC1305, DOI 10.1152/ajpcell.00007.2008; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; Daunt M, 2006, ENDOCRINOLOGY, V147, P1527, DOI 10.1210/en.2005-0873; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; Echevarria M, 2007, J BIOL CHEM, V282, P30207, DOI 10.1074/jbc.M702639200; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Endo H, 2007, CANCER RES, V67, P8095, DOI 10.1158/0008-5472.CAN-06-3389; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Gilbert M, 2008, J BIOL CHEM, V283, P24334, DOI 10.1074/jbc.M802097200; GROSS MW, 1995, INT J CANCER, V61, P567, DOI 10.1002/ijc.2910610422; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Guppy M, 1997, J CELL PHYSIOL, V170, P1, DOI 10.1002/(SICI)1097-4652(199701)170:1<1::AID-JCP1>3.0.CO;2-S; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; He FQ, 2008, CANCER RES, V68, P8597, DOI 10.1158/0008-5472.CAN-08-0677; Hochachka P. W., 2002, BIOCH ADAPTATION; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ivanov II, 2004, BIOCHEM BIOPH RES CO, V322, P746, DOI 10.1016/j.bbrc.2004.07.187; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; JANSSON L, 1986, AM J PHYSIOL, V251, pE644, DOI 10.1152/ajpendo.1986.251.6.E644; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Miao G, 2006, AM J TRANSPLANT, V6, P2636, DOI 10.1111/j.1600-6143.2006.01541.x; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mukai M, 2005, CANCER RES, V65, P9121, DOI 10.1158/0008-5472.CAN-04-4344; O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106; Okuyama H, 2006, J BIOL CHEM, V281, P15554, DOI 10.1074/jbc.M602003200; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Poitout V, 1996, DIABETES METAB, V22, P7; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Wang WJ, 2005, J ENDOCRINOL, V185, P445, DOI 10.1677/joe.1.06092; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908; Zhdanov AV, 2008, J BIOL CHEM, V283, P5650, DOI 10.1074/jbc.M706439200	44	113	114	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.194738	http://dx.doi.org/10.1074/jbc.M110.194738			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21296882	Green Published, hybrid			2022-12-25	WOS:000289077500065
J	Zahedi, B; Goo, HJ; Beaulieu, N; Tazmini, G; Kay, RJ; Cornell, RB				Zahedi, Bari; Goo, Hyun-Jung; Beaulieu, Nadine; Tazmini, Ghazaleh; Kay, Robert J.; Cornell, Rosemary B.			Phosphoinositide 3-Kinase Regulates Plasma Membrane Targeting of the Ras-specific Exchange Factor RasGRP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL ANTIGEN; PLECKSTRIN HOMOLOGY DOMAIN; BRUTONS TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOLIPID-MEMBRANES; DIFFERENTIAL ROLES; BINDING PROPERTIES; AROMATIC RESIDUES; C1 DOMAINS; DIACYLGLYCEROL	Receptor-induced targeting of exchange factors to specific cellular membranes is the predominant mechanism for initiating and compartmentalizing signal transduction by Ras GTPases. The exchange factor RasGRP1 has a C1 domain that binds the lipid diacylglycerol and thus can potentially mediate membrane localization in response to receptors that are coupled to diacylglycerol-generating phospholipase Cs. However, the C1 domain is insufficient for targeting RasGRP1 to the plasma membrane. We found that a basic/hydrophobic cluster of amino acids within the plasma membrane-targeting domain of RasGRP1 is instead responsible for plasma membrane targeting. This basic/hydrophobic cluster binds directly to phospholipid vesicles containing phosphoinositides via electrostatic interactions with polyanionic phosphoinositide headgroups and insertion of a tryptophan into the lipid bilayer. B cell antigen receptor ligation and other stimuli induce plasma membrane targeting of RasGRP1 by activating the phosphoinositide 3-kinase signaling pathway, which generates phosphoinositides within the plasma membrane. Direct detection of phosphoinositides by the basic/hydrophobic cluster of RasGRP1 provides a novel mechanism for coupling and co-compartmentalizing phosphoinositide 3-kinase and Ras signaling and, in coordination with diacylglycerol detection by the C1 domain, gives RasGRP1 the potential to serve as an integrator of converging signals from the phosphoinositide 3-kinase and phospholipase C pathways.	[Zahedi, Bari; Goo, Hyun-Jung; Beaulieu, Nadine; Tazmini, Ghazaleh; Kay, Robert J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Zahedi, Bari; Goo, Hyun-Jung; Beaulieu, Nadine; Tazmini, Ghazaleh; Kay, Robert J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1L3, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	British Columbia Cancer Agency; University of British Columbia; Simon Fraser University	Kay, RJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	rkay@bccrc.ca; cornell@sfu.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (to R. B. C. and R. J. K.).	Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Beaulieu N, 2007, MOL BIOL CELL, V18, P3156, DOI 10.1091/mbc.E06-10-0932; Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Caesar CEB, 2006, BIOCHEMISTRY-US, V45, P7682, DOI 10.1021/bi052095t; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Castellano E, 2010, CURR TOP MICROBIOL, V346, P143, DOI 10.1007/82_2010_56; Cheung SMS, 2007, CELL SIGNAL, V19, P902, DOI 10.1016/j.cellsig.2006.10.013; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; GOLD MR, 1994, J IMMUNOL, V152, P42; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hyun T, 2000, BLOOD, V96, P3560, DOI 10.1182/blood.V96.10.3560.h8003560_3560_3568; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P9509, DOI 10.1021/bi980340l; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Klinger MB, 2005, ONCOGENE, V24, P2695, DOI 10.1038/sj.onc.1208334; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; LAKOWICZ JR, 2006, PRINCIPLES FLUORESCE, pCH8, DOI DOI 10.1007/978-0-387-46312-4; Layer K, 2003, IMMUNITY, V19, P243, DOI 10.1016/S1074-7613(03)00209-7; Lazaridis T, 2005, PROTEINS, V58, P518, DOI 10.1002/prot.20358; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; Maass K, 2009, J CELL SCI, V122, P625, DOI 10.1242/jcs.036012; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Marshall AJ, 2002, MOL CELL BIOL, V22, P5479, DOI 10.1128/MCB.22.15.5479-5491.2002; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Nomikos M, 2007, J BIOL CHEM, V282, P16644, DOI 10.1074/jbc.M701072200; Oki-Idouchi CE, 2007, CANCER RES, V67, P276, DOI 10.1158/0008-5472.CAN-06-3080; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Priatel JJ, 2006, J IMMUNOL, V177, P1470, DOI 10.4049/jimmunol.177.3.1470; Qin SF, 2000, P NATL ACAD SCI USA, V97, P7118, DOI 10.1073/pnas.130198197; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Sanjuan MA, 2003, J IMMUNOL, V170, P2877, DOI 10.4049/jimmunol.170.6.2877; Skwarek LC, 2007, DEV CELL, V13, P783, DOI 10.1016/j.devcel.2007.10.020; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Sweede M, 2008, BIOCHEMISTRY-US, V47, P13524, DOI 10.1021/bi801037h; Takahashi S, 2007, MOL BIOL CELL, V18, P4945, DOI 10.1091/mbc.E07-07-0676; Tazmini G, 2009, BBA-MOL CELL RES, V1793, P447, DOI 10.1016/j.bbamcr.2008.12.019; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Varnai P, 2008, METHODS, V46, P167, DOI 10.1016/j.ymeth.2008.09.019; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Watt SA, 2004, BIOCHEM J, V377, P653, DOI 10.1042/BJ20031397; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200; Zugaza JL, 2004, ONCOGENE, V23, P5823, DOI 10.1038/sj.onc.1207768	72	14	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.189605	http://dx.doi.org/10.1074/jbc.M110.189605			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285350	hybrid, Green Published			2022-12-25	WOS:000289077500082
J	Amako, Y; Syed, GH; Siddiqui, A				Amako, Yutaka; Syed, Gulam H.; Siddiqui, Aleem			Protein Kinase D Negatively Regulates Hepatitis C Virus Secretion through Phosphorylation of Oxysterol-binding Protein and Ceramide Transfer Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; D-MEDIATED PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; HUMAN HEPATOCYTES; APOLIPOPROTEIN-E; RNA REPLICATION; PLASMA-MEMBRANE; GOLGI-APPARATUS; LIPID DROPLET; CELL MOTILITY	Hepatitis C virus (HCV) RNA replicates its genome on specialized endoplasmic reticulum modified membranes termed membranous web and utilizes lipid droplets for initiating the viral nucleocapsid assembly. HCV maturation and/or the egress pathway requires host sphingolipid synthesis, which occur in the Golgi. Ceramide transfer protein (CERT) and oxysterol-binding protein (OSBP) play a crucial role in sphingolipid biosynthesis. Protein kinase D (PKD), a serine/threonine kinase, is recruited to the trans-Golgi network where it influences vesicular trafficking to the plasma membrane by regulation of several important mediators via phosphorylation. PKD attenuates the function of both CERT and OSBP by phosphorylation at their respective Ser(132) and Ser(240) residues (phosphorylation inhibition). Here, we investigated the functional role of PKD in HCV secretion. Our studies show that HCV gene expression down-regulated PKD activation. PKD depletion by shRNA or inhibition by pharmacological inhibitor Go6976 enhanced HCV secretion. Overexpression of a constitutively active form of PKD suppressed HCV secretion. The suppression by PKD was subverted by the ectopic expression of nonphosphorylatable serine mutant CERT S132A or OSBP S240A. These observations imply that PKD negatively regulates HCV secretion/release by attenuating OSBP and CERT functions by phosphorylation inhibition. This study identifies the key role of the Golgi components in the HCV maturation process.	[Amako, Yutaka; Syed, Gulam H.; Siddiqui, Aleem] Univ Calif San Diego, Dept Med, Div Infect Dis, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Siddiqui, A (corresponding author), Univ Calif San Diego, Dept Med, Div Infect Dis, Moores Canc Ctr, Stein 409,9500 Gilman Dr,0711, La Jolla, CA 92093 USA.	asiddiqui@ucsd.edu	Syed, Gulam/N-7842-2013	Syed, Gulam/0000-0001-8540-6162	National Institutes of Health [DK077704, AI085087]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085087, R01AI085087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077704 and AI085087 (to A.S.).	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; AVITABILE E, 1994, J VIROL, V68, P7397, DOI 10.1128/JVI.68.11.7397-7405.1994; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Di Bisceglie AM, 2002, J VASC INTERV RADIOL, V13, pS169, DOI 10.1016/S1051-0443(07)61783-7; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Dubuisson J, 2002, TRENDS CELL BIOL, V12, P517, DOI 10.1016/S0962-8924(02)02383-8; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Gusarova V, 2007, J BIOL CHEM, V282, P19453, DOI 10.1074/jbc.M700475200; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Perry RJ, 2005, BBA-MOL CELL BIOL L, V1734, P220, DOI 10.1016/j.bbalip.2005.04.001; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Remillard-Labrosse Gaudeline, 2009, Commun Integr Biol, V2, P434; Remillard-Labrosse G, 2009, TRAFFIC, V10, P1074, DOI 10.1111/j.1600-0854.2009.00939.x; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Siddiqi SA, 2008, BIOCHEM J, V413, P333, DOI 10.1042/BJ20071469; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Ye J, 2007, PLOS PATHOG, V3, P1017, DOI 10.1371/journal.ppat.0030108; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	57	75	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11265	11274		10.1074/jbc.M110.182097	http://dx.doi.org/10.1074/jbc.M110.182097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21285358	Green Published, hybrid			2022-12-25	WOS:000288797100038
J	Belsham, GJ; Jamal, SM; Tjornehoj, K; Botner, A				Belsham, Graham J.; Jamal, Syed M.; Tjornehoj, Kirsten; Botner, Anette			Rescue of Foot-and-Mouth Disease Viruses That Are Pathogenic for Cattle from Preserved Viral RNA Samples	PLOS ONE			English	Article							RT-PCR; REPLICATION; DIAGNOSIS; ASSAY	Background: Foot and mouth disease is an economically important disease of cloven-hoofed animals including cattle, sheep and pigs. It is caused by a picornavirus, foot-and-mouth disease virus (FMDV), which has a positive sense RNA genome which, when introduced into cells, can initiate virus replication. Principal Findings: A system has been developed to rescue infectious FMDV from RNA preparations generated from clinical samples obtained under experimental conditions and then applied to samples collected in the "field". Clinical samples from suspect cases of foot-and-mouth disease (FMD) were obtained from within Pakistan and Afghanistan. The samples were treated to preserve the RNA and then transported to National Veterinary Institute, Lindholm, Denmark. Following RNA extraction, FMDV RNA was quantified by real-time RT-PCR and samples containing significant levels of FMDV RNA were introduced into susceptible cells using electroporation. Progeny viruses were amplified in primary bovine thyroid cells and characterized using antigen ELISA and also by RT-PCR plus sequencing. FMD viruses of three different serotypes and multiple lineages have been successfully rescued from the RNA samples. Two of the rescued viruses (of serotype O and Asia 1) were inoculated into bull calves under high containment conditions. Acute clinical disease was observed in each case which spread rapidly from the inoculated calves to in-contact animals. Thus the rescued viruses were highly pathogenic. The availability of the rescued viruses enabled serotyping by antigen ELISA and facilitated genome sequencing. Conclusions: The procedure described here should improve the characterization of FMDVs circulating in countries where the disease is endemic and thus enhance disease control globally.	[Belsham, Graham J.; Jamal, Syed M.; Tjornehoj, Kirsten; Botner, Anette] Tech Univ Denmark, Natl Vet Inst, Lindholm, Kalvehave, Denmark; [Jamal, Syed M.] Natl Vet Lab, Islamabad, Pakistan; [Jamal, Syed M.] Quaid I Azam Univ, Dept Microbiol, Islamabad, Pakistan	Technical University of Denmark; Quaid I Azam University	Belsham, GJ (corresponding author), Tech Univ Denmark, Natl Vet Inst, Lindholm, Kalvehave, Denmark.	grbe@vet.dtu.dk	Belsham, Graham/J-3132-2019; Jamal, Syed M./H-5394-2011; Belsham, Graham J./H-8589-2019	Belsham, Graham/0000-0003-1187-4873; Jamal, Syed M./0000-0002-0768-4471; Belsham, Graham J./0000-0003-1187-4873	EuFMD [LoA PR 40134]	EuFMD	The work by SMJ was supported by funds from the EuFMD (LoA PR 40134). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Balinda SN, 2009, TRANSBOUND EMERG DIS, V56, P362, DOI 10.1111/j.1865-1682.2009.01094.x; Belsham GJ, 2005, CURR TOP MICROBIOL, V288, P43; BELSHAM GJ, 1988, J GEN VIROL, V69, P265, DOI 10.1099/0022-1317-69-2-265; Belsham GJ, 2008, J GEN VIROL, V89, P485, DOI 10.1099/vir.0.83385-0; Brehm KE, 2009, J CLIN MICROBIOL, V47, P3156, DOI 10.1128/JCM.00510-09; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; Cottam EM, 2006, J VIROL, V80, P11274, DOI 10.1128/JVI.01236-06; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Have P, 1983, P SESS RES GROUP STA, P44; Hofmann MA, 2000, J VIROL METHODS, V87, P29, DOI 10.1016/S0166-0934(00)00154-3; Nayak A, 2006, J VIROL, V80, P9865, DOI 10.1128/JVI.00561-06; *OIE, FOOT AND MOUTH DIS M; Reed LJ, 1938, AM J HYG, V27, P493, DOI DOI 10.1093/OXFORDJOURNALS.AJE.A118408; Reid SM, 2003, J VIROL METHODS, V107, P129, DOI 10.1016/S0166-0934(02)00210-0; ROEDER PL, 1987, RES VET SCI, V43, P225, DOI 10.1016/S0034-5288(18)30778-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	19	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14621	10.1371/journal.pone.0014621	http://dx.doi.org/10.1371/journal.pone.0014621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21298025	Green Published, gold, Green Submitted			2022-12-25	WOS:000286664100006
J	Cortes-Campos, C; Elizondo, R; Llanos, P; Uranga, RM; Nualart, F; Garcia, MA				Cortes-Campos, Christian; Elizondo, Roberto; Llanos, Paula; Maria Uranga, Romina; Nualart, Francisco; Angeles Garcia, Maria			MCT Expression and Lactate Influx/Efflux in Tanycytes Involved in Glia-Neuron Metabolic Interaction	PLOS ONE			English	Article							MONOCARBOXYLATE TRANSPORTER MCT2; XENOPUS-LAEVIS OOCYTES; LACTIC-ACID EFFLUX; MOUSE-BRAIN; HYPOTHALAMIC NEURONS; CONFOCAL MICROSCOPY; SENSING NEURONS; ARCUATE NUCLEUS; SKELETAL-MUSCLE; CDNA CLONING	Metabolic interaction via lactate between glial cells and neurons has been proposed as one of the mechanisms involved in hypothalamic glucosensing. We have postulated that hypothalamic glial cells, also known as tanycytes, produce lactate by glycolytic metabolism of glucose. Transfer of lactate to neighboring neurons stimulates ATP synthesis and thus contributes to their activation. Because destruction of third ventricle (III-V) tanycytes is sufficient to alter blood glucose levels and food intake in rats, it is hypothesized that tanycytes are involved in the hypothalamic glucose sensing mechanism. Here, we demonstrate the presence and function of monocarboxylate transporters (MCTs) in tanycytes. Specifically, MCT1 and MCT4 expression as well as their distribution were analyzed in Sprague Dawley rat brain, and we demonstrate that both transporters are expressed in tanycytes. Using primary tanycyte cultures, kinetic analyses and sensitivity to inhibitors were undertaken to confirm that MCT1 and MCT4 were functional for lactate influx. Additionally, physiological concentrations of glucose induced lactate efflux in cultured tanycytes, which was inhibited by classical MCT inhibitors. Because the expression of both MCT1 and MCT4 has been linked to lactate efflux, we propose that tanycytes participate in glucose sensing based on a metabolic interaction with neurons of the arcuate nucleus, which are stimulated by lactate released from MCT1 and MCT4-expressing tanycytes.	[Cortes-Campos, Christian; Elizondo, Roberto; Llanos, Paula; Angeles Garcia, Maria] Univ Concepcion, Lab Biol Celular, Dept Biol Celular, Concepcion, Chile; [Nualart, Francisco] Univ Concepcion, Lab Neurobiol & Celulas Madre, Dept Biol Celular, Concepcion, Chile; [Maria Uranga, Romina] Univ Nacl Sur, Inst Invest Bioquim Bahia Blanca, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Maria Uranga, Romina] Consejo Nacl Invest Cient & Tecn, Bahia Blanca, Buenos Aires, Argentina	Universidad de Concepcion; Universidad de Concepcion; National University of the South; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Cortes-Campos, C (corresponding author), Univ Concepcion, Lab Biol Celular, Dept Biol Celular, Concepcion, Chile.	mgarcia@udec.cl	Garcia-Robles, Maria/F-4900-2014; Uranga, Romina M/A-7660-2011; Cortes Campos, Christian/Q-4096-2016; Nualart, Francisco/AAB-9342-2021	Cortes Campos, Christian/0000-0002-2532-9035; Garcia-Robles, Maria/0000-0001-8482-0361; Uranga, Romina Maria/0000-0002-8113-4646; Llanos Fuentes, Paula Lorena/0000-0002-4388-4737; Elizondo, Roberto/0000-0001-9790-0002	FONDECYT [1100705]; Ring of Research PBCT [ACT-02]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Ring of Research PBCT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/PBCT)	This work was supported by FONDECYT grant 1100705 (to MAG) and Ring of Research PBCT ACT-02 (to FN and MAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; AKMAYEV IG, 1977, CELL TISSUE RES, V180, P263; Bergersen L, 2001, EXP BRAIN RES, V136, P523, DOI 10.1007/s002210000600; Borg MA, 2003, DIABETES, V52, P663, DOI 10.2337/diabetes.52.3.663; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Burdakov D, 2005, PHILOS T R SOC B, V360, P2227, DOI 10.1098/rstb.2005.1763; CHAUVET N, 1995, J NEUROSCI RES, V41, P129, DOI 10.1002/jnr.490410115; Debernardi R, 2003, J NEUROSCI RES, V73, P141, DOI 10.1002/jnr.10660; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; FLAMENTDURAND J, 1985, INT REV CYTOL, V96, P121, DOI 10.1016/S0074-7696(08)60596-3; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Gabrion JB, 1998, MICROSC RES TECHNIQ, V41, P124, DOI 10.1002/(SICI)1097-0029(19980415)41:2<124::AID-JEMT3>3.0.CO;2-U; GARCIA CK, 1994, GENOMICS, V23, P500, DOI 10.1006/geno.1994.1532; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Garcia MD, 2003, J NEUROCHEM, V86, P709, DOI 10.1046/j.1471-4159.2003.01892.x; Garcia MDA, 2001, J CELL BIOCHEM, V80, P491; Garcia MDL, 2005, GLIA, V50, P32, DOI 10.1002/glia.20133; Gerhart DZ, 1997, AM J PHYSIOL-ENDOC M, V273, pE207, DOI 10.1152/ajpendo.1997.273.1.E207; Gerhart DZ, 1998, GLIA, V22, P272; Gonzalez JA, 2009, J PHYSIOL-LONDON, V587, P41, DOI 10.1113/jphysiol.2008.163410; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hanu R, 2000, AM J PHYSIOL-CELL PH, V278, pC921, DOI 10.1152/ajpcell.2000.278.5.C921; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; Koehler-Stec EM, 1998, AM J PHYSIOL-ENDOC M, V275, pE516, DOI 10.1152/ajpendo.1998.275.3.E516; Lam CKL, 2008, AM J PHYSIOL-ENDOC M, V295, pE491, DOI 10.1152/ajpendo.90481.2008; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Leino RL, 1999, DEV BRAIN RES, V113, P47, DOI 10.1016/S0165-3806(98)00188-6; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR1223; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; MANDERS EMM, 1992, J CELL SCI, V103, P857; Millan C, 2010, ASN NEURO, V2, P135, DOI 10.1042/AN20090059; Muroya S, 1999, NEUROSCI LETT, V264, P113, DOI 10.1016/S0304-3940(99)00185-8; Nualart FJ, 2003, J BIOL CHEM, V278, P10128, DOI 10.1074/jbc.M210686200; OOMURA Y, 1969, NATURE, V222, P282, DOI 10.1038/222282a0; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Rafiki A, 2003, NEUROSCIENCE, V122, P677, DOI 10.1016/j.neuroscience.2003.08.040; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Sanders NM, 2004, DIABETES, V53, P1230, DOI 10.2337/diabetes.53.5.1230; Song Z, 2005, DIABETES, V54, P15, DOI 10.2337/diabetes.54.1.15; Wang R, 2004, DIABETES, V53, P1959, DOI 10.2337/diabetes.53.8.1959; Wilson MC, 1998, J BIOL CHEM, V273, P15920, DOI 10.1074/jbc.273.26.15920; Yang XJ, 1999, DIABETES, V48, P1763, DOI 10.2337/diabetes.48.9.1763	49	63	64	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16411	10.1371/journal.pone.0016411	http://dx.doi.org/10.1371/journal.pone.0016411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297988	gold, Green Published, Green Submitted			2022-12-25	WOS:000286664100029
J	Jun, AS; Cope, L; Speck, C; Feng, XJ; Lee, SW; Meng, HA; Hamad, A; Chakravarti, S				Jun, Albert S.; Cope, Leslie; Speck, Caroline; Feng, Xiaojun; Lee, Seakwoo; Meng, Huan; Hamad, Abdel; Chakravarti, Shukti			Subnormal Cytokine Profile in the Tear Fluid of Keratoconus Patients	PLOS ONE			English	Article							COLONIC SUBEPITHELIAL MYOFIBROBLASTS; INFLAMMATORY MOLECULES; T-CELLS; FIBROBLASTS; INTERLEUKIN-17; EYE; ACTIVATION; EXPRESSION; HISTORY; DISEASE	Keratoconus, historically viewed as a non-inflammatory disease, is an ectatic corneal disorder associated with progressive thinning of the corneal stroma. Recently, a few inflammatory mediators have been reported to be elevated in the tear fluid of keratoconus patients. Consequently, we investigated a wide range of inflammation regulating cytokines in the tears and sera of keratoconus and control subjects. Interleukin (IL)-1 beta, IL-4, IL-6, IL-10, IL-12, IL-13, IL-17, interferon (IFN)-gamma, chemokine C-C motif ligand 5 (CCL5) and tumor necrosis factor (TNF)-alpha were tested in tear samples and sera of keratoconus and control individuals by multiplex immuno-bead assays. Selected cytokines were further tested by standard ELISA on pooled tear samples. All cytokines in the sera were generally low, with no significant changes between keratoconus and control subjects. However, in tear fluids, clear differences were detected between the two groups. These differences include increased IL-6, and decreased IL-12, TNF-alpha, IFN-gamma, IL-4, IL-13 and CCL5 in keratoconus compared to control tear fluids. The decreases in IL-12, TNF-alpha and CCL5 were statistically significant, while the IL-13 decrease was statistically significant in the severe keratoconus group only. IL-17 could not be detected by multiplex immuno-bead assay, but showed an increase in keratoconus by conventional ELISA on a limited number of pooled tear samples. Our findings confirm increased IL-6, but dispute earlier reports of increased TNF-alpha, and suggest a cytokine imbalance in keratoconus disrupting corneal homeostasis. Moreover, an increase in IL-17 suggests tissue degenerative processes at work, contributing to the thinning and weakening of the corneal connective tissue in keratoconus.	[Jun, Albert S.; Meng, Huan; Chakravarti, Shukti] Johns Hopkins Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Cope, Leslie] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; [Speck, Caroline] Johns Hopkins Sch Arts & Sci, Dept Psychol & Brain Sci, Baltimore, MD USA; [Feng, Xiaojun; Lee, Seakwoo; Chakravarti, Shukti] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Hamad, Abdel] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Chakravarti, Shukti] Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Jun, AS (corresponding author), Johns Hopkins Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.	schakra1@jhmi.edu	Feng, Xiaojun/K-4365-2012	Mills, Huan/0000-0002-8740-2074	Wilmer Openshaw Keratoconus Fund; National Eye Institute [EY11654]; Research to Prevent Blindness Dolly Green Special Scholar Award; NATIONAL EYE INSTITUTE [R56EY011654, R01EY011654] Funding Source: NIH RePORTER	Wilmer Openshaw Keratoconus Fund; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Dolly Green Special Scholar Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the Wilmer Openshaw Keratoconus Fund, National Eye Institute grant EY11654 (SC), and Research to Prevent Blindness Dolly Green Special Scholar Award (ASJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoudjehane L, 2008, LAB INVEST, V88, P973, DOI 10.1038/labinvest.2008.61; Awasthi A, 2008, J CLIN IMMUNOL, V28, P660, DOI 10.1007/s10875-008-9239-7; Bamba S, 2003, J GASTROENTEROL, V38, P548, DOI 10.1007/s00535-002-1101-8; Bhogal R, 2008, INT REV IMMUNOL, V27, P472, DOI 10.1080/08830180802430974; CARRENO E, 2010, ACTA OPHTHALMOL; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Cristina Kenney M, 2003, Cont Lens Anterior Eye, V26, P139; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; FABRE EJ, 1991, CURR EYE RES, V10, P585, DOI 10.3109/02713689109013850; FINI ME, 1992, CURR EYE RES, V11, P849, DOI 10.3109/02713689209033483; FUKUCHI T, 1994, ARCH OPHTHALMOL-CHIC, V112, P1368, DOI 10.1001/archopht.1994.01090220118033; GALIN MA, 1958, AM J OPHTHALMOL, V45, P904, DOI 10.1016/0002-9394(58)90403-3; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Jimenez JO, 1997, OPTOMETRY VISION SCI, V74, P147, DOI 10.1097/00006324-199703000-00025; Katsifis GE, 2007, CLIN REV ALLERG IMMU, V32, P252, DOI 10.1007/s12016-007-8011-8; KEMP EG, 1982, BRIT J OPHTHALMOL, V66, P717, DOI 10.1136/bjo.66.11.717; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Lema I, 2005, OPHTHALMOLOGY, V112, P654, DOI 10.1016/j.ophtha.2004.11.050; Lema I, 2009, BRIT J OPHTHALMOL, V93, P820, DOI 10.1136/bjo.2008.144253; Lema I, 2008, CORNEA, V27, P758, DOI 10.1097/ICO.0b013e31816a3591; Lema I, 2010, MOL VIS, V16, P2055; Leonardi A, 2006, CLIN EXP ALLERGY, V36, P777, DOI 10.1111/j.1365-2222.2006.02499.x; Li SM, 2008, OPTOMETRY VISION SCI, V85, P653, DOI 10.1097/OPX.0b013e3181824e20; Long Q, 2006, J REFRACT SURG, V22, P708, DOI 10.3928/1081-597X-20060901-13; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Pannebaker C, 2010, MOL VIS, V16, P1949; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Qiu Z, 2009, IMMUNOBIOLOGY, V214, P835, DOI 10.1016/j.imbio.2009.06.007; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; RAHI A, 1977, BRIT J OPHTHALMOL, V61, P761, DOI 10.1136/bjo.61.12.761; Rifas L, 2003, ARTHRITIS RHEUM-US, V48, P993, DOI 10.1002/art.10872; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Sylvester J, 2004, CELL SIGNAL, V16, P469, DOI 10.1016/j.cellsig.2003.09.008; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Wynn TA, 2005, NAT IMMUNOL, V6, P1069, DOI 10.1038/ni1105-1069; Yagi Y, 2007, J GASTROENTEROL, V42, P746, DOI 10.1007/s00535-007-2091-3; YUE BYJT, 1984, P SOC EXP BIOL MED, V175, P336; ZHENG X, 2010, INVEST OPHTHALMOL VI	41	129	130	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16437	10.1371/journal.pone.0016437	http://dx.doi.org/10.1371/journal.pone.0016437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298010	Green Published, gold, Green Submitted			2022-12-25	WOS:000286663900049
J	Dzialak, MR; Harju, SM; Osborn, RG; Wondzell, JJ; Hayden-Wing, LD; Winstead, JB; Webb, SL				Dzialak, Matthew R.; Harju, Seth M.; Osborn, Robert G.; Wondzell, John J.; Hayden-Wing, Larry D.; Winstead, Jeffrey B.; Webb, Stephen L.			Prioritizing Conservation of Ungulate Calving Resources in Multiple-Use Landscapes	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; WINTER HABITAT SELECTION; PREDATION RISK; FUNCTIONAL-RESPONSES; GROUP-SIZE; MULE DEER; ELK; DISTURBANCE; STRATEGIES; MOVEMENTS	Background: Conserving animal populations in places where human activity is increasing is an ongoing challenge in many parts of the world. We investigated how human activity interacted with maternal status and individual variation in behavior to affect reliability of spatially-explicit models intended to guide conservation of critical ungulate calving resources. We studied Rocky Mountain elk (Cervus elaphus) that occupy a region where 2900 natural gas wells have been drilled. Methodology/Principal Findings: We present novel applications of generalized additive modeling to predict maternal status based on movement, and of random-effects resource selection models to provide population and individual-based inference on the effects of maternal status and human activity. We used a 2x2 factorial design (treatment vs. control) that included elk that were either parturient or non-parturient and in areas either with or without industrial development. Generalized additive models predicted maternal status (parturiency) correctly 93% of the time based on movement. Human activity played a larger role than maternal status in shaping resource use; elk showed strong spatiotemporal patterns of selection or avoidance and marked individual variation in developed areas, but no such pattern in undeveloped areas. This difference had direct consequences for landscape-level conservation planning. When relative probability of use was calculated across the study area, there was disparity throughout 72-88% of the landscape in terms of where conservation intervention should be prioritized depending on whether models were based on behavior in developed areas or undeveloped areas. Model validation showed that models based on behavior in developed areas had poor predictive accuracy, whereas the model based on behavior in undeveloped areas had high predictive accuracy. Conclusions/Significance: By directly testing for differences between developed and undeveloped areas, and by modeling resource selection in a random-effects framework that provided individual-based inference, we conclude that: 1) amplified selection or avoidance behavior and individual variation, as responses to increasing human activity, complicate conservation planning in multiple-use landscapes, and 2) resource selection behavior in places where human activity is predictable or less dynamic may provide a more reliable basis from which to prioritize conservation action.	[Dzialak, Matthew R.; Harju, Seth M.; Osborn, Robert G.; Wondzell, John J.; Hayden-Wing, Larry D.; Winstead, Jeffrey B.; Webb, Stephen L.] Hayden Wing Associates LLC, Nat Resource Consultants, Laramie, WY USA		Dzialak, MR (corresponding author), Hayden Wing Associates LLC, Nat Resource Consultants, Laramie, WY USA.	matt@haydenwing.com	Webb, Stephen L./B-6473-2009	Webb, Stephen L./0000-0001-6034-5164	Pioneer Natural Resources Company; Hayden-Wing Associates, LLC	Pioneer Natural Resources Company; Hayden-Wing Associates, LLC	Pioneer Natural Resources Company funded this work. Hayden-Wing Associates, LLC provided in-kind contributions including travel costs associated with dissemination of this work, and materials associated with data collection and analysis including radio-telemetry equipment, GPS devices, and statistical analysis software. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DP, 2005, J WILDLIFE MANAGE, V69, P298, DOI 10.2193/0022-541X(2005)069&lt;0298:SSRSBR&gt;2.0.CO;2; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Beale CM, 2004, J APPL ECOL, V41, P335, DOI 10.1111/j.0021-8901.2004.00900.x; BECK N, 1997, GETTING MEAN RIGHT G; Bernardo J, 1996, AM ZOOL, V36, P83; Blount JD, 2002, P ROY SOC B-BIOL SCI, V269, P29, DOI 10.1098/rspb.2001.1840; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bowyer RT, 1999, J MAMMAL, V80, P1070, DOI 10.2307/1383161; Bowyer RT, 1998, J MAMMAL, V79, P415, DOI 10.2307/1382972; CAMERON RD, 1992, ARCTIC, V45, P338; CLUTTONBROCK TH, 1975, BEHAVIOUR, V55, P287, DOI 10.1163/156853975X00506; Cowie G. M., 1985, Proceedings of a Deer Course for Veterinarians, Ashburton, July 1985., P143; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062; Edge W. D., 1991, P ELK VULN S MONT ST, P132; EDGE WD, 1985, J WILDLIFE MANAGE, V49, P926, DOI 10.2307/3801372; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Fortin D, 2008, J APPL ECOL, V45, P1392, DOI 10.1111/j.1365-2664.2008.01542.x; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Franke A, 2006, ECOL MODEL, V197, P237, DOI 10.1016/j.ecolmodel.2006.02.043; Friar J. L., 2008, J APPL ECOL, V45, P1504; Frid A, 2002, CONSERV ECOL, V6; Geist Valerius, 2002, P389; GILLESPIE RG, 1987, ECOLOGY, V68, P887, DOI 10.2307/1938360; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; HEMBORG HT, 1998, COLORADO GEOLOGICAL, V33; Hudson Robert J., 2002, P199; JOHNSON DE, 1951, J WILDLIFE MANAGE, V15, P396, DOI 10.2307/3796583; Keech MA, 2000, J WILDLIFE MANAGE, V64, P450, DOI 10.2307/3803243; Kittle AM, 2008, OECOLOGIA, V157, P163, DOI 10.1007/s00442-008-1051-9; Long RA, 2009, WILDLIFE BIOL, V15, P288, DOI 10.2981/09-003; Manly B.F.J., 2002, RESOURCE SELECTION A; Manor R, 2003, ECOL APPL, V13, P1830, DOI 10.1890/01-5354; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; MORRISON JR, 1995, WILDLIFE SOC B, V23, P481; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Noyes JH, 1997, WILDLIFE SOC B, V25, P695; Phillips GE, 2000, J WILDLIFE MANAGE, V64, P521, DOI 10.2307/3803250; Poole KG, 2007, J MAMMAL, V88, P139, DOI 10.1644/06-MAMM-A-127R1.1; Potvin MJ, 2005, J WILDLIFE MANAGE, V69, P1660, DOI 10.2193/0022-541X(2005)69[1660:MAHAFW]2.0.CO;2; QUIMBY DON C., 1957, JOUR WILDLIFE MANAGEMENT, V21, P435, DOI 10.2307/3796676; Rowland MM, 2000, J WILDLIFE MANAGE, V64, P672, DOI 10.2307/3802737; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; Schaefer JA, 2000, LANDSCAPE ECOL, V15, P731, DOI 10.1023/A:1008160408257; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Singer FJ, 1997, J WILDLIFE MANAGE, V61, P12, DOI 10.2307/3802410; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P404, DOI 10.2193/0022-541X(2006)70[404:ABREDM]2.0.CO;2; Thompson MJ, 1998, WILDLIFE SOC B, V26, P477; Vander Wal E., 2009, J WILDLIFE MANAGE, V73, P1189; Vitt A., 2007, TRINCHERA DATA ANAL; Vore JM, 2001, WILDLIFE SOC B, V29, P720; White PJ, 2007, BIOL CONSERV, V135, P502, DOI 10.1016/j.biocon.2006.10.041; Winnie J, 2006, BEHAV ECOL SOCIOBIOL, V61, P277, DOI 10.1007/s00265-006-0258-1; Winter AG, 2006, ICES J MAR SCI, V63, P1118, DOI 10.1016/j.icesjms.2006.03.014; Yuan LL, 2004, FRESHWATER BIOL, V49, P662, DOI 10.1111/j.1365-2427.2004.01206.x	64	38	38	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14597	10.1371/journal.pone.0014597	http://dx.doi.org/10.1371/journal.pone.0014597			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21297866	Green Submitted, Green Published, gold			2022-12-25	WOS:000286662800008
J	Meredith, JM; Basu, S; Nimmo, DD; Larget-Thiery, I; Warr, EL; Underhill, A; McArthur, CC; Carter, V; Hurd, H; Bourgouin, C; Eggleston, P				Meredith, Janet M.; Basu, Sanjay; Nimmo, Derric D.; Larget-Thiery, Isabelle; Warr, Emma L.; Underhill, Ann; McArthur, Clare C.; Carter, Victoria; Hurd, Hilary; Bourgouin, Catherine; Eggleston, Paul			Site-Specific Integration and Expression of an Anti-Malarial Gene in Transgenic Anopheles gambiae Significantly Reduces Plasmodium Infections	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; MALARIA PARASITE; GERMLINE TRANSFORMATION; TRANSPOSABLE ELEMENT; BLOOD MEAL; VECTOR; FALCIPARUM; STEPHENSI; MOSQUITOS; DIPTERA	Diseases transmitted by mosquitoes have a devastating impact on global health and this is worsening due to difficulties with existing control measures and climate change. Genetically modified mosquitoes that are refractory to disease transmission are seen as having great potential in the delivery of novel control strategies. Historically the genetic modification of insects has relied upon transposable elements which have many limitations despite their successful use. To circumvent these limitations the Streptomyces phage phiC31 integrase system has been successfully adapted for site-specific transgene integration in insects. Here, we present the first site-specific transformation of Anopheles gambiae, the principal vector of human malaria. Mosquitoes were initially engineered to incorporate the phiC31 targeting site at a defined genomic location. A second phase of genetic modification then achieved site-specific integration of Vida3, a synthetic anti-malarial gene. Expression of Vida3, specifically in the midgut of bloodfed females, offered consistent and significant protection against Plasmodium yoelii nigeriensis, reducing average parasite intensity by 85%. Similar protection was observed against Plasmodium falciparum in some experiments, although protection was inconsistent. In the fight against malaria, it is imperative to establish a broad repertoire of both anti-malarial effector genes and tissue-specific promoters for their expression, enabling those offering maximum effect with minimum fitness cost to be identified. In the future, this technology will allow effective comparisons and informed choices to be made, potentially leading to complete transmission blockade.	[Meredith, Janet M.; Basu, Sanjay; Nimmo, Derric D.; Warr, Emma L.; Underhill, Ann; McArthur, Clare C.; Carter, Victoria; Hurd, Hilary; Eggleston, Paul] Keele Univ, Ctr Appl Entomol & Parasitol, Keele, Staffs, England; [Basu, Sanjay] Virginia Polytech Inst & State Univ, Dept Entomol, Blacksburg, VA 24061 USA; [Nimmo, Derric D.] Oxitec Ltd, Oxford, England; [Larget-Thiery, Isabelle; Bourgouin, Catherine] Inst Pasteur, Ctr Prod & Infect Anopheles, Parasitol & Mycol Dept, Paris, France	Keele University; Virginia Polytechnic Institute & State University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Meredith, JM (corresponding author), Keele Univ, Ctr Appl Entomol & Parasitol, Keele, Staffs, England.	p.eggleston@biol.keele.ac.uk	Bourgouin, Catherine/F-1253-2014	Bourgouin, Catherine/0000-0002-9209-845X	Wellcome Trust [077593, 069162]; UNICEF/UNDP/World Bank/WHO; EU [228421]; Fonds Dedie Sanofi-Aventis/Ministere de la Recherche (Combattre les Maladies Parasitaires)	Wellcome Trust(Wellcome TrustEuropean Commission); UNICEF/UNDP/World Bank/WHO(World Health Organization); EU(European Commission); Fonds Dedie Sanofi-Aventis/Ministere de la Recherche (Combattre les Maladies Parasitaires)(Sanofi-AventisMinistry of Research, France)	This investigation received financial support from the Wellcome Trust (grant numbers 077593 and 069162), the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) and from the EU:FP7 Infrastructures Programme (grant number 228421). The CEPIA received financial support from Fonds Dedie Sanofi-Aventis/Ministere de la Recherche (Combattre les Maladies Parasitaires). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amenya DA, 2010, INSECT MOL BIOL, V19, P263, DOI 10.1111/j.1365-2583.2009.00986.x; Arrighi RBG, 2002, ANTIMICROB AGENTS CH, V46, P2104, DOI 10.1128/AAC.46.7.2104-2110.2002; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Calvo E, 2005, INSECT BIOCHEM MOLEC, V35, P789, DOI 10.1016/j.ibmb.2005.02.007; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Crampton A, 2001, INFECT GENET EVOL, V1, P131, DOI 10.1016/S1567-1348(01)00017-X; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Edwards MJ, 1997, INSECT BIOCHEM MOLEC, V27, P1063, DOI 10.1016/S0965-1748(97)00093-3; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Jahan N, 1997, ANN TROP MED PARASIT, V91, P365, DOI 10.1080/00034989760987; Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447; Lombardo Fabrizio, 2009, BMC Res Notes, V2, P24, DOI 10.1186/1756-0500-2-24; Lopes LF, 2007, EXP PARASITOL, V115, P259, DOI 10.1016/j.exppara.2006.09.007; Lorenzen MD, 2002, INSECT MOL BIOL, V11, P399, DOI 10.1046/j.1365-2583.2002.00349.x; Marshall JM, 2009, PLOS MED, V6, P164, DOI 10.1371/journal.pmed.1000020; MILLER LH, 1987, SCIENCE, V237, P779, DOI 10.1126/science.3039658; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Mitri C, 2009, P ROY SOC B-BIOL SCI, V276, P3721, DOI 10.1098/rspb.2009.0962; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; O'Brochta DA, 2003, J EXP BIOL, V206, P3823, DOI 10.1242/jeb.00638; Papathanos PA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-65; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; SAKAI RK, 1992, J MED ENTOMOL, V29, P374, DOI 10.1093/jmedent/29.2.374; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Sinden RE, 2007, PLOS PATHOG, V3, P2005, DOI 10.1371/journal.ppat.0030195; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tahar R, 2002, EMBO J, V21, P6673, DOI 10.1093/emboj/cdf664; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Yoshida S, 2007, PLOS PATHOG, V3, P1962, DOI 10.1371/journal.ppat.0030192	38	77	79	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e14587	10.1371/journal.pone.0014587	http://dx.doi.org/10.1371/journal.pone.0014587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283619	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000286661400004
J	Malinouski, M; Zhou, Y; Belousov, VV; Hatfield, DL; Gladyshev, VN				Malinouski, Mikalai; Zhou, You; Belousov, Vsevolod V.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Hydrogen Peroxide Probes Directed to Different Cellular Compartments	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; DISULFIDE RELAY SYSTEM; GLUTATHIONE-PEROXIDASE; FLUORESCENT-PROBES; MAMMALIAN-CELLS; DNA-DAMAGE; GENERATION; H2O2; PERMEABILITY; MITOCHONDRIA	Background: Controlled generation and removal of hydrogen peroxide play important roles in cellular redox homeostasis and signaling. We used a hydrogen peroxide biosensor HyPer, targeted to different compartments, to examine these processes in mammalian cells. Principal Findings: Reversible responses were observed to various redox perturbations and signaling events. HyPer expressed in HEK 293 cells was found to sense low micromolar levels of hydrogen peroxide. When targeted to various cellular compartments, HyPer occurred in the reduced state in the nucleus, cytosol, peroxisomes, mitochondrial intermembrane space and mitochondrial matrix, but low levels of the oxidized form of the biosensor were also observed in each of these compartments, consistent with a low peroxide tone in mammalian cells. In contrast, HyPer was mostly oxidized in the endoplasmic reticulum. Using this system, we characterized control of hydrogen peroxide in various cell systems, such as cells deficient in thioredoxin reductase, sulfhydryl oxidases or subjected to selenium deficiency. Generation of hydrogen peroxide could also be monitored in various compartments following signaling events. Conclusions: We found that HyPer can be used as a valuable tool to monitor hydrogen peroxide generated in different cellular compartments. The data also show that hydrogen peroxide generated in one compartment could translocate to other compartments. Our data provide information on compartmentalization, dynamics and homeostatic control of hydrogen peroxide in mammalian cells.	[Malinouski, Mikalai; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Malinouski, Mikalai; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE USA; [Malinouski, Mikalai; Gladyshev, Vadim N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Zhou, You] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA; [Belousov, Vsevolod V.] Russian Acad Sci, Inst Bioorgan Chem, Moscow, Russia; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Malinouski, M (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013; Belousov, Vsevolod V/G-5562-2016	Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health; National Institutes of Health, National Cancer Institute, Center for Cancer Research; Russian Federation [DoeDs.-3567.2009.4]; Russian Foundation for Basic Research [10-04-01561]; NATIONAL CANCER INSTITUTE [ZIABC010889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603, R37GM065204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Russian Federation(Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health grants (to VNG), the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research (to DLH), a grant of the President of Russian Federation (DoeDs.-3567.2009.4) and the Russian Foundation for Basic Research (10-04-01561) (VVB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Bellomo G, 1997, MICROSC RES TECHNIQ, V36, P243, DOI 10.1002/(SICI)1097-0029(19970215)36:4<243::AID-JEMT3>3.0.CO;2-N; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Chen K, 2009, ANTIOXID REDOX SIGN, V11, P2467, DOI [10.1089/ars.2009.2594, 10.1089/ARS.2009.2594]; Cheng WH, 1998, J NUTR, V128, P1070, DOI 10.1093/jn/128.7.1070; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Dickinson BC, 2010, CURR OPIN CHEM BIOL, V14, P50, DOI 10.1016/j.cbpa.2009.10.014; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Espinosa A, 2009, J BIOL CHEM, V284, P2568, DOI 10.1074/jbc.M804249200; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; GO YM, BIOCH BIOPH IN PRESS; Go YM, 2010, ANTIOXID REDOX SIGN, V13, P489, DOI 10.1089/ars.2009.3021; Go Young-Mi, 2008, V464, P303; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Hadaszadeh BM, 2006, PHYSIOLOGY, V21, P307, DOI 10.1152/physiol.00021.2006; Hansen JM, 2006, TOXICOL SCI, V91, P643, DOI 10.1093/toxsci/kfj175; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Isenberg JS, 2000, TOXICOL SCI, V53, P340, DOI 10.1093/toxsci/53.2.340; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Koehler CM, 2006, ANTIOXID REDOX SIGN, V8, P813, DOI 10.1089/ars.2006.8.813; Koehler CM, 2009, BBA-MOL CELL RES, V1793, P139, DOI 10.1016/j.bbamcr.2008.08.002; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lee D, 2007, NAT MATER, V6, P765, DOI 10.1038/nmat1983; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Makino N, 2004, BBA-GEN SUBJECTS, V1673, P149, DOI 10.1016/j.bbagen.2004.04.011; Markovic J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006413; Markvicheva K. N., 2009, METHOD MOL BIOL, V476, P76; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Miller EW, 2007, NAT CHEM BIOL, V3, P263, DOI 10.1038/nchembio871; Millonig G, 2009, FREE RADICAL BIO MED, V46, P182, DOI 10.1016/j.freeradbiomed.2008.09.043; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; O'Rourke B, 2005, PHYSIOLOGY, V20, P303, DOI 10.1152/physiol.00020.2005; Papp LV, 2006, MOL CELL BIOL, V26, P4895, DOI 10.1128/MCB.02284-05; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; SANDSTROM BE, 1990, BIOCHEM J, V271, P17, DOI 10.1042/bj2710017; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Sousa-Lopes A, 2004, FEBS LETT, V578, P152, DOI 10.1016/j.febslet.2004.10.090; Souslova EA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P683, DOI 10.1134/S0006297907070012; Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TACHIKAWA T, 2009, NEW TRENDS MOL BIOL, V18; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Waypa GB, 2010, CIRC RES, V106, P526, DOI 10.1161/CIRCRESAHA.109.206334; Wolin MS, 2005, AM J PHYSIOL-LUNG C, V289, pL159, DOI 10.1152/ajplung.00060.2005; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yoo MH, 2007, RNA, V13, P921, DOI 10.1261/rna.533007; Youssef J, 2004, J BIOMED BIOTECHNOL, P156, DOI 10.1155/S1110724304308065	66	146	152	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14564	10.1371/journal.pone.0014564	http://dx.doi.org/10.1371/journal.pone.0014564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283738	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522300004
J	de Koning, JJ; Foster, C; Bakkum, A; Kloppenburg, S; Thiel, C; Joseph, T; Cohen, J; Porcari, JP				de Koning, Jos J.; Foster, Carl; Bakkum, Arjan; Kloppenburg, Sil; Thiel, Christian; Joseph, Trent; Cohen, Jacob; Porcari, John P.			Regulation of Pacing Strategy during Athletic Competition	PLOS ONE			English	Article							PERIPHERAL PHYSIOLOGICAL SYSTEMS; EXERCISE PERFORMANCE; PERCEIVED EXERTION; SIMULATED COMPETITION; HYPERTHERMIC FATIGUE; PROLONGED EXERCISE; MUSCLE GLYCOGEN; BRAIN ACTIVITY; PERCEPTION; HUMANS	Background: Athletic competition has been a source of interest to the scientific community for many years, as a surrogate of the limits of human ambulatory ability. One of the remarkable things about athletic competition is the observation that some athletes suddenly reduce their pace in the mid-portion of the race and drop back from their competitors. Alternatively, other athletes will perform great accelerations in mid-race (surges) or during the closing stages of the race (the endspurt). This observation fits well with recent evidence that muscular power output is regulated in an anticipatory way, designed to prevent unreasonably large homeostatic disturbances. Principal Findings: Here we demonstrate that a simple index, the product of the momentary Rating of Perceived Exertion (RPE) and the fraction of race distance remaining, the Hazard Score, defines the likelihood that athletes will change their velocity during simulated competitions; and may effectively represent the language used to allow anticipatory regulation of muscle power output. Conclusions: These data support the concept that the muscular power output during high intensity exercise performance is actively regulated in an anticipatory manner that accounts for both the momentary sensations the athlete is experiencing as well as the relative amount of a competition to be completed.	[de Koning, Jos J.; Foster, Carl; Bakkum, Arjan; Kloppenburg, Sil] Vrije Univ Amsterdam, Res Inst MOVE, Fac Human Movement Sci, Amsterdam, Netherlands; [de Koning, Jos J.; Foster, Carl; Joseph, Trent; Cohen, Jacob; Porcari, John P.] Univ Wisconsin La Crosse, Dept Exercise & Sport Sci, La Crosse, WI USA; [Thiel, Christian] Goethe Univ Frankfurt, Dept Sportmed, Frankfurt, Germany	Vrije Universiteit Amsterdam; University of Wisconsin System; University of Wisconsin La Crosse; Goethe University Frankfurt	de Koning, JJ (corresponding author), Vrije Univ Amsterdam, Res Inst MOVE, Fac Human Movement Sci, Amsterdam, Netherlands.	j.dekoning@fbw.vu.nl	Thiel, Christian/AAB-4695-2022	Thiel, Christian/0000-0003-4507-8787; de Koning, Jos J/0000-0002-5596-0282				Abbiss CR, 2008, SPORTS MED, V38, P239, DOI 10.2165/00007256-200838030-00004; Amann M, 2007, J PHYSIOL-LONDON, V581, P389, DOI 10.1113/jphysiol.2007.129700; Amann M, 2006, J PHYSIOL-LONDON, V575, P937, DOI 10.1113/jphysiol.2006.113936; Borg G., 1998, BORGS PERCEIVED EXER; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cheung SS, 2004, EXERC SPORT SCI REV, V32, P100, DOI 10.1097/00003677-200407000-00005; COYLE EF, 1983, J APPL PHYSIOL, V55, P230, DOI 10.1152/jappl.1983.55.1.230; DUGAS JP, 2010, INT J SPORT IN PRESS; Esteve-Lanao J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002943; Faulkner J, 2008, PSYCHOPHYSIOLOGY, V45, P977, DOI 10.1111/j.1469-8986.2008.00712.x; Foster C, 2004, INT J SPORTS MED, V25, P198, DOI 10.1055/s-2003-45260; Foster C, 2009, BRIT J SPORT MED, V43, P765, DOI 10.1136/bjsm.2008.054841; FOSTER C, 1994, SPORTS MED, V17, P77, DOI 10.2165/00007256-199417020-00001; Gibson ASC, 2006, SPORTS MED, V36, P705; Gonzalez-Alonso J, 2008, J PHYSIOL-LONDON, V586, P45, DOI 10.1113/jphysiol.2007.142158; Hettinga FJ, 2006, MED SCI SPORT EXER, V38, P1484, DOI 10.1249/01.mss.0000228956.75344.91; Jones AM, 2008, AM J PHYSIOL-REG I, V294, pR585, DOI 10.1152/ajpregu.00731.2007; Joseph T, 2008, MED SCI SPORT EXER, V40, P381, DOI 10.1249/mss.0b013e31815a83f6; KARLSSON J, 1970, J APPL PHYSIOL, V29, P598, DOI 10.1152/jappl.1970.29.5.598; KARLSSON J, 1971, J APPL PHYSIOL, V31, P203, DOI 10.1152/jappl.1971.31.2.203; Lambert EV, 2005, BRIT J SPORT MED, V39, P52, DOI 10.1136/bjsm.2003.011247; Laursen PB, 2009, INT J SPORT PHYSIOL, V4, P533, DOI 10.1123/ijspp.4.4.533; Nielsen B, 2001, PFLUG ARCH EUR J PHY, V442, P41, DOI 10.1007/s004240100515; Noakes TD, 2004, J APPL PHYSIOL, V96, P1571, DOI 10.1152/japplphysiol.01124.2003; Nybo L, 2001, J APPL PHYSIOL, V91, P2017, DOI 10.1152/jappl.2001.91.5.2017; Rauch HGL, 2005, BRIT J SPORT MED, V39, P34, DOI 10.1136/bjsm.2003.010645; Swart J, 2009, BRIT J SPORT MED, V43, P782, DOI 10.1136/bjsm.2008.055889; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Tucker R, 2009, BRIT J SPORT MED, V43, DOI 10.1136/bjsm.2009.057562; Tucker R, 2006, INT J SPORT PHYSIOL, V1, P233, DOI 10.1123/ijspp.1.3.233; Ulmer HV, 1996, EXPERIENTIA, V52, P416, DOI 10.1007/BF01919309	31	159	162	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15863	10.1371/journal.pone.0015863	http://dx.doi.org/10.1371/journal.pone.0015863			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283744	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522200016
J	Tzur, A; Moore, JK; Jorgensen, P; Shapiro, HM; Kirschner, MW				Tzur, Amit; Moore, Jodene K.; Jorgensen, Paul; Shapiro, Howard M.; Kirschner, Marc W.			Optimizing Optical Flow Cytometry for Cell Volume-Based Sorting and Analysis	PLOS ONE			English	Article							GROWTH; SIZE; YEAST; CYCLE	Cell size is a defining characteristic central to cell function and ultimately to tissue architecture. The ability to sort cell subpopulations of different sizes would facilitate investigation at genomic and proteomic levels of mechanisms by which cells attain and maintain their size. Currently available cell sorters, however, cannot directly measure cell volume electronically, and it would therefore be desirable to know which of the optical measurements that can be made in such instruments provide the best estimate of volume. We investigated several different light scattering and fluorescence measurements in several different cell lines, sorting cell fractions from the high and low end of distributions, and measuring volume electronically to determine which sorting strategy yielded the best separated volume distributions. Since we found that different optical measurements were optimal for different cell lines, we suggest that following this procedure will enable other investigators to optimize their own cell sorters for volume-based separation of the cell types with which they work.	[Tzur, Amit; Moore, Jodene K.; Jorgensen, Paul; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Tzur, Amit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci & Adv Mat, Ramat Gan, Israel; [Tzur, Amit] Bar Ilan Univ, Nanotechnol Inst, Ramat Gan, Israel; [Jorgensen, Paul] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Shapiro, Howard M.] Ctr Microbial Cytometry & Howard M Shapiro, W Newton, MA USA	Harvard University; Harvard Medical School; Bar Ilan University; Bar Ilan University; University of Toronto	Tzur, A (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu			NIH [RO1 GM02875]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH; RO1 GM02875. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBER RS, 1952, NATURE, V169, P200, DOI 10.1038/169200a0; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Dolznig H, 2004, NAT CELL BIOL, V6, P899, DOI 10.1038/ncb1166; FULWYLER MJ, 1965, SCIENCE, V150, P910, DOI 10.1126/science.150.3698.910; Givan A. L., 2001, FLOW CYTOMETRY 1 PRI; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Hoffman RA, 2009, CURR PROTOC CYTOM; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; MULLANEY PF, 1969, REV SCI INSTRUM, V40, P1029, DOI 10.1063/1.1684143; NAKAZAKI M, 1983, J CHEM SOC CHEM COMM, P787, DOI 10.1039/c39830000787; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Robertson BR, 1998, APPL ENVIRON MICROB, V64, P3900; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; STEEN HB, 1980, CYTOMETRY, V1, P26, DOI 10.1002/cyto.990010107; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; van Munster EB, 2002, CYTOMETRY, V47, P192, DOI 10.1002/cyto.10064; Watson JV, 1991, INTRO FLOW CYTOMETRY	19	124	131	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16053	10.1371/journal.pone.0016053	http://dx.doi.org/10.1371/journal.pone.0016053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283800	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522200025
J	Choileain, SN; Weyand, NJ; Neumann, C; Thomas, J; So, M; Astier, AL				Choileain, Siobhan Ni; Weyand, Nathan J.; Neumann, Christian; Thomas, Joelle; So, Magdalene; Astier, Anne L.			The Dynamic Processing of CD46 Intracellular Domains Provides a Molecular Rheostat for T Cell Activation	PLOS ONE			English	Article							MEMBRANE COFACTOR PROTEIN; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; EXPRESSION; CTLA-4; SIGNAL; MCP; PHOSPHORYLATION; COSTIMULATION; INDUCTION	Background: Adequate termination of an immune response is as important as the induction of an appropriate response. CD46, a regulator of complement activity, promotes T cell activation and differentiation towards a regulatory Tr1 phenotype. This Tr1 differentiation pathway is defective in patients with MS, asthma and rheumatoid arthritis, underlying its importance in controlling T cell function and the need to understand its regulatory mechanisms. CD46 has two cytoplasmic tails, Cyt1 and Cyt2, derived from alternative splicing, which are co-expressed in all nucleated human cells. The regulation of their expression and precise functions in regulating human T cell activation has not been fully elucidated. Methodology/Principal Findings: Here, we first report the novel role of CD46 in terminating T cell activation. Second, we demonstrate that its functions as an activator and inhibitor of T cell responses are mediated through the temporal processing of its cytoplasmic tails. Cyt1 processing is required to turn T cell activation on, while processing of Cyt2 switches T cell activation off, as demonstrated by proliferation, CD25 expression and cytokine secretion. Both tails require processing by Presenilin/gamma Secretase (P/gamma S) to exert these functions. This was confirmed by expressing wild-type Cyt1 and Cyt2 tails and uncleavable mutant tails in primary T cells. The role of CD46 tails was also demonstrated with T cells expressing CD19 ectodomain-CD46 C-Terminal Fragment (CTF) fusions, which allowed specific triggering of each tail individually. Conclusions/Significance: We conclude that CD46 acts as a molecular rheostat to control human T cell activation through the regulation of processing of its cytoplasmic tails.	[Choileain, Siobhan Ni; Neumann, Christian; Astier, Anne L.] Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Choileain, Siobhan Ni; Neumann, Christian; Astier, Anne L.] Univ Edinburgh, Queens Med Res Inst, Ctr Multiple Sclerosis Res, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Weyand, Nathan J.; So, Magdalene] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Weyand, Nathan J.; So, Magdalene] Univ Arizona, Dept Immunobiol, Tucson, AZ USA; [Thomas, Joelle] Univ Lyon 1, CNRS, UMR5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France	University of Edinburgh; University of Edinburgh; University of Arizona; University of Arizona; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Choileain, SN (corresponding author), Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	a.astier@ed.ac.uk	So, Magdalene/ABB-8918-2020; Astier, Anne L/A-1641-2008	Astier, Anne L/0000-0002-0144-3431; So, Magdalene/0000-0001-8301-0674; Thomas, Joelle/0000-0002-0461-6131	Multiple Sclerosis Society [859/07]	Multiple Sclerosis Society(National Multiple Sclerosis Society)	These studies were supported by a research grant to ALA from the Multiple Sclerosis Society (859/07) (www.mssociety.org.uk.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; Astier AL, 2007, J NEUROIMMUNOL, V191, P70, DOI 10.1016/j.jneuroim.2007.09.018; Astier AL, 2008, IMMUNOLOGY, V124, P149, DOI 10.1111/j.1365-2567.2008.02821.x; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Cobbold SP, 2010, IMMUNOL REV, V236, P203, DOI 10.1111/j.1600-065X.2010.00913.x; Cole DS, 2006, MOL IMMUNOL, V43, P1953, DOI 10.1016/j.molimm.2005.11.015; Crimeen-Irwin B, 2003, J BIOL CHEM, V278, P46927, DOI 10.1074/jbc.M308261200; Ferber IA, 1996, J IMMUNOL, V156, P5; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Hakulinen J, 2006, J BIOL CHEM, V281, P21369, DOI 10.1074/jbc.M602053200; Hedrick SM, 2010, IMMUNOL REV, V236, P41, DOI 10.1111/j.1600-065X.2010.00918.x; JOHNSTONE RW, 1993, MOL IMMUNOL, V30, P1231, DOI 10.1016/0161-5890(93)90038-D; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; LUBLIN DM, 1988, J EXP MED, V168, P181, DOI 10.1084/jem.168.1.181; Ma AL, 2009, INT IMMUNOPHARMACOL, V9, P599, DOI 10.1016/j.intimp.2009.01.034; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; Marrack P, 2010, IMMUNOL REV, V236, P5, DOI 10.1111/j.1600-065X.2010.00928.x; Martinez-Forero I, 2008, EUR J IMMUNOL, V38, P576, DOI 10.1002/eji.200737271; Meiffren G, 2006, J IMMUNOL, V177, P4957, DOI 10.4049/jimmunol.177.8.4957; Michalek RD, 2010, IMMUNOL REV, V236, P190, DOI 10.1111/j.1600-065X.2010.00911.x; Oliaro J, 2006, P NATL ACAD SCI USA, V103, P18685, DOI 10.1073/pnas.0602458103; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; RUSSELL SM, 1992, TRANSPLANT P, V24, P2329; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Seya T, 1999, INT J BIOCHEM CELL B, V31, P1255, DOI 10.1016/S1357-2725(99)00092-8; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; Tiroch K, 2002, J IMMUNOL, V168, P3275, DOI 10.4049/jimmunol.168.7.3275; Vaknin-Dembinsky A, 2008, J NEUROIMMUNOL, V195, P140, DOI 10.1016/j.jneuroim.2008.01.002; Walsh CM, 2010, IMMUNOL REV, V236, P95, DOI 10.1111/j.1600-065X.2010.00919.x; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839; Weyand NJ, 2010, J IMMUNOL, V184, P694, DOI 10.4049/jimmunol.0900522; Weyand NJ, 2006, INFECT IMMUN, V74, P2428, DOI 10.1128/IAI.74.4.2428-2435.2006; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Xu YQ, 2010, J ASTHMA, V47, P367, DOI 10.3109/02770903.2010.481340; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zaffran Y, 2001, J IMMUNOL, V167, P6780, DOI 10.4049/jimmunol.167.12.6780	41	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16287	10.1371/journal.pone.0016287	http://dx.doi.org/10.1371/journal.pone.0016287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283821	Green Submitted, Green Published, gold			2022-12-25	WOS:000286520600038
J	Trecesson, SD; Guillemin, Y; Belanger, A; Bernardi, AC; Preisser, L; Ravon, E; Gamelin, E; Juin, P; Barre, B; Coqueret, O				Trecesson, Sophie de Carne; Guillemin, Yannis; Belanger, Audrey; Bernardi, Anne-Charlotte; Preisser, Laurence; Ravon, Elisa; Gamelin, Erick; Juin, Philippe; Barre, Benjamin; Coqueret, Olivier			Escape from p21-mediated Oncogene-induced Senescence Leads to Cell Dedifferentiation and Dependence on Anti-apoptotic Bcl-xL and MCL1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-I INHIBITION; EPITHELIAL-MESENCHYMAL TRANSITION; DNA-DAMAGE; AURORA-A; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; CANCER-THERAPY; STEM-CELLS; CHECKPOINT; P21	Oncogene-induced senescence (OIS) is a tumor suppressor response that induces permanent cell cycle arrest in response to oncogenic signaling. Through the combined activation of the p53-p21 and p16-Rb suppressor pathways, OIS leads to the transcriptional repression of proliferative genes. Although this protective mechanism has been essentially described in primary cells, we surprisingly observed in this study that the ON program is conserved in established colorectal cell lines. In response to the RAS oncogene and despite the inactivation of p53 and p16(INK4), HT29 cells enter senescence, up-regulate p21(WAF1), and induce senescence-associated heterochromatin foci formation. The same effect was observed in response to B-RAF(v600E) in LS174T cells. We also observed that p21(WAF1) prevents the expression of the CDC25A and PLK1 genes to induce cell cycle arrest. Using ChIP and luciferase experiments, we have observed that p21(WAF1) binds to the PLK1 promoter to induce its down-regulation during OIS induction. Following 4-5 weeks, several clones were able to resume proliferation and escape this tumor suppressor pathway. Tumor progression was associated with p21(WAF1) down-regulation and CDC25A and PLK1 reexpression. In addition, OIS and p21(WAF1) escape was associated with an increase in DNA damage, an induction of the epithelial-mesenchymal transition program, and an increase in the proportion of cells expressing the CD24(low)/CD44(high) phenotype. Results also indicate that malignant cells having escaped OIS rely on survival pathways induced by Bcl-xL/MCL1 signaling. In light of these observations, it appears that the transcriptional functions of p21(WAF1) are active during OIS and that the inactivation of this protein is associated with cell dedifferentiation and enhanced survival.	[Trecesson, Sophie de Carne; Belanger, Audrey; Bernardi, Anne-Charlotte; Preisser, Laurence; Ravon, Elisa; Gamelin, Erick; Barre, Benjamin] Canc Ctr Paul Papin, INSERM, U892, F-49033 Angers, France; [Guillemin, Yannis; Juin, Philippe; Coqueret, Olivier] INSERM, Dept Canc Res, U892, F-44000 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm)	Coqueret, O (corresponding author), Canc Ctr Paul Papin, INSERM, U892, 2 Rue Moll, F-49033 Angers, France.	olivier.coqueret@univ-angers.fr	JUIN, Philippe/Q-1338-2019; Coqueret, Olivier/K-9660-2015; JUIN, Philippe P/H-3636-2014; preisser, laurence/K-7583-2015	JUIN, Philippe/0000-0002-4997-3888; Coqueret, Olivier/0000-0002-2843-7867; JUIN, Philippe P/0000-0002-4997-3888; 	Inserm-Pays de Loire; Ligue Contre le Cancer (comite du Maine et Loire); Institut du Cancer	Inserm-Pays de Loire; Ligue Contre le Cancer (comite du Maine et Loire); Institut du Cancer(Institut National du Cancer (INCA) France)	This work was supported by a fellowship from Inserm-Pays de Loire (to S. d. C. T.) and by an Equipe Labelisee grant from the Ligue Contre le Cancer (comite du Maine et Loire) and from the Institut du Cancer (to O.C.).	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Andreassen PR, 2001, CANCER RES, V61, P7660; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bienvenu F, 2005, MOL BIOL CELL, V16, P1850, DOI 10.1091/mbc.e04-08-0654; Bihani T, 2007, J BIOL CHEM, V282, P2666, DOI 10.1074/jbc.M608127200; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Courapied S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-205; Courapied S, 2010, J BIOL CHEM, V285, P26765, DOI 10.1074/jbc.M109.092304; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; Giraud S, 2004, ONCOGENE, V23, P7391, DOI 10.1038/sj.onc.1207972; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; HARPER JW, 1993, CELL, V75, P805; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; Krystyniak A, 2006, ONCOGENE, V25, P338, DOI 10.1038/sj.onc.1209056; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Roninson IB, 2003, CANCER RES, V63, P2705; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Tategu M, 2008, J GENET GENOMICS, V35, P215, DOI 10.1016/S1673-8527(08)60030-2; Uchiumi T, 1997, J BIOL CHEM, V272, P9166; Vigneron A, 2005, CANCER RES, V65, P8927, DOI 10.1158/0008-5472.CAN-05-0461; Vigneron A, 2008, CANCER RES, V68, P815, DOI 10.1158/0008-5472.CAN-07-5115; Vigneron A, 2006, J BIOL CHEM, V281, P34742, DOI 10.1074/jbc.M602492200; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wood A, 2006, GENE DEV, V20, P643, DOI 10.1101/gad.1414506; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	50	32	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12825	12838		10.1074/jbc.M110.186437	http://dx.doi.org/10.1074/jbc.M110.186437			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21292770	hybrid, Green Published			2022-12-25	WOS:000289282200003
J	Burns, KA; Li, Y; Arao, Y; Petrovich, RM; Korach, KS				Burns, Katherine A.; Li, Yin; Arao, Yukitomo; Petrovich, Robert M.; Korach, Kenneth S.			Selective Mutations in Estrogen Receptor alpha D-domain Alters Nuclear Translocation and Non-estrogen Response Element Gene Regulatory Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC-ACID-BINDING; BREAST-CANCER CELLS; ER-ALPHA; HINGE REGION; TRANSCRIPTIONAL ACTIVATION; GLUCOCORTICOID-RECEPTOR; IN-VIVO; LYSINE METHYLATION; PLASMA-MEMBRANE; EXPORT SIGNALS	The three main mechanisms of ER alpha action are: 1) nuclear, genomic, direct DNA binding, 2) nuclear, genomic, "tethered"-mediated, protein-protein interactions, and 3) non-nuclear, non-genomic, rapid action responses. Reports suggest the D-domain or hinge region of ER alpha plays an important role in mechanisms 1 and 2 above. Studies demonstrating the functionality of the ER alpha hinge region have resected the full D-domain; therefore, site directed mutations were made to attribute precise sequence functionality to this domain. This study focuses on the characterization and properties of three novel site directed ER alpha-D-domain mutants. The Hinge 1 (H1) ER alpha mutant has disrupted nuclear localization, can no longer perform tethered mediated responses and has lost interaction with c-Jun, but retains estrogen response element (ERE)-mediated functions as demonstrated by confocal microscopy, reporter assays, endogenous gene expression and co-immunoprecipitation. The H2 ER alpha mutant is non-nuclear, but translocates to the nucleus with estradiol (E-2) treatment and maintains ERE-mediated functionality. The H2 + NES ER alpha mutant does not maintain nuclear translocation with hormone binding, no longer activates ERE-target genes, functions in ERE-or tethered-mediated luciferase assays, but does retain the non-genomic, non-nuclear, rapid action response. These studies reveal the sequence(s) in the ER alpha hinge region that are involved in tethered-mediated actions as well as nuclear localization and attribute important functionality to this region of the receptor. In addition, the properties of these ER alpha mutants will allow future studies to further dissect and characterize the three main ER alpha mechanisms of action and determine the mechanistic role each action has in estrogen hormone regulation.	[Burns, Katherine A.; Li, Yin; Arao, Yukitomo; Korach, Kenneth S.] Natl Inst Environm Hlth Sci, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA; [Petrovich, Robert M.] Natl Inst Environm Hlth Sci, Prot Express Core Facil, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Korach, KS (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27790 USA.	Korach@niehs.nih.gov	Arao, Yukitomo/AAL-1665-2021	Korach, Kenneth/0000-0002-7765-418X; Arao, Yukitomo/0000-0003-1560-351X	National Institutes of Health [Z01ES70065, Z01ES102487-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065, Z01ES070065, ZICES102506, ZICES102487, Z01ES102487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants Z01ES70065 and Z01ES102487-01.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Carrigan A, 2007, J BIOL CHEM, V282, P10963, DOI 10.1074/jbc.M602931200; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Chambliss KL, 2005, MOL ENDOCRINOL, V19, P277, DOI 10.1210/me.2004-0008; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; FRANCIS MK, 1995, J BIOL CHEM, V270, P11502, DOI 10.1074/jbc.270.19.11502; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471; Hewitt SC, 2009, MOL ENDOCRINOL, V23, P2111, DOI 10.1210/me.2009-0356; Hong W, 2008, J MOL BIOL, V384, P22, DOI 10.1016/j.jmb.2008.09.010; Huq MDM, 2008, J PROTEOME RES, V7, P4538, DOI 10.1021/pr800375z; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; MADER S, 1993, NUCLEIC ACIDS RES, V21, P1125, DOI 10.1093/nar/21.5.1125; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McDevitta MA, 2008, MOL CELL ENDOCRINOL, V290, P24, DOI 10.1016/j.mce.2008.04.003; Mueller SO, 2003, J BIOL CHEM, V278, P12255, DOI 10.1074/jbc.M203578200; Nakielny S, 1996, J CELL BIOL, V134, P1365, DOI 10.1083/jcb.134.6.1365; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICARD D, 1990, CELL REGUL, V1, P291, DOI 10.1091/mbc.1.3.291; PONGLIKITMONGKOL M, 1988, EMBO J, V7, P3385, DOI 10.1002/j.1460-2075.1988.tb03211.x; Rai D, 2005, MOL ENDOCRINOL, V19, P1606, DOI 10.1210/me.2004-0468; Razandi M, 2003, MOL CELL BIOL, V23, P1633, DOI 10.1128/MCB.23.5.1633-1646.2003; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; SALMON P, 2006, CURRENT PROTOCOLS NE, V37; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Shaffer PL, 2005, BIOCHEMISTRY-US, V44, P2678, DOI 10.1021/bi0477182; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Tanner TM, 2010, CELL MOL LIFE SCI, V67, P1919, DOI 10.1007/s00018-010-0302-1; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; Winuthayanon W, 2009, ENVIRON HEALTH PERSP, V117, P1155, DOI 10.1289/ehp.0900613; Xu PL, 2004, MOL ENDOCRINOL, V18, P1887, DOI 10.1210/me.2003-0334; YLIKOMI T, 1992, EMBO J, V11, P3681, DOI 10.1002/j.1460-2075.1992.tb05453.x; Yoshikawa N, 2008, BIOCHEM BIOPH RES CO, V371, P44, DOI 10.1016/j.bbrc.2008.03.155; Yue W, 2007, J STEROID BIOCHEM, V106, P102, DOI 10.1016/j.jsbmb.2007.05.008; Zhang Z, 2004, J NEUROCHEM, V89, P674, DOI 10.1111/j.1471-4159.2004.02388.x; Zhang ZG, 2002, BIOCHEM BIOPH RES CO, V294, P926, DOI 10.1016/S0006-291X(02)00348-0; Zhou Q, 2009, ENDOCR-RELAT CANCER, V16, P319, DOI 10.1677/ERC-08-0305; ZWART W, J CELL SCI, V123, P1253	56	60	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.187773	http://dx.doi.org/10.1074/jbc.M110.187773			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285458	hybrid, Green Published			2022-12-25	WOS:000289077500075
J	Chung, IYW; Paetzel, M				Chung, Ivy Yeuk Wah; Paetzel, Mark			Crystal Structure of a Viral Protease Intramolecular Acyl-enzyme Complex INSIGHTS INTO cis-CLEAVAGE AT THE VP4/VP3 JUNCTION OF TELLINA BIRNAVIRUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC NECROSIS VIRUS; BURSAL DISEASE VIRUS; BACTERIAL SIGNAL PEPTIDASE; SER-LYS DYAD; CLEAVAGE SITES; VP4 PROTEASE; SUBSTRATE; IDENTIFICATION; BIRNAVIRUS; POLYMERASE	Viruses of the Birnaviridae family are characterized by their bisegmented double-stranded RNA genome that resides within a single-shelled non-enveloped icosahedral particle. They infect birds, aquatic organisms, and insects. Tellina virus 1 (TV-1) is an Aquabirnavirus isolated from the mollusk Tellina tenuis. It encodes a polyprotein (NH2-pVP2-X-VP4-VP3-COOH) that is cleaved by the self-encoded protease VP4 to yield capsid precursor protein pVP2, peptide X, and ribonucleoprotein VP3. Here we report the crystal structure of an intramolecular (cis) acylenzyme complex of TV-1 VP4 at 2.1-angstrom resolution. The structure reveals how the enzyme can recognize its own carboxyl terminus during the VP4/VP3 cleavage event. The methyl side chains of Ala(830)(P1) and Ala(828)(P3) at the VP4/VP3 junction point into complementary shallow and hydrophobic S1 and S3 binding pockets adjacent to the VP4 catalytic residues: nucleophile Ser(738) and general base Lys(777). The electron density clearly shows that the carbonyl carbon of Ala(830) is covalently attached via an ester bond to the O gamma of Ser(738). A highly ordered water molecule in the active site is coordinated in the proper position to act as the deacylating water. A comparative analysis of this intramolecular (cis) acyl-enzyme structure with the previously solved intermolecular (trans) acyl-enzyme structure of infectious pancreatic necrosis virus VP4 explains the narrower specificity observed in the cleavage sites of TV-1 VP4.	[Chung, Ivy Yeuk Wah; Paetzel, Mark] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Paetzel, M (corresponding author), S Sci Bldg,8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	mpaetzel@sfu.ca		Paetzel, Mark/0000-0002-7408-5487	Canadian Institute of Health Research; National Science and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; Canadian Foundation of Innovation; Natural Sciences and Engineering Research Council of Canada; National Research Council; Canadian Institutes of Health Research; University of Saskatchewan	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Foundation of Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan	This work was supported in part by grants from the Canadian Institute of Health Research (to M. P.), the National Science and Engineering Research Council of Canada (to M. P.), the Michael Smith Foundation for Health Research (to M. P.), and the Canadian Foundation of Innovation (to M. P.).; We thank the staff at the macromolecular beamline 08ID-1,Canadian Light Source, Saskatoon, Canada, for technical assistance with data collection. The Canadian Light Source is supported by Natural Sciences and Engineering Research Council of Canada, National Research Council, Canadian Institutes of Health Research, and the University of Saskatchewan. We thank Bernard Delmas for providing the initial TV-1 cDNA.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALBER T, 1976, NATURE, V263, P297, DOI 10.1038/263297a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Botos I, 2007, CURR OPIN STRUC BIOL, V17, P683, DOI 10.1016/j.sbi.2007.08.003; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; Casanas A, 2008, STRUCTURE, V16, P29, DOI 10.1016/j.str.2007.10.023; Chung HK, 1996, VIROLOGY, V225, P359, DOI 10.1006/viro.1996.0610; Chung IYW, 2011, ACTA CRYSTALLOGR F, V67, P157, DOI 10.1107/S1744309110048803; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; Da Costa B, 2003, J VIROL, V77, P719, DOI 10.1128/JVI.77.1.719-725.2003; DELANO WL, 2002, PYMOL MOL USERS MANU; Delmas B, 2005, VIRUS TAXONOMY; DING XC, 1994, BIOCHEMISTRY-US, V33, P9285, DOI 10.1021/bi00197a032; DOBOS P, 1995, VIROLOGY, V208, P19, DOI 10.1006/viro.1995.1125; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinoza JC, 2000, ARCH VIROL, V145, P739, DOI 10.1007/s007050050667; Feldman AR, 2006, J MOL BIOL, V358, P1378, DOI 10.1016/j.jmb.2006.02.045; Ferentz AE, 2001, EMBO J, V20, P4287, DOI 10.1093/emboj/20.15.4287; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Hill B.J., 1976, P445; Hjalmarsson A, 1999, J VIROL, V73, P3484, DOI 10.1128/JVI.73.4.3484-3490.1999; Katona G, 2002, J BIOL CHEM, V277, P21962, DOI 10.1074/jbc.M200676200; Kim AC, 2008, J MOL BIOL, V376, P352, DOI 10.1016/j.jmb.2007.11.080; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JY, 2007, J BIOL CHEM, V282, P24928, DOI 10.1074/jbc.M701551200; Lejal N, 2000, J GEN VIROL, V81, P983, DOI 10.1099/0022-1317-81-4-983; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MENARD R, 1992, BIOL CHEM H-S, V373, P393, DOI 10.1515/bchm3.1992.373.2.393; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nobiron I, 2008, VIROLOGY, V371, P350, DOI 10.1016/j.virol.2007.09.022; Paetzel M, 2002, J BIOL CHEM, V277, P9512, DOI 10.1074/jbc.M110983200; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Petit S, 2000, J VIROL, V74, P2057, DOI 10.1128/JVI.74.5.2057-2066.2000; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Sanchez AB, 1999, VIROLOGY, V262, P190, DOI 10.1006/viro.1999.9910; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; UNDERWOOD BO, 1977, J GEN VIROL, V36, P93, DOI 10.1099/0022-1317-36-1-93; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wilmouth RC, 1997, NAT STRUCT BIOL, V4, P456, DOI 10.1038/nsb0697-456; Wilmouth RC, 1998, BIOCHEMISTRY-US, V37, P17506, DOI 10.1021/bi9816249	53	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.198812	http://dx.doi.org/10.1074/jbc.M110.198812			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288899	Green Published, hybrid			2022-12-25	WOS:000289077500061
J	Zhang, XYZ; Goemaere, EL; Seddiki, N; Celia, H; Gavioli, M; Cascales, E; Lloubes, R				Zhang, Xiang Y. -Z.; Goemaere, Emilie L.; Seddiki, Nadir; Celia, Herve; Gavioli, Marthe; Cascales, Eric; Lloubes, Roland			Mapping the Interactions between Escherichia coli TolQ Transmembrane Segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE INTEGRITY; CELL-ENVELOPE INTEGRITY; N-TERMINAL DOMAIN; CONFORMATIONAL-CHANGE; CYTOPLASMIC MEMBRANE; MUTATIONAL ANALYSIS; PERIPLASMIC DOMAIN; PROTONMOTIVE FORCE; STATOR COMPLEX; INNER MEMBRANE	The tolQRAB-pal operon is conserved in Gram-negative genomes. The TolQRA proteins of Escherichia coli form an inner membrane complex in which TolQR uses the proton-motive force to regulate TolA conformation and the in vivo interaction of TolA C-terminal region with the outer membrane Pal lipoprotein. The stoichiometry of the TolQ, TolR, and TolA has been estimated and suggests that 4-6 TolQ molecules are associated in the complex, thus involving interactions between the transmembrane helices (TMHs) of TolQ, TolR, and TolA. It has been proposed that an ion channel forms at the interface between two TolQ and one TolR TMHs involving the TolR-Asp23, TolQ-Thr145, and TolQ-Thr178 residues. To define the organization of the three TMHs of TolQ, we constructed epitope-tagged versions of TolQ. Immunodetection of in vivo and in vitro chemically cross-linked TolQ proteins showed that TolQ exists as multimers in the complex. To understand how TolQ multimerizes, we initiated a cysteine-scanning study. Results of single and tandem cysteine substitution suggest a dynamic model of helix interactions in which the hairpin formed by the two last TMHs of TolQ change conformation, whereas the first TMH of TolQ forms intramolecular interactions.	[Zhang, Xiang Y. -Z.; Goemaere, Emilie L.; Seddiki, Nadir; Celia, Herve; Gavioli, Marthe; Cascales, Eric; Lloubes, Roland] Aix Marseille Univ, CNRS, Lab Ingn Syst Macromol UPR9027, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lloubes, R (corresponding author), Aix Marseille Univ, CNRS, Lab Ingn Syst Macromol UPR9027, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	roland.lloubes@ifr88.cnrs-mrs.fr	CASCALES, ERIC/G-7420-2011	CASCALES, ERIC/0000-0003-0611-9179; LLOUBES, Roland/0000-0002-9520-1053	CNRS; Agence National de la Recherche [SODATOL (ANR-07-BLAN-67)]; SODATOL; Fondation pour la Recherche Medicale (FRM)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche(French National Research Agency (ANR)); SODATOL; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the CNRS and a grant from the Agence National de la Recherche (SODATOL (ANR-07-BLAN-67)), by a grant from SODATOL (to X. Y.-Z. Z.), and a one-year fellowship from the Fondation pour la Recherche Medicale (FRM) (to E. L. G.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Anwari K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008619; Barneoud-Arnoulet A, 2010, J BACTERIOL, V192, P5934, DOI 10.1128/JB.00936-10; BLAIR DF, 1991, J MOL BIOL, V221, P1433, DOI 10.1016/0022-2836(91)90943-Z; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; BOUVERET E, 1995, J BIOL CHEM, V270, P11071, DOI 10.1074/jbc.270.19.11071; Braun TF, 2001, BIOCHEMISTRY-US, V40, P13051, DOI 10.1021/bi011264g; Braun TF, 2004, BIOCHEMISTRY-US, V43, P35, DOI 10.1021/bi035406d; Braun V, 2004, J BACTERIOL, V186, P4402, DOI 10.1128/JB.186.13.4402-4406.2004; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2004, MOL MICROBIOL, V51, P873, DOI 10.1046/j.1365-2958.2003.03881.x; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; DEROUICHE R, 1995, J BIOL CHEM, V270, P11078, DOI 10.1074/jbc.270.19.11078; Ding PZ, 2001, J MEMBRANE BIOL, V183, P33, DOI 10.1007/s00232-001-0053-x; Garcia-Herrero A, 2007, MOL MICROBIOL, V66, P872, DOI 10.1111/j.1365-2958.2007.05957.x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Germon P, 1998, J BACTERIOL, V180, P6433, DOI 10.1128/JB.180.24.6433-6439.1998; Germon P, 2001, J BACTERIOL, V183, P4110, DOI 10.1128/JB.183.14.4110-4114.2001; Goemaere EL, 2007, J BIOL CHEM, V282, P17749, DOI 10.1074/jbc.M701002200; GUIHARD G, 1994, J BIOL CHEM, V269, P5874; Hermolin J, 1999, J BIOL CHEM, V274, P17011, DOI 10.1074/jbc.274.24.17011; Higgs PI, 1998, J BACTERIOL, V180, P6031, DOI 10.1128/JB.180.22.6031-6038.1998; Journet L, 1999, J BACTERIOL, V181, P4476, DOI 10.1128/JB.181.15.4476-4484.1999; Kim EA, 2008, BIOCHEMISTRY-US, V47, P11332, DOI 10.1021/bi801347a; Kojima S, 2004, BIOCHEMISTRY-US, V43, P26, DOI 10.1021/bi035405l; Larsen RA, 1999, MOL MICROBIOL, V31, P1809, DOI 10.1046/j.1365-2958.1999.01317.x; LAZZARONI JC, 1995, J MOL BIOL, V246, P1, DOI 10.1006/jmbi.1994.0058; Lazzaroni JC, 1999, FEMS MICROBIOL LETT, V177, P191, DOI 10.1016/S0378-1097(99)00293-1; LEE GF, 1995, P NATL ACAD SCI USA, V92, P5416, DOI 10.1073/pnas.92.12.5416; LEVENGOODFREYERMUTH SK, 1993, J BACTERIOL, V175, P222, DOI 10.1128/JB.175.1.222-228.1993; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; MULLER MM, 1993, J BACTERIOL, V175, P6059, DOI 10.1128/JB.175.18.6059-6061.1993; Ollis AA, 2009, MOL MICROBIOL, V73, P466, DOI 10.1111/j.1365-2958.2009.06785.x; Parsons LM, 2008, BIOCHEMISTRY-US, V47, P3131, DOI 10.1021/bi702283x; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Pramanik A, 2010, BIOCHEMISTRY-US, V49, P8721, DOI 10.1021/bi101143y; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; VIANNEY A, 1994, J BACTERIOL, V176, P822, DOI 10.1128/jb.176.3.822-829.1994; Vianney A, 1996, J BACTERIOL, V178, P4031, DOI 10.1128/jb.178.14.4031-4038.1996; Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10; Zhang XYZ, 2009, J BIOL CHEM, V284, P4275, DOI 10.1074/jbc.M805257200	44	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11756	11764		10.1074/jbc.M110.192773	http://dx.doi.org/10.1074/jbc.M110.192773			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21285349	Green Published, hybrid			2022-12-25	WOS:000288797100083
J	Huang, YC; Wu, YR; Tseng, MY; Chen, YC; Hsieh, SY; Chen, CM				Huang, Yen-Chu; Wu, Yih-Ru; Tseng, Mu-Yun; Chen, Yi-Chun; Hsieh, Sen-Yung; Chen, Chiung-Mei			Increased Prothrombin, Apolipoprotein A-IV, and Haptoglobin in the Cerebrospinal Fluid of Patients with Huntington's Disease	PLOS ONE			English	Article							INDUCED MICROGLIAL ACTIVATION; DOPAMINERGIC-NEURONS; THROMBIN; BRAIN; EXPRESSION; NEURODEGENERATION; BLOOD; PARTICIPATION; ASTROCYTES; RECEPTORS	Huntington's disease (HD) is a progressive neurodegenerative disease caused by an unstable CAG trinucleotide repeat expansion. The need for biomarkers of onset and progression in HD is imperative, since currently reliable outcome measures are lacking. We used two-dimensional electrophoresis and mass spectrometry to analyze the proteome profiles in cerebrospinal fluid (CSF) of 6 pairs of HD patients and controls. Prothrombin, apolipoprotein A-IV (Apo A-IV) and haptoglobin were elevated in CSF of the HD patients in comparison with the controls. We used western blot as a semi-quantified measurement for prothrombin and Apo A-IV, as well as enzyme linked immunosorbent assay (ELISA) for measurement of haptoglobin, in 9 HD patients and 9 controls. The albumin quotient (Qalb), a marker of blood-brain barrier (BBB) function, was not different between the HD patients and the controls. The ratios of CSF prothrombin/albumin (prothrombin/Alb) and Apo A-IV/albumin (Apo A-IV/Alb), and haptoglobin level were significantly elevated in HD. The ratio of CSF prothrombin/Alb significantly correlated with the disease severity assessed by Unified Huntington's Disease Rating Scale (UHDRS). The results implicate that increased CSF prothrombin, Apo A-IV, and haptoglobin may be involved in pathogenesis of HD and may serve as potential biomarkers for HD.	[Huang, Yen-Chu; Wu, Yih-Ru; Tseng, Mu-Yun; Chen, Yi-Chun; Chen, Chiung-Mei] Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurol, Coll Med, Taipei, Taiwan; [Hsieh, Sen-Yung] Chang Gung Mem Hosp, Clin Prote Ctr, Taipei 10591, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, YC (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurol, Coll Med, Taipei, Taiwan.	cmchen@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020; Huang, Yenchu/AAO-1140-2020		Academia Sinica, Republic of China [23-4b]; Chang Gung Memorial Hospital, Taipei, Republic of China [CMRPG 38138]; National Science Council [NSC 94-3112-P-001-010-Y]; Academia Sinica	Academia Sinica, Republic of China(Academia Sinica - Taiwan); Chang Gung Memorial Hospital, Taipei, Republic of China(Chang Gung Memorial Hospital); National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Academia Sinica, Republic of China (23-4b, http://www.sinica.edu.tw/) and by Chang Gung Memorial Hospital, Taipei, Republic of China (CMRPG 38138, http://www.cgmh.org.tw/). MALDI-TOF MS/MS analyses were performed by the Core Facilities for Proteomics Research located at the Institute of Biological Chemistry, Academia Sinica, supported by a National Science Council grant (NSC 94-3112-P-001-010-Y, http://web1.nsc.gov.tw/) and the Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AN, 2008, BRAIN, V131, P381, DOI 10.1093/brain/awm312; Arai T, 2006, J NEUROPATH EXP NEUR, V65, P19, DOI 10.1097/01.jnen.0000196133.74087.cb; Bai SM, 2010, MOL BIOL REP, V37, P1619, DOI 10.1007/s11033-009-9574-7; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Bjorkqvist M, 2007, MOVEMENT DISORD, V22, P1952, DOI 10.1002/mds.21447; Carter K, 2007, INT J LAB HEMATOL, V29, P92, DOI 10.1111/j.1751-553X.2007.00898.x; Chang KH, 2007, PROTEOM CLIN APPL, V1, P467, DOI 10.1002/prca.200600949; Chen CM, 2007, BIOCHEM BIOPH RES CO, V359, P335, DOI 10.1016/j.bbrc.2007.05.093; Choi SH, 2005, J NEUROCHEM, V95, P1755, DOI 10.1111/j.1471-4159.2005.03503.x; Choi SH, 2003, NEUROBIOL DIS, V14, P181, DOI 10.1016/S0969-9961(03)00085-8; Choi SH, 2003, J NEUROSCI, V23, P5877; Constantinescu R, 2009, PARKINSONISM RELAT D, V15, P245, DOI 10.1016/j.parkreldis.2008.05.012; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; Dalrymple A, 2007, J PROTEOME RES, V6, P2833, DOI 10.1021/pr0700753; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Fang QJ, 2009, MOL CELL PROTEOMICS, V8, P451, DOI 10.1074/mcp.M800231-MCP200; FUJIMOTO K, 1993, J CLIN INVEST, V91, P1830, DOI 10.1172/JCI116395; Hsiao HY, 2010, MOL NEUROBIOL, V41, P248, DOI 10.1007/s12035-009-8097-5; Jeitner TM, 2008, J NEUROCHEM, V106, P37, DOI 10.1111/j.1471-4159.2008.05350.x; Jeitner TM, 2001, J NEUROCHEM, V79, P1109, DOI 10.1046/j.1471-4159.2001.00673.x; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Lee MY, 2002, J CEREBR BLOOD F MET, V22, P1176, DOI 10.1097/01.wcb.0000037989.07114.d1; Li X, 2006, ACTA NEUROCHIR, V148, P859, DOI 10.1007/s00701-006-0787-4; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Montine TJ, 1999, NEUROLOGY, V52, P1104, DOI 10.1212/WNL.52.5.1104; Nemes Z, 2001, NEUROBIOL AGING, V22, P403, DOI 10.1016/S0197-4580(01)00224-X; PANTONI L, 1995, ACTA NEUROL SCAND, V91, P225; Roze E, 2008, CURR OPIN NEUROL, V21, P497, DOI 10.1097/WCO.0b013e328304b692; Saft C, 2005, MOVEMENT DISORD, V20, P674, DOI 10.1002/mds.20373; Sarvari M, 2002, DRUG DEVELOP RES, V56, P458, DOI 10.1002/ddr.10098; Shen L, 2008, PHYSIOL BEHAV, V95, P161, DOI 10.1016/j.physbeh.2008.05.022; Shen L, 2007, ENDOCRINOLOGY, V148, P2681, DOI 10.1210/en.2006-1596; Sokolova E, 2008, THROMB HAEMOSTASIS, V100, P576, DOI 10.1160/TH08-03-0131; Strehlow ANT, 2007, HUM MOL GENET, V16, P391, DOI 10.1093/hmg/ddl467; Suo ZM, 2002, J NEUROCHEM, V80, P655, DOI 10.1046/j.0022-3042.2001.00745.x; TANEDA H, 1994, J BIOCHEM-TOKYO, V116, P589, DOI 10.1093/oxfordjournals.jbchem.a124565; Tang TS, 2007, J NEUROSCI, V27, P7899, DOI 10.1523/JNEUROSCI.1396-07.2007; Tso P, 2001, ANNU REV NUTR, V21, P231, DOI 10.1146/annurev.nutr.21.1.231; Underwood BR, 2006, BRAIN, V129, P877, DOI 10.1093/brain/awl027; Wang H, 2002, AM J PHYSIOL-CELL PH, V283, pC1351, DOI 10.1152/ajpcell.00001.2002; Won SY, 2009, J NEUROIMMUNOL, V214, P83, DOI 10.1016/j.jneuroim.2009.07.005; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	47	36	38	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15809	10.1371/journal.pone.0015809	http://dx.doi.org/10.1371/journal.pone.0015809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297956	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300027
J	Tabach, Y; Kogan-Sakin, I; Buganim, Y; Solomon, H; Goldfinger, N; Hovland, R; Ke, XS; Oyan, AM; Kalland, KH; Rotter, V; Domany, E				Tabach, Yuval; Kogan-Sakin, Ira; Buganim, Yosef; Solomon, Hilla; Goldfinger, Naomi; Hovland, Randi; Ke, Xi-Song; Oyan, Anne M.; Kalland, Karl-H.; Rotter, Varda; Domany, Eytan			Amplification of the 20q Chromosomal Arm Occurs Early in Tumorigenic Transformation and May Initiate Cancer	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BREAST-CANCER; GENE-EXPRESSION; PROSTATIC ADENOCARCINOMAS; FREQUENT AMPLIFICATION; ANEUPLOIDY; INSTABILITY; PROGRESSION; VISUALIZATION; CHEMOTHERAPY	Duplication of chromosomal arm 20q occurs in prostate, cervical, colon, gastric, bladder, melanoma, pancreas and breast cancer, suggesting that 20q amplification may play a causal role in tumorigenesis. According to an alternative view, chromosomal imbalance is mainly a common side effect of cancer progression. To test whether a specific genomic aberration might serve as a cancer initiating event, we established an in vitro system that models the evolutionary process of early stages of prostate tumor formation; normal prostate cells were immortalized by the over-expression of human telomerase catalytic subunit hTERT, and cultured for 650 days till several transformation hallmarks were observed. Gene expression patterns were measured and chromosomal aberrations were monitored by spectral karyotype analysis at different times. Several chromosomal aberrations, in particular duplication of chromosomal arm 20q, occurred early in the process and were fixed in the cell populations, while other aberrations became extinct shortly after their appearance. A wide range of bioinformatic tools, applied to our data and to data from several cancer databases, revealed that spontaneous 20q amplification can promote cancer initiation. Our computational model suggests that 20q amplification induced deregulation of several specific cancer-related pathways including the MAPK pathway, the p53 pathway and Polycomb group factors. In addition, activation of Myc, AML, B-Catenin and the ETS family transcription factors was identified as an important step in cancer development driven by 20q amplification. Finally we identified 13 "cancer initiating genes", located on 20q13, which were significantly over-expressed in many tumors, with expression levels correlated with tumor grade and outcome suggesting that these genes induce the malignant process upon 20q amplification.	[Tabach, Yuval; Domany, Eytan] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Tabach, Yuval; Kogan-Sakin, Ira; Buganim, Yosef; Solomon, Hilla; Goldfinger, Naomi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Hovland, Randi] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Hovland, Randi] Univ Bergen, Dept Biomed, Bergen, Norway; [Ke, Xi-Song; Oyan, Anne M.; Kalland, Karl-H.] Univ Bergen, Gade Inst, Bergen, Norway; [Ke, Xi-Song; Oyan, Anne M.; Kalland, Karl-H.] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway	Weizmann Institute of Science; Weizmann Institute of Science; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Tabach, Y (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02115 USA.	eytan.domany@weizmann.ac.il	Kalland, Karl-Henning/B-9445-2017; DOMANY, EYTAN/K-1560-2012; Tabach, Yuval/Q-8488-2019	Kalland, Karl-Henning/0000-0003-4486-2334; 	Leir Charitable Foundation; EC; Center for Women's Health Research	Leir Charitable Foundation; EC(European CommissionEuropean Commission Joint Research Centre); Center for Women's Health Research	This research was supported by a grant from the Leir Charitable Foundation and by EC FP6 funding. Partial funding was provided by the Center for Women's Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers JC, 2001, AM J PATHOL, V158, P399, DOI 10.1016/S0002-9440(10)63983-1; Barks JH, 1997, GENE CHROMOSOME CANC, V19, P278, DOI 10.1002/(SICI)1098-2264(199708)19:4<278::AID-GCC11>3.3.CO;2-9; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Brookman-Amissah N, 2005, PROSTATE CANCER P D, V8, P335, DOI 10.1038/sj.pcan.4500826; Buganim Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009657; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duesberg P, 2005, SCIENCE, V307, P41; Duesberg P, 2004, IUBMB LIFE, V56, P65, DOI 10.1080/15216540410001667902; Fauth C, 2004, GENE CHROMOSOME CANC, V40, P298, DOI 10.1002/gcc.20051; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hertzberg L, 2007, GENE CHROMOSOME CANC, V46, P75, DOI 10.1002/gcc.20391; Hodgson JG, 2003, BREAST CANCER RES TR, V78, P337, DOI 10.1023/A:1023085825042; Huret JL, 2003, NUCLEIC ACIDS RES, V31, P272, DOI 10.1093/nar/gkg126; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishiguro R, 2003, ANTICANCER RES, V23, P5213; Jarrard DF, 1999, CANCER RES, V59, P2957; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karhu R, 2006, GENE CHROMOSOME CANC, V45, P721, DOI 10.1002/gcc.20337; Kimura Y, 2004, MODERN PATHOL, V17, P1328, DOI 10.1038/modpathol.3800180; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; KOGANSAKIN I, 2010, CELL DEATH DIFFER; Korn WM, 1999, GENE CHROMOSOME CANC, V25, P82, DOI 10.1002/(SICI)1098-2264(199906)25:2<82::AID-GCC2>3.0.CO;2-6; Kyomoto R, 1997, INT J CANCER, V74, P576, DOI 10.1002/(SICI)1097-0215(19971219)74:6<576::AID-IJC3>3.0.CO;2-R; Lai LA, 2007, GENE CHROMOSOME CANC, V46, P532, DOI 10.1002/gcc.20435; Lengauer C, 2004, NAT GENET, V36, P1144, DOI 10.1038/ng1104-1144; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Marx J, 2002, SCIENCE, V297, P544, DOI 10.1126/science.297.5581.544; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Milyavsky M, 2005, CANCER RES, V65, P4530, DOI 10.1158/0008-5472.CAN-04-3880; Milyavsky M, 2003, CANCER RES, V63, P7147; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Nakopoulou L, 2002, CANCER GENET CYTOGEN, V134, P127, DOI 10.1016/S0165-4608(01)00614-8; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Palmberg C, 2000, J UROLOGY, V164, P1992, DOI 10.1016/S0022-5347(05)66935-2; Postma C, 2007, CELL ONCOL, V29, P73; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tabach Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000807; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Tsafrir D, 2005, BIOINFORMATICS, V21, P2301, DOI 10.1093/bioinformatics/bti329; van Dekken H, 2004, GENE CHROMOSOME CANC, V39, P249, DOI 10.1002/gcc.20001; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wullich B, 2004, CANCER GENET CYTOGEN, V154, P119, DOI 10.1016/j.cancergencyto.2004.01.005	56	61	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14632	10.1371/journal.pone.0014632	http://dx.doi.org/10.1371/journal.pone.0014632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297939	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300014
J	Smits, M; Mir, SE; Nilsson, RJA; van der Stoop, PM; Niers, JM; Marquez, VE; Cloos, J; Breakefield, XO; Krichevsky, AM; Noske, DP; Tannous, BA; Wurdinger, T				Smits, Michiel; Mir, Shahryar E.; Nilsson, R. Jonas A.; van der Stoop, Petra M.; Niers, Johanna M.; Marquez, Victor E.; Cloos, Jacqueline; Breakefield, Xandra O.; Krichevsky, Anna M.; Noske, David P.; Tannous, Bakhos A.; Wuerdinger, Thomas			Down-Regulation of miR-101 in Endothelial Cells Promotes Blood Vessel Formation through Reduced Repression of EZH2	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; GROUP PROTEIN EZH2; GENE-EXPRESSION; TUMOR-GROWTH; ANGIOGENESIS; CANCER; MICRORNAS; COMPLEX; OVEREXPRESSION	Angiogenesis is a balanced process controlled by pro-and anti-angiogenic molecules of which the regulation is not fully understood. Besides classical gene regulation, miRNAs have emerged as post-transcriptional regulators of angiogenesis. Furthermore, epigenetic changes caused by histone-modifying enzymes were shown to modulate angiogenesis as well. However, a possible interplay between miRNAs and histone-modulating enzymes during angiogenesis has not been described. Here we show that VEGF-mediated down-regulation of miR-101 caused pro-angiogenic effects. We found that the pro-angiogenic effects are partly mediated through reduced repression by miR-101 of the histone-methyltransferase EZH2, a member of the Polycomb group family, thereby increasing methylation of histone H3 at lysine 27 and transcriptome alterations. In vitro, the sprouting and migratory properties of primary endothelial cell cultures were reduced by inhibiting EZH2 through up-regulation of miR-101, siRNA-mediated knockdown of EZH2, or treatment with 3-Deazaneplanocin-A (DZNep), a small molecule inhibitor of EZH2 methyltransferase activity. In addition, we found that systemic DZNep administration reduced the number of blood vessels in a subcutaneous glioblastoma mouse model, without showing adverse toxicities. Altogether, by identifying a pro-angiogenic VEGF/miR-101/EZH2 axis in endothelial cells we provide evidence for a functional link between growth factor-mediated signaling, post-transcriptional silencing, and histone-methylation in the angiogenesis process. Inhibition of EZH2 may prove therapeutic in diseases in which aberrant vascularization plays a role.	[Smits, Michiel; Mir, Shahryar E.; Nilsson, R. Jonas A.; van der Stoop, Petra M.; Niers, Johanna M.; Cloos, Jacqueline; Noske, David P.; Wuerdinger, Thomas] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Neurooncol Res Grp,Dept Neurosurg, Amsterdam, Netherlands; [Smits, Michiel; Mir, Shahryar E.; Nilsson, R. Jonas A.; van der Stoop, Petra M.; Niers, Johanna M.; Cloos, Jacqueline; Noske, David P.; Wuerdinger, Thomas] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Neurooncol Res Grp,Dept Pediat Oncol Hematol, Amsterdam, Netherlands; [Niers, Johanna M.; Breakefield, Xandra O.; Tannous, Bakhos A.; Wuerdinger, Thomas] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Mol Neurogenet Unit, Boston, MA USA; [Niers, Johanna M.; Breakefield, Xandra O.; Tannous, Bakhos A.; Wuerdinger, Thomas] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol,Mol Neurogenet Unit, Boston, MA USA; [Niers, Johanna M.; Breakefield, Xandra O.; Tannous, Bakhos A.; Wuerdinger, Thomas] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Marquez, Victor E.] NCI, Ctr Canc Res, Frederick, MD 21701 USA; [Krichevsky, Anna M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Smits, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Neurooncol Res Grp,Dept Neurosurg, Amsterdam, Netherlands.	t.wurdinger@vumc.nl	Wurdinger, Thomas/AAA-5645-2022; Nilsson, Jonas/AAS-7101-2020; Marquez, Victor/AAP-3549-2021	Nilsson, Jonas/0000-0002-1933-1104; Cloos, Jacqueline/0000-0001-9150-8026; Noske, David/0000-0001-5992-4468; Krichevsky, Anna/0000-0002-5080-5507	Dutch Cancer Society/KWF; Lions Cancer Research Foundation; Umea University, Sweden; Stichting Translational Research CCA/VU University Medical Center; Swedish Research Counsil; National Cancer Institute (NCI) [CA069246, CA86355]; American Brain Tumor Association; NATIONAL CANCER INSTITUTE [P50CA086355, P01CA069246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064983] Funding Source: NIH RePORTER	Dutch Cancer Society/KWF(KWF Kankerbestrijding); Lions Cancer Research Foundation; Umea University, Sweden; Stichting Translational Research CCA/VU University Medical Center; Swedish Research Counsil; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Brain Tumor Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Dutch Cancer Society/KWF (S. E. M.), Lions Cancer Research Foundation, Umea University, Sweden; Stichting Translational Research CCA/VU University Medical Center; Swedish Research Counsil (R.J.A.N.), National Cancer Institute (NCI) CA069246 and CA86355 (X.O.B.), and the American Brain Tumor Association (T. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Burdach S, 2009, CELL CYCLE, V8, P1991, DOI 10.4161/cc.8.13.8929; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Croonquist PA, 2005, ONCOGENE, V24, P6269, DOI 10.1038/sj.onc.1208771; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Heusschen R, 2010, BBA-REV CANCER, V1805, P87, DOI 10.1016/j.bbcan.2009.09.005; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Khodarev NN, 2003, J CELL SCI, V116, P1013, DOI 10.1242/jcs.00281; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Lu CH, 2007, CANCER RES, V67, P1757, DOI 10.1158/0008-5472.CAN-06-3700; Miebach S, 2006, J NEURO-ONCOL, V76, P39, DOI 10.1007/s11060-005-3674-6; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Raaphorst FM, 2003, NEOPLASIA, V5, P481, DOI 10.1016/S1476-5586(03)80032-5; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Rossig L, 2002, CIRC RES, V91, P837, DOI 10.1161/01.RES.0000037983.07158.B1; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Urbich C, 2009, BLOOD, V113, P5669, DOI 10.1182/blood-2009-01-196485; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Wurdinger T, 2009, CELL ADHES MIGR, V3, P230, DOI 10.4161/cam.3.2.7910; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177	50	79	83	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16282	10.1371/journal.pone.0016282	http://dx.doi.org/10.1371/journal.pone.0016282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297974	Green Published, Green Submitted, gold			2022-12-25	WOS:000286664100018
J	Castillo-Olivares, J; Calvo-Pinilla, E; Casanova, I; Bachanek-Bankowska, K; Chiam, R; Maan, S; Nieto, JM; Ortego, J; Mertens, PPC				Castillo-Olivares, Javier; Calvo-Pinilla, Eva; Casanova, Isabel; Bachanek-Bankowska, Katarzyna; Chiam, Rachael; Maan, Sushila; Maria Nieto, Jose; Ortego, Javier; Mertens, Peter Paul Clement			A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR -/- Mouse Model	PLOS ONE			English	Article							BLUETONGUE-VIRUS; HORSESICKNESS AHS; IMMUNIZATION; LETHAL; MICE	African horse sickness (AHS) is a lethal viral disease of equids, which is transmitted by Culicoides midges that become infected after biting a viraemic host. The use of live attenuated vaccines has been vital for the control of this disease in endemic regions. However, there are safety concerns over their use in non-endemic countries. Research efforts over the last two decades have therefore focused on developing alternative vaccines based on recombinant baculovirus or live viral vectors expressing structural components of the AHS virion. However, ethical and financial considerations, relating to the use of infected horses in high biosecurity installations, have made progress very slow. We have therefore assessed the potential of an experimental mouse-model for AHSV infection for vaccine and immunology research. We initially characterised AHSV infection in this model, then tested the protective efficacy of a recombinant vaccine based on modified vaccinia Ankara expressing AHS-4 VP2 (MVA-VP2).	[Castillo-Olivares, Javier; Bachanek-Bankowska, Katarzyna; Maan, Sushila; Mertens, Peter Paul Clement] Inst Anim Hlth, Surrey, England; [Calvo-Pinilla, Eva; Casanova, Isabel; Maria Nieto, Jose; Ortego, Javier] CISA, Madrid, Spain; [Chiam, Rachael] Wellcome Trust Sanger Inst, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Wellcome Trust Sanger Institute	Castillo-Olivares, J (corresponding author), Inst Anim Hlth, Surrey, England.	javier.castillo-olivares@bbsrc.ac.uk	ortego, javier/K-6020-2014; Castillo-Olivares, Javier/L-5337-2014; Ortego, Javier/M-6810-2019; CALVO-PINILLA, EVA/L-5348-2014; Castillo-Olivares, Javier/AAA-8837-2019; Castillo-Olivares, Javier/AAA-7603-2019	ortego, javier/0000-0002-4275-7277; Castillo-Olivares, Javier/0000-0003-3453-8557; Ortego, Javier/0000-0002-4275-7277; CALVO-PINILLA, EVA/0000-0002-4667-4081; Castillo-Olivares, Javier/0000-0003-3453-8557; Mertens, Peter/0000-0002-3438-3738	BBSRC; Department for the Environment Food and Rural Affairs (DEFRA) [SE4109]; EPIZONE; Biotechnology and Biological Sciences Research Council [BBS/B/00654] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for the Environment Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); EPIZONE; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the BBSRC (IAH-ISPG grant) and the Department for the Environment Food and Rural Affairs (DEFRA), grant number: SE4109. Additional funds were obtained from EPIZONE through their short-term mission project programme. Kasia Bankowska is recipient of a BBSRC funded doctoral Training Award (DTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batten CA, 2008, VIRUS RES, V137, P56, DOI 10.1016/j.virusres.2008.05.016; BURRAGE TG, 1993, VIROLOGY, V196, P799, DOI 10.1006/viro.1993.1537; Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027; Calvo-Pinilla E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005171; Chiam R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005997; Coetzer J. A. W., 2004, Infectious diseases of livestock. Volume Two, P1231; Guthrie AJ, 2009, VACCINE, V27, P4434, DOI 10.1016/j.vaccine.2009.05.044; HOUSE C, 1992, ANN NY ACAD SCI, V653, P228, DOI 10.1111/j.1749-6632.1992.tb19651.x; Howell P. G., 1960, Journal of the South African Veterinary Medical Association, V31, P329; JAMESON P, 1978, INFECT IMMUN, V20, P321, DOI 10.1128/IAI.20.1.321-323.1978; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; Martinez-Torrecuadrada JL, 1999, VIROLOGY, V257, P449, DOI 10.1006/viro.1999.9680; MartinezTorrecuadrada JL, 1996, J GEN VIROL, V77, P1211, DOI 10.1099/0022-1317-77-6-1211; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; MONTILLA RD, 1967, B OFF INT EPIZOOT, V68, P705; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; O'Hara RS, 1998, ARCH VIROL, P259; Rafyi A., 1961, Bulletin de l'Office International des Epizooties, V56, P216; RANZ AI, 1992, VET MICROBIOL, V33, P143, DOI 10.1016/0378-1135(92)90042-R; RODRIGUEZ M, 1992, VET MICROBIOL, V33, P129, DOI 10.1016/0378-1135(92)90041-Q; Roy P, 1998, ARCH VIROL, P177; Roy P, 1996, J GEN VIROL, V77, P2053, DOI 10.1099/0022-1317-77-9-2053; ROY P, 1994, COMP IMMUNOL MICROB, V17, P243, DOI 10.1016/0147-9571(94)90046-9; Scanlen M, 2002, VACCINE, V20, P1079, DOI 10.1016/S0264-410X(01)00445-5; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; StoneMarschat MA, 1996, VIROLOGY, V220, P219, DOI 10.1006/viro.1996.0304; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; VANDIJK AA, 1998, AFRICAN HORSE SICKNE; von Teichman BF, 2008, VACCINE, V26, P5014, DOI 10.1016/j.vaccine.2008.07.037; WadeEvans AM, 1997, J GEN VIROL, V78, P1611, DOI 10.1099/0022-1317-78-7-1611; ZINKERNAGEL RM, 1993, IMMUNOL REV, V133, P199, DOI 10.1111/j.1600-065X.1993.tb01517.x	31	49	49	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16503	10.1371/journal.pone.0016503	http://dx.doi.org/10.1371/journal.pone.0016503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298069	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800050
J	Mckay, SL; Johnson, TL				McKay, Susannah L.; Johnson, Tracy L.			An Investigation of a Role for U2 snRNP Spliceosomal Components in Regulating Transcription	PLOS ONE			English	Article							RNA-POLYMERASE-II; CYCLIN-DEPENDENT KINASE; C-TERMINAL DOMAIN; SMALL NUCLEAR-RNA; SACCHAROMYCES-CEREVISIAE; IN-VIVO; P-TEFB; ELONGATION-FACTOR; HIV-1 TAT; CTDK-I	There is mounting evidence to suggest that the synthesis of pre-mRNA transcripts and their subsequent splicing are coordinated events. Previous studies have implicated the mammalian spliceosomal U2 snRNP as having a novel role in stimulating transcriptional elongation in vitro through interactions with the elongation factors P-TEFb and Tat-SF1; however, the mechanism remains unknown [1]. These factors are conserved in Saccharomyces cerevisiae, a fact that suggests that a similar interaction may occur in yeast to stimulate transcriptional elongation in vivo. To address this possibility we have looked for evidence of a role for the yeast Tat-SF1 homolog, Cus2, and the U2 snRNA in regulating transcription. Specifically, we have performed a genetic analysis to look for functional interactions between Cus2 or U2 snRNA and the P-TEFb yeast homologs, the Bur1/2 and Ctk1/2/3 complexes. In addition, we have analyzed Cus2-deleted or -overexpressing cells and U2 snRNA mutant cells to determine if they show transcription-related phenotypes similar to those displayed by the P-TEFb homolog mutants. In no case have we been able to observe phenotypes consistent with a role for either spliceosomal factor in transcription elongation. Furthermore, we did not find evidence for physical interactions between the yeast U2 snRNP factors and the P-TEFb homologs. These results suggest that in vivo, S. cerevisiae do not exhibit functional or physical interactions similar to those exhibited by their mammalian counterparts in vitro. The significance of the difference between our in vivo findings and the previously published in vitro results remains unclear; however, we discuss the potential importance of other factors, including viral proteins, in mediating the mammalian interactions.	[McKay, Susannah L.; Johnson, Tracy L.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Mckay, SL (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	johnsont@ucsd.edu			NSF [MCB-0448010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085474] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NSF CAREER award to T.L.J. (MCB-0448010) and an NSF predoctoral fellowship to S.L.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Conrad NK, 2000, GENETICS, V154, P557; Corden JL, 1997, TRENDS BIOCHEM SCI, V22, P413, DOI 10.1016/S0968-0004(97)01125-0; Costa PJ, 2000, GENETICS, V156, P535; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Doonan JH, 2009, MOL BIOTECHNOL, V42, P14, DOI 10.1007/s12033-008-9126-8; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500; Ganem C, 2006, MOL GENET GENOMICS, V275, P136, DOI 10.1007/s00438-005-0071-y; Ge H, 1998, MOL CELL, V2, P751, DOI 10.1016/S1097-2765(00)80290-7; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Hautbergue G, 2001, J BIOL CHEM, V276, P8005, DOI 10.1074/jbc.M010162200; Hilliker AK, 2007, GENE DEV, V21, P821, DOI 10.1101/gad.1536107; Hirose Y, 1999, GENE DEV, V13, P1234, DOI 10.1101/gad.13.10.1234; IGEL AH, 1988, NATURE, V334, P450, DOI 10.1038/334450a0; Igel H, 1998, RNA, V4, P1; Jablonski JA, 2010, NUCLEIC ACIDS RES, V38, P1249, DOI 10.1093/nar/gkp1105; Jona G, 2001, GENE, V267, P31, DOI 10.1016/S0378-1119(01)00389-4; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Kim D, 2003, GENES CELLS, V8, P371, DOI 10.1046/j.1365-2443.2003.00638.x; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Lenasi T, 2010, RNA BIOL, V7, P145, DOI 10.4161/rna.7.2.11057; Li XY, 1998, GENE DEV, V12, P2992, DOI 10.1101/gad.12.19.2992; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Lindstrom DL, 2001, GENETICS, V159, P487; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; MALONE EA, 1993, MOL GEN GENET, V237, P449, DOI 10.1007/BF00279450; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Miller HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005710; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Murray S, 2001, MOL CELL BIOL, V21, P4089, DOI 10.1128/MCB.21.13.4089-4096.2001; Naito T, 2007, P NATL ACAD SCI USA, V104, P18235, DOI 10.1073/pnas.0705856104; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Patturajan M, 1999, J BIOL CHEM, V274, P27823, DOI 10.1074/jbc.274.39.27823; Perriman R, 2003, P NATL ACAD SCI USA, V100, P13857, DOI 10.1073/pnas.2036312100; Perriman R, 2010, MOL CELL, V38, P416, DOI 10.1016/j.molcel.2010.02.036; Perriman RJ, 2007, GENE DEV, V21, P811, DOI 10.1101/gad.1524307; PRELICH G, 1993, GENETICS, V135, P665; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Riles L, 2004, YEAST, V21, P241, DOI 10.1002/yea.1068; Selth LA, 2009, COLD SPRING HARB PRO; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; STERNER DE, 1995, MOL CELL BIOL, V15, P5716; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Wells SE, 1996, GENE DEV, V10, P220, DOI 10.1101/gad.10.2.220; Wilcox CB, 2004, GENETICS, V167, P93, DOI 10.1534/genetics.167.1.93; WINSTON F, 1984, GENETICS, V107, P179; Wood A, 2007, MOL CELL BIOL, V27, P709, DOI 10.1128/MCB.01627-06; Wood A, 2006, CELL CYCLE, V5, P1066, DOI 10.4161/cc.5.10.2769; XIAO B, 2001, MOL CELL BIOL, V27, P721; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; Yao S, 2000, MOL CELL BIOL, V20, P7080, DOI 10.1128/MCB.20.19.7080-7087.2000; Yao S, 2002, MOL CELL BIOL, V22, P6750, DOI 10.1128/MCB.22.19.6750-6758.2002; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; ZAVANELLI MI, 1994, MOL CELL BIOL, V14, P1689, DOI 10.1128/MCB.14.3.1689; ZAVANELLI MI, 1991, GENE DEV, V5, P2521, DOI 10.1101/gad.5.12b.2521; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	72	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16077	10.1371/journal.pone.0016077	http://dx.doi.org/10.1371/journal.pone.0016077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283673	Green Submitted, gold, Green Published			2022-12-25	WOS:000286523400014
J	Kalghatgi, S; Kelly, CM; Cerchar, E; Torabi, B; Alekseev, O; Fridman, A; Friedman, G; Azizkhan-Clifford, J				Kalghatgi, Sameer; Kelly, Crystal M.; Cerchar, Ekaterina; Torabi, Behzad; Alekseev, Oleg; Fridman, Alexander; Friedman, Gary; Azizkhan-Clifford, Jane			Effects of Non-Thermal Plasma on Mammalian Cells	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; DNA-DAMAGE; BLOOD-COAGULATION; HISTONE H2AX; STERILIZATION; INACTIVATION; APOPTOSIS; BACTERIA; PHOSPHORYLATION; RADIATION	Thermal plasmas and lasers have been widely used in medicine to cut, ablate and cauterize tissues through heating; in contrast, non-thermal plasma produces no heat, so its effects can be selective. In order to exploit the potential for clinical applications, including wound healing, sterilization, blood coagulation, and cancer treatment, a mechanistic understanding of the interaction of non-thermal plasma with living tissues is required. Using mammalian cells in culture, it is shown here that non-thermal plasma created by dielectric barrier discharge (DBD) has dose-dependent effects that range from increasing cell proliferation to inducing apoptosis. It is also shown that these effects are primarily due to formation of intracellular reactive oxygen species (ROS). We have utilized gamma-H2AX to detect DNA damage induced by non-thermal plasma and found that it is initiated by production of active neutral species that most likely induce formation of organic peroxides in cell medium. Phosphorylation of H2AX following non-thermal plasma treatment is ATR dependent and ATM independent, suggesting that plasma treatment may lead to replication arrest or formation of single-stranded DNA breaks; however, plasma does not lead to formation of bulky adducts/thymine dimers.	[Kalghatgi, Sameer; Friedman, Gary] Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA; [Kelly, Crystal M.; Torabi, Behzad; Alekseev, Oleg; Azizkhan-Clifford, Jane] Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19104 USA; [Cerchar, Ekaterina] Drexel Univ, Dept Surg, Coll Med, Philadelphia, PA 19104 USA; [Fridman, Alexander] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Drexel University; Drexel University	Azizkhan-Clifford, J (corresponding author), Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA.	jc19072@gmail.com			Drexel University Major Research Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013011] Funding Source: NIH RePORTER	Drexel University Major Research Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Drexel University Major Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Ayan H, 2009, IEEE T PLASMA SCI, V37, P113, DOI 10.1109/TPS.2008.2006899; Coulombe S, 2006, PURE APPL CHEM, V78, P1147, DOI 10.1351/pac200678061147; D Bomgarden R, 2006, EMBO J, V25, P2605, DOI 10.1038/sj.emboj.7601123; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; ELIASSON B, 1994, PURE APPL CHEM, V66, pU1766; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Fitch ME, 2003, CARCINOGENESIS, V24, P843, DOI 10.1093/carcin/bgg031; Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01; FRIDMAN A, 2008, PLASMA BIOL PLASMA M; FRIDMAN A, 2008, PLASMA CHEM, P848; FRIDMAN A, 2008, PLASMA CHEM; FRIDMAN A, 2004, PLASMA PHYS ENG, P853; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; GEBICKI S, 1993, BIOCHEM J, V289, P743, DOI 10.1042/bj2890743; Goree J, 2006, IEEE T PLASMA SCI, V34, P1317, DOI 10.1109/TPS.2006.878431; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jiang C, 2008, IEEE INT POWER MODUL, P77, DOI 10.1109/IPMC.2008.4743581; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kalghatgi SU, 2007, IEEE T PLASMA SCI, V35, P1559, DOI 10.1109/TPS.2007.905953; Kieft IE, 2005, IEEE T PLASMA SCI, V33, P771, DOI 10.1109/TPS.2005.844528; Kieft IE, 2006, IEEE T PLASMA SCI, V34, P1331, DOI 10.1109/TPS.2006.876511; KOGELSCHATZ U, 2004, NONEQUILIBRIUM AIR P; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Laroussi M, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/341; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Laroussi M, 2000, IEEE T PLASMA SCI, V28, P184, DOI 10.1109/27.842899; Laroussi M, 2006, PLASMA PROCESS POLYM, V3, P470, DOI 10.1002/ppap.200600005; Leduc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115021; Lehnert BE, 2002, HUM EXP TOXICOL, V21, P65, DOI 10.1191/0960327102ht212oa; Lu XP, 2009, IEEE T PLASMA SCI, V37, P668, DOI 10.1109/TPS.2009.2015454; MAJNO G, 1995, AM J PATHOL, V146, P3; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Olofsson BA, 2007, MOL CANCER RES, V5, P1319, DOI 10.1158/1541-7786.MCR-07-0374; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shekhter AB, 2005, NITRIC OXIDE-BIOL CH, V12, P210, DOI 10.1016/j.niox.2005.03.004; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Siemens C. W., 1862, J FRANKLIN I, V74, P166, DOI DOI 10.1016/0016-0032(62)90468-4; Sladek REJ, 2005, J PHYS D APPL PHYS, V38, P1716, DOI 10.1088/0022-3727/38/11/012; Sladek REJ, 2004, IEEE T PLASMA SCI, V32, P1540, DOI 10.1109/TPS.2004.832636; STOFFELS E, 2008, ADV PLASMA TECHNOLOG, P301; Stoffels E, 2006, J PHYS D APPL PHYS, V39, DOI 10.1088/0022-3727/39/16/E01; Vargo JJ, 2004, GASTROINTEST ENDOSC, V59, P81, DOI 10.1016/S0016-5107(03)02296-X; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Weng CC, 2009, INT J RADIAT BIOL, V85, P362, DOI 10.1080/09553000902781105	49	379	394	6	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16270	10.1371/journal.pone.0016270	http://dx.doi.org/10.1371/journal.pone.0016270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283714	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522300026
J	Cao, HB; Wu, J; Lam, S; Duan, RQ; Newnham, C; Molday, RS; Graziotto, JJ; Pierce, EA; Hu, J				Cao, Huibi; Wu, Jing; Lam, Simon; Duan, Rongqi; Newnham, Catherine; Molday, Robert S.; Graziotto, John J.; Pierce, Eric A.; Hu, Jim			Temporal and Tissue Specific Regulation of RP-Associated Splicing Factor Genes PRPF3, PRPF31 and PRPC8-Implications in the Pathogenesis of RP	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; MESSENGER-RNA; DISEASE MECHANISM; EPITHELIAL-CELLS; SNRNP; MUTATIONS; PROTEIN; EXPRESSION; COMPLEX; HPRP3P	Background: Genetic mutations in several ubiquitously expressed RNA splicing genes such as PRPF3, PRP31 and PRPC8, have been found to cause retina-specific diseases in humans. To understand this intriguing phenomenon, most studies have been focused on testing two major hypotheses. One hypothesis assumes that these mutations interrupt retina-specific interactions that are important for RNA splicing, implying that there are specific components in the retina interacting with these splicing factors. The second hypothesis suggests that these mutations have only a mild effect on the protein function and thus affect only the metabolically highly active cells such as retinal photoreceptors. Methodology/Principal Findings: We examined the second hypothesis using the PRPF3 gene as an example. We analyzed the spatial and temporal expression of the PRPF3 gene in mice and found that it is highly expressed in retinal cells relative to other tissues and its expression is developmentally regulated. In addition, we also found that PRP31 and PRPC8 as well as snRNAs are highly expressed in retinal cells. Conclusions/Significance: Our data suggest that the retina requires a relatively high level of RNA splicing activity for optimal tissue-specific physiological function. Because the RP18 mutation has neither a debilitating nor acute effect on protein function, we suggest that retinal degeneration is the accumulative effect of decades of suboptimal RNA splicing due to the mildly impaired protein.	[Cao, Huibi; Wu, Jing; Lam, Simon; Duan, Rongqi; Newnham, Catherine; Hu, Jim] Univ Toronto, Physiol & Expt Med Program, Toronto, ON, Canada; [Hu, Jim] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hu, Jim] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Graziotto, John J.; Pierce, Eric A.] Univ Penn, Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA	University of Toronto; University of Toronto; University of Toronto; University of British Columbia; University of Pennsylvania; Pennsylvania Medicine	Cao, HB (corresponding author), Univ Toronto, Physiol & Expt Med Program, Toronto, ON, Canada.	jim.hu@utoronto.ca		Hu, Jim/0000-0001-9134-7103; Pierce, Eric/0000-0002-2354-4102	Canadian Institutes of Health Research [MOP-77750, CIHR RMF-92101]; Canadian Cystic Fibrosis Foundation; Foundation Fighting Blindness-Canada; NATIONAL EYE INSTITUTE [R01EY020902] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation; Foundation Fighting Blindness-Canada; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was partially supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (funding reference numbers MOP-77750, CIHR RMF-92101), the Canadian Cystic Fibrosis Foundation (http://www.cysticfibrosis.ca/en/index.php) (grants to JH) and Foundation Fighting Blindness-Canada (http://www.ffb.ca/research_ffb-funded.php?hc = 1) (grant to JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon KL, 2007, NAT STRUCT MOL BIOL, V14, P1077, DOI 10.1038/nsmb1303; BOUGHMAN JA, 1983, BRIT J OPHTHALMOL, V67, P449, DOI 10.1136/bjo.67.7.449; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P3754, DOI 10.1167/iovs.06-0207; Bujakowska K, 2009, INVEST OPHTH VIS SCI, V50, P5927, DOI 10.1167/iovs.08-3275; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; Deery EC, 2002, HUM MOL GENET, V11, P3209, DOI 10.1093/hmg/11.25.3209; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Gonzalez-Santos JM, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni093; Gonzalez-Santos JM, 2002, J BIOL CHEM, V277, P23764, DOI 10.1074/jbc.M111461200; Gonzalez-Santos JM, 2008, HUM MOL GENET, V17, P225, DOI 10.1093/hmg/ddm300; GRAZIOTTO JJ, 2006, INVEST OPHTHALMOL VI, V47; GRAZIOTTO JJ, 2010, INVEST OPHTHALMOL VI; Graziotto JJ, 2008, INVEST OPHTH VIS SCI, V49, P3830, DOI 10.1167/iovs.07-1483; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hong WJ, 1997, NUCLEIC ACIDS RES, V25, P354, DOI 10.1093/nar/25.2.354; Horowitz DS, 1997, RNA, V3, P1374; Jin ZB, 2007, AM J MED GENET A, V143A, P2544, DOI 10.1002/ajmg.a.31984; Lauber J, 1997, RNA, V3, P926; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Little JT, 2008, J BIOL CHEM, V283, P8145, DOI 10.1074/jbc.M707984200; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P1096; Maita H, 2005, EXP CELL RES, V302, P61, DOI 10.1016/j.yexcr.2004.08.022; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Medenbach J, 2004, MOL CELL BIOL, V24, P7392, DOI 10.1128/MCB.24.17.7392-7401.2004; Mordes D, 2006, MOL VIS, V12, P1259; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Rivolta C, 2006, HUM MUTAT, V27, P644, DOI 10.1002/humu.20325; Schmidt-Kastner R, 2008, MOL VIS, V14, P125; STEINBERG RH, 1987, INVEST OPHTH VIS SCI, V28, P1888; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; Valadkhan S, 2005, CURR OPIN CHEM BIOL, V9, P603, DOI 10.1016/j.cbpa.2005.10.008; Vithana EN, 2003, INVEST OPHTH VIS SCI, V44, pU333; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Wang A, 1997, HUM MOL GENET, V6, P2117, DOI 10.1093/hmg/6.12.2117; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wilkie SE, 2008, MOL VIS, V14, P683; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57	44	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15860	10.1371/journal.pone.0015860	http://dx.doi.org/10.1371/journal.pone.0015860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283520	gold, Green Published, Green Submitted			2022-12-25	WOS:000286520600015
J	Cheng, YA; McNamara, DE; Miley, MJ; Nash, RP; Redinbo, MR				Cheng, Yuan; McNamara, Dan E.; Miley, Michael J.; Nash, Rebekah P.; Redinbo, Matthew R.			Functional Characterization of the Multidomain F Plasmid TraI Relaxase-Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; DIMENSIONAL HOMOGENEOUS LATTICE; NUCLEIC-ACID INTERACTIONS; RAY SOLUTION SCATTERING; ESCHERICHIA-COLI; LARGE LIGANDS; BIOLOGICAL MACROMOLECULES; COOPERATIVE BINDING; PROTEIN HEXAMER; PRIA PROTEIN	TraI, a bifunctional enzyme containing relaxase and helicase activities, initiates and drives the conjugative transfer of the Escherichia coli F plasmid. Here, we examined the structure and function of the TraI helicase. We show that TraI binds to single-stranded DNA (ssDNA) with a site size of similar to 25 nucleotides, which is significantly longer than the site size of other known superfamily I helicases. Low cooperativity was observed with the binding of TraI to ssDNA, and a double-stranded DNA-binding site was identified within the N-terminal region of TraI 1-858, outside the core helicase motifs of TraI. We have revealed that the affinity of TraI for DNA is negatively correlated with the ionic strength of the solution. The binding of AMPPNP or ADP results in a 3-fold increase in the affinity of TraI for ssDNA. Moreover, TraI prefers to bind ssDNA oligomers containing a single type of base. Finally, we elucidated the solution structure of TraI using small angle x-ray scattering. TraI exhibits an ellipsoidal shape in solution with four domains aligning along one axis. Taken together, these data result in the assembly of a model for the multidomain helicase activity of TraI.	[McNamara, Dan E.; Miley, Michael J.; Nash, Rebekah P.; Redinbo, Matthew R.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Cheng, Yuan; Redinbo, Matthew R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Cheng, Yuan; Redinbo, Matthew R.] Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC 27599 USA; [Redinbo, Matthew R.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Redinbo, MR (corresponding author), Univ N Carolina, Dept Chem, Campus Box 3290, Chapel Hill, NC 27599 USA.	redinbo@unc.edu	, PEP-MX Core/AGV-4051-2022	McNamara, Dan/0000-0003-0600-7847	National Institutes of Health [AI78924, P41 RR001081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES016488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI78924.; We thank Dr. Liang Guo at beamline 18-ID (Bio-CAT), Advanced Photon Source, Argonne, IL, for assistance in data collection, analysis, and manuscript preparation. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081).	ABDELMONEM M, 1983, P NATL ACAD SCI-BIOL, V80, P4659, DOI 10.1073/pnas.80.15.4659; ABDELMONEM M, 1976, EUR J BIOCHEM, V65, P431, DOI 10.1111/j.1432-1033.1976.tb10358.x; Anderson BJ, 2008, METHOD ENZYMOL, V450, P253, DOI 10.1016/S0076-6879(08)03412-5; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; BUJALOWSKI W, 1989, BIOPOLYMERS, V28, P1637, DOI 10.1002/bip.360280912; BUJALOWSKI W, 1987, J MOL BIOL, V195, P897, DOI 10.1016/0022-2836(87)90493-1; Byrd DR, 2002, J BIOL CHEM, V277, P42645, DOI 10.1074/jbc.M205984200; COMISRUTH FX, 2006, CURR OPIN STRUC BIOL, V16, P744; Csitkovits VC, 2003, J BIOL CHEM, V278, P48696, DOI 10.1074/jbc.M310025200; Datta K, 2003, J BIOL CHEM, V278, P5694, DOI 10.1074/jbc.M208133200; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; DOSTAL L, 2010, NUCL ACIDS RES; Dostal L, 2010, J BACTERIOL, V192, P3620, DOI 10.1128/JB.00154-10; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; EPSTEIN IR, 1978, BIOPHYS CHEM, V8, P327, DOI 10.1016/0301-4622(78)80015-5; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Gourves AS, 2000, J BIOL CHEM, V275, P10864, DOI 10.1074/jbc.275.15.10864; HOWARD MT, 1995, J BIOL CHEM, V270, P28381; Jezewska MJ, 1996, J BIOL CHEM, V271, P4261; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2117, DOI 10.1021/bi952344l; Jezewska MJ, 2004, J MOL BIOL, V343, P115, DOI 10.1016/j.jmb.2004.08.021; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; Jezewska MJ, 2000, J BIOL CHEM, V275, P27865; Jezewska MJ, 2000, BIOCHEMISTRY-US, V39, P10454, DOI 10.1021/bi001113y; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KORANGY F, 1993, BIOCHEMISTRY-US, V32, P4873, DOI 10.1021/bi00069a024; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; KUHN B, 1979, J BIOL CHEM, V254, P1343; LAHUE EE, 1988, J BIOL CHEM, V263, P3208; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MATSON SW, 1991, J BIOL CHEM, V266, P16232; Matson SW, 2005, J BACTERIOL, V187, P697, DOI 10.1128/JB.187.2.697-706.2005; Matson SW, 2001, J BIOL CHEM, V276, P2372, DOI 10.1074/jbc.M008728200; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Myong S, 2010, CURR OPIN STRUC BIOL, V20, P121, DOI 10.1016/j.sbi.2009.12.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ragonese H, 2007, MOL MICROBIOL, V63, P1173, DOI 10.1111/j.1365-2958.2006.05576.x; Saikrishnan K, 2008, EMBO J, V27, P2222, DOI 10.1038/emboj.2008.144; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Sikora B, 2006, J BIOL CHEM, V281, P36110, DOI 10.1074/jbc.M604412200; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Street LM, 2003, BBA-PROTEINS PROTEOM, V1646, P86, DOI 10.1016/S1570-9639(02)00553-8; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TRAXLER BA, 1988, J MOL BIOL, V204, P205, DOI 10.1016/0022-2836(88)90609-2; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JL, 2004, J BIOL CHEM, V279, P52024, DOI 10.1074/jbc.M408645200; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869	54	13	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.207563	http://dx.doi.org/10.1074/jbc.M110.207563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288910	Green Published, hybrid			2022-12-25	WOS:000289077500078
J	Jama, AM; Gabriel, J; Al-Nagar, AJ; Martin, S; Baig, SZ; Soleymani, H; Chowdhury, Z; Beesley, P; Torok, K				Jama, Abdirahman M.; Gabriel, Jonathan; Al-Nagar, Ahmed J.; Martin, Stephen; Baig, Sana Z.; Soleymani, Homan; Chowdhury, Zawahir; Beesley, Philip; Toeroek, Katalin			Lobe-specific Functions of Ca2+center dot Calmodulin in alpha Ca2+center dot Calmodulin-dependent Protein Kinase II Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; ALPHA-CAMKII; CALCIUM DISSOCIATION; DENDRITIC SPINES; STOPPED-FLOW; BINDING-SITE; CALMODULIN; MECHANISM; AUTOPHOSPHORYLATION; RECEPTOR	N-Methyl-D-aspartic acid receptor-dependent long term potentiation (LTP), a model of memory formation, requires Ca2+center dot calmodulin-dependent protein kinase II (alpha CaMKII) activity and Thr(286) autophosphorylation via both global and local Ca2+ signaling, but the mechanisms of signal transduction are not understood. We tested the hypothesis that the Ca2+-binding activator protein calmodulin (CaM) is the primary decoder of Ca2+ signals, thereby determining the output, e. g. LTP. Thus, we investigated the function of CaM mutants, deficient in Ca2+ binding at sites 1 and 2 of the N-terminal lobe or sites 3 and 4 of the C-terminal CaM lobe, in the activation of alpha CaMKII. Occupancy of CaM Ca2+ binding sites 1, 3, and 4 is necessary and sufficient for full activation. Moreover, the N- and C-terminal CaM lobes have distinct functions. Ca2+ binding toNlobe Ca2+ binding site 1 increases the turnover rate of the enzyme 5-fold, whereas the Clobe plays a dual role; it is required for full activity, but in addition, via Ca2+ binding site 3, it stabilizes ATP binding to alpha CaMKII 4-fold. Thr(286) autophosphorylation is also dependent on Ca2+ binding sites on both the N and the C lobes of CaM. As the CaM C lobe sites are populated by low amplitude/low frequency (global) Ca2+ signals, but occupancy of N lobe site 1 and thus activation of alpha CaMKII requires high amplitude/high frequency (local) Ca2+ signals, lobe-specific sensing of Ca2+ signaling patterns by CaM is proposed to explain the requirement for both global and local Ca2+ signaling in the induction of LTP via alpha CaMKII.	[Jama, Abdirahman M.; Gabriel, Jonathan; Al-Nagar, Ahmed J.; Baig, Sana Z.; Soleymani, Homan; Chowdhury, Zawahir; Toeroek, Katalin] Univ London, Div Basic Med Sci, London SW17 0RE, England; [Martin, Stephen] Natl Inst Med Res, London NW7 1AA, England; [Beesley, Philip] Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England	University of London; MRC National Institute for Medical Research; University of London; Royal Holloway University London	Torok, K (corresponding author), Univ London, Div Basic Med Sci, London SW17 0RE, England.	k.torok@sgul.ac.uk		Torok, Katalin/0000-0002-3107-4534	Wellcome Trust [075931]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Project Grant 075931 (to K. T.).	BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bradshaw JM, 2002, J BIOL CHEM, V277, P20991, DOI 10.1074/jbc.M202154200; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dodd R, 2008, J BIOL CHEM, V283, P26911, DOI 10.1074/jbc.M801434200; Evans TIA, 2009, PROTEINS, V76, P47, DOI 10.1002/prot.22317; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Grant PAA, 2008, CELL CALCIUM, V44, P465, DOI 10.1016/j.ceca.2008.03.003; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Jama AM, 2009, J BIOL CHEM, V284, P28146, DOI 10.1074/jbc.M109.005900; KEMP BE, 1989, CELL SIGNAL, V1, P303, DOI 10.1016/0898-6568(89)90049-1; KING MM, 1988, ARCH BIOCHEM BIOPHYS, V267, P467, DOI 10.1016/0003-9861(88)90052-5; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; LINSE S, 1991, J BIOL CHEM, V266, P8050; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; Martin SR, 1996, BIOCHEMISTRY-US, V35, P3508, DOI 10.1021/bi952522a; MARTIN SR, 1985, EUR J BIOCHEM, V151, P543, DOI 10.1111/j.1432-1033.1985.tb09137.x; MARTIN SR, 1992, EUR J BIOCHEM, V205, P1107, DOI 10.1111/j.1432-1033.1992.tb16879.x; Migues PV, 2006, J NEUROCHEM, V98, P289, DOI 10.1111/j.1471-4159.2006.03876.x; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; Morris EP, 2001, J MOL BIOL, V308, P1, DOI 10.1006/jmbi.2001.4584; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ohmae S, 2006, J BIOL CHEM, V281, P20427, DOI 10.1074/jbc.M513212200; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Rose J, 2009, NEURON, V61, P351, DOI 10.1016/j.neuron.2008.12.030; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; SMITH GL, 1985, BIOCHIM BIOPHYS ACTA, V839, P287, DOI 10.1016/0304-4165(85)90011-X; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Thalhammer A, 2006, EMBO J, V25, P5873, DOI 10.1038/sj.emboj.7601420; Topolnik L, 2009, J NEUROSCI, V29, P4658, DOI 10.1523/JNEUROSCI.0493-09.2009; Torok K, 1998, BIOCHEMISTRY-US, V37, P6188, DOI 10.1021/bi972773e; Torok K, 2001, BIOCHEMISTRY-US, V40, P14878, DOI 10.1021/bi010920+; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6404, DOI 10.1021/bi036224m; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6270, DOI 10.1021/bi035449u; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	39	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.157057	http://dx.doi.org/10.1074/jbc.M110.157057			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21300804	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000289077500045
J	Gilbert, ER; Cox, CM; Williams, PM; McElroy, AP; Dalloul, RA; Ray, WK; Barri, A; Emmerson, DA; Wong, EA; Webb, KE				Gilbert, Elizabeth R.; Cox, Chasity M.; Williams, Patricia M.; McElroy, Audrey P.; Dalloul, Rami A.; Ray, W. Keith; Barri, Adriana; Emmerson, Derek A.; Wong, Eric A.; Webb, Kenneth E., Jr.			Eimeria Species and Genetic Background Influence the Serum Protein Profile of Broilers with Coccidiosis	PLOS ONE			English	Article							COMPLEMENT COMPONENT C3; AVIAN COCCIDIOSIS; VACCINATION STRATEGIES; ANTIVIRAL ACTIVITY; TENELLA; OVOTRANSFERRIN; INHIBITORS; IMMUNITY; ACERVULINA; EXPRESSION	Background: Coccidiosis is an intestinal disease caused by protozoal parasites of the genus Eimeria. Despite the advent of anti-coccidial drugs and vaccines, the disease continues to result in substantial annual economic losses to the poultry industry. There is still much unknown about the host response to infection and to date there are no reports of protein profiles in the blood of Eimeria-infected animals. The objective of this study was to evaluate the serum proteome of two genetic lines of broiler chickens after infection with one of three species of Eimeria. Methodology/Principal Findings: Birds from lines A and B were either not infected or inoculated with sporulated oocysts from one of the three Eimeria strains at 15 d post-hatch. At 21 d (6 d post-infection), whole blood was collected and lesion scoring was performed. Serum was harvested and used for 2-dimensional gel electrophoresis. A total of 1,266 spots were quantitatively assessed by densitometry. Protein spots showing a significant effect of coccidia strain and/or broiler genetic line on density at P<0.05-0.01 (250 spots), P<0.01-0.001 (248 spots), and P<0.001 (314 spots) were excised and analyzed by matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry. Proteins were identified in 172 spots. A total of 46 different proteins were identified. Of the spots with a corresponding protein identification, 57 showed a main effect of coccidia infection and/or 2-way interaction of coccidia infectionxbroiler genetic line at P<0.001. Conclusions/Significance: Several of the metabolic enzymes identified in this study are potential candidates for early diagnostic markers of E. acervulina infection including malate dehydrogenase 2, NADH dehydrogenase 1 alpha subcomplex 9, and an ATP synthase. These proteins were detected only in Line A birds that were inoculated with E. acervulina. Results from this study provide a basic framework for future research aimed at uncovering the complex biochemical mechanisms involved in host response to Eimeria infection and in identifying molecular targets for diagnostic screening and development of alternative preventative and therapeutic methods.	[Gilbert, Elizabeth R.; Cox, Chasity M.; Williams, Patricia M.; McElroy, Audrey P.; Dalloul, Rami A.; Barri, Adriana; Wong, Eric A.; Webb, Kenneth E., Jr.] Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA; [Ray, W. Keith] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Emmerson, Derek A.] Aviagen, Huntsville, AL USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Gilbert, ER (corresponding author), Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA.	webbk@vt.edu		Dalloul, Rami/0000-0003-4690-9220	KEW [231908]	KEW	Funding for this research came from unrestricted funds accumulated by KEW over time in return for his having performed amino acid analyses for various investigators (Fund # 231908). Only the authors of the current manuscript had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other individual or agency was involved.	ADAMS JH, 1988, INT J PARASITOL, V18, P683, DOI 10.1016/0020-7519(88)90104-X; Adkins JN, 2002, MOL CELL PROTEOMICS, V1, P947, DOI 10.1074/mcp.M200066-MCP200; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Becker D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008689; Berruyer C, 2006, J EXP MED, V203, P2817, DOI 10.1084/jem.20061640; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Cornelissen JBWJ, 2009, VET PARASITOL, V162, P58, DOI 10.1016/j.vetpar.2009.02.001; Dalloul RA, 2005, AVIAN DIS, V49, P1, DOI 10.1637/7306-11150R; Dalloul RA, 2007, MOL IMMUNOL, V44, P558, DOI 10.1016/j.molimm.2006.02.004; Dalloul RA, 2006, EXPERT REV VACCINES, V5, P143, DOI 10.1586/14760584.5.1.143; Fasquelle C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000666; Fetterer RH, 2007, J PARASITOL, V93, P333, DOI 10.1645/GE-824R1.1; Fetterer RH, 2008, J PARASITOL, V94, P1269, DOI 10.1645/GE-1559.1; FULLER AL, 1990, J PARASITOL, V76, P464, DOI 10.2307/3282822; Georgieva NV, 2006, VET J, V172, P488, DOI 10.1016/j.tvjl.2005.07.016; GIAMBRONE JJ, 1981, POULTRY SCI, V60, P2612, DOI 10.3382/ps.0602612; Giansanti F, 2005, BIOCHEM BIOPH RES CO, V331, P69, DOI 10.1016/j.bbrc.2005.03.125; Giansanti F, 2002, BIOCHEM CELL BIOL, V80, P125, DOI 10.1139/o01-208; Giansanti F, 2007, BIOCHEM CELL BIOL, V85, P150, DOI 10.1139/O06-210; Gilbert ER, 2007, POULTRY SCI, V86, P1739, DOI 10.1093/ps/86.8.1739; Gilbert ER, 2010, J PROTEOME RES, V9, P4628, DOI 10.1021/pr1003533; Granjeaud S, 1999, IMMUNOGENETICS, V49, P964, DOI 10.1007/s002510050580; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Huang SY, 2006, PROTEOMICS, V6, P2217, DOI 10.1002/pmic.200500410; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; Kim DK, 2009, POULTRY SCI, V88, P1565, DOI 10.3382/ps.2009-00012; Kurokawa H, 1999, J BIOL CHEM, V274, P28445, DOI 10.1074/jbc.274.40.28445; LAURSEN I, 1989, SCAND J IMMUNOL, V30, P529, DOI 10.1111/j.1365-3083.1989.tb02460.x; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; LILLEHOJ HS, 1987, INFECT IMMUN, V55, P1616, DOI 10.1128/IAI.55.7.1616-1621.1987; Lillehoj HS, 1996, CLIN MICROBIOL REV, V9, P349, DOI 10.1128/CMR.9.3.349; Lillehoj HS, 2000, AVIAN DIS, V44, P408, DOI 10.2307/1592556; Loeffen JLCM, 1998, BIOCHEM BIOPH RES CO, V253, P415, DOI 10.1006/bbrc.1998.9786; MAVROIDIS M, 1995, J IMMUNOL, V154, P2164; Meilinger M, 1999, J BIOL CHEM, V274, P38091, DOI 10.1074/jbc.274.53.38091; Minarik P, 2002, GEN PHYSIOL BIOPHYS, V21, P257; Nelson MM, 2008, INFECT IMMUN, V76, P828, DOI 10.1128/IAI.01115-07; OLSON ST, 2010, BIOCHIMIE; PETERS T, 1987, CLIN CHEM, V33, P1317; Pieper R, 2003, PROTEOMICS, V3, P1345, DOI 10.1002/pmic.200300449; RICHARDS MP, 1988, BIOL TRACE ELEM RES, V17, P207, DOI 10.1007/BF02795457; Saxena I, 1997, CELL MOL LIFE SCI, V53, P13, DOI 10.1007/PL00000575; STROUT RG, 1994, J PARASITOL, V80, P946, DOI 10.2307/3283444; TURK DE, 1986, POULTRY SCI, V65, P2098, DOI 10.3382/ps.0652098; Weinberg RB, 2000, J LIPID RES, V41, P1410; ZHIRNOV OP, 1982, ARCH VIROL, V73, P263, DOI 10.1007/BF01318080	47	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14636	10.1371/journal.pone.0014636	http://dx.doi.org/10.1371/journal.pone.0014636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297942	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300018
J	Chatterjee, N; Rollins, J; Mahowald, AP; Bazinet, C				Chatterjee, Nabanita; Rollins, Janet; Mahowald, Anthony P.; Bazinet, Christopher			Neurotransmitter Transporter-Like: A Male Germline-specific SLC6 Transporter Required for Drosophila Spermiogenesis	PLOS ONE			English	Article							AMINO-ACID TRANSPORTERS; BETA-TUBULIN; NEURONAL EXCITABILITY; SEROTONIN TRANSPORTER; AXONEMAL TUBULIN; GENETIC-ANALYSIS; ALPHA-TUBULIN; MELANOGASTER; SPERMATOGENESIS; MUTATIONS	The SLC6 class of membrane transporters, known primarily as neurotransmitter transporters, is increasingly appreciated for its roles in nutritional uptake of amino acids and other developmentally specific functions. A Drosophila SLC6 gene, Neurotransmitter transporter-like (Ntl), is expressed only in the male germline. Mobilization of a transposon inserted near the 39 end of the Ntl coding region yields male-sterile mutants defining a single complementation group. Germline transformation with Ntl cDNAs under control of male germline-specific control elements restores Ntl/Ntl homozygotes to normal fertility, indicating that Ntl is required only in the germ cells. In mutant males, sperm morphogenesis appears normal, with elongated, individualized and coiled spermiogenic cysts accumulating at the base of the testes. However, no sperm are transferred to the seminal vesicle. The level of polyglycylation of Ntl mutant sperm tubulin appears to be significantly lower than that of wild type controls. Glycine transporters are the most closely related SLC6 transporters to Ntl, suggesting that Ntl functions as a glycine transporter in developing sperm, where augmentation of the cytosolic pool of glycine may be required for the polyglycylation of the massive amounts of tubulin in the fly's giant sperm. The male-sterile phenotype of Ntl mutants may provide a powerful genetic system for studying the function of an SLC6 transporter family in a model organism.	[Chatterjee, Nabanita; Rollins, Janet; Bazinet, Christopher] St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA; [Mahowald, Anthony P.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Saint John's University; University of Chicago	Chatterjee, N (corresponding author), St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA.	bazinetc@stjohns.edu			National Institutes of Health (NIH) [HD043885, R15HD043885]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD043885] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (NIH) grant HD043885. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Eric Kubli for encouraging us to study this gene. Anti poly-G was generously provided by Martin Gorovsky. Thanks also to Ming Guo for pTMR vector and S. Goto and Karen Hales for the tubulin-GFP-expressing flies. We thank colleagues Paromita Gupta, Roshni Ghosh, Maurice Kernan, Rachel Zufferey, Sergio Bibis, and Julie Brill for critical comments and discussion. Critical reagents and information were provided by FLYBASE, the Bloomington Drosophila Stock Center, and the Drosophila Genome Disruption Project. This work was funded in part by NIH Grant R15HD043885 to C. B.	Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; Arama E, 2007, PLOS BIOL, V5, P2745, DOI 10.1371/journal.pbio.0050251; Baker JD, 2004, DEVELOPMENT, V131, P3411, DOI 10.1242/dev.01229; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BIGLER D, 1994, NACHWEIS NEUROTRANSM; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Boudko DY, 2005, P NATL ACAD SCI USA, V102, P1360, DOI 10.1073/pnas.0405183101; Bre MH, 1996, J CELL SCI, V109, P727; BRESSAC C, 1995, EUR J CELL BIOL, V67, P346; Broer S, 2006, NEUROCHEM INT, V48, P559, DOI 10.1016/j.neuint.2005.11.021; Bulinski JC, 2009, DEV CELL, V16, P773, DOI 10.1016/j.devcel.2009.06.003; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; COREY JL, 1994, P NATL ACAD SCI USA, V91, P1188, DOI 10.1073/pnas.91.3.1188; DEMCHYSHYN LL, 1994, P NATL ACAD SCI USA, V91, P5158, DOI 10.1073/pnas.91.11.5158; DORIG R, 1991, ANAL DROSOPHILA GENC; Duan JM, 2002, CURR BIOL, V12, P313, DOI 10.1016/S0960-9822(02)00651-6; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Enomoto A, 2002, J BIOL CHEM, V277, P36262, DOI 10.1074/jbc.M203883200; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Gavin BA, 2007, PLOS GENET, V3, P2358, DOI 10.1371/journal.pgen.0030206; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Guo JH, 2005, CYTOGENET GENOME RES, V111, P107, DOI 10.1159/000086378; Hafen E., 1997, NATURE, V389, P559; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hoyle HD, 2008, CELL MOTIL CYTOSKEL, V65, P295, DOI 10.1002/cm.20261; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Hummel T, 2002, NEURON, V33, P193, DOI 10.1016/S0896-6273(01)00581-5; Johnson K, 1999, DEV BIOL, V212, P440, DOI 10.1006/dbio.1999.9351; KALTSCHMIDT B, 1991, EUR J CELL BIOL, V54, P110; KEMPHUES KJ, 1982, CELL, V31, P655, DOI 10.1016/0092-8674(82)90321-X; LIFSCHYTZ E, 1987, INT REV CYTOL, V109, P211, DOI 10.1016/S0074-7696(08)61723-4; LIFSCHYTZ E, 1977, CHROMOSOMA, V64, P371, DOI 10.1007/BF00294944; Masson J, 1999, PHARMACOL REV, V51, P439; MATTHEWS KA, 1994, DROSOPHILA MELANGOST, P13; Miller MM, 2008, INSECT BIOCHEM MOLEC, V38, P923, DOI 10.1016/j.ibmb.2008.07.005; Nerusheva OO, 2009, CELL BIOL INT, V33, P586, DOI 10.1016/j.cellbi.2009.02.009; Noguchi T, 2008, MOL BIOL CELL, V19, P2363, DOI 10.1091/mbc.E07-08-0840; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Redeker V, 2005, J BIOL CHEM, V280, P596, DOI 10.1074/jbc.M408324200; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Richards S, 1996, GENETICS, V142, P1215; Riparbelli MG, 2007, DEV BIOL, V303, P108, DOI 10.1016/j.ydbio.2006.10.038; ROBERTSON HM, 1988, GENETICS, V118, P461; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; Santel A, 1998, J CELL SCI, V111, P3299; Soehnge H, 1996, P NATL ACAD SCI USA, V93, P13262, DOI 10.1073/pnas.93.23.13262; STERN M, 1992, J NEUROGENET, V8, P157, DOI 10.3109/01677069209083445; Tan Y, 2010, NEURON, V67, P810, DOI 10.1016/j.neuron.2010.08.020; Texada MJ, 2008, J CELL SCI, V121, P1926, DOI 10.1242/jcs.026559; Thimgan MS, 2006, J EXP BIOL, V209, P3383, DOI 10.1242/jeb.02328; TOKUYASU KT, 1972, Z ZELLFORSCH MIK ANA, V124, P479, DOI 10.1007/BF00335253; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Wakimoto BT, 2004, GENETICS, V167, P207, DOI 10.1534/genetics.167.1.207; Xia L, 2000, J CELL BIOL, V149, P1097, DOI 10.1083/jcb.149.5.1097; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; ZHANG P, 1993, GENETICS, V133, P361; Zhang YQ, 2004, DEV BIOL, V270, P290, DOI 10.1016/j.ydbio.2004.02.010	65	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16275	10.1371/journal.pone.0016275	http://dx.doi.org/10.1371/journal.pone.0016275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298005	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900028
J	Tyralla, K; Adamczak, M; Benz, K; Campean, V; Gross, ML; Hilgers, KF; Ritz, E; Amann, K				Tyralla, Karin; Adamczak, Marcin; Benz, Kerstin; Campean, Valentina; Gross, Marie-Luise; Hilgers, Karl F.; Ritz, Eberhard; Amann, Kerstin			High-Dose Enalapril Treatment Reverses Myocardial Fibrosis in Experimental Uremic Cardiomyopathy	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CHRONIC-RENAL-FAILURE; RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; CARDIAC-HYPERTROPHY; INTERSTITIAL FIBROSIS; HEMODIALYSIS-PATIENTS; HEART-FAILURE; RATS; BRADYKININ	Aims: Patients with renal failure develop cardiovascular alterations which contribute to the higher rate of cardiac death. Blockade of the renin angiotensin system ameliorates the development of such changes. It is unclear, however, to what extent ACE-inhibitors can also reverse existing cardiovascular alterations. Therefore, we investigated the effect of high dose enalapril treatment on these alterations. Methods: Male Sprague Dawley rats underwent subtotal nephrectomy (SNX, n = 34) or sham operation (sham, n = 39). Eight weeks after surgery, rats were sacrificed or allocated to treatment with either high-dose enalapril, combination of furosemide/dihydralazine or solvent for 4 weeks. Heart and aorta were evaluated using morphometry, stereological techniques and TaqMan PCR. Results: After 8 and 12 weeks systolic blood pressure, albumin excretion, and left ventricular weight were significantly higher in untreated SNX compared to sham. Twelve weeks after SNX a significantly higher volume density of cardiac interstitial tissue (2.57 +/- 0.43% in SNX vs 1.50 +/- 0.43% in sham, p < 0.05) and a significantly lower capillary length density (4532 +/- 355 mm/mm(3) in SNX vs 50236624 mm/mm(3) in sham, p < 0.05) were found. Treatment of SNX with enalapril from week 8-12 significantly improved myocardial fibrosis (1.63 +/- 0.25%, p < 0.05), but not capillary reduction (3908 +/- 486 mm/mm(3)) or increased intercapillary distance. In contrast, alternative antihypertensive treatment showed no such effect. Significantly increased media thickness together with decreased vascular smooth muscles cell number and a disarray of elastic fibres were found in the aorta of SNX animals compared to sham. Both antihypertensive treatments failed to cause complete regression of these alterations. Conclusions: The study indicates that high dose ACE-I treatment causes partial, but not complete, reversal of cardiovascular changes in SNX.	[Tyralla, Karin; Benz, Kerstin; Campean, Valentina; Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany; [Adamczak, Marcin; Gross, Marie-Luise] Heidelberg Univ, Dept Pathol, D-6900 Heidelberg, Germany; [Adamczak, Marcin] Silesian Univ Sch Med, Dept Nephrol Endocrinol & Metab Dis, Katowice, Poland; [Hilgers, Karl F.] Univ Erlangen Nurnberg, Dept Internal Med Nephrol, Erlangen, Germany; [Ritz, Eberhard] Heidelberg Univ, Dept Internal Med, D-6900 Heidelberg, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; Medical University Silesia; University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg	Tyralla, K (corresponding author), Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany.	kerstin.amann@uk-erlangen.de		Adamczak, Marcin/0000-0002-0804-1718	IZKF Erlangen [A11]	IZKF Erlangen	Parts of the study were sponsored by a grant from the IZKF Erlangen (project A11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak M, 2003, J AM SOC NEPHROL, V14, P2833, DOI 10.1097/01.ASN.0000095248.91994.D3; AMANN K, 1994, J AM SOC NEPHROL, V4, P1814; Amann K, 1998, J AM SOC NEPHROL, V9, P1018; AMANN K, 1995, NEPHROL DIAL TRANSPL, V10, P2043; Amann K, 1997, AM J KIDNEY DIS, V30, P382, DOI 10.1016/S0272-6386(97)90283-3; Amann K, 2003, KIDNEY INT, V63, P1708, DOI 10.1046/j.1523-1755.2003.00927.x; Amann K, 2002, KIDNEY INT, V62, P877, DOI 10.1046/j.1523-1755.2002.00518.x; AMANN K, 1995, AM J HYPERTENS, V8, P409, DOI 10.1016/0895-7061(94)00248-A; Amann K, 1997, Adv Ren Replace Ther, V4, P212; Amann K, 2000, KIDNEY INT, V58, P153, DOI 10.1046/j.1523-1755.2000.00163.x; Amann K, 2000, J AM SOC NEPHROL, V11, P1702, DOI 10.1681/ASN.V1191702; AMANN K, 1992, KIDNEY INT, V42, P1079, DOI 10.1038/ki.1992.390; Amann K, 2001, J CLIN BAS CARDIOL, V4, P109; Cannella G, 1997, AM J KIDNEY DIS, V30, P659, DOI 10.1016/S0272-6386(97)90490-X; Clerk A, 1996, BIOCHEM J, V317, P109, DOI 10.1042/bj3170109; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Eckardt KU, 2009, J AM SOC NEPHROL, V20, P2651, DOI 10.1681/ASN.2009060631; Fernandez-Juarez G, 2006, J AM SOC NEPHROL, V17, pS250, DOI 10.1681/ASN.2006080922; GOHLKE P, 1993, AM J CARDIOL, V72, pE2; Gonzalez A, 2002, J MOL CELL CARDIOL, V34, P1585, DOI 10.1006/jmcc.2002.2081; Gretz N, 1988, Contrib Nephrol, V60, P46; GRIFFIN KA, 1994, J AM SOC NEPHROL, V4, P2023; Hampl H, 2005, AM J NEPHROL, V25, P211, DOI 10.1159/000085881; Hartner Andrea, 2005, BMC Nephrol, V6, P6, DOI 10.1186/1471-2369-6-6; Hui AY, 2006, LIVER INT, V26, P125, DOI 10.1111/j.1478-3231.2005.01202.x; IKOMA M, 1991, KIDNEY INT, V40, P195, DOI 10.1038/ki.1991.200; Imai C, 2005, CLIN EXP HYPERTENS, V27, P59, DOI 10.1081/CEH-200044262; JACKSON B, 1988, AM J HYPERTENS, V1, P298, DOI 10.1093/ajh/1.3.298; KAKINUMA Y, 1992, KIDNEY INT, V42, P46, DOI 10.1038/ki.1992.259; KUNCZERA M, 1991, J HYPERTENS, V9, P41; Li YW, 2007, J CARD FAIL, V13, P155, DOI 10.1016/j.cardfail.2006.11.005; LONDON GM, 1990, KIDNEY INT, V37, P137, DOI 10.1038/ki.1990.19; MALL G, 1990, NEPHROL DIAL TRANSPL, V5, P39, DOI 10.1093/ndt/5.1.39; MALL G, 1988, KIDNEY INT, V33, P804, DOI 10.1038/ki.1988.71; MATTFELDT T, 1990, J MICROSC-OXFORD, V159, P301, DOI 10.1111/j.1365-2818.1990.tb03036.x; MINSHALL RD, 1995, CIRC RES, V76, P773, DOI 10.1161/01.RES.76.5.773; Ozkahya M, 1998, NEPHROL DIAL TRANSPL, V13, P1489, DOI 10.1093/ndt/13.6.1489; RAMBAUSEK M, 1985, KIDNEY INT, V28, P775, DOI 10.1038/ki.1985.197; Ritz E, 1997, Adv Nephrol Necker Hosp, V27, P85; Ritz E, 2009, KIDNEY INT, V75, P771, DOI 10.1038/ki.2009.35; Ruiz V, 2003, AM J PHYSIOL-LUNG C, V285, pL1026, DOI 10.1152/ajplung.00183.2003; Schwarz U, 1998, KIDNEY INT, V53, P1696, DOI 10.1046/j.1523-1755.1998.00951.x; Siedlecki AM, 2009, KIDNEY INT, V75, P800, DOI 10.1038/ki.2008.690; SUZUKI H, 1995, AM J NEPHROL, V15, P129, DOI 10.1159/000168817; Tornig J, 1996, J AM SOC NEPHROL, V7, P667; Toz H, 1999, KIDNEY INT, V56, P350; WEIZ MR, 2007, CLIN THER, V9, P1803; Wolf G, 1996, HYPERTENSION, V27, P897, DOI 10.1161/01.HYP.27.4.897; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	49	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15287	10.1371/journal.pone.0015287	http://dx.doi.org/10.1371/journal.pone.0015287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298056	gold, Green Submitted, Green Published			2022-12-25	WOS:000286663900014
J	Williams-Guillen, K; Perfecto, I				Williams-Guillen, Kimberly; Perfecto, Ivette			Ensemble Composition and Activity Levels of Insectivorous Bats in Response to Management Intensification in Coffee Agroforestry Systems	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; FOREST FRAGMENTS; ECHOLOCATION; DIVERSITY; PHYLLOSTOMIDAE; IDENTIFICATION; COMPLETENESS; COMMUNITIES; CHIROPTERA; INDICATORS	Shade coffee plantations have received attention for their role in biodiversity conservation. Bats are among the most diverse mammalian taxa in these systems; however, previous studies of bats in coffee plantations have focused on the largely herbivorous leaf-nosed bats (Phyllostomidae). In contrast, we have virtually no information on how ensembles of aerial insectivorous bats - nearly half the Neotropical bat species - change in response to habitat modification. To evaluate the effects of agroecosystem management on insectivorous bats, we studied their diversity and activity in southern Chiapas, Mexico, a landscape dominated by coffee agroforestry. We used acoustic monitoring and live captures to characterize the insectivorous bat ensemble in forest fragments and coffee plantations differing in the structural and taxonomic complexity of shade trees. We captured bats of 12 non-phyllostomid species; acoustic monitoring revealed the presence of at least 12 more species of aerial insectivores. Richness of forest bats was the same across all land-use types; in contrast, species richness of open-space bats increased in low shade, intensively managed coffee plantations. Conversely, only forest bats demonstrated significant differences in ensemble structure (as measured by similarity indices) across land-use types. Both overall activity and feeding activity of forest bats declined significantly with increasing management intensity, while the overall activity, but not feeding activity, of open-space bats increased. We conclude that diverse shade coffee plantations in our study area serve as valuable foraging and commuting habitat for aerial insectivorous bats, and several species also commute through or forage in low shade coffee monocultures.	[Williams-Guillen, Kimberly; Perfecto, Ivette] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Williams-Guillen, K (corresponding author), Univ Washington, Bothell, WA USA.	kimwg@uw.edu			National Science Foundation [DBI-0610473]; Bat Conservation International	National Science Foundation(National Science Foundation (NSF)); Bat Conservation International	Funding provided by National Science Foundation (DBI-0610473 to KWG) and Bat Conservation International (www.batcon.org). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Colwell RK, 2013, ESTIMATES STAT ESTIM; Corben C., 2004, BAT ECHOLOCATION RES, P95; Cosson JF, 1999, J TROP ECOL, V15, P515, DOI 10.1017/S026646749900098X; Cruz-Lara Laura E., 2004, Acta Zool. Mex, V20, P63; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Estrada A, 2002, BIOL CONSERV, V103, P237, DOI 10.1016/S0006-3207(01)00135-5; Estrada A., 2004, ANIMAL BIODIVERSITY, V27, P1; Estrada-Villegas S, 2010, BIOL CONSERV, V143, P597, DOI 10.1016/j.biocon.2009.11.009; FENTON MB, 1970, CAN J ZOOLOG, V48, P847, DOI 10.1139/z70-148; FENTON MB, 1992, BIOTROPICA, V24, P440, DOI 10.2307/2388615; Fenton MB, 2000, ACTA CHIROPTEROL, V2, P215; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Estrada CG, 2006, BIOL CONSERV, V132, P351, DOI 10.1016/j.biocon.2006.04.027; Jung K, 2007, J ZOOL, V272, P125, DOI 10.1111/j.1469-7998.2006.00250.x; Jung K, 2010, J MAMMAL, V91, P144, DOI [10.1644/08-MAMM-A-313R.1, 10.1644/08-MAMM-A-313R.1.]; Kalko EKV, 1998, ZOOL-ANAL COMPLEX SY, V101, P281; Kelm DH, 2008, CONSERV BIOL, V22, P733, DOI 10.1111/j.1523-1739.2008.00925.x; KUNZ TH, 1996, MEASURING MONITORING, P122; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Law B, 2002, J APPL ECOL, V39, P605, DOI 10.1046/j.1365-2664.2002.00739.x; MacSwiney MC, 2008, J APPL ECOL, V45, P1364, DOI 10.1111/j.1365-2664.2008.01531.x; MacSwiney MC, 2007, BIOL CONSERV, V136, P499, DOI 10.1016/j.biocon.2006.12.021; Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI [10.1046/j.1523-1739.2000.99068.x, 10.1111/j.1523-1739.2000.99068.x]; Miller BW, 2001, ACTA CHIROPTEROL, V3, P93; MILLER BW, 2003, COMMUNITY ECOLOGY NO; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; Mooney KA, 2010, P NATL ACAD SCI USA, V107, P7335, DOI 10.1073/pnas.1001934107; Moreno CE, 2000, J APPL ECOL, V37, P149, DOI 10.1046/j.1365-2664.2000.00483.x; O'Farrell MJ, 1999, BIOTROPICA, V31, P507, DOI 10.1111/j.1744-7429.1999.tb00394.x; O'Farrell MJ, 1999, J MAMMAL, V80, P11, DOI 10.2307/1383203; Perfecto I, 2003, ADV AGROECOL, P159; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Reid F. A., 2009, FIELD GUIDE MAMMALS; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rydell J, 2002, J ZOOL, V257, P27, DOI 10.1017/S0952836902000626; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Siemers BM, 2001, BEHAV ECOL SOCIOBIOL, V50, P317, DOI 10.1007/s002650100379; Somarriba Eduardo, 2004, P198; Struebig MJ, 2008, BIOL CONSERV, V141, P2112, DOI 10.1016/j.biocon.2008.06.009; Wickramasinghe LP, 2003, J APPL ECOL, V40, P984, DOI 10.1111/j.1365-2664.2003.00856.x; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944; Williams-Guillen K, 2010, BIOTROPICA, V42, P605, DOI 10.1111/j.1744-7429.2010.00626.x; Willig Michael R., 1996, P399; Wilson Don E., 1996, P613	50	37	44	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16502	10.1371/journal.pone.0016502	http://dx.doi.org/10.1371/journal.pone.0016502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298059	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800049
J	Stollhoff, R; Jost, J; Elze, T; Kennerknecht, I				Stollhoff, Rainer; Jost, Juergen; Elze, Tobias; Kennerknecht, Ingo			Deficits in Long-Term Recognition Memory Reveal Dissociated Subtypes in Congenital Prosopagnosia	PLOS ONE			English	Article							VENTRAL VISUAL-CORTEX; HUMAN NEURAL SYSTEM; FUSIFORM FACE AREA; DEVELOPMENTAL PROSOPAGNOSIA; HEREDITARY PROSOPAGNOSIA; DETAILED EXPLORATION; COVERT RECOGNITION; UNFAMILIAR FACES; 1ST REPORT; PERCEPTION	The study investigates long-term recognition memory in congenital prosopagnosia (CP), a lifelong impairment in face identification that is present from birth. Previous investigations of processing deficits in CP have mostly relied on short-term recognition tests to estimate the scope and severity of individual deficits. We firstly report on a controlled test of long-term (one year) recognition memory for faces and objects conducted with a large group of participants with CP. Long-term recognition memory is significantly impaired in eight CP participants (CPs). In all but one case, this deficit was selective to faces and didn't extend to intra-class recognition of object stimuli. In a test of famous face recognition, long-term recognition deficits were less pronounced, even after accounting for differences in media consumption between controls and CPs. Secondly, we combined test results on long-term and short-term recognition of faces and objects, and found a large heterogeneity in severity and scope of individual deficits. Analysis of the observed heterogeneity revealed a dissociation of CP into subtypes with a homogeneous phenotypical profile. Thirdly, we found that among CPs self-assessment of real-life difficulties, based on a standardized questionnaire, and experimentally assessed face recognition deficits are strongly correlated. Our results demonstrate that controlled tests of long-term recognition memory are needed to fully assess face recognition deficits in CP. Based on controlled and comprehensive experimental testing, CP can be dissociated into subtypes with a homogeneous phenotypical profile. The CP subtypes identified align with those found in prosopagnosia caused by cortical lesions; they can be interpreted with respect to a hierarchical neural system for face perception.	[Stollhoff, Rainer; Jost, Juergen; Elze, Tobias] Max Planck Inst Math Sci, Leipzig, Germany; [Jost, Juergen] Santa Fe Inst Sci Complex, Santa Fe, NM USA; [Kennerknecht, Ingo] Univ Munster, Inst Human Genet, D-4400 Munster, Germany	Max Planck Society; The Santa Fe Institute; University of Munster	Stollhoff, R (corresponding author), Max Planck Inst Math Sci, Leipzig, Germany.	rainer.stollhoff@mis.mpg.de		Elze, Tobias/0000-0002-2032-0496; Jost, Juergen/0000-0001-5258-6590				Ariel R, 1996, CORTEX, V32, P221, DOI 10.1016/S0010-9452(96)80048-7; Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Avidan G, 2009, CURR BIOL, V19, P1146, DOI 10.1016/j.cub.2009.04.060; Baayen R., 2008, J MEMORY LANGUAGE; Barton JJS, 2005, NEUROLOGY, V65, P270, DOI 10.1212/01.wnl.0000168901.98616.1c; Barton JJS, 2003, NEUROPSYCHOLOGIA, V41, P1703, DOI 10.1016/S0028-3932(03)00115-5; Barton JJS, 2003, NEUROLOGY, V61, P220, DOI 10.1212/01.WNL.0000071229.11658.F8; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Barton JJS, 2001, NEUROLOGY, V57, P1161, DOI 10.1212/WNL.57.7.1161; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; BAUER RM, 1984, NEUROPSYCHOLOGIA, V22, P457, DOI 10.1016/0028-3932(84)90040-X; Behrmann M, 2005, J COGNITIVE NEUROSCI, V17, P1130, DOI 10.1162/0898929054475154; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Behrmann M, 2007, CEREB CORTEX, V17, P2354, DOI 10.1093/cercor/bhl144; Bobes MA, 2003, CORTEX, V39, P41, DOI 10.1016/S0010-9452(08)70073-X; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; Breen N, 2000, COGNITIVE NEUROPSYCH, V17, P55, DOI 10.1080/026432900380481; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Crawford JR, 2006, NEUROPSYCHOLOGY, V20, P259, DOI 10.1037/0894-4105.20.3.259; Crawford JR, 2006, NEUROPSYCHOLOGIA, V44, P666, DOI 10.1016/j.neuropsychologia.2005.06.001; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; de Gelder B, 2000, NEUROREPORT, V11, P3145, DOI 10.1097/00001756-200009280-00021; De Haan EHF, 1999, J CLIN EXP NEUROPSYC, V21, P312, DOI 10.1076/jcen.21.3.312.917; de Haan M, 2002, DEV PSYCHOBIOL, V40, P200, DOI 10.1002/dev.10027; de Haan M, 2001, COGNITIVE DEV, V16, P659, DOI 10.1016/S0885-2014(01)00051-X; Della Sala S, 2003, CORTEX, V39, P533; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; DERENZI E, 1991, CORTEX, V27, P213, DOI 10.1016/S0010-9452(13)80125-6; DINKELACKER V, 2010, J NEUROLOGY IN PRESS; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duchaine B, 2005, J COGNITIVE NEUROSCI, V17, P249, DOI 10.1162/0898929053124857; Duchaine BC, 2003, NEUROPSYCHOLOGIA, V41, P713, DOI 10.1016/S0028-3932(02)00222-1; Duchaine BC, 2000, NEUROREPORT, V11, P79, DOI 10.1097/00001756-200001170-00016; Duchaine B, 2008, AM J MED GENET A, V146A, P2860, DOI 10.1002/ajmg.a.32548; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Efron B., 1994, INTRO BOOTSTRAP; Ellis HD, 2001, TRENDS COGN SCI, V5, P149, DOI 10.1016/S1364-6613(00)01620-X; ELZE T, 2009, J VIS, V9, P58; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; FAUST C, 1947, PARTIELLE SEELENBLIN, P294; Fox CJ, 2008, CORTEX, V44, P996, DOI 10.1016/j.cortex.2008.04.003; Garrido L, 2009, BRAIN, V132, P3443, DOI 10.1093/brain/awp271; Garrido L, 2008, J NEUROPSYCHOL, V2, P119, DOI 10.1348/174866407X246843; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; GRUETER M, 2004, GENETIK KONGENITALEN; Grueter M, 2007, CORTEX, V43, P734, DOI 10.1016/S0010-9452(08)70502-1; Gruter T, 2009, NEUROSCI LETT, V453, P135, DOI 10.1016/j.neulet.2009.02.021; Hadfield J., 2009, MCMC METHODS MULTIRE; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HECAEN H, 1962, ARCH NEUROL-CHICAGO, V7, P92, DOI 10.1001/archneur.1962.04210020014002; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Humphreys K, 2007, EXP BRAIN RES, V176, P356, DOI 10.1007/s00221-006-0621-5; JANICKE C, 2001, THESIS; Kalbe E, 2008, NEUROCASE, V14, P15, DOI 10.1080/13554790801992735; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kennerknecht I, 2008, AM J MED GENET A, V146A, P2863, DOI 10.1002/ajmg.a.32552; Kennerknecht I, 2008, FRONT BIOSCI-LANDMRK, V13, P3150, DOI 10.2741/2916; Kennerknecht I, 2007, J HUM GENET, V52, P230, DOI 10.1007/s10038-006-0101-6; Kennerknecht I, 2006, AM J MED GENET A, V140A, P1617, DOI 10.1002/ajmg.a.31343; Kress T, 2003, BEHAV NEUROL, V14, P109, DOI 10.1155/2003/520476; Lange J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007414; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Lissauer H., 1890, ARCH PSYCHIAT NERVEN, V21, P22; MAZZUCCHI A, 1983, CORTEX, V19, P509, DOI 10.1016/S0010-9452(83)80032-X; MCCONACHIE HR, 1976, CORTEX, V12, P76, DOI 10.1016/S0010-9452(76)80033-0; MCNEIL JE, 1993, Q J EXP PSYCHOL-A, V46, P1, DOI 10.1080/14640749308401064; Mondloch CJ, 2003, J EXP CHILD PSYCHOL, V86, P67, DOI 10.1016/S0022-0965(03)00102-4; Palmeri TJ, 2004, NAT REV NEUROSCI, V5, P291, DOI 10.1038/nrn1364; PASCALIS O, 1994, NEUROREPORT, V5, P1721, DOI 10.1097/00001756-199409080-00008; Polk TA, 2007, J NEUROSCI, V27, P13921, DOI 10.1523/JNEUROSCI.4001-07.2007; R Development Core Team, 2009, R FDN STAT COMP; Riddoch JM, 1993, BORB BIRMINGHAM OBJE; Scherf KS, 2007, DEVELOPMENTAL SCI, V10, pF15, DOI 10.1111/j.1467-7687.2007.00595.x; Schmalzl L, 2008, J NEUROPSYCHOL, V2, P99, DOI 10.1348/174866407X256554; Schmalzl L, 2008, COGN NEUROPSYCHOL, V25, P704, DOI 10.1080/02643290802299350; Schwarzer G, 2007, PSYCHOL RES-PSYCH FO, V71, P583, DOI 10.1007/s00426-006-0068-0; Sperber S, 2003, CORTEX, V39, P57, DOI 10.1016/S0010-9452(08)70074-1; Stollhoff R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011482; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Thomas M, 2002, BEHAV BRAIN SCI, V25, P727, DOI 10.1017/S0140525X02000134; TRANEL D, 1995, J COGNITIVE NEUROSCI, V7, P425, DOI 10.1162/jocn.1995.7.4.425; Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8; Tuerlinckx F, 2006, BRIT J MATH STAT PSY, V59, P225, DOI 10.1348/000711005x79857; Turati C, 2008, COGNITION, V106, P1300, DOI 10.1016/j.cognition.2007.06.005; von Kriegstein K, 2006, CEREB CORTEX, V16, P1314, DOI 10.1093/cercor/bhj073; Warrington EK., 1991, VISUAL OBJECT SPACE; WILBRAND H, 1892, DTSCH Z NERVENHEILKD, V2, P361, DOI DOI 10.1007/BF01667704; Williams MA, 2007, CURR BIOL, V17, P1259, DOI 10.1016/j.cub.2007.06.042; Young AW, 1999, COGN NEUROPSYCHOL, V16, P1, DOI 10.1080/026432999380960	92	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15702	10.1371/journal.pone.0015702	http://dx.doi.org/10.1371/journal.pone.0015702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712IZ	21283572	gold, Green Published, Green Submitted			2022-12-25	WOS:000286661400011
J	van der Heide, T; van Nes, EH; van Katwijk, MM; Olff, H; Smolders, AJP				van der Heide, Tjisse; van Nes, Egbert H.; van Katwijk, Marieke M.; Olff, Han; Smolders, Alfons J. P.			Positive Feedbacks in Seagrass Ecosystems - Evidence from Large-Scale Empirical Data	PLOS ONE			English	Article							POSIDONIA-OCEANICA; ZOSTERA-MARINA; WATER; TOXICITY; NITROGEN; SHIFTS; FLOW	Positive feedbacks cause a nonlinear response of ecosystems to environmental change and may even cause bistability. Even though the importance of feedback mechanisms has been demonstrated for many types of ecosystems, their identification and quantification is still difficult. Here, we investigated whether positive feedbacks between seagrasses and light conditions are likely in seagrass ecosystems dominated by the temperate seagrass Zostera marina. We applied a combination of multiple linear regression and structural equation modeling (SEM) on a dataset containing 83 sites scattered across Western Europe. Results confirmed that a positive feedback between sediment conditions, light conditions and seagrass density is likely to exist in seagrass ecosystems. This feedback indicated that seagrasses are able to trap and stabilize suspended sediments, which in turn improves water clarity and seagrass growth conditions. Furthermore, our analyses demonstrated that effects of eutrophication on light conditions, as indicated by surface water total nitrogen, were on average at least as important as sediment conditions. This suggests that in general, eutrophication might be the most important factor controlling seagrasses in sheltered estuaries, while the seagrass-sediment-light feedback is a dominant mechanism in more exposed areas. Our study demonstrates the potentials of SEM to identify and quantify positive feedbacks mechanisms for ecosystems and other complex systems.	[van der Heide, Tjisse; Olff, Han] Univ Groningen, Community & Conservat Ecol Grp, Ctr Ecol & Evolutionary Studies, Haren, Netherlands; [van Nes, Egbert H.] Wageningen Univ, Aquat Ecol & Water Qual Management Grp, Dept Environm Sci, Wageningen, Netherlands; [van Katwijk, Marieke M.] Radboud Univ Nijmegen, Dept Environm Sci, Inst Wetland & Water Res, Fac Sci, NL-6525 ED Nijmegen, Netherlands; [Smolders, Alfons J. P.] Radboud Univ Nijmegen, Dept Aquat Ecol & Environm Biol, Inst Water & Wetland Res, Fac Sci, NL-6525 ED Nijmegen, Netherlands	University of Groningen; Wageningen University & Research; Radboud University Nijmegen; Radboud University Nijmegen	van der Heide, T (corresponding author), Univ Groningen, Community & Conservat Ecol Grp, Ctr Ecol & Evolutionary Studies, Haren, Netherlands.	T.van.der.Heide@rug.nl	van Katwijk, Marieke M/B-1709-2012; van der Heide, Tjisse/M-3000-2013; Olff, Han/A-8516-2008; van Nes, Egbert H/F-2681-2011; Smolders, Alfons J.P./H-2583-2012	van Katwijk, Marieke M/0000-0002-4482-5835; Olff, Han/0000-0003-2154-3576; van Nes, Egbert/0000-0002-6345-104X	Netherlands Organization of Scientific Research - Earth and Life Sciences (NWO-ALW)	Netherlands Organization of Scientific Research - Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	The data presented in this study were collected as part of the project "Macrophytes in Estuarine Gradients (MEG)." This project was funded by the Netherlands Organization of Scientific Research - Earth and Life Sciences (NWO-ALW) as part of the framework "Land-Ocean Interactions in the Coastal Zone (LOICZ)." Website: http://www.nwo.nl/projecten.nsf/pages/1900121750. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agawin NSR, 2002, ESTUARIES, V25, P1205, DOI 10.1007/BF02692217; ARBUCKLE J. L., 2007, AMOS 16 0 USERS GUID; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barron C, 2006, LIMNOL OCEANOGR, V51, P1648, DOI 10.4319/lo.2006.51.4.1648; Bos AR, 2007, ESTUAR COAST SHELF S, V74, P344, DOI 10.1016/j.ecss.2007.04.006; Bouma TJ, 2005, ECOLOGY, V86, P2187, DOI 10.1890/04-1588; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carpenter SR, 2001, ECOLOGY: ACHIEVEMENT AND CHALLENGE, P357; DUARTE CM, 1991, AQUAT BOT, V40, P363, DOI 10.1016/0304-3770(91)90081-F; FONSECA MS, 1992, ESTUAR COAST SHELF S, V35, P565, DOI 10.1016/S0272-7714(05)80039-3; Gacia E, 2001, ESTUAR COAST SHELF S, V52, P505, DOI 10.1006/ecss.2000.0753; GAMBI MC, 1990, MAR ECOL PROG SER, V61, P159, DOI 10.3354/meps061159; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Hendriks IE, 2008, MAR ECOL PROG SER, V356, P163, DOI 10.3354/meps07316; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Koroleff F., 1983, METHODS SEAWATER ANA, V2nd, P205; Lamers LPM, 1998, ENVIRON SCI TECHNOL, V32, P199, DOI 10.1021/es970362f; Moore KA, 2004, J COASTAL RES, P162, DOI 10.2112/SI45-162.1; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; van der Heide T, 2008, OECOLOGIA, V158, P411, DOI 10.1007/s00442-008-1155-2; van der Heide T, 2009, LIMNOL OCEANOGR, V54, P2018, DOI 10.4319/lo.2009.54.6.2018; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; van der Heide T, 2010, ECOLOGY, V91, P362, DOI 10.1890/08-1567.1; van Katwijk MM, 2010, ESTUAR COAST SHELF S, V89, P175, DOI 10.1016/j.ecss.2010.06.008; vanKatwijk MM, 1997, MAR ECOL PROG SER, V157, P159, DOI 10.3354/meps157159; WARD LG, 1984, MAR GEOL, V59, P85, DOI 10.1016/0025-3227(84)90089-6; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WOOD ED, 1967, J MAR BIOL ASSOC UK, V47, P23, DOI 10.1017/S002531540003352X	32	87	90	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16504	10.1371/journal.pone.0016504	http://dx.doi.org/10.1371/journal.pone.0016504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283684	Green Published, Green Submitted, gold			2022-12-25	WOS:000286523400039
J	Guerrero, PA; Maggert, KA				Guerrero, Paola A.; Maggert, Keith A.			The CCCTC-Binding Factor (CTCF) of Drosophila Contributes to the Regulation of the Ribosomal DNA and Nucleolar Stability	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; CHROMATIN-STRUCTURE; RNA GENES; EPIGENETIC REGULATION; GENOME ORGANIZATION; ENHANCER BLOCKING; POLYMERASE PARP; RDNA; MELANOGASTER; INSULATOR	In the repeat array of ribosomal DNA (rDNA), only about half of the genes are actively transcribed while the others are silenced. In arthropods, transposable elements interrupt a subset of genes, often inactivating transcription of those genes. Little is known about the establishment or separation of juxtaposed active and inactive chromatin domains, or preferential inactivation of transposable element interrupted genes, despite identity in promoter sequences. CTCF is a sequence-specific DNA binding protein which is thought to act as a transcriptional repressor, block enhancer-promoter communication, and delimit juxtaposed domains of active and inactive chromatin; one or more of these activities might contribute to the regulation of this repeated gene cluster. In support of this hypothesis, we show that the Drosophila nucleolus contains CTCF, which is bound to transposable element sequences within the rDNA. Reduction in CTCF gene activity results in nucleolar fragmentation and reduced rDNA silencing, as does disruption of poly-ADP-ribosylation thought to be necessary for CTCF nucleolar localization. Our data establish a role for CTCF as a component necessary for proper control of transposable element-laden rDNA transcription and nucleolar stability.	[Guerrero, Paola A.] Texas A&M Univ, Dept Biochem Biophys, College Stn, TX 77843 USA; [Maggert, Keith A.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Guerrero, PA (corresponding author), Texas A&M Univ, Dept Biochem Biophys, College Stn, TX 77843 USA.	kmaggert@tamu.edu		Maggert, Keith/0000-0002-9291-9481	National Institutes of Health [R01 GM076092]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by National Institutes of Health R01 GM076092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGSHUMAN S, 2007, COLD SPRING HARB PRO; ASHBURNER M, 2005, DROSOPHILA LAB HDB, P1409; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; BOGART K, 2006, EXTRACTION TOTAL RNA; BROWNE MJ, 1984, NUCLEIC ACIDS RES, V12, P9111, DOI 10.1093/nar/12.23.9111; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Cohen S, 2003, GENOME RES, V13, P1133, DOI 10.1101/gr.907603; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Eickbush DG, 2008, MOL CELL BIOL, V28, P6452, DOI 10.1128/MCB.01015-08; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; HAWLEY RS, 1985, GENETICS, V109, P691; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; JAKUBCZAK JL, 1992, GENETICS, V131, P129; JAMRICH M, 1984, EMBO J, V3, P1541, DOI 10.1002/j.1460-2075.1984.tb02008.x; KIDD SJ, 1980, CELL, V19, P103, DOI 10.1016/0092-8674(80)90392-X; Konev AY, 2003, GENETICS, V165, P2039; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Langst G, 1998, EMBO J, V17, P3135, DOI 10.1093/emboj/17.11.3135; Maggert KA, 2002, GENETICS, V162, P1245; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; Ohlsson R, 2010, CHROMOSOMA; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Paredes S, 2009, GENETICS, V181, P1661, DOI 10.1534/genetics.108.099093; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Perrin L, 1998, J CELL SCI, V111, P2753; PLATA MP, 2008, CHROMOSOMA; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Smith ST, 2009, DEV BIOL, V328, P518, DOI 10.1016/j.ydbio.2008.12.039; Stage DE, 2007, GENOME RES, V17, P1888, DOI 10.1101/gr.6376807; STEFFENSEN DM, 1981, CHROMOSOMA, V82, P525, DOI 10.1007/BF00295011; Torrano V, 2006, J CELL SCI, V119, P1746, DOI 10.1242/jcs.02890; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Tulin A, 2006, GENETICS, V172, P363, DOI 10.1534/genetics.105.049239; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; VANDERNOBELEN S, 2008, TOUCHED CTCF ANAL MU, P175; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; WINKLES JA, 1985, J BIOL CHEM, V260, P7716; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhou J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000386	59	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16401	10.1371/journal.pone.0016401	http://dx.doi.org/10.1371/journal.pone.0016401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283722	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522200061
J	Opsteegh, M; Swart, A; Fonville, M; Dekkers, L; van der Giessen, J				Opsteegh, Marieke; Swart, Arno; Fonville, Manoj; Dekkers, Leo; van der Giessen, Joke			Age-Related Toxoplasma gondii Seroprevalence in Dutch Wild Boar Inconsistent with Lifelong Persistence of Antibodies	PLOS ONE			English	Article							RANGING DOMESTIC PIGS; SUS-SCROFA; NETHERLANDS; PREVALENCE; TESTS; INFECTION; ANIMALS; SYSTEMS; ISLAND; SPAIN	Toxoplasma gondii is an important zoonotic pathogen that is best known as a cause of abortion or abnormalities in the newborn after primary infection during pregnancy. Our aim was to determine the prevalence of T. gondii in wild boar to investigate the possible role of their meat in human infection and to get an indication of the environmental contamination with T. gondii. The presence of anti-T. gondii antibodies was determined by in-house ELISA in 509 wild boar shot in 2002/2003 and 464 wild boar shot in 2007. Most of the boar originated from the "Roerstreek'' (n = 673) or the "Veluwe'' (n = 241). A binormal mixture model was fitted to the log-transformed optical density values for wild boar up to 20 months old to estimate the optimal cut-off value (-0.685) and accompanying sensitivity (90.6%) and specificity (93.6%). The overall seroprevalence was estimated at 24.4% (95% CI: 21.1-27.7%). The prevalence did not show variation between sampling years or regions, indicating a stable and homogeneous infection pressure from the environment. The relation between age and seroprevalence was studied in two stages. Firstly, seroprevalence by age group was determined by fitting the binary mixture model to 200 animals per age category. The prevalence showed a steep increase until approximately 10 months of age but stabilized at approximately 35% thereafter. Secondly, we fitted the age-dependent seroprevalence data to several SIR-type models, with seropositives as infected (I) and seronegatives as either susceptible (S) or resistant (R). A model with a recovery rate (SIS) was superior to a model without a recovery rate (SI). This finding is not consistent with the traditional view of lifelong persistence of T. gondii infections. The high seroprevalence suggests that eating undercooked wild boar meat may pose a risk of infection with T. gondii.	[Opsteegh, Marieke; Swart, Arno; Fonville, Manoj; van der Giessen, Joke] Natl Inst Publ Hlth & Environm RIVM, Lab Zoonoses & Environm Microbiol, Bilthoven, Netherlands; [Opsteegh, Marieke] Univ Utrecht, Fac Vet Med, IRAS, Utrecht, Netherlands; [Dekkers, Leo] Anim Hlth Serv GD, Deventer, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University	Opsteegh, M (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Zoonoses & Environm Microbiol, Bilthoven, Netherlands.	marieke.opsteegh@rivm.nl			Dutch Food and Consumer Product Safety Authority (VWA)	Dutch Food and Consumer Product Safety Authority (VWA)	This work was financially supported by the Dutch Food and Consumer Product Safety Authority (VWA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolova D, 2007, ANN AGR ENV MED, V14, P71; Bartova E, 2006, VET PARASITOL, V142, P150, DOI 10.1016/j.vetpar.2006.06.022; Canters Kees J., 2005, Lutra, V48, P67; Choi WY, 1997, J INFECT DIS, V175, P1280, DOI 10.1086/593702; Diderrich V, 1996, J EUKARYOT MICROBIOL, V43, pS122, DOI 10.1111/j.1550-7408.1996.tb05038.x; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Dubey JP, 2009, VET PARASITOL, V164, P89, DOI 10.1016/j.vetpar.2009.05.018; Dubey JP, 1997, VET PARASITOL, V68, P41, DOI 10.1016/S0304-4017(96)01053-9; Dubey JP, 1997, J PARASITOL, V83, P839, DOI 10.2307/3284277; Edelhofer R, 1996, WIEN TIERARZTL MONAT, V83, P225; Elbers ARW, 2000, REV SCI TECH OIE, V19, P848, DOI 10.20506/rst.19.3.1254; Gauss CBL, 2005, VET PARASITOL, V131, P151, DOI 10.1016/j.vetpar.2005.04.023; Greiner M, 2000, PREV VET MED, V45, P43, DOI 10.1016/S0167-5877(00)00116-1; Hejlicek K, 1997, J WILDLIFE DIS, V33, P480, DOI 10.7589/0090-3558-33.3.480; Hofhuis A, 2010, EPIDEMIOL INFECT, V24, P1; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; JENSEN P, 1989, APPL ANIM BEHAV SCI, V23, P49, DOI 10.1016/0168-1591(89)90006-3; JENSEN P, 1986, APPL ANIM BEHAV SCI, V16, P131, DOI 10.1016/0168-1591(86)90105-X; Kijlstra A, 2004, INVEST OPHTH VIS SCI, V45, P3165, DOI 10.1167/iovs.04-0326; MULDER JL, 2007, MET FOTOVAL SCHROEVE; Opsteegh M, 2010, PREV VET MED, V96, P232, DOI 10.1016/j.prevetmed.2010.06.009; Richomme C, 2010, EPIDEMIOL INFECT, V138, P1257, DOI 10.1017/S0950268810000117; Richomme C, 2009, VET PARASITOL, V164, P296, DOI 10.1016/j.vetpar.2009.06.014; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Ruiz-Fons F, 2006, THERIOGENOLOGY, V65, P731, DOI 10.1016/j.theriogenology.2005.07.001; Schley L, 2003, MAMMAL REV, V33, P43, DOI 10.1046/j.1365-2907.2003.00010.x; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; van der Giessen J, 2007, VET PARASITOL, V148, P371, DOI 10.1016/j.vetpar.2007.06.009; VANKNAPEN F, 1982, VET QUART, V4, P101, DOI 10.1080/01652176.1982.9693848	29	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16240	10.1371/journal.pone.0016240	http://dx.doi.org/10.1371/journal.pone.0016240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283764	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200042
J	Boivin, A; Hanot, M; Malesys, C; Maalouf, M; Rousson, R; Rodriguez-Lafrasse, C; Ardail, D				Boivin, Anthony; Hanot, Maite; Malesys, Celine; Maalouf, Mira; Rousson, Robert; Rodriguez-Lafrasse, Claire; Ardail, Dominique			Transient Alteration of Cellular Redox Buffering before Irradiation Triggers Apoptosis in Head and Neck Carcinoma Stem and Non-Stem Cells	PLOS ONE			English	Article							L-BUTHIONINE-SULFOXIMINE; HUMAN-TUMOR-CELLS; CANCER-CELLS; OXIDATIVE STRESS; GLUTATHIONE DEPLETION; RADIATION RESPONSE; REACTIVE OXYGEN; BREAST-CANCER; IN-VITRO; PHASE-I	Background: Head and neck squamous cell carcinoma (HNSCC) is an aggressive and recurrent malignancy owing to intrinsic radioresistance and lack of induction of apoptosis. The major focus of this work was to design a transient glutathione depleting strategy during the course of irradiation of HNSCC in order to overcome their radioresistance associated with redox adaptation. Methodology/Principal Findings: Treatment of SQ20B cells with dimethylfumarate (DMF), a GSH-depleting agent, and L-Buthionine sulfoximine (BSO), an inhibitor of GSH biosynthesis 4 h before a 10 Gy irradiation led to the lowering of the endogenous GSH content to less than 10% of that in control cells and to the triggering of radiation-induced apoptotic cell death. The sequence of biochemical events after GSH depletion and irradiation included ASK-1 followed by JNK activation which resulted in the triggering of the intrinsic apoptotic pathway through Bax translocation to mitochondria. Conclusions: This transient GSH depletion also triggered radiation-induced cell death in SQ20B stem cells, a key event to overcome locoregional recurrence of HNSCC. Finally, our in vivo data highlight the relevance for further clinical trials of endogenous redox modulation to enhance the cytotoxic effects of radiotherapy.	[Boivin, Anthony; Hanot, Maite; Malesys, Celine; Maalouf, Mira; Rodriguez-Lafrasse, Claire; Ardail, Dominique] Univ Lyon 1, F-69365 Lyon, France; [Boivin, Anthony; Hanot, Maite; Malesys, Celine; Maalouf, Mira; Rodriguez-Lafrasse, Claire; Ardail, Dominique] Fac Med Lyon Sud, Lab Radiobiol Cellulaire & Mol, EA 3738, Oullins, France; [Rousson, Robert; Rodriguez-Lafrasse, Claire; Ardail, Dominique] Hosp Civils Lyon, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Boivin, A (corresponding author), Univ Lyon 1, F-69365 Lyon, France.	Dominique.ardail@univ-lyon1.fr	Rodriguez-Lafrasse, Claire/G-7741-2018		Ligue Contre le Cancer (Comite de l'Ain); Espace de Traitement Oncologique par Ions Legers a dimension Europeenne (ETOILE)	Ligue Contre le Cancer (Comite de l'Ain); Espace de Traitement Oncologique par Ions Legers a dimension Europeenne (ETOILE)	This work was supported by the Ligue Contre le Cancer (Comite de l'Ain) and Espace de Traitement Oncologique par Ions Legers a dimension Europeenne (ETOILE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Alphonse G, 2004, ONCOGENE, V23, P2703, DOI 10.1038/sj.onc.1207357; Alphonse G, 2002, INT J RADIAT BIOL, V78, P821, DOI 10.1080/09553000210153943; Andringa KK, 2006, CANCER RES, V66, P1605, DOI 10.1158/0008-5472.CAN-05-3462; Bailey HH, 1997, J NATL CANCER I, V89, P1789, DOI 10.1093/jnci/89.23.1789; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Bernier J, 2009, NAT REV CLIN ONCOL, V6, P266, DOI 10.1038/nrclinonc.2009.40; Biaglow JE, 2003, RADIAT RES, V159, P484, DOI 10.1667/0033-7587(2003)159[0484:RROCDA]2.0.CO;2; Bionda C, 2007, FREE RADICAL BIO MED, V43, P681, DOI 10.1016/j.freeradbiomed.2007.04.031; Castro B, 2002, ANTI-CANCER DRUG, V13, P281, DOI 10.1097/00001813-200203000-00010; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Chin D, 2006, EXPERT REV ANTICANC, V6, P1111, DOI 10.1586/14737140.6.7.1111; DETHLEFSEN LA, 1988, RADIAT RES, V114, P215, DOI 10.2307/3577219; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Fujisawa T, 2007, MOL BIOTECHNOL, V37, P13, DOI 10.1007/s12033-007-0053-x; GIGANTE M, 2003, AM J CLIN ONCOL-CANC, V26, P73; Graziano A, 2008, J CELL BIOCHEM, V103, P408, DOI 10.1002/jcb.21436; Gu B, 2005, ANTI-CANCER DRUG, V16, P167, DOI 10.1097/00001813-200502000-00008; Inci E, 2003, TOHOKU J EXP MED, V200, P17, DOI 10.1620/tjem.200.17; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; LEHNERT S, 1990, RADIAT RES, V124, P208, DOI 10.2307/3577868; LEUNG SW, 1993, CANCER-AM CANCER SOC, V71, P2276, DOI 10.1002/1097-0142(19930401)71:7<2276::AID-CNCR2820710718>3.0.CO;2-7; Lewis-Wambi JS, 2009, J STEROID BIOCHEM, V114, P33, DOI 10.1016/j.jsbmb.2008.12.016; Li LY, 2003, RADIAT RES, V160, P617, DOI 10.1667/RR3076; LIPPITZ BE, 1990, NEUROSURGERY, V26, P255, DOI 10.1227/00006123-199002000-00012; Lo Russo L, 2009, CURR OPIN INVEST DR, V10, P1325; Maalouf M, 2009, INT J RADIAT ONCOL, V74, P200, DOI 10.1016/j.ijrobp.2009.01.012; Maeda H, 2004, CELL DEATH DIFFER, V11, P737, DOI 10.1038/sj.cdd.4401389; Magwere T, 2008, EUR J CANCER, V44, P2276, DOI 10.1016/j.ejca.2008.06.008; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Mazeron R, 2009, ORAL ONCOL, V45, P402, DOI 10.1016/j.oraloncology.2009.01.010; Mirkovic N, 1997, ONCOGENE, V15, P1461, DOI 10.1038/sj.onc.1201310; MIURA M, 1991, RADIAT RES, V126, P229, DOI 10.2307/3577823; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Nelson KC, 1999, INVEST OPHTH VIS SCI, V40, P1927; Odom RY, 2009, NUTR CANCER, V61, P332, DOI 10.1080/01635580802549982; ODwyer PJ, 1996, J CLIN ONCOL, V14, P249, DOI 10.1200/JCO.1996.14.1.249; ORTA T, 1995, INT J RADIAT BIOL, V68, P413, DOI 10.1080/09553009514551371; Palomares T, 1999, MELANOMA RES, V9, P233, DOI 10.1097/00008390-199906000-00004; Palomares T, 2009, ANTICANCER RES, V29, P3957; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pervaiz S, 2004, CURR PHARM DESIGN, V10, P1969, DOI 10.2174/1381612043384411; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; SCHWARTZ JL, 1988, INT J RADIAT ONCOL, V15, P907, DOI 10.1016/0360-3016(88)90125-3; Sumbayev VV, 2005, ARCH BIOCHEM BIOPHYS, V436, P406, DOI 10.1016/j.abb.2005.02.021; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Thomas SM, 2009, HUM GENE THER, V20, P1565, DOI 10.1089/hum.2009.163; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vahrmeijer AL, 1999, CANCER CHEMOTH PHARM, V44, P111, DOI 10.1007/s002800050954; Wick W, 2002, INT J ONCOL, V21, P213; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8	63	47	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e14558	10.1371/journal.pone.0014558	http://dx.doi.org/10.1371/journal.pone.0014558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283807	Green Submitted, Green Published, gold			2022-12-25	WOS:000286520600005
J	Ren, YZR; Patel, K; Paun, BC; Kern, SE				Ren, Yunzhao R.; Patel, Kalpesh; Paun, Bogdan C.; Kern, Scott E.			Structural Analysis of the Cancer-specific Promoter in Mesothelin and in Other Genes Overexpressed in Cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; PANCREATIC CANCERS; TISSUE MICROARRAY; IMMUNOTOXIN SS1P; SERIAL ANALYSIS; PHASE-I; EXPRESSION; CARCINOMAS; PROTEINS; OVARIAN	Mesothelin (MSLN) may be the most "dramatic" of the tumor markers, being strongly overexpressed in nearly one-third of human malignancies. The biochemical cause is unclear. We previously ascribed this cancer-specific overexpression to an element, Canscript, residing around 50 bp 5` of the transcription start site in cancer (Hucl, T., Brody, J. R., Gallmeier, E., Iacobuzio-Donahue, C. A., Farrance, I. K., and Kern, S. E. (2007) Cancer Res. 67, 9055-9065). Herein, we found a Canscript promoter activity elevated over 100-fold in cancer cells. In addition to a highly conserved TEAD1 (TEA domain family member 1)-binding MCAT motif, nucleotide substitution revealed the consensus core sequence (WCYCCACCC) of an SP1-like motif in Canscript. The unknown transcription factor binding to the SP1-like motif may hold the key for the cancer specificity of Canscript. SP1, GLI1, and RUNX1, -2, and -3 appeared unlikely to be the direct transcription factors acting at the SP1-like motif, but KLF6 had some features of such a candidate. YAP1, a TEAD1-binding protein, appeared necessary, but not sufficient, for Canscript activity; knockdown of YAP1 by small interfering RNAs greatly reduced MSLN levels in MSLN-overexpressing cells, but overexpressing YAP1 in MSLN-negative cells did not induce MSLN expression. Cansript-like sequences were found in other genes up-regulated in pancreatic cancer; reporters driven by the sequences from FXYD3, MUC1, and TIMP1 had activities more than 2 times that of the control. This suggested that the cause of MSLN overexpression might also contribute mechanistically to the overexpression of other tumor markers.	[Ren, Yunzhao R.; Patel, Kalpesh; Paun, Bogdan C.; Kern, Scott E.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Kern, SE (corresponding author), CRB1 451,1650 Orleans St, Baltimore, MD 21231 USA.	sk@jhmi.edu	Patel, Kalpesh/G-6685-2012	Patel, Kalpesh/0000-0002-2952-6773	National Institutes of Health [CA62924]; Everett and Marjorie Kovler Professorship in Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Everett and Marjorie Kovler Professorship in Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA62924. This work was also supported by the Everett and Marjorie Kovler Professorship in Pancreatic Cancer Research.	Argani P, 2001, CLIN CANCER RES, V7, P3862; BERG JM, 1992, P NATL ACAD SCI USA, V89, P11109, DOI 10.1073/pnas.89.23.11109; BYRNE BJ, 1983, P NATL ACAD SCI-BIOL, V80, P721; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Cook T, 1999, ANN NY ACAD SCI, V880, P94, DOI 10.1111/j.1749-6632.1999.tb09513.x; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Frierson HF, 2003, HUM PATHOL, V34, P605, DOI 10.1016/S0046-8177(03)00177-1; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Hassan R, 2007, CLIN CANCER RES, V13, P5144, DOI 10.1158/1078-0432.CCR-07-0869; HAUCK W, 1994, EUR J BIOCHEM, V223, P529, DOI 10.1111/j.1432-1033.1994.tb19022.x; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Huang YH, 2010, CANCER BIOL THER, V10, P882, DOI 10.4161/cbt.10.9.13234; Hucl T, 2007, CANCER RES, V67, P9055, DOI 10.1158/0008-5472.CAN-07-0474; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Kitagawa M, 2007, BIOCHEM BIOPH RES CO, V361, P1022, DOI 10.1016/j.bbrc.2007.07.129; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Larkin SB, 1996, MOL CELL BIOL, V16, P3742; Maitra A, 2003, MODERN PATHOL, V16, P902, DOI 10.1097/01.MP.0000086072.56290.FB; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Muminova ZE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-19; Ryu B, 2002, CANCER RES, V62, P819; Sathyanarayana BK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-1; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Thiagalingam A, 1996, MOL CELL BIOL, V16, P5335; Urwin Debra, 2000, Molecular Cell Biology Research Communications, V3, P26, DOI 10.1006/mcbr.2000.0181; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; WATANABE K, 1987, J BIOL CHEM, V262, P4812; Yoshida T, 2008, ARTERIOSCL THROM VAS, V28, P8, DOI 10.1161/ATVBAHA.107.155788; Zhang YJ, 2006, CLIN CANCER RES, V12, P4695, DOI 10.1158/1078-0432.CCR-06-0346; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200	36	22	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.193458	http://dx.doi.org/10.1074/jbc.M110.193458			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288909	Green Published, hybrid			2022-12-25	WOS:000289077500009
J	Anunciado-Koza, RP; Zhang, JY; Ukropec, J; Bajpeyi, S; Koza, RA; Rogers, RC; Cefalu, WT; Mynatt, RL; Kozak, LP				Anunciado-Koza, Rea P.; Zhang, Jingying; Ukropec, Jozef; Bajpeyi, Sudip; Koza, Robert A.; Rogers, Richard C.; Cefalu, William T.; Mynatt, Randall L.; Kozak, Leslie P.			Inactivation of the Mitochondrial Carrier SLC25A25 (ATP-Mg2+/P-i Transporter) Reduces Physical Endurance and Metabolic Efficiency in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; RAT-LIVER MITOCHONDRIA; ATP-MG/PI CARRIER; ENERGY-EXPENDITURE; NONSHIVERING THERMOGENESIS; INSULIN SENSITIVITY; ADENINE-NUCLEOTIDES; UNCOUPLING PROTEIN; BODY-WEIGHT; CALCIUM	An ATP-Mg2+/P-i inner mitochondrial membrane solute transporter (SLC25A25), which is induced during adaptation to cold stress in the skeletal muscle of mice with defective UCP1/brown adipose tissue thermogenesis, has been evaluated for its role in metabolic efficiency. SLC25A25 is thought to control ATP homeostasis by functioning as a Ca2+-regulated shuttle of ATP-Mg2+ and P-i across the inner mitochondrial membrane. Mice with an inactivated Slc25a25 gene have reduced metabolic efficiency as evidenced by enhanced resistance to diet-induced obesity and impaired exercise performance on a treadmill. Mouse embryo fibroblasts from Slc25a25(-/-) mice have reduced Ca2+ flux across the endoplasmic reticulum, basal mitochondrial respiration, and ATP content. Although Slc25a25(-/-) mice are metabolically inefficient, the source of the inefficiency is not from a primary function in thermogenesis, because Slc25a25(-/-) mice maintain body temperature upon acute exposure to the cold (4 degrees C). Rather, the role of SLC25A25 in metabolic efficiency is most likely linked to muscle function as evidenced from the physical endurance test of mutant mice on a treadmill. Consequently, in the absence of SLC25A25 the efficiency of ATP production required for skeletal muscle function is diminished with secondary effects on adiposity. However, in the absence of UCP1-based thermogenesis, induction of Slc25a25 in mice with an intact gene may contribute to an alternative thermogenic pathway for the maintenance of body temperature during cold stress.	[Anunciado-Koza, Rea P.; Zhang, Jingying; Ukropec, Jozef; Bajpeyi, Sudip; Koza, Robert A.; Rogers, Richard C.; Cefalu, William T.; Mynatt, Randall L.; Kozak, Leslie P.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Kozak, LP (corresponding author), Polish Acad Sci Olsztyn, Ul Tuwima 10, PL-10747 Olsztyn, Poland.	l.kozak@pan.olsztyn.pl	Rogers, Richard/N-1988-2017; zhang, jingying R/R-4262-2018; Ukropec, Jozef/D-5960-2018; Mynatt, Randall L/N-1980-2017; Ukropec, Jozef/AAI-5590-2020	Ukropec, Jozef/0000-0001-8401-6621; Mynatt, Randall L/0000-0003-4399-0019; Bajpeyi, Sudip/0000-0002-5336-8330	National Institutes of Health [R01-HD008431, 1P30 DK07246, P20-TT021925]; Nutrition Obesity Research Center [1P30 DK07246]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD008431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, R01DK089641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutrition Obesity Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HD008431 (to L. P. K.) and 1P30 DK07246.; We thank Tamra Mendoza and Cody Giardina for excellent technical assistance. This work used the Genomics and Cell Biology an Bioimaging core facilities supported in part by the Nutrition Obesity Research Center Grant 1P30 DK07246 and COBRE (National Institutes of Health Grant P20-TT021925).	Alekseev AE, 2010, CELL METAB, V11, P58, DOI 10.1016/j.cmet.2009.11.009; Amo T, 2008, GENE, V411, P69, DOI 10.1016/j.gene.2008.01.007; Anunciado-Koza R, 2008, J BIOL CHEM, V283, P27688, DOI 10.1074/jbc.M804268200; APRILLE JR, 1988, FASEB J, V2, P2547, DOI 10.1096/fasebj.2.10.3290024; APRILLE JR, 1993, J BIOENERG BIOMEMBR, V25, P473, DOI 10.1007/BF01108404; Bajpeyi S, 2009, J APPL PHYSIOL, V106, P1079, DOI 10.1152/japplphysiol.91262.2008; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; Brown LJ, 2002, J BIOL CHEM, V277, P32892, DOI 10.1074/jbc.M202408200; BROWN LJ, 1994, J BIOL CHEM, V269, P14363; Cavero S, 2005, BIOCHEM J, V392, P537, DOI 10.1042/BJ20050806; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; del Arco A, 2005, BIOCHEM J, V389, P647, DOI 10.1042/BJ20050283; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Guerra C, 1998, J CLIN INVEST, V102, P1724, DOI 10.1172/JCI4532; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hawley JA, 2009, NUTR REV, V67, P172, DOI 10.1111/j.1753-4887.2009.00185.x; HAYNES RC, 1986, J BIOL CHEM, V261, P6121; HEMINGWAY A, 1963, PHYSIOL REV, V43, P397, DOI 10.1152/physrev.1963.43.3.397; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; JOYAL JL, 1992, J BIOL CHEM, V267, P19198; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Kranias E. G., 2007, V45, P523; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NOSEK MT, 1990, J BIOL CHEM, V265, P8444; Ochala J, 2009, UPSALA J MED SCI, V114, P235, DOI 10.3109/03009730903276399; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Periasamy M, 1999, J BIOL CHEM, V274, P2556, DOI 10.1074/jbc.274.4.2556; POLLAK JK, 1980, BIOCHEM J, V192, P75, DOI 10.1042/bj1920075; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; TRAYHURN P, 1978, PFLUG ARCH EUR J PHY, V373, P189, DOI 10.1007/BF00584859; Ukropec J, 2006, ENDOCRINOLOGY, V147, P2468, DOI 10.1210/en.2005-1216; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; ZURLO F, 1990, AM J PHYSIOL, V259, pE650	44	62	62	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11659	11671		10.1074/jbc.M110.203000	http://dx.doi.org/10.1074/jbc.M110.203000			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296886	hybrid, Green Published			2022-12-25	WOS:000288797100074
J	Engqvist, MKM; Kuhn, A; Wienstroer, J; Weber, K; Jansen, EEW; Jakobs, C; Weber, APM; Maurino, VG				Engqvist, Martin K. M.; Kuhn, Anke; Wienstroer, Judith; Weber, Katrin; Jansen, Erwin E. W.; Jakobs, Cornelis; Weber, Andreas P. M.; Maurino, Veronica G.			Plant D-2-Hydroxyglutarate Dehydrogenase Participates in the Catabolism of Lysine Especially during Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; L-2-HYDROXYGLUTARIC ACID; ALPHA-HYDROXYGLUTARATE; GENE-EXPRESSION; METABOLISM; OXIDATION; IDENTIFICATION; MITOCHONDRIA; PATHWAYS; PROTEINS	D-2-Hydroxyglutarate dehydrogenase (D-2HGDH) catalyzes the specific and efficient oxidation of D-2-hydroxyglutarate (D-2HG) to 2-oxoglutarate using FAD as a cofactor. In this work, we demonstrate that D-2HGDH localizes to plant mitochondria and that its expression increases gradually during developmental and dark-induced senescence in Arabidopsis thaliana, indicating an enhanced demand of respiration of alternative substrates through this enzymatic system under these conditions. Using loss-of-function mutants in D-2HGDH(d2hgdh1) and stable isotope dilution LC-MS/MS, we found that the D-isomer of 2HG accumulated in leaves of d2hgdh1 during both forms of carbon starvation. In addition to this, d2hgdh1 presented enhanced levels of most TCA cycle intermediates and free amino acids. In contrast to the deleterious effects caused by a deficiency in D-2HGDH in humans, d2hgdh1 and overexpressing lines of D-2HGDH showed normal developmental and senescence phenotypes, indicating a mild role of D-2HGDH in the tested conditions. Moreover, metabolic fingerprinting of leaves of plants grown in media supplemented with putative precursors indicated that D-2HG most probably originates during the catabolism of lysine. Finally, the L-isomer of 2HG was also detected in leaf extracts, indicating that both chiral forms of 2HG participate in plant metabolism.	[Engqvist, Martin K. M.; Kuhn, Anke; Wienstroer, Judith; Maurino, Veronica G.] Univ Cologne, Inst Bot, Biozentrum Koln, D-50674 Cologne, Germany; [Jansen, Erwin E. W.; Jakobs, Cornelis] Vrije Univ Amsterdam Med Ctr, Metab Unit, NL-1081 HV Amsterdam, Netherlands; [Weber, Katrin; Weber, Andreas P. M.] Univ Dusseldorf, Inst Biochem Pflanzen, D-40225 Dusseldorf, Germany	University of Cologne; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Heinrich Heine University Dusseldorf	Maurino, VG (corresponding author), Univ Cologne, Inst Bot, Biozentrum Koln, Zulpicher Str 47B, D-50674 Cologne, Germany.	v.maurino@uni-koeln.de	Weber, Andreas Paul Michael/O-3043-2019; Weber, Andreas PM/A-6250-2011	Weber, Andreas Paul Michael/0000-0003-0970-4672; Weber, Andreas PM/0000-0003-0970-4672; Engqvist, Martin/0000-0003-2174-2225	Deutsche Forschungsgemeinschaft, German Photorespiration Research Network Promics	Deutsche Forschungsgemeinschaft, German Photorespiration Research Network Promics(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grants (to V. G. M. and A. P. M. W.) as part of the German Photorespiration Research Network Promics.	Achouri Y, 2004, BIOCHEM J, V381, P35, DOI 10.1042/BJ20031933; Albers E, 1998, MICROBIOL-UK, V144, P1683, DOI 10.1099/00221287-144-6-1683; Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Bari R, 2004, J EXP BOT, V55, P623, DOI 10.1093/jxb/erh079; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Diaz C, 2005, PLANT PHYSIOL, V138, P898, DOI 10.1104/pp.105.060764; Engqvist M, 2009, J BIOL CHEM, V284, P25026, DOI 10.1074/jbc.M109.021253; Fahnenstich H, 2007, PLANT PHYSIOL, V145, P640, DOI 10.1104/pp.107.104455; Frerman F.E., 2001, METABOLIC MOL BASES; GIBSON KM, 1993, PEDIATR RES, V34, P277, DOI 10.1203/00006450-199309000-00007; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; KAUFMAN EE, 1988, J NEUROCHEM, V51, P1079, DOI 10.1111/j.1471-4159.1988.tb03071.x; KOPCHICK JJ, 1979, J BIOL CHEM, V254, P3259; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CP, 2008, MOL CELL PROTEOMICS, V7, P1297, DOI 10.1074/mcp.M700535-MCP200; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Lehmann M, 2009, MOL PLANT, V2, P390, DOI 10.1093/mp/ssn080; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Stepansky A, 2006, AMINO ACIDS, V30, P121, DOI 10.1007/s00726-005-0246-1; Struys EA, 2007, J INHERIT METAB DIS, V30, P690, DOI 10.1007/s10545-007-0697-5; Struys EA, 2006, J INHERIT METAB DIS, V29, P21, DOI 10.1007/s10545-006-0317-9; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Struys EA, 2004, CLIN CHEM, V50, P1391, DOI 10.1373/clinchem.2004.033399; Tomaz T, 2010, PLANT PHYSIOL, V154, P1143, DOI 10.1104/pp.110.161612; TUBBS PK, 1961, BIOCHEM J, V81, P104, DOI 10.1042/bj0810104; WEGENER WS, 1968, ARCH BIOCHEM BIOPHYS, V123, P62, DOI 10.1016/0003-9861(68)90103-3; Wydro M, 2006, ACTA BIOCHIM POL, V53, P289; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996	34	53	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11382	11390		10.1074/jbc.M110.194175	http://dx.doi.org/10.1074/jbc.M110.194175			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296880	hybrid, Green Published			2022-12-25	WOS:000288797100050
J	Sudo, Y; Yuasa, Y; Shibata, J; Suzuki, D; Homma, M				Sudo, Yuki; Yuasa, Yasufumi; Shibata, Jun; Suzuki, Daisuke; Homma, Michio			Spectral Tuning in Sensory Rhodopsin I from Salinibacter ruber	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHARAONIS PHOBORHODOPSIN; PROTON PUMP; WAVELENGTH REGULATION; OPSIN SHIFT; BACTERIORHODOPSIN; PROTEIN; BINDING; TRANSDUCTION; MECHANISM; RESIDUES	Organisms utilize light as energy sources and as signals. Rhodopsins, which have seven transmembrane alpha-helices with retinal covalently linked to a conserved Lys residue, are found in various organisms as distant in evolution as bacteria, archaea, and eukarya. One of the most notable properties of rhodopsin molecules is the large variation in their absorption spectrum. Sensory rhodopsin I (SRI) and sensory rhodopsin II (SRII) function as photosensors and have similar properties (retinal composition, photocycle, structure, and function) except for their lambda(max) (SRI, similar to 560 nm; SRII, similar to 500 nm). An expression system utilizing Escherichia coli and the high protein stability of a newly found SRI-like protein, SrSRI, enables studies of mutant proteins. To determine the residue contributing to the spectral shift from SRI to SRII, we constructed various SRI mutants, in which individual residues were substituted with the corresponding residues of SRII. Three such mutants of SrSRI showed a large spectral blue-shift (> 14 nm) without a large alteration of their retinal composition. Two of them, A136Y and A200T, are newly discovered color tuning residues. In the triple mutant, the lambda(max) was 525 nm. The inverse mutation of SRII (F134H/Y139A/T204A) generated a spectral-shifted SRII toward longer wavelengths, although the effect is smaller than in the case of SRI, which is probably due to the lack of anion binding in the SRII mutant. Thus, half of the spectral shift from SRI to SRII could be explained by only those three residues taking into account the effect of Cl- binding.	[Sudo, Yuki] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Sudo, Yuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Sudo, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	z47867a@cc.nagoya-u.ac.jp	Sudo, Yuki/AGY-0493-2022	Sudo, Yuki/0000-0001-8155-9356	Ministry of Education, Culture, Sports, Science, and Technology of Japan [477]; Japanese Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [23657100] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research on Priority Area 477 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to M. H. and Y. S.).	Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; BLATZ PE, 1972, BIOCHEMISTRY-US, V11, P848, DOI 10.1021/bi00755a026; Brown LS, 2004, PHOTOCH PHOTOBIO SCI, V3, P555, DOI 10.1039/b315527g; Costanzi S, 2009, CURR PHARM DESIGN, V15, P3994, DOI 10.2174/138161209789824795; Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367; Hayashi S, 2001, J PHYS CHEM B, V105, P10124, DOI 10.1021/jp011362b; HONIG B, 1979, J AM CHEM SOC, V101, P7084, DOI 10.1021/ja00517a060; HU JG, 1994, P NATL ACAD SCI USA, V91, P8880, DOI 10.1073/pnas.91.19.8880; Jung KH, 2007, PHOTOCHEM PHOTOBIOL, V83, P63, DOI 10.1562/2006-03-20-IR-853; Kitajima-Ihara T, 2008, J BIOL CHEM, V283, P23533, DOI 10.1074/jbc.M802990200; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Lin SL, 1997, PROTEIN ENG, V10, P197, DOI 10.1093/protein/10.3.197; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Rajamani R, 2002, J COMPUT CHEM, V23, P96, DOI 10.1002/jcc.1159; Ren L, 2001, BIOCHEMISTRY-US, V40, P13906, DOI 10.1021/bi0116487; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Sasaki J, 2008, PHOTOCHEM PHOTOBIOL, V84, P863, DOI 10.1111/j.1751-1097.2008.00314.x; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Shimono K, 2001, BBA-BIOMEMBRANES, V1515, P92, DOI 10.1016/S0005-2736(01)00394-7; Shimono K, 2000, PHOTOCHEM PHOTOBIOL, V72, P141; Spudich JL, 1996, CURR OPIN CELL BIOL, V8, P452, DOI 10.1016/S0955-0674(96)80020-2; Spudich JL, 2002, CURR OPIN STRUC BIOL, V12, P540, DOI 10.1016/S0959-440X(02)00359-7; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Sudo Y, 2006, J MOL BIOL, V357, P1274, DOI 10.1016/j.jmb.2006.01.061; Sudo Y, 2001, PHOTOCHEM PHOTOBIOL, V74, P489, DOI 10.1562/0031-8655(2001)074<0489:PPBTIC>2.0.CO;2; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Sudo Y, 2009, BIOCHEMISTRY-US, V48, P10136, DOI 10.1021/bi901338d; Suzuki D, 2010, SENSORS-BASEL, V10, P4010, DOI 10.3390/s100404010; Suzuki D, 2009, J MOL BIOL, V392, P48, DOI 10.1016/j.jmb.2009.06.050; Suzuki D, 2008, BIOCHEMISTRY-US, V47, P12750, DOI 10.1021/bi801358b; Walter JM, 2010, CURR OPIN BIOTECH, V21, P265, DOI 10.1016/j.copbio.2010.03.007; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Yagasaki J, 2010, BIOCHEMISTRY-US, V49, P1183, DOI 10.1021/bi901824a; YAN B, 1995, J BIOL CHEM, V270, P29668; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Yoshitsugu M, 2008, ANGEW CHEM INT EDIT, V47, P3923, DOI 10.1002/anie.200705989; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192	42	24	25	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11328	11336		10.1074/jbc.M110.187948	http://dx.doi.org/10.1074/jbc.M110.187948			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21288897	Green Published, hybrid			2022-12-25	WOS:000288797100045
J	Bonadies, N; Foster, SD; Chan, WI; Kvinlaug, BT; Spensberger, D; Dawson, MA; Spooncer, E; Whetton, AD; Bannister, AJ; Huntly, BJ; Gottgens, B				Bonadies, Nicolas; Foster, Samuel D.; Chan, Wai-In; Kvinlaug, Brynn T.; Spensberger, Dominik; Dawson, Mark A.; Spooncer, Elaine; Whetton, Anthony D.; Bannister, Andrew J.; Huntly, Brian J.; Goettgens, Berthold			Genome-Wide Analysis of Transcriptional Reprogramming in Mouse Models of Acute Myeloid Leukaemia	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; MLL; GATA-2; TRANSFORMATION; DIFFERENTIATION; PROGENITOR; REGULATORS; CANCER; BLOOD	Acute leukaemias are commonly caused by mutations that corrupt the transcriptional circuitry of haematopoietic stem/progenitor cells. However, the mechanisms underlying large-scale transcriptional reprogramming remain largely unknown. Here we investigated transcriptional reprogramming at genome-scale in mouse retroviral transplant models of acute myeloid leukaemia (AML) using both gene-expression profiling and ChIP-sequencing. We identified several thousand candidate regulatory regions with altered levels of histone acetylation that were characterised by differential distribution of consensus motifs for key haematopoietic transcription factors including Gata2, Gfi1 and Sfpi1/Pu.1. In particular, downregulation of Gata2 expression was mirrored by abundant GATA motifs in regions of reduced histone acetylation suggesting an important role in leukaemogenic transcriptional reprogramming. Forced re-expression of Gata2 was not compatible with sustained growth of leukaemic cells thus suggesting a previously unrecognised role for Gata2 in downregulation during the development of AML. Additionally, large scale human AML datasets revealed significantly higher expression of GATA2 in CD34+ cells from healthy controls compared with AML blast cells. The integrated genome-scale analysis applied in this study represents a valuable and widely applicable approach to study the transcriptional control of both normal and aberrant haematopoiesis and to identify critical factors responsible for transcriptional reprogramming in human cancer.	[Bonadies, Nicolas; Foster, Samuel D.; Chan, Wai-In; Kvinlaug, Brynn T.; Spensberger, Dominik; Dawson, Mark A.; Huntly, Brian J.; Goettgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England; [Bannister, Andrew J.] Univ Cambridge, Gurdon Inst, Cambridge, England; [Bannister, Andrew J.] Univ Cambridge, Dept Pathol, Cambridge, England; [Spooncer, Elaine; Whetton, Anthony D.] Univ Manchester, Sch Canc & Imaging Sci, Manchester, Lancs, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Manchester	Bonadies, N (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England.	bg200@cam.ac.uk	Foster, Samantha Michelle/GQI-0807-2022; Dawson, Mark A/B-9317-2017; Bonadies, Nicolas/F-2388-2017; huntly, brian/E-6725-2014	Dawson, Mark A/0000-0002-5464-5029; Bonadies, Nicolas/0000-0001-8761-2066; Gottgens, Berthold/0000-0001-6302-5705; WHETTON, ANTHONY D/0000-0002-1098-3878; Bannister, Andrew/0000-0002-6312-4436; Spensberger, Dominik/0000-0002-9798-2949; huntly, brian/0000-0003-0312-161X; Foster, Samuel/0000-0001-5375-7080	Leukemia & Lymphoma Research; Leukemia & Lymphoma Society; Cambridge Cancer Centre; Cancer Research UK; Medical Research Council; Roche Research Foundation; Huggenberger-Bischoff Stiftung zur Krebsforschung; Newton Trust; MRC [G116/187, G0800784] Funding Source: UKRI; Medical Research Council [G116/187, G0800784, G0800784B] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish	Leukemia & Lymphoma Research; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Cambridge Cancer Centre; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Roche Research Foundation; Huggenberger-Bischoff Stiftung zur Krebsforschung; Newton Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	This work was supported by grants from Leukemia & Lymphoma Research, Newton Trust, Leukemia & Lymphoma Society, Cambridge Cancer Centre, Cancer Research UK, Medical Research Council and fellowships to N.B. from the Roche Research Foundation and Huggenberger-Bischoff Stiftung zur Krebsforschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala RM, 2009, AM J HEMATOL, V84, P79, DOI 10.1002/ajh.21332; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; Carapeti M, 1998, BLOOD, V91, P3127, DOI 10.1182/blood.V91.9.3127.3127_3127_3133; Carver BS, 2006, CLIN CANCER RES, V12, P5305, DOI 10.1158/1078-0432.CCR-06-0482; Chan WYI, 2007, BLOOD, V109, P1908, DOI 10.1182/blood-2006-05-023226; Chapman MA, 2004, GENOME RES, V14, P313, DOI 10.1101/gr.1759004; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Donaldson IJ, 2005, HUM MOL GENET, V14, P595, DOI 10.1093/hmg/ddi056; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Eklund EA, 2007, CURR OPIN HEMATOL, V14, P85, DOI 10.1097/MOH.0b013e32801684b6; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; FOSTER SD, 2009, MOL BIOSYST; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harigae H, 2006, TOHOKU J EXP MED, V210, P1, DOI 10.1620/tjem.210.1; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hernandez JM, 2005, LEUKEMIA, V19, P1088, DOI 10.1038/sj.leu.2403753; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Heuser M, 2005, HAEMATOLOGICA, V90, P1484; Horton SJ, 2005, CANCER RES, V65, P9245, DOI 10.1158/0008-5472.CAN-05-1691; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Katsumoto T, 2008, CANCER SCI, V99, P1523, DOI 10.1111/j.1349-7006.2008.00865.x; Kennedy JA, 2008, LEUKEMIA, V22, P2029, DOI 10.1038/leu.2008.206; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Landry JR, 2009, BLOOD, V113, P5783, DOI 10.1182/blood-2008-11-187757; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; MARTENS JH, CANC CELL, V17, P173; Melnick AM, 2005, J CLIN ONCOL, V23, P3957, DOI 10.1200/JCO.2005.14.498; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park DJ, 2003, BLOOD, V102, P3727, DOI 10.1182/blood-2003-02-0412; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pimanda JE, 2008, BLOOD, V112, P4512, DOI 10.1182/blood-2008-05-157560; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Romer KA, 2007, NUCLEIC ACIDS RES, V35, pW217, DOI 10.1093/nar/gkm376; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; SPOONCER E, 1986, DIFFERENTIATION, V31, P111, DOI 10.1111/j.1432-0436.1986.tb00391.x; Stam RW, 2006, LEUKEMIA, V20, P264, DOI 10.1038/sj.leu.2404074; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tipping AJ, 2009, BLOOD, V113, P2661, DOI 10.1182/blood-2008-06-161117; Tonelli R, 2006, LEUKEMIA, V20, P1307, DOI 10.1038/sj.leu.2404221; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; VISVADER J, 1993, BLOOD, V82, P1493; Wang GG, 2005, BLOOD, V106, P254, DOI 10.1182/blood-2004-12-4664; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Wood AD, 2009, BLOOD, V114, P1820, DOI 10.1182/blood-2009-02-206573; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zhang SJ, 2008, P NATL ACAD SCI USA, V105, P2076, DOI 10.1073/pnas.0711824105	66	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16330	10.1371/journal.pone.0016330	http://dx.doi.org/10.1371/journal.pone.0016330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297973	Green Submitted, Green Published, gold			2022-12-25	WOS:000286664100023
J	Baird, AM; Gray, SG; O'Byrne, KJ				Baird, Anne-Marie; Gray, Steven G.; O'Byrne, Kenneth J.			Epigenetics Underpinning the Regulation of the CXC (ELR+) Chemokines in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							DUFFY ANTIGEN RECEPTOR; GROWTH-FACTOR; TUMOR-GROWTH; OXIDATIVE STRESS; MELANOMA GROWTH; BREAST-CANCER; INTERLEUKIN-8; ANGIOGENESIS; EXPRESSION; CARCINOMA	Background: Angiogenesis may play a role in the pathogenesis of Non-Small Cell Lung cancer (NSCLC). The CXC (ELR+) chemokine family are powerful promoters of the angiogenic response. Methods: The expression of the CXC (ELR+) family members (CXCL1-3/GRO alpha-gamma, CXCL8/IL-8, CXCR1/2) was examined in a series of resected fresh frozen NSCLC tumours. Additionally, the expression and epigenetic regulation of these chemokines was examined in normal bronchial epithelial and NSCLC cell lines. Results: Overall, expression of the chemokine ligands (CXCL1, 2, 8) and their receptors (CXCR1/2) were down regulated in tumour samples compared with normal, with the exception of CXCL3. CXCL8 and CXCR1/2 were found to be epigenetically regulated by histone post-translational modifications. Recombinant CXCL8 did not stimulate cell growth in either a normal bronchial epithelial or a squamous carcinoma cell line (SKMES-1). However, an increase was observed at 72 hours post treatment in an adenocarcinoma cell line. Conclusions: CXC (ELR+) chemokines are dysregulated in NSCLC. The balance of these chemokines may be critical in the tumour microenvironment and requires further elucidation. It remains to be seen if epigenetic targeting of these pathways is a viable therapeutic option in lung cancer treatment.	[Baird, Anne-Marie; Gray, Steven G.; O'Byrne, Kenneth J.] Trinity Coll Dublin, Inst Mol Med, Thorac Oncol Res Grp, Dublin, Ireland; [O'Byrne, Kenneth J.] St James Hosp, HOPE Directorate, Dublin 8, Ireland	Trinity College Dublin; Trinity College Dublin	Baird, AM (corresponding author), Trinity Coll Dublin, Inst Mol Med, Thorac Oncol Res Grp, Dublin, Ireland.	kobyrne@stjames.ie	Gray, Steven G./I-3081-2019	Gray, Steven G./0000-0002-5850-6392; Baird, Anne-Marie/0000-0001-7501-1159; O'Byrne, Kenneth/0000-0002-6754-5633	Pfizer	Pfizer(Pfizer)	This work was supported by an unrestricted educational grant from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Acosta JC, 2009, CANCER RES, V69, P2167, DOI 10.1158/0008-5472.CAN-08-3772; Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Addison CL, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-28; Anderson IC, 2000, CANCER RES, V60, P269; Arenberg DA, 1997, J LEUKOCYTE BIOL, V62, P554, DOI 10.1002/jlb.62.5.554; Arenberg DA, 1996, J CLIN INVEST, V97, P2792, DOI 10.1172/JCI118734; Arenberg D, 2006, J THORAC ONCOL, V1, P287, DOI 10.1097/01243894-200605000-00003; Atanackovic D, 2008, TUMOR BIOL, V29, P93, DOI 10.1159/000135689; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; Chavey C, 2008, MOL PHARMACOL, V74, P1359, DOI 10.1124/mol.108.047332; Colasante A, 1997, AM J RESP CRIT CARE, V156, P968, DOI 10.1164/ajrccm.156.3.9701122; Gabellini C, 2009, EUR J CANCER, V45, P2618, DOI 10.1016/j.ejca.2009.07.007; Gilmour PS, 2003, AM J PHYSIOL-LUNG C, V284, pL533, DOI 10.1152/ajplung.00277.2002; Heller G, 2010, CANCER METAST REV, V29, P95, DOI 10.1007/s10555-010-9203-x; Horton LW, 2007, CANCER RES, V67, P9791, DOI 10.1158/0008-5472.CAN-07-0246; Keane MP, 2004, J IMMUNOL, V172, P2853, DOI 10.4049/jimmunol.172.5.2853; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Lawless MW, 2009, J CELL MOL MED, V13, P2800, DOI 10.1111/j.1582-4934.2009.00845.x; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Luppi F, 2007, LUNG CANCER, V56, P25, DOI 10.1016/j.lungcan.2006.11.014; Makki MS, 2008, NUCLEIC ACIDS RES, V36, P4067, DOI 10.1093/nar/gkn356; Masuya D, 2001, CANCER, V92, P2628, DOI 10.1002/1097-0142(20011115)92:10<2628::AID-CNCR1616>3.0.CO;2-F; Mestas J, 2005, J IMMUNOL, V175, P5351, DOI 10.4049/jimmunol.175.8.5351; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; O'Byrne KJ, 2000, EUR J CANCER, V36, P151, DOI 10.1016/S0959-8049(99)00241-5; Ohri CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-172; Orditura M, 2002, J INTERF CYTOK RES, V22, P1129, DOI 10.1089/10799900260442557; Owen JD, 1997, INT J CANCER, V73, P94, DOI 10.1002/(SICI)1097-0215(19970926)73:1<94::AID-IJC15>3.0.CO;2-5; Pinskaya M, 2009, EPIGENETICS-US, V4, P302, DOI 10.4161/epi.4.5.9369; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Seike M, 2007, JNCI-J NATL CANCER I, V99, P1257, DOI 10.1093/jnci/djm083; Singh S, 2009, CANCER RES, V69, P411, DOI 10.1158/0008-5472.CAN-08-3378; Slettenaar VIF, 2006, ADV DRUG DELIVER REV, V58, P962, DOI 10.1016/j.addr.2006.03.012; Strieter RM, 2005, CYTOKINE GROWTH F R, V16, P593, DOI 10.1016/j.cytogfr.2005.04.007; Strieter RM, 2004, ANN NY ACAD SCI, V1028, P351, DOI 10.1196/annals.1322.041; Wang JY, 1996, J INTERF CYTOK RES, V16, P53, DOI 10.1089/jir.1996.16.53; Wente MN, 2006, CANCER LETT, V241, P221, DOI 10.1016/j.canlet.2005.10.041; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; Wislez M, 2004, INFLAMM RES, V53, P4, DOI 10.1007/s00011-003-1215-3; Yanagawa J, 2009, CLIN CANCER RES, V15, P6820, DOI 10.1158/1078-0432.CCR-09-1558; Zhou Q, 2009, BREAST CANCER RES TR, V117, P443, DOI 10.1007/s10549-008-0148-5; Zhu YM, 2004, BRIT J CANCER, V91, P1970, DOI 10.1038/sj.bjc.6602227; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	47	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e14593	10.1371/journal.pone.0014593	http://dx.doi.org/10.1371/journal.pone.0014593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298036	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900002
J	Gatta, V; Drago, D; Fincati, K; Valenti, MT; Carbonare, LD; Sensi, SL; Zatta, P				Gatta, Valentina; Drago, Denise; Fincati, Karina; Valenti, Maria Teresa; Carbonare, Luca Dalle; Sensi, Stefano L.; Zatta, Paolo			Microarray Analysis on Human Neuroblastoma Cells Exposed to Aluminum, beta(1-42)-Amyloid or the beta(1-42)-Amyloid Aluminum Complex	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; INSULIN-DEGRADING ENZYME; LONG-TERM POTENTIATION; ESTROGEN-RECEPTOR-ALPHA; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; GENE-EXPRESSION; TRANSCRIPTION FACTORS; INTRACELLULAR DOMAIN; CALCIUM HOMEOSTASIS	Background: A typical pathological feature of Alzheimer's disease (AD) is the appearance in the brain of senile plaques made up of beta-amyloid (A beta) and neurofibrillary tangles. AD is also associated with an abnormal accumulation of some metal ions, and we have recently shown that one of these, aluminum (Al), plays a relevant role in affecting A beta aggregation and neurotoxicity. Methodology: In this study, employing a microarray analysis of 35,129 genes, we investigated the effects induced by the exposure to the A beta(1-42)-Al (A beta-Al) complex on the gene expression profile of the neuronal-like cell line, SH-SY5Y. Principal Findings: The microarray assay indicated that, compared to A beta or Al alone, exposure to A beta-Al complex produced selective changes in gene expression. Some of the genes selectively over or underexpressed are directly related to AD. A further evaluation performed with Ingenuity Pathway analysis revealed that these genes are nodes of networks and pathways that are involved in the modulation of Ca2+ homeostasis as well as in the regulation of glutamatergic transmission and synaptic plasticity. Conclusions and Significance: A beta-Al appears to be largely involved in the molecular machinery that regulates neuronal as well as synaptic dysfunction and loss. A beta-Al seems critical in modulating key AD-related pathways such as glutamatergic transmission, Ca2+ homeostasis, oxidative stress, inflammation, and neuronal apoptosis.	[Gatta, Valentina] Univ G DAnnunzio, Dept Biomed Sci, Chieti Pescara, Italy; [Gatta, Valentina] Ctr Excellence Aging CeSI, Funct Genet Unit, Chieti, Italy; [Drago, Denise; Zatta, Paolo] Univ Padua, CNR Inst Biomed Technol, Dept Biol, Metalloprot Unit, Padua, Italy; [Fincati, Karina] Assoc Univ Padua, Venice, Italy; [Valenti, Maria Teresa; Carbonare, Luca Dalle] Univ Verona, Dept Biomed & Surg Sci, I-37100 Verona, Italy; [Sensi, Stefano L.] Mol Neurol Unit CeSI, Chieti, Italy; [Sensi, Stefano L.] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Sensi, Stefano L.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA	G d'Annunzio University of Chieti-Pescara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Padua; University of Padua; University of Verona; G d'Annunzio University of Chieti-Pescara; University of California System; University of California Irvine	Gatta, V (corresponding author), Univ G DAnnunzio, Dept Biomed Sci, Chieti Pescara, Italy.	ssensi@uci.edu; zatta@bio.unipd.it	Drago, Denise/K-8551-2016; Valenti, Maria Teresa/F-4712-2011; Carbonare, Luca Dalle/E-5720-2011; Sensi, Stefano L./O-1335-2019; Gatta, Valentina/G-5765-2014; Sensi, Stefano L./J-3164-2016	Drago, Denise/0000-0003-1363-5518; Sensi, Stefano L./0000-0002-0710-2574; Sensi, Stefano L./0000-0002-0710-2574; Valenti, Maria Teresa/0000-0003-1166-8033; GATTA, Valentina/0000-0002-9999-5823	Italian Ministry of Research and University [GNEO3PX83]	Italian Ministry of Research and University(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from Italian Ministry of Research and University "Fondo per gli Investimenti della Ricerca di Base (FIRB GNEO3PX83; PZ and SLS) and Progetti Ricerca di Interesse Nazionale (PRIN 2006; PRIN 2008 SLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerz L, 2007, J BIOL CHEM, V282, P10203, DOI 10.1074/jbc.M611183200; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Alexandrov PN, 2005, J ALZHEIMERS DIS, V8, P117; Aliev G, 2009, NEUROTOX RES, V16, P293, DOI 10.1007/s12640-009-9066-5; Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; Almeida A, 2005, J NEUROSCI, V25, P8115, DOI 10.1523/JNEUROSCI.1143-05.2005; Aronica E, 1998, NEUROSCIENCE, V82, P979; Aulia S, 2006, BIOCHEM BIOPH RES CO, V339, P1, DOI 10.1016/j.bbrc.2005.10.059; Balsinde J, 1999, J BIOL CHEM, V274, P25967, DOI 10.1074/jbc.274.37.25967; Bamburg JR, 2009, CELL MOTIL CYTOSKEL, V66, P635, DOI 10.1002/cm.20388; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; BATAILLE N, 1994, BIOCHEM BIOPH RES CO, V203, P1477, DOI 10.1006/bbrc.1994.2351; Bayer TA, 1997, ACTA NEUROPATHOL, V94, P519, DOI 10.1007/s004010050745; Bazan NG, 2002, PROSTAG OTH LIPID M, V68-9, P197, DOI 10.1016/S0090-6980(02)00031-X; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bernardini S, 2005, CLIN CHEM, V51, P944, DOI 10.1373/clinchem.2004.045955; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Canzoniero LMT, 2004, NEUROBIOL DIS, V15, P520, DOI 10.1016/j.nbd.2003.10.013; Carrasquillo MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008764; Carrasquillo MM, 2010, ARCH NEUROL; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Citri A, 2009, EUR J NEUROSCI, V30, P1443, DOI 10.1111/j.1460-9568.2009.06950.x; Cuello AC, 2010, NEURODEGENER DIS, V7, P96, DOI 10.1159/000285514; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Drago D, 2008, REJUV RES, V11, P861, DOI 10.1089/rej.2008.0761; Drago D, 2008, INT J BIOCHEM CELL B, V40, P731, DOI 10.1016/j.biocel.2007.10.014; Fahrenholz F, 2000, ANN NY ACAD SCI, V920, P215; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Francis YI, 2007, NEUROSCI LETT, V413, P137, DOI 10.1016/j.neulet.2006.11.036; Fu HJ, 2009, EUR J PHARMACOL, V623, P14, DOI 10.1016/j.ejphar.2009.09.013; Gerber U, 2007, CURR OPIN PHARMACOL, V7, P56, DOI 10.1016/j.coph.2006.08.008; GOOD PF, 1992, ANN NEUROL, V31, P286, DOI 10.1002/ana.410310310; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Guo Q, 1999, J NEUROSCI RES, V56, P457, DOI 10.1002/(SICI)1097-4547(19990601)56:5<457::AID-JNR2>3.0.CO;2-P; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Hoerndli FJ, 2004, ANAL BIOCHEM, V335, P30, DOI 10.1016/j.ab.2004.08.028; House E, 2004, J ALZHEIMERS DIS, V6, P291; Hwang EM, 2006, BIOCHEM BIOPH RES CO, V349, P654, DOI 10.1016/j.bbrc.2006.08.077; Ishunina TA, 2010, NEUROBIOL AGING; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Liang KW, 2010, J BIOL CHEM, V285, P935, DOI 10.1074/jbc.M109.051664; Lipton SA, 2007, CURR DRUG TARGETS, V8, P621, DOI 10.2174/138945007780618472; Liu GJ, 2006, J STRUCT BIOL, V155, P45, DOI 10.1016/j.jsb.2005.12.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lovell MA, 1998, NEUROLOGY, V51, P1562, DOI 10.1212/WNL.51.6.1562; Lukiw WJ, 1998, J MOL NEUROSCI, V11, P67, DOI 10.1385/JMN:11:1:67; Lukiw WJ, 2005, J INORG BIOCHEM, V99, P1895, DOI 10.1016/j.jinorgbio.2005.04.021; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Miners JS, 2009, J NEUROPATH EXP NEUR, V68, P902, DOI 10.1097/NEN.0b013e3181afe475; Morrison BE, 2007, CELL MOL LIFE SCI, V64, P2258, DOI 10.1007/s00018-007-7035-9; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Neumann S, 2006, J BIOL CHEM, V281, P7583, DOI 10.1074/jbc.M508340200; Pascale A, 2007, PHARMACOL RES, V55, P560, DOI 10.1016/j.phrs.2007.04.013; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Porrello E, 2006, EUR J NEUROL, V13, P639, DOI 10.1111/j.1468-1331.2006.01333.x; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; QUERFURTH HW, 1994, BIOCHEMISTRY-US, V33, P4550, DOI 10.1021/bi00181a016; Querfurth HW, 1997, J NEUROCHEM, V69, P1580; Ricchelli F, 2005, CELL MOL LIFE SCI, V62, P1724, DOI 10.1007/s00018-005-5141-0; Ricciarelli R, 2004, IUBMB LIFE, V56, P349, DOI 10.1080/15216540412331286002; Richartz-Salzburger E, 2007, J PSYCHIATR RES, V41, P174, DOI 10.1016/j.jpsychires.2006.01.010; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Roselli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006011; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Savaskan E, 2001, BRAIN RES, V908, P113, DOI 10.1016/S0006-8993(01)02610-5; Schaeffer EL, 2009, PSYCHOPHARMACOLOGY, V202, P37, DOI 10.1007/s00213-008-1351-0; Schupf N, 2008, DEMENT GERIATR COGN, V25, P476, DOI 10.1159/000126495; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Sheng M, 2000, J CELL SCI, V113, P1851; Spalletta G, 2007, AM J GERIAT PSYCHIAT, V15, P879, DOI 10.1097/JGP.0b013e3180547076; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Vukic V, 2009, NEUROBIOL DIS, V34, P95, DOI 10.1016/j.nbd.2008.12.007; Wang YP, 2007, J NEUROCHEM, V102, P957, DOI 10.1111/j.1471-4159.2007.04606.x; Wang ZF, 2006, J NEUROCHEM, V98, P1167, DOI 10.1111/j.1471-4159.2006.03956.x; Weihl CC, 1999, J NEUROCHEM, V73, P31, DOI 10.1046/j.1471-4159.1999.0730031.x; Wu FB, 2009, AGEING RES REV, V8, P147, DOI 10.1016/j.arr.2009.03.002; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	109	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15965	10.1371/journal.pone.0015965	http://dx.doi.org/10.1371/journal.pone.0015965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298039	gold, Green Published			2022-12-25	WOS:000286663900019
J	Niehof, M; Borlak, J				Niehof, Monika; Borlak, Juergen			HNF4alpha Dysfunction as a Molecular Rational for Cyclosporine Induced Hypertension	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; NUCLEAR FACTOR; II RECEPTORS; A TREATMENT; EXPRESSION; NEPHROTOXICITY; MECHANISM; GENE; ENDOTHELIN-1; MODULATION	Induction of tolerance against grafted organs is achieved by the immunosuppressive agent cyclosporine, a prominent member of the calcineurin inhibitors. Unfortunately, its lifetime use is associated with hypertension and nephrotoxicity. Several mechanism for cyclosporine induced hypertension have been proposed, i.e. activation of the sympathetic nervous system, endothelin-mediated systemic vasoconstriction, impaired vasodilatation secondary to reduction in prostaglandin and nitric oxide, altered cytosolic calcium translocation, and activation of the renin-angiotensin system (RAS). In this regard the molecular basis for undue RAS activation and an increased signaling of the vasoactive oligopeptide angiotensin II (AngII) remain elusive. Notably, angiotensinogen (AGT) is the precursor of AngII and transcriptional regulation of AGT is controlled by the hepatic nuclear factor HNF4alpha. To better understand the molecular events associated with cyclosporine induced hypertension, we investigated the effect of cyclosporine on HNF4alpha expression and activity and searched for novel HNF4alpha target genes among members of the RAS cascade. Using bioinformatic algorithm and EMSA bandshift assays we identified angiotensin II receptor type 1 (AGTR1), angiotensin I converting enzyme (ACE), and angiotensin I converting enzyme 2 (ACE2) as genes targeted by HNF4alpha. Notably, cyclosporine represses HNF4alpha gene and protein expression and its DNA-binding activity at consensus sequences to AGT, AGTR1, ACE, and ACE2. Consequently, the gene expression of AGT, AGTR1, and ACE2 was significantly reduced as evidenced by quantitative real-time RT-PCR. While RAS is composed of a sophisticated interplay between multiple factors we propose a decrease of ACE2 to enforce AngII signaling via AGTR1 to ultimately result in vasoconstriction and hypertension. Taken collectively we demonstrate cyclosporine to repress HNF4alpha activity through calcineurin inhibitor mediated inhibition of nuclear factor of activation of T-cells (NFAT) which in turn represses HNF4alpha that leads to a disturbed balance of RAS.	[Niehof, Monika; Borlak, Juergen] Fraunhofer Inst Toxicol & Expt Med, Ctr Mol Med & Med Biotechnol, Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany	Fraunhofer Gesellschaft; Hannover Medical School	Niehof, M (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Ctr Mol Med & Med Biotechnol, Hannover, Germany.	borlak@item.fraunhofer.de			Lower Saxony Ministry of Culture and Science; Volkswagen Foundation, Germany [25A.5-7251-99-3/00]	Lower Saxony Ministry of Culture and Science; Volkswagen Foundation, Germany(Volkswagen)	This work was supported by a grant of the Lower Saxony Ministry of Culture and Science and the Volkswagen Foundation, Germany, to J.B. (grant number: 25A.5-7251-99-3/00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson N, 2009, TOXICOL SCI, V112, P507, DOI 10.1093/toxsci/kfp216; Avdonin PV, 1999, KIDNEY INT, V55, P2407, DOI 10.1046/j.1523-1755.1999.00481.x; Bai JPF, 2010, PHARMACOTHERAPY, V30, P195, DOI 10.1592/phco.30.2.195; BANTLE JP, 1987, AM J MED, V83, P59, DOI 10.1016/0002-9343(87)90497-9; Bartholomeusz B, 1998, J HUM HYPERTENS, V12, P839, DOI 10.1038/sj.jhh.1000709; Batlle D, 2008, CURR OPIN NEPHROL HY, V17, P250, DOI 10.1097/MNH.0b013e3282f945c2; Borlak J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004662; Busauschina A, 2004, TRANSPL P, V36, p229S, DOI 10.1016/j.transproceed.2004.01.021; CARRIER M, 1991, AM J PHYSIOL, V261, pH1791, DOI 10.1152/ajpheart.1991.261.6.H1791; Cauduro RL, 2005, CLIN TRANSPLANT, V19, P470, DOI 10.1111/j.1399-0012.2005.00357.x; CLOZEL JP, 1993, J HYPERTENS, V11, P75, DOI 10.1097/00004872-199301000-00011; Curnow KM, 1996, CLIN EXP PHARMACOL P, V23, pS67, DOI 10.1111/j.1440-1681.1996.tb02816.x; EDWARDS BD, 1994, CLIN NEPHROL, V41, P350; Elton TS, 2003, TRENDS ENDOCRIN MET, V14, P66, DOI 10.1016/S1043-2760(02)00038-3; ERMAN A, 1990, J PHARM PHARMACOL, V42, P525, DOI 10.1111/j.2042-7158.1990.tb06614.x; Grobecker H. F., 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS94, DOI 10.1111/j.1440-1681.1995.tb02984.x; Heinze G, 2006, J AM SOC NEPHROL, V17, P889, DOI 10.1681/ASN.2005090955; Heisel O, 2004, AM J TRANSPLANT, V4, P583, DOI 10.1046/j.1600-6143.2003.00372.x; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; IWAI J, 1993, EUR J PHARM-ENVIRON, V248, P341; Jamaluddin M, 2000, MOL ENDOCRINOL, V14, P99, DOI 10.1210/me.14.1.99; JULIEN J, 1993, TRANSPLANTATION, V56, P885, DOI 10.1097/00007890-199310000-00022; Keidar S, 2007, CARDIOVASC RES, V73, P463, DOI 10.1016/j.cardiores.2006.09.006; Kel A, 2004, MOL PHARMACOL, V66, P1557, DOI 10.1124/mol.104.001677; Lassila M, 2002, CURR DRUG METAB, V3, P61, DOI 10.2174/1389200023337964; Letizia C, 1995, INT J CLIN PHARM RES, V15, P209; Li C, 2004, YONSEI MED J, V45, P1004, DOI 10.3349/ymj.2004.45.6.1004; LUKE RG, 1991, AM J HYPERTENS, V4, P468, DOI 10.1093/ajh/4.5.468; MASON J, 1991, KIDNEY INT, V39, pS28; MASON J, 1990, PEDIATR NEPHROL, V4, P554, DOI 10.1007/BF00869843; MORGAN BJ, 1991, HYPERTENSION, V18, P458, DOI 10.1161/01.HYP.18.4.458; Moser Marvin, 2007, J Clin Hypertens (Greenwich), V9, P9; MYERS BD, 1988, KIDNEY INT, V33, P590, DOI 10.1038/ki.1988.38; Niehof M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-68; Nishiyama A, 2003, HYPERTENSION, V42, P754, DOI 10.1161/01.HYP.0000085195.38870.44; Oudit GY, 2003, TRENDS CARDIOVAS MED, V13, P93, DOI 10.1016/S1050-1738(02)00233-5; PICHLER RH, 1995, J AM SOC NEPHROL, V6, P1186; Porrello ER, 2009, FRONT BIOSCI-LANDMRK, V14, P958, DOI 10.2741/3289; Ramirez C, 2000, EXP NEPHROL, V8, P161; REGITZZAGROSEK V, 1995, J CARDIOVASC PHARM, V26, P66, DOI 10.1097/00005344-199507000-00011; REGO A, 1991, J PHARMACOL EXP THER, V259, P905; RICHER C, 1984, BRIT J CLIN PHARMACO, V17, P243, DOI 10.1111/j.1365-2125.1984.tb02338.x; Robert N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007893.pub2; ROLLS KA, 1994, CLIN EXP PHARMACOL P, V21, P227, DOI 10.1111/j.1440-1681.1994.tb02502.x; Shang MH, 2008, CHINESE MED J-PEKING, V121, P983, DOI 10.1097/00029330-200806010-00005; SHEHATA M, 1995, EXP NEPHROL, V3, P173; Shimamoto Y, 2004, J BIOL CHEM, V279, P7770, DOI 10.1074/jbc.M310577200; Singer DRJ, 1996, J HUM HYPERTENS, V10, P395; TRESHAM JJ, 1990, TRANSPLANTATION, V49, P144, DOI 10.1097/00007890-199001000-00032; TRONC F, 1991, ANN CHIR, V45, P827; Varagic J, 2002, J MOL CELL CARDIOL, V34, P1435, DOI 10.1006/jmcc.2002.2075; Ventura HO, 1997, CURR OPIN CARDIOL, V12, P375, DOI 10.1097/00001573-199707000-00005; WOLF G, 1995, TRANSPLANTATION, V60, P237, DOI 10.1097/00007890-199508000-00005; Wu Mai-Szu, 2007, Chang Gung Med J, V30, P7; Yanai K, 1999, J BIOL CHEM, V274, P34605, DOI 10.1074/jbc.274.49.34605; YOUNG BA, 1995, KIDNEY INT, V48, P439, DOI 10.1038/ki.1995.312	57	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16319	10.1371/journal.pone.0016319	http://dx.doi.org/10.1371/journal.pone.0016319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298017	Green Published, gold, Green Submitted			2022-12-25	WOS:000286663900033
J	Tobler, M; Healey, M; Olsson, M				Tobler, Michael; Healey, Mo; Olsson, Mats			Digit Ratio, Color Polymorphism and Egg Testosterone in the Australian Painted Dragon	PLOS ONE			English	Article							SECONDARY SEXUAL CHARACTERS; LENGTH RATIO; DEVELOPMENTAL PLASTICITY; PHASIANUS-COLCHICUS; YOLK TESTOSTERONE; MATERNAL HORMONES; MATING-BEHAVIOR; ZEBRA FINCH; LIZARD; DIFFERENTIATION	Variation in exposure to sex hormones during early development contributes to phenotypic plasticity in vertebrate offspring. As a proposed marker for prenatal sex hormone exposure and because of their association with various physiological and behavioral characteristics, digit ratio and/or digit length have received notable interest within the field of evolutionary ecology. However, the validity of digit measures as a proxy of prenatal sex hormone exposure is controversial and only few studies have provided direct evidence for the link between digit development and prenatal sex hormones. Here, we report morph- and sex-specific variation in digit ratio in wild painted dragon lizards (Ctenophorus pictus). Lizards expressing a yellow bib have significantly larger third-to-fourth toe ratios (3D:4D) than lizards without a bib. Males have significantly smaller 3D:4D than females. Furthermore, we show that experimental elevation of yolk testosterone significantly increases 3D:4D in hatchling painted dragon lizards, but has no influence on hatchling size. Our results provide direct and indirect evidence for the involvement of prenatal sex steroids in digit development and it is suggested that digit ratio may be used as a biomarker for prenatal steroid exposure in this reptilian species. As such, digit ratio may provide a useful tool to study temporal or spatial differences in the proximate hormonal mechanisms modulating physiological and behavioural phenotypes.	[Tobler, Michael] Lund Univ, Dept Biol, Sect Anim Ecol, Lund, Sweden; [Tobler, Michael; Healey, Mo; Olsson, Mats] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Tobler, Michael; Healey, Mo; Olsson, Mats] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Lund University; University of Wollongong; University of Sydney	Tobler, M (corresponding author), Lund Univ, Dept Biol, Sect Anim Ecol, Lund, Sweden.	michael.tobler@zooekol.lu.se	Tobler, Michael/B-2754-2013; Olsson, Mats/AAK-5565-2021	Tobler, Michael/0000-0001-5895-6302; Olsson, Mats/0000-0002-4130-1323	Swiss National Science Foundation [PBSKA-119056]; Australian Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Australian Research Council(Australian Research Council)	The Swiss National Science Foundation (postdoctoral research fellowship PBSKA-119056 to M.T.) and the Australian Research Council (to M.O.) provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS EK, 1979, NEUROENDOCRINOLOGY, V29, P178, DOI 10.1159/000122920; Adkins-Regan E, 2009, DEV NEUROSCI-BASEL, V31, P342, DOI 10.1159/000216545; BALTHAZART J, 2003, HORMONES BRAIN BEHAV; Berenbaum SA, 2009, ENDOCRINOLOGY, V150, P5119, DOI 10.1210/en.2009-0774; Brana F, 2008, OECOLOGIA, V156, P275, DOI 10.1007/s00442-008-0996-z; BREEDLOVE SM, 1982, BRAIN RES, V237, P173, DOI 10.1016/0006-8993(82)90565-0; Carere C, 2007, TRENDS ENDOCRIN MET, V18, P73, DOI 10.1016/j.tem.2007.01.003; Chang JL, 2006, CAN J ZOOL, V84, P1489, DOI 10.1139/Z06-144; CLARK MM, 1995, TRENDS ECOL EVOL, V10, P151, DOI 10.1016/S0169-5347(00)89025-4; COLLAER ML, 1995, PSYCHOL BULL, V118, P55, DOI 10.1037/0033-2909.118.1.55; Crews D, 1998, AM ZOOL, V38, P118; Cutler GB, 1997, J STEROID BIOCHEM, V61, P141; DOHLER KD, 1984, BRAIN RES, V302, P291, DOI 10.1016/0006-8993(84)90242-7; Dreiss AN, 2008, BEHAV ECOL, V19, P16, DOI 10.1093/beheco/arm095; Dufty AM, 2002, TRENDS ECOL EVOL, V17, P190, DOI 10.1016/S0169-5347(02)02498-9; Forstmeier W, 2005, P R SOC B, V272, P2641, DOI 10.1098/rspb.2005.3264; Forstmeier W, 2008, GEN COMP ENDOCR, V156, P379, DOI 10.1016/j.ygcen.2008.01.007; Forstmeier W, 2010, P ROY SOC B-BIOL SCI, V277, P3353, DOI 10.1098/rspb.2010.1007; Garamszegi LZ, 2007, ANIM BEHAV, V74, P641, DOI 10.1016/j.anbehav.2006.11.023; Genovart M, 2008, BIOL LETTERS, V4, P461, DOI 10.1098/rsbl.2008.0272; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Healey M, 2007, ANIM BEHAV, V74, P337, DOI 10.1016/j.anbehav.2006.09.017; Healey M, 2009, AUSTRAL ECOL, V34, P636, DOI 10.1111/j.1442-9993.2009.01968.x; Helle S, 2010, BEHAV ECOL, V21, P1061, DOI 10.1093/beheco/arq105; HEWS DK, 1994, HORM BEHAV, V28, P1; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; Kratochvil L, 2009, BIOL LETTERS, V5, P643, DOI 10.1098/rsbl.2009.0346; Lancaster LT, 2007, ECOL LETT, V10, P798, DOI 10.1111/j.1461-0248.2007.01069.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Littell R.C., 2004, SAS SYSTEM MIXED MOD, Vsixth; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; McFadden D, 2002, HORM BEHAV, V42, P492, DOI 10.1006/hbeh.2002.1833; McIntyre MH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-10; Moore MC, 1998, AM ZOOL, V38, P133; Navarro C, 2007, BEHAV ECOL SOCIOBIOL, V61, P1161, DOI 10.1007/s00265-006-0329-3; Olsson M, 2007, MOL ECOL, V16, P5307, DOI 10.1111/j.1365-294X.2007.03578.x; Olsson M, 2007, PHYSIOL BEHAV, V91, P531, DOI 10.1016/j.physbeh.2007.04.025; Olsson M, 2009, EVOLUTION, V63, P695, DOI 10.1111/j.1558-5646.2008.00569.x; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Putz DA, 2004, EVOL HUM BEHAV, V25, P182, DOI 10.1016/j.evolhumbehav.2004.03.005; Radder RS, 2009, CURR BIOL, V19, P1102, DOI 10.1016/j.cub.2009.05.027; Rhen T, 2002, J NEUROENDOCRINOL, V14, P517, DOI 10.1046/j.1365-2826.2002.00820.x; Roberts EK, 2008, BIOL REPROD, V79, P43, DOI 10.1095/biolreprod.107.067074; Romano M, 2005, HORM BEHAV, V48, P342, DOI 10.1016/j.yhbeh.2005.03.007; Rubolini D, 2006, ANAT REC PART A, V288A, P491, DOI 10.1002/ar.a.20323; Saino N, 2007, NATURWISSENSCHAFTEN, V94, P207, DOI 10.1007/s00114-006-0188-9; Schlinger BA, 1998, ANNU REV PHYSIOL, V60, P407, DOI 10.1146/annurev.physiol.60.1.407; Talarovicova A, 2009, HORM BEHAV, V55, P235, DOI 10.1016/j.yhbeh.2008.10.010; Thornton J, 2009, HORM BEHAV, V55, P633, DOI 10.1016/j.yhbeh.2009.03.015; Uller T, 2007, FUNCT ECOL, V21, P544, DOI 10.1111/j.1365-2435.2007.01264.x; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Uller T, 2006, BIOL LETTERS, V2, P569, DOI 10.1098/rsbl.2006.0526; Voracek M, 2007, AM J HUM BIOL, V19, P142, DOI 10.1002/ajhb.20581; Voracek M, 2009, PSYCHOL REP, V104, P922, DOI 10.2466/PR0.104.3.922-956	54	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16225	10.1371/journal.pone.0016225	http://dx.doi.org/10.1371/journal.pone.0016225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283539	Green Submitted, gold, Green Published			2022-12-25	WOS:000286661400036
J	Zhang, JS; Zhao, QM; Guo, XF; Zuo, SQ; Cheng, JX; Jia, N; Wu, C; Dai, PF; Zhao, JY				Zhang, Jiu-Song; Zhao, Qiu-Min; Guo, Xiao-Fang; Zuo, Shu-Qing; Cheng, Jing-Xia; Jia, Na; Wu, Chao; Dai, Pei-Fang; Zhao, Jun-Ying			Isolation and Genetic Characteristics of Human Genotype 1 Japanese Encephalitis Virus, China, 2009	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; NS1 PROTEIN; IMMUNIZATION; SEQUENCE; EPITOPE; DOMAIN	Background: Several studies have shown that the predominant genotype of Chinese Japanese encephalitis virus (JEV) is evolving from genotype 3 to genotype 1. However, in recent years, almost all genotype 1 isolates were from mosquitoes, and genotype 1 has been less associated with human disease than genotype 3. This study reports the isolation of human genotype 1 JEV and its genetic characteristics to provide additional insights into human JE pathogens that are currently circulating in China. Methods and Results: In 2009, 31 cerebrospinal fluid samples were collected from patients living in Yunnan and Shanxi provinces and were used to inoculate Aedes albopictus C6/36 cells for virus isolation. The JEV strains were identified using immunofluorescent assays and the reverse transcription-polymerase chain reaction. Phylogenetic analyses based on the partial capsid/pre-membrane and full envelope (E) sequences were performed using Clustalx 1.8 software. Three JEV isolates were obtained from a 4-year-old girl and a 2-year-old boy living in Yunnan and an 82-year-old woman in Shanxi. The boy had been immunized with one dose of JE live attenuated vaccine. New isolates were grouped into genotype 1. Amino acid sequence for the viral E protein indicated 95% to 100% identity with each other and with other JEV strains. When compared with a consensus sequence of E protein, two amino acid substitutions were found: Ser(E-123)-Asn in the two Yunnan isolates and Lys(E-166)-Arg in the Shanxi isolate. Conclusions: Our findings indicate that the genotype 1 of JEV is causing human infections in China. Our observation of a previously vaccinated boy developing JE from genotype 1 virus infection also calls for more detailed studies, both in vitro and in vivo neutralization tests as well as active surveillance, to examine the possibility of a lack of complete protection conferred by the live attenuated JE vaccine against genotype 1 virus.	[Zhang, Jiu-Song; Zhao, Qiu-Min; Zuo, Shu-Qing; Jia, Na] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Guo, Xiao-Fang] Yunnan Inst Parasit Dis, Simao, Peoples R China; [Cheng, Jing-Xia; Dai, Pei-Fang; Zhao, Jun-Ying] Shanxi Ctr Dis Control & Prevent, Taiyuan, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Zhang, JS (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	zhang_jiusong@yahoo.com.cn			National High-Tech R & D Program (863 Project), China [2007AA02Z481]; National Natural Science Fund of China [30872152]	National High-Tech R & D Program (863 Project), China(National High Technology Research and Development Program of China); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This research was supported by National High-Tech R & D Program (863 Project) (No. 2007AA02Z481) of China and the National Natural Science Fund of China (No. 30872152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN WR, 1992, AM J TROP MED HYG, V47, P61, DOI 10.4269/ajtmh.1992.47.61; CHEN WR, 1990, J GEN VIROL, V71, P2915, DOI 10.1099/0022-1317-71-12-2915; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Kuwayama M, 2005, EMERG INFECT DIS, V11, P471; Lin CW, 2008, BIOTECHNOL LETT, V30, P205, DOI 10.1007/s10529-007-9529-9; Lin CW, 2003, J VIROL, V77, P2600, DOI 10.1128/JVI.77.4.2600-2606.2003; Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998; Liu W, 2006, VACCINE, V24, P5178, DOI 10.1016/j.vaccine.2006.04.006; MASON PW, 1989, J GEN VIROL, V70, P2037, DOI 10.1099/0022-1317-70-8-2037; NI HL, 1995, J GEN VIROL, V76, P409, DOI 10.1099/0022-1317-76-2-409; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9; Tajima S, 2010, VIROLOGY, V396, P298, DOI 10.1016/j.virol.2009.10.035; Takada K, 2000, ARCH VIROL, V145, P523, DOI 10.1007/s007050050043; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0; WANG HY, 2009, CHIN J VACCINES IMMU, V15, P337; Wang LH, 2007, EMERG INFECT DIS, V13, P1123, DOI 10.3201/eid1307.070010; Wang XJ, 2004, CHIN J VACCINES IMMU, V10, P215; WESTAWAY EG, 1987, ADV VIRUS RES, V33, P45, DOI 10.1016/S0065-3527(08)60316-4; Xu GY, 2004, VACCINE, V22, P1846, DOI 10.1016/j.vaccine.2003.09.015; Ye XF, 2010, J CLIN MICROBIOL, V48, P1343, DOI 10.1128/JCM.01009-09; Zhang JS, 2009, ARCH VIROL, V154, P1177, DOI 10.1007/s00705-009-0421-x; 梁国栋, 2005, [中华实验和临床病毒学杂志, Chinese Journal of Experimental and Clinical Virology], V19, P305	27	37	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16418	10.1371/journal.pone.0016418	http://dx.doi.org/10.1371/journal.pone.0016418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283590	gold, Green Published, Green Submitted			2022-12-25	WOS:000286661400049
J	Zimmer, I; Ropert-Coudert, Y; Kato, A; Ancel, A; Chiaradia, A				Zimmer, Ilka; Ropert-Coudert, Yan; Kato, Akiko; Ancel, Andre; Chiaradia, Andre			Does Foraging Performance Change with Age in Female Little Penguins (Eudyptula minor)?	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; DIVING BEHAVIOR; BREEDING PERFORMANCE; ATTACHMENT; PATTERNS; SUCCESS; BIRDS; PERTURBATIONS	Age-related changes in breeding performance are likely to be mediated through changes in parental foraging performance. We investigated the relationship of foraging performance with age in female little penguins at Phillip Island, Australia, during the guard phase of the 2005 breeding season. Foraging parameters were recorded with accelerometers for birds grouped into three age-classes: (1) young, (2) middle age and (3) old females. We found the diving behaviour of middle-aged birds differed from young and old birds. The dive duration of middle age females was shorter than that of young and old birds while their dive effort (measure for dive and post-dive duration relation) was lower than that of young ones, suggesting middle-aged birds were in better physical condition than other ones. There was no difference in prey pursuit frequency or duration between age classes, but in the hunting tactic. Females pursued more prey around and after reaching the maximum depth of dives the more experienced they were (old > middle age > young), an energy saving hunting tactic by probably taking advantage of up-thrust momentum. We suggest middle age penguins forage better than young or old ones because good physical condition and foraging experience could act simultaneously.	[Zimmer, Ilka; Ropert-Coudert, Yan; Kato, Akiko; Ancel, Andre] Univ Strasbourg, IPHC, Strasbourg, France; [Zimmer, Ilka; Ropert-Coudert, Yan; Kato, Akiko; Ancel, Andre] CNRS, UMR7178, Strasbourg, France; [Kato, Akiko] Natl Inst Polar Res, Tokyo, Japan; [Chiaradia, Andre] Phillip Isl Nat Pk, Res Dept, Cowes, Vic, Australia	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Zimmer, I (corresponding author), Univ Strasbourg, IPHC, Strasbourg, France.	yan.ropert-coudert@c-strasbourg.fr	Chiaradia, Andre/AAG-4928-2022; Kato, Akiko/W-2447-2019; Chiaradia, Andre/AFK-6634-2022	Chiaradia, Andre/0000-0002-6178-4211; Chiaradia, Andre/0000-0002-6178-4211; Kato, Akiko/0000-0002-8947-3634	BHP-Billiton; Japan Science Society; Australian Academy of Science; University of Strasbourg; Penguin Foundation; Japan Society for the Promotion of Science	BHP-Billiton; Japan Science Society; Australian Academy of Science; University of Strasbourg; Penguin Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the BHP-Billiton, the Japan Science Society, the Australian Academy of Science, the University of Strasbourg, the Penguin Foundation and the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Note that Phillip Island Nature Park is a not-for-profit organization dedicated to the protection and conservation of little penguins. The Park is controlled by a Board of Management appointed by the Minister for Environment of Victoria, Australia.	BANNASCH R, 1994, J EXP BIOL, V194, P83; Bethge P, 1997, J ZOOL, V242, P483; BUCKLEY FG, 1974, ECOLOGY, V55, P1053, DOI 10.2307/1940355; Bunce A, 2005, J ZOOL, V266, P163, DOI 10.1017/S0952836905006734; Cherel Y, 1999, MAR BIOL, V134, P375, DOI 10.1007/s002270050554; Chiaradia A, 2007, MAR BIOL, V151, P1535, DOI 10.1007/s00227-006-0593-9; Chiaradia A, 2006, ARDEA, V94, P257; Chiaradia Andre F., 1999, Marine Ornithology, V27, P13; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Cockburn A., 1991, INTRO EVOLUTIONARY E; Daniel TA, 2007, ANIM BEHAV, V74, P1241, DOI 10.1016/j.anbehav.2007.01.029; Daunt F, 2007, FUNCT ECOL, V21, P561, DOI 10.1111/j.1365-2435.2007.01260.x; Daunt F, 1999, P ROY SOC B-BIOL SCI, V266, P1489, DOI 10.1098/rspb.1999.0805; Devevey G, 2010, J ORNITHOL, V151, P251, DOI 10.1007/s10336-009-0456-5; DUNN EK, 1972, IBIS, V114, P360, DOI 10.1111/j.1474-919X.1972.tb00833.x; Elliott KH, 2008, ANIM BEHAV, V75, P1301, DOI 10.1016/j.anbehav.2007.09.024; Finch CE, 1990, LONGEVITY SENESCENCE; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; GREIG SA, 1983, ANIM BEHAV, V31, P1237, DOI 10.1016/S0003-3472(83)80030-X; Gremillet D, 1999, MAR ECOL PROG SER, V183, P263, DOI 10.3354/meps183263; Gurven M, 2006, J HUM EVOL, V51, P454, DOI 10.1016/j.jhevol.2006.05.003; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HOLMES DJ, 1995, AM ZOOL, V35, P307; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Limmer B, 2009, ANIM BEHAV, V77, P1095, DOI 10.1016/j.anbehav.2009.01.015; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; MORRIS M, 1990, SLEEP, V13, P1; Newton I, 1989, LIFETIME REPROD BIRD; Nisbet ICT, 2009, J AVIAN BIOL, V40, P296, DOI 10.1111/j.1600-048X.2008.04563.x; Nisbet ICT, 2002, J FIELD ORNITHOL, V73, P117, DOI 10.1648/0273-8570-73.2.117; Part T, 2001, ANIM BEHAV, V62, P379, DOI 10.1006/anbe.2001.1754; Part T, 1995, P ROY SOC LOND B BIO, V360, P113, DOI DOI 10.1098/RSPB.1995.0067; PUGESEK BH, 1983, ECOLOGY, V84, P829; Reid JM, 2003, J ANIM ECOL, V72, P765, DOI 10.1046/j.1365-2656.2003.00750.x; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Ropert-Coudert Y, 2007, DEEP-SEA RES PT II, V54, P415, DOI 10.1016/j.dsr2.2006.11.018; Ropert-Coudert Y, 2009, P ROY SOC B-BIOL SCI, V276, P4105, DOI 10.1098/rspb.2009.1399; Rose M.R., 1991, EVOLUTIONARY BIOL AG; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P579, DOI 10.1098/rspb.2005.3353; Simeone A, 2003, MAR BIOL, V143, P825, DOI 10.1007/s00227-003-1114-8; Stearns S.C., 1992, pi; WEIMERSKIRCH H, 1992, OIKOS, V64, P464, DOI 10.2307/3545162; Wilson RP, 2010, AQUAT BIOL, V8, P193, DOI 10.3354/ab00230; Wilson RP, 1997, POLAR BIOL, V17, P323, DOI 10.1007/PL00013373; WILSON RP, 1989, WILDLIFE SOC B, V17, P77; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; WILSON RP, 1992, AM NAT, V140, P179, DOI 10.1086/285409; Wilson RP, 2004, MAR ECOL PROG SER, V278, P303, DOI 10.3354/meps278303; WOOLLER RD, 1992, TRENDS ECOL EVOL, V7, P111, DOI 10.1016/0169-5347(92)90143-Y; WUNDERLE JM, 1991, CURR ORNITHOL, V8, P273; Zuur Alain F., 2009, P1	51	54	54	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16098	10.1371/journal.pone.0016098	http://dx.doi.org/10.1371/journal.pone.0016098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283573	Green Published, gold			2022-12-25	WOS:000286661400025
J	Ashby, JA; Stevenson, CEM; Jarvis, GE; Lawson, DM; Maule, AJ				Ashby, Jamie A.; Stevenson, Clare E. M.; Jarvis, Gavin E.; Lawson, David M.; Maule, Andrew J.			Structure-Based Mutational Analysis of eIF4E in Relation to sbm1 Resistance to Pea Seed-Borne Mosaic Virus in Pea	PLOS ONE			English	Article							INITIATION-FACTOR 4E; GENOME-LINKED PROTEIN; CAP-BINDING PROTEIN; TOBACCO-ETCH-VIRUS; BIMOLECULAR FLUORESCENCE COMPLEMENTATION; RECESSIVE POTYVIRUS RESISTANCE; TRANSLATION INITIATION; PISUM-SATIVUM; EIF4E-MEDIATED RESISTANCE; MACROMOLECULAR STRUCTURES	Background: Pea encodes eukaryotic translation initiation factor eIF4E (eIF4E(S)), which supports the multiplication of Pea seed-borne mosaic virus (PSbMV). In common with hosts for other potyviruses, some pea lines contain a recessive allele (sbm1) encoding a mutant eIF4E (eIF4E(R)) that fails to interact functionally with the PSbMV avirulence protein, VPg, giving genetic resistance to infection. Methodology/Principal Findings: To study structure-function relationships between pea eIF4E and PSbMV VPg, we obtained an X-ray structure for eIF4E(S) bound to m(7)GTP. The crystallographic asymmetric unit contained eight independent copies of the protein, providing insights into the structurally conserved and flexible regions of eIF4E. To assess indirectly the importance of key residues in binding to VPg and/or m(7)GTP, an extensive range of point mutants in eIF4E was tested for their ability to complement PSbMV multiplication in resistant pea tissues and for complementation of protein translation, and hence growth, in an eIF4E-defective yeast strain conditionally dependent upon ectopic expression of eIF4E. The mutants also dissected individual contributions from polymorphisms present in eIF4E(R) and compared the impact of individual residues altered in orthologous resistance alleles from other crop species. The data showed that essential resistance determinants in eIF4E differed for different viruses although the critical region involved (possibly in VPg-binding) was conserved and partially overlapped with the m(7)GTP-binding region. This overlap resulted in coupled inhibition of virus multiplication and translation in the majority of cases, although the existence of a few mutants that uncoupled the two processes supported the view that the specific role of eIF4E in potyvirus infection may not be restricted to translation. Conclusions/Significance: The work describes the most extensive structural analysis of eIF4E in relation to potyvirus resistance. In addition to defining functional domains within the eIF4E structure, we identified eIF4E alleles with the potential to convey novel virus resistance phenotypes.	[Ashby, Jamie A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Stevenson, Clare E. M.; Lawson, David M.; Maule, Andrew J.] John Innes Ctr, Norwich, Norfolk, England; [Jarvis, Gavin E.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland	University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Queens University Belfast	Ashby, JA (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	andy.maule@bbsrc.ac.uk		Jarvis, Gavin/0000-0003-4362-1133	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D521949/1]; BBSRC; BBSRC [BB/D521949/1] Funding Source: UKRI; MRC [G0601378] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D521949/1] Funding Source: researchfish; Medical Research Council [G0601378] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JAA was supported by UK Biotechnology and Biological Sciences Research Council (BBSRC) grant number BB/D521949/1. The BBSRC also provides a grant-in-aid to the John Innes Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Razzak A, 2009, MOL PLANT PATHOL, V10, P109, DOI 10.1111/j.1364-3703.2008.00513.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashby JA, 2009, ACTA CRYSTALLOGR F, V65, P836, DOI 10.1107/S1744309109027389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Brown CJ, 2007, J MOL BIOL, V372, P7, DOI 10.1016/j.jmb.2007.06.033; Brown CJ, 2009, CELL CYCLE, V8, P1905, DOI 10.4161/cc.8.12.8742; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1075, DOI 10.1094/MPMI-20-9-1075; CARRINGTON JC, 1990, J VIROL, V64, P1590, DOI 10.1128/JVI.64.4.1590-1597.1990; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallie DR, 2001, J VIROL, V75, P12141, DOI 10.1128/JVI.75.24.12141-12152.2001; Gao ZH, 2004, PLANT J, V40, P376, DOI 10.1111/j.1365-313X.2004.02215.x; German-Retana S, 2008, J VIROL, V82, P7601, DOI 10.1128/JVI.00209-08; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Grzela R, 2006, BIOCHIMIE, V88, P887, DOI 10.1016/j.biochi.2006.02.012; Hebrard E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-23; Hirsch S, 2009, PLANT CELL, V21, P545, DOI 10.1105/tpc.108.064501; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Hughes JMX, 1999, J BIOL CHEM, V274, P3261, DOI 10.1074/jbc.274.6.3261; Hwang J, 2009, MOL CELLS, V27, P329, DOI 10.1007/s10059-009-0042-y; Johansen IE, 2001, J VIROL, V75, P6609, DOI 10.1128/JVI.75.14.6609-6614.2001; Kang BC, 2005, PLANT J, V42, P392, DOI 10.1111/j.1365-313X.2005.02381.x; Keller KE, 1998, MOL PLANT MICROBE IN, V11, P124, DOI 10.1094/MPMI.1998.11.2.124; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; Khan MA, 2006, J BIOL CHEM, V281, P28002, DOI 10.1074/jbc.M605479200; Khan MA, 2009, J BIOL CHEM, V284, P35461, DOI 10.1074/jbc.M109.038463; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; LEVIS C, 1993, VIRUS GENES, V7, P367, DOI 10.1007/BF01703392; Ling KS, 2009, THEOR APPL GENET, V120, P191, DOI 10.1007/s00122-009-1169-0; Liu WZ, 2009, J BIOL CHEM, V284, P31336, DOI 10.1074/jbc.M109.049858; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; MARCOTRIGIANO J, 1997, NUCL ACIDS S SER; Michon T, 2006, FEBS J, V273, P1312, DOI 10.1111/j.1742-4658.2006.05156.x; Miyoshi H, 2006, BIOCHIMIE, V88, P329, DOI 10.1016/j.biochi.2005.09.002; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naderpour M, 2010, MOL PLANT PATHOL, V11, P255, DOI 10.1111/j.1364-3703.2009.00602.x; Nakahara KS, 2010, MOL PLANT MICROBE IN, V23, P1460, DOI 10.1094/MPMI-11-09-0277; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nicaise V, 2003, PLANT PHYSIOL, V132, P1272, DOI 10.1104/pp.102.017855; Nicaise V, 2007, FEBS LETT, V581, P1041, DOI 10.1016/j.febslet.2007.02.007; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Okade H, 2009, J BIOCHEM, V145, P299, DOI 10.1093/jb/mvn180; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rantalainen KI, 2008, VIROLOGY, V377, P280, DOI 10.1016/j.virol.2008.04.025; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Ruffel S, 2005, MOL GENET GENOMICS, V274, P346, DOI 10.1007/s00438-005-0003-x; Ruffel S, 2002, PLANT J, V32, P1067, DOI 10.1046/j.1365-313X.2002.01499.x; Sato M, 2005, FEBS LETT, V579, P1167, DOI 10.1016/j.febslet.2004.12.086; Stein N, 2005, PLANT J, V42, P912, DOI 10.1111/j.1365-313X.2005.02424.x; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tomoo K, 2005, BBA-PROTEINS PROTEOM, V1753, P191, DOI 10.1016/j.bbapap.2005.07.023; Truniger V, 2009, ADV VIRUS RES, V75, P119, DOI 10.1016/S0065-3527(09)07504-6; Truniger V, 2008, PLANT J, V56, P716, DOI 10.1111/j.1365-313X.2008.03630.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Yeam I, 2007, PLANT CELL, V19, P2913, DOI 10.1105/tpc.107.050997	68	35	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e15873	10.1371/journal.pone.0015873	http://dx.doi.org/10.1371/journal.pone.0015873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283665	Green Published, Green Submitted, gold			2022-12-25	WOS:000286523400008
J	Haddock, RE; Grayson, TH; Morris, MJ; Howitt, L; Chadha, PS; Sandow, SL				Haddock, Rebecca E.; Grayson, T. Hilton; Morris, Margaret J.; Howitt, Lauren; Chadha, Preet S.; Sandow, Shaun L.			Diet-Induced Obesity Impairs Endothelium-Derived Hyperpolarization via Altered Potassium Channel Signaling Mechanisms	PLOS ONE			English	Article							MYOENDOTHELIAL GAP-JUNCTIONS; CA2+-ACTIVATED K+ CHANNEL; SPONTANEOUSLY HYPERTENSIVE-RATS; MESENTERIC SMALL ARTERIES; DIABETIC ZDF RATS; SMALL-CONDUCTANCE; GUINEA-PIG; DEPENDENT HYPERPOLARIZATION; VASODILATOR FUNCTION; RESISTANCE ARTERIES	Background: The vascular endothelium plays a critical role in the control of blood flow. Altered endothelium-mediated vasodilator and vasoconstrictor mechanisms underlie key aspects of cardiovascular disease, including those in obesity. Whilst the mechanism of nitric oxide (NO)-mediated vasodilation has been extensively studied in obesity, little is known about the impact of obesity on vasodilation to the endothelium-derived hyperpolarization (EDH) mechanism; which predominates in smaller resistance vessels and is characterized in this study. Methodology/Principal Findings: Membrane potential, vessel diameter and luminal pressure were recorded in 4(th) order mesenteric arteries with pressure-induced myogenic tone, in control and diet-induced obese rats. Obesity, reflecting that of human dietary etiology, was induced with a cafeteria-style diet (similar to 30 kJ, fat) over 16-20 weeks. Age and sexed matched controls received standard chow (similar to 12 kJ, fat). Channel protein distribution, expression and vessel morphology were determined using immunohistochemistry, Western blotting and ultrastructural techniques. In control and obese rat vessels, acetylcholine-mediated EDH was abolished by small and intermediate conductance calcium-activated potassium channel (SK(Ca)/IK(Ca)) inhibition; with such activity being impaired in obesity. SK(Ca)-IK(Ca) activation with cyclohexyl-[2-(3,5-dimethylpyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine (CyPPA) and 1-ethyl-2-benzimidazolinone (1-EBIO), respectively, hyperpolarized and relaxed vessels from control and obese rats. IK(Ca)-mediated EDH contribution was increased in obesity, and associated with altered IK(Ca) distribution and elevated expression. In contrast, the SK(Ca)-dependent-EDH component was reduced in obesity. Inward-rectifying potassium channel (K(ir)) and Na(+)/K(+)-ATPase inhibition by barium/ouabain, respectively, attenuated and abolished EDH in arteries from control and obese rats, respectively; reflecting differential Kir expression and distribution. Although changes in medial properties occurred, obesity had no effect on myoendothelial gap junction density. Conclusion/Significance: In obese rats, vasodilation to EDH is impaired due to changes in the underlying potassium channel signaling mechanisms. Whilst myoendothelial gap junction density is unchanged in arteries of obese compared to control, increased IK(Ca) and Na(+)/K(+)-ATPase, and decreased Kir underlie changes in the EDH mechanism.	[Haddock, Rebecca E.; Grayson, T. Hilton; Morris, Margaret J.; Howitt, Lauren; Chadha, Preet S.; Sandow, Shaun L.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia; [Haddock, Rebecca E.] Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 2601, Australia	University of New South Wales Sydney; Australian National University; John Curtin School of Medical Research	Haddock, RE (corresponding author), Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia.	Rebecca.Haddock@anu.edu.au; Shaun.Sandow@unsw.edu.au	Morris, Margaret J/J-4285-2013; Sandow, Shaun/N-4256-2016; Grayson, Thomas H/F-2708-2011	Sandow, Shaun/0000-0002-0753-2742; Haddock, Rebecca/0000-0001-7755-7841; Morris, Margaret/0000-0003-2285-5117	National Health and Medical Research Council of Australia [ID 466009, ID 401112, ID 455243]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia [ID 466009 to REH, ID 401112 SLS and ID 455243 to SLS and MJM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003; Boettger MK, 2002, BRAIN, V125, P252, DOI 10.1093/brain/awf026; Brondum E, 2010, BRIT J PHARMACOL, V159, P154, DOI 10.1111/j.1476-5381.2009.00525.x; Bund SJ, 2003, J VASC RES, V40, P547, DOI 10.1159/000075678; Burnham MP, 2006, BRIT J PHARMACOL, V148, P434, DOI 10.1038/sj.bjp.0706748; Burnham MP, 2002, BRIT J PHARMACOL, V135, P1133, DOI 10.1038/sj.bjp.0704551; Cao YX, 2005, ARCH PHARM RES, V28, P709, DOI 10.1007/BF02969362; Chadha PS, 2010, J PHARMACOL EXP THER, V335, P284, DOI 10.1124/jpet.110.167593; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006259; Chen MX, 2004, N-S ARCH PHARMACOL, V369, P602, DOI 10.1007/s00210-004-0934-5; Coleman HA, 2001, J PHYSIOL-LONDON, V531, P359, DOI 10.1111/j.1469-7793.2001.0359i.x; Dalsgaard T, 2010, BRIT J PHARMACOL, V160, P1496, DOI 10.1111/j.1476-5381.2010.00803.x; de Kreutzenberg SV, 2003, ATHEROSCLEROSIS, V169, P147, DOI 10.1016/S0021-9150(03)00153-9; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Ellis A, 2009, J PHARMACOL EXP THER, V330, P413, DOI 10.1124/jpet.109.152116; Erdei N, 2006, AM J PHYSIOL-HEART C, V291, pH2107, DOI 10.1152/ajpheart.00389.2006; Feletou M, 2004, PHARMACOL RES, V49, P565, DOI 10.1016/j.phrs.2003.10.017; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; FENGERGRON J, 1995, J PHYSIOL-LONDON, V488, P753, DOI 10.1113/jphysiol.1995.sp021006; Figueroa XF, 2009, ANTIOXID REDOX SIGN, V11, P251, DOI 10.1089/ars.2008.2117; Frisbee JC, 2002, AM J PHYSIOL-HEART C, V283, pH2160, DOI 10.1152/ajpheart.00379.2002; Fukao M, 1997, BRIT J PHARMACOL, V120, P1328, DOI 10.1038/sj.bjp.0701027; GARLAND CJ, 1995, TRENDS PHARMACOL SCI, V16, P23, DOI 10.1016/S0165-6147(00)88969-5; Giachini FRC, 2009, TRANSL RES, V154, P183, DOI 10.1016/j.trsl.2009.07.003; Giachini FRC, 2009, HYPERTENSION, V53, P409, DOI 10.1161/HYPERTENSIONAHA.108.124404; Grassi G, 2010, OBESITY, V18, P92, DOI 10.1038/oby.2009.195; Haddock RE, 2006, AM J PHYSIOL-HEART C, V291, pH2047, DOI 10.1152/ajpheart.00484.2006; Hansen MJ, 2004, J NEUROCHEM, V88, P909, DOI 10.1046/j.1471-4159.2003.02217.x; Haslam D, 2010, PRIM CARE DIABETES, V4, P105, DOI 10.1016/j.pcd.2010.04.002; Hayashi K, 2002, METABOLISM, V51, P1553, DOI 10.1053/meta.2002.36311; Hilgers RHP, 2010, J PHARMACOL EXP THER, V333, P210, DOI 10.1124/jpet.109.161448; Hougaard C, 2007, BRIT J PHARMACOL, V151, P655, DOI 10.1038/sj.bjp.0707281; Jebelovszki E, 2008, AM J PHYSIOL-HEART C, V294, pH2558, DOI 10.1152/ajpheart.01198.2007; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kusama N, 2005, BRIT J PHARMACOL, V146, P487, DOI 10.1038/sj.bjp.0706363; Leuranguer V, 2008, N-S ARCH PHARMACOL, V377, P101, DOI 10.1007/s00210-008-0267-x; Matchkov VV, 2004, BRIT J PHARMACOL, V142, P961, DOI 10.1038/sj.bjp.0705870; Mather S, 2005, CIRC RES, V97, P399, DOI 10.1161/01.RES.0000178008.46759.d0; McGuire JJ, 2001, CAN J PHYSIOL PHARM, V79, P443, DOI 10.1139/cjpp-79-6-443; MCNAMEE CJ, 1994, CIRC RES, V74, P1126, DOI 10.1161/01.RES.74.6.1126; Mongan LC, 2005, NEUROSCIENCE, V131, P161, DOI 10.1016/j.neuroscience.2004.09.062; Mulvany MJ, 1996, HYPERTENSION, V28, P505; Murphy TV, 2007, BRIT J PHARMACOL, V151, P602, DOI 10.1038/sj.bjp.0707262; NEILD TO, 1989, BLOOD VESSELS, V26, P48; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Rummery NM, 2005, J HYPERTENS, V23, P317, DOI 10.1097/00004872-200502000-00014; Sandow SL, 2007, TRENDS PHARMACOL SCI, V28, P61, DOI 10.1016/j.tips.2006.12.007; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sandow SL, 2009, CLIN EXP PHARMACOL P, V36, P67, DOI 10.1111/j.1440-1681.2008.05076.x; Sandow SL, 2004, CLIN EXP PHARMACOL P, V31, P563, DOI 10.1111/j.1440-1681.2004.04048.x; Sandow SL, 2004, J PHYSIOL-LONDON, V556, P875, DOI 10.1113/jphysiol.2003.058669; Sandow SL, 2003, CARDIOVASC RES, V60, P643, DOI 10.1016/j.cardiores.2003.09.017; Sandow SL, 2002, CIRC RES, V90, P1108, DOI 10.1161/01.RES.0000019756.88731.83; Tare M, 2002, AM J PHYSIOL-HEART C, V282, pH335, DOI 10.1152/ajpheart.2002.282.1.H335; Vanhoutte PM, 2005, BRIT J PHARMACOL, V144, P449, DOI 10.1038/sj.bjp.0706042; Velkoska E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1236, DOI 10.1152/ajpendo.00505.2004; Weston AH, 2010, BRIT J PHARMACOL, V160, P836, DOI 10.1111/j.1476-5381.2010.00657.x; Young EJ, 2008, DIABETOLOGIA, V51, P872, DOI 10.1007/s00125-008-0934-y	58	55	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16423	10.1371/journal.pone.0016423	http://dx.doi.org/10.1371/journal.pone.0016423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283658	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522300045
J	Matsunoshita, Y; Ijiri, K; Ishidou, Y; Nagano, S; Yamamoto, T; Nagao, H; Komiya, S; Setoguchi, T				Matsunoshita, Yukihiro; Ijiri, Kosei; Ishidou, Yasuhiro; Nagano, Satoshi; Yamamoto, Takuya; Nagao, Hiroko; Komiya, Setsuro; Setoguchi, Takao			Suppression of Osteosarcoma Cell Invasion by Chemotherapy Is Mediated by Urokinase Plasminogen Activator Activity via Up-Regulation of EGR1	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITOR; EARLY GROWTH RESPONSE-1; NONMETASTATIC OSTEOSARCOMA; NEOADJUVANT CHEMOTHERAPY; MULTIDRUG-RESISTANCE; CANINE OSTEOSARCOMA; 27-YEAR EXPERIENCE; TUMOR-SUPPRESSOR; RECEPTOR GENE; EXPRESSION	Background: The cellular and molecular mechanisms of tumour response following chemotherapy are largely unknown. We found that low dose anti-tumour agents up-regulate early growth response 1 (EGR1) expression. EGR1 is a member of the immediate-early gene group of transcription factors which modulate transcription of multiple genes involved in cell proliferation, differentiation, and development. It has been reported that EGR1 act as either tumour promoting factor or suppressor. We therefore examined the expression and function of EGR1 in osteosarcoma. Methods: We investigated the expression of EGR1 in human osteosarcoma cell lines and biopsy specimens. We next examined the expression of EGR1 following anti-tumour agents treatment. To examine the function of EGR1 in osteosarcoma, we assessed the tumour growth and invasion in vitro and in vivo. Results: Real-time PCR revealed that EGR1 was down-regulated both in osteosarcoma cell lines and osteosarcoma patients' biopsy specimens. In addition, EGR1 was up-regulated both in osteosarcoma patient' specimens and osteosarcoma cell lines following anti-tumour agent treatment. Although forced expression of EGR1 did not prevent osteosarcoma growth, forced expression of EGR1 prevented osteosarcoma cell invasion in vitro. In addition, forced expression of EGR1 promoted down-regulation of urokinase plasminogen activator, urokinase receptor, and urokinase plasminogen activity. Xenograft mice models showed that forced expression of EGR1 prevents osteosarcoma cell migration into blood vessels. Conclusions: These findings suggest that although chemotherapy could not prevent osteosarcoma growth in chemotherapy-resistant patients, it did prevent osteosarcoma cell invasion by down-regulation of urokinase plasminogen activity via up-regulation of EGR1 during chemotherapy periods.	[Matsunoshita, Yukihiro; Ijiri, Kosei; Nagano, Satoshi; Yamamoto, Takuya; Nagao, Hiroko; Komiya, Setsuro; Setoguchi, Takao] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthopaed Surg, Kagoshima 890, Japan; [Ishidou, Yasuhiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Med Joint Mat, Kagoshima 890, Japan	Kagoshima University; Kagoshima University	Matsunoshita, Y (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthopaed Surg, Kagoshima 890, Japan.	setoro@m2.kufm.kagoshima-u.ac.jp		Nagano, Satoshi/0000-0003-2015-1730	Ministry of Health, Labour, and Welfare of Japan for the Third Term Comprehensive Control Research for Cancer [18390419, 19591725, 20591786, 21591919, 21591920, 22591663]	Ministry of Health, Labour, and Welfare of Japan for the Third Term Comprehensive Control Research for Cancer	This work was supported by Grants-in-Aid for Scientific Research (B) 18390419, (C) 19591725, (C) 20591786, (C) 21591919, (C) 21591920, and (C) 22591663 (KAKENHI), and a Grant-in-Aid from the Ministry of Health, Labour, and Welfare of Japan for the Third Term Comprehensive Control Research for Cancer (http://www.jsps.go.jp/j-grantsinaid/index.html, http://ganjoho.ncc.go.jp/pro/taigan/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bacci G, 2005, EUR J CANCER, V41, P2836, DOI 10.1016/j.ejca.2005.08.026; Bacci G, 2007, J SURG ONCOL, V96, P118, DOI 10.1002/jso.20628; Baek SJ, 2005, MOL PHARMACOL, V67, P356, DOI 10.1124/mol.104.005108; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Chang Y, 2006, J VIROL, V80, P7748, DOI 10.1128/JVI.02608-05; Chen CC, 2004, J CELL BIOCHEM, V93, P1063, DOI 10.1002/jcb.20257; Dass CR, 2005, CLIN EXP METASTAS, V22, P643, DOI 10.1007/s10585-006-9004-3; de Belle I, 1999, ONCOGENE, V18, P3633, DOI 10.1038/sj.onc.1202696; de Bock CE, 2005, FEBS J, V272, P3572, DOI 10.1111/j.1742-4658.2005.04778.x; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Goorin AM, 2003, J CLIN ONCOL, V21, P1574, DOI 10.1200/JCO.2003.08.165; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HAMILTON JW, 1994, ANN NY ACAD SCI, V726, P343, DOI 10.1111/j.1749-6632.1994.tb52846.x; Henley DB, 2009, EXPERT OPIN PHARMACO, V10, P1657, DOI 10.1517/14656560903044982; Hirotsu M, 2009, BRIT J CANCER, V101, P2030, DOI 10.1038/sj.bjc.6605407; Hirotsu M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-5; HOTTA T, 1992, ACTA PATHOL JAPON, V42, P595; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; HUANG RP, 1995, CANCER RES, V55, P5054; Ihnat MA, 1997, CLIN CANCER RES, V3, P1339; Iwamoto Y, 2009, J ORTHOP SCI, V14, P397, DOI 10.1007/s00776-009-1347-6; KARIKO K, 1993, CANCER RES, V53, P3109; Kim J, 2006, CANCER RES, V66, P784, DOI 10.1158/0008-5472.CAN-05-1316; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lammers T, 2008, BRIT J CANCER, V99, P392, DOI 10.1038/sj.bjc.6604483; Lengyel E, 1996, J BIOL CHEM, V271, P23176, DOI 10.1074/jbc.271.38.23176; LEVIN WJ, 1995, ONCOGENE, V11, P1261; Lewis IJ, 2007, JNCI-J NATL CANCER I, V99, P112, DOI 10.1093/jnci/djk015; Lim CP, 1998, ONCOGENE, V16, P2915, DOI 10.1038/sj.onc.1201834; Liu CT, 2000, J BIOL CHEM, V275, P20315, DOI 10.1074/jbc.M909046199; Liu XY, 2009, MOL BIOL CELL, V20, P2174, DOI 10.1091/mbc.E08-10-0994; MacEwen EG, 2004, J CELL BIOCHEM, V92, P77, DOI 10.1002/jcb.20046; MacEwen EG, 2003, CLIN EXP METASTAS, V20, P421; Mahalingam D, 2010, BRIT J CANCER, V102, P754, DOI 10.1038/sj.bjc.6605545; Mahalingam D, 2009, CURR DRUG TARGETS, V10, P937, DOI 10.2174/138945009789577990; Mazar AP, 2008, CLIN CANCER RES, V14, P5649, DOI 10.1158/1078-0432.CCR-07-4863; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Mirabello L, 2009, INT J CANCER, V125, P229, DOI 10.1002/ijc.24320; Patel SJ, 2002, AM J CLIN ONCOL-CANC, V25, P489, DOI 10.1097/00000421-200210000-00014; Quinones A, 2003, LIFE SCI, V72, P2975, DOI 10.1016/S0024-3205(03)00230-3; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Santiago FS, 1999, AM J PATHOL, V154, P937, DOI 10.1016/S0002-9440(10)65341-2; Sasaki H, 2010, ONCOL REP, V23, P677, DOI 10.3892/or_00000684; Schwachtgen JL, 1998, J CLIN INVEST, V101, P2540, DOI 10.1172/JCI1404; SHINGU T, 1994, J BIOL CHEM, V269, P32551; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Su L, 2010, ONCOGENE, V29, P4352, DOI 10.1038/onc.2010.204; Ta H, 2009, CANCER METAST REV, V28, P247, DOI 10.1007/s10555-009-9186-7; Tanaka M, 2009, BRIT J CANCER, V100, P1957, DOI 10.1038/sj.bjc.6605060; Wittig JC, 2002, AM FAM PHYSICIAN, V65, P1123; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	56	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16234	10.1371/journal.pone.0016234	http://dx.doi.org/10.1371/journal.pone.0016234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283769	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200041
J	Wang, C; Fan, XL; Wang, GC; Niu, JF; Zhou, BC				Wang, Chao; Fan, Xiaolei; Wang, Guangce; Niu, Jianfeng; Zhou, Baicheng			Differential Expression of Rubisco in Sporophytes and Gametophytes of Some Marine Macroalgae	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; CARBOXYLASE ACTIVITY; LEAF DEVELOPMENT; MESSENGER-RNAS; GENE DOSAGE; POLYPLOIDY; RIBULOSE; PLANTS; CHLOROPHYLL; DIVERSITY	Rubisco (ribulose-1, 5-bisphosphate carboxylase/oxygenase), a key enzyme of photosynthetic CO2 fixation, is one of the most abundant proteins in both higher plants and algae. In this study, the differential expression of Rubisco in sporophytes and gametophytes of four seaweed species - Porphyra yezoensis, P. haitanensis, Bangia fuscopurpurea (Rhodophyte) and Laminaria japonica (Phaeophyceae) - was studied in terms of the levels of transcription, translation and enzyme activity. Results indicated that both the Rubisco content and the initial carboxylase activity were notably higher in algal gametophytes than in the sporophytes, which suggested that the Rubisco content and the initial carboxylase activity were related to the ploidy of the generations of the four algal species.	[Wang, Chao; Wang, Guangce; Niu, Jianfeng; Zhou, Baicheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wang, Chao] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Fan, Xiaolei] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Wang, C (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	gcwang@ms.qdio.ac.cn			National Natural Science Foundation of China [30830015]; Project for Supporting the National Development [2006BAD09A04]; 863 High Technology projects [2007AA09Z406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for Supporting the National Development; 863 High Technology projects(National High Technology Research and Development Program of China)	This study was supported by the National Natural Science Foundation of China (No. 30830015), Project for Supporting the National Development (No. 2006BAD09A04) and 863 High Technology projects (No. 2007AA09Z406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asamizu E, 2003, J PHYCOL, V39, P923, DOI 10.1046/j.1529-8817.2003.03003.x; BEER S, 1991, OECOLOGIA, V87, P429, DOI 10.1007/BF00634602; BHASKARAN S, 1987, J EXP BOT, V38, P270, DOI 10.1093/jxb/38.2.270; BHASKARAN S, 1983, PLANT PHYSIOL, V73, P639, DOI 10.1104/pp.73.3.639; Bischof K, 2002, PLANTA, V215, P502, DOI 10.1007/s00425-002-0774-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Cabello-Pasini A, 2001, REV CHIL HIST NAT, V74, P229; CARLSON PS, 1972, MOL GEN GENET, V114, P273, DOI 10.1007/BF00267495; CIFERRI O, 1969, GENETICS, V61, P567; DEAN C, 1982, PLANT PHYSIOL, V70, P1605, DOI 10.1104/pp.70.6.1605; DEMAGGIO AE, 1974, BIOCHEM GENET, V12, P429, DOI 10.1007/BF00486060; DUDGEON SR, 1989, MAR BIOL, V101, P107, DOI 10.1007/BF00393483; Fan XL, 2007, J PHYCOL, V43, P1287, DOI 10.1111/j.1529-8817.2007.00415.x; GA YC, 2001, ALGAE, V16, P145; Gerard VA, 1996, J PHYCOL, V32, P880, DOI 10.1111/j.0022-3646.1996.00880.x; GUERN M, 1980, PLANTA, V149, P27, DOI 10.1007/BF00386223; [何培民 He Peimin], 2004, [水产学报, Journal of Fisheries of China], V28, P255; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEECH RM, 1985, PLANTA, V166, P259, DOI 10.1007/BF00397357; Lin AP, 2009, PLANTA, V229, P803, DOI 10.1007/s00425-008-0874-2; Maayan I, 2008, PHYSIOL PLANTARUM, V134, P547, DOI 10.1111/j.1399-3054.2008.01150.x; MALCOLM MJ, 1988, J BIOL CHEM, V263, P6005; MASCARENHAS JP, 1989, PLANT CELL, V1, P657, DOI 10.1105/tpc.1.7.657; MEYERS SP, 1982, PLANT PHYSIOL, V70, P1704, DOI 10.1104/pp.70.6.1704; Miao YouGang, 1996, Acta Phytophysiologica Sinica, V22, P40; Patel M, 2008, J EXP BOT, V59, P1625, DOI 10.1093/jxb/erm368; REISKIND JB, 1991, P NATL ACAD SCI USA, V88, P2883, DOI 10.1073/pnas.88.7.2883; Rodermel S, 1999, PHOTOSYNTH RES, V59, P105, DOI 10.1023/A:1006122619851; SATOKO I, 2009, PLOS ONE, V4, P1; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schwender J, 2004, NATURE, V432, P779, DOI 10.1038/nature03145; TWELL D, 1994, SOC EXP BIOL SEMIN S, V55, P83, DOI 10.1017/CBO9780511752339.007; VALENTIN K, 1990, MOL GEN GENET, V222, P425, DOI 10.1007/BF00633849; WANG WG, 1985, EXPT HDB PLANT PHYSL, P125; WANNER LA, 1991, PLANT CELL, V3, P1289, DOI 10.1105/tpc.3.12.1289; WARNER DA, 1989, PLANT PHYSIOL, V91, P1143, DOI 10.1104/pp.91.3.1143; WILLING RP, 1988, THEOR APPL GENET, V75, P751, DOI 10.1007/BF00265600; WILLING RP, 1984, PLANT PHYSIOL, V75, P865, DOI 10.1104/pp.75.3.865; XU ZM, 1991, MAR SCI, V2, P41; Zhang BY, 2010, J PHYCOL, V46, P290, DOI 10.1111/j.1529-8817.2009.00801.x; [张国 Zhang Guo], 2004, [植物生理学通讯, Plant Physiology Communications], V40, P633	43	27	28	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16351	10.1371/journal.pone.0016351	http://dx.doi.org/10.1371/journal.pone.0016351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283730	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522200054
J	Sserwanga, A; Harris, JC; Kigozi, R; Menon, M; Bukirwa, H; Gasasira, A; Kakeeto, S; Kizito, F; Quinto, E; Rubahika, D; Nasr, S; Filler, S; Kamya, MR; Dorsey, G				Sserwanga, Asadu; Harris, Jamal C.; Kigozi, Ruth; Menon, Manoj; Bukirwa, Hasifa; Gasasira, Anne; Kakeeto, Stella; Kizito, Fred; Quinto, Ebony; Rubahika, Denis; Nasr, Sussann; Filler, Scott; Kamya, Moses R.; Dorsey, Grant			Improved Malaria Case Management through the Implementation of a Health Facility-Based Sentinel Site Surveillance System in Uganda	PLOS ONE			English	Article							COMBINATION THERAPY; COST-EFFECTIVENESS; MICROSCOPY; TRANSMISSION; TANZANIA; AFRICA; ZAMBIA; KENYA; ERA	Background: Heath facility-based sentinel site surveillance has been proposed as a means of monitoring trends in malaria morbidity but may also provide an opportunity to improve malaria case management. Here we described the impact of a sentinel site malaria surveillance system on promoting laboratory testing and rational antimalarial drug use. Methodology/Principal Findings: Sentinel site malaria surveillance was established at six health facilities in Uganda between September 2006 and January 2007. Data were collected from all patients presenting to the outpatient departments including demographics, laboratory results, diagnoses, and treatments prescribed. Between the start of surveillance and March 2010, a total 424,701 patients were seen of which 229,375 (54%) were suspected of having malaria. Comparing the first three months with the last three months of surveillance, the proportion of patients with suspected malaria who underwent diagnostic testing increased from 39% to 97% (p<0.001). The proportion of patients with an appropriate decision to prescribe antimalarial therapy (positive test result prescribed, negative test result not prescribed) increased from 64% to 95% (p<0.001). The proportion of patients appropriately prescribed antimalarial therapy who were prescribed the recommended first-line regimen artemether-lumefantrine increased from 48% to 69% (p<0.001). Conclusions/Significance: The establishment of a sentinel site malaria surveillance system in Uganda achieved almost universal utilization of diagnostic testing in patients with suspected malaria and appropriate decisions to prescribed antimalarial based on test results. Less success was achieved in promoting prescribing practice for the recommended first-line therapy. This system could provide a model for improving malaria case management in other health facilities in Africa.	[Sserwanga, Asadu; Kigozi, Ruth; Bukirwa, Hasifa; Gasasira, Anne; Kakeeto, Stella; Kizito, Fred] Uganda Malaria Surveillance Project, Kampala, Uganda; [Harris, Jamal C.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Menon, Manoj; Nasr, Sussann; Filler, Scott] Ctr Dis Control & Prevent, Atlanta, GA USA; [Quinto, Ebony; Rubahika, Denis] Uganda Minist Hlth, Kampala, Uganda; [Kamya, Moses R.] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda; [Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; Makerere University; University of California System; University of California San Francisco	Sserwanga, A (corresponding author), Uganda Malaria Surveillance Project, Kampala, Uganda.	gdorsey@medsfgh.ucsf.edu			President's Malaria Initiative; Centers for Disease Control and Prevention [U50/CCU925122]; National Institute of Mental Health [T32MH019105]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105] Funding Source: NIH RePORTER	President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study received financial support from the President's Malaria Initiative through a cooperative agreement with the Centers for Disease Control and Prevention (U50/CCU925122). JH was supported in part by an Institutional Research Training Grant (T32MH019105) from the National Institute of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funding agencies had no role in the design and conduct of the study; collection, management, and analysis of the data. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. Members of the Centers for Disease Control and Prevention (MM, SN, and SF) were involved in the preparation, review, and approval of the manuscript.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], 2008, WORLD MAL REP 2008; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Breman JG, 2007, AM J TROP MED HYG, V77, P36; BRYCE J, 1994, B WORLD HEALTH ORGAN, V72, P371; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Cibulskis RE, 2007, AM J TROP MED HYG, V77, P133; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Kamya MR, 2002, TROP MED INT HEALTH, V7, P1031, DOI 10.1046/j.1365-3156.2002.00974.x; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Reyburn H, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-4; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Ssekabira U, 2008, AM J TROP MED HYG, V79, P826, DOI 10.4269/ajtmh.2008.79.826; Wasunna B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-29; WHO, 2010, GUID TREATM MAL, V2nd; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x; Zurovac D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-181	19	56	57	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16316	10.1371/journal.pone.0016316	http://dx.doi.org/10.1371/journal.pone.0016316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283815	Green Published, Green Submitted, gold			2022-12-25	WOS:000286520600040
J	Switzer, CH; Cheng, RYS; Vitek, TM; Christensen, DJ; Wink, DA; Vitek, MP				Switzer, C. H.; Cheng, R. Y. S.; Vitek, T. M.; Christensen, D. J.; Wink, D. A.; Vitek, M. P.			Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy	ONCOGENE			English	Article						SET/I(2)PP2A; PP2A; Akt; nm23-H1; Rac1	PROTEIN PHOSPHATASE 2A; CHRONIC MYELOGENOUS LEUKEMIA; ACUTE UNDIFFERENTIATED LEUKEMIA; TUMOR-SUPPRESSOR; APOLIPOPROTEIN-E; GENE-EXPRESSION; CARCINOMA CELLS; BLAST CRISIS; HUMAN BREAST; C-MYC	The SET oncoprotein participates in cancer progression by affecting multiple cellular processes, inhibiting the tumor suppressor protein phosphatase 2A (PP2A), and inhibiting the metastasis suppressor nm23-H1. On the basis of these multiple activities, we hypothesized that targeted inhibition of SET would have multiple discrete and measurable effects on cancer cells. Here, the effects of inhibiting SET oncoprotein function on intracellular signaling and proliferation of human cancer cell lines was investigated. We observed the effects of COG112, a novel SET interacting peptide, on PP2A activity, Akt signaling, nm23-H1 activity and cellular migration/invasion in human U87 glioblastoma and MDA-MB-231 breast adenocarcinoma cancer cell lines. We found that COG112 interacted with SET protein and inhibited the association between SET and PP2A catalytic subunit (PP2A-c) and nm23-H1. The interaction between COG112 and SET caused PP2A phosphatase and nm23-H1 exonuclease activities to increase. COG112-mediated increases in PP2A activity resulted in the inhibition of Akt signaling and cellular proliferation. Additionally, COG112 inhibited SET association with Ras-related C-3 botulinum toxin substrate 1 (Rac1), leading to decreased cellular migration and invasion. COG112 treatment releases the SET-mediated inhibition of the tumor suppressor PP2A, as well as the metastasis suppressor nm23-H1. These results establish SET as a novel molecular target and that the inhibition of SET may have beneficial effects in cancer chemotherapy. Oncogene (2011) 30, 2504-2513; doi: 10.1038/onc.2010.622; published online 7 February 2011	[Switzer, C. H.; Cheng, R. Y. S.; Vitek, T. M.; Wink, D. A.] NCI, Radiat Biol Branch, NIH, Bethesda, MD 20892 USA; [Christensen, D. J.; Vitek, M. P.] Cognosci Inc, Res Triangle Pk, NC 27709 USA; [Vitek, M. P.] Duke Univ, Med Ctr, Div Neurol, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University	Wink, DA (corresponding author), NCI, Radiat Biol Branch, NIH, Bldg 10,Room B3-B35, Bethesda, MD 20892 USA.	wink@mail.nih.gov; mikevitek@cognosci.com	Switzer, Christopher/D-9203-2013; Cheng, Robert/E-9799-2013	Cheng, Robert/0000-0003-0287-6439; Azad, Mahan/0000-0002-8633-3513; Vitek, Michael/0000-0001-8140-8048; Wink, David/0000-0002-5652-7480	Intramural NIH HHS [ZIA SC007281-17, ZIA BC010899-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIASC007281, ZIABC010899] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADACHI Y, 1994, J BIOL CHEM, V269, P2258; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Carlson SG, 1998, J AM SOC NEPHROL, V9, P1873; Carujo S, 2006, ONCOGENE, V25, P4033, DOI 10.1038/sj.onc.1209433; CHRISTENSEN D, 2011, J IMMUNOL IN PRESS, V186; Compagnone NA, 2000, MOL ENDOCRINOL, V14, P875, DOI 10.1210/me.14.6.875; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Feschenko MS, 2002, J PHARMACOL EXP THER, V302, P111, DOI 10.1124/jpet.302.1.111; Freije JMP, 1998, BIOCHEM SOC SYMP, P261; Fukukawa C, 2000, CANCER LETT, V161, P89, DOI 10.1016/S0304-3835(00)00598-X; Gotz J, 2000, MECH DEVELOP, V93, P83, DOI 10.1016/S0925-4773(00)00267-7; Guichard C, 2006, CARCINOGENESIS, V27, P1812, DOI 10.1093/carcin/bgl009; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Li FQ, 2006, J PHARMACOL EXP THER, V318, P956, DOI 10.1124/jpet.106.103671; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; LoPiccolo J, 2007, ANTI-CANCER DRUG, V18, P861; Ma DQ, 2002, J BIOL CHEM, V277, P1560, DOI 10.1074/jbc.M108359200; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Ouatas T, 2003, CLIN CANCER RES, V9, P3763; Ozbek U, 2007, AM J PATHOL, V171, P654, DOI 10.2353/ajpath.2007.060934; Palmieri D, 2005, JNCI-J NATL CANCER I, V97, P632, DOI 10.1093/jnci/dji111; Perrotti D, 2006, BRIT J CANCER, V95, P775, DOI 10.1038/sj.bjc.6603317; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; Samanta AK, 2009, ONCOGENE, V28, P1669, DOI 10.1038/onc.2009.7; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Sommer D, 2002, ARCH BIOCHEM BIOPHYS, V404, P271, DOI 10.1016/S0003-9861(02)00242-4; STEEG PS, 1988, CANCER RES, V48, P6550; Stewart TJ, 2008, ONCOGENE, V27, P5894, DOI 10.1038/onc.2008.268; Sundaresan P, 2002, FEBS LETT, V528, P139, DOI 10.1016/S0014-5793(02)03277-5; Switzer CH, 2009, ONCOGENE, V28, P3837, DOI 10.1038/onc.2009.244; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Zhang QB, 2011, INT J CANCER, V128, P40, DOI 10.1002/ijc.25307; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhu F, 2008, Curr Mol Pharmacol, V1, P213	49	128	131	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	22					2504	2513		10.1038/onc.2010.622	http://dx.doi.org/10.1038/onc.2010.622			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	771ZE	21297667	Green Accepted			2022-12-25	WOS:000291198400002
J	Hikasa, H; Sokol, SY				Hikasa, Hiroki; Sokol, Sergei Y.			Phosphorylation of TCF Proteins by Homeodomain-interacting Protein Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS HOMEOBOX GENE; WNT SIGNALING PATHWAY; NEMO-LIKE-KINASE; BETA-CATENIN; DEPENDENT PHOSPHORYLATION; MEDIATED TRANSCRIPTION; POLARITY SIGNALS; DISTINCT ROLES; AXIS FORMATION; MAP KINASE	Wnt pathways play essential roles in cell proliferation, morphogenesis, and cell fate specification during embryonic development. According to the consensus view, the Wnt pathway prevents the degradation of the key signaling component beta-catenin by the protein complex containing the negative regulators Axin and glycogen synthase kinase 3 (GSK3). Stabilized beta-catenin associates with TCF proteins and enters the nucleus to promote target gene expression. This study examines the involvement of HIPK2 (homeodomain-interacting protein kinase (2) under bar) in the regulation of different TCF proteins in Xenopus embryos in vivo. We show that the TCF family members LEF1, TCF4, and TCF3 are phosphorylated in embryonic ectoderm after Wnt8 stimulation and HIPK2 overexpression. We also find that TCF3 phosphorylation is triggered by canonical Wnt ligands, LRP6, and dominant negative mutants for Axin and GSK3, indicating that this process shares the same upstream regulators with beta-catenin stabilization. HIPK2-dependent phosphorylation caused the dissociation of LEF1, TCF4, and TCF3 from a target promoter in vivo. This result provides a mechanistic explanation for the context-dependent function of HIPK2 in Wnt signaling; HIPK2 up-regulates transcription by phosphorylating TCF3, a transcriptional repressor, but inhibits transcription by phosphorylating LEF1, a transcriptional activator. Finally, we show that upon HIPK2-mediated phosphorylation, TCF3 is replaced with positively acting TCF1 at a target promoter. These observations emphasize a critical role for Wnt/HIPK2-dependent TCF phosphorylation and suggest that TCF switching is an important mechanism of Wnt target gene activation in vertebrate embryos.	[Hikasa, Hiroki; Sokol, Sergei Y.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sokol, SY (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	sergei.sokol@mssm.edu		Sokol, Sergei/0000-0002-3963-9202	National Institutes of Health [HD031247, GM096959, NS040972]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R55HD031247, R01HD031247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS040972, R01NS040972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD031247, GM096959, and NS040972 (to S. Y. S.).	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Candia AF, 1997, DEVELOPMENT, V124, P4467; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Choi CY, 2005, J BIOL CHEM, V280, P21427, DOI 10.1074/jbc.M500496200; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Dorsky RI, 2003, DEVELOPMENT, V130, P1937, DOI 10.1242/dev.00402; Doxakis E, 2004, CURR BIOL, V14, P1761, DOI 10.1016/j.cub.2004.09.050; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Erter CE, 2001, DEVELOPMENT, V128, P3571; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Hikasa H, 2010, DEV CELL, V19, P521, DOI 10.1016/j.devcel.2010.09.005; Hofmann TG, 2003, CANCER RES, V63, P8271; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Houston DW, 2002, DEVELOPMENT, V129, P4015; Imai Y, 2001, DEVELOPMENT, V128, P2407; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Itoh K, 1998, MECH DEVELOP, V74, P145, DOI 10.1016/S0925-4773(98)00076-8; Itoh K, 2005, J BIOL, V4; Kaletta T, 1997, NATURE, V390, P294, DOI 10.1038/36869; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kim EA, 2010, BIOCHEM BIOPH RES CO, V394, P966, DOI 10.1016/j.bbrc.2010.03.099; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100; Ladher R, 1996, DEVELOPMENT, V122, P2385; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Lee W, 2009, DEVELOPMENT, V136, P241, DOI 10.1242/dev.025460; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Liu F, 2005, DEVELOPMENT, V132, P5375, DOI 10.1242/dev.02152; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Louie SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004310; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Ossipova O, 2009, DEV CELL, V17, P222, DOI 10.1016/j.devcel.2009.06.010; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; PENG HB, 1991, METHOD CELL BIOL, V36, P657; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Phillips BT, 2009, DEV CELL, V17, P27, DOI 10.1016/j.devcel.2009.07.002; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Pierantoni GM, 2002, BIOCHEM BIOPH RES CO, V290, P942, DOI 10.1006/bbrc.2001.6310; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Pukrop T, 2001, J BIOL CHEM, V276, P8968, DOI 10.1074/jbc.M007533200; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Roel G, 2002, CURR BIOL, V12, P1941, DOI 10.1016/S0960-9822(02)01280-0; Schmidt JE, 1996, DEVELOPMENT, V122, P1711; Shin TH, 1999, MOL CELL, V4, P275, DOI 10.1016/S1097-2765(00)80375-5; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; Sokol SY, 2007, DEVELOPMENT, V134, P3393, DOI 10.1242/dev.008169; Standley HJ, 2006, DEV BIOL, V289, P318, DOI 10.1016/j.ydbio.2005.10.012; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Tutter AV, 2001, GENE DEV, V15, P3342, DOI 10.1101/gad.946501; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang C, 2003, DEVELOPMENT, V130, P5609, DOI 10.1242/dev.00798; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X	88	80	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.185280	http://dx.doi.org/10.1074/jbc.M110.185280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285352	Green Published, hybrid			2022-12-25	WOS:000289077500024
J	Wu, ZP; Gogonea, V; Lee, X; May, RP; Pipich, V; Wagner, MA; Undurti, A; Tallant, TC; Baleanu-Gogonea, C; Charlton, F; Ioffe, A; DiDonato, JA; Rye, KA; Hazen, SL				Wu, Zhiping; Gogonea, Valentin; Lee, Xavier; May, Roland P.; Pipich, Vitaliy; Wagner, Matthew A.; Undurti, Arundhati; Tallant, Thomas C.; Baleanu-Gogonea, Camelia; Charlton, Francesca; Ioffe, Alexander; DiDonato, Joseph A.; Rye, Kerry-Anne; Hazen, Stanley L.			The Low Resolution Structure of ApoA1 in Spherical High Density Lipoprotein Revealed by Small Angle Neutron Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; ESTER TRANSFER PROTEIN; COMPUTATIONAL-EXPERIMENTAL-APPROACH; LIPID-BOUND CONFORMATION; CORONARY-ARTERY DISEASE; C-TERMINAL DOMAIN; HEART-DISEASE; SR-BI; X-RAY; CELLULAR CHOLESTEROL	Spherical high density lipoprotein (sHDL), a key player in reverse cholesterol transport and the most abundant form of HDL, is associated with cardiovascular diseases. Small angle neutron scattering with contrast variation was used to determine the solution structure of protein and lipid components of reconstituted sHDL. Apolipoprotein A1, the major protein of sHDL, forms a hollow structure that cradles a central compact lipid core. Three apoA1 chains are arranged within the low resolution structure of the protein component as one of three possible global architectures: (i) a helical dimer with a hairpin (HdHp), (ii) three hairpins (3Hp), or (iii) an integrated trimer (iT) in which the three apoA1 monomers mutually associate over a portion of the sHDL surface. Cross-linking and mass spectrometry analyses help to discriminate among the three molecular models and are most consistent with the HdHp overall architecture of apoA1 within sHDL.	[Wu, Zhiping; Gogonea, Valentin; Lee, Xavier; Wagner, Matthew A.; Undurti, Arundhati; Tallant, Thomas C.; Baleanu-Gogonea, Camelia; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Wu, Zhiping; Gogonea, Valentin; Lee, Xavier; Wagner, Matthew A.; Undurti, Arundhati; Tallant, Thomas C.; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Gogonea, Valentin; Baleanu-Gogonea, Camelia; Hazen, Stanley L.] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [May, Roland P.] Inst Laue Langevin, F-38042 Grenoble 9, France; [Pipich, Vitaliy; Ioffe, Alexander] Forschungszentrum Julich, Inst Festkorperforsch, Julich Ctr Neutron Sci FRM II, D-85747 Garching, Germany; [Charlton, Francesca; Rye, Kerry-Anne] Heart Res Inst, Lipid Res Grp, Sydney, NSW 2042, Australia; [Rye, Kerry-Anne] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Rye, Kerry-Anne] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Institut Laue-Langevin (ILL); Helmholtz Association; Research Center Julich; University of Sydney; Heart Research Institute; University of Sydney; University of Melbourne	Hazen, SL (corresponding author), Cleveland Clin, Dept Cell Biol, 9500 Euclid Ave,NE-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021; Ioffe, Alexander/C-1815-2014	Pipich, Vitaliy/0000-0002-3930-3602	National Institutes of Health [P01 HL098055, P01 HL076491-055328, P01 HL087018-02001]; Foundation Leducq; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, P01HL087018, P01HL098055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL098055, P01 HL076491-055328, and P01 HL087018-02001. This work was also supported in part by a grant from the Foundation Leducq.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ANDERSON DW, 1978, ATHEROSCLEROSIS, V29, P161, DOI 10.1016/0021-9150(78)90005-9; ATKINSON D, 1976, EUR J BIOCHEM, V64, P541, DOI 10.1111/j.1432-1033.1976.tb10334.x; Atkinson D, 1980, Ann N Y Acad Sci, V348, P284, DOI 10.1111/j.1749-6632.1980.tb21308.x; BALDWIN JP, 1975, NATURE, V253, P245, DOI 10.1038/253245a0; Barter PJ, 2001, CURR OPIN LIPIDOL, V12, P377, DOI 10.1097/00041433-200108000-00002; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; BRESLOW JL, 1991, ANNU REV MED, V42, P357, DOI 10.1146/annurev.me.42.020191.002041; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; Catte A, 2008, BIOPHYS J, V94, P2306, DOI 10.1529/biophysj.107.115857; CHEUNG MC, 1987, J LIPID RES, V28, P913; DALTON MB, 1993, J BIOL CHEM, V268, P19274; DAVIDSON WS, 1994, J BIOL CHEM, V269, P8959; Davidson WS, 2003, J BIOL CHEM, V278, P27199, DOI 10.1074/jbc.M302764200; DURRINGTON PN, 1988, LANCET, V1, P1070; FIELDING C J, 1981, Proceedings of the National Academy of Sciences of the United States of America, V78, P3911, DOI 10.1073/pnas.78.6.3911; FRANCONE OL, 1989, J BIOL CHEM, V264, P7066; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Gogonea V, 2010, BIOCHEMISTRY-US, V49, P7323, DOI 10.1021/bi100588a; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; GUILBAUD JB, 2010, CHEM SOC REV; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; JONAS A, 1990, J BIOL CHEM, V265, P22123; Jonas A., 2002, BIOCH LIPIDS LIPOPRO, P483; Jones MK, 2010, J BIOL CHEM, V285, P41161, DOI 10.1074/jbc.M110.187799; KARATHANASIS SK, 1983, NATURE, V301, P718, DOI 10.1038/301718a0; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lagerstedt JO, 2011, J BIOL CHEM, V286, P2966, DOI 10.1074/jbc.M110.163097; Li HH, 2002, J BIOL CHEM, V277, P39093, DOI 10.1074/jbc.M206770200; Lund-Katz S, 2003, FRONT BIOSCI-LANDMRK, V8, pD1044, DOI 10.2741/1077; Maiorano JN, 2004, BIOCHEMISTRY-US, V43, P11717, DOI 10.1021/bi0496642; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; MAY RP, 1992, EMBO J, V11, P373, DOI 10.1002/j.1460-2075.1992.tb05060.x; Moore RE, 2005, CIRC RES, V97, P763, DOI 10.1161/01.RES.0000185320.82962.F7; Nicholls SJ, 2005, CIRCULATION, V111, P1543, DOI 10.1161/01.CIR.0000159351.95399.50; NORUM RA, 1982, NEW ENGL J MED, V306, P1513, DOI 10.1056/NEJM198206243062503; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Pajkrt D, 1996, J EXP MED, V184, P1601, DOI 10.1084/jem.184.5.1601; PARDON JF, 1977, NUCLEIC ACIDS RES, V4, P3199, DOI 10.1093/nar/4.9.3199; PEKKANEN J, 1990, NEW ENGL J MED, V322, P1700, DOI 10.1056/NEJM199006143222403; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Peters-Libeu CA, 2007, J LIPID RES, V48, P1035, DOI 10.1194/jlr.M600545-JLR200; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; RAMAKRISHNAN V, 1986, SCIENCE, V231, P1562, DOI 10.1126/science.3513310; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; RYE KA, 1995, J BIOL CHEM, V270, P189, DOI 10.1074/jbc.270.1.189; SAIBIL H, 1976, NATURE, V262, P266, DOI 10.1038/262266a0; SCHAEFER EJ, 1982, ARTERIOSCLEROSIS, V2, P16, DOI 10.1161/01.ATV.2.1.16; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SERDYUK IN, 2007, METHODS MOL BIOPHYSI, P794; Shih AY, 2009, J R SOC INTERFACE, V6, P863, DOI 10.1098/rsif.2009.0173; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P8600, DOI 10.1021/bi050421z; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; STUHRMAN.HB, 1970, ACTA CRYSTALL A-CRYS, VA 26, P297, DOI 10.1107/S0567739470000748; Stuhrmann HB, 2008, ACTA CRYSTALLOGR A, V64, P181, DOI 10.1107/S0108767307046569; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vuorela T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000964; Wang JJ, 2002, P NATL ACAD SCI USA, V99, P1188, DOI 10.1073/pnas.032565999; Wang L, 2005, J BIOL CHEM, V280, P4154, DOI 10.1074/bc.M411618200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 1996, J BIOL CHEM, V271, P21001, DOI 10.1074/jbc.271.35.21001; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; Zhang L, 2011, J LIPID RES, V52, P175, DOI 10.1194/jlr.D010959; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0	78	42	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.209130	http://dx.doi.org/10.1074/jbc.M110.209130			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21292766	Green Published, hybrid			2022-12-25	WOS:000289077500063
J	An, HJ; Kim, YJ; Song, DH; Park, BS; Kim, HM; Lee, JD; Paik, SG; Lee, JO; Lee, H				An, Hyun-Jung; Kim, Young Jin; Song, Dong Hyun; Park, Beom Suk; Kim, Ho Min; Lee, Ju Dong; Paik, Sang-Gi; Lee, Jie-Oh; Lee, Hayyoung			Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CD40 LIGAND; X-LINKED IMMUNODEFICIENCY; HYPER-IGM SYNDROME; CRYSTAL-STRUCTURE; MOLECULAR-MODELS; FACTORS TRAFS; BINDING; DOMAIN; CELLS; GP39	CD40 is a tumor necrosis factor receptor (TNFR) family protein that plays an important role in B cell development. CD154/CD40L is the physiological ligand of CD40. We have determined the crystal structure of the CD40-CD154 complex at 3.5 angstrom resolution. The binding site of CD40 is located in a crevice formed between two CD154 subunits. Charge complementarity plays a critical role in the CD40-CD154 interaction. Some of the missense mutations found in hereditary hyper-IgM syndrome can be mapped to the CD40-CD154 interface. The CD40 interaction area of one of the CD154 subunits is twice as large as that of the other subunit forming the binding crevice. This is because cysteine-rich domain 3 (CRD3) of CD40 has a disulfide bridge in an unusual position that alters the direction of the ladder-like structure of CD40. The Ser(132) loop of CD154 is not involved in CD40 binding but its substitution significantly reduces p38- and ERK-dependent signaling by CD40, whereas JNK-dependent signaling is not affected. These findings suggest that ligand-induced di- or trimerization is necessary but not sufficient for complete activation of CD40.	[Kim, Young Jin; Song, Dong Hyun; Park, Beom Suk; Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [An, Hyun-Jung; Paik, Sang-Gi] Chungnam Natl Univ, Coll Biosci & Biotechnol, Dept Biol, Taejon 305764, South Korea; [An, Hyun-Jung; Paik, Sang-Gi] Chungnam Natl Univ, Coll Biosci & Biotechnol, Daedeok R&D Innopolis Bio Brain Ctr BK21, Taejon 305764, South Korea; [Lee, Hayyoung] Chungnam Natl Univ, Coll Biosci & Biotechnol, Inst Biotechnol, Taejon 305764, South Korea; [Kim, Ho Min; Lee, Ju Dong] Korea Adv Inst Sci & Technol, Biomed Res Ctr, Taejon 305701, South Korea; [Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University; Chungnam National University; Chungnam National University; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Lee, JO (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, 335 Gwahag No, Taejon 305701, South Korea.	jieoh@kaist.ac.kr; hlee@cnu.ac.kr	Lee, Jie-Oh/C-1581-2011; Lee, Jie-Oh/AAG-4302-2020; Kim, Ho Min/G-2712-2011	Lee, Jie-Oh/0000-0001-6519-6049; kim, youngjin/0000-0001-6505-9212	National Research Foundation [2010-0000101]; Ministry of Education, Science, and Technology of Korea [2008-00539]	National Research Foundation; Ministry of Education, Science, and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation (2010-0000101) and the Japanese-Korean Cooperative Program (2008-00539) of the Ministry of Education, Science, and Technology of Korea.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; BAJORATH J, 1993, PROTEIN SCI, V2, P1798, DOI 10.1002/pro.5560021103; Bajorath J, 1998, J BIOL CHEM, V273, P24603, DOI 10.1074/jbc.273.38.24603; Bajorath J, 1997, PROTEINS, V27, P59; BAJORATH J, 1995, BIOCHEMISTRY-US, V34, P9884, DOI 10.1021/bi00031a009; BAJORATH J, 1995, BIOCHEMISTRY-US, V34, P1833, DOI 10.1021/bi00006a003; Bajorath J, 1996, PROTEIN SCI, V5, P531; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; Eldredge J, 2006, BIOCHEMISTRY-US, V45, P10117, DOI 10.1021/bi060210+; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Hassan GS, 2009, TRENDS IMMUNOL, V30, P165, DOI 10.1016/j.it.2009.01.004; Haswell LE, 2001, EUR J IMMUNOL, V31, P3094, DOI 10.1002/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO;2-F; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8; Karpusas M, 2001, STRUCTURE, V9, P321, DOI 10.1016/S0969-2126(01)00590-1; Kashiwada M, 1998, J EXP MED, V187, P237, DOI 10.1084/jem.187.2.237; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KIENER PA, 1995, J IMMUNOL, V155, P4917; Kilinc MO, 2006, EXP MOL PATHOL, V80, P252, DOI 10.1016/j.yexmp.2005.12.004; Kim HM, 2003, NAT STRUCT BIOL, V10, P342, DOI 10.1038/nsb925; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; Leveille C, 2007, J BIOL CHEM, V282, P5143, DOI 10.1074/jbc.M608342200; Liu YF, 2003, NATURE, V423, P49, DOI 10.1038/nature01543; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miconnet I, 2008, VACCINE, V26, P4006, DOI 10.1016/j.vaccine.2008.05.028; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Pearson LL, 2001, INT IMMUNOL, V13, P273, DOI 10.1093/intimm/13.3.273; Piirila H, 2006, HUM MUTAT, V27, P1200, DOI 10.1002/humu.20405; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Pullen SS, 1999, BIOCHEMISTRY-US, V38, P10168, DOI 10.1021/bi9909905; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Singh J, 1998, PROTEIN SCI, V7, P1124, DOI 10.1002/pro.5560070506; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vonderheide RH, 2007, CLIN CANCER RES, V13, P1083, DOI 10.1158/1078-0432.CCR-06-1893; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	47	65	70	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11226	11235		10.1074/jbc.M110.208215	http://dx.doi.org/10.1074/jbc.M110.208215			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21285457	hybrid, Green Published			2022-12-25	WOS:000288797100034
J	Lukashova, V; Szabo, EZ; Jinadasa, T; Mokhov, A; Litchfield, DW; Orlowski, J				Lukashova, Viktoria; Szabo, Eloed Z.; Jinadasa, Tushare; Mokhov, Alexei; Litchfield, David W.; Orlowski, John			CK2 Phosphorylation of an Acidic Ser/Thr Di-isoleucine Motif in the Na+/H+ Exchanger NHE5 Isoform Promotes Association with beta-Arrestin2 and Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CASEIN KINASE-II; CLATHRIN-MEDIATED ENDOCYTOSIS; BETA-ARRESTIN TRANSLOCATION; C-TERMINAL DOMAIN; BETA(2)-ADRENERGIC RECEPTOR; HORMONE RECEPTOR; DEPENDENT INTERNALIZATION; CONSTITUTIVE ENDOCYTOSIS; SUBSTRATE DETERMINANTS	Internalization of the Na+/H+ exchanger NHE5 into recycling endosomes is enhanced by the endocytic adaptor proteins beta-arrestin1 and -2, best known for their preferential recognition of ligand-activated G protein-coupled receptors (GPCRs). However, the mechanism underlying their atypical association with non-GPCRs, such as NHE5, is unknown. In this study, we identified a highly acidic, serine/threonine-rich, di-isoleucine motif (amino acids 697-723) in the cytoplasmic C terminus of NHE5 that is recognized by beta-arrestin2. Gross deletions of this site decreased the state of phosphorylation of NHE5 as well as its binding and responsiveness to beta-arrestin2 in intact cells. More refined in vitro analyses showed that this site was robustly phosphorylated by the acidotropic protein kinase CK2, whereas other kinases, such as CK1 or the GPCR kinase GRK2, were considerably less potent. Simultaneous mutation of five Ser/Thr residues within 702-714 to Ala ((ST)-S-702/AA(714)) abolished phosphorylation and binding of beta-arrestin2. In transfected cells, the CK2 catalytic alpha subunit formed a complex with NHE5 and decreased wild-type but not (ST)-S-702/AA(714) NHE5 activity, further supporting a regulatory role for this kinase. The rate of internalization of (ST)-S-702/AA(714) was also diminished and relatively insensitive to overexpression of beta-arrestin2. However, unlike in vitro, this mutant retained its ability to form a complex with beta-arrestin2 despite its lack of responsiveness. Additional mutations of two di-isoleucine-based motifs (I697A/L698A and I722A/I723A) that immediately flank the acidic cluster, either separately or together, were required to disrupt their association. These data demonstrate that discrete elements of an elaborate sorting signal in NHE5 contribute to beta-arrestin2 binding and trafficking along the recycling endosomal pathway.	[Lukashova, Viktoria; Jinadasa, Tushare; Mokhov, Alexei; Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Szabo, Eloed Z.] Hosp Sick Children, Dept Anaesthesia, Toronto, ON M5G 1X8, Canada; [Litchfield, David W.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Western University (University of Western Ontario)	Orlowski, J (corresponding author), McGill Univ, Dept Physiol, Mclntyre Med Sci Bldg,3655 Promenade Sir William, Montreal, PQ H3G 1Y6, Canada.	john.orlowski@mcgill.ca	Litchfield, David/E-4636-2015	Litchfield, David/0000-0002-2425-6620; Orlowski, John/0000-0001-7371-175X	Canadian Institutes for Health Research [MOP-11221]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Grant MOP-11221 (to J. O.).	Allende CC, 1998, J CELL BIOCHEM, P129; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Budd DC, 2000, J BIOL CHEM, V275, P19667, DOI 10.1074/jbc.M000492200; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Cotlin LF, 1999, J BIOL CHEM, V274, P30550, DOI 10.1074/jbc.274.43.30550; Diering GH, 2009, J BIOL CHEM, V284, P13892, DOI 10.1074/jbc.M807055200; Diviani D, 1997, J BIOL CHEM, V272, P28712, DOI 10.1074/jbc.272.45.28712; Doring M, 2006, J NEUROCHEM, V98, P2013, DOI 10.1111/j.1471-4159.2006.04037.x; Feliciangeli S, 2010, J BIOL CHEM, V285, P4798, DOI 10.1074/jbc.M109.078535; Filhol O, 2003, MOL CELL BIOL, V23, P975, DOI 10.1128/MCB.23.3.975-987.2003; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Gabilondo AM, 1997, P NATL ACAD SCI USA, V94, P12285, DOI 10.1073/pnas.94.23.12285; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hammes SR, 1999, BIOCHEMISTRY-US, V38, P9308, DOI 10.1021/bi9902236; Hanyaloglu AC, 2001, J BIOL CHEM, V276, P18066, DOI 10.1074/jbc.M009275200; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Jones BW, 2007, J BIOL CHEM, V282, P12893, DOI 10.1074/jbc.M610854200; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kim YM, 2002, J BIOL CHEM, V277, P16837, DOI 10.1074/jbc.M201379200; Kimura T, 2007, MOL BIOL CELL, V18, P4508, DOI 10.1091/mbc.E06-08-0711; Korn I, 2001, MOL CELL BIOCHEM, V227, P37, DOI 10.1023/A:1013100604191; Korolchuk VI, 2002, TRAFFIC, V3, P428, DOI 10.1034/j.1600-0854.2002.30606.x; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Lee KB, 2000, J BIOL CHEM, V275, P35767, DOI 10.1074/jbc.M002225200; Liang M, 1998, MOL PHARMACOL, V54, P44, DOI 10.1124/mol.54.1.44; Lin FT, 2002, BIOCHEMISTRY-US, V41, P10692, DOI 10.1021/bi025705n; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Lipsky R, 2008, J BIOL CHEM, V283, P17221, DOI 10.1074/jbc.C800061200; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Marin O, 1999, BIOCHEM BIOPH RES CO, V256, P442, DOI 10.1006/bbrc.1999.0348; Mason AK, 2008, J BIOL CHEM, V283, P5973, DOI 10.1074/jbc.M709756200; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Min L, 2002, J BIOL CHEM, V277, P702, DOI 10.1074/jbc.M106082200; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mukherjee S, 2002, J BIOL CHEM, V277, P17916, DOI 10.1074/jbc.M110479200; Mundell SJ, 2006, MOL PHARMACOL, V70, P1132, DOI 10.1124/mol.106.023549; Nakata A, 2007, J NEUROSCI RES, V85, P723, DOI 10.1002/jnr.21185; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Olsten MEK, 2005, MOL CELL BIOCHEM, V274, P115, DOI 10.1007/s11010-005-3072-6; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Orsini MJ, 2000, J BIOL CHEM, V275, P25876; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Penner CG, 1997, J CELL BIOCHEM, V64, P525; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Preisser L, 1999, FEBS LETT, V460, P303, DOI 10.1016/S0014-5793(99)01360-5; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Puckerin A, 2006, J BIOL CHEM, V281, P31131, DOI 10.1074/jbc.M605000200; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Richardson MD, 2003, J NEUROCHEM, V84, P854, DOI 10.1046/j.1471-4159.2003.01577.x; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; SMITH DB, 1994, CURRENT PROTOCOLS MO; Szabo EZ, 2000, J BIOL CHEM, V275, P6302, DOI 10.1074/jbc.275.9.6302; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; Szaszi K, 2002, J BIOL CHEM, V277, P42623, DOI 10.1074/jbc.M206629200; Teuchert M, 1999, J BIOL CHEM, V274, P36781, DOI 10.1074/jbc.274.51.36781; Tobin AB, 1997, J BIOL CHEM, V272, P20844, DOI 10.1074/jbc.272.33.20844; Tobin AB, 2002, TRENDS PHARMACOL SCI, V23, P337, DOI 10.1016/S0165-6147(02)02043-6; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104; Waugh MG, 1999, BIOCHEM J, V338, P175, DOI 10.1042/0264-6021:3380175; Wu JH, 2003, J BIOL CHEM, V278, P44238, DOI 10.1074/jbc.M309450200; YUAN NY, 1994, J BIOL CHEM, V269, P23032; Zhao BB, 2008, CELL SIGNAL, V20, P1769, DOI 10.1016/j.cellsig.2008.06.011	83	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11456	11468		10.1074/jbc.M110.182881	http://dx.doi.org/10.1074/jbc.M110.182881			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296876	Green Published, hybrid			2022-12-25	WOS:000288797100057
J	Nishi, M; Akutsu, H; Masui, S; Kondo, A; Nagashima, Y; Kimura, H; Perrem, K; Shigeri, Y; Toyoda, M; Okayama, A; Hirano, H; Umezawa, A; Yamamoto, N; Lee, SW; Ryo, A				Nishi, Mayuko; Akutsu, Hidenori; Masui, Shinji; Kondo, Asami; Nagashima, Yoji; Kimura, Hirokazu; Perrem, Kilian; Shigeri, Yasushi; Toyoda, Masashi; Okayama, Akiko; Hirano, Hisashi; Umezawa, Akihiro; Yamamoto, Naoki; Lee, Sam W.; Ryo, Akihide			A Distinct Role for Pin1 in the Induction and Maintenance of Pluripotency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; PROLYL ISOMERASE PIN1; SELF-RENEWAL; PHOSPHORYLATION; EXPRESSION; DIFFERENTIATION; ISOMERIZATION; SURVIVAL; MICE	The prominent characteristics of pluripotent stem cells are their unique capacity to self-renew and pluripotency. Although pluripotent stem cell proliferation is maintained by specific intracellular phosphorylation signaling events, it has not been well characterized how the resulting phosphorylated proteins are subsequently regulated. We here report that the peptidylprolyl isomerase Pin1 is indispensable for the self-renewal and maintenance of pluripotent stem cells via the regulation of phosphorylated Oct4 and other substrates. Pin1 expression was found to be up-regulated upon the induction of induced pluripotent stem (iPS) cells, and the forced expression of Pin1 with defined reprogramming factors was observed to further enhance the frequency of iPS cell generation. The inhibition of Pin1 activity significantly suppressed colony formation and induced the aberrant differentiation of human iPS cells as well as murine ES cells. We further found that Pin1 interacts with the phosphorylated Ser(12)-Pro motif of Oct4 and that this in turn facilitates the stability and transcriptional activity functions of Oct4. Our current findings thus uncover an atypical role for Pin1 as a putative regulator of the induction and maintenance of pluripotency via the control of phosphorylation signaling. These data suggest that the manipulation of Pin1 function could be a potential strategy for the stable induction and proliferation of human iPS cells.	[Ryo, Akihide] Yokohama City Univ, Sch Med, Dept Microbiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Nagashima, Yoji] Yokohama City Univ, Sch Med, Dept Pathol, Yokohama, Kanagawa 2360004, Japan; [Okayama, Akiko; Hirano, Hisashi] Yokohama City Univ, Sch Med, Dept Supramol Biol, Yokohama, Kanagawa 2360004, Japan; [Akutsu, Hidenori; Toyoda, Masashi; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo 1578535, Japan; [Masui, Shinji] Int Med Ctr Japan, Res Inst, Dept Regenerat Med, Tokyo 1628655, Japan; [Kimura, Hirokazu] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo 2080011, Japan; [Perrem, Kilian] Commonwealth Sci & Ind Res Org, Dickson, ACT 2602, Australia; [Shigeri, Yasushi] Natl Inst Adv Ind Sci & Technol, Osaka 5638577, Japan; [Yamamoto, Naoki] Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore; [Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Lee, Sam W.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Yokohama City University; Yokohama City University; Yokohama City University; National Center for Child Health & Development - Japan; National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID); Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Institute of Advanced Industrial Science & Technology (AIST); National University of Singapore; Harvard University; Massachusetts General Hospital; Harvard University	Ryo, A (corresponding author), Yokohama City Univ, Sch Med, Dept Microbiol, Kanazawa Ku, 3-9 Fuku Ura, Yokohama, Kanagawa 2360004, Japan.	aryo@yokohama-cu.ac.jp	Nagashima, Yoji/AAA-2591-2021	Masui, Shinji/0000-0001-7417-0019	Takeda Science Foundation; Uehara Memorial Foundation; Kanagawa Nanbyo Foundation; NATIONAL CANCER INSTITUTE [R01CA149477] Funding Source: NIH RePORTER	Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Kanagawa Nanbyo Foundation(Kanagawa Nanbyo Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the Takeda Science Foundation, Uehara Memorial Foundation, and Kanagawa Nanbyo Foundation (to A. R.).	Atchison FW, 2003, BIOL REPROD, V69, P1989, DOI 10.1095/biolreprod.103.020859; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Esnault S, 2008, CRIT REV IMMUNOL, V28, P45, DOI 10.1615/CritRevImmunol.v28.i1.30; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Prudhomme W, 2004, P NATL ACAD SCI USA, V101, P2900, DOI 10.1073/pnas.0308768101; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Ryo A, 2007, J BIOL CHEM, V282, P36671, DOI 10.1074/jbc.M704145200; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi Kazutoshi, 2006, V329, P449; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yamada M, 2010, HUM MOL GENET, V19, P480, DOI 10.1093/hmg/ddp512; Yang HM, 2005, J CELL BIOCHEM, V96, P821, DOI 10.1002/jcb.20588; Zhang ZH, 2007, FASEB J, V21, P3042, DOI 10.1096/fj.06-6914com	35	38	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11593	11603		10.1074/jbc.M110.187989	http://dx.doi.org/10.1074/jbc.M110.187989			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21296877	Green Published, hybrid			2022-12-25	WOS:000288797100069
J	Gazzin, S; Berengeno, AL; Strazielle, N; Fazzari, F; Raseni, A; Ostrow, JD; Wennberg, R; Ghersi-Egea, JF; Tiribelli, C				Gazzin, Silvia; Berengeno, Andrea Lorena; Strazielle, Nathalie; Fazzari, Francesco; Raseni, Alan; Ostrow, J. Donald; Wennberg, Richard; Ghersi-Egea, Jean-Francois; Tiribelli, Claudio			Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by Bilirubin at the Blood-CSF and Blood-Brain Barriers in the Gunn Rat	PLOS ONE			English	Article							P-GLYCOPROTEIN EXPRESSION; MULTIDRUG-RESISTANCE; OXIDATIVE STRESS; CHOROID-PLEXUS; UNCONJUGATED BILIRUBIN; CEREBELLAR HYPOPLASIA; ENDOTHELIAL-CELLS; DIFFERENTIAL EXPRESSION; INCREASED SENSITIVITY; DRUG-METABOLISM	Accumulation of unconjugated bilirubin (UCB) in the brain causes bilirubin encephalopathy. Pgp (ABCb1) and Mrp1 (ABCc1), highly expressed in the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB) respectively, may modulate the accumulation of UCB in brain. We examined the effect of prolonged exposure to elevated concentrations of UCB on expression of the two transporters in homozygous, jaundiced (jj) Gunn rats compared to heterozygous, not jaundiced (Jj) littermates at different developmental stages (2, 9, 17 and 60 days after birth). BBB Pgp protein expression was low in both jj and Jj pups at 9 days (about 16-27% of adult values), despite the up-regulation in jj animals (2 and 1.3 fold higher than age matched Jj animals at P9 and P17-P60, respectively); Mrp1 protein expression was barely detectable. Conversely, at the BCSFB Mrp1 protein expression was rather high (60-70% of the adult values) in both jj and Jj at P2, but was markedly (50%) down-regulated in jj pups starting at P9, particularly in the 4(th) ventricle choroid plexuses: Pgp was almost undetectable. The Mrp1 protein down regulation was accompanied by a modest up-regulation of mRNA, suggesting a translational rather than a transcriptional inhibition. In vitro exposure of choroid plexus epithelial cells obtained from normal rats to UCB, also resulted in a down-regulation of Mrp1 protein. These data suggest that down-regulation of Mrp1 protein at the BSCFB, resulting from a direct effect of UCB on epithelial cells, may impact the Mrp1-mediated neuroprotective functions of the blood-cerebrospinal fluid barrier and actually potentiate UCB neurotoxicity.	[Gazzin, Silvia; Berengeno, Andrea Lorena; Fazzari, Francesco; Tiribelli, Claudio] Ctr Fegato, Basovizza Trieste, Italy; [Strazielle, Nathalie] Univ Lyon 1, Fac Med Laennec, Brain I INSERM U842, F-69365 Lyon, France; [Raseni, Alan] SC Lab Anal Clin IRCCS Burlo Garofolo, Trieste, Italy; [Ostrow, J. Donald] Univ Washington, Sch Med, Div Gastroenterol Hepatol, Seattle, WA USA; [Ostrow, J. Donald] VA Puget Sound Hlth Care System, Seattle Div, Seattle, WA USA; [Wennberg, Richard] Univ Washington, Sch Med, Div Neonatol, Seattle, WA USA; [Ghersi-Egea, Jean-Francois] Univ Lyon 1, INSERM U842, Fac Med Laennec, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; IRCCS Burlo Garofolo; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gazzin, S (corresponding author), Ctr Fegato, Basovizza Trieste, Italy.	silvia.gazzin@csf.units.it	; Tiribelli, Claudio/A-4716-2014	Ghersi-Egea, Jean-Francois/0000-0002-0181-4909; Tiribelli, Claudio/0000-0001-6596-7595	Fondo Regionale FVG [legge 23/00]; Telethon [GGP05062]; Italian Liver Foundation; Italian Ministry of Foreign Affairs, Rome, Italy	Fondo Regionale FVG; Telethon(Fondazione Telethon); Italian Liver Foundation; Italian Ministry of Foreign Affairs, Rome, Italy	This work was supported in part by a grant from the Fondo Regionale FVG (legge 23/00) and in part from a Telethon grant number GGP05062. The reimaging costs were covered by an in house grant from the Italian Liver Foundation. ALB was supported by a PhD fellowship from the Italian Ministry of Foreign Affairs, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSMA PJ, 1993, GASTROENTEROLOGY, V105, P216, DOI 10.1016/0016-5085(93)90029-C; Brito MA, 2008, NEUROTOXICOLOGY, V29, P259, DOI 10.1016/j.neuro.2007.11.002; Brito MA, 2008, NEUROBIOL DIS, V29, P30, DOI 10.1016/j.nbd.2007.07.023; Cannon C, 2006, BIOL NEONATE, V90, P40, DOI 10.1159/000091843; Cesaratto L, 2007, J MOL MED, V85, P1099, DOI 10.1007/s00109-007-0204-3; CHOWDHURY JR, 1993, ADV VET SCI COMP MED, V37, P149; CHOWDHURY JR, 1991, J BIOL CHEM, V266, P18294; COLE SPC, 1994, CANCER RES, V54, P5902; Conlee JW, 1997, ACTA NEUROPATHOL, V93, P450, DOI 10.1007/s004010050639; Corich L, 2009, BIOCHEM J, V417, P305, DOI 10.1042/BJ20080918; Daood M, 2008, NEUROPEDIATRICS, V39, P211, DOI 10.1055/s-0028-1103272; DIAMOND I, 1966, J CLIN INVEST, V45, P678, DOI 10.1172/JCI105383; EHRLICH P, 1883, CENTR KLIN MED, V4, P721; Elferink MGL, 2004, AM J PHYSIOL-GASTR L, V287, pG1008, DOI 10.1152/ajpgi.00071.2004; Felix RA, 2002, J NEUROCHEM, V80, P64, DOI 10.1046/j.0022-3042.2001.00660.x; Fernetti C, 2001, BIOCHEM BIOPH RES CO, V288, P1064, DOI 10.1006/bbrc.2001.5885; Gazzin S, 2008, J COMP NEUROL, V510, P497, DOI 10.1002/cne.21808; Ghersi-Egea JF, 2009, CURR PHARM DESIGN, V15, P2893, DOI 10.2174/138161209789058147; Ghersi-Egea JF, 2001, MICROSC RES TECHNIQ, V52, P83, DOI 10.1002/1097-0029(20010101)52:1<83::AID-JEMT10>3.0.CO;2-N; GHERSIEGEA JF, 1994, J NEUROCHEM, V62, P1089; GhersiEgea JF, 1995, TOXICOL LETT, V82-3, P645, DOI 10.1016/0378-4274(95)03510-9; Gourley G R, 1997, Adv Pediatr, V44, P173; Gunn CH, 1938, J HERED, V29, P137, DOI 10.1093/oxfordjournals.jhered.a104478; Hirrlinger J, 2001, J NEUROCHEM, V76, P627, DOI 10.1046/j.1471-4159.2001.00101.x; Hong H, 2006, J NEUROCHEM, V98, P1465, DOI 10.1111/j.1471-4159.2006.03993.x; IYANAGI T, 1989, J BIOL CHEM, V264, P21302; Jedlitschky G, 1996, CANCER RES, V56, P988; JETTE L, 1995, BIOCHEM PHARMACOL, V50, P1701, DOI 10.1016/0006-2952(95)02073-X; JOHNSON JA, 1993, BIOCHEM J, V291, P453, DOI 10.1042/bj2910453; Jones BR, 2005, MOL PHARMACOL, V68, P701, DOI 10.1124/mol.105.013144; Kadakol A, 2000, HUM MUTAT, V16, P297, DOI 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z; Kaplan M, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e47; KEINO H, 1986, PEDIATR NEUROSCI, V12, P145, DOI 10.1159/000120237; Lawrenson JG, 1999, ANAT EMBRYOL, V199, P29, DOI 10.1007/s004290050206; LEIER I, 1994, J BIOL CHEM, V269, P27807; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Lin SZ, 2005, EUR J NEUROSCI, V22, P21, DOI 10.1111/j.1460-9568.2005.04182.x; Lippoldt A, 2000, NEUROREPORT, V11, P1427, DOI 10.1097/00001756-200005150-00015; Lorico A, 1997, CANCER RES, V57, P5238; Matsuoka Y, 1999, J NEUROBIOL, V39, P383, DOI 10.1002/(SICI)1097-4695(19990605)39:3<383::AID-NEU5>3.0.CO;2-4; Mediavilla MG, 1999, FEBS LETT, V463, P143, DOI 10.1016/S0014-5793(99)01606-3; NAG S, 2003, METH MOLEC MED, V89, pR5; Ostrow JD, 2004, TRENDS MOL MED, V10, P65, DOI 10.1016/j.molmed.2003.12.003; Ostrow JD, 2003, EUR J CLIN INVEST, V33, P988, DOI 10.1046/j.1365-2362.2003.01261.x; OSTROW JD, 1994, J LIPID RES, V35, P1715; OSTROW JD, 1987, BILE PIGMENTS JAUNDI; Rigato L, 2004, BIOCHEM J, V383, P335, DOI 10.1042/BJ20040599; Roca L, 2006, PEDIATR RES, V60, P724, DOI 10.1203/01.pdr.0000245992.89965.94; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; SAWASAKI Y, 1976, J NEUROCHEM, V27, P577, DOI 10.1111/j.1471-4159.1976.tb12285.x; SCHMID R, 1958, J CLIN INVEST, V37, P1123, DOI 10.1172/JCI103702; Shapiro SM, 2002, PEDIATR RES, V52, P844, DOI 10.1203/01.PDR.0000036880.02060.EE; Shapiro SM, 2006, CLIN PERINATOL, V33, P387, DOI 10.1016/j.clp.2006.03.010; Strazielle N, 1999, J NEUROSCI, V19, P6275; Strazielle N, 2003, AIDS, V17, P1473, DOI 10.1097/00002030-200307040-00008; Sugiyama D, 2003, PHARM RES-DORDR, V20, P1394, DOI 10.1023/A:1025749925541; TAKAHASHI M, 1984, J BIOCHEM-TOKYO, V96, P1705, DOI 10.1093/oxfordjournals.jbchem.a135003; Tell G, 2009, CURR PHARM DESIGN, V15, P2908, DOI 10.2174/138161209789058174; Tsai CE, 2002, BIOL NEONATE, V81, P58, DOI 10.1159/000047185; Virgintino D, 2008, J NEUROPATH EXP NEUR, V67, P50, DOI 10.1097/nen.0b013e31815f65d9; Watchko J F, 2001, J Perinatol, V21 Suppl 1, pS43, DOI 10.1038/sj.jp.7210633; Wennberg RP, 2006, PEDIATRICS, V117, P474, DOI 10.1542/peds.2005-0395; Wennberg RP, 2000, CELL MOL NEUROBIOL, V20, P97, DOI 10.1023/A:1006900111744; Wijnholds J, 2000, J CLIN INVEST, V105, P279, DOI 10.1172/JCI8267; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275	65	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16165	10.1371/journal.pone.0016165	http://dx.doi.org/10.1371/journal.pone.0016165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21297965	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300038
J	Guenaga, J; Dosenovic, P; Ofek, G; Baker, D; Schief, WR; Kwong, PD; Hedestam, GBK; Wyatt, RT				Guenaga, Javier; Dosenovic, Pia; Ofek, Gilad; Baker, David; Schief, William R.; Kwong, Peter D.; Hedestam, Gunilla B. Karlsson; Wyatt, Richard T.			Heterologous Epitope-Scaffold Prime:Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; V3-SPECIFIC ANTIBODIES; STRUCTURAL ELEMENTS; GP120 GLYCOPROTEIN; ENVELOPE PROTEIN; IMMUNOGENICITY; BROAD; IMMUNIZATION; INDUCTION	The HIV-1 envelope glycoproteins (Env) gp120 and gp41 mediate entry and are the targets for neutralizing antibodies. Within gp41, a continuous epitope defined by the broadly neutralizing antibody 2F5, is one of the few conserved sites accessible to antibodies on the functional HIV Env spike. Recently, as an initial attempt at structure-guided design, we transplanted the 2F5 epitope onto several non-HIV acceptor scaffold proteins that we termed epitope scaffolds (ES). As immunogens, these ES proteins elicited antibodies with exquisite binding specificity matching that of the 2F5 antibody. These novel 2F5 epitope scaffolds presented us with the opportunity to test heterologous prime: boost immunization strategies to selectively boost antibody responses against the engrafted gp41 2F5 epitope. Such strategies might be employed to target conserved but poorly immunogenic sites on the HIV-1 Env, and, more generally, other structurally defined pathogen targets. Here, we assessed ES prime: boosting by measuring epitope specific serum antibody titers by ELISA and B cell responses by ELISpot analysis using both free 2F5 peptide and an unrelated ES protein as probes. We found that the heterologous ES prime: boosting immunization regimen elicits cross-reactive humoral responses to the structurally constrained 2F5 epitope target, and that incorporating a promiscuous T cell helper epitope in the immunogens resulted in higher antibody titers against the 2F5 graft, but did not result in virus neutralization. Interestingly, two epitope scaffolds (ES1 and ES2), which did not elicit a detectable 2F5 epitope-specific response on their own, boosted such responses when primed with the ES5. Together, these results indicate that heterologous ES prime: boost immunization regimens effectively focus the humoral immune response on the structurally defined and immunogen-conserved HIV-1 2F5 epitope.	[Guenaga, Javier; Ofek, Gilad; Kwong, Peter D.; Wyatt, Richard T.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Dosenovic, Pia; Hedestam, Gunilla B. Karlsson] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Baker, David; Schief, William R.] Univ Washington, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; Karolinska Institutet; University of Washington; University of Washington Seattle	Guenaga, J (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA USA.	wyatt@scripps.edu	Dosenovic, Pia/S-6894-2018; Schief, William/ABF-3645-2020; Hedestam, Gunilla Karlsson/AAN-9616-2021; Baker, David/K-8941-2012	Dosenovic, Pia/0000-0002-0426-4586; Schief, William/0000-0002-1120-0150; Baker, David/0000-0001-7896-6217	National Institutes of Health; Bill and Melinda Gates Foundation, International AIDS Vaccine Initiative; Swedish Research Council [K2008-56X-20666-01-3]; Karolinska Institutet; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation, International AIDS Vaccine Initiative(Bill & Melinda Gates Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health intramural funds, The Bill and Melinda Gates Foundation (www.gatesfoundation.org) International AIDS Vaccine Initiative (www.iavi.org), The Swedish Research Council (project No. K2008-56X-20666-01-3), and a Karolinska Institutet doctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Biron Z, 2002, BIOCHEMISTRY-US, V41, P12687, DOI 10.1021/bi026261y; Braibant M, 2006, AIDS, V20, P1923, DOI 10.1097/01.aids.0000247113.43714.5e; Brown BK, 2008, VIROLOGY, V375, P529, DOI 10.1016/j.virol.2008.02.022; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; CHENGMAYER C, 1988, P NATL ACAD SCI USA, V85, P2815, DOI 10.1073/pnas.85.8.2815; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; Davis KL, 2009, J VIROL, V83, P1240, DOI 10.1128/JVI.01743-08; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Dosenovic P, 2009, J IMMUNOL, V183, P3373, DOI 10.4049/jimmunol.0900407; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; GILDEN RV, 1963, IMMUNOLOGY, V6, P30; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Ho J, 2005, VACCINE, V23, P1559, DOI 10.1016/j.vaccine.2004.09.037; Hoffman TL, 1999, MOL MEMBR BIOL, V16, P57, DOI 10.1080/096876899294760; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kusov YY, 2007, ANTIVIR RES, V73, P101, DOI 10.1016/j.antiviral.2006.08.003; LAROSA GJ, 1990, SCIENCE, V249, P932, DOI 10.1126/science.2392685; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liang XP, 1999, VACCINE, V17, P2862, DOI 10.1016/S0264-410X(99)00125-5; Luo M, 2006, VACCINE, V24, P435, DOI 10.1016/j.vaccine.2005.08.006; Moore JP, 1996, J VIROL, V70, P427, DOI 10.1128/JVI.70.1.427-444.1996; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; OFEK G, 2010, P NATL ACAD SCI US; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Plotkin SA, 2001, PEDIATR INFECT DIS J, V20, P63, DOI 10.1097/00006454-200101000-00013; Rademeyer C, 2007, VIROLOGY, V368, P172, DOI 10.1016/j.virol.2007.06.013; RAJEWSKY K, 1969, J EXP MED, V129, P1131, DOI 10.1084/jem.129.6.1131; Sather DN, 2010, VACCINE, V28, pB8, DOI 10.1016/j.vaccine.2009.07.085; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhang HT, 2004, J VIROL, V78, P8342, DOI 10.1128/jvi.78.15.8342-8348.2004	55	69	74	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16074	10.1371/journal.pone.0016074	http://dx.doi.org/10.1371/journal.pone.0016074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21297864	gold, Green Submitted, Green Published			2022-12-25	WOS:000286662800016
J	Kuhn, S; Gallinat, J; Brass, M				Kuehn, Simone; Gallinat, Juergen; Brass, Marcel			"Keep Calm and Carry On'': Structural Correlates of Expressive Suppression of Emotions	PLOS ONE			English	Article							NEGATIVE EMOTION; INHIBITION; PHYSIOLOGY; STOP	There is a growing appreciation that individuals differ systematically in their use of particular emotion regulation strategies. Our aim was to examine the structural correlates of the habitual use of expressive suppression of emotions. Based on our previous research on the voluntary suppression of actions we expected this response-focused emotion regulation strategy to be associated with increased grey matter volume in the dorsomedial prefrontal cortex (dmPFC). On high-resolution MRI scans of 42 college-aged healthy adults we computed optimized voxel-based-morphometry (VBM) to explore the correlation between grey matter volume and inter-individual differences in the tendency to suppress the expression of emotions assessed by means of the Emotion Regulation Questionnaire (Gross & John, 2003). We found a positive correlation between the habitual use of expressive suppression as an emotion regulation strategy and grey matter volume in the dmPFC. No other brain area showed a significant positive or negative correlation with the Emotion Regulation Questionnaire scores. The association between the suppression of expression of emotions and volume in the dmPFC supports the behavioural stability and biological foundation of the concept of this particular emotion regulation strategy within an age-homogenous sample of adults.	[Kuehn, Simone; Brass, Marcel] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Kuehn, Simone; Brass, Marcel] Univ Ghent, Ghent Inst Funct & Metab Imaging, Fac Psychol & Educ Sci, B-9000 Ghent, Belgium; [Kuehn, Simone; Gallinat, Juergen] Charite, Clin Psychiat & Psychotherapy, St Hedwig Krankenhaus, D-13353 Berlin, Germany	Ghent University; Ghent University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kuhn, S (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	simone.kuhn@ugent.be	Brass, Marcel/J-7082-2012; Kuehn, Simone/P-6145-2014	Brass, Marcel/0000-0002-3364-4019; Kuhn, Simone/0000-0001-6823-7969	AstraZeneca; Eli Lilly Co; Janssen-Cilag; Bristol-Myers Squibb	AstraZeneca(AstraZeneca); Eli Lilly Co(Eli Lilly); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bristol-Myers Squibb(Bristol-Myers Squibb)	JG has received research funding from AstraZeneca, Eli Lilly & Co, Janssen-Cilag, Bristol-Myers Squibb and speaker fees from AstraZeneca, Janssen-Cilag, and Bristol-Myers Squibb. The authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baumeister RF, 1994, LOSING CONTROL WHY P, DOI 10.5860/choice.32-6508; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Brass M, 2007, J NEUROSCI, V27, P9141, DOI 10.1523/JNEUROSCI.0924-07.2007; Brody AL, 2007, BIOL PSYCHIAT, V62, P642, DOI 10.1016/j.biopsych.2006.10.026; Campbell-Meiklejohn DK, 2008, BIOL PSYCHIAT, V63, P293, DOI 10.1016/j.biopsych.2007.05.014; Carver CS, 1981, ATTENTION SELF CONTR; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Gaser C, 2003, J NEUROSCI, V23, P9240; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; Gross JJ, 1997, J ABNORM PSYCHOL, V106, P95, DOI 10.1037/0021-843X.106.1.95; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Jaffard M, 2008, NEUROIMAGE, V42, P1196, DOI 10.1016/j.neuroimage.2008.05.041; Kuhn S, 2009, HUM BRAIN MAPP, V30, P2834, DOI 10.1002/hbm.20711; LAZARUS RS, 1964, J ABNORM SOC PSYCH, V69, P195, DOI 10.1037/h0044635; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; MEISSNER WW, 1981, INTERNALIZATION PSYC; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parsons T., 1967, SOCIOL THEOR; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Schmidt-Wilcke T, 2010, NEUROIMAGE, V51, P1234, DOI 10.1016/j.neuroimage.2010.03.042; TUCKER DM, 1981, PSYCHOL BULL, V89, P19, DOI 10.1037/0033-2909.89.1.19; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf	32	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16569	10.1371/journal.pone.0016569	http://dx.doi.org/10.1371/journal.pone.0016569			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JL	21298057	Green Submitted, Green Published, gold			2022-12-25	WOS:000286662800056
J	Reynolds, MM; Bogomolnaya, L; Guo, JB; Aldrich, L; Bokhari, D; Santiviago, CA; McClelland, M; Andrews-Polymenis, H				Reynolds, M. Megan; Bogomolnaya, Lydia; Guo, Jinbai; Aldrich, Lindsay; Bokhari, Danial; Santiviago, Carlos A.; McClelland, Michael; Andrews-Polymenis, Helene			Abrogation of the Twin Arginine Transport System in Salmonella enterica Serovar Typhimurium Leads to Colonization Defects during Infection	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRANSLOCATION PATHWAY; SIGNAL PEPTIDE; MOLECULAR CHARACTERIZATION; PROTEIN TRANSLOCATION; PUTATIVE COMPONENTS; SWARMING MOTILITY; VIRULENCE FACTORS; FLIR PROTEINS; TAT	TatC (STM3975) is a highly conserved component of the Twin Arginine Transport (Tat) systems that is required for transport of folded proteins across the inner membrane in gram-negative bacteria. We previously identified a Delta tatC mutant as defective in competitive infections with wild type ATCC14028 during systemic infection of Salmonella-susceptible BALB/c mice. Here we confirm these results and show that the Delta tatC mutant is internalized poorly by cultured J774-A.1 mouse macrophages a phenotype that may be related to the systemic infection defect. This mutant is also defective for short-term intestinal and systemic colonization after oral infection of BALB/c mice and is shed in reduced numbers in feces from orally infected Salmonella-resistant (CBA/J) mice. We show that the Delta tatC mutant is highly sensitive to bile acids perhaps resulting in the defect in intestinal infection that we observe. Finally, the Delta tatC mutant has an unusual combination of motility phenotypes in Salmonella; it is severely defective for swimming motility but is able to swarm well. The Delta tatC mutant has a lower amount of flagellin on the bacterial surface during swimming motility but normal levels under swarming conditions.	[Reynolds, M. Megan; Bogomolnaya, Lydia; Guo, Jinbai; Aldrich, Lindsay; Bokhari, Danial; Andrews-Polymenis, Helene] Texas A&M Univ Syst, Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, College Stn, TX 77843 USA; [Santiviago, Carlos A.] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Santiago, Chile; [McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [McClelland, Michael] Univ Calif Irvine, Dept Pathol & Lab Med, Coll Hlth Sci, Irvine, CA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Universidad de Chile; University of California System; University of California Irvine	Reynolds, MM (corresponding author), Texas A&M Univ Syst, Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, College Stn, TX 77843 USA.	handrews@medicine.tamhsc.edu	Santiviago, Carlos/N-9991-2018; McClelland, Michael/A-8583-2011	Santiviago, Carlos/0000-0002-7043-7908; Bogomolnaya, Lydia/0000-0001-7041-1815; McClelland, Michael/0000-0003-1788-9347	National Institutes of Health [AI075093, AI052237, AI073971, AI083964, AI039557, AI077645, AI083646]; USDA [2009-03579]; DOD [IS-4267-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI077645, R01AI052237, R21AI083964, R01AI075093, R01AI073971, R21AI039557, R01AI039557, R01AI083646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); DOD(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	HAP is supported by National Institutes of Health grants AI083964, AI083646, AI077645, AI075093, and USDA grant 2009-03579. MM is supported by NIH grants AI052237, AI073971, AI075093, AI083964, AI039557, AI077645, AI083646, and DOD grant IS-4267-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Allen SCH, 2002, J BIOL CHEM, V277, P10362, DOI 10.1074/jbc.M109135200; Barrett CML, 2005, FEBS J, V272, P2261, DOI 10.1111/j.1742-4658.2005.04654.x; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; BENJAMIN WH, 1990, J IMMUNOL, V144, P3143; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x; BOGOMOLNAYA LM, 2008, FORM VARIATION O12 A; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Brink S, 1998, FEBS LETT, V434, P425, DOI 10.1016/S0014-5793(98)01028-X; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; BUCHMEIER NA, 1989, INFECT IMMUN, V57, P1; Chen L, 2009, ARCH MICROBIOL, V191, P163, DOI 10.1007/s00203-008-0440-0; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Buck E, 2005, BIOCHEM BIOPH RES CO, V331, P1413, DOI 10.1016/j.bbrc.2005.04.060; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Ding ZY, 2003, J BACTERIOL, V185, P760, DOI 10.1128/JB.185.3.760-771.2003; Fan F, 1997, MOL MICROBIOL, V26, P1035, DOI 10.1046/j.1365-2958.1997.6412010.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; GuardPetter J, 1997, FEMS MICROBIOL LETT, V149, P173, DOI 10.1016/S0378-1097(97)00071-2; Hinsley AP, 2001, FEBS LETT, V497, P45, DOI 10.1016/S0014-5793(01)02428-0; HORMAECHE CE, 1989, RES IMMUNOL, V140, P791, DOI 10.1016/0923-2494(89)90034-5; Ize B, 2004, J BIOL CHEM, V279, P47543, DOI 10.1074/jbc.M406910200; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jeong KJ, 2004, J MOL BIOL, V341, P901, DOI 10.1016/j.jmb.2004.05.078; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; Lavander M, 2006, INFECT IMMUN, V74, P1768, DOI 10.1128/IAI.74.3.1768-1776.2006; Maniatis T, 1989, MOL CLONING; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; Mickael CS, 2010, INFECT IMMUN, V78, P3493, DOI 10.1128/IAI.00090-10; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Ohnishi K, 1997, J BACTERIOL, V179, P6092, DOI 10.1128/jb.179.19.6092-6099.1997; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; Posey JE, 2006, J BACTERIOL, V188, P1332, DOI 10.1128/JB.188.4.1332-1340.2006; Pradel N, 2003, INFECT IMMUN, V71, P4908, DOI 10.1128/IAI.71.9.4908-4916.2003; Pradel N, 2003, BIOCHEM BIOPH RES CO, V306, P786, DOI 10.1016/S0006-291X(03)01043-X; Rajashekara G, 2009, FOODBORNE PATHOG DIS, V6, P935, DOI 10.1089/fpd.2009.0298; Ramos-Morales F, 2003, J BACTERIOL, V185, P5328, DOI 10.1128/JB.185.17.5328-5332.2003; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Wang QF, 2007, J BACTERIOL, V189, P8447, DOI 10.1128/JB.01198-07; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Zhang LJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-114	54	28	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e15800	10.1371/journal.pone.0015800	http://dx.doi.org/10.1371/journal.pone.0015800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298091	Green Published, gold			2022-12-25	WOS:000286662800011
J	Antunes, MS; Morey, KJ; Smith, JJ; Albrecht, KD; Bowen, TA; Zdunek, JK; Troupe, JF; Cuneo, MJ; Webb, CT; Hellinga, HW; Medford, JI				Antunes, Mauricio S.; Morey, Kevin J.; Smith, J. Jeff; Albrecht, Kirk D.; Bowen, Tessa A.; Zdunek, Jeffrey K.; Troupe, Jared F.; Cuneo, Matthew J.; Webb, Colleen T.; Hellinga, Homme W.; Medford, June I.			Programmable Ligand Detection System in Plants through a Synthetic Signal Transduction Pathway	PLOS ONE			English	Article							PERIPLASMIC BINDING-PROTEINS; COMPUTATIONAL DESIGN; ESCHERICHIA-COLI; ARABIDOPSIS; NOISE; PHOB; IDENTIFICATION; PERCEPTION; PHOSPHATE; EVOLUTION	Background: There is an unmet need to monitor human and natural environments for substances that are intentionally or unintentionally introduced. A long-sought goal is to adapt plants to sense and respond to specific substances for use as environmental monitors. Computationally re-designed periplasmic binding proteins (PBPs) provide a means to design highly sensitive and specific ligand sensing capabilities in receptors. Input from these proteins can be linked to gene expression through histidine kinase (HK) mediated signaling. Components of HK signaling systems are evolutionarily conserved between bacteria and plants. We previously reported that in response to cytokinin-mediated HK activation in plants, the bacterial response regulator PhoB translocates to the nucleus and activates transcription. Also, we previously described a plant visual response system, the de-greening circuit, a threshold sensitive reporter system that produces a visual response which is remotely detectable and quantifiable. Methodology/Principal Findings: We describe assembly and function of a complete synthetic signal transduction pathway in plants that links input from computationally re-designed PBPs to a visual response. To sense extracellular ligands, we targeted the computational re-designed PBPs to the apoplast. PBPs bind the ligand and develop affinity for the extracellular domain of a chemotactic protein, Trg. We experimentally developed Trg fusions proteins, which bind the ligand-PBP complex, and activate intracellular PhoR, the HK cognate of PhoB. We then adapted Trg-PhoR fusions for function in plants showing that in the presence of an external ligand PhoB translocates to the nucleus and activates transcription. We linked this input to the de-greening circuit creating a detector plant. Conclusions/Significance: Our system is modular and PBPs can theoretically be designed to bind most small molecules. Hence our system, with improvements, may allow plants to serve as a simple and inexpensive means to monitor human surroundings for substances such as pollutants, explosives, or chemical agents.	[Antunes, Mauricio S.; Morey, Kevin J.; Albrecht, Kirk D.; Bowen, Tessa A.; Zdunek, Jeffrey K.; Troupe, Jared F.; Webb, Colleen T.; Medford, June I.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Smith, J. Jeff; Cuneo, Matthew J.; Hellinga, Homme W.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Colorado State University; Duke University	Antunes, MS (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	June.Medford@colostate.edu	Antunes, Mauricio/AAC-8139-2020	Cuneo, Matthew/0000-0002-1475-6656	United States Defense Advanced Research Project Agency (DARPA, Defense Science Office); Office of Naval Research (United States, ONR)	United States Defense Advanced Research Project Agency (DARPA, Defense Science Office)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research (United States, ONR)(Office of Naval Research)	This work was supported by grants to June Medford and Homme Hellinga from the United States Defense Advanced Research Project Agency (DARPA, Defense Science Office) and the Office of Naval Research (United States, ONR). Dr. J. Jeff Smith was at Duke University when this work was accomplished. His current employer, Precision Biosciences did not provide funds nor did it play any role in this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allert M, 2004, P NATL ACAD SCI USA, V101, P7907, DOI 10.1073/pnas.0401309101; Antunes MS, 2006, PLANT BIOTECHNOL J, V4, P605, DOI 10.1111/j.1467-7652.2006.00205.x; Antunes MS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.28; Baumberger N, 2003, PLANT PHYSIOL, V131, P1313, DOI 10.1104/pp.102.014928; BAUMGARTNER JW, 1994, J BACTERIOL, V176, P1157, DOI 10.1128/JB.176.4.1157-1163.1994; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; De Lorimier RM, 2006, PROTEIN SCI, V15, P1936, DOI 10.1110/ps.062261606; Dougherty MJ, 2009, CURR OPIN BIOTECH, V20, P486, DOI 10.1016/j.copbio.2009.08.005; Dwyer MA, 2004, CURR OPIN STRUC BIOL, V14, P495, DOI 10.1016/j.sbi.2004.07.004; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; Feng XJ, 2004, BIOPHYS J, V87, P2195, DOI 10.1529/biophysj.104.044131; Gallagher S.R., 1992, GUS PROTOCOLS USING; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Harper RJ, 2005, TALANTA, V67, P313, DOI 10.1016/j.talanta.2005.05.019; HUPPERT H, 2004, MAKING UK SAFER DETE, P1; Johnston J.M., 1999, CANINE DETECTION CAP, P1; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kant P, 2008, PLANT CELL ENVIRON, V31, P697, DOI 10.1111/j.1365-3040.2008.01779.x; Koretke KK, 2000, MOL BIOL EVOL, V17, P1956, DOI 10.1093/oxfordjournals.molbev.a026297; KURY J, 1995, UCRLID120385 LAWR LI, P1; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; Masuda T, 2003, PLANT CELL PHYSIOL, V44, P963, DOI 10.1093/pcp/pcg128; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McCleary WR, 1996, MOL MICROBIOL, V20, P1155, DOI 10.1111/j.1365-2958.1996.tb02636.x; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Oxley JC, 2009, ASPECTS OF EXPLOSIVES DETECTION, P27, DOI 10.1016/B978-0-12-374533-0.00003-9; Schreier B, 2009, P NATL ACAD SCI USA, V106, P18491, DOI 10.1073/pnas.0907950106; Shaw AK, 2007, PROC SPIE, V6554, DOI 10.1117/12.723247; Sola M, 2006, ACTA CRYSTALLOGR D, V62, P1046, DOI 10.1107/S0907444906024541; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	39	74	76	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16292	10.1371/journal.pone.0016292	http://dx.doi.org/10.1371/journal.pone.0016292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283542	Green Published, gold			2022-12-25	WOS:000286661400040
J	Scarf, D; Miles, K; Sloan, A; Goulter, N; Hegan, M; Seid-Fatemi, A; Harper, D; Colombo, M				Scarf, Damian; Miles, Kirby; Sloan, Amanda; Goulter, Natalie; Hegan, Matt; Seid-Fatemi, Azade; Harper, David; Colombo, Michael			Brain Cells in the Avian 'Prefrontal Cortex' Code for Features of Slot-Machine-Like Gambling	PLOS ONE			English	Article							PRIMATE ORBITOFRONTAL CORTEX; PATHOLOGICAL GAMBLERS; REWARD EXPECTANCY; NEURONAL-ACTIVITY; DECISION-MAKING; PREMOTOR CORTEX; PERIOD ACTIVITY; WORKING-MEMORY; FRONTAL-CORTEX; PIGEON	Slot machines are the most common and addictive form of gambling. In the current study, we recorded from single neurons in the 'prefrontal cortex' of pigeons while they played a slot-machine-like task. We identified four categories of neurons that coded for different aspects of our slot-machine-like task. Reward-Proximity neurons showed a linear increase in activity as the opportunity for a reward drew near. I-Won neurons fired only when the fourth stimulus of a winning (four-of-a-kind) combination was displayed. I-Lost neurons changed their firing rate at the presentation of the first nonidentical stimulus, that is, when it was apparent that no reward was forthcoming. Finally, Near-Miss neurons also changed their activity the moment it was recognized that a reward was no longer available, but more importantly, the activity level was related to whether the trial contained one, two, or three identical stimuli prior to the display of the nonidentical stimulus. These findings not only add to recent neurophysiological research employing simulated gambling paradigms, but also add to research addressing the functional correspondence between the avian NCL and primate PFC.	[Scarf, Damian; Miles, Kirby; Sloan, Amanda; Goulter, Natalie; Hegan, Matt; Colombo, Michael] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Seid-Fatemi, Azade] Ruhr Univ Bochum, AE Biopsychol, Fak Psychol, Bochum, Germany; [Harper, David] Victoria Univ Wellington, Dept Psychol, Wellington, New Zealand	University of Otago; Ruhr University Bochum; Victoria University Wellington	Scarf, D (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	colombo@psy.otago.ac.nz		Goulter, Natalie/0000-0003-0682-7781; Scarf, Damian/0000-0002-9486-8059; Colombo, Michael/0000-0002-2574-4888	University of Otago [0109-0310]	University of Otago	The work was funded by a University of Otago Research Grant 0109-0310 to M. Colombo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Becona E, 1995, J Gambl Stud, V11, P265, DOI 10.1007/BF02104793; Bilkey DK, 2003, METHODS, V30, P152, DOI 10.1016/S1046-2023(03)00076-8; Breen Robert B, 2002, J Gambl Stud, V18, P31, DOI 10.1023/A:1014580112648; Campos M, 2005, J NEUROPHYSIOL, V94, P1325, DOI 10.1152/jn.00022.2005; Cavedini P, 2002, BIOL PSYCHIAT, V51, P334, DOI 10.1016/S0006-3223(01)01227-6; Chantal Y, 1996, J Gambl Stud, V12, P407, DOI 10.1007/BF01539185; Clark L, 2009, NEURON, V61, P481, DOI 10.1016/j.neuron.2008.12.031; Cote D., 2003, J GAMBL STUD, V19, P380; Crockford DN, 2005, BIOL PSYCHIAT, V58, P787, DOI 10.1016/j.biopsych.2005.04.037; de Ruiter MB, 2009, NEUROPSYCHOPHARMACOL, V34, P1027, DOI 10.1038/npp.2008.175; DIVAC I, 1985, BRAIN RES, V332, P365, DOI 10.1016/0006-8993(85)90606-7; Dixon MR, 2002, PSYCHOL REC, V52, P417, DOI 10.1007/BF03395195; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Echeburua E, 2005, J GAMBL STUD, V21, P21, DOI 10.1007/s10899-004-1918-6; Forbush KT, 2008, CNS SPECTRUMS, V13, P306, DOI 10.1017/S1092852900016424; GRIFFITHS M, 1991, J COMMUNITY APPL SOC, V1, P309, DOI 10.1002/casp.2450010406; Gunturkun O, 1997, NEUROREPORT, V8, pR3; Gunturkun O, 2005, BRAIN RES BULL, V66, P311, DOI 10.1016/j.brainresbull.2005.02.004; Gunturkun O, 1997, J BRAIN RES, V38, P133; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Ichihara-Takeda S, 2006, J COGNITIVE NEUROSCI, V18, P212, DOI 10.1162/089892906775783679; Ichihara-Takeda S, 2008, J COGNITIVE NEUROSCI, V20, P563, DOI 10.1162/jocn.2008.20047; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Karten H.J., 1967, STEREOTAXIC ATLAS BR; Kassinove JI, 2001, PSYCHOL ADDICT BEHAV, V15, P155, DOI 10.1037/0893-164X.15.2.155; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Kroner S, 1999, J COMP NEUROL, V407, P228, DOI 10.1002/(SICI)1096-9861(19990503)407:2<228::AID-CNE6>3.0.CO;2-2; Lakey CE, 2007, J GAMBL STUD, V23, P285, DOI 10.1007/s10899-006-9034-4; Leaver AM, 2009, J NEUROSCI, V29, P2477, DOI 10.1523/JNEUROSCI.4921-08.2009; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Linnet J, 2006, SCAND J PSYCHOL, V47, P43, DOI 10.1111/j.1467-9450.2006.00491.x; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; MOGENSEN J, 1982, BRAIN BEHAV EVOLUT, V21, P60, DOI 10.1159/000121617; MOGENSEN J, 1993, BEHAV BRAIN RES, V55, P101, DOI 10.1016/0166-4328(93)90012-F; Nakamura K, 2006, J NEUROPHYSIOL, V96, P478, DOI 10.1152/jn.01326.2005; Petry NM, 2001, DRUG ALCOHOL DEPEN, V63, P29, DOI 10.1016/S0376-8716(00)00188-5; Petry NM, 2003, ADDICTION, V98, P645, DOI 10.1046/j.1360-0443.2003.00336.x; PLUME J, 2001, CASINO EXECUTIVE REP, P22; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Roca M, 2008, COGN BEHAV NEUROL, V21, P1, DOI 10.1097/WNN.0b013e3181684358; Roesch MR, 2007, ANN NY ACAD SCI, V1121, P431, DOI 10.1196/annals.1401.004; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rose J, 2005, PLOS BIOL, V3, P1139, DOI 10.1371/journal.pbio.0030190; Samanez-Larkin GR, 2007, NAT NEUROSCI, V10, P787, DOI 10.1038/nn1894; Schull ND, 2005, ANN AM ACAD POLIT SS, V597, P65, DOI 10.1177/0002716204270435; Shidara M, 1998, J NEUROSCI, V18, P2613; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Skinner B. F., 1953, SCI HUMAN BEHAV; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; TURNER N, 2004, J GAMBLING       NOV; WASHINGTON G, 1783, WORDS WASHINGTON, P693; Watanabe M, 2005, EXP BRAIN RES, V166, P263, DOI 10.1007/s00221-005-2358-y; Watanabe M, 2002, J NEUROSCI, V22, P2391, DOI 10.1523/JNEUROSCI.22-06-02391.2002; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; 2004, NY TIMES        0713; 2003, NY TIMES        0103	65	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e14589	10.1371/journal.pone.0014589	http://dx.doi.org/10.1371/journal.pone.0014589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283622	Green Published, Green Submitted, gold			2022-12-25	WOS:000286661400006
J	Jerome, JP; Bell, JA; Plovanich-Jones, AE; Barrick, JE; Brown, CT; Mansfield, LS				Jerome, John P.; Bell, Julia A.; Plovanich-Jones, Anne E.; Barrick, Jeffrey E.; Brown, C. Titus; Mansfield, Linda S.			Standing Genetic Variation in Contingency Loci Drives the Rapid Adaptation of Campylobacter jejuni to a Novel Host	PLOS ONE			English	Article							GENOME-WIDE EXPRESSION; PHASE VARIATION; GASTROINTESTINAL-TRACT; ESCHERICHIA-COLI; MULTIPLE GENES; IN-VITRO; COLONIZATION; EVOLUTION; VIRULENCE; DNA	The genome of the food-borne pathogen Campylobacter jejuni contains multiple highly mutable sites, or contingency loci. It has been suggested that standing variation at these loci is a mechanism for rapid adaptation to a novel environment, but this phenomenon has not been shown experimentally. In previous work we showed that the virulence of C. jejuni NCTC11168 increased after serial passage through a C57BL/6 IL-10(-/-) mouse model of campylobacteriosis. Here we sought to determine the genetic basis of this adaptation during passage. Re-sequencing of the 1.64Mb genome to 200-500X coverage allowed us to define variation in 23 contingency loci to an unprecedented depth both before and after in vivo adaptation. Mutations in the mouse-adapted C. jejuni were largely restricted to the homopolymeric tracts of thirteen contingency loci. These changes cause significant alterations in open reading frames of genes in surface structure biosynthesis loci and in genes with only putative functions. Several loci with open reading frame changes also had altered transcript abundance. The increase in specific phases of contingency loci during in vivo passage of C. jejuni, coupled with the observed virulence increase and the lack of other types of genetic changes, is the first experimental evidence that these variable regions play a significant role in C. jejuni adaptation and virulence in a novel host.	[Jerome, John P.; Bell, Julia A.; Plovanich-Jones, Anne E.; Mansfield, Linda S.] Michigan State Univ, Comparat Enter Dis Lab, E Lansing, MI 48824 USA; [Jerome, John P.; Brown, C. Titus; Mansfield, Linda S.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Brown, C. Titus] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Barrick, Jeffrey E.] Univ Texas Austin, Dept Chem & Biochem, Inst Cell & Mol Biol, Austin, TX 78712 USA	Michigan State University; Michigan State University; Michigan State University; University of Texas System; University of Texas Austin	Jerome, JP (corresponding author), Michigan State Univ, Comparat Enter Dis Lab, E Lansing, MI 48824 USA.	mansfie4@cvm.msu.edu	Barrick, Jeffrey/A-3046-2012	Barrick, Jeffrey/0000-0003-0888-7358; Brown, C. Titus/0000-0001-6001-2677; Mansfield, Linda S./0000-0002-7523-7577	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH) [K99GM087550]; Department of Health and Human Services [NO1-AI-30058]; United States Department of Agriculture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM087550, R00GM087550] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in whole by funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services, under Contract No. NO1-AI-30058. JPJ was also supported as a United States Department of Agriculture National Needs Graduate Fellow, and JEB had support from NIH grant K99GM087550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acke E, 2010, VET REC, V166, P102, DOI 10.1136/vr.c357; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; BARRICK JE, 2009, GENOME WIDE MUTATION; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bell JA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-57; Bhagwat AA, 2003, J MICROBIOL METH, V55, P399, DOI 10.1016/S0167-7012(03)00175-1; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Chatre P, 2010, J FOOD PROTECT, V73, P825, DOI 10.4315/0362-028X-73.5.825; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Fenton JI, 2006, CARCINOGENESIS, V27, P893, DOI 10.1093/carcin/bgi355; Forster M, 2009, J MED ENTOMOL, V46, P1164, DOI 10.1603/033.046.0526; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Hitchen P, 2010, MICROBIOL-SGM, V156, P1953, DOI 10.1099/mic.0.038091-0; Holmes EC, 2010, J MOL BIOL, V400, P271, DOI 10.1016/j.jmb.2010.05.032; Houliston RS, 2009, GLYCOBIOLOGY, V19, P153, DOI 10.1093/glycob/cwn117; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Jones MA, 2004, INFECT IMMUN, V72, P3769, DOI 10.1128/IAI.72.7.3769-3776.2004; Josenhans C, 2000, INFECT IMMUN, V68, P4598, DOI 10.1128/IAI.68.8.4598-4603.2000; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lavitola A, 1999, MOL MICROBIOL, V33, P119, DOI 10.1046/j.1365-2958.1999.01454.x; Law BF, 2009, FOODBORNE PATHOG DIS, V6, P377, DOI 10.1089/fpd.2008.0183; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Lin H, 2008, BIOINFORMATICS, V24, P2431, DOI 10.1093/bioinformatics/btn416; Lippert E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007413; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; Mas A, 2010, J MOL BIOL, V397, P865, DOI 10.1016/j.jmb.2010.02.005; Misawa N, 2000, INFECT IMMUN, V68, P6168, DOI 10.1128/IAI.68.11.6168-6175.2000; Moore JE, 2002, J VET MED B, V49, P388, DOI 10.1046/j.1439-0450.2002.00595.x; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Novik V, 2010, INFECT IMMUN, V78, P3540, DOI 10.1128/IAI.00109-10; PACHA RE, 1988, CAN J MICROBIOL, V34, P80, DOI 10.1139/m88-015; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Ribot EM, 2001, J CLIN MICROBIOL, V39, P1889, DOI 10.1128/JCM.39.5.1889-1894.2001; Ridley AM, 2008, J APPL MICROBIOL, V105, P95, DOI 10.1111/j.1365-2672.2008.03759.x; Ringoir DD, 2003, VET MICROBIOL, V92, P225, DOI 10.1016/S0378-1135(02)00378-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Slev PR, 2002, CURR OPIN IMMUNOL, V14, P609, DOI 10.1016/S0952-7915(02)00381-3; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Srikhanta YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/pnas.0501169102; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Stintzi A, 2005, INFECT IMMUN, V73, P1797, DOI 10.1128/IAI.73.3.1797-1810.2005; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; VANHAM SM, 1993, CELL, V73, P1187, DOI 10.1016/0092-8674(93)90647-9; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033; Wassenaar TM, 2002, FEMS MICROBIOL LETT, V212, P77, DOI 10.1111/j.1574-6968.2002.tb11248.x; Wassenaar TM, 1998, APPL ENVIRON MICROB, V64, P1816; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Wilson DL, 2010, MICROBIOL-SGM, V156, P2046, DOI 10.1099/mic.0.035717-0; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zoetendal EG, 2006, NAT PROTOC, V1, P954, DOI 10.1038/nprot.2006.143; 2001, J AM VET MED ASS, V218, P669	64	76	79	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16399	10.1371/journal.pone.0016399	http://dx.doi.org/10.1371/journal.pone.0016399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283682	Green Published, gold, Green Submitted			2022-12-25	WOS:000286523400033
J	Liu, Z; Fan, FY; Xiao, XJ; Sun, YM				Liu, Zheng; Fan, Feiyue; Xiao, Xiangjun; Sun, Yuanming			Constitutive Activation of the Thyroid-Stimulating Hormone Receptor (TSHR) by Mutating Ile(691) in the Cytoplasmic Tail Segment	PLOS ONE			English	Article							HUMAN THYROTROPIN RECEPTOR; GERMLINE MUTATION; GENE; LOOP; PHOSPHOINOSITIDE; FAMILY	Background: Autosomal dominant non-autoimmune hyperthyroidism (ADNAH) is a rare genetic disorder of the endocrine system. Molecular genetic studies in ADNAH have revealed heterozygous germline mutations in the TSHR. To data, mutations leading to an increase in the constitutive activation of the TSHR have been described in the transmembrane segments, exoloops and cytoplasmic loop of TSHR. These mutations result in constitutive activation of the G(alpha s)/cAMP or G(alpha q/11)/inositol phosphate (IP) pathways, which stimulate thyroid hormone production and thyroid proliferation. Methodology/Principal Findings: In a previous study, we reported a new TSHR mutation located in the C-terminal domain of TSHR, which results in a substitution of the conserved Ile(691) for Phe. In this study, to address the question of whether the I691F mutated receptor could be responsible for G(alpha s)/cAMP or G(alpha q/11)/IP constitutive activity, wild-type and TSHR mutants were expressed in COS-7 cells to determine cAMP constitutive activity and IP formation. Compared to the cell surface with expression of the A623V mutated receptor as positive control, the I691F mutated receptor showed a slight increase of cAMP accumulation. Furthermore, I691F resulted in constitutive activation of the G(alpha q/11)/IP signaling pathway. Conclusions/Significance: Our results indicate that Ile(691) not only contributes to keeping TSHR inactive in the G(alpha s)/cAMP pathways but also in the G(alpha q/11)/IP cascade.	[Liu, Zheng; Fan, Feiyue; Sun, Yuanming] Chinese Acad Med Sci, Inst Radiat Med, Tianjin Key Lab Mol Nucl Med, Tianjin, Peoples R China; [Liu, Zheng; Fan, Feiyue; Sun, Yuanming] Peking Union Med Coll, Tianjin, Peoples R China; [Liu, Zheng] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Xiao, Xiangjun] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University System of Georgia; Georgia Institute of Technology; University of Texas System; UTMD Anderson Cancer Center	Liu, Z (corresponding author), Chinese Acad Med Sci, Inst Radiat Med, Tianjin Key Lab Mol Nucl Med, Tianjin, Peoples R China.	liu.zheng1111@gmail.com	xiao, xiang/GWU-6035-2022; Liu, Zheng/GVU-3695-2022	Liu, Zheng/0000-0003-4158-6768	National Nature Science Foundation of China [30970867, 30400240]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation of China (No. 30970867, 30400240). (http://www.nsfc.gov.cn.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agretti P, 2003, EUR J BIOCHEM, V270, P3839, DOI 10.1046/j.1432-1033.2003.03778.x; Alberti L, 2001, EUR J ENDOCRINOL, V145, P249, DOI 10.1530/eje.0.1450249; Biebermann H, 1998, FASEB J, V12, P1461, DOI 10.1096/fasebj.12.14.1461; Biebermann H, 2001, J CLIN ENDOCR METAB, V86, P4429, DOI 10.1210/jc.86.9.4429; CHAZENBALK GD, 1990, J BIOL CHEM, V265, P20970; Claus M, 2006, J MOL MED, V84, P943, DOI 10.1007/s00109-006-0087-8; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; DUPREZ L, 1994, NAT GENET, V7, P396, DOI 10.1038/ng0794-396; Farid NR, 2004, ENDOCRINOLOGY, V145, P4048, DOI 10.1210/en.2004-0437; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; Holzapfel HP, 2002, EUR J ENDOCRINOL, V147, P109, DOI 10.1530/eje.0.1470109; Khoo DHC, 1999, J CLIN ENDOCR METAB, V84, P1459, DOI 10.1210/jc.84.4.1459; Kleinau G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009745; KOSUGI S, 1994, BIOCHEM BIOPH RES CO, V200, P401, DOI 10.1006/bbrc.1994.1463; KOSUGI S, 1992, J BIOL CHEM, V267, P24153; KOSUGI S, 1993, MOL ENDOCRINOL, V7, P1009, DOI 10.1210/me.7.8.1009; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; Lee YS, 2002, J PEDIATR ENDOCR MET, V15, P211; Liu Z, 2008, J HUM GENET, V53, P475, DOI 10.1007/s10038-008-0257-3; Ohmura T, 2001, PROTEIN ENG, V14, P421, DOI 10.1093/protein/14.6.421; PARMA J, 1995, MOL ENDOCRINOL, V9, P725, DOI 10.1210/me.9.6.725; Rodien P, 1998, NEW ENGL J MED, V339, P1823, DOI 10.1056/NEJM199812173392505; Schwab KO, 1997, J PEDIATR-US, V131, P899, DOI 10.1016/S0022-3476(97)70040-4; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Tonacchera M, 1996, J CLIN ENDOCR METAB, V81, P547, DOI 10.1210/jc.81.2.547; Wonerow P, 2000, CLIN ENDOCRINOL, V53, P461, DOI 10.1046/j.1365-2265.2000.01119.x	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16335	10.1371/journal.pone.0016335	http://dx.doi.org/10.1371/journal.pone.0016335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283701	Green Submitted, gold, Green Published			2022-12-25	WOS:000286522300035
J	Raja, SB; Murali, MR; Kumar, NK; Devaraj, SN				Raja, Subramaniya Bharathi; Murali, Malliga Raman; Kumar, Nirmal Kasinathan; Devaraj, Sivasitambaram Niranjali			Isolation and Partial Characterisation of a Novel Lectin from Aegle marmelos Fruit and Its Effect on Adherence and Invasion of Shigellae to HT29 Cells	PLOS ONE			English	Article							PURIFICATION; FLEXNERI; EXPRESSION; APOPTOSIS; SEEDS; ACID	Lectins are a class of ubiquitous proteins/glycoproteins that are abundantly found in nature. Lectins have unique carbohydrate binding property and hence have been exploited as drugs against various infectious diseases. We have isolated one such novel lectin from the fruit pulp of Aegle marmelos. The isolated lectin was partially characterised and its effect against Shigella dysenteriae infection was evaluated. The isolated lectin was found to be a dimeric protein with N-acetylgalactosamine, mannose and sialic acid binding specificity. The effect of Aegle marmelos fruit lectin on the adherence of Shigella dysenteriae to human colonic epithelial cells (HT29 cells) was evaluated by Enzyme Linked Immune Sorbent Assay and invasion was analysed. The protective nature of the Aegle marmelos fruit lectin was assessed by analyzing apoptosis through dual staining method. Aegle marmelos fruit lectin significantly inhibited hemagglutination activity of Shigella and its minimum inhibitory concentration is 0.625 mu g/well. Further, at this concentration lectin inhibited Shigella dysenteriae adherence and invasion of HT29 cells and protects the HT29 cells from Shigella dysenteriae induced apoptosis. To conclude, isolated lectin dimeric protein with N-acetylgalactosamine, Mannose and sialic acid binding specificity and inhibits adherence and invasion of Shigellae to HT29 cells thus, protects the host.	[Raja, Subramaniya Bharathi; Murali, Malliga Raman; Kumar, Nirmal Kasinathan; Devaraj, Sivasitambaram Niranjali] Univ Madras, Sch Life Sci, Dept Biochem, Madras, Tamil Nadu, India	University of Madras	Raja, SB (corresponding author), Univ Madras, Sch Life Sci, Dept Biochem, Madras, Tamil Nadu, India.	niranjali@yahoo.com	Raman, Murali Malliga/A-6987-2012; Subramaniya, Bharathi raja/A-7024-2012; Kasinathan, Nirmal Kumar/AAU-9161-2021	Raman, Murali Malliga/0000-0002-5696-4541; Kasinathan, Nirmal Kumar/0000-0002-8980-7198; S, BHARATHIRAJA/0000-0002-5680-7036	Indian Council of Medical Research (ICMR), Government of India	Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR))	This study was supported by Junior Research Fellowship from the Indian Council of Medical Research (ICMR), Government of India to S. Bharathi Raja. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINOUZ IL, 1992, BOT MAR, V35, P475; ALI M, 1987, J INDIAN CHEM SOC, V64, P230; Alwan A, 1998, J MICROBIOL METH, V33, P163, DOI 10.1016/S0167-7012(98)00052-9; Assreuy AMS, 1999, J UROLOGY, V161, P1988, DOI 10.1016/S0022-5347(05)68870-2; AYOUBA A, 1991, FEBS LETT, V289, P102, DOI 10.1016/0014-5793(91)80918-S; Benevides NMB, 1998, BOT MAR, V41, P521, DOI 10.1515/botm.1998.41.1-6.521; CALDEON AM, 1997, ELECT LECTIN J LECTI, V12; CAMMUE BP, 1985, BIOCHEM J, V227, P949, DOI 10.1042/bj2270949; CHATTERJEE A, 1994, TREATISE INDIAN MED, V3, P86; DeBolle MFC, 1996, PLANT MOL BIOL, V31, P993, DOI 10.1007/BF00040718; DIGGER HR, 1998, ACTA ANAT, V16, P30; DIKSHIT BBL, 1932, J INDIAN CHEM SOC, V9, P271; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; GOLDSTEIN IJ, 1980, NATURE, V285, P66, DOI 10.1038/285066b0; HIRMO S, 1997, ELECT LECTIN J LECTI, V12; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIENER IE, 1976, ANNU REV PLANT PHYS, V27, P291, DOI 10.1146/annurev.pp.27.060176.001451; MACH L, 1991, BIOCHEM J, V278, P667, DOI 10.1042/bj2780667; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; Neumann D, 2004, ADV DRUG DELIVER REV, V56, P437, DOI 10.1016/j.addr.2003.10.019; PARIKH V. M., 1958, JOUR INDIAN CHEM SOC, V35, P125; PEREIRA MEA, 1974, BIOCHEMISTRY-US, V13, P3184, DOI 10.1021/bi00712a029; PEREIRA MEA, 1979, ARCH BIOCHEM BIOPHYS, V194, P511, DOI 10.1016/0003-9861(79)90646-5; PEUMANS WJ, 1984, PLANTA, V160, P222, DOI 10.1007/BF00402858; Raja SB, 2009, AM J INFECT DIS, V5, P154, DOI 10.3844/ajidsp.2009.154.162; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Sansonetti PJ, 1998, FOLIA MICROBIOL, V43, P239, DOI 10.1007/BF02818608; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Sansonetti PJ, 1996, INFECT IMMUN, V64, P2752, DOI 10.1128/IAI.64.7.2752-2764.1996; Santi-Gadelha T, 2006, BIOCHEM BIOPH RES CO, V350, P1050, DOI 10.1016/j.bbrc.2006.09.149; Utsunomiya A, 2000, MICROBIOL IMMUNOL, V44, P529, DOI 10.1111/j.1348-0421.2000.tb02529.x; ZYCHLINSKY A, 1994, J CLIN INVEST, V94, P1328, DOI 10.1172/JCI117452; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	33	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16231	10.1371/journal.pone.0016231	http://dx.doi.org/10.1371/journal.pone.0016231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283697	gold, Green Submitted, Green Published			2022-12-25	WOS:000286522300022
J	Bora, H; Garg, S; Sen, P; Kumar, D; Kaur, P; Khan, RH; Sharma, YD				Bora, Hema; Garg, Sheena; Sen, Priyankar; Kumar, Deepak; Kaur, Punit; Khan, Rizwan Hasan; Sharma, Yagya D.			Plasmodium vivax Tryptophan-Rich Antigen PvTRAg33.5 Contains Alpha Helical Structure and Multidomain Architecture	PLOS ONE			English	Article							YOELII-INFECTED ERYTHROCYTES; CIRCULAR-DICHROISM; IMMUNOLOGICAL RESPONSES; CRYSTAL-STRUCTURE; IMMUNE-RESPONSES; CYTOCHROME-C; IN-VITRO; PROTEINS; MALARIA; FALCIPARUM	Tryptophan-rich proteins from several malarial parasites have been identified where they play an important role in host-parasite interaction. Structural characterization of these proteins is needed to develop them as therapeutic targets. Here, we describe a novel Plasmodium vivax tryptophan-rich protein named PvTRAg33.5. It is expressed by blood stage(s) of the parasite and its gene contains two exons. The exon 1 encodes for a 23 amino acids long putative signal peptide which is likely to be cleaved off whereas the exon 2 encodes for the mature protein of 252 amino acids. The mature protein contains B-cell epitopes which were recognized by the human immune system during P. vivax infection. The PvTRAg33.5 contains 24 (9.5%) tryptophan residues and six motifs whose patterns were similar among tryptophan-rich proteins. The modeled structure of the PvTRAg33.5 consists of a multidomain architecture which is stabilized by the presence of large number of tryptophan residues. The recombinant PvTRAg33.5 showed predominantly a helical structure and alpha helix to beta sheet transition at pH below 4.5. Protein acquires an irreversible non-native state at temperature more than 50 degrees C at neutral pH. Its secondary and tertiary structures remain stable in the presence of 35% alcohol but these structures are destabilized at higher alcohol concentrations due to the disturbance of hydrophobic interactions between tryptophanyl residues. These structural changes in the protein might occur during its translocation to interact with other proteins at its final destination for biological function such as erythrocyte invasion.	[Bora, Hema; Garg, Sheena; Kumar, Deepak; Sharma, Yagya D.] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Sen, Priyankar; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Kumar, Deepak; Kaur, Punit] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Aligarh Muslim University; All India Institute of Medical Sciences (AIIMS) New Delhi	Bora, H (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	rizwanhkhan@hotmail.com; ydsharma_aiims@yahoo.com	Khan, Rizwan Hasan/F-8276-2014; Khan, Rizwan/GXZ-5789-2022	Khan, Rizwan Hasan/0000-0002-9965-8982; Sen, Priyankar/0000-0003-4729-7297	Department of Biotechnology; Indian Council of Medical Research; Department of Science and Technology; Council for Scientific and Industrial Research	Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Science and Technology(Department of Science & Technology (India)); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from Department of Biotechnology (to YDS and RHK), Indian Council of Medical Research (to YDS and PK), Department of Science and Technology (to RHK) and Council for Scientific and Industrial Research (to RHK). Junior Research Fellowship (to HB) and Senior Research Fellowships (to PS and SG) from Department of Biotechnology are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2004, PROTEIN PEPTIDE LETT, V11, P307, DOI 10.2174/0929866043406887; Alam MT, 2008, PARASITE IMMUNOL, V30, P379, DOI 10.1111/j.1365-3024.2008.01033.x; Alam MT, 2008, VACCINE, V26, P3787, DOI 10.1016/j.vaccine.2008.05.059; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bhakuni V, 1998, ARCH BIOCHEM BIOPHYS, V357, P274, DOI 10.1006/abbi.1998.0794; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burns JM, 2000, MOL BIOCHEM PARASIT, V110, P11, DOI 10.1016/S0166-6851(00)00252-8; Burns JM, 1999, INFECT IMMUN, V67, P675, DOI 10.1128/IAI.67.2.675-680.1999; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Curtidor H, 2006, BIOCHEM BIOPH RES CO, V339, P888, DOI 10.1016/j.bbrc.2005.11.089; DIVITA G, 1995, J BIOL CHEM, V270, P28642, DOI 10.1074/jbc.270.48.28642; Garg S, 2008, MICROBES INFECT, V10, P1097, DOI 10.1016/j.micinf.2008.05.008; Gomi M., 2004, CHEM BIO INFORMATICS, V4, P142, DOI DOI 10.1273/CBIJ.4.142; Grundy WN, 1999, BIOINFORMATICS, V15, P463, DOI 10.1093/bioinformatics/15.6.463; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jalah R, 2005, MOL BIOCHEM PARASIT, V142, P158, DOI 10.1016/j.molbiopara.2005.01.020; Karplus K, 2001, PROTEINS, P86, DOI 10.1002/prot.10021; Khan F, 2000, BBA-PROTEIN STRUCT M, V1481, P229, DOI 10.1016/S0167-4838(00)00129-1; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; Konno T, 2000, PROTEIN SCI, V9, P564; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li B, 2004, BIOCHEMISTRY-US, V43, P2550, DOI 10.1021/bi0357863; Malkin EM, 2005, VACCINE, V23, P3131, DOI 10.1016/j.vaccine.2004.12.019; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Mcnae IW, 2009, J MOL BIOL, V385, P1519, DOI 10.1016/j.jmb.2008.11.047; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nishio M, 2002, VIROLOGY, V300, P92, DOI 10.1006/viro.2002.1509; Ntumngia FB, 2005, PARASITOL RES, V96, P347, DOI 10.1007/s00436-005-1398-3; Ntumngia FB, 2004, MOL BIOCHEM PARASIT, V137, P349, DOI 10.1016/j.molbiopara.2004.06.008; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; RAY P, 1994, AM J TROP MED HYG, V51, P436, DOI 10.4269/ajtmh.1994.51.436; Reed ZH, 2006, CURR MOL MED, V6, P231, DOI 10.2174/156652406776055195; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; Schulz H, 2000, MOL MICROBIOL, V37, P1379, DOI 10.1046/j.1365-2958.2000.02083.x; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Siddiqui AA, 2008, INFECT IMMUN, V76, P2576, DOI 10.1128/IAI.00677-07; Siddiqui AA, 2007, VACCINE, V26, P96, DOI 10.1016/j.vaccine.2007.10.042; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Uhlemann AC, 2001, MOL BIOCHEM PARASIT, V118, P41, DOI 10.1016/S0166-6851(01)00370-X; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; XUE H, 1995, GENE, V165, P335, DOI 10.1016/0378-1119(95)00550-P; Yeliseev AA, 2000, J BIOL CHEM, V275, P5657, DOI 10.1074/jbc.275.8.5657; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zsila F, 2004, ORG BIOMOL CHEM, V2, P2902, DOI 10.1039/b409724f; [No title captured]	56	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16294	10.1371/journal.pone.0016294	http://dx.doi.org/10.1371/journal.pone.0016294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283717	gold, Green Submitted, Green Published			2022-12-25	WOS:000286522200048
J	Coumes-Florens, S; Brochier-Armanet, C; Guiseppi, A; Denizot, F; Foglino, M				Coumes-Florens, Stephanie; Brochier-Armanet, Celine; Guiseppi, Annick; Denizot, Francois; Foglino, Maryline			A New Highly Conserved Antibiotic Sensing/Resistance Pathway in Firmicutes Involves an ABC Transporter Interplaying with a Signal Transduction System	PLOS ONE			English	Article							BACILLUS-SUBTILIS; BACITRACIN RESISTANCE; BACTERIAL LIPOPROTEINS; REGULATORY NETWORK; EXPRESSION; PYROPHOSPHATE; DETACHMENT; MECHANISM; PROTEINS; DATABASE	Signal transduction systems and ABC transporters often contribute jointly to adaptive bacterial responses to environmental changes. In Bacillus subtilis, three such pairs are involved in responses to antibiotics: BceRSAB, YvcPQRS and YxdJKLM. They are characterized by a histidine kinase belonging to the intramembrane sensing kinase family and by a translocator possessing an unusually large extracytoplasmic loop. It was established here using a phylogenomic approach that systems of this kind are specific but widespread in Firmicutes, where they originated. The present phylogenetic analyses brought to light a highly dynamic evolutionary history involving numerous horizontal gene transfers, duplications and lost events, leading to a great variety of Bce-like repertories in members of this bacterial phylum. Based on these phylogenetic analyses, it was proposed to subdivide the Bce-like modules into six well-defined subfamilies. Functional studies were performed on members of subfamily IV comprising BceRSAB from B. subtilis, the expression of which was found to require the signal transduction system as well as the ABC transporter itself. The present results suggest, for the members of this subfamily, the occurrence of interactions between one component of each partner, the kinase and the corresponding translocator. At functional and/or structural levels, bacitracin dependent expression of bceAB and bacitracin resistance processes require the presence of the BceB translocator loop. Some other members of subfamily IV were also found to participate in bacitracin resistance processes. Taken together our study suggests that this regulatory mechanism might constitute an important common antibiotic resistance mechanism in Firmicutes. [Supplemental material is available online at http://www.genome.org.]	[Coumes-Florens, Stephanie; Brochier-Armanet, Celine; Guiseppi, Annick; Denizot, Francois; Foglino, Maryline] CNRS, Inst Microbiol Mediterranee IFR88, Lab Chim Bacterienne UPR9043, Marseille, France; [Coumes-Florens, Stephanie; Guiseppi, Annick; Denizot, Francois; Foglino, Maryline] Univ Aix Marseille 2, Marseille, France; [Brochier-Armanet, Celine] Univ Aix Marseille 1, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Coumes-Florens, S (corresponding author), CNRS, Inst Microbiol Mediterranee IFR88, Lab Chim Bacterienne UPR9043, Marseille, France.	denizot@ifr88.cnrs-mrs.fr	Brochier-Armanet, Celine/B-7898-2011	Brochier-Armanet, Celine/0000-0003-4669-3589	Ministere de la Recherche et de la Technologie (France); Centre National de la Recherche Scientifique (CNRS); Universite de la Mediterranee; CNRS	Ministere de la Recherche et de la Technologie (France); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite de la Mediterranee; CNRS(Centre National de la Recherche Scientifique (CNRS))	S. Coumes-Florens was supported by a fellowship from the Ministere de la Recherche et de la Technologie (France). C. Brochier-Armanet is supported by an "Action Thematique et Incitative sur Programme (ATIP)" from the Centre National de la Recherche Scientifique (CNRS). This work was supported by the Universite de la Mediterranee and the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; Becker P, 2009, ANTIMICROB AGENTS CH, V53, P2034, DOI 10.1128/AAC.01485-08; Bernard R, 2005, J BIOL CHEM, V280, P28852, DOI 10.1074/jbc.M413750200; Bernard R, 2003, FEMS MICROBIOL LETT, V228, P93, DOI 10.1016/S0378-1097(03)00738-9; Bernard R, 2007, J BACTERIOL, V189, P8636, DOI 10.1128/JB.01132-07; Collins B, 2010, ANTIMICROB AGENTS CH, V54, P4416, DOI 10.1128/AAC.00503-10; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Liu PQ, 1998, P NATL ACAD SCI USA, V95, P3495, DOI 10.1073/pnas.95.7.3495; Majchrzykiewicz JA, 2010, ANTIMICROB AGENTS CH, V54, P440, DOI 10.1128/AAC.00769-09; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; Mascher T, 2006, FEMS MICROBIOL LETT, V264, P133, DOI 10.1111/j.1574-6968.2006.00444.x; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Narita S, 2006, FEBS LETT, V580, P1164, DOI 10.1016/j.febslet.2005.10.038; Ohki R, 2003, MOL MICROBIOL, V49, P1135, DOI 10.1046/j.1365-2958.2003.03653.x; Okuda S, 2009, P NATL ACAD SCI USA, V106, P5877, DOI 10.1073/pnas.0900896106; Ouyang J, 2010, ANTIMICROB AGENTS CH, V54, P3895, DOI 10.1128/AAC.01802-09; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Pietiainen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-429; Quentin Y, 1999, J MOL BIOL, V287, P467, DOI 10.1006/jmbi.1999.2624; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Rietkotter E, 2008, MOL MICROBIOL, V68, P768, DOI 10.1111/j.1365-2958.2008.06194.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J, 2001, MOL CLONING LAB MANU; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stock J. B., 1995, 2 COMPONENT SIGNAL T; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; Tetsch L, 2009, MOL MICROBIOL, V73, P982, DOI 10.1111/j.1365-2958.2009.06847.x; Tetsch L, 2009, AMINO ACIDS, V37, P467, DOI 10.1007/s00726-009-0235-x; Tomii K, 1998, GENOME RES, V8, P1048, DOI 10.1101/gr.8.10.1048; Tsuda H, 2002, ANTIMICROB AGENTS CH, V46, P3756, DOI 10.1128/AAC.46.12.3756-3764.2002; Upton M, 2001, J BACTERIOL, V183, P3931, DOI 10.1128/JB.183.13.3931-3938.2001; Wecke T, 2006, J BACTERIOL, V188, P7500, DOI 10.1128/JB.01110-06; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635	40	23	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15951	10.1371/journal.pone.0015951	http://dx.doi.org/10.1371/journal.pone.0015951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283517	Green Submitted, Green Published, gold			2022-12-25	WOS:000286520600016
J	Montserrat, N; Garreta, E; Gonzalez, F; Gutierrez, J; Eguizabal, C; Ramos, V; Borros, S; Belmonte, JCI				Montserrat, Nuria; Garreta, Elena; Gonzalez, Federico; Gutierrez, Jordan; Eguizabal, Cristina; Ramos, Victor; Borros, Salvador; Izpisua Belmonte, Juan Carlos			Simple Generation of Human Induced Pluripotent Stem Cells Using Poly-beta-amino Esters As the Non-viral Gene Delivery System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATIC-CELLS; FIBROBLASTS; MOUSE; LIBRARY; ADULT; EXPRESSION; INDUCTION	Reprogramming of somatic cells to induced pluripotent stem (iPS) cells can be achieved by the delivery of a combination of transcription factors, including Oct4, Sox2, Klf4, and c-Myc. Retroviral and lentiviral vectors are commonly used to express these four reprogramming factors separately and obtain reprogrammed iPS cells. Although efficient and reproducible, these approaches involve the time-consuming and labor-intensive production of retroviral or lentiviral particles together with a high risk of working with potentially harmful viruses overexpressing potent oncogenes, such as c-Myc. Here, we describe a simple method to produce bona fide iPS cells from human fibroblasts using poly-beta-amino esters as the transfection reagent for the delivery of a single CAG-driven polycistronic plasmid expressing Oct4, Sox2, Klf4, c-Myc, and a GFP reporter gene (OSKMG). We demonstrate for the first time that poly-beta-amino esters can be used to deliver a single polycistronic reprogramming vector into human fibroblasts, achieving significantly higher transfection efficiency than with conventional transfection reagents. After a protocol of serial transfections using poly-beta-amino esters, we report a simple methodology to generate human iPS cells from human fibroblasts avoiding the use of viral vectors.	[Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Montserrat, Nuria; Garreta, Elena; Gonzalez, Federico; Eguizabal, Cristina; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Gutierrez, Jordan; Ramos, Victor; Borros, Salvador] Univ Ramon Llull, Inst Quim Sarria, Grp Engn Mat, Barcelona 08017, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Universitat Ramon Llull; Institut Quimic de Sarria	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Garreta, Elena/AAQ-4739-2020; Borrós, Salvador/A-3950-2016; Montserrat, Nuria/F-3136-2016	Garreta, Elena/0000-0002-1071-9794; Borrós, Salvador/0000-0002-4003-0381; Montserrat, Nuria/0000-0002-1603-1755; Gonzalez Grassi, Federico/0000-0002-7147-2246; Eguizabal, Cristina/0000-0002-8738-2077; Ramos Perez, Victor/0000-0002-2099-5557	Sara Borrell program; Juan de La Cierva program; Swiss National Science Foundation; CIBER; MICINN; Fundacion Cellex; SanofiAventis; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Sara Borrell program; Juan de La Cierva program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CIBER; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Cellex(Foundation CELLEX); SanofiAventis(Sanofi-Aventis); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a fellowship from the Sara Borrell program (to E. G.), by the Juan de La Cierva program (N. M.), the Swiss National Science Foundation (to F. G.), CIBER, MICINN, Fundacion Cellex, SanofiAventis, and the G. Harold and Leila Y. Mathers Charitable Foundation (to J. C. I. B.).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244; Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Green JJ, 2008, NANO LETT, V8, P3126, DOI 10.1021/nl8012665; Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336; Green JJ, 2007, ADV MATER, V19, P2836, DOI 10.1002/adma.200700371; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Raya A, 2008, COLD SH Q B, V73, P127, DOI 10.1101/sqb.2008.73.038; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yang F, 2009, GENE THER, V16, P533, DOI 10.1038/gt.2008.182; Yang F, 2010, P NATL ACAD SCI USA, V107, P3317, DOI 10.1073/pnas.0905432106; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201; Zugates GT, 2007, MOL THER, V15, P1306, DOI 10.1038/sj.mt.6300132	36	56	60	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.168013	http://dx.doi.org/10.1074/jbc.M110.168013			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285354	Green Published, hybrid			2022-12-25	WOS:000289077500056
J	Gutierrez-Martin, Y; Bustillo, D; Gomez-Villafuertes, R; Sanchez-Nogueiro, J; Torregrosa-Hetland, C; Binz, T; Gutierrez, LM; Miras-Portugal, MT; Artalejo, AR				Gutierrez-Martin, Yolanda; Bustillo, Diego; Gomez-Villafuertes, Rosa; Sanchez-Nogueiro, Jesus; Torregrosa-Hetland, Cristina; Binz, Thomas; Miguel Gutierrez, Luis; Teresa Miras-Portugal, Maria; Artalejo, Antonio R.			P2X7 Receptors Trigger ATP Exocytosis and Modify Secretory Vesicle Dynamics in Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; BOTULINUM NEUROTOXIN-A; PATCH-CLAMP TECHNIQUES; NEUROTRANSMITTER RELEASE; PLASMA-MEMBRANE; FLUORESCENCE MICROSCOPY; REGULATED EXOCYTOSIS; P2X(7) RECEPTORS; SUBSTANCE-P; PC12 CELLS	Previously, we reported that purinergic ionotropic P2X7 receptors negatively regulate neurite formation in Neuro-2a (N2a) mouse neuroblastoma cells through a Ca2+/calmodulin-dependent kinase II-related mechanism. In the present study we used this cell line to investigate a parallel though faster P2X7 receptor- mediated signaling pathway, namely Ca2+-regulated exocytosis. Selective activation of P2X7 receptors evoked exocytosis as assayed by high resolution membrane capacitance measurements. Using dual-wavelength total internal reflection microscopy, we have observed both the increase in near-membrane Ca2+ concentration and the exocytosis of fluorescently labeled vesicles in response to P2X7 receptor stimulation. Moreover, activation of P2X7 receptors also affects vesicle motion in the vertical and horizontal directions, thus, involving this receptor type in the control of early steps (docking and priming) of the secretory pathway. Immunocytochemical and RT-PCR experiments evidenced that N2a cells express the three neuronal SNAREs as well as vesicular nucleotide and monoamine (VMAT-1 and VMAT-2) transporters. Biochemical measurements indicated that ionomycin induced a significant release of ATP from N2a cells. Finally, P2X7 receptor stimulation and ionomycin increased the incidence of small transient inward currents, reminiscent of postsynaptic quantal events observed at synapses. Small transient inward currents were dependent on extracellular Ca2+ and were abolished by Brilliant Blue G, suggesting they were mediated by P2X7 receptors. Altogether, these results suggest the existence of a positive feedback mechanism mediated by P2X7 receptor-stimulated exocytotic release of ATP that would act on P2X7 receptors on the same or neighbor cells to further stimulate its own release and negatively control N2a cell differentiation.	[Artalejo, Antonio R.] Univ Complutense Madrid, Fac Vet, Dept Farmacol & Toxicol, E-28040 Madrid, Spain; [Gutierrez-Martin, Yolanda; Bustillo, Diego; Gomez-Villafuertes, Rosa; Sanchez-Nogueiro, Jesus; Teresa Miras-Portugal, Maria; Artalejo, Antonio R.] Univ Complutense Madrid, Inst Univ Invest Neuroquim, E-28040 Madrid, Spain; [Torregrosa-Hetland, Cristina; Miguel Gutierrez, Luis] Univ Miguel Hernandez, Ctr Mixto, CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain; [Binz, Thomas] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany	Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Hannover Medical School	Artalejo, AR (corresponding author), Univ Complutense Madrid, Fac Vet, Dept Farmacol & Toxicol, Avda Puerta de Hierro S-N, E-28040 Madrid, Spain.	antonio.artalejo@vet.ucm.es	Artalejo, Antonio R./ABG-2009-2020; Miras-Portugal, Maria Teresa/L-7137-2014; Gomez-Villafuertes, Rosa/L-7181-2014; Gutierrez, Luis/K-8633-2014; Gutierrez, Yolanda/R-5474-2019; Artalejo, Antonio R./H-4378-2015	Artalejo, Antonio R./0000-0001-9720-9190; Gomez-Villafuertes, Rosa/0000-0002-7064-0906; Gutierrez, Luis/0000-0002-0512-7858; Gutierrez, Yolanda/0000-0002-7552-1092; Artalejo, Antonio R./0000-0001-9720-9190; Pintor, Jesus/0000-0002-9191-7679	Ministerio de Ciencia e Innovacion [BFU2008-02699, BFU2005-0634]; Comunidad de Madrid [S-SAL-0253-2006]; Fundacion Marcelino Botin; "Spanish Ion Channel Initiative" (SICI) [CSD2008-00005]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid(Comunidad de Madrid); Fundacion Marcelino Botin; "Spanish Ion Channel Initiative" (SICI)	This work was supported by Ministerio de Ciencia e Innovacion Grants BFU2008-02699 and BFU2005-0634, Comunidad de Madrid Grant S-SAL-0253-2006, the Fundacion Marcelino Botin, and "Spanish Ion Channel Initiative" (SICI) Grant CSD2008-00005.	Adrian K, 2000, BBA-GENE STRUCT EXPR, V1492, P127, DOI 10.1016/S0167-4781(00)00094-4; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Becherer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000505; Becherer U, 2006, CELL TISSUE RES, V326, P393, DOI 10.1007/s00441-006-0243-z; Bhaskar K, 2004, NEUROCHEM INT, V44, P35, DOI 10.1016/S0197-0186(03)00099-8; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Brandle U, 1999, NEUROSCI LETT, V273, P105, DOI 10.1016/S0304-3940(99)00648-5; BURNSTOCK G, 1985, GEN PHARMACOL, V16, P433, DOI 10.1016/0306-3623(85)90001-1; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Carabelli V, 2003, BIOPHYS J, V85, P1326, DOI 10.1016/S0006-3495(03)74567-6; CHEVRIER D, 1991, MOL CELL ENDOCRINOL, V79, P109, DOI 10.1016/0303-7207(91)90101-W; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Dernick G, 2005, NAT METHODS, V2, P699, DOI 10.1038/nmeth0905-699; Diaz-Hernandez M, 2008, J CELL SCI, V121, P3717, DOI 10.1242/jcs.034082; Dinkelacker V, 2000, J NEUROSCI, V20, P8377, DOI 10.1523/JNEUROSCI.20-22-08377.2000; Fabbro A, 2004, J PHYSIOL-LONDON, V560, P505, DOI 10.1113/jphysiol.2004.068924; Gil A, 2002, J BIOL CHEM, V277, P9904, DOI 10.1074/jbc.M110182200; Giner D, 2007, NEUROSCIENCE, V146, P659, DOI 10.1016/j.neuroscience.2007.02.039; Gomez-Villafuertes R, 2009, FEBS J, V276, P5307, DOI 10.1111/j.1742-4658.2009.07228.x; Gualix J, 1996, FEBS LETT, V391, P195, DOI 10.1016/0014-5793(96)00732-6; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Heo JS, 2006, STEM CELLS, V24, P2637, DOI 10.1634/stemcells.2005-0588; Holz RW, 2006, CELL MOL NEUROBIOL, V26, P439, DOI 10.1007/s10571-006-9049-5; HUANG NN, 1989, P NATL ACAD SCI USA, V86, P7904, DOI 10.1073/pnas.86.20.7904; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Khakh BS, 2001, PHARMACOL REV, V53, P107; Koticha DK, 2002, J CELL SCI, V115, P3341; LEINDERS T, 1992, PFLUG ARCH EUR J PHY, V422, P223, DOI 10.1007/BF00376206; Levesque SA, 2007, BRIT J PHARMACOL, V152, P141, DOI 10.1038/sj.bjp.0707361; LEVRAM V, 1992, J NEUROPHYSIOL, V68, P1167, DOI 10.1152/jn.1992.68.4.1167; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Luna C, 2009, INVEST OPHTH VIS SCI, V50, P5805, DOI 10.1167/iovs.09-3796; Munoz M, 2005, NEUROPEPTIDES, V39, P427, DOI 10.1016/j.npep.2005.03.004; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Orriss IR, 2009, J CELL PHYSIOL, V220, P155, DOI 10.1002/jcp.21745; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sperlagh B, 2007, PURINERG SIGNAL, V3, P269, DOI 10.1007/s11302-007-9080-0; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Wu PY, 2009, CELL SIGNAL, V21, P881, DOI 10.1016/j.cellsig.2009.01.036; Wu ZX, 2003, ACTA BIOCH BIOPH SIN, V35, P381; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu T, 1999, EMBO J, V18, P3293, DOI 10.1093/emboj/18.12.3293; Yamamoto H, 2003, J PHARMACOL SCI, V93, P30, DOI 10.1254/jphs.93.30	67	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11370	11381		10.1074/jbc.M110.139410	http://dx.doi.org/10.1074/jbc.M110.139410			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21292765	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000288797100049
J	Johnson, TR; Johnson, CN; Corbett, KS; Edwards, GC; Graham, BS				Johnson, Teresa R.; Johnson, Christina N.; Corbett, Kizzmekia S.; Edwards, Gretchen C.; Graham, Barney S.			Primary Human mDC1, mDC2, and pDC Dendritic Cells Are Differentially Infected and Activated by Respiratory Syncytial Virus	PLOS ONE			English	Article							INTERFERON-PRODUCING CELLS; ALLERGIC AIRWAY DISEASE; CD4 T-CELLS; VIRAL-INFECTION; CYTOKINE PRODUCTION; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; EPITHELIAL-CELLS; ADAPTIVE IMMUNITY; INFLUENZA-VIRUS	Respiratory syncytial virus (RSV) causes recurrent infections throughout life. Vaccine development may depend upon understanding the molecular basis for induction of ineffective immunity. Because dendritic cells (DCs) are critically involved in early responses to infection, their interaction with RSV may determine the immunological outcome of RSV infection. Therefore, we investigated the ability of RSV to infect and activate primary mDCs and pDCs using recombinant RSV expressing green fluorescent protein (GFP). At a multiplicity of infection of 5, initial studies demonstrated similar to 6.8% of mDC1 and similar to 0.9% pDCs were infected. We extended these studies to include CD1c(-)CD141(+) mDC2, finding mDC2 infected at similar frequencies as mDC1. Both infected and uninfected cells upregulated phenotypic markers of maturation. Divalent cations were required for infection and maturation, but maturation did not require viral replication. There is evidence that attachment and entry/replication processes exert distinct effects on DC activation. Cell-specific patterns of RSV-induced maturation and cytokine production were detected in mDC1, mDC2, and pDC. We also demonstrate for the first time that RSV induces significant TIMP-2 production in all DC subsets. Defining the influence of RSV on the function of selected DC subsets may improve the likelihood of achieving protective vaccine-induced immunity.	[Johnson, Teresa R.; Johnson, Christina N.; Corbett, Kizzmekia S.; Edwards, Gretchen C.; Graham, Barney S.] NIAID, Viral Pathogenesis Lab, Vaccine Res Ctr, Natl Inst Hlth Bethesda, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Johnson, TR (corresponding author), NIAID, Viral Pathogenesis Lab, Vaccine Res Ctr, Natl Inst Hlth Bethesda, 9000 Rockville Pike, Bethesda, MD 20892 USA.	teresaj@nih.gov	Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853	NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005029] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH intramural funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DM, 2005, MOL IMMUNOL, V42, P547, DOI 10.1016/j.molimm.2004.07.040; AUCELIO JG, 1984, NEUROPEPTIDES, V5, P141, DOI 10.1016/0143-4179(84)90047-7; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bartz H, 2003, IMMUNOLOGY, V109, P49, DOI 10.1046/j.1365-2567.2003.01629.x; Bartz H, 2002, CLIN EXP IMMUNOL, V129, P438, DOI 10.1046/j.1365-2249.2002.01927.x; Bhardwaj N, 1997, J EXP MED, V186, P795, DOI 10.1084/jem.186.6.795; Bont L, 2002, PEDIATR RES, V52, P363, DOI [10.1203/01.PDR.0000028458.76706.C7, 10.1203/00006450-200209000-00009]; Chang CCJ, 2000, J IMMUNOL, V165, P3584, DOI 10.4049/jimmunol.165.7.3584; Chi B, 2006, J VIROL, V80, P5032, DOI 10.1128/JVI.80.10.5032-5040.2006; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Demedts IK, 2006, AM J RESP CELL MOL, V35, P387, DOI 10.1165/rcmb.2005-0382OC; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Ebihara T, 2007, INT IMMUNOL, V19, P1145, DOI 10.1093/intimm/dxm073; Elliott MB, 2007, J MED VIROL, V79, P447, DOI 10.1002/jmv.20830; EVONIUK G, 1989, MOL PHARMACOL, V35, P695; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Freeman CM, 2009, AM J RESP CRIT CARE, V180, P1179, DOI 10.1164/rccm.200904-0552OC; Gersuk G, 2005, J IMMUNOL METHODS, V299, P99, DOI 10.1016/j.jim.2005.01.018; Ghildyal R, 1999, J INFECT DIS, V180, P2009, DOI 10.1086/315134; Gill MA, 2005, J INFECT DIS, V191, P1105, DOI 10.1086/428589; Gill MA, 2008, J INFECT DIS, V198, P1667, DOI 10.1086/593018; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Grayson MH, 2007, J MOL MED, V85, P1057, DOI 10.1007/s00109-007-0212-3; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; HALL CB, 1986, NEW ENGL J MED, V315, P77, DOI 10.1056/NEJM198607103150201; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Hickling TP, 1999, EUR J IMMUNOL, V29, P3478, DOI 10.1002/(SICI)1521-4141(199911)29:11<3478::AID-IMMU3478>3.0.CO;2-W; Hirose H, 2008, INT ARCH ALLERGY IMM, V146, P149, DOI 10.1159/000113518; Hobson L, 2008, CLIN EXP IMMUNOL, V151, P359, DOI 10.1111/j.1365-2249.2007.03560.x; Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; Jones A, 2006, CLIN EXP IMMUNOL, V143, P513, DOI 10.1111/j.1365-2249.2005.03004.x; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Krishnan S, 2003, J INFECT DIS, V188, P433, DOI 10.1086/376530; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Looney RJ, 2002, J INFECT DIS, V185, P682, DOI 10.1086/339008; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Martinez FD, 2003, PEDIATR INFECT DIS J, V22, pS76, DOI 10.1097/00006454-200302001-00011; Munir S, 2008, J VIROL, V82, P8780, DOI 10.1128/JVI.00630-08; MURPHY BR, 1986, J CLIN MICROBIOL, V23, P1009, DOI 10.1128/JCM.23.6.1009-1014.1986; Ono K, 2007, IMMUNOL RES, V38, P319, DOI 10.1007/s12026-007-0011-5; Piccioli D, 2007, BLOOD, V109, P5371, DOI 10.1182/blood-2006-08-038422; PRESTON FM, 1992, J INFECT DIS, V165, P819, DOI 10.1093/infdis/165.5.819; Rate A, 2009, J IMMUNOL, V182, P72, DOI 10.4049/jimmunol.182.1.72; ROBERTS NJ, 1982, INFECT IMMUN, V35, P1142, DOI 10.1128/IAI.35.3.1142-1146.1982; Rothoeft T, 2007, CLIN EXP IMMUNOL, V150, P263, DOI 10.1111/j.1365-2249.2007.03497.x; Schauer U, 2004, CLIN EXP IMMUNOL, V138, P102, DOI 10.1111/j.1365-2249.2004.02582.x; Schauer U, 2002, EUR RESPIR J, V20, P1277, DOI 10.1183/09031936.02.00019902; Schlender J, 2005, J VIROL, V79, P5507, DOI 10.1128/JVI.79.9.5507-5515.2005; SHAHRABADI MS, 1988, J CLIN MICROBIOL, V26, P139, DOI 10.1128/JCM.26.1.139-141.1988; Shingai M, 2008, INT IMMUNOL, V20, P1169, DOI 10.1093/intimm/dxn074; Shinoff JJ, 2008, J INFECT DIS, V198, P1007, DOI 10.1086/591460; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Silver E, 2009, PEDIAT ALLERG IMM-UK, V20, P471, DOI 10.1111/j.1399-3038.2008.00818.x; Singleton R, 2003, J VIROL, V77, P11303, DOI 10.1128/JVI.77.21.11303-11311.2003; Swedan S, 2009, J VIROL, V83, P9682, DOI 10.1128/JVI.00715-09; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; van Tongeren J, 2008, ALLERGY, V63, P1124, DOI 10.1111/j.1398-9995.2008.01791.x; Vanhooren A, 2002, BIOCHEMISTRY-US, V41, P11035, DOI 10.1021/bi0258851; Vass I, 1996, BIOCHEMISTRY-US, V35, P8964, DOI 10.1021/bi9530595; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; WELLIVER RC, 1984, J IMMUNOL, V133, P1925; Yeo SJ, 2002, ARCH VIROL, V147, P229, DOI 10.1007/s705-002-8316-1; Yerkovich ST, 2009, J ALLERGY CLIN IMMUN, V123, P209, DOI 10.1016/j.jaci.2008.09.009	79	55	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16458	10.1371/journal.pone.0016458	http://dx.doi.org/10.1371/journal.pone.0016458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297989	Green Published, Green Submitted, gold			2022-12-25	WOS:000286664100033
J	Mueller, EE; Eder, W; Ebner, S; Schwaiger, E; Santic, D; Kreindl, T; Stanger, O; Paulweber, B; Iglseder, B; Oberkofler, H; Maier, R; Mayr, JA; Krempler, F; Weitgasser, R; Patsch, W; Sperl, W; Kofler, B				Mueller, Edith E.; Eder, Waltraud; Ebner, Sabine; Schwaiger, Eva; Santic, Danijela; Kreindl, Tanja; Stanger, Olaf; Paulweber, Bernhard; Iglseder, Bernhard; Oberkofler, Hannes; Maier, Richard; Mayr, Johannes A.; Krempler, Franz; Weitgasser, Raimund; Patsch, Wolfgang; Sperl, Wolfgang; Kofler, Barbara			The Mitochondrial T16189C Polymorphism Is Associated with Coronary Artery Disease in Middle European Populations	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; DNA VARIANT; INSULIN-RESISTANCE; OXIDATIVE STRESS; C VARIANT; 16189 T; SUSCEPTIBILITY; INFARCTION; THINNESS	Background: The pivotal role of mitochondria in energy production and free radical generation suggests that the mitochondrial genome could have an important influence on the expression of multifactorial age related diseases. Substitution of T to C at nucleotide position 16189 in the hypervariable D-loop of the control region (CR) of mitochondrial DNA (mtDNA) has attracted research interest because of its suspected association with various multifactorial diseases. The aim of the present study was to compare the frequency of this polymorphism in the CR of mtDNA in patients with coronary artery disease (CAD, n = 482) and type 2 diabetes mellitus (T2DM, n = 505) from two study centers, with healthy individuals (n = 1481) of Middle European descent in Austria. Methodology and Principal Findings: CR polymorphisms and the nine major European haplogroups were identified by DNA sequencing and primer extension analysis, respectively. Frequencies and Odds Ratios for the association between cases and controls were calculated. Compared to healthy controls, the prevalence of T16189C was significantly higher in patients with CAD (11.8% vs 21.6%), as well as in patients with T2DM (11.8% vs 19.4%). The association of CAD, but not the one of T2DM, with T16189C remained highly significant after correction for age, sex and body mass index (BMI) and was independent of the two study centers. Conclusions and Significance: Our results show for the first time a significant association of T16189C with CAD in a Middle European population. As reported in other studies, in patients with T2DM an association with T16189C in individuals of European decent remains questionable.	[Mueller, Edith E.; Eder, Waltraud; Ebner, Sabine; Schwaiger, Eva; Santic, Danijela; Kreindl, Tanja; Mayr, Johannes A.; Sperl, Wolfgang; Kofler, Barbara] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria; [Stanger, Olaf] Paracelsus Med Univ, Dept Cardiac Surg, Salzburg, Austria; [Paulweber, Bernhard; Weitgasser, Raimund] Paracelsus Med Univ, Dept Internal Med, Salzburg, Austria; [Iglseder, Bernhard] Paracelsus Med Univ, Dept Geriatr, Salzburg, Austria; [Oberkofler, Hannes; Patsch, Wolfgang] Paracelsus Med Univ, Dept Lab Med, Salzburg, Austria; [Maier, Richard] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Krempler, Franz] Hosp Hallein, Dept Internal Med, Hallein, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Medical University of Graz	Mueller, EE (corresponding author), Paracelsus Med Univ, Dept Pediat, Salzburg, Austria.	b.kofler@salk.at		Kofler, Barbara/0000-0002-1198-4776; Iglseder, Bernhard/0000-0002-6132-8670; Mayr, Johannes/0000-0001-6970-336X	Medizinische Forschungsgesellschaft Salzburg; Kamillo-Eisner Stiftung	Medizinische Forschungsgesellschaft Salzburg; Kamillo-Eisner Stiftung	The project was supported by the "Medizinische Forschungsgesellschaft Salzburg" and by a grant from the "Kamillo-Eisner Stiftung" (www.kamillo-eisner-stiftung.ch/) to B. Paulweber. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2010, GENET TEST MOL BIOMA, V14, P43, DOI 10.1089/gtmb.2009.0095; Bhat A, 2007, HUM GENET, V120, P821, DOI 10.1007/s00439-006-0272-4; Casteels K, 1999, LANCET, V353, P1499, DOI 10.1016/S0140-6736(98)05817-6; Chinnery PF, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.048876; Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2; Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x; Das S, 2007, J CLIN ENDOCR METAB, V92, P3219, DOI 10.1210/jc.2007-0702; Fearon IM, 2009, J MOL CELL CARDIOL, V47, P372, DOI 10.1016/j.yjmcc.2009.05.013; Gill-Randall R, 2001, DIABETIC MED, V18, P413, DOI 10.1046/j.1464-5491.2001.00477.x; Harrison D, 2003, AM J CARDIOL, V91, p7A; Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6; Kim JH, 2002, DIABETIC MED, V19, P681, DOI 10.1046/j.1464-5491.2002.00747.x; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7; Liao WQ, 2008, TOHOKU J EXP MED, V215, P377, DOI 10.1620/tjem.215.377; Lin TK, 2005, ANN NY ACAD SCI, V1042, P64, DOI 10.1196/annals.1338.007; Liou CW, 2007, J CLIN ENDOCR METAB, V92, P235, DOI 10.1210/jc.2006-0653; Liou CW, 2004, ANN NY ACAD SCI, V1011, P317, DOI 10.1196/annals.1293.031; Livesey KJ, 2004, J MED GENET, V41, P6, DOI 10.1136/jmg.2003.008805; Maassen JA, 2006, BIOCHEM SOC T, V34, P819, DOI 10.1042/BST0340819; Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4; Momiyama Y, 2003, BIOCHEM BIOPH RES CO, V312, P858, DOI 10.1016/j.bbrc.2003.10.195; MORTEN K, 2003, DIABETIC MED, V13, pP13; Mueller EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006370; Mulder H, 2009, MOL CELL ENDOCRINOL, V297, P34, DOI 10.1016/j.mce.2008.05.015; Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z; Parker E, 2005, AM J PHYSIOL-ENDOC M, V289, pE1110, DOI 10.1152/ajpendo.00600.2004; Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Poulton J, 2002, DIABETIC MED, V19, P969, DOI 10.1046/j.0742-3071.2002.00836.x; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Tang DL, 2006, DIABETES RES CLIN PR, V73, P77, DOI 10.1016/j.diabres.2005.12.001; Tsutsui Hiroyuki, 2008, Circ J, V72 Suppl A, pA31, DOI 10.1253/circj.CJ-08-0014; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang Pei-Wen, 2009, Rev Diabet Stud, V6, P237, DOI 10.1900/RDS.2009.6.237; Weitgasser R, 2004, BIOMED PHARMACOTHER, V58, P619, DOI 10.1016/j.biopha.2004.09.010; Weng SW, 2005, J CLIN ENDOCR METAB, V90, P5037, DOI 10.1210/jc.2005-0227; Wiesbauer M, 2006, ELECTROPHORESIS, V27, P3864, DOI 10.1002/elps.200600086	39	45	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16455	10.1371/journal.pone.0016455	http://dx.doi.org/10.1371/journal.pone.0016455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298061	Green Submitted, Green Published, gold			2022-12-25	WOS:000286662800042
J	Taylor, SH; Al-Youha, S; Van Agtmael, T; Lu, YH; Wong, J; McGrouther, DA; Kadler, KE				Taylor, Susan H.; Al-Youha, Sarah; Van Agtmael, Tom; Lu, Yinhui; Wong, Jason; McGrouther, Duncan A.; Kadler, Karl E.			Tendon Is Covered by a Basement Membrane Epithelium That Is Required for Cell Retention and the Prevention of Adhesion Formation	PLOS ONE			English	Article							COLLAGEN-IV; JUNCTIONS; SHEATHS; MUTATIONS; DISEASE	The ability of tendons to glide smoothly during muscle contraction is impaired after injury by fibrous adhesions that form between the damaged tendon surface and surrounding tissues. To understand how adhesions form we incubated excised tendons in fibrin gels (to mimic the homeostatic environment at the injury site) and assessed cell migration. We noticed cells exiting the tendon from only the cut ends. Furthermore, treatment of the tendon with trypsin resulted in cell extravagation from the shaft of the tendons. Electron microscopy and immunolocalisation studies showed that the tendons are covered by a novel cell layer in which a collagen type IV/laminin basement membrane (BM) overlies a keratinised epithelium. PCR and western blot analyses confirmed the expression of laminin beta 1 in surface cells, only. To evaluate the cell retentive properties of the BM in vivo we examined the tendons of the Col4a1(+/Svc) mouse that is heterozygous for a G-to-A transition in the Col4a1 gene that produces a G1064D substitution in the alpha 1(IV) chain of collagen IV. The flexor tendons had a discontinuous BM, developed fibrous adhesions with overlying tissues, and were acellular at sites of adhesion formation. In further experiments, tenotomy of wild-type mice resulted in expression of laminin throughout the adhesion. In conclusion, we show the existence of a novel tendon BM-epithelium that is required to prevent adhesion formation. The Col4a1(+/Svc) mouse is an effective animal model for studying adhesion formation because of the presence of a structurally-defective collagen type IV-containing BM.	[Taylor, Susan H.; Al-Youha, Sarah; Lu, Yinhui; Kadler, Karl E.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Al-Youha, Sarah; Wong, Jason; McGrouther, Duncan A.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Van Agtmael, Tom] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Manchester; University of Manchester; University of Glasgow	Taylor, SH (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	karl.kadler@manchester.ac.uk	Wong, Jason/AAQ-9239-2020; KADLER, KARL/ABI-2403-2020; Zeef, Leo/D-6922-2011	Wong, Jason/0000-0003-2592-3226; KADLER, KARL/0000-0003-4977-4683; Taylor, Susan/0000-0001-9554-055X; Van Agtmael, Tom/0000-0003-4282-449X	The Wellcome Trust [076939/Z/05/Z]; The Medical Research Council [G0601268]; Kuwaiti Ministry of Higher Education [aa08961]; MRC [G0601268] Funding Source: UKRI; Medical Research Council [G0601268] Funding Source: researchfish; National Institute for Health Research [CL-2006-06-004] Funding Source: researchfish	The Wellcome Trust(Wellcome TrustEuropean Commission); The Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kuwaiti Ministry of Higher Education; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by The Wellcome Trust (076939/Z/05/Z) to KEK and The Medical Research Council (G0601268) to TVA. SA-Y was funded by a grant (aa08961) from the Kuwaiti Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpay Z, 2008, SEMIN REPROD MED, V26, P313, DOI 10.1055/s-0028-1082389; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BANES AJ, 1988, J ORTHOP RES, V6, P83, DOI 10.1002/jor.1100060111; BECKSTEAD JH, 1995, J HISTOCHEM CYTOCHEM, V43, P345, DOI 10.1177/43.3.7868864; BECKSTEAD JH, 1994, J HISTOCHEM CYTOCHEM, V42, P1127, DOI 10.1177/42.8.8027531; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; DUANCE VC, 1977, FEBS LETT, V79, P248, DOI 10.1016/0014-5793(77)80797-7; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; GUIZZARDI S, 1987, BASIC APPL HISTOCHEM, V31, P177; HUMPHRIES SM, 2008, J BIOL CHEM; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; Kapacce Z, 2008, MATRIX BIOL, V27, P371, DOI 10.1016/j.matbio.2007.11.006; Khanna A, 2009, BRIT MED BULL, V90, P85, DOI 10.1093/bmb/ldp013; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Lee DBN, 2006, AM J PHYSIOL-RENAL, V290, pF20, DOI 10.1152/ajprenal.00052.2005; McNeilly CM, 1996, J ANAT, V189, P593; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; POTENZA AD, 1963, J BONE JOINT SURG AM, V45, P1217, DOI 10.2106/00004623-196345060-00009; Richardson SH, 2007, MOL CELL BIOL, V27, P6218, DOI 10.1128/MCB.00261-07; RISBERG B, 1997, EUR J SURG S, V577, P32; Schwarzbauer J, 1999, CURR BIOL, V9, pR242, DOI 10.1016/S0960-9822(99)80153-5; STROCCHI R, 1985, J ANAT, V140, P57; Thaung C, 2002, HUM MOL GENET, V11, P755, DOI 10.1093/hmg/11.7.755; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Agtmael T, 2005, HUM MOL GENET, V14, P3161, DOI 10.1093/hmg/ddi348; Wong JKF, 2006, J HAND SURG-BRIT EUR, V31B, P358, DOI 10.1016/j.jhsb.2006.03.162; Wong JKF, 2009, AM J PATHOL, V175, P1938, DOI 10.2353/ajpath.2009.090380	29	56	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16337	10.1371/journal.pone.0016337	http://dx.doi.org/10.1371/journal.pone.0016337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298098	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000286662800028
J	Xia, JQ; Sedransk, N; Feng, XD				Xia, Jessie Q.; Sedransk, Nell; Feng, Xingdong			Variance Component Analysis of a Multi-Site Study for the Reproducibility of Multiple Reaction Monitoring Measurements of Peptides in Human Plasma	PLOS ONE			English	Article							MASS-SPECTROMETRY; PROTEOMICS	Background: In the Addona et al. paper (Nature Biotechnology 2009), a large-scale multi-site study was performed to quantify Multiple Reaction Monitoring (MRM) measurements of proteins spiked in human plasma. The unlabeled signature peptides derived from the seven target proteins were measured at nine different concentration levels, and their isotopic counterparts were served as the internal standards. Methodology/Principal Findings: In this paper, the sources of variation are analyzed by decomposing the variance into parts attributable to specific experimental factors: technical replicates, sites, peptides, transitions within each peptide, and higher-order interaction terms based on carefully built mixed effects models. The factors of peptides and transitions are shown to be major contributors to the variance of the measurements considering heavy (isotopic) peptides alone. For the light ((12)C) peptides alone, in addition to these factors, the factor of study*peptide also contributes significantly to the variance of the measurements. Heterogeneous peptide component models as well as influence analysis identify the outlier peptides in the study, which are then excluded from the analysis. Using a log-log scale transformation and subtracting the heavy/isotopic peptide [internal standard] measurement from the peptide measurements (i.e., taking the logarithm of the peak area ratio in the original scale establishes that), the MRM measurements are overall consistent across laboratories following the same standard operating procedures, and the variance components related to sites, transitions and higher-order interaction terms involving sites have greatly reduced impact. Thus the heavy peptides have been effective in reducing apparent inter-site variability. In addition, the estimates of intercepts and slopes of the calibration curves are calculated for the sub-studies. Conclusions/Significance: The MRM measurements are overall consistent across laboratories following the same standard operating procedures, and heavy peptides can be used as an effective internal standard for reducing apparent inter-site variability. Mixed effects modeling is a valuable tool in mass spectrometry-based proteomics research.	[Xia, Jessie Q.; Sedransk, Nell; Feng, Xingdong] Natl Inst Stat Sci, Res Triangle Pk, NC USA; [Xia, Jessie Q.; Feng, Xingdong] Duke Univ, Dept Stat, Durham, NC USA	Duke University	Xia, JQ (corresponding author), Natl Inst Stat Sci, Res Triangle Pk, NC USA.	xq8@niss.org			National Cancer Institute [29XS081]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is supported by a subcontract (29XS081) from the National Cancer Institute. The funder had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]; Box G.E.P., 2005, STAT EXPT DESIGN INN, V2nd ed.; Diamandis EP, 2004, MOL CELL PROTEOMICS, V3, P367, DOI 10.1074/mcp.R400007-MCP200; Eckel-Passow JE, 2009, BIOSTATISTICS, V10, P481, DOI 10.1093/biostatistics/kxp006; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Mercier C, 2009, J PROTEOMICS, V72, P974, DOI 10.1016/j.jprot.2009.05.005; Sprinthall R.C., 2011, BASIC STAT ANAL; Wang JS, 2008, ECOTOXICOLOGY, V17, P213, DOI 10.1007/s10646-007-0187-4	10	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e14590	10.1371/journal.pone.0014590	http://dx.doi.org/10.1371/journal.pone.0014590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298095	Green Published, Green Submitted, gold			2022-12-25	WOS:000286662800003
J	Luise, C; Capra, M; Donzelli, M; Mazzarol, G; Jodice, MG; Nuciforo, P; Viale, G; Di Fiore, PP; Confalonieri, S				Luise, Chiara; Capra, Maria; Donzelli, Maddalena; Mazzarol, Giovanni; Jodice, Maria Giovanna; Nuciforo, Paolo; Viale, Giuseppe; Di Fiore, Pier Paolo; Confalonieri, Stefano			An Atlas of Altered Expression of Deubiquitinating Enzymes in Human Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; FANCONI-ANEMIA PATHWAY; BETA-CATENIN; BREAST-CANCER; DEUBIQUITYLATING ENZYMES; PROTEIN TRAFFICKING; CYSTEINE PROTEASES; THERAPY FAILURE; TGF-BETA; TUMOR	Background: Deubiquitinating enzymes (DUBs) are proteases that process ubiquitin (Ub) or ubiquitin-like gene products, remodel polyubiquitin(-like) chains on target proteins, and counteract protein ubiquitination exerted by E3 ubiquitin-ligases. A wealth of studies has established the relevance of DUBs to the control of physiological processes whose subversion is known to cause cellular transformation, including cell cycle progression, DNA repair, endocytosis and signal transduction. Altered expression of DUBs might, therefore, subvert both the proteolytic and signaling functions of the Ub system. Methodology/Principal Findings: In this study, we report the first comprehensive screening of DUB dysregulation in human cancers by in situ hybridization on tissue microarrays (ISH-TMA). ISH-TMA has proven to be a reliable methodology to conduct this kind of study, particularly because it allows the precise identification of the cellular origin of the signals. Thus, signals associated with the tumor component can be distinguished from those associated with the tumor microenvironment. Specimens derived from various normal and malignant tumor tissues were analyzed, and the "normal'' samples were derived, whenever possible, from the same patients from whom tumors were obtained. Of the similar to 90 DUBs encoded by the human genome, 33 were found to be expressed in at least one of the analyzed tissues, of which 22 were altered in cancers. Selected DUBs were subjected to further validation, by analyzing their expression in large cohorts of tumor samples. This analysis unveiled significant correlations between DUB expression and relevant clinical and pathological parameters, which were in some cases indicative of aggressive disease. Conclusions/Significance: The results presented here demonstrate that DUB dysregulation is a frequent event in cancer, and have implications for therapeutic approaches based on DUB inhibition.	[Luise, Chiara; Capra, Maria; Jodice, Maria Giovanna; Nuciforo, Paolo; Di Fiore, Pier Paolo; Confalonieri, Stefano] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Donzelli, Maddalena; Mazzarol, Giovanni; Viale, Giuseppe; Di Fiore, Pier Paolo] Ist Europeo Oncol, Milan, Italy; [Viale, Giuseppe; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan	Luise, C (corresponding author), Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it; stefano.confalonieri@ifom-ieo-campus.it	Viale, Giuseppe/AAE-8921-2019; Confalonieri, Stefano/AAQ-6786-2020; Donzelli, Maddalena/ABD-3774-2020; Nuciforo, Paolo/Q-2885-2019; Capra, Maria/AAM-8054-2020; Di Fiore, Pier Paolo/K-2130-2012	Confalonieri, Stefano/0000-0001-6886-9851; Di Fiore, Pier Paolo/0000-0002-2252-0950; Nuciforo, Paolo/0000-0003-1380-0990; DONZELLI, MADDALENA/0000-0002-4045-0802; Iodice, Maria Giovanna/0000-0002-6173-1080	Associazione Italiana per la Ricerca sul Cancro; European Community; European Research Council; Italian Ministry of Education-University-Research (MIUR); Ferrari Foundation; Monzino Foundation; CARIPLO Foundation; Italian Ministry of Health	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); Italian Ministry of Education-University-Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ferrari Foundation; Monzino Foundation; CARIPLO Foundation(Fondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy)	The work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro, the European Community (FP6 and FP7), the European Research Council, the Italian Ministries of Education-University-Research (MIUR) and of Health, the Ferrari Foundation, the Monzino Foundation, and the CARIPLO Foundation to PPDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AS, 2008, CANCER RES, V68, P506, DOI 10.1158/0008-5472.CAN-07-3060; Akishima-Fukasawa Y, 2010, AM J CLIN PATHOL, V134, P71, DOI 10.1309/AJCPRJP39MIDSGBH; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005955; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472.CAN-05-3489; Carolan BJ, 2006, CANCER RES, V66, P10729, DOI 10.1158/0008-5472.CAN-06-2224; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Colland F, 2010, BIOCHEM SOC T, V38, P137, DOI 10.1042/BST0380137; Confalonieri S, 2009, ONCOGENE, V28, P2959, DOI 10.1038/onc.2009.156; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Dong YY, 2005, CLIN CANCER RES, V11, P259; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Glickman MH, 2004, PLOS BIOL, V2, P25, DOI 10.1371/journal.pbio.0020013; Glinsky GV, 2005, CELL CYCLE, V4, P1171, DOI 10.4161/cc.4.9.2001; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Glittenberg M, 2007, FLY, V1, P330, DOI 10.4161/fly.5399; Goldenberg SJ, 2008, BIOCHEM SOC T, V36, P828, DOI 10.1042/BST0360828; Hibi K, 1999, AM J PATHOL, V155, P711, DOI 10.1016/S0002-9440(10)65169-3; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Hussain S, 2010, LEUKEMIA, V24, P1641, DOI 10.1038/leu.2010.138; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Ivan D, 2004, MODERN PATHOL, V17, P811, DOI 10.1038/modpathol.3800123; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Kaufmann SH, 1998, BLOOD, V91, P991, DOI 10.1182/blood.V91.3.991.991_991_1000; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Liu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005544; Liu YL, 2010, J GASTROEN HEPATOL, V25, P1800, DOI 10.1111/j.1440-1746.2010.06352.x; LV L, 2010, MOL CELL BIOCH; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Nabhan JF, 2006, J BIOL CHEM, V281, P16099, DOI 10.1074/jbc.M512086200; Nicassio F, 2005, J CLIN INVEST, V115, P3015, DOI 10.1172/JCI24862; Nicholson Benjamin, 2007, Future Oncol, V3, P191, DOI 10.2217/14796694.3.2.191; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Osoegawa A, 2006, CANCER, V107, P154, DOI 10.1002/cncr.21961; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Sasaki H, 2001, JPN J CLIN ONCOL, V31, P532, DOI 10.1093/jjco/hye113; Schwarz T, 2010, J CELL BIOCHEM, V109, P967, DOI 10.1002/jcb.22475; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Seki S, 2007, GENES CELLS, V12, P299, DOI 10.1111/j.1365-2443.2007.01054.x; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spataro V, 1997, J BIOL CHEM, V272, P30470, DOI 10.1074/jbc.272.48.30470; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Sun WJ, 2010, CELL SIGNAL, V22, P386, DOI 10.1016/j.cellsig.2009.10.008; Takemaru K. -I., 2008, V186, P261, DOI 10.1007/978-3-540-72843-6_11; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Vecchi M, 2008, ONCOGENE, V27, P2148, DOI 10.1038/sj.onc.1210858; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Watt FM, 2008, COLD SH Q B, V73, P503, DOI 10.1101/sqb.2008.73.011; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Yamaguchi T, 2007, J BIOL CHEM, V282, P33943, DOI 10.1074/jbc.M706282200; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang XC, 2008, J CELL BIOCHEM, V103, P1219, DOI 10.1002/jcb.21504; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403	75	75	82	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15891	10.1371/journal.pone.0015891	http://dx.doi.org/10.1371/journal.pone.0015891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283576	Green Published, gold			2022-12-25	WOS:000286661400017
J	Wang, L; Lai, LH; Qi, OY; Tang, C				Wang, Lu; Lai, Luhua; Qi Ouyang; Tang, Chao			Flux Balance Analysis of Ammonia Assimilation Network in E. coli Predicts Preferred Regulation Point	PLOS ONE			English	Article							INTERCONVERTIBLE ENZYME CASCADES; SIGNAL-TRANSDUCTION PROTEINS; ESCHERICHIA-COLI; GLUTAMINE-SYNTHETASE; SALMONELLA-TYPHIMURIUM; NITROGEN-METABOLISM; STOICHIOMETRIC MODEL; ALPHA-KETOGLUTARATE; BIOMASS COMPOSITION; KINETIC MECHANISM	Nitrogen assimilation is a critical biological process for the synthesis of biomolecules in Escherichia coli. The central ammonium assimilation network in E. coli converts carbon skeleton a-ketoglutarate and ammonium into glutamate and glutamine, which further serve as nitrogen donors for nitrogen metabolism in the cell. This reaction network involves three enzymes: glutamate dehydrogenase (GDH), glutamine synthetase (GS) and glutamate synthase (GOGAT). In minimal media, E. coli tries to maintain an optimal growth rate by regulating the activity of the enzymes to match the availability of the external ammonia. The molecular mechanism and the strategy of the regulation in this network have been the research topics for many investigators. In this paper, we develop a flux balance model for the nitrogen metabolism, taking into account of the cellular composition and biosynthetic requirements for nitrogen. The model agrees well with known experimental results. Specifically, it reproduces all the N-15 isotope labeling experiments in the wild type and the two mutant (Delta GDH and Delta GOGAT) strains of E. coli. Furthermore, the predicted catalytic activities of GDH, GS and GOGAT in different ammonium concentrations and growth rates for the wild type, Delta GDH and Delta GOGAT strains agree well with the enzyme concentrations obtained from western blots. Based on this flux balance model, we show that GS is the preferred regulation point among the three enzymes in the nitrogen assimilation network. Our analysis reveals the pattern of regulation in this central and highly regulated network, thus providing insights into the regulation strategy adopted by the bacteria. Our model and methods may also be useful in future investigations in this and other networks.	[Wang, Lu; Qi Ouyang] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Wang, Lu; Lai, Luhua; Qi Ouyang; Tang, Chao] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Lai, Luhua] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Qi Ouyang] Hong Kong Baptist Univ, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Tang, Chao] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	Peking University; Peking University; Peking University; Hong Kong Baptist University; University of California System; University of California San Francisco	Wang, L (corresponding author), Peking Univ, Sch Phys, Beijing 100871, Peoples R China.	qi@pku.edu.cn; chao.tang@ucsf.edu		Tang, Chao/0000-0003-1474-3705	Natural Science Foundation of China [10721403]; Ministry of Science and Technology of China [2009CB918500]; U.S. National Science Foundation [0804183, 0941355]; Direct For Mathematical & Physical Scien [0804183] Funding Source: National Science Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by Natural Science Foundation of China (10721403), Ministry of Science and Technology of China (2009CB918500) and U.S. National Science Foundation (0804183; 0941355). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELL LM, 1991, BIOCHEMISTRY-US, V30, P1413, DOI 10.1021/bi00219a035; ALIBHAI M, 1994, BIOCHEMISTRY-US, V33, P682, DOI 10.1021/bi00169a008; Atkinson MR, 2002, J BACTERIOL, V184, P5358, DOI 10.1128/JB.184.19.5358-5363.2002; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Bremer H, 1996, ESCHERICHIA COLI SAL; Bruggeman FJ, 2005, FEBS J, V272, P1965, DOI 10.1111/j.1742-4658.2005.04626.x; CHOCK PB, 1977, P NATL ACAD SCI USA, V74, P2766, DOI 10.1073/pnas.74.7.2766; Gianchandani EP, 2010, WIRES SYST BIOL MED, V2, P372, DOI 10.1002/wsbm.60; GINSBURG A, 1970, BIOCHEMISTRY-US, V9, P633, DOI 10.1021/bi00805a025; GOTTSCHALK G, 1986, BACTERIAL METABOLISM, pR13; Helling RB, 2002, J BACTERIOL, V184, P1041, DOI 10.1128/jb.184.4.1041-1045.2002; Helling RB, 1998, J BACTERIOL, V180, P4571, DOI 10.1128/JB.180.17.4571-4575.1998; HELLING RB, 1994, J BACTERIOL, V176, P4664, DOI 10.1128/JB.176.15.4664-4668.1994; Hill WG, 2000, J BIOL CHEM, V275, P30176, DOI 10.1074/jbc.M003494200; Ikeda TP, 1996, J MOL BIOL, V259, P589, DOI 10.1006/jmbi.1996.0342; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Jiang P, 1998, BIOCHEMISTRY-US, V37, P12795, DOI 10.1021/bi9802420; Jiang P, 1998, BIOCHEMISTRY-US, V37, P12782, DOI 10.1021/bi980667m; Jiang P, 2007, BIOCHEMISTRY-US, V46, P4133, DOI 10.1021/bi0620510; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Khademi S, 2006, PHYSIOLOGY, V21, P419, DOI 10.1152/physiol.00051.2005; KLEINER D, 1985, FEBS LETT, V187, P237, DOI 10.1016/0014-5793(85)81249-7; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kurata H, 2005, GENOME RES, V15, P590, DOI 10.1101/gr.3463705; Lodeiro A, 2008, J BIOL PHYS, V34, P91, DOI 10.1007/s10867-008-9109-9; Maaloe O., 1979, BIOL REGUL DEV, V1, P487; Mathai JC, 2001, J BIOL CHEM, V276, P27266, DOI 10.1074/jbc.M103265200; MEEK TD, 1980, BIOCHEMISTRY-US, V19, P5513, DOI 10.1021/bi00565a008; Merrick M, 2006, TRANSFUS CLIN BIOL, V13, P97, DOI 10.1016/j.tracli.2006.02.015; Mutalik VK, 2007, BIOSYSTEMS, V90, P1, DOI 10.1016/j.biosystems.2006.06.003; Mutalik VK, 2003, J BIOL CHEM, V278, P26327, DOI 10.1074/jbc.M300129200; NEIDHARDT FC, 1990, PHYSL BACTERIAL CELL, pR7; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Ortega F, 2002, MOL BIOL REP, V29, P211, DOI 10.1023/A:1020334014497; Phillips R, 2009, PHYS BIOL CELL, pxxiv; Pramanik J, 1997, BIOTECHNOL BIOENG, V56, P398, DOI 10.1002/(SICI)1097-0290(19971120)56:4<398::AID-BIT6>3.0.CO;2-J; Pramanik J, 1998, BIOTECHNOL BIOENG, V60, P230, DOI 10.1002/(SICI)1097-0290(19981020)60:2<230::AID-BIT10>3.0.CO;2-Q; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; REITZER L, 1996, ESCHERICHIA COLI SAL; RENDINA AR, 1978, BIOCHEMISTRY-US, V17, P5388, DOI 10.1021/bi00618a011; RHEE SG, 1978, P NATL ACAD SCI USA, V75, P3138, DOI 10.1073/pnas.75.7.3138; RITCHIE AWS, 1987, SEMIN NEPHROL, V7, P131; SAKAMOTO N, 1975, J BACTERIOL, V124, P775, DOI 10.1128/JB.124.2.775-783.1975; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; SCHUTT H, 1972, EUR J BIOCHEM, V26, P68, DOI 10.1111/j.1432-1033.1972.tb01740.x; SENIOR PJ, 1975, J BACTERIOL, V123, P407, DOI 10.1128/JB.123.2.407-418.1975; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; STADTMAN ER, 1977, P NATL ACAD SCI USA, V74, P2761, DOI 10.1073/pnas.74.7.2761; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; van Heeswijk WC, 2009, FEBS J, V276, P3324, DOI 10.1111/j.1742-4658.2009.07058.x; van Riel NAW, 1998, J THEOR BIOL, V191, P397, DOI 10.1006/jtbi.1997.0600; WHITE D, 2007, PHYSL BIOCH PROKARYO, pR19; Winkler F, 2006, PFLUG ARCH EUR J PHY, V451, P701, DOI 10.1007/s00424-005-1511-6; Yan DL, 2007, P NATL ACAD SCI USA, V104, P9475, DOI 10.1073/pnas.0703360104; Yan DL, 1996, P NATL ACAD SCI USA, V93, P6527, DOI 10.1073/pnas.93.13.6527; Yuan J, 2006, NAT CHEM BIOL, V2, P529, DOI 10.1038/nchembio816; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	61	8	8	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16362	10.1371/journal.pone.0016362	http://dx.doi.org/10.1371/journal.pone.0016362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283535	Green Published, gold			2022-12-25	WOS:000286661400045
J	de Vries, M; Deijs, M; Canuti, M; van Schaik, BDC; Faria, NR; van de Garde, MDB; Jachimowski, LCM; Jebbink, MF; Jakobs, M; Luyf, ACM; Coenjaerts, FEJ; Claas, ECJ; Molenkamp, R; Koekkoek, SM; Lammens, C; Leus, F; Goossens, H; Ieven, M; Baas, F; van der Hoek, L				de Vries, Michel; Deijs, Martin; Canuti, Marta; van Schaik, Barbera D. C.; Faria, Nuno R.; van de Garde, Martijn D. B.; Jachimowski, Loes C. M.; Jebbink, Maarten F.; Jakobs, Marja; Luyf, Angela C. M.; Coenjaerts, Frank E. J.; Claas, Eric C. J.; Molenkamp, Richard; Koekkoek, Sylvie M.; Lammens, Christine; Leus, Frank; Goossens, Herman; Ieven, Margareta; Baas, Frank; van der Hoek, Lia			A Sensitive Assay for Virus Discovery in Respiratory Clinical Samples	PLOS ONE			English	Article							INFECTIONS; COMMUNITY; CHILDREN; DISEASE; IDENTIFICATION; CORONAVIRUS; PNEUMONIA; DIAGNOSIS; ETIOLOGY; PCR	In 5-40% of respiratory infections in children, the diagnostics remain negative, suggesting that the patients might be infected with a yet unknown pathogen. Virus discovery cDNA-AFLP (VIDISCA) is a virus discovery method based on recognition of restriction enzyme cleavage sites, ligation of adaptors and subsequent amplification by PCR. However, direct discovery of unknown pathogens in nasopharyngeal swabs is difficult due to the high concentration of ribosomal RNA (rRNA) that acts as competitor. In the current study we optimized VIDISCA by adjusting the reverse transcription enzymes and decreasing rRNA amplification in the reverse transcription, using hexamer oligonucleotides that do not anneal to rRNA. Residual cDNA synthesis on rRNA templates was further reduced with oligonucleotides that anneal to rRNA but can not be extended due to 3'-dideoxy-C6-modification. With these modifications >90% reduction of rRNA amplification was established. Further improvement of the VIDISCA sensitivity was obtained by high throughput sequencing (VIDISCA-454). Eighteen nasopharyngeal swabs were analysed, all containing known respiratory viruses. We could identify the proper virus in the majority of samples tested (11/18). The median load in the VIDISCA-454 positive samples was 7.2 E5 viral genome copies/ml (ranging from 1.4 E3-7.7 E6). Our results show that optimization of VIDISCA and subsequent high-throughput-sequencing enhances sensitivity drastically and provides the opportunity to perform virus discovery directly in patient material.	[de Vries, Michel; Deijs, Martin; Canuti, Marta; Faria, Nuno R.; van de Garde, Martijn D. B.; Jachimowski, Loes C. M.; Jebbink, Maarten F.; van der Hoek, Lia] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van Schaik, Barbera D. C.; Luyf, Angela C. M.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Jakobs, Marja; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Coenjaerts, Frank E. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Claas, Eric C. J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Molenkamp, Richard; Koekkoek, Sylvie M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Clin Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Lammens, Christine; Goossens, Herman; Ieven, Margareta] Univ Antwerp, Univ Antwerp Hosp, Vaccine & Infect Dis Inst, Dept Med Microbiol, Antwerp, Belgium; [Leus, Frank] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Data Management, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Antwerp; Utrecht University; Utrecht University Medical Center	de Vries, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.m.vanderhoek@amc.uva.nl	Canuti, Marta/I-3145-2019; Faria, Nuno R/I-2975-2012; van der Hoek, Lia/Y-6412-2019; Baas, Frank/F-9574-2010	Canuti, Marta/0000-0002-9959-128X; Faria, Nuno R/0000-0001-8839-2798; Baas, Frank/0000-0003-3912-5428; van Schaik, Barbera/0000-0002-5568-8127; van de Garde, Martijn/0000-0003-0509-7713; Rodrigues Faria, Nuno/0000-0002-9747-8822	European Community (EC) [FP7/2007-2013, 223498, LSHM-CT-2005-518226]; Netherlands Organization for Scientific Research (NWO) [016.066.318]	European Community (EC)(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project EMPERIE, EC grant agreement number 223498, European Community's Sixth Framework Programme under the project GRACE, EC grant agreement number LSHM-CT-2005-518226 and VIDI grant 016.066.318 from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Benschop KSM, 2006, EMERG INFECT DIS, V12, P1572, DOI 10.3201/eid1210.051647; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brilot F, 2004, J VIROL, V78, P9854, DOI 10.1128/JVI.78.18.9854-9861.2004; de Pol ACV, 2010, J CLIN MICROBIOL, V48, P3569, DOI 10.1128/JCM.00097-10; de Vries M, 2008, J CLIN MICROBIOL, V46, P759, DOI 10.1128/JCM.02009-07; Endoh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni064; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Jubelt B, 2001, NEUROLOGY, V57, P945, DOI 10.1212/WNL.57.6.945; Leitch ECM, 2009, J CLIN VIROL, V44, P119, DOI 10.1016/j.jcv.2008.11.015; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Pyrc K, 2006, ANTIMICROB AGENTS CH, V50, P2000, DOI 10.1128/AAC.01598-05; Regamey N, 2008, PEDIATR INFECT DIS J, V27, P100, DOI 10.1097/INF.0b013e31815922c8; Scheltinga SA, 2005, J CLIN VIROL, V33, P306, DOI 10.1016/j.jcv.2004.08.021; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Shingadia D, 2002, LANCET INFECT DIS, V2, P310, DOI 10.1016/S1473-3099(02)00265-7; Stohlman SA, 2001, BRAIN PATHOL, V11, P92; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; van de Pol AC, 2006, CRIT CARE, V10, DOI 10.1186/cc4895; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005	25	66	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16118	10.1371/journal.pone.0016118	http://dx.doi.org/10.1371/journal.pone.0016118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283679	Green Published, gold, Green Submitted			2022-12-25	WOS:000286523400019
J	Tarazona-Santos, E; Castilho, L; Amaral, DRT; Costa, DC; Furlani, NG; Zuccherato, LW; Machado, M; Reid, ME; Zalis, MG; Rossit, AR; Santos, SEB; Machado, RL; Lustigman, S				Tarazona-Santos, Eduardo; Castilho, Lilian; Amaral, Daphne R. T.; Costa, Daiane C.; Furlani, Natalia G.; Zuccherato, Luciana W.; Machado, Moara; Reid, Marion E.; Zalis, Mariano G.; Rossit, Andrea R.; Santos, Sidney E. B.; Machado, Ricardo L.; Lustigman, Sara			Population Genetics of GYPB and Association Study between GYPB*S/s Polymorphism and Susceptibility to P. falciparum Infection in the Brazilian Amazon	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; ERYTHROCYTE INVASION PHENOTYPES; PLASMODIUM-FALCIPARUM; BLOOD-GROUP; MALARIA PARASITES; RED-CELLS; LINKAGE DISEQUILIBRIUM; ANTIGEN DANTU; HUMAN GENOME; GLYCOPHORIN	Background: Merozoites of Plasmodium falciparum invade through several pathways using different RBC receptors. Field isolates appear to use a greater variability of these receptors than laboratory isolates. Brazilian field isolates were shown to mostly utilize glycophorin A-independent invasion pathways via glycophorin B (GPB) and/or other receptors. The Brazilian population exhibits extensive polymorphism in blood group antigens, however, no studies have been done to relate the prevalence of the antigens that function as receptors for P. falciparum and the ability of the parasite to invade. Our study aimed to establish whether variation in the GYPB*S/s alleles influences susceptibility to infection with P. falciparum in the admixed population of Brazil. Methods: Two groups of Brazilian Amazonians from Porto Velho were studied: P. falciparum infected individuals (cases); and uninfected individuals who were born and/or have lived in the same endemic region for over ten years, were exposed to infection but have not had malaria over the study period (controls). The GPB Ss phenotype and GYPB*S/s alleles were determined by standard methods. Sixty two Ancestry Informative Markers were genotyped on each individual to estimate admixture and control its potential effect on the association between frequency of GYPB*S and malaria infection. Results: GYPB*S is associated with host susceptibility to infection with P. falciparum; GYPB*S/GYPB*S and GYPB*S/GYPB*s were significantly more prevalent in the in the P. falciparum infected individuals than in the controls (69.87% vs. 49.75%; P<0.02). Moreover, population genetics tests applied on the GYPB exon sequencing data suggest that natural selection shaped the observed pattern of nucleotide diversity. Conclusion: Epidemiological and evolutionary approaches suggest an important role for the GPB receptor in RBC invasion by P. falciparum in Brazilian Amazons. Moreover, an increased susceptibility to infection by this parasite is associated with the GPB S+ variant in this population.	[Tarazona-Santos, Eduardo; Zuccherato, Luciana W.; Machado, Moara] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Castilho, Lilian; Amaral, Daphne R. T.; Costa, Daiane C.] Hemoterapia Hemoctr Campinas, Lab Pesquisa, Sao Paulo, Brazil; [Furlani, Natalia G.; Rossit, Andrea R.; Machado, Ricardo L.] Fac Med Sao Jose do Rio Preto, Centro Invest Microrganismos, Sao Jose Do Rio Preto, Brazil; [Reid, Marion E.] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Immunochem, New York, NY 10021 USA; [Zalis, Mariano G.] Univ Fed Rio de Janeiro, Lab Infectol & Parasitol Mol, Rio De Janeiro, Brazil; [Santos, Sidney E. B.] Fed Univ Para, Lab Genet Humana & Med, BR-66059 Belem, Para, Brazil; [Lustigman, Sara] New York Blood Ctr, Lindsley F Kimball Res Inst, Mol Parasitol Lab, New York, NY 10021 USA	Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); New York Blood Center; Universidade Federal do Rio de Janeiro; Universidade Federal do Para; New York Blood Center	Tarazona-Santos, E (corresponding author), Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil.	slustigman@nybloodcenter.org	Tarazona-Santos, Eduardo/AAF-1110-2019; Machado, Ricardo Luiz Dantas Dantas/P-1288-2014; Castilho, Lilian/F-6123-2012; Baptista, Andrea/N-2879-2017; Machado, Ricardo/GXM-8198-2022; baptista, Andrea/L-5970-2016; de Souza Baptista, Andrea Regina/AAA-2998-2019	Machado, Ricardo Luiz Dantas Dantas/0000-0002-8955-3204; Castilho, Lilian/0000-0002-3104-647X; Baptista, Andrea/0000-0002-0461-7521; baptista, Andrea/0000-0002-0461-7521; de Souza Baptista, Andrea Regina/0000-0002-0461-7521; Tarazona, Eduardo/0000-0003-3508-3160; Zalis, Mariano/0000-0002-6858-8483	National Institute of Allergy and Infectious Diseases, National Institutes of Health [5R03TW007349-3, 1R56AI069547-01A2]; New York Blood Center; Brazilian National Research Council (CNPq); Sao Paulo State Research Agency (FAPESP); Minas Gerais State Research Agency (FAPEMIG); Brazilian Ministry of Education (CAPES); Hematology and Hemotherapy Center - Hemocentro UNICAMP; National Institute of Science and Technology of Blood, Brazil (INCT do Sangue -CNPq / MCT / FAPESP); FOGARTY INTERNATIONAL CENTER [R03TW007349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069547] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); New York Blood Center; Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Agency (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Minas Gerais State Research Agency (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Hematology and Hemotherapy Center - Hemocentro UNICAMP; National Institute of Science and Technology of Blood, Brazil (INCT do Sangue -CNPq / MCT / FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health number 5R03TW007349-3 and 1R56AI069547-01A2 to SL. This research was also supported in part by the intramural funding of the New York Blood Center to SL and by funding from Brazilian National Research Council (CNPq) to LC, ETS and MM; Sao Paulo State Research Agency (FAPESP) to LC, DRTA, DCC, NGF, ARBR, RLDM; Minas Gerais State Research Agency (FAPEMIG) to ETS, Brazilian Ministry of Education (CAPES) to LWZ. The Hematology and Hemotherapy Center - Hemocentro UNICAMP, forms part of the National Institute of Science and Technology of Blood, Brazil (INCT do Sangue -CNPq / MCT / FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Allen SJ, 1999, AM J TROP MED HYG, V60, P1056, DOI 10.4269/ajtmh.1999.60.1056; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ayodo G, 2007, AM J HUM GENET, V81, P234, DOI 10.1086/519221; Baleotti W, 2006, VOX SANG, V91, P81, DOI 10.1111/j.1423-0410.2006.00787.x; Baleotti W, 2003, VOX SANG, V84, P326, DOI 10.1046/j.1423-0410.2003.00297.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baum J, 2003, GENETICS, V163, P1327; Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003; Bei AK, 2007, MOL BIOCHEM PARASIT, V153, P66, DOI 10.1016/j.molbiopara.2007.01.007; Beiguelman B, 2003, MEM I OSWALDO CRUZ, V98, P455, DOI 10.1590/S0074-02762003000400004; Blumenfeld OO, 1997, TRANSFUS CLIN BIOL, V4, P357, DOI 10.1016/S1246-7820(97)80041-9; BOOTH P B, 1972, Human Biology in Oceania, V1, P259; BOOTH PB, 1970, NATURE, V228, P462, DOI 10.1038/228462a0; BOOTH PB, 1982, HUM HERED, V32, P385, DOI 10.1159/000153328; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Castilho L, 2004, VOX SANG, V87, P190, DOI 10.1111/j.1423-0410.2004.00554.x; Cavasini CE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-167; Cavasini CE, 2006, HUM BIOL, V78, P215, DOI 10.1353/hub.2006.0034; CONRAD DF, NATURE, V464, P704; CONTRERAS M, 1984, VOX SANG, V46, P377, DOI 10.1111/j.1423-0410.1984.tb00102.x; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DAHR W, 1987, BIOL CHEM H-S, V368, P659, DOI 10.1515/bchm3.1987.368.1.659; DAHR W, 1986, RECENT ADV BLOOD GRO, P23; DASILVA MC, 2010, GENET MOL RES, V9, P2069; Deans AM, 2007, INFECT IMMUN, V75, P3014, DOI 10.1128/IAI.00249-07; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; FACER CA, 1983, B SOC PATHOL EXOT, V76, P463; FACER CA, 1983, T ROY SOC TROP MED H, V77, P524, DOI 10.1016/0035-9203(83)90130-X; FIELD SP, 1994, HUM GENET, V93, P148; FRASER GR, 1966, AM J HUM GENET, V18, P546; FU YX, 1993, GENETICS, V133, P693; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; HADLEY TJ, 1986, ANNU REV MICROBIOL, V40, P451, DOI 10.1146/annurev.mi.40.100186.002315; Haldane J. B. S, 1949, RICERCA SCIENTIFIC S, V19, P3; Hashmi G, 2005, TRANSFUSION, V45, P680, DOI 10.1111/j.1537-2995.2005.04362.x; Hashmi G, 2007, TRANSFUSION, V47, P736, DOI 10.1111/j.1537-2995.2007.01178.x; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HUANG CH, 1988, P NATL ACAD SCI USA, V85, P9640, DOI 10.1073/pnas.85.24.9640; Huang CH, 1997, BLOOD, V90, P391; Issitt, 1998, APPL BLOOD GROUP SER; Jennings CV, 2007, INFECT IMMUN, V75, P3531, DOI 10.1128/IAI.00122-07; Kimura Masatsugu, 1997, Parasitology International, V46, P91, DOI 10.1016/S1383-5769(97)00013-5; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lell B, 1999, CLIN INFECT DIS, V28, P794, DOI 10.1086/515193; Li N, 2003, GENETICS, V165, P2213; Lobo CA, 2004, INFECT IMMUN, V72, P5886, DOI 10.1128/IAI.72.10.5886-5891.2004; LOWE RF, 1972, HUM HERED, V22, P344, DOI 10.1159/000152509; MACGREGOR A, 1973, VOX SANG, V25, P474, DOI 10.1111/j.1423-0410.1973.tb03540.x; MACHADO M, 2010, INVESTIGATI IN PRESS; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; MCGHEE RB, 1953, J EXP MED, V97, P773, DOI 10.1084/jem.97.6.773; Michon P, 2001, FEBS LETT, V495, P111, DOI 10.1016/S0014-5793(01)02370-5; MILLER LH, 1994, P NATL ACAD SCI USA, V91, P2415, DOI 10.1073/pnas.91.7.2415; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1977, J EXP MED, V146, P277, DOI 10.1084/jem.146.1.277; Montgomery KT, 2008, CURR PROTOC HUM GENE; Montoya Fabiola, 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P33, DOI 10.1590/S0036-46651994000100006; Neafsey DE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r171; Okoyeh JN, 1999, INFECT IMMUN, V67, P5784, DOI 10.1128/IAI.67.11.5784-5791.1999; Omoto R, 2008, Immunohematology, V24, P148; PASVOL G, 1984, PHILOS T ROY SOC B, V307, P189, DOI 10.1098/rstb.1984.0119; PASVOL G, 1982, NATURE, V297, P64, DOI 10.1038/297064a0; PASVOL G, 1982, LANCET, V2, P947; Patel SS, 2004, AM J HEMATOL, V75, P1, DOI 10.1002/ajh.10448; PATEL SS, 2004, MULTIPLE ERYTHROCYTE, V913, P2004; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reid ME, 1996, TRANSFUSION, V36, P719, DOI 10.1046/j.1537-2995.1996.36896374376.x; Reid ME., 2012, BLOOD GROUP ANTIGEN; Sabeti P, 2008, NATURE ED, V1; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; SERJEANTSON SW, 1994, IMMUNOL CELL BIOL, V72, P23, DOI 10.1038/icb.1994.4; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Storry JR, 2003, TRANSFUSION, V43, p1A; Storry JR, 2001, TRANSFUSION, V41, P269, DOI 10.1046/j.1537-2995.2001.41020269.x; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; UNGER P, 1987, BLUT, V55, P33, DOI 10.1007/BF00319639; VOS G H, 1971, South African Journal of Medical Sciences, V36, P1; Wang HY, 2003, MOL BIOL EVOL, V20, P1795, DOI 10.1093/molbev/msg185; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weatherall DJ, 1996, PARASITOLOGY, V112, pS23, DOI 10.1017/S0031182000076630; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Zimmerman PA, 2003, TRENDS PARASITOL, V19, P250, DOI 10.1016/S1471-4922(03)00112-0	90	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16123	10.1371/journal.pone.0016123	http://dx.doi.org/10.1371/journal.pone.0016123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283638	Green Published, gold, Green Submitted			2022-12-25	WOS:000286523400021
J	Velthuis, AJWT; Sakalis, PA; Fowler, DA; Bagowski, CP				Velthuis, Aartjan J. W. te; Sakalis, Philippe A.; Fowler, Donald A.; Bagowski, Christoph P.			Genome-Wide Analysis of PDZ Domain Binding Reveals Inherent Functional Overlap within the PDZ Interaction Network	PLOS ONE			English	Article							PEPTIDE INTERACTIONS; ESCHERICHIA-COLI; PROTEIN; PROMISCUITY; RECOGNITION; SPECIFICITY; SELECTIVITY; PHOSPHORYLATION; CLASSIFICATION; ORGANIZATION	Binding selectivity and cross-reactivity within one of the largest and most abundant interaction domain families, the PDZ family, has long been enigmatic. The complete human PDZ domain complement (the PDZome) consists of 267 domains and we applied here a Bayesian selectivity model to predict hundreds of human PDZ domain interactions, using target sequences of 22,997 non-redundant proteins. Subsequent analysis of these binding scores shows that PDZs can be divided into two genome-wide clusters that coincide well with the division between canonical class 1 and 2 PDZs. Within the class 1 PDZs we observed binding overlap at unprecedented levels, mediated by two residues at positions 1 and 5 of the second alpha-helix of the binding pocket. Eight PDZ domains were subsequently selected for experimental binding studies and to verify the basics of our predictions. Overall, the PDZ domain class 1 cross-reactivity identified here implies that auxiliary mechanisms must be in place to overcome this inherent functional overlap and to minimize cross-selectivity within the living cell. Indeed, when we superimpose PDZ domain binding affinities with gene ontologies, network topology data and the domain position within a PDZ superfamily protein, functional overlap is minimized and PDZ domains position optimally in the binding space. We therefore propose that PDZ domain selectivity is achieved through cellular context rather than inherent binding specificity.	[Velthuis, Aartjan J. W. te] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Velthuis, Aartjan J. W. te] Delft Univ Technol, Dept Bionanosci, Delft, Netherlands; [Sakalis, Philippe A.; Fowler, Donald A.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Bagowski, Christoph P.] German Univ Cairo, Inst Pharm & Biotechnol, New Cairo City, Egypt	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology; Leiden University; Leiden University - Excl LUMC; Egyptian Knowledge Bank (EKB); German University in Cairo	Velthuis, AJWT (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands.	christoph.bagowski@guc.edu.eg	Velthuis, AJ te/H-7981-2019	Velthuis, AJ te/0000-0002-5129-3953	Nederlands Organization for Scientific Research (NWO) [021.001.037]	Nederlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	AV is supported by a Toptalent grant from the Nederlands Organization for Scientific Research (NWO) via grant 021.001.037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basdevant N, 2006, J AM CHEM SOC, V128, P12766, DOI 10.1021/ja060830y; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; Basu MK, 2009, BRIEF BIOINFORM, V10, P205, DOI 10.1093/bib/bbn057; Bezprozvanny I, 2001, FEBS LETT, V509, P457, DOI 10.1016/S0014-5793(01)03214-8; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gerek ZN, 2009, PROTEINS, V77, P796, DOI 10.1002/prot.22492; Harris BZ, 2001, J CELL SCI, V114, P3219; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Hu ZJ, 2007, NAT BIOTECHNOL, V25, P547, DOI 10.1038/nbt1304; Hui S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-507; Inaba K, 2008, J BIOL CHEM, V283, P35042, DOI 10.1074/jbc.M806603200; Ivarsson Y, 2008, J BIOL CHEM, V283, P8954, DOI 10.1074/jbc.M707424200; Kalyoncu S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-357; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Pallen MJ, 1997, MOL MICROBIOL, V26, P411, DOI 10.1046/j.1365-2958.1997.5591911.x; Sakarya O, 2010, MOL BIOL EVOL, V27, P1058, DOI 10.1093/molbev/msp311; Schillinger C, 2009, BIOINFORMATICS, V25, P1632, DOI 10.1093/bioinformatics/btp264; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Te Velthuis Aartjan J W, 2007, PLoS One, V2, pe189, DOI 10.1371/journal.pone.0000189; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Velthuis AJWT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-129; Velthuis AJWT, 2008, CURR GENOMICS, V9, P88, DOI 10.2174/138920208784139537; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Zhang MJ, 2003, ACCOUNTS CHEM RES, V36, P530, DOI 10.1021/ar020210b	46	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16047	10.1371/journal.pone.0016047	http://dx.doi.org/10.1371/journal.pone.0016047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283644	Green Published, Green Submitted, gold			2022-12-25	WOS:000286523400013
J	Baliga, SS; Merrill, GF; Shinohara, ML; Denhardt, DT				Baliga, Sunanda S.; Merrill, Gary F.; Shinohara, Mari L.; Denhardt, David T.			Osteopontin Expression during Early Cerebral Ischemia-Reperfusion in Rats: Enhanced Expression in the Right Cortex Is Suppressed by Acetaminophen	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TRANSIENT FOREBRAIN ISCHEMIA; MESSENGER-RNA; POSTISCHEMIC REPERFUSION; STRESS RESPONSES; GENE-EXPRESSION; UP-REGULATION; BRAIN; INFLAMMATION; INFARCTION	Osteopontin (OPN) is a pleiotropic protein implicated in various inflammatory responses including ischemia-reperfusion (I-R) injury. Two distinct forms of the protein have been identified: an extensively studied secreted form (sOPN) and a less-well-known intracellular form (iOPN). Studies have shown that increased OPN expression parallels the time course of macrophage infiltration into injured tissue, a late event in the development of cerebral infarcts. sOPN has been suggested to promote remodeling of the extracellular matrix in the brain; the function of iOPN may be to facilitate certain signal transduction processes. Here, we studied OPN expression in adult male Sprague-Dawley rats subjected to global forebrain I-R injury. We found iOPN in the cytoplasm of both cortices and the hippocampus, but unexpectedly only the right cortex exhibited a marked increase in the iOPN level after 45 min of reperfusion. Acetaminophen, a drug recently shown to decrease apoptotic incidence, caspase-9 activation, and mitochondrial dysfunction during global I-R, significantly inhibited the increase in iOPN protein in the right cortex, suggesting a role for iOPN in the response to I-R injury in the right cortex.	[Baliga, Sunanda S.; Merrill, Gary F.; Denhardt, David T.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA; [Shinohara, Mari L.] Duke Univ, Med Ctr, Div Immunol, Durham, NC 27710 USA	Rutgers State University New Brunswick; Duke University	Baliga, SS (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA.	denhardt@biology.rutgers.edu		Shinohara, Mari/0000-0002-6808-9844	Johnson & Johnson Corporate Office of Science and Technology/McNeil; J&J Corporate Office of Science and Technology; McNeil; JJ-owned company; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088100] Funding Source: NIH RePORTER	Johnson & Johnson Corporate Office of Science and Technology/McNeil(Johnson & JohnsonJohnson & Johnson USA); J&J Corporate Office of Science and Technology; McNeil; JJ-owned company; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by a donation from Mrs. J. G. Harrar and from Johnson & Johnson Corporate Office of Science and Technology/McNeil Consumer Specialty Products (http://www.jnj.com) to Gary F. Merrill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; G.F. Merrill was funded by J&J Corporate Office of Science and Technology in 1992-1995 (Focused Funding, adenosine research) and again in 2001-2003 (Seed Grant, acetaminophen in the heart). This was not contract research and Merrill was not a consultant for J&J nor was he ever employed by them. The experiments described herein were funded, in part, by McNeil, and J&J-owned company. Merrill has never been employed by McNeil, is not currently a consultant for them, nor has any conflict of interest related to them and this research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682; Baliga SS, 2010, BRAIN RES, V1319, P142, DOI 10.1016/j.brainres.2010.01.013; BUTTINI M, 1994, MOL BRAIN RES, V23, P126, DOI 10.1016/0169-328X(94)90218-6; Choi JS, 2007, BRAIN RES, V1151, P195, DOI 10.1016/j.brainres.2007.03.016; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; El-Tanani MK, 2008, FRONT BIOSCI, V13, P4276, DOI 10.2741/3004; GLICK SD, 1979, LIFE SCI, V25, P395, DOI 10.1016/0024-3205(79)90272-8; GRAY H, 1973, GRAYS ANATOMY, V14; Holtz ML, 2001, BRAIN RES, V898, P49, DOI 10.1016/S0006-8993(01)02140-0; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; HWANG S, 1994, J BIOL CHEM, V269, P711; INOUE M, 2010, IMMUNOL RES IN PRESS; Iwanaga Y, 2008, NEUROPATH APPL NEURO, V34, P145, DOI 10.1111/j.1365-2990.2007.00877.x; Kang WS, 2008, BRAIN RES, V1228, P208, DOI 10.1016/j.brainres.2008.06.106; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P925, DOI 10.1002/jcb.21487; Kleinschnitz C, 2003, J CEREBR BLOOD F MET, V23, P1356, DOI 10.1097/01.WCB.0000090505.76664.DB; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; KOLB B, 2010, DEV PSYCHOBIOL  1124; Kristofikova Z, 2010, NEUROCHEM RES, V35, P1138, DOI 10.1007/s11064-010-0165-8; Lajtha A., 2007, HDB NEUROCHEMISTRY M; Lee MY, 1999, NEUROSCI LETT, V271, P81, DOI 10.1016/S0304-3940(99)00526-1; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; PARIKH RM, 1988, STROKE, V19, P472, DOI 10.1161/01.STR.19.4.472; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; ROBINSON RG, 1980, BRAIN RES, V188, P63, DOI 10.1016/0006-8993(80)90557-0; ROBINSON RG, 1979, SCIENCE, V205, P707, DOI 10.1126/science.462179; SAMARA A, 2009, HIPPOCAMPUS     1217; Shimoda K, 1999, BIOL PSYCHIAT, V45, P187, DOI 10.1016/S0006-3223(98)00178-4; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; SINGH K, 1995, J BIOL CHEM, V270, P28471; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; SORIANO MA, 1995, BRAIN RES, V670, P317, DOI 10.1016/0006-8993(94)01352-I; Spalletta G, 2002, J NEUROL, V249, P1541, DOI 10.1007/s00415-002-0885-z; Sullivan RM, 1999, J NEUROSCI, V19, P2834; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wang XK, 1998, J NEUROSCI, V18, P2075; Westedt U, 2004, EUR J PHARM BIOPHARM, V58, P161, DOI 10.1016/j.ejpb.2004.03.009; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; WU B, 2010, NEUROCRIT CARE  0504; Wung JK, 2007, CURR ALZHEIMER RES, V4, P67, DOI 10.2174/156720507779939869; Yokasaki Y, 2000, TRENDS CARDIOVAS MED, V10, P155, DOI 10.1016/S1050-1738(00)00055-4; ZHANG ZG, 1993, STROKE, V24, P2016, DOI 10.1161/01.STR.24.12.2016	48	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14568	10.1371/journal.pone.0014568	http://dx.doi.org/10.1371/journal.pone.0014568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283687	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522300006
J	Lopez-Bao, JV; Gonzalez-Varo, JP				Lopez-Bao, Jose V.; Gonzalez-Varo, Juan P.			Frugivory and Spatial Patterns of Seed Deposition by Carnivorous Mammals in Anthropogenic Landscapes: A Multi-Scale Approach	PLOS ONE			English	Article							DISPERSAL PATTERNS; AVIAN FRUGIVORES; FRUIT CONSUMPTION; RESOURCE TRACKING; NORTHERN SPAIN; SCENT-MARKING; HABITAT; BIRDS; POPULATION; MANAGEMENT	Background: Knowledge about how frugivory and seed deposition are spatially distributed is valuable to understand the role of dispersers on the structure and dynamics of plant populations. This may be particularly important within anthropogenic areas, where either the patchy distribution of wild plants or the presence of cultivated fleshy-fruits may influence plant-disperser interactions. Methodology/Principal Findings: We investigated frugivory and spatial patterns of seed deposition by carnivorous mammals in anthropogenic landscapes considering two spatial scales: 'landscape' (similar to 10 km(2)) and 'habitat type' (similar to 1-2 km(2)). We sampled carnivore faeces and plant abundance at three contrasting habitats (chestnut woods, mosaics and scrublands), each replicated within three different landscapes. Sixty-five percent of faeces collected (n = 1077) contained seeds, among which wild and cultivated seeds appeared in similar proportions (58% and 53%) despite that cultivated fruiting plants were much less abundant. Seed deposition was spatially structured among both spatial scales being different between fruit types. Whereas the most important source of spatial variation in deposition of wild seeds was the landscape scale, it was the habitat scale for cultivated seeds. At the habitat scale, seeds of wild species were mostly deposited within mosaics while seeds of cultivated species were within chestnut woods and scrublands. Spatial concordance between seed deposition and plant abundance was found only for wild species. Conclusions/Significance: Spatial patterns of seed deposition by carnivores differed between fruit types and seemed to be modulated by the fleshy-fruited plant assemblages and the behaviour of dispersers. Our results suggest that a strong preference for cultivated fruits by carnivores may influence their spatial foraging behaviour and lower their dispersal services to wild species. However, the high amount of seeds removed within and between habitats suggests that carnivores must play an important role - often overlooked - as 'restorers' and 'habitat shapers' in anthropogenic areas.	[Lopez-Bao, Jose V.] Estac Biol Donana, Dept Conservat Biol, E-41013 Seville, Spain; [Gonzalez-Varo, Juan P.] Univ Seville, Dept Biol Vegetal & Ecol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Sevilla	Lopez-Bao, JV (corresponding author), Estac Biol Donana, Dept Conservat Biol, E-41013 Seville, Spain.	jvlb@ebd.csic.es	González-Varo, Juan P./E-6395-2011	González-Varo, Juan P./0000-0003-1439-6475; Lopez-Bao, Jose Vicente/0000-0001-9213-998X	Conselleria de Educacion Xunta de Galicia [05RFO 20001 PR]	Conselleria de Educacion Xunta de Galicia(Xunta de Galicia)	This research was funded by the project PGIDIT 05RFO 20001 PR (Conselleria de Educacion Xunta de Galicia) coordinated by the Grupo Biologia Evolutiva de Plantas (Universidad de Santiago de Compostela). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger J, 2002, AM MIDL NAT, V147, P352, DOI 10.1674/0003-0031(2002)147[0352:AABBUA]2.0.CO;2; BAS S, 1978, CONTRIBUCION ESTUDIO, V1; Bermejo T, 2000, FOLIA ZOOL, V49, P89; Cavallini P, 1996, ETHOL ECOL EVOL, V8, P323; DEBUSSCHE M, 1989, OIKOS, V56, P327, DOI 10.2307/3565617; Fedriani JM, 2010, ECOGRAPHY, V33, P545, DOI 10.1111/j.1600-0587.2009.06052.x; Garcia D, 2005, J ECOL, V93, P693, DOI 10.1111/j.1365-2745.2005.01004.x; Garcia D, 2004, ECOGRAPHY, V27, P187, DOI 10.1111/j.0906-7590.2004.03751.x; Garcia D, 2009, J ECOL, V97, P217, DOI 10.1111/j.1365-2745.2008.01470.x; Gonzalez-Varo JP, 2008, LANDSCAPE ECOL, V23, P79, DOI 10.1007/s10980-007-9166-7; Gonzalez-Varo JP, 2010, ECOGRAPHY, V33, P185, DOI 10.1111/j.1600-0587.2009.06021.x; GORMAN ML, 1990, REV SUISSE ZOOL, V97, P3, DOI 10.5962/bhl.part.79722; Guitian J, 2008, OIKOS, V117, P265, DOI 10.1111/j.2007.0030-1299.16316.x; Guitian J, 2010, ACTA OECOL, V36, P242, DOI 10.1016/j.actao.2010.01.005; Guix J.C., 2001, ORSIS, V16, P145; Hernandez A, 2008, POL J ECOL, V56, P127; Herrera Carlos M., 2002, P185; HERRERA CM, 1995, ANNU REV ECOL SYST, V26, P705, DOI 10.1146/annurev.es.26.110195.003421; HERRERA CM, 1989, OIKOS, V55, P250, DOI 10.2307/3565429; Herrmann Mathias, 1994, P122; Hickey JR, 1999, OIKOS, V87, P499, DOI 10.2307/3546814; Hutchings MR, 2000, MAMMAL REV, V30, P157, DOI 10.1046/j.1365-2907.2000.00065.x; IZHAKI I, 1991, J ECOL, V79, P575, DOI 10.2307/2260654; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Kimura K, 2001, J TROP ECOL, V17, P833, DOI 10.1017/S0266467401001626; Koike S, 2008, J FOREST RES-JPN, V13, P215, DOI 10.1007/s10310-008-0069-5; Kollmann Johannes, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P29, DOI 10.1078/1433-8319-00003; Kuiters AT, 2003, FOREST ECOL MANAG, V181, P239, DOI 10.1016/S0378-1127(03)00136-1; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Martinez I, 2008, ECOSCIENCE, V15, P189, DOI 10.2980/15-2-3096; Matias L, 2010, RESTOR ECOL, V18, P619, DOI 10.1111/j.1526-100X.2008.00475.x; McIntyre S, 1999, CONSERV BIOL, V13, P1282, DOI 10.1046/j.1523-1739.1999.97509.x; Mortelliti A, 2008, LANDSCAPE ECOL, V23, P285, DOI 10.1007/s10980-007-9182-7; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; R Core Team, 2022, R LANG ENV STAT COMP; RODRIGUEZ A, 1992, J ZOOL, V227, P347, DOI 10.1111/j.1469-7998.1992.tb04833.x; Rosalino LM, 2004, CAN J ZOOL, V82, P1493, DOI 10.1139/Z04-130; Rosalino LM, 2009, MAMMAL REV, V39, P67, DOI 10.1111/j.1365-2907.2008.00134.x; Rumbao IM, 2008, ARDEOLA, V55, P221; Schaumann F, 2002, FLORA, V197, P370, DOI 10.1078/0367-2530-00053; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Suarez-Seoane S, 2002, BIOL CONSERV, V105, P333, DOI 10.1016/S0006-3207(01)00213-0; Traveset Anna, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P151, DOI 10.1078/1433-8319-00057; Verdu M, 1998, J VEG SCI, V9, P713, DOI 10.2307/3237289; WILLSON MF, 1993, OIKOS, V67, P159, DOI 10.2307/3545106; Wright S. J., 2007, Seed dispersal: theory and its application in a changing world, P599, DOI 10.1079/9781845931650.0599; Zalewski A, 2004, ECOSCIENCE, V11, P113, DOI 10.1080/11956860.2004.11682815; Zhou YB, 2008, FOREST ECOL MANAG, V255, P1595, DOI 10.1016/j.foreco.2007.11.018	50	54	55	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14569	10.1371/journal.pone.0014569	http://dx.doi.org/10.1371/journal.pone.0014569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21297861	Green Published, gold			2022-12-25	WOS:000286522300007
J	Hu, S; Dong, TS; Dalal, SR; Wu, F; Bissonnette, M; Kwon, JH; Chang, EB				Hu, Shien; Dong, Tien Sy; Dalal, Sushila R.; Wu, Feng; Bissonnette, Marc; Kwon, John H.; Chang, Eugene B.			The Microbe-Derived Short Chain Fatty Acid Butyrate Targets miRNA-Dependent p21 Gene Expression in Human Colon Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; GASTRIC-CANCER; MICRORNAS; CELLS; INHIBITION; PHENOTYPE; PROMOTER; CLONING; ARREST	Colonic microbiota ferment non-absorbed dietary fiber to produce prodigious amounts of short chain fatty acids (SCFAs) that benefit the host through a myriad of metabolic, trophic, and chemopreventative effects. The chemopreventative effects of the SCFA butyrate are, in part, mediated through induction of p21 gene expression. In this study, we assessed the role of microRNA(miRNA) in butyrate's induction of p21 expression. The expression profiles of miRNAs in HCT-116 cells and in human sporadic colon cancers were assessed by microarray and quantitative PCR. Regulation of p21 gene expression by miR-106b was assessed by 3' UTR luciferase reporter assays and transfection of specific miRNA mimics. Butyrate changed the expression of 44 miRNAs in HCT-116 cells, many of which were aberrantly expressed in colon cancer tissues. Members of the miR-106b family were decreased in the former and increased in the latter. Butyrate-induced p21 protein expression was dampened by treatment with a miR-106b mimic. Mutated p21 3'UTR-reporter constructs expressed in HCT-116 cells confirmed direct miR-106b targeting. Butyrate decreased HCT-116 proliferation, an effect reversed with the addition of the miR-106b mimic. We conclude that microbe-derived SCFAs regulate host gene expression involved in intestinal homeostasis as well as carcinogenesis through modulation of miRNAs.	[Hu, Shien; Dong, Tien Sy; Dalal, Sushila R.; Wu, Feng; Bissonnette, Marc; Kwon, John H.; Chang, Eugene B.] Univ Chicago, Dept Med, Martin Boyer Labs, Chicago, IL 60637 USA	University of Chicago	Hu, S (corresponding author), Univ Chicago, Dept Med, Martin Boyer Labs, 5841 S Maryland Ave, Chicago, IL 60637 USA.	echang@medicine.bsd.uchicago.edu		Dong, Tien/0000-0003-0105-8063	Human Microbiome Project [DK083993, HG004858, R37 DK47722, K08 DK078046]; Digestive Disease Research Core Center of the University of Chicago [DK-42086]; Gastro-intestinal Research Foundation Associates' Board; Crohn's and Colitis Foundation of America [T35 DK62719, T32 DK07074]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH3DK083993, T32DK007074, P30DK042086, UH2DK083993, T35DK062719, R37DK047722, K08DK078046] Funding Source: NIH RePORTER	Human Microbiome Project; Digestive Disease Research Core Center of the University of Chicago(University of Chicago); Gastro-intestinal Research Foundation Associates' Board; Crohn's and Colitis Foundation of America; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Human Microbiome Project (DK083993, HG004858), R37 DK47722 (EBC), K08 DK078046 (JHK), the Digestive Disease Research Core Center DK-42086 of the University of Chicago, and the Gastro-intestinal Research Foundation Associates' Board (SRD). Trainees were supported by a Research Fellowship Award from the Crohn's and Colitis Foundation of America (SH), T35 DK62719 (TSD), and (SRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramova MV, 2006, J BIOL CHEM, V281, P21040, DOI 10.1074/jbc.M511059200; Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Comalada M, 2006, J CANCER RES CLIN, V132, P487, DOI 10.1007/s00432-006-0092-x; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dahm CC, 2010, JNCI-J NATL CANCER I, V102, P614, DOI 10.1093/jnci/djq092; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hallert C, 2003, INFLAMM BOWEL DIS, V9, P116, DOI 10.1097/00054725-200303000-00005; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hinnebusch BF, 2002, J NUTR, V132, P1012, DOI 10.1093/jn/132.5.1012; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Lee EM, 2009, INT J MOL MED, V24, P45, DOI 10.3892/ijmm_00000204; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Ogino S, 2009, CANCER EPIDEM BIOMAR, V18, P2513, DOI 10.1158/1055-9965.EPI-09-0451; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Saito Y, 2009, J GASTROENTEROL, V44, P18, DOI 10.1007/s00535-008-2285-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Suzuki S, 1998, GENE, V216, P85, DOI 10.1016/S0378-1119(98)00323-0; Weaver GA, 1997, J NUTR, V127, P717, DOI 10.1093/jn/127.5.717; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	33	151	166	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16221	10.1371/journal.pone.0016221	http://dx.doi.org/10.1371/journal.pone.0016221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283757	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522200038
J	Lin, XZ; Liang, DG; He, ZH; Deng, QA; Robertson, ES; Lan, K				Lin, Xianzhi; Liang, Deguang; He, Zhiheng; Deng, Qiang; Robertson, Erle S.; Lan, Ke			miR-K12-7-5p Encoded by Kaposi's Sarcoma-Associated Herpesvirus Stabilizes the Latent State by Targeting Viral ORF50/RTA	PLOS ONE			English	Article							RBP-J-KAPPA; TRANSCRIPTIONAL REGULATION; LYTIC REACTIVATION; MICRORNAS; GENE; RTA; IDENTIFICATION; EXPRESSION; RNA; REPLICATION	Seventeen miRNAs encoded by Kaposi's sarcoma-associated herpesvirus (KSHV) have been identified and their functions have begun to be characterized. Among these miRNAs, we report here that miR-K12-7 directly targets the replication and transcription activator (RTA) encoded by open reading frame 50. We found that miR-K12-7 targeted the RTA 39 untranslated region (RTA3'UTR) in a seed sequence-dependent manner. miR-K12-7-5p derived from miR-K12-7 mediates the inhibition of RTA expression, and the mutation of the seed match site totally abrogated the inhibitory effect of miR-K12-7 on RTA3'UTR. The inhibition of RTA expression by miR-K12-7 was further confirmed in the latently KSHV-infected 293/Bac36 cell line through transient transfection of miR-K12-7 expression plasmid or specific inhibitor of miR-K12-7-5p, respectively. The transient transfection of miR-K12-7 into 293/Bac36 cells reduced RTA expression and the expression of the downstream early genes regulated by RTA, and also the production of progeny virus was significantly reduced after treatment with chemical inducers. Our study revealed that another miRNA, miR-K12-7-5p, targets the viral immediate early gene RTA and that this miRNA contributes to the maintenance of viral latency.	[Lin, Xianzhi; Liang, Deguang; He, Zhiheng; Deng, Qiang; Lan, Ke] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Robertson, Erle S.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Robertson, Erle S.] Univ Penn, Sch Med, Abramson Comprehens Canc Ctr, Philadelphia, PA 19104 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Lin, XZ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	lanke@sibs.ac.cn	Lin, Xianzhi/O-2130-2017; HE, ZHIHENG/E-4354-2016	Lin, Xianzhi/0000-0001-9802-9896; Lan, Ke/0000-0002-0384-8598; HE, ZHIHENG/0000-0002-0088-178X	Natural Science Foundation of China [30770098, 30970154]; 973 program of China [2011CB504800]; Pu Jiang Talent Program (A) [08PJ14103]; Chinese Academy of Sciences	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program of China(National Basic Research Program of China); Pu Jiang Talent Program (A); Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors are grateful to SA-SIBS Scholarship program. This was supported by grants from the 100 Talent Program of the Chinese Academy of Sciences, Natural Science Foundation of China (30770098 and 30970154), 973 program of China (No. 2011CB504800), and the Pu Jiang Talent Program (A) (08PJ14103) to KL. KL is a special fellow and ESR is a scholar of the Leukemia and Lymphoma Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellare P, 2009, CELL HOST MICROBE, V6, P570, DOI 10.1016/j.chom.2009.11.008; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chang PJ, 2002, J VIROL, V76, P3168, DOI 10.1128/JVI.76.7.3168-3178.2002; Chen JG, 2000, J VIROL, V74, P8623, DOI 10.1128/JVI.74.18.8623-8634.2000; Deng HY, 2002, J VIROL, V76, P8252, DOI 10.1128/JVI.76.16.8252-8264.2002; Grey F, 2008, MED MICROBIOL IMMUN, V197, P261, DOI 10.1007/s00430-007-0070-1; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Izumiya Y, 2009, J VIROL, V83, P4435, DOI 10.1128/JVI.01999-08; Lan K, 2004, J VIROL, V78, P6585, DOI 10.1128/JVI.78.12.6585-6594.2004; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Lin YT, 2010, RNA, V16, P1540, DOI 10.1261/rna.1967910; Liu YH, 2008, VIROLOGY, V380, P264, DOI 10.1016/j.virol.2008.08.011; Lu F, 2010, J VIROL, V84, P2697, DOI 10.1128/JVI.01997-09; McAllister SC, 2005, J VIROL, V79, P2626, DOI 10.1128/JVI.79.4.2626-2630.2005; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Schulz R, 2009, HUM MOL GENET, V18, P118, DOI 10.1093/hmg/ddn322; Song MJ, 2001, J VIROL, V75, P3129, DOI 10.1128/JVI.75.7.3129-3140.2001; Staudt MR, 2007, CURR TOP MICROBIOL, V312, P71; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Zhang L, 1998, DNA CELL BIOL, V17, P735; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999; Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266	29	98	105	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16224	10.1371/journal.pone.0016224	http://dx.doi.org/10.1371/journal.pone.0016224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283761	gold, Green Published			2022-12-25	WOS:000286522200040
J	Tarabbo, M; Lapa, D; Castilletti, C; Tommaselli, P; Guarducci, R; Luca, G; Emanuele, A; Zaccaria, O; La Gioia, VFP; Girardi, E; Capobianchi, MR; Ippolito, G				Tarabbo, Mario; Lapa, Daniele; Castilletti, Concetta; Tommaselli, Pietro; Guarducci, Riccardo; Luca, Giuditta; Emanuele, Alessandro; Zaccaria, Onofrio; La Gioia, Vincenzo F. P.; Girardi, Enrico; Capobianchi, Maria R.; Ippolito, Giuseppe			Retrospective Investigation of an Influenza A/H1N1pdm Outbreak in an Italian Military Ship Cruising in the Mediterranean Sea, May-September 2009	PLOS ONE			English	Article								Background: Clinical surveillance may have underestimated the real extent of the spread of the new strain of influenza A/H1N1, which surfaced in April 2009 originating the first influenza pandemic of the 21(st) century. Here we report a serological investigation on an influenza A/H1N1pdm outbreak in an Italian military ship while cruising in the Mediterranean Sea (May 24-September 6, 2009). Methods: The contemporary presence of HAI and CF antibodies was used to retrospectively estimate the extent of influenza A/H1N1pdm spread across the crew members (median age: 29 years). Findings: During the cruise, 2 crew members fulfilled the surveillance case definition for influenza, but only one was laboratory confirmed by influenza A/H1N1pdm-specific RT-PCR; 52 reported acute respiratory illness (ARI) episodes, and 183 reported no ARI episodes. Overall, among the 211 crew member for whom a valid serological result was available, 39.3% tested seropositive for influenza A/H1N1pdm. The proportion of seropositives was significantly associated with more crowded living quarters and tended to be higher in those aged <40 and in those reporting ARI or suspected/confirmed influenza A/H1N1pdm compared to the asymptomatic individuals. No association was found with previous seasonal influenza vaccination. Conclusions: These findings underline the risk for rapid spread of novel strains of influenza A in confined environment, such as military ships, where crowding, rigorous working environment, physiologic stress occur. The high proportion of asymptomatic infections in this ship-borne outbreak supports the concept that serological surveillance in such semi-closed communities is essential to appreciate the real extent of influenza A/H1N1pdm spread and can constitute, since the early stage of a pandemic, an useful model to predict the public health impact of pandemic influenza and to establish proportionate and effective countermeasures.	[Tarabbo, Mario] ITA Navy, Inspectorate Hlth, Rome, Italy; [Lapa, Daniele; Castilletti, Concetta; Capobianchi, Maria R.] Natl Inst Infect Dis L Spallanzani, Virol Lab, Rome, Italy; [Guarducci, Riccardo; Emanuele, Alessandro] ITA Navy, Mil Hosp, Taranto, Italy; [Zaccaria, Onofrio; La Gioia, Vincenzo F. P.] ITA Def Gen Staff, Med Situat Awareness Off, Rome, Italy; [Girardi, Enrico; Ippolito, Giuseppe] Natl Inst Infect Dis L Spallanzani, Dept Epidemiol, Rome, Italy; [Ippolito, Giuseppe] Natl Inst Infect Dis L Spallanzani, Sci Direct, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Tarabbo, M (corresponding author), ITA Navy, Inspectorate Hlth, Rome, Italy.	maria.capobianchi@inmi.it	Castilletti, Concetta/AAA-8408-2019; Ippolito, Giuseppe/J-7207-2017; Castilletti, Concetta/B-6545-2016	Castilletti, Concetta/0000-0001-9819-236X; Castilletti, Concetta/0000-0001-9819-236X; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Ippolito, Giuseppe/0000-0002-1076-2979; Girardi, Enrico/0000-0001-8182-5896	Italian Ministry of Health; Ricerca Corrente; Ricerca Finalizzata	Italian Ministry of Health(Ministry of Health, Italy); Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	This work has been partly supported by the Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond N. B., 2009, Medical Surveillance Montly Report, V16, P8; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; *CDCP, 2010, MMWR-MORBID MORTAL W, V51, P1440; *CDCP, 2010, MMWR-MORBID MORTAL W, V6, P162; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Crum-Cianflone NF, 2009, CLIN INFECT DIS, V49, P1801, DOI 10.1086/648508; Dill CE, 2009, DISASTER MED PUBLIC, V3, pS117, DOI 10.1097/DMP.0b013e3181bf249b; FIELD AM, 1967, J HYG-CAMB, V65, P409, DOI 10.1017/S0022172400045927; Ikonen N, 2010, EURO SURVEILL, V15; Lennette EH, 1979, DIAGNOSTIC PROCEDURE; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; LOUIE JK, 2009, JAMA-J AM MED ASSOC, V17, P1896; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; MORGAN OW, 2010, EID, V4, P631; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; Pebody RG, 2010, EUROSURVEILLANCE, V15; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Reed C, 2010, LANCET, V375, P1062, DOI 10.1016/S0140-6736(09)62194-2; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; ROSS T, 2010, PLOS CURR INFLUENZA, V24; *WHO, WHOCDSCRS20025; World Health Organization, CDC PROT REALT RT PC; 2010, NEJM, V18, P1708	24	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15933	10.1371/journal.pone.0015933	http://dx.doi.org/10.1371/journal.pone.0015933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283749	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200018
J	Aziz, A; Harrop, SP; Bishop, NE				Aziz, Azhari; Harrop, Sean P.; Bishop, Naomi E.			Characterization of the Deleted in Autism 1 Protein Family: Implications for Studying Cognitive Disorders	PLOS ONE			English	Article							COMPARATIVE GENOMICS; SEQUENCE DIVERGENCE; SPECTRUM DISORDERS; VERTEBRATE GENOME; GENE DUPLICATION; AMPHIOXUS GENOME; NERVOUS-SYSTEM; MODEL ORGANISM; ANIMAL-MODELS; GOLGI PROTEIN	Autism spectrum disorders (ASDs) are a group of commonly occurring, highly-heritable developmental disabilities. Human genes c3orf58 or Deleted In Autism-1 (DIA1) and cXorf36 or Deleted in Autism-1 Related (DIA1R) are implicated in ASD and mental retardation. Both gene products encode signal peptides for targeting to the secretory pathway. As evolutionary medicine has emerged as a key tool for understanding increasing numbers of human diseases, we have used an evolutionary approach to study DIA1 and DIA1R. We found DIA1 conserved from cnidarians to humans, indicating DIA1 evolution coincided with the development of the first primitive synapses. Nematodes lack a DIA1 homologue, indicating Caenorhabditis elegans is not suitable for studying all aspects of ASD etiology, while zebrafish encode two DIA1 paralogues. By contrast to DIA1, DIA1R was found exclusively in vertebrates, with an origin coinciding with the whole-genome duplication events occurring early in the vertebrate lineage, and the evolution of the more complex vertebrate nervous system. Strikingly, DIA1R was present in schooling fish but absent in fish that have adopted a more solitary lifestyle. An additional DIA1-related gene we named DIA1-Like (DIA1L), lacks a signal peptide and is restricted to the genomes of the echinoderm Strongylocentrotus purpuratus and cephalochordate Branchiostoma floridae. Evidence for remarkable DIA1L gene expansion was found in B. floridae. Amino acid alignments of DIA1 family gene products revealed a potential Golgi-retention motif and a number of conserved motifs with unknown function. Furthermore, a glycine and three cysteine residues were absolutely conserved in all DIA1-family proteins, indicating a critical role in protein structure and/or function. We have therefore identified a new metazoan protein family, the DIA1-family, and understanding the biological roles of DIA1-family members will have implications for our understanding of autism and mental retardation.	[Aziz, Azhari; Harrop, Sean P.; Bishop, Naomi E.] La Trobe Univ, Dept Microbiol, Bundoora, Vic 3083, Australia	La Trobe University	Aziz, A (corresponding author), La Trobe Univ, Dept Microbiol, Bundoora, Vic 3083, Australia.	N.Bishop@latrobe.edu.au			La Trobe University; Malaysian Ministry of Higher Education; Islamic Science University of Malaysia	La Trobe University; Malaysian Ministry of Higher Education; Islamic Science University of Malaysia	NEB and SPH were supported by La Trobe University and AA by La Trobe University, the Malaysian Ministry of Higher Education, and the Islamic Science University of Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; AZIZ A, 2010, PLOS ONE IN PRESS; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Best J D, 2008, Neuropsychiatr Dis Treat, V4, P567; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Bitto E, 2008, J BIOL CHEM, V283, P30184, DOI 10.1074/jbc.M804746200; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Burbach JPH, 2009, TRENDS NEUROSCI, V32, P69, DOI 10.1016/j.tins.2008.11.002; Castagnola M, 2008, J PROTEOME RES, V7, P5327, DOI 10.1021/pr8004088; Castermans D, 2010, HUM MOL GENET, V19, P1368, DOI 10.1093/hmg/ddq013; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chapleau CA, 2009, J NEURODEV DISORD, V1, P185, DOI 10.1007/s11689-009-9027-6; Cheung C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012233; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Conant GC, 2003, GENOME RES, V13, P2052, DOI 10.1101/gr.1252603; Cossins AR, 2005, NAT REV GENET, V6, P324, DOI 10.1038/nrg1590; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; D'Aniello S, 2008, MOL BIOL EVOL, V25, P1841, DOI 10.1093/molbev/msn132; D'Elia D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S1; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Douard V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-336; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Eisen GE, 2009, DEV BIOL, V335, P78, DOI 10.1016/j.ydbio.2009.08.024; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Finn RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000169; Flicek Paul, 2010, Nucleic Acids Res, V38, pD557, DOI 10.1093/nar/gkp972; Flint J, 2008, CURR OPIN GENET DEV, V18, P235, DOI 10.1016/j.gde.2008.07.002; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Fontanillas E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-95; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Froschauer A, 2006, CURR GENOMICS, V7, P43, DOI 10.2174/138920206776389766; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Gerlach Daniel, 2007, In Silico Biology, V7, P151; Giannandrea M, 2010, AM J HUM GENET, V86, P185, DOI 10.1016/j.ajhg.2010.01.011; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Grimmelikhuijzen C.J.P., 1995, Experientia Supplementum (Basel), V72, P7; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Halanych KM, 2001, AM ZOOL, V41, P629, DOI 10.1668/0003-1569(2001)041[0629:ABROMP]2.0.CO;2; Hardham AR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-63; Harper RA, 1996, TRENDS BIOCHEM SCI, V21, P150, DOI 10.1016/S0968-0004(96)80170-8; Hoegg S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-317; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holland LZ, 2008, BRAIN BEHAV EVOLUT, V72, P91, DOI 10.1159/000151470; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Holland LZ, 2004, CELL MOL LIFE SCI, V61, P2290, DOI 10.1007/s00018-004-4075-2; Holland LZ, 2003, BIOESSAYS, V25, P529, DOI 10.1002/bies.10302; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hufton AL, 2008, GENOME RES, V18, P1582, DOI 10.1101/gr.080119.108; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2002, MOL PSYCHIATR, V7, P302, DOI 10.1038/sj.mp.4000979; KABASHI E, 2010, BIOCH BIOPH IN PRESS; Kanehisa M, 1997, TRENDS BIOCHEM SCI, V22, P442, DOI 10.1016/S0968-0004(97)01130-4; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kawano T, 1997, BIOSCI BIOTECH BIOCH, V61, P927, DOI 10.1271/bbb.61.927; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; Klee EW, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-256; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Kumar RA, 2009, CURR NEUROL NEUROSCI, V9, P188, DOI 10.1007/s11910-009-0029-2; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Kurosawa G, 1999, BIOCHEM BIOPH RES CO, V260, P66, DOI 10.1006/bbrc.1999.0834; Laviola G, 2009, NEUROSCI BIOBEHAV R, V33, P560, DOI 10.1016/j.neubiorev.2008.09.006; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Li C, 2005, PARASITOLOGY, V131, pS109, DOI 10.1017/S0031182005009376; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; Losh M, 2008, J NEUROPATH EXP NEUR, V67, P829, DOI 10.1097/NEN.0b013e318184482d; Ma DQ, 2005, AM J HUM GENET, V77, P377, DOI 10.1086/433195; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Marques AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r54; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mathur P, 2010, NEUROBIOL DIS, V40, P66, DOI 10.1016/j.nbd.2010.05.016; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Menne KML, 2000, BIOINFORMATICS, V16, P741, DOI 10.1093/bioinformatics/16.8.741; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Miller G, 2009, SCIENCE, V325, P24, DOI 10.1126/science.325_24; MILPETZ F, 1995, TRENDS BIOCHEM SCI, V20, P204, DOI 10.1016/S0968-0004(00)89009-X; Mitreva M, 2005, TRENDS GENET, V21, P573, DOI 10.1016/j.tig.2005.08.003; Morris JA, 2009, PROG BRAIN RES, V179, P97, DOI 10.1016/S0079-6123(09)17911-6; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Mushegian AR, 1998, GENOME RES, V8, P590, DOI 10.1101/gr.8.6.590; NELSON J S, 1976, P416; Nesselhut J, 2001, FEBS LETT, V509, P469, DOI 10.1016/S0014-5793(01)03187-8; Newman M, 2007, BBA-MOL BASIS DIS, V1772, P285, DOI 10.1016/j.bbadis.2006.12.001; Oota S, 1999, MOL BIOL EVOL, V16, P856, DOI 10.1093/oxfordjournals.molbev.a026170; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Paxton J.R., 1998, ENCY FISHES; Permanyer J, 2006, INT J BIOL SCI, V2, P48; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qian WF, 2009, GENOME BIOL EVOL, V1, P198, DOI 10.1093/gbe/evp021; Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Rosso L, 2008, PLOS BIOL, V6, P1281, DOI 10.1371/journal.pbio.0060140; Rupp B, 1996, ANAT EMBRYOL, V194, P187; Rutter M, 2000, J ABNORM CHILD PSYCH, V28, P3, DOI 10.1023/A:1005113900068; Sadakata T, 2007, J CLIN INVEST, V117, P931, DOI 10.1172/JCI29031; Sadakata T, 2009, CEREBELLUM, V8, P312, DOI 10.1007/s12311-009-0097-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satoh N, 2006, GENOME DYN, V2, P198, DOI 10.1159/000095105; Sawa A, 2009, PROG BRAIN RES, V179, pVII, DOI 10.1016/S0079-6123(09)17919-0; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schioth HB, 2005, ANN NY ACAD SCI, V1040, P460, DOI 10.1196/annals.1327.090; Schubert M, 2008, DEV GENES EVOL, V218, P651, DOI 10.1007/s00427-008-0251-y; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Takatalo MS, 2009, J DENT RES, V88, P534, DOI 10.1177/0022034509338452; Takatalo M, 2008, DEV DYNAM, V237, P2243, DOI 10.1002/dvdy.21646; Takatalo MS, 2006, PROTEOMICS, V6, P3502, DOI 10.1002/pmic.200500516; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Talebizadeh Z, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036897; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taniai H, 2008, AM J MED GENET B, V147B, P844, DOI 10.1002/ajmg.b.30740; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tordjman S, 2007, BEHAV GENET, V37, P61, DOI 10.1007/s10519-006-9120-5; Tropepe V, 2003, GENES BRAIN BEHAV, V2, P268, DOI 10.1034/j.1601-183X.2003.00038.x; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Van de Peer Y, 2001, J MOL EVOL, V53, P436, DOI 10.1007/s002390010233; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; VANEGAS H, 1983, BRAIN RES REV, V6, P117, DOI 10.1016/0165-0173(83)90036-X; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Wagele JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-147; Wang YF, 2000, J MOL EVOL, V51, P88, DOI 10.1007/s002390010069; WARING R, 2001, SULPHATION AUTISM WH; WARING R, 2001, Patent No. 2001077681; Weiss LA, 2009, EXPERT REV MOL DIAGN, V9, P795, DOI 10.1586/ERM.09.59; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wilkins MR, 1999, METH MOL B, V112, P531; WINNEPENNINCKX B, 1995, MOL BIOL EVOL, V12, P641; Wood JD, 2009, HUM MOL GENET, V18, P391, DOI 10.1093/hmg/ddn361; WULLIMANN MF, 1991, J COMP NEUROL, V312, P415, DOI 10.1002/cne.903120309; Xue HG, 2005, NEUROSCI LETT, V390, P104, DOI 10.1016/j.neulet.2005.08.007; Yoshihara Motojiro, 2001, Functional and Integrative Genomics, V1, P235, DOI 10.1007/s101420000029; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	170	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e14547	10.1371/journal.pone.0014547	http://dx.doi.org/10.1371/journal.pone.0014547			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283809	Green Published, gold, Green Submitted			2022-12-25	WOS:000286520600002
J	Kim, CS; Epand, RF; Leikina, E; Epand, RM; Chernomordik, LV				Kim, Chang Sup; Epand, Raquel F.; Leikina, Eugenia; Epand, Richard M.; Chernomordik, Leonid V.			The Final Conformation of the Complete Ectodomain of the HA2 Subunit of Influenza Hemagglutinin Can by Itself Drive Low pH-dependent Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS MEMBRANE-FUSION; HEMIFUSION INTERMEDIATE; TRANSMEMBRANE DOMAIN; PORE FORMATION; COILED-COIL; PROTEINS; MECHANISM; PEPTIDE; STABILITY; STATE	One of the best characterized fusion proteins, the influenza virus hemagglutinin (HA), mediates fusion between the viral envelope and the endosomal membrane during viral entry into the cell. In the initial conformation of HA, its fusogenic subunit, the transmembrane protein HA2, is locked in a metastable conformation by the receptor-binding HA1 subunit of HA. Acidification in the endosome triggers HA2 refolding toward the final lowest energy conformation. Is the fusion process driven by this final conformation or, as often suggested, by the energy released by protein restructuring? Here we explored structural properties as well as the fusogenic activity of the full sized trimeric HA2(1-185) (here called HA2*) that presents the final conformation of the HA2 ectodomain. We found HA2* to mediate fusion between lipid bilayers and between biological membranes in a low pH-dependent manner. Two mutations known to inhibit HA-mediated fusion strongly inhibited the fusogenic activity of HA2*. At surface densities similar to those of HA in the influenza virus particle, HA2* formed small fusion pores but did not expand them. Our results confirm that the HA1 subunit responsible for receptor binding as well as the transmembrane and cytosolic domains of HA2 is not required for fusion pore opening and substantiate the hypothesis that the final form of HA2 is more important for fusion than the conformational change that generates this form.	[Kim, Chang Sup] Hanbat Natl Univ, Div Appl Chem & Biotechnol, Dept Biotechnol, Taejon 305719, South Korea; [Epand, Raquel F.; Epand, Richard M.] McMaster Univ, Dept Biochem, Hamilton, ON L8N 3Z5, Canada; [Leikina, Eugenia; Chernomordik, Leonid V.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Membrane Biol, Program Phys Biol, NIH, Bethesda, MD 20892 USA	Hanbat National University; McMaster University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kim, CS (corresponding author), Hanbat Natl Univ, Div Appl Chem & Biotechnol, Dept Biotechnol, Taejon 305719, South Korea.	changskim@hanbat.ac.kr; epand@mcmaster.ca; chernoml@mail.nih.gov	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558	Ministry of Education, Science and Technology [NRF-2007-313-D00237]; Canadian Institutes of Health Research [MOP 86608]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001501] Funding Source: NIH RePORTER	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD and by an intramural biodefense research grant from the NIAID (both to L. V. C.). This work was also supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant NRF-2007-313-D00237) (to C. S. K.) and in part by Canadian Institutes of Health Research Grant MOP 86608 (to R. M. E.).	Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Bentz J, 2000, BIOPHYS J, V78, P886, DOI 10.1016/S0006-3495(00)76646-X; Borrego-Diaz E, 2003, VIROLOGY, V316, P234, DOI 10.1016/j.virol.2003.07.006; Bottcher C, 1999, FEBS LETT, V463, P255, DOI 10.1016/S0014-5793(99)01475-1; Brugger B, 2000, EMBO J, V19, P1272, DOI 10.1093/emboj/19.6.1272; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; CHERNOMORDIK L, 1995, J VIROL, V69, P3049, DOI 10.1128/JVI.69.5.3049-3058.1995; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Curtis-Fisk J, 2007, J AM CHEM SOC, V129, P11320, DOI 10.1021/ja073644g; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; DOXSEY SJ, 1985, J CELL BIOL, V101, P19, DOI 10.1083/jcb.101.1.19; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Epand RF, 2003, BIOCHEMISTRY-US, V42, P5052, DOI 10.1021/bi034094b; Epand RF, 1999, J MOL BIOL, V286, P489, DOI 10.1006/jmbi.1998.2500; Epand RM, 2002, BIOCHEM J, V365, P841, DOI 10.1042/BJ20020290; Epand RM, 2001, BIOCHEMISTRY-US, V40, P8800, DOI 10.1021/bi0107187; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; Frolov VA, 2000, TRAFFIC, V1, P622, DOI 10.1034/j.1600-0854.2000.010806.x; GETHING MJ, 1986, J CELL BIOL, V102, P11, DOI 10.1083/jcb.102.1.11; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Huang Q, 2003, BBA-BIOMEMBRANES, V1614, P3, DOI 10.1016/S0005-2736(03)00158-5; Huang Q, 2009, PROTEINS, V74, P291, DOI 10.1002/prot.22157; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kim CH, 1998, BIOCHEMISTRY-US, V37, P137, DOI 10.1021/bi971982w; Kim CH, 1996, BIOCHEMISTRY-US, V35, P5359, DOI 10.1021/bi960332+; Kozerski C, 2000, J VIROL, V74, P7529, DOI 10.1128/JVI.74.16.7529-7537.2000; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; Kozlov MM, 1998, BIOPHYS J, V75, P1384, DOI 10.1016/S0006-3495(98)74056-1; LeDuc DL, 2000, BIOCHEMISTRY-US, V39, P2733, DOI 10.1021/bi992457v; Leikina E, 2001, BIOCHEMISTRY-US, V40, P8378, DOI 10.1021/bi010466+; Li JY, 2010, J PHYS CHEM B, V114, P8799, DOI 10.1021/jp1029163; Macosko JC, 1997, J MOL BIOL, V267, P1139, DOI 10.1006/jmbi.1997.0931; Markosyan RM, 2000, MOL BIOL CELL, V11, P1143, DOI 10.1091/mbc.11.4.1143; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; Melikyan GB, 2000, MOL BIOL CELL, V11, P3765, DOI 10.1091/mbc.11.11.3765; MELIKYAN GB, 1995, J CELL BIOL, V131, P679, DOI 10.1083/jcb.131.3.679; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; NIR S, 1993, METHOD ENZYMOL, V220, P379, DOI 10.1016/0076-6879(93)20096-L; Nussler F, 1997, BIOPHYS J, V73, P2280; Plonsky I, 2008, BIOL CELL, V100, P377, DOI 10.1042/BC20070040; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; Rafikova ER, 2009, J BIOL CHEM, V284, P29847, DOI 10.1074/jbc.M109.044453; Ramos C, 2006, BIOCHEM J, V400, P393, DOI 10.1042/BJ20061218; Remeta DP, 2002, BIOCHEMISTRY-US, V41, P2044, DOI 10.1021/bi015614a; RUIGROK RWH, 1986, VIROLOGY, V155, P484, DOI 10.1016/0042-6822(86)90210-2; Sapir A, 2008, DEV CELL, V14, P11, DOI 10.1016/j.devcel.2007.12.008; SATO SB, 1983, P NATL ACAD SCI-BIOL, V80, P3153, DOI 10.1073/pnas.80.11.3153; Shen S, 2009, MOL BIOL CELL, V20, P2438, DOI 10.1091/mbc.E08-10-0987; Sreerama N, 1999, PROTEIN SCI, V8, P370; STEGMANN T, 1990, EMBO J, V9, P4231, DOI 10.1002/j.1460-2075.1990.tb07871.x; Steinhauer DA, 1996, P NATL ACAD SCI USA, V93, P12873, DOI 10.1073/pnas.93.23.12873; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Swalley SE, 2004, BIOCHEMISTRY-US, V43, P5902, DOI 10.1021/bi049807k; TAYLOR HP, 1987, VIROLOGY, V159, P288, DOI 10.1016/0042-6822(87)90466-1; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Zhou Z, 2000, BIOPHYS J, V78, P2418, DOI 10.1016/S0006-3495(00)76785-3; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	70	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13226	13234		10.1074/jbc.M110.181297	http://dx.doi.org/10.1074/jbc.M110.181297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21292763	Green Published, hybrid			2022-12-25	WOS:000289282200043
J	Durgan, J; Kaji, N; Jin, D; Hall, A				Durgan, Joanne; Kaji, Noriko; Jin, Dan; Hall, Alan			Par6B and Atypical PKC Regulate Mitotic Spindle Orientation during Epithelial Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CELL-POLARITY PROTEIN; ELEGANS EMBRYOS; PLASMA-MEMBRANE; ADHERENT CELLS; CDC42 GEF; APKC; COMPLEX; ZETA; ISOFORMS	Cdc42 plays an evolutionarily conserved role in promoting cell polarity and is indispensable during epithelial morphogenesis. To further investigate the role of Cdc42, we have used a three-dimensional matrigel model, in which single Caco-2 cells develop to form polarized cysts. Using this system, we previously reported that Cdc42 controls mitotic spindle orientation during cell division to correctly position the apical surface in a growing epithelial structure. In the present study, we have investigated the specific downstream effectors through which Cdc42 controls this process. Here, we report that Par6B and its binding partner, atypical protein kinase C (aPKC), are required to regulate Caco-2 morphogenesis. Depletion or inhibition of Par6B or aPKC phenocopies the loss of Cdc42, inducing misorientation of the mitotic spindle, mispositioning of the nascent apical surface, and ultimately, the formation of aberrant cysts with multiple lumens. Mechanistically, Par6B and aPKC function interdependently in this context. Par6B localizes to the apical surface of Caco-2 cysts and is required to recruit aPKC to this compartment. Conversely, aPKC protects Par6B from proteasomal degradation, in a kinase-independent manner. In addition, we report that depletion or inhibition of aPKC induces robust apoptotic cell death in Caco-2 cells, significantly reducing both cyst size and number. Cell survival and apical positioning depend upon different thresholds of aPKC expression, suggesting that they are controlled by distinct downstream pathways. We conclude that Par6B and aPKC control mitotic spindle orientation in polarized epithelia and, furthermore, that aPKC coordinately regulates multiple processes to promote morphogenesis.	[Durgan, Joanne; Kaji, Noriko; Jin, Dan; Hall, Alan] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Durgan, J (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10065 USA.	durganj@mskcc.org			National Institutes of Health [GM081435]; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081435 (to A. H.).; Supported by the Uehara Memorial Foundation.	ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Anderson DC, 2008, SCIENCE, V320, P1771, DOI 10.1126/science.1156063; Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; BERRA E, 1993, CELL, V74, P555, DOI 10.1016/0092-8674(93)80056-K; Berra E, 1997, MOL CELL BIOL, V17, P4346, DOI 10.1128/MCB.17.8.4346; Cameron AJM, 2010, ADV ENZYME REGUL, V50, P169, DOI 10.1016/j.advenzreg.2009.10.004; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; DOMINGUEZ I, 1992, MOL CELL BIOL, V12, P3776, DOI 10.1128/MCB.12.9.3776; Durgan J, 2008, BIOCHEM J, V411, P319, DOI [10.1042/BJ20071348, 10.1042/bj20071348]; Durgan J, 2007, FEBS LETT, V581, P3377, DOI 10.1016/j.febslet.2007.06.035; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Gao L, 2004, J BIOL CHEM, V279, P41557, DOI 10.1074/jbc.M403723200; Garrard SM, 2003, EMBO J, V22, P1125, DOI 10.1093/emboj/cdg110; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Henrique D, 2003, CURR OPIN GENET DEV, V13, P341, DOI 10.1016/S0959-437X(03)00077-7; Hirano Y, 2004, J BIOL CHEM, V279, P31883, DOI 10.1074/jbc.M403092200; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kim M, 2007, J CELL SCI, V120, P2309, DOI 10.1242/jcs.007443; Kim S, 2009, J CELL SCI, V122, P3759, DOI 10.1242/jcs.052514; Kishikawa M, 2008, J CELL SCI, V121, P2481, DOI 10.1242/jcs.024109; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; LAMPRECHT J, 1986, ANAT EMBRYOL, V175, P129, DOI 10.1007/BF00315463; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Mitsushima M, 2009, MOL CELL BIOL, V29, P2816, DOI 10.1128/MCB.01713-08; Munson C, 2008, DEV BIOL, V324, P41, DOI 10.1016/j.ydbio.2008.08.033; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Parkinson SJ, 2004, EMBO J, V23, P77, DOI 10.1038/sj.emboj.7600023; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; Rosse C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000235; Schluter MA, 2009, MOL BIOL CELL, V20, P4652, DOI 10.1091/mbc.E09-02-0137; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Wallace SW, 2010, MOL BIOL CELL, V21, P2996, DOI 10.1091/mbc.E10-05-0429; Warner SJ, 2010, CURR BIOL, V20, P677, DOI 10.1016/j.cub.2010.03.025; Watts JL, 1996, DEVELOPMENT, V122, P3133; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	70	103	104	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.174235	http://dx.doi.org/10.1074/jbc.M110.174235			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21300793	Green Published, hybrid			2022-12-25	WOS:000289077500060
J	Kumar, S; Raj, I; Nagpal, I; Subbarao, N; Gourinath, S				Kumar, Sudhir; Raj, Isha; Nagpal, Isha; Subbarao, Naidu; Gourinath, Samudrala			Structural and Biochemical Studies of Serine Acetyltransferase Reveal Why the Parasite Entamoeba histolytica Cannot Form a Cysteine Synthase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; HAEMOPHILUS-INFLUENZAE; MOLECULAR-CLONING; BIOSYNTHESIS; PURIFICATION; MECHANISM; MODEL; SYNTHETASE	Cysteine (Cys) plays a major role in growth and survival of the human parasite Entamoeba histolytica. We report here the crystal structure of serine acetyltransferase (SAT) isoform 1, a cysteine biosynthetic pathway enzyme from E. histolytica (EhSAT1) at 1.77 angstrom, in complex with its substrate serine (Ser) at 1.59 angstrom and inhibitor Cys at 1.78 angstrom resolution. EhSAT1 exists as a trimer both in solution as well as in crystal structure, unlike hexamers formed by other known SATs. The difference in oligomeric state is due to the N-terminal region of the EhSAT1, which has very low sequence similarity to known structures, also differs in orientation and charge distribution. The Ser and Cys bind to the same site, confirming that Cys is a competitive inhibitor of Ser. The disordered C-terminal region and the loop near the active site are responsible for solvent-accessible acetyl-CoA binding site and, thus, lose inhibition to acetyl-CoA by the feedback inhibitor Cys. Docking and fluorescence studies show that EhSAT1 C-terminal-mimicking peptides can bind to O-acetyl serine sulfhydrylase (EhOASS), whereas native C-terminal peptide does not show any binding. To test further, C-terminal end of EhSAT1 was mutated and found that it inhibits EhOASS, confirming modified EhSAT1 can bind to EhOASS. The apparent inability of EhSAT1 to form a hexamer and differences in the C-terminal region are likely to be the major reasons for the lack of formation of the large cysteine synthase complex and loss of a complex regulatory mechanism in E. histolytica.	[Kumar, Sudhir; Raj, Isha; Nagpal, Isha; Gourinath, Samudrala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Gourinath, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	samudralag@yahoo.com	Subbarao, Prof Naidu/AAZ-1832-2020; Kumar, Sudhir/AAE-3615-2020	Subbarao, Prof Naidu/0000-0002-1720-2165; Kumar, Sudhir/0000-0001-9673-5842; Raj, Isha/0000-0003-4686-0498	Council for Scientific and Industrial Research, Government of India; Council of Scientific and Industrial Research (India); Indo-U. S. Science and Technology	Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Indo-U. S. Science and Technology	This work was supported by the Council for Scientific and Industrial Research, Government of India.; Recipient of a Council of Scientific and Industrial Research (India) fellowship.; Recipient of a Indo-U. S. Science and Technology Forum fellowship. To whom correspondence should be addressed. E-mail: samudralag@yahoo.com.	Agarwal SM, 2008, INT J PARASITOL, V38, P137, DOI 10.1016/j.ijpara.2007.09.009; BECKER MA, 1969, J BIOL CHEM, V244, P2418; Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805; Chinthalapudi K, 2008, PROTEINS, V72, P1222, DOI 10.1002/prot.22013; COOK PF, 1976, J BIOL CHEM, V251, P2023; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DENK D, 1987, J GEN MICROBIOL, V133, P515; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; Gorman J, 2004, ACTA CRYSTALLOGR D, V60, P1600, DOI 10.1107/S0907444904015240; Hindson VJ, 2000, J BIOL CHEM, V275, P461, DOI 10.1074/jbc.275.1.461; Hindson VJ, 2003, BIOCHEM J, V375, P745, DOI 10.1042/BJ20030429; Hussain S, 2009, MOL BIOCHEM PARASIT, V163, P39, DOI 10.1016/j.molbiopara.2008.09.006; Johnson CM, 2004, ARCH BIOCHEM BIOPHYS, V429, P115, DOI 10.1016/j.abb.2004.06.006; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; Krishna C, 2007, ACTA CRYSTALLOGR F, V63, P512, DOI 10.1107/S1744309107022154; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1628, DOI 10.1271/bbb.64.1628; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1874, DOI 10.1271/bbb.64.1874; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nozaki T, 1999, J BIOL CHEM, V274, P32445, DOI 10.1074/jbc.274.45.32445; Nozaki T, 2005, ADV PARASIT, V60, P1, DOI 10.1016/S0065-308X(05)60001-2; Nozaki T, 1998, MOL BIOCHEM PARASIT, V97, P33, DOI 10.1016/S0166-6851(98)00129-7; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; SAITO K, 1995, J BIOL CHEM, V270, P16321, DOI 10.1074/jbc.270.27.16321; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; SMITH IK, 1971, BIOCHIM BIOPHYS ACTA, V227, P288, DOI 10.1016/0005-2744(71)90061-1; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WHO PAHO UNE, 1997, EPIDEMIOL B, V18, P13; Zhao CH, 2006, BIOCHEM BIOPH RES CO, V341, P911, DOI 10.1016/j.bbrc.2006.01.054	34	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.197376	http://dx.doi.org/10.1074/jbc.M110.197376			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21297164	Green Published, hybrid			2022-12-25	WOS:000289077500066
J	Pabla, N; Ma, ZW; McIlhatton, MA; Fishel, R; Dong, Z				Pabla, Navjotsingh; Ma, Zhengwei; McIlhatton, Michael A.; Fishel, Richard; Dong, Zheng			hMSH2 Recruits ATR to DNA Damage Sites for Activation during DNA Damage-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISMATCH-REPAIR SYSTEM; ACUTE KIDNEY INJURY; CELL-CYCLE; CISPLATIN NEPHROTOXICITY; GENOME INTEGRITY; MECHANISMS; P53; CHECKPOINTS; RESISTANCE; PROTEINS	DNA damage response (DDR) activates a complex signaling network that triggers DNA repair, cell cycle arrest, and/or cell death. Depending on the type and severity of DNA lesion, DDR is controlled by "master" regulators including ATM and ATR protein kinases. Cisplatin, a major chemotherapy drug that cross-links DNA, induces ATR-dependent DDR, resulting in apoptosis. However, it is unclear how ATR is activated. To identify the key regulators of ATR, we analyzed the proteins that associate with ATR after cisplatin treatment by blue native-PAGE and co-immunoprecipitation. The mismatch repair protein hMSH2 was found to be a major ATR-binding protein. Functionally, ATR activation and its recruitment to nuclear foci during cisplatin treatment were attenuated, and DNA damage signaling, involving Chk2, p53, and PUMA-alpha, was suppressed in hMSH2-deficient cells. ATR activation induced by the DNA methylating agent N-methyl-N-nitrosourea was also shown to be hMSH2-dependent. Intriguingly, hMSH2-mediated ATR recruitment and activation appeared independent of replication protein A, Rad17, and the Rad9-Hus1-Rad1 protein complex. Together the results support a hMSH2-dependent pathway of ATR activation and downstream Chk2/p53 signaling.	[Pabla, Navjotsingh; Ma, Zhengwei; Dong, Zheng] Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [McIlhatton, Michael A.; Fishel, Richard] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Dong, Zheng] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA 30904 USA	University System of Georgia; Augusta University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Dong, Z (corresponding author), Med Coll Georgia, Dept Cellular Biol & Anat, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	zdong@mail.mcg.edu	Pabla, Navjotsingh/H-3568-2011	Pabla, Navjot/0000-0001-9408-0539	National Institutes of Health [DK087843, DK058831, CA067007, GM080176]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA067007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058831, R01DK087843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK087843 and DK058831 (to Z. D.) and CA067007 and GM080176 (to R. F.). This work was also supported by funds from the Department of Veterans Affairs (to Z. D.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Aebi S, 1996, CANCER RES, V56, P3087; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Fishel R, 1999, NAT MED, V5, P1239, DOI 10.1038/15191; Gong JG, 1999, NATURE, V399, P806; Guggenheim ER, 2009, CHEMBIOCHEM, V10, P141, DOI 10.1002/cbic.200800471; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jiang M, 2008, J PHARMACOL EXP THER, V327, P300, DOI 10.1124/jpet.108.139162; Jiang M, 2007, J BIOL CHEM, V282, P2636, DOI 10.1074/jbc.M606928200; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Jun SH, 2006, FEBS J, V273, P1609, DOI 10.1111/j.1742-4658.2006.05190.x; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; McIlhatton NA, 2007, CANCER RES, V67, P10966, DOI 10.1158/0008-5472.CAN-07-2562; Mello JA, 1996, CHEM BIOL, V3, P579, DOI 10.1016/S1074-5521(96)90149-0; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Meyers M, 1997, CANCER RES, V57, P206; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; O'Brien V, 2006, CARCINOGENESIS, V27, P682, DOI 10.1093/carcin/bgi298; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; SWAMY M, 2006, SCI STKE, P14, DOI DOI 10.1126/STKE.3452006PL4; Toft NJ, 1999, P NATL ACAD SCI USA, V96, P3911, DOI 10.1073/pnas.96.7.3911; Topping RP, 2009, J BIOL CHEM, V284, P14029, DOI 10.1074/jbc.M809303200; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang JYJ, 2006, CANCER CELL, V9, P417, DOI 10.1016/j.ccr.2006.05.013; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhang H, 1999, CANCER RES, V59, P3021; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	47	67	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10411	10418		10.1074/jbc.M110.210989	http://dx.doi.org/10.1074/jbc.M110.210989			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21285353	Green Published, hybrid			2022-12-25	WOS:000288547000057
J	Wang, Y; Sun, DQ; Liu, DG				Wang, Ying; Sun, Da-Quan; Liu, Ding-Gan			Tumor Suppression by RNA from C/EBP beta 3 ' UTR through the Inhibition of Protein Kinase C epsilon Activity	PLOS ONE			English	Article							3 UNTRANSLATED REGIONS; PKC-EPSILON; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; GROWTH; ACTIVATION; CELLS; OVEREXPRESSION; SEQUENCES; REVERSION	Background: Since the end of last century, RNAs from the 3' untranslated region (3'UTR) of several eukaryotic mRNAs have been found to exert tumor suppression activity when introduced into malignant cells independent of their whole mRNAs. In this study, we sought to determine the molecular mechanism of the tumor suppression activity of a short RNA from 3'UTR of C/EBP beta mRNA (C/EBP beta 3'UTR RNA) in human hepatocarcinoma cells SMMC-7721. Methodology/Principal Findings: By using Western blotting, immunocytochemistry, molecular beacon, confocal microscopy, protein kinase inhibitors and in vitro kinase assays, we found that, in the C/EBP beta 3'UTR-transfectant cells of SMMC-7721, the overexpressed C/EBP beta 3'UTR RNA induced reorganization of keratin 18 by binding to this keratin; that the C/EBP beta 3'UTR RNA also reduced phosphorylation and expression of keratin 18; and that the enzyme responsible for phosphorylating keratin 18 is protein kinase Ce. We then found that the C/EBP beta 3'UTR RNA directly inhibited the phosphorylating activity of protein kinase C epsilon; and that C/EBP beta 3'UTR RNA specifically bound with the protein kinase C epsilon-keratin 18 conjugate. Conclusion/Significance: Together, these facts suggest that the tumor suppression in SMMC-7721 by C/EBP beta 3'UTR RNA is due to the inhibition of protein kinase Ce activity through direct physical interaction between C/EBP beta 3'UTR RNA and protein kinase Ce. These facts indicate that the 3'UTR of some eukaryotic mRNAs may function as regulators for genes other than their own.	[Wang, Ying; Sun, Da-Quan; Liu, Ding-Gan] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, Y (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	kinverskur@gmail.com			State Natural Science Foundation of China [30670449, 30540079, 30970585]; State Key Laboratory of Molecular Biology open research team [0109S 11282]	State Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Molecular Biology open research team	State Natural Science Foundation of China (www.nsfc.gov.cn), grants number: 30670449, 30540079, 30970585 (for free applications). State Key Laboratory of Molecular Biology (www.sibcb.ac.cn) open research team grant, number: 0109S 11282 (for open research teams). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita Y, 2002, J BIOCHEM, V132, P847, DOI 10.1093/oxfordjournals.jbchem.a003296; Batarseh A, 2010, BIOCHEMISTRY-US, V49, P4766, DOI 10.1021/bi100020e; Bronfman M, 1998, ANAL BIOCHEM, V255, P252, DOI 10.1006/abio.1997.2453; Cacace AM, 1996, ONCOGENE, V13, P2517; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Davis S, 1996, P NATL ACAD SCI USA, V93, P508, DOI 10.1073/pnas.93.1.508; Dong R, 1980, J 2 MILITARY MED U S, V1, P5; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fan HZ, 1996, CANCER RES, V56, P4366; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Gramolini AO, 2001, J CELL BIOL, V154, P1173, DOI 10.1083/jcb.200101108; Ishiwatari H, 1997, CANCER LETT, V117, P57, DOI 10.1016/S0304-3835(97)00200-0; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Kim S, 2007, NAT STRUCT MOL BIOL, V14, P982, DOI 10.1038/nsmb1301; Liu DG, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni133; LIU DG, 1992, SCI CHINA SER B, V35, P822; Liu DG, 1996, SCI CHINA SER C, V39, P300; Liu DG, 2003, CELL RES, V13, P509, DOI 10.1038/sj.cr.7290195; Manjeshwar S, 2003, CANCER RES, V63, P5251; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Newton PM, 2010, BIOCHEM J, V427, P189, DOI 10.1042/BJ20091302; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; OMARY MB, 1992, J CELL BIOL, V117, P583, DOI 10.1083/jcb.117.3.583; Perletti GP, 1998, ONCOGENE, V16, P3345, DOI 10.1038/sj.onc.1201871; Pesole G, 2000, Brief Bioinform, V1, P236, DOI 10.1093/bib/1.3.236; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; RASTINEJAD F, 1993, CELL, V75, P1107, DOI 10.1016/0092-8674(93)90320-P; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Steitz JA, 2009, BIOCHEM SOC T, V37, P931, DOI 10.1042/BST0370931; Ueffing M, 1997, ONCOGENE, V15, P2921, DOI 10.1038/sj.onc.1201477; Veyrune J L, 1997, Prog Mol Subcell Biol, V18, P35; Vondriska TM, 2001, CIRC RES, V88, P1306, DOI 10.1161/hh1201.092994; Wang HZ, 2009, ACTA BIOCH BIOPH SIN, V41, P456, DOI 10.1093/abbs/gmp032; Wu DQ, 2002, CANCER RES, V62, P2423; Yoon KH, 2008, RNA BIOL, V5, P255, DOI 10.4161/rna.7116; ZHANG WY, 1980, J 2 MILITARY MED U, V1, P10; 刘定干, 1991, 生物化学与生物物理学报, V23, P246	39	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16543	10.1371/journal.pone.0016543	http://dx.doi.org/10.1371/journal.pone.0016543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283634	Green Submitted, Green Published, gold			2022-12-25	WOS:000286523400041
J	Al-Alem, L; Southard, RC; Kilgore, MW; Curry, TE				Al-Alem, Linah; Southard, R. Chase; Kilgore, Michael W.; Curry, Thomas E.			Specific Thiazolidinediones Inhibit Ovarian Cancer Cell Line Proliferation and Cause Cell Cycle Arrest in a PPAR gamma Independent Manner	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; HUMAN BREAST-CANCER; IN-VITRO; LIGAND TROGLITAZONE; INDUCE APOPTOSIS; CARCINOMA CELLS; GROWTH; EXPRESSION; ROSIGLITAZONE; MICE	Background: Peroxisome Proliferator Activated Receptor gamma (PPAR gamma) agonists, such as the thiazolinediones (TZDs), have been studied for their potential use as cancer therapeutic agents. We investigated the effect of four TZDs-Rosiglitazone (Rosi), Ciglitazone (CGZ), Troglitazone (TGZ), and Pioglitazone (Pio)-on ovarian cancer cell proliferation, PPAR gamma expression and PPAR luciferase reporter activity. We explored whether TZDs act in a PPAR gamma dependent or independent manner by utilizing molecular approaches to inhibit or overexpress PPAR gamma activity. Principal Findings: Treatment with CGZ or TGZ for 24 hours decreased proliferation in three ovarian cancer cell lines, Ovcar3, CaOv3, and Skov3, whereas Rosi and Pio had no effect. This decrease in Ovcar3 cell proliferation was due to a higher fraction of cells in the G(0)/G(1) stage of the cell cycle. CGZ and TGZ treatment increased apoptosis after 4 hours of treatment but not after 8 or 12 hours. Treatment with TGZ or CGZ increased PPAR gamma mRNA expression in Ovcar3 cells; however, protein levels were unchanged. Surprisingly, luciferase promoter assays revealed that none of the TZDs increased PPAR gamma activity. Overexpression of wild type PPAR gamma increased reporter activity. This was further augmented by TGZ, Rosi, and Pio indicating that these cells have the endogenous capacity to mediate PPAR gamma transactivation. To determine whether PPAR gamma mediates the TZD-induced decrease in proliferation, cells were treated with CGZ or TGZ in the absence or presence of a dominant negative (DN) or wild type overexpression PPAR gamma construct. Neither vector changed the TZD-mediated cell proliferation suggesting this effect of TZDs on ovarian cancer cells may be PPAR gamma independent. Conclusions: CGZ and TGZ cause a decrease in ovarian cancer cell proliferation that is PPAR gamma independent. This concept is supported by the finding that a DN or overexpression of the wild type PPAR gamma did not affect the changes in cell proliferation and cell cycle.	[Al-Alem, Linah; Southard, R. Chase; Kilgore, Michael W.] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40506 USA; [Al-Alem, Linah; Curry, Thomas E.] Univ Kentucky, Coll Med, Dept Obstet & Gynecol, Lexington, KY USA	University of Kentucky; University of Kentucky	Al-Alem, L (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40506 USA.	tecurry@uky.edu			National Institutes of Health [CA95609, HD057446, RR15592]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057446] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095609] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health (grant numbers CA95609, HD057446 and RR15592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred CD, 2005, MOL CELL ENDOCRINOL, V235, P21, DOI 10.1016/j.mce.2005.02.003; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Berger J, 1996, ENDOCRINOLOGY, V137, P4189, DOI 10.1210/en.137.10.4189; Blanquicett Carmelo, 2008, Cancer Ther, V6, P25; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Burstein HJ, 2003, BREAST CANCER RES TR, V79, P391, DOI 10.1023/A:1024038127156; Camp HS, 2000, DIABETES, V49, P539, DOI 10.2337/diabetes.49.4.539; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Choi JH, 2007, ENDOCR REV, V28, P440, DOI 10.1210/er.2006-0036; Clay CE, 2001, J INVEST MED, V49, P413, DOI 10.2310/6650.2001.33786; Demetri GD, 1999, P NATL ACAD SCI USA, V96, P3951, DOI 10.1073/pnas.96.7.3951; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Faich GA, 2001, PHARMACOEPIDEM DR S, V10, P537, DOI 10.1002/pds.652; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Flessner MF, 2004, J APPL PHYSIOL, V97, P1518, DOI 10.1152/japplphysiol.00305.2004; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Houseknecht KL, 2002, DOMEST ANIM ENDOCRIN, V22, P1, DOI 10.1016/S0739-7240(01)00117-5; Jarrar MH, 2007, J CELL MOL MED, V11, P71, DOI 10.1111/j.1582-4934.2007.00003.x; Jiang GQ, 2002, DIABETES, V51, P2412, DOI 10.2337/diabetes.51.8.2412; KOSZEWSKI NJ, 2010, J STEROID BIOCH MOL; Kubota T, 1998, CANCER RES, V58, P3344; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Melichar B, 2004, GYNECOL ONCOL, V93, P149, DOI 10.1016/j.ygyno.2004.01.008; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Mustafa A, 2008, CLIN CANCER RES, V14, P4935, DOI 10.1158/1078-0432.CCR-08-0958; Nakashiro K, 2001, AM J PATHOL, V159, P591, DOI 10.1016/S0002-9440(10)61730-0; Ohta K, 2001, J CLIN ENDOCR METAB, V86, P2170, DOI 10.1210/jc.86.5.2170; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Panigrahy D, 2005, CANCER BIOL THER, V4, P687, DOI 10.4161/cbt.4.7.2014; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Qi C, 2000, CELL BIOCHEM BIOPHYS, V32, P187, DOI 10.1385/CBB:32:1-3:187; R Development Core Team, 2005, R LANG ENV STAT COMP; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Saiki M, 2006, INT J ONCOL, V29, P437; Seargent JM, 2004, BRIT J PHARMACOL, V143, P933, DOI 10.1038/sj.bjp.0705973; Shigeto T, 2007, ONCOL REP, V18, P833; Smith U, 2001, INT J CLIN PRACT, P13; Soller M, 2007, MOL PHARMACOL, V71, P1535, DOI 10.1124/mol.107.034371; Talbert DR, 2008, BREAST CANCER RES TR, V108, P23, DOI 10.1007/s10549-007-9575-y; Valentiner U, 2005, TOXICOLOGY, V213, P157, DOI 10.1016/j.tox.2005.05.024; Vanderhyden Barbara C, 2003, Reprod Biol Endocrinol, V1, P67, DOI 10.1186/1477-7827-1-67; VEATCH AL, 1995, CLIN EXP METASTAS, V13, P165, DOI 10.1007/BF00132204; Vignati S, 2006, NEOPLASIA, V8, P851, DOI 10.1593/neo.06433; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Wang X, 2004, CANCER RES, V64, P5592, DOI 10.1158/0008-5472.CAN-04-0043; Wei S, 2008, J BIOL CHEM, V283, P26759, DOI 10.1074/jbc.M802160200; Yang FG, 2005, ACTA PHARMACOL SIN, V26, P753, DOI 10.1111/j.1745-7254.2005.00753.x; Yang YC, 2007, INT J GYNECOL CANCER, V17, P418, DOI 10.1111/j.1525-1438.2006.00866.x; Yang ZB, 2003, CLIN CANCER RES, V9, P3198; Zaytseva YY, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-90; Zhang GY, 2005, BRIT J CANCER, V92, P113, DOI 10.1038/sj.bjc.6602244; ZHANG Z, 2010, J CELL PHYSL	56	32	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16179	10.1371/journal.pone.0016179	http://dx.doi.org/10.1371/journal.pone.0016179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283708	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522300018
J	Bippes, CC; Feldmann, A; Stamova, S; Cartellieri, M; Schwarzer, A; Wehner, R; Schmitz, M; Rieber, EP; Zhao, SM; Schakel, K; Temme, A; Scofield, RH; Kurien, BT; Bartsch, H; Bachmann, M				Bippes, Claudia C.; Feldmann, Anja; Stamova, Slava; Cartellieri, Marc; Schwarzer, Adrian; Wehner, Rebekka; Schmitz, Marc; Rieber, E. Peter; Zhao, Senming; Schaekel, Knut; Temme, Achim; Scofield, R. Hal; Kurien, Biji T.; Bartsch, Holger; Bachmann, Michael			A Novel Modular Antigen Delivery System for Immuno Targeting of Human 6-sulfo LacNAc-Positive Blood Dendritic Cells (SlanDCs)	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; CD8(+) T-CELLS; IN-VIVO; SOMATIC HYPERMUTATION; DEC-205 RECEPTOR; PROTEIN; ACTIVATION; UNRESPONSIVENESS; AUTOIMMUNITY; AUTOANTIBODY	Background: Previously, we identified a major myeloid-derived proinflammatory subpopulation of human blood dendritic cells which we termed slanDCs (e.g. Schakel et al. (2006) Immunity 24, 767-777). The slan epitope is an O-linked sugar modification (6-sulfo LacNAc, slan) of P-selectin glycoprotein ligand-1 (PSGL-1). As slanDCs can induce neoantigen-specific CD4+ T cells and tumor-reactive CD8+ cytotoxic T cells, they appear as promising targets for an in vivo delivery of antigens for vaccination. However, tools for delivery of antigens to slanDCs were not available until now. Moreover, it is unknown whether or not antigens delivered via the slan epitope can be taken up, properly processed and presented by slanDCs to T cells. Methodology/Principal Findings: Single chain fragment variables were prepared from presently available decavalent monoclonal anti-slan IgM antibodies but failed to bind to slanDCs. Therefore, a novel multivalent anti-slanDC scaffold was developed which consists of two components: (i) a single chain bispecific recombinant diabody (scBsDb) that is directed on the one hand to the slan epitope and on the other hand to a novel peptide epitope tag, and (ii) modular (antigen-containing) linker peptides that are flanked at both their termini with at least one peptide epitope tag. Delivery of a Tetanus Toxin-derived antigen to slanDCs via such a scBsDb/antigen scaffold allowed us to recall autologous Tetanus-specific memory T cells. Conclusions/Significance: In summary our data show that (i) the slan epitope can be used for delivery of antigens to this class of human-specific DCs, and (ii) antigens bound to the slan epitope can be taken up by slanDCs, processed and presented to T cells. Consequently, our novel modular scaffold system may be useful for the development of human vaccines.	[Bippes, Claudia C.; Feldmann, Anja; Stamova, Slava; Cartellieri, Marc; Schwarzer, Adrian; Wehner, Rebekka; Schmitz, Marc; Rieber, E. Peter; Zhao, Senming; Schaekel, Knut; Temme, Achim; Bartsch, Holger; Bachmann, Michael] Tech Univ Dresden, Inst Immunol, Med Fac Carl Gustav Carus, Dresden, Germany; [Schmitz, Marc; Bachmann, Michael] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany; [Zhao, Senming] Hebei Med Univ, Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Scofield, R. Hal; Kurien, Biji T.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Hebei Medical University; Oklahoma Medical Research Foundation	Bippes, CC (corresponding author), Tech Univ Dresden, Inst Immunol, Med Fac Carl Gustav Carus, Dresden, Germany.	michael.bachmann@tu-dresden.de	Cartellieri, Marc/M-3281-2013; Scofield, Robert Hal/AEJ-8314-2022; Cartellieri, Marc/AAL-8197-2020; Bachmann, Michael P/E-8850-2010; Schwarzer, Adrian/AAA-2571-2022; Feldmann, Anja/AAI-1809-2020; Kurien, Biji T/C-2392-2008; Feldmann, Anja/D-7843-2014; Bachmann, Michael/AAA-5153-2020	Cartellieri, Marc/0000-0002-4672-3963; Bachmann, Michael P/0000-0002-8029-5755; Feldmann, Anja/0000-0001-5099-2448; Kurien, Biji T/0000-0002-7877-6859; Feldmann, Anja/0000-0001-5099-2448; Bachmann, Michael/0000-0002-8029-5755; Schwarzer, Adrian/0000-0001-5684-2280; Stamova, Slava/0000-0002-2543-1523	Center for Regenerative Therapies Dresden (CRTD), Technical University Dresden, Germany; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053483] Funding Source: NIH RePORTER	Center for Regenerative Therapies Dresden (CRTD), Technical University Dresden, Germany; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by a seed grant given to MB by the Center for Regenerative Therapies Dresden (CRTD), Technical University Dresden, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; BIRKHOLZ K, 2010, BLOOD; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bruder D, 2005, DIABETES, V54, P3395, DOI 10.2337/diabetes.54.12.3395; CARMOFONSECA M, 1989, EXP CELL RES, V185, P73, DOI 10.1016/0014-4827(89)90038-4; Charalambous A, 2006, J IMMUNOL, V177, P8410, DOI 10.4049/jimmunol.177.12.8410; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Do Y, 2008, EUR J IMMUNOL, V38, P20, DOI 10.1002/eji.200737799; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; GAITHER KK, 1987, J CLIN INVEST, V79, P841, DOI 10.1172/JCI112892; Gurer C, 2008, BLOOD, V112, P1231, DOI 10.1182/blood-2008-03-148072; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Malik S, 2007, LUPUS, V16, P863, DOI 10.1177/0961203307083365; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Mannering SI, 2003, J IMMUNOL METHODS, V283, P173, DOI 10.1016/j.jim.2003.09.004; Maugeri N, 2009, BLOOD, V113, P5254, DOI 10.1182/blood-2008-09-180794; Moll H, 2003, CELL MICROBIOL, V5, P493, DOI 10.1046/j.1462-5822.2003.00291.x; Morgenroth A, 2007, PROSTATE, V67, P1121, DOI 10.1002/pros.20608; Mukhopadhaya A, 2008, P NATL ACAD SCI USA, V105, P6374, DOI 10.1073/pnas.0802644105; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Proudfoot O, 2007, MOL PHARMACEUT, V4, P58, DOI 10.1021/mp0601087; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Schakel K, 2006, IMMUNITY, V24, P767, DOI 10.1016/j.immuni.2006.03.020; Schakel K, 1998, EUR J IMMUNOL, V28, P4084, DOI 10.1002/(SICI)1521-4141(199812)28:12<4084::AID-IMMU4084>3.0.CO;2-4; Schakel K, 1999, PATHOBIOLOGY, V67, P287, DOI 10.1159/000028081; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Schmitz M, 2005, J IMMUNOL, V174, P4127, DOI 10.4049/jimmunol.174.7.4127; Sousa CRE, 1999, CURR OPIN IMMUNOL, V11, P392, DOI 10.1016/S0952-7915(99)80066-1; Stavnezer J, 2000, CURR TOP MICROBIOL, V245, P127; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3	39	25	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16315	10.1371/journal.pone.0016315	http://dx.doi.org/10.1371/journal.pone.0016315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283706	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522300033
J	Rhome, R; Singh, A; Kechichian, T; Drago, M; Morace, G; Luberto, C; Del Poeta, M				Rhome, Ryan; Singh, Arpita; Kechichian, Talar; Drago, Monica; Morace, Giulia; Luberto, Chiara; Del Poeta, Maurizio			Surface Localization of Glucosylceramide during Cryptococcus neoformans Infection Allows Targeting as a Potential Antifungal	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; DIACYLGLYCEROL; SPHINGOLIPIDS; SYNTHASE; PATHWAY; BURDEN	Cryptococcus neoformans (Cn) is a significant human pathogen that, despite current treatments, continues to have a high morbidity rate especially in sub-Saharan Africa. The need for more tolerable and specific therapies has been clearly shown. In the search for novel drug targets, the gene for glucosylceramide synthase (GCS1) was deleted in Cn, resulting in a strain (Delta gcs1) that does not produce glucosylceramide (GlcCer) and is avirulent in mouse models of infection. To understand the biology behind the connection between virulence and GlcCer, the production and localization of GlcCer must be characterized in conditions that are prohibitive to the growth of Delta gcs1 (neutral pH and high CO2). These prohibitive conditions are physiologically similar to those found in the extracellular spaces of the lung during infection. Here, using immunofluorescence, we have shown that GlcCer localization to the cell surface is significantly increased during growth in these conditions and during infection. We further seek to exploit this localization by treatment with Cerezyme (Cz), a recombinant enzyme that metabolizes GlcCer, as a potential treatment for Cn. Cz treatment was found to reduce the amount of GlcCer in vitro, in cultures, and in Cn cells inhabiting the mouse lung. Treatment with Cz induced a membrane integrity defect in wild type Cn cells similar to Delta gcs1. Cz treatment also reduced the in vitro growth of Cn in a dose and condition dependent manner. Finally, Cz treatment was shown to have a protective effect on survival in mice infected with Cn. Taken together, these studies have established the legitimacy of targeting the GlcCer and other related sphingolipid systems in the development of novel therapeutics.	[Rhome, Ryan; Singh, Arpita; Kechichian, Talar; Luberto, Chiara; Del Poeta, Maurizio] Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; [Rhome, Ryan; Singh, Arpita; Kechichian, Talar; Luberto, Chiara; Del Poeta, Maurizio] Med Univ S Carolina, Dept Mol Biol, Charleston, SC 29425 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Dept Microbiol, Charleston, SC 29425 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Dept Immunol, Charleston, SC 29425 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Dept Craniofacial Biol, Charleston, SC 29425 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Div Infect Dis, Charleston, SC 29425 USA; [Drago, Monica; Morace, Giulia] Univ Milan, Dipartimento Sanita Pubbl, Milan, Italy	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of Milan	Rhome, R (corresponding author), Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA.	delpoeta@musc.edu	Morace, Giulia/I-8809-2012	Morace, Giulia/0000-0003-1696-1183	National Institutes of Health; National Center for Research Resources [C06 RR015455]; United States Department of Education; American Heart Association;  [AI56168];  [AI72142];  [AI78493]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072142, R56AI072142, R01AI056168, R21AI078493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Education(US Department of Education); American Heart Association(American Heart Association); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants AI56168, AI72142, and AI78493 (to M.D.P) and was conducted in a facility constructed with support from the National Institutes of Health, Grant Number C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources. During his PhD Program, RR was supported in part by the Graduate Assistance in Areas of National Need (GAANN) training grant in "Lipidology and New Technologies'' (to M.D.P.) from the United States Department of Education and in part by an American Heart Association Pre-doctoral Fellowship Program. Dr. Maurizio Del Poeta is a Burroughs Wellcome New Investigator in Pathogenesis of Infectious Diseases.	CASADEVALL A, 1998, CRYPTOCOCCUS NEOFORM, P381; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen LC, 1996, CLIN DIAGN LAB IMMUN, V3, P570, DOI 10.1128/CDLI.3.5.570-574.1996; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Garcia J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.17; Hanada K, 2005, JPN J INFECT DIS, V58, P131; HARLOW E, 1988, ANTIBODIES LABORATOR, P274; Harrison TS, 2009, AIDS, V23, P531, DOI 10.1097/QAD.0b013e328322ffc3; Heung LJ, 2006, INFECT IMMUN, V74, P28, DOI 10.1128/IAI.74.1.28-39.2006; Heung LJ, 2005, J BIOL CHEM, V280, P28547, DOI 10.1074/jbc.M503404200; Heung LJ, 2004, J BIOL CHEM, V279, P21144, DOI 10.1074/jbc.M312995200; Hillig I, 2003, FEBS LETT, V553, P365, DOI 10.1016/S0014-5793(03)01058-5; Kechichian TB, 2007, INFECT IMMUN, V75, P4792, DOI 10.1128/IAI.00587-07; Levery SB, 2002, FEBS LETT, V525, P59, DOI 10.1016/S0014-5793(02)03067-3; Luberto C, 2001, GENE DEV, V15, P201, DOI 10.1101/gad.856001; MANDALA SM, 1995, J ANTIBIOT, V48, P349, DOI 10.7164/antibiotics.48.349; MCQUISTON T, INFECT IMMUN, P2342; Oura T, 2010, MICROBIOL-SGM, V156, P1234, DOI 10.1099/mic.0.033985-0; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Rhome R, 2007, EUKARYOT CELL, V6, P1715, DOI 10.1128/EC.00208-07; Rhome R, 2010, ADV EXP MED BIOL, V688, P232; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2007, CLIN VACCINE IMMUNOL, V14, P1372, DOI 10.1128/CVI.00202-07; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Rodrigues ML, 2000, INFECT IMMUN, V68, P7049, DOI 10.1128/IAI.68.12.7049-7060.2000; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Saito K, 2006, APPL MICROBIOL BIOT, V71, P515, DOI 10.1007/s00253-005-0187-3; SHEA J, 2005, IDENTIFICATION CHARA; Shea JM, 2006, CURR OPIN MICROBIOL, V9, P352, DOI 10.1016/j.mib.2006.06.003; Thevissen K, 1999, APPL ENVIRON MICROB, V65, P5451; Toledo MS, 2001, GLYCOBIOLOGY, V11, P105, DOI 10.1093/glycob/11.2.105; Warnecke D, 2003, CELL MOL LIFE SCI, V60, P919, DOI 10.1007/s00018-003-2243-4	33	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e15572	10.1371/journal.pone.0015572	http://dx.doi.org/10.1371/journal.pone.0015572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283686	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522300013
J	Tollner, T; Zehetleitner, M; Gramann, K; Muller, HJ				Toellner, Thomas; Zehetleitner, Michael; Gramann, Klaus; Mueller, Hermann J.			Stimulus Saliency Modulates Pre-Attentive Processing Speed in Human Visual Cortex	PLOS ONE			English	Article							LATERAL INTRAPARIETAL AREA; SINGLETON FEATURE TARGETS; NEURAL-CONTROL; SEARCH; PARIETAL; INTERFERENCE; DIMENSIONS; SELECTION; SHIFTS; DISCRIMINATION	The notion of a saliency-based processing architecture [1] underlying human vision is central to a number of current theories of visual selective attention [e.g., 2]. On this view, focal-attention is guided by an overall-saliency map of the scene, which integrates (sums) signals from pre-attentive sensory feature-contrast computations (e. g., for color, motion, etc.). By linking the Posterior Contralateral Negativity (PCN) component to reaction time (RT) performance, we tested one specific prediction of such salience summation models: expedited shifts of focal-attention to targets with low, as compared to high, target-distracter similarity. For two feature-dimensions (color and orientation), we observed decreasing RTs with increasing target saliency. Importantly, this pattern was systematically mirrored by the timing, as well as amplitude, of the PCN. This pattern demonstrates that visual saliency is a key determinant of the time it takes for focal-attention to be engaged onto the target item, even when it is just a feature singleton.	[Toellner, Thomas; Zehetleitner, Michael; Mueller, Hermann J.] Univ Munich, Dept Psychol, Munich, Germany; [Gramann, Klaus] Univ Calif San Diego, Swartz Ctr Computat Neurosci, Inst Neural Computat, La Jolla, CA 92093 USA; [Mueller, Hermann J.] Univ London, Birkbeck Coll, Dept Psychol Sci, London, England	University of Munich; University of California System; University of California San Diego; University of London; Birkbeck University London	Tollner, T (corresponding author), Univ Munich, Dept Psychol, Munich, Germany.	thomas.toellner@psy.lmu.de	Töllner, Thomas/E-4912-2012; Gramann, Klaus/AAD-7313-2019; Zehetleitner, Michael/AHE-2494-2022		German Research Foundation (DFG) [EC142]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by the German Research Foundation (DFG) grant EC142 (Excellence Cluster 'CoTeSys'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Beck DM, 2005, NAT NEUROSCI, V8, P1110, DOI 10.1038/nn1501; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Blaser E, 1999, P NATL ACAD SCI USA, V96, P11681, DOI 10.1073/pnas.96.20.11681; Brisson B, 2007, NEUROREPORT, V18, P1627, DOI 10.1097/WNR.0b013e3282f0b559; Chan LKH, 2009, J EXP PSYCHOL HUMAN, V35, P119, DOI 10.1037/0096-1523.35.1.119; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Edelman JA, 2003, J NEUROPHYSIOL, V90, P1728, DOI 10.1152/jn.00016.2003; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Eimer M, 2008, J COGNITIVE NEUROSCI, V20, P1423, DOI 10.1162/jocn.2008.20099; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Found A, 1996, PERCEPT PSYCHOPHYS, V58, P88, DOI 10.3758/BF03205479; Geyer T, 2010, J VISION, V10, DOI 10.1167/10.2.3; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hopf JM, 2006, J NEUROSCI, V26, P3532, DOI 10.1523/JNEUROSCI.4510-05.2006; Hopf JM, 2002, COGNITIVE BRAIN RES, V15, P17, DOI 10.1016/S0926-6410(02)00213-6; Ipata AE, 2006, NAT NEUROSCI, V9, P1071, DOI 10.1038/nn1734; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Krummenacher J, 2001, PERCEPT PSYCHOPHYS, V63, P901, DOI 10.3758/BF03194446; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; LABERGE D, 1990, J NEUROSCI, V10, P613; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Luck SJ, 2006, SCHIZOPHR RES, V85, P174, DOI 10.1016/j.schres.2006.03.040; Mevorach C, 2006, NAT NEUROSCI, V9, P740, DOI 10.1038/nn1709; MEVORACH C, J COGNITIVE IN PRESS; MORDKOFF JT, 1991, J EXP PSYCHOL HUMAN, V17, P520, DOI 10.1037/0096-1523.17.2.520; MULLER HJ, 1995, PERCEPT PSYCHOPHYS, V57, P1, DOI 10.3758/BF03211845; Muller HJ, 2003, J EXP PSYCHOL HUMAN, V29, P1021, DOI 10.1037/0096-1523.29.5.1021; NAGY AL, 1990, J OPT SOC AM A, V7, P1209, DOI 10.1364/JOSAA.7.001209; NOTHDURFT HC, 1990, EXP BRAIN RES, V82, P48; Nothdurft HC, 2000, VISION RES, V40, P3181, DOI 10.1016/S0042-6989(00)00168-1; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Roitman JD, 2002, J NEUROSCI, V22, P9475; Sato T, 2001, NEURON, V30, P583, DOI 10.1016/S0896-6273(01)00304-X; Sato TR, 2003, EXP BRAIN RES, V151, P356, DOI 10.1007/s00221-003-1461-1; Shedden JM, 2001, COGNITIVE BRAIN RES, V11, P59, DOI 10.1016/S0926-6410(00)00064-1; Tollner T, 2008, J EXP PSYCHOL HUMAN, V34, P531, DOI 10.1037/0096-1523.34.3.531; Tollner T, 2011, J COGNITIVE NEUROSCI, V23, P137, DOI 10.1162/jocn.2010.21422; Tollner T, 2010, VISION RES, V50, P1372, DOI 10.1016/j.visres.2009.11.009; Tollner T, 2009, J COGNITIVE NEUROSCI, V21, P1653, DOI 10.1162/jocn.2009.21108; TOLLNER T, 2010, DETECTING LOCA UNPUB; TOLLNER T, 2010, TOP DOWN DIMEN UNPUB; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; Treue S, 2003, CURR OPIN NEUROBIOL, V13, P428, DOI 10.1016/S0959-4388(03)00105-3; Ulrich R, 2001, PSYCHOPHYSIOLOGY, V38, P816, DOI 10.1017/S0048577201000610; Wolber M, 2005, J PSYCHOPHYSIOL, V19, P182, DOI 10.1027/0269-8803.19.3.182; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Wolfe JM, 1998, PSYCHOL SCI, V9, P33, DOI 10.1111/1467-9280.00006; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698; ZEHETLEITNER M, ATTENTION P IN PRESS; Zehetleitner M, 2010, J VISION, V10, DOI 10.1167/10.14.35; Zehetleitner M, 2009, ATTEN PERCEPT PSYCHO, V71, P1739, DOI 10.3758/APP.71.8.1739; Zehetleitner M, 2009, ATTEN PERCEPT PSYCHO, V71, P1760, DOI 10.3758/APP.71.8.1760; Zenon A, 2010, J COGNITIVE NEUROSCI, V22, P918, DOI 10.1162/jocn.2009.21233	63	81	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16276	10.1371/journal.pone.0016276	http://dx.doi.org/10.1371/journal.pone.0016276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710OY	21283699	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000286522300028
J	Ewens, KG; Jones, MR; Ankener, W; Stewart, DR; Urbanek, M; Dunaif, A; Legro, RS; Chua, A; Azziz, R; Spielman, RS; Goodarzi, MO; Strauss, JF				Ewens, Kathryn G.; Jones, Michelle R.; Ankener, Wendy; Stewart, Douglas R.; Urbanek, Margrit; Dunaif, Andrea; Legro, Richard S.; Chua, Angela; Azziz, Ricardo; Spielman, Richard S.; Goodarzi, Mark O.; Strauss, Jerome F., III			FTO and MC4R Gene Variants Are Associated with Obesity in Polycystic Ovary Syndrome	PLOS ONE			English	Article							DIABETES-MELLITUS; FAT MASS; PREVALENCE; LINKAGE; REGION; ADULT; RISK	Polycystic ovary syndrome (PCOS) is the leading cause of anovulatory infertility in women. It is also associated with metabolic disturbances that place women at increased risk for obesity and type 2 diabetes. There is strong evidence for familial clustering of PCOS and a genetic predisposition. However, the gene(s) responsible for the PCOS phenotypes have not been elucidated. This two-phase family-based and case-control genetic study was designed to address the question of whether SNPs identified as susceptibility loci for obesity in genome-wide association studies (GWAS) are also associated with PCOS and elevated BMI. Members of 439 families having at least one offspring with PCOS were genotyped for 15 SNPs previously shown to be associated with obesity. Linkage and association with PCOS was assessed using the transmission/disequilibrium test (TDT). These SNPs were also analyzed in an independent case-control study involving 395 women with PCOS and 176 healthy women with regular menstrual cycles. Only one of these 15 SNPs (rs2815752 in NEGR1) was found to have a nominally significant association with PCOS (chi(2) = 6.11, P = 0.013), but this association failed to replicate in the case-control study. While not associated with PCOS itself, five SNPs in FTO and two in MC4R were associated with BMI as assessed with a quantitative-TDT analysis, several of which replicated association with BMI in the case-control cohort. These findings demonstrate that certain SNPs associated with obesity contribute to elevated BMI in PCOS, but do not appear to play a major role in PCOS per se. These findings support the notion that PCOS phenotypes are a consequence of an oligogenic/polygenic mechanism.	[Ewens, Kathryn G.; Ankener, Wendy; Spielman, Richard S.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Stewart, Douglas R.] NCI, Div Canc Epidemiol & Genet, Clin Genet Branch, Rockville, MD USA; [Urbanek, Margrit; Dunaif, Andrea] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Legro, Richard S.] Penn State Hershey Coll Med, Dept Obstet & Gynecol, Hershey, PA USA; [Jones, Michelle R.; Chua, Angela; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Azziz, Ricardo] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Virginia Commonwealth University	Ewens, KG (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	mark.goodarzi@cshs.org; jfstrauss@vcu.edu	Azziz, Ricardo/N-7229-2014; Goodarzi, Mark/AAH-7106-2021	Azziz, Ricardo/0000-0002-3917-0483; Goodarzi, Mark/0000-0001-6364-5103; Legro, Richard/0000-0001-9927-7584; Urbanek, Margrit/0000-0001-6994-7110	National Institutes of Health (NIH) [U54HD034449]; Division of Intramural Research of the National Human Genome Research Institute; NCRR [M01-RR00425]; Winnick Clinical Scholars Award; Pennsylvania Department of Health [RSL- SAP 41-000-26343];  [P50 HD44405];  [U54 HD34449];  [RR10732];  [C06 RR016499];  [M01 RR00048];  [M01 RR10732];  [M01 RR02635];  [R01-HD29364];  [K24-HD01346];  [R01-DK79888]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD034449, R01HD056510, P50HD044405] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029364, K24HD001346] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010144] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425, M01RR010732, M01RR000048, M01RR002635, C06RR016499, UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079888] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Winnick Clinical Scholars Award; Pennsylvania Department of Health; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health (NIH) Grants U54HD034449 (to J.F.S. and R.S.S.); Division of Intramural Research of the National Human Genome Research Institute (D.R.S.); P50 HD44405 (A.D.); U54 HD34449 (to M.U. and A.D.); RR10732 and C06 RR016499 (to Pennsylvania State University General Clinical Research Center (GCRC)); M01 RR00048 (to Northwestern University GCRC); M01 RR10732 and M01 RR02635 (to Brigham and Women's Hospital GCRC); R01-HD29364 and K24-HD01346 (to RA); R01-DK79888 (to M.O.G.); and M01-RR00425 (General Clinical Research Center Grant from the NCRR); the Winnick Clinical Scholars Award (to M.O.G.); and an endowment from the Helping Hand of Los Angeles, Inc. This project is funded, in part, under a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds (RSL- SAP 41-000-26343). The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Barber TM, 2008, DIABETOLOGIA, V51, P1153, DOI 10.1007/s00125-008-1028-6; Barber TM, 2006, CLIN ENDOCRINOL, V65, P137, DOI 10.1111/j.1365-2265.2006.02587.x; Biyasheva A, 2009, J CLIN ENDOCR METAB, V94, P2617, DOI 10.1210/jc.2008-1664; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; EWENS KG, 2010, J CLIN ENDOCR METAB, P2306; Gunderson KL, 2006, METHOD ENZYMOL, V410, P359, DOI 10.1016/S0076-6879(06)10017-8; Gunderson KL, 2006, PHARMACOGENOMICS, V7, P641, DOI 10.2217/14622416.7.4.641; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hetherington MM, 2010, FORUM NUTR, V63, P195, DOI 10.1159/000264407; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Millington GWM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-18; Pasquali R., 1997, Human Reproduction (Oxford), V12, P82; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Simoni M, 2008, HUM REPROD UPDATE, V14, P459, DOI 10.1093/humupd/dmn024; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stewart DR, 2006, J CLIN ENDOCR METAB, V91, P4112, DOI 10.1210/jc.2006-0951; Tan S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-12; Urbanek M, 2005, J CLIN ENDOCR METAB, V90, P6623, DOI 10.1210/jc.2005-0622; Urbanek M, 2007, J CLIN ENDOCR METAB, V92, P4191, DOI 10.1210/jc.2007-0761; Urbanek M, 2007, NAT CLIN PRACT ENDOC, V3, P103, DOI 10.1038/ncpendmet0400; Wehr E, 2010, METABOLISM, V59, P575, DOI 10.1016/j.metabol.2009.08.023; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377	31	77	80	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16390	10.1371/journal.pone.0016390	http://dx.doi.org/10.1371/journal.pone.0016390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283731	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522200057
J	Chen, EYT; Garnica, M; Wang, YC; Chen, CS; Chin, WC				Chen, Eric Y. T.; Garnica, Maria; Wang, Yung-Chen; Chen, Chi-Shuo; Chin, Wei-Chun			Mucin Secretion Induced by Titanium Dioxide Nanoparticles	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; PROTEIN-KINASE-C; AIR-POLLUTION; OXIDATIVE STRESS; GENE-EXPRESSION; GOBLET CELLS; CA2+; CALCIUM; PARTICLES; ULTRAFINE	Nanoparticle (NP) exposure has been closely associated with the exacerbation and pathophysiology of many respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. Mucus hypersecretion and accumulation in the airway are major clinical manifestations commonly found in these diseases. Among a broad spectrum of NPs, titanium dioxide (TiO2), one of the PM10 components, is widely utilized in the nanoindustry for manufacturing and processing of various commercial products. Although TiO2 NPs have been shown to induce cellular nanotoxicity and emphysema-like symptoms, whether TiO2 NPs can directly induce mucus secretion from airway cells is currently unknown. Herein, we showed that TiO2 NPs (<75 nm) can directly stimulate mucin secretion from human bronchial ChaGo-K1 epithelial cells via a Ca2+ signaling mediated pathway. The amount of mucin secreted was quantified with enzyme-linked lectin assay (ELLA). The corresponding changes in cytosolic Ca2+ concentration were monitored with Rhod-2, a fluorescent Ca2+ dye. We found that TiO2 NP-evoked mucin secretion was a function of increasing intracellular Ca2+ concentration resulting from an extracellular Ca2+ influx via membrane Ca2+ channels and cytosolic ER Ca2+ release. The calcium-induced calcium release (CICR) mechanism played a major role in further amplifying the intracellular Ca2+ signal and in sustaining a cytosolic Ca2+ increase. This study provides a potential mechanistic link between airborne NPs and the pathoetiology of pulmonary diseases involving mucus hypersecretion.	[Chen, Eric Y. T.; Garnica, Maria; Wang, Yung-Chen; Chen, Chi-Shuo; Chin, Wei-Chun] Univ Calif Merced, Merced, CA 95344 USA	University of California System; University of California Merced	Chen, EYT (corresponding author), Univ Calif Merced, Merced, CA 95344 USA.	wchin2@ucmerced.edu	Chin, Wei-Chun/A-6068-2008	Chin, Wei-Chun/0000-0003-4881-9085	NIH [1R15HL095039]; NSF [CBET-0932404]; UC CITRIS Program; UC Merced Center of Excellence on Health Disparities, National Center on Minority Health and Health Disparities [1P20MD005049-01]; UC Merced; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD005049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL095039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); UC CITRIS Program; UC Merced Center of Excellence on Health Disparities, National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); UC Merced; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from NIH (1R15HL095039), NSF (CBET-0932404) and the UC CITRIS Program. CSC was supported by UC Merced Center of Excellence on Health Disparities (1P20MD005049-01 from the National Center on Minority Health and Health Disparities). EYTC was supported by GRC summer fellowship from UC Merced. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah LH, 1997, AM J PHYSIOL-LUNG C, V273, pL201, DOI 10.1152/ajplung.1997.273.1.L201; Ahn MH, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-34; Alfaro-Moreno E, 2007, CURR OPIN PULM MED, V13, P98, DOI 10.1097/MCP.0b013e328013f47e; Ashby MC, 2002, J CELL BIOL, V158, P283, DOI 10.1083/jcb.200112025; Atkinson RW, 2001, AM J RESP CRIT CARE, V164, P1860, DOI 10.1164/ajrccm.164.10.2010138; Barlow PG, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-11; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Boezen M, 1998, AM J RESP CRIT CARE, V158, P1848, DOI 10.1164/ajrccm.158.6.9804072; BOULTON CL, 1991, EUR J NEUROSCI, V3, P992, DOI 10.1111/j.1460-9568.1991.tb00035.x; Brown DM, 2007, TOXICOL LETT, V168, P1, DOI 10.1016/j.toxlet.2006.10.016; Brown DM, 2007, AM J PHYSIOL-LUNG C, V292, pL1444, DOI 10.1152/ajplung.00162.2006; Brown DM, 2004, AM J PHYSIOL-LUNG C, V286, pL344, DOI 10.1152/ajplung.00139.2003; Card JW, 2008, AM J PHYSIOL-LUNG C, V295, pL400, DOI 10.1152/ajplung.00041.2008; Chen E, 2008, J EXP NANOSCI, V3, P171, DOI 10.1080/17458080802412430; Chen EYT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015434; CHEN EY, 2010, AM J PHYSL LUNG CELL; Chen HW, 2006, FASEB J, V20, P2393, DOI 10.1096/fj.06-6485fje; Chou HT, 2010, PEPTIDES, V31, P1811, DOI 10.1016/j.peptides.2010.06.021; DAHIYA R, 1993, CANCER RES, V53, P1437; Donaldson K, 2003, FREE RADICAL BIO MED, V34, P1369, DOI 10.1016/S0891-5849(03)00150-3; EDWARDS DA, 1995, J CONTROL RELEASE, V34, P211, DOI 10.1016/0168-3659(94)00132-E; GARABRANT DH, 1987, SCAND J WORK ENV HEA, V13, P47, DOI 10.5271/sjweh.2087; Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007; Gwinn MR, 2006, ENVIRON HEALTH PERSP, V114, P1818, DOI 10.1289/ehp.8871; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Hyun JS, 2008, TOXICOL LETT, V182, P24, DOI 10.1016/j.toxlet.2008.08.003; Johnston HJ, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-33; Kawasaki S, 2001, AM J RESP CELL MOL, V24, P419, DOI 10.1165/ajrcmb.24.4.4085; Kelly CV, 2008, J PHYS CHEM B, V112, P9346, DOI 10.1021/jp8013783; Kemp PA, 2004, AM J RESP CELL MOL, V31, P446, DOI 10.1165/rcmb.2003-0211OC; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Mogami H, 2003, J BIOL CHEM, V278, P9896, DOI 10.1074/jbc.M210653200; Nguyen T, 2001, J PHYSIOL-LONDON, V531, P131, DOI 10.1111/j.1469-7793.2001.0131j.x; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; PETERSEN CCH, 1991, EMBO J, V10, P527, DOI 10.1002/j.1460-2075.1991.tb07979.x; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Rogers DF, 2007, RESP CARE, V52, P1134; Sayes CM, 2006, TOXICOL SCI, V92, P174, DOI 10.1093/toxsci/kfj197; Sethi S, 2004, CURR OPIN INFECT DIS, V17, P113, DOI 10.1097/00001432-200404000-00008; Solovyova N, 2002, EMBO J, V21, P622, DOI 10.1093/emboj/21.4.622; Stone V, 2000, EUR RESPIR J, V15, P297, DOI 10.1034/j.1399-3003.2000.15b13.x; Stone V, 2000, AM J RESP CRIT CARE, V162, pS44, DOI 10.1164/ajrccm.162.supplement_1.maic-12; Stone V, 2007, IEEE T NANOBIOSCI, V6, P331, DOI 10.1109/TNB.2007.909005; VERDUGO P, 1990, ANNU REV PHYSIOL, V52, P157, DOI 10.1146/annurev.ph.52.030190.001105; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Zhang AP, 2004, WORLD J GASTROENTERO, V10, P3191; Zhu HL, 2002, P NATL ACAD SCI USA, V99, P17055, DOI 10.1073/pnas.232588899	50	55	56	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16198	10.1371/journal.pone.0016198	http://dx.doi.org/10.1371/journal.pone.0016198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283816	Green Submitted, gold, Green Published			2022-12-25	WOS:000286520600028
J	Normand, JM; Giannopoulos, E; Spanlang, B; Slater, M				Normand, Jean-Marie; Giannopoulos, Elias; Spanlang, Bernhard; Slater, Mel			Multisensory Stimulation Can Induce an Illusion of Larger Belly Size in Immersive Virtual Reality	PLOS ONE			English	Article							RUBBER HAND ILLUSION; BODY; SUM; ONLINE; TOUCH; FEEL	Background: Body change illusions have been of great interest in recent years for the understanding of how the brain represents the body. Appropriate multisensory stimulation can induce an illusion of ownership over a rubber or virtual arm, simple types of out-of-the-body experiences, and even ownership with respect to an alternate whole body. Here we use immersive virtual reality to investigate whether the illusion of a dramatic increase in belly size can be induced in males through (a) first person perspective position (b) synchronous visual-motor correlation between real and virtual arm movements, and (c) self-induced synchronous visual-tactile stimulation in the stomach area. Methodology: Twenty two participants entered into a virtual reality (VR) delivered through a stereo head-tracked wide field-of-view head-mounted display. They saw from a first person perspective a virtual body substituting their own that had an inflated belly. For four minutes they repeatedly prodded their real belly with a rod that had a virtual counterpart that they saw in the VR. There was a synchronous condition where their prodding movements were synchronous with what they felt and saw and an asynchronous condition where this was not the case. The experiment was repeated twice for each participant in counter-balanced order. Responses were measured by questionnaire, and also a comparison of before and after self-estimates of belly size produced by direct visual manipulation of the virtual body seen from the first person perspective. Conclusions: The results show that first person perspective of a virtual body that substitutes for the own body in virtual reality, together with synchronous multisensory stimulation can temporarily produce changes in body representation towards the larger belly size. This was demonstrated by (a) questionnaire results, (b) the difference between the self-estimated belly size, judged from a first person perspective, after and before the experimental manipulation, and (c) significant positive correlations between these two measures. We discuss this result in the general context of body ownership illusions, and suggest applications including treatment for body size distortion illnesses.	[Normand, Jean-Marie; Giannopoulos, Elias; Spanlang, Bernhard; Slater, Mel] Univ Barcelona, Fac Psicol, EVENT Lab, Barcelona, Spain; [Slater, Mel] ICREA, Barcelona, Spain; [Slater, Mel] UCL, Dept Comp Sci, London, England	University of Barcelona; ICREA; University of London; University College London	Normand, JM (corresponding author), Univ Barcelona, Fac Psicol, EVENT Lab, Barcelona, Spain.	melslater@ub.edu	Slater, Mel/M-5210-2014	Slater, Mel/0000-0002-6223-0050; Spanlang, Bernhard/0000-0002-9659-635X; Normand, Jean-Marie/0000-0003-0557-4356	European Union; European Research Council; ICREA Funding Source: Custom	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	The work was funded under the European Union FET project IMMERSENCE cordis.europa.eu/ist/fet/pr-sy.htm. There was also funding from the European Research Council project TRAVERSE. The ERC web page is erc.europa.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Carruthers G, 2008, CONSCIOUS COGN, V17, P1321, DOI 10.1016/j.concog.2008.07.008; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2005, PLOS BIOL, V3, P2200, DOI 10.1371/journal.pbio.0030412; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Fox J, 2009, PRESENCE-TELEOP VIRT, V18, P294, DOI 10.1162/pres.18.4.294; Gillies M, 2010, PRESENCE-VIRTUAL AUG, V19, P95, DOI 10.1162/pres.19.2.95; Gonzalez-Franco M, 2010, P IEEE VIRT REAL ANN, P111, DOI 10.1109/VR.2010.5444805; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Holmes NP, 2006, PERCEPT PSYCHOPHYS, V68, P685, DOI 10.3758/BF03208768; Holmes NP, 2007, BEHAV BRAIN SCI, V30, P211, DOI 10.1017/S0140525X07001501; JARQUE CM, 1980, ECON LETT, V6, P255, DOI 10.1016/0165-1765(80)90024-5; KAMMERS M, EXPT BRAIN RES, V202, P203; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lenggenhager B, 2009, CONSCIOUS COGN, V18, P110, DOI 10.1016/j.concog.2008.11.003; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; NIELSEN TI, 1963, SCAND J PSYCHOL, V4, P225, DOI 10.1111/j.1467-9450.1963.tb01326.x; Perpina C, 2003, EUR EAT DISORD REV, V11, P261, DOI 10.1002/erv.520; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Slachevsky A, 2001, J COGNITIVE NEUROSCI, V13, P332, DOI 10.1162/08989290151137386; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Tecchia F, 2010, PRESENCE-VIRTUAL AUG, V19, P302, DOI 10.1162/PRES_a_00002; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2008, CONSCIOUS COGN, V17, P1317, DOI 10.1016/j.concog.2008.06.012; Yuan Y, 2010, P IEEE VIRT REAL ANN, P95, DOI 10.1109/VR.2010.5444807	34	145	146	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16128	10.1371/journal.pone.0016128	http://dx.doi.org/10.1371/journal.pone.0016128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710OH	21283823	Green Published, Green Submitted, gold			2022-12-25	WOS:000286520600024
J	Pollock, CB; Yin, YZ; Yuan, HY; Zeng, XA; King, S; Li, X; Kopelovich, L; Albanese, C; Glazer, RI				Pollock, Claire B.; Yin, Yuzhi; Yuan, Hongyan; Zeng, Xiao; King, Sruthi; Li, Xin; Kopelovich, Levy; Albanese, Chris; Glazer, Robert I.			PPAR delta Activation Acts Cooperatively with 3-Phosphoinositide-Dependent Protein Kinase-1 to Enhance Mammary Tumorigenesis	PLOS ONE			English	Article							HUMAN BREAST-CANCER; ATP CITRATE LYASE; RECEPTOR-DELTA; EPITHELIAL-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL CONTROL; SKELETAL-MUSCLE; GROWTH-FACTOR; PDK1; PHOSPHORYLATION	Peroxisome proliferator-activated receptor delta (PPAR delta) is a transcription factor that is associated with metabolic gene regulation and inflammation. It has been implicated in tumor promotion and in the regulation of 3-phosphoinositide-dependent kinase-1 (PDK1). PDK1 is a key regulator of the AGC protein kinase family, which includes the proto-oncogene AKT/PKB implicated in several malignancies, including breast cancer. To assess the role of PDK1 in mammary tumorigenesis and its interaction with PPAR delta, transgenic mice were generated in which PDK1 was expressed in mammary epithelium under the control of the MMTV enhancer/promoter region. Transgene expression increased pT308AKT and pS9GSK3 beta, but did not alter phosphorylation of mTOR, 4EBP1, ribosomal protein S6 and PKC alpha. The transgenic mammary gland also expressed higher levels of PPAR delta and a gene expression profile resembling wild-type mice maintained on a diet containing the PPAR delta agonist, GW501516. Both wild-type and transgenic mice treated with GW501516 exhibited accelerated rates of tumor formation that were more pronounced in transgenic animals. GW501516 treatment was accompanied by a distinct metabolic gene expression and metabolomic signature that was not present in untreated animals. GW501516-treated transgenic mice expressed higher levels of fatty acid and phospholipid metabolites than treated wild-type mice, suggesting the involvement of PDK1 in enhancing PPAR delta-driven energy metabolism. These results reveal that PPAR delta activation elicits a distinct metabolic and metabolomic profile in tumors that is in part related to PDK1 and AKT signaling.	[Pollock, Claire B.; Yin, Yuzhi; Yuan, Hongyan; Zeng, Xiao; Albanese, Chris; Glazer, Robert I.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Pollock, Claire B.; Yin, Yuzhi; Yuan, Hongyan; Zeng, Xiao; Albanese, Chris; Glazer, Robert I.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [King, Sruthi] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA; [Li, Xin] Georgetown Univ, Med Ctr, Dept Biostat Bioinformat & Biomath, Washington, DC 20007 USA; [Kopelovich, Levy] NCI, Chemoprevent Agent Dev & Res Grp, Canc Prevent Div, Bethesda, MD 20892 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pollock, CB (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA.	glazerr@georgetown.edu			National Institutes of Health, Bethesda, MD [R01 CA111482, N01 CN43309]; National Cancer Institute [1P30-CA-51008]; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA111482] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R01 CA111482 and contract N01 CN43309 from the National Institutes of Health, Bethesda, MD. This investigation was conducted using the Animal Research, Histopathology and Tissue, Genomics and Epigenomics, Preclinical Imaging, and Proteomics and Metabolomics Shared Resources supported in part by Cancer Center Support Grant 1P30-CA-51008 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot EL, 2005, FEBS J, V272, P3004, DOI 10.1111/j.1742-4658.2005.04713.x; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bayascas JR, 2005, CURR BIOL, V15, P1839, DOI 10.1016/j.cub.2005.08.066; Behbod F, 2006, STEM CELLS, V24, P1065, DOI 10.1634/stemcells.2005-0375; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Genini D, 2007, J BIOL CHEM, V282, P11776, DOI 10.1074/jbc.M609149200; Ghosh M, 2009, PROSTAG OTH LIPID M, V88, P97, DOI 10.1016/j.prostaglandins.2008.11.004; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Glazer RI, 2008, PPAR RES, V2008, DOI 10.1155/2008/247379; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; Han SW, 2009, AM J RESP CELL MOL, V40, P325, DOI 10.1165/rcmb.2008-0197OC; Harman FS, 2004, NAT MED, V10, P481, DOI 10.1038/nm1026; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Jaeckel EC, 2001, ARCH OTOLARYNGOL, V127, P1253, DOI 10.1001/archotol.127.10.1253; Kikani CK, 2005, J CELL BIOCHEM, V96, P1157, DOI 10.1002/jcb.20651; Knutsen HK, 2005, ANTICANCER RES, V25, P3781; Koeffler HP, 2003, CLIN CANCER RES, V9, P1; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Li YP, 2008, BIOCHEM BIOPH RES CO, V369, P1034, DOI 10.1016/j.bbrc.2008.02.147; Liang K, 2006, MOL PHARMACOL, V70, P1045, DOI 10.1124/mol.106.023333; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Liu Y, 2009, MOL CANCER RES, V7, P944, DOI 10.1158/1541-7786.MCR-08-0368; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Patterson AD, 2008, ANAL CHEM, V80, P665, DOI 10.1021/ac701807v; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; PEDCHENKO TV, 2008, AM J RESP CELL MOL B; POLLOCK CB, 2010, PPAR RES IN PRESS; Riojas RA, 2006, J BIOL CHEM, V281, P21588, DOI 10.1074/jbc.M600393200; Sato S, 2004, J BIOL CHEM, V279, P33759, DOI 10.1074/jbc.M402055200; SCHMIDT M, 2009, J CANC RES CLIN ONCO; Sedlakova I, 2008, EUR J GYNAECOL ONCOL, V29, P511; Shao JY, 2002, CANCER RES, V62, P3282; Stephen RL, 2004, CANCER RES, V64, P3162, DOI 10.1158/0008-5472.CAN-03-2760; Suchanek KM, 2002, INT J BIOCHEM CELL B, V34, P1051, DOI 10.1016/S1357-2725(02)00025-0; Tian XJ, 2002, EMBO J, V21, P1327, DOI 10.1093/emboj/21.6.1327; Tong BJ, 2000, NEOPLASIA, V2, P483, DOI 10.1038/sj.neo.7900119; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Xie ZH, 2003, CANCER RES, V63, P5370; Xie ZH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-77; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200; Yin Y, 2005, MOL CARCINOGEN, V44, P42, DOI 10.1002/mc.20119; Yin YZ, 2009, CANCER RES, V69, P687, DOI 10.1158/0008-5472.CAN-08-2446; Yin YZ, 2006, MOL ENDOCRINOL, V20, P268, DOI 10.1210/me.2005-0197; Yin YZ, 2005, CANCER RES, V65, P3950, DOI 10.1158/0008-5472.CAN-04-3990; Zeng X, 2002, CANCER RES, V62, P3538	61	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16215	10.1371/journal.pone.0016215	http://dx.doi.org/10.1371/journal.pone.0016215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21297860	gold, Green Published, Green Submitted			2022-12-25	WOS:000286515000033
J	Sotillo, E; Laver, T; Mellert, H; Schelter, JM; Cleary, MA; McMahon, S; Thomas-Tikhonenko, A				Sotillo, E.; Laver, T.; Mellert, H.; Schelter, J. M.; Cleary, M. A.; McMahon, S.; Thomas-Tikhonenko, A.			Myc overexpression brings out unexpected antiapoptotic effects of miR-34a	ONCOGENE			English	Article						microRNA; Myc; p53	B-CELL LINE; TUMOR-SUPPRESSOR; DOWN-REGULATION; C-MYC; P53; MICRORNAS; ACTIVATION; REPRESSION; EXPRESSION; APOPTOSIS	Downregulation of microRNA-34a by Myc is known to be essential for tumorigenesis and improve tumor-cell survival. Conversely, upregulation of miR-34a by p53 is thought to enhance its acetylation and activity and contribute to the pro-apoptotic effects of this tumor suppressor. We sought to determine whether restoration of miR-34a levels in B-lymphoid cells with Myc overexpression would aid therapeutic apoptosis. Unexpectedly, delivery of miR-34a, which doesn't target p53 directly, severely compromised steady-state p53 levels. This effect was preceded and mediated by direct targeting of Myc, which sustained p53 protein levels via the Arf-Hdm2 pathway. As a result, in the presence of Myc, miR-34a inhibited p53-dependent bortezomib-induced apoptosis as efficiently as anti-p53 small interfering RNA. Conversely, inhibition of miR-34a using antisense RNA sensitized lymphoma cells to therapeutic apoptosis. Thus, in tumors with deregulated Myc expression, miR-34a confers drug resistance and could be considered a therapeutic target. Oncogene (2011) 30, 2587-2594; doi:10.1038/onc.2010.634; published online 7 February 2011	[Sotillo, E.; Thomas-Tikhonenko, A.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Canc Pathobiol, Philadelphia, PA 19104 USA; [Laver, T.; Thomas-Tikhonenko, A.] Univ Penn, NIH Merck Summer Program, Philadelphia, PA 19104 USA; [Mellert, H.; McMahon, S.; Thomas-Tikhonenko, A.] Univ Penn, Canc Biol CAMB Grad Program, Philadelphia, PA 19104 USA; [Schelter, J. M.; Cleary, M. A.] Rosetta Inpharmat, Seattle, WA USA; [McMahon, S.] Thomas Jefferson Med Coll, Dept Canc Biol, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Merck & Company; Jefferson University	Thomas-Tikhonenko, A (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Canc Pathobiol, 4056 Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	andreit@mail.med.upenn.edu	laver, travis/AAA-2025-2020; Thomas-Tikhonenko, Andrei/E-5329-2011	Thomas-Tikhonenko, Andrei/0000-0002-2739-2206; Sotillo, Elena/0000-0002-3993-1932; McMahon, Steven/0000-0002-3405-1768	US National Institutes of Health [CA 122334]; Children's Hospital of Philadelphia; NIH [R01CA098172-07, R21CA152786-01, R01CA090465-08]; NATIONAL CANCER INSTITUTE [R21CA152786, R01CA098172, R01CA122334, R01CA090465] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Philadelphia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Joshua Mendell and Tsung-Cheng Chang (Johns Hopkins University) for sharing unpublished data on miR-34a function in B-cells. Current and past members of our laboratories (in particular Drs Duonan Yu, James Psathas, Michael Dews and Elaine Chung) are acknowledged for many stimulating discussions. We are grateful to the Rosetta Gene Expression Laboratory for performing microarray hybridization experiments and Miho Kibukawa (Merck & Co., Inc.)-for technical support. We thank Dr Dirk Eick (GSF Research Centre, Munich) for P493-6 cells, Dr Carlo Croce (Ohio State University, Columbus) for GM607 cells and Dr Joelle Wiels (Institut Gustave Roussy, Villejuif, France) for Ly47cells. This work was supported by US National Institutes of Health grant CA 122334 to ATT and the Institutional Development Fund of the Children's Hospital of Philadelphia (ATT), as well as NIH grants R01CA098172-07, R21CA152786-01 and R01CA090465-08 to SBM.	Adachi N, 2006, DNA CELL BIOL, V25, P19, DOI 10.1089/dna.2006.25.19; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BHATIA KG, 1992, CANCER RES, V52, P4273; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2007, J CLIN INVEST, V117, P2059, DOI 10.1172/JCI32577; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; Dalgard CL, 2009, INVEST OPHTH VIS SCI, V50, P4542, DOI 10.1167/iovs.09-3520; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Kong YW, 2008, P NATL ACAD SCI USA, V105, P8866, DOI 10.1073/pnas.0800650105; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Lindstrom MS, 2002, SEMIN CANCER BIOL, V12, P381, DOI 10.1016/S1044-579X(02)00058-5; Lindstrom MS, 2001, ONCOGENE, V20, P2171, DOI 10.1038/sj.onc.1204303; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Luan SH, 2010, ARCH MED RES, V41, P67, DOI 10.1016/j.arcmed.2010.02.007; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Navarro F, 2009, BLOOD, V114, P2181, DOI 10.1182/blood-2009-02-205062; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sala A, 2009, ADV CANCER RES, V105, P115, DOI 10.1016/S0065-230X(09)05007-6; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yu DN, 2005, CANCER RES, V65, P5454, DOI 10.1158/0008-5472.CAN-04-4197; Yu DN, 2002, ONCOGENE, V21, P1922, DOI 10.1038/sj.onc.1205244; Yu DN, 2007, BLOOD, V109, P4936, DOI 10.1182/blood-2006-10-050294	58	66	68	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	22					2587	2594		10.1038/onc.2010.634	http://dx.doi.org/10.1038/onc.2010.634			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	771ZE	21297663	Green Accepted			2022-12-25	WOS:000291198400010
J	Calmettes, C; Yu, RH; Silva, LP; Curran, D; Schriemer, DC; Schryvers, AB; Moraes, TF				Calmettes, Charles; Yu, Rong-hua; Silva, Leslie P.; Curran, Dave; Schriemer, David C.; Schryvers, Anthony B.; Moraes, Trevor F.			Structural Variations within the Transferrin Binding Site on Transferrin-binding Protein B, TbpB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTINOBACILLUS-PLEUROPNEUMONIAE; IRON ACQUISITION; BACTERICIDAL ANTIBODIES; NEISSERIA-MENINGITIDIS; PATHOGENIC BACTERIA; RECEPTOR; IDENTIFICATION; INFECTION; COMPLEX; ANTIGEN	Pathogenic bacteria acquire the essential element iron through specialized uptake pathways that are necessary in the iron-limiting environments of the host. Members of the Gram-negative Neisseriaceae and Pasteurellaceae families have adapted to acquire iron from the host iron binding glycoprotein, transferrin (Tf), through a receptor complex comprised of transferring-binding protein (Tbp) A and B. Because of the critical role they play in the host, these surface-exposed proteins are invariably present in clinical isolates and thus are considered prime vaccine targets. The specific interactions between TbpB and Tf are essential and ultimately might be exploited to create a broad-spectrum vaccine. In this study, we report the structure of TbpBs from two porcine pathogens, Actinobacillus pleuropneumoniae and suis. Paradoxically, despite a common Tf target, these swine related TbpBs show substantial sequence variation in their Tf-binding site. The TbpB structures, supported by docking simulations, surface plasmon resonance and hydrogen/deuterium exchange experiments with wild-type and mutant TbpBs, explain why there are structurally conserved elements within TbpB homologs despite major sequence variation that are required for binding Tf.	[Yu, Rong-hua; Curran, Dave; Schryvers, Anthony B.] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada; [Calmettes, Charles; Moraes, Trevor F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Silva, Leslie P.; Schriemer, David C.; Schryvers, Anthony B.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Toronto; University of Calgary	Schryvers, AB (corresponding author), Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada.	schryver@ucalgary.ca; trevor.moraes@utoronto.ca	Schryvers, Anthony B./AAF-3417-2020	calmettes, charles/0000-0002-2542-4382	Canadian Foundation for Innovation (CFI); Alberta Heritage Foundation for Medical Research (AHFMR); Canadian Institutes of Health Research (CIHR)	Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was funded with operating and infrastructure support provided by Canadian Foundation for Innovation (CFI), Alberta Heritage Foundation for Medical Research (AHFMR), and Canadian Institutes of Health Research (CIHR).	Bahrami F, 2003, VET MICROBIOL, V94, P79, DOI 10.1016/S0378-1135(03)00082-8; Baltes N, 2002, FEMS MICROBIOL LETT, V209, P283, DOI 10.1111/j.1574-6968.2002.tb11145.x; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; CORNELISSEN CN, 1992, J BACTERIOL, V174, P5788, DOI 10.1128/jb.174.18.5788-5797.1992; Cornelissen CN, 1998, MOL MICROBIOL, V27, P611, DOI 10.1046/j.1365-2958.1998.00710.x; DANVE B, 1993, VACCINE, V11, P1214, DOI 10.1016/0264-410X(93)90045-Y; del Rio ML, 2005, FEMS IMMUNOL MED MIC, V45, P75, DOI 10.1016/j.femsim.2005.02.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GONZALEZ GC, 1990, MOL MICROBIOL, V4, P1173, DOI 10.1111/j.1365-2958.1990.tb00692.x; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; GRAYOWEN SD, 1993, MICROB PATHOGENESIS, V14, P389, DOI 10.1006/mpat.1993.1038; GrayOwen SD, 1996, TRENDS MICROBIOL, V4, P185, DOI 10.1016/0966-842X(96)10025-1; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan J, 2002, CELL, V111, P603, DOI 10.1016/S0092-8674(02)01164-9; Ling JML, 2010, MOL MICROBIOL, V77, P1301, DOI 10.1111/j.1365-2958.2010.07289.x; LISSOLO L, 1995, INFECT IMMUN, V63, P884, DOI 10.1128/IAI.63.3.884-890.1995; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moraes TF, 2009, MOL CELL, V35, P523, DOI 10.1016/j.molcel.2009.06.029; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers LE, 1998, INFECT IMMUN, V66, P4183; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Potter AA, 1999, MICROB PATHOGENESIS, V27, P197, DOI 10.1006/mpat.1999.0297; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Retzer MD, 1998, MICROB PATHOGENESIS, V25, P175, DOI 10.1006/mpat.1998.0226; ROSSICAMPOS A, 1992, VACCINE, V10, P512, DOI 10.1016/0264-410X(92)90349-O; SCHRYVERS AB, 1990, CAN J MICROBIOL, V36, P145, DOI 10.1139/m90-026; Slysz GW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-162; YU RH, 1993, MICROB PATHOGENESIS, V15, P433, DOI 10.1006/mpat.1993.1092; ZAK O, 1986, BLOOD, V68, P157	29	37	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.206102	http://dx.doi.org/10.1074/jbc.M110.206102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21297163	Green Published, hybrid			2022-12-25	WOS:000289077500079
J	Huang, KF; Liaw, SS; Huang, WL; Chia, CY; Lo, YC; Chen, YL; Wang, AHJ				Huang, Kai-Fa; Liaw, Su-Sen; Huang, Wei-Lin; Chia, Cho-Yun; Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H. -J.			Structures of Human Golgi-resident Glutaminyl Cyclase and Its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURE REFINEMENT; ALZHEIMERS-DISEASE; PYROGLUTAMIC ACID; GENE-EXPRESSION; A-BETA; PROTEIN; BOND; AMINOPEPTIDASE; PITUITARY	Aberrant pyroglutamate formation at the N terminus of certain peptides and proteins, catalyzed by glutaminyl cyclases (QCs), is linked to some pathological conditions, such as Alzheimer disease. Recently, a glutaminyl cyclase (QC) inhibitor, PBD150, was shown to be able to reduce the deposition of pyroglutamate-modified amyloid-beta peptides in brain of transgenic mouse models of Alzheimer disease, leading to a significant improvement of learning and memory in those transgenic animals. Here, we report the 1.05-1.40 angstrom resolution structures, solved by the sulfur single-wavelength anomalous dispersion phasing method, of the Golgi-luminal catalytic domain of the recently identified Golgi-resident QC (gQC) and its complex with PBD150. We also describe the high-resolution structures of secretory QC (sQC)-PBD150 complex and two other gQC-inhibitor complexes. gQC structure has a scaffold similar to that of sQC but with a relatively wider and negatively charged active site, suggesting a distinct substrate specificity from sQC. Upon binding to PBD150, a large loop movement in gQC allows the inhibitor to be tightly held in its active site primarily by hydrophobic interactions. Further comparisons of the inhibitor-bound structures revealed distinct interactions of the inhibitors with gQC and sQC, which are consistent with the results from our inhibitor assays reported here. Because gQC and sQC may play different biological roles in vivo, the different inhibitor binding modes allow the design of specific inhibitors toward gQC and sQC.	[Huang, Kai-Fa; Liaw, Su-Sen; Huang, Wei-Lin; Chia, Cho-Yun; Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Huang, Kai-Fa; Liaw, Su-Sen; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Prod & Xray Struct Anal, Taipei 11529, Taiwan; [Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H. -J.] Natl Yang Ming Univ, Dept Pharmacol, Taipei 11221, Taiwan; [Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H. -J.] Natl Yang Ming Univ, Inst Pharmacol, Taipei 11221, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.	ahjwang@gate.sinica.edu.tw			Academia Sinica; National Research Program for Genomic Medicine [NSC97-3112-B-001-035-B4]	Academia Sinica(Academia Sinica - Taiwan); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan)	This work was supported by the Academia Sinica and Core Facility for Protein Production and X-Ray Structural Analysis of the National Research Program for Genomic Medicine (Grant NSC97-3112-B-001-035-B4 to A. H.-J.W.).	Batliwalla FM, 2005, GENES IMMUN, V6, P388, DOI 10.1038/sj.gene.6364209; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchholz M, 2006, J MED CHEM, V49, P664, DOI 10.1021/jm050756e; Buchholz M, 2009, J MED CHEM, V52, P7069, DOI 10.1021/jm900969p; BUSBY WH, 1987, J BIOL CHEM, V262, P8532; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Cynis H, 2008, BIOCHEMISTRY-US, V47, P7405, DOI 10.1021/bi800250p; Cynis H, 2008, J MOL BIOL, V379, P966, DOI 10.1016/j.jmb.2008.03.078; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Ezura Y, 2004, J BONE MINER RES, V19, P1296, DOI 10.1359/JBMR.040324; Gillis JS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-27; GOREN HJ, 1977, MOL PHARMACOL, V13, P606; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; Guevara T, 2006, BIOL CHEM, V387, P1479, DOI 10.1515/BC.2006.185; Hook V, 2008, BIOL CHEM, V389, P993, DOI 10.1515/BC.2008.124; Huang KF, 2008, BIOCHEM J, V411, P181, DOI 10.1042/BJ20071073; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Huang KF, 2005, PROTEIN EXPRES PURIF, V43, P65, DOI 10.1016/j.pep.2005.02.020; Huang WL, 2010, J MOL BIOL, V401, P374, DOI 10.1016/j.jmb.2010.06.012; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Schilling S, 2003, BIOL CHEM, V384, P1583, DOI 10.1515/BC.2003.175; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2007, BIOCHEMISTRY-US, V46, P10921, DOI 10.1021/bi701043x; Schilling S, 2007, BIOL CHEM, V388, P145, DOI 10.1515/BC.2007.016; Schilling S, 2008, J NEUROCHEM, V106, P1225, DOI 10.1111/j.1471-4159.2008.05471.x; Segel I. H., 1993, ENZYME KINETICS BEHA, P100; Seifert F, 2009, BIOCHEMISTRY-US, V48, P11831, DOI 10.1021/bi9018835; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stephan A, 2009, FEBS J, V276, P6522, DOI 10.1111/j.1742-4658.2009.07337.x; Sykes PA, 1999, FEBS LETT, V455, P159, DOI 10.1016/S0014-5793(99)00872-8; Thouennon E, 2007, J CLIN ENDOCR METAB, V92, P4865, DOI 10.1210/jc.2007-1253; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valdes-Martinez J, 2004, J CHEM CRYSTALLOGR, V34, P533, DOI 10.1023/B:JOCC.0000042022.16392.99; Van Coillie E, 1998, BIOCHEMISTRY-US, V37, P12672, DOI 10.1021/bi980497d; Wintjens R, 2006, J MOL BIOL, V357, P457, DOI 10.1016/j.jmb.2005.12.029	46	39	42	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.208595	http://dx.doi.org/10.1074/jbc.M110.208595			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21288892	Green Published, hybrid			2022-12-25	WOS:000289077500058
J	Ramachandran, S; Cerione, RA				Ramachandran, Sekar; Cerione, Richard A.			A Dominant-negative G alpha Mutant That Traps a Stable Rhodopsin-G alpha-GTP-beta gamma Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-BINDING; HETEROTRIMERIC G-PROTEIN; ROD OUTER SEGMENTS; TRANSDUCIN-ALPHA; CRYSTAL-STRUCTURE; SUBUNIT COMPLEX; COUPLED RECEPTORS; STRUCTURAL BASIS; ACTIVATION; MECHANISM	Residues comprising the guanine nucleotide-binding sites of the alpha subunits of heterotrimeric (large) G-proteins (G alpha subunits), as well as the Ras-related (small) G-proteins, are highly conserved. This is especially the case for the phosphate-binding loop (P-loop) where both G alpha subunits and Ras-related G-proteins have a conserved serine or threonine residue. Substitutions for this residue in Ras and related (small) G-proteins yield nucleotide-depleted, dominant-negative mutants. Here we have examined the consequences of changing the conserved serine residue in the P-loop to asparagine, within a chimeric G alpha subunit (designated alpha(T)*) that is mainly comprised of the alpha subunit of the retinal G-protein transducin and a limited region from the alpha subunit of Gi1. The alpha(T)*(S43N) mutant exhibits a significantly higher rate of intrinsic GDP-GTP exchange compared with wild-type alpha(T)*, with light-activated rhodopsin (R*) causing only a moderate increase in the kinetics of nucleotide exchange on alpha(T)*(S43N). The alpha(T)*(S43N) mutant, when bound to either GDP or GTP, was able to significantly slow the rate of R*-catalyzed GDP-GTP exchange on wild-type alpha(T)*. Thus, GTP-bound alpha(T)*(S43N), as well as the GDP-bound mutant, is capable of forming a stable complex with R*. alpha(T)*(S43N) activated the cGMP phosphodiesterase (PDE) with a dose-response similar to wild-type alpha(T)*. Activation of the PDE by alpha(T)*(S43N) was unaffected if either R* or beta 1 gamma 1 alone was present, whereas it was inhibited when R* and the beta 1 gamma 1 subunit were added together. Overall, our studies suggest that the S43N substitution on alpha(T)* stabilizes an intermediate on the G-protein activation pathway consisting of an activated G-protein-coupled receptor, a GTP-bound G alpha subunit, and the beta 1 gamma 1 complex.	[Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Ramachandran, Sekar/AAP-2287-2020	Ramachandran, Sekar/0000-0002-2243-1368	National Institutes of Health [GM047458]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM047458.	ABOOD ME, 1982, J BIOL CHEM, V257, P540; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Berlot CH, 2002, J BIOL CHEM, V277, P21080, DOI 10.1074/jbc.M201330200; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chen CK, 2005, REV PHYSIOL BIOCH P, V154, P101, DOI 10.1007/s10254-005-0004-5; Cleator JH, 1999, FEBS LETT, V443, P205, DOI 10.1016/S0014-5793(98)01704-9; Cleator JH, 2004, J BIOL CHEM, V279, P36601, DOI 10.1074/jbc.M406232200; FAWZI AB, 1990, BIOCHEMISTRY-US, V29, P3804, DOI 10.1021/bi00467a030; FAWZI AB, 1991, J BIOL CHEM, V266, P12194; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; FUNG BKK, 1983, J BIOL CHEM, V258, P495; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; Iiri T, 1999, P NATL ACAD SCI USA, V96, P499, DOI 10.1073/pnas.96.2.499; Jian XY, 2001, J BIOL CHEM, V276, P48518, DOI 10.1074/jbc.M107129200; JOHN J, 1993, J BIOL CHEM, V268, P923; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; KROLL S, 1989, J BIOL CHEM, V264, P4490; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li QB, 1997, J BIOL CHEM, V272, P21673, DOI 10.1074/jbc.272.35.21673; LIEBMAN PA, 1982, METHOD ENZYMOL, V81, P532; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; Majumdar S, 2004, J BIOL CHEM, V279, P40137, DOI 10.1074/jbc.M405420200; Min KC, 2000, PROTEIN EXPRES PURIF, V20, P514, DOI 10.1006/prep.2000.1326; Mittal R, 1996, SCIENCE, V271, P1413, DOI 10.1126/science.271.5254.1413; Natochin M, 1999, J BIOL CHEM, V274, P7865, DOI 10.1074/jbc.274.12.7865; Natochin M, 2006, BIOCHEMISTRY-US, V45, P6488, DOI 10.1021/bi060381e; NAVON SE, 1984, J BIOL CHEM, V259, P6686; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2007, ADV PROTEIN CHEM, V74, P67, DOI 10.1016/S0065-3233(07)74002-0; Pereira R, 2005, J BIOL CHEM, V280, P35696, DOI 10.1074/jbc.M504935200; PHILLIPS WJ, 1988, J BIOL CHEM, V263, P15498; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17040; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17032; Skiba NP, 2000, METHOD ENZYMOL, V315, P502; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; SLEPAK VZ, 1993, J BIOL CHEM, V268, P21889; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; WILDMAN DE, 1993, P NATL ACAD SCI USA, V90, P794, DOI 10.1073/pnas.90.3.794; Zelent B, 2001, BIOCHEMISTRY-US, V40, P9647, DOI 10.1021/bi010272u	45	11	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.166538	http://dx.doi.org/10.1074/jbc.M110.166538			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21285355	Green Published, hybrid			2022-12-25	WOS:000289077500081
J	Mahmud, SM; Franco, EL; Turner, D; Platt, RW; Beck, P; Skarsgard, D; Tonita, J; Sharpe, C; Aprikian, AG				Mahmud, Salaheddin M.; Franco, Eduardo L.; Turner, Donna; Platt, Robert W.; Beck, Patricia; Skarsgard, David; Tonita, Jon; Sharpe, Colin; Aprikian, Armen G.			Use of Non-Steroidal Anti-Inflammatory Drugs and Prostate Cancer Risk: A Population-Based Nested Case-Control Study	PLOS ONE			English	Article							ASPIRIN USE; BREAST-CANCER; CYCLOOXYGENASE-2; SASKATCHEWAN; PREVENTION; COHORT; INHIBITION; AGENTS	Background: Despite strong laboratory evidence that non-steroidal anti-inflammatory drugs (NSAIDs) could prevent prostate cancer, epidemiological studies have so far reported conflicting results. Most studies were limited by lack of information on dosage and duration of use of the different classes of NSAIDs. Methods: We conducted a nested case-control study using data from Saskatchewan Prescription Drug Plan (SPDP) and Cancer Registry to examine the effects of dose and duration of use of five classes of NSAIDs on prostate cancer risk. Cases (N = 9,007) were men aged >= 40 years diagnosed with prostatic carcinoma between 1985 and 2000, and were matched to four controls on age and duration of SPDP membership. Detailed histories of exposure to prescription NSAIDs and other drugs were obtained from the SPDP. Results: Any use of propionates (e. g., ibuprofen, naproxen) was associated with a modest reduction in prostate cancer risk (Odds ratio = 0.90; 95% CI 0.84-0.95), whereas use of other NSAIDs was not. In particular, we did not observe the hypothesized inverse association with aspirin use (1.01; 0.95-1.07). There was no clear evidence of dose-response or duration-response relationships for any of the examined NSAID classes. Conclusions: Our findings suggest modest benefits of at least some NSAIDs in reducing prostate cancer risk.	[Mahmud, Salaheddin M.; Franco, Eduardo L.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Mahmud, Salaheddin M.; Aprikian, Armen G.] McGill Univ, Dept Urol Surg, Montreal, PQ, Canada; [Mahmud, Salaheddin M.; Turner, Donna] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Franco, Eduardo L.; Platt, Robert W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Beck, Patricia] Saskatchewan Minist Hlth, Populat Hlth Branch, Regina, SK, Canada; [Skarsgard, David] Univ Calgary, Div Radiat Oncol, Calgary, AB, Canada; [Skarsgard, David] Tom Baker Canc Clin, Calgary, AB, Canada; [Tonita, Jon] Saskatchewan Canc Agcy, Populat Hlth Div, Regina, SK, Canada	McGill University; McGill University; University of Manitoba; McGill University; University of Calgary; Tom Baker Cancer Clinic; University of Calgary	Mahmud, SM (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ, Canada.	Salah.mahmud@gmail.com	; Franco, Eduardo/C-6445-2014	Platt, Robert/0000-0002-5981-8443; Franco, Eduardo/0000-0002-4409-8084; Mahmud, Salaheddin/0000-0002-6574-0574	United States Department of Defense [W81XWH-04-1-0175]; CancerCare Manitoba Foundation; FRSQ	United States Department of Defense(United States Department of Defense); CancerCare Manitoba Foundation; FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by the United States Department of Defense Prostate Cancer Research Program [W81XWH-04-1-0175]. SMM is the recipient of the Mona and Allen Copp Award from the CancerCare Manitoba Foundation. RWP is a chercheur-boursier of the Fonds de Recherche en Sante du Quebec (FRSQ) and is a member of the Research Institute of the McGill University Health Centre, which is supported in part by the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosetti C, 2006, EUR J CANCER PREV, V15, P43, DOI 10.1097/01.cej.0000180665.04335.de; CHAUDRY AA, 1994, INT J CANCER, V57, P176, DOI 10.1002/ijc.2910570208; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; Downey W, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P295; Frolich JC, 1997, TRENDS PHARMACOL SCI, V18, P30, DOI 10.1016/S0165-6147(96)01017-6; Godley PA, 1999, J CLIN EPIDEMIOL, V52, P129, DOI 10.1016/S0895-4356(98)00152-8; Greenland S, 2005, J R STAT SOC A STAT, V168, P267, DOI 10.1111/j.1467-985X.2004.00349.x; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G; Habel LA, 2002, CANCER CAUSE CONTROL, V13, P427, DOI 10.1023/A:1015788502099; Harris RE, 2005, ONCOL REP, V13, P559; Hsu AL, 2000, J BIOL CHEM, V275, P11397, DOI 10.1074/jbc.275.15.11397; Irani J, 2002, J UROLOGY, V168, P1985, DOI 10.1016/S0022-5347(05)64277-2; Jacobs EJ, 2007, JNCI-J NATL CANCER I, V99, P608, DOI 10.1093/jnci/djk132; Jafari S, 2009, CUAJ-CAN UROL ASSOC, V3, P323; Khuder SA, 2001, BRIT J CANCER, V84, P1188, DOI 10.1054/bjoc.2000.1709; Kirschenbaum A, 2001, UROLOGY, V58, P127, DOI 10.1016/S0090-4295(01)01255-9; Leitzmann MF, 2002, CANCER EPIDEM BIOMAR, V11, P1108; Lipworth Loren, 2004, Am J Ther, V11, P156, DOI 10.1097/00045391-200405000-00002; Lix L, 2006, DEFINING VALIDATING; MACLURE M, 1992, AM J EPIDEMIOL, V135, P96; Mahmud S, 2004, BRIT J CANCER, V90, P93, DOI 10.1038/sj.bjc.6601416; Mahmud SM, 2010, INT J CANCER, V127, P1680, DOI 10.1002/ijc.25186; Mahmud SM, 2006, EUR J CANCER PREV, V15, P158, DOI 10.1097/01.cej.0000197451.02604.25; Mahmud SM, 2007, INT J CANC PREV, V3, P39; Narayanan BA, 2006, MOL CANCER THER, V5, P1117, DOI 10.1158/1535-7163.MCT-05-0520; Norrish AE, 1998, INT J CANCER, V77, P511; PAGANINIHILL A, 1989, BRIT MED J, V299, P1247, DOI 10.1136/bmj.299.6710.1247; Perron L, 2003, INT J CANCER, V106, P409, DOI 10.1002/ijc.11250; Platz EA, 2007, CANCER EPIDEM BIOMAR, V16, P2175, DOI 10.1158/1055-9965.EPI-07-0777; RISCH HA, 1994, AM J EPIDEMIOL, V139, P670, DOI 10.1093/oxfordjournals.aje.a117057; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Rothman K., 1998, MODERN EPIDEMIOLOGY; ROTHMAN KJ, 1981, AM J EPIDEMIOL, V114, P253, DOI 10.1093/oxfordjournals.aje.a113189; Sabichi AL, 2004, SEMIN ONCOL, V31, P36, DOI 10.1053/j.seminoncol.2004.03.044; Salas M, 1999, AM J EPIDEMIOL, V149, P981; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; Skarsgard D, 2000, CANCER CAUSE CONTROL, V11, P79, DOI 10.1023/A:1008965617078; *STAT CAN, 2008, AB POP PROF; Stock DC, 2008, PROSTATE, V68, P1655, DOI 10.1002/pros.20834; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; TONITA JM, 2008, CHANGES CASE MIX TRE; Varas-Lorenzo C, 2008, PHARMACOEPIDEM DR S, V17, P842, DOI 10.1002/pds.1619; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Wechter WJ, 2000, CANCER RES, V60, P2203; Weiss NS, 2003, AM J EPIDEMIOL, V157, P957, DOI 10.1093/aje/kwg062; *WHO COLL CTR DRUG, 2002, ATC IND DDDS	47	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16412	10.1371/journal.pone.0016412	http://dx.doi.org/10.1371/journal.pone.0016412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21297996	Green Submitted, Green Published, gold			2022-12-25	WOS:000286664100030
J	Filenko, NA; Kolar, C; West, JT; Smith, SA; Hassan, YI; Borgstahl, GEO; Zempleni, J; Lyubchenko, YL				Filenko, Nina A.; Kolar, Carol; West, John T.; Smith, S. Abbie; Hassan, Yousef I.; Borgstahl, Gloria E. O.; Zempleni, Janos; Lyubchenko, Yuri L.			The Role of Histone H4 Biotinylation in the Structure of Nucleosomes	PLOS ONE			English	Article							PROTEIN-DNA COMPLEXES; HOLOCARBOXYLASE SYNTHETASE; DROSOPHILA-MELANOGASTER; RECOMBINANT HISTONES; ENERGY-TRANSFER; CORE PARTICLE; BIOTIN; CELLS; TRANSCRIPTION; ACETYLATION	Background: Post-translational modifications of histones play important roles in regulating nucleosome structure and gene transcription. It has been shown that biotinylation of histone H4 at lysine-12 in histone H4 (K12Bio-H4) is associated with repression of a number of genes. We hypothesized that biotinylation modifies the physical structure of nucleosomes, and that biotin-induced conformational changes contribute to gene silencing associated with histone biotinylation. Methodology/Principal Findings: To test this hypothesis we used atomic force microscopy to directly analyze structures of nucleosomes formed with biotin-modified and non-modified H4. The analysis of the AFM images revealed a 13% increase in the length of DNA wrapped around the histone core in nucleosomes with biotinylated H4. This statistically significant (p<0.001) difference between native and biotinylated nucleosomes corresponds to adding approximately 20 bp to the classical 147 bp length of nucleosomal DNA. Conclusions/Significance: The increase in nucleosomal DNA length is predicted to stabilize the association of DNA with histones and therefore to prevent nucleosomes from unwrapping. This provides a mechanistic explanation for the gene silencing associated with K12Bio-H4. The proposed single-molecule AFM approach will be instrumental for studying the effects of various epigenetic modifications of nucleosomes, in addition to biotinylation.	[Filenko, Nina A.; Lyubchenko, Yuri L.] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA; [Kolar, Carol; Borgstahl, Gloria E. O.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Hassan, Yousef I.; Zempleni, Janos] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE USA; [West, John T.; Smith, S. Abbie] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of Oklahoma System; University of Oklahoma Health Sciences Center	Filenko, NA (corresponding author), Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA.	ylyubchenko@unmc.edu	Borgstahl, Gloria/AAZ-4114-2020		National Science Foundation [EPS-0701892]; Nebraska Research Initiative; University of Nebraska Agricultural Research Division; National Institutes of Health [DK063945, DK077816, DK082476]; National Cancer Institute Eppley Cancer Center Support Grant [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082476, R01DK063945, R01DK077816] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Nebraska Research Initiative; University of Nebraska Agricultural Research Division; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Eppley Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by the National Science Foundation-Experimental Program to Stimulate Competitive Research EPS-0701892. Additional support was provided by Nebraska Research Initiative (to YLL), the University of Nebraska Agricultural Research Division (Hatch Act), and National Institutes of Health grants DK063945, DK077816, and DK082476 (all to JZ) and National Cancer Institute Eppley Cancer Center Support Grant [P30CA036727] (to GEOB and YLL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao B, J NUTR BIOCH; Bussiek M, 2006, BIOCHEMISTRY-US, V45, P10838, DOI 10.1021/bi060807p; Camporeale G, 2004, EUR J BIOCHEM, V271, P2257, DOI 10.1111/j.1432-1033.2004.04167.x; Camporeale G, 2007, J NUTR BIOCHEM, V18, P760, DOI 10.1016/j.jnutbio.2006.12.014; Camporeale G, 2006, J NUTR, V136, P2735, DOI 10.1093/jn/136.11.2735; Chew YC, 2008, J NUTR, V138, P2316, DOI 10.3945/jn.108.098673; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Gansen A, 2009, J PHYS CHEM B, V113, P2604, DOI 10.1021/jp7114737; Ghosh, 2009, THESIS U NEBRASKA LI; Gralla M, 2008, J NUTR BIOCHEM, V19, P400, DOI 10.1016/j.jnutbio.2007.06.002; HYMES J, 1995, BIOCHEM MOL MED, V56, P76, DOI 10.1006/bmme.1995.1059; Kobza K, 2005, FEBS J, V272, P4249, DOI 10.1111/j.1742-4658.2005.04839.x; Kobza K, 2008, BMB REP, V41, P310, DOI 10.5483/BMBRep.2008.41.4.310; Li JW, 2002, MOL CELL BIOL, V22, P5688, DOI 10.1128/MCB.22.16.5688-5697.2002; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lyubchenko YL, 2009, METHODS, V47, P206, DOI 10.1016/j.ymeth.2008.09.002; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Osley MA, 2006, RES PRO CEL, V41, P47, DOI 10.1007/006; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6; Shlyakhtenko LS, 2009, BIOCHEMISTRY-US, V48, P7842, DOI 10.1021/bi900977t; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Stanley JS, 2001, EUR J BIOCHEM, V268, P5424, DOI 10.1046/j.0014-2956.2001.02481.x; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suzuki Y, 2010, ULTRAMICROSCOPY, V110, P682, DOI 10.1016/j.ultramic.2010.02.032; Takechi R, 2008, J NUTR, V138, P680, DOI 10.1093/jn/138.4.680; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Toth K, 2006, BIOCHEMISTRY-US, V45, P1591, DOI 10.1021/bi052110u; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; Wijeratne SSK, 2010, J NUTR BIOCHEM, V21, P310, DOI 10.1016/j.jnutbio.2009.01.010; Zempleni J, 2009, BIOFACTORS, V35, P36, DOI 10.1002/biof.8	34	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16299	10.1371/journal.pone.0016299	http://dx.doi.org/10.1371/journal.pone.0016299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21298003	gold, Green Published, Green Submitted			2022-12-25	WOS:000286663900030
J	Paixao-Cortes, VR; Meyer, D; Pereira, TV; Mazieres, S; Elion, J; Krishnamoorthy, R; Zago, MA; Silva, WA; Salzano, FM; Bortolini, MC				Paixao-Cortes, Vanessa R.; Meyer, Diogo; Pereira, Tiago V.; Mazieres, Stephane; Elion, Jacques; Krishnamoorthy, Rajagopal; Zago, Marco A.; Silva, Wilson A., Jr.; Salzano, Francisco M.; Bortolini, Maria Catira			Genetic Variation among Major Human Geographic Groups Supports a Peculiar Evolutionary Trend in PAX9	PLOS ONE			English	Article							POSITIVE SELECTION; NATURAL-SELECTION; POPULATION DIFFERENTIATION; MUTATION; POLYMORPHISM; REVEALS; HISTORY; MODELS; MOLAR	A total of 172 persons from nine South Amerindian, three African and one Eskimo populations were studied in relation to the Paired box gene 9 (PAX9) exon 3 (138 base pairs) as well as its 5' and 3' flanking intronic segments (232 bp and 220 bp, respectively) and integrated with the information available for the same genetic region from individuals of different geographical origins. Nine mutations were scored in exon 3 and six in its flanking regions; four of them are new South American tribe-specific singletons. Exon3 nucleotide diversity is several orders of magnitude higher than its intronic regions. Additionally, a set of variants in the PAX9 and 101 other genes related with dentition can define at least some dental morphological differences between Sub-Saharan Africans and non-Africans, probably associated with adaptations after the modern human exodus from Africa. Exon 3 of PAX9 could be a good molecular example of how evolvability works.	[Paixao-Cortes, Vanessa R.; Salzano, Francisco M.; Bortolini, Maria Catira] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Meyer, Diogo] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Pereira, Tiago V.] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Mazieres, Stephane] CNRS, Lab Anthropobiol, FRE2960, Toulouse, France; [Mazieres, Stephane] Fac Med, CS80011, Marseille, France; [Elion, Jacques; Krishnamoorthy, Rajagopal] Univ Paris Diderot, Hop Robert Debre, Insern, UMR 763, Paris, France; [Zago, Marco A.] Univ Sao Paulo, Fac Med, Dept Clin Med, Sao Paulo, Brazil; [Silva, Wilson A., Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil	Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade de Sao Paulo; Universidade de Sao Paulo	Paixao-Cortes, VR (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	maria.bortolini@ufrgs.br	Silva Jr, Wilson Araújo/E-9487-2011; Paixão-Côrtes, Vanessa R/H-3564-2011; Mazières, Stéphane/R-2061-2019; ZAGO, MARCO A/E-9442-2017; Elion, Jacques/A-1048-2014; Salzano, Francisco M/L-7916-2015; Meyer, Diogo/A-1868-2008; Mazieres, Stephane/G-1702-2010	Silva Jr, Wilson Araújo/0000-0001-9364-2886; Paixão-Côrtes, Vanessa R/0000-0003-2677-0903; Elion, Jacques/0000-0002-8407-1783; Mazieres, Stephane/0000-0003-1266-4659	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Institutos do Milenio and Programa de Apoio a Nucleos de Excelencia Programs; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul; Inserm-FAPESP	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institutos do Milenio and Programa de Apoio a Nucleos de Excelencia Programs; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Inserm-FAPESP	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Institutos do Milenio and Programa de Apoio a Nucleos de Excelencia Programs, Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, and Inserm-FAPESP 2010-2011 Joint Projects Agreement, Brazil and France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; Alonso S, 2001, P NATL ACAD SCI USA, V98, P864, DOI 10.1073/pnas.011244998; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CHAGULA WK, 1960, AM J PHYS ANTHROPOL, V18, P77, DOI 10.1002/ajpa.1330180202; Cheng F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-221; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frazier-Bowers SA, 2002, J DENT RES, V81, P129, DOI 10.1177/154405910208100209; FU YX, 1993, GENETICS, V133, P693; Gomez-Valdes J, 2005, THESIS ESCUELA NACL; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; Harris EE, 2006, YEARB PHYS ANTHROPOL, V49, P89, DOI 10.1002/ajpa.20518; Haydenblit R, 1996, AM J PHYS ANTHROPOL, V100, P225; Hetzer-Egger C, 2000, BBA-GENE STRUCT EXPR, V1492, P517, DOI 10.1016/S0167-4781(00)00130-5; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; Hughes DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001686; IRISH JD, 1993, THESIS ARIZONA STATE; Kula Katherine, 2008, World J Orthod, V9, pe55; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Nei M, 1987, MOL EVOLUTIONARY GEN; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Paixao-Cortes VR, 2010, ARCH ORAL B IN PRESS; Pan YC, 2008, EUR J ORAL SCI, V116, P98, DOI 10.1111/j.1600-0722.2007.00517.x; Pereira TV, 2006, P NATL ACAD SCI USA, V103, P5676, DOI 10.1073/pnas.0509562103; Peters H, 1998, EUR J ORAL SCI, V106, P38, DOI 10.1111/j.1600-0722.1998.tb02151.x; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; ROGERS J, 1995, AM J PHYS ANTHROPOL, V98, P216, DOI 10.1002/ajpa.1330980212; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozkovcova E, 2004, Prague Med Rep, V105, P391; Rozkovcova E, 2004, Prague Med Rep, V105, P35; Rozkovcova E, 1999, Sb Lek, V100, P71; Santagati F, 2003, GENETICS, V165, P235; Santos-Lopes SS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000557; Silvestri AR, 2003, J AM DENT ASSOC, V134, P450, DOI 10.14219/jada.archive.2003.0194; Stelzer G, 2009, OMICS, V13, P477, DOI 10.1089/omi.2009.0069; Sutter R, 2005, ANDEAN, V7; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TRIMMELL JB, 2004, THESIS U MISSOURI KA; TURNER CG, 1987, AM J PHYS ANTHROPOL, V73, P305, DOI 10.1002/ajpa.1330730304; TURNER CG, 1986, NATL GEOGR RES, V2, P37; TURNER CG, 1981, SCIENCE, V212, P1053, DOI 10.1126/science.7015507; Urban G., 1998, HIST INDIOS BRASIL, P87; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wooding S, 2004, HUM GENET, V115, P221, DOI 10.1007/s00439-004-1130-x; Wu DD, 2010, HUM MOL GENET, V19, P2341, DOI 10.1093/hmg/ddq107; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; Yang ZH, 2000, GENETICS, V155, P431	56	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e15656	10.1371/journal.pone.0015656	http://dx.doi.org/10.1371/journal.pone.0015656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712JV	21298044	Green Published, gold, Green Submitted			2022-12-25	WOS:000286663900016
J	Beisner, BA; Jackson, ME; Cameron, AN; McCowan, B				Beisner, Brianne A.; Jackson, Megan E.; Cameron, Ashley N.; McCowan, Brenda			Detecting Instability in Animal Social Networks: Genetic Fragmentation Is Associated with Social Instability in Rhesus Macaques	PLOS ONE			English	Article							MATRILINEAL OVERTHROWS; KIN BIAS; RANK; AGGRESSION; BEHAVIOR; ROBUSTNESS; MECHANISMS; EVOLUTION; MONKEYS; KINSHIP	The persistence of biological systems requires evolved mechanisms which promote stability. Cohesive primate social groups are one example of stable biological systems, which persist in spite of regular conflict. We suggest that genetic relatedness and its associated kinship structure are a potential source of stability in primate social groups as kinship structure is an important organizing principle in many animal societies. We investigated the effect of average genetic relatedness per matrilineal family on the stability of matrilineal grooming and agonistic interactions in 48 matrilines from seven captive groups of rhesus macaques. Matrilines with low average genetic relatedness show increased family-level instability such as: more sub-grouping in their matrilineal groom network, more frequent fighting with kin, and higher rates of wounding. Family-level instability in multiple matrilines within a group is further associated with group-level instability such as increased wounding. Stability appears to arise from the presence of clear matrilineal structure in the rhesus macaque group hierarchy, which is derived from cohesion among kin in their affiliative and agonistic interactions with each other. We conclude that genetic relatedness and kinship structure are an important source of group stability in animal societies, particularly when dominance and/or affilative interactions are typically governed by kinship.	[Beisner, Brianne A.; Jackson, Megan E.; Cameron, Ashley N.; McCowan, Brenda] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Beisner, Brianne A.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [McCowan, Brenda] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Davis	Beisner, BA (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	bab42@psu.edu			NIH [R24 RR024396, PR51 RR000169]; IACUC [11843]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068335] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR024396, P51RR000169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011136] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IACUC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by NIH grants #R24 RR024396 and #PR51 RR000169, and conducted under IACUC protocol #11843. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; BEISNER BA, 2010, AM J PRIMAT IN PRESS; Berman CM, 1999, ANIM BEHAV, V58, P883, DOI 10.1006/anbe.1999.1221; BERNSTEIN IS, 1985, AM J PRIMATOL, V8, P37, DOI 10.1002/ajp.1350080105; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Borgatti S., 2002, UCINET WINDOWS SOFTW; CHAPAIS B, 1985, Primates, V26, P407, DOI 10.1007/BF02382456; CHAPAIS B, 1988, ANIM BEHAV, V36, P1025, DOI 10.1016/S0003-3472(88)80062-9; CHAPAIS B, 1994, ANIM BEHAV, V48, P1335, DOI 10.1006/anbe.1994.1370; CHAPAIS B, 1988, BEHAVIOUR, V104, P41, DOI 10.1163/156853988X00593; Chapais Bernard, 1992, P29; CHENEY DL, 1977, BEHAV ECOL SOCIOBIOL, V2, P303, DOI 10.1007/BF00299742; Csardi N., 2006, INT J COMP SYST, V1695, P1; Datta S. B., 1992, P61; DAZEY J, 1977, AM J PHYS ANTHROPOL, V46, P73, DOI 10.1002/ajpa.1330460110; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; DITTUS WPJ, 1988, ANIM BEHAV, V36, P1626, DOI 10.1016/S0003-3472(88)80104-0; Dunbar R.I.M., 1988, PRIMATE SOCIAL SYSTE; DUNBAR RIM, 1992, BEHAV ECOL SOCIOBIOL, V31, P35, DOI 10.1007/BF00167814; DUNBAR RIM, 1995, HUM NATURE-INT BIOS, V6, P273, DOI 10.1007/BF02734142; EHARDT CL, 1986, INT J PRIMATOL, V7, P157, DOI 10.1007/BF02692316; EMLEN ST, 1994, TRENDS ECOL EVOL, V9, P282, DOI 10.1016/0169-5347(94)90030-2; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, P ROY SOC B-BIOL SCI, V272, P1091, DOI 10.1098/rspb.2004.3019; Flack JC, 2005, AM NAT, V165, pE126, DOI 10.1086/429277; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; GOUZOULES H, 1980, Primates, V21, P262, DOI 10.1007/BF02374039; GOUZOULES S, 1984, YEARB PHYS ANTHROPOL, V27, P99; Gustafsson M, 2009, IET SYST BIOL, V3, P219, DOI 10.1049/iet-syb.2008.0112; Gygax L, 1997, PRIMATES, V38, P149, DOI 10.1007/BF02382005; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HORROCKS J, 1983, ANIM BEHAV, V31, P772, DOI 10.1016/S0003-3472(83)80234-6; KAPLAN JR, 1978, AM J PHYS ANTHROPOL, V49, P241, DOI 10.1002/ajpa.1330490212; Krakauer David C., 2006, P183; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; McCowan B, 2008, APPL ANIM BEHAV SCI, V109, P396, DOI 10.1016/j.applanim.2007.02.009; MISSAKIAN E A, 1972, Primates, V13, P169, DOI 10.1007/BF01840878; Moller LM, 2006, BEHAV ECOL SOCIOBIOL, V61, P109, DOI 10.1007/s00265-006-0241-x; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; NEWSON R, 1999, STATA TECHN B, V50, P27; Oates-O'Brien RS, 2010, J AM ASSOC LAB ANIM, V49, P196; Packer C., 1986, P429; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; PONS P, 2005, ARXIVPHYSICS0512106V; R Core Team, 2021, R LANG ENV STAT COMP; Rogers WH., 1993, STATA TECHNICAL B RE, V13, P19; Rubenstein D.I., 1986, P282; Sade D.S., 1967, P99; SADE DS, 1969, AM J PHYS ANTHROPOL, V31, P261; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Thierry B, 2004, WURZBURG, P267; Voelkl B, 2009, BIOL LETTERS, V5, P462, DOI 10.1098/rsbl.2009.0204; Wey TW, 2010, ANIM BEHAV, V79, P1343, DOI 10.1016/j.anbehav.2010.03.008; Widdig A, 2006, BEHAV ECOL SOCIOBIOL, V61, P205, DOI 10.1007/s00265-006-0251-8; Wolf JBW, 2007, ANIM BEHAV, V74, P1293, DOI 10.1016/j.anbehav.2007.02.024; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447	59	39	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e16365	10.1371/journal.pone.0016365	http://dx.doi.org/10.1371/journal.pone.0016365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21298105	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800031
J	Gauthier, L; Ravallec, M; Tournaire, M; Cousserans, F; Bergoin, M; Dainat, B; de Miranda, JR				Gauthier, Laurent; Ravallec, Marc; Tournaire, Magali; Cousserans, Francois; Bergoin, Max; Dainat, Benjamin; de Miranda, Joachim R.			Viruses Associated with Ovarian Degeneration in Apis mellifera L. Queens	PLOS ONE			English	Article							DEFORMED WING VIRUS; BEE PARALYSIS VIRUS; HONEY-BEE; VERTICAL-TRANSMISSION; NOSEMA-APIS; VIRAL LOAD; INFECTION; DIFFERENTIATION; VITELLOGENIN; POPULATIONS	Queen fecundity is a critical issue for the health of honeybee (Apis mellifera L.) colonies, as she is the only reproductive female in the colony and responsible for the constant renewal of the worker bee population. Any factor affecting the queen's fecundity will stagnate colony development, increasing its susceptibility to opportunistic pathogens. We discovered a pathology affecting the ovaries, characterized by a yellow discoloration concentrated in the apex of the ovaries resulting from degenerative lesions in the follicles. In extreme cases, marked by intense discoloration, the majority of the ovarioles were affected and these cases were universally associated with egg-laying deficiencies in the queens. Microscopic examination of the degenerated follicles showed extensive paracrystal lattices of 30 nm icosahedral viral particles. A cDNA library from degenerated ovaries contained a high frequency of deformed wing virus (DWV) and Varroa destructor virus 1 (VDV-1) sequences, two common and closely related honeybee Iflaviruses. These could also be identified by in situ hybridization in various parts of the ovary. A large-scale survey for 10 distinct honeybee viruses showed that DWV and VDV-1 were by far the most prevalent honeybee viruses in queen populations, with distinctly higher prevalence in mated queens (100% and 67%, respectively for DWV and VDV-1) than in virgin queens (37% and 0%, respectively). Since very high viral titres could be recorded in the ovaries and abdomens of both functional and deficient queens, no significant correlation could be made between viral titre and ovarian degeneration or egg-laying deficiency among the wider population of queens. Although our data suggest that DWV and VDV-1 have a role in extreme cases of ovarian degeneration, infection of the ovaries by these viruses does not necessarily result in ovarian degeneration, even at high titres, and additional factors are likely to be involved in this pathology.	[Gauthier, Laurent; Dainat, Benjamin] Agroscope Liebefeld Posieux Res Stn ALP, Swiss Bee Res Ctr, Bern, Switzerland; [Gauthier, Laurent; Ravallec, Marc; Cousserans, Francois; Bergoin, Max] Univ Montpellier 2, UMR 1231, Lab Biol Integrat & Virol Insectes, Montpellier, France; [Gauthier, Laurent; Tournaire, Magali] Montpellier SupAgro, Montpellier, France; [de Miranda, Joachim R.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [de Miranda, Joachim R.] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swiss Federal Research Station Agroscope; Universite de Montpellier; Institut Agro; Montpellier SupAgro; Queens University Belfast; Swedish University of Agricultural Sciences	Gauthier, L (corresponding author), Agroscope Liebefeld Posieux Res Stn ALP, Swiss Bee Res Ctr, Bern, Switzerland.	laurent.gauthier@alp.admin.ch	Dainat, Benjamin/AFN-8922-2022	Dainat, Benjamin/0000-0002-1740-7136; Rodrigues de Miranda, Joachim/0000-0002-0335-0386	French Ministere de l'agriculture et de l'Alimentation; "Fonds Europeens d'Orientation et de Garantie Agricole" (FEOGA)	French Ministere de l'agriculture et de l'Alimentation; "Fonds Europeens d'Orientation et de Garantie Agricole" (FEOGA)	This work was supported by the French Ministere de l'agriculture et de l'Alimentation and with funds from the "Fonds Europeens d'Orientation et de Garantie Agricole" (FEOGA), in accordance with the French programme for the improvement of the production and commercialization of beekeeping products. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Allen M, 1996, BEE WORLD, V77, P141, DOI 10.1080/0005772X.1996.11099306; Anderson D., 1993, Australasian Beekeeper, V94, P292; AUSUBEL FM, 2007, CURRENTS PROTOCOLS M; Baker A, 2008, J INVERTEBR PATHOL, V98, P239, DOI 10.1016/j.jip.2008.02.010; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; BRUN G, 1977, ANN INST PASTEUR MIC, VA128, P119; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Camazine S, 1998, AM BEE J, V138, P677; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chen YP, 2009, J EUKARYOT MICROBIOL, V56, P142, DOI 10.1111/j.1550-7408.2008.00374.x; Chen YP, 2005, J INVERTEBR PATHOL, V90, P118, DOI 10.1016/j.jip.2005.08.005; CHEN YP, 2007, HONEY BEE VIRUSES AD, P33; Czekonska K, 2000, APIDOLOGIE, V31, P701, DOI 10.1051/apido:2000154; de Miranda JR, 2008, J INVERTEBR PATHOL, V98, P184, DOI 10.1016/j.jip.2008.02.004; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; de Miranda JR, 2010, J GEN VIROL, V91, P2524, DOI 10.1099/vir.0.022434-0; DEBURON I, 1998, VIRUSES INSECT CELLS, P1143; Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109; ENGELS W, 1974, AM ZOOL, V14, P1229; Fievet J, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-16; Fujiyuki T, 2005, ADV VIRUS RES, V65, P1, DOI 10.1016/S0065-3527(05)65001-4; Fujiyuki T, 2009, J VIROL, V83, P11560, DOI 10.1128/JVI.00519-09; FYG W, 1964, ANNU REV ENTOMOL, V9, P207, DOI 10.1146/annurev.en.09.010164.001231; FYG W., 1945, SCHWEIZ BIENEN ZEITUNG, V68, P67; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; GENERSCH E, 2010, APIDOLOGIE, P1; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Guidugli-Lazzarini KR, 2008, J INSECT PHYSIOL, V54, P1138, DOI 10.1016/j.jinsphys.2008.04.021; GUTZEIT HO, 1993, ROUX ARCH DEV BIOL, V202, P181, DOI 10.1007/BF00365309; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; Haydak MH, 1943, J ECON ENTOMOL, V36, P778, DOI 10.1093/jee/36.5.778; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Iqbal J, 2007, P R SOC B, V274, P1517, DOI 10.1098/rspb.2007.0022; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; LIU TP, 1992, TISSUE CELL, V24, P131, DOI 10.1016/0040-8166(92)90087-N; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nielsen SL, 2008, APIDOLOGIE, V39, P310, DOI 10.1051/apido:2008007; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; ONGUS JR, 2006, THESIS WAGENINGEN U; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Patricio K, 2008, IHERINGIA SER ZOOL, V98, P421, DOI 10.1590/S0073-47212008000400001; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Ramamurty P.S., 1977, Proceedings Congr Int Un Study Soc Ins, V8, P30; Rhodes JW, 2004, APIDOLOGIE, V35, P383, DOI 10.1051/apido:2004028; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Tanaka ED, 2004, ARTHROPOD STRUCT DEV, V33, P431, DOI 10.1016/j.asd.2004.06.006; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Tettamanti G, 2008, CURR PHARM DESIGN, V14, P116, DOI 10.2174/138161208783378716; Valles SM, 2007, J INVERTEBR PATHOL, V96, P18, DOI 10.1016/j.jip.2007.02.006; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Webster TC, 2008, J APICULT RES, V47, P53, DOI 10.1080/00218839.2008.11101423; Winston, 1987, BIOL HONEYBEE; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0; Yue C, 2006, J INVERTEBR PATHOL, V92, P105, DOI 10.1016/j.jip.2006.03.001	68	49	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16217	10.1371/journal.pone.0016217	http://dx.doi.org/10.1371/journal.pone.0016217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283547	Green Published, Green Submitted, gold			2022-12-25	WOS:000286661400034
J	Liu, Z; Kim, W; Chen, ZK; Shin, YK; Carlson, OD; Fiori, JL; Xin, L; Napora, JK; Short, R; Odetunde, JO; Lao, QZ; Egan, JM				Liu, Zhuo; Kim, Wook; Chen, Zhike; Shin, Yu-Kyong; Carlson, Olga D.; Fiori, Jennifer L.; Xin, Li; Napora, Joshua K.; Short, Ryan; Odetunde, Juliana O.; Lao, Qizong; Egan, Josephine M.			Insulin and Glucagon Regulate Pancreatic alpha-Cell Proliferation	PLOS ONE			English	Article							DIABETES-MELLITUS; GLUCOSE-HOMEOSTASIS; GENE-EXPRESSION; CANCER-CELLS; BETA-CELLS; IN-VIVO; RECEPTOR; GROWTH; MICE; HYPERGLUCAGONEMIA	Type 2 diabetes mellitus (T2DM) results from insulin resistance and beta-cell dysfunction, in the setting of hyperglucagonemia. Glucagon is a 29 amino acid peptide hormone, which is secreted from pancreatic alpha cells: excessively high circulating levels of glucagon lead to excessive hepatic glucose output. We investigated if alpha-cell numbers increase in T2DM and what factor (s) regulate alpha-cell turnover. Lepr(db)/Lepr(db) (db/db) mice were used as a T2DM model and alpha TC1 cells were used to study potential alpha-cell trophic factors. Here, we demonstrate that in db/db mice alpha-cell number and plasma glucagon levels increased as diabetes progressed. Insulin treatment (EC50 = 2 nM) of alpha cells significantly increased alpha-cell proliferation in a concentration-dependent manner compared to non-insulin-treated alpha cells. Insulin up-regulated alpha-cell proliferation through the IR/IRS2/AKT/mTOR signaling pathway, and increased insulin-mediated proliferation was prevented by pretreatment with rapamycin, a specific mTOR inhibitor. GcgR antagonism resulted in reduced rates of cell proliferation in alpha TC1 cells. In addition, blockade of GcgRs in db/db mice improved glucose homeostasis, lessened alpha-cell proliferation, and increased intraislet insulin content in beta cells in db/db mice. These studies illustrate that pancreatic alpha-cell proliferation increases as diabetes develops, resulting in elevated plasma glucagon levels, and both insulin and glucagon are trophic factors to alpha-cells. Our current findings suggest that new therapeutic strategies for the treatment of T2DM may include targeting alpha cells and glucagon.	[Liu, Zhuo; Kim, Wook; Chen, Zhike; Shin, Yu-Kyong; Carlson, Olga D.; Fiori, Jennifer L.; Xin, Li; Napora, Joshua K.; Short, Ryan; Odetunde, Juliana O.; Lao, Qizong; Egan, Josephine M.] NIA, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Liu, Z (corresponding author), NIA, NIH, Baltimore, MD 21224 USA.	eganj@grc.nia.nih.gov		Short, Ryan/0000-0003-3483-2895	NIH, National Institute on Aging	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research was supported by the Intramural Research Program of the NIH, National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bae-Jump VL, 2009, CANCER-AM CANCER SOC, V115, P3887, DOI 10.1002/cncr.24431; BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; Cassidy RS, 2008, BIOL CHEM, V389, P189, DOI 10.1515/BC.2008.019; Conarello SL, 2007, DIABETOLOGIA, V50, P142, DOI 10.1007/s00125-006-0481-3; COX LS, 2009, AGING CELL; DOBBS R, 1975, SCIENCE, V187, P544, DOI 10.1126/science.1089999; Gelling RW, 2009, AM J PHYSIOL-ENDOC M, V297, pE695, DOI 10.1152/ajpendo.00082.2009; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz George G, 2005, Sci STKE, V2005, ppe2; Hudes GR, 2009, CANCER, V115, P2313, DOI 10.1002/cncr.24239; Iki K, 2007, J HISTOCHEM CYTOCHEM, V55, P111, DOI 10.1369/jhc.6A7024.2006; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Li XC, 2008, CLIN SCI, V114, P591, DOI 10.1042/CS20070257; Li XC, 2007, CLIN SCI, V113, P183, DOI 10.1042/CS20070040; Ma XS, 2005, MOL ENDOCRINOL, V19, P198, DOI 10.1210/me.2004-0059; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; McBride SM, 2010, J NEURO-ONCOL, V97, P33, DOI 10.1007/s11060-009-0004-4; McKinnon CM, 2006, J BIOL CHEM, V281, P39358, DOI 10.1074/jbc.M605022200; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Muller D, 2006, FEBS LETT, V580, P6977, DOI 10.1016/j.febslet.2006.11.066; Nakao T, 2008, CELL CYCLE, V7, P257, DOI 10.4161/cc.7.2.5148; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Petersen KF, 2001, DIABETOLOGIA, V44, P2018, DOI 10.1007/s001250100006; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; RASKIN P, 1978, NEW ENGL J MED, V299, P433, DOI 10.1056/NEJM197808312990901; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; SAKURAI H, 1975, METABOLISM, V24, P1287, DOI 10.1016/0026-0495(75)90067-0; Schlosshauer PW, 2009, GYNECOL ONCOL, V114, P516, DOI 10.1016/j.ygyno.2009.06.002; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Tornehave D, 2008, J HISTOCHEM CYTOCHEM, V56, P841, DOI 10.1369/jhc.2008.951319; UNGER RH, 1975, LANCET, V1, P14; Wagner M, 2009, J GASTROINTEST SURG, V13, P1781, DOI 10.1007/s11605-009-0948-x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu GG, 1998, DIABETES, V47, P1243, DOI 10.2337/diabetes.47.8.1243; Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009	44	51	52	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16096	10.1371/journal.pone.0016096	http://dx.doi.org/10.1371/journal.pone.0016096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283589	Green Submitted, Green Published, gold			2022-12-25	WOS:000286661400024
J	Wurbel, MA; McIntire, MG; Dwyer, P; Fiebiger, E				Wurbel, Marc-Andre; McIntire, Maria G.; Dwyer, Peter; Fiebiger, Edda			CCL25/CCR9 Interactions Regulate Large Intestinal Inflammation in a Murine Model of Acute Colitis	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; SULFATE-MEDIATED COLITIS; CD4(+) T-CELLS; CHEMOKINE RECEPTOR; BOWEL-DISEASE; CROHNS-DISEASE; ULCERATIVE-COLITIS; MICE; CCR9; EXPRESSION	Background & Aims: CCL25/CCR9 is a non-promiscuous chemokine/receptor pair and a key regulator of leukocyte migration to the small intestine. We investigated here whether CCL25/CCR9 interactions also play a role in the regulation of inflammatory responses in the large intestine. Methods: Acute inflammation and recovery in wild-type (WT) and CCR9(-/-) mice was studied in a model of dextran sulfate sodium (DSS)-induced colitis. Distribution studies and phenotypic characterization of dendritic cell subsets and macrophage were performed by flow cytometry. Inflammatory bowel disease (IBD) scores were assessed and expression of inflammatory cytokines was studied at the mRNA and the protein level. Results: CCL25 and CCR9 are both expressed in the large intestine and are upregulated during DSS colitis. CCR9(-/-) mice are more susceptible to DSS colitis than WT littermate controls as shown by higher mortality, increased IBD score and delayed recovery. During recovery, the CCR9(-/-) colonic mucosa is characterized by the accumulation of activated macrophages and elevated levels of Th1/Th17 inflammatory cytokines. Activated plasmacytoid dendritic cells (DCs) accumulate in mesenteric lymph nodes (MLNs) of CCR9(-/-) animals, altering the local ratio of DC subsets. Upon re-stimulation, T cells isolated from these MLNs secrete significantly higher levels of TNF alpha, IFN gamma, IL2, IL-6 and IL-17A while down modulating IL-10 production. Conclusions: Our results demonstrate that CCL25/CCR9 interactions regulate inflammatory immune responses in the large intestinal mucosa by balancing different subsets of dendritic cells. These findings have important implications for the use of CCR9-inhibitors in therapy of human IBD as they indicate a potential risk for patients with large intestinal inflammation.	[Wurbel, Marc-Andre; Dwyer, Peter; Fiebiger, Edda] Harvard Univ, Sch Med, Div Gastroenterol & Nutr, Childrens Hosp Boston, Boston, MA 02115 USA; [Wurbel, Marc-Andre; Dwyer, Peter; Fiebiger, Edda] Harvard Univ, Sch Med, Dept Pediat, Boston, MA USA; [McIntire, Maria G.] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wurbel, MA (corresponding author), Harvard Univ, Sch Med, Div Gastroenterol & Nutr, Childrens Hosp Boston, Boston, MA 02115 USA.	marc-andre.wurbel@childrens.harvard.edu; edda.fiebiger@childrens.harvard.edu			Crohn's & Colitis Foundation of America; Harvard Digestive Diseases Center [P30 DK034854]; American Gastroenterological Association; National Institutes of Health [R01AI075037]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	Crohn's & Colitis Foundation of America; Harvard Digestive Diseases Center; American Gastroenterological Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Crohn's & Colitis Foundation of America Career Development Award (to MAW), by a Pilot Project Grant from the Harvard Digestive Diseases Center P30 DK034854 (to MAW), by a Research Scholar Award from the American Gastroenterological Association (to EF) and by grant R01AI075037 from the National Institutes of Health (to EF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2007, P NATL ACAD SCI USA, V104, P17022, DOI 10.1073/pnas.0708469104; Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Apostolaki M, 2008, GASTROENTEROLOGY, V134, P2025, DOI 10.1053/j.gastro.2008.02.085; Autschbach F, 2002, VIRCHOWS ARCH, V441, P500, DOI 10.1007/s00428-002-0684-z; Berndt BE, 2007, J IMMUNOL, V179, P6255, DOI 10.4049/jimmunol.179.9.6255; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Garside P, 1999, CLIN EXP IMMUNOL, V118, P337; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Hosoe N, 2004, AM J PHYSIOL-GASTR L, V286, pG458, DOI 10.1152/ajpgi.00167.2003; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Kaser A, 2008, CURR OPIN GASTROEN, V24, P455, DOI 10.1097/MOG.0b013e328304d60d; Kelsall B, 2008, MUCOSAL IMMUNOL, V1, P460, DOI 10.1038/mi.2008.61; Keshav S, 2009, GASTROENTEROLOGY, V136, pA65; KOSTADINOVA FI, 2010, J LEUKOC BIOL; Matsuzaki K, 2005, CLIN EXP IMMUNOL, V140, P22, DOI 10.1111/j.1365-2249.2005.02742.x; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nguyen DD, 2007, GASTROENTEROLOGY, V133, P1188, DOI 10.1053/j.gastro.2007.07.010; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; Qualls JE, 2009, INFLAMM BOWEL DIS, V15, P236, DOI 10.1002/ibd.20733; Rivera-Nieves J, 2006, GASTROENTEROLOGY, V131, P1518, DOI 10.1053/j.gastro.2006.08.031; Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401; Sainathan SK, 2008, INFLAMM BOWEL DIS, V14, P88, DOI 10.1002/ibd.20279; Shintani N, 1998, GEN PHARMACOL-VASC S, V31, P477, DOI 10.1016/S0306-3623(98)00004-4; Shintani N, 1997, SCAND J IMMUNOL, V46, P581, DOI 10.1046/j.1365-3083.1997.d01-169.x; Stenstad H, 2006, BLOOD, V107, P3447, DOI 10.1182/blood-2005-07-2860; Stenstad H, 2007, P NATL ACAD SCI USA, V104, P10122, DOI 10.1073/pnas.0700269104; Tokuyama H, 2005, INT IMMUNOL, V17, P1023, DOI 10.1093/intimm/dxh284; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Varona R, 2003, EUR J IMMUNOL, V33, P2937, DOI 10.1002/eji.200324347; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Weber B, 2009, SEMIN IMMUNOPATHOL, V31, P171, DOI 10.1007/s00281-009-0156-5; Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Wurbel MA, 2007, J IMMUNOL, V178, P7598, DOI 10.4049/jimmunol.178.12.7598	49	102	107	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16442	10.1371/journal.pone.0016442	http://dx.doi.org/10.1371/journal.pone.0016442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283540	gold, Green Submitted, Green Published			2022-12-25	WOS:000286661400053
J	Liu, L; Fang, Y; Huang, QS; Wu, JH				Liu, Li; Fang, Ying; Huang, Qingsheng; Wu, Jianhua			A Rigidity-Enhanced Antimicrobial Activity: A Case for Linear Cationic alpha-Helical Peptide HP(2-20) and Its Four Analogues	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPE; MOLECULAR-DYNAMICS; HELICOBACTER-PYLORI; MECHANICS; SIMULATIONS; POLYPEPTIDE; ELASTICITY; RESISTANCE; STABILITY; MEMBRANE	Linear cationic a-helical antimicrobial peptides are referred to as one of the most likely substitutes for common antibiotics, due to their relatively simple structures (<= 40 residues) and various antimicrobial activities against a wide range of pathogens. Of those, HP(2-20) was isolated from Helicobacter pylori ribosomal protein. To reveal a mechanical determinant that may mediate the antimicrobial activities, we examined the mechanical properties and structural stabilities of HP(2-20) and its four analogues of same chain length by steered molecular dynamics simulation. The results indicated the following: the resistance of H-bonds to the tensile extension mediated the early extensive stage; with the loss of H-bonds, the tensile force was dispensed to prompt the conformational phase transition; and Young's moduli (N/m(2)) of the peptides were about 4 similar to 8 x 10(9). These mechanical features were sensitive to the variation of the residue compositions. Furthermore, we found that the antimicrobial activity is rigidity-enhanced, that is, a harder peptide has stronger antimicrobial activity. It suggests that the molecular spring constant may be used to seek a new structure-activity relationship for different a-helical peptide groups. This exciting result was reasonably explained by a possible mechanical mechanism that regulates both the membrane pore formation and the peptide insertion.	[Liu, Li; Fang, Ying; Huang, Qingsheng; Wu, Jianhua] S China Univ Technol, Inst Biomech, Guangzhou, Guangdong, Peoples R China; [Liu, Li; Fang, Ying; Huang, Qingsheng; Wu, Jianhua] S China Univ Technol, Dept Biomed Engn, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Huang, Qingsheng] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	South China University of Technology; South China University of Technology; Sun Yat Sen University	Liu, L (corresponding author), S China Univ Technol, Inst Biomech, Guangzhou, Guangdong, Peoples R China.	wujianhua@scut.edu.cn	Huang, Alexander/AAL-5365-2021	Huang, Alexander/0000-0001-7352-0435	NSFC [10772069, 10972081]; Guangdong Science and Technology Projects of Industrial Research grant [B011000017]	NSFC(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Projects of Industrial Research grant	This work was supported by NSFC grants 10772069 (JW) and 10972081 (YF) and by Guangdong Science and Technology Projects of Industrial Research grant B011000017 (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin R, 2009, BIOPHYS J, V96, P1105, DOI 10.1016/j.bpj.2008.10.046; Ajesh K, 2009, PEPTIDES, V30, P999, DOI 10.1016/j.peptides.2009.01.026; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Carl P, 2001, P NATL ACAD SCI USA, V98, P1565, DOI 10.1073/pnas.031409698; Chakrabarti B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031903; Chen HM, 2001, J BIOMOL STRUCT DYN, V19, P193, DOI 10.1080/07391102.2001.10506731; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; GREENLEAF WJ, 2007, HIGH RESOLUTION SING; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Gunnerson KN, 2009, J PHYS CHEM B, V113, P2090, DOI 10.1021/jp803955u; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hertadi R, 2002, PROTEIN SCI, V11, P1532, DOI 10.1110/ps.3600102; Houston ME, 1998, J PEPT RES, V52, P81; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Idiris A, 2000, PROTEIN ENG, V13, P763, DOI 10.1093/protein/13.11.763; Jiang ZQ, 2008, BIOPOLYMERS, V90, P369, DOI 10.1002/bip.20911; Kageshima M, 2001, CHEM PHYS LETT, V343, P77, DOI 10.1016/S0009-2614(01)00678-9; KATAOKA N, 2002, PNAS, V99, P24; Lee KH, 2006, BIOCHEM J, V394, P105, DOI 10.1042/BJ20051574; Lee SA, 2007, BIOCHEMISTRY-US, V46, P3653, DOI 10.1021/bi062233u; Leontiadou H, 2006, J AM CHEM SOC, V128, P12156, DOI 10.1021/ja062927q; Lim SS, 2005, BIOCHEM BIOPH RES CO, V334, P1329, DOI 10.1016/j.bbrc.2005.07.029; LIPHARDT J, 1997, BIOL, V32, P101; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Marshall BT, 2006, BIOPHYS J, V90, P681, DOI 10.1529/biophysj.105.061010; MEHTA AD, SINGLE MOL BIOMECHAN; Oh D, 2000, BIOCHEMISTRY-US, V39, P11855, DOI 10.1021/bi000453g; Oren Z, 1998, BIOPOLYMERS, V47, P451; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Park IY, 2004, J BIOL CHEM, V279, P13896, DOI 10.1074/jbc.M311418200; Park SC, 2008, BBA-BIOMEMBRANES, V1778, P229, DOI 10.1016/j.bbamem.2007.09.020; PAULITSCHKE M, 1995, BLOOD, V86, P342, DOI 10.1182/blood.V86.1.342.bloodjournal861342; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rohs R, 1999, BIOPHYS J, V76, P2760, DOI 10.1016/S0006-3495(99)77429-1; Root DD, 2006, BIOPHYS J, V90, P2852, DOI 10.1529/biophysj.105.071597; Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007; Vanselow DG, 2002, BIOPHYS J, V82, P2293, DOI 10.1016/S0006-3495(02)75575-6; WANG N, 1994, BIOPHYS J, V66, P2181, DOI 10.1016/S0006-3495(94)81014-8; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	45	12	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16441	10.1371/journal.pone.0016441	http://dx.doi.org/10.1371/journal.pone.0016441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283643	Green Published, gold, Green Submitted			2022-12-25	WOS:000286523400036
J	Strnad, P; Schwarz, P; Rasenack, MCD; Kucukoglu, O; Habib, RI; Heuberger, D; Ehehalt, R; Muller, MW; Stiehl, A; Adler, G; Kulaksiz, H				Strnad, Pavel; Schwarz, Peggy; Rasenack, Maria C. D.; Kucukoglu, Ozlem; Habib, Rayan I.; Heuberger, Dominik; Ehehalt, Robert; Mueller, Michael W.; Stiehl, Adolf; Adler, Guido; Kulaksiz, Hasan			Hepcidin Is an Antibacterial, Stress-Inducible Peptide of the Biliary System	PLOS ONE			English	Article							REGULATORY PEPTIDE; CELL-LINES; IRON; EXPRESSION; INFLAMMATION; HEMOCHROMATOSIS; LOCALIZATION; ANEMIA; CHOLESTASIS; NEPHRITIS	Background/Aims: Hepcidin (gene name HAMP), an IL-6-inducible acute phase peptide with antimicrobial properties, is the key negative regulator of iron metabolism. Liver is the primary source of HAMP synthesis, but it is also produced by other tissues such as kidney or heart and is found in body fluids such as urine or cerebrospinal fluid. While the role of hepcidin in biliary system is unknown, a recent study demonstrated that conditional gp130-knockout mice display diminished hepcidin levels and increased rate of biliary infections. Methods: Expression and localization of HAMP in biliary system was analyzed by real time RT-PCR, in-situ hybridization, immunostaining and -blotting, while prohepcidin levels in human bile were determined by ELISA. Results: Hepcidin was detected in mouse/human gallbladder and bile duct epithelia. Biliary HAMP is stress-inducible, in that it is increased in biliary cell lines upon IL-6 stimulation and in gallbladder mucosa of patients with acute cholecystitis. Hepcidin is also present in the bile and elevated prohepcidin levels were observed in bile of primary sclerosing cholangitis ( PSC) patients with concurrent bacterial cholangitis compared to PSC subjects without bacterial infection ( median values 22.3 vs. 8.9; p = 0.03). In PSC-cholangitis subjects, bile prohepcidin levels positively correlated with C-reactive protein and bilirubin levels ( r = 0.48 and r = 0.71, respectively). In vitro, hepcidin enhanced the antimicrobial capacity of human bile (p < 0.05). Conclusion: Hepcidin is a stress-inducible peptide of the biliary epithelia and a potential marker of biliary stress. In the bile, hepcidin may serve local functions such as protection from bacterial infections.	[Strnad, Pavel; Schwarz, Peggy; Rasenack, Maria C. D.; Kucukoglu, Ozlem; Habib, Rayan I.; Adler, Guido; Kulaksiz, Hasan] Univ Hosp Ulm, Dept Internal Med 1, Ulm, Germany; [Heuberger, Dominik; Ehehalt, Robert; Stiehl, Adolf; Kulaksiz, Hasan] Univ Heidelberg Hosp, Dept Internal Med, Div Gastroenterol, Heidelberg, Germany; [Mueller, Michael W.] Med Ctr Stuttgart, Dept Gen & Visceral Surg, Stuttgart, Germany	Ulm University; Ruprecht Karls University Heidelberg	Strnad, P (corresponding author), Univ Hosp Ulm, Dept Internal Med 1, Ulm, Germany.	hasan.kulaksiz@uniklinik-ulm.de	Kucukoglu, Ozlem/J-4713-2019	Kucukoglu, Ozlem/0000-0002-4217-9075; Ehehalt, Robert/0000-0003-4252-5801	Deutsche Forschungsgemeinschaft [KU 1253/5-3]; Emmy-Noether-Programme funding [STR 1095/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Emmy-Noether-Programme funding	Funded by grant of the Deutsche Forschungsgemeinschaft (KU 1253/5-3) to H. K. and by the Emmy-Noether-Programme funding to P. S. (STR 1095/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold J, 2010, WORLD J GASTROENTERO, V16, P2129, DOI 10.3748/wjg.v16.i17.2129; Ashrafian H, 2003, INFECT IMMUN, V71, P6693, DOI 10.1128/IAI.71.12.6693-6700.2003; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Brissot P, 1997, HEPATOLOGY, V25, P1457, DOI 10.1002/hep.510250625; Chen XM, 2008, IMMUNOL CELL BIOL, V86, P497, DOI 10.1038/icb.2008.37; Falzacappa MVV, 2005, GENE, V364, P37, DOI 10.1016/j.gene.2005.07.020; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Huang YH, 2009, LAB INVEST, V89, P1128, DOI 10.1038/labinvest.2009.82; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Knutson MD, 2010, ANNU REV NUTR, V30, P149, DOI 10.1146/annurev.nutr.012809.104801; Kroot JJC, 2009, ANAL BIOCHEM, V389, P124, DOI 10.1016/j.ab.2009.03.039; Kulaksiz H, 2004, GUT, V53, P735, DOI 10.1136/gut.2003.022863; Kulaksiz H, 2005, J ENDOCRINOL, V184, P361, DOI 10.1677/joe.1.05729; Kulaksiz H, 2008, J ENDOCRINOL, V197, P241, DOI 10.1677/JOE-07-0528; Marques F, 2009, ENDOCRINOLOGY, V150, P2822, DOI 10.1210/en.2008-1610; Merle U, 2007, ENDOCRINOLOGY, V148, P2663, DOI 10.1210/en.2006-1331; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Pietrangelo A, 2007, HEPATOLOGY, V46, P1291, DOI 10.1002/hep.21886; Punnonen EL, 1999, J HISTOCHEM CYTOCHEM, V47, P99, DOI 10.1177/002215549904700111; STORTO PD, 1990, GENE CHROMOSOME CANC, V2, P300, DOI 10.1002/gcc.2870020408; Viatte L, 2009, BIOCHIMIE, V91, P1223, DOI 10.1016/j.biochi.2009.06.012; Wenderfer SE, 2009, AM J NEPHROL, V30, P450, DOI 10.1159/000242430; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Wuestefeld T, 2005, HEPATOLOGY, V42, P1082, DOI 10.1002/hep.20912; Zhang XL, 2008, KIDNEY INT, V74, P799, DOI 10.1038/ki.2008.316; Zhong BH, 2007, MOL BIOL CELL, V18, P4969, DOI 10.1091/mbc.E07-02-0180	29	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16454	10.1371/journal.pone.0016454	http://dx.doi.org/10.1371/journal.pone.0016454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283681	Green Published, Green Submitted, gold			2022-12-25	WOS:000286523400038
J	Vavricka, C; Han, QA; Huang, YP; Erickson, SM; Harich, K; Christensen, BM; Li, JY				Vavricka, Christopher; Han, Qian; Huang, Yongping; Erickson, Sara M.; Harich, Kim; Christensen, Bruce M.; Li, Jianyong			From L-Dopa to Dihydroxyphenylacetaldehyde: A Toxic Biochemical Pathway Plays a Vital Physiological Function in Insects	PLOS ONE			English	Article							ALPHA-METHYL-DOPA; DROSOPHILA-MELANOGASTER; MONOAMINE-OXIDASE; HYPERSENSITIVE GENE; PARKINSONS-DISEASE; DECARBOXYLASE; EXPRESSION; INHIBITOR; MUTANTS; 3,4-DIHYDROXYPHENYLACETALDEHYDE	One protein in Aedes aegypti, classified into the aromatic amino acid decarboxylase (AAAD) family based on extremely high sequence homology (similar to 70%) with dopa decarboxylase (Ddc), was biochemically investigated. Our data revealed that this predicted AAAD protein use L-dopa as a substrate, as does Ddc, but it catalyzes the production of 3,4-dihydroxylphenylacetaldehyde (DHPAA) directly from L-dopa and apparently has nothing to do with the production of any aromatic amine. The protein is therefore named DHPAA synthase. This subsequently led to the identification of the same enzyme in Drosophila melanogaster, Anopheles gambiae and Culex quinquefasciatus by an initial prediction of putative DHPAA synthase based on sequence homology and subsequent verification of DHPAA synthase identity through protein expression and activity assays. DHPAA is highly toxic because its aldehyde group readily reacts with the primary amino groups of proteins, leading to protein crosslinking and inactivation. It has previously been demonstrated by several research groups that Drosophila DHPAA synthase was expressed in tissues that produce cuticle materials and apparent defects in regions of colorless, flexible cuticular structures have been observed in its gene mutants. The presence of free amino groups in proteins, the high reactivity of DHPAA with the free amino groups, and the genetically ascertained function of the Drosophila DHPAA synthase in the formation of colorless, flexible cuticle, when taken together, suggest that mosquito and Drosophila DHPAA synthases are involved in the formation of flexible cuticle through their reactive DHPAA-mediated protein crosslinking reactions. Our data illustrate how a seemingly highly toxic pathway can serve for an important physiological function in insects.	[Vavricka, Christopher; Han, Qian; Harich, Kim; Li, Jianyong] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Huang, Yongping] Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Erickson, Sara M.; Christensen, Bruce M.] Univ Wisconsin, Dept Pathobiol, Madison, WI USA	Virginia Polytechnic Institute & State University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Wisconsin System; University of Wisconsin Madison	Vavricka, C (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	lij@vt.edu	Han, Qian/AAS-2134-2020; Han, Qian/J-8696-2014; Vavricka, Christopher/AAU-8080-2021	Han, Qian/0000-0001-6245-5252; 	National Institutes of Health [AI 19769]; College of Agriculture and Life Sciences, Virginia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019769, R37AI019769, R22AI019769, T32AI007414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Agriculture and Life Sciences, Virginia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by National Institutes of Health grant AI 19769 and the College of Agriculture and Life Sciences, Virginia Tech (http://www.cals.vt.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Andersen SO, 2001, INSECT BIOCHEM MOLEC, V31, P445, DOI 10.1016/S0965-1748(00)00139-9; ANDERSEN SO, 2005, COMPREHENSIVE MOL IN, V4, P145; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; BLACK BC, 1987, MOL GEN GENET, V209, P306, DOI 10.1007/BF00329658; Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002; Burke WJ, 2004, NEUROTOXICOLOGY, V25, P101, DOI 10.1016/S0161-813X(03)00090-1; Cutillas B, 2002, NEUROSCI LETT, V329, P165, DOI 10.1016/S0304-3940(02)00614-6; Dunkel P, 2008, CURR MED CHEM, V15, P1827, DOI 10.2174/092986708785133022; Han Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008826; Loutelier-Bourhis C, 2004, RAPID COMMUN MASS SP, V18, P571, DOI 10.1002/rcm.1369; Luz C, 2005, MYCOPATHOLOGIA, V160, P51, DOI 10.1007/s11046-005-0210-3; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; MARSH JL, 1986, GENETICS, V112, P249; MARSH JL, 1986, GENETICS, V114, P453; MATTAMMAL MB, 1993, J CHROMATOGR-BIOMED, V614, P205, DOI 10.1016/0378-4347(93)80310-Z; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Petzer JP, 2009, NEUROTHERAPEUTICS, V6, P141, DOI 10.1016/j.nurt.2008.10.035; Rees JN, 2009, CHEM RES TOXICOL, V22, P1256, DOI 10.1021/tx9000557; Saunder EFH, 2009, J CLIN PSYCHOPHARM, V29, P461, DOI 10.1097/JCP.0b013e3181b2b9f3; Sheng JZ, 2006, CURR MICROBIOL, V53, P124, DOI 10.1007/s00284-005-5336-5; SHERALD AF, 1974, MOL GEN GENET, V133, P25, DOI 10.1007/BF00268674; SLATES HL, 1964, J ORG CHEM, V29, P1424, DOI 10.1021/jo01029a039; SPARROW JC, 1974, MOL GEN GENET, V130, P127, DOI 10.1007/BF00269084; WANG DG, 1995, DEV BIOL, V168, P598, DOI 10.1006/dbio.1995.1105; Wang DG, 1996, P NATL ACAD SCI USA, V93, P7103, DOI 10.1073/pnas.93.14.7103; WRIGHT TRF, 1976, GENETICS, V84, P287; WRIGHT TRF, 1976, GENETICS, V84, P267; Youdim MBH, 2006, BRIT J PHARMACOL, V147, pS287, DOI 10.1038/sj.bjp.0706464; Youdim Moussa B. H., 2006, Current Alzheimer Research, V3, P541, DOI 10.2174/156720506779025288	31	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e16124	10.1371/journal.pone.0016124	http://dx.doi.org/10.1371/journal.pone.0016124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	21283636	Green Published, gold			2022-12-25	WOS:000286523400022
J	Hirrlinger, PG; Pannicke, T; Winkler, U; Claudepierre, T; Varshney, S; Schulze, C; Reichenbach, A; Brunken, WJ; Hirrlinger, J				Hirrlinger, Petra G.; Pannicke, Thomas; Winkler, Ulrike; Claudepierre, Thomas; Varshney, Shweta; Schulze, Christine; Reichenbach, Andreas; Brunken, William J.; Hirrlinger, Johannes			Genetic Deletion of Laminin Isoforms beta 2 and gamma 3 Induces a Reduction in Kir4.1 and Aquaporin-4 Expression and Function in the Retina	PLOS ONE			English	Article							RECTIFYING POTASSIUM CHANNEL; MULLER GLIAL-CELLS; SENSORINEURAL DEAFNESS; GLYCOPROTEIN COMPLEX; GLUTAMATE UPTAKE; MOUSE RETINA; RAT RETINA; MEMBRANE; MICE; MUTATIONS	Background: Glial cells such as retinal Muller glial cells are involved in potassium ion and water homeostasis of the neural tissue. In these cells, inwardly rectifying potassium (Kir) channels and aquaporin-4 water channels play an important role in the process of spatial potassium buffering and water drainage. Moreover, Kir4.1 channels are involved in the maintenance of the negative Muller cell membrane potential. The subcellular distribution of Kir4.1 and aquaporin-4 channels appears to be maintained by interactions with extracellular and intracellular molecules. Laminins in the extracellular matrix, dystroglycan in the membrane, and dystrophins in the cytomatrix form a complex mediating the polarized expression of Kir4.1 and aquaporin-4 in Muller cells. Methodology/Principal Findings: The aim of the present study was to test the function of the beta 2 and gamma 3 containing laminins in murine Muller cells. We used knockout mice with genetic deletion of both beta 2 and gamma 3 laminin genes to assay the effects on Kir4.1 and aquaporin-4. We studied protein and mRNA expression by immunohistochemistry, Western Blot, and quantitative RT-PCR, respectively, and membrane currents of isolated cells by patch-clamp experiments. We found a down-regulation of mRNA and protein of Kir4.1 as well as of aquaporin-4 protein in laminin knockout mice. Moreover, Muller cells from laminin beta 2 and gamma 3 knockout mice had reduced Kir-mediated inward currents and their membrane potentials were more positive than those in age-matched wild-type mice. Conclusion: These findings demonstrate a strong impact of laminin beta 2 and gamma 3 subunits on the expression and function of both aquaporin-4 and Kir4.1, two important membrane proteins in Muller cells.	[Hirrlinger, Petra G.; Pannicke, Thomas; Reichenbach, Andreas] Univ Leipzig, Paul Flechsig Inst Brain Res, Leipzig, Germany; [Winkler, Ulrike; Schulze, Christine; Hirrlinger, Johannes] Univ Leipzig, Carl Ludwig Inst Physiol, Leipzig, Germany; [Winkler, Ulrike; Schulze, Christine; Hirrlinger, Johannes] Univ Leipzig, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Claudepierre, Thomas] Univ Leipzig, Dept Ophthalmol, Leipzig, Germany; [Claudepierre, Thomas] Univ Leipzig, Hosp Eye, Leipzig, Germany; [Varshney, Shweta; Brunken, William J.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Varshney, Shweta; Brunken, William J.] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Hirrlinger, PG (corresponding author), Univ Leipzig, Paul Flechsig Inst Brain Res, Leipzig, Germany.	petra.hirrlinger@medizin.uni-leipzig.de	Pannicke, Thomas/A-5078-2017; Hirrlinger, Johannes/F-5984-2010; Reichenbach, Andreas/B-2510-2017	Pannicke, Thomas/0000-0001-7435-9540; Brunken, William J/0000-0001-7330-1814; Claudepierre, Thomas/0000-0001-6968-8518	Deutsche Forschungsgemeinschaft [RE 849/10 (SSP1172), RE 849/12 (FOR748), GRK 1097/1, HI1414/1 (SPP1172)]; Bundesministerium fur Bildung und Forschung [DLR/01GZ0703]; Interdisciplinary Centre for Clinical Research (IZKF) at the Faculty of Medicine, University of Leipzig [N05]; National Institutes of Health [EY12676, NS39502]; NATIONAL EYE INSTITUTE [R01EY012676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039502] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Centre for Clinical Research (IZKF) at the Faculty of Medicine, University of Leipzig; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by grants from the Deutsche Forschungsgemeinschaft (RE 849/10 (SSP1172), RE 849/12 (FOR748), GRK 1097/1, to A.R.; HI1414/1 (SPP1172) to J.H.), the Bundesministerium fur Bildung und Forschung (DLR/01GZ0703, to A. R.), the Interdisciplinary Centre for Clinical Research (IZKF) at the Faculty of Medicine, University of Leipzig (N05 to J.H.) and the National Institutes of Health (EY12676; NS39502 to W.J.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Blank M, 2002, NEUROSCIENCE, V111, P259, DOI 10.1016/S0306-4522(02)00032-5; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Bolz S, 2008, GRAEF ARCH CLIN EXP, V246, P1249, DOI 10.1007/s00417-008-0872-x; Bringmann A, 2000, GLIA, V29, P35, DOI 10.1002/(SICI)1098-1136(20000101)29:1<35::AID-GLIA4>3.0.CO;2-A; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Claudepierre T, 2000, J CELL SCI, V113, P3409; Connors NC, 2006, GLIA, V53, P124, DOI 10.1002/glia.20271; Dalloz C, 2003, HUM MOL GENET, V12, P1543, DOI 10.1093/hmg/ddg170; Denes V, 2007, VISUAL NEUROSCI, V24, P549, DOI 10.1017/S0952523807070514; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Egles C, 2007, MOL CELL NEUROSCI, V34, P288, DOI 10.1016/j.mcn.2006.11.004; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Francke M, 1997, GLIA, V20, P210, DOI 10.1002/(SICI)1098-1136(199707)20:3<210::AID-GLIA5>3.0.CO;2-B; Guadagno E, 2004, GLIA, V47, P138, DOI 10.1002/glia.20039; Halfter W, 1998, J COMP NEUROL, V397, P89, DOI 10.1002/(SICI)1096-9861(19980720)397:1<89::AID-CNE7>3.0.CO;2-E; Heuser K, 2010, EPILEPSY RES, V88, P55, DOI 10.1016/j.eplepsyres.2009.09.023; Hirrlinger PG, 2010, NEUROSCI LETT, V472, P73, DOI 10.1016/j.neulet.2010.01.062; Iandiev I, 2006, INVEST OPHTH VIS SCI, V47, P2161, DOI 10.1167/iovs.05-0595; Ishii M, 1997, J NEUROSCI, V17, P7725; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Landiev I, 2006, EXP EYE RES, V82, P449, DOI 10.1016/j.exer.2005.07.018; Libby RT, 1999, J NEUROSCI, V19, P9399; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; NEWMAN EA, 1984, SCIENCE, V225, P1174, DOI 10.1126/science.6474173; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; Noel G, 2005, J NEUROCHEM, V94, P691, DOI 10.1111/j.1471-4159.2005.03191.x; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; Pannicke T, 2006, DIABETES, V55, P633, DOI 10.2337/diabetes.55.03.06.db05-1349; Pannicke T, 2005, GLIA, V50, P1, DOI 10.1002/glia.20151; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Pannicke T, 2002, GLIA, V38, P268, DOI 10.1002/glia.10068; Pinzon-Duarte G, 2010, INVEST OPHTH VIS SCI, V51, P1773, DOI 10.1167/iovs.09-4645; Puwarawuttipanit W, 2006, NEUROSCIENCE, V137, P165, DOI 10.1016/j.neuroscience.2005.08.051; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tang XF, 2010, BIOCHEM BIOPH RES CO, V399, P537, DOI 10.1016/j.bbrc.2010.07.105; TOUT S, 1993, NEUROSCIENCE, V55, P291, DOI 10.1016/0306-4522(93)90473-S; Tzu J, 2008, INT J BIOCHEM CELL B, V40, P199, DOI 10.1016/j.biocel.2007.07.015; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284	51	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16106	10.1371/journal.pone.0016106	http://dx.doi.org/10.1371/journal.pone.0016106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283711	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522300017
J	Kundu, P; De, R; Pal, I; Mukhopadhyay, AK; Saha, DR; Swarnakar, S				Kundu, Parag; De, Ronita; Pal, Ipsita; Mukhopadhyay, Asish K.; Saha, Dhira Rani; Swarnakar, Snehasikta			Curcumin Alleviates Matrix Metalloproteinase-3 and-9 Activities during Eradication of Helicobacter pylori Infection in Cultured Cells and Mice	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED RECEPTOR-GAMMA; GASTRIC EPITHELIAL-CELLS; NITRIC-OXIDE; DOWN-REGULATION; MOLECULAR-MECHANISMS; EXPRESSION; MATRIX-METALLOPROTEINASE-9; SECRETION; SUPPRESSION	Current therapy-regimens against Helicobacter pylori (Hp) infections have considerable failure rates and adverse side effects that urge the quest for an effective alternative therapy. We have shown that curcumin is capable of eradicating Hp-infection in mice. Here we examine the mechanism by which curcumin protects Hp infection in cultured cells and mice. Since, MMP-3 and -9 are inflammatory molecules associated to the pathogenesis of Hp-infection, we investigated the role of curcumin on inflammatory MMPs as well as proinflammatory molecules. Curcumin dose dependently suppressed MMP-3 and -9 expression in Hp infected human gastric epithelial (AGS) cells. Consistently, Hp-eradication by curcumin-therapy involved significant downregulation of MMP-3 and -9 activities and expression in both cytotoxic associated gene (cag)(+ve) and cag(-ve) Hp-infected mouse gastric tissues. Moreover, we demonstrate that the conventional triple therapy (TT) alleviated MMP-3 and -9 activities less efficiently than curcumin and curcumin's action on MMPs was linked to decreased pro-inflammatory molecules and activator protein-1 activation in Hp-infected gastric tissues. Although both curcumin and TT were associated with MMP-3 and -9 downregulation during Hp-eradication, but unlike TT, curcumin enhanced peroxisome proliferator-activated receptor-gamma and inhibitor of kappa B-alpha. These data indicate that curcumin-mediated healing of Hp-infection involves regulation of MMP-3 and -9 activities.	[Kundu, Parag; Pal, Ipsita; Swarnakar, Snehasikta] Indian Inst Chem Biol, Kolkata, India; [De, Ronita; Mukhopadhyay, Asish K.; Saha, Dhira Rani] Natl Inst Cholera & Enter Dis, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Kundu, P (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	snehasiktas@hotmail.com	DE, RONITA/HDM-7066-2022; Mukhopadhyay, Asish/ABE-7697-2020; Pal, Ipsita/AAX-4410-2020	Kundu, Parag/0000-0002-8684-7530; Swarnakar, Snehasikta/0000-0002-7139-9683; De, Ronita/0000-0002-1469-6139	Council of Scientific and Industrial Research, India [IAP001]; National Tea Research Foundation, India; Founding Research Center for Emerging and Reemerging Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology of Japan	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); National Tea Research Foundation, India(National Tea Research Foundation (NTRF), Government of India); Founding Research Center for Emerging and Reemerging Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by IAP001 grant of Council of Scientific and Industrial Research, India, National Tea Research Foundation, India. Part of the work was supported by the "Program of Founding Research Center for Emerging and Reemerging Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology of Japan". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Bergin PJ, 2004, HELICOBACTER, V9, P201, DOI 10.1111/j.1083-4389.2004.00232.x; Blaser MJ, 1998, BRIT MED J, V316, P1507, DOI 10.1136/bmj.316.7143.1507; Bytzer P, 2005, HELICOBACTER, V10, P40, DOI 10.1111/j.1523-5378.2005.00333.x; Cameron EAB, 2004, J MED MICROBIOL, V53, P535, DOI 10.1099/jmm.0.05499-0; Chattopadhyay S, 2002, J CLIN MICROBIOL, V40, P2622, DOI 10.1128/JCM.40.7.2622-2625.2002; Clutterbuck AL, 2009, CURR DRUG TARGETS, V10, P1245, DOI 10.2174/138945009789753264; De R, 2009, ANTIMICROB AGENTS CH, V53, P1592, DOI 10.1128/AAC.01242-08; Fahmi H, 2001, ARTHRITIS RHEUM, V44, P595, DOI 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.3.CO;2-#; Foryst-Ludwig A, 2004, BIOCHEM BIOPH RES CO, V316, P1065, DOI 10.1016/j.bbrc.2004.02.158; Franchi A, 2002, CANCER-AM CANCER SOC, V95, P1902, DOI 10.1002/cncr.10916; Francois M, 2004, J BIOL CHEM, V279, P28411, DOI 10.1074/jbc.M312708200; Ganguly K, 2006, FREE RADICAL BIO MED, V41, P911, DOI 10.1016/j.freeradbiomed.2006.04.022; Ganguly K, 2010, J PINEAL RES, V49, P130, DOI 10.1111/j.1600-079X.2010.00776.x; GHOSH MN, 2005, FUNDAMENTALS PHARM; Gooz M, 2003, GUT, V52, P1250, DOI 10.1136/gut.52.9.1250; Han C, 2006, FEBS J, V273, P4682, DOI 10.1111/j.1742-4658.2006.05469.x; Kasperczyk H, 2005, ONCOGENE, V24, P6945, DOI 10.1038/sj.onc.1208842; Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim SY, 2005, BIOCHEM BIOPH RES CO, V337, P510, DOI 10.1016/j.bbrc.2005.09.079; KONTUREK PC, 2003, MED SCI MONITOR, V9, pSR65; Kositchaiwat Chomsri, 1993, Journal of the Medical Association of Thailand, V76, P601; Kundu P, 2006, J BIOL CHEM, V281, P34651, DOI 10.1074/jbc.M604574200; Lee KJ, 2004, EXP MOL MED, V36, P534, DOI 10.1038/emm.2004.68; Mahady GB, 2002, ANTICANCER RES, V22, P4179; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Meyer-ter-Vehn T, 2000, J BIOL CHEM, V275, P16064, DOI 10.1074/jbc.M000959200; Mian BM, 2003, CLIN CANCER RES, V9, P3167; MOLLER H, 1995, INT J CANCER, V60, P587, DOI 10.1002/ijc.2910600502; MONCADA S, 1991, PHARMACOL REV, V43, P109; Mori N, 2003, GASTROENTEROLOGY, V124, P983, DOI 10.1053/gast.2003.50152; Munzenmaier A, 1997, J IMMUNOL, V159, P6140; Nam KT, 2004, GUT, V53, P1250, DOI 10.1136/gut.2003.030684; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Parks WC, 1998, BIOL EXTRAC, P263; Pillinger MH, 2005, J BIOL CHEM, V280, P9973, DOI 10.1074/jbc.M413522200; QURESHI S, 1992, PLANTA MED, V58, P124, DOI 10.1055/s-2006-961412; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ridnour LA, 2007, P NATL ACAD SCI USA, V104, P16898, DOI 10.1073/pnas.0702761104; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Saia K, 2007, INT IMMUNOPHARMACOL, V7, P1659, DOI 10.1016/j.intimp.2007.08.018; Sambrook J, 2001, MOL CLONING LAB MANU; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Shimada T, 1998, J GASTROENTEROL, V33, P613, DOI 10.1007/s005350050146; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Swarnakar S, 2005, J BIOL CHEM, V280, P9409, DOI 10.1074/jbc.M413398200; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wroblewski LE, 2003, J CELL SCI, V116, P3017, DOI 10.1242/jcs.00518; Wu CY, 2005, WORLD J GASTROENTERO, V11, P3197, DOI 10.3748/wjg.v11.i21.3197; Zhang M, 2006, INT IMMUNOPHARMACOL, V6, P1233, DOI 10.1016/j.intimp.2006.02.013	54	53	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16306	10.1371/journal.pone.0016306	http://dx.doi.org/10.1371/journal.pone.0016306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283694	Green Submitted, gold, Green Published			2022-12-25	WOS:000286522300032
J	Miller-Delaney, SFC; Lieberam, I; Murphy, P; Mitchell, KJ				Miller-Delaney, Suzanne F. C. d; Lieberam, Ivo; Murphy, Paula; Mitchell, Kevin J.			Plxdc2 Is a Mitogen for Neural Progenitors	PLOS ONE			English	Article							DEVELOPING NERVOUS-SYSTEM; GENE-EXPRESSION; ENDOTHELIAL MARKERS; CEREBRAL-CORTEX; IN-VIVO; CELLS; PROLIFERATION; MICE; DIFFERENTIATION; CANCER	The development of different brain regions involves the coordinated control of proliferation and cell fate specification along and across the neuraxis. Here, we identify Plxdc2 as a novel regulator of these processes, using in ovo electroporation and in vitro cultures of mammalian cells. Plxdc2 is a type I transmembrane protein with some homology to nidogen and to plexins. It is expressed in a highly discrete and dynamic pattern in the developing nervous system, with prominent expression in various patterning centres. In the chick neural tube, where Plxdc2 expression parallels that seen in the mouse, misexpression of Plxdc2 increases proliferation and alters patterns of neurogenesis, resulting in neural tube thickening at early stages. Expression of the Plxdc2 extracellular domain alone, which can be cleaved and shed in vivo, is sufficient for this activity, demonstrating a cell non-autonomous function. Induction of proliferation is also observed in cultured embryonic neuroepithelial cells( ENCs) derived from E9.5 mouse neural tube, which express a Plxdc2-binding activity. These experiments uncover a direct molecular activity of Plxdc2 in the control of proliferation, of relevance in understanding the role of this protein in various cancers, where its expression has been shown to be altered. They also implicate Plxdc2 as a novel component of the network of signalling molecules known to coordinate proliferation and differentiation in the developing nervous system.	[Miller-Delaney, Suzanne F. C. d; Mitchell, Kevin J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Miller-Delaney, Suzanne F. C. d; Mitchell, Kevin J.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Lieberam, Ivo] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; [Murphy, Paula] Trinity Coll Dublin, Dept Zool, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Columbia University; Howard Hughes Medical Institute; Trinity College Dublin	Miller-Delaney, SFC (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.	Kevin.Mitchell@tcd.ie		Murphy, Paula/0000-0002-8048-6850; Lieberam, Ivo/0000-0003-3539-3054; Mitchell, Kevin/0000-0002-3433-4530	Science Foundation Ireland [01/F1/B006, 02/IN1/B267]; MRC [G0900585] Funding Source: UKRI; Medical Research Council [G0900585] Funding Source: researchfish	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Science Foundation Ireland (www.sfi.ie) Investigator grants to KJM (01/F1/B006) and PM (02/IN1/B267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaty RM, 2007, J NEURO-ONCOL, V81, P241, DOI 10.1007/s11060-006-9227-9; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Cheung AFP, 2007, J ANAT, V211, P164, DOI 10.1111/j.1469-7580.2007.00769.x; Davies G, 2004, CLIN EXP METASTAS, V21, P31, DOI 10.1023/B:CLIN.0000017168.83616.d0; DICKINSON ME, 1994, DEVELOPMENT, V120, P1453; Echevarria D, 2003, BRAIN RES REV, V43, P179, DOI 10.1016/j.brainresrev.2003.08.002; El Wakil A, 2006, DEVELOPMENT, V133, P2155, DOI 10.1242/dev.02377; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Funahashi J, 1999, DEV GROWTH DIFFER, V41, P59; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hemming ML, 2008, PLOS BIOL, V6, P2314, DOI 10.1371/journal.pbio.0060257; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Ishibashi Makoto, 2005, Anatomical Science International, V80, P30; JASONI CL, 1994, DEVELOPMENT, V120, P769; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee HK, 2006, FEBS LETT, V580, P2253, DOI 10.1016/j.febslet.2006.03.033; Lee HK, 2007, J NEUROCHEM, V102, P686, DOI 10.1111/j.1471-4159.2007.04580.x; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lee SMK, 1997, DEVELOPMENT, V124, P959; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Matsunaga E, 2002, DEVELOPMENT, V129, P5269; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Megason SG, 2002, DEVELOPMENT, V129, P2087; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Miller SFC, 2007, GENE EXPR PATTERNS, V7, P635, DOI 10.1016/j.modgep.2006.12.002; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nanda A, 2004, CANCER RES, V64, P8507, DOI 10.1158/0008-5472.CAN-04-2716; Nardelli J, 2003, J NEUROSCI RES, V73, P737, DOI 10.1002/jnr.10716; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Placzek M, 2005, NAT REV NEUROSCI, V6, P230, DOI 10.1038/nrn1628; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Rmali KA, 2007, COLORECTAL DIS, V9, P3, DOI 10.1111/j.1463-1318.2006.01089.x; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2; Schwarze SR, 2005, NEOPLASIA, V7, P816, DOI 10.1593/neo.05250; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; St Croix B, 2000, SCIENCE, V289, P1197; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Ulloa F, 2007, CELL CYCLE, V6, P2640, DOI 10.4161/cc.6.21.4822; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wang XQ, 2005, MICROVASC RES, V70, P189, DOI 10.1016/j.mvr.2005.08.004; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yu JM, 2006, MOL CELL BIOCHEM, V288, P17, DOI 10.1007/s11010-005-9113-3	50	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14565	10.1371/journal.pone.0014565	http://dx.doi.org/10.1371/journal.pone.0014565			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21283688	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522300005
J	Campbell, MG; Karbstein, K				Campbell, Melody G.; Karbstein, Katrin			Protein-Protein Interactions within Late Pre-40S Ribosomes	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CYTOPLASMIC MATURATION; EUKARYOTIC RIBOSOME; SUBUNIT PRECURSORS; PRE-RIBOSOMES; CROSS-LINKING; PIN DOMAIN; RNA; BIOGENESIS; YEAST	Ribosome assembly in eukaryotic organisms requires more than 200 assembly factors to facilitate and coordinate rRNA transcription, processing, and folding with the binding of the ribosomal proteins. Many of these assembly factors bind and dissociate at defined times giving rise to discrete assembly intermediates, some of which have been partially characterized with regards to their protein and RNA composition. Here, we have analyzed the protein-protein interactions between the seven assembly factors bound to late cytoplasmic pre-40S ribosomes using recombinant proteins in binding assays. Our data show that these factors form two modules: one comprising Enp1 and the export adaptor Ltv1 near the beak structure, and the second comprising the kinase Rio2, the nuclease Nob1, and a regulatory RNA binding protein Dim2/Pno1 on the front of the head. The GTPase-like Tsr1 and the universally conserved methylase Dim1 are also peripherally connected to this second module. Additionally, in an effort to further define the locations for these essential proteins, we have analyzed the interactions between these assembly factors and six ribosomal proteins: Rps0, Rps3, Rps5, Rps14, Rps15 and Rps29. Together, these results and previous RNA-protein crosslinking data allow us to propose a model for the binding sites of these seven assembly factors. Furthermore, our data show that the essential kinase Rio2 is located at the center of the pre-ribosomal particle and interacts, directly or indirectly, with every other assembly factor, as well as three ribosomal proteins required for cytoplasmic 40S maturation. These data suggest that Rio2 could play a central role in regulating cytoplasmic maturation steps.	[Campbell, Melody G.; Karbstein, Katrin] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA	Scripps Research Institute	Campbell, MG (corresponding author), Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	kkarbst@scripps.edu		Karbstein, Katrin/0000-0002-4034-1331; Campbell, Melody/0000-0003-1909-5751	NIH [R01-GM086451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086451] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grant R01-GM086451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnsack MT, 2009, MOL CELL, V36, P583, DOI 10.1016/j.molcel.2009.09.039; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Chen WD, 2003, NUCLEIC ACIDS RES, V31, P690, DOI 10.1093/nar/gkg145; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fassio CA, 2010, GENETICS, V185, P199, DOI 10.1534/genetics.110.115584; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Freed EF, 2010, NUCLEIC ACIDS RES, V38, P4798, DOI 10.1093/nar/gkq185; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Granneman S, 2010, EMBO J, V29, P2026, DOI 10.1038/emboj.2010.86; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jakovljevic J, 2004, MOL CELL, V14, P331, DOI 10.1016/S1097-2765(04)00215-1; Jia MZ, 2010, J MOL BIOL, V398, P774, DOI 10.1016/j.jmb.2010.03.055; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; LAFONTAINE D, 1995, GENE DEV, V9, P2470, DOI 10.1101/gad.9.20.2470; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Lee SJ, 1999, MOL CELL BIOL, V19, P5441; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Merl J, 2010, NUCLEIC ACIDS RES, V38, P3068, DOI 10.1093/nar/gkp1244; Neueder A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010194; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Pertschy B, 2009, J BIOL CHEM, V284, P35079, DOI 10.1074/jbc.M109.040774; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; TONE Y, 2002, GENE DEV, V16; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Wehner KA, 2002, MOL CELL BIOL, V22, P7258, DOI 10.1128/MCB.22.20.7258-7267.2002; Woolls HA, 2011, J BIOL CHEM, V286, P2578, DOI 10.1074/jbc.M110.191494; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P534, DOI 10.1038/nsmb.1408; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	44	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16194	10.1371/journal.pone.0016194	http://dx.doi.org/10.1371/journal.pone.0016194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283762	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200034
J	Goyal, P; Behring, A; Kumar, A; Siess, W				Goyal, Pankaj; Behring, Antje; Kumar, Abhishek; Siess, Wolfgang			STK35L1 Associates with Nuclear Actin and Regulates Cell Cycle and Migration of Endothelial Cells	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; SMOOTH-MUSCLE-CELLS; BETA-CATENIN; PROTEIN; P27(KIP1); PHOSPHORYLATION; DISEASE; ATHEROSCLEROSIS; DIFFERENTIATION; IDENTIFICATION	Background: Migration and proliferation of vascular endothelial cells are essential for repair of injured endothelium and angiogenesis. Cyclins, cyclin-dependent kinases (CDKs), and cyclin-dependent kinase inhibitors play an important role in vascular tissue injury and wound healing. Previous studies suggest a link between the cell cycle and cell migration: cells present in the G(1) phase have the highest potential to migrate. The molecular mechanism linking these two processes is not understood. Methodology/Principal Findings: In this study, we explored the function of STK35L1, a novel Ser/Thr kinase, localized in the nucleus and nucleolus of endothelial cells. Molecular biological analysis identified a bipartite nuclear localization signal, and nucleolar localization sequences in the N-terminal part of STK35L1. Nuclear actin was identified as a novel binding partner of STK35L1. A class III PDZ binding domains motif was identified in STK35L1 that mediated its interaction with actin. Depletion of STK35L1 by siRNA lead to an accelerated G(1) to S phase transition after serum-stimulation of endothelial cells indicating an inhibitory role of the kinase in G(1) to S phase progression. Cell cycle specific genes array analysis revealed that one gene was prominently downregulated (8.8 fold) in STK35L1 silenced cells: CDKN2A alpha transcript, which codes for p16(INK4a) leading to G(1) arrest by inhibition of CDK4/6. Moreover in endothelial cells seeded on Matrigel, STK35L1 expression was rapidly upregulated, and silencing of STK35L1 drastically inhibited endothelial sprouting that is required for angiogenesis. Furthermore, STK35L1 depletion profoundly impaired endothelial cell migration in two wound healing assays. Conclusion/Significance: The results indicate that by regulating CDKN2A and inhibiting G(1)-to S-phase transition STK35L1 may act as a central kinase linking the cell cycle and migration of endothelial cells. The interaction of STK35L1 with nuclear actin might be critical in the regulation of these fundamental endothelial functions.	[Goyal, Pankaj; Behring, Antje; Siess, Wolfgang] Univ Munich, Klinikum Innenstadt, Inst Prophylaxe & Epidemiol Kreislaufkrankheiten, D-8000 Munich, Germany; [Kumar, Abhishek] Univ Padua, Dept Biol, Padua, Italy	University of Munich; University of Padua	Goyal, P (corresponding author), Ernst Moritz Arndt Univ Greifswald, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Greifswald, Germany.	pankaj.goyal@med.uni-muenchen.de	Goyal, Pankaj/C-3567-2012; Siess, Wolfgang/A-6430-2009; Kumar, Abhishek/A-8727-2012	Siess, Wolfgang/0000-0003-0698-6416; Kumar, Abhishek/0000-0003-4172-4059	August-Lenz-Stiftung [Si 274/11-1]; Deutsche Forschungsgemeinschaft [GRK 438]; Forderprogramm fur Forschung und Lehre (FoFoLe) [541]; Medical Faculty, University of Munich	August-Lenz-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forderprogramm fur Forschung und Lehre (FoFoLe); Medical Faculty, University of Munich	The work was supported by grants from the Si 274/11-1, August-Lenz-Stiftung and the Deutsche Forschungsgemeinschaft (Graduate Program "Vascular Biology in Medicine'' Grants GRK 438 to PG and AB), and Forderprogramm fur Forschung und Lehre (FoFoLe) Reg. Nr. 541 (to AB), Medical Faculty, University of Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 2004, CARDIOVASC RES, V63, P11, DOI 10.1016/j.cardiores.2004.02.009; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bauer K, 2000, BLOOD, V96, P4236; Bonneton C, 1999, CELL MOTIL CYTOSKEL, V43, P288, DOI 10.1002/(SICI)1097-0169(1999)43:4<288::AID-CM2>3.3.CO;2-P; Bornfeldt KE, 2003, CIRC RES, V92, P345, DOI 10.1161/01.RES.0000061765.06145.10; Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472.CAN-05-3489; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Denicourt C, 2004, GENE DEV, V18, P851, DOI 10.1101/gad.1205304; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Everett AD, 2001, J BIOL CHEM, V276, P37564, DOI 10.1074/jbc.M105109200; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Freedman DA, 2005, EXP CELL RES, V307, P118, DOI 10.1016/j.yexcr.2005.03.025; Fukui R, 2000, AM J PHYSIOL-CELL PH, V279, pC999, DOI 10.1152/ajpcell.2000.279.4.C999; Goukassian D, 2001, FASEB J, V15, P1877, DOI 10.1096/fj.01-0065com; Goyal P, 2005, J BIOL CHEM, V280, P27569, DOI 10.1074/jbc.M504448200; Goyal P, 2006, J BIOL CHEM, V281, P25223, DOI 10.1074/jbc.M603399200; Goyal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006981; Heist EK, 1998, J BIOL CHEM, V273, P19763, DOI 10.1074/jbc.273.31.19763; Hofmann WA, 2006, J CELL BIOL, V172, P495, DOI 10.1083/jcb.200601095; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Hourani Mou'ath, 2008, V453, P379, DOI 10.1007/978-1-60327-429-6_20; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Larson EM, 1997, INVEST OPHTH VIS SCI, V38, P1929; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; Nabel EG, 2002, NAT REV DRUG DISCOV, V1, P587, DOI 10.1038/nrd869; Nourry Claire, 2003, Sci STKE, V2003, pRE7; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Prudencio M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000201; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Russo G, 1997, J BIOL CHEM, V272, P5229, DOI 10.1074/jbc.272.8.5229; Saegusa M, 2006, INT J CANCER, V119, P2294, DOI 10.1002/ijc.22112; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009; Sun J, 2001, CIRCULATION, V103, P2967, DOI 10.1161/01.CIR.103.24.2967; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Wassermann S, 2009, GASTROENTEROLOGY, V136, P196, DOI 10.1053/j.gastro.2008.09.019; Wu FY, 2006, CANCER RES, V66, P2162, DOI 10.1158/0008-5472.CAN-05-3304	49	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16249	10.1371/journal.pone.0016249	http://dx.doi.org/10.1371/journal.pone.0016249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283756	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522200043
J	Russ, PK; Pino, CJ; Williams, CS; Bader, DM; Haselton, FR; Chang, MS				Russ, Patricia K.; Pino, Christopher J.; Williams, Christopher S.; Bader, David M.; Haselton, Frederick R.; Chang, Min S.			Bves Modulates Tight Junction Associated Signaling	PLOS ONE			English	Article							CONTAINING GENE FAMILY; SKELETAL-MUSCLE; EXPRESSION; INHIBITION; INTEGRITY; INTERACTS; MOVEMENT; BARRIER; HEART; ZO-1	Blood vessel epicardial substance (Bves) is a transmembrane adhesion protein that regulates tight junction (TJ) formation in a variety of epithelia. The role of TJs within epithelium extends beyond the mechanical properties. They have been shown to play a direct role in regulation of RhoA and ZONAB/DbpA, a y-box transcription factor. We hypothesize that Bves can modulate RhoA activation and ZONAB/DbpA activity through its regulatory effect on TJ formation. Immortalized human corneal epithelial (HCE) cells were stably transfected with Flag-tagged full length chicken Bves (w-Bves) or C-terminus truncated Bves (t-Bves). We found that stably transfected w-Bves and t-Bves were interacting with endogenous human Bves. However, interaction with t-Bves appeared to disrupt cell membrane localization of endogenous Bves and interaction with ZO-1. w-Bves cells exhibited increased TJ function reflected by increased trans-epithelial electrical resistance, while t-Bves cells lost TJ protein immunolocalization at cell-cell contacts and exhibited decreased trans-epithelial electrical resistance. In parental HCE and w-Bves cells ZONAB/DbpA and GEF-H1 were seen at cell borders in the same pattern as ZO-1. However, expression of t-Bves led to decreased membrane localization of both ZONAB/DbpA and GEF-H1. t-Bves cells had increased RhoA activity, as indicated by a significant 30% increase in FRET activity compared to parental HCE cells. ZONAB/DbpA transcriptional activity, assessed using a luciferase reporter probe, was increased in t-Bves cells. These studies demonstrate that Bves expression and localization can regulate RhoA and ZONAB/DbpA activity.	[Russ, Patricia K.; Pino, Christopher J.; Haselton, Frederick R.; Chang, Min S.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Haselton, Frederick R.; Chang, Min S.] Vanderbilt Univ, Dept Ophthalmol & Visual Sci, Nashville, TN USA; [Williams, Christopher S.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN USA; [Bader, David M.] Vanderbilt Univ, Dept Cardiovasc Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Russ, PK (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	patricia.k.russ@vanderbilt.edu	Williams, Christopher/W-3524-2019	Williams, Christopher/0000-0002-1541-579X; Pino, Christopher/0000-0003-4063-9215	NIH [EY 13593, EY 13451, HL 07751]; Vanderbilt University; NATIONAL EYE INSTITUTE [R01EY013451, R01EY017185] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079050, T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080221] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was sponsored in part by NIH grants EY 13593, EY 13451, HL 07751, and by a Vanderbilt University discovery grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Andree B, 2000, DEV BIOL, V223, P371, DOI 10.1006/dbio.2000.9751; Andree B, 2002, MOL CELL BIOL, V22, P1504, DOI 10.1128/MCB.22.5.1504-1512.2002; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; Balda MS, 1998, J CELL SCI, V111, P541; Brand T, 2005, CELL BIOCHEM BIOPHYS, V43, P95, DOI 10.1385/CBB:43:1:095; Chusainow J, 2005, RNA, V11, P1201, DOI 10.1261/rna.7277705; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Frankel P, 2005, EMBO J, V24, P54, DOI 10.1038/sj.emboj.7600497; Hager HA, 2009, HISTOL HISTOPATHOL, V24, P777, DOI 10.14670/HH-24.777; Hamada K, 2010, CANCER CHEMOTH PHARM, V66, P1031, DOI 10.1007/s00280-010-1253-9; Kavanagh E, 2006, J CELL SCI, V119, P5098, DOI 10.1242/jcs.03297; Kawaguchi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002261; Knight RF, 2003, J BIOL CHEM, V278, P32872, DOI 10.1074/jbc.M301961200; Matter K, 1999, INT REV CYTOL, V186, P117; Oshima T, 2001, MICROVASC RES, V61, P130, DOI 10.1006/mvre.2000.2288; Osler ME, 2006, DEV DYNAM, V235, P586, DOI 10.1002/dvdy.20688; Osler ME, 2005, J CELL SCI, V118, P4667, DOI 10.1242/jcs.02588; Osler ME, 2004, DEV DYNAM, V229, P658, DOI 10.1002/dvdy.10490; Reese DE, 1999, MAMM GENOME, V10, P913, DOI 10.1007/s003359901113; Ripley AN, 2006, P NATL ACAD SCI USA, V103, P614, DOI 10.1073/pnas.0506095103; Ripley AN, 2004, INVEST OPHTH VIS SCI, V45, P2475, DOI 10.1167/iovs.04-0013; Russ PK, 2010, INVEST OPHTH VIS SCI, V51, P223, DOI 10.1167/iovs.09-3539; Smith TK, 2008, P NATL ACAD SCI USA, V105, P8298, DOI 10.1073/pnas.0802345105; TSAPARA A, 2010, MOL BIOL CELL; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Vasavada TK, 2004, J HISTOCHEM CYTOCHEM, V52, P371, DOI 10.1177/002215540405200308; Wada AM, 2001, DEVELOPMENT, V128, P2085	29	34	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e14563	10.1371/journal.pone.0014563	http://dx.doi.org/10.1371/journal.pone.0014563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283798	gold, Green Published, Green Submitted			2022-12-25	WOS:000286522200006
J	Park, BS; Jin, SH; Park, JJ; Park, JW; Namgoong, IS; Kim, YI; Lee, BJ; Kim, JG				Park, Byong Seo; Jin, Sung Ho; Park, Joong Jean; Park, Jeong Woo; Namgoong, Il Seong; Kim, Young Il; Lee, Byung Ju; Kim, Jae Geun			Visfatin Induces Sickness Responses in the Brain	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; INSULIN-RESISTANCE; INFLAMMATION; ANOREXIA; BEHAVIOR; OBESITY; ADIPOCYTOKINE; HYPOTHALAMUS; MECHANISMS; APPETITE	Background/Objective: Visfatin, also known as nicotiamide phosphoribosyltransferase or pre-B cell colony enhancing factor, is a pro-inflammatory cytokine whose serum level is increased in sepsis and cancer as well as in obesity. Here we report a pro-inflammatory role of visfatin in the brain, to mediate sickness responses including anorexia, hyperthermia and hypoactivity. Methodology: Rats were intracerebroventricularly (ICV) injected with visfatin, and changes in food intake, body weight, body temperature and locomotor activity were monitored. Real-time PCR was applied to determine the expressions of proinflammatory cytokines, proopiomelanocortin (POMC) and prostaglandin-synthesizing enzymes in their brain. To determine the roles of cyclooxygenase (COX) and melanocortin in the visfatin action, rats were ICV-injected with visfatin with or without SHU9119, a melanocortin receptor antagonist, or indomethacin, a COX inhibitor, and their sickness behaviors were evaluated. Principal Findings: Administration of visfatin decreased food intake, body weight and locomotor activity and increased body temperature. Visfatin evoked significant increases in the levels of pro-inflammatory cytokines, prostaglandin-synthesizing enzymes and POMC, an anorexigenic neuropeptide. Indomethacin attenuated the effects of visfatin on hyperthermia and hypoactivity, but not anorexia. Further, SHU9119 blocked visfatin-induced anorexia but did not affect hyperthermia or hypoactivity. Conclusions: Visfatin induced sickness responses via regulation of COX and the melanocortin pathway in the brain.	[Park, Byong Seo; Jin, Sung Ho; Park, Jeong Woo; Lee, Byung Ju; Kim, Jae Geun] Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea; [Park, Jeong Woo; Lee, Byung Ju; Kim, Jae Geun] Univ Ulsan, Biomed Res Ctr, Coll Med, Ulsan 680749, South Korea; [Park, Joong Jean] Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; [Namgoong, Il Seong; Kim, Young Il] Ulsan Univ Hosp, Dept Internal Med, Ulsan, South Korea	University of Ulsan; University of Ulsan; Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Ulsan University Hospital	Park, BS (corresponding author), Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea.	bjlee@ulsan.ac.kr; jg-kim@mail.ulsan.ac.kr		NAM-GOONG, IL SEONG/0000-0002-0492-0467; Park, Byong Seo/0000-0001-6463-9645; Park, Joong-Jean/0000-0002-4534-3002	National Research Foundation (NRF) of Korea [BRL 2009-0087350]; Brain Research Center [2009K001268]; Ministry of Education, Science and Technology (MEST) [2009-0076067]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Brain Research Center; Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	B.J.L. was supported by the National Research Foundation (NRF) of Korea Grant (BRL 2009-0087350) and by Research Grant (2009K001268) from the Brain Research Center of the 21st Century Frontier Research Program. J.G.K. was supported by the Basic Science Research Program through the NRF funded by the Ministry of Education, Science and Technology (MEST; 2009-0076067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson A, 2007, BRAIN BEHAV IMMUN, V21, P147, DOI 10.1016/j.bbi.2006.08.002; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Carrero JJ, 2010, NEPHROL DIAL TRANSPL, V25, P901, DOI 10.1093/ndt/gfp587; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Harden LM, 2008, BRAIN BEHAV IMMUN, V22, P838, DOI 10.1016/j.bbi.2007.12.006; Huang QH, 1999, AM J PHYSIOL-REG I, V276, pR864, DOI 10.1152/ajpregu.1999.276.3.R864; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Johnson PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE650, DOI 10.1152/ajpendo.00388.2001; Kim JG, 2006, BIOCHEM BIOPH RES CO, V349, P969, DOI 10.1016/j.bbrc.2006.08.147; KLUGER MJ, 1991, PHYSIOL REV, V71, P93, DOI 10.1152/physrev.1991.71.1.93; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Laviano A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1000, DOI 10.1152/ajpendo.90252.2008; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Mercader J, 2008, HORM METAB RES, V40, P467, DOI 10.1055/s-2008-1065324; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Moschen AR, 2010, CURR PHARM DESIGN, V16, P1913, DOI 10.2174/138161210791208947; Nakajima TE, 2009, J GASTROENTEROL, V44, P685, DOI 10.1007/s00535-009-0063-5; Oki K, 2007, CLIN ENDOCRINOL, V67, P796, DOI 10.1111/j.1365-2265.2007.02966.x; Pagano C, 2006, J CLIN ENDOCR METAB, V91, P3165, DOI 10.1210/jc.2006-0361; Pecchi E, 2009, PHYSIOL BEHAV, V97, P279, DOI 10.1016/j.physbeh.2009.02.040; Reyes TM, 2002, J NEUROSCI, V22, P5091, DOI 10.1523/JNEUROSCI.22-12-05091.2002; Rorato R, 2009, EXP PHYSIOL, V94, P371, DOI 10.1113/expphysiol.2008.045435; Sainsbury A, 2010, MOL CELL ENDOCRINOL, V316, P109, DOI 10.1016/j.mce.2009.09.025; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Shimizu H, 2007, J ENDOCRINOL, V193, P1, DOI 10.1677/JOE-06-0144; Skinner GW, 2009, PHYSIOL BEHAV, V96, P421, DOI 10.1016/j.physbeh.2008.11.004; Sun G, 2007, AM J CLIN NUTR, V85, P399, DOI 10.1093/ajcn/85.2.399; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002	29	32	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15981	10.1371/journal.pone.0015981	http://dx.doi.org/10.1371/journal.pone.0015981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283791	Green Submitted, Green Published, gold			2022-12-25	WOS:000286522200020
J	Handel, AE; Williamson, AJ; Disanto, G; Dobson, R; Giovannoni, G; Ramagopalan, SV				Handel, Adam E.; Williamson, Alexander J.; Disanto, Giulio; Dobson, Ruth; Giovannoni, Gavin; Ramagopalan, Sreeram V.			Smoking and Multiple Sclerosis: An Updated Meta-Analysis	PLOS ONE			English	Article							LIFE-STYLE FACTORS; CIGARETTE-SMOKING; RHEUMATOID-ARTHRITIS; ORAL-CONTRACEPTIVES; RISK-FACTOR; PROGRESSION; EXPOSURE; DISEASE; MS; EPIDEMIOLOGY	Background: Multiple sclerosis (MS) is a leading cause of disability in young adults. Susceptibility to MS is determined by environmental exposure on the background of genetic risk factors. A previous meta-analysis suggested that smoking was an important risk factor for MS but many other studies have been published since then. Methods/Principal Findings: We performed a Medline search to identify articles published that investigated MS risk following cigarette smoking. A total of 14 articles were included in this study. This represented data on 3,052 cases and 457,619 controls. We analysed these studies in both a conservative (limiting our analysis to only those where smoking behaviour was described prior to disease onset) and non-conservative manner. Our results show that smoking is associated with MS susceptibility (conservative: risk ratio (RR) 1.48, 95% confidence interval (CI) 1.35-1.63, p<10(-15); non-conservative: RR 1.52, 95% CI 1.39-1.66, p<10(-19)). We also analysed 4 studies reporting risk of secondary progression in MS and found that this fell just short of statistical significance with considerable heterogeneity (RR 1.88, 95% CI 0.98-3.61, p = 0.06). Discussion: Our results demonstrate that cigarette smoking is important in determining MS susceptibility but the effect on the progression of disease is less certain. Further work is needed to understand the mechanism behind this association and how smoking integrates with other established risk factors.	[Handel, Adam E.; Disanto, Giulio; Ramagopalan, Sreeram V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Handel, Adam E.; Disanto, Giulio; Ramagopalan, Sreeram V.] Univ Oxford, Dept Clin Neurol, Oxford, England; [Williamson, Alexander J.] Univ Oxford, Dept Phys & Theoret Chem, Oxford, England; [Dobson, Ruth; Giovannoni, Gavin; Ramagopalan, Sreeram V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of London; Queen Mary University London	Handel, AE (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	g.giovannoni@qmul.ac.uk; sreeramr@well.ox.ac.uk	Handel, Adam/F-2489-2011	Ebers, George/0000-0003-4771-4177; McKeating, Jane/0000-0002-7229-5886; Handel, Adam/0000-0001-8385-6346	Wellcome Trust [075491/Z/04]; Medical Research Council [G0801976]; MRC [G0801976] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust [GRANT NUMBER 075491/Z/04] and Medical Research Council [GRANT NUMBER G0801976]. SVR is a Goodger Scholar at the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONOVSKY A, 1965, ARCH NEUROL-CHICAGO, V13, P183, DOI 10.1001/archneur.1965.00470020073010; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Carlens C, 2010, AM J RESP CRIT CARE, V181, P1217, DOI 10.1164/rccm.200909-1338OC; CLAYTON D, 1993, STAT MODELS EPIDEMIO, pR8; Dahl J, 2007, EUR J NEUROL, V14, P1113, DOI 10.1111/j.1468-1331.2007.01913.x; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; Fowles Jeff, 2006, N Z Med J, V119, pU1931; Frutos-Alegria MT, 2002, REV NEUROLOGIA, V34, P813, DOI 10.33588/rn.3409.2001502; Frutos-Alegria MT, 2002, REV NEUROLOGIA, V34, P1013, DOI 10.33588/rn.3411.2001503; Fusby JS, 2010, INHAL TOXICOL, V22, P785, DOI 10.3109/08958378.2010.483258; George J, 1997, SCAND J IMMUNOL, V45, P1, DOI 10.1046/j.1365-3083.1997.d01-366.x; Ghadirian T, 2001, CAN J PUBLIC HEALTH, V92, P281, DOI 10.1007/BF03404961; GRAHAM NMH, 1990, EPIDEMIOL REV, V12, P149, DOI 10.1093/oxfordjournals.epirev.a036050; Green RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006860; Handel AE, 2010, NAT REV NEUROL, V6, P156, DOI 10.1038/nrneurol.2010.1; HANDEL AE, 2010, EUR J NEUROL; Hawkes CH, 2007, MULT SCLER J, V13, P610, DOI 10.1177/1352458506073501; Healy BC, 2009, ARCH NEUROL-CHICAGO, V66, P858, DOI 10.1001/archneurol.2009.122; Hedstrom AK, 2009, NEUROLOGY, V73, P696, DOI 10.1212/WNL.0b013e3181b59c40; Hernan MA, 2005, BRAIN, V128, P1461, DOI 10.1093/brain/awh471; Hernan MA, 2001, AM J EPIDEMIOL, V154, P69, DOI 10.1093/aje/154.1.69; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jafari N, 2009, MULT SCLER J, V15, P1363, DOI 10.1177/1352458509345907; Koch M, 2007, NEUROLOGY, V69, P1515, DOI 10.1212/01.wnl.0000277658.78381.db; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Mack WP, 1999, OPHTHAL PLAST RECONS, V15, P260, DOI 10.1097/00002341-199907000-00007; Mahdi H, 2009, NAT GENET, V41, P1319, DOI 10.1038/ng.480; Motz GT, 2010, J IMMUNOL, V184, P4460, DOI 10.4049/jimmunol.0903654; Munger KL, 2009, NEUROLOGY, V73, P1543, DOI 10.1212/WNL.0b013e3181c0d6e0; Munger KL, 2003, EPIDEMIOLOGY, V14, P141, DOI 10.1097/00001648-200303000-00006; Nortvedt MW, 2005, NEUROL SCI, V26, P334, DOI 10.1007/s10072-005-0498-2; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Pekmezovic T, 2006, NEUROEPIDEMIOLOGY, V27, P212, DOI 10.1159/000096853; da Silva KRP, 2009, ARQ NEURO-PSIQUIAT, V67, P229, DOI 10.1590/S0004-282X2009000200011; PITTAS F, 2009, J NEUROL; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Riise T, 2003, NEUROLOGY, V61, P1122, DOI 10.1212/01.WNL.0000081305.66687.D2; Regal AR, 2009, NEUROLOGIA, V24, P177; Russo C, 2008, J NEUROL, V255, P64, DOI 10.1007/s00415-007-0668-7; Scolding N, 1998, LANCET, V352, P340, DOI 10.1016/S0140-6736(05)60463-1; SENECALQUEVILLON M, 1986, MUTAT RES, V161, P65, DOI 10.1016/0027-5107(86)90100-4; Simon KC, 2010, NEUROLOGY, V74, P1365, DOI 10.1212/WNL.0b013e3181dad57e; Smith KJ, 1999, BRAIN PATHOL, V9, P69; Sundstrom P, 2008, MULT SCLER J, V14, P1031, DOI 10.1177/1352458508093615; Sundstrom P, 2008, EUR J NEUROL, V15, P579, DOI 10.1111/j.1468-1331.2008.02122.x; Thorogood M, 1998, BRIT J OBSTET GYNAEC, V105, P1296, DOI 10.1111/j.1471-0528.1998.tb10008.x; Tremlett H, 2008, NEUROEPIDEMIOLOGY, V31, P271, DOI 10.1159/000166602; Turner AP, 2007, ARCH PHYS MED REHAB, V88, P1394, DOI 10.1016/j.apmr.2007.08.003; VILLARDMACKINTOSH L, 1993, CONTRACEPTION, V47, P161, DOI 10.1016/0010-7824(93)90088-O	52	176	177	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16149	10.1371/journal.pone.0016149	http://dx.doi.org/10.1371/journal.pone.0016149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249154	Green Published, gold, Green Submitted			2022-12-25	WOS:000286515000022
J	Zhao, YH; Calon, F; Julien, C; Winkler, JW; Petasis, NA; Lukiw, WJ; Bazan, NG				Zhao, Yuhai; Calon, Frederic; Julien, Carl; Winkler, Jeremy W.; Petasis, Nicos A.; Lukiw, Walter J.; Bazan, Nicolas G.			Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPAR gamma-Mediated Mechanisms in Alzheimer's Disease Models	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; AMYLOID-PRECURSOR-PROTEIN; HUMAN BRAIN-CELLS; POLYUNSATURATED FATTY-ACID; PIGMENT EPITHELIAL-CELLS; STRESS-INDUCED APOPTOSIS; OXIDATIVE STRESS; A-BETA; IN-VITRO; SIGNALING PATHWAY	Neuroprotectin D1 (NPD1) is a stereoselective mediator derived from the omega-3 essential fatty acid docosahexaenoic acid (DHA) with potent inflammatory resolving and neuroprotective bioactivity. NPD1 reduces A beta 42 peptide release from aging human brain cells and is severely depleted in Alzheimer's disease (AD) brain. Here we further characterize the mechanism of NPD1's neurogenic actions using 3xTg-AD mouse models and human neuronal-glial (HNG) cells in primary culture, either challenged with A beta 42 oligomeric peptide, or transfected with beta amyloid precursor protein (beta APP)(sw) (Swedish double mutation APP695(sw), K595N-M596L). We also show that NPD1 downregulates A beta 42-triggered expression of the pro-inflammatory enzyme cyclooxygenase-2 (COX-2) and of B-94 (a TNF-alpha-inducible pro-inflammatory element) and apoptosis in HNG cells. Moreover, NPD1 suppresses A beta 42 peptide shedding by down-regulating beta-secretase-1 (BACE1) while activating the alpha-secretase ADAM10 and up-regulating sAPP alpha, thus shifting the cleavage of beta APP holoenzyme from an amyloidogenic into the non-amyloidogenic pathway. Use of the thiazolidinedione peroxisome proliferator-activated receptor gamma (PPAR gamma) agonist rosiglitazone, the irreversible PPAR gamma antagonist GW9662, and overexpressing PPAR gamma suggests that the NPD1-mediated down-regulation of BACE1 and A beta 42 peptide release is PPAR gamma-dependent. In conclusion, NPD1 bioactivity potently down regulates inflammatory signaling, amyloidogenic APP cleavage and apoptosis, underscoring the potential of this lipid mediator to rescue human brain cells in early stages of neurodegenerations.	[Zhao, Yuhai; Lukiw, Walter J.; Bazan, Nicolas G.] Louisiana State Univ, Neurosci Ctr Excellence, Sch Med, Hlth Sci Ctr, New Orleans, LA USA; [Calon, Frederic; Julien, Carl] Ctr Hosp Univ Laval Res Ctr CHUL, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ, Canada; [Winkler, Jeremy W.; Petasis, Nicos A.] Univ So Calif, Dept Chem, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Laval University; University of Southern California	Zhao, YH (corresponding author), Univ Texas Hlth Sci Ctr, Houston, TX USA.	wlukiw@lsuhsc.edu; nbazan@lsuhsc.edu	Winkler, Jeremy/C-3198-2008; Petasis, Nicos/B-3162-2009; Bazan, Nicolas/AAN-4121-2020; Calon, Frederic/AAF-4390-2020; Julien, Carl/AAU-5309-2021	Petasis, Nicos/0000-0002-8864-4446; Bazan, Nicolas/0000-0002-9243-5444; Calon, Frederic/0000-0002-4203-0887	National Institutes of Health, National Center for Research Resource [P20 RR016816]; Edward G. Schlieder Educational Foundation; Eye, Ear, Nose & Throat Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038834] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resource(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Edward G. Schlieder Educational Foundation; Eye, Ear, Nose & Throat Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health, National Center for Research Resource grant (P20 RR016816), the Edward G. Schlieder Educational Foundation, and the Eye, Ear, Nose & Throat Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Antony R, 2010, J BIOL CHEM, V285, P18301, DOI 10.1074/jbc.M109.095232; Astarita G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012538; Avramovich Y, 2002, J BIOL CHEM, V277, P31466, DOI 10.1074/jbc.M201308200; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Camacho IE, 2004, J NEUROSCI, V24, P10908, DOI 10.1523/JNEUROSCI.3987-04.2004; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; d'Abramo C, 2005, BIOCHEM J, V391, P693, DOI 10.1042/BJ20050560; Faghiri Z, 2010, EXP EYE RES, V90, P718, DOI 10.1016/j.exer.2010.03.002; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Galasko D, 2010, BIOMARK MED, V4, P27, DOI 10.2217/BMM.09.89; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; Gonzalez-Periz A, 2006, FASEB J, V20, P2537, DOI 10.1096/fj.06-6250fje; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haass C, 2010, NAT MED, V16, P1201, DOI 10.1038/nm.2223; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; Henke BR, 2004, PROGR MED CHEM, V42, P1, DOI 10.1016/S0079-6468(04)42001-3; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Jang JH, 2005, FREE RADICAL BIO MED, V38, P1604, DOI 10.1016/j.freeradbiomed.2005.02.023; JULIEN C, 2008, NEUROBIOL AGING, V159, P296; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Ma QL, 2007, J NEUROSCI, V27, P14299, DOI 10.1523/JNEUROSCI.3593-07.2007; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Marion-Letellier R, 2008, AM J CLIN NUTR, V87, P939, DOI 10.1093/ajcn/87.4.939; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MCLACHLAN DRC, 1988, MOL BRAIN RES, V3, P255, DOI 10.1016/0169-328X(88)90048-4; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13158, DOI 10.1073/pnas.0705963104; Musiek ES, 2008, J BIOL CHEM, V283, P19927, DOI 10.1074/jbc.M803625200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Peng Y, 2007, NEUROSCIENCE, V150, P386, DOI 10.1016/j.neuroscience.2007.09.022; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Roberts LJ, 2005, BRAIN PATHOL, V15, P143; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Sahlin C, 2007, EUR J NEUROSCI, V26, P882, DOI 10.1111/j.1460-9568.2007.05719.x; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shie FS, 2009, CURR MED CHEM, V16, P643, DOI 10.2174/092986709787458399; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Yamamoto K, 2005, BIOORG MED CHEM LETT, V15, P517, DOI 10.1016/j.bmcl.2004.11.053; Yang HQ, 2007, EUR J NEUROSCI, V26, P381, DOI 10.1111/j.1460-9568.2007.05648.x; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com; Zhao YH, 2007, NEUROREPORT, V18, P1187, DOI 10.1097/WNR.0b013e32821c56c4	68	195	206	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15816	10.1371/journal.pone.0015816	http://dx.doi.org/10.1371/journal.pone.0015816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246057	Green Submitted, gold, Green Published			2022-12-25	WOS:000286511200016
J	Hu, AYC; Tseng, YF; Weng, TC; Liao, CC; Wu, J; Chou, AH; Chao, HJ; Gu, AN; Chen, J; Lin, SC; Hsiao, CH; Wu, SC; Chong, P				Hu, Alan Yung-Chih; Tseng, Yu-Fen; Weng, Tsai-Chuan; Liao, Chien-Chun; Wu, Johnson; Chou, Ai-Hsiang; Chao, Hsin-Ju; Gu, Anna; Chen, Janice; Lin, Su-Chen; Hsiao, Chia-Hsin; Wu, Suh-Chin; Chong, Pele			Production of Inactivated Influenza H5N1 Vaccines from MDCK Cells in Serum-Free Medium	PLOS ONE			English	Article							SCALE MICROCARRIER CULTURE; VIRUS PRODUCTION; ANIMAL-CELLS; VERO CELLS; RABIES VACCINE; WHOLE VIRUS; CULTIVATION; BIOREACTOR; SYSTEM; GROWTH	Background: Highly pathogenic influenza viruses pose a constant threat which could lead to a global pandemic. Vaccination remains the principal measure to reduce morbidity and mortality from such pandemics. The availability and surging demand for pandemic vaccines needs to be addressed in the preparedness plans. This study presents an improved high-yield manufacturing process for the inactivated influenza H5N1 vaccines using Madin-Darby canine kidney (MDCK) cells grown in a serum-free (SF) medium microcarrier cell culture system. Principal Finding: The current study has evaluated the performance of cell adaptation switched from serum-containing (SC) medium to several commercial SF media. The selected SF medium was further evaluated in various bioreactor culture systems for process scale-up evaluation. No significant difference was found in the cell growth in different sizes of bioreactors studied. In the 7.5 L bioreactor runs, the cell concentration reached to 2.3x10(6) cells/mL after 5 days. The maximum virus titers of 1024 Hemagglutinin (HA) units/50 mu L and 7.1 +/- 0.3x10(8) pfu/mL were obtained after 3 days infection. The concentration of HA antigen as determined by SRID was found to be 14.1 mu g/mL which was higher than those obtained from the SC medium. A mouse immunogenicity study showed that the formalin-inactivated purified SF vaccine candidate formulated with alum adjuvant could induce protective level of virus neutralization titers similar to those obtained from the SC medium. In addition, the H5N1 viruses produced from either SC or SF media showed the same antigenic reactivity with the NIBRG14 standard antisera. Conclusions: The advantages of this SF cell-based manufacturing process could reduce the animal serum contamination, the cost and lot-to-lot variation of SC medium production. This study provides useful information to manufacturers that are planning to use SF medium for cell-based influenza vaccine production.	[Hu, Alan Yung-Chih; Tseng, Yu-Fen; Weng, Tsai-Chuan; Liao, Chien-Chun; Wu, Johnson; Chou, Ai-Hsiang; Chao, Hsin-Ju; Gu, Anna; Chen, Janice; Lin, Su-Chen; Hsiao, Chia-Hsin; Wu, Suh-Chin; Chong, Pele] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan, Taiwan; [Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Hu, AYC (corresponding author), Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan, Taiwan.	pelechong@nhri.org.tw	Chong, Pele/E-3855-2010; Hu, Alan Yung-Chih/G-3708-2011; Wu, Suh-Chin/AAV-6233-2021		Taiwan Pandemic Influenza Vaccine Research and Development Program [DOH95-DC-1408]	Taiwan Pandemic Influenza Vaccine Research and Development Program	This study was funded by the Taiwan Pandemic Influenza Vaccine Research and Development Program (Grant no. DOH95-DC-1408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler M, 2000, BIOTECHNOL PROGR, V16, P854, DOI 10.1021/bp000110+; Croughan MS, 2000, BIOTECHNOL BIOENG, V67, P841, DOI 10.1002/(SICI)1097-0290(20000320)67:6<841::AID-BIT19>3.0.CO;2-K; FISHBEIN DB, 1993, VACCINE, V11, P1390, DOI 10.1016/0264-410X(93)90167-V; Frazatti-Gallina NM, 2004, VACCINE, V23, P511, DOI 10.1016/j.vaccine.2004.06.014; Genzel Y, 2006, VACCINE, V24, P6074, DOI 10.1016/j.vaccine.2006.05.023; Genzel Y, 2006, VACCINE, V24, P3261, DOI 10.1016/j.vaccine.2006.01.019; Genzel Y, 2004, VACCINE, V22, P2202, DOI 10.1016/j.vaccine.2003.11.041; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Hu AYC, 2008, VACCINE, V26, P5736, DOI 10.1016/j.vaccine.2008.08.015; Kistner O, 1999, WIEN KLIN WOCHENSCHR, V111, P207; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Liu J, 2009, VACCINE, V27, P6460, DOI 10.1016/j.vaccine.2009.06.024; Merten O W, 2002, Dev Biol (Basel), V111, P233; Merten OW, 2000, CYTOTECHNOLOGY, V34, P181, DOI 10.1023/A:1008160817560; Merten OW, 1999, CYTOTECHNOLOGY, V30, pIX; Minor PD, 2009, VACCINE, V27, P2907, DOI 10.1016/j.vaccine.2009.02.064; Nerome K, 1999, Dev Biol Stand, V98, P53; Rourou S, 2007, VACCINE, V25, P3879, DOI 10.1016/j.vaccine.2007.01.086; Toriniwa H, 2007, BIOLOGICALS, V35, P221, DOI 10.1016/j.biologicals.2007.02.002; Tree JA, 2001, VACCINE, V19, P3444, DOI 10.1016/S0264-410X(01)00053-6; van der Pol L, 1998, TRENDS BIOTECHNOL, V16, P323, DOI 10.1016/S0167-7799(98)01209-8; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; WOOD JM, 1989, VIROLOGY, V171, P214, DOI 10.1016/0042-6822(89)90528-X; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA; Wright PF, 2008, NEW ENGL J MED, V358, P2540, DOI 10.1056/NEJMp0803650; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; ZHANG S, 1992, J BIOTECHNOL, V25, P289, DOI 10.1016/0168-1656(92)90162-3	29	88	102	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2011	6	1							e14578	10.1371/journal.pone.0014578	http://dx.doi.org/10.1371/journal.pone.0014578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710PJ	22216221	Green Published, Green Submitted, gold			2022-12-25	WOS:000286523400002
J	Liu, Y; McNevin, JP; Holte, S; McElrath, MJ; Mullins, JI				Liu, Yi; McNevin, John P.; Holte, Sarah; McElrath, M. Juliana; Mullins, James I.			Dynamics of Viral Evolution and CTL Responses in HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTOTOXIC T-LYMPHOCYTES; ESCAPE; CELLS; VIREMIA; SELECTION; ANTIGEN; REPLICATION; VARIANTS; EPITOPES	Improved understanding of the dynamics of host immune responses and viral evolution is critical for effective HIV-1 vaccine design. We comprehensively analyzed Cytotoxic T-lymphocyte (CTL)-viral epitope dynamics in an antiretroviral therapy-naive subject over the first four years of HIV-1 infection. We found that CTL responses developed sequentially and required constant antigenic stimulation for maintenance. CTL responses exerting strong selective pressure emerged early and led to rapid escape, proliferated rapidly and were predominant during acute/early infection. Although CTL responses to a few persistent epitopes developed over the first two months of infection, they proliferated slowly. As CTL epitopes were replaced by mutational variants, the corresponding responses immediately declined, most rapidly in the cases of strongly selected epitopes. CTL recognition of epitope variants, via cross-reactivity and de novo responses, was common throughout the period of study. Our data demonstrate that HIV-specific CTL responses, especially in the critical acute/early stage, were focused on regions that are prone to escape. Failure of CTL responses to strongly target functional or structurally critical regions of the virus, as well as the sequential cascade of CTL responses, followed closely by viral escape and decline of the corresponding responses, likely contribute to a lack of sustainable viral suppression. Focusing early and rapidly proliferating CTL on persistent epitopes may be essential for durable viral control in HIV-1 infection.	[Liu, Yi; Mullins, James I.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [McElrath, M. Juliana; Mullins, James I.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [McNevin, John P.; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA; [Holte, Sarah] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Liu, Y (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@uw.edu		mcnevin, john paul/0000-0002-9893-9256; Li, Yong/0000-0003-2651-8791	United States Public Health Service [P01 AI57005, R01 AI055343]; University of Washington Center for AIDS Research Computational Biology Core [P30 AI27757];  [M01-RR-00037]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, R01AI055343, P30AI027757] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Washington Center for AIDS Research Computational Biology Core; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the United States Public Health Service to JIM (P01 AI57005), to SH (R01 AI055343) and the University of Washington Center for AIDS Research Computational Biology Core (P30 AI27757), and by grant M01-RR-00037 for leukapheresis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bennett MS, 2007, J VIROL, V81, P4973, DOI 10.1128/JVI.02362-06; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Buseyne F, 2001, INT IMMUNOL, V13, P941, DOI 10.1093/intimm/13.7.941; Cao JH, 2003, J VIROL, V77, P6867, DOI 10.1128/JVI.77.12.6867-6878.2003; Cao JH, 2003, J IMMUNOL, V171, P3837, DOI 10.4049/jimmunol.171.7.3837; Feeney ME, 2005, J IMMUNOL, V174, P7524, DOI 10.4049/jimmunol.174.12.7524; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Fujiwara M, 2008, J VIROL, V82, P138, DOI 10.1128/JVI.01452-07; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Jamieson BD, 2003, J IMMUNOL, V171, P5372, DOI 10.4049/jimmunol.171.10.5372; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; LEITNER TF, 2006, HIV SEQUENCE COMPEND; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; Liu Y, 2007, J VIROL, V81, P12179, DOI 10.1128/JVI.01277-07; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Liu Y, 2009, J INFECT DIS, V200, P1825, DOI 10.1086/648401; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Streeck H, 2006, J INFECT DIS, V194, P734, DOI 10.1086/503811; Tomiyama H, 2000, EUR J IMMUNOL, V30, P2521, DOI 10.1002/1521-4141(200009)30:9<2521::AID-IMMU2521>3.0.CO;2-Q; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; Welsh RM, 2001, J EXP MED, V193, pF19, DOI 10.1084/jem.193.5.F19; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101	34	121	129	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15639	10.1371/journal.pone.0015639	http://dx.doi.org/10.1371/journal.pone.0015639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283794	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522200010
J	Wei, J; Wu, A; Kong, LY; Wang, YT; Fuller, G; Fokt, I; Melillo, G; Priebe, W; Heimberger, AB				Wei, Jun; Wu, Adam; Kong, Ling-Yuan; Wang, Yongtao; Fuller, Gregory; Fokt, Isabella; Melillo, Giovanni; Priebe, Waldemar; Heimberger, Amy B.			Hypoxia Potentiates Glioma-Mediated Immunosuppression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; IMMUNE DYSFUNCTION; SIGNAL TRANSDUCERS; INDUCIBLE FACTORS; TUMOR; MACROPHAGE; CANCER; EXPRESSION; HIF-1-ALPHA	Glioblastoma multiforme (GBM) is a lethal cancer that exerts potent immune suppression. Hypoxia is a predominant feature of GBM, but it is unclear to the degree in which tumor hypoxia contributes to this tumor-mediated immunosuppression. Utilizing GBM associated cancer stem cells (gCSCs) as a treatment resistant population that has been shown to inhibit both innate and adaptive immune responses, we compared immunosuppressive properties under both normoxic and hypoxic conditions. Functional immunosuppression was characterized based on production of immunosuppressive cytokines and chemokines, the inhibition of T cell proliferation and effector responses, induction of FoxP3+ regulatory T cells, effect on macrophage phagocytosis, and skewing to the immunosuppressive M2 phenotype. We found that hypoxia potentiated the gCSC-mediated inhibition of T cell proliferation and activation and especially the induction of FoxP3+T cells, and further inhibited macrophage phagocytosis compared to normoxia condition. These immunosuppressive hypoxic effects were mediated by signal transducer and activator of transcription 3 (STAT3) and its transcriptionally regulated products such as hypoxia inducible factor (HIF)-1 alpha and vascular endothelial growth factor (VEGF). Inhibitors of STAT3 and HIF-1 alpha down modulated the gCSCs' hypoxia-induced immunosuppressive effects. Thus, hypoxia further enhances GBM-mediated immunosuppression, which can be reversed with therapeutic inhibition of STAT3 and HIF-1 alpha and also helps to reconcile the disparate findings that immune therapeutic approaches can be used successfully in model systems but have yet to achieve generalized successful responses in the vast majority of GBM patients by demonstrating the importance of the tumor hypoxic environment.	[Wei, Jun; Wu, Adam; Kong, Ling-Yuan; Wang, Yongtao; Heimberger, Amy B.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Fuller, Gregory] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Fokt, Isabella; Priebe, Waldemar] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Melillo, Giovanni] NCI, Frederick, MD 21701 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wei, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA.	aheimber@mdanderson.org		Fuller, Gregory/0000-0001-9447-2647	Anthony Bullock III Foundation; Mitchell Foundation; Dr. Marnie Rose Foundation; U.S. National Institutes of Health [CA120813-03, A177225-01, P50 CA093459]; NATIONAL CANCER INSTITUTE [P50CA093459, R01CA120813] Funding Source: NIH RePORTER	Anthony Bullock III Foundation; Mitchell Foundation; Dr. Marnie Rose Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Anthony Bullock III Foundation (ABH), the Mitchell Foundation (ABH), the Dr. Marnie Rose Foundation (ABH), and the U.S. National Institutes of Health grants CA120813-03, A177225-01, P50 CA093459 (ABH), and P50 CA093459 (WP). The funding organizations had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Iborra B, 2009, J IMMUNOL, V182, P3155, DOI 10.4049/jimmunol.0801710; Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Biollaz G, 2009, EUR J IMMUNOL, V39, P1323, DOI 10.1002/eji.200838921; Bodor J, 2007, EUR J IMMUNOL, V37, P884, DOI 10.1002/eji.200636510; Brault MS, 2005, J BIOMED BIOTECHNOL, P37, DOI 10.1155/JBB.2005.37; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; CRANE CA, NEURO ONCOL, V12, P7; Di Tomaso T, 2010, CLIN CANCER RES, V16, P800, DOI 10.1158/1078-0432.CCR-09-2730; Elgert KD, 1998, J LEUKOCYTE BIOL, V64, P275, DOI 10.1002/jlb.64.3.275; Faderl S, 2001, ANTICANCER RES, V21, P3777; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Grimshaw MJ, 2002, EUR J IMMUNOL, V32, P2393, DOI 10.1002/1521-4141(200209)32:9<2393::AID-IMMU2393>3.0.CO;2-4; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Johnson B, 2009, CURR MOL MED, V9, P702, DOI 10.2174/156652409788970634; Johnson BF, 2007, EXPERT OPIN BIOL TH, V7, P449, DOI 10.1517/14712598.7.4.449; Jordan JT, 2008, CANCER IMMUNOL IMMUN, V57, P123, DOI 10.1007/s00262-007-0336-x; Jung JI, 2005, FASEB J, V19, pA81; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Knowles HJ, 2008, J PATHOL, V215, P56, DOI 10.1002/path.2319; Kong LY, 2008, CLIN CANCER RES, V14, P5759, DOI 10.1158/1078-0432.CCR-08-0377; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kostianovsky AM, 2008, J IMMUNOL, V181, P5425, DOI 10.4049/jimmunol.181.8.5425; Kuklinski S, 2000, J NEUROSCI RES, V60, P45, DOI 10.1002/(SICI)1097-4547(20000401)60:1<45::AID-JNR5>3.0.CO;2-Y; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lucas T, 2008, FRONT BIOSCI, V13, P5580; MAEDA H, 1995, J IMMUNOL, V155, P4926; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Murdoch C, 2005, INT J CANCER, V117, P701, DOI 10.1002/ijc.21422; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Negus RPM, 1997, AM J PATHOL, V150, P1723; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Owegi Henry O, 2010, Biomed Sci Instrum, V46, P57; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Peng W, 2008, CANCER RES, V68, P7228, DOI 10.1158/0008-5472.CAN-08-1245; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sarwat AM, 2009, J NEURO-ONCOL, V92, P111, DOI 10.1007/s11060-008-9729-8; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Tabatabai G, 2006, BRAIN, V129, P2426, DOI 10.1093/brain/awl173; WEI J, CLIN CANC RES, V16, P461; WEI J, MOL CANC THER, V9, P67; WU A, NEURO ONCOL; Xu QJ, 2009, STEM CELLS, V27, P1734, DOI 10.1002/stem.102	58	149	156	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16195	10.1371/journal.pone.0016195	http://dx.doi.org/10.1371/journal.pone.0016195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283755	Green Published, gold, Green Submitted			2022-12-25	WOS:000286522200035
J	Yu, ZY; Wang, R; Xu, LY; Xie, SW; Dong, JH; Jing, YK				Yu, Zhiying; Wang, Rui; Xu, Liying; Xie, Siwei; Dong, Jinhua; Jing, Yongkui			beta-Elemene Piperazine Derivatives Induce Apoptosis in Human Leukemia Cells through Downregulation of c-FLIP and Generation of ROS	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; LUNG-CANCER CELLS; PEROXIDE-DEPENDENT PATHWAY; ARSENIC TRIOXIDE; PROSTATE-CANCER; UP-REGULATION; PROTEIN; DEATH; EXPRESSION; TARGET	beta-Elemene is an active component of the herb medicine Curcuma Wenyujin with reported antitumor activity. To improve its antitumor ability, five novel piperazine derivatives of beta-elemene, 13-(3-methyl-1-piperazinyl)-beta-elemene (DX1), 13-(cis-3,5-dimethyl-1-piperazinyl)-beta-elemene (DX2), 13-(4-ethyl-1-piperazinyl)-beta-elemene (DX3), 13-(4-isopropyl-1-piperazinyl)-beta-elemene (DX4) and 13-piperazinyl-beta-elemene (DX5), were synthesized. The antiproliferative and apoptotic effects of these derivatives were determined in human leukemia HL-60, NB4, K562 and HP100-1 cells. DX1, DX2 and DX5, which contain a secondary amino moiety, were more active in inhibiting cell growth and in inducing apoptosis than DX3 and DX4. The apoptosis induction ability of DX1 was associated with the generation of hydrogen peroxide (H(2)O(2)), a decrease of mitochondrial membrane potential (MMP), and the activation of caspase-8. Pretreatment with the antioxidants N-acetylcysteine and catalase completely blocked DX1-induced H(2)O(2) production, but only partially its activation of caspase-8 and induction of apoptosis. HL-60 cells were more sensitive than its H(2)O(2)-resistant subclone HP100-1 cells to DX1-induced apoptosis. The activation of caspase-8 by these compounds was correlated with the decrease in the levels of cellular FLICE-inhibitory protein (c-FLIP). The proteasome inhibitor MG-132 augmented the decrease in c-FLIP levels and apoptosis induced by these derivatives. FADD-and caspase-8-deficient Jurkat subclones have a decreased response to DX1-induced apoptosis. Our data indicate that these novel beta-elemene piperazine derivatives induce apoptosis through the decrease in c-FLIP levels and the production of H(2)O(2) which leads to activation of both death receptor-and mitochondrial-mediated apoptotic pathways.	[Yu, Zhiying] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China; [Xu, Liying; Xie, Siwei; Dong, Jinhua] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang, Peoples R China; [Wang, Rui; Jing, Yongkui] Mt Sinai Sch Med, Dept Med, Tisch Canc Inst, New York, NY USA	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University; Icahn School of Medicine at Mount Sinai	Yu, ZY (corresponding author), Guangdong Food & Drug Vocat Coll, Guangzhou, Guangdong, Peoples R China.	yongkui.jing@mssm.edu		Bonini, Nancy/0000-0003-0226-5291; Gitler, Aaron/0000-0001-8603-1526	National Natural Science Foundation of China [30328030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the past funding from National Natural Science Foundation of China (No. 30328030) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Armstrong JS, 2006, BRIT J PHARMACOL, V147, P239, DOI 10.1038/sj.bjp.0706556; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dai J, 1999, BLOOD, V93, P268, DOI 10.1182/blood.V93.1.268.401a21_268_277; Day TW, 2006, BIOCHEM PHARMACOL, V71, P1551, DOI 10.1016/j.bcp.2006.02.015; Decaudin D, 1998, INT J ONCOL, V12, P141; Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673; Guseva NV, 2004, J CELL BIOCHEM, V91, P70, DOI 10.1002/jcb.10707; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Kabore AF, 2006, APOPTOSIS, V11, P1175, DOI 10.1007/s10495-006-8048-9; KASUGAI I, 1992, LEUKEMIA RES, V16, P173, DOI 10.1016/0145-2126(92)90129-U; KAUH J, PLOS ONE, V5; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kouhara J, 2007, INT J ONCOL, V30, P679; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; Li WH, 2007, CANCER RES, V67, P2247, DOI 10.1158/0008-5472.CAN-06-3793; Li X, 2005, CELL MOL LIFE SCI, V62, P894, DOI 10.1007/s00018-005-5027-1; Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Liu X, 2006, CANCER RES, V66, P11115, DOI 10.1158/0008-5472.CAN-06-2471; Lombard C, 2005, LEUKEMIA RES, V29, P915, DOI 10.1016/j.leukres.2005.01.014; Lu M, 2008, CANCER RES, V68, P1180, DOI 10.1158/0008-5472.CAN-07-2978; Nakazato T, 2005, CLIN CANCER RES, V11, P6040, DOI 10.1158/1078-0432.CCR-04-2273; Ozoren N, 2003, SEMIN CANCER BIOL, V13, P135, DOI 10.1016/S1044-579X(02)00131-1; Peter Marcus E, 2004, Biochem J, V382, pe1; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Wang G, 2005, CELL MOL LIFE SCI, V62, P881, DOI 10.1007/s00018-005-5017-3; Wang YZ, 2005, DRUG DEV IND PHARM, V31, P769, DOI 10.1080/03639040500216329; Xia LJ, 2005, MOL CANCER THER, V4, P381; Xu LY, 2006, BIOORGAN MED CHEM, V14, P5351, DOI 10.1016/j.bmc.2006.03.041; YAMADA M, 1991, DNA CELL BIOL, V10, P735, DOI 10.1089/dna.1991.10.735; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Yu ZY, 2008, CANCER LETT, V269, P165, DOI 10.1016/j.canlet.2008.04.034; Zhang SY, 2005, MOL CANCER THER, V4, P1972, DOI 10.1158/1535-7163.MCT-05-0249	36	171	176	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15843	10.1371/journal.pone.0015843	http://dx.doi.org/10.1371/journal.pone.0015843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283566	Green Published, gold, Green Submitted			2022-12-25	WOS:000286661400015
J	Wang, Y; Yan, LL; Jin, ZD; Xin, X				Wang, Yan; Yan, Lingling; Jin, Zhendong; Xin, Xin			Effects of Sleeve Gastrectomy in Neonatally Streptozotocin-Induced Diabetic Rats	PLOS ONE			English	Article							PLASMA GHRELIN CONCENTRATIONS; WEIGHT-LOSS; BETA-CELLS; MODEL; MELLITUS; REGENERATION; MANAGEMENT; EFFICACY; SURGERY	Background: Sleeve gastrectomy (SG) has emerged recently as a stand-alone bariatric procedure to treat morbid obesity and enhance glucose homeostasis. The aim of the study was to evaluate its effects in neonatally streptozotocin (STZ)induced diabetic rats (n-STZ diabetic rats). Methodology and Principal Findings: To induce diabetes, STZ (90 mg/kg) was administered intraperitoneally to 2-day-old male pups. When 12 weeks old, diabetic rats were randomized into sleeve operation group (SLG, n = 6) and sham operation group (SOG, n = 6). Body weights were monitored weekly, and daily consumption of water and food were followed for eight consecutive weeks postoperatively. Serum glucose levels were measured periodically at the 4th and 8th week after surgery. Insulin, ghrelin, glucose-dependent insulinotropic polypeptide (GIP) and Glucagon-like peptide-1 (GLP-1) levels were assayed at the end of the study. Our data showed that SLG rats exhibited significantly lower body weight gain in addition to reduced food and water intakes postoperatively compared to their sham-operation counterparts. However, resolution of diabetes was not observed in our study. Correspondingly, there were no significant differences between SOG rats and SLG rats in glucose metabolism-associated hormones, including insulin, GIP and GLP-1. In contrast, ghrelin level significantly decreased (P<0.01) in SLG group (58.01 +/- 3.75 pg/ml) after SG surgery compared to SOG group (76.36 +/- 3.51 pg/ml). Conclusions: These observations strongly suggest that SG is effective in controlling body weight. However, SG did not achieve resolution or improvement of diabetes in n-STZ diabetic rats.	[Wang, Yan; Jin, Zhendong; Xin, Xin] Tongji Med Coll, Basic Med Sch, Dept Pharmacol, Wuhan, Hubei, Peoples R China; [Yan, Lingling] Tongji Hosp, Dept Plast Surg, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, Y (corresponding author), Tongji Med Coll, Basic Med Sch, Dept Pharmacol, Wuhan, Hubei, Peoples R China.	wangyantj2008@yahoo.com.cn						Abbatini F, 2010, SURG ENDOSC, V24, P1005, DOI 10.1007/s00464-009-0715-9; Akkary E, 2008, OBES SURG, V18, P1323, DOI 10.1007/s11695-008-9551-6; Bohdjalian A, 2010, OBES SURG, V20, P535, DOI 10.1007/s11695-009-0066-6; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; CASTELAN JD, 2007, OBES SURG, V17, P957; Chakrabarti S, 2005, J ETHNOPHARMACOL, V97, P117, DOI 10.1016/j.jep.2004.10.025; Chen D, 2005, DIABETES OBES METAB, V7, P307, DOI 10.1111/j.1463-1326.2004.00392.x; Deitel M, 2008, OBES SURG, V18, P487, DOI 10.1007/s11695-008-9471-5; Frezza EE, 2009, OBES SURG, V19, P684, DOI 10.1007/s11695-008-9677-6; Fuks D, 2009, SURGERY, V145, P106, DOI 10.1016/j.surg.2008.07.013; Gelling RW, 2004, ENDOCRINOLOGY, V145, P4575, DOI 10.1210/en.2004-0605; Goitein D, 2009, SURG ENDOSC, V23, P1559, DOI 10.1007/s00464-009-0337-2; Goldfine AB, 2009, NAT MED, V15, P616, DOI 10.1038/nm0609-616; Hemmings SJ, 2000, INT J BIOCHEM CELL B, V32, P905, DOI 10.1016/S1357-2725(00)00019-4; Herron DM, 2009, MT SINAI J MED, V76, P281, DOI 10.1002/msj.20114; Ishii S, 2002, ENDOCRINOLOGY, V143, P4934, DOI 10.1210/en.2002-220612; Kindel TL, 2009, J GASTROINTEST SURG, V13, P1762, DOI 10.1007/s11605-009-0912-9; Langer FB, 2005, OBES SURG, V15, P1024, DOI 10.1381/0960892054621125; Lee WJ, 2010, SURGERY, V147, P664, DOI 10.1016/j.surg.2009.10.059; Li F, 2009, J GASTROINTEST SURG, V13, P2302, DOI 10.1007/s11605-009-0997-1; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; Lopez PP, 2009, J SURG RES, V157, P243, DOI 10.1016/j.jss.2008.10.025; Melissas J, 2008, OBES SURG, V18, P1251, DOI 10.1007/s11695-008-9634-4; Otto B, 2001, EUR J ENDOCRINOL, V145, pR5; Patrikakos P, 2009, OBES SURG, V19, P1586, DOI 10.1007/s11695-009-9965-9; Pereferrer FS, 2008, OBES SURG, V18, P97, DOI 10.1007/s11695-007-9351-4; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Rizzello M, 2010, OBES SURG, V20, P50, DOI 10.1007/s11695-009-0017-2; Rosenthal R, 2009, SURG OBES RELAT DIS, V5, P429, DOI 10.1016/j.soard.2008.11.006; Sabbagh C, 2010, OBES SURG, V20, P679, DOI 10.1007/s11695-009-0007-4; Saber AA, 2008, OBES SURG, V18, P121, DOI 10.1007/s11695-007-9308-7; Sammour T, 2010, OBES SURG, V20, P271, DOI 10.1007/s11695-009-0038-x; Shiiya T, 2002, J CLIN ENDOCR METAB, V87, P240, DOI 10.1210/jc.87.1.240; Takada J, 2007, METABOLISM, V56, P977, DOI 10.1016/j.metabol.2006.05.021; Tan JT, 2010, OBES SURG, V20, P403, DOI 10.1007/s11695-009-0020-7; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Tsubone T, 2005, AM J PHYSIOL-REG I, V289, pR1703, DOI 10.1152/ajpregu.00773.2004; Vidal J, 2007, OBES SURG, V17, P1069, DOI 10.1007/s11695-007-9180-5; Wang Y, 2009, OBES SURG, V19, P921, DOI 10.1007/s11695-008-9663-z	39	53	64	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e16383	10.1371/journal.pone.0016383	http://dx.doi.org/10.1371/journal.pone.0016383			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21655253	Green Submitted, gold, Green Published			2022-12-25	WOS:000286522300043
J	Lee, DH; Steffes, MW; Sjodin, A; Jones, RS; Needham, LL; Jacobs, DR				Lee, Duk-Hee; Steffes, Michael W.; Sjoedin, Andreas; Jones, Richard S.; Needham, Larry L.; Jacobs, David R., Jr.			Low Dose Organochlorine Pesticides and Polychlorinated Biphenyls Predict Obesity, Dyslipidemia, and Insulin Resistance among People Free of Diabetes	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; ENDOCRINE-DISRUPTING CHEMICALS; SERUM CONCENTRATIONS; NONDIABETIC ADULTS; NATIONAL-HEALTH; ASSOCIATION; MECHANISMS	Background: There is emerging evidence that background exposure to persistent organic pollutants (POPs) are important in the development of conditions predisposing to diabetes as well as of type 2 diabetes itself. We recently reported that low dose POPs predicted incident type 2 diabetes in a nested case-control study. The current study examined if low dose POPs predicted future adiposity, dyslipidemia, and insulin resistance among controls without diabetes in that study. Methodology/Principal Findings: The 90 controls were diabetes-free during 20 years follow-up. They were a stratified random sample, enriched with overweight and obese persons. POPs measured in 1987-88 (year 2) sera included 8 organochlorine (OC) pesticides, 22 polychlorinated biphenyls (PCBs), and 1 polybrominated biphenyl (PBB). Body mass index (BMI), triglycerides, HDL-cholesterol, LDL-cholesterol, and homeostasis model assessment value for insulin resistance (HOMA-IR) were study outcomes at 2005-06 (year 20). The evolution of study outcomes during 18 years by categories of serum concentrations of POPs at year 2 was evaluated by adjusting for the baseline values of outcomes plus potential confounders. Parallel to prediction of type 2 diabetes, many statistically significant associations of POPs with dysmetabolic conditions appeared at low dose, forming inverted U-shaped dose-response relations. Among OC pesticides, p,p'-DDE most consistently predicted higher BMI, triglycerides, and HOMA-IR and lower HDL-cholesterol at year 20 after adjusting for baseline values. Oxychlordane, trans-nonachlor, and hexachlorobenzene also significantly predicted higher triglycerides. Persistent PCBs with >= 7 chlorides predicted higher BMI, triglycerides, and HOMA-IR and lower HDL-cholesterol at year 20 with similar dose-response curves. Conclusions/Significance: Simultaneous exposure to various POPs in the general population may contribute to development of obesity, dyslipidemia, and insulin resistance, common precursors of type 2 diabetes and cardiovascular diseases. Although obesity is a primary cause of these metabolic abnormalities, POPs exposure may contribute to excess adiposity and other features of dysmetabolism.	[Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Taegu, South Korea; [Steffes, Michael W.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Sjoedin, Andreas; Jones, Richard S.; Needham, Larry L.] Ctr Dis Control & Prevent, Organ Analyt Toxicol Branch OAT, DLS, NCEH, Atlanta, GA USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway	Kyungpook National University; University of Minnesota System; University of Minnesota Twin Cities; Centers for Disease Control & Prevention - USA; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo	Lee, DH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Taegu, South Korea.	jacob004@umn.edu	Needham, Larry/E-4930-2011; Sjodin, Andreas/F-2464-2010	Jacobs, David/0000-0002-7232-0543; Palsson, Bernhard/0000-0003-2357-6785	National Heart, Lung, and Blood Institute (CARDIA field centers), (CARDIA Coordinating Center) [N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-95095]; YALTA [R01-HL-53560]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC048049, N01HC095095, N01HC048047, N01HC048050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL048048, R01HL053560, R01HL048050, R01HL048049, R01HL048048] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (CARDIA field centers), (CARDIA Coordinating Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); YALTA; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Heart, Lung, and Blood Institute contracts N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050 (CARDIA field centers), N01-HC-95095 (CARDIA Coordinating Center), and grant R01-HL-53560 (YALTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie-Hamilton PF, 2002, J ALTERN COMPLEM MED, V8, P185, DOI 10.1089/107555302317371479; Daston GP, 2003, TOXICOL SCI, V74, P245, DOI 10.1093/toxsci/kfg105; Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karmaus W, 2009, OCCUP ENVIRON MED, V66, P143, DOI 10.1136/oem.2008.041921; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Lee DH, 2007, DIABETOLOGIA, V50, P1841, DOI 10.1007/s00125-007-0755-4; LEE DH, 2010, LOW DOSE PERSISTENT; Lee DH, 2007, DIABETES CARE, V30, P1596, DOI 10.2337/dc07-0072; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lopez MCC, 2003, ENVIRON INT, V28, P751, DOI 10.1016/S0160-4120(02)00120-4; Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024; OBANA H, 1987, ENVIRON RES, V42, P500, DOI 10.1016/S0013-9351(87)80217-7; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Schisterman EF, 2005, ENVIRON HEALTH PERSP, V113, P853, DOI 10.1289/ehp.7640; Sjodin A, 2004, ANAL CHEM, V76, P1921, DOI 10.1021/ac030381; Szapary PO, 2004, AM HEART J, V148, P211, DOI 10.1016/j.ahj.2004.03.037; Turyk M, 2009, ENVIRON HEALTH PERSP, V117, P1076, DOI 10.1289/ehp.0800281; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494	23	276	299	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e15977	10.1371/journal.pone.0015977	http://dx.doi.org/10.1371/journal.pone.0015977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	22028828	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800014
J	Yu, XY; Chen, HM; Liang, JL; Lin, QX; Tan, HH; Fu, YH; Liu, XY; Shan, ZX; Li, XH; Yang, HZ; Yang, M; Li, YX; Lin, SG				Yu, Xi-Yong; Chen, Hong-Mei; Liang, Jia-Liang; Lin, Qiu-Xiong; Tan, Hong-Hong; Fu, Yong-Heng; Liu, Xiao-Ying; Shan, Zhi-Xin; Li, Xiao-Hong; Yang, Hua-Zhang; Yang, Min; Li, Yangxin; Lin, Shu-Guang			Hyperglycemic Myocardial Damage Is Mediated by Proinflammatory Cytokine: Macrophage Migration Inhibitory Factor	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; COUPLED RECEPTOR KINASES; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DEFICIENT MICE; ATHEROSCLEROSIS; MIF; INFLAMMATION; MECHANISMS; EXPRESSION	Background: Diabetes has been regarded as an inflammatory condition which is associated with left ventricular diastolic dysfunction (LVDD). The purpose of this study was to examine the expression levels of macrophage migration inhibitory factor (MIF) and G protein-coupled receptor kinase 2 (GRK2) in patients with early diabetic cardiomyopathy, and to investigate the mechanisms involved in MIF expression and GRK2 activation. Methods: 83 patients in the age range of 30-64 years with type 2 diabetes and 30 matched healthy men were recruited. Left ventricular diastolic function was evaluated by cardiac Doppler echocardiography. Plasma MIF levels were determined by ELISA. To confirm the clinical observation, we also studied MIF expression in prediabetic rats with impaired glucose tolerance (IGT) and relationship between MIF and GRK2 expression in H9C2 cardiomyoblasts exposed to high glucose. Results: Compared with healthy subjects, patients with diabetes have significantly increased levels of plasma MIF which was further increased in diabetic patients with Left ventricular diastolic dysfunction (LVDD). The increased plasma MIF levels in diabetic patients correlated with plasma glucose, glycosylated hemoglobin and urine albumin levels. We observed a significant number of TUNEL-positive cells in the myocardium of IGT-rats but not in the control rats. Moreover, we found higher MIF expression in the heart of IGT with cardiac dysfunction compared to that of the controls. In H9C2 cardiomyoblast cells, MIF and GRK2 expression was significantly increased in a glucose concentration-dependant manner. Furthermore, GRK2 expression was abolished by siRNA knockdown of MIF and by the inhibition of CXCR4 in H9C2 cells. Conclusions: Our findings indicate that hyperglycemia is a causal factor for increased levels of pro-inflammatory cytokine MIF which plays a role in the development of cardiomyopathy occurring in patients with type 2 diabetes. The elevated levels of MIF are associated with cardiac dysfunction in diabetic patients, and the MIF effects are mediated by GRK2.	[Yu, Xi-Yong; Chen, Hong-Mei; Liang, Jia-Liang; Lin, Qiu-Xiong; Tan, Hong-Hong; Fu, Yong-Heng; Liu, Xiao-Ying; Shan, Zhi-Xin; Li, Xiao-Hong; Yang, Min; Lin, Shu-Guang] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Cardiovasc Inst, Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Chen, Hong-Mei; Yang, Hua-Zhang] Guangdong Acad Med Sci, Guangdong Gen Hosp, Div Endocrinol, Guangzhou, Guangdong, Peoples R China; [Li, Yangxin] Texas Heart Inst, Houston, TX 77025 USA; [Li, Yangxin] Univ Texas Hlth Sci Ctr, Houston, TX USA	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Texas Heart Institute; University of Texas System; University of Texas Health Science Center Houston	Yu, XY (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Cardiovasc Inst, Med Res Ctr, Guangzhou, Guangdong, Peoples R China.	yuxycn@hotmail.com; yangxin_li@yahoo.com; yuxycn@163.com	LIANG, JIALIANG/L-5865-2015	LIANG, JIALIANG/0000-0001-8033-741X; Liang, Jialiang/0000-0002-1556-7195	National Natural Science Foundation of China [30772142, 81070103, 81070102, 30900610]; National Key Basic Research Program (NKBRP) of China [2006CB503806]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program (NKBRP) of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30772142, 81070103, 81070102, 30900610) and the National Key Basic Research Program (NKBRP) of China (No. 2006CB503806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Bacha F, 2009, DIABETES CARE, V32, P100, DOI 10.2337/dc08-1030; Bartels ED, 2009, EUR J CLIN INVEST, V39, P190, DOI 10.1111/j.1365-2362.2009.02086.x; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Boyer JK, 2004, AM J CARDIOL, V93, P870, DOI 10.1016/j.amjcard.2003.12.026; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Dandona P, 2004, J CLIN ENDOCR METAB, V89, P5043, DOI 10.1210/jc.2004-0436; Dhanantwari P, 2008, BIOCHEM BIOPH RES CO, V371, P298, DOI 10.1016/j.bbrc.2008.04.070; Garner LB, 2003, AM J PHYSIOL-HEART C, V285, pH2500, DOI 10.1152/ajpheart.00432.2003; Grandi AM, 2006, AM J CARDIOL, V97, P71, DOI 10.1016/j.amjcard.2005.07.110; Hansen JL, 2006, TRENDS CARDIOVAS MED, V16, P169, DOI 10.1016/j.tcm.2006.03.004; Herder C, 2006, DIABETES CARE, V29, P368, DOI 10.2337/diacare.29.02.06.dc05-1474; Liang JL, 2010, CLIN EXP PHARMACOL P, V37, P969, DOI 10.1111/j.1440-1681.2010.05420.x; Mandrup-Poulsen T, 2003, BIOCHEM PHARMACOL, V66, P1433, DOI 10.1016/S0006-2952(03)00494-5; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Noels H, 2009, TRENDS CARDIOVAS MED, V19, P76, DOI 10.1016/j.tcm.2009.05.002; O'Keefe JH, 2007, AM J CARDIOL, V100, P899, DOI 10.1016/j.amjcard.2007.03.107; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Penela P, 2006, CARDIOVASC RES, V69, P46, DOI 10.1016/j.cardiores.2005.09.011; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5; Schober A, 2004, CIRCULATION, V109, P380, DOI 10.1161/01.CIR.0000109201.72441.09; Suys BE, 2004, DIABETES CARE, V27, P1947, DOI 10.2337/diacare.27.8.1947; Takahashi M, 2001, CARDIOVASC RES, V52, P438, DOI 10.1016/S0008-6363(01)00408-4; Tevaearai HT, 2004, TRENDS CARDIOVAS MED, V14, P252, DOI 10.1016/j.tcm.2004.07.002; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Willis MS, 2005, AM J PHYSIOL-HEART C, V288, pH795, DOI 10.1152/ajpheart.00189.2004; Yabunaka N, 2000, DIABETES CARE, V23, P256, DOI 10.2337/diacare.23.2.256; Yu XY, 2008, BIOCHEM BIOPH RES CO, V376, P548, DOI 10.1016/j.bbrc.2008.09.025; Yu XY, 2007, J INTERF CYTOK RES, V27, P103, DOI 10.1089/jir.2006.0054	32	81	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16239	10.1371/journal.pone.0016239	http://dx.doi.org/10.1371/journal.pone.0016239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	22163012	Green Submitted, gold, Green Published			2022-12-25	WOS:000286661400038
